Citrus Sinensis ID: 042123

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------85
Protein Sequence
CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI
Secondary Structure (PSIPRED)
ccccccEEEEEccccccEEEEccccccccccccEEEcccccccccccccccccccccEEEccccccEEcccccccccccccccccccEEEcccccccccccccccccccccEEEEccccccccccHHHHcccccccEEcccccccccccHHHHcccccccEEccccEEEccccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccHHccccccccEEEcccccccccccccccccccccEEEEccEEEEcccHHHHcccccccccccccEEEccccccccccccccEEEcccccccccccHHHcccccccEEEccccEEEEEcccccccccccccEEcccccccccccHHccccccccEEEcccccccccccHHHccccccccEEcccccccccccHHHHccccccccccccccccHHHHHccccccccccccccccccccccccccccccEEcccccccccccccccccccccHHHcccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEEEEcccccEEEEEEEccccccccccccHHHHHHHHHHHcccccccccEEEEcccccccccHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccEEcccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccccccccccccHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccccccEEEEEEccccccccccHHHHcccccccEEEcccccccccccHHHcccccccEEEcccccccccccHHHccccHccccccccEEEEEEEccEEEccHHHHHcccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHcccEEEEEEccccccccccHHHcccccccEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEEccccccccccHHHcccccccEEEcccccccccccHHHccccccEEEEEccccccccccHHHccccccEEEEcccccccccccHHHcccccEEEEEccccccccHHHcccccccEEEcccccccccccHHHcccccccEEEEcccccccccccccccccccHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccHHHHHHHHHccccccEEEccccEEEEEEEcccccEEEEEEcccccccccccccHHHHHHHHHHHHHcccccccEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEEccccHHHHHHHcHHEEEcccccccEEEEcccccccccHEEEEEEcccccHHHHHHHHHHHHcccccccccHccEEEEEcccccHHHHcccccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHcc
Coil and Loop (DISEMBL)
cndagrvinislpnigvngtlhdfsfssfphlayldltwngffgtippqisnlsnLRYLYLGSNQFSGNILAevssessggnlrYMSRLVindnslsgfipphignlkflsqldltnnkfsgpiplsfdnlsNLIFLYLYGNLLSGSILSSLGKLKSLFDlqlndnqligyiprpfsnltsvSTLRLSrndlfgsipdeigkMRSLSVldlnqnqfkgvlppsisnltNLKELALLYNHlsgsippslGNLILRQLLLsgnhftgylpynicrggaLEIFTVsenhfqgtiptslrncTSLIRVRLngnnltgnisealgiypnltfidlsrnnfygeissnwgkfpklgtlnvsmnnitgglpreignssqlqAFDLSLnhivgeipkelgklnpltklilrgnqitgrlpkeigsltkleyldfsaigelpsqicnmkslEKLNlshnnlsgsipscfegmhglsFIDMsynelqcpvpnsttfrgaSVEAlkgnkglcgsakglqpckplrqeksnsgaKWFAIVFPLLGALFVSIALISIFFILRKqksdsgdrqsnnqipqgslsilnfeGKILYDEIVKATndfdakycigngghasvyraelpsgevVAVKKFhsllpcdqtvdqKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSylhhdcfppivhrdissknllldleYEAHVADFgiakslkpdssnwtefagtcgyiapelaytmkitekcdvYSFGVLMWEVIkgkhprdflssisssslntdvaldqmldprlpapsrsAQEKLISIMEVAFScfnespesrptmKIISQQLRI
Flexible Loop (DISEMBL)
CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFqgtiptslrnCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPkelgklnplTKLILrgnqitgrlpkeiGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQksdsgdrqsnnqipqgslsiLNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIakslkpdssnwTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCfnespesrptmkiisqqlri
Low Complexity Region (SEG)
CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFlylygnllsgsilsslgklkslFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLssissssLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI
Disordered region (IsUnstruct)
*****RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEV******GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLC*******************GAKWFAIVFPLLGALFVSIALISIFFILR*******************LSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDF*********************************LISIMEVAFSCF*******************
Disordered Region (DISOPRED)
*NDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSA**********************IVFPLLGALFVSIALISIFFIL*********************SILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLP********EFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI
Disordered Region (DISEMBL)
CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQ***********QIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI
Disordered Region (DISPRO)
***AGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQP*********NSGAKWFAIVFPLLGALFVSIALISIFFILRKQKS*************GSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	849	2.2.26 [Sep-21-2011]
Q8VZG8	1045	Probable LRR receptor-lik	yes	no	0.984	0.8	0.426	0.0
Q9LP24	1120	Probable leucine-rich rep	no	no	0.952	0.722	0.448	0.0
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.938	0.723	0.361	1e-127
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.948	0.731	0.331	1e-125
O49318	1124	Probable leucine-rich rep	no	no	0.931	0.703	0.341	1e-124
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.939	0.638	0.336	1e-118
C0LGV1	1135	LRR receptor-like serine/	no	no	0.975	0.729	0.322	1e-118
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.952	0.646	0.332	1e-118
Q9LHP4	1141	Receptor-like protein kin	no	no	0.981	0.730	0.316	1e-114
O49545	1003	Leucine-rich repeat recep	no	no	0.963	0.815	0.342	1e-114

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  732 bits (1890), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/953 (42%), Positives = 570/953 (59%), Gaps = 117/953 (12%)

Query: 5    GRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTI------------------ 46
            G +I ++L N G+ GT  DF FSS P+L ++DL+ N F GTI                  
Sbjct: 93   GSIIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSIN 152

Query: 47   ------PPQISNLSNLRYLYLGSNQFSGNILAEVSS------------------ESSGGN 82
                  PP++ +LSNL  L+L  N+ +G+I +E+                     SS GN
Sbjct: 153  QLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGN 212

Query: 83   LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN 142
            L  +  L +  NSLSG IP  IGNL  L +L L  N  +G IP SF NL N+  L ++ N
Sbjct: 213  LTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFEN 272

Query: 143  LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGK 202
             LSG I   +G + +L  L L+ N+L G IP    N+ +++ L L  N L GSIP E+G+
Sbjct: 273  QLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGE 332

Query: 203  MRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGN 261
            M S+  L++++N+  G +P S   LT L+ L L  N LSG IPP + N   L  L L  N
Sbjct: 333  MESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTN 392

Query: 262  HFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGI 321
            +FTG+LP  ICRGG LE  T+ +NHF+G +P SLR+C SLIRVR  GN+ +G+ISEA G+
Sbjct: 393  NFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGV 452

Query: 322  YPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLN 381
            YP L FIDLS NNF+G++S+NW +  KL    +S N+ITG +P EI N +QL   DLS N
Sbjct: 453  YPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSN 512

Query: 382  HIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA------------- 428
             I GE+P+ +  +N ++KL L GN+++G++P  I  LT LEYLD S+             
Sbjct: 513  RITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNN 572

Query: 429  --------------------------------------IGELPSQICNMKSLEKLNLSHN 450
                                                   GE+ SQ  ++++LE+L+LSHN
Sbjct: 573  LPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHN 632

Query: 451  NLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGS---AKGL 507
            NLSG IP  F+ M  L+ +D+S+N LQ P+P++  FR A  +A +GNK LCGS    +GL
Sbjct: 633  NLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGL 692

Query: 508  QPCKPLRQEKSNSGAKWFA-IVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQ 566
            +PC     +KS+        I+ P++GA+ +      IF   RK ++   +  ++++   
Sbjct: 693  KPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRK-RTKQIEEHTDSESGG 751

Query: 567  GSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPC 626
             +LSI +F+GK+ Y EI+KAT +FD KY IG GGH  VY+A+LP+  ++AVKK +     
Sbjct: 752  ETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNET--T 808

Query: 627  DQTVD----QKEFLTEVEAF-----------YGFCSHARHSFLLYEFLERGSLAAILNTD 671
            D ++     ++EFL E+ A            +GFCSH R++FL+YE++ERGSL  +L  D
Sbjct: 809  DSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLEND 868

Query: 672  AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK 731
              A++L W +R+NV+K VAHALSY+HHD  P IVHRDISS N+LL  +YEA ++DFG AK
Sbjct: 869  DEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAK 928

Query: 732  SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS 791
             LKPDSSNW+  AGT GY+APELAY MK+TEKCDVYSFGVL  EVIKG+HP D +S++SS
Sbjct: 929  LLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSS 988

Query: 792  SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIIS 844
            S  +  ++L  + D RLP P+   +E+++ I++VA  C +  P++RPTM  IS
Sbjct: 989  SPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  715 bits (1845), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 398/887 (44%), Positives = 556/887 (62%), Gaps = 78/887 (8%)

Query: 25   SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
            +  +  +L  L L  N   G IPP+I N+ ++  L L  N+ +G+I       SS GNL+
Sbjct: 241  TLGNLKNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSI------PSSLGNLK 294

Query: 85   YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
             ++ L +  N L+G IPP +GN++ +  L+L+NNK +G IP S  NL NL  LYLY N L
Sbjct: 295  NLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYL 354

Query: 145  SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR 204
            +G I   LG ++S+ DLQLN+N+L G IP  F NL +++ L L  N L G IP E+G M 
Sbjct: 355  TGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNME 414

Query: 205  SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHF 263
            S+  LDL+QN+  G +P S  N T L+ L L  NHLSG+IPP + N   L  L+L  N+F
Sbjct: 415  SMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNF 474

Query: 264  TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYP 323
            TG+ P  +C+G  L+  ++  NH +G IP SLR+C SLIR R  GN  TG+I EA GIYP
Sbjct: 475  TGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYP 534

Query: 324  NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI 383
            +L FID S N F+GEISSNW K PKLG L +S NNITG +P EI N +QL   DLS N++
Sbjct: 535  DLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNL 594

Query: 384  VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--------------- 428
             GE+P+ +G L  L++L L GNQ++GR+P  +  LT LE LD S+               
Sbjct: 595  FGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFL 654

Query: 429  -----------------------------------IGELPSQICNMKSLEKLNLSHNNLS 453
                                                GE+PSQ+ +++SL+KL+LSHNNLS
Sbjct: 655  KLHDMNLSRNKFDGSIPRLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLS 714

Query: 454  GSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGS--AKGLQPCK 511
            G IP+ FEGM  L+ +D+S N+L+ P+P++ TFR A+ +AL+ N GLC +   + L+PC+
Sbjct: 715  GLIPTTFEGMIALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCR 774

Query: 512  PLRQEKSNSGAKWFAIVFPLLGALFV-SIALISIFFILRKQKSDSGDRQSNNQIPQGSLS 570
             L++ K N G     I+ P+LG L + SI   +  + +RK+K  +G R ++ +  + ++S
Sbjct: 775  ELKKPKKN-GNLVVWILVPILGVLVILSICANTFTYCIRKRKLQNG-RNTDPETGE-NMS 831

Query: 571  ILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLL--PCDQ 628
            I + +GK  Y +I+++TN+FD  + IG GG++ VYRA L    ++AVK+ H  +     +
Sbjct: 832  IFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKVYRANL-QDTIIAVKRLHDTIDEEISK 890

Query: 629  TVDQKEFLTEVEAF-----------YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQEL 677
             V ++EFL EV+A            +GFCSH RH+FL+YE++E+GSL  +L  D  A+ L
Sbjct: 891  PVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRL 950

Query: 678  GWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS 737
             W++R+NV+K VAHALSY+HHD   PIVHRDISS N+LLD +Y A ++DFG AK LK DS
Sbjct: 951  TWTKRINVVKGVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDS 1010

Query: 738  SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTD 797
            SNW+  AGT GY+APE AYTMK+TEKCDVYSFGVL+ E+I GKHP D +SS+SSS     
Sbjct: 1011 SNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSLSSSP-GEA 1069

Query: 798  VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIIS 844
            ++L  + D R+  P    +EKL+ ++E+A  C   +PESRPTM  IS
Sbjct: 1070 LSLRSISDERVLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  458 bits (1178), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 306/847 (36%), Positives = 463/847 (54%), Gaps = 50/847 (5%)

Query: 32   LAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVI 91
            L+ + L  N F G IP +ISN ++L  L L  NQ  G I  E+      G+L+ +  L +
Sbjct: 243  LSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKEL------GDLQSLEFLYL 296

Query: 92   NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
              N L+G IP  IGNL +  ++D + N  +G IPL   N+  L  LYL+ N L+G+I   
Sbjct: 297  YRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVE 356

Query: 152  LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDL 211
            L  LK+L  L L+ N L G IP  F  L  +  L+L +N L G+IP ++G    L VLD+
Sbjct: 357  LSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDM 416

Query: 212  NQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFTGYLPYN 270
            + N   G +P  +   +N+  L L  N+LSG+IP  +     L QL L+ N+  G  P N
Sbjct: 417  SDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSN 476

Query: 271  ICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDL 330
            +C+   +    + +N F+G+IP  + NC++L R++L  N  TG +   +G+   L  +++
Sbjct: 477  LCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNI 536

Query: 331  SRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKE 390
            S N   GE+ S       L  L++  NN +G LP E+G+  QL+   LS N++ G IP  
Sbjct: 537  SSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVA 596

Query: 391  LGKLNPLTKLILRGNQITGRLPKEIGSLTKLEY---LDFSAI-GELPSQICNMKSLEKLN 446
            LG L+ LT+L + GN   G +P+E+GSLT L+    L ++ + GE+P ++ N+  LE L 
Sbjct: 597  LGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLL 656

Query: 447  LSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCG---- 502
            L++NNLSG IPS F  +  L   + SYN L  P+P     R  S+ +  GN+GLCG    
Sbjct: 657  LNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLN 713

Query: 503  SAKGLQPCKPLRQEKSNSG---AKWFAIVFPLLGALFVSIALIS-IFFILRKQKSDSGDR 558
                 QP  P +      G   +K  AI   ++G   VS+ LI+ I +++R+        
Sbjct: 714  QCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGG--VSLMLIALIVYLMRRPVRTVASS 771

Query: 559  QSNNQIPQGSLSILNFEGK--ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVA 616
              + Q  + SL I  F  K    + ++V AT++FD  + +G G   +VY+A LP+G  +A
Sbjct: 772  AQDGQPSEMSLDIY-FPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLA 830

Query: 617  VKKFHSLLPC--DQTVD---QKEFLT-------EVEAFYGFCSHARHSFLLYEFLERGSL 664
            VKK  S      +  VD   + E LT        +   +GFC+H   + LLYE++ +GSL
Sbjct: 831  VKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSL 890

Query: 665  AAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV 724
              IL+  +    L WS+R  +    A  L+YLHHDC P I HRDI S N+LLD ++EAHV
Sbjct: 891  GEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 948

Query: 725  ADFGIAKSLK-PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPR 783
             DFG+AK +  P S + +  AG+ GYIAPE AYTMK+TEK D+YS+GV++ E++ GK P 
Sbjct: 949  GDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPV 1008

Query: 784  -------DFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPES 836
                   D ++ +  S +  D     +LD RL          +++++++A  C + SP +
Sbjct: 1009 QPIDQGGDVVNWV-RSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVA 1067

Query: 837  RPTMKII 843
            RP+M+ +
Sbjct: 1068 RPSMRQV 1074

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  449 bits (1154), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 297/897 (33%), Positives = 439/897 (48%), Gaps = 92/897 (10%)

Query: 25   SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
            S +    L  +    NGF G IP +IS   +L+ L L  N   G++  ++        L+
Sbjct: 182  SMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEK------LQ 235

Query: 85   YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
             ++ L++  N LSG IPP +GN+  L  L L  N F+G IP     L+ +  LYLY N L
Sbjct: 236  NLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQL 295

Query: 145  SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR 204
            +G I   +G L    ++  ++NQL G+IP+ F ++ ++  L L  N L G IP E+G++ 
Sbjct: 296  TGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELT 355

Query: 205  SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLL-LSGNHF 263
             L  LDL+ N+  G +P  +  L  L +L L  N L G IPP +G      +L +S N  
Sbjct: 356  LLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSL 415

Query: 264  TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYP 323
            +G +P + CR   L + ++  N   G IP  L+ C SL ++ L  N LTG++   L    
Sbjct: 416  SGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQ 475

Query: 324  NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI 383
            NLT ++L +N   G IS++ GK   L  L ++ NN TG +P EIGN +++  F++S N +
Sbjct: 476  NLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQL 535

Query: 384  VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS---AIGELPSQICNMK 440
             G IPKELG    + +L L GN+ +G + +E+G L  LE L  S     GE+P    ++ 
Sbjct: 536  TGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLT 595

Query: 441  SLEK-------------------------LNLSHNNLSGSIPSCFEGMHGLSFI------ 469
             L +                         LN+SHNNLSG+IP     +  L  +      
Sbjct: 596  RLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNK 655

Query: 470  ------------------DMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKG-LQPC 510
                              ++S N L   VP++  F+        GN GLC S +   QP 
Sbjct: 656  LSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPL 715

Query: 511  KPLRQEKSN------SGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQI 564
             P    K N         K   I   ++G++F+   L   + I R++ +        +Q 
Sbjct: 716  VPHSDSKLNWLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVA---LEDQT 772

Query: 565  PQGSLSILNFEGK-ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSL 623
                +    F  K   Y  +V AT +F     +G G   +VY+AE+  GEV+AVKK +S 
Sbjct: 773  KPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNS- 831

Query: 624  LPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDA 672
               +       F  E+              YGFC H   + LLYE++ +GSL   L    
Sbjct: 832  -RGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGE 890

Query: 673  AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS 732
                L W+ R  +    A  L YLHHDC P IVHRDI S N+LLD  ++AHV DFG+AK 
Sbjct: 891  KNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKL 950

Query: 733  LKPD-SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPR-------D 784
            +    S + +  AG+ GYIAPE AYTMK+TEKCD+YSFGV++ E+I GK P        D
Sbjct: 951  IDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGD 1010

Query: 785  FLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
             ++ +  S  N  +   +M D RL    +    ++  ++++A  C + SP SRPTM+
Sbjct: 1011 LVNWVRRSIRNM-IPTIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMR 1066

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  446 bits (1147), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 304/890 (34%), Positives = 445/890 (50%), Gaps = 99/890 (11%)

Query: 40   NGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGF 99
            N F G IP +I    NL+ L L  N  SG +  E+      G L  +  +++  N  SGF
Sbjct: 215  NDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEI------GMLVKLQEVILWQNKFSGF 268

Query: 100  IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLF 159
            IP  IGNL  L  L L  N   GPIP    N+ +L  LYLY N L+G+I   LGKL  + 
Sbjct: 269  IPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVM 328

Query: 160  DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV 219
            ++  ++N L G IP   S ++ +  L L +N L G IP+E+ K+R+L+ LDL+ N   G 
Sbjct: 329  EIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGP 388

Query: 220  LPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALE 278
            +PP   NLT++++L L +N LSG IP  LG    L  +  S N  +G +P  IC+   L 
Sbjct: 389  IPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLI 448

Query: 279  IFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGE 338
            +  +  N   G IP  +  C SL+++R+ GN LTG     L    NL+ I+L +N F G 
Sbjct: 449  LLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGP 508

Query: 339  ISSNWG------------------------KFPKLGTLNVSMNNITGGLPREIGNSSQLQ 374
            +    G                        K   L T NVS N++TG +P EI N   LQ
Sbjct: 509  LPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQ 568

Query: 375  AFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLT--------------- 419
              DLS N  +G +P ELG L+ L  L L  N+ +G +P  IG+LT               
Sbjct: 569  RLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGS 628

Query: 420  ---------------KLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMH 464
                            L Y DFS  GE+P +I N+  L  L+L++N+LSG IP+ FE + 
Sbjct: 629  IPPQLGLLSSLQIAMNLSYNDFS--GEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLS 686

Query: 465  GLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKP-------LRQEK 517
             L   + SYN L   +P++  F+  ++ +  GNKGLCG    L+ C P       +   K
Sbjct: 687  SLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGH--LRSCDPSHSSWPHISSLK 744

Query: 518  SNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNF--E 575
            + S  +   I+        +S+ LI+I     +   +      +++ P    S + F  +
Sbjct: 745  AGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPK 804

Query: 576  GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---- 631
             +    +I++AT  F   Y +G G   +VY+A +PSG+ +AVKK  S    +        
Sbjct: 805  ERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTD 864

Query: 632  ---QKEFLT-------EVEAFYGFCSH--ARHSFLLYEFLERGSLAAILNTDAAAQELGW 679
               + E LT        +   Y FC H  +  + LLYE++ RGSL  +L+    +  + W
Sbjct: 865  NSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLH-GGKSHSMDW 923

Query: 680  SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK-PDSS 738
              R  +    A  L+YLHHDC P I+HRDI S N+L+D  +EAHV DFG+AK +  P S 
Sbjct: 924  PTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSK 983

Query: 739  NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD------FLSSISSS 792
            + +  AG+ GYIAPE AYTMK+TEKCD+YSFGV++ E++ GK P         L++ + +
Sbjct: 984  SVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRN 1043

Query: 793  SLNTDVALDQMLDPRLPAPSRSA-QEKLISIMEVAFSCFNESPESRPTMK 841
             +       ++LDP L           +I++ ++A  C   SP  RPTM+
Sbjct: 1044 HIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMR 1093

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  427 bits (1098), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 300/892 (33%), Positives = 441/892 (49%), Gaps = 94/892 (10%)

Query: 26   FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
             S    L  LDL+ N   G+IP  +  L  L  LYL +N   G +   +S      NL  
Sbjct: 356  LSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSIS------NLTN 409

Query: 86   MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS 145
            +  LV+  N+L G +P  I  L+ L  L L  N+FSG IP    N ++L  + ++GN   
Sbjct: 410  LQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFE 469

Query: 146  GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRS 205
            G I  S+G+LK L  L L  N+L+G +P    N   ++ L L+ N L GSIP   G ++ 
Sbjct: 470  GEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKG 529

Query: 206  LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP------------------- 246
            L  L L  N  +G LP S+ +L NL  + L +N L+G+I P                   
Sbjct: 530  LEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFED 589

Query: 247  ----SLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSL 301
                 LGN   L +L L  N  TG +P+ + +   L +  +S N   GTIP  L  C  L
Sbjct: 590  EIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKL 649

Query: 302  IRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITG 361
              + LN N L+G I   LG    L  + LS N F   + +      KL  L++  N++ G
Sbjct: 650  THIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNG 709

Query: 362  GLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKL 421
             +P+EIGN   L   +L  N   G +P+ +GKL+ L +L L  N +TG +P EIG L  L
Sbjct: 710  SIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDL 769

Query: 422  E-YLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
            +  LD S     G++PS I  +  LE L+LSHN L+G +P     M  L ++++S+N L 
Sbjct: 770  QSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLG 829

Query: 478  CPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIV----FPLLG 533
              +     F     ++  GN GLCGS   L  C  +R      G    ++V       L 
Sbjct: 830  GKL--KKQFSRWPADSFLGNTGLCGSP--LSRCNRVRSNNKQQGLSARSVVIISAISALT 885

Query: 534  ALFVSIALISIFFILRKQKSD--------SGDRQSNNQIPQGSLSILNFEG----KILYD 581
            A+ + I +I++FF   KQ+ D        S    S++   Q +   L   G     I ++
Sbjct: 886  AIGLMILVIALFF---KQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWE 942

Query: 582  EIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA 641
            +I++AT++   ++ IG+GG   VY+AEL +GE VAVKK   +L  D  +  K F  EV+ 
Sbjct: 943  DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKK---ILWKDDLMSNKSFSREVKT 999

Query: 642  -----------FYGFCSHARH--SFLLYEFLERGSLAAILNTDAAAQE-----LGWSQRM 683
                         G+CS      + L+YE+++ GS+   L+ D    E     L W  R+
Sbjct: 1000 LGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARL 1059

Query: 684  NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL------KPDS 737
             +   +A  + YLHHDC PPIVHRDI S N+LLD   EAH+ DFG+AK L        DS
Sbjct: 1060 RIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDS 1119

Query: 738  SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPR--------DFLSSI 789
            + W  FA + GYIAPE AY++K TEK DVYS G+++ E++ GK P         D +  +
Sbjct: 1120 NTW--FACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWV 1177

Query: 790  SSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
             +       A D+++DP+L       ++    ++E+A  C   SP+ RP+ +
Sbjct: 1178 ETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSR 1229

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1

 Score =  427 bits (1098), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 307/953 (32%), Positives = 460/953 (48%), Gaps = 125/953 (13%)

Query: 3    DAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLG 62
            D   +I I L +  + G +   S     +L  L L  NG  G IPP++ +  +L+ L + 
Sbjct: 128  DCSELIVIDLSSNSLVGEIPS-SLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIF 186

Query: 63   SNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG 122
             N  S N+  E+   S+  ++R        ++ LSG IP  IGN + L  L L   K SG
Sbjct: 187  DNYLSENLPLELGKISTLESIRAGG-----NSELSGKIPEEIGNCRNLKVLGLAATKISG 241

Query: 123  PIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSV 182
             +P+S   LS L  L +Y  +LSG I   LG    L +L L DN L G +P+    L ++
Sbjct: 242  SLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNL 301

Query: 183  STLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG 242
              + L +N+L G IP+EIG M+SL+ +DL+ N F G +P S  NL+NL+EL L  N+++G
Sbjct: 302  EKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITG 361

Query: 243  SIPPSLGNLI-------------------------------------------------L 253
            SIP  L N                                                   L
Sbjct: 362  SIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNL 421

Query: 254  RQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG 313
            + L LS N+ TG LP  + +   L    +  N   G IP  + NCTSL+R+RL  N +TG
Sbjct: 422  QALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITG 481

Query: 314  NISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQL 373
             I + +G   NL+F+DLS NN  G +        +L  LN+S N + G LP  + + ++L
Sbjct: 482  EIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKL 541

Query: 374  QAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA---IG 430
            Q  D+S N + G+IP  LG L  L +LIL  N   G +P  +G  T L+ LD S+    G
Sbjct: 542  QVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISG 601

Query: 431  ELPSQICNMKSLE-KLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPV--------- 480
             +P ++ +++ L+  LNLS N+L G IP     ++ LS +D+S+N L   +         
Sbjct: 602  TIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLENL 661

Query: 481  --------------PNSTTFRGASVEALKGNKGLCGSAKGLQPC--KPLRQEKSNSG--A 522
                          P+S  FR      ++GN GLC  +KG + C      Q  +  G  +
Sbjct: 662  VSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLC--SKGFRSCFVSNSSQLTTQRGVHS 719

Query: 523  KWFAIVFPLLGALFVSIALISIFFILRKQK--SDSGDRQSNNQIPQGSLS---ILNFEGK 577
                I   LL ++   +A++ +  ++R ++   D  D ++   +     +    LNF  +
Sbjct: 720  HRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFTVE 779

Query: 578  ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKE--- 634
             +   +V+          IG G    VY+AE+P+ EV+AVKK   +   +     K    
Sbjct: 780  HVLKCLVEGN-------VIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGV 832

Query: 635  ---FLTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWS 680
               F  EV+            F G C +     L+Y+++  GSL ++L+  +    LGW 
Sbjct: 833  RDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWE 892

Query: 681  QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK----PD 736
             R  +I   A  L+YLHHDC PPIVHRDI + N+L+  ++E ++ DFG+AK +       
Sbjct: 893  VRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFAR 952

Query: 737  SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD--FLSSISSSSL 794
            SSN    AG+ GYIAPE  Y+MKITEK DVYS+GV++ EV+ GK P D      +     
Sbjct: 953  SSN--TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDW 1010

Query: 795  NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               +   Q++D  L A   S  E+++  + VA  C N  PE RPTMK ++  L
Sbjct: 1011 VKKIRDIQVIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAML 1063

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  425 bits (1093), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 296/889 (33%), Positives = 440/889 (49%), Gaps = 80/889 (8%)

Query: 26   FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
             S+   L  LDL+ N   G IP  +  L  L  LYL +N   G + + +S      NL  
Sbjct: 357  ISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSLEGTLSSSIS------NLTN 410

Query: 86   MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS 145
            +    +  N+L G +P  IG L  L  + L  N+FSG +P+   N + L  +  YGN LS
Sbjct: 411  LQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLS 470

Query: 146  GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRS 205
            G I SS+G+LK L  L L +N+L+G IP    N   ++ + L+ N L GSIP   G + +
Sbjct: 471  GEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTA 530

Query: 206  LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLG---------------- 249
            L +  +  N  +G LP S+ NL NL  +    N  +GSI P  G                
Sbjct: 531  LELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFEG 590

Query: 250  --------NLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSL 301
                    +  L +L L  N FTG +P    +   L +  +S N   G IP  L  C  L
Sbjct: 591  DIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKL 650

Query: 302  IRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITG 361
              + LN N L+G I   LG  P L  + LS N F G + +       + TL +  N++ G
Sbjct: 651  THIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNG 710

Query: 362  GLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKL 421
             +P+EIGN   L A +L  N + G +P  +GKL+ L +L L  N +TG +P EIG L  L
Sbjct: 711  SIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDL 770

Query: 422  E-YLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
            +  LD S     G +PS I  +  LE L+LSHN L G +P     M  L ++++SYN L+
Sbjct: 771  QSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLE 830

Query: 478  CPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNS-GAKWFAIVFPL--LGA 534
              +     F     +A  GN GLCGS   L  C     +   S   K   I+  +  L A
Sbjct: 831  GKLKKQ--FSRWQADAFVGNAGLCGSP--LSHCNRAGSKNQRSLSPKTVVIISAISSLAA 886

Query: 535  LFVSIALISIFF-----ILRKQKSDSGDRQSNNQIPQGSL-SILNFEGKILYDEIVKATN 588
            + + + +I +FF     + +K +  +    SN+   Q  L S    +  I +D+I++AT+
Sbjct: 887  IALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATH 946

Query: 589  DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------- 641
              + ++ IG+GG   VY+AEL +GE +AVKK   +L  D  +  K F  EV+        
Sbjct: 947  YLNEEFMIGSGGSGKVYKAELKNGETIAVKK---ILWKDDLMSNKSFNREVKTLGTIRHR 1003

Query: 642  ----FYGFCSHARH--SFLLYEFLERGSLAAILNTDAAAQE---LGWSQRMNVIKAVAHA 692
                  G+CS      + L+YE++  GS+   L+ +   ++   LGW  R+ +   +A  
Sbjct: 1004 HLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQG 1063

Query: 693  LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE----FAGTCG 748
            + YLH+DC PPIVHRDI S N+LLD   EAH+ DFG+AK L  +    TE    FAG+ G
Sbjct: 1064 VEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYG 1123

Query: 749  YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN-TDVALD------ 801
            YIAPE AY++K TEK DVYS G+++ E++ GK P + +    +  +   +  LD      
Sbjct: 1124 YIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSE 1183

Query: 802  ---QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               +++D  L +     +E    ++E+A  C    P+ RP+ +  S+ L
Sbjct: 1184 AREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  414 bits (1065), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 301/950 (31%), Positives = 467/950 (49%), Gaps = 117/950 (12%)

Query: 5    GRVINISLPNIGVNGTLHD--FSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLG 62
            G  + + + ++  NG + D  +S S   +L  L L  N   G IPP IS  S L+ L L 
Sbjct: 126  GDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILF 185

Query: 63   SNQFSGNILAEV-------------SSESSG------GNLRYMSRLVINDNSLSGFIPPH 103
             N  +G+I  E+             + E SG      G+   ++ L + + S+SG +P  
Sbjct: 186  DNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSS 245

Query: 104  IGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL 163
            +G LK L  L +     SG IP    N S L+ L+LY N LSGSI   +G+L  L  L L
Sbjct: 246  LGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFL 305

Query: 164  NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPS 223
              N L+G IP    N +++  + LS N L GSIP  IG++  L    ++ N+F G +P +
Sbjct: 306  WQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTT 365

Query: 224  ISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLS-GNHFTGYLPYNICRGGALEIFTV 282
            ISN ++L +L L  N +SG IP  LG L    L  +  N   G +P  +     L+   +
Sbjct: 366  ISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDL 425

Query: 283  SENHFQGTIPTSL------------------------RNCTSLIRVRLNGNNLTGNISEA 318
            S N   GTIP+ L                         NC+SL+R+RL  N +TG I   
Sbjct: 426  SRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSG 485

Query: 319  LGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDL 378
            +G    + F+D S N  +G++    G   +L  +++S N++ G LP  + + S LQ  D+
Sbjct: 486  IGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDV 545

Query: 379  SLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA---IGELPSQ 435
            S N   G+IP  LG+L  L KLIL  N  +G +P  +G  + L+ LD  +    GE+PS+
Sbjct: 546  SANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSE 605

Query: 436  ICNMKSLE-KLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ---CP------------ 479
            + ++++LE  LNLS N L+G IPS    ++ LS +D+S+N L+    P            
Sbjct: 606  LGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDLAPLANIENLVSLNI 665

Query: 480  --------VPNSTTFRGASVEALKGNKGLCGSAKG-----LQPCKPLRQEKSNSGAKWFA 526
                    +P++  FR  S + L+GNK LC S +       +    L  +   S  +   
Sbjct: 666  SYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLR 725

Query: 527  IVFPLLGALFVSIALISIFFILRKQKSDSGDRQS----NNQIPQGSLSILNFEGKILYDE 582
            +   LL  L V + ++    ++R +++   +R S      +        LNF      D+
Sbjct: 726  LTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFS----VDQ 781

Query: 583  IVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQK------EFL 636
            I++   + +    IG G    VYRA++ +GEV+AVKK    +  +   D+K       F 
Sbjct: 782  IIRCLVEPNV---IGKGCSGVVYRADVDNGEVIAVKKLWPAM-VNGGHDEKTKNVRDSFS 837

Query: 637  TEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNV 685
             EV+            F G C +     L+Y+++  GSL ++L+ +     L W  R  +
Sbjct: 838  AEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLH-ERRGSSLDWDLRYRI 896

Query: 686  IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE--F 743
            +   A  L+YLHHDC PPIVHRDI + N+L+ L++E ++ADFG+AK +            
Sbjct: 897  LLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTV 956

Query: 744  AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD-- 801
            AG+ GYIAPE  Y+MKITEK DVYS+GV++ EV+ GK P D   ++       D      
Sbjct: 957  AGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPID--PTVPEGIHLVDWVRQNR 1014

Query: 802  ---QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
               ++LD  L + + +  ++++ ++  A  C N SP+ RPTMK ++  L+
Sbjct: 1015 GSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDVAAMLK 1064

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1

 Score =  414 bits (1064), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 297/866 (34%), Positives = 439/866 (50%), Gaps = 48/866 (5%)

Query: 9   NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSG 68
           +++L N   NG+  D   S   +L  LD+  N   G +P  ++NL+ LR+L+LG N F+G
Sbjct: 121 HLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAG 180

Query: 69  NILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN-NKFSGPIPLS 127
            I        S G+   +  L ++ N L G IPP IGNL  L +L +   N F   +P  
Sbjct: 181 KI------PPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPE 234

Query: 128 FDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL 187
             NLS L+        L+G I   +GKL+ L  L L  N   G +      L+S+ ++ L
Sbjct: 235 IGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDL 294

Query: 188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS 247
           S N   G IP    ++++L++L+L +N+  G +P  I +L  L+ L L  N+ +GSIP  
Sbjct: 295 SNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQK 354

Query: 248 LG-NLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRL 306
           LG N  L  + LS N  TG LP N+C G  LE      N   G+IP SL  C SL R+R+
Sbjct: 355 LGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRM 414

Query: 307 NGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPRE 366
             N L G+I + L   P LT ++L  N   GE+    G    LG +++S N ++G LP  
Sbjct: 415 GENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPA 474

Query: 367 IGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDF 426
           IGN + +Q   L  N   G IP E+GKL  L+K+    N  +GR+  EI     L ++D 
Sbjct: 475 IGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDL 534

Query: 427 SA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
           S     GE+P++I  MK L  LNLS N+L GSIP     M  L+ +D SYN L   VP +
Sbjct: 535 SRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGT 594

Query: 484 TTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIVFPLLGALFVSIALIS 543
             F   +  +  GN  LCG   G  PCK    +  +       +   +   L + + + S
Sbjct: 595 GQFSYFNYTSFLGNPDLCGPYLG--PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCS 652

Query: 544 I-FFILRKQKSDSGDRQSNNQIPQ-GSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGH 601
           I F ++   K+ S  + S ++  +  +   L+F    + D + K  N       IG GG 
Sbjct: 653 IAFAVVAIIKARSLKKASESRAWRLTAFQRLDFTCDDVLDSL-KEDN------IIGKGGA 705

Query: 602 ASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR 650
             VY+  +P+G++VAVK+  ++     +     F  E++              GFCS+  
Sbjct: 706 GIVYKGVMPNGDLVAVKRLAAM--SRGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHE 763

Query: 651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
            + L+YE++  GSL  +L+       L W  R  +    A  L YLHHDC P IVHRD+ 
Sbjct: 764 TNLLVYEYMPNGSLGEVLHGKKGGH-LHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVK 822

Query: 711 SKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYS 768
           S N+LLD  +EAHVADFG+AK L+   ++   +  AG+ GYIAPE AYT+K+ EK DVYS
Sbjct: 823 SNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYS 882

Query: 769 FGVLMWEVIKGKHP-------RDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLIS 821
           FGV++ E++ G+ P        D +  +   + +   ++ ++LDPRL   S     ++  
Sbjct: 883 FGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRL---SSIPIHEVTH 939

Query: 822 IMEVAFSCFNESPESRPTMKIISQQL 847
           +  VA  C  E    RPTM+ + Q L
Sbjct: 940 VFYVAMLCVEEQAVERPTMREVVQIL 965

Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	849
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.984	0.810	0.479	0.0
359491509	1032	PREDICTED: probable LRR receptor-like se	0.984	0.810	0.478	0.0
225456159	1038	PREDICTED: probable LRR receptor-like se	0.985	0.806	0.472	0.0
225456161	1037	PREDICTED: probable LRR receptor-like se	0.984	0.806	0.476	0.0
359491512	1078	PREDICTED: probable LRR receptor-like se	0.985	0.776	0.484	0.0
147772402	996	hypothetical protein VITISV_022117 [Viti	0.948	0.808	0.475	0.0
255545702	1008	receptor protein kinase, putative [Ricin	0.982	0.827	0.461	0.0
297846642	1007	hypothetical protein ARALYDRAFT_891227 [	0.988	0.833	0.445	0.0
297846638	1123	hypothetical protein ARALYDRAFT_473694 [	0.952	0.720	0.454	0.0
186511602	1045	Leucine-rich repeat-containing protein [	0.984	0.8	0.426	0.0

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  837 bits (2163), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 457/953 (47%), Positives = 592/953 (62%), Gaps = 117/953 (12%)

Query: 4    AGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGS 63
            AG VI I+L ++G+ GTL DFSFSSFP+LAY D+  N   G IPPQI  LS L+YL L +
Sbjct: 84   AGSVIRINLTDLGLIGTLQDFSFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLST 143

Query: 64   NQFSGNILAEV------------------------------------------SSESSGG 81
            NQFSG I +E+                                          S  +S G
Sbjct: 144  NQFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGSIPASLG 203

Query: 82   NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
            NL  ++ L +++N LSG IPP +GNL  L +L L  N  +GPIP +  NL +L  L LY 
Sbjct: 204  NLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYN 263

Query: 142  NLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG 201
            N LSG I + +G LK L +L L+ N L G IP    +L+ + +L+L  N L G IP E+G
Sbjct: 264  NQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMG 323

Query: 202  KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSG 260
             +RSL  L+++QNQ  G +P S+ NL NL+ L L  N LS SIPP +G L  L +L +  
Sbjct: 324  NLRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDT 383

Query: 261  NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALG 320
            N  +G+LP  IC+GG+LE FTV +N   G IP SL+NC SL R RL  N LTGNISEA G
Sbjct: 384  NQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQRNQLTGNISEAFG 443

Query: 321  IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSL 380
            + PNL  I+LS N FYGE+S NWG+  KL  L+++ NNITG +P + G S+QL   +LS 
Sbjct: 444  VCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSS 503

Query: 381  NHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA------------ 428
            NH+VGEIPK+LG ++ L KLIL  N+++G +P E+GSL  L YLD S             
Sbjct: 504  NHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLG 563

Query: 429  ---------------------------------------IGELPSQICNMKSLEKLNLSH 449
                                                    GE+PSQI  ++SLEKLNLSH
Sbjct: 564  NCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSH 623

Query: 450  NNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQP 509
            NNLSG IP  FE MHGL  +D+SYN+LQ  +PNS  F+  ++E L+GNKGLCGS KGLQP
Sbjct: 624  NNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQP 683

Query: 510  CKPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKS----DSGDRQSNNQIP 565
            C+  R     +    F I+F LLGAL +  A I I  I + +++     +GD Q+ N   
Sbjct: 684  CEN-RSATKGTHKAVFIIIFSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENL-- 740

Query: 566  QGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLP 625
                SI  F+G+  Y+ I++AT DFD  YCIG GGH SVY+AELPSG +VAVKK H    
Sbjct: 741  ---FSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRF-- 795

Query: 626  CDQTVDQKEFLTEVEAF-----------YGFCSHARHSFLLYEFLERGSLAAILNTDAAA 674
                  QK+F+ E+ A             GFCSH+RHSFL+YE+LERGSL  IL+ +  A
Sbjct: 796  DIDMAHQKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQA 855

Query: 675  QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK 734
            +E+GW  R+N+IK VAHALSYLHHDC PPIVHRDISS N+LLD +YEAHV+DFG AK LK
Sbjct: 856  KEVGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLK 915

Query: 735  PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL 794
             DSSNW+  AGT GY+APELAYTMK+TEKCDVYSFGVL  EV++G+HP D +SS+S+S  
Sbjct: 916  LDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSASPG 975

Query: 795  NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              +V L  +LDPRLP P+   + +++S++++A +C N SP+SRPTM+++SQ L
Sbjct: 976  KDNVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQSRPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  834 bits (2154), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 456/953 (47%), Positives = 590/953 (61%), Gaps = 117/953 (12%)

Query: 4    AGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGS 63
            AG VI I+L ++G+ GTL DFSFSSFP+LAY D+  N   G IPPQI  LS L+YL L +
Sbjct: 84   AGSVIRINLTDLGLIGTLQDFSFSSFPNLAYFDINMNKLSGPIPPQIGFLSKLKYLDLST 143

Query: 64   NQFSGNILAEV------------------------------------------SSESSGG 81
            NQFSG I +E+                                          +  +S G
Sbjct: 144  NQFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIGQLKSLCDLSLYTNKLEGTIPASLG 203

Query: 82   NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
            NL  ++ L +++N LSG IPP +GNL  L +L L  N  +GPIP +  NL +L  L LY 
Sbjct: 204  NLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNANNLTGPIPSTLGNLKSLTLLRLYN 263

Query: 142  NLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG 201
            N LSG I + +G LK L +L L+ N L G IP    +L+ + +L+L  N L G IP E+G
Sbjct: 264  NQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLGDLSGLKSLQLFDNQLSGPIPQEMG 323

Query: 202  KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSG 260
             +RSL  L+++QNQ  G +P  + NL NL+ L L  N LS SIPP +G L  L +L +  
Sbjct: 324  NLRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRDNKLSSSIPPEIGKLHKLVELEIDT 383

Query: 261  NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALG 320
            N  +G+LP  IC+GG+LE FTV +N   G IP SL+NC SL R RL GN LTGNISEA G
Sbjct: 384  NQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLKNCPSLARARLQGNQLTGNISEAFG 443

Query: 321  IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSL 380
            + PNL  I+LS N FYGE+S NWG+  KL  L+++ NNITG +P + G S+QL   +LS 
Sbjct: 444  VCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAGNNITGSIPADFGISTQLTVLNLSS 503

Query: 381  NHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA------------ 428
            NH+VGEIPK+LG ++ L KLIL  N+++G +P E+GSL  L YLD S             
Sbjct: 504  NHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELGSLADLGYLDLSGNRLNGSIPEHLG 563

Query: 429  ---------------------------------------IGELPSQICNMKSLEKLNLSH 449
                                                    GE+PSQI  ++SLEKLNLSH
Sbjct: 564  NCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSHNLLTGEIPSQIQGLQSLEKLNLSH 623

Query: 450  NNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQP 509
            NNLSG IP  FE MHGL  +D+SYN+LQ  +PNS  F+  ++E L+GNKGLCGS KGLQP
Sbjct: 624  NNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEAFQNVTIEVLQGNKGLCGSVKGLQP 683

Query: 510  CKPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKS----DSGDRQSNNQIP 565
            C+     K    A  F I+F LLGAL +  A I I  I + +++     +GD Q+ N   
Sbjct: 684  CENRSATKGTHKAV-FIIIFSLLGALLILSAFIGISLISQGRRNAKMEKAGDVQTENL-- 740

Query: 566  QGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLP 625
                SI  F+G+  Y+ I++AT DFD  YCIG GGH SVY+AELPSG +VAVKK H    
Sbjct: 741  ---FSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYKAELPSGNIVAVKKLHRF-- 795

Query: 626  CDQTVDQKEFLTEVEAF-----------YGFCSHARHSFLLYEFLERGSLAAILNTDAAA 674
                  QK+F+ E+ A             GFCSH+RHSFL+YE+LERGSL  IL+ +  A
Sbjct: 796  DIDMAHQKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVYEYLERGSLGTILSKELQA 855

Query: 675  QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK 734
            +E+GW  R+N+IK V+HALSYLHHDC PPIVHRDISS N+LLD +YEAHV+DFG AK LK
Sbjct: 856  KEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLLDSKYEAHVSDFGTAKFLK 915

Query: 735  PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL 794
             DSSNW+  AGT GY+APELAYTMK+TEKCDVYSFGVL  EV++G+HP D +SS+S S  
Sbjct: 916  LDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEVMRGRHPGDLISSLSDSPG 975

Query: 795  NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              +V L  +LDPRLP P+   + ++ S++++A +C N SP+SRPTM+++SQ L
Sbjct: 976  KDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQSRPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  814 bits (2103), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 454/961 (47%), Positives = 585/961 (60%), Gaps = 124/961 (12%)

Query: 1    CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLY 60
            CN AG VI I+L   G+NGTL DFSFSSFP+LAY+D++ N   G IPPQI  L  L+YL 
Sbjct: 84   CNHAGSVIKINLTESGLNGTLMDFSFSSFPNLAYVDISMNNLSGPIPPQIGLLFELKYLD 143

Query: 61   LGSNQFSGNILAEV------------------------------------------SSES 78
            L  NQFSG I +E+                                          S  +
Sbjct: 144  LSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLYELALYTNQLEGSIPA 203

Query: 79   SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLY 138
            S GNL  ++ L + +N LSG IPP +GNL  L ++   NN  +GPIP +F NL  L  LY
Sbjct: 204  SLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNNNNLTGPIPSTFGNLKRLTVLY 263

Query: 139  LYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPD 198
            L+ N LSG I   +G LKSL +L L +N L G IP    +L+ ++ L L  N L G IP 
Sbjct: 264  LFNNSLSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQ 323

Query: 199  EIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLL 257
            EIG ++SL  L+L++NQ  G +P S+ NLTNL+ L L  N LSG IP  +G L  L  L 
Sbjct: 324  EIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNQLSGYIPQEIGKLHKLVVLE 383

Query: 258  LSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISE 317
            +  N   G LP  IC+ G+L  F VS+NH  G IP SL+NC +L R    GN LTGNISE
Sbjct: 384  IDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNISE 443

Query: 318  ALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFD 377
             +G  PNL FIDLS N F+GE+S NWG+ P+L  L ++ NNITG +P + G S+ L   D
Sbjct: 444  VVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLTLLD 503

Query: 378  LSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--------- 428
            LS NH+VGEIPK++G L  L  LIL  NQ++G +P E+GSL+ LEYLD SA         
Sbjct: 504  LSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPE 563

Query: 429  ------------------------------------------IGELPSQICNMKSLEKLN 446
                                                       G +P QI  ++SLE L+
Sbjct: 564  HLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLAGGIPPQIQGLQSLEMLD 623

Query: 447  LSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKG 506
            LSHNNL G IP  FE M  LS++D+SYN+LQ P+P+S  FR A++E LKGNK LCG+ KG
Sbjct: 624  LSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKG 683

Query: 507  LQPCK----PLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKS----DSGDR 558
            LQPCK      +Q    S    F I+FPLLGAL +  A I IF I  +++     + GD 
Sbjct: 684  LQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLIAERRERTPEIEEGDV 743

Query: 559  QSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVK 618
            Q++        SI NF+G+ +Y+EI+KAT DFD  YCIG GGH SVY+AELPS  +VAVK
Sbjct: 744  QND------LFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVK 797

Query: 619  KFHSLLPCD-QTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAA 666
            K H   P D +  +QK+FL E+ A             GFCSH RH FL+YE+LERGSLA 
Sbjct: 798  KLH---PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLERGSLAT 854

Query: 667  ILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD 726
            IL+ +  A++LGW+ R+N+IK VAHAL+Y+HHDC PPIVHRD+SS N+LLD +YEAH++D
Sbjct: 855  ILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSSNNILLDSQYEAHISD 913

Query: 727  FGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFL 786
            FG AK LK DSSN +  AGT GY+APELAYTMK+TEK DV+SFGV+  EVIKG+HP D +
Sbjct: 914  FGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQI 973

Query: 787  SSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ 846
             S+S S    ++AL+ MLDPRLP  +   + ++I+I++ A  C   +P+SRPTM+ +SQ 
Sbjct: 974  LSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAILKQAIECLKANPQSRPTMQTVSQM 1033

Query: 847  L 847
            L
Sbjct: 1034 L 1034

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  810 bits (2093), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 458/961 (47%), Positives = 586/961 (60%), Gaps = 125/961 (13%)

Query: 1    CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLY 60
            CN AG VI I+L   G+ GTL  FSFSSFP+LAY+D++ N   G IPPQI  LS L+YL 
Sbjct: 84   CNHAGSVIRINLTESGLGGTLQAFSFSSFPNLAYVDISMNNLSGPIPPQIGLLSKLKYLD 143

Query: 61   LGSNQFSGNILAEV------------------------------------------SSES 78
            L  NQFSG I  E+                                          S  +
Sbjct: 144  LSINQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIGQLTSLYELALYTNQLEGSIPA 203

Query: 79   SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLY 138
            S GNL  ++ L + +N LSG IPP +GNL  L QL    N  +GPIP +F NL +L  LY
Sbjct: 204  SLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVQLYSDTNNLTGPIPSTFGNLKHLTVLY 263

Query: 139  LYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPD 198
            L+ N LSG I   +G LKSL  L L  N L G IP    +L+ ++ L L  N L G IP 
Sbjct: 264  LFNNSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLCDLSGLTLLHLYANQLSGPIPQ 323

Query: 199  EIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLL 257
            EIG ++SL  L+L++NQ  G +P S+ NLTNL+ L L  N LSG  P  +G L  L  L 
Sbjct: 324  EIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRDNRLSGYFPQEIGKLHKLVVLE 383

Query: 258  LSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISE 317
            +  N   G LP  IC+GG+LE FTVS+NH  G IP SL+NC +L R    GN LTGN+SE
Sbjct: 384  IDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCRNLTRALFQGNRLTGNVSE 443

Query: 318  ALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFD 377
             +G  PNL FIDLS N F+GE+S NWG+ P+L  L ++ NNITG +P + G S+ L   D
Sbjct: 444  VVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAGNNITGSIPEDFGISTNLILLD 503

Query: 378  LSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--------- 428
            LS NH+VGEIPK++G L  L  LIL  NQ++G +P E+GSL+ LEYLD SA         
Sbjct: 504  LSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELGSLSHLEYLDLSANRLNGSIPE 563

Query: 429  ------------------------------------------IGELPSQICNMKSLEKLN 446
                                                       G +P+QI  ++SLE L+
Sbjct: 564  HLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSHNLLTGGIPAQIQGLESLEMLD 623

Query: 447  LSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKG 506
            LSHNNL G IP  FE M  LS++D+SYN+LQ P+P+S  FR A++E LKGNK LCG+ KG
Sbjct: 624  LSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNAFRNATIEVLKGNKDLCGNVKG 683

Query: 507  LQPCK----PLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKS----DSGDR 558
            LQPCK      +Q    S    F I+FPLLGAL +  A I IF I  +++     + GD 
Sbjct: 684  LQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAFIGIFLIAERRERTPEIEEGDV 743

Query: 559  QSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVK 618
            Q+N       LSI  F+G+ +Y+EI+KAT DFD  YCIG GGH SVY+AELPSG +VAVK
Sbjct: 744  QNN------LLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSGNIVAVK 797

Query: 619  KFHSLLPCDQTV-DQKEFLTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAA 666
            K H   P D  + +QK+FL +V A             GFCS+ RHSFL+YE+LERGSLA 
Sbjct: 798  KLH---PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRHSFLVYEYLERGSLAT 854

Query: 667  ILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD 726
            IL+ +  A++LGW+ R+ +IK VAHALSY+HHDC PPIVHRDISS N+LLD +YEAH+++
Sbjct: 855  ILSRE-EAKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEAHISN 913

Query: 727  FGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFL 786
             G AK LK DSSN ++ AGT GY+APE AYTMK+TEK DVYSFGV+  EVIKG+HP D +
Sbjct: 914  LGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGVIALEVIKGRHPGDQI 973

Query: 787  SSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ 846
             SIS S    ++ L  MLDPRLP  +   + ++++I+++A +C N +P+SRPTM+IISQ 
Sbjct: 974  LSISVSP-EKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLNANPQSRPTMEIISQM 1032

Query: 847  L 847
            L
Sbjct: 1033 L 1033

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491512|ref|XP_002278614.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  802 bits (2072), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 455/940 (48%), Positives = 579/940 (61%), Gaps = 103/940 (10%)

Query: 1    CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLY 60
            CN AG VI I+L   G+ GTL  FSFSSFP+LAY+D+  N   G IPPQI  LS L+YL 
Sbjct: 112  CNHAGSVIRINLTESGLRGTLQAFSFSSFPNLAYVDVCINNLSGPIPPQIGLLSKLKYLD 171

Query: 61   LGSNQFSGNILAEV---------------------SSESSGGNLRYMSRLVINDNSLSGF 99
            L +NQFSG I  E+                     S  +S GNL  ++ L + +N LSG 
Sbjct: 172  LSTNQFSGGIPPEIGLLTNLEVLHLLALYTNQLEGSIPASLGNLSNLASLYLYENQLSGS 231

Query: 100  IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLF 159
            IPP +GNL  L ++    N  +G IP +F NL  L  LYL+ N LSG I   +G L SL 
Sbjct: 232  IPPEMGNLANLVEIYSDTNNLTGLIPSTFGNLKRLTTLYLFNNQLSGHIPPEIGNLTSLQ 291

Query: 160  DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV 219
             + L  N L G IP    +L+ ++ L L  N L G IP EIG ++SL  L+L++NQ  G 
Sbjct: 292  GISLYANNLSGPIPASLGDLSGLTLLHLYANQLSGPIPPEIGNLKSLVDLELSENQLNGS 351

Query: 220  LPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFTGYLPYNICRGGALE 278
            +P S+ NLTNL+ L L  NHLSG  P  +G L  L  L +  N  +G LP  IC+GG+L 
Sbjct: 352  IPTSLGNLTNLEILFLRDNHLSGYFPKEIGKLHKLVVLEIDTNRLSGSLPEGICQGGSLV 411

Query: 279  IFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGE 338
             FTVS+N   G IP S++NC +L R    GN LTGNISE +G  PNL +IDLS N F+GE
Sbjct: 412  RFTVSDNLLSGPIPKSMKNCRNLTRALFGGNQLTGNISEVVGDCPNLEYIDLSYNRFHGE 471

Query: 339  ISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLT 398
            +S NWG+ P+L  L ++ N+ITG +P + G S+ L   DLS NH+VGEIPK++G L  L 
Sbjct: 472  LSHNWGRCPQLQRLEMAGNDITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLL 531

Query: 399  KLILRGNQITGRLPKEIGSLTKLEYLDFSA------------------------------ 428
            +L L  NQ++G +P E+GSL  L +LD SA                              
Sbjct: 532  ELKLNDNQLSGSIPPELGSLFSLAHLDLSANRLNGSITENLGACLNLHYLNLSNNKLSNR 591

Query: 429  ---------------------IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLS 467
                                  GE+P QI  ++SLE LNLSHNNLSG IP  FE M GLS
Sbjct: 592  IPAQMGKLSHLSQLDLSHNLLSGEIPPQIEGLESLENLNLSHNNLSGFIPKAFEEMRGLS 651

Query: 468  FIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCK---PLRQEKSNSGAKW 524
             ID+SYN+LQ P+PNS  FR A++E LKGNK LCG+ KGLQPCK      Q+    G K 
Sbjct: 652  DIDISYNQLQGPIPNSKAFRDATIELLKGNKDLCGNVKGLQPCKNDSGAGQQPVKKGHKI 711

Query: 525  -FAIVFPLLGALFVSIALISIFFILRKQKS----DSGDRQSNNQIPQGSLSILNFEGKIL 579
             F IVFPLLGAL +  A I IF I  + K     + GD Q++        SI  F+G+ +
Sbjct: 712  VFIIVFPLLGALVLLFAFIGIFLIAERTKRTPEIEEGDVQND------LFSISTFDGRAM 765

Query: 580  YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCD-QTVDQKEFLTE 638
            Y+EI+KAT DFD  YCIG GGH SVY+AEL SG +VAVKK ++    D    +Q++F  E
Sbjct: 766  YEEIIKATKDFDPMYCIGKGGHGSVYKAELSSGNIVAVKKLYA---SDIDMANQRDFFNE 822

Query: 639  VEAF-----------YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
            V A             GFCSH RHSFL+YE+LERGSLAA+L+ + A ++LGW+ R+N+IK
Sbjct: 823  VRALTEIKHRNIVKLLGFCSHPRHSFLVYEYLERGSLAAMLSREEA-KKLGWATRINIIK 881

Query: 688  AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
             VAHALSY+HHDC PPIVHRDISS N+LLD +YE H++DFG AK LK DSSN +  AGT 
Sbjct: 882  GVAHALSYMHHDCSPPIVHRDISSNNILLDSQYEPHISDFGTAKLLKLDSSNQSALAGTF 941

Query: 748  GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR 807
            GY+APE AYTMK+TEK DVYSFGV+  EVIKG+HP D + S+S S    ++ L+ MLDPR
Sbjct: 942  GYVAPEHAYTMKVTEKTDVYSFGVITLEVIKGRHPGDQILSLSVSPEKENIVLEDMLDPR 1001

Query: 808  LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            LP  +   + ++ISI+ +A +C + +PESRPTMKIISQ L
Sbjct: 1002 LPPLTAQDEGEVISIINLATACLSVNPESRPTMKIISQML 1041

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera]

 Score =  774 bits (1998), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 431/907 (47%), Positives = 560/907 (61%), Gaps = 102/907 (11%)

Query: 32  LAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEV----------------- 74
           L YLDL+ N F G IP +I  L+NL  L+L  NQ +G+I  E+                 
Sbjct: 97  LKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLYELALYTNQLE 156

Query: 75  -SSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSN 133
            S  +S GNL  ++ L + +N LS  IPP +GNL  L ++    N   GPIP +F NL  
Sbjct: 157 GSIPASLGNLSNLAYLYLYENQLSDSIPPEMGNLTNLVEIYSDTNNLIGPIPSTFGNLKR 216

Query: 134 LIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF 193
           L  LYL+ N LSG I   +G LKSL  L L +N L G IP    +L+ ++ L L  N L 
Sbjct: 217 LTVLYLFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPIPASLGDLSGLTLLHLYANQLS 276

Query: 194 GSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-I 252
           G IP EIG ++SL  L+L++NQ  G +P S+ NLTNL+ L L  N LSG IP  +G L  
Sbjct: 277 GPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRDNQLSGYIPQEIGKLHK 336

Query: 253 LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
           L  L +  N   G LP  IC+GG+LE FTVS+NH  G IP SL+NC +L R    GN LT
Sbjct: 337 LVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQLT 396

Query: 313 GNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQ 372
           GNISE +G  PNL +I++S N+F+GE+S NWG++P+L  L ++ NNITG +P + G S+ 
Sbjct: 397 GNISEVVGDCPNLEYINVSYNSFHGELSHNWGRYPRLQRLEMAWNNITGSIPEDFGISTD 456

Query: 373 LQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA---- 428
           L   DLS NH+ GEIPK++G +  L KLIL  NQ++G +P E+GSL  L YLD SA    
Sbjct: 457 LTLLDLSSNHLFGEIPKKMGSVTSLWKLILNDNQLSGNIPPELGSLADLGYLDLSANRLN 516

Query: 429 -----------------------------------------------IGELPSQICNMKS 441
                                                           G++P QI  ++S
Sbjct: 517 GSIPEHLGDCLGLNYLNLSNNKLSHGIPVQMGKLGHLSQLDLSHNLLTGDIPPQIEGLQS 576

Query: 442 LEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLC 501
           LE LNLSHNNLSG IP  FE M GLS +D+SYN+LQ P+PNS  FR A++EALKGNKGLC
Sbjct: 577 LENLNLSHNNLSGFIPKAFEEMLGLSDVDISYNQLQGPIPNSKAFRDATIEALKGNKGLC 636

Query: 502 GSAKGLQPCK----PLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGD 557
           G+ K L+PCK      +Q    S    F I+FPLLGAL +  A I IF I       +  
Sbjct: 637 GNVKRLRPCKYGSGVDQQPVKKSHKVVFIIIFPLLGALVLLFAFIGIFLI-------AAR 689

Query: 558 RQSNNQIPQGSL-----SILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSG 612
           R+   +I +G +     SI  F+G+ +Y+EI+KAT DFD  YCIG GGH SVY+AELPS 
Sbjct: 690 RERTPEIKEGEVQNDLFSISTFDGRTMYEEIIKATKDFDPMYCIGKGGHGSVYKAELPSS 749

Query: 613 EVVAVKKFHSLLPCD-QTVDQKEFLTEVEAF-----------YGFCSHARHSFLLYEFLE 660
            +VAVKK H   P D +  +QK+FL E+ A             GFCSH RH FL+YE+LE
Sbjct: 750 NIVAVKKLH---PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRHKFLVYEYLE 806

Query: 661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY 720
           RGSLA IL+ + A ++LGW+ R+N+IK VAHAL+Y+HHDC PPIVHRDISS N+LLD +Y
Sbjct: 807 RGSLATILSREEA-KKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDISSNNILLDSQY 865

Query: 721 EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK 780
           EAH++DFG AK LK DSSN +  AGT GY+APELAYTMK+TEK DV+SFGV+  EVIKG+
Sbjct: 866 EAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGVIALEVIKGR 925

Query: 781 HPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTM 840
           HP D + S+S S    ++AL+ MLDPRLP  +   + ++I+I++ A  C   +P+SRPTM
Sbjct: 926 HPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAIIKQATECLKANPQSRPTM 985

Query: 841 KIISQQL 847
           + +SQ L
Sbjct: 986 QTVSQML 992

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545702|ref|XP_002513911.1| receptor protein kinase, putative [Ricinus communis] gi|223546997|gb|EEF48494.1| receptor protein kinase, putative [Ricinus communis]

 Score =  760 bits (1963), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 435/943 (46%), Positives = 583/943 (61%), Gaps = 109/943 (11%)

Query: 1    CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLY 60
            CN  G V+ I+L   G+NGTLH+ SFS+FP L +LDL+ N    TIP +I+ L  L +L 
Sbjct: 79   CNRGGSVVRINLTTSGLNGTLHELSFSAFPDLEFLDLSCNSLSSTIPLEITQLPKLIFLD 138

Query: 61   LGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKF 120
            L SNQ SG I  ++      G L  ++ L ++ N L G IP  +GNL  L+ L L +N+F
Sbjct: 139  LSSNQLSGVIPPDI------GLLTNLNTLRLSANRLDGSIPSSVGNLTELAWLHLYDNRF 192

Query: 121  SGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLT 180
            SG IP    NL NL+ L++  NLL+GSI S+ G L  L  L L +NQL G+IP+   +L 
Sbjct: 193  SGSIPSEMGNLKNLVELFMDTNLLTGSIPSTFGSLTKLVQLFLYNNQLSGHIPQELGDLK 252

Query: 181  SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
            S+++L L  N+L G IP  +G + SL++L L QNQ  G +P  + NL +L  L L  N L
Sbjct: 253  SLTSLSLFGNNLSGPIPASLGGLTSLTILHLYQNQLSGTIPKELGNLNSLSNLELSENKL 312

Query: 241  SGSIPPSLGNLILRQLL------LSG-------------------NHFTGYLPYNICRGG 275
            +GSIP SLGNL   +LL      LSG                   N  TGYLP NIC+  
Sbjct: 313  TGSIPASLGNLSRLELLFLKNNQLSGPIPEQIANLSKLSLLQLQSNQLTGYLPQNICQSK 372

Query: 276  ALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNF 335
             L+ F+V++N  +G IP S+R+C SL+R+ L GN   GNISE  G+YP L F+D+  N F
Sbjct: 373  VLQNFSVNDNRLEGPIPKSMRDCKSLVRLHLEGNQFIGNISEDFGVYPYLQFVDIRYNKF 432

Query: 336  YGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLN 395
            +GEISS WG  P LGTL +S NNI+G +P EIGN+++LQ  D S N +VG IPKELGKL 
Sbjct: 433  HGEISSKWGMCPHLGTLLISGNNISGIIPPEIGNAARLQGLDFSSNQLVGRIPKELGKLT 492

Query: 396  PLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--------------------------- 428
             L ++ L  NQ++  +P E GSLT LE LD SA                           
Sbjct: 493  SLVRVNLEDNQLSDGVPSEFGSLTDLESLDLSANRFNQSIPGNIGNLVKLNYLNLSNNQF 552

Query: 429  ------------------------IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMH 464
                                    IGE+PS++  M+SLE LNLS NNLSG IP   + MH
Sbjct: 553  SQEIPIQLGKLVHLSKLDLSQNFLIGEIPSELSGMQSLEVLNLSRNNLSGFIPGDLKEMH 612

Query: 465  GLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNS---- 520
            GLS ID+SYN+L+ PVP++  F+ +S+EA +GNKGLCG  +GLQPCKP   E+ +S    
Sbjct: 613  GLSSIDISYNKLEGPVPDNKAFQNSSIEAFQGNKGLCGHVQGLQPCKPSSTEQGSSIKFH 672

Query: 521  GAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILY 580
               +  I  PL GA F+ ++ + + F   K+  ++ + + ++Q  +  L I +F+GK ++
Sbjct: 673  KRLFLVISLPLFGA-FLILSFLGVLFFQSKRSKEALEAEKSSQESEEILLITSFDGKSMH 731

Query: 581  DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD-----QKEF 635
            DEI++AT+ F+  YCIG GG  SVY+A+L SG  VAVKK H      Q+ D     QKEF
Sbjct: 732  DEIIEATDSFNDIYCIGKGGCGSVYKAKLSSGSTVAVKKLH------QSHDAWKPYQKEF 785

Query: 636  LTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
             +E+ A           FYGFCS++ +SFL+YE +E+GSLA IL  + AA+EL W +R N
Sbjct: 786  WSEIRALTEIKHRNIVKFYGFCSYSAYSFLVYECIEKGSLATILRDNEAAKELEWFKRAN 845

Query: 685  VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
            +IK VA+ALSY+HHDC PPIVHRDISSKN+LLD E EA V+DFGIA+ L  DSS+ T  A
Sbjct: 846  IIKGVANALSYMHHDCSPPIVHRDISSKNILLDSENEARVSDFGIARILNLDSSHRTALA 905

Query: 745  GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML 804
            GT GY+APELAY++ +TEKCDVYSFGVL  EVI GKHP + +SSISSSS    + L+ ++
Sbjct: 906  GTFGYMAPELAYSIVVTEKCDVYSFGVLALEVINGKHPGEIISSISSSSSTRKMLLENIV 965

Query: 805  DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            D RLP PS   Q +L++I+ +AF+C N +P+ RPTM++I   L
Sbjct: 966  DLRLPFPSPEVQVELVNILNLAFTCLNSNPQVRPTMEMICHML 1008

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297846642|ref|XP_002891202.1| hypothetical protein ARALYDRAFT_891227 [Arabidopsis lyrata subsp. lyrata] gi|297337044|gb|EFH67461.1| hypothetical protein ARALYDRAFT_891227 [Arabidopsis lyrata subsp. lyrata]

 Score =  758 bits (1956), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 416/933 (44%), Positives = 579/933 (62%), Gaps = 94/933 (10%)

Query: 1    CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLY 60
            CN  G +  ++L    + GT  DF FSS P+LAY+D + N F GTIPPQ  NL  L Y  
Sbjct: 76   CNSRGSIKKLNLTGNAIEGTFQDFPFSSLPNLAYIDFSMNRFSGTIPPQFGNLFKLIYFD 135

Query: 61   LGSNQFSGNILAEV------------------SSESSGGNLRYMSRLVINDNSLSGFIPP 102
            L +N  +  I  E+                  S  SS G L+ ++ L +  N L+G IPP
Sbjct: 136  LSTNHLTREIPPELGNLQNLKGLSLSNNKLAGSIPSSIGKLKNLTVLYLYKNYLTGVIPP 195

Query: 103  HIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQ 162
             +GN++++  L+L++NK +G IP S  NL NL  LYL+ N L+G I   LG ++S+  L 
Sbjct: 196  DLGNMEYMIDLELSHNKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGNMESMISLA 255

Query: 163  LNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPP 222
            L++N+L G IP    NL +++ L L +N + G IP E+G M S+  L+L+QN   G +P 
Sbjct: 256  LSENKLTGSIPSSLGNLKNLTVLYLHQNYITGVIPPELGNMESMIDLELSQNNLTGSIPS 315

Query: 223  SISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFT 281
            S  N T LK L L YNHLSG+IPP + N   L +L L+ N+F+G+LP NIC+GG L+   
Sbjct: 316  SFGNFTKLKSLYLSYNHLSGAIPPGVANSSELTELQLAINNFSGFLPKNICKGGKLQFIA 375

Query: 282  VSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISS 341
            + +NH +G IP SLR+C SLIR +  GN   GNISEA G+YP+L FIDLS N F GEISS
Sbjct: 376  LYDNHLKGPIPKSLRDCKSLIRAKFVGNKFVGNISEAFGVYPDLNFIDLSHNKFNGEISS 435

Query: 342  NWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLI 401
            NW K PKLG L +S NNITG +P EI N  QL   DLS N++ GE+P+ +G L  L++L 
Sbjct: 436  NWQKSPKLGALIMSNNNITGAIPPEIWNMKQLGELDLSANNLSGELPEAIGNLTNLSRLR 495

Query: 402  LRGNQITGRLPKEIGSLTKLEYLDFSA--------------------------------- 428
            L GNQ++GR+P  I  LT LE LD S+                                 
Sbjct: 496  LNGNQLSGRVPAGISFLTNLESLDLSSNRFSSQIPQTFDSFLKLHEMNLSRNNFDGRIPG 555

Query: 429  -----------------IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDM 471
                              GE+PSQ+ +++SL+KLNLSHNNLSG IP+ FE M  L+FID+
Sbjct: 556  LTKLTQLTHLDLSHNQLDGEIPSQLSSLQSLDKLNLSHNNLSGFIPTTFESMKALTFIDI 615

Query: 472  SYNELQCPVPNSTTFRGASVEALKGNKGLCGS--AKGLQPCKPLR----QEKSNSGAKWF 525
            S N+L+ P+P++  F+ A+ +AL+GN+GLC +   + L+ C P+     Q+   +G    
Sbjct: 616  SNNKLEGPLPDNPAFQNATSDALEGNRGLCSNIPKQRLKSC-PITSGGFQKPKKNGNLLV 674

Query: 526  AIVFPLLGALFV-SIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIV 584
             I+ P+LGAL + SI   +  + +RK+K  +G R ++++  + ++SI + +GK  Y +I+
Sbjct: 675  WILVPILGALVILSICAGAFTYYIRKRKPHNG-RNTDSETGE-NMSIFSVDGKFKYQDII 732

Query: 585  KATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLL--PCDQTVDQKEFLTEVEAF 642
            ++TN+FD +Y IG+GG++ VY+A LP   +VAVK+ H  +     + V ++EFL EV A 
Sbjct: 733  ESTNEFDQRYLIGSGGYSKVYKANLPDA-IVAVKRLHDTIDEEISKPVVKQEFLNEVRAL 791

Query: 643  -----------YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
                       +GFCSH RH+FL+YE++E+GSL  +L  +  A+ L W++R+N++K VAH
Sbjct: 792  TEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANEEEAKRLTWTKRINIVKGVAH 851

Query: 692  ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            ALSY+HHD   PIVHRDISS N+LLD +Y A ++DFG AK LK DSSNW+  AGT GY+A
Sbjct: 852  ALSYMHHDRSTPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVA 911

Query: 752  PELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
            PE AYTMK+TEKCDVYSFGVL+ EVI GKHP D ++S+SSS   T ++L  + D R+  P
Sbjct: 912  PEFAYTMKVTEKCDVYSFGVLILEVIMGKHPGDLVASLSSSPGET-LSLRSISDERILEP 970

Query: 812  SRSAQEKLISIMEVAFSCFNESPESRPTMKIIS 844
                +EKLI ++EVA SC    P+SRPTM  IS
Sbjct: 971  RGQNREKLIKMVEVALSCLQADPQSRPTMLSIS 1003

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata]

 Score =  734 bits (1894), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 403/887 (45%), Positives = 561/887 (63%), Gaps = 78/887 (8%)

Query: 25   SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
            S  +  +L  L L  N   G IPP++ N+ ++  L L  N+ +G+I       SS GNL+
Sbjct: 244  SLGNLKNLTVLYLHHNYLTGVIPPELGNMESMIDLELSDNKLTGSI------PSSLGNLK 297

Query: 85   YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
             ++ L +  N L+G IPP +GN++ ++ LDL+ NK +G IP S  NL NL  LYL+ N L
Sbjct: 298  NLTVLYLYKNYLTGVIPPELGNMESMTYLDLSENKLTGSIPSSLGNLKNLTVLYLHHNYL 357

Query: 145  SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR 204
            +G I   LG L+S+ DL+L+DN+L G IP    NL +++ L L  N L G IP E+G M 
Sbjct: 358  TGVIPPELGNLESMIDLELSDNKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGNME 417

Query: 205  SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHF 263
            S+  L L+QN   G +P S  N T L+ L L  NHLSG+IP  + N   L +LLL  N+F
Sbjct: 418  SMIDLALSQNNLTGSIPSSFGNFTKLESLYLRDNHLSGTIPRGVANSSELTELLLDINNF 477

Query: 264  TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYP 323
            TG+LP NIC+GG L+ F++  NH +G IP SLR+C SLIR +  GN   GNISEA G+YP
Sbjct: 478  TGFLPENICKGGKLQNFSLDYNHLEGHIPKSLRDCKSLIRAKFVGNKFIGNISEAFGVYP 537

Query: 324  NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI 383
            +L FIDLS N F GEISSNW K PKLG L +S NNITG +P EI N  QL   DLS N++
Sbjct: 538  DLDFIDLSHNKFNGEISSNWQKSPKLGALIMSNNNITGAIPPEIWNMKQLGELDLSTNNL 597

Query: 384  VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--------------- 428
             GE+P+ +G L  L+KL+L GN+++GR+P  +  LT LE LD S+               
Sbjct: 598  TGELPEAIGNLTGLSKLLLNGNKLSGRVPTGLSFLTNLESLDLSSNRFSSQIPQTFDSFL 657

Query: 429  -----------------------------------IGELPSQICNMKSLEKLNLSHNNLS 453
                                                GE+PSQ+ +++SL+KLNLSHNNLS
Sbjct: 658  KLHEMNLSKNNFDGRIPGLTKLTQLTHLDLSHNQLDGEIPSQLSSLQSLDKLNLSHNNLS 717

Query: 454  GSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGS--AKGLQPCK 511
            G IP+ FE M  L+FID+S N+L+ P+P++  F+ A+ +AL+GN+GLC +   + L+ C+
Sbjct: 718  GFIPTTFESMKALTFIDISNNKLEGPLPDNPAFQNATSDALEGNRGLCSNIPKQRLKSCR 777

Query: 512  PLRQEKSNSGAKWFAIVFPLLGALFV-SIALISIFFILRKQKSDSGDRQSNNQIPQGSLS 570
              ++ K N G     I+ P+LGAL + SI   +  + +RK+K  +G R ++++  + ++S
Sbjct: 778  GFQKPKKN-GNLLVWILVPILGALVILSICAGAFTYYIRKRKPHNG-RNTDSETGE-NMS 834

Query: 571  ILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLL--PCDQ 628
            I + +GK  Y +I+++TN+FD +Y IG+GG++ VY+A LP   +VAVK+ H  +     +
Sbjct: 835  IFSVDGKFKYQDIIESTNEFDQRYLIGSGGYSKVYKANLPDA-IVAVKRLHDTIDEEISK 893

Query: 629  TVDQKEFLTEVEAF-----------YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQEL 677
             V ++EFL EV A            +GFCSH RH+FL+YE++E+GSL  +L  +  A+ L
Sbjct: 894  PVVKQEFLNEVRALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANEEEAKRL 953

Query: 678  GWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS 737
             W++R+N++K VAHALSY+HHD   PIVHRDISS N+LLD +Y A ++DFG AK LK DS
Sbjct: 954  TWTKRINIVKGVAHALSYMHHDRSTPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDS 1013

Query: 738  SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTD 797
            SNW+  AGT GY+APE AYTMK+TEKCDVYSFGVL+ EVI GKHP D ++S+SSS   T 
Sbjct: 1014 SNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGVLILEVIMGKHPGDLVASLSSSPGET- 1072

Query: 798  VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIIS 844
            ++L  + D R+  P    +EKLI ++EVA SC    P+SRPTM  IS
Sbjct: 1073 LSLRSISDERILEPRGQNREKLIKMVEVALSCLQADPQSRPTMLSIS 1119

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|186511602|ref|NP_849538.2| Leucine-rich repeat-containing protein [Arabidopsis thaliana] gi|281185491|sp|Q8VZG8.3|Y4885_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At4g08850; Flags: Precursor gi|18086327|gb|AAL57627.1| AT4g08850/T32A17_160 [Arabidopsis thaliana] gi|224589610|gb|ACN59338.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332657282|gb|AEE82682.1| Leucine-rich repeat-containing protein [Arabidopsis thaliana]

 Score =  732 bits (1890), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 406/953 (42%), Positives = 570/953 (59%), Gaps = 117/953 (12%)

Query: 5    GRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTI------------------ 46
            G +I ++L N G+ GT  DF FSS P+L ++DL+ N F GTI                  
Sbjct: 93   GSIIRLNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSIN 152

Query: 47   ------PPQISNLSNLRYLYLGSNQFSGNILAEVSS------------------ESSGGN 82
                  PP++ +LSNL  L+L  N+ +G+I +E+                     SS GN
Sbjct: 153  QLVGEIPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGN 212

Query: 83   LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN 142
            L  +  L +  NSLSG IP  IGNL  L +L L  N  +G IP SF NL N+  L ++ N
Sbjct: 213  LTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFEN 272

Query: 143  LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGK 202
             LSG I   +G + +L  L L+ N+L G IP    N+ +++ L L  N L GSIP E+G+
Sbjct: 273  QLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGE 332

Query: 203  MRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGN 261
            M S+  L++++N+  G +P S   LT L+ L L  N LSG IPP + N   L  L L  N
Sbjct: 333  MESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTN 392

Query: 262  HFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGI 321
            +FTG+LP  ICRGG LE  T+ +NHF+G +P SLR+C SLIRVR  GN+ +G+ISEA G+
Sbjct: 393  NFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGV 452

Query: 322  YPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLN 381
            YP L FIDLS NNF+G++S+NW +  KL    +S N+ITG +P EI N +QL   DLS N
Sbjct: 453  YPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSN 512

Query: 382  HIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA------------- 428
             I GE+P+ +  +N ++KL L GN+++G++P  I  LT LEYLD S+             
Sbjct: 513  RITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNN 572

Query: 429  --------------------------------------IGELPSQICNMKSLEKLNLSHN 450
                                                   GE+ SQ  ++++LE+L+LSHN
Sbjct: 573  LPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHN 632

Query: 451  NLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGS---AKGL 507
            NLSG IP  F+ M  L+ +D+S+N LQ P+P++  FR A  +A +GNK LCGS    +GL
Sbjct: 633  NLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGL 692

Query: 508  QPCKPLRQEKSNSGAKWFA-IVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQ 566
            +PC     +KS+        I+ P++GA+ +      IF   RK ++   +  ++++   
Sbjct: 693  KPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRK-RTKQIEEHTDSESGG 751

Query: 567  GSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPC 626
             +LSI +F+GK+ Y EI+KAT +FD KY IG GGH  VY+A+LP+  ++AVKK +     
Sbjct: 752  ETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNET--T 808

Query: 627  DQTVD----QKEFLTEVEAF-----------YGFCSHARHSFLLYEFLERGSLAAILNTD 671
            D ++     ++EFL E+ A            +GFCSH R++FL+YE++ERGSL  +L  D
Sbjct: 809  DSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLEND 868

Query: 672  AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK 731
              A++L W +R+NV+K VAHALSY+HHD  P IVHRDISS N+LL  +YEA ++DFG AK
Sbjct: 869  DEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAK 928

Query: 732  SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS 791
             LKPDSSNW+  AGT GY+APELAY MK+TEKCDVYSFGVL  EVIKG+HP D +S++SS
Sbjct: 929  LLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSS 988

Query: 792  SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIIS 844
            S  +  ++L  + D RLP P+   +E+++ I++VA  C +  P++RPTM  IS
Sbjct: 989  SPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	849
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.964	0.731	0.389	6.7e-152
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.950	0.772	0.376	3.4e-141
TAIR|locus:2120362	1249	GSO1 "GASSHO1" [Arabidopsis th	0.736	0.500	0.325	3.6e-116
TAIR|locus:2169965	1003	BAM1 "BARELY ANY MERISTEM 1" [	0.961	0.813	0.341	2.1e-107
TAIR|locus:2097310	1002	BAM2 "BARELY ANY MERISTEM 2" [	0.959	0.813	0.339	4.4e-107
TAIR|locus:2005540	999	HAE "HAESA" [Arabidopsis thali	0.696	0.591	0.318	4.5e-107
UNIPROTKB|Q5Z9N5	994	P0481E08.42 "Os06g0717200 prot	0.970	0.828	0.324	2.3e-103
TAIR|locus:2120412	992	BAM3 "BARELY ANY MERISTEM 3" [	0.963	0.824	0.330	3.7e-103
TAIR|locus:2032697	1123	PEPR1 "PEP1 receptor 1" [Arabi	0.968	0.731	0.306	2e-102
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.583	0.415	0.336	2.5e-102

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 1482 (526.7 bits), Expect = 6.7e-152, P = 6.7e-152
 Identities = 335/860 (38%), Positives = 499/860 (58%)

Query:     9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSG 68
             N++L    + G++   S  +  +L  L L  N   G IPP++ N+ ++  L L +N+ +G
Sbjct:   274 NLALSQNKLTGSIPS-SLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNNKLTG 332

Query:    69 NILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSF 128
             +I       SS GNL+ ++ L + +N L+G IPP +GN++ +  L L NNK +G IP SF
Sbjct:   333 SI------PSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSF 386

Query:   129 DNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS 188
              NL NL +                       +L L+ N+L G +P  F N T + +L L 
Sbjct:   387 GNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLR 446

Query:   189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL 248
              N L G+IP  +     L+ L L+ N F G  P ++     L+ ++L YNHL G IP SL
Sbjct:   447 VNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSL 506

Query:   249 GNL--ILRQLLLSGNHFTG--YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRV 304
              +   ++R   L GN FTG  +  + I     L     S N F G I ++      L  +
Sbjct:   507 RDCKSLIRARFL-GNKFTGDIFEAFGIYPD--LNFIDFSHNKFHGEISSNWEKSPKLGAL 563

Query:   305 RLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLP 364
              ++ NN+TG I   +     L  +DLS NN +GE+    G    L  L ++ N ++G +P
Sbjct:   564 IMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVP 623

Query:   365 REIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL 424
               +   + L++ DLS N+   EIP+       L  + L  N+  G +P+ +  LT+L  L
Sbjct:   624 AGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIPR-LSKLTQLTQL 682

Query:   425 DFS---AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVP 481
             D S     GE+PSQ+ +++SL+KL+LSHNNLSG IP+ FEGM  L+ +D+S N+L+ P+P
Sbjct:   683 DLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLP 742

Query:   482 NSTTFRGASVEALKGNKGLCGSA--KGLQPCKPLRQEKSNSG-AKWFAIVFPLLGALFV- 537
             ++ TFR A+ +AL+ N GLC +   + L+PC+ L++ K N     W  I+ P+LG L + 
Sbjct:   743 DTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVW--ILVPILGVLVIL 800

Query:   538 SIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIG 597
             SI   +  + +RK+K  +G R ++ +  + ++SI + +GK  Y +I+++TN+FD  + IG
Sbjct:   801 SICANTFTYCIRKRKLQNG-RNTDPETGE-NMSIFSVDGKFKYQDIIESTNEFDPTHLIG 858

Query:   598 NGGHASVYRAELPSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVEAF-----------YG 644
              GG++ VYRA L    ++AVK+ H  +     + V ++EFL EV+A            +G
Sbjct:   859 TGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFG 917

Query:   645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
             FCSH RH+FL+YE++E+GSL  +L  D  A+ L W++R+NV+K VAHALSY+HHD   PI
Sbjct:   918 FCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPI 977

Query:   705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKC 764
             VHRDISS N+LLD +Y A ++DFG AK LK DSSNW+  AGT GY+APE AYTMK+TEKC
Sbjct:   978 VHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKC 1037

Query:   765 DVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIME 824
             DVYSFGVL+ E+I GKHP D L           ++L  + D R+  P    +EKL+ ++E
Sbjct:  1038 DVYSFGVLILELIIGKHPGD-LVSSLSSSPGEALSLRSISDERVLEPRGQNREKLLKMVE 1096

Query:   825 VAFSCFNESPESRPTMKIIS 844
             +A  C   +PESRPTM  IS
Sbjct:  1097 MALLCLQANPESRPTMLSIS 1116

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 1381 (491.2 bits), Expect = 3.4e-141, P = 3.4e-141
 Identities = 323/859 (37%), Positives = 476/859 (55%)

Query:     6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQ 65
             +++N+ L    ++G++      + P+L  L L  N   G IP    NL N+  L +  NQ
Sbjct:   215 KLVNLYLFINSLSGSIPS-EIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQ 273

Query:    66 FSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP 125
              SG I  E+      GN+  +  L ++ N L+G IP  +GN+K L+ L L  N+ +G IP
Sbjct:   274 LSGEIPPEI------GNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIP 327

Query:   126 LSFDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTL 185
                  + ++I                         L L DNQL G IP   +N T ++ L
Sbjct:   328 PELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVL 387

Query:   186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP 245
             +L  N+  G +PD I +   L  L L+ N F+G +P S+ +  +L  +    N  SG I 
Sbjct:   388 QLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDIS 447

Query:   246 PSLGNL-ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRV 304
              + G    L  + LS N+F G L  N  +   L  F +S N   G IP  + N T L ++
Sbjct:   448 EAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQL 507

Query:   305 RLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLP 364
              L+ N +TG + E++     ++ + L+ N   G+I S       L  L++S N  +  +P
Sbjct:   508 DLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIP 567

Query:   365 REIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL 424
               + N  +L   +LS N +   IP+ L KL+ L  L L  NQ                 L
Sbjct:   568 PTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQ-----------------L 610

Query:   425 DFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNST 484
             D    GE+ SQ  ++++LE+L+LSHNNLSG IP  F+ M  L+ +D+S+N LQ P+P++ 
Sbjct:   611 D----GEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNA 666

Query:   485 TFRGASVEALKGNKGLCGSA---KGLQPCKPLRQEKSNSGAKWFA-IVFPLLGALFVSIA 540
              FR A  +A +GNK LCGS    +GL+PC     +KS+        I+ P++GA+ +   
Sbjct:   667 AFRNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSV 726

Query:   541 LISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGG 600
                IF   RK+     +  ++++    +LSI +F+GK+ Y EI+KAT +FD KY IG GG
Sbjct:   727 CAGIFICFRKRTKQI-EEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGG 785

Query:   601 HASVYRAELPSGEVVAVKKFHSLLPCDQTVD----QKEFLTEVEAF-----------YGF 645
             H  VY+A+LP+  ++AVKK +     D ++     ++EFL E+ A            +GF
Sbjct:   786 HGKVYKAKLPNA-IMAVKKLNETT--DSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGF 842

Query:   646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
             CSH R++FL+YE++ERGSL  +L  D  A++L W +R+NV+K VAHALSY+HHD  P IV
Sbjct:   843 CSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIV 902

Query:   706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCD 765
             HRDISS N+LL  +YEA ++DFG AK LKPDSSNW+  AGT GY+APELAY MK+TEKCD
Sbjct:   903 HRDISSGNILLGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCD 962

Query:   766 VYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEV 825
             VYSFGVL  EVIKG+HP D +        +  ++L  + D RLP P+   +E+++ I++V
Sbjct:   963 VYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKV 1022

Query:   826 AFSCFNESPESRPTMKIIS 844
             A  C +  P++RPTM  IS
Sbjct:  1023 ALLCLHSDPQARPTMLSIS 1041

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)]

 Score = 729 (261.7 bits), Expect = 3.6e-116, Sum P(2) = 3.6e-116
 Identities = 215/660 (32%), Positives = 316/660 (47%)

Query:    10 ISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGN 69
             + L N  + G++ +  F     L  L L  N   GT+ P ISNL+NL++L L  N   G 
Sbjct:   365 LDLSNNSLAGSIPEALFE-LVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGK 423

Query:    70 ILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFD 129
             +  E+S+      LR +  L + +N  SG IP  IGN   L  +D+  N F G IP S  
Sbjct:   424 LPKEISA------LRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIG 477

Query:   130 NLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSR 189
              L  L                          L L DNQL G IP  F  L  +  L L  
Sbjct:   478 RLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYN 537

Query:   190 NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLG 249
             N L G++PD +  +R+L+ ++L+ N+  G + P   + + L    +  N     IP  LG
Sbjct:   538 NSLQGNLPDSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLS-FDVTNNGFEDEIPLELG 596

Query:   250 NLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNG 308
             N   L +L L  N  TG +P+ + +   L +  +S N   GTIP  L  C  L  + LN 
Sbjct:   597 NSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNN 656

Query:   309 NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIG 368
             N L+G I   LG    L  + LS N F   + +      KL  L++  N++ G +P+EIG
Sbjct:   657 NFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIG 716

Query:   369 NSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEY-LDFS 427
             N   L   +L  N   G +P+ +GKL+ L +L L  N +TG +P EIG L  L+  LD S
Sbjct:   717 NLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLS 776

Query:   428 A---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNST 484
                  G++PS I  +  LE L+LSHN L+G +P     M  L ++++S+N L   +    
Sbjct:   777 YNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ- 835

Query:   485 TFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSG--AKWFAIVFPL--LGALFVSIA 540
              F     ++  GN GLCGS   L  C  +R      G  A+   I+  +  L A+ + I 
Sbjct:   836 -FSRWPADSFLGNTGLCGSP--LSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMIL 892

Query:   541 LISIFFILRK---QKSDSGDRQ--SNNQIPQGSLSIL--NFEGK--ILYDEIVKATNDFD 591
             +I++FF  R    +K   G     S++   Q +   L  N   K  I +++I++AT++  
Sbjct:   893 VIALFFKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLS 952

Query:   592 AKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARH 651
              ++ IG+GG   VY+AEL +GE VAVKK   +L  D  +  K F  EV+   G   H RH
Sbjct:   953 EEFMIGSGGSGKVYKAELENGETVAVKK---ILWKDDLMSNKSFSREVKTL-GRIRH-RH 1007

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1062 (378.9 bits), Expect = 2.1e-107, P = 2.1e-107
 Identities = 296/868 (34%), Positives = 422/868 (48%)

Query:     9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSG 68
             +++L N   NG+  D   S   +L  LD+  N   G +P  ++NL+ LR+L+LG N F+G
Sbjct:   121 HLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAG 180

Query:    69 NILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN-NKFSGPIPLS 127
              I        S G+   +  L ++ N L G IPP IGNL  L +L +   N F   +P  
Sbjct:   181 KI------PPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPE 234

Query:   128 FDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTLRL 187
               NLS L+                         L L  N   G +      L+S+ ++ L
Sbjct:   235 IGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDL 294

Query:   188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS 247
             S N   G IP    ++++L++L+L +N+  G +P  I +L  L+ L L  N+ +GSIP  
Sbjct:   295 SNNMFTGEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQK 354

Query:   248 LG-NLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRL 306
             LG N  L  + LS N  TG LP N+C G  LE      N   G+IP SL  C SL R+R+
Sbjct:   355 LGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRM 414

Query:   307 NGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPRE 366
               N L G+I + L   P LT ++L  N   GE+    G    LG +++S N ++G LP  
Sbjct:   415 GENFLNGSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPA 474

Query:   367 IGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDF 426
             IGN + +Q   L  N   G IP E+GKL  L+K+    N  +GR+  EI     L ++D 
Sbjct:   475 IGNFTGVQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDL 534

Query:   427 SA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
             S     GE+P++I  MK L  LNLS N+L GSIP     M  L+ +D SYN L   VP +
Sbjct:   535 SRNELSGEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGT 594

Query:   484 TTFRGASVEALKGNKGLCGSAKGLQPCKPL-----RQEKSNSGAKWFAIVFPLLGALFVS 538
               F   +  +  GN  LCG   G  PCK        Q  S         +  +LG L  S
Sbjct:   595 GQFSYFNYTSFLGNPDLCGPYLG--PCKDGVAKGGHQSHSKGPLSASMKLLLVLGLLVCS 652

Query:   539 IALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGN 598
             IA   +  I  +    + + ++       +   L+F    + D + K  N       IG 
Sbjct:   653 IAFAVVAIIKARSLKKASESRAWRLT---AFQRLDFTCDDVLDSL-KEDN------IIGK 702

Query:   599 GGHASVYRAELPSGEVVAVKKF----------HSLLPCDQTVDQKEFLTEVEAFYGFCSH 648
             GG   VY+  +P+G++VAVK+           H      QT+ +      +    GFCS+
Sbjct:   703 GGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRH-RHIVRLLGFCSN 761

Query:   649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRD 708
                + L+YE++  GSL  +L+       L W  R  +    A  L YLHHDC P IVHRD
Sbjct:   762 HETNLLVYEYMPNGSLGEVLHGKKGGH-LHWDTRYKIALEAAKGLCYLHHDCSPLIVHRD 820

Query:   709 ISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDV 766
             + S N+LLD  +EAHVADFG+AK L+   ++   +  AG+ GYIAPE AYT+K+ EK DV
Sbjct:   821 VKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDV 880

Query:   767 YSFGVLMWEVIKGKHP----RDFLXXXXXXXLNTDVALD---QMLDPRLPAPSRSAQEKL 819
             YSFGV++ E++ G+ P     D +         TD   D   ++LDPRL   S     ++
Sbjct:   881 YSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKDSVLKVLDPRL---SSIPIHEV 937

Query:   820 ISIMEVAFSCFNESPESRPTMKIISQQL 847
               +  VA  C  E    RPTM+ + Q L
Sbjct:   938 THVFYVAMLCVEEQAVERPTMREVVQIL 965

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0043621 "protein self-association" evidence=IDA

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1059 (377.8 bits), Expect = 4.4e-107, P = 4.4e-107
 Identities = 294/865 (33%), Positives = 424/865 (49%)

Query:     9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSG 68
             +++L N   NG+  D   S   +L  LDL  N   G +P  ++NL+ LR+L+LG N FSG
Sbjct:   121 HLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSG 180

Query:    69 NILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN-NKFSGPIPLS 127
              I A        G    +  L ++ N L+G IPP IGNL  L +L +   N F   +P  
Sbjct:   181 KIPATY------GTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPE 234

Query:   128 FDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTLRL 187
               NLS L+                         L L  N   G I +    ++S+ ++ L
Sbjct:   235 IGNLSELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDL 294

Query:   188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS 247
             S N   G IP    ++++L++L+L +N+  G +P  I  +  L+ L L  N+ +GSIP  
Sbjct:   295 SNNMFTGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQK 354

Query:   248 LG-NLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRL 306
             LG N  L  L LS N  TG LP N+C G  L       N   G+IP SL  C SL R+R+
Sbjct:   355 LGENGRLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRM 414

Query:   307 NGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS-SNWGKFPKLGTLNVSMNNITGGLPR 365
               N L G+I + L   P L+ ++L  N   GE+  S  G    LG +++S N ++G LP 
Sbjct:   415 GENFLNGSIPKELFGLPKLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPA 474

Query:   366 EIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLD 425
              IGN S +Q   L  N   G IP E+G+L  L+KL    N  +GR+  EI     L ++D
Sbjct:   475 AIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVD 534

Query:   426 FSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPN 482
              S     G++P+++  MK L  LNLS N+L GSIP     M  L+ +D SYN L   VP+
Sbjct:   535 LSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPS 594

Query:   483 STTFRGASVEALKGNKGLCGSAKGLQPC-KPLRQEKSNSGAKWFAIVFPLLGALFVSIAL 541
             +  F   +  +  GN  LCG   G  PC K   Q      +    ++  +LG LF S+  
Sbjct:   595 TGQFSYFNYTSFVGNSHLCGPYLG--PCGKGTHQSHVKPLSATTKLLL-VLGLLFCSMVF 651

Query:   542 ISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGH 601
               +  I  +   ++ + ++       +   L+F    + D + K  N       IG GG 
Sbjct:   652 AIVAIIKARSLRNASEAKAWRLT---AFQRLDFTCDDVLDSL-KEDN------IIGKGGA 701

Query:   602 ASVYRAELPSGEVVAVKKF----------HSLLPCDQTVDQKEFLTEVEAFYGFCSHARH 651
               VY+  +P G++VAVK+           H      QT+ +      +    GFCS+   
Sbjct:   702 GIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRH-RHIVRLLGFCSNHET 760

Query:   652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS 711
             + L+YE++  GSL  +L+       L W+ R  +    A  L YLHHDC P IVHRD+ S
Sbjct:   761 NLLVYEYMPNGSLGEVLHGKKGGH-LHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKS 819

Query:   712 KNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
              N+LLD  +EAHVADFG+AK L+   ++   +  AG+ GYIAPE AYT+K+ EK DVYSF
Sbjct:   820 NNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSF 879

Query:   770 GVLMWEVIKGKHP----RDFLXXXXXXXLNTDVALD---QMLDPRLPAPSRSAQEKLISI 822
             GV++ E+I GK P     D +         TD   D   +++D RL   S     ++  +
Sbjct:   880 GVVLLELITGKKPVGEFGDGVDIVQWVRSMTDSNKDCVLKVIDLRL---SSVPVHEVTHV 936

Query:   823 MEVAFSCFNESPESRPTMKIISQQL 847
               VA  C  E    RPTM+ + Q L
Sbjct:   937 FYVALLCVEEQAVERPTMREVVQIL 961

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048229 "gametophyte development" evidence=IGI

GO:0048437 "floral organ development" evidence=IGI

GO:0010480 "microsporocyte differentiation" evidence=IGI

GO:0048653 "anther development" evidence=IGI;RCA

GO:0009934 "regulation of meristem structural organization" evidence=IGI

GO:0005515 "protein binding" evidence=IPI

GO:0033612 "receptor serine/threonine kinase binding" evidence=IPI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009740 "gibberellic acid mediated signaling pathway" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010162 "seed dormancy process" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)]

 Score = 685 (246.2 bits), Expect = 4.5e-107, Sum P(2) = 4.5e-107
 Identities = 205/644 (31%), Positives = 311/644 (48%)

Query:     9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQIS-NLSNLRYLYLGSNQFS 67
             ++SL N  +NG+L    F +  +L  LDL+ N   G+IP  +  NL NL++L     + S
Sbjct:    93 SLSLYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLKFL-----EIS 147

Query:    68 GNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFS------ 121
             GN L++ +  SS G  R +  L +  N LSG IP  +GN+  L +L L  N FS      
Sbjct:   148 GNNLSD-TIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNLFSPSQIPS 206

Query:   122 -------------------GPIPLSFDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQ 162
                                GPIP S   L++L+                         ++
Sbjct:   207 QLGNLTELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKTVEQIE 266

Query:   163 LNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPP 222
             L +N   G +P    N+T++     S N L G IPD +  + +L  L+L +N  +G LP 
Sbjct:   267 LFNNSFSGELPESMGNMTTLKRFDASMNKLTGKIPDNLNLL-NLESLNLFENMLEGPLPE 325

Query:   223 SISNLTNLKELALLYNHLSGSIPPSLG-NLILRQLLLSGNHFTGYLPYNICRGGALEIFT 281
             SI+    L EL L  N L+G +P  LG N  L+ + LS N F+G +P N+C  G LE   
Sbjct:   326 SITRSKTLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLI 385

Query:   282 VSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISS 341
             + +N F G I  +L  C SL RVRL+ N L+G I       P L+ ++LS N+F G I  
Sbjct:   386 LIDNSFSGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPK 445

Query:   342 NWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLI 401
                    L  L +S N  +G +P EIG+ + +     + N   GEIP+ L KL  L++L 
Sbjct:   446 TIIGAKNLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLD 505

Query:   402 LRGNQITGRLPKEI-G--SLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPS 458
             L  NQ++G +P+E+ G  +L +L   +    GE+P ++  +  L  L+LS N  SG IP 
Sbjct:   506 LSKNQLSGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPL 565

Query:   459 CFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKS 518
               + +  L+ +++SYN L   +P     +  + + + GN GLC    GL  C+ + + K 
Sbjct:   566 ELQNLK-LNVLNLSYNHLSGKIPPLYANKIYAHDFI-GNPGLCVDLDGL--CRKITRSK- 620

Query:   519 NSGAKWFAI-VFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGK 577
             N G  W  + +F L G +FV + ++      RK ++      + ++    S   L+F   
Sbjct:   621 NIGYVWILLTIFLLAGLVFV-VGIVMFIAKCRKLRALKSSTLAASK--WRSFHKLHFSEH 677

Query:   578 ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFH 621
              + D +       D K  IG G    VY+ EL  GEVVAVKK +
Sbjct:   678 EIADCL-------DEKNVIGFGSSGKVYKVELRGGEVVAVKKLN 714

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)]

 Score = 1024 (365.5 bits), Expect = 2.3e-103, P = 2.3e-103
 Identities = 284/875 (32%), Positives = 431/875 (49%)

Query:     6 RVINISLPNIGVNGTLHDFSFSS---FPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLG 62
             R +N+S  N+  +  + D    +   FP L  +D   N   G +PP  ++ + LRYL+LG
Sbjct:   121 RHLNLSNNNLSGHFPVPDSGGGASPYFPSLELIDAYNNNLSGLLPPFSASHARLRYLHLG 180

Query:    63 SNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN-NKFS 121
              N F+G I        S G+L  +  L +N N+LSG +P  +  L  L ++ +   N++ 
Sbjct:   181 GNYFTGAI------PDSYGDLAALEYLGLNGNTLSGHVPVSLSRLTRLREMYIGYYNQYD 234

Query:   122 GPIPLSFDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTS 181
             G +P  F +L  L+                         L L  N+L G IP    +L+S
Sbjct:   235 GGVPPEFGDLGALLRLDMSSCNLTGPVPPELGRLQRLDTLFLQWNRLSGEIPPQLGDLSS 294

Query:   182 VSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS 241
             +++L LS NDL G IP  +  + +L +L+L +N  +G +P  ++    L+ L L  N+L+
Sbjct:   295 LASLDLSVNDLAGEIPPSLANLSNLKLLNLFRNHLRGSIPDFVAGFAQLEVLQLWDNNLT 354

Query:   242 GSIPPSLG-NLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTS 300
             G+IP  LG N  L+ L L+ NH TG +P ++C G  LE+  + EN   G IP SL +C +
Sbjct:   355 GNIPAGLGKNGRLKTLDLATNHLTGPIPADLCAGRRLEMLVLMENGLFGPIPDSLGDCKT 414

Query:   301 LIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT 360
             L RVRL  N LTG +   L   P    ++L+ N   GE+    G   K+G L +  N I 
Sbjct:   415 LTRVRLAKNFLTGPVPAGLFNLPQANMVELTDNLLTGELPDVIGG-DKIGMLLLGNNGIG 473

Query:   361 GGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTK 420
             G +P  IGN   LQ   L  N+  G +P E+G L  L++L + GN +TG +P E+     
Sbjct:   474 GRIPPAIGNLPALQTLSLESNNFSGALPPEIGNLKNLSRLNVSGNALTGAIPDELIRCAS 533

Query:   421 LEYLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
             L  +D S     GE+P  I ++K L  LN+S N L+G +P     M  L+ +D+SYN L 
Sbjct:   534 LAAVDLSRNGFSGEIPESITSLKILCTLNVSRNRLTGELPPEMSNMTSLTTLDVSYNSLS 593

Query:   478 CPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIVFP---LLGA 534
              PVP    F   +  +  GN GLCG       C P              + +    +L A
Sbjct:   594 GPVPMQGQFLVFNESSFVGNPGLCGGPVA-DACPPSMAGGGGGAGSQLRLRWDSKKMLVA 652

Query:   535 LFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILY--DEIVKATNDFDA 592
             L  + A +++ F L  +K  S  R +  +   G+  +  F+ K+ +  +++V+   + + 
Sbjct:   653 LVAAFAAVAVAF-LGARKGCSAWRSAARR-RSGAWKMTAFQ-KLEFSAEDVVECVKEDNI 709

Query:   593 KYCIGNGGHASVYRAELPSGEVVAVKKF-------HSL-LPCDQTVDQKEFLTEVEAFYG 644
                IG GG   VY   +  G  +A+K+        H      + T   +     +    G
Sbjct:   710 ---IGKGGAGIVYHG-VTRGAELAIKRLVGRGGGEHDRGFSAEVTTLGRIRHRNIVRLLG 765

Query:   645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
             F S+   + LLYE++  GSL  +L+       LGW  R  V    A  L YLHHDC P I
Sbjct:   766 FVSNRETNLLLYEYMPNGSLGEMLHGGKGGH-LGWEARARVAAEAACGLCYLHHDCAPRI 824

Query:   705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-WTEFAGTCGYIAPELAYTMKITEK 763
             +HRD+ S N+LLD  +EAHVADFG+AK L   +S   +  AG+ GYIAPE AYT+++ EK
Sbjct:   825 IHRDVKSNNILLDSAFEAHVADFGLAKFLGGATSECMSAIAGSYGYIAPEYAYTLRVDEK 884

Query:   764 CDVYSFGVLMWEVIKGKHPR-------DFLXXXXXXXL----NTDVALDQMLDPRLPAPS 812
              DVYSFGV++ E+I G+ P        D +            N+D A    +  R   P 
Sbjct:   885 SDVYSFGVVLLELITGRRPVGGFGDGVDIVHWVRKVTAELPDNSDTAAVLAVADRRLTPE 944

Query:   813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               A   ++++ +VA +C  E+  +RPTM+ +   L
Sbjct:   945 PVAL--MVNLYKVAMACVEEASTARPTMREVVHML 977

GO:0010080 "regulation of floral meristem growth" evidence=IMP

GO:0048833 "specification of floral organ number" evidence=IMP

TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1022 (364.8 bits), Expect = 3.7e-103, P = 3.7e-103
 Identities = 290/878 (33%), Positives = 426/878 (48%)

Query:     7 VINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQF 66
             V+NIS  N+   G L    FS    L  LD   N F G++P  ++ L+ L +L LG N F
Sbjct:   129 VLNIS-SNV-FEGELETRGFSQMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYF 186

Query:    67 SGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN-NKFSGPIP 125
              G I     S  S   L+++S   ++ N L G IP  + N+  L QL L   N + G IP
Sbjct:   187 DGEIPRSYGSFLS---LKFLS---LSGNDLRGRIPNELANITTLVQLYLGYYNDYRGGIP 240

Query:   126 LSFDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTL 185
               F  L NL+                         L L  N+L G +PR   N+TS+ TL
Sbjct:   241 ADFGRLINLVHLDLANCSLKGSIPAELGNLKNLEVLFLQTNELTGSVPRELGNMTSLKTL 300

Query:   186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP 245
              LS N L G IP E+  ++ L + +L  N+  G +P  +S L +L+ L L +N+ +G IP
Sbjct:   301 DLSNNFLEGEIPLELSGLQKLQLFNLFFNRLHGEIPEFVSELPDLQILKLWHNNFTGKIP 360

Query:   246 PSLG-NLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRV 304
               LG N  L ++ LS N  TG +P ++C G  L+I  +  N   G +P  L  C  L R 
Sbjct:   361 SKLGSNGNLIEIDLSTNKLTGLIPESLCFGRRLKILILFNNFLFGPLPEDLGQCEPLWRF 420

Query:   305 RLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEI---SSNWGKFPKLGTLNVSMNNITG 361
             RL  N LT  + + L   PNL+ ++L  N   GEI    +   +F  L  +N+S N ++G
Sbjct:   421 RLGQNFLTSKLPKGLIYLPNLSLLELQNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSG 480

Query:   362 GLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKL 421
              +P  I N   LQ   L  N + G+IP E+G L  L K+ +  N  +G+ P E G    L
Sbjct:   481 PIPGSIRNLRSLQILLLGANRLSGQIPGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSL 540

Query:   422 EYLDFS---AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC 478
              YLD S     G++P QI  ++ L  LN+S N+ + S+P+    M  L+  D S+N    
Sbjct:   541 TYLDLSHNQISGQIPVQISQIRILNYLNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSG 600

Query:   479 PVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSN-----SGAKWFAIVFPLLG 533
              VP S  F   +  +  GN  LCG +    PC   + +  +     + A+    +     
Sbjct:   601 SVPTSGQFSYFNNTSFLGNPFLCGFSSN--PCNGSQNQSQSQLLNQNNARSRGEISAKF- 657

Query:   534 ALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILY--DEIVKATNDFD 591
              LF  + L+  F +          R   N  P     ++ F+ K+ +  + I++   +  
Sbjct:   658 KLFFGLGLLGFFLVFVVLAVVKNRRMRKNN-PN-LWKLIGFQ-KLGFRSEHILECVKE-- 712

Query:   592 AKYCIGNGGHASVYRAELPSGEVVAVKKFHSL---------LPCD-QTVDQKEFLTEVEA 641
               + IG GG   VY+  +P+GE VAVKK  ++         L  + QT+ +      V  
Sbjct:   713 -NHVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTLGRIRHRNIVRL 771

Query:   642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
                FCS+   + L+YE++  GSL  +L+  A    L W  R+ +    A  L YLHHDC 
Sbjct:   772 L-AFCSNKDVNLLVYEYMPNGSLGEVLHGKAGVF-LKWETRLQIALEAAKGLCYLHHDCS 829

Query:   702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
             P I+HRD+ S N+LL  E+EAHVADFG+AK +  D   S   +  AG+ GYIAPE AYT+
Sbjct:   830 PLIIHRDVKSNNILLGPEFEAHVADFGLAKFMMQDNGASECMSSIAGSYGYIAPEYAYTL 889

Query:   759 KITEKCDVYSFGVLMWEVIKGKHPRD-F----LXXXXXXXLNTDV---ALDQMLDPRLP- 809
             +I EK DVYSFGV++ E+I G+ P D F    +       + T+     + +++D RL  
Sbjct:   890 RIDEKSDVYSFGVVLLELITGRKPVDNFGEEGIDIVQWSKIQTNCNRQGVVKIIDQRLSN 949

Query:   810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              P   A E    +  VA  C  E    RPTM+ + Q +
Sbjct:   950 IPLAEAME----LFFVAMLCVQEHSVERPTMREVVQMI 983

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048437 "floral organ development" evidence=IGI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 993 (354.6 bits), Expect = 2.0e-102, Sum P(2) = 2.0e-102
 Identities = 270/880 (30%), Positives = 439/880 (49%)

Query:     2 NDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYL 61
             N  G +  + + N  + G +  F   +  +L  LDL++N F G +PP + N S+L  L +
Sbjct:   240 NLLGNLTTLFVGNNSLQGPVR-FGSPNCKNLLTLDLSYNEFEGGVPPALGNCSSLDALVI 298

Query:    62 GSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFS 121
              S   SG I       SS G L+ ++ L +++N LSG IP  +GN   L+ L L +N+  
Sbjct:   299 VSGNLSGTI------PSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQLV 352

Query:   122 GPIPLSFDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTS 181
             G IP +   L  L                          L +  N L G +P   + +  
Sbjct:   353 GGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKK 412

Query:   182 VSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS 241
             +    L  N  +G+IP  +G   SL  +D   N+  G +PP++ +   L+ L L  N L 
Sbjct:   413 LKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNLLH 472

Query:   242 GSIPPSLGNL-ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTS 300
             G+IP S+G+   +R+ +L  N+ +G LP    +  +L     + N+F+G IP SL +C +
Sbjct:   473 GTIPASIGHCKTIRRFILRENNLSGLLP-EFSQDHSLSFLDFNSNNFEGPIPGSLGSCKN 531

Query:   301 LIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT 360
             L  + L+ N  TG I   LG   NL +++LSRN   G + +       L   +V  N++ 
Sbjct:   532 LSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSLN 591

Query:   361 GGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTK 420
             G +P    N   L    LS N   G IP+ L +L  L+ L +  N   G +P  IG +  
Sbjct:   592 GSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIED 651

Query:   421 LEY-LDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNEL 476
             L Y LD S     GE+P+++ ++  L +LN+S+NNL+GS+ S  +G+  L  +D+S N+ 
Sbjct:   652 LIYDLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVSNNQF 710

Query:   477 QCPVPNSTTFRGASV-EALKGNKGLC---------GSAKGLQPCKPLRQEKSNSGAKWFA 526
               P+P++   +  S   +  GN  LC          S   L+ CK   + + +  + W  
Sbjct:   711 TGPIPDNLEGQLLSEPSSFSGNPNLCIPHSFSASNNSRSALKYCKDQSKSRKSGLSTWQI 770

Query:   527 IVFPLLGALFVSIALISIFFI-LRKQKSDSGDRQSNNQIPQGSLSILNFEG-KILYDEIV 584
             ++  +L +L V + ++++ FI LR++K   G  + +  +          EG  +L ++++
Sbjct:   771 VLIAVLSSLLVLVVVLALVFICLRRRK---GRPEKDAYV------FTQEEGPSLLLNKVL 821

Query:   585 KATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKK--FHSLLPCDQTVDQK-EFLTEVE- 640
              AT++ + KY IG G H  VYRA L SG+V AVK+  F S +  +Q++ ++ + + +V  
Sbjct:   822 AATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASHIRANQSMMREIDTIGKVRH 881

Query:   641 ----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSY 695
                    GF        +LY ++ +GSL  +L+  +  +  L WS R NV   VAH L+Y
Sbjct:   882 RNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHGLAY 941

Query:   696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
             LH+DC PPIVHRDI  +N+L+D + E H+ DFG+A+ L   + +     GT GYIAPE A
Sbjct:   942 LHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDSTVSTATVTGTTGYIAPENA 1001

Query:   756 YTMKITEKCDVYSFGVLMWEVIKGKHPRD--F-----LXXXXXXXL-----NTDVALDQM 803
             +      + DVYS+GV++ E++  K   D  F     +       L     N +  +  +
Sbjct:  1002 FKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTI 1061

Query:   804 LDPRLPAP--SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
             +DP L       S +E+++ + E+A SC  + P  RPTM+
Sbjct:  1062 VDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMR 1101

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0045087 "innate immune response" evidence=TAS

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0006955 "immune response" evidence=IMP

GO:0009506 "plasmodesma" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0052542 "defense response by callose deposition" evidence=RCA

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 630 (226.8 bits), Expect = 2.5e-102, Sum P(2) = 2.5e-102
 Identities = 176/523 (33%), Positives = 254/523 (48%)

Query:    30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRL 89
             P L +L L  N   G+IP ++    +L  + L  N  SG I  EV    S      +  L
Sbjct:   353 PMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTI-EEVFDGCSS-----LGEL 406

Query:    90 VINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFXXXXXXXXXXXXX 149
             ++ +N ++G IP  +  L  ++ LDL +N F+G IP S    +NL+              
Sbjct:   407 LLTNNQINGSIPEDLWKLPLMA-LDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLP 465

Query:   150 XXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVL 209
                        L L+DNQL G IPR    LTS+S L L+ N   G IP E+G   SL+ L
Sbjct:   466 AEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTL 525

Query:   210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPY 269
             DL  N  +G +P  I+ L  L+ L L YN+LSGSIP S  +    Q+ +    F  +   
Sbjct:   526 DLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIP-SKPSAYFHQIEMPDLSFLQH--- 581

Query:   270 NICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFID 329
                 G    IF +S N   G IP  L  C  L+ + L+ N+L+G I  +L    NLT +D
Sbjct:   582 ---HG----IFDLSYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILD 634

Query:   330 LSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPK 389
             LS N   G I    G   KL  LN++ N + G +P   G    L   +L+ N + G +P 
Sbjct:   635 LSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPA 694

Query:   390 ELGKLNPLTKLILRGNQITGRLPKEIGSLTKLE--YLDFSAI-GELPSQICNMKSLEKLN 446
              LG L  LT + L  N ++G L  E+ ++ KL   Y++ +   GE+PS++ N+  LE L+
Sbjct:   695 SLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLD 754

Query:   447 LSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKG 506
             +S N LSG IP+   G+  L F++++ N L+  VP+    +  S   L GNK LCG   G
Sbjct:   755 VSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVG 814

Query:   507 LQPCKPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILR 549
                CK +   K  S   W  I   +LG  F  I  + +F + R
Sbjct:   815 -SDCK-IEGTKLRSA--W-GIAGLMLG--FTIIVFVFVFSLRR 850

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: scaffold_104021.1 annotation not avaliable (1007 aa) (Arabidopsis lyrata)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	849
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-108
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-68
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-35
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-35
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-34
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-33
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-33
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-33
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-26
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-25
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-25
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-22
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-20
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-20
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-20
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-19
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-18
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-17
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-17
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-17
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-17
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-17
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-16
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-16
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-15
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-15
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-15
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-14
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-14
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	5e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	7e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-13
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-13
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-13
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-13
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-12
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-12
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-12
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-12
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-12
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	5e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-12
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	9e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-11
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-11
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-11
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	7e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	9e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-10
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-10
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-10
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-10
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	4e-10
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-10
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-10
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-10
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	9e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-09
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-09
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-09
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-08
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-08
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-08
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-08
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-08
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	5e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-08
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	9e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-08
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	9e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-07
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	3e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-07
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-07
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-07
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-06
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-06
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	6e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-05
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-05
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-05
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-05
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-05
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	8e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-05
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-04
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-04
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-04
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-04
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	9e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.002
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	0.003
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.003
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.004
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	0.004
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  356 bits (914), Expect = e-108
 Identities = 262/882 (29%), Positives = 427/882 (48%), Gaps = 75/882 (8%)

Query: 10  ISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGN 69
           I+L N  ++G + D  F++   L YL+L+ N F G+IP    ++ NL  L L +N  SG 
Sbjct: 98  INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGE 155

Query: 70  ILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFD 129
           I  ++ S S   +L+    L +  N L G IP  + NL  L  L L +N+  G IP    
Sbjct: 156 IPNDIGSFS---SLKV---LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELG 209

Query: 130 NLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSR 189
            + +L ++YL  N LSG I   +G L SL  L L  N L G IP    NL ++  L L +
Sbjct: 210 QMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ 269

Query: 190 NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLG 249
           N L G IP  I  ++ L  LDL+ N   G +P  +  L NL+ L L  N+ +G IP +L 
Sbjct: 270 NKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329

Query: 250 NLILRQLL-LSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNG 308
           +L   Q+L L  N F+G +P N+ +   L +  +S N+  G IP  L +  +L ++ L  
Sbjct: 330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389

Query: 309 NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIG 368
           N+L G I ++LG   +L  + L  N+F GE+ S + K P +  L++S NN+ G +     
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449

Query: 369 NSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA 428
           +   LQ   L+ N   G +P   G    L  L L  NQ +G +P+++GSL++L  L  S 
Sbjct: 450 DMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSELMQLKLSE 508

Query: 429 ---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVP---- 481
               GE+P ++ + K L  L+LSHN LSG IP+ F  M  LS +D+S N+L   +P    
Sbjct: 509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLG 568

Query: 482 ----------------NSTTFRGA----SVEALKGNKGLCG--SAKGLQPCKPLRQEKSN 519
                            S    GA    +  A+ GN  LCG  +  GL PCK +R+  S 
Sbjct: 569 NVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPS- 627

Query: 520 SGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGK-- 577
               W+  +   LGA F+ +AL++  F+  + +++   ++  N+   G+  +  F+ K  
Sbjct: 628 ----WWFYITCTLGA-FLVLALVAFGFVFIRGRNNLELKRVENE--DGTWELQFFDSKVS 680

Query: 578 --ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVD 631
             I  ++I+ +  +   +  I  G   + Y+ +         V  +   +S+   +    
Sbjct: 681 KSITINDILSSLKE---ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADM 737

Query: 632 QKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
            K     +    G C   + ++L++E++E  +L+ +L        L W +R  +   +A 
Sbjct: 738 GKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAK 791

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           AL +LH  C P +V  ++S + +++D + E H+    +   L  D+  +   A    Y+A
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSA----YVA 846

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN------TDVALDQMLD 805
           PE   T  ITEK D+Y FG+++ E++ GK P D    +  S +       +D  LD  +D
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID 906

Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P +       Q +++ +M +A  C    P +RP    + + L
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  245 bits (627), Expect = 1e-68
 Identities = 168/487 (34%), Positives = 239/487 (49%), Gaps = 39/487 (8%)

Query: 1   CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLS-NLRYL 59
           CN++ RV++I L    ++G +    F   P++  ++L+ N   G IP  I   S +LRYL
Sbjct: 65  CNNSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123

Query: 60  YLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNK 119
            L +N F+G+I                           G IP        L  LDL+NN 
Sbjct: 124 NLSNNNFTGSIP-------------------------RGSIP-------NLETLDLSNNM 151

Query: 120 FSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNL 179
            SG IP    + S+L  L L GN+L G I +SL  L SL  L L  NQL+G IPR    +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH 239
            S+  + L  N+L G IP EIG + SL+ LDL  N   G +P S+ NL NL+ L L  N 
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271

Query: 240 LSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNC 298
           LSG IPPS+ +L  L  L LS N  +G +P  + +   LEI  +  N+F G IP +L + 
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331

Query: 299 TSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNN 358
             L  ++L  N  +G I + LG + NLT +DLS NN  GEI         L  L +  N+
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391

Query: 359 ITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSL 418
           + G +P+ +G    L+   L  N   GE+P E  KL  +  L +  N + GR+      +
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451

Query: 419 TKLEYLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNE 475
             L+ L  +     G LP      K LE L+LS N  SG++P     +  L  + +S N+
Sbjct: 452 PSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510

Query: 476 LQCPVPN 482
           L   +P+
Sbjct: 511 LSGEIPD 517

Length = 968

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  135 bits (343), Expect = 1e-35
 Identities = 71/279 (25%), Positives = 110/279 (39%), Gaps = 55/279 (19%)

Query: 596 IGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---------- 640
           +G G    VY+ +L          VAVK    L         +EFL E            
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 641 -AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
               G C+     +++ E++E G L + L       +L  S  ++    +A  + YL   
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR--KNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WTEFAGTCGY 749
                +HRD++++N L+       ++DFG+++ L  D             W         
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM-------- 170

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRL 808
            APE     K T K DV+SFGVL+WE+   G+ P   +S       N +V        RL
Sbjct: 171 -APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-------NEEVLEYLKNGYRL 222

Query: 809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P P  +   +L  +M     C+ E PE RPT   + + L
Sbjct: 223 PQPP-NCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  135 bits (342), Expect = 1e-35
 Identities = 71/279 (25%), Positives = 107/279 (38%), Gaps = 54/279 (19%)

Query: 596 IGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---------- 640
           +G G    VY+  L          VAVK    L         +EFL E            
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 641 -AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
               G C+      ++ E++  G L   L      +EL  S  ++    +A  + YL   
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WTEFAGTCGY 749
                +HRD++++N L+       ++DFG+++ L  D             W         
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWM-------- 171

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRL 808
            APE     K T K DV+SFGVL+WE+   G+ P   +S       N +V        RL
Sbjct: 172 -APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-------NAEVLEYLKKGYRL 223

Query: 809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P P  +   +L  +M     C+ E PE RPT   + + L
Sbjct: 224 PKPP-NCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  131 bits (331), Expect = 1e-34
 Identities = 60/194 (30%), Positives = 95/194 (48%), Gaps = 22/194 (11%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           +G GG  +VY A    +G+ VA+K        D +   +E L E+E             Y
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIK---KEDSSSLLEELLREIEILKKLNHPNIVKLY 57

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G      H +L+ E+ E GSL  +L  +    +L   + + ++  +   L YLH +    
Sbjct: 58  GVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---G 112

Query: 704 IVHRDISSKNLLLD-LEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKIT 761
           I+HRD+  +N+LLD    +  +ADFG++K L  D S      GT  Y+APE L      +
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 762 EKCDVYSFGVLMWE 775
           EK D++S GV+++E
Sbjct: 173 EKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  131 bits (332), Expect = 3e-34
 Identities = 71/263 (26%), Positives = 116/263 (44%), Gaps = 32/263 (12%)

Query: 595 CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------F 642
            +G+G   +VY+A    +G++VAVK        +++   +    E+              
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILK--KRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
                   H +L+ E+ E G L   L+       L   +   +   +   L YLH +   
Sbjct: 64  IDAFEDKDHLYLVMEYCEGGDLFDYLSRG---GPLSEDEAKKIALQILRGLEYLHSN--- 117

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKIT 761
            I+HRD+  +N+LLD      +ADFG+AK L   SS+ T F GT  Y+APE L       
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 762 EKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP---SRSAQEK 818
            K DV+S GV+++E++ GK P         + L+    + ++L P L        S  E+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFS-----GENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232

Query: 819 LISIMEVAFSCFNESPESRPTMK 841
              +++    C N+ P  RPT +
Sbjct: 233 AKDLIK---KCLNKDPSKRPTAE 252

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  129 bits (328), Expect = 1e-33
 Identities = 65/287 (22%), Positives = 108/287 (37%), Gaps = 70/287 (24%)

Query: 596 IGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G G    VY+  L      +   VAVK   +L       +++EFL E            
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVK---TLKEGASEEEREEFLEEASIMKKLSHPNI 63

Query: 642 --FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-H 698
               G C+     +++ E++  G L   L      ++L     + +   +A  + YL   
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG--EKLTLKDLLQMALQIAKGMEYLESK 121

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS-----------NWTEFAGTC 747
           +     VHRD++++N L+       ++DFG+++ +  D              W       
Sbjct: 122 NF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------ 171

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVI-------KGKHPRDFLSSISSSSLNTDVAL 800
              APE     K T K DV+SFGVL+WE+         G    + L  +           
Sbjct: 172 ---APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED--------- 219

Query: 801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 RLP P  +  ++L  +M     C+   PE RPT   + + L
Sbjct: 220 ----GYRLPRP-ENCPDELYELML---QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  128 bits (325), Expect = 3e-33
 Identities = 70/287 (24%), Positives = 114/287 (39%), Gaps = 61/287 (21%)

Query: 596 IGNGGHASVYRAEL---PSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVE----------- 640
           +G G    VY+ +L         VAVK   +L       ++K+FL E             
Sbjct: 3   LGEGAFGEVYKGKLKGKDGKTTEVAVK---TLKEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 641 AFYGFCSHARHSFLLYEFLERGSL------AAILNTDAAAQELGWSQRMNVIKAVAHALS 694
              G C+     +L+ E++E G L      +  +        L     ++    +A  + 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-----------WTEF 743
           YL        VHRD++++N L+  +    ++DFG+++ +  D              W   
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM-- 174

Query: 744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQ 802
                  APE       T K DV+SFGVL+WE+   G  P      +S    N +V L+ 
Sbjct: 175 -------APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLS----NEEV-LEY 219

Query: 803 MLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           +    RLP P     ++L  +M    SC+   PE RPT   + ++L 
Sbjct: 220 LRKGYRLPKPE-YCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  127 bits (322), Expect = 6e-33
 Identities = 65/260 (25%), Positives = 108/260 (41%), Gaps = 34/260 (13%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFY 643
           +G G    VY A +  +G++VA+K            D++  L E++             Y
Sbjct: 7   LGEGSFGKVYLARDKKTGKLVAIKVIKKK---KIKKDRERILREIKILKKLKHPNIVRLY 63

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
                    +L+ E+ E G L  +L       E    +    ++ +  AL YLH      
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHSKG--- 117

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           IVHRD+  +N+LLD +    +ADFG+A+ L P     T F GT  Y+APE+       + 
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGKGYGKA 176

Query: 764 CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ--EKLIS 821
            D++S GV+++E++ GK P  F                ++  P+ P P        +   
Sbjct: 177 VDIWSLGVILYELLTGKPP--F-----PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKD 229

Query: 822 IMEVAFSCFNESPESRPTMK 841
           ++        + PE R T +
Sbjct: 230 LIR---KLLVKDPEKRLTAE 246

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  109 bits (275), Expect = 1e-26
 Identities = 69/274 (25%), Positives = 115/274 (41%), Gaps = 53/274 (19%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
            F+    IG GG   VY+A    +G+ VA+K     +  +    +++ + E++       
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKV----IKLESKEKKEKIINEIQILKKCKH 56

Query: 641 ----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN------VIKAVA 690
                +YG        +++ EF   GSL  +L +         +Q +       V K + 
Sbjct: 57  PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKELL 108

Query: 691 HALSYLH--HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
             L YLH        I+HRDI + N+LL  + E  + DFG++  L  D+       GT  
Sbjct: 109 KGLEYLHSNG-----IIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPY 162

Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--- 805
           ++APE+        K D++S G+   E+ +GK P         S L    AL ++     
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--------SELPPMKALFKIATNGP 214

Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           P L  P + + E     ++    C  ++PE RPT
Sbjct: 215 PGLRNPEKWSDE-FKDFLK---KCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  108 bits (271), Expect = 3e-26
 Identities = 73/274 (26%), Positives = 123/274 (44%), Gaps = 51/274 (18%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           +G+G    V+     +   VA+K    +L  D  + Q++F  EV+A            + 
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIK----ILKSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
            CS     +++ E +E+GSL A L      Q L  +  +++   VA  ++YL        
Sbjct: 70  VCSVGEPVYIITELMEKGSLLAFLR-SPEGQVLPVASLIDMACQVAEGMAYLEEQ---NS 125

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLK-----PDSSN----WTEFAGTCGYIAPELA 755
           +HRD++++N+L+  +    VADFG+A+ +K              WT         APE A
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT---------APEAA 176

Query: 756 YTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQ-MLDPRLPAPSR 813
                + K DV+SFG+L++E+   G+ P           +N     DQ     R+P P++
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYP--------GMNNHEVYDQITAGYRMPCPAK 228

Query: 814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             QE +  IM     C+   PE RP+ K + ++L
Sbjct: 229 CPQE-IYKIM---LECWAAEPEDRPSFKALREEL 258

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  106 bits (267), Expect = 1e-25
 Identities = 66/268 (24%), Positives = 110/268 (41%), Gaps = 35/268 (13%)

Query: 588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           +D +    +G G    VY+    P+G++ A+KK H          +K+ L E++      
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVD---GDEEFRKQLLRELKTLRSCE 57

Query: 642 ------FYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRM--NVIKAVAHA 692
                  YG F      S +L E+++ GSLA     D   +     + +   + + +   
Sbjct: 58  SPYVVKCYGAFYKEGEISIVL-EYMDGGSLA-----DLLKKVGKIPEPVLAYIARQILKG 111

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YLH      I+HRDI   NLL++ + E  +ADFGI+K L+        F GT  Y++P
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSP 169

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ-MLDPRLPAP 811
           E       +   D++S G+ + E   GK P       S   L     +      P    P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-----MQAICDGPPPSLP 224

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPT 839
           +     +    +    +C  + P+ RP+
Sbjct: 225 AEEFSPEFRDFIS---ACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  104 bits (263), Expect = 4e-25
 Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 53/271 (19%)

Query: 595 CIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AF 642
            +G G   SVY A    +GE++AVK     L  D   + +    E+             +
Sbjct: 7   LLGRGSFGSVYLALDKDTGELMAVKS--VELSGDSEEELEALEREIRILSSLQHPNIVRY 64

Query: 643 YGFC-SHARHSFLLY-EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA----HALSYL 696
           YG      +++  ++ E++  GSL+++L       E        VI+         L+YL
Sbjct: 65  YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYL 117

Query: 697 H-HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE--FAGTCGYIAPE 753
           H +     IVHRDI   N+L+D +    +ADFG AK L    +        GT  ++APE
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP----RDFLSSISSSSLNTDVALDQMLDPRLP 809
           +    +     D++S G  + E+  GK P     + ++++     + +        P +P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------PEIP 226

Query: 810 A-PSRSAQEKLISIMEVAFSCFNESPESRPT 839
              S  A++ L         C    P+ RPT
Sbjct: 227 EHLSEEAKDFL-------RKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 5e-25
 Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 38/267 (14%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           +G+G    V+  +      VA+K        +  + + +F+ E +             YG
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR-----EGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
            C+  R  F++ E++  G L   L          W   +++   V  A+ YL  + F   
Sbjct: 67  VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNGF--- 121

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTMKIT 761
           +HRD++++N L+  +    V+DFG+A+ +  D   SS  T+F     +  PE+    + +
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFS 179

Query: 762 EKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI 820
            K DV+SFGVLMWEV  +GK P +  S       N++V        RL  P + A  ++ 
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFS-------NSEVVESVSAGYRLYRP-KLAPTEVY 231

Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
           +IM   +SC++E PE RP  K +  QL
Sbjct: 232 TIM---YSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 98.0 bits (244), Expect = 1e-22
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 22/206 (10%)

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C+  R  +++ E++  G L   L      +    SQ + + K V   ++YL    F
Sbjct: 64  LYGVCTKQRPIYIVTEYMSNGCLLNYLRE--HGKRFQPSQLLEMCKDVCEGMAYLESKQF 121

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
              +HRD++++N L+D +    V+DFG+++ +  D   SS  ++F     +  PE+    
Sbjct: 122 ---IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYS 176

Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K DV++FGVLMWEV   GK P +  +       N++         RL  P   A E
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFN-------NSETVEKVSQGLRLYRP-HLASE 228

Query: 818 KLISIMEVAFSCFNESPESRPTMKII 843
           K+ +IM   +SC++E  E RPT + +
Sbjct: 229 KVYAIM---YSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 68/261 (26%), Positives = 109/261 (41%), Gaps = 35/261 (13%)

Query: 595 CIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AF 642
            IG G    VY+   L +G+ VA+K+  SL    +    K  + E++            +
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQI-SLEKIKEE-ALKSIMQEIDLLKNLKHPNIVKY 64

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
            G    +   +++ E+ E GSL  I+       E   S     +  V   L+YLH     
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE---SLVAVYVYQVLQGLAYLHEQ--- 118

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITE 762
            ++HRDI + N+L   +    +ADFG+A  L   S +     GT  ++APE+      + 
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178

Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML-DPRLPAPSR-SAQEKLI 820
             D++S G  + E++ G  P           LN   AL +++ D   P P   S + K  
Sbjct: 179 ASDIWSLGCTVIELLTGNPP--------YYDLNPMAALFRIVQDDHPPLPEGISPELK-- 228

Query: 821 SIMEVAFSCFNESPESRPTMK 841
              +    CF + P  RPT K
Sbjct: 229 ---DFLMQCFQKDPNLRPTAK 246

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 28/212 (13%)

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           YG C+  +  +++ EF+E G L   L       +L     +++ + V   + YL  + F 
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSF- 121

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG------YIAPELAY 756
             +HRD++++N L+       V+DFG+ + +  D     E+  + G      +  PE+  
Sbjct: 122 --IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFN 174

Query: 757 TMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
             K + K DV+SFGVLMWEV  +GK P +          N +V        RL  P  ++
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGKMPFE-------KKSNYEVVEMISRGFRLYRPKLAS 227

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                ++ EV +SC++E PE RPT   + + +
Sbjct: 228 M----TVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 1e-20
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 46/275 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVD-QKE--FLTE--------VEAFY 643
           IG G + +VYR   +P+G VVA+K  +   P D   D Q+E   L++        +  +Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G        +++ E+ E GS+  ++     A  +       +I+ V  AL Y+H      
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKV---G 121

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITE- 762
           ++HRDI + N+L+       + DFG+A  L  +SS  + F GT  ++APE+     ITE 
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEV-----ITEG 176

Query: 763 -----KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
                K D++S G+ ++E+  G  P   + +  +  L           PRL     S   
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-----PPRLEDNGYSK-- 229

Query: 818 KLISIMEVAFSCFNESPESRPT------MKIISQQ 846
               + E   +C +E P+ R +       K I   
Sbjct: 230 ---LLREFVAACLDEEPKERLSAEELLKSKWIKAH 261

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 77/280 (27%), Positives = 114/280 (40%), Gaps = 52/280 (18%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
            +      IG G    V   +   G+ VAVK     L  D T  Q  FL E         
Sbjct: 6   KELKLGATIGKGEFGDVMLGDY-RGQKVAVKC----LKDDSTAAQA-FLAEASVMTTLRH 59

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                  G        +++ E++ +GSL   L +   A  +  +Q++     V   + YL
Sbjct: 60  PNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYL 118

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK--SLKPDSS----NWTEFAGTCGYI 750
               F   VHRD++++N+L+  +  A V+DFG+AK  S   DS      WT         
Sbjct: 119 EEKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT--------- 166

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVI---KGKHPRDFLSSISSSSLNTDVALDQMLDPR 807
           APE     K + K DV+SFG+L+WE+    +  +PR  L          DV        R
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---------DVVPHVEKGYR 217

Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           + AP     E    + +V   C+   P  RPT K + +QL
Sbjct: 218 MEAPEGCPPE----VYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 74/269 (27%), Positives = 122/269 (45%), Gaps = 42/269 (15%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G    V+         VA+K        +  + +++F+ E +             YG
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR-----EGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQR--MNVIKAVAHALSYLHHDCFP 702
            C+      L++EF+E G L+  L      Q   +SQ   + +   V   ++YL      
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRA----QRGKFSQETLLGMCLDVCEGMAYLESSNV- 121

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTMK 759
             +HRD++++N L+       V+DFG+ + +  D   SS  T+F     + +PE+    K
Sbjct: 122 --IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP--VKWSSPEVFSFSK 177

Query: 760 ITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK 818
            + K DV+SFGVLMWEV  +GK P +  S       N++V        RL  P  ++Q  
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRS-------NSEVVETINAGFRLYKPRLASQ-- 228

Query: 819 LISIMEVAFSCFNESPESRPTMKIISQQL 847
             S+ E+   C+ E PE RP+  ++  QL
Sbjct: 229 --SVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 91.1 bits (227), Expect = 4e-20
 Identities = 71/289 (24%), Positives = 112/289 (38%), Gaps = 69/289 (23%)

Query: 577 KILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           + LY  + K          IG G    VY+A +  +G+ VA+KK             KE 
Sbjct: 18  RELYKNLEK----------IGEGASGEVYKATDRATGKEVAIKK------MRLRKQNKEL 61

Query: 636 L-TEVEAFYGFCSH------------ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQR 682
           +  E+      C H                +++ E+++ GSL  I+             R
Sbjct: 62  IINEILIMKD-CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT--------QNFVR 112

Query: 683 MN------VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD 736
           MN      V + V   L YLH      ++HRDI S N+LL  +    +ADFG A  L  +
Sbjct: 113 MNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169

Query: 737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPR-DF-----LSSIS 790
            S      GT  ++APE+        K D++S G++  E+ +G+ P         L  I+
Sbjct: 170 KSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229

Query: 791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +  +           P L  P + + E     +     C  + PE RP+
Sbjct: 230 TKGI-----------PPLKNPEKWSPE-FKDFLN---KCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 76/272 (27%), Positives = 121/272 (44%), Gaps = 41/272 (15%)

Query: 596 IGNGGHASVYRA--ELPSGEV--VAVKKFHSLLPCDQTVDQKEFLTE-----------VE 640
           IG G    V R   +LP  +   VA+K   +     Q +D   FLTE           + 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD---FLTEASIMGQFDHPNII 68

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              G  + +R   ++ E++E GSL   L   D    +    Q + +++ +A  + YL   
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG--YIAPE-LAY 756
            +   VHRD++++N+L++      V+DFG+++ L+   + +T   G     + APE +AY
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 757 TMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
             K T   DV+SFG++MWEV+  G+ P   +S       N DV        RLP P    
Sbjct: 183 R-KFTSASDVWSFGIVMWEVMSYGERPYWDMS-------NQDVIKAVEDGYRLPPP-MDC 233

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              L  +M     C+ +    RPT   I   L
Sbjct: 234 PSALYQLM---LDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 89.8 bits (221), Expect = 6e-19
 Identities = 64/269 (23%), Positives = 116/269 (43%), Gaps = 29/269 (10%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------------FY 643
           +G G    VY A     ++VA+K     L   ++ + + FL E++              Y
Sbjct: 8   LGEGSFGEVYLARDR--KLVALKVLAKKLE-SKSKEVERFLREIQILASLNHPPNIVKLY 64

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
            F       +L+ E+++ GSL  +L        L  S+ + ++  +  AL YLH      
Sbjct: 65  DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--- 121

Query: 704 IVHRDISSKNLLLDLEY-EAHVADFGIAKSLKPDSSN------WTEFAGTCGYIAPELAY 756
           I+HRDI  +N+LLD +     + DFG+AK L    S        +   GT GY+APE+  
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 757 TM---KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR 813
            +     +   D++S G+ ++E++ G  P +   + S++S    + L+          S 
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 814 SAQEKLIS-IMEVAFSCFNESPESRPTMK 841
           S  E +     ++      + P++R +  
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSS 270

Length = 384

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 7e-19
 Identities = 73/267 (27%), Positives = 122/267 (45%), Gaps = 37/267 (13%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           +G G    V+     +   VAVK          T+D K+FL E +             Y 
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKP-----GTMDPKDFLAEAQIMKKLRHPKLIQLYA 68

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
            C+     +++ E ++ GSL   L   A    L   Q +++   VA  ++YL    +   
Sbjct: 69  VCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYLEAQNY--- 124

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEK 763
           +HRD++++N+L+       VADFG+A+ +K D     E A     + APE A   + + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 764 CDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
            DV+SFG+L+ E++  G+ P   ++       N +V   Q +D   R+P P     ++L 
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMT-------NAEVL--QQVDQGYRMPCPP-GCPKELY 234

Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            IM     C+ E P+ RPT + +  +L
Sbjct: 235 DIM---LDCWKEDPDDRPTFETLQWKL 258

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 67/272 (24%), Positives = 116/272 (42%), Gaps = 41/272 (15%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           IG G    VY+  L     VAVK   S LP D    +++FL E E              G
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
            C   +  +++ E +  GSL   L        +   + + +    A  + YL        
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYLESKN---C 114

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAPELAYTMKI 760
           +HRD++++N L+       ++DFG+  S + +   +T   G       + APE     + 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGM--SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172

Query: 761 TEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRSAQE 817
           T + DV+S+G+L+WE    G  P   +S+  +          + ++   R+PAP +   E
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---------ERIESGYRMPAP-QLCPE 222

Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQLRI 849
           ++  +M     C+   PE+RP+   I  +L+I
Sbjct: 223 EIYRLML---QCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.4 bits (214), Expect = 1e-18
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 29/210 (13%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQK-----------EFLTEVE--- 640
           IG+G   SVY      SGE++AVK+         + D+K             L E++   
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 641 --AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
              + G    A H  +  E++  GS+AA+LN   A +E   +   N ++ +   L+YLH+
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT------EFAGTCGYIAP 752
                I+HRDI   N+L+D +    ++DFGI+K L+ +S +           G+  ++AP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+      T K D++S G L+ E++ GKHP
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 79/277 (28%), Positives = 113/277 (40%), Gaps = 54/277 (19%)

Query: 597 GNGG--HASVYRAELPSGEV--VAVKKFHSLLPCDQTVDQKEFLTEVEA----------- 641
           GN G     VY   + SG+   VAVK             +KEFL E              
Sbjct: 6   GNFGSVVKGVYL--MKSGKEVEVAVKTLK---QEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAIL--NTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
             G C       L+ E    G L   L    +    +L       +   VA  ++YL   
Sbjct: 61  LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLESK 114

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPEL 754
            F   VHRD++++N+LL   ++A ++DFG++++L   S  +   A T G     + APE 
Sbjct: 115 HF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR--ATTAGRWPLKWYAPEC 169

Query: 755 AYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAP 811
               K + K DV+S+GV +WE    G  P   +          +V    ML+   RLP P
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK-------GAEVI--AMLESGERLPRP 220

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
               QE + SIM    SC+   PE RPT   +    R
Sbjct: 221 EECPQE-IYSIML---SCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 67/248 (27%), Positives = 116/248 (46%), Gaps = 53/248 (21%)

Query: 615 VAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGS 663
           VAVK   +L P   T+  + FL E +             Y  CS     +++ E++ +GS
Sbjct: 33  VAVK---TLKP--GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGS 87

Query: 664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH 723
           L   L +    ++L   Q +++   +A  ++YL    +   +HRD++++N+L+       
Sbjct: 88  LLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRNY---IHRDLAARNILVGENLVCK 143

Query: 724 VADFGIAKSLKPDSSN----------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           +ADFG+A+ ++ D             WT         APE A   + T K DV+SFG+L+
Sbjct: 144 IADFGLARLIEDDEYTAREGAKFPIKWT---------APEAANYGRFTIKSDVWSFGILL 194

Query: 774 WEVI-KGKHPRDFLSSISSSSLNTDVALDQ-MLDPRLPAPSRSAQEKLISIMEVAFSCFN 831
            E++  G+ P   ++       N +V L+Q     R+P P    +E L  +M     C++
Sbjct: 195 TEIVTYGRVPYPGMT-------NREV-LEQVERGYRMPRPPNCPEE-LYDLML---QCWD 242

Query: 832 ESPESRPT 839
           + PE RPT
Sbjct: 243 KDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 70/267 (26%), Positives = 106/267 (39%), Gaps = 43/267 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPC--DQTVDQKEFLT-----EVEAFYGF 645
           IG G    VY A  L +GE++AVK  +     P    +  D+ + L       +  +YG 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH----ALSYLHHDCF 701
             H    ++  E+   G+L  +L       E G     +VI+         L+YLH    
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLHSH-- 118

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE----FAGTCGYIAPELAYT 757
             IVHRDI   N+ LD      + DFG A  LK +++   E     AGT  Y+APE+   
Sbjct: 119 -GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 758 MKITEK---CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
            K        D++S G ++ E+  GK P   L     +       +     P +P   + 
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSEL----DNEFQIMFHVGAGHKPPIPDSLQL 233

Query: 815 AQE--KLISIMEVAFSCFNESPESRPT 839
           + E    +        C    P+ RPT
Sbjct: 234 SPEGKDFLD------RCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.5 bits (206), Expect = 2e-17
 Identities = 74/290 (25%), Positives = 130/290 (44%), Gaps = 46/290 (15%)

Query: 589 DFDAKYCIGNGGHASVYRAE----LPSGE--VVAVKKFHSLLPCDQTVDQKE--FLTEVE 640
           D   K+ +G G    V+ AE    LP  +  +VAVK         +   Q+E   LT ++
Sbjct: 6   DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ 65

Query: 641 -----AFYGFCSHARHSFLLYEFLERGSLAAILNT------------DAAAQELGWSQRM 683
                 FYG C+  R   +++E++  G L   L +            D A  +L   Q +
Sbjct: 66  HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125

Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF 743
            +   +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++   
Sbjct: 126 AIASQIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRV 180

Query: 744 AGTC----GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDV 798
            G       ++ PE     K T + D++SFGV++WE+   GK P   LS       NT+ 
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS-------NTE- 232

Query: 799 ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           A++ +   R     R+   ++ +IM+    C+   P+ R  +K I  +L+
Sbjct: 233 AIECITQGRELERPRTCPPEVYAIMQ---GCWQREPQQRMVIKDIHSRLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 38/104 (36%), Positives = 53/104 (50%), Gaps = 4/104 (3%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +  AL YLH      I+HRDI   N+LLD +   H+ DF IA  + PD+   T  +GT G
Sbjct: 109 IVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPG 164

Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS 792
           Y+APE+      +   D +S GV  +E ++GK P    S     
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD 208

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 66/205 (32%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH-----A 649
           IG G  A VY A  LP+ E VA+K+   L  C  +VD  E   EV+A    C+H      
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVD--ELRKEVQAMSQ-CNHPNVVKY 64

Query: 650 RHSF-------LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
             SF       L+  +L  GSL  I+ +      L  +    V+K V   L YLH +   
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN--- 121

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW----TEFAGTCGYIAPELAYTM 758
             +HRDI + N+LL  +    +ADFG++ SL             F GT  ++APE+   +
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181

Query: 759 K-ITEKCDVYSFGVLMWEVIKGKHP 782
                K D++SFG+   E+  G  P
Sbjct: 182 HGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 35/265 (13%)

Query: 589 DFDAKYCIGNGGHASVYRAELPS-GEVVAVKKFH----SLLPCDQTVDQKEFLTEVEAFY 643
           DF+    IG G    V++    +   V A+K+      +    ++ +D+   L ++++ Y
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 644 GFCSHARH--SFL-------LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                 R+  SFL       + E+ E G L  +L      + L   Q       +   L+
Sbjct: 61  II----RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLA 115

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           +LH      I+HRDI S NL LD      + D G+AK L  +++      GT  Y++PEL
Sbjct: 116 HLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172

Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL-DQMLDPRLPAPSR 813
                  EK DV++ GV+++E   GKHP D          N   AL  +++    P  S+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD---------ANNQGALILKIIRGVFPPVSQ 223

Query: 814 SAQEKLISIMEVAFSCFNESPESRP 838
              ++L  +++    C  +    RP
Sbjct: 224 MYSQQLAQLID---QCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 82.5 bits (204), Expect = 3e-17
 Identities = 73/288 (25%), Positives = 123/288 (42%), Gaps = 56/288 (19%)

Query: 596 IGNGGHASVYRAELPSG------EVVAVKKFHSLLPCDQTVDQKEFLTEVE--------- 640
           +G G    V+  E          E+VAVK        D    +K+F  E E         
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA---RKDFEREAELLTNFQHEN 69

Query: 641 --AFYGFCSHARHSFLLYEFLERGSLAAIL-----------NTDAAAQELGWSQRMNVIK 687
              FYG C+      +++E++E G L   L           + D+   EL  SQ + +  
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            +A  + YL    F   VHRD++++N L+  +    + DFG+++ +   ++++    G  
Sbjct: 130 QIASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHT 184

Query: 747 ---CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVA--L 800
                ++ PE     K T + DV+SFGV++WE+   GK P   LS       N +V   +
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-------NEEVIECI 237

Query: 801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            Q    RL    R+   ++  IM     C+   P+ R  +K I ++L+
Sbjct: 238 TQ---GRLLQRPRTCPSEVYDIML---GCWKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 4e-17
 Identities = 73/272 (26%), Positives = 117/272 (43%), Gaps = 58/272 (21%)

Query: 595 CIGNGGHASVYRA-ELPSGEVVAVKKF---HSLLPCDQTVD-QKE--FLTE-----VEAF 642
           CIG G    VY+A +  + +VVA+K      +    D+  D Q+E  FL++     +  +
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE---DEIEDIQQEIQFLSQCRSPYITKY 64

Query: 643 YGFCSHARHSFL-------LYEFLERGSLAAILNTDAAAQELGWSQRMN------VIKAV 689
           YG       SFL       + E+   GS   +L             +++      +++ V
Sbjct: 65  YG-------SFLKGSKLWIIMEYCGGGSCLDLLK----------PGKLDETYIAFILREV 107

Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGY 749
              L YLH +     +HRDI + N+LL  E +  +ADFG++  L    S    F GT  +
Sbjct: 108 LLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFW 164

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP 809
           +APE+       EK D++S G+   E+ KG+ P         S L+    L   L P+  
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL--------SDLHPMRVL--FLIPKNN 214

Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
            PS    +      +    C N+ P+ RP+ K
Sbjct: 215 PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAK 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 81.1 bits (200), Expect = 7e-17
 Identities = 69/239 (28%), Positives = 116/239 (48%), Gaps = 40/239 (16%)

Query: 596 IGNGGHASVYRAEL-PSGE---VVAVKKFHSLLPCDQTVDQKEFLTE-----------VE 640
           IG G    V R  L   G+    VA+K   S     Q   +++FL+E           + 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ---RRDFLSEASIMGQFDHPNII 68

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
              G  + +R   ++ EF+E G+L + L  +    +    Q + +++ +A  + YL    
Sbjct: 69  HLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN 126

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APELA 755
           +   VHRD++++N+L++      V+DFG+++ L+ D+S+ T  +   G I     APE  
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDV--ALDQMLDPRLPAP 811
              K T   DV+S+G++MWEV+  G+ P   +S       N DV  A++Q  D RLP P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-------NQDVINAIEQ--DYRLPPP 233

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 74/267 (27%), Positives = 114/267 (42%), Gaps = 47/267 (17%)

Query: 597 GNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           GNGG  SV + + +P+G V+A K  H  +    +V +K+ L E++           +FYG
Sbjct: 16  GNGG--SVSKVKHIPTGTVMAKKVVH--IGAKSSV-RKQILRELQIMHECRSPYIVSFYG 70

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSYL---HHD 699
              +  +  +  EF++ GSL  I           LG      +  AV   L+YL   H  
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNVHR- 124

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK 759
               I+HRDI   N+L++   +  + DFG++  L    ++   F GT  Y++PE     K
Sbjct: 125 ----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGGK 178

Query: 760 ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD------QMLDPRLPAPSR 813
            T K DV+S G+ + E+  GK P  F +       +    LD      Q   PRLP+   
Sbjct: 179 YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238

Query: 814 SAQ-EKLISIMEVAFSCFNESPESRPT 839
                  +        C  + P  RPT
Sbjct: 239 PEDLRDFVDA------CLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 25/200 (12%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHA----- 649
           IG G +  VY+A +  +GE+VA+KK    L  +     K  L E++      +H      
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGIPKTALREIKLLKEL-NHPNIIKL 63

Query: 650 -------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCF 701
                     +L++EF++   L  ++      + L  S   + +  +   L++ H H   
Sbjct: 64  LDVFRHKGDLYLVFEFMDT-DLYKLI--KDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI- 760
               HRD+  +NLL++ E    +ADFG+A+S       +T +  T  Y APEL    K  
Sbjct: 121 ----HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 761 TEKCDVYSFGVLMWEVIKGK 780
           +   D++S G +  E++  +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 40/262 (15%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           +GNG    V+         VAVK   +L P   T+  + FL E +             Y 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVK---TLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYA 68

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
             S     +++ E++ +GSL   L  D   + L     +++   VA  ++Y+    +   
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERMNY--- 123

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKIT 761
           +HRD+ S N+L+       +ADFG+A+ +  + + +T   G      + APE A   + T
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 762 EKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQM-LDPRLPAPSRSAQEKL 819
            K DV+SFG+L+ E++ KG+ P           +N    L+Q+    R+P P    Q+  
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP--------YPGMNNREVLEQVERGYRMPCP----QDCP 229

Query: 820 ISIMEVAFSCFNESPESRPTMK 841
           IS+ E+   C+ + PE RPT +
Sbjct: 230 ISLHELMLQCWKKDPEERPTFE 251

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 78.4 bits (193), Expect = 7e-16
 Identities = 71/278 (25%), Positives = 122/278 (43%), Gaps = 44/278 (15%)

Query: 589 DFDAKYCIGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
           D   K+ +G G +  VY          VAVK        + T++ +EFL E         
Sbjct: 7   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 61

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                  G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ YL
Sbjct: 62  PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEYL 120

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPE 753
               F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG      + APE
Sbjct: 121 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 175

Query: 754 -LAYTMKITEKCDVYSFGVLMWEVIK---GKHPRDFLSSISSSSLNTDVALDQMLDPRLP 809
            LAY  K + K DV++FGVL+WE+       +P   LS +          L++    R+ 
Sbjct: 176 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-------LLEK--GYRME 225

Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            P     +    + E+  +C+  +P  RP+   I Q  
Sbjct: 226 RPEGCPPK----VYELMRACWQWNPSDRPSFAEIHQAF 259

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 62/261 (23%), Positives = 107/261 (40%), Gaps = 32/261 (12%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFY 643
           +G G    V +    P+G+++AVK     +       QK+ L E++            FY
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFY 65

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G   +     +  E+++ GSL  IL        +       +  AV   L+YLH      
Sbjct: 66  GAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKH--K 121

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+L++   +  + DFG++  L    +    F GT  Y+APE       + K
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGNDYSVK 179

Query: 764 CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD---PRLPAPSRSAQEKLI 820
            D++S G+ + E+  G+ P    +            L  +++   PRLP+   S      
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFEL---LQYIVNEPPPRLPSGKFS--PDFQ 234

Query: 821 SIMEVAFSCFNESPESRPTMK 841
             + +   C  + P  RP+ K
Sbjct: 235 DFVNL---CLIKDPRERPSYK 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 38/262 (14%)

Query: 596 IGNGGHASVYRA--ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHA---- 649
           IG G    V+R   ++P  + VAV    +L P      +++FL+E      F  H     
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVA-IKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 650 -------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
                  + + ++ E++E G+L   L       E    Q + +++ +A  + YL    + 
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMNY- 128

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGTCG--YIAPELAYTMK 759
             VHRD++++N+L++   E  V+DFG+++ L+ D    +T   G     + APE     K
Sbjct: 129 --VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 760 ITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDV--ALDQMLDPRLPAPSRSAQ 816
            T   DV+SFG++MWEV+  G+ P   +S       N +V  A++     RLPAP     
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMS-------NHEVMKAINDGF--RLPAPMDCPS 237

Query: 817 EKLISIMEVAFSCFNESPESRP 838
               ++ ++   C+ +    RP
Sbjct: 238 ----AVYQLMLQCWQQDRARRP 255

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 53/283 (18%)

Query: 589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
           D++    IG+G +  VY+A ++ +GE+VA+K    ++  +   D +    E+        
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIK----VIKLEPGDDFEIIQQEISMLKECRH 59

Query: 641 ----AFYGFCSHARHSFL--LYEFLERGSLAAILN-TDAAAQELGWSQRMNVIKAVAHAL 693
               A++G  S+ R   L  + E+   GSL  I   T     EL   Q   V +     L
Sbjct: 60  PNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---QIAYVCRETLKGL 114

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           +YLH       +HRDI   N+LL  + +  +ADFG++  L    +    F GT  ++APE
Sbjct: 115 AYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPE 171

Query: 754 LA---YTMKITEKCDVYSFGVLMWEVIKGK------HPRDFLSSISSSSLNTDVALDQML 804
           +A          KCD+++ G+   E+ + +      HP   L  IS S+           
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSN----------- 220

Query: 805 DPRLPAPSRSAQEKLISIMEVAF--SCFNESPESRPTMKIISQ 845
               P P    +EK   +    F   C  + P+ RPT   + Q
Sbjct: 221 ---FPPPKLKDKEKWSPVFH-DFIKKCLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 30/213 (14%)

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +    E   ++   ++  V+  + YL    F  
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF-- 116

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHRD++++N+LL  ++ A ++DFG++K+L  D + +   A T G     + APE     
Sbjct: 117 -VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK--AKTHGKWPVKWYAPECMNYY 173

Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD--PRLPAPSRSA 815
           K + K DV+SFGVLMWE    G+ P   +          +V   QM++   R+  P R  
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVT--QMIESGERMECPQRCP 224

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            E +  +M++   C+    + RP   ++  +LR
Sbjct: 225 PE-MYDLMKL---CWTYGVDERPGFAVVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 76.2 bits (187), Expect = 4e-15
 Identities = 67/257 (26%), Positives = 111/257 (43%), Gaps = 31/257 (12%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT--------EVEAFYGFC 646
           IG G    V++  +  + +VVA+K        D+  D ++ +T         V  +YG  
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
                 +++ E+L  GS   +L     A      Q   ++K +   L YLH +     +H
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSE---KKIH 124

Query: 707 RDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDV 766
           RDI + N+LL  + +  +ADFG+A  L         F GT  ++APE+        K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADI 184

Query: 767 YSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML--DPRLPAPSRSAQEKLISIME 824
           +S G+   E+ KG+ P            N+D+   ++L   P+   P+ +  E      E
Sbjct: 185 WSLGITAIELAKGEPP------------NSDMHPMRVLFLIPKNNPPTLTG-EFSKPFKE 231

Query: 825 VAFSCFNESPESRPTMK 841
              +C N+ P  RPT K
Sbjct: 232 FIDACLNKDPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 34/280 (12%)

Query: 589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFH----SLLPCDQTVDQKEFLTEV--EA 641
           D++    IG G   +V +      G+++  K+      +     Q V +   L E+    
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 642 FYGFCSHA--RHSFLLY---EFLERGSLAAIL-----NTDAAAQELGWSQRMNVIKAVAH 691
              +      R +  LY   E+ E G LA ++           +E  W     ++  +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR----ILTQLLL 116

Query: 692 ALSYLHH--DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGY 749
           AL   H+  D    ++HRD+   N+ LD      + DFG+AK L  DSS    + GT  Y
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYY 176

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP 809
           ++PE    M   EK D++S G L++E+     P  F +  +   L + +   +    R+P
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--FTAR-NQLQLASKIK--EGKFRRIP 231

Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI 849
               S   ++I       S  N  P+ RP+ + + Q   I
Sbjct: 232 YRYSSELNEVIK------SMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 79.1 bits (195), Expect = 5e-15
 Identities = 48/123 (39%), Positives = 69/123 (56%), Gaps = 7/123 (5%)

Query: 182 VSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS 241
           +  L L    L G IP++I K+R L  ++L+ N  +G +PPS+ ++T+L+ L L YN  +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 242 GSIPPSLGNL-ILRQLLLSGNHFTGYLPYNICRGGAL---EIFTVSENHFQGTIPTSLRN 297
           GSIP SLG L  LR L L+GN  +G +P  +  GG L     F  ++N     IP  LR 
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAAL--GGRLLHRASFNFTDNAGLCGIP-GLRA 536

Query: 298 CTS 300
           C  
Sbjct: 537 CGP 539

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 78.7 bits (194), Expect = 6e-15
 Identities = 39/94 (41%), Positives = 57/94 (60%)

Query: 161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVL 220
           L L++  L G+IP   S L  + ++ LS N + G+IP  +G + SL VLDL+ N F G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 221 PPSISNLTNLKELALLYNHLSGSIPPSLGNLILR 254
           P S+  LT+L+ L L  N LSG +P +LG  +L 
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLH 516

Length = 623

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 70/264 (26%), Positives = 119/264 (45%), Gaps = 32/264 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVD--QKE--FLTE---- 638
             FD    +G G + SVY+A    +G+VVA+K     +P ++ +    KE   L +    
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKV----VPVEEDLQEIIKEISILKQCDSP 58

Query: 639 -VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
            +  +YG        +++ E+   GS++ I+      + L   +   ++      L YLH
Sbjct: 59  YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
                  +HRDI + N+LL+ E +A +ADFG++  L    +      GT  ++APE+   
Sbjct: 117 ---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE 173

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
           +    K D++S G+   E+ +GK P         S ++   A+   + P  P P+ S  E
Sbjct: 174 IGYNNKADIWSLGITAIEMAEGKPPY--------SDIHPMRAI--FMIPNKPPPTLSDPE 223

Query: 818 KLISIMEVAF--SCFNESPESRPT 839
           K  S     F   C  + PE RP+
Sbjct: 224 KW-SPEFNDFVKKCLVKDPEERPS 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 75.5 bits (186), Expect = 8e-15
 Identities = 62/271 (22%), Positives = 104/271 (38%), Gaps = 41/271 (15%)

Query: 597 GNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY--------GF 645
           G+ G   + R +     +GE VAVK  +         D +  +  +            G 
Sbjct: 15  GHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGV 74

Query: 646 C--SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           C     R   L+ E+L  GSL   L        L   + +     +   + YL       
Sbjct: 75  CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK--RLLLFSSQICKGMDYLGSQ---R 129

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT-----EFAGTCGYIAPELAYTM 758
            +HRD++++N+L++ E    ++DFG+AK L  D   +      E      + APE   T 
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP--IFWYAPECLRTS 187

Query: 759 KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML----------DPRL 808
           K +   DV+SFGV ++E+    +     S  +       +A  QM+            RL
Sbjct: 188 KFSSASDVWSFGVTLYELF--TYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL 245

Query: 809 PAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           P P     E    + ++   C+   P+ RP+
Sbjct: 246 PRPPSCPDE----VYDLMKLCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 8e-15
 Identities = 35/92 (38%), Positives = 52/92 (56%), Gaps = 5/92 (5%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
           AL YLH       I++RD+  +N+LLD +    + DFG+AK L  + S    F GT  Y+
Sbjct: 105 ALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           APE+       +  D +S GVL++E++ GK P
Sbjct: 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 72/273 (26%), Positives = 119/273 (43%), Gaps = 56/273 (20%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHS--- 652
           IG G   +V + E  +G+ VAVK     + CD T   + FL E        +   H    
Sbjct: 14  IGEGEFGAVLQGEY-TGQKVAVK----NIKCDVTA--QAFLEETAVM----TKLHHKNLV 62

Query: 653 -----------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
                      +++ E + +G+L   L T   A  +   Q +     VA  + YL     
Sbjct: 63  RLLGVILHNGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK-- 119

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAK--SLKPDSS----NWTEFAGTCGYIAPELA 755
             +VHRD++++N+L+  +  A V+DFG+A+  S+  D+S     WT         APE  
Sbjct: 120 -KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT---------APEAL 169

Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
              K + K DV+S+GVL+WEV   G+ P      +S   +   V     ++P    P+  
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAP---YPKMSLKEVKECVEKGYRMEPPEGCPA-- 224

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               +  +M    SC+   P+ RP+   + ++L
Sbjct: 225 ---DVYVLMT---SCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 75.1 bits (184), Expect = 9e-15
 Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 33/265 (12%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           +G G    V+     +   VAVK   +L P   +V  + FL E               Y 
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVK---TLKPGTMSV--QAFLEEANLMKTLQHDKLVRLYA 68

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
             +     +++ E++ +GSL   L +D   + L   + ++    +A  ++Y+    +   
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY--- 124

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEK 763
           +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 764 CDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISI 822
            DV+SFG+L++E++  GK P   +S       N+DV        R+P       E L  I
Sbjct: 185 SDVWSFGILLYEIVTYGKIPYPGMS-------NSDVMSALQRGYRMPRMENCPDE-LYDI 236

Query: 823 MEVAFSCFNESPESRPTMKIISQQL 847
           M+   +C+ E  E RPT   +   L
Sbjct: 237 MK---TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 47/290 (16%)

Query: 589 DFDAKYCIGNGGHASVYRAEL----PSGE--VVAVK--KFHSLLPCDQTVDQKEFLTEVE 640
           D   K  +G G    V+ AE     P+ +  +VAVK  K  +L        + E LT ++
Sbjct: 6   DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 65

Query: 641 -----AFYGFCSHARHSFLLYEFLERGSLAAILNT---DA----------AAQELGWSQR 682
                 FYG C       +++E+++ G L   L     DA          A  ELG SQ 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           +++   +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++  
Sbjct: 126 LHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYR 180

Query: 743 FAG----TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTD 797
             G       ++ PE     K T + DV+SFGV++WE+   GK P   LS       NT+
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTE 233

Query: 798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           V ++ +   R+    R   +++  IM     C+   P+ R  +K I + L
Sbjct: 234 V-IECITQGRVLERPRVCPKEVYDIM---LGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 67/277 (24%), Positives = 115/277 (41%), Gaps = 41/277 (14%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
            ++    IG G    VY       G++  +K+    L      ++++ L EV+       
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58

Query: 641 ----AFYGFCSHARHSFLLYEFLERGSLA-AILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                +Y          ++ E+ + G L+  I       +     Q ++    +  AL Y
Sbjct: 59  PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118

Query: 696 LH--HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-CG---Y 749
           LH        I+HRDI  +N+ L       + DFGI+K L    S+  + A T  G   Y
Sbjct: 119 LHSRK-----ILHRDIKPQNIFLTSNGLVKLGDFGISKVL----SSTVDLAKTVVGTPYY 169

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP 809
           ++PEL        K D++S G +++E+   KHP  F       +L  ++AL  +     P
Sbjct: 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--F----EGENLL-ELALKILKGQYPP 222

Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ 846
            PS+ + E L +++    S   + PE RP++  I Q 
Sbjct: 223 IPSQYSSE-LRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 69/267 (25%), Positives = 110/267 (41%), Gaps = 43/267 (16%)

Query: 596 IGNGGHASVYRAE-LPSGE----VVAVKKFHSLLPCDQTVDQKEFLTE-----------V 639
           +G+G   +VY+   +P GE     VA+K    L         KE L E           V
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIK---VLREETSPKANKEILDEAYVMASVDHPHV 71

Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL--H 697
               G C  ++   L+ + +  G L   +        +G    +N    +A  +SYL   
Sbjct: 72  VRLLGICLSSQVQ-LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEK 128

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC--GYIAPELA 755
                 +VHRD++++N+L+       + DFG+AK L  D   +    G     ++A E  
Sbjct: 129 R-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
                T K DV+S+GV +WE++  G  P + + ++    L     L++    RLP P   
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-----LEKGE--RLPQPPIC 236

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMK 841
                I +  V   C+    ESRPT K
Sbjct: 237 T----IDVYMVLVKCWMIDAESRPTFK 259

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.8 bits (189), Expect = 2e-14
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 3/95 (3%)

Query: 327 FID-LSRNN--FYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI 383
           FID L  +N    G I ++  K   L ++N+S N+I G +P  +G+ + L+  DLS N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 384 VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSL 418
            G IP+ LG+L  L  L L GN ++GR+P  +G  
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 57/285 (20%)

Query: 596 IGNGGHASVYRAELPSGE------VVAVKKFHSLLPCDQTVDQKEFLTEVEAF------- 642
           +G G    V+ A+    E      +V VK             Q EF  E++ F       
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKN 69

Query: 643 ----YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE------LGWSQRMNVIKAVAHA 692
                G C  A   +++ E+ + G L   L    +  E      L   Q++ +   +A  
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGY 749
           + +L +  F   VHRD++++N L+  + E  V+   ++K     +S + +         +
Sbjct: 130 MDHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKD--VYNSEYYKLRNALIPLRW 184

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHP------RDFLSSISSSSLNTDVALDQ 802
           +APE       + K DV+SFGVLMWEV  +G+ P       + L+ + +  L        
Sbjct: 185 LAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL-------- 236

Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                LP P      +L  +M     C+  +P+ RP+   +   L
Sbjct: 237 ----ELPVPE-GCPSRLYKLMT---RCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 75.4 bits (185), Expect = 2e-14
 Identities = 87/324 (26%), Positives = 130/324 (40%), Gaps = 24/324 (7%)

Query: 141 GNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI 200
             + S     +L  L  L  L LN N+L   I      LT++++L L  N++   IP  I
Sbjct: 78  SGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNIT-DIPPLI 135

Query: 201 GKMRS-LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLL 258
           G ++S L  LDL+ N+ +  LP  + NL NLK L L +N LS  +P  L NL  L  L L
Sbjct: 136 GLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193

Query: 259 SGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEA 318
           SGN  +  LP  I    ALE   +S N     + +SL N  +L  + L+ N L  ++ E+
Sbjct: 194 SGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPES 250

Query: 319 LGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREI-GNSSQLQAFD 377
           +G   NL  +DLS N       S+ G    L  L++S N+++  LP             +
Sbjct: 251 IGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLN 308

Query: 378 LSLNHIVGEIPKELGKLNPL----------TKLILRGNQITGRLPKEIGSLTKLEYLDFS 427
           L L     E+      LN              L +  +             + L      
Sbjct: 309 LLLTLKALELKLNSILLNNNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVK 368

Query: 428 AIGELPSQICNMKSLEKLNLSHNN 451
               + S        + +N     
Sbjct: 369 NPNAIGS--LLDLVKKHVNQLLEK 390

Length = 394

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 73/285 (25%), Positives = 110/285 (38%), Gaps = 65/285 (22%)

Query: 596 IGNGGHASVYRAEL--PSGEV--VAVKKFHSLLPCDQTVD-QKEFLTEVEAFYGFCSHAR 650
           +G+G    V R E     G+V  VAVK     L  D+  D   +FL E    +       
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVK----CLKSDKLSDIMDDFLKEAAIMHSL----D 54

Query: 651 HSFL--LY------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
           H  L  LY            E    GSL   L  DA       S   +    +A+ + YL
Sbjct: 55  HENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRYL 113

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT-------EFAGTCGY 749
               F   +HRD++++N+LL  + +  + DFG+ ++L  +  ++         FA    +
Sbjct: 114 ESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA----W 166

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHP------RDFLSSISSSSLNTDVALDQ 802
            APE   T   +   DV+ FGV +WE+   G+ P         L  I       D   + 
Sbjct: 167 CAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-------DKEGE- 218

Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               RL  P    Q+    I  V   C+  +P  RPT   + + L
Sbjct: 219 ----RLERPEACPQD----IYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 589 DFDAKYC----IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY 643
           D   KY     IG G   +VY A ++ +G+ VA+K+ +      + +   E L   E  +
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH 75

Query: 644 GFCSHARHSFLL-------YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
               +   S+L+        E+L  GSL  ++ T+    E    Q   V +    AL +L
Sbjct: 76  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFL 131

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H +    ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+  
Sbjct: 132 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHP 782
                 K D++S G++  E+++G+ P
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 35/211 (16%)

Query: 596 IGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQT-----VDQ----KEFLTE------V 639
           I  G +  V+ A+  S G++ A+K     +          VDQ    ++ L++      V
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKV----IKKADMIRKNQVDQVLTERDILSQAQSPYVV 56

Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
           + +Y F    ++ +L+ E+L  G LA++L    +  E         I  +  AL YLH +
Sbjct: 57  KLYYSFQ-GKKNLYLVMEYLPGGDLASLLENVGSLDE---DVARIYIAEIVLALEYLHSN 112

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAK--------SLKPDSSNWTEFAGTCGYIA 751
               I+HRD+   N+L+D      + DFG++K        +L  D        GT  YIA
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+      ++  D +S G +++E + G  P
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 73.6 bits (180), Expect = 4e-14
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 15/195 (7%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IG G   +VY A ++ +G+ VA+++ +      + +   E L   E       +   S+L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 655 L-------YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
           +        E+L  GSL  ++ T+    E    Q   V +    AL +LH +    ++HR
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140

Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

Query: 768 SFGVLMWEVIKGKHP 782
           S G++  E+I+G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 71/270 (26%), Positives = 121/270 (44%), Gaps = 37/270 (13%)

Query: 597 GNGGHASVYR---AELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY--------GF 645
           G+ G  S+Y    A   +GE+VAVK          T   K+ +  ++  Y        G 
Sbjct: 15  GHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGC 74

Query: 646 CSHA--RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           CS    +   L+ E++  GSL   L       +L  +Q +   + +   ++YLH   +  
Sbjct: 75  CSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQHY-- 128

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA----GTCGYIAPELAYTMK 759
            +HRD++++N+LLD +    + DFG+AK++ P+   +            + A E     K
Sbjct: 129 -IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECLKENK 186

Query: 760 ITEKCDVYSFGVLMWEVI-----KGKHPRDFLSSIS-SSSLNTDVALDQMLD--PRLPAP 811
            +   DV+SFGV ++E++     K   P+ F   I       T V L ++L+   RLP P
Sbjct: 187 FSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP 246

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
               QE  I +M+   +C+    + RPT +
Sbjct: 247 KNCPQEVYI-LMK---NCWETEAKFRPTFR 272

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 46/267 (17%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHS--- 652
           +G G    V+         VA+K   +L P   T+  + FL E +         RH    
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIK---TLKP--GTMSPEAFLQEAQVM----KKLRHEKLV 64

Query: 653 -----------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
                      +++ E++ +GSL   L  +     L   Q +++   +A  ++Y+    +
Sbjct: 65  QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNY 123

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTM 758
              VHRD+ + N+L+       VADFG+A+ +  + + +T   G      + APE A   
Sbjct: 124 ---VHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 759 KITEKCDVYSFGVLMWEV-IKGKHPRDFLSSISSSSLNTDVALDQM-LDPRLPAPSRSAQ 816
           + T K DV+SFG+L+ E+  KG+ P           +N +V LDQ+    R+P P    +
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP-------YPGMVNREV-LDQVERGYRMPCPPECPE 230

Query: 817 EKLISIMEVAFSCFNESPESRPTMKII 843
               S+ ++   C+ + PE RPT + +
Sbjct: 231 ----SLHDLMCQCWRKEPEERPTFEYL 253

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 7e-14
 Identities = 66/255 (25%), Positives = 109/255 (42%), Gaps = 27/255 (10%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT--------EVEAFYGFC 646
           IG G    VY+  +  + EVVA+K        D+  D ++ +T         +  +YG  
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
                 +++ E+L  GS   +L      +    +    +++ +   L YLH +     +H
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSE---RKIH 124

Query: 707 RDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDV 766
           RDI + N+LL  + +  +ADFG+A  L         F GT  ++APE+        K D+
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADI 184

Query: 767 YSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVA 826
           +S G+   E+ KG+ P        +S L+    L   L P+   P+   Q       E  
Sbjct: 185 WSLGITAIELAKGEPP--------NSDLHPMRVL--FLIPKNSPPTLEGQYSK-PFKEFV 233

Query: 827 FSCFNESPESRPTMK 841
            +C N+ P  RPT K
Sbjct: 234 EACLNKDPRFRPTAK 248

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 71.8 bits (176), Expect = 1e-13
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 25/206 (12%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTEVEAF---------- 642
           +G G  +S Y+A ++ +G ++AVK   +      +Q    +    E+             
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 643 -YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
             G      H  L  E++  GS++ +L+   A +E   +  +N  + +   LSYLH +  
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN-- 122

Query: 702 PPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAG----TCGYIAPELAY 756
             I+HRD+   NLL+D       +ADFG A  L    +   EF G    T  ++APE+  
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHP 782
             +    CDV+S G ++ E+   K P
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 17/197 (8%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T    + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 76  YIITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFIERKNY---IHRDLRAA 131

Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 132 NILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 191

Query: 772 LMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   ++       N +V  +     R+P P    +E    + E+   C+
Sbjct: 192 LLTEIVTYGRIPYPGMT-------NPEVIQNLERGYRMPRPDNCPEE----LYELMRLCW 240

Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT + +   L
Sbjct: 241 KEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 71.7 bits (175), Expect = 2e-13
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 15/195 (7%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IG G   +VY A ++ +G+ VA+K+ +      + +   E L   E       +   S+L
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 655 L-------YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
           +        E+L  GSL  ++ T+    E    Q   V +    AL +LH +    ++HR
Sbjct: 87  VGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALDFLHSN---QVIHR 139

Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K D++
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 199

Query: 768 SFGVLMWEVIKGKHP 782
           S G++  E+++G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 71.3 bits (174), Expect = 2e-13
 Identities = 39/130 (30%), Positives = 69/130 (53%), Gaps = 7/130 (5%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           F++ E+L  GSL  ++ T+    E   +Q   V +    AL +LH +    ++HRDI S 
Sbjct: 92  FVVMEYLAGGSLTDVV-TETCMDE---AQIAAVCRECLQALEFLHAN---QVIHRDIKSD 144

Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K D++S G++
Sbjct: 145 NVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204

Query: 773 MWEVIKGKHP 782
             E+++G+ P
Sbjct: 205 AIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 7/130 (5%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           ++L EFL+ G+L  I++     +E    Q   V ++V  AL YLH      ++HRDI S 
Sbjct: 94  WVLMEFLQGGALTDIVSQTRLNEE----QIATVCESVLQALCYLHSQ---GVIHRDIKSD 146

Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           ++LL L+    ++DFG    +  D        GT  ++APE+        + D++S G++
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206

Query: 773 MWEVIKGKHP 782
           + E++ G+ P
Sbjct: 207 VIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 71/296 (23%), Positives = 121/296 (40%), Gaps = 70/296 (23%)

Query: 596 IGNGGHASVYRAEL--PSGE-------VVAVKKFHSLLPCDQTVD-QKEFLTEVEA---- 641
           +G G    VY+ EL  P+         +  +K+             Q+EF  E E     
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-------PKVQQEFRQEAELMSDL 65

Query: 642 -------FYGFCSHARHSFLLYEFLERGSLAAIL-----NTDAAAQE--------LGWSQ 681
                    G C+  + + +L+E+L  G L   L     ++D  A+         L  S 
Sbjct: 66  QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 682 RMNVIKAVAHALSYL--HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
            +++   +A  + YL  HH      VHRD++++N L+       ++DFG+++ +   S++
Sbjct: 126 FLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIY--SAD 178

Query: 740 WTEFAGT----CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSL 794
           +            ++ PE     K T + D++SFGV++WE+   G  P    S       
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS------- 231

Query: 795 NTDVALDQMLDPR--LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           N +V   +M+  R  LP P          +  +   C+NE P  RP  K I  +LR
Sbjct: 232 NQEVI--EMIRSRQLLPCPEDCPA----RVYALMIECWNEIPARRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 53/199 (26%), Positives = 96/199 (48%), Gaps = 20/199 (10%)

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G  + ++   ++ E++E GSL A L       +    Q + +++ +A  + YL    +  
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMGY-- 127

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGTCG--YIAPELAYTMKI 760
            VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE     K 
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKL 819
           T   DV+S+G++MWEV+  G+ P   +S       N DV        RLPAP        
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMS-------NQDVIKAIEEGYRLPAPMDCP---- 235

Query: 820 ISIMEVAFSCFNESPESRP 838
            ++ ++   C+ +    RP
Sbjct: 236 AALHQLMLDCWQKDRNERP 254

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.9 bits (173), Expect = 3e-13
 Identities = 65/255 (25%), Positives = 106/255 (41%), Gaps = 27/255 (10%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT--------EVEAFYGFC 646
           IG G    V++  +  + +VVA+K        D+  D ++ +T         V  +YG  
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
                 +++ E+L  GS   +L        L  +Q   +++ +   L YLH +     +H
Sbjct: 72  LKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHSE---KKIH 124

Query: 707 RDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDV 766
           RDI + N+LL    E  +ADFG+A  L         F GT  ++APE+        K D+
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADI 184

Query: 767 YSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVA 826
           +S G+   E+ KG+ P   L  +              L P+   P+         + E  
Sbjct: 185 WSLGITAIELAKGEPPHSELHPMKV----------LFLIPKNNPPTLEGNYSK-PLKEFV 233

Query: 827 FSCFNESPESRPTMK 841
            +C N+ P  RPT K
Sbjct: 234 EACLNKEPSFRPTAK 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 50/151 (33%), Positives = 82/151 (54%), Gaps = 10/151 (6%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFAGTC 747
           ++ AL+YLH      I++RD+   N+LLD E    + D+G+ K  L+P  +  + F GT 
Sbjct: 105 ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTP 160

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ-MLDP 806
            YIAPE+          D ++ GVLM+E++ G+ P D + S  +   NT+  L Q +L+ 
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220

Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESR 837
           ++  P RS   K  S+++   S  N+ P+ R
Sbjct: 221 QIRIP-RSLSVKAASVLK---SFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.5 bits (172), Expect = 4e-13
 Identities = 58/238 (24%), Positives = 106/238 (44%), Gaps = 38/238 (15%)

Query: 632 QKEFLTEVE-----AFYGFCSHARHSFLLYEFLERGSL----------AAILNTDAAAQE 676
           + E LT ++      FYG C       +++E+++ G L          A ++       E
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116

Query: 677 LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD 736
           L  SQ +++ + +A  + YL    F   VHRD++++N L+       + DFG+++ +   
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY-- 171

Query: 737 SSNWTEFAG----TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISS 791
           S+++    G       ++ PE     K T + DV+S GV++WE+   GK P   LS    
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---- 227

Query: 792 SSLNTDVALDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
              N +V ++ +   R L  P    +E    + ++   C+   P  R  +K I   L+
Sbjct: 228 ---NNEV-IECITQGRVLQRPRTCPKE----VYDLMLGCWQREPHMRLNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 69.3 bits (169), Expect = 6e-13
 Identities = 52/199 (26%), Positives = 97/199 (48%), Gaps = 21/199 (10%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ EF+ +GSL   L  +   + L   Q +++   +A  ++Y+    +   +HRD+ + 
Sbjct: 76  YIVTEFMGKGSLLDFLK-EGDGKYLKLPQLVDMAAQIADGMAYIERMNY---IHRDLRAA 131

Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       +ADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 132 NILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189

Query: 770 GVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFS 828
           G+L+ E++ KG+ P           +N +V        R+P P    +    S+ E+   
Sbjct: 190 GILLTELVTKGRVP-------YPGMVNREVLEQVERGYRMPCPQGCPE----SLHELMKL 238

Query: 829 CFNESPESRPTMKIISQQL 847
           C+ + P+ RPT + I   L
Sbjct: 239 CWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 69.6 bits (170), Expect = 7e-13
 Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 36/264 (13%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEF--LTE------------VEA 641
           +G G + +VY      G+++AVK+   L   +    +KE+  L E            +  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
           + G C       +  EF+  GS+++ILN      E  + +     K +   ++YLH++C 
Sbjct: 67  YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC- 122

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE------FAGTCGYIAPELA 755
             +VHRDI   N++L       + DFG A+ L     + T         GT  ++APE+ 
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
                  K D++S G  ++E+  GK P   L+S+   +    +   + L PRLP    +A
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPP---LASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237

Query: 816 QEKLISIMEVAFSCFNESPESRPT 839
               ++      SC       RP+
Sbjct: 238 AIDFVT------SCLTRDQHERPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.1 bits (169), Expect = 9e-13
 Identities = 65/272 (23%), Positives = 105/272 (38%), Gaps = 39/272 (14%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY-----------G 644
           IGNG    V   E   G   A      L       +Q  FL EV+ +            G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA---VAHALSYLHHDCF 701
            C  +    L+ EF   G L   L ++        +Q+  + +    VA  L +LH   F
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGM-VAQMAQKDVLQRMACEVASGLLWLHQADF 121

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE--FAGTCGYIAPELA---- 755
              +H D++ +N  L  +    + D+G+A    P+    T+   A    ++APEL     
Sbjct: 122 ---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 756 ---YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
                   T+K +++S GV MWE+      P      +S   +   V  +Q  D +LP P
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQP---YPDLSDEQVLKQVVREQ--DIKLPKP 233

Query: 812 S--RSAQEKLISIMEVAFSCFNESPESRPTMK 841
                  ++   +M+  +      PE+RPT +
Sbjct: 234 QLDLKYSDRWYEVMQFCWL----DPETRPTAE 261

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.4 bits (175), Expect = 1e-12
 Identities = 35/89 (39%), Positives = 51/89 (57%)

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
           ++  L +++  L GFIP  I  L+ L  ++L+ N   G IP S  ++++L  L L  N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIP 173
           +GSI  SLG+L SL  L LN N L G +P
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 30/233 (12%)

Query: 627 DQTVDQKEFLTEVEAFY-----GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQ 681
           D+ + + E + +++  Y     G C  A    L+ E    G L   L+      E+  S 
Sbjct: 40  DEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSN 96

Query: 682 RMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT 741
            + ++  V+  + YL    F   VHRD++++N+LL  ++ A ++DFG++K+L  D S + 
Sbjct: 97  VVELMHQVSMGMKYLEGKNF---VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153

Query: 742 EFAGTCG-----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLN 795
             A + G     + APE     K + + DV+S+G+ MWE    G+ P   +      S  
Sbjct: 154 --ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF- 210

Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
               ++Q    RL  P+    E    +  +   C+    E RP    + +++R
Sbjct: 211 ----IEQ--GKRLDCPAECPPE----MYALMKDCWIYKWEDRPNFAKVEERMR 253

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 69.1 bits (170), Expect = 1e-12
 Identities = 58/220 (26%), Positives = 93/220 (42%), Gaps = 48/220 (21%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQ---TVDQKEFLTEVEA 641
           +DF+    +G G    V       SG+  A+K      ++   Q    +++K  L  +  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAIL-------NTDA---AAQELGWSQRMNVI 686
                 YG      + +L+ E++  G L + L          A   AAQ           
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ----------- 109

Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
             V  AL YLH      IV+RD+  +NLLLD +    + DFG AK +K  +  +T   GT
Sbjct: 110 --VVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCGT 161

Query: 747 CGYIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y+APE+     Y   +    D ++ G+L++E++ G  P
Sbjct: 162 PEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 53/156 (33%), Positives = 77/156 (49%), Gaps = 19/156 (12%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSS--NWTEFA 744
           VA  + YL    F   VHRD++++N +LD  +   VADFG+A+ +  K   S  N T   
Sbjct: 107 VAKGMEYLASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQM 803
               ++A E   T K T K DV+SFGVL+WE++ +G  P   + S        D+ +  +
Sbjct: 164 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-------DITVYLL 216

Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
              RL  P          + EV  SC++  PE RPT
Sbjct: 217 QGRRLLQPEYCPD----PLYEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 69.2 bits (169), Expect = 1e-12
 Identities = 66/265 (24%), Positives = 110/265 (41%), Gaps = 52/265 (19%)

Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHS-LLPCDQTVD-------------QKEFLTEVE 640
           +G G    V+ AEL  + +  A+K     ++  D  V+             +  FLT + 
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61

Query: 641 AFYGFCSH--ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA------ 692
               +C+     + F + E+L  G L   + +           + ++ +A  +A      
Sbjct: 62  ----YCTFQTKENLFFVMEYLNGGDLMFHIQS---------CHKFDLPRATFYAAEIICG 108

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L +LH      IV+RD+   N+LLD +    +ADFG+ K      +    F GT  YIAP
Sbjct: 109 LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAP 165

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS 812
           E+    K     D +SFGVL++E++ G+ P           L   + +D    PR    +
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP---FHGHDEEELFQSIRMDNPCYPRW--LT 220

Query: 813 RSAQEKLISIMEVAFSCFNESPESR 837
           R A++ L+ +       F   PE R
Sbjct: 221 REAKDILVKL-------FVREPERR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 68.8 bits (168), Expect = 1e-12
 Identities = 77/260 (29%), Positives = 120/260 (46%), Gaps = 42/260 (16%)

Query: 597 GNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVD-QKEFLTEVE-----------AFY 643
           GNGG  +VY+A  L +  ++AVK    ++P D TV+ QK+ ++E+E            FY
Sbjct: 12  GNGG--TVYKAYHLLTRRILAVK----VIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 644 G-FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           G F    R S +  EF++ GSL   +        LG   R+ V  AV   L+YL      
Sbjct: 66  GAFFVENRIS-ICTEFMDGGSLD--VYRKIPEHVLG---RIAV--AVVKGLTYLWS---L 114

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITE 762
            I+HRD+   N+L++   +  + DFG++  L   +S    + GT  Y+APE     +   
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGI 172

Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD---PRLPAPSRSAQEKL 819
             DV+S G+   E+  G+ P   +   +  SL     L  ++D   P LP    S  EK 
Sbjct: 173 HSDVWSLGISFMELALGRFPYPQIQK-NQGSLMPLQLLQCIVDEDPPVLPVGQFS--EKF 229

Query: 820 ISIMEVAFSCFNESPESRPT 839
           +  +     C  + P+ RP 
Sbjct: 230 VHFIT---QCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 66/276 (23%), Positives = 114/276 (41%), Gaps = 52/276 (18%)

Query: 596 IGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFY 643
           IG G    V+   L +    VAVK     LP D    + +FL E           +    
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 59

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C+  +  +++ E ++ G     L T+     L   + + +++  A  + YL       
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH--- 114

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKS-----------LKPDSSNWTEFAGTCGYIAP 752
            +HRD++++N L+  +    ++DFG+++            +K     WT         AP
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWT---------AP 165

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
           E     + + + DV+SFG+L+WE    G  P   L     S+  T  A++Q +  RLP P
Sbjct: 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-----SNQQTREAIEQGV--RLPCP 218

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                  +  +ME    C+   P  RP+   + Q+L
Sbjct: 219 ELCPDA-VYRLME---RCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 62/281 (22%), Positives = 118/281 (41%), Gaps = 53/281 (18%)

Query: 596 IGNGGHASVYR---AELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G G    VY      +  GE    VA+K   ++       ++ EFL E           
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIK---TVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
           V    G  S  + + ++ E + +G L + L +     E           + + +   +A 
Sbjct: 71  VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG--- 748
            ++YL    F   VHRD++++N ++  +    + DFG+ + +       T++    G   
Sbjct: 131 GMAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDI-----YETDYYRKGGKGL 182

Query: 749 ----YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML 804
               ++APE       T K DV+SFGV++WE+         L+      L+ +  L  ++
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT-------LAEQPYQGLSNEEVLKFVI 235

Query: 805 DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
           D        +  +KL+ +M +   C+  +P+ RPT ++I+S
Sbjct: 236 DGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVS 273

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 68.9 bits (169), Expect = 2e-12
 Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 35/206 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK-----------------FHSLLPCDQT--VDQKEF 635
           IG G +  VYRA +  SGE+VA+KK                    LL       V+ KE 
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 636 LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
           +           H    FL+ E+ E+  LA++L  D        SQ   ++  +   L Y
Sbjct: 75  VVG--------KHLDSIFLVMEYCEQ-DLASLL--DNMPTPFSESQVKCLMLQLLRGLQY 123

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           LH +    I+HRD+   NLLL  +    +ADFG+A++    +   T    T  Y APEL 
Sbjct: 124 LHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELL 180

Query: 756 YTMKI-TEKCDVYSFGVLMWEVIKGK 780
                 T   D+++ G ++ E++  K
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 59/291 (20%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAF-- 642
           ND   +  IG G    V +A +    +    A+K+       D   D ++F  E+E    
Sbjct: 7   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 63

Query: 643 ----------YGFCSHARHSFLLYEFLERGSL------AAILNTDAA-------AQELGW 679
                      G C H  + +L  E+   G+L      + +L TD A       A  L  
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
            Q ++    VA  + YL    F   +HRD++++N+L+   Y A +ADFG+++  +     
Sbjct: 124 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQE----- 175

Query: 740 WTEFAGTCG-----YIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSS 792
                 T G     ++A E L Y++  T   DV+S+GVL+WE++  G  P      ++ +
Sbjct: 176 -VYVKKTMGRLPVRWMAIESLNYSVYTTNS-DVWSYGVLLWEIVSLGGTP---YCGMTCA 230

Query: 793 SLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
            L   +        RL  P     E    + ++   C+ E P  RP+   I
Sbjct: 231 ELYEKLPQGY----RLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQI 273

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.0 bits (166), Expect = 3e-12
 Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 36/208 (17%)

Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHS-LLPCDQTVD-------------QKEFLTEVE 640
           +G G    V  AEL   GE  AVK     ++  D  V+             +  FLT + 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA------LS 694
             +       H F + EFL  G L   +      Q+ G   R ++ +A  +A      L 
Sbjct: 63  CTF---QTKEHLFFVMEFLNGGDLMFHI------QDKG---RFDLYRATFYAAEIVCGLQ 110

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           +LH      I++RD+   N++LD +    +ADFG+ K      +  + F GT  YIAPE+
Sbjct: 111 FLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEI 167

Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
              +K T   D +SFGVL++E++ G+ P
Sbjct: 168 LQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 47/211 (22%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L +   +  LG    +     V  A+ YL  + F   VHRD++++
Sbjct: 76  YIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNF---VHRDLAAR 131

Query: 713 NLLLDLEYEAHVADFGIAK--SLKPDSSN----WTEFAGTCGYIAPELAYTMKITEKCDV 766
           N+L+  +  A V+DFG+ K  S   D+      WT         APE     K + K DV
Sbjct: 132 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALREKKFSTKSDV 182

Query: 767 YSFGVLMWEVIK-GK--HPRDFLSSISSSSLNTDVALDQMLDPR------LPAPSRSAQE 817
           +SFG+L+WE+   G+  +PR              + L  ++ PR      + AP      
Sbjct: 183 WSFGILLWEIYSFGRVPYPR--------------IPLKDVV-PRVEKGYKMDAPD-GCPP 226

Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +  +M+    C++    +RP+   + +QL 
Sbjct: 227 VVYDVMK---QCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 37/96 (38%), Positives = 52/96 (54%), Gaps = 14/96 (14%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           A  YLH+     I++RD+  +NLLLD      + DFG AK LK     WT F GT  Y+A
Sbjct: 105 AFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVA 160

Query: 752 PELAYTMKITEK-----CDVYSFGVLMWEVIKGKHP 782
           PE+     I  K      D +S G+L++E++ G+ P
Sbjct: 161 PEI-----ILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 49/197 (24%), Positives = 91/197 (46%), Gaps = 17/197 (8%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ EF+ +GSL   L +D    +    + ++    +A  ++++    +   +HRD+ + 
Sbjct: 76  YIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAA 131

Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 191

Query: 772 LMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +S       N +V        R+P P    +E    +  +   C+
Sbjct: 192 LLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPEE----LYNIMMRCW 240

Query: 831 NESPESRPTMKIISQQL 847
              PE RPT + I   L
Sbjct: 241 KNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 71/267 (26%), Positives = 123/267 (46%), Gaps = 47/267 (17%)

Query: 596 IGNGGHASVYRAE------LPSGEVVAVKKFHSL------LPCDQTVDQKEFLTEVEAFY 643
           +G+G    VY+A+      L + +V+  K    L      +    T +    +  + AFY
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 644 GFCSHARHSFLLYEFLERGSLAAI-LNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
                    +++ EF   G++ AI L  D    E    Q   + + +  AL YLH     
Sbjct: 80  ----WDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVICRQMLEALQYLHSM--- 129

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGI-AKSLKP----DSSNWTEFAGTCGYIAPELAY- 756
            I+HRD+ + N+LL L+ +  +ADFG+ AK++K     DS     F GT  ++APE+   
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS-----FIGTPYWMAPEVVMC 184

Query: 757 -TMKITE---KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS 812
            TMK T    K D++S G+ + E+ + + P   L     + +   + + +   P L  PS
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSEPPTLSQPS 239

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT 839
           + + E     ++ A    ++ PE+RP+
Sbjct: 240 KWSME-FRDFLKTA---LDKHPETRPS 262

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 58/205 (28%), Positives = 89/205 (43%), Gaps = 33/205 (16%)

Query: 597 GNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD-QKEFLTEVE-----------AFYG 644
           G GG  SV +  L +  ++   K    +  D   D QK+ L E+E            +YG
Sbjct: 12  GAGG--SVTKCRLKNTGMIFALK---TITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 645 FCSHARHSFL--LYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
                  S +    E+ E GSL +I          +G      + ++V   LSYLH    
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-- 124

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE----LAYT 757
             I+HRDI   N+LL  + +  + DFG++  L   +S    F GT  Y+APE      Y+
Sbjct: 125 -KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQGKPYS 181

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHP 782
           +      DV+S G+ + EV + + P
Sbjct: 182 I----TSDVWSLGLTLLEVAQNRFP 202

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L +LH      I++RD+   N+LLD +    +ADFG+ K         + F GT  YIA
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIA 164

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+    K  E  D +SFGVL++E++ G+ P
Sbjct: 165 PEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 9e-12
 Identities = 63/231 (27%), Positives = 99/231 (42%), Gaps = 39/231 (16%)

Query: 606 RAELPSGEVVAVKKFHSLLPCDQTVDQ-KEFLTEVEAFYGFCSHARHSFLLYEFLERGSL 664
           R EL   EVV ++ +H     +  VD    +L   E +           ++ EFLE G+L
Sbjct: 62  RRELLFNEVVIMRDYHH----ENVVDMYNSYLVGDELW-----------VVMEFLEGGAL 106

Query: 665 AAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV 724
             I+      +E    Q   V  +V  ALSYLH+     ++HRDI S ++LL  +    +
Sbjct: 107 TDIVTHTRMNEE----QIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKL 159

Query: 725 ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP-- 782
           +DFG    +  +        GT  ++APE+   +    + D++S G+++ E+I G+ P  
Sbjct: 160 SDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219

Query: 783 -----------RDFLSSISSSSLNTDVALDQMLD---PRLPAPSRSAQEKL 819
                      RD L      S      L   LD    R P+   +AQE L
Sbjct: 220 NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.1 bits (162), Expect = 9e-12
 Identities = 66/288 (22%), Positives = 113/288 (39%), Gaps = 56/288 (19%)

Query: 586 ATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYG 644
            T  F+    IG G +  VY+A    +G++VA+K    +       +++E   E      
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-----EEEEIKEEYNILRK 58

Query: 645 FCSH------------ARHS------FLLYEFLERGSLAAILNTDAAAQELGWSQRMN-- 684
           + +H                      +L+ E    GS+     TD         +R+   
Sbjct: 59  YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-----TDLVKGLRKKGKRLKEE 113

Query: 685 ----VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
               +++     L+YLH +    ++HRDI  +N+LL    E  + DFG++  L       
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRR 170

Query: 741 TEFAGTCGYIAPELAYTMK-----ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN 795
             F GT  ++APE+    +        + DV+S G+   E+  GK P           ++
Sbjct: 171 NTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--------CDMH 222

Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAF--SCFNESPESRPTMK 841
              AL ++  PR P P+  + E   S     F   C  ++ E RP M+
Sbjct: 223 PMRALFKI--PRNPPPTLKSPENW-SKKFNDFISECLIKNYEQRPFME 267

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 68/269 (25%), Positives = 118/269 (43%), Gaps = 52/269 (19%)

Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFC-SHARHSF-LLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C S  R +  L+ E
Sbjct: 32  TGEVVAVKK----LQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87

Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA------LSYLHHDCFPPIVHRDISS 711
           +L  GSL   L            +R++  K + +A      + YL    +   VHRD+++
Sbjct: 88  YLPYGSLRDYLQKH--------RERLDHRKLLLYASQICKGMEYLGSKRY---VHRDLAT 136

Query: 712 KNLLLDLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYS 768
           +N+L++ E    + DFG+ K L  D   +           + APE     K +   DV+S
Sbjct: 137 RNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWS 196

Query: 769 FGVLMWEVI----KGKHP-RDFLSSISSSSLNTDVALDQMLD-----PRLPAPSRSAQEK 818
           FGV+++E+     K   P  +F+  + +      + +  +++      RLPAP      +
Sbjct: 197 FGVVLYELFTYSDKSCSPPAEFMRMMGNDK-QGQMIVYHLIELLKNNGRLPAPP-GCPAE 254

Query: 819 LISIMEVAFSCFNESPESRPTMKIISQQL 847
           + +IM+    C+N  P  RP+   ++ Q+
Sbjct: 255 IYAIMK---ECWNNDPSQRPSFSELALQV 280

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 66/259 (25%), Positives = 111/259 (42%), Gaps = 39/259 (15%)

Query: 615 VAVKKFHSLLPCDQTVD-QKEFLTEVEAF-----------YGFCSHARHSFLLYEFLERG 662
           VAVK     L  D + + +++FL EV+              G C+      ++ E++E G
Sbjct: 49  VAVKV----LRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104

Query: 663 SLAAIL-------NTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
            L   L       +  A   + L +S  + +   +A  + YL    F   VHRD++++N 
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNF---VHRDLATRNC 161

Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC----GYIAPELAYTMKITEKCDVYSFG 770
           L+   Y   +ADFG++++L   SS++    G       ++A E     K T K DV++FG
Sbjct: 162 LVGKNYTIKIADFGMSRNLY--SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219

Query: 771 VLMWEVIK--GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFS 828
           V +WE++    + P + L+             D      LP P    ++    I E+   
Sbjct: 220 VTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD----IYELMLE 275

Query: 829 CFNESPESRPTMKIISQQL 847
           C+    E RPT + I   L
Sbjct: 276 CWRRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 15/194 (7%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++  F E G L   L  +   + L  +Q +     +A AL YLH      I+HRD+ ++
Sbjct: 76  YIVMGFCEGGDLYHKLK-EQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQ 131

Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+ L       V D GIA+ L+      +   GT  Y++PEL        K DV++ G  
Sbjct: 132 NVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCC 191

Query: 773 MWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNE 832
           ++E+   KH      + ++  +N+ V   ++++ +LP   +    +L  ++    +  ++
Sbjct: 192 VYEMATLKH------AFNAKDMNSLVY--RIIEGKLPPMPKDYSPELGELIA---TMLSK 240

Query: 833 SPESRPTMKIISQQ 846
            PE RP++K I +Q
Sbjct: 241 RPEKRPSVKSILRQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 5/95 (5%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
           +   L +LH       I++RD+   N+LLD E    +ADFG+ K         + F GT 
Sbjct: 105 IVLGLQFLHERG----IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            YIAPE+          D ++ GVL++E++ G+ P
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 65/268 (24%), Positives = 121/268 (45%), Gaps = 38/268 (14%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQK------------EFLTEVE-- 640
           IG G +  VY A  + +GE++AVK+           D +            E L +++  
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 641 ---AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
               + GF +   +  +  E++  GS+ + L T    +E          + V   L+YLH
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE---QLVRFFTEQVLEGLAYLH 125

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP--DSSNWTEFAGTCGYIAPEL- 754
                 I+HRD+ + NLL+D +    ++DFGI+K      D+       G+  ++APE+ 
Sbjct: 126 SK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 755 -AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR 813
            +Y+   + K D++S G ++ E+  G+ P     +I+        A+ ++ + R   P  
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--------AMFKLGNKRSAPPIP 234

Query: 814 SAQEKLISIMEVAF--SCFNESPESRPT 839
                 +S + + F  +CF  +P++RPT
Sbjct: 235 PDVSMNLSPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.1 bits (164), Expect = 2e-11
 Identities = 39/112 (34%), Positives = 57/112 (50%), Gaps = 23/112 (20%)

Query: 209 LDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP 268
           L L+    +G +P  IS L +L+ + L  N + G+IPPSLG++                 
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSI----------------- 465

Query: 269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALG 320
                  +LE+  +S N F G+IP SL   TSL  + LNGN+L+G +  ALG
Sbjct: 466 ------TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 66.9 bits (163), Expect = 2e-11
 Identities = 63/203 (31%), Positives = 94/203 (46%), Gaps = 27/203 (13%)

Query: 50  ISNLSNLRYLYLGSNQ-------------------FSGNILAEVSSESSGGNLRYMSRLV 90
           +  L+NL  L L +N                     S N +  + S     NL  +  L 
Sbjct: 112 LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIESLPSPL--RNLPNLKNLD 169

Query: 91  INDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILS 150
           ++ N LS  +P  + NL  L+ LDL+ NK S  +P   + LS L  L L  N +   +LS
Sbjct: 170 LSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLS 226

Query: 151 SLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLD 210
           SL  LK+L  L+L++N+L   +P    NL+++ TL LS N +  S    +G + +L  LD
Sbjct: 227 SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELD 283

Query: 211 LNQNQFKGVLPPSISNLTNLKEL 233
           L+ N     LP     L  L+ L
Sbjct: 284 LSGNSLSNALPLIALLLLLLELL 306

Length = 394

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 17/196 (8%)

Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKF------HSLLPCDQTVDQKEFLTE--VEAFYGFC 646
           IG G    V  A +  SG++VAVKK          L  ++ V  +++  E  VE +  + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
                 +++ EFLE G+L  I+      +E    Q   V  AV  ALS LH      ++H
Sbjct: 88  V-GDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHAQ---GVIH 139

Query: 707 RDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDV 766
           RDI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    + D+
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDI 199

Query: 767 YSFGVLMWEVIKGKHP 782
           +S G+++ E++ G+ P
Sbjct: 200 WSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 53/285 (18%)

Query: 596 IGNGGHASVYRAELP------SGEV-VAVKKFHSLLPCDQTVDQKEFLTEVE-------- 640
           +G+G    VY           SG + VAVK   +L       ++KEFL E          
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVK---TLRKGATDQEKKEFLKEAHLMSNFNHP 59

Query: 641 ---AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-----LGWSQRMNVIKAVAHA 692
                 G C      +++ E +E G L + L  DA  +      L   + +++   VA  
Sbjct: 60  NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLR-DARVERFGPPLLTLKELLDICLDVAKG 118

Query: 693 LSYLHHDCFPPIVHRDISSKNLLL-----DLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
             YL    F   +HRD++++N L+     D +    + DFG+A+ +    S++    G  
Sbjct: 119 CVYLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEG 173

Query: 747 ---CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ 802
                ++APE     K T + DV+SFGVLMWE++  G+ P   L+       N +V    
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN-------NQEVLQHV 226

Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               RL  P  +  +K+  +M    +C+ + P  RPT   I + L
Sbjct: 227 TAGGRLQKP-ENCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 41/117 (35%), Positives = 60/117 (51%), Gaps = 15/117 (12%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
           V  AL +LH H     +++RD+   N+LLD E    +ADFG+ K    +    T F GT 
Sbjct: 105 VTLALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP------RDFLSSISSSSLNTDV 798
            YIAPE+   ++     D ++ GVLM+E++ G+ P       D   SI    L+ DV
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI----LHDDV 213

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 10/149 (6%)

Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +H R  F++ E+   G L   L+ +    E     R     A +  AL
Sbjct: 56  FLTALK--YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSAL 108

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 109 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 166

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 57/207 (27%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCD--QTVDQKEFLTE------ 638
           +D++    +G+G +  VY+A  L +GE+ AVK    L P D    + Q+ F+ +      
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKII-KLEPGDDFSLIQQEIFMVKECKHCN 67

Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           + A++G        ++  E+   GSL  I +      EL   Q   V +     L+YLH 
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAYLHS 124

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
                 +HRDI   N+LL    +  +ADFG+A  +    +    F GT  ++APE+A   
Sbjct: 125 KG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 759 K---ITEKCDVYSFGVLMWEVIKGKHP 782
           K     + CD+++ G+   E+ + + P
Sbjct: 182 KNGGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK-SLKPDSSNWTEFAGTCGYI 750
           AL++LH      I++RD+   N+LLD E    + D+G+ K  ++P  +  T F GT  YI
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA 810
           APE+          D ++ GVLM+E++ G+ P D +    +   NT+  L Q++  +   
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR 223

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESR 837
             RS   K  S+++      N+ P+ R
Sbjct: 224 IPRSLSVKASSVLK---GFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 64.5 bits (158), Expect = 3e-11
 Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 38/227 (16%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQ----KEFLTEVEA 641
           +DF     IG G  ++V  A E  + +  A+K      L  ++ V      KE LT +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 642 FYGF-----CSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
             G            + + + E+   G L   +    +  E   ++       +  AL Y
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-CTR--FYAAEILLALEY 117

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE------------- 742
           LH      I+HRD+  +N+LLD +    + DFG AK L P+SS  +              
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174

Query: 743 -------FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  F GT  Y++PEL       +  D+++ G ++++++ GK P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.7 bits (158), Expect = 3e-11
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 51/218 (23%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKE---FLTEVEA---------- 641
           IG G   +V +    PSG ++AVK+  S      TVD+KE    L +++           
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRS------TVDEKEQKRLLMDLDVVMRSSDCPYI 65

Query: 642 --FYGFCSHARHSFLLYEFLERGSLA-------AILNTDAAAQELGWSQRMNVIKAVAHA 692
             FYG        ++  E ++  SL         +L +    + LG      +  A   A
Sbjct: 66  VKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKA 119

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L+YL  +    I+HRD+   N+LLD      + DFGI+  L  DS   T  AG   Y+AP
Sbjct: 120 LNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 176

Query: 753 ELAYTMKITE--------KCDVYSFGVLMWEVIKGKHP 782
           E     +I          + DV+S G+ ++EV  GK P
Sbjct: 177 E-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 13/147 (8%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           AL YLH +    IVHRD++  N++L  + +  + DFG+AK  +P+S   T   GT  Y  
Sbjct: 125 ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTILYSC 181

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
           PE+       EK DV++FG +++++   + P  F S+ +  SL T + ++ + +P LP  
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYST-NMLSLATKI-VEAVYEP-LPEG 236

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRP 838
             S       + +V  SC     E+RP
Sbjct: 237 MYSED-----VTDVITSCLTPDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.0 bits (161), Expect = 5e-11
 Identities = 57/202 (28%), Positives = 83/202 (41%), Gaps = 56/202 (27%)

Query: 354 VSMNN--ITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRL 411
           + ++N  + G +P +I     LQ+ +LS N I G IP  LG +  L  L L  N   G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 412 PKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEG--MHGLSFI 469
           P+ +G LT                     SL  LNL+ N+LSG +P+   G  +H  SF 
Sbjct: 483 PESLGQLT---------------------SLRILNLNGNSLSGRVPAALGGRLLHRASF- 520

Query: 470 DMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLRQEKSNSGAKWFAIVF 529
                       N T            N GLCG   GL+ C P      + GAK   I F
Sbjct: 521 ------------NFTD-----------NAGLCG-IPGLRACGP----HLSVGAK-IGIAF 551

Query: 530 PLLGALFVSIALISIFFILRKQ 551
            +  A    + + ++ +  R+Q
Sbjct: 552 GVSVAFLF-LVICAMCWWKRRQ 572

Length = 623

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 63.6 bits (155), Expect = 6e-11
 Identities = 39/130 (30%), Positives = 67/130 (51%), Gaps = 7/130 (5%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ EFLE G+L  I+ T     E    Q   V  AV  ALS+LH      ++HRDI S 
Sbjct: 92  WVVMEFLEGGALTDIV-THTRMNE---EQIATVCLAVLKALSFLHAQ---GVIHRDIKSD 144

Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           ++LL  +    ++DFG    +  +        GT  ++APE+   +    + D++S G++
Sbjct: 145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 204

Query: 773 MWEVIKGKHP 782
           + E++ G+ P
Sbjct: 205 VIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 7e-11
 Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 28/202 (13%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVK--KFHSLLPCDQTVD----------QKEFLTEVEAF 642
           I  G   SVY A+   +G+  A+K  K   ++  +Q  +          Q E     + +
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           Y F S   + +L+ E+L  G  A+++ T     E  W++    I  V   +  LH     
Sbjct: 64  YSFQS-KDYLYLVMEYLNGGDCASLIKTLGGLPE-DWAK--QYIAEVVLGVEDLHQR--- 116

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKS--LKPDSSNWTEFAGTCGYIAPELAYTMKI 760
            I+HRDI  +NLL+D      + DFG++++            F GT  Y+APE    +  
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVGD 170

Query: 761 TEKCDVYSFGVLMWEVIKGKHP 782
            +  D +S G +++E + G  P
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 30/252 (11%)

Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY--------GFCSH--ARHSFLLYEFLE 660
           +GE VAVK        +   D K+ +  +   Y        G C+        L+ EFL 
Sbjct: 32  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91

Query: 661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY 720
            GSL   L  +     L   Q++     +   + YL    +   VHRD++++N+L++ E+
Sbjct: 92  SGSLKEYLPRNKNKINL--KQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEH 146

Query: 721 EAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
           +  + DFG+ K+++ D   +T   +      + APE     K     DV+SFGV ++E++
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Query: 778 -----KGKHPRDFLSSISSSSLNTDVA-LDQMLD--PRLPAPSRSAQEKLISIMEVAFSC 829
                +      FL  I  +     V  L ++L+   RLP P    +E    + ++   C
Sbjct: 207 TYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEE----VYQLMRKC 262

Query: 830 FNESPESRPTMK 841
           +   P  R T +
Sbjct: 263 WEFQPSKRTTFQ 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 9e-11
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 24/207 (11%)

Query: 589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFH-----SLLPCDQTVDQKEFLTEVEAF 642
           D +    +G G    V+   +  S    A+K         L       ++K  L EV   
Sbjct: 2   DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 643 Y---GFCSH--ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA--VAHALSY 695
           +    F +    R  ++L E++  G L + L          +S    +  A  +  AL Y
Sbjct: 62  FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEY 116

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           LH      IV+RD+  +N+LLD E    + DFG AK L+     WT   GT  Y+APE+ 
Sbjct: 117 LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLAPEVI 170

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
            +    +  D ++ G+L++E++ G  P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 64.8 bits (158), Expect = 1e-10
 Identities = 30/81 (37%), Positives = 48/81 (59%)

Query: 144 LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKM 203
           L G I + + KL+ L  + L+ N + G IP    ++TS+  L LS N   GSIP+ +G++
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 204 RSLSVLDLNQNQFKGVLPPSI 224
            SL +L+LN N   G +P ++
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 65/273 (23%), Positives = 115/273 (42%), Gaps = 47/273 (17%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           +G+G    VY+A+     + A  K   +   ++  D   F+ E++             Y 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPNIVGLYE 69

Query: 645 FCSHARHSFLLYEFLERGSLAAI-LNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
              +    ++L EF + G+L +I L  +    E    Q   V + +  AL++LH      
Sbjct: 70  AYFYENKLWILIEFCDGGALDSIMLELERGLTE---PQIRYVCRQMLEALNFLHSH---K 123

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY--TMKIT 761
           ++HRD+ + N+LL L+ +  +ADFG++   K        F GT  ++APE+    T K  
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDN 183

Query: 762 E---KCDVYSFGVLMWEVIKGK------HPRDFLSSISSSSLNTDVALDQMLDPRLPAPS 812
               K D++S G+ + E+ + +      +P   L  I  S             P L  PS
Sbjct: 184 PYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE-----------PPTLDQPS 232

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
           + +     S  +   SC  + P+ RPT   + +
Sbjct: 233 KWSS----SFNDFLKSCLVKDPDDRPTAAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 68/281 (24%), Positives = 118/281 (41%), Gaps = 53/281 (18%)

Query: 590 FDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH 648
           F+    +GNG +  VY+   + +G++ A+K        D T D++E + +        SH
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM------DVTGDEEEEIKQEINMLKKYSH 61

Query: 649 ARHS-------------------FLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKA 688
            R+                    +L+ EF   GS+  ++ NT     +  W     + + 
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICRE 119

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +   LS+LH      ++HRDI  +N+LL    E  + DFG++  L         F GT  
Sbjct: 120 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 176

Query: 749 YIAPELAYTMKITE-----KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM 803
           ++APE+    +  +     K D++S G+   E+ +G  P   +  + +            
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA----------LF 226

Query: 804 LDPRLPAP---SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           L PR PAP   S+   +K  S +E   SC  ++   RPT +
Sbjct: 227 LIPRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE 264

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 59/277 (21%), Positives = 110/277 (39%), Gaps = 52/277 (18%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYG 644
           +G G    V++  L     VAVK     LP +  +   +FL+E           +    G
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI---KFLSEARILKQYDHPNIVKLIG 59

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFPP 703
            C+  +  +++ E +  G   + L       EL   Q +      A  ++YL   +C   
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNC--- 114

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKS----------LKPDSSNWTEFAGTCGYIAPE 753
            +HRD++++N L+       ++DFG+++           LK     WT         APE
Sbjct: 115 -IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT---------APE 164

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS 812
                + + + DV+S+G+L+WE          L       +    A +Q+    R+  P 
Sbjct: 165 ALNYGRYSSESDVWSYGILLWETFS-------LGVCPYPGMTNQQAREQVEKGYRMSCPQ 217

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI 849
           +   +    + +V   C++  PE+RP    + ++L  
Sbjct: 218 KCPDD----VYKVMQRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 10/147 (6%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFAGTCGYI 750
           AL++LH      I++RD+   N+LLD +    + D+G+ K  L P  +  T F GT  YI
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYI 163

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA 810
           APE+    +     D ++ GVLM+E++ G+ P D ++   +  +NT+  L Q++   L  
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT--DNPDMNTEDYLFQVI---LEK 218

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESR 837
           P R  +   +    V     N+ P+ R
Sbjct: 219 PIRIPRFLSVKASHVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 28/200 (14%)

Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKNLLL 716
           ++++   + IL  D  A  L     ++    VA  +S+L   +C    +HRD++++N+LL
Sbjct: 194 YIDQDVTSEILEEDELA--LDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILL 247

Query: 717 DLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSFGVLM 773
                  + DFG+A+ ++ D SN+           ++APE  +    T + DV+S+G+L+
Sbjct: 248 THGRITKICDFGLARDIRND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 306

Query: 774 WEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFN 831
           WE+         L S     +  D    +M+    R+ +P  +  E +  IM+   SC++
Sbjct: 307 WEIFS-------LGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE-MYDIMK---SCWD 355

Query: 832 ESPESRPTMK----IISQQL 847
             P  RPT K    +I QQL
Sbjct: 356 ADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 32/203 (15%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFY 643
           +G G +  V +     +GE+VA+KKF      D    +K  L EV+              
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFP 702
                    +L++E++ER  L  +   +A+   L      + I  +  A++Y H H+   
Sbjct: 67  EAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSHN--- 120

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLK-PDSSNWTEFAGTCGYIAPEL-----AY 756
            I+HRDI  +N+L+       + DFG A++L+   +S  T++  T  Y APEL      Y
Sbjct: 121 -IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 757 TMKITEKCDVYSFGVLMWEVIKG 779
              +    DV++ G +M E++ G
Sbjct: 180 GKPV----DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 62.7 bits (152), Expect = 2e-10
 Identities = 36/132 (27%), Positives = 65/132 (49%), Gaps = 8/132 (6%)

Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L+ +    GSL   +     +  L   + +N    +A  + YL       +VHR+++++N
Sbjct: 85  LVTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARN 139

Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGV 771
           +LL  +    +ADFG+A  L PD     ++E      ++A E     + T + DV+S+GV
Sbjct: 140 ILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGV 199

Query: 772 LMWEVIK-GKHP 782
            +WE++  G  P
Sbjct: 200 TVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 11/149 (7%)

Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +H R  F++ E+   G L   L+ +    E    +R     A +  AL
Sbjct: 56  FLTALK--YAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSAL 108

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 109 EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 51/197 (25%), Positives = 80/197 (40%), Gaps = 32/197 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHS-- 652
           +G+G   SVY    L  G+  AVK+  SL    QT   +E + ++E      S  +H   
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEV-SLADDGQT--GQEAVKQLEQEIALLSKLQHPNI 64

Query: 653 -------------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
                        ++  E +  GSLA +L    +  E          + +   L YLH  
Sbjct: 65  VQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR 121

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK 759
                VHRDI   N+L+D      +ADFG+AK +  + S    F G+  ++APE      
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPE------ 171

Query: 760 ITEKCDVYSFGVLMWEV 776
           +  +   Y     +W +
Sbjct: 172 VIAQQGGYGLAADIWSL 188

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 3/94 (3%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +A AL +LH      I++RD+  +N+LLD E    + DFG++K           F GT  
Sbjct: 107 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163

Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           Y+APE+      T+  D +SFGVLM+E++ G  P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 44/263 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKF-----HSLLPCDQTVDQKEFLTEVE----AFYGF 645
           IG+G   +VY A ++ + EVVA+KK       S       + + +FL  ++      Y  
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92

Query: 646 CSHARHS-FLLYEFLERGSLAAILNTDAAA-QELGWSQRMNVIKAVAHA----LSYLHHD 699
           C    H+ +L+ E+   GS + +L       QE+        I A+ H     L+YLH  
Sbjct: 93  CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVE-------IAAITHGALQGLAYLHSH 144

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM- 758
               ++HRDI + N+LL    +  +ADFG A    P +S    F GT  ++APE+   M 
Sbjct: 145 ---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAMD 197

Query: 759 --KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ 816
             +   K DV+S G+   E+ + K P   L ++++ S    +A ++       +P+  + 
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE-------SPTLQSN 247

Query: 817 EKLISIMEVAFSCFNESPESRPT 839
           E          SC  + P+ RPT
Sbjct: 248 EWSDYFRNFVDSCLQKIPQDRPT 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 72/273 (26%), Positives = 109/273 (39%), Gaps = 39/273 (14%)

Query: 593 KYCIGNGGHASVYRA--ELPSGEV--VAVKKFHSLLPCDQTVDQKEFLTE---------- 638
             CIG G    VY+     P  E   VAVK   +      +V +K FL E          
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKN--CTSPSVREK-FLQEAYIMRQFDHP 67

Query: 639 -VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
            +    G  +     +++ E    G L + L  +     L  +  +     ++ AL+YL 
Sbjct: 68  HIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLE 124

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELA 755
              F   VHRDI+++N+L+       + DFG+++ L+ D S +    G     ++APE  
Sbjct: 125 SKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESI 180

Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
              + T   DV+ FGV MWE++  G  P   +        N DV        RLP P   
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK-------NNDVIGRIENGERLPMPPNC 233

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               L S+M     C+   P  RP    +  QL
Sbjct: 234 P-PTLYSLMT---KCWAYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFL-------TEVE 640
           DF+    IG+G +  VY+A  + +GE+ A+K        D  V Q+E +       + + 
Sbjct: 10  DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
           A++G        ++  EF   GSL  I +      E   SQ   V +     L YLH   
Sbjct: 70  AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSE---SQIAYVSRETLQGLYYLHSK- 125

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK- 759
               +HRDI   N+LL       +ADFG++  +    +    F GT  ++APE+A   + 
Sbjct: 126 --GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 760 --ITEKCDVYSFGVLMWEVIKGKHP 782
               + CD+++ G+   E+ + + P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPP 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 69/260 (26%), Positives = 115/260 (44%), Gaps = 38/260 (14%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQ-KEFLTEVEAF----------Y 643
           IG+G   +VY A    + EVVAVKK        QT ++ ++ + EV+            Y
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMS--YSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 644 GFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
             C    H+ +L+ E+   GS + +L  +   + L   +   +       L+YLH     
Sbjct: 87  KGCYLKEHTAWLVMEYC-LGSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM---K 759
            ++HRDI + N+LL    +  +ADFG A    P +S    F GT  ++APE+   M   +
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDEGQ 196

Query: 760 ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKL 819
              K DV+S G+   E+ + K P   L ++++ S    +A +        +P+  + E  
Sbjct: 197 YDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQND-------SPTLQSNEWT 246

Query: 820 ISIMEVAFSCFNESPESRPT 839
            S       C  + P+ RP 
Sbjct: 247 DSFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 62/295 (21%), Positives = 119/295 (40%), Gaps = 69/295 (23%)

Query: 596 IGNGGHASVYRAEL-----PSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEAF------- 642
           +G G    V +AE      P+    VAVK        ++  D  + ++E+E         
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEK--DLSDLVSEMEMMKMIGKHK 76

Query: 643 -----YGFCSHARHSFLLYEFLERGSLAAIL------NTDAA-------AQELGWSQRMN 684
                 G C+     +++ E+   G+L   L         A+        + L     ++
Sbjct: 77  NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
               VA  + +L        +HRD++++N+L+  ++   +ADFG+A+ +     +  ++ 
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDI-----HHIDYY 188

Query: 745 GTCG-------YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTD 797
                      ++APE  +    T + DV+SFGVL+WE+           ++  S     
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF----------TLGGSPYPG- 237

Query: 798 VALDQMLD-----PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           + ++++        R+  P    QE L  +M     C++E P  RPT K + + L
Sbjct: 238 IPVEELFKLLKEGYRMEKPQNCTQE-LYHLMR---DCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.4 bits (151), Expect = 3e-10
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 11/149 (7%)

Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +  R  F++ E++  G L   L+ +    E     R     A +  AL
Sbjct: 56  FLTSLK--YSFQTKDRLCFVM-EYVNGGELFFHLSRERVFSE----DRTRFYGAEIVSAL 108

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH      IV+RD+  +NL+LD +    + DFG+ K    D++    F GT  Y+APE
Sbjct: 109 DYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPE 165

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 62.3 bits (151), Expect = 4e-10
 Identities = 81/296 (27%), Positives = 130/296 (43%), Gaps = 55/296 (18%)

Query: 164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPS 223
             +  +  +P   S L S+  L  S         + +  +  L  LDLN N+ +  +   
Sbjct: 54  LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLL-PLPSLDLNLNRLRSNISE- 111

Query: 224 ISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVS 283
           +  LTNL  L L  N+++  IPP +G L                         L+   +S
Sbjct: 112 LLELTNLTSLDLDNNNIT-DIPPLIGLL----------------------KSNLKELDLS 148

Query: 284 ENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           +N  + ++P+ LRN  +L  + L+ N+L+ ++ + L    NL  +DLS N     IS   
Sbjct: 149 DNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK----ISD-- 200

Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
                              LP EI   S L+  DLS N I+ E+   L  L  L+ L L 
Sbjct: 201 -------------------LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS 240

Query: 404 GNQITGRLPKEIGSLTKLEYLDFSA-IGELPSQICNMKSLEKLNLSHNNLSGSIPS 458
            N++   LP+ IG+L+ LE LD S       S + ++ +L +L+LS N+LS ++P 
Sbjct: 241 NNKLE-DLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPL 295

Length = 394

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 62.1 bits (151), Expect = 4e-10
 Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 11/149 (7%)

Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +H R  F++ E+   G L   L+ +    E     R     A +  AL
Sbjct: 56  FLTALK--YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSAL 108

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH      +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 109 GYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 61.6 bits (149), Expect = 5e-10
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 34/265 (12%)

Query: 597 GNGGHASVYRAELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE-----VEAFYG-FCS 647
           GNGG  +  + + PSG ++A K  H  + P   +Q + + + L E     +  FYG F S
Sbjct: 16  GNGGVVTKVQHK-PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74

Query: 648 HARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
               S  + E ++ GSL  +L       E  LG      V  AV   L+YL       I+
Sbjct: 75  DGEISICM-EHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK--HQIM 126

Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCD 765
           HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE       + + D
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYSVQSD 184

Query: 766 VYSFGVLMWEVIKGKHP------RDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA---- 815
           ++S G+ + E+  G++P      ++  +      ++ +      + PR   P R      
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHG 244

Query: 816 --QEKLISIMEVAFSCFNESPESRP 838
                 ++I E+     NE P   P
Sbjct: 245 MDSRPAMAIFELLDYIVNEPPPKLP 269

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 60.6 bits (148), Expect = 7e-10
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 39/208 (18%)

Query: 595 CIGNGGHASVYRA-ELPSGEVVAVK----KFHSLLPCDQTVDQKEFLTEVEAFYGFCSHA 649
            +G+G   SVY A    +GE+VA+K    KF+S   C         L EV++      H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-------LREVKSLRKLNEHP 58

Query: 650 ------------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
                          + ++E++E G+L  ++  D   +    S   ++I  +   L+++H
Sbjct: 59  NIVKLKEVFRENDELYFVFEYME-GNLYQLM-KDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL--- 754
              F    HRD+  +NLL+       +ADFG+A+ ++     +T++  T  Y APE+   
Sbjct: 117 KHGF---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAPEILLR 172

Query: 755 --AYTMKITEKCDVYSFGVLMWEVIKGK 780
             +Y+  +    D+++ G +M E+   +
Sbjct: 173 STSYSSPV----DIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 60.1 bits (146), Expect = 7e-10
 Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 14/161 (8%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +  A+SY+H      I+HRDI + N+ L       + DFGI+K L  + S      GT  
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166

Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL 808
           Y++PEL   +K   K D+++ G +++E++  K   D     +++ LN  V +  +     
Sbjct: 167 YMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD-----ATNPLNLVVKI--VQGNYT 219

Query: 809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI 849
           P  S  + E LIS++    S   + PE RPT   +  Q  +
Sbjct: 220 PVVSVYSSE-LISLVH---SLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 63/226 (27%), Positives = 100/226 (44%), Gaps = 30/226 (13%)

Query: 626 CDQTVDQKEFLTEVEAFYGFCSHAR-HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
           C QTV+ + + + V     F  H   HSFLLY  L  G     L T    Q L     + 
Sbjct: 69  CLQTVESEGYPSPV-VILPFMKHGDLHSFLLYSRL--GDCPQYLPT----QML-----VK 116

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL-KPDSSNWTEF 743
            +  +A  + YL    F   +HRD++++N +L+      VADFG++K +   D       
Sbjct: 117 FMTDIASGMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173

Query: 744 AGT-CGYIAPELAYTMKITEKCDVYSFGVLMWEV-IKGKHPRDFLSSISSSSLNTDVALD 801
           A     +IA E       T K DV+SFGV MWE+  +G+ P   +        N+++   
Sbjct: 174 AKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE-------NSEIYDY 226

Query: 802 QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                RL  P     + L  +  +  SC+  +P+ RP+ + +  +L
Sbjct: 227 LRQGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 60.6 bits (147), Expect = 9e-10
 Identities = 34/97 (35%), Positives = 55/97 (56%), Gaps = 5/97 (5%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK-SLKPDSSNWTEFAGTC 747
           +A  L +LH      I++RD+   N++LD E    +ADFG+ K ++    +  T F GT 
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
            YIAPE+       +  D ++FGVL++E++ G+ P D
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 60.4 bits (147), Expect = 9e-10
 Identities = 49/205 (23%), Positives = 82/205 (40%), Gaps = 36/205 (17%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IG G H  V++A +  +GE VA+KK              + L E++A        +H ++
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI--PNQALREIKAL----QACQHPYV 61

Query: 655 --LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS----------------YL 696
             L +    GS   +        E   S    V++     L                 Y+
Sbjct: 62  VKLLDVFPHGSGFVL------VMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYM 115

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-WTEFAGTCGYIAPELA 755
           H +    I+HRD+   NLL+  +    +ADFG+A+    +    ++    T  Y APEL 
Sbjct: 116 HAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 756 Y-TMKITEKCDVYSFGVLMWEVIKG 779
           Y   K     D+++ G +  E++ G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.0 bits (148), Expect = 9e-10
 Identities = 49/169 (28%), Positives = 77/169 (45%), Gaps = 34/169 (20%)

Query: 689 VAHALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
           VA  + +L   +C    +HRD++++N+LL     A + DFG+A+ +  D SN+       
Sbjct: 221 VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYVVKGNAR 275

Query: 747 --CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHP-------RDFLSSISSSSLNT 796
               ++APE  +    T + DV+S+G+L+WE+   GK P         F   +       
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY--- 332

Query: 797 DVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
                QM  P    P      ++ SIM+    C+N  P  RPT   ISQ
Sbjct: 333 -----QMSRPDFAPP------EIYSIMK---MCWNLEPTERPTFSQISQ 367

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 33/215 (15%)

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C+      ++ E+   G L   L     +  L     ++    VA  +++L       
Sbjct: 106 GACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKGMAFL---ASKN 161

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKI 760
            +HRD++++N+LL       + DFG+A+ +  D SN+           ++APE  +    
Sbjct: 162 CIHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGNARLPVKWMAPESIFNCVY 220

Query: 761 TEKCDVYSFGVLMWEVIK-GKHP-------RDFLSSISSSSLNTDVALDQMLDPRLPAPS 812
           T + DV+S+G+L+WE+   G +P         F   I            +M  P      
Sbjct: 221 TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY--------RMAQPEH---- 268

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             A  ++  IM+   +C++  P  RPT K I Q +
Sbjct: 269 --APAEIYDIMK---TCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 63/245 (25%), Positives = 100/245 (40%), Gaps = 60/245 (24%)

Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVK--KFHSLLPCDQTVD---QKEFLTE--- 638
           +DF++   IG G    V   +   +G + A+K  +   +L  +Q      +++ L E   
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALS 694
              V+ FY F    R+ +L+ EFL  G +  +L   D  ++E         I     A+ 
Sbjct: 61  AWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIAETVLAID 115

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF----------- 743
            +H   F   +HRDI   NLLLD +    ++DFG+   LK   ++ TEF           
Sbjct: 116 AIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLK--KAHRTEFYRNLTHNPPSD 170

Query: 744 --------------------------AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
                                      GT  YIAPE+       + CD +S GV+M+E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 778 KGKHP 782
            G  P
Sbjct: 231 IGYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 21/157 (13%)

Query: 632 QKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA--- 688
              FLT++  +  F +  R  F + EF+  G L   +           S+R +  +A   
Sbjct: 54  NHPFLTQL--YCCFQTPDR-LFFVMEFVNGGDLMFHIQK---------SRRFDEARARFY 101

Query: 689 ---VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG 745
              +  AL +LH      I++RD+   N+LLD E    +ADFG+ K    +    + F G
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCG 158

Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T  YIAPE+   M      D ++ GVL++E++ G  P
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 3/96 (3%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +A  L +LH      I++RD+   N++LD E    +ADFG+ K    D      F GT  
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
           YIAPE+       +  D ++FGVL++E++ G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 33/218 (15%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKF-HSLLPCDQTVDQKEFLTEVEAF--- 642
            DFD K  +G G    V    E  +G++ A+K    S+L   +TV   E   ++ +    
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 643 -------YGFCSHARHSFLLYEFLERGSLAAILN--TDAAAQELGWSQRMNVIKAV--AH 691
                  Y F     + +L+ E+   G L ++LN   D   +++       ++ A+   H
Sbjct: 61  PWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS-NWTEFAGTCGYI 750
            + Y         VHRDI  +N+L+D      +ADFG A  L  +   N     GT  YI
Sbjct: 120 QMGY---------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170

Query: 751 APELAYTMKITEK------CDVYSFGVLMWEVIKGKHP 782
           APE+  TM    K      CD +S GV+ +E+I G+ P
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 32/96 (33%), Positives = 52/96 (54%), Gaps = 3/96 (3%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           ++  L +LH      I++RD+   N++LD E    +ADFG+ K    D      F GT  
Sbjct: 110 ISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166

Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
           YIAPE+       +  D +++GVL++E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 59/240 (24%), Positives = 106/240 (44%), Gaps = 33/240 (13%)

Query: 596 IGNGGHASVYRAE------LPSGEVVAVKKFHSL------LPCDQTVDQKEFLTEVEAFY 643
           +G+G    VY+A+      L + +V+  K    L      +    + D    +  ++AFY
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 644 GFCSHARHSFLLYEFLERGSL-AAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
               +  + ++L EF   G++ A +L  +    E    Q   V K    AL+YLH +   
Sbjct: 73  ----YENNLWILIEFCAGGAVDAVMLELERPLTE---PQIRVVCKQTLEALNYLHEN--- 122

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITE 762
            I+HRD+ + N+L  L+ +  +ADFG++            F GT  ++APE+       +
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 763 -----KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
                K DV+S G+ + E+ + + P   L     + +   + + +   P L  PSR + E
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSEPPTLAQPSRWSSE 237

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 72/272 (26%), Positives = 116/272 (42%), Gaps = 42/272 (15%)

Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG ++A K  H  + P   +Q + + + L E     
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64

Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 65  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 118

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 119 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 174

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP-----RDFLSSISSSSLNTDVALDQMLDPRLPA 810
                + + D++S G+ + E+  G++P        L  +    +  D A +    PR   
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPA-ESETSPRPRP 233

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKI 842
           P R                 +  P+SRP M I
Sbjct: 234 PGRPLS--------------SYGPDSRPPMAI 251

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 60.6 bits (147), Expect = 2e-09
 Identities = 30/71 (42%), Positives = 46/71 (64%)

Query: 83  LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN 142
           LR++  + ++ NS+ G IPP +G++  L  LDL+ N F+G IP S   L++L  L L GN
Sbjct: 441 LRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500

Query: 143 LLSGSILSSLG 153
            LSG + ++LG
Sbjct: 501 SLSGRVPAALG 511

Length = 623

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 64/270 (23%), Positives = 115/270 (42%), Gaps = 37/270 (13%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQK---EFLTE-----------VE 640
           +G+G   +VY+   +P GE V +     +L  ++T   K   EF+ E           + 
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
              G C       L+ + +  G L   ++       +G    +N    +A  + YL    
Sbjct: 73  RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER- 128

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTM 758
              +VHRD++++N+L+       + DFG+A+ L+ D   +    G     ++A E  +  
Sbjct: 129 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
           K T + DV+S+GV +WE++  G  P D + +     L     L++    RLP P      
Sbjct: 187 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-----LEK--GERLPQPPICT-- 237

Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
             I +  V   C+    +SRP  K ++ + 
Sbjct: 238 --IDVYMVMVKCWMIDADSRPKFKELAAEF 265

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 48/265 (18%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQ-KEFLTEVEAF----------Y 643
           IG+G   +VY A ++ + EVVA+KK        Q+ ++ ++ + EV             Y
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKM--SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 644 GFCSHARHS-FLLYEFLERGSLAAILNT-DAAAQELGWSQRMNVIKAVAH----ALSYLH 697
             C    H+ +L+ E+   GS + IL       QE+        I A+ H     L+YLH
Sbjct: 81  KGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVE-------IAAICHGALQGLAYLH 132

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
                  +HRDI + N+LL       +ADFG A  + P +S    F GT  ++APE+   
Sbjct: 133 SHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----FVGTPYWMAPEVILA 185

Query: 758 M---KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
           M   +   K DV+S G+   E+ + K P   L ++++ S    +A +   D     P+ S
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQN---DS----PTLS 235

Query: 815 AQEKLISIMEVAFSCFNESPESRPT 839
           + +          SC  + P+ RP+
Sbjct: 236 SNDWSDYFRNFVDSCLQKIPQDRPS 260

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL       + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L +     +  D    + L    R+ AP  +  E   
Sbjct: 261 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 310

Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 311 -MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 38/226 (16%)

Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              T    ++L +   ++    VA
Sbjct: 85  GVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVA 144

Query: 691 HALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK-----PDSSNWTEFA 744
             + YL    C    +HRD++++N+L+  +    +ADFG+A+ +        +SN     
Sbjct: 145 RGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRL-- 198

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQM 803
               ++APE  +    T + DV+SFG+LMWE+   G  P   +       L  +      
Sbjct: 199 -PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLRE------ 251

Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI 849
              R+  PS    E  + + E    C++  P  RPT K + + L  
Sbjct: 252 -GHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALDK 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 70/281 (24%), Positives = 107/281 (38%), Gaps = 48/281 (17%)

Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY               VAVK       C +  D+ +FL E           
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQ-DESDFLMEALIMSKFNHQN 70

Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRM----NVIKAVAHALS 694
           +    G        F+L E +  G L + L  +    E   S  M       + VA    
Sbjct: 71  IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTC---- 747
           YL  + F   +HRDI+++N LL  +     A +ADFG+A+ +    +++    G      
Sbjct: 131 YLEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPI 185

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP 806
            ++ PE       T K DV+SFGVL+WE+   G  P            N +V        
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP-------YPGRTNQEVMEFVTGGG 238

Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           RL  P +     +  IM     C+  +PE RP    I +++
Sbjct: 239 RLDPP-KGCPGPVYRIMT---DCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 39/146 (26%), Positives = 67/146 (45%), Gaps = 17/146 (11%)

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKIT 761
           VHRD++++N+LL       + DFG+A+ +  D SN+     T     ++APE  +    T
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYT 317

Query: 762 EKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRSAQEKL 819
              DV+S+G+L+WE+         L       +  D      +    R+  P  + QE  
Sbjct: 318 TLSDVWSYGILLWEIFS-------LGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQE-- 368

Query: 820 ISIMEVAFSCFNESPESRPTMKIISQ 845
             + ++   C+N  PE RP+   +S 
Sbjct: 369 --VYDIMVKCWNSEPEKRPSFLHLSD 392

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 61.0 bits (148), Expect = 2e-09
 Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 22/141 (15%)

Query: 653 FLLYEFLERGSLAAILNTDAA--AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
           F ++E++   +L  +L  D A  A E G    + V+ A+A A     H+    IVHRD+ 
Sbjct: 55  FAVFEYVPGRTLREVLAADGALPAGETG-RLMLQVLDALACA-----HN--QGIVHRDLK 106

Query: 711 SKNLLL---DLEYEAHVADFGIAKSLKPDSSNW--------TEFAGTCGYIAPELAYTMK 759
            +N+++    +   A V DFGI  +L P   +         TE  GT  Y APE      
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP 165

Query: 760 ITEKCDVYSFGVLMWEVIKGK 780
           +T   D+Y++G++  E + G+
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 59.0 bits (144), Expect = 3e-09
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 61/219 (27%)

Query: 595 CIGNGGHASVYRA-ELPSGEVVAVKKFH----------------SLLPCDQTVDQKEF-- 635
            +G G +  VY+A +  +GE+VA+KK                  SLL        KE   
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLL--------KELKH 57

Query: 636 -----LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
                L +V       +  R  +L++E+ +   L   L+       L      N+IK++ 
Sbjct: 58  PNIVKLLDV-----IHTE-RKLYLVFEYCDM-DLKKYLDK--RPGPL----SPNLIKSIM 104

Query: 691 ----HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
                 L+Y H      I+HRD+  +N+L++ +    +ADFG+A++       +T    T
Sbjct: 105 YQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVT 161

Query: 747 CGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
             Y APE+      Y+  +    D++S G +  E+I GK
Sbjct: 162 LWYRAPEILLGSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 27/148 (18%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           ++HRDI SKN+ L    +  + DFG A+ L    +    + GT  Y+ PE+   M    K
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNK 180

Query: 764 CDVYSFGVLMWEVIKGKHP------RDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
            D++S G +++E+   KHP      ++ +  +   S               P PS  + E
Sbjct: 181 SDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-------------PLPSHYSYE 227

Query: 818 --KLISIMEVAFSCFNESPESRPTMKII 843
              LI  M      F  +P SRP+   I
Sbjct: 228 LRSLIKQM------FKRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 12/98 (12%)

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGY 749
           H++  LH+      VHRDI   N+LLD+     +ADFG    +  D +  +  A GT  Y
Sbjct: 116 HSIHQLHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169

Query: 750 IAPELAYTM-----KITEKCDVYSFGVLMWEVIKGKHP 782
           I+PE+   M     K   +CD +S GV M+E++ G+ P
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 37/153 (24%), Positives = 75/153 (49%), Gaps = 26/153 (16%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TCGYIAPELAYTMKIT 761
           +VHRD++++N+L+    +  ++DFG+++ +  + S      G     ++A E  +    T
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207

Query: 762 EKCDVYSFGVLMWEVIK-------GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
            + DV+SFGVL+WE++        G  P    + + +               R+  P   
Sbjct: 208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY-------------RMERPENC 254

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           ++E + ++M    +C+ + P+ RPT   IS++L
Sbjct: 255 SEE-MYNLM---LTCWKQEPDKRPTFADISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 67/281 (23%), Positives = 119/281 (42%), Gaps = 57/281 (20%)

Query: 590 FDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLT----------- 637
           F+    +GNG +  VY+   + +G++ A+K        D T D++E +            
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM------DVTEDEEEEIKLEINMLKKYSH 71

Query: 638 --EVEAFYGF------CSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRM--NVI 686
              +  +YG         H    +L+ EF   GS+  ++ NT   A +  W   +   ++
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131

Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
           + +AH   + H      ++HRDI  +N+LL    E  + DFG++  L         F GT
Sbjct: 132 RGLAHL--HAHK-----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 184

Query: 747 CGYIAPELAYTMKITE-----KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD 801
             ++APE+    +  +     + D++S G+   E+ +G  P           ++   AL 
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL--------CDMHPMRAL- 235

Query: 802 QMLDPRLPAP---SRSAQEKLISIMEVAFSCFNESPESRPT 839
             L PR P P   S+   +K I  +E    C  ++  SRP+
Sbjct: 236 -FLIPRNPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPS 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 51/213 (23%), Positives = 87/213 (40%), Gaps = 33/213 (15%)

Query: 590 FDAKYCIGNGGHASVYRAELPSGEVVAVKK---FHSLLPCDQTVDQKEFL-------TEV 639
           ++    IG G    +Y A+  S     V K      +   ++   +KE +         +
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAA-----QELGWSQRMNVIKAVAHALS 694
             F+         F++ E+ + G L   +N          Q L W         ++  L 
Sbjct: 62  VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLK 115

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAGTCG----Y 749
           ++H      I+HRDI S+N+ L      A + DFGIA+ L    ++  E A TC     Y
Sbjct: 116 HIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYY 168

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           ++PE+        K D++S G +++E+   KHP
Sbjct: 169 LSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 3/90 (3%)

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L +LH      I++RD+  +N+LLD +    ++D G+A  LK   S    +AGT G++AP
Sbjct: 110 LEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           EL    +     D ++ GV ++E+I  + P
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 35/95 (36%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFAGTC 747
           V   L YLH +    IV+RD+   NLLLD E    +ADFG+ K  +       T F GT 
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTP 165

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            ++APE+      T   D +  GVL++E++ G+ P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 71/292 (24%), Positives = 119/292 (40%), Gaps = 69/292 (23%)

Query: 596 IGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF------- 642
           IG G    V RA +       +  +  +K+F S        D ++F  E+E         
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS------ENDHRDFAGELEVLCKLGHHP 63

Query: 643 -----YGFCSHARHSFLLYEFLERGSL------AAILNTDAA-------AQELGWSQRMN 684
                 G C +  + ++  E+   G+L      + +L TD A       A  L   Q + 
Sbjct: 64  NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
               VA  + YL    F   +HRD++++N+L+     + +ADFG+++  +          
Sbjct: 124 FASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSRGEE------VYVK 174

Query: 745 GTCG-----YIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTD 797
            T G     ++A E L Y++  T K DV+SFGVL+WE++  G  P   ++          
Sbjct: 175 KTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------- 226

Query: 798 VALDQMLDPRLPAPSRSAQEKLI--SIMEVAFSCFNESPESRPTMKIISQQL 847
                 L  +LP   R  + +     + E+   C+ + P  RP    IS QL
Sbjct: 227 ------LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 13/142 (9%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+ S N+LL       + D GI+K LK + +  T+  GT  Y+APE+      + K
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMAPEVWKGRPYSYK 181

Query: 764 CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIM 823
            D++S G L++E+     P     + S   L   V   +   P +P       +  I   
Sbjct: 182 SDIWSLGCLLYEMATFAPP---FEARSMQDLRYKVQRGKY--PPIPPIYSQDLQNFIR-- 234

Query: 824 EVAFSCFNESPESRPTMKIISQ 845
               S     P+ RP    I  
Sbjct: 235 ----SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 46/268 (17%)

Query: 595 CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------------ 641
            +G G    VY   ++ +G  +AVK+     P D   D  E   EV A            
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQV----PFDP--DSPETKKEVNALECEIQLLKNLQ 62

Query: 642 ------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                 +YG         +  E++  GS+   L    A  E   +      + +   + Y
Sbjct: 63  HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTE---TVTRKYTRQILEGVEY 119

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAP 752
           LH +    IVHRDI   N+L D      + DFG +K L+   S+ T      GT  +++P
Sbjct: 120 LHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP-RDFLSSISSSSLNTDVALDQMLDPRLPAP 811
           E+        K DV+S G  + E++  K P  +F +  +   + T     Q  +P+LP+ 
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTNPQLPSH 231

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPT 839
                   +         F E+ + RP+
Sbjct: 232 VSPDARNFLRR------TFVENAKKRPS 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 57.8 bits (139), Expect = 6e-09
 Identities = 67/286 (23%), Positives = 113/286 (39%), Gaps = 57/286 (19%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF------------Y 643
           IG G    V +A +    +        +       D ++F  E+E               
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 644 GFCSHARHSFLLYEFLERGSL------AAILNTDAA-------AQELGWSQRMNVIKAVA 690
           G C H  + +L  E+   G+L      + +L TD A       A  L   Q ++    VA
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-- 748
             + YL    F   +HRD++++N+L+   Y A +ADFG+++  +           T G  
Sbjct: 123 RGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKTMGRL 173

Query: 749 ---YIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQM 803
              ++A E L Y++  T   DV+S+GVL+WE++  G  P   ++                
Sbjct: 174 PVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------------- 219

Query: 804 LDPRLPAPSRSAQEKLI--SIMEVAFSCFNESPESRPTMKIISQQL 847
           L  +LP   R  +       + ++   C+ E P  RP+   I   L
Sbjct: 220 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (140), Expect = 6e-09
 Identities = 34/93 (36%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVA--DFGIAKSLKPDSSNWTEFAGTCGY 749
           AL  LH      +++RD+  +N+LLD  Y+ H+A  DFG+ K    D      F GT  Y
Sbjct: 105 ALENLHK---FNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +APEL      T+  D ++ GVL++E++ G  P
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 8e-09
 Identities = 32/84 (38%), Positives = 45/84 (53%), Gaps = 6/84 (7%)

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPELAYTM----- 758
           VHRDI   N+LLD      +ADFG    L  D +  +  A GT  YI+PE+   M     
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
           +   +CD +S GV M+E++ G+ P
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 50/216 (23%), Positives = 95/216 (43%), Gaps = 39/216 (18%)

Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQR--------------MNVIKAVAHALSYLHHD 699
           +L+E+L +G L   L   +   ++G S                +++   +A  + YL   
Sbjct: 84  MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC----GYIAPELA 755
            F   VH+D++++N+L+  +    ++D G+++ +   S+++            ++ PE  
Sbjct: 144 FF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQPKSLLPIRWMPPEAI 198

Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR--LPAPS 812
              K +   D++SFGV++WE+   G  P    S       N +V   +M+  R  LP   
Sbjct: 199 MYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-------NQEVI--EMVRKRQLLPCS- 248

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                ++ S+M     C+ E P  RP  K I  +LR
Sbjct: 249 EDCPPRMYSLMT---ECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 50/208 (24%), Positives = 92/208 (44%), Gaps = 23/208 (11%)

Query: 654 LLYEFLERGSLAAILN--------TDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
           ++ E++E G L   L+          A    + +S  + +   +A  + YL    F   V
Sbjct: 96  MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---V 152

Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC----GYIAPELAYTMKIT 761
           HRD++++N L+   Y   +ADFG++++L   S ++    G       +++ E     K T
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMSWESILLGKFT 210

Query: 762 EKCDVYSFGVLMWEVIK--GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKL 819
              DV++FGV +WE++    + P   LS         +   DQ     LP P+       
Sbjct: 211 TASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPD--- 267

Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQL 847
            S+ ++  SC+  + + RP+ + I   L
Sbjct: 268 -SLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 58/264 (21%), Positives = 110/264 (41%), Gaps = 37/264 (14%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVK---------KFHSLLPCDQTVDQKEFLTEVEAFYGF 645
           +G G + SVY+    P+G  +A+K         KF+ ++  +  +  K     +  FYG 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII-MELDILHKAVSPYIVDFYGA 67

Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
                  ++  E+++ GSL  +     A + +       +  AV   L +L  +    I+
Sbjct: 68  FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNII 125

Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE----------LA 755
           HRD+   N+L++   +  + DFG++ +L    +      G   Y+APE            
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGPNQNPT 183

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
           YT+    + DV+S G+ + E+  G++P  +     ++      A+     P LP+     
Sbjct: 184 YTV----QSDVWSLGLSILEMALGRYP--YPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237

Query: 816 QEKLISIMEVAFSCFNESPESRPT 839
            +  ++       C N+ P  RPT
Sbjct: 238 AQDFVA------KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 57.6 bits (139), Expect = 1e-08
 Identities = 41/139 (29%), Positives = 68/139 (48%), Gaps = 15/139 (10%)

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL       + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L +     +  D    + L    R+ AP  +  E + 
Sbjct: 255 QSDVWSFGVLLWEIFS-------LGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPE-IY 306

Query: 821 SIMEVAFSCFNESPESRPT 839
           SIM     C++ +PE RPT
Sbjct: 307 SIM---LDCWHNNPEDRPT 322

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 57.4 bits (138), Expect = 1e-08
 Identities = 70/268 (26%), Positives = 120/268 (44%), Gaps = 46/268 (17%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKF-----HSLLPCDQTVDQKEFLTEVE----AFYGF 645
           IG+G   +VY A ++ + EVVA+KK       S       + +  FL ++       Y  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 646 CSHARHS-FLLYEFLERGSLAAILNTDAAA-QELGWSQRMNVIKAVAHA----LSYLH-H 698
           C    H+ +L+ E+   GS + +L       QE+        I AV H     L+YLH H
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVE-------IAAVTHGALQGLAYLHSH 134

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +    ++HRD+ + N+LL       + DFG A  + P +     F GT  ++APE+   M
Sbjct: 135 N----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAM 186

Query: 759 ---KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
              +   K DV+S G+   E+ + K P   L ++++ S    +A ++       +P+  +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP---LFNMNAMSALYHIAQNE-------SPALQS 236

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKII 843
                       SC  + P+ RPT +++
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 56.8 bits (138), Expect = 1e-08
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 44/211 (20%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFH----------------SLLPCDQTVDQKEF--L 636
           IG G +  VY+A    +GE+VA+KK                   LL   Q +       L
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLL---QKLRHPNIVRL 63

Query: 637 TEVEAFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
            E+       S  + S ++++E+++   L  +L  D+   +   SQ    +K +   L Y
Sbjct: 64  KEI-----VTSKGKGSIYMVFEYMDH-DLTGLL--DSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS-NWTEFAGTCGYIAPEL 754
           LH +    I+HRDI   N+L++ +    +ADFG+A+     +S ++T    T  Y  PEL
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 755 -----AYTMKITEKCDVYSFGVLMWEVIKGK 780
                 Y  ++    D++S G ++ E+  GK
Sbjct: 173 LLGATRYGPEV----DMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 57.3 bits (138), Expect = 1e-08
 Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 13/138 (9%)

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL       + DFG+A+ +   PD            ++APE  +    T 
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 763 KCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLIS 821
           + DV+SFGVL+WE+   G  P           +N +         R+ AP  +  E    
Sbjct: 256 QSDVWSFGVLLWEIFSLGASP------YPGVQINEEFCQRLKDGTRMRAPENATPE---- 305

Query: 822 IMEVAFSCFNESPESRPT 839
           I  +  +C+   P+ RPT
Sbjct: 306 IYRIMLACWQGDPKERPT 323

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 43/174 (24%), Positives = 78/174 (44%), Gaps = 17/174 (9%)

Query: 677 LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD 736
           +G    +N    +A  +SYL       +VHRD++++N+L+       + DFG+A+ L  D
Sbjct: 106 IGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162

Query: 737 SSNWTEFAGTC--GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSS 793
            + +    G     ++A E     + T + DV+S+GV +WE++  G  P D + +     
Sbjct: 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222

Query: 794 LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           L     L++    RLP P        I +  +   C+    E RP  + +  + 
Sbjct: 223 L-----LEK--GERLPQPPICT----IDVYMIMVKCWMIDSECRPRFRELVDEF 265

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 54/219 (24%), Positives = 103/219 (47%), Gaps = 37/219 (16%)

Query: 643 YGFCSHARHSFLLYEFL-ERGSLAAILNTD---AAAQELGWSQRMNVIKAVAHALSYL-- 696
           + +CSH+     L+EFL  R   + + +TD        L  +  ++++  +A  + +L  
Sbjct: 87  FSYCSHSD----LHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS 142

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC----GYIAP 752
           HH     +VH+D++++N+L+  +    ++D G+ + +   ++++ +  G       +++P
Sbjct: 143 HH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVY--AADYYKLMGNSLLPIRWMSP 195

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR--LP 809
           E     K +   D++S+GV++WEV   G  P    S       N DV   +M+  R  LP
Sbjct: 196 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------NQDVI--EMIRNRQVLP 246

Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            P          +  +   C+NE P  RP  K I  +LR
Sbjct: 247 CPDDCPA----WVYTLMLECWNEFPSRRPRFKDIHSRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 40/225 (17%)

Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    VA
Sbjct: 88  GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVA 147

Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 148 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKKTTNG 199

Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P      I    L   +    
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP---YPGIPVEELFKLLKEGH 256

Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +D     P+    E L  +M     C++  P  RPT K + + L
Sbjct: 257 RMD----KPANCTNE-LYMMMR---DCWHAIPSHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 21/158 (13%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC- 747
           +A  ++YL       +VHRD++++N+L+       + DFG+AK L  D   +    G   
Sbjct: 118 IAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 748 -GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFL--SSISSSSLNTDVALDQM 803
             ++A E       T + DV+S+GV +WE++  G  P D +  S ISS     +      
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------ 228

Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
              RLP P        I +  +   C+    +SRP  +
Sbjct: 229 ---RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 259

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 2e-08
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 30/211 (14%)

Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKF-----HSLLPCDQTVDQKEFLTE--- 638
            DF     +G GG+  V+ A+   +GE+VA+K+        L      + +++ LT    
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
              V+  Y F     + +L  E++  G    +LN      E     R  + +    A+  
Sbjct: 61  EWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFE-AVDA 116

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA----GTCGYIA 751
           LH       +HRD+  +N L+D      + DFG+       S     +A    G+  Y+A
Sbjct: 117 LHE---LGYIHRDLKPENFLIDASGHIKLTDFGL-------SKGIVTYANSVVGSPDYMA 166

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+          D +S G +++E + G  P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 50/225 (22%), Positives = 102/225 (45%), Gaps = 28/225 (12%)

Query: 633 KEF-LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA--- 688
           KEF    V    G  S  + + ++ E + RG L + L +     E    Q    +K    
Sbjct: 64  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123

Query: 689 ----VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
               +A  ++YL+ + F   VHRD++++N ++  ++   + DFG+ + +    +++    
Sbjct: 124 MAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKG 178

Query: 745 GT----CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL 800
           G       +++PE       T   DV+SFGV++WE+         L+      ++ +  L
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGMSNEQVL 231

Query: 801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
             +++  L     +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 232 RFVMEGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 40/225 (17%)

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNT----------DAAA---QELGWSQRMNVIKAVA 690
           G C+     ++L E+  +G+L   L            D      ++L +   ++    VA
Sbjct: 85  GACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVA 144

Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+  +    +ADFG+A+    D  N   +  T   
Sbjct: 145 RGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYYKKTTNG 196

Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ 802
                ++APE  +    T + DV+SFGVL+WE+   G  P      I    L   +    
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP---YPGIPVEELFKLLKEGH 253

Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +D   PA   +   +L  IM     C++  P  RPT K + + L
Sbjct: 254 RMDK--PA---NCTHELYMIMR---ECWHAVPSQRPTFKQLVEDL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 44/177 (24%), Positives = 80/177 (45%), Gaps = 32/177 (18%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV--------------- 639
           IG G +  V++     +G++VA+KKF  +   D  V +K  L E+               
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66

Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNT-DAAAQELGWSQRMNVIKAVAHALSYLH- 697
           E F       R   L++E+ +      +LN  +   + +       +I     A+++ H 
Sbjct: 67  EVF----RRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           H+C    +HRD+  +N+L+  + +  + DFG A+ L     ++T++  T  Y APEL
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPEL 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 4/91 (4%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L  LH +    IV+RD+  +N+LLD      ++D G+A  + P+        GT GY+A
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVGYMA 169

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+    + T   D ++ G L++E+I G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 51/284 (17%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF-----------YG 644
           IGNG    V   E+ SG   A      L       +Q +FL E + +            G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQ----ELGWSQRMNVIKAVAHALSYLHHDC 700
            C+      L+ EF   G L   L +   A+    +    QRM     +A  L +LH + 
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLHKNN 120

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-------LKPDSSNWTEFAGTCGYIAPE 753
           F   +H D++ +N LL  +    + D+G++ +       + PD   W        +IAPE
Sbjct: 121 F---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL-WVPLR----WIAPE 172

Query: 754 LA-------YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD 805
           L          +  T++ +V+S GV +WE+ + G  P   LS      L   V   Q+  
Sbjct: 173 LVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS--DEQVLTYTVREQQL-- 228

Query: 806 PRLPAP--SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +LP P       ++   +M+    C+ + PE RP+ + +   L
Sbjct: 229 -KLPKPRLKLPLSDRWYEVMQ---FCWLQ-PEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 67/283 (23%), Positives = 119/283 (42%), Gaps = 51/283 (18%)

Query: 596 IGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VE 640
           +G G   SV  A+L     S + VAVK   + +    + D +EFL E           V 
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVI 64

Query: 641 AFYGFCSHARHS------FLLYEFLERGSLAAILNTDAAAQE---LGWSQRMNVIKAVAH 691
              G    +R         ++  F++ G L   L      +E   L     +  +  +A 
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG--- 748
            + YL    F   +HRD++++N +L+      VADFG++K  K  S ++  +   C    
Sbjct: 125 GMEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDY--YRQGCASKL 177

Query: 749 ---YIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQML 804
              ++A E       T   DV++FGV MWE++ +G+ P   +        N+++    + 
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-------NSEIYNYLIK 230

Query: 805 DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             RL  P    ++    + E+   C++  P+ RP+ + +  QL
Sbjct: 231 GNRLKQPPDCLED----VYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 32/84 (38%), Positives = 46/84 (54%), Gaps = 6/84 (7%)

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPELAYTM----- 758
           VHRDI   N+L+D+     +ADFG    L  D +  +  A GT  YI+PE+   M     
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
           K   +CD +S GV M+E++ G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 29/92 (31%), Positives = 51/92 (55%), Gaps = 2/92 (2%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           IV+RD+  +N+LLD +    ++D G+A  L  D    T+ AGT GY+APE+      +  
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 764 CDVYSFGVLMWEVIKGKHP-RDFLSSISSSSL 794
            D ++ G  ++E++ G+ P +D    ++   L
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 53/210 (25%), Positives = 84/210 (40%), Gaps = 29/210 (13%)

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
           + G  S      +  E +  GSL+A+L +     +      +   K +   L YLH +  
Sbjct: 70  YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN-- 127

Query: 702 PPIVHRDISSKNLLLDLEYEA--HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK 759
             IVHRDI   N+L++  Y     ++DFG +K L   +     F GT  Y+APE      
Sbjct: 128 -QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPE------ 179

Query: 760 ITEK--------CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
           + +K         D++S G  + E+  GK P   L    ++     +       P +P  
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH---PEIPE- 235

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           S SA+ K          CF   P+ R +  
Sbjct: 236 SLSAEAK-----NFILRCFEPDPDKRASAH 260

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 2/91 (2%)

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPE 753
           +HH     ++HRDI S N+LL       + DFG +K      S+     F GT  Y+APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
           +      ++K D++S GVL++E++  K P D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 4e-08
 Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 6/93 (6%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
           AL +LH +D    IV+RD+  +N+LLD      + DFG++K+   D+     F GT  Y+
Sbjct: 108 ALEHLHKYD----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYL 163

Query: 751 APELAYTMK-ITEKCDVYSFGVLMWEVIKGKHP 782
           APE+    K  T+  D +S GVL++E+  G  P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 27/209 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSL-------------LPCDQTVDQK 633
           N F+    +G G +  V +     + E+VA+KKF                L   +T+ Q+
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 634 EFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILN-TDAAAQELGWSQRMNVIKAVAHA 692
             +   EAF          +L++E++E+  L  +    +    E   S    +IKA+   
Sbjct: 61  NIVELKEAF----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAI--- 113

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS-SNWTEFAGTCGYIA 751
             + H +    IVHRDI  +NLL+       + DFG A++L   S +N+TE+  T  Y +
Sbjct: 114 -HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRS 169

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGK 780
           PEL       +  D++S G ++ E+  G+
Sbjct: 170 PELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 26/79 (32%), Positives = 41/79 (51%), Gaps = 1/79 (1%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           IV+RD+  +N+LLD      ++D G+A  L          AGT GY+APE+         
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174

Query: 764 CDVYSFGVLMWEVIKGKHP 782
            D ++ G  ++E+I G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 55.6 bits (134), Expect = 4e-08
 Identities = 56/205 (27%), Positives = 89/205 (43%), Gaps = 32/205 (15%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKF---HSLLPCDQTVDQKEFLTEVE-----AFYGFC 646
           IG+G   +VY+    P+G + A+K     H      Q   + E L +V        +   
Sbjct: 82  IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF 141

Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
            H     +L EF++ GSL         A E       +V + +   ++YLH      IVH
Sbjct: 142 DHNGEIQVLLEFMDGGSLEG----THIADEQ---FLADVARQILSGIAYLHRR---HIVH 191

Query: 707 RDISSKNLLLDLEYEAHVADFGI----AKSLKPDSSNWTEFAGTCGYIAPE-----LAYT 757
           RDI   NLL++      +ADFG+    A+++ P +S+     GT  Y++PE     L + 
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS----VGTIAYMSPERINTDLNHG 247

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHP 782
                  D++S GV + E   G+ P
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 59/222 (26%), Positives = 97/222 (43%), Gaps = 34/222 (15%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKF--HSLL---PCDQTVDQKEFLTEVE- 640
            DF+    I NG + +VY      + +  A+KK    +L+      Q   +++ LT  E 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 641 ----AFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALSY 695
               + +      RH  ++ E++E G  A +L N  A   ++    RM   + V  AL Y
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA---RMYFAETVL-ALEY 116

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK-SLKPDSSNWTE------------ 742
           LH+     IVHRD+   NLL+       + DFG++K  L   ++N  E            
Sbjct: 117 LHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 743 --FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
               GT  YIAPE+       +  D ++ G++++E + G  P
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 45/280 (16%)

Query: 587 TNDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFHSLLPCDQTVDQK----EFLTE--- 638
           T+ ++    IG G +  VY+      G + AVK    +   D+ ++ +    + L     
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPN 80

Query: 639 VEAFYGFCSHARHS-----FLLYEFLERGSLAAILN-TDAAAQELGWSQRMNVIKAVAHA 692
           V  FYG    A        +L+ E    GS+  ++       Q L  +    ++      
Sbjct: 81  VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L +LH++    I+HRD+   N+LL  E    + DFG++  L           GT  ++AP
Sbjct: 141 LQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197

Query: 753 EL-----AYTMKITEKCDVYSFGVLMWEVIKGK------HPRDFLSSISSSSLNTDVALD 801
           E+      Y      +CDV+S G+   E+  G       HP   L  I            
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI------------ 245

Query: 802 QMLDPRLPAPSRSAQEKLI-SIMEVAFSCFNESPESRPTM 840
               PR P P+    EK   S       C  +  E+RP++
Sbjct: 246 ----PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 55.4 bits (133), Expect = 5e-08
 Identities = 63/244 (25%), Positives = 97/244 (39%), Gaps = 60/244 (24%)

Query: 589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHS--LLPCDQTVD---QKEFLTE---- 638
           DF++   IG G    V   +   +G V A+K      +L  +Q      +++ L E    
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 639 --VEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALSY 695
             V+ FY F     + +L+ EFL  G +  +L   D   +E    +    I     A+  
Sbjct: 62  WVVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIAETVLAIDS 116

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF------------ 743
           +H   F   +HRDI   NLLLD +    ++DFG+   LK   ++ TEF            
Sbjct: 117 IHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLK--KAHRTEFYRNLNHSLPSDF 171

Query: 744 -------------------------AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK 778
                                     GT  YIAPE+       + CD +S GV+M+E++ 
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 779 GKHP 782
           G  P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 54.9 bits (133), Expect = 7e-08
 Identities = 33/101 (32%), Positives = 48/101 (47%), Gaps = 21/101 (20%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW-----TEFAGT 746
           AL Y+H      ++HRD+   N+LL+ +    +ADFG+A+SL     N      T++  T
Sbjct: 119 ALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMW-------EVIKGK 780
             Y APE      I      Y+ GV MW       E++ GK
Sbjct: 176 RWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 54.4 bits (131), Expect = 8e-08
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 6/101 (5%)

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT-EF 743
            I  +  AL +LH      I++RDI  +N+LLD E    + DFG++K    +       F
Sbjct: 110 YIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF 166

Query: 744 AGTCGYIAPELAYTMKI--TEKCDVYSFGVLMWEVIKGKHP 782
            GT  Y+APE+         +  D +S GVL +E++ G  P
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.6 bits (131), Expect = 9e-08
 Identities = 38/133 (28%), Positives = 67/133 (50%), Gaps = 7/133 (5%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK-SLKPDSSNWTEFAGTC 747
           +A AL YLH      IV+RD+  +N+LLD +    + DFG+ K +++ + +  T F GT 
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTP 160

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR 807
            Y+APE+ +        D +  G +++E++ G  P  F S  ++   +  +     L P 
Sbjct: 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP--FYSRNTAEMYDNILNKPLQLKPN 218

Query: 808 LPAPSRSAQEKLI 820
           +   +R   E L+
Sbjct: 219 ITNSARHLLEGLL 231

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 54.1 bits (130), Expect = 9e-08
 Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L  LH +    IV+RD+  +N+LLD      ++D G+A  + P+        GT GY+AP
Sbjct: 115 LEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRVGTVGYMAP 170

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+    + T   D +  G L++E+I+GK P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 28/79 (35%), Positives = 45/79 (56%), Gaps = 1/79 (1%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           IV+RD+  +N+LLD      ++D G+A  + P+        GT GY+APE+    K T  
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVINNEKYTFS 181

Query: 764 CDVYSFGVLMWEVIKGKHP 782
            D +  G L++E+I+G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 9e-08
 Identities = 57/253 (22%), Positives = 94/253 (37%), Gaps = 72/253 (28%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK---KFHSLLPCDQTVD--QKEFLTE--- 638
           +DF+    IG G    V+   +  +G+V A+K   K   +          +++ L +   
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNV---------I 686
              V+ +Y F     H +L+ E++  G L            +    R +V         I
Sbjct: 61  PWIVKLYYSF-QDEEHLYLVMEYMPGGDL------------MNLLIRKDVFPEETARFYI 107

Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEF- 743
             +  AL  +H   F   +HRDI   N+L+D +   H+  ADFG+ K +           
Sbjct: 108 AELVLALDSVHKLGF---IHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLN 162

Query: 744 ----------------------------AGTCGYIAPELAYTMKITEKCDVYSFGVLMWE 775
                                        GT  YIAPE+        +CD +S GV+++E
Sbjct: 163 DSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222

Query: 776 VIKGKHPRDFLSS 788
           ++ G  P  F S 
Sbjct: 223 MLYGFPP--FYSD 233

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 9e-08
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 18/197 (9%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +    + VAVKK    F SL+   +T  +   L  +  E   G    
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 649 ARHSFLLYEFLE----RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  +  F E       + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 83  FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AGI 139

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   N+ ++ + E  + DFG+A+    +    T +  T  Y APE+    M   + 
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQT 196

Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++KGK
Sbjct: 197 VDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 54.2 bits (130), Expect = 9e-08
 Identities = 61/283 (21%), Positives = 116/283 (40%), Gaps = 50/283 (17%)

Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF-CSH 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF C H
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 70

Query: 649 ----------ARHSFLLYEFLERGSLAAIL---------NTDAAAQELGWSQRMNVIKAV 689
                      + + ++ E +  G L + L         N       L   + + +   +
Sbjct: 71  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEI 128

Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--- 746
           A  ++YL+   F   VHRD++++N ++  ++   + DFG+ + +    +++    G    
Sbjct: 129 ADGMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLL 183

Query: 747 -CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD 805
              ++APE       T   D++SFGV++WE+         L+      L+ +  L  ++D
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMD 236

Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                   +  E++  +M +   C+  +P+ RPT   I   L+
Sbjct: 237 GGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 54.0 bits (130), Expect = 9e-08
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 32/164 (19%)

Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
           ++  AL YLH      ++HRD+   N+L++   +  + DFGI+  L  DS   T  AG  
Sbjct: 111 SIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCK 167

Query: 748 GYIAPEL--------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDV- 798
            Y+APE          Y +    K DV+S G+ M E+  G+ P D        S  T   
Sbjct: 168 PYMAPERINPELNQKGYDV----KSDVWSLGITMIELATGRFPYD--------SWKTPFQ 215

Query: 799 ALDQMLD---PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
            L Q+++   P+LPA   S +       +    C  ++ + RP 
Sbjct: 216 QLKQVVEEPSPQLPAEKFSPE-----FQDFVNKCLKKNYKERPN 254

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 55.6 bits (134), Expect = 1e-07
 Identities = 48/159 (30%), Positives = 67/159 (42%), Gaps = 48/159 (30%)

Query: 328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREI-GNSSQLQAFDLSLNHIVGE 386
           IDLS  N  G+ISS   + P + T+N+S N ++G +P +I   SS L+  +LS N+  G 
Sbjct: 74  IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133

Query: 387 IPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLN 446
           IP+                          GS+  LE LD                     
Sbjct: 134 IPR--------------------------GSIPNLETLD--------------------- 146

Query: 447 LSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTT 485
           LS+N LSG IP+       L  +D+  N L   +PNS T
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185

Length = 968

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.8 bits (132), Expect = 1e-07
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 7/96 (7%)

Query: 10  ISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGN 69
           + L N G+ G + +   S   HL  ++L+ N   G IPP + ++++L  L L  N F+G+
Sbjct: 423 LGLDNQGLRGFIPN-DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 70  ILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG 105
           I        S G L  +  L +N NSLSG +P  +G
Sbjct: 482 IPE------SLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 53/226 (23%), Positives = 95/226 (42%), Gaps = 42/226 (18%)

Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              T    ++L +   ++    VA
Sbjct: 91  GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVA 150

Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TC 747
             + YL    C    +HRD++++N+L+  +    +ADFG+A+ +           G    
Sbjct: 151 RGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD- 805
            ++APE  +    T + DV+SFGVL+WE+   G  P               V ++++   
Sbjct: 207 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------------PGVPVEELFKL 254

Query: 806 ----PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                R+  PS    E L  +M     C++  P  RPT K + + L
Sbjct: 255 LKEGHRMDKPSNCTNE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 1e-07
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 31/190 (16%)

Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY +L + S           + L   Q + + K +   L YLH      I+HRD+ ++N+
Sbjct: 143 LYTYLTKRS-----------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENI 188

Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMW 774
            ++   +  + D G A+     +  +   AGT    APE+    K   K D++S G++++
Sbjct: 189 FINDVDQVCIGDLGAAQ-FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247

Query: 775 EVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS-RSAQEKLISIMEVAFSCFNES 833
           E++   +P        S+             P     S  S   K+IS ++V    F   
Sbjct: 248 EML--AYPSTIFEDPPST-------------PEEYVKSCHSHLLKIISTLKVHPEEFPRD 292

Query: 834 PESRPTMKII 843
           P SR     I
Sbjct: 293 PGSRLVRGFI 302

Length = 357

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 29/91 (31%), Positives = 49/91 (53%), Gaps = 4/91 (4%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L  LH +     V+RD+  +N+LLD      ++D G+A  + P+  +     GT GY+A
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMA 169

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+    + T   D +  G L++E+I+G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 64/210 (30%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVK--KFHSLLPCDQT---VDQKEFLTE---- 638
           DF+    +G G    V  A+   +GE  A+K  K   +L   Q      +K  L E    
Sbjct: 19  DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 639 --VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK----AVAHA 692
             V     F    R  FLL EF+  G L   L               +V K     +  A
Sbjct: 79  FIVNMMCSFQDENRVYFLL-EFVVGGELFTHLRKAGRFPN-------DVAKFYHAELVLA 130

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
             YLH      I++RD+  +NLLLD +    V DFG AK + PD + +T   GT  Y+AP
Sbjct: 131 FEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRT-FT-LCGTPEYLAP 184

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+  +    +  D ++ GVL++E I G  P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 30/82 (36%), Positives = 47/82 (57%), Gaps = 2/82 (2%)

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           LHH     I+HRD+ ++N+LLD       + DFGI+K L   S  +T   GT  YI+PEL
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPEL 172

Query: 755 AYTMKITEKCDVYSFGVLMWEV 776
                  +K D+++ G +++E+
Sbjct: 173 CEGKPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 11/101 (10%)

Query: 688 AVAHALSYL--HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG 745
           A+  AL YL   H     ++HRD+   N+LLD      + DFGI+  L  DS   T  AG
Sbjct: 122 AIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSAG 176

Query: 746 TCGYIAPELAYTMKITEK----CDVYSFGVLMWEVIKGKHP 782
              Y+APE         K     DV+S G+ + E+  G+ P
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 53.7 bits (130), Expect = 1e-07
 Identities = 30/86 (34%), Positives = 40/86 (46%), Gaps = 9/86 (10%)

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
             L YLH   +  I+HRD+   NLL+  +    +ADFG+A+S    +   T    T  Y 
Sbjct: 113 RGLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR 169

Query: 751 APELAYTMKITEKCDVYSFGVLMWEV 776
           APEL +          Y  GV MW V
Sbjct: 170 APELLF------GARHYGVGVDMWSV 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 54.3 bits (130), Expect = 1e-07
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 17/170 (10%)

Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           V+ FY F    R+ +++ E++  G L  ++ N D   +   W++       V  AL  +H
Sbjct: 106 VQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVLALDAIH 159

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPELAY 756
              F   +HRD+   N+LLD      +ADFG    +  +     + A GT  YI+PE+  
Sbjct: 160 SMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLK 216

Query: 757 TMK----ITEKCDVYSFGVLMWEVIKGKHP--RDFLSSISSSSLNTDVAL 800
           +         +CD +S GV ++E++ G  P   D L    S  +N   +L
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 266

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 3/97 (3%)

Query: 686 IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG 745
              +A AL YLH      IV+RD+  +N+LLD +    + DFG+ K     S   T F G
Sbjct: 102 AAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG 158

Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T  Y+APE+          D +  G +++E++ G  P
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 2e-07
 Identities = 35/93 (37%), Positives = 46/93 (49%)

Query: 109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQL 168
           F+  L L N    G IP     L +L  + L GN + G+I  SLG + SL  L L+ N  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 169 IGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG 201
            G IP     LTS+  L L+ N L G +P  +G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.8 bits (129), Expect = 2e-07
 Identities = 40/123 (32%), Positives = 59/123 (47%), Gaps = 11/123 (8%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT-EFAGTCGYI 750
           AL +LH      IV+RDI  +N+LLD E    + DFG++K    +    T  F GT  Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173

Query: 751 APELAYTMKITEKC-DVYSFGVLMWEVIKGKHP------RDFLSSISSSSLNTDVALDQM 803
           APE+        K  D +S G+L++E++ G  P      R+  S +S   L  D      
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSF 233

Query: 804 LDP 806
           + P
Sbjct: 234 IGP 236

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 2e-07
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 141

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 142 IHRDLKPSNLAVNEDCELKILDFGLARH---TDDEMTGYVATRWYRAPEIMLNWMHYNQT 198

Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 199 VDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 39/211 (18%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHS-- 652
           IG G +  V  A +  +GE VA+KK + +   +   D    L E++         RH   
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVF--EHVSDATRILREIK----LLRLLRHPDI 61

Query: 653 ------------------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                             ++++E +E      I   D    E         +  +  AL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALK 117

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAGTCGYIA 751
           Y+H      + HRD+  KN+L + + +  + DFG+A+    D+     WT++  T  Y A
Sbjct: 118 YIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174

Query: 752 PEL--AYTMKITEKCDVYSFGVLMWEVIKGK 780
           PEL  ++  K T   D++S G +  EV+ GK
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 53.4 bits (128), Expect = 3e-07
 Identities = 51/208 (24%), Positives = 84/208 (40%), Gaps = 9/208 (4%)

Query: 299 TSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNF--YGEISSNWGKFPKLGTLNVSM 356
            S+   RL  N  +  +         L  +DL   +     + S N              
Sbjct: 43  ESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLN 101

Query: 357 NNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNP-LTKLILRGNQITGRLPKEI 415
            N       E+   + L + DL  N+I  +IP  +G L   L +L L  N+I   LP  +
Sbjct: 102 LNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPL 159

Query: 416 GSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSY 473
            +L  L+ LD S   + +LP  + N+ +L  L+LS N +S  +P   E +  L  +D+S 
Sbjct: 160 RNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218

Query: 474 NELQCPVPNSTTFRGASVEALKGNKGLC 501
           N +   + + +  +  S   L  NK   
Sbjct: 219 NSIIELLSSLSNLKNLSGLELSNNKLED 246

Length = 394

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 41/278 (14%)

Query: 596 IGNGGHASVYRAELPSGEVVAVK---KFHSLLPCDQTVDQKEFLTE-----------VEA 641
           +G G   SV   +L   +   +K   K   L     + + +EFL+E           V  
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYS-EIEEFLSEAACMKDFDHPNVMK 65

Query: 642 FYGFC--SHARHSF----LLYEFLERGSLAAIL---NTDAAAQELGWSQRMNVIKAVAHA 692
             G C  + +        ++  F++ G L + L         ++L     +  +  +A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL-KPDSSNWTEFAGT-CGYI 750
           + YL +  F   +HRD++++N +L  +    VADFG++K +   D       A     +I
Sbjct: 126 MEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLP 809
           A E       T K DV++FGV MWE+  +G+ P   +        N ++        RL 
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-------NHEIYDYLRHGNRLK 235

Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            P     ++L  +M   +SC+   P+ RPT   + + L
Sbjct: 236 QPE-DCLDELYDLM---YSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.1 bits (128), Expect = 3e-07
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL--KPD--SSNWTEFAGTCG 748
           L Y+H      ++HRD+   NLL++ + E  + DFG+A+ L   P       TE+  T  
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176

Query: 749 YIAPELAYTM-KITEKCDVYSFGVLMWEVI 777
           Y APEL  ++ + T   D++S G +  E++
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 71/295 (24%), Positives = 119/295 (40%), Gaps = 39/295 (13%)

Query: 578 ILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFL 636
           I++D     ++ ++    IG G +  V++     +G   AVK    +   D+ ++ +  +
Sbjct: 8   IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNI 67

Query: 637 TE-------VEAFYGF-----CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
            +       V  FYG        +    +L+ E    GS+     TD     L   +RM 
Sbjct: 68  LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-----TDLVKGFLKRGERME 122

Query: 685 --VIKAVAH-ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT 741
             +I  + H AL  L H      +HRD+   N+LL  E    + DFG++  L        
Sbjct: 123 EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182

Query: 742 EFAGTCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNT 796
              GT  ++APE+             +CDV+S G+   E+  G  P         + L+ 
Sbjct: 183 TSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL--------ADLHP 234

Query: 797 DVALDQMLDPRLPAPSRSAQEKLIS--IMEVAFSCFNESPESRPTMKIISQQLRI 849
             AL ++  PR P P+   Q +L S    +    C  +  E RPT+  + Q + I
Sbjct: 235 MRALFKI--PRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 48/274 (17%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY-----------G 644
           IGNG    V  +E+ +   VA      L     + +Q EFL + + +            G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 645 FCSHARHSFLLYEFLERGSLAAILNT------DAAAQELGWSQRMNVIKAVAHALSYLHH 698
            C  A    L++E+ E G L + L+       ++    L   QRM     +A  ++++H 
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL---QRMAC--EIAAGVTHMHK 117

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE--FAGTCGYIAPELA- 755
             F   +H D++ +N  L  +    V D+GI  S   +    TE        ++APEL  
Sbjct: 118 HNF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174

Query: 756 ------YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ---MLD 805
                  T + T+  +V++ GV +WE+ +    P    S +S   +   V  DQ   +  
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELFENAAQP---YSHLSDREVLNHVIKDQQVKLFK 231

Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           P+L  P     E+   +++  +     SPE R T
Sbjct: 232 PQLELPY---SERWYEVLQFCWL----SPEKRAT 258

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 52.9 bits (128), Expect = 3e-07
 Identities = 31/98 (31%), Positives = 48/98 (48%), Gaps = 15/98 (15%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS---NWTEFAGTCG 748
            L YLH      ++HRD+   N+L++   +  + DFG+A+ + PD       TE+  T  
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 749 YIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGKH 781
           Y APEL      YT  I    D++S G +  E++  K 
Sbjct: 172 YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.4 bits (126), Expect = 4e-07
 Identities = 60/201 (29%), Positives = 95/201 (47%), Gaps = 30/201 (14%)

Query: 597 GNGG--HASVYRAELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE-----VEAFYG-F 645
           GNGG     ++R   PSG ++A K  H  + P   +Q + + + L E     +  FYG F
Sbjct: 12  GNGGVVTKVLHR---PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAF 68

Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSYLH--HDCF 701
            S    S  + E ++ GSL  +L       E  LG      +  AV   L+YL   H   
Sbjct: 69  YSDGEISICM-EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREKHK-- 120

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT 761
             I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE       T
Sbjct: 121 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERLQGTHYT 176

Query: 762 EKCDVYSFGVLMWEVIKGKHP 782
            + D++S G+ + E+  G++P
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 35/178 (19%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQE---LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDI 709
           FL+ +  E G L + ++      E     W+  M V      AL  LH +    IV RD+
Sbjct: 61  FLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALDALHRE---GIVCRDL 111

Query: 710 SSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-------YIAPELAYTMKITE 762
           +  N+LLD      +  F            W+E   +C        Y APE+    + TE
Sbjct: 112 NPNNILLDDRGHIQLTYFS----------RWSEVEDSCDGEAVENMYCAPEVGGISEETE 161

Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI 820
            CD +S G +++E++ GK     L     S +NT   L+  +   +   +RS  ++L+
Sbjct: 162 ACDWWSLGAILFELLTGKT----LVECHPSGINTHTTLN--IPEWVSEEARSLLQQLL 213

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 52.1 bits (125), Expect = 4e-07
 Identities = 62/271 (22%), Positives = 110/271 (40%), Gaps = 23/271 (8%)

Query: 587 TNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKK---FHSLLP-----CDQTVDQKEFLT 637
             +F  +  IG G  + VY+A  L  G VVA+KK   F  +       C + +D  + L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 638 EVEAFYGFCSHARHSFL--LYEFLERGSLA-AILNTDAAAQELGWSQRMNVIKAVAHALS 694
                    S   ++ L  + E  + G L+  I +     + +           +  AL 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           ++H      I+HRDI   N+ +       + D G+ +     ++      GT  Y++PE 
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
            +      K D++S G L++E+   + P  +   ++  SL   +  ++   P LPA   S
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKI--EKCDYPPLPADHYS 234

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
            +  L  ++     C N  PE RP +  + Q
Sbjct: 235 EE--LRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 52.7 bits (126), Expect = 4e-07
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 36/229 (15%)

Query: 580 YDEIVK-------ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQ 632
           Y++IV+          D+D    IG G    V      S + V   K  S     +  D 
Sbjct: 28  YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDS 87

Query: 633 KEFLTE--VEAFYG-------FCSHA--RHSFLLYEFLERGSLAAIL-NTDAAAQELGWS 680
             F  E  + AF         FC+    ++ +++ E++  G L  ++ N D   +   W+
Sbjct: 88  AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---WA 144

Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           +       V  AL  +H      ++HRD+   N+LLD      +ADFG    +K D +  
Sbjct: 145 KFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGM 197

Query: 741 TE---FAGTCGYIAPELAYTMK----ITEKCDVYSFGVLMWEVIKGKHP 782
                  GT  YI+PE+  +         +CD +S GV ++E++ G  P
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 44/221 (19%)

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           YG C     S ++ E+++ GSL   L  +     + W  ++ V K +A AL +L      
Sbjct: 65  YGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDK--- 119

Query: 703 PIVHRDISSKNLLLDLEYEAH--------VADFGIAKSLKP-----DSSNWTEFAGTCGY 749
            + H ++ +KN+LL  E +          ++D GI+ ++ P     +   W         
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPW--------- 170

Query: 750 IAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR- 807
           + PE +     ++   D +SFG  +WE+  G            S+L++   L Q  + R 
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG-------GDKPLSALDSQKKL-QFYEDRH 222

Query: 808 -LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            LPAP  +    LI+       C +  P+ RP+ + I + L
Sbjct: 223 QLPAPKWTELANLIN------QCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 5/95 (5%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFAGTC 747
           VA A+ YLH      I++RD+  +N+LLD +    + DFG+ K  ++P+ +  T F GT 
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTP 160

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            Y+APE+          D +  G +++E++ G  P
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 52.6 bits (126), Expect = 5e-07
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 49/212 (23%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           +G+G + SV  A +  +GE VA+KK             + F +E+     F   A     
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLS-----------RPFQSEI-----FAKRAYRELT 66

Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQ---------RMNVIKAVAHALS----------- 694
           L + ++  ++  +L+   +A      Q         + ++ K + H LS           
Sbjct: 67  LLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126

Query: 695 -----YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGY 749
                Y+H      I+HRD+   NL ++ + E  + DFG+A+      +  T +  T  Y
Sbjct: 127 LCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWY 180

Query: 750 IAPELAYT-MKITEKCDVYSFGVLMWEVIKGK 780
            APE+    M   +  D++S G +M E++ GK
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 5e-07
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 13/108 (12%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAGTCG 748
            L Y+H      ++HRD+   NLLL+   +  + DFG+A+   P+  +    TE+  T  
Sbjct: 118 GLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 749 YIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFLSSI 789
           Y APE+    K  T+  D++S G ++ E++       GK     L+ I
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI 222

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 51.8 bits (125), Expect = 5e-07
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 35/206 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVK--KFHS---------------LLPC--DQTVDQKEF 635
           I  G +  VYRA +  +GE+VA+K  K                  LL       V  KE 
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEV 72

Query: 636 LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
           +          S+    +++ E++E   L +++ T    Q    S+   ++  +   +++
Sbjct: 73  VVG--------SNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAH 121

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           LH +    I+HRD+ + NLLL+      + DFG+A+        +T+   T  Y APEL 
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178

Query: 756 Y-TMKITEKCDVYSFGVLMWEVIKGK 780
               + +   D++S G +  E++  K
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 36/137 (26%), Positives = 66/137 (48%), Gaps = 16/137 (11%)

Query: 651 HSFLLYEFLERGSLAAILNTDAAA--QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRD 708
           + +++ ++ E G L   +N        E    Q ++    +  AL ++H      I+HRD
Sbjct: 73  NLYIVMDYCEGGDLYKKINAQRGVLFPE---DQILDWFVQICLALKHVHDR---KILHRD 126

Query: 709 ISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC----GYIAPELAYTMKITEKC 764
           I S+N+ L  +    + DFGIA+ L    ++  E A TC     Y++PE+        K 
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSPEICENRPYNNKS 182

Query: 765 DVYSFGVLMWEVIKGKH 781
           D+++ G +++E+   KH
Sbjct: 183 DIWALGCVLYEMCTLKH 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 52.9 bits (127), Expect = 6e-07
 Identities = 28/81 (34%), Positives = 47/81 (58%)

Query: 288 QGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFP 347
           +G IP  +     L  + L+GN++ GNI  +LG   +L  +DLS N+F G I  + G+  
Sbjct: 431 RGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490

Query: 348 KLGTLNVSMNNITGGLPREIG 368
            L  LN++ N+++G +P  +G
Sbjct: 491 SLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 51.6 bits (124), Expect = 7e-07
 Identities = 53/219 (24%), Positives = 86/219 (39%), Gaps = 71/219 (32%)

Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           L  FL++  L    N     Q L   Q +++   +A  +SYLH      ++H+DI+++N 
Sbjct: 96  LKLFLQQCRLGEANN----PQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNC 148

Query: 715 LLDLEYEAHVADFGIAKSLKP-------DSSN----WTEFAGTCGYIAPELAYTMKITEK 763
           ++D E +  + D  +++ L P       D+ N    W         +A E     + +  
Sbjct: 149 VIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW---------MALESLVNKEYSSA 199

Query: 764 CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM----LDP-----------RL 808
            DV+SFGVL+WE+                     + L Q     +DP           RL
Sbjct: 200 SDVWSFGVLLWEL---------------------MTLGQTPYVEIDPFEMAAYLKDGYRL 238

Query: 809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             P     E L ++M     C+   PE RP+      QL
Sbjct: 239 AQPINCPDE-LFAVMAC---CWALDPEERPS----FSQL 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 62/266 (23%), Positives = 107/266 (40%), Gaps = 21/266 (7%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFH--------SLLPCDQTVDQKEFLTEV 639
           +F  +  IG G  + VYRA  L  G  VA+KK          +   C + +D  + L   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 640 EAFYGFCSHARHSFL--LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
                + S    + L  + E  + G L+ ++      + L       V K      S L 
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPEKTVWKYFVQLCSALE 120

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
           H     ++HRDI   N+ +       + D G+ +     ++      GT  Y++PE  + 
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
                K D++S G L++E+   + P  +   ++  SL   +  +Q   P  P PS    E
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKI--EQCDYP--PLPSDHYSE 235

Query: 818 KLISIMEVAFSCFNESPESRPTMKII 843
           +L  ++ +   C N  PE RP +  +
Sbjct: 236 ELRQLVNM---CINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 51.5 bits (123), Expect = 7e-07
 Identities = 51/220 (23%), Positives = 88/220 (40%), Gaps = 24/220 (10%)

Query: 644 GFCSHARHSFLLYEFLERGSLAAILN------TDAAAQELGWSQRMNVI---KAVAHALS 694
           G C       ++ E++E G L   L+      T   A  +      N++     +A  + 
Sbjct: 84  GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK 143

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC----GYI 750
           YL    F   VHRD++++N L+   Y   +ADFG++++L   S ++    G       ++
Sbjct: 144 YLASLNF---VHRDLATRNCLVGNHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWM 198

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK--GKHPRDFLSSISSSSLNTDVALDQMLDPRL 808
           A E     K T   DV++FGV +WE+     + P   LS         +   +Q     L
Sbjct: 199 AWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYL 258

Query: 809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                        + ++   C++   + RPT   I   LR
Sbjct: 259 SQTPLCPS----PVFKLMMRCWSRDIKDRPTFNKIHHFLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 51.7 bits (124), Expect = 7e-07
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 5/92 (5%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK-SLKPDSSNWTEFAGTCGYI 750
           AL +LH      I++RD+  +N+LLD +    + DFG+ K S+   +   T F GT  Y+
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYM 167

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           APE+       +  D +S G LM++++ G  P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 51.6 bits (124), Expect = 8e-07
 Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 47/220 (21%)

Query: 591 DAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
           D KY     IG G +  V  A    + E VA+KK  +    D  +D K  L E++     
Sbjct: 4   DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF--DNRIDAKRTLREIK----L 57

Query: 646 CSHARHS--------------------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNV 685
             H  H                     +++YE ++   L  I+ +   +Q L        
Sbjct: 58  LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRS---SQTLSDDHCQYF 113

Query: 686 IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG 745
           +  +   L Y+H      ++HRD+   NLLL+   +  + DFG+A++        TE+  
Sbjct: 114 LYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV 170

Query: 746 TCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           T  Y APEL      YT  I    DV+S G +  E++  K
Sbjct: 171 TRWYRAPELLLNCSEYTTAI----DVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 6/94 (6%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT-EFAGTCGYI 750
           AL +LH      I++RDI  +N+LLD      + DFG++K    D       F GT  Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 751 APELAYTMKI--TEKCDVYSFGVLMWEVIKGKHP 782
           AP++         +  D +S GVLM+E++ G  P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.3 bits (123), Expect = 9e-07
 Identities = 30/94 (31%), Positives = 48/94 (51%), Gaps = 3/94 (3%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +A AL YLH      I++RD+  +N+LLD +    + DFG+ K     S   + F GT  
Sbjct: 105 IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161

Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           Y+APE+          D +  G +++E++ G  P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 11/146 (7%)

Query: 642 FYG-FCSHARHSFLLY-EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
           +YG     A  +  ++ E++  GS+   L    A  E   S      + +   +SYLH +
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRKYTRQILEGMSYLHSN 125

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAY 756
               IVHRDI   N+L D      + DFG +K L+    + T      GT  +++PE+  
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHP 782
                 K DV+S G  + E++  K P
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 33/194 (17%)

Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKN 713
           L    ER     ++N   A   L +   +     VA+ + +L   +C    VHRD++++N
Sbjct: 217 LPSAPERTRRDTLINESPA---LSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARN 269

Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSFG 770
           +L+       + DFG+A+ +  DS N+     T     ++APE  +    T   DV+SFG
Sbjct: 270 VLICEGKLVKICDFGLARDIMRDS-NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFG 328

Query: 771 VLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-----RLPAPSRSAQEKLISIME 824
           +L+WE+   G  P   L       +N     +Q  +      R+  P+ ++ E    I E
Sbjct: 329 ILLWEIFTLGGTPYPEL------PMN-----EQFYNAIKRGYRMAKPAHASDE----IYE 373

Query: 825 VAFSCFNESPESRP 838
           +   C+ E  E RP
Sbjct: 374 IMQKCWEEKFEIRP 387

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 40/168 (23%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK------SLKPDSSNWTEFAG 745
           AL  +H      ++HRD+ S N+ L       + DFG +K      SL   SS    F G
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS----FCG 233

Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVI------KGKHPRDFLSSISSSSLNTDVA 799
           T  Y+APEL    + ++K D++S GV+++E++      KG   R+ +  +          
Sbjct: 234 TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV---------- 283

Query: 800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           L    DP  P P  S  + L+  +       +++P  RPT    +QQL
Sbjct: 284 LYGKYDP-FPCPVSSGMKALLDPL------LSKNPALRPT----TQQL 320

Length = 478

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 30/89 (33%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L Y+H      I+HRD+   NL ++ + E  + DFG+A+      S  T +  T  Y AP
Sbjct: 131 LKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ---TDSEMTGYVVTRWYRAP 184

Query: 753 ELAYT-MKITEKCDVYSFGVLMWEVIKGK 780
           E+    M  T+  D++S G +M E++ GK
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 21/268 (7%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCS 647
           +F  +  IG G  + VYRA  L   + VA+KK       D    Q + + E++      +
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ-DCVKEIDLLKQL-N 60

Query: 648 HARHSFLLYEFLERGSLAAILNTDAA---AQELGWSQRM-------NVIKAVAHALSYLH 697
           H      L  F+E   L  +L    A   +Q + + ++         V K      S + 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
           H     ++HRDI   N+ +       + D G+ +     ++      GT  Y++PE  + 
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
                K D++S G L++E+   + P         +  +    ++Q   P  P P+    E
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLFSLCQKIEQCDYP--PLPTEHYSE 235

Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQ 845
           KL    E+   C    P+ RP +  + Q
Sbjct: 236 KL---RELVSMCIYPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.9 bits (122), Expect = 2e-06
 Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 13/149 (8%)

Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V+  Y F    ++ +++ E++  G L  +++     ++  W++       V  AL  +H 
Sbjct: 106 VQLHYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARFY--TAEVVLALDAIHS 160

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPELAYT 757
             F   +HRD+   N+LLD      +ADFG    +  +     + A GT  YI+PE+  +
Sbjct: 161 MGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 758 MKIT----EKCDVYSFGVLMWEVIKGKHP 782
                    +CD +S GV ++E++ G  P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.5 bits (121), Expect = 2e-06
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 39/212 (18%)

Query: 596 IGNGGHA---SVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHS 652
           +G G +    S   AE    E VA+KK  ++    + +  K  L E++    F  H   +
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNIT 65

Query: 653 FL---------------LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
            L               LYE L    L  I+ +    Q L  +   + I  +   L Y+H
Sbjct: 66  CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIH 122

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD----SSNWTEFAGTCGYIAPE 753
                 ++HRD+   NLL++ + E  + DFG+A+    +    +   TE+  T  Y APE
Sbjct: 123 S---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 754 L-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           +     +YT  I    DV+S G ++ E++  K
Sbjct: 180 IMLSFQSYTKAI----DVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 28/201 (13%)

Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           ++ E++  G+L + L       +L   Q M ++  +A  + YL    +   VH+ +++  
Sbjct: 83  IVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMGY---VHKGLAAHK 137

Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCG--YIAPELAYTMKITEKCDVYSF 769
           +L++ +    ++ F     L+ D S   +T  +G     + APE       +   DV+SF
Sbjct: 138 VLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSF 194

Query: 770 GVLMWEVIK-GKHPRDFLSSISSSSLNTDV--ALDQMLDPRLPAPSRSAQEKLISIMEVA 826
           G++MWEV+  G+ P   +S         DV  A++     RLPAP R+    L  +M   
Sbjct: 195 GIVMWEVMSYGERPYWDMS-------GQDVIKAVEDGF--RLPAP-RNCPNLLHQLM--- 241

Query: 827 FSCFNESPESRPTMKIISQQL 847
             C+ +    RP    I   L
Sbjct: 242 LDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 25/78 (32%), Positives = 44/78 (56%), Gaps = 5/78 (6%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW--TEFAGTCGYIAPELAYTMKIT 761
           I+HRD+   N+++  +    + DFG+A++     +N+  T +  T  Y APE+   M   
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYK 200

Query: 762 EKCDVYSFGVLMWEVIKG 779
           E  D++S G +M E++KG
Sbjct: 201 ENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 46/199 (23%), Positives = 89/199 (44%), Gaps = 25/199 (12%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF--------- 645
           +G G +  V + +   +G++VA+KKF  L   D  + +K  + E+               
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 646 --CSHARHSFLLYEFLERGSLAAILNT-DAAAQELGWSQRMNVIKAVAHALSYLH-HDCF 701
                 +  +L++EF++      +L+  +     L  S+    +  +   + + H H+  
Sbjct: 67  EVFRRKKRLYLVFEFVDH----TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-TMKI 760
             I+HRDI  +N+L+       + DFG A++L      +T++  T  Y APEL     K 
Sbjct: 121 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKY 178

Query: 761 TEKCDVYSFGVLMWEVIKG 779
               D+++ G L+ E++ G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 49.9 bits (119), Expect = 2e-06
 Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 14/117 (11%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIA---KSLKPDSSNWTEFAGTCGYIAPE-LAYTMK 759
           +V+RD+   N+LLD      ++D G+A      KP +S      GT GY+APE L   + 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVA 172

Query: 760 ITEKCDVYSFGVLMWEVIKGKHPRDFLSS-----ISSSSLNTDVALDQMLDPRLPAP 811
                D +S G +++++++G  P     +     I   +L   V L     P L + 
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 229

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 54/224 (24%)

Query: 596 IGNGGHASVYRAELP---SGE---VVAVKKFHSLLPCDQTVD-QKEFLTE---------- 638
           IG G    V++A  P     E   +VAVK    +L  + + D Q +F  E          
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVK----MLKEEASADMQADFQREAALMAEFDHP 68

Query: 639 -VEAFYGFCSHARHSFLLYEFLERGSLAAIL------NTDAAAQ-------------ELG 678
            +    G C+  +   LL+E++  G L   L         + +               L 
Sbjct: 69  NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128

Query: 679 WSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL----- 733
            ++++ + K VA  ++YL    F   VHRD++++N L+       +ADFG+++++     
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185

Query: 734 -KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEV 776
            K   ++    A    ++ PE  +  + T + DV+++GV++WE+
Sbjct: 186 YKASEND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 49.6 bits (119), Expect = 3e-06
 Identities = 48/200 (24%), Positives = 89/200 (44%), Gaps = 28/200 (14%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQ------TVDQKEFLTEVEAF------ 642
           IG G + +VY+A +L +G  VA+KK    +P  +      T+ +   L ++E+F      
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 643 --YGFC-----SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                C            L++E +++  LA  L+       L      ++++ +   + +
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLS-KCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           LH      IVHRD+  +N+L+  + +  +ADFG+A+    + +  T    T  Y APE+ 
Sbjct: 123 LHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPEVL 178

Query: 756 YTMKITEKCDVYSFGVLMWE 775
                    D++S G +  E
Sbjct: 179 LQSSYATPVDMWSVGCIFAE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 63/249 (25%), Positives = 100/249 (40%), Gaps = 40/249 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKF-----HSLLPCDQTVDQKEFLTEVEAF------- 642
           IG G + +VY+A +  SG  VA+K          LP   TV +   L  +EAF       
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPL-STVREVALLKRLEAFDHPNIVR 66

Query: 643 -YGFCSHARHS-----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
               C+ +R        L++E +++  L   L+       L      ++++     L +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDK-VPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H +C   IVHRD+  +N+L+    +  +ADFG+A+      +  T    T  Y APE+  
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVLL 180

Query: 757 TMKITEKCDVYSFGVLMWEVIK------GKHPRDFLSSI-------SSSSLNTDVALDQ- 802
                   D++S G +  E+ +      G    D L  I              DV L + 
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRG 240

Query: 803 MLDPRLPAP 811
              PR P P
Sbjct: 241 AFSPRGPRP 249

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 49.1 bits (117), Expect = 5e-06
 Identities = 27/89 (30%), Positives = 46/89 (51%), Gaps = 7/89 (7%)

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L Y+H      +VHRD+   N+L++   +  + DFG+A   +      T +  T  Y AP
Sbjct: 121 LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAP 174

Query: 753 ELAYT-MKITEKCDVYSFGVLMWEVIKGK 780
           E+  T  K   + D++S G +  E+++GK
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.8 bits (117), Expect = 6e-06
 Identities = 33/124 (26%), Positives = 52/124 (41%), Gaps = 28/124 (22%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L Y+H      I+HRD+   N+ ++ + E  + DFG+A+         T +  T  Y A
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRA 183

Query: 752 PELAYT-MKITEKCDVYSFGVLMWEVIKGK-------H--------------PRDFLSSI 789
           PE+    M   +  D++S G +M E++ GK       H                + L  I
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243

Query: 790 SSSS 793
           SS S
Sbjct: 244 SSES 247

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 6e-06
 Identities = 19/61 (31%), Positives = 31/61 (50%), Gaps = 2/61 (3%)

Query: 417 SLTKLEYLDFSAIGELPSQIC-NMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNE 475
           +L  L  L  + +  +P      + +L+ L+LS NNL+   P  F G+  L  +D+S N 
Sbjct: 1   NLKSL-DLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 476 L 476
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 48.3 bits (115), Expect = 1e-05
 Identities = 32/91 (35%), Positives = 44/91 (48%), Gaps = 6/91 (6%)

Query: 35  LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDN 94
           L L   G  G IP  IS L +L+ + L  N   GNI        S G++  +  L ++ N
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNI------PPSLGSITSLEVLDLSYN 476

Query: 95  SLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP 125
           S +G IP  +G L  L  L+L  N  SG +P
Sbjct: 477 SFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 48.4 bits (115), Expect = 1e-05
 Identities = 28/79 (35%), Positives = 46/79 (58%), Gaps = 3/79 (3%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           IV+RD+  +NLLLD +    + DFG AK +  D+  +T   GT  YIAPE+   +   + 
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIAPEILLNVGHGKA 208

Query: 764 CDVYSFGVLMWEVIKGKHP 782
            D ++ G+ ++E++ G  P
Sbjct: 209 ADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 48.2 bits (115), Expect = 1e-05
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 13/94 (13%)

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS-NWTEFAGTCGYIA 751
           L YLH      I+HRDI   NLL++      + DFG+A+  +PD S + T+   T  Y A
Sbjct: 116 LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRA 172

Query: 752 PELA-----YTMKITEKCDVYSFGVLMWEVIKGK 780
           PE+      YT  +    D++S G +  E++  +
Sbjct: 173 PEILMGSRHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 33/215 (15%)

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           YG C    +  +  E+++ G L   L+ +     L W  +++V K +A AL YL      
Sbjct: 67  YGVCVRDENIMVE-EYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLEDK--- 120

Query: 703 PIVHRDISSKNLLL---DLEYE----AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
            +VH ++  KN+L+    L         ++D GI  ++        E      +IAPE  
Sbjct: 121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE----ERVERIPWIAPECI 176

Query: 756 Y--TMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS 812
                 +T   D +SFG  + E+   G+ P   LS++SSS    +         RLP P 
Sbjct: 177 RNGQASLTIAADKWSFGTTLLEICSNGEEP---LSTLSSS----EKERFYQDQHRLPMPD 229

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +    LI+       C+   P  RP+ + I + L
Sbjct: 230 CAELANLIN------QCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 1/117 (0%)

Query: 249 GNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNG 308
           G   +  L L      G++P +I +   L+   +S N  +G IP SL + TSL  + L+ 
Sbjct: 416 GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY 475

Query: 309 NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGT-LNVSMNNITGGLP 364
           N+  G+I E+LG   +L  ++L+ N+  G + +  G         N + N    G+P
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 60/193 (31%), Positives = 86/193 (44%), Gaps = 15/193 (7%)

Query: 46  IPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG 105
           +P  +SNLSNL  L L  N+ S               L  +  L +++NS+   +   + 
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-------DLPPEIELLSALEELDLSNNSIIELLSS-LS 229

Query: 106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND 165
           NLK LS L+L+NNK    +P S  NLSNL  L L  N +  S +SSLG L +L +L L+ 
Sbjct: 230 NLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSG 286

Query: 166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSIS 225
           N L   +P     L  +  L      L      E+     L   ++  N      P ++S
Sbjct: 287 NSLSNALPLIALLLLLLELLLNLLLTL---KALELKLNSILLNNNILSNGE-TSSPEALS 342

Query: 226 NLTNLKELALLYN 238
            L +L  L  L N
Sbjct: 343 ILESLNNLWTLDN 355

Length = 394

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 47.1 bits (112), Expect = 2e-05
 Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 32/201 (15%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFH----------------SLLPCDQTVDQKEFLTE 638
           IG G +  VY+A    +GEVVA+KK                  SLL   + ++    +  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLL---KELNHPNIVKL 64

Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH- 697
           ++  +         +L++EFL +  L   ++  +    +      + +  +   L++ H 
Sbjct: 65  LDVIH----TENKLYLVFEFLHQ-DLKKFMDA-SPLSGIPLPLIKSYLFQLLQGLAFCHS 118

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
           H     ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+   
Sbjct: 119 HR----VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 174

Query: 758 MKI-TEKCDVYSFGVLMWEVI 777
            K  +   D++S G +  E++
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 48.2 bits (115), Expect = 2e-05
 Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 40/224 (17%)

Query: 596 IGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFY 643
           IG GG   VY A  P     VA+KK    L  +  + +K FL E           +   Y
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDL-SENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP- 702
             CS     +    ++E  +L ++L +    + L  S+ +    +V   LS  H  C   
Sbjct: 69  SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATI 126

Query: 703 ------PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---------------SSNWT 741
                  ++HRD+   N+LL L  E  + D+G A   K +                S+ T
Sbjct: 127 EYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186

Query: 742 ---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
              +  GT  Y+APE    +  +E  D+Y+ GV++++++    P
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 54/234 (23%), Positives = 92/234 (39%), Gaps = 30/234 (12%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH------------SLLPCDQTVDQKEFLTEVEAF 642
           +G G    VY   +  +G  +AVK+              + L C+  + +      +  +
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 643 YGFCSHARHSFL--LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
           YG         L    E +  GS+   L +  A  E   +      + +   +SYLH + 
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE---NVTRKYTRQILEGVSYLHSNM 126

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP---DSSNWTEFAGTCGYIAPELAYT 757
              IVHRDI   N+L D      + DFG +K L+      +      GT  +++PE+   
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHP-RDFLSSISSSSLNTDVALDQMLDPRLPA 810
                K D++S G  + E++  K P  +F +  +   + T     Q  +P LP 
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTNPVLPP 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 39/143 (27%), Positives = 65/143 (45%), Gaps = 17/143 (11%)

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C     + ++ EF+E G L   ++  +      W  +  V K +A ALSYL     
Sbjct: 69  LYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSYLEDK-- 124

Query: 702 PPIVHRDISSKNLLL-----DLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGYIAPE- 753
             +VH ++ +KN+LL     D E    +  +D GI  ++        E      +IAPE 
Sbjct: 125 -DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ----ECVERIPWIAPEC 179

Query: 754 LAYTMKITEKCDVYSFGVLMWEV 776
           +  +  ++   D +SFG  +WE+
Sbjct: 180 VEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 26/98 (26%), Positives = 41/98 (41%), Gaps = 17/98 (17%)

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-----LKPDSS---------NWTEF 743
           H  +   +HRD+S  N+ ++ +    +ADFG+A+           S           T  
Sbjct: 136 HKWY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193

Query: 744 AGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVIKGK 780
             T  Y APEL     K     D++S G +  E++ GK
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.0 bits (112), Expect = 3e-05
 Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 75/258 (29%)

Query: 588 NDFDAKYCIGNGGHASVYR--AELPSGEVVAVKKFH--SLLPCDQTVD---QKEFLTE-- 638
           +DF++   IG G    V R   +  +G + A+KK     +L  +Q      +++ L E  
Sbjct: 1   DDFESIKVIGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD 59

Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILN-----TDAAAQELGWSQRMNVIKAV 689
               V+ +Y F     + +L+ E+L  G +  +L      T+   +    ++ +  I ++
Sbjct: 60  NPWVVKLYYSF-QDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETR-FYIAETILAIDSI 117

Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA----- 744
            H L Y         +HRDI   NLLLD +    ++DFG+   LK   S+ TEF      
Sbjct: 118 -HKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFYRILSH 165

Query: 745 -----------------------------------GTCGYIAPELAYTMKITEKCDVYSF 769
                                              GT  YIAPE+       ++CD +S 
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225

Query: 770 GVLMWEVIKGKHPRDFLS 787
           GV+M+E++ G  P  F S
Sbjct: 226 GVIMYEMLVGYPP--FCS 241

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 32/116 (27%), Positives = 53/116 (45%), Gaps = 14/116 (12%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIA---KSLKPDSSNWTEFAGTCGYIAPE-LAYTMK 759
           +V+RD+   N+LLD      ++D G+A      KP +S      GT GY+APE L     
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGTA 172

Query: 760 ITEKCDVYSFGVLMWEVIKG-----KHPRDFLSSISSSSLNTDVALDQMLDPRLPA 810
                D +S G +++++++G     +H       I   +L  +V L     P L +
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKS 228

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 46.5 bits (110), Expect = 3e-05
 Identities = 46/196 (23%), Positives = 84/196 (42%), Gaps = 41/196 (20%)

Query: 614 VVAVKKFHSLLPCDQTVDQK-EFLTEVEA-----------FYGFCSHARHSFLLYEFLER 661
           +VAVK    +L  D   + + +FL EV+              G C       ++ E++E 
Sbjct: 48  LVAVK----ILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMEN 103

Query: 662 GSLAAILNT----------------DAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
           G L   L++                      + +S  ++V   +A  + YL    F   V
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---V 160

Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC----GYIAPELAYTMKIT 761
           HRD++++N L+       +ADFG++++L   + ++    G       ++A E     K T
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLY--AGDYYRIQGRAVLPIRWMAWECILMGKFT 218

Query: 762 EKCDVYSFGVLMWEVI 777
              DV++FGV +WE++
Sbjct: 219 TASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 46.1 bits (110), Expect = 4e-05
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 35/202 (17%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           IG G  + V +A    +G+  A+K     F SL       +Q   L E++A      H  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-------EQVNNLREIQALRRLSPHP- 58

Query: 651 HSFLLYEFL---ERGSLAAILN-TDAAAQELGWSQR--------MNVIKAVAHALSYLHH 698
           +   L E L   + G LA +    D    EL   ++         + +  +  +L ++H 
Sbjct: 59  NILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR 118

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAY 756
           +    I HRDI  +N+L+  +    +ADFG  + +  KP    +TE+  T  Y APE   
Sbjct: 119 N---GIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLL 171

Query: 757 TMKI-TEKCDVYSFGVLMWEVI 777
           T      K D+++ G + +E++
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 49/199 (24%), Positives = 91/199 (45%), Gaps = 24/199 (12%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHS-- 652
           +G G +A+VY+     +G++VA+K         +T +   F    EA        +H+  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISM-----KTEEGVPFTAIREA--SLLKGLKHANI 65

Query: 653 FLLYEFLE-RGSLAAIL---NTDAA---AQELGWSQRMNV---IKAVAHALSYLHHDCFP 702
            LL++ +  + +L  +    +TD A    Q  G     NV   +  +   L+Y+H     
Sbjct: 66  VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ--- 122

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKIT 761
            I+HRD+  +NLL+    E  +ADFG+A++    S  ++    T  Y  P+ L      +
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYS 182

Query: 762 EKCDVYSFGVLMWEVIKGK 780
              D++  G +  E+++G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.1 bits (109), Expect = 5e-05
 Identities = 28/110 (25%), Positives = 57/110 (51%), Gaps = 4/110 (3%)

Query: 672 AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA- 730
           AA + +     + + ++V  A+ YLH +    I+HRDI ++N+ ++   +  + DFG A 
Sbjct: 174 AAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230

Query: 731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK 780
             +  +++ +  +AGT    APEL          D++S G++++E+    
Sbjct: 231 FPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 45.7 bits (108), Expect = 5e-05
 Identities = 37/136 (27%), Positives = 64/136 (47%), Gaps = 12/136 (8%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+ +KN+ L       + DFG+++ L       T F GT  Y++PE         K
Sbjct: 127 ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185

Query: 764 CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIM 823
            D++S G +++E+    H     +    + L+  + + +   P LP    +   +L SIM
Sbjct: 186 SDIWSLGCILYEMCCLAH-----AFEGQNFLSVVLRIVEGPTPSLP---ETYSRQLNSIM 237

Query: 824 EVAFSCFNESPESRPT 839
           +   S  N+ P  RP+
Sbjct: 238 Q---SMLNKDPSLRPS 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.7 bits (108), Expect = 5e-05
 Identities = 52/227 (22%), Positives = 85/227 (37%), Gaps = 57/227 (25%)

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           +G C     + ++ EF+E G L   L  +     + W  ++ V + +A ALSYL      
Sbjct: 82  HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK--- 136

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP-----------DSSNWTEFAGTCGYIA 751
            +VH ++ +KN+LL        A  G+A+   P            + +  E      +IA
Sbjct: 137 NLVHGNVCAKNILL--------ARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIA 188

Query: 752 PE-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP---- 806
           PE +     ++   D +SFG  + E+                  + +V L +        
Sbjct: 189 PECVPGGNSLSTAADKWSFGTTLLEI----------------CFDGEVPLKERTPSEKER 232

Query: 807 ------RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 RLP PS      LIS       C    P  RP+ + I + L
Sbjct: 233 FYEKKHRLPEPSCKELATLIS------QCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 5/87 (5%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK--PDSSNWTEFAGTCGY 749
           AL+YLH      I+HRD+ ++N+ LD    A + DFG A  L   PD+     ++GT   
Sbjct: 197 ALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEV 776
            +PEL        K D++S G++++E+
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 36/217 (16%)

Query: 590 FDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFH-------------------SLLPCDQT 629
           FD    IG G +  VY+A +  +GE+VA+KK                       L     
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 630 VDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
           V+ KE +T+ +    F       +L++E+++   L  +L  ++           + +K +
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLL--ESGLVHFSEDHIKSFMKQL 125

Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-WTEFAGTCG 748
              L+Y H   F   +HRDI   N+LL+ + +  +ADFG+A+    + S  +T    T  
Sbjct: 126 LEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 749 YIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           Y  PEL      Y   I    DV+S G ++ E+   K
Sbjct: 183 YRPPELLLGEERYGPAI----DVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 45.1 bits (107), Expect = 8e-05
 Identities = 45/201 (22%), Positives = 91/201 (45%), Gaps = 23/201 (11%)

Query: 603 SVYRAELPSGEVV--AVKKFH--SLLPCDQTVDQKEFLTEVEAF-----YGF----CSHA 649
           S+Y+    + EV+    KKFH    +  D T ++ + L  +++      YGF        
Sbjct: 35  SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDI 709
               L+ E+  RG L  +L+ +   ++L +  ++++       L  L+     P  ++++
Sbjct: 95  PRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149

Query: 710 SSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM--KITEKCDVY 767
           +S + L+   Y+  +   G+ K L         F     Y + ++   +  + T K D+Y
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV---YFSYKMLNDIFSEYTIKDDIY 206

Query: 768 SFGVLMWEVIKGKHPRDFLSS 788
           S GV++WE+  GK P + L++
Sbjct: 207 SLGVVLWEIFTGKIPFENLTT 227

Length = 283

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 9e-05
 Identities = 26/77 (33%), Positives = 42/77 (54%), Gaps = 1/77 (1%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205

Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+IKG 
Sbjct: 206 VDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 45.5 bits (108), Expect = 9e-05
 Identities = 25/77 (32%), Positives = 42/77 (54%), Gaps = 1/77 (1%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKEN 197

Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+I+G 
Sbjct: 198 VDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 43/185 (23%), Positives = 70/185 (37%), Gaps = 59/185 (31%)

Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNV---------IKAVAHALSYLHHDCFPPI 704
           L Y F ++ +L  +++       +    RM V         I  +  A+  +H   F   
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF--- 122

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAK--------------------SLKP-----DSSN 739
           +HRDI   N+L+DL+    + DFG+                      S++P     D SN
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 740 WT----------------------EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
                                      GT  YIAPE+      T+ CD +S GV+++E++
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Query: 778 KGKHP 782
            G+ P
Sbjct: 243 VGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKEN 198

Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 47/207 (22%), Positives = 93/207 (44%), Gaps = 38/207 (18%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFH---------------SLLPCDQTVDQKEFLTE- 638
           +G G +A+VY+     +GE+VA+K+ H               SL+        KE   E 
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLM--------KELKHEN 59

Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           +   +          L++E+++   L   ++T      L  +   +    +   +++ H 
Sbjct: 60  IVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL---- 754
           +    ++HRD+  +NLL++   E  +ADFG+A++     + ++    T  Y AP++    
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 755 -AYTMKITEKCDVYSFGVLMWEVIKGK 780
             Y+  I    D++S G +M E+I G+
Sbjct: 176 RTYSTSI----DIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.8 bits (106), Expect = 1e-04
 Identities = 32/140 (22%), Positives = 52/140 (37%), Gaps = 46/140 (32%)

Query: 686 IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK-------------- 731
           I  +  A+  +H   F   +HRDI   N+L+D +    + DFG+                
Sbjct: 107 IAELTCAIESVHKMGF---IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163

Query: 732 ------SLKPDSSNWTE-----------------------FAGTCGYIAPELAYTMKITE 762
                 S++P                                GT  YIAPE+      T+
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223

Query: 763 KCDVYSFGVLMWEVIKGKHP 782
            CD +S GV+++E++ G+ P
Sbjct: 224 LCDWWSVGVILYEMLVGQPP 243

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 35/132 (26%), Positives = 58/132 (43%), Gaps = 9/132 (6%)

Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           +  E++  GS+   L    A  E   +      + +   +SYLH +    IVHRDI   N
Sbjct: 83  IFVEYMPGGSIKDQLKAYGALTE---NVTRRYTRQILQGVSYLHSNM---IVHRDIKGAN 136

Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFG 770
           +L D      + DFG +K ++    + T      GT  +++PE+        K DV+S  
Sbjct: 137 ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVA 196

Query: 771 VLMWEVIKGKHP 782
             + E++  K P
Sbjct: 197 CTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 30/117 (25%), Positives = 49/117 (41%), Gaps = 23/117 (19%)

Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
           SQ    +  +   ++YLH +    I+HRDI + N+L+D +    +ADFG+A+       N
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 740 WTEFAG-----------TCGYIAPELA-----YTMKITEKCDVYSFGVLMWEVIKGK 780
                G           T  Y  PEL      YT  +    D++  G +  E+   +
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 25/89 (28%), Positives = 49/89 (55%), Gaps = 4/89 (4%)

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           LSY H      I+HRD+  +NLL++ + E  +ADFG+A++    +  ++    T  Y  P
Sbjct: 116 LSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172

Query: 753 E-LAYTMKITEKCDVYSFGVLMWEVIKGK 780
           + L  + + +   D++  G +++E+  G+
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 43.1 bits (102), Expect = 4e-04
 Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 19/132 (14%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +L++EF E   LA +L+       L   +++  +K + + L Y+H      I+HRD+ + 
Sbjct: 95  YLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLNGLYYIH---RNKILHRDMKAA 148

Query: 713 NLLLDLEYEAHVADFGIAKSL----KPDSSNWTEFAGTCGYIAPELA-----YTMKITEK 763
           N+L+  +    +ADFG+A++         + +T    T  Y  PEL      Y   I   
Sbjct: 149 NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPI--- 205

Query: 764 CDVYSFGVLMWE 775
            D++  G +M E
Sbjct: 206 -DMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 43.6 bits (102), Expect = 5e-04
 Identities = 38/156 (24%), Positives = 72/156 (46%), Gaps = 29/156 (18%)

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQR---MNVIKAVAHALSYLHHDCFPP----IV 705
           ++L EF + G L+   N     +  G  +    +++ + + HAL+Y H+    P    ++
Sbjct: 90  YILMEFCDAGDLSR--NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVL 147

Query: 706 HRDISSKNLLLDLEYE-----------------AHVADFGIAKSLKPDSSNWTEFAGTCG 748
           HRD+  +N+ L                      A + DFG++K++  +S   +   GT  
Sbjct: 148 HRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPY 206

Query: 749 YIAPELAY--TMKITEKCDVYSFGVLMWEVIKGKHP 782
           Y +PEL    T    +K D+++ G +++E+  GK P
Sbjct: 207 YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Length = 1021

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 11/129 (8%)

Query: 650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDI 709
           ++ F LY F+   +       D   + L    R  ++K +  A+ Y+H      ++HRDI
Sbjct: 244 KYDFDLYSFMYDEAF------DWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDI 293

Query: 710 SSKNLLLDLEYEAHVADFGIAKSL-KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYS 768
             +N+ L+ + +  + DFG A    K   +    + GT    +PE+       E  D++S
Sbjct: 294 KLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353

Query: 769 FGVLMWEVI 777
            G+++ +++
Sbjct: 354 CGLILLDML 362

Length = 501

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.5 bits (101), Expect = 5e-04
 Identities = 35/107 (32%), Positives = 54/107 (50%), Gaps = 22/107 (20%)

Query: 684 NVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLD-LEYEAHVADFGIAKSLKPDSSNWT 741
            +I+ +  AL+ LH H+    I+H DI  +N+L D  +   ++ D+G+ K +   S    
Sbjct: 113 KIIRQLVEALNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC--- 165

Query: 742 EFAGTCGYIAPELAYTMKIT-EKCDVYSF-----GVLMWEVIKGKHP 782
            + GT  Y +PE     KI     D  SF     GVL +E++ GKHP
Sbjct: 166 -YDGTLDYFSPE-----KIKGHNYD-VSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 42.9 bits (101), Expect = 6e-04
 Identities = 28/87 (32%), Positives = 43/87 (49%), Gaps = 6/87 (6%)

Query: 9   NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSG 68
           +I+L    + G +   S  S   L  LDL++N F G+IP  +  L++LR L L  N  SG
Sbjct: 446 SINLSGNSIRGNI-PPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSG 504

Query: 69  NILAEVSSESSGGNLRYMSRLVINDNS 95
            + A +     GG L + +     DN+
Sbjct: 505 RVPAAL-----GGRLLHRASFNFTDNA 526

Length = 623

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 42.4 bits (99), Expect = 6e-04
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            LSY+H      I+HRD+  +NLL+    E  +ADFG+A++    S  ++    T  Y  
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRP 171

Query: 752 PELAYTMKITEKC-DVYSFGVLMWEVIKG 779
           P++         C D++  G +  E+I+G
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 8e-04
 Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 51/206 (24%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH----------------SLL---PCDQTVDQKEF 635
           IG G +  VY+A +  +GE+VA+KK                  SLL        V   + 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 636 LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
           +      Y          L++EFL+   L   +++   +   G    +  IK+    +  
Sbjct: 67  VHSENKLY----------LVFEFLDL-DLKKYMDS---SPLTGLDPPL--IKSYLYQLLQ 110

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
            ++Y H H     ++HRD+  +NLL+D E    +ADFG+A++       +T    T  Y 
Sbjct: 111 GIAYCHSHR----VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR 166

Query: 751 APELAYTMKITEKCDVYSFGVLMWEV 776
           APE      I      YS  V +W +
Sbjct: 167 APE------ILLGSRQYSTPVDIWSI 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.9 bits (89), Expect = 9e-04
 Identities = 22/59 (37%), Positives = 29/59 (49%)

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQL 168
           L  LDL+NN+ +     +F  L NL  L L GN L+     +   L SL  L L+ N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 9e-04
 Identities = 60/260 (23%), Positives = 96/260 (36%), Gaps = 78/260 (30%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPC-----DQTVD---QKEFLTE 638
            DF     IG G    V   +   +G++ A+K   +LL       DQ      +++ L E
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMK---TLLKSEMFKKDQLAHVKAERDVLAE 57

Query: 639 ------VEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVA- 690
                 V  +Y F   A++ +L+ EFL  G L  +L   D  ++++        + A+  
Sbjct: 58  SDSPWVVSLYYSF-QDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEA 116

Query: 691 -HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA------------------K 731
            H L +         +HRDI   N+L+D      ++DFG++                  K
Sbjct: 117 VHKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGK 167

Query: 732 SLKPDSSNWTEFA-----------------------------GTCGYIAPELAYTMKITE 762
           S K    N    A                             GT  YIAPE+       +
Sbjct: 168 SNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227

Query: 763 KCDVYSFGVLMWEVIKGKHP 782
           +CD +S G +M+E + G  P
Sbjct: 228 ECDWWSLGAIMFECLIGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.5 bits (88), Expect = 0.001
 Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 181 SVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH 239
           ++ +L LS N L   IPD     + +L VLDL+ N    + P + S L +L+ L L  N+
Sbjct: 1   NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 240 L 240
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 22/60 (36%), Positives = 31/60 (51%), Gaps = 1/60 (1%)

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHF 263
           +L  LDL+ N+   +   +   L NLK L L  N+L+   P +   L  LR L LSGN+ 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 49/202 (24%), Positives = 91/202 (45%), Gaps = 27/202 (13%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQK-----EFLTEVE-----AFYG 644
           IG G +  VY+A +  + E +A+KK   L   D+ V          L E++         
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHALSYLHHDC 700
                +  +L++E+L+   L    + D++     +++   +IK     +   ++Y H   
Sbjct: 69  VVHSEKRLYLVFEYLD---LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSH- 121

Query: 701 FPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTM 758
              ++HRD+  +NLL+D    A  +ADFG+A++       +T    T  Y APE L  + 
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR 179

Query: 759 KITEKCDVYSFGVLMWEVIKGK 780
             +   D++S G +  E++  K
Sbjct: 180 HYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 38/185 (20%), Positives = 70/185 (37%), Gaps = 59/185 (31%)

Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVI-KAVAH--------ALSYLHHDCFPPI 704
           L Y F ++ +L  +++       +    RM +  + +A         A+  +H   F   
Sbjct: 66  LYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF--- 122

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKS---------------LKPDSSNWT-------- 741
           +HRDI   N+L+D +    + DFG+                  ++ DS +++        
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 742 ------------------------EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
                                      GT  YIAPE+      T+ CD +S GV+++E++
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 778 KGKHP 782
            G+ P
Sbjct: 243 VGQPP 247

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 40.4 bits (94), Expect = 0.003
 Identities = 23/90 (25%), Positives = 47/90 (52%), Gaps = 4/90 (4%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L+Y H      ++HRD+  +NLL++   E  +ADFG+A++    +  ++    T  Y  
Sbjct: 116 GLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRP 172

Query: 752 PE-LAYTMKITEKCDVYSFGVLMWEVIKGK 780
           P+ L  +   + + D++  G + +E+  G+
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 31/106 (29%), Positives = 55/106 (51%), Gaps = 5/106 (4%)

Query: 672 AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK 731
           A  + LG +Q   V + +  A+ Y+H +    I+HRDI ++N+L++   +  + DFG A 
Sbjct: 252 ARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308

Query: 732 SLKPDSSNWTEF--AGTCGYIAPELAYTMKITEKCDVYSFGVLMWE 775
             +   S    +  AGT    APE+      T   D++S G++++E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 23/93 (24%), Positives = 49/93 (52%), Gaps = 4/93 (4%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +   L+Y H      ++HRD+  +NLL++   E  +ADFG+A++    +  ++    T  
Sbjct: 113 ILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLW 169

Query: 749 YIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGK 780
           Y  P+ L  + + + + D++  G + +E+  G+
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.0 bits (84), Expect = 0.004
 Identities = 22/60 (36%), Positives = 29/60 (48%)

Query: 133 NLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL 192
           NL  L L  N L+     +   L +L  L L+ N L    P  FS L S+ +L LS N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.004
 Identities = 55/230 (23%), Positives = 92/230 (40%), Gaps = 63/230 (27%)

Query: 590 FDAKYCIGNGGHASVYRA---ELPSGEVVAVKKFHSLLPCDQTVDQ---------KEF-- 635
           ++ + CIG G +  VY+A       G+  A+KKF         + Q         +E   
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 636 -----LTEVEAFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRM--NVIK 687
                L EV     F  HA  S +LL+++ E   L  I+     A+ +     M  +++ 
Sbjct: 62  ENVVSLVEV-----FLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH----VADFGIA----KSLKPDSSN 739
            + + + YLH +    ++HRD+   N+L+  E        + D G+A      LKP +  
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 740 -------WTEFAGTCGYIAPELA-----YTMKITEKCDVYSFGVLMWEVI 777
                  W        Y APEL      YT  I    D+++ G +  E++
Sbjct: 173 DPVVVTIW--------YRAPELLLGARHYTKAI----DIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 43/170 (25%), Positives = 68/170 (40%), Gaps = 29/170 (17%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L +LH      +VHRD+  +N+L+    +  +ADFG+A+      +  T    T  Y A
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRA 177

Query: 752 PELAYTMKITEKCDVYSFGVLMWE------VIKGKHPRDFLSSI-------SSSSLNTDV 798
           PE+          D++S G +  E      + +G    D L  I              DV
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237

Query: 799 ALDQMLDPRLPAPSRSAQ--EKLISIME-----VAFSCFNESPESRPTMK 841
           AL     PR    S+SAQ  EK ++ ++     +   C   +P  R +  
Sbjct: 238 AL-----PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	849
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.98
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.98
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.98
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.98
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.98
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.98
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.98
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.98
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.98
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.98
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.98
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.98
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.98
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.98
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.98
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.98
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.98
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.98
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.98
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.98
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.98
PTZ00036	440	glycogen synthase kinase; Provisional	99.98
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.98
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.98
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.98
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.98
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.98
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.98
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.98
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.98
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.98
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.98
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.98
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.98
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.98
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.98
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.98
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.98
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.98
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.98
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.98
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.98
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.98
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.98
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.98
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.98
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.98
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.98
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.98
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.96
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.96
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.94
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.94
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.94
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.93
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.92
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
KOG1152	772	consensus Signal transduction serine/threonine kin	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.9
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
PRK09188	365	serine/threonine protein kinase; Provisional	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.76
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.71
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.71
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.7
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.69
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.67
PRK12274	218	serine/threonine protein kinase; Provisional	99.67
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
smart00090	237	RIO RIO-like kinase.	99.62
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.61
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.59
PRK14879	211	serine/threonine protein kinase; Provisional	99.52
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.51
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.5
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.47
PRK10345	210	hypothetical protein; Provisional	99.47
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.46
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.41
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
PLN03150	623	hypothetical protein; Provisional	99.39
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.38
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.36
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.29
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.27
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.26
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.22
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.21
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.21
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.2
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.2
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.17
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.17
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.12
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.09
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.02
PLN03150	623	hypothetical protein; Provisional	98.99
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.98
COG4248	637	Uncharacterized protein with protein kinase and he	98.95
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.94
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.93
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.93
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.92
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.92
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.9
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.75
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.72
KOG1243	690	consensus Protein kinase [General function predict	98.72
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.65
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.64
KOG3087	229	consensus Serine/threonine protein kinase [General	98.61
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.57
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.53
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.53
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.52
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.51
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.45
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.44
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.3
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.29
PRK09902	216	hypothetical protein; Provisional	98.23
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.22

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.8e-98  Score=924.07  Aligned_cols=824  Identities=31%  Similarity=0.541  Sum_probs=539.6

Q ss_pred             CCCCCcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccc-cCCCCCCEeeCCCCcCcccccccc-----
Q 042123            1 CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEV-----   74 (849)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~-----   74 (849)
                      |+.+++|+.++++.+++.|.+.. +|..+++|++|+|++|++.+.+|..+ ..+++|++|+|++|++++.++...     
T Consensus        65 c~~~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~  143 (968)
T PLN00113         65 CNNSSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLE  143 (968)
T ss_pred             cCCCCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCC
Confidence            77789999999999999998854 79999999999999999987677654 489999999999998876543210     


Q ss_pred             -----------cccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcc
Q 042123           75 -----------SSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNL  143 (849)
Q Consensus        75 -----------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~  143 (849)
                                 ..+..++++++|++|+|++|.+.+.+|..+.++++|++|+|++|++.+..|..|.++++|++|+|++|.
T Consensus       144 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~  223 (968)
T PLN00113        144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN  223 (968)
T ss_pred             EEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCc
Confidence                       011223445555555555555554555555555555555555555554455555555555555555555


Q ss_pred             cccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcC
Q 042123          144 LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPS  223 (849)
Q Consensus       144 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  223 (849)
                      +++..|..|+++++|++|+|++|.+.+..|..|.++++|++|+|++|++.+..|..+.++++|++|++++|.+.+.+|..
T Consensus       224 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~  303 (968)
T PLN00113        224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL  303 (968)
T ss_pred             cCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChh
Confidence            55445555555555555555555555445555555555555555555555445555555555555555555555445555


Q ss_pred             ccCccccchhhhccccccCCCCcchhhhh-hhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCc----
Q 042123          224 ISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNC----  298 (849)
Q Consensus       224 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~-L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l----  298 (849)
                      +..+++|++|++++|.+.+..|..+..+. |+.|++++|.+.+.+|..+..+++|+.|++++|++.+.+|..+..+    
T Consensus       304 ~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~  383 (968)
T PLN00113        304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLF  383 (968)
T ss_pred             HcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCC
Confidence            55555555555555555444444443332 4555555555554445444445555555555554444444443333    


Q ss_pred             --------------------ccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCc
Q 042123          299 --------------------TSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNN  358 (849)
Q Consensus       299 --------------------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  358 (849)
                                          ++|+.|++++|++++..|..+..+++|+.|++++|.+.+.++..+..+++|+.|++++|.
T Consensus       384 ~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~  463 (968)
T PLN00113        384 KLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNK  463 (968)
T ss_pred             EEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCce
Confidence                                334444444444443344444444444444444444444444444444555555555555


Q ss_pred             cccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCccccccccccccccccc---CCCCChh
Q 042123          359 ITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA---IGELPSQ  435 (849)
Q Consensus       359 i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~---l~~lp~~  435 (849)
                      +.+.+|..+ ..++|+.|++++|++++..|..|..+++|+.|+|++|++++.+|..++++++|++|+++.   .+.+|..
T Consensus       464 ~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  542 (968)
T PLN00113        464 FFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPAS  542 (968)
T ss_pred             eeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChh
Confidence            554444443 345677788888888888888899999999999999999999999999999999999986   4578999


Q ss_pred             hhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCCcccccCcccccccCCCccCCCC--CCCCCCCC
Q 042123          436 ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAK--GLQPCKPL  513 (849)
Q Consensus       436 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~c~~~~--~~~~~~~~  513 (849)
                      +..+++|+.|+|++|++++.+|..+..+++|+.|++++|++.|.+|....|.......+.+|+.+|+...  ...+|...
T Consensus       543 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~  622 (968)
T PLN00113        543 FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV  622 (968)
T ss_pred             HhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc
Confidence            9999999999999999999999999999999999999999999999988888888888999999998653  23455321


Q ss_pred             cccCCCCCcceEEeehhhhhHHHHHHHHHHHhhhhhcccCCcCCccCCCCCCCCCcccccc--CccccHHHHHHHhcCCC
Q 042123          514 RQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSGDRQSNNQIPQGSLSILNF--EGKILYDEIVKATNDFD  591 (849)
Q Consensus       514 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~f~  591 (849)
                          .. ...|..++++++++++++++++++++++++++.....+... ............  ...+.++++   ...|.
T Consensus       623 ----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  693 (968)
T PLN00113        623 ----RK-TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN-EDGTWELQFFDSKVSKSITINDI---LSSLK  693 (968)
T ss_pred             ----cc-cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccc-ccccccccccccccchhhhHHHH---HhhCC
Confidence                11 22333344444444444444444444444332211111100 000000000110  112233333   35677


Q ss_pred             cCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHH-----HHHHHhhceeecCCeeEEEEEeccCCChh
Q 042123          592 AKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFL-----TEVEAFYGFCSHARHSFLLYEFLERGSLA  665 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~-----~ei~~~~~~~~~~~~~~lV~e~~~~gsL~  665 (849)
                      ..+.||+|+||.||+|+. .++..||||++.......  ....+.+     ..|.+++++|.+.+..++||||+++|+|.
T Consensus       694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~  771 (968)
T PLN00113        694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP--SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS  771 (968)
T ss_pred             cccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc--HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHH
Confidence            888999999999999965 579999999986532211  1111122     23556899999999999999999999999


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccC
Q 042123          666 AILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG  745 (849)
Q Consensus       666 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g  745 (849)
                      ++++      .++|.++.+++.|||+|++|||+.+.++|+|||+||+||+++.++.+++. ||.+.....+    ....+
T Consensus       772 ~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~  840 (968)
T PLN00113        772 EVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFI  840 (968)
T ss_pred             HHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccc
Confidence            9984      28999999999999999999996655699999999999999999988875 6665543222    22367


Q ss_pred             CccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------ccccccccccccCCCCCCCChhhHHHH
Q 042123          746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS------SLNTDVALDQMLDPRLPAPSRSAQEKL  819 (849)
Q Consensus       746 ~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~  819 (849)
                      ++.|+|||++.+..++.++|||||||++|||+||+.||+........      ..........++++.+........+..
T Consensus       841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  920 (968)
T PLN00113        841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEI  920 (968)
T ss_pred             cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHH
Confidence            89999999999999999999999999999999999998632211000      000111223344555443333344556


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          820 ISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       820 ~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .++.+++.+||+.||++||||+||++.|+
T Consensus       921 ~~~~~l~~~Cl~~~P~~RPt~~evl~~L~  949 (968)
T PLN00113        921 VEVMNLALHCTATDPTARPCANDVLKTLE  949 (968)
T ss_pred             HHHHHHHHhhCcCCchhCcCHHHHHHHHH
Confidence            67889999999999999999999999885

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.3e-53  Score=528.11  Aligned_cols=462  Identities=35%  Similarity=0.573  Sum_probs=346.8

Q ss_pred             EEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCe
Q 042123            9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR   88 (849)
Q Consensus         9 ~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~   88 (849)
                      .|+++++.+.|.++. .+..+++|++|+|++|.+.+..|..|+++++|++|+|++|++++.++      ..++.+++|+.
T Consensus       144 ~L~Ls~n~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p------~~l~~l~~L~~  216 (968)
T PLN00113        144 TLDLSNNMLSGEIPN-DIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIP------RELGQMKSLKW  216 (968)
T ss_pred             EEECcCCcccccCCh-HHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCC------hHHcCcCCccE
Confidence            334444444333332 34455555555555555555555555555555555555555543322      22345566666


Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcc
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQL  168 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  168 (849)
                      |+|++|.+.+.+|..|+++++|++|++++|++++..|..|.++++|++|+|++|++++..|..+.++++|+.|+|++|.+
T Consensus       217 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l  296 (968)
T PLN00113        217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL  296 (968)
T ss_pred             EECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCee
Confidence            66666666656666666666666666666666656666666666666666666666655666666666666666666666


Q ss_pred             cccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcch
Q 042123          169 IGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL  248 (849)
Q Consensus       169 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  248 (849)
                      .+..|..+.++++|++|++++|.+.+..|..+..+++|+.|++++|.+.+.+|..+..+++|+.|++++|++.+.+|..+
T Consensus       297 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~  376 (968)
T PLN00113        297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL  376 (968)
T ss_pred             ccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhH
Confidence            66666666666666666666666666666666666666666666666666666666666677777777777666666666


Q ss_pred             hhh-hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCE
Q 042123          249 GNL-ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF  327 (849)
Q Consensus       249 ~~~-~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  327 (849)
                      ... .++.|++++|++.+..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+++.++..+..+++|+.
T Consensus       377 ~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  456 (968)
T PLN00113        377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQM  456 (968)
T ss_pred             hCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcE
Confidence            544 3777777777777778888888889999999999999999999999999999999999999999999999999999


Q ss_pred             EeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccc
Q 042123          328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQI  407 (849)
Q Consensus       328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  407 (849)
                      |+|++|++.+.+|..+ ..++|+.|++++|++++..|..+.++++|+.|+|++|++.+.+|..+..+++|+.|+|++|++
T Consensus       457 L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  535 (968)
T PLN00113        457 LSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL  535 (968)
T ss_pred             EECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcc
Confidence            9999999998888766 468999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCccccccccccccccccc---CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccC
Q 042123          408 TGRLPKEIGSLTKLEYLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCP  479 (849)
Q Consensus       408 ~~~~p~~~~~l~~L~~L~l~~---l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  479 (849)
                      ++.+|..|+.+++|+.||++.   .+.+|..+..+++|+.|++++|++++.+|.. ..+..+....+.+|+..|.
T Consensus       536 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~lc~  609 (968)
T PLN00113        536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNIDLCG  609 (968)
T ss_pred             cccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCccccC
Confidence            999999999999999999986   4688999999999999999999999999864 3445556667789987664

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=394.29  Aligned_cols=268  Identities=40%  Similarity=0.694  Sum_probs=222.7

Q ss_pred             CccccHHHHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhh
Q 042123          575 EGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFY  643 (849)
Q Consensus       575 ~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~  643 (849)
                      ...++++++..||++|...+.||+|+||.||+|..++|+.||||++.......    .++|..|+.           .++
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~----~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG----EREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc----hhHHHHHHHHHhcCCCcCcccEE
Confidence            34589999999999999999999999999999999999999999876543211    445887766           489


Q ss_pred             ceeecCC-eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 042123          644 GFCSHAR-HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA  722 (849)
Q Consensus       644 ~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  722 (849)
                      |||.+.+ +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.|+|+||||||+|||+|+++++
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999988 599999999999999999876543 79999999999999999999999988899999999999999999999


Q ss_pred             EEeeecCCcccCC-CCCCeeec-cCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------cc
Q 042123          723 HVADFGIAKSLKP-DSSNWTEF-AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------SS  793 (849)
Q Consensus       723 kl~DfG~a~~~~~-~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------~~  793 (849)
                      ||+|||+|+.... ... .... .||.+|+|||+...+..+.|+|||||||++.|++||+.|.+.......       ..
T Consensus       217 KlsDFGLa~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             EccCccCcccCCccccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999999976654 222 2222 899999999999999999999999999999999999998874321100       11


Q ss_pred             cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          794 LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+....+++|+++........+.+.++..++.+|++.+|.+||+|.||++.|+
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            2223367888998876322222267777999999999999999999999998873

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=383.79  Aligned_cols=401  Identities=24%  Similarity=0.245  Sum_probs=330.3

Q ss_pred             CCCCEEeCcCCccccCCCccccCCC--CCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLS--NLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNL  107 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  107 (849)
                      -....||.+++.+..+....+.++=  .-+.|++|+|+|+.      .+...|.++++|+.+++.+|.++ .+|...+..
T Consensus        52 c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~------id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~s  124 (873)
T KOG4194|consen   52 CNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSH------IDFEFFYNLPNLQEVNLNKNELT-RIPRFGHES  124 (873)
T ss_pred             CCceeeecCccccccccccccCCcCccceeeeecccccccc------CcHHHHhcCCcceeeeeccchhh-hcccccccc
Confidence            3457788888888766555555543  34458899888874      23445678888888888888888 677777777


Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      .+|+.|+|.+|.|+++...++..++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+.+..+.|..+.+|.+|.|
T Consensus       125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL  204 (873)
T KOG4194|consen  125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL  204 (873)
T ss_pred             cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence            78999999999999888888999999999999999998777778888888999999999999998899999999999999


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                      ++|+|+...+..|.+|++|+.|+|..|+|.-+..-.|.+|++|+.|.|..|.+..                       .-
T Consensus       205 srNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~k-----------------------L~  261 (873)
T KOG4194|consen  205 SRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISK-----------------------LD  261 (873)
T ss_pred             ccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCccc-----------------------cc
Confidence            9999987777788889999999999999985556778888888888888888762                       22


Q ss_pred             CcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCC
Q 042123          268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFP  347 (849)
Q Consensus       268 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  347 (849)
                      ..+|..+.+++.|+|+.|+++..-..++.++++|+.|+|+.|.|..+-++.+...++|+.||||+|+|+...++.|..+.
T Consensus       262 DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~  341 (873)
T KOG4194|consen  262 DGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS  341 (873)
T ss_pred             CcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence            34666777888888888888877788888899999999999999888888888888999999999999888888888889


Q ss_pred             CCcEEeccCCccccCCCCCccccccccccccccccccccCc---hhhcCCCCCcEEEccCccccccCccccccccccccc
Q 042123          348 KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIP---KELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL  424 (849)
Q Consensus       348 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  424 (849)
                      .|++|+|++|.|+..-...|..+++|+.|||++|.|+..+.   ..|.+|++|+.|.|.||+|..+.-.+|.        
T Consensus       342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfs--------  413 (873)
T KOG4194|consen  342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFS--------  413 (873)
T ss_pred             HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhc--------
Confidence            99999999999988778888899999999999999887664   3578899999999999998844334444        


Q ss_pred             ccccCCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCC
Q 042123          425 DFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       425 ~l~~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                                   .++.|++|||.+|.|..+.|.+|..| .|+.|-+..-.+-|+|.-
T Consensus       414 -------------gl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql  457 (873)
T KOG4194|consen  414 -------------GLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQL  457 (873)
T ss_pred             -------------cCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccH
Confidence                         44566677788899988899999998 889888888888888864

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=353.49  Aligned_cols=243  Identities=27%  Similarity=0.414  Sum_probs=197.8

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC-eeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR-HSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~-~~~lV  655 (849)
                      +.+....||+|..|+|||++++ +++.+|+|.+...   .....++.+.+|++.           ++|.|.++. ...++
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~  156 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC  156 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence            4455778999999999999664 7889999998543   233446677777653           677788888 59999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|||++++...   +.+++....+++.+|++||.|||+..  +|+||||||+|||++..|++||||||.++.+..
T Consensus       157 mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  157 MEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             hhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            9999999999998754   45899999999999999999999732  999999999999999999999999999998765


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .  ...+++||..|||||.+.+..|+.++||||||+.++|+.+|+.||....   .......+.+..+.+...+..+.. 
T Consensus       232 S--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~---~~~~~~~~Ll~~Iv~~ppP~lP~~-  305 (364)
T KOG0581|consen  232 S--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN---PPYLDIFELLCAIVDEPPPRLPEG-  305 (364)
T ss_pred             h--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC---CCCCCHHHHHHHHhcCCCCCCCcc-
Confidence            4  4577899999999999999999999999999999999999999987431   112233344555555333322221 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ....++.+|+..|+++||.+|||+.|+++|
T Consensus       306 -~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  306 -EFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             344568899999999999999999999876

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=375.62  Aligned_cols=390  Identities=21%  Similarity=0.203  Sum_probs=291.5

Q ss_pred             cEEEEecCCCceeeeeCCccCCCC--CCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSF--PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNL   83 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l   83 (849)
                      ...-+||+..++...-. ..+.++  +..+.|||++|++..+.+..|.++++|+.++|.+|.++..       +..-+..
T Consensus        53 ~~~lldcs~~~lea~~~-~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~I-------P~f~~~s  124 (873)
T KOG4194|consen   53 NTRLLDCSDRELEAIDK-SRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRI-------PRFGHES  124 (873)
T ss_pred             CceeeecCccccccccc-cccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhc-------ccccccc
Confidence            34557777777543211 123332  5578899999999999999999999999999999999731       2233456


Q ss_pred             cccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEc
Q 042123           84 RYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL  163 (849)
Q Consensus        84 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  163 (849)
                      .+|+.|+|.+|.|+++....++-++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+....+.|.++.+|..|.|
T Consensus       125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL  204 (873)
T KOG4194|consen  125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL  204 (873)
T ss_pred             cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence            67999999999999988889999999999999999999988889999999999999999999999999999999999999


Q ss_pred             CCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCC
Q 042123          164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS  243 (849)
Q Consensus       164 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  243 (849)
                      +.|+|+.+++..|.+|++|+.|+|.+|+|.....-.|.+|++|+.|.|..|.|......+|..|.++++|+|+.|++...
T Consensus       205 srNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~v  284 (873)
T KOG4194|consen  205 SRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAV  284 (873)
T ss_pred             ccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhh
Confidence            99999999999999999999999999999844466899999999999999999988899999999999999999999855


Q ss_pred             CCcchhhh-hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCC
Q 042123          244 IPPSLGNL-ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY  322 (849)
Q Consensus       244 ~p~~~~~~-~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  322 (849)
                      -..++..+ .|+.|+||.|.|..+-++.....++|+.|+|++|+|                        +...++.|..+
T Consensus       285 n~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i------------------------~~l~~~sf~~L  340 (873)
T KOG4194|consen  285 NEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRI------------------------TRLDEGSFRVL  340 (873)
T ss_pred             hcccccccchhhhhccchhhhheeecchhhhcccceeEecccccc------------------------ccCChhHHHHH
Confidence            55554444 255555555555555444444444455555555554                        44444444444


Q ss_pred             CCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCC---CCccccccccccccccccccccCchhhcCCCCCcE
Q 042123          323 PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLP---REIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTK  399 (849)
Q Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p---~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  399 (849)
                      ..|+.|.|++|++...-...|..+.+|++|||++|.|+..+.   ..|.+|++|+.|+|.+|+|..+...+|.++++|+.
T Consensus       341 ~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~  420 (873)
T KOG4194|consen  341 SQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEH  420 (873)
T ss_pred             HHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccce
Confidence            445555555555444444444445555555555555443322   24556666666666666666555566777777777


Q ss_pred             EEccCccccccCccccccccccccccccc
Q 042123          400 LILRGNQITGRLPKEIGSLTKLEYLDFSA  428 (849)
Q Consensus       400 L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  428 (849)
                      |+|.+|.|..+-|++|..+ +|+.|-++.
T Consensus       421 LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  421 LDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             ecCCCCcceeecccccccc-hhhhhhhcc
Confidence            7777777776667777766 666666553

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=360.18  Aligned_cols=244  Identities=28%  Similarity=0.529  Sum_probs=193.4

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC-eeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR-HSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~-~~~lV  655 (849)
                      .++...+.+|+|+||+||+|.+.....||||++.........  .+.|.+|+.           .++|+|.... ..++|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~--~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV  118 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES--RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV  118 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH--HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence            334445569999999999999974444999999764322222  667777755           4789998887 79999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCeeecCCC-cEEEeeecCCccc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP-IVHRDISSKNLLLDLEY-EAHVADFGIAKSL  733 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Nill~~~~-~~kl~DfG~a~~~  733 (849)
                      |||+++|+|.++++.. ....+++..+.+|+.|||+||+|||++   + |+||||||+|||++.++ ++||+|||+++..
T Consensus       119 tEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  119 TEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             EEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            9999999999999874 235699999999999999999999999   7 99999999999999998 9999999999876


Q ss_pred             CCCCCCeeeccCCcccccccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc-CCCCCC
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAY--TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML-DPRLPA  810 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~  810 (849)
                      .......+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||.......        ....+. ....+.
T Consensus       195 ~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~--------~~~~v~~~~~Rp~  266 (362)
T KOG0192|consen  195 VISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ--------VASAVVVGGLRPP  266 (362)
T ss_pred             ccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcCCCCC
Confidence            54333344478999999999999  6699999999999999999999999998654311        111111 122222


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+..   ....+..++.+||+.||+.||++.+|+..|+
T Consensus       267 ~p~~---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  267 IPKE---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             CCcc---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence            1111   2334778888999999999999999998875

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-40  Score=351.55  Aligned_cols=240  Identities=26%  Similarity=0.463  Sum_probs=199.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .+|...+.||+|+|+.||+++. .+|+.||+|++.+....... .+....+||+           ++++|+++..++|+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~-~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPK-QREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcc-hHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            5799999999999999999966 88999999999764332222 2334445544           589999999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      .|+|+.|+|..++++.   +.+++.+++.++.||+.|+.|||+.   +|+|||||..|+|++++.++||+|||+|.....
T Consensus        97 LELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EEecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            9999999999998743   4699999999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      +.+...+.+|||.|.|||++.+...+..+||||+||++|.|+.|++||+...        ..+....+.......|.   
T Consensus       171 ~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vkety~~Ik~~~Y~~P~---  239 (592)
T KOG0575|consen  171 DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKETYNKIKLNEYSMPS---  239 (592)
T ss_pred             cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHHHHHHHhcCccccc---
Confidence            8788888999999999999999999999999999999999999999997321        11222222222222111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .......++|..+++++|.+|||+++|+.+
T Consensus       240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             122236789999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-41  Score=351.73  Aligned_cols=240  Identities=28%  Similarity=0.525  Sum_probs=191.3

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +.+...+.||+|.||+||.|.+.....||||.++..     ......|.+|+.           +++|+|..++..+|||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt  280 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT  280 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence            445567789999999999999987779999998753     223344555543           5899999988999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      |||+.|+|.++|... .+..+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+....+
T Consensus       281 E~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCC
Confidence            999999999999863 345689999999999999999999999   9999999999999999999999999999954433


Q ss_pred             CCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCCh
Q 042123          737 SSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-PRLPAPSR  813 (849)
Q Consensus       737 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  813 (849)
                      ... .....-+..|.|||.+..+.|+.|||||||||+||||+| |+.||..+.        ..+.+..+-. .+++.|..
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms--------n~ev~~~le~GyRlp~P~~  428 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS--------NEEVLELLERGYRLPRPEG  428 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC--------HHHHHHHHhccCcCCCCCC
Confidence            221 111223568999999999999999999999999999998 999987433        2223333322 34554444


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ++.    .+.++|..||+.+|++|||++.+...|+
T Consensus       429 CP~----~vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  429 CPD----EVYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             CCH----HHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence            443    3888999999999999999998877653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-41  Score=337.08  Aligned_cols=246  Identities=23%  Similarity=0.340  Sum_probs=202.2

Q ss_pred             hcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCch---hhHHHHHHHHH-----------HhhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQT---VDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      .+.|...+.+|+|+||.|-+| ..++|+.||||.+++.......   .......+|++           ++.+++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            356778899999999999999 6778999999999764322211   11222334433           47889999999


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeec
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEAHVADFG  728 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG  728 (849)
                      .||||||++||+|.+++-...   .+.+..-..+++|++.|+.|||++   ||+||||||+|||+..+   ..+||+|||
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccc
Confidence            999999999999999986543   366777789999999999999999   99999999999999766   779999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCCCCC---ccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT---EKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD  805 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  805 (849)
                      +|+... ......+.+||+.|.|||++..+.++   .+.|+||+||++|-+++|.+||....       ......+++..
T Consensus       325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~-------~~~sl~eQI~~  396 (475)
T KOG0615|consen  325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY-------TDPSLKEQILK  396 (475)
T ss_pred             hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc-------CCccHHHHHhc
Confidence            999876 34567889999999999999876543   36799999999999999999997432       22224566777


Q ss_pred             CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       806 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ++....+..+.+...+..++|.+|+..||+.|||++|+++|
T Consensus       397 G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  397 GRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             CcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            78777777888888999999999999999999999999876

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.8e-44  Score=357.56  Aligned_cols=430  Identities=29%  Similarity=0.383  Sum_probs=299.5

Q ss_pred             cCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccC
Q 042123           25 SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI  104 (849)
Q Consensus        25 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  104 (849)
                      ..+.-..++.|++++|.++ ...+.+.++..|+.|++++|+++.       .+.+++.+..++.|+.++|+++ .+|+.+
T Consensus        40 ~wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~~-------lp~aig~l~~l~~l~vs~n~ls-~lp~~i  110 (565)
T KOG0472|consen   40 NWWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLSQ-------LPAAIGELEALKSLNVSHNKLS-ELPEQI  110 (565)
T ss_pred             hhhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhhh-------CCHHHHHHHHHHHhhcccchHh-hccHHH
Confidence            4555666778888888875 444457778888888888888762       2344566777888888888887 677777


Q ss_pred             CCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCE
Q 042123          105 GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVST  184 (849)
Q Consensus       105 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  184 (849)
                      ..+.+|..|++++|.+. ..|+.++.+..|+.|+..+|+|+ ..|..+..+.+|..|++.+|++...+|+.+. ++.|++
T Consensus       111 ~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~  187 (565)
T KOG0472|consen  111 GSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKH  187 (565)
T ss_pred             hhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHh
Confidence            77888888888888887 56667777777888888888887 5667777777788888888888776665555 788888


Q ss_pred             EEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchh-hh-hhhhhhccCcC
Q 042123          185 LRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLG-NL-ILRQLLLSGNH  262 (849)
Q Consensus       185 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~~-~L~~L~L~~n~  262 (849)
                      ||...|-+. .+|..++++.+|..|+|.+|+|. ..| .|.++..|++|+++.|.|+ .+|+... .+ .+..|||..|+
T Consensus       188 ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNk  263 (565)
T KOG0472|consen  188 LDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNK  263 (565)
T ss_pred             cccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccc
Confidence            888887776 67777888888888888888877 445 6777888888888888876 6666554 33 37778888888


Q ss_pred             CCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCc----------------------------
Q 042123          263 FTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGN----------------------------  314 (849)
Q Consensus       263 i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~----------------------------  314 (849)
                      ++ ..|..+|-+.+|+.||+|+|.|+ ..|..++++ .|+.|-+.+|.+..+                            
T Consensus       264 lk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~s  340 (565)
T KOG0472|consen  264 LK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQS  340 (565)
T ss_pred             cc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCC
Confidence            77 45777788888888888888887 566677777 777777777766421                            


Q ss_pred             ----------hhhh---hCCCCCCCEEeccCccccC-------------------------cccccCCCCCCCc-EEecc
Q 042123          315 ----------ISEA---LGIYPNLTFIDLSRNNFYG-------------------------EISSNWGKFPKLG-TLNVS  355 (849)
Q Consensus       315 ----------~~~~---~~~l~~L~~L~Ls~N~l~~-------------------------~~~~~~~~l~~L~-~L~Ls  355 (849)
                                ++..   .....+.+.|++++-+++.                         ++|..+..++.+. .+.++
T Consensus       341 e~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~ls  420 (565)
T KOG0472|consen  341 EGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLS  420 (565)
T ss_pred             cccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhh
Confidence                      0000   0112234445555544442                         3333333333222 23344


Q ss_pred             CCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccccccccccc--cCCCCC
Q 042123          356 MNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELP  433 (849)
Q Consensus       356 ~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~--~l~~lp  433 (849)
                      +|.++ .+|..++.+++|..|+|++|-+. .+|..++.+..|+.|+++.|+|. .+|..+-.+..|+.+-.+  .++.+|
T Consensus       421 nn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd  497 (565)
T KOG0472|consen  421 NNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVD  497 (565)
T ss_pred             cCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccC
Confidence            44443 55555666666666666666665 56666666666666666666666 666666555555554444  267777


Q ss_pred             hh-hhcccccceeccCCcccccCCCccccccCCCcEEeccCCccc
Q 042123          434 SQ-ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ  477 (849)
Q Consensus       434 ~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  477 (849)
                      +. +.+|.+|..|||.+|.|. .+|+.+++|++|++|+++|||++
T Consensus       498 ~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  498 PSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            65 999999999999999998 88889999999999999999998

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.2e-39  Score=313.41  Aligned_cols=251  Identities=22%  Similarity=0.361  Sum_probs=192.1

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|+...++|+|+||.|||++.+ +|+.||||+|...  .+.....+..++||.           .+..+|......++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            45677789999999999999665 6999999999764  223334455556654           467788889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      +|||+..-| +-+++..  ..++.+.+.++++|++.|+.|+|++   +++||||||+|||++.+|.+|+||||+|+.+..
T Consensus        80 FE~~dhTvL-~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   80 FEYCDHTVL-HELERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             eeecchHHH-HHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            999998444 4444433  3488999999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccc------ccccccc-----
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNT------DVALDQM-----  803 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~------~~~~~~~-----  803 (849)
                      ++..++.++.|.+|+|||.+.+ ..|....||||+||++.||++|.+-|...++++.-....      -.+..++     
T Consensus       154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence            7778899999999999999887 789999999999999999999999887554432200000      0000011     


Q ss_pred             -cC-CCCCCCCh--hh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 -LD-PRLPAPSR--SA----QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 -~~-~~~~~~~~--~~----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       +. -++|.+..  ..    +....-+.+++..|++.||++|++.+|++.|
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence             10 01221111  11    1223357899999999999999999999865

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-40  Score=314.54  Aligned_cols=246  Identities=21%  Similarity=0.323  Sum_probs=192.4

Q ss_pred             cCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhc--eeecCCeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYG--FCSHARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~--~~~~~~~~~  653 (849)
                      .+|++.++||+|.||+|||+ ...+|..+|.|.++-  .......+....+|+           +++++  +.++....+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f--~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF--GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch--hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            46778889999999999999 667999999999862  222233344444553           34444  223344489


Q ss_pred             EEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          654 LLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPP--IVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ||||||++|+|...++..+ ..+.+++..+++++.|++.||+++|+. .+.  |+||||||-||+++.+|.+|++|||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhH
Confidence            9999999999999997654 345689999999999999999999994 235  999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      +.+..........+|||.||+||.+.+.+|+.||||||+||++|||+.-+.||....        .......+-....++
T Consensus       176 r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--------~~~L~~KI~qgd~~~  247 (375)
T KOG0591|consen  176 RFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--------LLSLCKKIEQGDYPP  247 (375)
T ss_pred             hHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--------HHHHHHHHHcCCCCC
Confidence            999887777788999999999999999999999999999999999999999997432        222223333344432


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+  ..-....+..++..|+..||+.||+...++..
T Consensus       248 ~p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  248 LP--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             Cc--HHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence            22  12334557888999999999999985554443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-40  Score=355.61  Aligned_cols=253  Identities=26%  Similarity=0.508  Sum_probs=206.7

Q ss_pred             ccccHHHHHHHhcCCC---------cCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHH--
Q 042123          576 GKILYDEIVKATNDFD---------AKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE--  640 (849)
Q Consensus       576 ~~~~~~~~~~~~~~f~---------~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~--  640 (849)
                      ...+|++.-.|..+|.         +.++||.|.||+||+|+++    ....||||.++.-.   ....+++|+.|..  
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy---tekqrrdFL~EAsIM  684 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY---TEKQRRDFLSEASIM  684 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc---cHHHHhhhhhhhhhc
Confidence            4567777777766664         4678999999999999764    24569999987643   3345677888744  


Q ss_pred             ---------HhhceeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 042123          641 ---------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS  711 (849)
Q Consensus       641 ---------~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~  711 (849)
                               ++.|+.+....++||+|||++|+|+.||...+  +++++.+...++++||.||.||.++   ++|||||.+
T Consensus       685 GQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAA  759 (996)
T KOG0196|consen  685 GQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAA  759 (996)
T ss_pred             ccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhh
Confidence                     47788888889999999999999999998766  3599999999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEeeecCCcccCCCCC-CeeeccC--CccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccc
Q 042123          712 KNLLLDLEYEAHVADFGIAKSLKPDSS-NWTEFAG--TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLS  787 (849)
Q Consensus       712 ~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~  787 (849)
                      +|||++.+...|++|||+++.+..+.+ .+++..|  ..+|.|||.+...++|.+||||||||++||.++ |..||+++.
T Consensus       760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS  839 (996)
T KOG0196|consen  760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS  839 (996)
T ss_pred             hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence            999999999999999999998766543 3333334  468999999999999999999999999999886 999988543


Q ss_pred             cccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          788 SISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      .       .+....-..+.++|+|...+.    .+.++|..||++|-.+||++.+|+..|
T Consensus       840 N-------QdVIkaIe~gyRLPpPmDCP~----aL~qLMldCWqkdR~~RP~F~qiV~~l  888 (996)
T KOG0196|consen  840 N-------QDVIKAIEQGYRLPPPMDCPA----ALYQLMLDCWQKDRNRRPKFAQIVSTL  888 (996)
T ss_pred             h-------HHHHHHHHhccCCCCCCCCcH----HHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence            2       222223334567777665554    489999999999999999999999876

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-39  Score=325.19  Aligned_cols=191  Identities=27%  Similarity=0.460  Sum_probs=162.7

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhH------HHHHHH-----HHHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQ------KEFLTE-----VEAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~------~~~~~e-----i~~~~~~~~~~~~~~l  654 (849)
                      ..+|...+.||+|+||+||+|++. ++.+||||.+....-  ....+      ..+++|     |+.+++++..++..|+
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence            467888889999999999999664 689999999865421  11122      233333     3358889999999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC------CcEEEeeec
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE------YEAHVADFG  728 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~------~~~kl~DfG  728 (849)
                      |||||+||+|.+++++.+   .+++..++.++.|+|.||++||++   +|+||||||.|||++..      -.+||+|||
T Consensus        87 VMEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            999999999999998654   489999999999999999999999   99999999999999875      458999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFL  786 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~  786 (849)
                      +|+...+. ....+.+|++.|||||++..++|+.|+|+||+|+++|+|++|+.||+..
T Consensus       161 fAR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  161 FARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99988743 3456789999999999999999999999999999999999999999843

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=341.91  Aligned_cols=241  Identities=30%  Similarity=0.492  Sum_probs=196.8

Q ss_pred             CcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHHhhceeecCCeeEEEEEeccCCChhhhhcc
Q 042123          591 DAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNT  670 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~  670 (849)
                      ...+.||.|+.|.||.|+++ ++.||||+++.....+....++--+.+|..|.|+|.....++||||||..|-|+.+|+.
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka  205 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA  205 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc
Confidence            45678999999999999996 78899999876533333333333445677899999999999999999999999999975


Q ss_pred             cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCcccc
Q 042123          671 DAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI  750 (849)
Q Consensus       671 ~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~  750 (849)
                      .+   +++......|..+||.||.|||..   .|+|||||.-||||+.+..+||+|||-++..... .....++||..||
T Consensus       206 ~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWM  278 (904)
T KOG4721|consen  206 GR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWM  278 (904)
T ss_pred             cC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhh
Confidence            44   589999999999999999999998   8999999999999999999999999999877643 5566789999999


Q ss_pred             ccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhcc
Q 042123          751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF  830 (849)
Q Consensus       751 aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  830 (849)
                      |||++...+.++|.||||||||+|||+||..||...+......-.+...    +  .++.+...+    ..+.-++++||
T Consensus       279 APEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNs----L--~LpvPstcP----~GfklL~Kqcw  348 (904)
T KOG4721|consen  279 APEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNS----L--HLPVPSTCP----DGFKLLLKQCW  348 (904)
T ss_pred             CHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCc----c--cccCcccCc----hHHHHHHHHHH
Confidence            9999999999999999999999999999999997554322211111111    1  123222222    23777888999


Q ss_pred             CCCCCCCCCHHHHHhhhcC
Q 042123          831 NESPESRPTMKIISQQLRI  849 (849)
Q Consensus       831 ~~dP~~RPt~~eil~~L~~  849 (849)
                      +-.|..||++++|+.||.|
T Consensus       349 ~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  349 NSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             hcCCCCCccHHHHHHHHhh
Confidence            9999999999999999976

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4.4e-39  Score=354.99  Aligned_cols=245  Identities=25%  Similarity=0.476  Sum_probs=199.1

Q ss_pred             hcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      ..+....+.||+|+||+||+|+..      +...||||.+++..   ....+++|.+|++           +++|.|.++
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a---~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~  561 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA---ENQARQDFRREAELLAELQHPNIVRLLGVCREG  561 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc---cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence            345566789999999999999643      35569999988753   3345677887754           589999999


Q ss_pred             CeeEEEEEeccCCChhhhhcccc-------c----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDA-------A----AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL  718 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  718 (849)
                      +..++|+|||..|||.+||....       .    ..+++..+.+.||.|||.||+||.++   .+|||||..+|+||.+
T Consensus       562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE  638 (774)
T ss_pred             CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence            99999999999999999995321       1    22388999999999999999999999   8999999999999999


Q ss_pred             CCcEEEeeecCCcccCCCCCCee--eccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042123          719 EYEAHVADFGIAKSLKPDSSNWT--EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLN  795 (849)
Q Consensus       719 ~~~~kl~DfG~a~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~  795 (849)
                      +..|||+|||+++.....+++..  ...-..+|||||.+..++||.+||||||||++||+++ |+.||...        .
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl--------S  710 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL--------S  710 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc--------c
Confidence            99999999999998766554321  2234679999999999999999999999999999998 99998643        3


Q ss_pred             cccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .++..+.+.++++-+.++.+   +.++..+|.+||+..|++||++.||-..|+
T Consensus       711 n~EVIe~i~~g~lL~~Pe~C---P~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  711 NQEVIECIRAGQLLSCPENC---PTEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             hHHHHHHHHcCCcccCCCCC---CHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence            44555566666664444433   335788899999999999999999988775

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-39  Score=322.04  Aligned_cols=242  Identities=24%  Similarity=0.414  Sum_probs=191.6

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc-----hhhHHHHHHHHH-----HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ-----TVDQKEFLTEVE-----AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~~~~~~ei~-----~~~~~~~~~~~~~lV  655 (849)
                      .++|+..++||+|+||+||.++. .+++.+|+|++++......     ...++.++.++.     .+.-.++..+..|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            47899999999999999999954 5689999999876432221     111222333322     244455778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      +||+.||.|...+.+.+   .+++..+.-++..|+.||.|||+.   +|+|||+||+|||+|.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999997654   489999999999999999999999   999999999999999999999999999997766


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      +.....+++||+.|||||++.+..|+..+|.||+|+++|||++|..||...+        .....+.+...+.+.++...
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--------~~~~~~~I~~~k~~~~p~~l  249 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--------VKKMYDKILKGKLPLPPGYL  249 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--------HHHHHHHHhcCcCCCCCccC
Confidence            6666677899999999999999999999999999999999999999997432        23344455555544333322


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC----CHHHHHh
Q 042123          816 QEKLISIMEVAFSCFNESPESRP----TMKIISQ  845 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RP----t~~eil~  845 (849)
                      ..   ...+++...++.||++|.    ++++|-+
T Consensus       250 s~---~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  250 SE---EARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             CH---HHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            22   366788899999999995    5555543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=334.43  Aligned_cols=251  Identities=23%  Similarity=0.384  Sum_probs=195.2

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA  649 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~  649 (849)
                      +++++..+++...+.||+|.||+||+|+|.  ..||||.+.......  ...+.|..||..           +.|||..+
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~--~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTP--EQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCH--HHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            455566677778899999999999999995  359999997654433  245677777663           78899888


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      .. .||+.||+|-+|+.+++..+  .+|+..+.+.|++|||+||.|||.+   +|+|||||..||++.+++.|||+|||+
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGL  534 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGL  534 (678)
T ss_pred             ce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccc
Confidence            77 89999999999999999776  3588899999999999999999999   999999999999999999999999999


Q ss_pred             CcccC--CCCCCeeeccCCccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042123          730 AKSLK--PDSSNWTEFAGTCGYIAPELAYT---MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML  804 (849)
Q Consensus       730 a~~~~--~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  804 (849)
                      +..-.  ..........|...|||||+++.   .+|++.+||||||+|+|||++|..||......    ......-...+
T Consensus       535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d----qIifmVGrG~l  610 (678)
T KOG0193|consen  535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD----QIIFMVGRGYL  610 (678)
T ss_pred             eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh----heEEEeccccc
Confidence            86432  12233455678889999999875   46899999999999999999999998722211    11111111111


Q ss_pred             CCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          805 DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       805 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .++..   ........++.+++..||..++++||.+.+|+..|+
T Consensus       611 ~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  611 MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence            22222   222333445778888999999999999999998654

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=331.36  Aligned_cols=239  Identities=21%  Similarity=0.369  Sum_probs=195.3

Q ss_pred             cCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHH-----------HHHHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT-----------EVEAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-----------ei~~~~~~~~~~~~~~lV  655 (849)
                      ..|....+||+|+.|.||.| +..+++.||||++......    .++-.+.           +++.++..|...+..|+|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~----~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV  348 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP----KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV  348 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC----chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence            45667778999999999999 5667999999998653211    1222333           345566666677899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+......    +++.++..|++++++||+|||.+   +|+|||||.+|||++.+|.+||+|||++..+..
T Consensus       349 MEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            99999999999986543    89999999999999999999999   999999999999999999999999999998887


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      ......+.+|||.|||||++....|.+|.||||||++++||+.|++||-....+..         ...+.....+....+
T Consensus       422 ~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA---------lyLIa~ng~P~lk~~  492 (550)
T KOG0578|consen  422 EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---------LYLIATNGTPKLKNP  492 (550)
T ss_pred             ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH---------HHHHhhcCCCCcCCc
Confidence            76677888999999999999999999999999999999999999999865433221         112222222233334


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+|+.+|++.|+++||++.|+++|
T Consensus       493 ~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  493 EKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             cccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            4445568899999999999999999999986

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=330.63  Aligned_cols=244  Identities=23%  Similarity=0.388  Sum_probs=192.8

Q ss_pred             HHhcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCc-h----hhHHHHHHH------HHHhhceeecCCee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQ-T----VDQKEFLTE------VEAFYGFCSHARHS  652 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~-~----~~~~~~~~e------i~~~~~~~~~~~~~  652 (849)
                      +...+|..++.||+|+|++||+| ...+++.||||++.+...... .    ..+++.+..      +.+++-.++++...
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            34578999999999999999999 556799999998765321111 0    111222222      22356667888899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      |+|+||+++|+|.+++++.+   .+++.-.+.++.+|+.|++|||++   |||||||||+|||+|+||++||+|||.|+.
T Consensus       150 YFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence            99999999999999998764   589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCC-------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 042123          733 LKPDSS-------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       733 ~~~~~~-------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      +.+...             ....++||..|.+||.+.....++.+|+|+|||++|+|+.|++||....        ....
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--------eyli  295 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--------EYLI  295 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--------HHHH
Confidence            754211             1245899999999999999999999999999999999999999997433        2233


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+++++-....+...+    ..+.+++.+.+..||.+|+|+.+|.+|
T Consensus       296 FqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  296 FQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence            4444433333333333    337788999999999999999999886

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=323.55  Aligned_cols=242  Identities=25%  Similarity=0.413  Sum_probs=194.5

Q ss_pred             cCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhh---HHHHHH-----HHHHhhceeecCCeeEEEEEe
Q 042123          588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVD---QKEFLT-----EVEAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~---~~~~~~-----ei~~~~~~~~~~~~~~lV~e~  658 (849)
                      ..|+..+.||+|.||.|||| ...+++.||+|++.-........+   ...++.     .+..++|.+-.+...|++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            46777889999999999999 556799999999865432221111   111111     144688888899999999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      |.||++.+.++...   .+++.++.-+++++..|+.|+|++   +.+|||||+.||++..+|.+|++|||++..+.....
T Consensus        93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            99999999997544   357888889999999999999999   999999999999999999999999999998877666


Q ss_pred             CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          739 NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       739 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      ...+++||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+....++         ++.-.+....++..+  ...
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm---------rvlflIpk~~PP~L~--~~~  235 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM---------RVLFLIPKSAPPRLD--GDF  235 (467)
T ss_pred             ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc---------eEEEeccCCCCCccc--ccc
Confidence            668899999999999999989999999999999999999999998755432         222223333332221  134


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          819 LISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+.+||..|++++|+.||||.++++|
T Consensus       236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  236 SPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            4458899999999999999999999986

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-38  Score=323.18  Aligned_cols=251  Identities=22%  Similarity=0.320  Sum_probs=192.9

Q ss_pred             HhcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCC-e
Q 042123          586 ATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHAR-H  651 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~-~  651 (849)
                      ..++|...++||.|.||+||+| ...+|+.||||++++....  .. +..-++||.            .+.+++.+.+ +
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s--~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS--WE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc--HH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            4468889999999999999999 5567999999998764322  11 222334433            4666666666 9


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++|||||+. +|++.++..  .+.+++.+++.|+.||.+||+|+|.+   |+.|||+||+|||+.....+||+|||+||
T Consensus        85 L~fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence            9999999987 999999765  46799999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCCCeeeccCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----------c---ccccc
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----------S---SLNTD  797 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----------~---~~~~~  797 (849)
                      .+... ..++.++.|.+|+|||++. .+-|+.+.||||+|||++|+.+-++-|......+.          +   .....
T Consensus       159 ev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg  237 (538)
T KOG0661|consen  159 EVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG  237 (538)
T ss_pred             ccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence            88754 4578899999999999875 56789999999999999999999888875443221          0   00110


Q ss_pred             cccccccCCCCCCCChh-----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 VALDQMLDPRLPAPSRS-----AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 ~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+...+.-+++.....     -.....+..+++.+|+++||++|||+.|.+++
T Consensus       238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            11222222222211111     11234568899999999999999999999875

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-36  Score=289.32  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=191.6

Q ss_pred             cCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCc----hhhHHHHHHH-----HHHhhceeecCCeeEEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQ----TVDQKEFLTE-----VEAFYGFCSHARHSFLLYE  657 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e-----i~~~~~~~~~~~~~~lV~e  657 (849)
                      .+|...+++|+|.||.||+| +.++|+.||||+++.....+.    ...+...++|     |..+.+++.+.+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            46777889999999999999 567899999999875422111    1122233333     3357888999999999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      ||+. +|+..++...  ..++..++..++.++.+|++|||++   .|+||||||.|+|++++|.+|++|||+|+.+....
T Consensus        82 fm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9987 9999997554  4689999999999999999999999   89999999999999999999999999999998877


Q ss_pred             CCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc----------cccccccccccccC-
Q 042123          738 SNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----------SSLNTDVALDQMLD-  805 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----------~~~~~~~~~~~~~~-  805 (849)
                      ......+.|.+|+|||.+.+ +.|+...||||.||++.||+.|.+-|...++++.          +.......+..+-| 
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            77677789999999998876 5689999999999999999998877664433211          11111111111111 


Q ss_pred             --C-CCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          806 --P-RLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       806 --~-~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        - ..+.+.  ..-........+++..+|..+|.+|.|+.|.+++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence              0 011111  0111223346899999999999999999999875

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.3e-40  Score=331.23  Aligned_cols=429  Identities=29%  Similarity=0.412  Sum_probs=362.1

Q ss_pred             cCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcC
Q 042123           51 SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDN  130 (849)
Q Consensus        51 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~  130 (849)
                      .+-..|+.|.|++|.+..       ....+.+|..|++|++.+|.++ ..|.+++.+..++.|+.++|+++ .+|.++..
T Consensus        42 W~qv~l~~lils~N~l~~-------l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s  112 (565)
T KOG0472|consen   42 WEQVDLQKLILSHNDLEV-------LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGS  112 (565)
T ss_pred             hhhcchhhhhhccCchhh-------ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhh
Confidence            345679999999999862       2233567899999999999999 67889999999999999999999 78889999


Q ss_pred             CCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEe
Q 042123          131 LSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLD  210 (849)
Q Consensus       131 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  210 (849)
                      +.+|+.|+++.|.+. ..++.++.+-.|+.|+..+|++.+ .|+++..+.+|..|++.+|+++...|+.+. ++.|++||
T Consensus       113 ~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~s-lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld  189 (565)
T KOG0472|consen  113 LISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISS-LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLD  189 (565)
T ss_pred             hhhhhhhhcccccee-ecCchHHHHhhhhhhhcccccccc-CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcc
Confidence            999999999999998 678889999999999999999998 567788999999999999999965555555 99999999


Q ss_pred             ccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccc
Q 042123          211 LNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGT  290 (849)
Q Consensus       211 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~  290 (849)
                      ..+|-++ .+|+.+++|.+|..|+|.+|++. .+|+.-+...|++++++.|+|.-.......+++++.+||+.+|+++ .
T Consensus       190 ~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e  266 (565)
T KOG0472|consen  190 CNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-E  266 (565)
T ss_pred             cchhhhh-cCChhhcchhhhHHHHhhhcccc-cCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-c
Confidence            9999998 78889999999999999999998 8887667777999999999999554444458999999999999999 7


Q ss_pred             cCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCc--------------------------------
Q 042123          291 IPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGE--------------------------------  338 (849)
Q Consensus       291 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--------------------------------  338 (849)
                      .|..+.-+.+|++|++++|.|++ .|..++++ +|++|-+-+|.+...                                
T Consensus       267 ~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~  344 (565)
T KOG0472|consen  267 VPDEICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGT  344 (565)
T ss_pred             CchHHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccc
Confidence            89999999999999999999995 56678999 999999999998521                                


Q ss_pred             ------ccccCC---CCCC--------------------------CcEEeccCCccccCCCCCcccccccc-cccccccc
Q 042123          339 ------ISSNWG---KFPK--------------------------LGTLNVSMNNITGGLPREIGNSSQLQ-AFDLSLNH  382 (849)
Q Consensus       339 ------~~~~~~---~l~~--------------------------L~~L~Ls~N~i~~~~p~~~~~l~~L~-~L~L~~N~  382 (849)
                            .+..|.   ...+                          ....+++.|++. .+|..+..+..+. .+++++|.
T Consensus       345 e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~  423 (565)
T KOG0472|consen  345 ETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNK  423 (565)
T ss_pred             cccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCc
Confidence                  000110   1112                          344566666666 5666666665544 45666666


Q ss_pred             ccccCchhhcCCCCCcEEEccCccccccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCCccc
Q 042123          383 IVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCF  460 (849)
Q Consensus       383 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~  460 (849)
                      ++ .+|..++.+++|..|+|++|.+. .+|.+++.+..|+.||++.  ++.+|..+..+..|+.+-.++|++....|+.+
T Consensus       424 is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l  501 (565)
T KOG0472|consen  424 IS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGL  501 (565)
T ss_pred             cc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHh
Confidence            65 78889999999999999999998 8999999999999999985  78899999999999999999999998888889


Q ss_pred             cccCCCcEEeccCCccccCCCCCcccccCcccccccCCC
Q 042123          461 EGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKG  499 (849)
Q Consensus       461 ~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~  499 (849)
                      .+|.+|.+|||.+|.++..+|.-+.........+.|||.
T Consensus       502 ~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf  540 (565)
T KOG0472|consen  502 KNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF  540 (565)
T ss_pred             hhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence            999999999999999998887766555555566777765

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=347.97  Aligned_cols=243  Identities=28%  Similarity=0.491  Sum_probs=193.3

Q ss_pred             cCCCcCceecCCccceEEEEEec--CCc----EEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP--SGE----VVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~  650 (849)
                      ..-+..+.||+|+||.||+|+..  .|.    .||||.+.+.   .......+|++|           |.+++|.|....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            34455678999999999999654  343    4899988764   244556778877           345889998899


Q ss_pred             eeEEEEEeccCCChhhhhccccc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          651 HSFLLYEFLERGSLAAILNTDAA----AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                      ..+|++|||++|+|..|+...+.    ...++....+.++.|||+|+.||+++   ++|||||.++|+|+++...+||+|
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD  845 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD  845 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence            99999999999999999976532    24588999999999999999999999   899999999999999999999999


Q ss_pred             ecCCcccCCCCCCeeec--cCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccc-c
Q 042123          727 FGIAKSLKPDSSNWTEF--AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALD-Q  802 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~--~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~-~  802 (849)
                      ||+|+.+...+......  .-...|||||.+..+.|+.|+|||||||++||++| |..||...+.        .+.+. -
T Consensus       846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--------~~v~~~~  917 (1025)
T KOG1095|consen  846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--------FEVLLDV  917 (1025)
T ss_pred             cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--------HHHHHHH
Confidence            99999655433322221  23468999999999999999999999999999998 9999874332        22223 3


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+++..+...+.    .+.++|..||+.+|++||++.+|++++.
T Consensus       918 ~~ggRL~~P~~CP~----~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  918 LEGGRLDPPSYCPE----KLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             HhCCccCCCCCCCh----HHHHHHHHHccCChhhCccHHHHHhhhh
Confidence            34455655544443    3778999999999999999999998763

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.6e-37  Score=317.69  Aligned_cols=238  Identities=24%  Similarity=0.359  Sum_probs=195.1

Q ss_pred             cCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV  655 (849)
                      ++|.+.+.||+|+||+||||+ ..+.+.||+|.+.+..+.+  .+-+...+|           |..++++|+...+.|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~--k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE--KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch--HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            567788899999999999994 4578999999987754322  222333333           44588899999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      .||+.| +|..++..+.   .++++++..++.|++.||.|||+.   +|.|||+||.||+++..|.+|++|||+|+.+..
T Consensus        80 te~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             ehhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            999988 9999997654   499999999999999999999999   999999999999999999999999999999887


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .....+...|||-|||||...++.|+..+|.||+||++||+++|++||-...        .......+.......+    
T Consensus       153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--------i~~Lv~~I~~d~v~~p----  220 (808)
T KOG0597|consen  153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--------ITQLVKSILKDPVKPP----  220 (808)
T ss_pred             CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--------HHHHHHHHhcCCCCCc----
Confidence            7767788899999999999999999999999999999999999999985221        1112222222222222    


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+..++...+.+||.+|.|..+++.|
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            2444558889999999999999999998765

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.4e-36  Score=317.15  Aligned_cols=244  Identities=24%  Similarity=0.349  Sum_probs=186.6

Q ss_pred             HhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCc-----hhhHHHHHHH-----HHHhhceeecCCeeEE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQ-----TVDQKEFLTE-----VEAFYGFCSHARHSFL  654 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-----~~~~~~~~~e-----i~~~~~~~~~~~~~~l  654 (849)
                      ..++|+....||+|+||+||.|+ ..+|..+|+|++++......     ...++.++.|     +++++-.+++....|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            45789999999999999999995 45799999999876422111     1112333333     2346777788999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||++||++..+|.+.+   .|++..+..++.+++.|++.+|+.   |++||||||+|+|||..|++||+|||++..+.
T Consensus       219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999997654   599999999999999999999999   99999999999999999999999999985332


Q ss_pred             C----------------------CCCC-------------------------eeeccCCccccccccccCCCCCccchHH
Q 042123          735 P----------------------DSSN-------------------------WTEFAGTCGYIAPELAYTMKITEKCDVY  767 (849)
Q Consensus       735 ~----------------------~~~~-------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~  767 (849)
                      .                      ++..                         ....+|||.|+|||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                      0000                         0124699999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCccccccccccccccccccccCCC--CCCCChhhHHHHHHHHHHHhhccCCCCCCCC---CHHH
Q 042123          768 SFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR--LPAPSRSAQEKLISIMEVAFSCFNESPESRP---TMKI  842 (849)
Q Consensus       768 SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~e  842 (849)
                      |+|||+|||+.|.+||...+.        .+....++..+  +..|.+.  ....+..++|.+|+. ||+.|.   .++|
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp--------~~T~rkI~nwr~~l~fP~~~--~~s~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETP--------QETYRKIVNWRETLKFPEEV--DLSDEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhhhccCCCcC--cccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            999999999999999974432        22333333333  2211111  112457789999999 999995   5777


Q ss_pred             HHhh
Q 042123          843 ISQQ  846 (849)
Q Consensus       843 il~~  846 (849)
                      |.+|
T Consensus       442 IK~H  445 (550)
T KOG0605|consen  442 IKKH  445 (550)
T ss_pred             HhcC
Confidence            7664

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=304.60  Aligned_cols=245  Identities=27%  Similarity=0.415  Sum_probs=190.2

Q ss_pred             hcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~l  654 (849)
                      .++|+..++||.|..++||+| ..+.++.||||++.-.....   ....+.+|+..           ++..+..+...|+
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~---~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN---DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh---hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            368999999999999999999 55678999999986542211   13455556543           4455567789999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||.||.+||+.+++...-. ..+.+..+..|.+++++||.|||++   |.+|||+|+.|||++.+|.|||+|||.+..+.
T Consensus       102 VmpfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eehhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            9999999999999976543 3489999999999999999999999   99999999999999999999999999887665


Q ss_pred             CCCCCe----eeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          735 PDSSNW----TEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       735 ~~~~~~----~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ..+...    ..++||+.|||||+++.  ..|+.|+||||||++..|+.+|+.||....+.        +.+..-+....
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------kvLl~tLqn~p  249 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------KVLLLTLQNDP  249 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------HHHHHHhcCCC
Confidence            544332    45689999999999653  57999999999999999999999999854432        22222222222


Q ss_pred             CC------CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PA------PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +.      +.+........+.+++..|+++||.+|||+++++++
T Consensus       250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            20      111111222358899999999999999999999875

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=300.65  Aligned_cols=257  Identities=27%  Similarity=0.399  Sum_probs=192.4

Q ss_pred             HHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH----HhhceeecC-------Cee
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----AFYGFCSHA-------RHS  652 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~----~~~~~~~~~-------~~~  652 (849)
                      .....+....+.||+|.||+||+|+|. |+.||||+|..... .++..+.++.+-+-    .++||.-.+       ...
T Consensus       207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch-hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            344567788899999999999999996 99999999976422 22333333332211    244444221       267


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-----FPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                      |+|.+|.+.|||+|||.+.    .++.+..++++..+|.||+|||..-     .|.|+|||||++|||+.+++...|+|+
T Consensus       285 wLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL  360 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  360 (513)
T ss_pred             EEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence            9999999999999999763    4899999999999999999999743     478999999999999999999999999


Q ss_pred             cCCcccCCCC----CCeeeccCCccccccccccCC----CC--CccchHHHHHHHHHHHHhC----------CCCCCccc
Q 042123          728 GIAKSLKPDS----SNWTEFAGTCGYIAPELAYTM----KI--TEKCDVYSFGVLMWEVIKG----------KHPRDFLS  787 (849)
Q Consensus       728 G~a~~~~~~~----~~~~~~~g~~~y~aPE~~~~~----~~--~~~~Dv~SlGvil~el~tg----------~~Pf~~~~  787 (849)
                      |+|.....+.    ......+||.+|||||++...    .+  -..+||||||.|+||+..+          +.||...-
T Consensus       361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V  440 (513)
T KOG2052|consen  361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV  440 (513)
T ss_pred             eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence            9998876552    234567899999999988542    22  1359999999999999864          35654332


Q ss_pred             -cccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          788 -SISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       788 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                       ..+..+...+....+.+.|.++.+... .+.+..+.++|+.||..+|+.|-|+-.|.+.|
T Consensus       441 p~DPs~eeMrkVVCv~~~RP~ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  441 PSDPSFEEMRKVVCVQKLRPNIPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             CCCCCHHHHhcceeecccCCCCCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence             222223333444455556666655543 35677899999999999999999998887765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=317.11  Aligned_cols=245  Identities=26%  Similarity=0.395  Sum_probs=180.6

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCC--chhhHHHHHHH-----HHHhhceeecCC--eeEEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD--QTVDQKEFLTE-----VEAFYGFCSHAR--HSFLLYE  657 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~~e-----i~~~~~~~~~~~--~~~lV~e  657 (849)
                      .+|...+.||+|+||+||.+... +|+..|||.........  ....+..++.+     |++++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45777889999999999999654 58999999876531111  01111222222     334556533333  6899999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeecCCcccCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-EYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~~  736 (849)
                      |+++|+|.+++.+...  .+++..+..+.+||++||+|||++   +|+||||||+|||++. ++.+||+|||+++.....
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999987653  599999999999999999999999   9999999999999999 799999999999876631


Q ss_pred             ---CCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcc-ccccccccccccccccccCCCCCCC
Q 042123          737 ---SSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFL-SSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       737 ---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                         ........||+.|||||++..+ ...+++||||+||++.||+||+.||... ...       ............|. 
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~-------~~~~~ig~~~~~P~-  243 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA-------EALLLIGREDSLPE-  243 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH-------HHHHHHhccCCCCC-
Confidence               1223457899999999999853 3345899999999999999999998753 110       01111111111111 


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                        .+........+|+..|++.+|+.||||+++++|-
T Consensus       244 --ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  244 --IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             --CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence              1112333477889999999999999999999874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-36  Score=319.73  Aligned_cols=244  Identities=20%  Similarity=0.303  Sum_probs=190.7

Q ss_pred             HhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCch-hhHHHHHHHH------------HHhhceeecCCe
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQT-VDQKEFLTEV------------EAFYGFCSHARH  651 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~~~~~~ei------------~~~~~~~~~~~~  651 (849)
                      ..+.|...+.||+|+||.||.|. ..+++.||||.+......... .......+|+            .+++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            34688999999999999999994 457899999976553111011 1111222333            345667777788


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCC
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIA  730 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a  730 (849)
                      .++||||+.+|+|.+++...   ..+.+.++.++++|++.|++|||+.   +|+||||||+||+++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            99999999999999999762   4588999999999999999999999   99999999999999999 99999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCC-CC-ccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMK-IT-EKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ......+....+.+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||+....        ......+.....
T Consensus       169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~--------~~l~~ki~~~~~  240 (370)
T KOG0583|consen  169 AISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV--------PNLYRKIRKGEF  240 (370)
T ss_pred             cccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH--------HHHHHHHhcCCc
Confidence            98753445667889999999999999987 85 679999999999999999999985221        112222333333


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+....   ...+..++.+|+..+|.+|+|+.+|+++
T Consensus       241 ~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  241 KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            3332221   3347888999999999999999999864

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=305.06  Aligned_cols=253  Identities=25%  Similarity=0.466  Sum_probs=182.6

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHH-------HHHHhhceeecCC----eeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLT-------EVEAFYGFCSHAR----HSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-------ei~~~~~~~~~~~----~~~lV~  656 (849)
                      ...+..+.+|+|.||.||||++. ++.||||+|.... ......++++..       +|.+++++-....    .+++|+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~-kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE-KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHHH-HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            34555678999999999999995 6999999987532 222333333332       3555666554444    789999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCC------CCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF------PPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~------~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ||.+.|+|.++|..    ..++|.+..+|+..+++||+|||+...      |+|+|||||++|||+.+|++..|+|||+|
T Consensus       288 ~fh~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeccCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            99999999999965    358999999999999999999998653      78999999999999999999999999999


Q ss_pred             cccCCCCC--CeeeccCCccccccccccCCC-C-----CccchHHHHHHHHHHHHhCCCCCCc--cccc-----------
Q 042123          731 KSLKPDSS--NWTEFAGTCGYIAPELAYTMK-I-----TEKCDVYSFGVLMWEVIKGKHPRDF--LSSI-----------  789 (849)
Q Consensus       731 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~-----~~~~Dv~SlGvil~el~tg~~Pf~~--~~~~-----------  789 (849)
                      ..+.....  .....+||.+|||||++.+.- +     -.+.||||+|.|+|||+++..-++.  ....           
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            98765432  233478999999999987532 2     2368999999999999997655431  1100           


Q ss_pred             cccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          790 SSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      +..+...+..+.+..+|.++...... ..+..+.+.+..||+.||+.|.|+.=+-+++
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~  500 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM  500 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence            00111111222222334443332222 3355678889999999999999987665543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-36  Score=291.11  Aligned_cols=229  Identities=24%  Similarity=0.362  Sum_probs=186.8

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCC-----chhhHHHHHHHHH-----HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD-----QTVDQKEFLTEVE-----AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~~~~ei~-----~~~~~~~~~~~~~lV~  656 (849)
                      .+|+..+.||.|+||+|..++.+ +|..+|+|.+.+.....     ...+++..++.+.     ++.+.+.+....|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            57888999999999999999654 68899999986531111     1112223333322     3667788899999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||++||-|.+++++.+   ++++..++-+|.||+.|++|||+.   +|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus       124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999997643   599999999999999999999999   9999999999999999999999999999987532


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                         .-+.+|||.|+|||++..+.|..++|.|||||++|||+.|..||....        .....+.++.+.+..|.....
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--------~~~iY~KI~~~~v~fP~~fs~  266 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--------PIQIYEKILEGKVKFPSYFSS  266 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--------hHHHHHHHHhCcccCCcccCH
Confidence               456799999999999999999999999999999999999999997332        234556666666665554444


Q ss_pred             HHHHHHHHHHhhccCCCCCCC
Q 042123          817 EKLISIMEVAFSCFNESPESR  837 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~R  837 (849)
                      +    +.+++...++.|-.+|
T Consensus       267 ~----~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  267 D----AKDLLKKLLQVDLTKR  283 (355)
T ss_pred             H----HHHHHHHHHhhhhHhh
Confidence            3    7788889999998888

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=298.41  Aligned_cols=238  Identities=27%  Similarity=0.411  Sum_probs=197.1

Q ss_pred             CCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV~  656 (849)
                      -|++..+||+|+||.||+| ...+|..+|||++....      +-+++.+|           |+++||.|......|+||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s------DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT------DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc------hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            3566778999999999999 44579999999976432      23344444           446888888889999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      |||..|+..+.+.-.+  ..+++.++..+++.-++||+|||..   .-+|||||+-|||++.+|.+|++|||.|..+...
T Consensus       108 EYCGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hhcCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            9999999999986544  4699999999999999999999998   7799999999999999999999999999877654


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      .....+..|||.|||||++..-.|..++||||+|+...||..|++||......         +.--++....++....+.
T Consensus       183 MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM---------RAIFMIPT~PPPTF~KPE  253 (502)
T KOG0574|consen  183 MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM---------RAIFMIPTKPPPTFKKPE  253 (502)
T ss_pred             HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc---------ceeEeccCCCCCCCCChH
Confidence            44566788999999999999999999999999999999999999998744322         111223334444455566


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....++.++++.|+-+.|++|-|+-++++|
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            677789999999999999999999999876

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.9e-35  Score=321.97  Aligned_cols=247  Identities=23%  Similarity=0.412  Sum_probs=182.8

Q ss_pred             HhcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS  647 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~  647 (849)
                      ..++|++.+.||+|+||.||+|.+      .+++.||||++.....   ......+.+|+.            .+++++.
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT---ASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc---hHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            346889999999999999999953      2357899999864321   122334555543            2455554


Q ss_pred             c-CCeeEEEEEeccCCChhhhhccccc-----------------------------------------------------
Q 042123          648 H-ARHSFLLYEFLERGSLAAILNTDAA-----------------------------------------------------  673 (849)
Q Consensus       648 ~-~~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------------  673 (849)
                      . ....++||||+++|+|.+++.....                                                     
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            4 3467899999999999999864321                                                     


Q ss_pred             ------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC--CeeeccC
Q 042123          674 ------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS--NWTEFAG  745 (849)
Q Consensus       674 ------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g  745 (849)
                            ...+++.++.+++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......  ......+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                  13478899999999999999999998   999999999999999999999999999986543322  1123345


Q ss_pred             CccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHH
Q 042123          746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIME  824 (849)
Q Consensus       746 ~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  824 (849)
                      +..|+|||++.+..++.++|||||||++|||++ |..||......       ......+.++.....+   ......+.+
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~---~~~~~~l~~  308 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGTRMRAP---ENATPEIYR  308 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCCCCCCC---CCCCHHHHH
Confidence            678999999999899999999999999999997 99998743211       0111111111111111   112234788


Q ss_pred             HHhhccCCCCCCCCCHHHHHhhhc
Q 042123          825 VAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       825 li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ++.+||+.||++|||+.|+++.|+
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~  332 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILG  332 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHH
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-36  Score=316.66  Aligned_cols=241  Identities=24%  Similarity=0.353  Sum_probs=197.3

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~l  654 (849)
                      .+.|..++.||.|+.|.|-.|++ .+|+.+|||.+.+...... .....+-+|           |.+++++++...+.|+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~-s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSS-SQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeecccccccc-ccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence            36788899999999999999955 6899999999976532111 112222333           3358899999999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |.||+++|-|.+++-+.+   ++++.++.++++||+.|+.|+|..   +|+|||+||+|+|+|..+++||+|||+|..-.
T Consensus        90 vlEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            999999999999997644   589999999999999999999998   99999999999999999999999999998655


Q ss_pred             CCCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      + +.-..+.+|+|.|.|||++.+..| ..++||||.|||+|.|+||+.||++.        +....+.++..+.+..+..
T Consensus       164 ~-gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd--------Nir~LLlKV~~G~f~MPs~  234 (786)
T KOG0588|consen  164 P-GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD--------NIRVLLLKVQRGVFEMPSN  234 (786)
T ss_pred             C-CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc--------cHHHHHHHHHcCcccCCCc
Confidence            4 345677899999999999999999 57899999999999999999999832        2334444555555554443


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ...    +..+++.+|+..||+.|-|++||.+|-
T Consensus       235 Is~----eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  235 ISS----EAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             CCH----HHHHHHHHHhccCccccccHHHHhhCc
Confidence            333    478899999999999999999999874

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=317.02  Aligned_cols=234  Identities=23%  Similarity=0.367  Sum_probs=188.0

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSF  653 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~  653 (849)
                      .++|...++||+|+||.|+.|..+ +++.+|||.+++...-... +.+..+.|            +..++.+++..++.|
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d-~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRD-EVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccc-cHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            468999999999999999999654 6889999999875432221 12222222            113778888999999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      .||||+.||++..+.+.    ..+++..+.-++..|+.||.|||++   +|+|||||.+|||+|.+|.+||+|||+++..
T Consensus       446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            99999999995544432    3599999999999999999999999   9999999999999999999999999999976


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      -..+....+++|||.|||||++.+..|+.+.|.|||||++|||+.|+.||...        ..++..+.++.....    
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd--------dEee~FdsI~~d~~~----  586 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD--------DEEEVFDSIVNDEVR----  586 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHhcCCCC----
Confidence            65556678899999999999999999999999999999999999999999732        233444444433333    


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCH
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTM  840 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~  840 (849)
                      ++.....+.+.++.+.+.++|++|.-+
T Consensus       587 yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCcccHHHHHHHHHHhccCcccccCC
Confidence            223334457889999999999999754

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=308.54  Aligned_cols=248  Identities=23%  Similarity=0.368  Sum_probs=193.0

Q ss_pred             CCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYE  657 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~e  657 (849)
                      ...++++||+|.||+|..+....+..||||.++...   ....+.+|.+|++.           ++|+|..++..++|+|
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a---~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA---TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCccc---chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            345678999999999999988878999999987652   33446788888774           7889999999999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      ||++|+|..|+....... ..-....+|+.|||.||+||.+.   ++||||+.++|+|++.++++||+|||+++.+...+
T Consensus       616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999997654221 34456678999999999999998   99999999999999999999999999999766554


Q ss_pred             CC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh--CCCCCCccccccccccccccccccccCCCC-CCCC
Q 042123          738 SN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK--GKHPRDFLSSISSSSLNTDVALDQMLDPRL-PAPS  812 (849)
Q Consensus       738 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  812 (849)
                      ..  ....+-...|||||.+.-++++.++|||+||+++||+++  ...||..+...+..     +....+++..- ....
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv-----en~~~~~~~~~~~~~l  766 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV-----ENAGEFFRDQGRQVVL  766 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH-----HhhhhhcCCCCcceec
Confidence            43  233556789999999999999999999999999999875  88998765533211     11111221110 0000


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.-...++.+++.+||..|-++||+++++...|.
T Consensus       767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence            011122334789999999999999999999988763

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-35  Score=303.68  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=185.2

Q ss_pred             cCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC--CeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~--~~~~  653 (849)
                      +.|+..++||+|.||.||+| +..+|+.||+|++.-......  ......+||.           .+.+...+.  +..|
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~--~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG--FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc--chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            45677789999999999999 567899999999865432211  1222334433           456655554  6899


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|+|||+. +|.-++....  -.|++.++..+++|++.||+|||++   +|+|||||.+|||||.+|.+||+|||+|+.+
T Consensus       195 lVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence            99999998 8888876533  4699999999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCC-CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc----------ccccccc--c
Q 042123          734 KPDSS-NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----------SSLNTDV--A  799 (849)
Q Consensus       734 ~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----------~~~~~~~--~  799 (849)
                      ..... .++..+.|.+|+|||.+.+ ..|+.+.|+||.|||+.||+.|++.|.....+.-          +....+.  .
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            76543 4788899999999999886 5799999999999999999999999875332211          0011111  0


Q ss_pred             c--ccccCCCCCCCChhhHH----HHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 L--DQMLDPRLPAPSRSAQE----KLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~--~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +  ...+.+..+-. ....+    .....++++..++..||.+|.|+.+.++.
T Consensus       349 LP~~~~~kp~~~y~-r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  349 LPHATIFKPQQPYK-RRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CCcccccCCCCccc-chHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            0  00111111100 00011    12246788889999999999999998753

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=4.2e-35  Score=310.87  Aligned_cols=244  Identities=19%  Similarity=0.254  Sum_probs=183.1

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      .|+..+.||+|+||.||+|.. .+|+.||||.+....... ......+.+|+.           .+.+++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhh-hhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEE
Confidence            367788999999999999954 579999999886432111 111233444543           2455667778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        80 e~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          80 TIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             EecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            9999999998875432 23589999999999999999999998   9999999999999999999999999999875432


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      . ......|+..|+|||++.+..++.++||||+||++|||++|+.||.......    ................    ..
T Consensus       156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~----~~  226 (285)
T cd05631         156 E-TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREEVDRRVKEDQEEY----SE  226 (285)
T ss_pred             C-eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHHHHHHhhcccccC----Cc
Confidence            2 2344578999999999999999999999999999999999999997432110    0001111111111111    11


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                      .....+.+++.+||+.||++||+     +++++++
T Consensus       227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            12334788999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=4.8e-35  Score=315.98  Aligned_cols=234  Identities=22%  Similarity=0.293  Sum_probs=180.5

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccC
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      +.||+|+||.||+|+. .+|+.||||++...... .......+.+|+.           .+++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVII-AKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999955 57899999998653211 1112223344433           255677788899999999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCee
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT  741 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  741 (849)
                      |+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          80 GELFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            9999998653   3589999999999999999999999   999999999999999999999999999986543333345


Q ss_pred             eccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHH
Q 042123          742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLIS  821 (849)
Q Consensus       742 ~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (849)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+..    ....
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~~~~p~~----~~~~  221 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEEIRFPRT----LSPE  221 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----CCHH
Confidence            56799999999999999999999999999999999999999964221        11111122222221111    2234


Q ss_pred             HHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          822 IMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       822 l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      +.+++.+||+.||++||     ++.++++|
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            77899999999999999     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-35  Score=276.52  Aligned_cols=242  Identities=25%  Similarity=0.363  Sum_probs=195.5

Q ss_pred             hcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|.||.||.|+ .+++..||+|++.+... ........+.+|           |.++++++.+....|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-HHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4689999999999999999995 45788999999865321 111122333344           4469999999999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ++||..+|.+...++... ...+++.....++.|+|.|+.|+|..   +|+||||||+|+|++..+..|++|||-+..-.
T Consensus       100 ilEya~~gel~k~L~~~~-~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGR-MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHhcc-cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            999999999999997544 34589999999999999999999998   99999999999999999999999999987554


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                        .....+.+||..|.|||+..+..++...|+|++|++.||++.|..||....        ..+...++..-++..+...
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--------~~etYkrI~k~~~~~p~~i  245 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--------HSETYKRIRKVDLKFPSTI  245 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--------hHHHHHHHHHccccCCccc
Confidence              344567899999999999999999999999999999999999999997432        2233333333333333222


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                          .....++|.+|+.++|.+|.+..|+++|=
T Consensus       246 ----s~~a~dlI~~ll~~~p~~r~~l~~v~~hp  274 (281)
T KOG0580|consen  246 ----SGGAADLISRLLVKNPIERLALTEVMDHP  274 (281)
T ss_pred             ----ChhHHHHHHHHhccCccccccHHHHhhhH
Confidence                23477899999999999999999999874

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.5e-35  Score=314.79  Aligned_cols=239  Identities=22%  Similarity=0.342  Sum_probs=182.0

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~lV  655 (849)
                      +|+..+.||+|+||.||+|+.. +++.||||.+....... ......+..|+.            .+++++...+..|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ-DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            5788899999999999999654 67899999986532111 111223333322            245666777889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          80 MEYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            9999999999988643   3488999999999999999999998   999999999999999999999999999875433


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+..  
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~~~~--  223 (324)
T cd05587         154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPKS--  223 (324)
T ss_pred             CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCCC--
Confidence            33334556799999999999999999999999999999999999999974321        11112222222221111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCH-----HHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTM-----KIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~~  846 (849)
                        ....+.+++.+||++||.+|++.     +++.++
T Consensus       224 --~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         224 --LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence              12347789999999999999986     666654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=8.9e-38  Score=327.54  Aligned_cols=321  Identities=26%  Similarity=0.354  Sum_probs=182.2

Q ss_pred             CCCCCEEeCcCCccc-cCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCC
Q 042123           29 FPHLAYLDLTWNGFF-GTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNL  107 (849)
Q Consensus        29 l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  107 (849)
                      +|-++-.|+++|.+. +..|.....++++++|.|...++. .+|.      .++.|.+|++|.+++|++. .+.+.+..+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPe------EL~~lqkLEHLs~~HN~L~-~vhGELs~L   77 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPE------ELSRLQKLEHLSMAHNQLI-SVHGELSDL   77 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChH------HHHHHhhhhhhhhhhhhhH-hhhhhhccc
Confidence            344566777777776 566777777777777777777764 1222      2345666666666666666 345556666


Q ss_pred             CCCCEEEccCCcccC-CCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEE
Q 042123          108 KFLSQLDLTNNKFSG-PIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLR  186 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  186 (849)
                      +.|+.+++.+|+++. -+|..+-.+..|+.|+||+|+++ ..|..+...+++-.|+||+|+|.+|+...|.+|+.|-.||
T Consensus        78 p~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLD  156 (1255)
T KOG0444|consen   78 PRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLD  156 (1255)
T ss_pred             hhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhc
Confidence            777777777776652 23445556667777777777776 5566666666777777777777776666666777777777


Q ss_pred             ccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCC
Q 042123          187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGY  266 (849)
Q Consensus       187 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~  266 (849)
                      ||+|++. .+|..+..|..|++|+|++|.+...--..+-.|++|+.|.+++.+-+                         
T Consensus       157 LS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRT-------------------------  210 (1255)
T KOG0444|consen  157 LSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRT-------------------------  210 (1255)
T ss_pred             cccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccch-------------------------
Confidence            7777765 55555666777777777777665322222333344444444443322                         


Q ss_pred             CCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCC
Q 042123          267 LPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKF  346 (849)
Q Consensus       267 ~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  346 (849)
                                           ...+|.++..+.+|..++++.|+++ ..|+.+-.+++|+.|+||+|+|+ .+....+.+
T Consensus       211 ---------------------l~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W  267 (1255)
T KOG0444|consen  211 ---------------------LDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEW  267 (1255)
T ss_pred             ---------------------hhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHH
Confidence                                 0123344444444444444444444 34444444444444444444444 233333344


Q ss_pred             CCCcEEeccCCccccCCCCCccccccccccccccccccc-cCchhhcCCCCCcEEEccCcccc
Q 042123          347 PKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVG-EIPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       347 ~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                      .+|++|+||.|+++ .+|+.++.|+.|+.|.+.+|+++- -+|..+++|.+|+.+..++|.+.
T Consensus       268 ~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE  329 (1255)
T KOG0444|consen  268 ENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE  329 (1255)
T ss_pred             hhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc
Confidence            45555555555555 455555555555555555555431 24555555555555555555544

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=317.98  Aligned_cols=245  Identities=28%  Similarity=0.446  Sum_probs=189.1

Q ss_pred             HhcCCCcCceecCCccceEEEEEecC--C---cEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPS--G---EVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      ..++....++||+|+||+||+|++..  +   ..||||..+.. .........++++|..           +++|++...
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~-~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS-SELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLE  233 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc-ccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCC
Confidence            33455556899999999999996542  2   23899987752 1123445667777743           589999999


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++|||+|+||+|.+++.+...  .++..++.+++.+.|+||+|||++   +++||||.++|+|++.++.+||+|||+
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence            999999999999999999986553  589999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--C
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD--P  806 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~  806 (849)
                      ++.............-...|+|||.+..+.|++++|||||||++||+++ |..||......        .....++.  .
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~~~~~  380 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIVKNGY  380 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHHhcCc
Confidence            8765311111112235679999999999999999999999999999998 88898754422        22222212  2


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+.+.    ..+..+..++.+||..+|++||||.++.+.++
T Consensus       381 r~~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  381 RMPIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             cCCCCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence            222222    22234667778999999999999999998875

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.9e-35  Score=314.91  Aligned_cols=239  Identities=22%  Similarity=0.342  Sum_probs=182.6

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~~~~~~lV  655 (849)
                      +|+..+.||+|+||.||+|... +++.||||.+....... ......+..|.            ..+.+++...+..++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ-DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            5788899999999999999654 67899999987532111 11112222222            1255677778889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          80 MEYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            9999999999988643   3489999999999999999999998   999999999999999999999999999986543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.......+..  
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~p~~--  223 (323)
T cd05616         154 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPKS--  223 (323)
T ss_pred             CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCc--
Confidence            33334456789999999999999999999999999999999999999974321        11222222222222221  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCH-----HHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTM-----KIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~~  846 (849)
                        ....+.+++.+|++++|++|+++     .++.++
T Consensus       224 --~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         224 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             --CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence              22347789999999999999985     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=307.74  Aligned_cols=237  Identities=22%  Similarity=0.288  Sum_probs=184.4

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +++.||+|++...... .......+.+|           +..+++++.+....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVI-RLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHh-hhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            36888999999999999999654 6899999998642111 11112223333           33467777888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          80 MEYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            9999999999998653   3589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .   .....|++.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.......+... 
T Consensus       154 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~-  221 (291)
T cd05612         154 R---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGKLEFPRHL-  221 (291)
T ss_pred             C---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCcCCCccC-
Confidence            2   2335789999999999988899999999999999999999999974321        111222222222211111 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                         ...+.+++.+||+.||.+||+     ++++++|
T Consensus       222 ---~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         222 ---DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               234778999999999999995     8998876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-35  Score=293.13  Aligned_cols=240  Identities=22%  Similarity=0.349  Sum_probs=197.5

Q ss_pred             cCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .+|++.+.||+|.||.|-+| .+..|+.||||.+++.... ..++...+.+||+           +++.++...+...+|
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIk-deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIK-DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcc-cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            56778889999999999999 5678999999998765332 3333445566665           367888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||..+|.|++++.+.+   .+++.+++.+++||..|+.|+|.+   +|+|||||.+|||+|.++++||+|||++..+..
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999997654   599999999999999999999999   999999999999999999999999999988764


Q ss_pred             CCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                       +...++++|++-|.+||++.+.+| .+..|.||+||++|-++.|..||+..+        ....+.++-.+....+...
T Consensus       206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk~lvrQIs~GaYrEP~~P  276 (668)
T KOG0611|consen  206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HKRLVRQISRGAYREPETP  276 (668)
T ss_pred             -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HHHHHHHhhcccccCCCCC
Confidence             455688999999999999999998 577999999999999999999998543        2233344444444443322


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      . +    ..-+|.+|+..+|++|.|+++|..|-.
T Consensus       277 S-d----A~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  277 S-D----ASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             c-h----HHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            2 1    446777999999999999999988754

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3.2e-37  Score=323.36  Aligned_cols=368  Identities=29%  Similarity=0.403  Sum_probs=286.4

Q ss_pred             cccCeEeccCCccc-ccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEE
Q 042123           84 RYMSRLVINDNSLS-GFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQ  162 (849)
Q Consensus        84 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  162 (849)
                      +-.+-.++++|.++ +..|.....+++++.|.|...++. .+|..++.+.+|++|.+++|++. .+-..+..++.|+.+.
T Consensus         7 pFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~   84 (1255)
T KOG0444|consen    7 PFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVI   84 (1255)
T ss_pred             ceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHh
Confidence            33344444444444 345566666667777777777766 46666777777777777777766 3445566677777777


Q ss_pred             cCCCccccc-CCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccccc
Q 042123          163 LNDNQLIGY-IPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       163 L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      +.+|++... .|..+..+..|+.||||+|+++ ..|..+...+++-.|+||+|+|..+.-..|.+++.|-.||||+|++.
T Consensus        85 ~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe  163 (1255)
T KOG0444|consen   85 VRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE  163 (1255)
T ss_pred             hhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh
Confidence            777766432 3455667888888888888887 77777888888888888888888655566778888888888888886


Q ss_pred             CCCCcchhhhh-hhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCcccc-Cchhhhh
Q 042123          242 GSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT-GNISEAL  319 (849)
Q Consensus       242 ~~~p~~~~~~~-L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~  319 (849)
                       .+|+.+..+. |++|.|++|.+..                        .--..+..|++|+.|++++.+=| ..+|.++
T Consensus       164 -~LPPQ~RRL~~LqtL~Ls~NPL~h------------------------fQLrQLPsmtsL~vLhms~TqRTl~N~Ptsl  218 (1255)
T KOG0444|consen  164 -MLPPQIRRLSMLQTLKLSNNPLNH------------------------FQLRQLPSMTSLSVLHMSNTQRTLDNIPTSL  218 (1255)
T ss_pred             -hcCHHHHHHhhhhhhhcCCChhhH------------------------HHHhcCccchhhhhhhcccccchhhcCCCch
Confidence             6666665543 6666666665441                        11123445788899999987644 4678889


Q ss_pred             CCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcE
Q 042123          320 GIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTK  399 (849)
Q Consensus       320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~  399 (849)
                      ..+.+|..+|||.|.+. ..|+.+..+++|+.|+||+|+|+ .+....+.-.+|+.|+||.|+++ .+|+++++|++|+.
T Consensus       219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k  295 (1255)
T KOG0444|consen  219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK  295 (1255)
T ss_pred             hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence            99999999999999998 88999999999999999999999 66666777789999999999998 89999999999999


Q ss_pred             EEccCcccc-ccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCcc
Q 042123          400 LILRGNQIT-GRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNEL  476 (849)
Q Consensus       400 L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  476 (849)
                      |++.+|+++ .-+|..++.|.+|+.+..++  +.-+|+.++.+..|++|.|++|++- .+|+.+.-++.|..||+..||=
T Consensus       296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             HHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence            999999987 45899999999999887664  7889999999999999999999998 8999999999999999999997


Q ss_pred             ccCCCCC
Q 042123          477 QCPVPNS  483 (849)
Q Consensus       477 ~~~~~~~  483 (849)
                      --.+|..
T Consensus       375 LVMPPKP  381 (1255)
T KOG0444|consen  375 LVMPPKP  381 (1255)
T ss_pred             ccCCCCc
Confidence            6655543

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-34  Score=312.50  Aligned_cols=234  Identities=24%  Similarity=0.369  Sum_probs=179.2

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|.. .+++.||||.+....... ......+..|            +..+++++...+..|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQ-DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            3699999999999965 468899999986432111 1111222222            3346777788889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++.+.   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          80 GGDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             CchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            99999988654   3489999999999999999999998   99999999999999999999999999987654333334


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+..    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~----~~~  221 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDEVVYPTW----LSQ  221 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCCCCCCCC----CCH
Confidence            4567899999999999889999999999999999999999999743211        1122222222222111    123


Q ss_pred             HHHHHHhhccCCCCCCCCCH------HHHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTM------KIISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~------~eil~~  846 (849)
                      .+.+++.+|++.||++||++      +++++|
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         222 DAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             HHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            47789999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.7e-34  Score=307.93  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=182.1

Q ss_pred             cCCCcCceecCCccceEEEEEecC-----------------CcEEEEEEecccCCCCchhhHHHHHHHHH----------
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPS-----------------GEVVAVKKFHSLLPCDQTVDQKEFLTEVE----------  640 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~ei~----------  640 (849)
                      ++|...+.||+|+||.||+|.+.+                 +..||+|.+....   .......+.+|+.          
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA---NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC---CHHHHHHHHHHHHHHhhcCCCCe
Confidence            578888999999999999996532                 3469999886532   1223445666654          


Q ss_pred             -HhhceeecCCeeEEEEEeccCCChhhhhcccc----------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 042123          641 -AFYGFCSHARHSFLLYEFLERGSLAAILNTDA----------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPP  703 (849)
Q Consensus       641 -~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~  703 (849)
                       .+++++...+..++||||+++|+|.+++....                ....+++.++.+++.||+.||+|||+.   +
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence             35677777788999999999999999885421                112478899999999999999999998   9


Q ss_pred             eEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh--C
Q 042123          704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK--G  779 (849)
Q Consensus       704 ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g  779 (849)
                      |+||||||+||+++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999999999999999999865433211  122345778999999988889999999999999999987  5


Q ss_pred             CCCCCccccccccccccccccccccCCC-CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          780 KHPRDFLSSISSSSLNTDVALDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       780 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..||............. .......... ...+.    .....+.+++.+||+.||++|||+++|.+.|+
T Consensus       239 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         239 EQPYGELTDEQVIENAG-EFFRDQGRQVYLFRPP----PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCcCCHHHHHHHHH-HHhhhccccccccCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            66776432211000000 0000000000 00011    11234789999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.6e-34  Score=310.80  Aligned_cols=234  Identities=26%  Similarity=0.386  Sum_probs=176.4

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|+. .+++.||||.++........ ....+..|            +.++++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDD-DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhh-hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            3699999999999965 46889999998753211111 11111111            2345667778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 gg~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          80 GGDLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            99999988643   3589999999999999999999998   99999999999999999999999999998654333344


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+..    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~----~~~  221 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILNDRPHFPRW----ISK  221 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCCC----CCH
Confidence            4567899999999999989999999999999999999999999743211        1111111111111111    123


Q ss_pred             HHHHHHhhccCCCCCCCCCHH-HHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTMK-IISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~-eil~~  846 (849)
                      .+.+++.+||+.+|++||++. +++++
T Consensus       222 ~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         222 EAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            467888999999999999875 55543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.4e-34  Score=312.68  Aligned_cols=237  Identities=24%  Similarity=0.354  Sum_probs=182.3

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH--------------HHHhhceeecCCeeEE
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE--------------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e--------------i~~~~~~~~~~~~~~l  654 (849)
                      |++.+.||+|+||.||+|.. .+++.||||.+....... ......+..|              +.++++++...+..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            56788999999999999955 468999999986432111 1111222222              3347788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|..++..    ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        80 v~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          80 VMEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EEcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            9999999999988854    3489999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........|++.|+|||.+.+..++.++|||||||++|||++|+.||.....        ......+.......+...
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~~~p~~~  224 (324)
T cd05589         153 GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVNDEVRYPRFL  224 (324)
T ss_pred             CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCCC
Confidence            333334556799999999999999999999999999999999999999974321        111122222222211111


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                          ...+.+++.+||+.||++||     ++.+++++
T Consensus       225 ----~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         225 ----SREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             ----CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                23477899999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=271.57  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=188.7

Q ss_pred             hcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhcee-----ecC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFC-----SHA  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~-----~~~  649 (849)
                      .++|++.+.+|+|||+-||.++ ..+++.||+|++.-.    .....+..++|+.           ++++++     +..
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            3689999999999999999994 678999999997543    2233445555554           233332     233


Q ss_pred             CeeEEEEEeccCCChhhhhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      ...|+++.|+..|+|.+.+..... +..+++.++++|+.+|++||++||+.. |+++||||||.||++++++.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence            468999999999999999976543 347899999999999999999999973 469999999999999999999999999


Q ss_pred             CCcccCCCCC---------CeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 042123          729 IAKSLKPDSS---------NWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNT  796 (849)
Q Consensus       729 ~a~~~~~~~~---------~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~  796 (849)
                      .+....-.-.         .+.....|..|+|||.+.   +...++++|||||||++|+|+.|..||+..-.      .+
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------~G  248 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------QG  248 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------cC
Confidence            9876532211         122345789999999875   45678999999999999999999999984321      22


Q ss_pred             ccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          797 DVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....-.+..+.+..+....  ....+.++++.|++.||.+||++.+++.++.
T Consensus       249 gSlaLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  249 GSLALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             CeEEEeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            2222233333333332222  4456889999999999999999999998763

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-34  Score=310.47  Aligned_cols=234  Identities=21%  Similarity=0.283  Sum_probs=179.5

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccC
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      +.||+|+||.||+|+. .+|+.||+|.+....... ......+.+|+.           .+++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA-KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            3699999999999954 478999999986532111 111223333432           356777888899999999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCee
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT  741 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  741 (849)
                      |+|..++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          80 GELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            9999888643   3589999999999999999999999   999999999999999999999999999876443333334


Q ss_pred             eccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHH
Q 042123          742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLIS  821 (849)
Q Consensus       742 ~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (849)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+..    ....
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~~~~~~~~~p~~----~~~~  221 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------RLFELILMEEIRFPRT----LSPE  221 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCCCCCCC----CCHH
Confidence            567899999999999999999999999999999999999998643211        1111222222221111    1234


Q ss_pred             HHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          822 IMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       822 l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      +.+++.+||+.||++||     ++.+++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            77899999999999998     88888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.7e-34  Score=310.46  Aligned_cols=234  Identities=22%  Similarity=0.293  Sum_probs=179.9

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccC
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      +.||+|+||.||+|+. .+++.||||.+....... ......+.+|+.           .+.+++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIA-KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999954 578999999987532111 112233444433           245677788899999999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCee
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT  741 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  741 (849)
                      |+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        80 g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          80 GELFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            9999888653   3589999999999999999999999   999999999999999999999999999886443333344


Q ss_pred             eccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHH
Q 042123          742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLIS  821 (849)
Q Consensus       742 ~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (849)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||...+..        .....+.......+..    ....
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--------~~~~~~~~~~~~~p~~----~~~~  221 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEDIKFPRT----LSAD  221 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--------HHHHHhccCCccCCCC----CCHH
Confidence            567999999999999889999999999999999999999999643211        1111111111111111    1234


Q ss_pred             HHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          822 IMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       822 l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      +.+++.+||++||++||     ++.+++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            77889999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-34  Score=283.30  Aligned_cols=251  Identities=22%  Similarity=0.259  Sum_probs=188.3

Q ss_pred             cCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHHHhhcee-------------ecCCeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFC-------------SHARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~~~~-------------~~~~~~~  653 (849)
                      ++|+..+.|++|.||.||+|+ .++++.||+|+++........  -...++||..+..+.             .+-+..|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF--PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF--PITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC--cchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            567888999999999999995 457999999999765322221  234556666543322             2345689


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|||||+. +|...++...  +++...++..++.|+++|++|||..   .|+|||||++|+|++..|.+||+|||+|+.+
T Consensus       154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence            99999998 9999998765  5689999999999999999999999   8999999999999999999999999999999


Q ss_pred             CCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc----------c---ccccccc
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----------S---SLNTDVA  799 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----------~---~~~~~~~  799 (849)
                      ..+...++..+.|.+|+|||.+.+ ..|+.+.||||+|||+.||+++++-|...+.+..          +   .+.+...
T Consensus       228 gsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  228 GSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             cCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            988777888999999999999876 4689999999999999999999988865432211          0   0000000


Q ss_pred             cccccCCCCCC-CChhhHH------HHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQMLDPRLPA-PSRSAQE------KLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~~~~~~~~~-~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+-.-..+. ++.....      -...-.+++...+..||.+|-|++|-++|
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            00000000110 0110000      12346688889999999999999998875

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.6e-34  Score=310.17  Aligned_cols=233  Identities=22%  Similarity=0.356  Sum_probs=178.7

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV  655 (849)
                      +|+..+.||+|+||+||+|.. .+|+.||+|.+........ .....+..|            +..+.+++...+..++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD-DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence            477789999999999999955 4789999999865321111 111222222            22456677778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+.   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          80 MEYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            9999999999998643   3489999999999999999999998   999999999999999999999999999886543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+..  
T Consensus       154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~p~~--  223 (323)
T cd05615         154 DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPKS--  223 (323)
T ss_pred             CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCcc--
Confidence            33333445689999999999988999999999999999999999999974321        11222222222221111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCH
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTM  840 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~  840 (849)
                        ....+.+++.+|++++|++|++.
T Consensus       224 --~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         224 --LSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCHHHHHHHHHHcccCHhhCCCC
Confidence              12347788999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2e-34  Score=311.11  Aligned_cols=234  Identities=25%  Similarity=0.371  Sum_probs=179.5

Q ss_pred             ceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|+.. +++.||||.+........ .....+..|            +..+++++...+..|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQD-DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhh-hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            36999999999999654 688999999865321111 111122222            2346677888889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|..++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..........
T Consensus        80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  153 (321)
T cd05591          80 GGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT  153 (321)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence            99999888643   3589999999999999999999999   99999999999999999999999999988654333334


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....|++.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+..    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~~~~p~~----~~~  221 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDDVLYPVW----LSK  221 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----CCH
Confidence            456789999999999998999999999999999999999999974331        11122222222221111    123


Q ss_pred             HHHHHHhhccCCCCCCCC-------CHHHHHhh
Q 042123          821 SIMEVAFSCFNESPESRP-------TMKIISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RP-------t~~eil~~  846 (849)
                      .+.+++.+|++.||++||       ++++++++
T Consensus       222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            477899999999999999       88888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=308.11  Aligned_cols=232  Identities=22%  Similarity=0.315  Sum_probs=178.1

Q ss_pred             ecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCCC
Q 042123          596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       596 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ||+|+||.||+|+.. +++.||+|.+...... .......+.+|+.           .+++++...+..++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIV-SRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            699999999999654 6889999998643111 1112233444433           35677788889999999999999


Q ss_pred             hhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeec
Q 042123          664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF  743 (849)
Q Consensus       664 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  743 (849)
                      |.+++.+.   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++............
T Consensus        80 L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  153 (312)
T cd05585          80 LFHHLQRE---GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF  153 (312)
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence            99998653   3489999999999999999999998   99999999999999999999999999998654333334456


Q ss_pred             cCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHH
Q 042123          744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIM  823 (849)
Q Consensus       744 ~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  823 (849)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ..............+..    ....+.
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~  221 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV--------NEMYRKILQEPLRFPDG----FDRDAK  221 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCCCCCc----CCHHHH
Confidence            799999999999999999999999999999999999999964321        11122222222222211    223477


Q ss_pred             HHHhhccCCCCCCCCC---HHHHHhh
Q 042123          824 EVAFSCFNESPESRPT---MKIISQQ  846 (849)
Q Consensus       824 ~li~~cl~~dP~~RPt---~~eil~~  846 (849)
                      +++.+||+.||++||+   +.+++.|
T Consensus       222 ~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         222 DLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             HHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            8899999999999974   6777664

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.5e-34  Score=309.26  Aligned_cols=235  Identities=22%  Similarity=0.351  Sum_probs=180.1

Q ss_pred             ceecCCccceEEEEEe----cCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEEEEe
Q 042123          594 YCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV~e~  658 (849)
                      +.||+|+||.||+++.    .+++.||||.+..............+..|           +..+++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999964    35889999998643211111112223333           33467788888899999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +++|+|.+++.+.   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            9999999998653   3478889999999999999999998   999999999999999999999999999875543333


Q ss_pred             CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          739 NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       739 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.......+...    
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~~~~~~~~----  223 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGKLNLPPYL----  223 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC----
Confidence            33445789999999999988899999999999999999999999974321        112222233332222222    


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          819 LISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      ...+.+++.+||+++|++||     ++++++++
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            23477899999999999999     88888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.8e-34  Score=308.80  Aligned_cols=234  Identities=25%  Similarity=0.343  Sum_probs=176.7

Q ss_pred             ceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|+.. +|+.||+|.+........ ........|            +..+++++...+..|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLID-DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhc-chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            36999999999999654 688999999865321111 111122222            2235667778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05620          80 GGDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA  153 (316)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence            99999988653   3488999999999999999999999   99999999999999999999999999987543333344


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~~~~~~~----~~~~  221 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVDTPHYPR----WITK  221 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCC----CCCH
Confidence            5567999999999999999999999999999999999999999743211        111111111111111    1123


Q ss_pred             HHHHHHhhccCCCCCCCCCHH-HHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTMK-IISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~-eil~~  846 (849)
                      ++.+++.+||+.||++||++. ++.+|
T Consensus       222 ~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         222 ESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence            477889999999999999984 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-34  Score=311.30  Aligned_cols=237  Identities=23%  Similarity=0.298  Sum_probs=184.9

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+...... .......+.+|+.           .+++++..++..++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            57888999999999999999664 6899999998643110 1111233444433           467778888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            9999999999998653   3588999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      ..   ....|++.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+... 
T Consensus       171 ~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~p~~~-  238 (329)
T PTZ00263        171 RT---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--------RIYEKILAGRLKFPNWF-  238 (329)
T ss_pred             Cc---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--------HHHHHHhcCCcCCCCCC-
Confidence            22   3457899999999999999999999999999999999999999643211        11122222222222111 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                         ...+.+++.+||+.||.+||+     ++++++|
T Consensus       239 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        239 ---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               224778999999999999997     6888765

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=8.6e-34  Score=307.37  Aligned_cols=249  Identities=22%  Similarity=0.363  Sum_probs=186.4

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|+.. ++..||+|.+.....   ......+.+|+.           ++++++...+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            368999999999999999999654 688999998865321   122344555544           36677788889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++....   .+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          81 CMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             EeecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            999999999999986533   4889999999999999999999862  69999999999999999999999999997654


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc------cccc----------
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL------NTDV----------  798 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~------~~~~----------  798 (849)
                      ..  ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........      ....          
T Consensus       156 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             cc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            32  22345789999999999998999999999999999999999999964321100000      0000          


Q ss_pred             ----------------------ccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          799 ----------------------ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       799 ----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                                            ....+.....+..  ........+.+++.+||++||++|||++|++++-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                  0000000000000  0011234588999999999999999999999874

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-34  Score=311.33  Aligned_cols=244  Identities=21%  Similarity=0.299  Sum_probs=179.9

Q ss_pred             CCCcCceecCCccceEEEEEe----cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCee
Q 042123          589 DFDAKYCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHS  652 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~  652 (849)
                      +|++.+.||+|+||.||+|+.    .+++.||+|.+..............+..|+.            .+++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478889999999999999854    3688999999864321111111222333322            345566777889


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999998643   3489999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCC-CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          733 LKPDS-SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       733 ~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      ..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......    ........+.......
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~  230 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILKCDPPF  230 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhcCCCCC
Confidence            54332 223345789999999998765 47889999999999999999999996332111    0011111111111111


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      +..    ....+.+++.+||+.||++||     ++++++++
T Consensus       231 ~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         231 PSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            111    223477889999999999999     77788765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=304.34  Aligned_cols=242  Identities=19%  Similarity=0.315  Sum_probs=195.9

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe-eEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH-SFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~-~~l  654 (849)
                      ++|...+.+|+|+||.++.++++ ++..|++|++.-....  ...++..++|+.           .+.+.+..++. .+|
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t--~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT--EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC--chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence            57888999999999999999554 6788999998654322  222335555544           24555556666 999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||+||+||++.+.+.+.+ +..++++++.+|+.|++.|+.|||++   +|+|||||+.||+++.++.||++|||+|+.+.
T Consensus        82 vm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            999999999999998776 45689999999999999999999988   99999999999999999999999999999998


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      .+.....+.+||+.|++||.+.+.+|..|+||||+||++|||++-+++|...+..        ....++......+.+  
T Consensus       158 ~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~--------~Li~ki~~~~~~Plp--  227 (426)
T KOG0589|consen  158 PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS--------ELILKINRGLYSPLP--  227 (426)
T ss_pred             CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH--------HHHHHHhhccCCCCC--
Confidence            8776777889999999999999999999999999999999999999999844322        222333333322221  


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....++..+|..|++++|..||++.+++.+
T Consensus       228 -~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  228 -SMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             1223347788899999999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9.7e-34  Score=299.55  Aligned_cols=233  Identities=21%  Similarity=0.360  Sum_probs=179.3

Q ss_pred             ceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec----CCeeEEEEEe
Q 042123          594 YCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH----ARHSFLLYEF  658 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~----~~~~~lV~e~  658 (849)
                      ..||+|++|.||+|.+ +|+.||||++...... .....+.+.+|+.           ++++++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKG-HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccc-cHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999988 5899999998754221 1112344555544           36666655    3467899999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +++|+|.+++...   ..+++.+..+++.|++.|+.|||+..  +++||||||+||+++.++.+|++|||+++...... 
T Consensus       104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            9999999999754   35899999999999999999999742  67899999999999999999999999998654322 


Q ss_pred             CeeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCChh
Q 042123          739 NWTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--PRLPAPSRS  814 (849)
Q Consensus       739 ~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  814 (849)
                        ....++..|+|||++.+  ..++.++|||||||++|||++|+.||......        .....+..  .+.+.+.  
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~--  245 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--------EIYDLIINKNNSLKLPL--  245 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcCCCCCCCC--
Confidence              23467899999999876  67899999999999999999999999743211        11111111  1111111  


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        .....+.+++.+||+.||++|||++|+++.|+
T Consensus       246 --~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~  277 (283)
T PHA02988        246 --DCPLEIKCIVEACTSHDSIKRPNIKEILYNLS  277 (283)
T ss_pred             --cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence              12335888999999999999999999999875

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=312.03  Aligned_cols=244  Identities=20%  Similarity=0.291  Sum_probs=185.2

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||.||+|+.. +++.||||++...... .......+..|+.           .+++++...+..++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence            36888999999999999999664 6899999998653211 1112233444433           356777888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          80 MEYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            9999999999999643   3488999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCChh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD-PRLPAPSRS  814 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  814 (849)
                         ......|++.|+|||++.+..++.++||||+||++|||++|+.||...........  ......... +....   .
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--i~~~~~~~~~~~~~~---~  225 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN--LKYWKETLQRPVYDD---P  225 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH--HHhccccccCCCCCc---c
Confidence               22345789999999999999999999999999999999999999974332110000  000000011 11110   0


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.+++.+||+.+|.+||++++++++
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            01123347789999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.9e-34  Score=308.19  Aligned_cols=242  Identities=25%  Similarity=0.371  Sum_probs=180.8

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|+. .+++.||||.++....... .....+..|            +..+++++......++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~-~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDD-EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh-hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            3699999999999965 4689999999875321111 111222222            2246677778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++.+.   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            99999888543   3589999999999999999999999   99999999999999999999999999987543333334


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccc-cccccccCCCCCCCChhhHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTD-VALDQMLDPRLPAPSRSAQEKL  819 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  819 (849)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||+............. .....+.......+...    .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~----~  229 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSL----S  229 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCC----C
Confidence            456789999999999999999999999999999999999999974332211111111 11122222222222211    2


Q ss_pred             HHHHHHHhhccCCCCCCCCC------HHHHHhh
Q 042123          820 ISIMEVAFSCFNESPESRPT------MKIISQQ  846 (849)
Q Consensus       820 ~~l~~li~~cl~~dP~~RPt------~~eil~~  846 (849)
                      ..+.+++.+|++.||.+|||      ++++++|
T Consensus       230 ~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            34778999999999999997      6788765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.1e-34  Score=306.62  Aligned_cols=233  Identities=25%  Similarity=0.362  Sum_probs=175.8

Q ss_pred             ceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||+||+|+.. +++.||||.+......... ....+..|            +..+++++...+..++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDD-DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcc-hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            36999999999999654 5789999998653211011 11111222            2346677778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          80 GGDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            99999998643   3588999999999999999999999   99999999999999999999999999987643333334


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+.    ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~i~~~~~~~~~----~~~~  221 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--------ELFQSIRMDNPCYPR----WLTR  221 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCc----cCCH
Confidence            4567899999999999989999999999999999999999999743211        111111111111111    1123


Q ss_pred             HHHHHHhhccCCCCCCCCCHH-HHHh
Q 042123          821 SIMEVAFSCFNESPESRPTMK-IISQ  845 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~-eil~  845 (849)
                      .+.+++.+||+.||++||++. ++.+
T Consensus       222 ~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         222 EAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHHhccCHhhcCCChHHHHc
Confidence            477889999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-34  Score=293.94  Aligned_cols=249  Identities=22%  Similarity=0.298  Sum_probs=186.5

Q ss_pred             HHHhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCC----------CchhhHHHHHHHHHH-----------
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPC----------DQTVDQKEFLTEVEA-----------  641 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~~~~~ei~~-----------  641 (849)
                      .+..++|++...||+|.||.|-+|. ..+++.||||++.+....          ......+...+||..           
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            3456899999999999999999994 457999999998642110          011112345556553           


Q ss_pred             hhceeec--CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          642 FYGFCSH--ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       642 ~~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      ++.+..+  .+..|||+|||..|.+...   ......+++.++++++++++.||+|||.+   +|+||||||+|+|++++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence            4444443  3578999999998876543   22223489999999999999999999999   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCC-----CCCeeeccCCccccccccccCCC---C-CccchHHHHHHHHHHHHhCCCCCCcccccc
Q 042123          720 YEAHVADFGIAKSLKPD-----SSNWTEFAGTCGYIAPELAYTMK---I-TEKCDVYSFGVLMWEVIKGKHPRDFLSSIS  790 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~---~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~  790 (849)
                      |++||+|||.+......     +......+|||.|+|||.+.++.   + +.+.||||+||++|.|+.|+.||-...   
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---  323 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---  323 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch---
Confidence            99999999999866322     11234478999999999988733   2 567899999999999999999996322   


Q ss_pred             ccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                           ..+..++++...+..+...  +....+.+++.+++.+||+.|.+..+|..|..
T Consensus       324 -----~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw  374 (576)
T KOG0585|consen  324 -----ELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKLHPW  374 (576)
T ss_pred             -----HHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhheecce
Confidence                 2233444444444333221  33445789999999999999999999988764

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9e-34  Score=285.13  Aligned_cols=256  Identities=21%  Similarity=0.303  Sum_probs=189.1

Q ss_pred             hcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCc----hhhHHHHHHH------HHHhhceeecCC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQ----TVDQKEFLTE------VEAFYGFCSHAR-----  650 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~----~~~~~~~~~e------i~~~~~~~~~~~-----  650 (849)
                      ...|+..++||+|+||+||+|+ ..+|+.||+|++.-....+.    ...+...+++      ++.+++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            3456677789999999999994 45789999999875433211    1222333333      344666666555     


Q ss_pred             -eeEEEEEeccCCChhhhhcccccc-cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          651 -HSFLLYEFLERGSLAAILNTDAAA-QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       651 -~~~lV~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                       ..++||||++. +|..+++..... ..++...+..+++|+++|++|||++   +|+||||||.||+++++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             78899999987 999999765432 3577789999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccc----------cccccc
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----------SSLNTD  797 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----------~~~~~~  797 (849)
                      +|+.+.-+...++..++|.+|+|||++.+. .|+...||||+||+++||++++.-|........          +.....
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999887666667888999999999999876 789999999999999999999888875432211          111111


Q ss_pred             cccccccCCC-----CCCCChhhH---HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 VALDQMLDPR-----LPAPSRSAQ---EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 ~~~~~~~~~~-----~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.+     ...+.....   .......+++..|++.+|..|.|++..+.|
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111111111     110000111   111357899999999999999999999876

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.5e-34  Score=300.93  Aligned_cols=239  Identities=20%  Similarity=0.287  Sum_probs=178.4

Q ss_pred             ecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCCC
Q 042123          596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       596 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ||+|+||+||++.. .+++.||+|.+...... .......+..|+.           .+.+++......++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            69999999999955 47899999998643211 1111223334433           24556667788999999999999


Q ss_pred             hhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeee
Q 042123          664 LAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE  742 (849)
Q Consensus       664 L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  742 (849)
                      |.+++.... ....+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.++|+|||.+............
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            998875322 234589999999999999999999998   9999999999999999999999999999876544433445


Q ss_pred             ccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHH
Q 042123          743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISI  822 (849)
Q Consensus       743 ~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  822 (849)
                      ..|++.|+|||++.+..++.++||||||+++|||++|+.||.......    ................+    ......+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~----~~~~~~~  228 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILNDSVTYP----DKFSPAS  228 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhcccCCCCc----ccCCHHH
Confidence            678999999999999999999999999999999999999997432110    00111111122111111    1223347


Q ss_pred             HHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          823 MEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       823 ~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      .+++.+||+.||++||     |+++++++
T Consensus       229 ~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         229 KSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            8899999999999999     77888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6e-34  Score=311.54  Aligned_cols=238  Identities=23%  Similarity=0.341  Sum_probs=177.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+. .+++.||||.+....   .......+.+|+.           .+++++.+.+..++|
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH---EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC---cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence            3556678999999999999965 478999999985432   1222344555544           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+..       ..++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       151 ~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        151 LEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             EecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            9999999986542       246678889999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-----MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      .........|+..|+|||++..     ...+.++|||||||++|||++|+.||.......     ...............
T Consensus       221 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~  295 (353)
T PLN00034        221 TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-----WASLMCAICMSQPPE  295 (353)
T ss_pred             ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhccCCCC
Confidence            3333345678999999998743     233568999999999999999999997321100     000001111101111


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ........+.+++.+||+.||++|||+.|+++|
T Consensus       296 ---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               111223348899999999999999999999986

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.8e-34  Score=313.00  Aligned_cols=246  Identities=24%  Similarity=0.405  Sum_probs=182.4

Q ss_pred             hcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceeec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~  648 (849)
                      .++|+..+.||+|+||.||+|..      .++..||||++......   .....+.+|+.            ++++++..
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT---DEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH---HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            45788999999999999999853      23457999998654221   11233444433            35677788


Q ss_pred             CCeeEEEEEeccCCChhhhhccccc-------------------------------------------------------
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAA-------------------------------------------------------  673 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------  673 (849)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            8899999999999999999854211                                                       


Q ss_pred             ------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC--
Q 042123          674 ------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--  739 (849)
Q Consensus       674 ------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--  739 (849)
                                  ...+++.++.+++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++........  
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                        12478899999999999999999998   9999999999999999999999999999865433211  


Q ss_pred             eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       740 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||......        ...............  +...
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--------~~~~~~~~~~~~~~~--~~~~  340 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--------SKFYKMVKRGYQMSR--PDFA  340 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--------HHHHHHHHcccCccC--CCCC
Confidence            112234567999999998899999999999999999997 99998643211        011111111111000  0011


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          819 LISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+.+++.+||+.||++|||+.+|++.|+
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~  370 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQ  370 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            234788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.3e-34  Score=309.90  Aligned_cols=234  Identities=22%  Similarity=0.290  Sum_probs=178.7

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccC
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      +.||+|+||.||+|.. .+++.||+|.+....... ......+..|+.           .+.+++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-KDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3699999999999954 578999999987532111 111223333433           245677778899999999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      |+|.+++...   ..+++.++..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          80 GELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             CcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            9999988653   358999999999999999999997 6   89999999999999999999999999987654333333


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+...    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~----~~  221 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPRTL----SP  221 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH--------HHHHHHhcCCCCCCCCC----CH
Confidence            4567999999999999989999999999999999999999999643211        11111111121111111    23


Q ss_pred             HHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          821 SIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      .+.+++.+||+.||++|+     ++.++++|
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            477889999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=9.4e-34  Score=311.66  Aligned_cols=245  Identities=23%  Similarity=0.404  Sum_probs=183.2

Q ss_pred             hcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~  648 (849)
                      .++|+..+.||+|+||.||+|++      .++..||||+++.....   .....+.+|+            ..+++++..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL---TEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc---HHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            35788899999999999999953      24668999998643211   1123334443            346778888


Q ss_pred             CCeeEEEEEeccCCChhhhhccccc-------------------------------------------------------
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAA-------------------------------------------------------  673 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------  673 (849)
                      ....++||||+++|+|.+++.....                                                       
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            8899999999999999999864221                                                       


Q ss_pred             -----------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          674 -----------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       674 -----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                                       ...+++.++.+++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                             12478899999999999999999998   9999999999999999999999999999866433


Q ss_pred             CCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC-CCCC
Q 042123          737 SSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRL-PAPS  812 (849)
Q Consensus       737 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  812 (849)
                      ...  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......        ...+.+.... ...+
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~  339 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--------KFYKMIKEGYRMLSP  339 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--------HHHHHHHhCccCCCC
Confidence            221  122334567999999999999999999999999999998 889986432110        0011111111 1001


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .   ....++.+++.+||+.||++|||+.||++.|+
T Consensus       340 ~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~  372 (375)
T cd05104         340 E---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE  372 (375)
T ss_pred             C---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            1   11234789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-33  Score=295.67  Aligned_cols=242  Identities=21%  Similarity=0.370  Sum_probs=184.4

Q ss_pred             hcCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.++....   ......+.+|+.           ++++++...+.
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS---DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            357888999999999999999643    466899999875421   222345555644           35677778889


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++....  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            999999999999999986543  3589999999999999999999998   99999999999999999999999999876


Q ss_pred             ccCCCCCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 042123          732 SLKPDSSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RL  808 (849)
Q Consensus       732 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~  808 (849)
                      ........ .....++..|+|||.+.+..++.++|||||||++||+++ |+.||......        .....+.+. ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~--------~~~~~~~~~~~~  227 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ--------DVIKAVEDGFRL  227 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCCCC
Confidence            54322111 112234578999999999999999999999999999875 99999744321        111111111 11


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+.    .....+.+++.+||+.+|++|||+++|.+.|+
T Consensus       228 ~~~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         228 PAPR----NCPNLLHQLMLDCWQKERGERPRFSQIHSILS  263 (266)
T ss_pred             CCCC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence            1111    12334788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-33  Score=299.96  Aligned_cols=251  Identities=22%  Similarity=0.296  Sum_probs=183.4

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||.||+|+.. +++.||||++......  ......+.+|+           ..+++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN--EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            36888999999999999999664 6889999998653221  11223333443           3467788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||++++.+..+...   ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          79 FEYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             EecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            999999877655432   23589999999999999999999998   999999999999999999999999999987643


Q ss_pred             CC-CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc---------
Q 042123          736 DS-SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTDV---------  798 (849)
Q Consensus       736 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~~---------  798 (849)
                      .. .......|++.|+|||++.+..++.++||||+||++|||++|+.||.........       ......         
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            32 2233457899999999999888999999999999999999999999743221100       000000         


Q ss_pred             ccccccCCCCCCCCh----hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQMLDPRLPAPSR----SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+....+..    ........+.+++.+|++.||++|||++|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000000000    001123458899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=6.7e-34  Score=306.38  Aligned_cols=234  Identities=24%  Similarity=0.329  Sum_probs=178.9

Q ss_pred             ceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|... +++.||||.+........ .....+..|            +..+++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQD-DDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            36999999999999654 588999999875321111 111122222            3346777888889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|..++.+.   ..+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+++.........
T Consensus        80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          80 GGDLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            99999888654   3589999999999999999999998   99999999999999999999999999987643333333


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||......        .....+.......+..    ...
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~~~~~~~~----~~~  221 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILEDEVRYPRW----LSK  221 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCCCCc----CCH
Confidence            4457899999999999999999999999999999999999999743211        1111122222211111    123


Q ss_pred             HHHHHHhhccCCCCCCCCCH-----HHHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTM-----KIISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~-----~eil~~  846 (849)
                      .+.+++.+||+.||++|||+     .+++++
T Consensus       222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            47889999999999999999     888764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.9e-34  Score=307.46  Aligned_cols=242  Identities=26%  Similarity=0.367  Sum_probs=180.2

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|+. .+++.||+|.+........ .....+..|            +..+++++......++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcch-hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            4699999999999965 4688999999875422111 111222222            2346677888889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|..++...   ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          80 GGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            99999887543   3589999999999999999999999   99999999999999999999999999997644333334


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccc-ccccccCCCCCCCChhhHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDV-ALDQMLDPRLPAPSRSAQEKL  819 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  819 (849)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||............... ....+.......+..    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~----~~  229 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LS  229 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCC----CC
Confidence            4567899999999999999999999999999999999999999643322111111111 111122222221111    22


Q ss_pred             HHHHHHHhhccCCCCCCCCC------HHHHHhh
Q 042123          820 ISIMEVAFSCFNESPESRPT------MKIISQQ  846 (849)
Q Consensus       820 ~~l~~li~~cl~~dP~~RPt------~~eil~~  846 (849)
                      ..+.+++.+||+.||++|||      ++++++|
T Consensus       230 ~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            34778999999999999998      4677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-34  Score=308.77  Aligned_cols=237  Identities=21%  Similarity=0.301  Sum_probs=183.8

Q ss_pred             cCCCcCceecCCccceEEEEEecC--CcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPS--GEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~l  654 (849)
                      ++|+..+.||+|+||.||+|....  +..||+|++...... .......+.+|+           ..+++++...+..++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII-KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            578899999999999999996542  368999988643111 111122333343           246778888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999986543   489999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..   .....||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+.......+...
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~  251 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL--------LIYQKILEGIIYFPKFL  251 (340)
T ss_pred             CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH--------HHHHHHhcCCCCCCCCC
Confidence            32   23457899999999999888999999999999999999999999743321        11122222222222211


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      .    ..+.+++.+|++.||++|+     |++++++|
T Consensus       252 ~----~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        252 D----NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C----HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            1    2367889999999999995     89999876

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.7e-34  Score=308.47  Aligned_cols=234  Identities=23%  Similarity=0.313  Sum_probs=177.2

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||+||+|+. .+|+.||||++....... ......+..|.            ..+++++...+..++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhh-hhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            3699999999999965 478999999986431111 11122233322            235566777889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            99999988653   3588999999999999999999999   99999999999999999999999999987654333334


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.......+...    ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~~----~~  221 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT--------AEMYDNILNKPLRLKPNI----SV  221 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC----CH
Confidence            456789999999999999999999999999999999999999974321        111122222222211111    23


Q ss_pred             HHHHHHhhccCCCCCCCCCHH----HHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTMK----IISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~----eil~~  846 (849)
                      .+.+++.+|++.||++||++.    +++++
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         222 SARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             HHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence            477899999999999999884    65543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-34  Score=314.07  Aligned_cols=241  Identities=23%  Similarity=0.343  Sum_probs=185.3

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||+||+|+.. +++.||||++....... ......+..|+           ..+++++.+++..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh-ccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence            46888999999999999999654 79999999986532111 11122333332           3466777888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          80 MEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             EcCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            9999999999999754   3589999999999999999999998   999999999999999999999999999986654


Q ss_pred             CC-----------------------------CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 042123          736 DS-----------------------------SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFL  786 (849)
Q Consensus       736 ~~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~  786 (849)
                      ..                             .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            33                             1223456899999999999999999999999999999999999999743


Q ss_pred             ccccccccccccccccccC--CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCC-HHHHHhh
Q 042123          787 SSISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT-MKIISQQ  846 (849)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~~  846 (849)
                      ...        .....+..  .....+...  .....+.+++.+|+. ||.+||+ +++++++
T Consensus       234 ~~~--------~~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         234 TLQ--------ETYNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CHH--------HHHHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            311        11111111  111111111  022347788899997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-33  Score=295.45  Aligned_cols=243  Identities=27%  Similarity=0.487  Sum_probs=189.8

Q ss_pred             HhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~l  654 (849)
                      +..+|+..+.||+|+||.||+|...+++.+|+|.+.....    .....+..|           +..+++++......++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL----LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch----hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            4567888999999999999999887799999999865422    112233333           3346778888889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          80 ITELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            999999999999997643 34689999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      .+........++..|+|||...+..++.++||||||+++|+|++ |+.||......        ......... +.+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~  227 (261)
T cd05148         156 EDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITAGYRMPCPA  227 (261)
T ss_pred             CccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHhCCcCCCCC
Confidence            43322233445678999999988889999999999999999998 89998643311        111111111 111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          .....+.+++.+||+.+|.+|||++++.+.|+
T Consensus       228 ----~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         228 ----KCPQEIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             ----CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                22234789999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-34  Score=299.77  Aligned_cols=246  Identities=28%  Similarity=0.448  Sum_probs=194.4

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEecC-CcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeec
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSH  648 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~  648 (849)
                      ++++-...+....++||-|.||.||.|.|+. .-.||||.++..     .+...+|++|           +++++|+|.+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            5555566777888999999999999998763 556999988753     3344556555           3469999999


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      +..+|||+|||..|+|.+++.+... ..++.-..+.++.||+.||+||..+   +++||||.++|+|+.++..+|++|||
T Consensus       335 EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFG  410 (1157)
T KOG4278|consen  335 EPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFG  410 (1157)
T ss_pred             CCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccc
Confidence            9999999999999999999976553 4467777889999999999999999   89999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccC---CccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc
Q 042123          729 IAKSLKPDSSNWTEFAG---TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQML  804 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g---~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~  804 (849)
                      +++.+..+.+  +...|   ...|.|||.+....++.|+|||+|||++||+.| |..||...+....     ...++.  
T Consensus       411 LsRlMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-----Y~LLEk--  481 (1157)
T KOG4278|consen  411 LSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----YGLLEK--  481 (1157)
T ss_pred             hhhhhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-----HHHHhc--
Confidence            9999986543  33344   568999999999999999999999999999998 8888764321100     001110  


Q ss_pred             CCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          805 DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       805 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.++..+..    +..++.++|..||++.|.+||+++||-+.++
T Consensus       482 gyRM~~PeG----CPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  482 GYRMDGPEG----CPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             cccccCCCC----CCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            112222222    2335888999999999999999999988775

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-34  Score=274.61  Aligned_cols=247  Identities=22%  Similarity=0.375  Sum_probs=197.3

Q ss_pred             HHhcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhh----HHHHHHHHH------------Hhhceee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVD----QKEFLTEVE------------AFYGFCS  647 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~ei~------------~~~~~~~  647 (849)
                      ..-+.|...+.+|+|..++|-+. ..++|..+|+|++...........    .+.-.+|+.            .+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34467788899999999999988 456789999999864333222222    222334433            2566777


Q ss_pred             cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                      .+...++|+|.|+.|.|.|++...-   .+++.+.++|++|+..|++|||..   +|||||+||+|||++++.++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            7888899999999999999996543   489999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCCCeeeccCCcccccccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAY------TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD  801 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~  801 (849)
                      |+|..+.++ +.....+|||+|.|||.+.      ...|+...|+||.||++|.++.|.+||..-..+        ..+.
T Consensus       168 GFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm--------lMLR  238 (411)
T KOG0599|consen  168 GFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM--------LMLR  238 (411)
T ss_pred             ceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH--------HHHH
Confidence            999988754 4567789999999999875      345788899999999999999999999743211        2233


Q ss_pred             cccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      -+..++..-....+.+......+++.+|++.||.+|-|++|.++|
T Consensus       239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            344455554555667777778999999999999999999999876

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9e-34  Score=311.23  Aligned_cols=192  Identities=27%  Similarity=0.385  Sum_probs=155.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|.. .+++.||||.+....... ......+..|+.           .+++++.+....|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLE-KEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence            4788999999999999999954 468999999986531111 111222333322           356677788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+.   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          80 MEFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             EcCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            9999999999998654   3589999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCC-----------------------------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 042123          736 DSS-----------------------------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK  780 (849)
Q Consensus       736 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~  780 (849)
                      ...                                   .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                   012357899999999999999999999999999999999999


Q ss_pred             CCCCcc
Q 042123          781 HPRDFL  786 (849)
Q Consensus       781 ~Pf~~~  786 (849)
                      .||...
T Consensus       234 ~Pf~~~  239 (363)
T cd05628         234 PPFCSE  239 (363)
T ss_pred             CCCCCC
Confidence            999743

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.2e-33  Score=297.77  Aligned_cols=244  Identities=25%  Similarity=0.476  Sum_probs=186.2

Q ss_pred             cCCCcCceecCCccceEEEEEecC------CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPS------GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      ++|+..+.||+|+||.||+|....      ...||+|.+....   .......+.+|+.           .+++++....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~---~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA---EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC---CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            478889999999999999996532      2579999876432   2222344555544           3566777778


Q ss_pred             eeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 042123          651 HSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD  717 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  717 (849)
                      ..+++|||+++|+|.+++.....             ...+++.++..++.|++.|++|||+.   +++||||||+||+++
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~  158 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG  158 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence            89999999999999999865321             14588999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 042123          718 LEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSL  794 (849)
Q Consensus       718 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~  794 (849)
                      .++.++|+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.....      
T Consensus       159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------  232 (283)
T cd05048         159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------  232 (283)
T ss_pred             CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------
Confidence            999999999999986543321  1223456788999999988899999999999999999998 9999864321      


Q ss_pred             ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        ......+.....+..   ......++.+++.+||+.+|++|||+.||+++|+
T Consensus       233 --~~~~~~i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         233 --QEVIEMIRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRLR  281 (283)
T ss_pred             --HHHHHHHHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence              111111212221111   1223345889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.9e-33  Score=292.15  Aligned_cols=240  Identities=25%  Similarity=0.448  Sum_probs=184.5

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      ++|+..+.||+|+||.||+|++.++..+|+|.+.....     ....+.+|+.           .+++++......++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            56888899999999999999888888999998764311     1233444433           3677888888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.++++...  ..+++..+..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.++.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          79 EFMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            9999999999986533  2589999999999999999999998   9999999999999999999999999998865432


Q ss_pred             CCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          737 SSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       737 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......        .....+........+. 
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~-  224 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--------EVVEMISRGFRLYRPK-  224 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCCCCC-
Confidence            211 112234568999999988889999999999999999999 89998743211        1111111111111111 


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        .....+.+++.+||+.+|++|||++++++.|.
T Consensus       225 --~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 --LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              11235789999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-34  Score=287.42  Aligned_cols=252  Identities=22%  Similarity=0.334  Sum_probs=186.3

Q ss_pred             HhcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHHHh-----------hcee-----ec
Q 042123          586 ATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF-----------YGFC-----SH  648 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~-----------~~~~-----~~  648 (849)
                      ....|...+.||+|+||.|++| ...+|+.||||++....  ......++..+|+.-+           .+..     ..
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            3456666789999999999999 45579999999987543  3344455666666532           1111     23


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      -..+|+|+|+|+. +|...++...   .++...+.-+++|+++|+.|+|+.   +|+|||+||+|++++.+..+||+|||
T Consensus        98 f~DvYiV~elMet-DL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   98 FNDVYLVFELMET-DLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cceeEEehhHHhh-HHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence            4578999999965 9999987543   389999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCC--CCCeeeccCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccccccc
Q 042123          729 IAKSLKPD--SSNWTEFAGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------SSLNTDV  798 (849)
Q Consensus       729 ~a~~~~~~--~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------~~~~~~~  798 (849)
                      +|+.....  +...+..+.|.+|+|||.+. ...|+.+.||||.|||+.||++|+.-|.+.+....       .....++
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            99987542  34457788999999999875 56899999999999999999999998875443211       0000111


Q ss_pred             c--------cccccCCCCCCCChhh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 A--------LDQMLDPRLPAPSRSA----QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~--------~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .        ....+......+....    .......++++.+|+..||.+|+|++|.++|
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1        1111111111111111    1222347789999999999999999999876

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.8e-33  Score=298.76  Aligned_cols=250  Identities=18%  Similarity=0.267  Sum_probs=181.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+.......   ....+.+|+.           ++++++......++|
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG---APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV   81 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC---cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence            5788999999999999999955 478999999986432211   1122333332           366777778889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++ +|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~  155 (288)
T cd07871          82 FEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV  155 (288)
T ss_pred             EeCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence            999985 8988875432  3478899999999999999999998   999999999999999999999999999986544


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc----------------ccccccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----------------SSLNTDV  798 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----------------~~~~~~~  798 (849)
                      .........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........                .......
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         156 PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            3333344578999999998865 5688999999999999999999999964321100                0000000


Q ss_pred             ccccccCCCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQMLDPRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+......  ...........+++.+|++.||.+|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00001111100000  0001112347789999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.1e-33  Score=293.97  Aligned_cols=249  Identities=18%  Similarity=0.272  Sum_probs=189.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||.||+|+. .+++.||||.+..... ........+.+|+.           .+++++...+..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            5788999999999999999965 4789999998764321 12222344555544           356677778889999


Q ss_pred             EEeccCCChhhhhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      +||+++|+|.+++..... ...+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999999998854322 23578999999999999999999998   99999999999999999999999999988765


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........+++.|+|||.+.+..++.++||||+|+++|||++|+.||......      .......+.....++  ..
T Consensus       158 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~--~~  229 (267)
T cd08228         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCDYPP--LP  229 (267)
T ss_pred             chhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCCCCC--CC
Confidence            4333333456888999999998888999999999999999999999998532210      001111111111111  11


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .......+.+++.+||+.+|++||++.+|++.++
T Consensus       230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~  263 (267)
T cd08228         230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK  263 (267)
T ss_pred             hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence            1223345889999999999999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.8e-33  Score=304.16  Aligned_cols=241  Identities=24%  Similarity=0.352  Sum_probs=178.5

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||+||+|.. .+++.||+|.+....... ......+..|+.            .+++++......++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHD-DEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            3699999999999965 468899999987532111 111222333322            35667777889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|..++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          80 GGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            99999888643   3589999999999999999999998   99999999999999999999999999987643333334


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||+......... ................+..    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~p~~----~~~  228 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN-TEDYLFQVILEKPIRIPRF----LSV  228 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc-cHHHHHHHHHhCCCCCCCC----CCH
Confidence            55679999999999999999999999999999999999999996432211100 0111111222222222211    123


Q ss_pred             HHHHHHhhccCCCCCCCCCH------HHHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTM------KIISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~------~eil~~  846 (849)
                      .+.+++.+||+.||++||++      +++.+|
T Consensus       229 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         229 KASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            46788999999999999984      577654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.7e-33  Score=301.54  Aligned_cols=251  Identities=20%  Similarity=0.296  Sum_probs=180.7

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|+.. +++.||||.+........   ...+.+|+           ..+++++......++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT---PFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc---chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            468999999999999999999654 789999999864322111   12223332           246777888889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||++ +++.+++....  ..++++++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  154 (303)
T cd07869          81 VFEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS  154 (303)
T ss_pred             EEECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence            999996 57877775432  3588999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---------cccccc-----c
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS---------SLNTDV-----A  799 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~---------~~~~~~-----~  799 (849)
                      ..........+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........         ......     .
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (303)
T cd07869         155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS  234 (303)
T ss_pred             CCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence            33333345678999999998865 45788999999999999999999999753221000         000000     0


Q ss_pred             cccccCCCCC--CCChhhH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQMLDPRLP--APSRSAQ-----EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~~~~~~~~--~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........  .+.....     .....+.+++.+|++.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            0000000000  0000000     011346789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=8.3e-34  Score=311.52  Aligned_cols=243  Identities=22%  Similarity=0.330  Sum_probs=183.0

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||.||+|+. .+++.||+|.+...... .......+.+|+.           .+++++.++...+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI-KRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            346899999999999999999965 46899999998642110 1111222333332           3666778888999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++|+|.+++...    .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~  192 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence            999999999999998542    478889999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCC-CeeeccCCccccccccccCC----CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC-
Q 042123          734 KPDSS-NWTEFAGTCGYIAPELAYTM----KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR-  807 (849)
Q Consensus       734 ~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  807 (849)
                      ..... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||......        .....+.... 
T Consensus       193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~  264 (370)
T cd05596         193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIMDHKN  264 (370)
T ss_pred             cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH--------HHHHHHHcCCC
Confidence            43322 22345799999999988653    4788999999999999999999999743321        1112222111 


Q ss_pred             -CCCCChhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHhh
Q 042123          808 -LPAPSRSAQEKLISIMEVAFSCFNESPES--RPTMKIISQQ  846 (849)
Q Consensus       808 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~  846 (849)
                       +..+.  .......+.+++.+|++.+|++  |||++|+++|
T Consensus       265 ~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 SLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             cCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence             11111  0112234778899999999988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-35  Score=274.81  Aligned_cols=245  Identities=22%  Similarity=0.341  Sum_probs=192.8

Q ss_pred             hcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~l  654 (849)
                      .+.|++.+.||+|.|+.||+. ..++|+.+|+|.+....-...  ..++..+|+           .++...+.+....|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            357788889999999999999 667899999987753221111  223333332           246667777888999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~a~  731 (849)
                      |+|+|+|++|..-+-..   ..+++..+..+++||+.|+.|+|.+   +|||||+||+|+++...   .-+|++|||+|.
T Consensus        88 vFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999986655332   3478888899999999999999999   99999999999999543   468999999999


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ... +...+..++|||+|||||+++..+|+..+|||+.||++|-++.|+.||...+.        ....+++..+....+
T Consensus       162 ~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rlye~I~~g~yd~~  232 (355)
T KOG0033|consen  162 EVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYEQIKAGAYDYP  232 (355)
T ss_pred             EeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHHHHHHhccccCCC
Confidence            888 66677888999999999999999999999999999999999999999975332        223344444444333


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+....++..+++.+|+..||++|-|+.|.++|=.
T Consensus       233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW  269 (355)
T KOG0033|consen  233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW  269 (355)
T ss_pred             CcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence            3345555566889999999999999999999988743

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.3e-33  Score=317.67  Aligned_cols=245  Identities=22%  Similarity=0.302  Sum_probs=184.3

Q ss_pred             HhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHHHhhc-----------eeecC----
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYG-----------FCSHA----  649 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~~-----------~~~~~----  649 (849)
                      ..++|.+.+.||+|+||+||+|+ ..+|+.||||.+.....  .......+.+|+..+..           .+...    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            34689999999999999999995 45799999999865321  22233445556553221           11111    


Q ss_pred             ----CeeEEEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          650 ----RHSFLLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       650 ----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                          ...++||||+++|+|.++++... ....+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL  184 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKL  184 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEE
Confidence                13679999999999999986432 234689999999999999999999998   9999999999999999999999


Q ss_pred             eeecCCcccCCC--CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042123          725 ADFGIAKSLKPD--SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       725 ~DfG~a~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      +|||+++.+...  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......
T Consensus       185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~--------~~~~~~  256 (496)
T PTZ00283        185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM--------EEVMHK  256 (496)
T ss_pred             EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHH
Confidence            999999865432  1223446789999999999999999999999999999999999999974321        111122


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.+.   .....+.+++.+||+.||++||++.+++++
T Consensus       257 ~~~~~~~~~~~---~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TLAGRYDPLPP---SISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HhcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            22222111111   122347889999999999999999999875

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.4e-33  Score=311.60  Aligned_cols=239  Identities=19%  Similarity=0.284  Sum_probs=178.2

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      .|+..+.||+|+||+||+|+. .+++.||||++...... .......+.+|+.           ++++++.+.+..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            578889999999999999954 57899999998653211 1111233444433           3677888889999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.+..   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          81 DYIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            9999999999986543   488999999999999999999998   9999999999999999999999999997643110


Q ss_pred             CC-----------------------------------------------CeeeccCCccccccccccCCCCCccchHHHH
Q 042123          737 SS-----------------------------------------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSF  769 (849)
Q Consensus       737 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~Sl  769 (849)
                      ..                                               ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                               0123468999999999998899999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccccccccccccccccC----CCCCCCChhhHHHHHHHHHHHhh--ccCCCCCCCCCHHHH
Q 042123          770 GVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD----PRLPAPSRSAQEKLISIMEVAFS--CFNESPESRPTMKII  843 (849)
Q Consensus       770 Gvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~ei  843 (849)
                      ||++|||++|+.||......        .....+..    ...+.....    ..++.+++.+  |+..+|..||+++++
T Consensus       235 G~il~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~~----s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPT--------ETQLKVINWENTLHIPPQVKL----SPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHH--------HHHHHHHccccccCCCCCCCC----CHHHHHHHHHHccCcccccCCCCHHHH
Confidence            99999999999999743211        11111111    111211111    2236677766  666777779999999


Q ss_pred             Hhh
Q 042123          844 SQQ  846 (849)
Q Consensus       844 l~~  846 (849)
                      ++|
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.4e-33  Score=301.03  Aligned_cols=189  Identities=25%  Similarity=0.413  Sum_probs=157.2

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|... ++..+|+|.+.....   ......+.+|+.           .+++++...+..++
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            368999999999999999999664 688899998765321   122334445543           46778888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++...   ..+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||++....
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  155 (333)
T cd06650          81 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (333)
T ss_pred             EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence            99999999999998653   34788999999999999999999752  69999999999999999999999999987654


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                      ..  ......++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         156 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            32  12345689999999999988899999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.4e-33  Score=292.78  Aligned_cols=243  Identities=25%  Similarity=0.361  Sum_probs=183.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||+|++......    ....+.+|+.           .+++++......++|
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD----DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc----hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            5789999999999999999965 57889999998643211    1222333432           356677778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++.++..++.|++.|+.|||+.   +|+|||++|+||+++.++.++++|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            9999999999998643   3589999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .........++..|+|||.+.   ...++.++||||+||++|||++|+.||............   .......+....  
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~--  233 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---SKSNFQPPKLKD--  233 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee---ecCCCCCCCCcc--
Confidence            333233456888999999874   445788999999999999999999998643321110000   000001111111  


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                        .......+.+++.+||+.+|++|||++++++++
T Consensus       234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              112234588999999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3e-33  Score=295.69  Aligned_cols=246  Identities=21%  Similarity=0.396  Sum_probs=184.9

Q ss_pred             HhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH  648 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~  648 (849)
                      +.++|+..+.||+|+||.||+|...      ++..||||++....   ......++.+|+.           ++++++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~   80 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   80 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4578999999999999999998643      35679999875431   1222334555543           36677777


Q ss_pred             CCeeEEEEEeccCCChhhhhccccc-------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAA-------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE  721 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  721 (849)
                      ....++||||+++|+|.+++.....       ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~  157 (277)
T cd05062          81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  157 (277)
T ss_pred             CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCC
Confidence            8889999999999999999864321       12467889999999999999999998   9999999999999999999


Q ss_pred             EEEeeecCCcccCCCCCCe--eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 042123          722 AHVADFGIAKSLKPDSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDV  798 (849)
Q Consensus       722 ~kl~DfG~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~  798 (849)
                      ++++|||+++.........  ....+++.|+|||++.+..++.++|||||||++|||++ |..||.....        ..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~  229 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQ  229 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HH
Confidence            9999999987654332211  12344678999999998889999999999999999999 7888864321        11


Q ss_pred             ccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          799 ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...............   .....+.+++.+||+.+|++|||+.|+++.|+
T Consensus       230 ~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         230 VLRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            111111211111111   12234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7e-33  Score=289.32  Aligned_cols=241  Identities=25%  Similarity=0.381  Sum_probs=189.1

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|++|.||+|.. .+++.||+|.+.....  .......+.+|+.           .+++++...+..++||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            477788999999999999965 4689999998864321  1223445555544           3667777888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++.... ...+++.++.+++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||+++.....
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          79 EYAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             EeCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            9999999999987542 34689999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      ........+++.|+|||+..+..++.++||||||+++|+|++|+.||.....        ............+....   
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---  223 (256)
T cd08529         155 TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPPVSQ---  223 (256)
T ss_pred             cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCcc---
Confidence            4334445688999999999998899999999999999999999999974331        11112222222221111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.+++.+||+.+|++||++.+++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            223458899999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.3e-33  Score=291.77  Aligned_cols=241  Identities=22%  Similarity=0.418  Sum_probs=185.6

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..++||+|+||.||+|...++..||+|.+....     .....+.+|+.           ++++++......++|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII   79 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence            46788999999999999999988888899999875421     12234444433           355677777889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+.. ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++....
T Consensus        80 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          80 TEYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            99999999999986543 34588999999999999999999998   999999999999999999999999999987643


Q ss_pred             CCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      ... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......        ....+... ..+...
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~  227 (261)
T cd05072         156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--------VMSALQRGYRMPRME  227 (261)
T ss_pred             CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCCCCCC
Confidence            221 1122345678999999988889999999999999999998 999986432110        11111111 111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .    ....+.+++.+||+.+|++|||++++.+.|+
T Consensus       228 ~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         228 N----CPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             C----CCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence            1    2234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.2e-33  Score=297.62  Aligned_cols=251  Identities=19%  Similarity=0.286  Sum_probs=178.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-c-CCcEEEEEEecccCCCCchhhHHHHHHH--------------HHHhhceee----
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-P-SGEVVAVKKFHSLLPCDQTVDQKEFLTE--------------VEAFYGFCS----  647 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~~e--------------i~~~~~~~~----  647 (849)
                      .+|+..+.||+|+||.||+|+. . +++.||||.+.........  ...+.+|              +.++++++.    
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM--PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCc--hHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            3688899999999999999965 3 4688999988653322111  1112222              223455543    


Q ss_pred             -cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          648 -HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       648 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                       .....++||||++ ++|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        79 ~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          79 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCCCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcc
Confidence             2456899999997 58999886543 23489999999999999999999998   999999999999999999999999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------ccccc
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-------NTDVA  799 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-------~~~~~  799 (849)
                      ||+++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...........       .....
T Consensus       154 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         154 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            9999865433 223445689999999999888899999999999999999999999975432110000       00000


Q ss_pred             c-------ccccCCCCCCCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 L-------DQMLDPRLPAPS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~-------~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .       ..........+. .........+.+++.+|++.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            0       000000100000 0011123356789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-33  Score=305.96  Aligned_cols=230  Identities=22%  Similarity=0.283  Sum_probs=174.6

Q ss_pred             ceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||+||+|+.. +++.||+|.+....... ......+..|            +..+++++...+..++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHh-hhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            36999999999999654 67889999986431111 1111222222            2235667778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          80 GGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            99999998653   3478889999999999999999998   99999999999999999999999999998654333344


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||......        .....+..........    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------~~~~~i~~~~~~~~~~----~~~  221 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--------EMYDNILNKPLQLKPN----ITN  221 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--------HHHHHHHhCCcCCCCC----CCH
Confidence            5567999999999999999999999999999999999999999743211        1111222222211111    223


Q ss_pred             HHHHHHhhccCCCCCCCCCHHH
Q 042123          821 SIMEVAFSCFNESPESRPTMKI  842 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~e  842 (849)
                      .+.+++.+|++.+|.+||++.+
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         222 SARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             HHHHHHHHHcccCHHHCCCCCC
Confidence            4778899999999999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=297.84  Aligned_cols=244  Identities=19%  Similarity=0.274  Sum_probs=183.2

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||+||+|.. .+++.||||++...... .......+.+|+.           .+++++..++..++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            477889999999999999965 47899999998643211 1111223344433           2456667778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.++|+|||++......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          80 TLMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             eccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            9999999998886432 24589999999999999999999998   9999999999999999999999999999875432


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      . ......|+..|+|||.+.+..++.++||||+||++|||++|+.||.......    ... .....+.....   ....
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~----~~~-~~~~~~~~~~~---~~~~  226 (285)
T cd05605         156 E-TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV----KRE-EVERRVKEDQE---EYSE  226 (285)
T ss_pred             C-ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh----HHH-HHHHHhhhccc---ccCc
Confidence            2 2234578999999999998889999999999999999999999997432110    000 11111111111   1111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      .....+.+++.+||+.||++||     ++++++++
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            2334478899999999999999     88898775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=299.64  Aligned_cols=239  Identities=25%  Similarity=0.328  Sum_probs=188.1

Q ss_pred             eecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHH-------HHHHHHHHhhceeecCCeeEEEEEeccCCChhh
Q 042123          595 CIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQK-------EFLTEVEAFYGFCSHARHSFLLYEFLERGSLAA  666 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~-------~~~~ei~~~~~~~~~~~~~~lV~e~~~~gsL~~  666 (849)
                      ++|+|.||+||.|+. .+...+|||.+............+       --+++|+++.|.+.+++..-|.||-++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            799999999999955 457789999987543322221111       233568889999999999999999999999999


Q ss_pred             hhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEeeecCCcccCCCCCCeeeccC
Q 042123          667 ILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD-LEYEAHVADFGIAKSLKPDSSNWTEFAG  745 (849)
Q Consensus       667 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~g  745 (849)
                      .+...-+.-+=.+.++-.+.+||++||.|||++   .|||||||-.|||++ -.|.+||+|||-++....-..-..++.|
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            997654322226788889999999999999999   999999999999995 4599999999999988766666678899


Q ss_pred             CccccccccccCC--CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHH
Q 042123          746 TCGYIAPELAYTM--KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIM  823 (849)
Q Consensus       746 ~~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  823 (849)
                      |..|||||++..+  .|..++|||||||++.||.||++||-+++........   .-.-...|.      .+.+...+..
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk---VGmyKvHP~------iPeelsaeak  809 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK---VGMYKVHPP------IPEELSAEAK  809 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh---hcceecCCC------CcHHHHHHHH
Confidence            9999999999754  5889999999999999999999999876543322111   111111122      2234455688


Q ss_pred             HHHhhccCCCCCCCCCHHHHHh
Q 042123          824 EVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       824 ~li~~cl~~dP~~RPt~~eil~  845 (849)
                      .|+.+|+.+||.+||++.+++.
T Consensus       810 ~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  810 NFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHcCCCcccCccHHHhcc
Confidence            8999999999999999999875

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.5e-33  Score=290.40  Aligned_cols=243  Identities=26%  Similarity=0.447  Sum_probs=185.8

Q ss_pred             hcCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      .++|+..+.||+|+||.||+|.+.    +...||||.+....   .......+..|+.           ++++++...+.
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            357889999999999999999764    24579999876432   2223344555544           35667777888


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++....  ..+++.++.+++.|++.|++|||+.   +|+||||||+||++++++.++++|||+++
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          80 VMIITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence            999999999999999986543  3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCee--eccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 042123          732 SLKPDSSNWT--EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       732 ~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ..........  ...++..|+|||.+.+..++.++||||||+++|+|++ |..||......        .....+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~  226 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--------DVIKAVEDGYR  226 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            7753222222  2234568999999998899999999999999999998 99998643211        11111111111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+...   .....+.+++.+||+.+|++||++++|+++|+
T Consensus       227 ~~~~~---~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~  263 (266)
T cd05033         227 LPPPM---DCPSALYQLMLDCWQKDRNERPTFSQIVSTLD  263 (266)
T ss_pred             CCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11111   12234789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=6.9e-34  Score=308.37  Aligned_cols=240  Identities=23%  Similarity=0.325  Sum_probs=181.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|.. .+++.||+|++...... .......+.+|+.           .+++++......++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLL-AQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            4688899999999999999955 47899999998753211 1112223333332           355677778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+..  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          80 MEYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             ECCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            99999999999997542  3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCC-eeeccCCcccccccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---
Q 042123          736 DSSN-WTEFAGTCGYIAPELAY------TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD---  805 (849)
Q Consensus       736 ~~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---  805 (849)
                      .... .....||+.|+|||++.      ...++.++|||||||++|||++|+.||.......        ....+..   
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~  226 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNFQR  226 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            3322 23356899999999986      4567889999999999999999999997433211        1111111   


Q ss_pred             -CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          806 -PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       806 -~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ...+....    ....+.+++..|++ +|++|||++++++|
T Consensus       227 ~~~~~~~~~----~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 FLKFPEDPK----VSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ccCCCCCCC----CCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence             01111111    22347788889998 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=7e-33  Score=291.25  Aligned_cols=249  Identities=19%  Similarity=0.294  Sum_probs=188.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.+|||.+..... ........+.+|+.           .+++++..++..++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            4688889999999999999964 5799999998764321 11122334444433           467777788899999


Q ss_pred             EEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |||+++++|.+++.... ....+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999999886422 234589999999999999999999999   99999999999999999999999999988765


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........++..|+|||++.+..++.++||||||+++|+|++|..||......      .............++.  .
T Consensus       158 ~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~--~  229 (267)
T cd08229         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPL--P  229 (267)
T ss_pred             cCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhcCCCCCC--C
Confidence            4433334456888999999998888999999999999999999999998632210      0111111111111111  1


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .......+.+++.+||+.+|++|||+.+|++.++
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~  263 (267)
T cd08229         230 SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK  263 (267)
T ss_pred             cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence            1123345889999999999999999998888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.5e-33  Score=304.26  Aligned_cols=234  Identities=22%  Similarity=0.324  Sum_probs=176.1

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|+. .+++.||+|.+....... ......+..|            +..+++++...+..++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            3699999999999965 468899999986432111 1112223332            2235667778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|...+...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          80 GGELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            99998887543   3488899999999999999999998   99999999999999999999999999987643333333


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||...+.        ......+.......+..    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~~----~~~  221 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV--------SQMYDNILHKPLQLPGG----KTV  221 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH--------HHHHHHHhcCCCCCCCC----CCH
Confidence            456789999999999988899999999999999999999999964321        11112222222222211    123


Q ss_pred             HHHHHHhhccCCCCCCCCCHH----HHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTMK----IISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~----eil~~  846 (849)
                      .+.+++.+|++.||.+||++.    +++++
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         222 AACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             HHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence            477889999999999998764    55544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.9e-33  Score=303.34  Aligned_cols=246  Identities=23%  Similarity=0.404  Sum_probs=180.7

Q ss_pred             hcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee-
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS-  647 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~-  647 (849)
                      .++|++.+.||+|+||.||+|..      .+++.||+|++......   .....+.+|+.            .+++++. 
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA---SEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH---HHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            35788999999999999999943      23578999998643211   11223333433            3445444 


Q ss_pred             cCCeeEEEEEeccCCChhhhhccccc------------------------------------------------------
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAA------------------------------------------------------  673 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------  673 (849)
                      .+...++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            34567899999999999999854221                                                      


Q ss_pred             ----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCc
Q 042123          674 ----AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTC  747 (849)
Q Consensus       674 ----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~  747 (849)
                          ...+++.++.+++.||+.|++|||+.   +|+||||||+||+++.++.++|+|||+++.+......  .....++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                12589999999999999999999998   9999999999999999999999999999876433221  22334567


Q ss_pred             cccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHH
Q 042123          748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVA  826 (849)
Q Consensus       748 ~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  826 (849)
                      .|+|||++.+..++.++|||||||++|||++ |..||......        ......+.......  ........+.+++
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~--~~~~~~~~~~~l~  309 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRMR--APEYATPEIYSIM  309 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCCC--CCccCCHHHHHHH
Confidence            8999999999999999999999999999998 99998632111        00111111110000  0111233588999


Q ss_pred             hhccCCCCCCCCCHHHHHhhhc
Q 042123          827 FSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       827 ~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+||+.+|++||++.||+++|+
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~  331 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILG  331 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHH
Confidence            9999999999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.4e-33  Score=289.92  Aligned_cols=240  Identities=25%  Similarity=0.435  Sum_probs=184.7

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      ++|+..+.||+|+||.||+|+..++..+|||.+.....     ....+.+|+.           ++++++......++||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            46788899999999999999887777899998764321     1234555543           3677888888889999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++....  ..+++.++++++.||+.|++|||+.   +++|+||||+||+++.++.+|++|||.++.....
T Consensus        79 e~~~~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05113          79 EYMSNGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence            9999999999986533  2589999999999999999999998   9999999999999999999999999998865433


Q ss_pred             CCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          737 SSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       737 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ... .....++..|+|||...+..++.++||||||+++|||++ |+.||......        .................
T Consensus       154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  225 (256)
T cd05113         154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS--------ETVEKVSQGLRLYRPHL  225 (256)
T ss_pred             ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHhcCCCCCCCCC
Confidence            211 111234567999999988889999999999999999998 99998643311        11111111111111111


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         ....+.+++.+||+.+|++|||+.+|++.++
T Consensus       226 ---~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         226 ---ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               1245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-33  Score=309.51  Aligned_cols=246  Identities=21%  Similarity=0.309  Sum_probs=181.9

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ...++|+..+.||+|+||.||+|+.. +++.||+|.+.+.... .......+.+|+.           .+++++..+...
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            34578999999999999999999654 6889999998642111 1111223334432           366777888899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++...    .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            9999999999999998543    478899999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCC-CeeeccCCccccccccccCCC----CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042123          733 LKPDSS-NWTEFAGTCGYIAPELAYTMK----ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       733 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      ...... ......||+.|+|||++.+..    ++.++||||+||++|||++|+.||......        .....+.+..
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--------~~~~~i~~~~  263 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--------GTYSKIMDHK  263 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC
Confidence            643322 223567999999999986543    788999999999999999999999743211        1112222211


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHhh
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPES--RPTMKIISQQ  846 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~  846 (849)
                      ..............+.+++..|++.+|.+  |||++|+++|
T Consensus       264 ~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11000011112334677888999865544  8999999886

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=310.76  Aligned_cols=241  Identities=23%  Similarity=0.318  Sum_probs=180.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|+. .+++.||||++...... .......+.+|+           ..+++++..+...++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEML-EKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence            4788999999999999999965 46899999998643110 111122233332           2467778888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..+..
T Consensus        80 ~E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          80 MEYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             ECCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            99999999999986543   489999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCC--------------------------------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 042123          736 DSS--------------------------------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI  777 (849)
Q Consensus       736 ~~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~  777 (849)
                      ...                                      .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            110                                      001246899999999999999999999999999999999


Q ss_pred             hCCCCCCccccccccccccccccccccCC--CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCC---HHHHHhh
Q 042123          778 KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPT---MKIISQQ  846 (849)
Q Consensus       778 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~  846 (849)
                      +|+.||.......        ....+...  ....+...  .....+.+++.+|+. +|.+|++   ++|++++
T Consensus       234 ~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~~~--~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         234 VGYPPFCSDNPQE--------TYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCCCCCHHH--------HHHHHHcCCCccCCCCCC--CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999997433211        11111111  11111100  112346788889986 8999997   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-33  Score=289.39  Aligned_cols=241  Identities=27%  Similarity=0.481  Sum_probs=186.0

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|++|.||+|...+++.||+|.++....     ..+.+.+|+.           .+++++...+..++|
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV   79 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence            467888999999999999999877788899999865321     1233444433           356778888889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.... ...+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||+++....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            99999999999986543 34589999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          736 DSSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       736 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      .... ......+..|+|||+..+..++.++||||||+++|||++ |+.||......        .....+... ..+.+.
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~  227 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA--------EVLQQVDQGYRMPCPP  227 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCCC
Confidence            2211 111122457999999998899999999999999999999 99998643211        111111110 111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          .....+.+++.+||+.+|++||++.++.+.|+
T Consensus       228 ----~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         228 ----GCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             ----cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence                12345888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-33  Score=310.47  Aligned_cols=240  Identities=22%  Similarity=0.344  Sum_probs=186.7

Q ss_pred             cCCCcCceecCCccceEEEEEecCC-cEEEEEEecccCCCCchhhHHHHHHHHHH---------hhceee-c--------
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSG-EVVAVKKFHSLLPCDQTVDQKEFLTEVEA---------FYGFCS-H--------  648 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~~ei~~---------~~~~~~-~--------  648 (849)
                      .+.++.+.|.+|||+.||.|+...+ ..||+|++-..    ....-+..++||..         +++|+. +        
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~----de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN----DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC----CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            4566788999999999999976555 99999997553    23334555666553         445554 1        


Q ss_pred             -CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          649 -ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       649 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                       ...+++.||||.+|+|-+++...-.. .|++.++++|+.|+++|+++||.. .|+|+|||||-+|||++.+|..|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence             13678999999999999999765443 399999999999999999999986 568999999999999999999999999


Q ss_pred             cCCcccCCCCCCe---------eeccCCccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccc
Q 042123          728 GIAKSLKPDSSNW---------TEFAGTCGYIAPELA---YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN  795 (849)
Q Consensus       728 G~a~~~~~~~~~~---------~~~~g~~~y~aPE~~---~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~  795 (849)
                      |.|..........         -...-|+.|+|||++   .+...++|+||||+||++|-|+....||+..+.       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            9987543332110         112458999999986   477889999999999999999999999985432       


Q ss_pred             cccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                           ..++..+...++.  ......+.+||..||+.+|.+||++-+|+.++
T Consensus       264 -----laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  264 -----LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             -----eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence                 2344444433322  23455689999999999999999999998875

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.4e-33  Score=305.07  Aligned_cols=229  Identities=23%  Similarity=0.324  Sum_probs=174.7

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|+. .+|+.||+|.+....... ......+..|.            ..+++++...+..++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLN-RKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            3699999999999954 578999999986532111 11122333332            235567778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|..++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  153 (325)
T cd05604          80 GGELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT  153 (325)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence            99999888643   3589999999999999999999998   99999999999999999999999999987644333334


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.||......        .............++.    ...
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--------~~~~~~~~~~~~~~~~----~~~  221 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--------EMYDNILHKPLVLRPG----ASL  221 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--------HHHHHHHcCCccCCCC----CCH
Confidence            4567999999999999999999999999999999999999999643211        1112222222211111    123


Q ss_pred             HHHHHHhhccCCCCCCCCCHH
Q 042123          821 SIMEVAFSCFNESPESRPTMK  841 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~  841 (849)
                      .+.+++.+|++.+|.+||++.
T Consensus       222 ~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         222 TAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             HHHHHHHHHhccCHHhcCCCC
Confidence            467889999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9e-34  Score=296.05  Aligned_cols=238  Identities=31%  Similarity=0.532  Sum_probs=176.8

Q ss_pred             cCceecCCccceEEEEEec-----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          592 AKYCIGNGGHASVYRAELP-----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ..+.||.|.||.||+|.+.     .+..|+||.+....   .......+.+|+.           +++|++.+.+..++|
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS---SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS---SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc---ccccceeeeeccccccccccccccccccccccccccccc
Confidence            3568999999999999765     36779999985431   2223556666655           478888888889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.... ...+++.++.+|+.|||.||+|||+.   +++|+||+++||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~  155 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE  155 (259)
T ss_dssp             EE--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred             ccccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence            99999999999997652 24589999999999999999999999   999999999999999999999999999987633


Q ss_pred             CCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ....  .........|+|||.+....++.++||||||+++||+++ |+.||.....        ......+.+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--------~~~~~~~~~~~~~~~~  227 (259)
T PF07714_consen  156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--------EEIIEKLKQGQRLPIP  227 (259)
T ss_dssp             SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--------HHHHHHHHTTEETTSB
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccccceec
Confidence            2221  122346678999999998889999999999999999999 7899864321        1122222222221111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ..   ....+.+++.+||+.+|++|||+.+|++.|
T Consensus       228 ~~---~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 DN---CPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TT---SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cc---hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11   122377889999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-36  Score=332.30  Aligned_cols=418  Identities=29%  Similarity=0.344  Sum_probs=263.9

Q ss_pred             CCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCC
Q 042123           32 LAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLS  111 (849)
Q Consensus        32 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  111 (849)
                      |+.|||++|++ +..|..+..+.+|+.|+++.|.|..       .+.+..++++|+.|.|..|.+. ..|..+..+++|+
T Consensus        47 L~~l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~i~~-------vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~  117 (1081)
T KOG0618|consen   47 LKSLDLSNNQI-SSFPIQITLLSHLRQLNLSRNYIRS-------VPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQ  117 (1081)
T ss_pred             eEEeecccccc-ccCCchhhhHHHHhhcccchhhHhh-------Cchhhhhhhcchhheeccchhh-cCchhHHhhhccc
Confidence            77777777777 4666677777777777777777752       2245567777777777777777 5677777777777


Q ss_pred             EEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCC
Q 042123          112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND  191 (849)
Q Consensus       112 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  191 (849)
                      +|++|.|++. ..|..+..++.++.+..++|.....    ++... ++.++|..|.+.+..+..+..++.  .|+|++|.
T Consensus       118 ~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~  189 (1081)
T KOG0618|consen  118 YLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNE  189 (1081)
T ss_pred             ccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccch
Confidence            8888877777 5666666677777777776611111    11111 444444444444433333333333  34555554


Q ss_pred             CcCcCcccccCCC--------------------CCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh
Q 042123          192 LFGSIPDEIGKMR--------------------SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL  251 (849)
Q Consensus       192 l~~~~~~~~~~l~--------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  251 (849)
                      +. .  -.+..+.                    +|+.|+.++|.++...+ .+ .-.+|+++++++|+++ .+|.++...
T Consensus       190 ~~-~--~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~-~p-~p~nl~~~dis~n~l~-~lp~wi~~~  263 (1081)
T KOG0618|consen  190 ME-V--LDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDV-HP-VPLNLQYLDISHNNLS-NLPEWIGAC  263 (1081)
T ss_pred             hh-h--hhhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeecc-cc-ccccceeeecchhhhh-cchHHHHhc
Confidence            43 1  1133334                    44444444444442211 11 1124455555555554 344444433


Q ss_pred             h-hhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCC-CCEEe
Q 042123          252 I-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPN-LTFID  329 (849)
Q Consensus       252 ~-L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~-L~~L~  329 (849)
                      . |+.+...+|++. .+|..+....+|+.|.+..|.+. -+|....++++|+.|+|..|+|...++..+..+.. |+.|.
T Consensus       264 ~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln  341 (1081)
T KOG0618|consen  264 ANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLN  341 (1081)
T ss_pred             ccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHh
Confidence            2 555555555552 33444444445555555555554 34444455555555555555555444433333333 45555


Q ss_pred             ccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccc
Q 042123          330 LSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG  409 (849)
Q Consensus       330 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  409 (849)
                      .|.|++...+.-.=..++.|+.|++.+|.++...-..+.+..+|+.|+|++|++.......+.++..|++|+||||+++ 
T Consensus       342 ~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-  420 (1081)
T KOG0618|consen  342 VSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-  420 (1081)
T ss_pred             hhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-
Confidence            5555554332222223456888999999999888788889999999999999998666678899999999999999999 


Q ss_pred             cCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCcc
Q 042123          410 RLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNEL  476 (849)
Q Consensus       410 ~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  476 (849)
                      .+|.++..+..|++|....  +..+| ++.++++|+.+|++.|+|+...-..-...++|++|||+||.+
T Consensus       421 ~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  421 TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            8899999999999987654  67788 899999999999999999865444444458999999999997

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.7e-33  Score=305.96  Aligned_cols=245  Identities=22%  Similarity=0.410  Sum_probs=184.5

Q ss_pred             hcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceeec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~  648 (849)
                      .++|.+.+.||+|+||.||+|+..      .+..||||++.....   ......+..|+.            ++++++..
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR---SSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            468888999999999999999642      234699999865322   122334555543            46778888


Q ss_pred             CCeeEEEEEeccCCChhhhhccccc-------------------------------------------------------
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAA-------------------------------------------------------  673 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------------------------  673 (849)
                      ....++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            8899999999999999998864311                                                       


Q ss_pred             --------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 042123          674 --------------------------------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLL  715 (849)
Q Consensus       674 --------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil  715 (849)
                                                            ...+++.++..++.||+.|++|||+.   +|+||||||+||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                  12478889999999999999999998   9999999999999


Q ss_pred             ecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 042123          716 LDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSS  792 (849)
Q Consensus       716 l~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~  792 (849)
                      ++.++.+|++|||+++.......  ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---  346 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---  346 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---
Confidence            99999999999999986543222  1223346778999999988889999999999999999997 99998643211   


Q ss_pred             ccccccccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          793 SLNTDVALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       793 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          .......... +...+    ......+.+++.+||+.+|++|||+.+|.+.|+
T Consensus       347 ----~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         347 ----STFYNKIKSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             ----HHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence                0001111111 11111    122345889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-33  Score=304.29  Aligned_cols=249  Identities=22%  Similarity=0.376  Sum_probs=176.9

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC-----Ce
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA-----RH  651 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~-----~~  651 (849)
                      +|+..+.||+|+||.||+|.. .++..||||++......  ......+.+|+..           +++++...     ..
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH--VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc--chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            477889999999999999964 57899999998643221  1223345555442           34444322     35


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .|+||||++ ++|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        79 ~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          79 IYVVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            799999996 6898888643   3489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC---CeeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc
Q 042123          732 SLKPDSS---NWTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTDVA  799 (849)
Q Consensus       732 ~~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~~~  799 (849)
                      .......   ......|++.|+|||++.+  ..++.++|||||||++|||++|+.||.........       .......
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  231 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET  231 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6533221   2234578999999998865  67899999999999999999999999643311000       0000000


Q ss_pred             c--------cc---ccCCCCCCCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 L--------DQ---MLDPRLPAPS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~--------~~---~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .        ..   .+....+.+. .........+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            0        00   0001111000 0000112346789999999999999999999875

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.9e-33  Score=280.27  Aligned_cols=245  Identities=21%  Similarity=0.303  Sum_probs=190.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCC-chhhHHHHHHHHH---------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD-QTVDQKEFLTEVE---------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~ei~---------~~~~~~~~~~~~~lV~  656 (849)
                      +.|+..+.||.|.-|+||.++.. ++..+|+|++.+..... ....+...-+||-         .+|+.++.+...++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            45677889999999999999775 45889999987643221 1112223333433         4788889999999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC-
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP-  735 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~-  735 (849)
                      |||+||+|...++++. .+.++++.++-++..|+-||+|||..   |||+|||||+||||.++|++.++||.++..... 
T Consensus       157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999987765 45699999999999999999999999   999999999999999999999999997642210 


Q ss_pred             ---------------------------------CC----------------------CCeeeccCCccccccccccCCCC
Q 042123          736 ---------------------------------DS----------------------SNWTEFAGTCGYIAPELAYTMKI  760 (849)
Q Consensus       736 ---------------------------------~~----------------------~~~~~~~g~~~y~aPE~~~~~~~  760 (849)
                                                       ..                      .....++||-.|.|||++.+...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                             00                      01123578999999999999999


Q ss_pred             CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCC-
Q 042123          761 TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT-  839 (849)
Q Consensus       761 ~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-  839 (849)
                      +.+.|.|+|||++|||+.|..||...+        ..+.+..++...+..+...  ..+..+.++|.+.+.+||.+|.- 
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~--------~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSN--------NKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCC--------chhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhcc
Confidence            999999999999999999999997433        3344444444443332221  44456889999999999999987 


Q ss_pred             ---HHHHHhh
Q 042123          840 ---MKIISQQ  846 (849)
Q Consensus       840 ---~~eil~~  846 (849)
                         +.||.+|
T Consensus       383 ~rGA~eIK~H  392 (459)
T KOG0610|consen  383 KRGAAEIKRH  392 (459)
T ss_pred             ccchHHhhcC
Confidence               8888765

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.4e-33  Score=288.25  Aligned_cols=240  Identities=27%  Similarity=0.468  Sum_probs=182.8

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      .+|+..+.||+|+||.||+|.++++..+|+|.+.....     ....+.+|+.           ++++++......++||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            46788899999999999999887778899998764321     1233444433           3566777778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.....
T Consensus        79 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          79 EYMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             ecCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence            9999999999986543  2589999999999999999999999   9999999999999999999999999998865432


Q ss_pred             CCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          737 SSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       737 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||+........     ........  ...+.  
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-----~~~~~~~~--~~~~~--  224 (256)
T cd05059         154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-----ESVSAGYR--LYRPK--  224 (256)
T ss_pred             cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH-----HHHHcCCc--CCCCC--
Confidence            111 111223457999999998899999999999999999999 89998743221100     00010011  11111  


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        ....++.+++.+||+.+|++|||+.|+++.|.
T Consensus       225 --~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         225 --LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence              12335889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.4e-33  Score=294.86  Aligned_cols=239  Identities=22%  Similarity=0.368  Sum_probs=184.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+......    ....+.+|+.           .+++++......++|
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc----hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            5788889999999999999964 57899999988653221    1233444433           356677778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...    .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             ecccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999998532    478999999999999999999999   999999999999999999999999999886554


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........+++.|+|||.+.+..++.++|||||||++|+|++|+.||.......       ........+...  ....
T Consensus       169 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~--~~~~  239 (296)
T cd06654         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNGTPE--LQNP  239 (296)
T ss_pred             cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHhcCCCCC--CCCc
Confidence            3333344578899999999988889999999999999999999999996432211       000111111110  0111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++|||+.+++++
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            2233457889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-32  Score=287.66  Aligned_cols=249  Identities=20%  Similarity=0.305  Sum_probs=189.5

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++..... .......+.+|++           .+++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMM-DAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeeccccc-chhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            57889999999999999999665 7999999988642211 1222344555544           256677777889999


Q ss_pred             EEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |||+++|+|.+++.... ....+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999999999986432 234589999999999999999999998   99999999999999999999999999988665


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++|+.||......      .............++.+  
T Consensus       158 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~--  229 (267)
T cd08224         158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEKCDYPPLP--  229 (267)
T ss_pred             CCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc------HHHHHhhhhcCCCCCCC--
Confidence            4333334456888999999998888999999999999999999999998532210      00111111111111111  


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .......+.+++.+||+.+|++|||+.+|++.|+
T Consensus       230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~  263 (267)
T cd08224         230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK  263 (267)
T ss_pred             hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence            1123345788999999999999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-32  Score=292.12  Aligned_cols=244  Identities=27%  Similarity=0.494  Sum_probs=186.8

Q ss_pred             cCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      ++|.+.+.||+|+||.||+|...      +++.||||.+.....   ......+.+|+.           .+++++....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS---NDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC---HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            46788889999999999999653      357899999865422   212345555544           3667777788


Q ss_pred             eeEEEEEeccCCChhhhhcccc-----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDA-----------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      ..++||||+++|+|.+++....           ....+++.++..++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~  158 (280)
T cd05049          82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence            9999999999999999996532           123578999999999999999999998   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNT  796 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~  796 (849)
                      +.+|++|||+++.......  ......+++.|+|||++.+..++.++||||||+++|||++ |..||......       
T Consensus       159 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------  231 (280)
T cd05049         159 LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------  231 (280)
T ss_pred             CeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------
Confidence            9999999999976533221  1123345678999999999999999999999999999998 99998643211       


Q ss_pred             ccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          797 DVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       ................   .....+.+++.+||+.+|++|||+.||++.|+
T Consensus       232 -~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 -EVIECITQGRLLQRPR---TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence             1112222222221111   12234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.8e-33  Score=295.12  Aligned_cols=243  Identities=23%  Similarity=0.382  Sum_probs=180.7

Q ss_pred             HHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceeec---
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH---  648 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~---  648 (849)
                      .+.+.|+..+.||+|+||.||+|.. .+++.||+|.+......     ...+.+|+.            ++.+++..   
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   77 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence            3567788889999999999999965 46889999998643211     122333322            24455443   


Q ss_pred             ---CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 042123          649 ---ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVA  725 (849)
Q Consensus       649 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  725 (849)
                         ....++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+.   +|+||||+|+||++++++.++|+
T Consensus        78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          78 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             CCCCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence               246789999999999999986533 24589999999999999999999998   99999999999999999999999


Q ss_pred             eecCCcccCCCCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 042123          726 DFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL  800 (849)
Q Consensus       726 DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~  800 (849)
                      |||++..............|+..|+|||++.     +..++.++||||+||++|||++|+.||..........     ..
T Consensus       154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~  228 (272)
T cd06637         154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LI  228 (272)
T ss_pred             cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HH
Confidence            9999986544333334567889999999886     3457889999999999999999999986433211100     00


Q ss_pred             ccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......... .    .....+.+++.+||+.+|.+|||+.+++++
T Consensus       229 ~~~~~~~~~~-~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 PRNPAPRLKS-K----KWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             hcCCCCCCCC-C----CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            0000111111 1    122347889999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-32  Score=296.84  Aligned_cols=239  Identities=25%  Similarity=0.479  Sum_probs=180.3

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCc----EEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+....   .....+.+.+|+.           .+++++.. ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~   82 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT-ST   82 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CC
Confidence            57899999999999999999653 333    38999876431   2223344555543           35666654 45


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++|+||+++|+|.+++....  ..+++..+++++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~  157 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccc
Confidence            679999999999999987543  3488999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCee--eccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--C
Q 042123          732 SLKPDSSNWT--EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD--P  806 (849)
Q Consensus       732 ~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~  806 (849)
                      ..........  ...++..|+|||++.+..++.++||||||+++|||++ |+.||+......         ......  .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~  228 (316)
T cd05108         158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---------ISSILEKGE  228 (316)
T ss_pred             cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHhCCC
Confidence            7654332211  1234568999999999999999999999999999998 999987432111         011111  1


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.+...    ...+.+++.+||+.+|++|||+.+++.++.
T Consensus       229 ~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         229 RLPQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFS  266 (316)
T ss_pred             CCCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11211111    224778999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-33  Score=301.57  Aligned_cols=189  Identities=21%  Similarity=0.321  Sum_probs=157.4

Q ss_pred             CCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCch-hhHHHHHHH-----------HHHhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQT-VDQKEFLTE-----------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~-~~~~~~~~e-----------i~~~~~~~~~~~~~~lV  655 (849)
                      +|.+.+.||+|+||.|-|| +.++++.||||+++........ ..+..+++.           ++++++|+.+.+|.|||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV  266 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV  266 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence            8889999999999999999 6778999999999865332111 112222222           22478899999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC--CcEEEeeecCCccc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE--YEAHVADFGIAKSL  733 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfG~a~~~  733 (849)
                      +|.++. +|+++++.... ..++...++.++.||+.||.+||+.   +|+|+||||+|||+...  ..+||+|||.|...
T Consensus       267 fELL~~-NLYellK~n~f-~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  267 FELLST-NLYELLKNNKF-RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             ehhhhh-hHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            999977 99999987653 4589999999999999999999998   99999999999999655  47999999999875


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                      ...  .+ ....+..|+|||++.+.+|+.+.||||||||++||++|.+-|..
T Consensus       342 ~q~--vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  342 SQR--VY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             CCc--ce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            432  22 66788999999999999999999999999999999999766653

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.9e-32  Score=287.19  Aligned_cols=240  Identities=25%  Similarity=0.422  Sum_probs=183.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .+|+..+.||+|+||.||+|.. ..++.||+|.+....     .....+.+|+.           ++++++......++|
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence            5678889999999999999955 458899999876431     11233444433           467777888889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.+|++|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            99999999999986533 24589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCe-eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          736 DSSNW-TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       736 ~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      ..... .....+..|+|||.+.+..++.++||||||+++|||++ |..||......        ......... ....+.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~  228 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKGYRMERPE  228 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCCCCCCC
Confidence            32111 11223567999999998899999999999999999998 99998643211        111111110 111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 ----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~  260 (263)
T cd05052         229 ----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFE  260 (263)
T ss_pred             ----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence                12234888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=295.17  Aligned_cols=245  Identities=23%  Similarity=0.308  Sum_probs=200.4

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSF  653 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~  653 (849)
                      ...|+..+.||+|.||.||+++.+ +|+.+|+|.+.+....... ......+|+.            .+.+.++.....+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~-~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE-DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc-cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            357888899999999999999655 5999999999765432221 1223333332            3677888889999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC----CcEEEeeecC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE----YEAHVADFGI  729 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~DfG~  729 (849)
                      +|||+++||.|.+.+...    .+++..+..++.|++.|+.|||+.   +|+|||+||+|+|+...    +.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999999655    289999999999999999999998   99999999999999644    4799999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      +..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||......        .....+......
T Consensus       186 a~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~--------~~~~~i~~~~~~  256 (382)
T KOG0032|consen  186 AKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF--------EIFLAILRGDFD  256 (382)
T ss_pred             ceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh--------HHHHHHHcCCCC
Confidence            998876 56678889999999999999999999999999999999999999999854321        222344444444


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .....+......+.+++..|+..||.+|+|+.++++|-.
T Consensus       257 f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  257 FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence            444555566677889999999999999999999998743

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-34  Score=298.88  Aligned_cols=236  Identities=27%  Similarity=0.381  Sum_probs=184.0

Q ss_pred             CCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e  657 (849)
                      |...+.||+|+||.||-|+ ..+.+.||||++.-.-. .....-..+++||.           .+.|||-.+...|+|||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeecccccc-ccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            4556789999999999994 45789999999864322 22333445555554           37788888899999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      ||-| |-.|++.-..  .++.+.++..|..+.+.||+|||+.   +.+|||||+-|||+++.|.||++|||.|....+  
T Consensus       107 YClG-SAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HHhc-cHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            9965 7777775443  4588899999999999999999998   899999999999999999999999999987654  


Q ss_pred             CCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          738 SNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                        ...++|||.|||||++.   .+.|+-++||||+|++..|+..+++|...+.....-+-.     .+--.|.++     
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-----AQNesPtLq-----  246 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-----AQNESPTLQ-----  246 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-----HhcCCCCCC-----
Confidence              35689999999999875   467999999999999999999999997654433211100     000011222     


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..++...+..|+..|+++-|.+|||.+++++|
T Consensus       247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            22445557788889999999999999999886

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-33  Score=302.10  Aligned_cols=229  Identities=24%  Similarity=0.319  Sum_probs=176.0

Q ss_pred             ceecCCccceEEEEEe----cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEEEe
Q 042123          594 YCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~e~  658 (849)
                      +.||+|+||.||+++.    .+|+.||+|++......  ......+..|+           .++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK--VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh--hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            5799999999999854    36889999998653211  11122233332           2466778888899999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        80 ~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          80 LRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            9999999998643   3489999999999999999999998   999999999999999999999999999987654433


Q ss_pred             CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          739 NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       739 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......        .....+.......+..    .
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~~~~~p~~----~  221 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKAKLGMPQF----L  221 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcCCCCCCCC----C
Confidence            344567899999999999888999999999999999999999999743211        1112222222221111    1


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHH
Q 042123          819 LISIMEVAFSCFNESPESRPTMKI  842 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RPt~~e  842 (849)
                      ...+.+++.+||+.||++||++.+
T Consensus       222 ~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         222 SPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CHHHHHHHHHHhhcCHhHcCCCCC
Confidence            234778899999999999999443

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-32  Score=318.85  Aligned_cols=247  Identities=25%  Similarity=0.386  Sum_probs=183.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||||++...... .....+++.+|+.           .+++++.+.+..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~-~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSE-NPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECccccc-CHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            5788999999999999999965 46899999998754322 2223445666654           366777888899999


Q ss_pred             EEeccCCChhhhhcccc--------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          656 YEFLERGSLAAILNTDA--------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                      |||+++|+|.+++....        ....+++.++.+++.||+.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence            99999999999986421        123456788899999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCCCCC------------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 042123          728 GIAKSLKPDSS------------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSI  789 (849)
Q Consensus       728 G~a~~~~~~~~------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~  789 (849)
                      |+++.......                  .....+||+.|+|||++.+..++.++||||+||++|||+||+.||......
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~  237 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR  237 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence            99986521110                  012246899999999999999999999999999999999999999742211


Q ss_pred             cccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCC-CHHHHHhhh
Q 042123          790 SSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRP-TMKIISQQL  847 (849)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L  847 (849)
                      ..   .   .......+....+   ..+....+.+++.+|++.||++|| +++++.+.|
T Consensus       238 ki---~---~~~~i~~P~~~~p---~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        238 KI---S---YRDVILSPIEVAP---YREIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             hh---h---hhhhccChhhccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            00   0   0011111110000   112234477899999999999996 555555544

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-33  Score=310.20  Aligned_cols=240  Identities=19%  Similarity=0.266  Sum_probs=176.8

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~  656 (849)
                      +|++.+.||+|+||.||+|+. .+++.||||.+...... .......+.+|+           .++++.+.+++..++||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVL-MRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHH-hhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            688899999999999999954 46899999998642110 011122233333           23667778889999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.+.   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|..+...
T Consensus        81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            999999999998654   3478899999999999999999999   9999999999999999999999999997533100


Q ss_pred             C-------------------------------------------CCeeeccCCccccccccccCCCCCccchHHHHHHHH
Q 042123          737 S-------------------------------------------SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM  773 (849)
Q Consensus       737 ~-------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil  773 (849)
                      .                                           .......||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                           001134689999999999999999999999999999


Q ss_pred             HHHHhCCCCCCccccccccccccccccccccC--CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCC---CHHHHHhh
Q 042123          774 WEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESRP---TMKIISQQ  846 (849)
Q Consensus       774 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~eil~~  846 (849)
                      |||++|+.||.......        ....+..  .....+.  .......+.+++.+|+ .+|.+|+   |+.++++|
T Consensus       235 yell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         235 YEMLVGQPPFLADTPAE--------TQLKVINWETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eehhhCCCCCCCCCHHH--------HHHHHhccCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999997433211        0011111  1111110  0111223566777766 4999999   89999876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-33  Score=292.13  Aligned_cols=242  Identities=27%  Similarity=0.433  Sum_probs=189.2

Q ss_pred             hcCCCcCceecCCccceEEEEEec---CCc--EEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP---SGE--VVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHAR  650 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~  650 (849)
                      .+.....+.||.|.||.||+|...   .|+  -||||.-+.....   ...+.|++|           |.+++|.|.+ .
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~---d~tekflqEa~iMrnfdHphIikLIGv~~e-~  463 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP---DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q  463 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh---hhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence            344556778999999999999543   233  3788887664322   235667766           4468888865 5


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..|+|||.++-|.|..+++...  ..++......++.||..||+|||+.   .+|||||.++|||+.....+|++|||++
T Consensus       464 P~WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             ceeEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchh
Confidence            6789999999999999998654  4588889999999999999999999   8999999999999999999999999999


Q ss_pred             cccCCCCCCeee-ccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 042123          731 KSLKPDSSNWTE-FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       731 ~~~~~~~~~~~~-~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      +.+..+...... ..-...|||||.+.-.+++.++|||-|||++||++. |..||......       +....---..++
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-------DVI~~iEnGeRl  611 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-------DVIGHIENGERL  611 (974)
T ss_pred             hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-------ceEEEecCCCCC
Confidence            988766543322 223568999999999999999999999999999986 99999854321       112221223355


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      |.++.++.    .+..++.+||++||.+||++.+|...|+
T Consensus       612 P~P~nCPp----~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  612 PCPPNCPP----ALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             CCCCCCCh----HHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            55544443    3778899999999999999999987763

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-32  Score=311.50  Aligned_cols=240  Identities=19%  Similarity=0.235  Sum_probs=183.9

Q ss_pred             CCCcCceecCCccceEEEEEe-cC-CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PS-GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .|...+.||+|+||.||+|.. .+ ++.||+|.+...    .......+..|+.           ++++++...+..|+|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            488899999999999999944 34 678888876432    1122233444533           467788888999999


Q ss_pred             EEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |||+++|+|.+++... .....+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            9999999999988543 2234588999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          735 PDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       735 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .............+.+
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~~~  292 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGKYDPFP  292 (478)
T ss_pred             CccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC
Confidence            3321  23445689999999999999999999999999999999999999864321        1112222222221111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .   .....+.+++.+||+.+|++||++++++.+
T Consensus       293 ~---~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        293 C---PVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             c---cCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            1   122347889999999999999999999764

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.3e-33  Score=308.27  Aligned_cols=238  Identities=19%  Similarity=0.296  Sum_probs=175.5

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      .|+..+.||+|+||+||+|+. .+++.||+|.+...... .......+.+|+.           ++++++...+..++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVL-LRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhh-hHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            578899999999999999954 57889999998643110 1111223333432           3667778888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.+.   ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          81 DYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            999999999998654   3478899999999999999999999   9999999999999999999999999997533110


Q ss_pred             C-----------------------------------------------CCeeeccCCccccccccccCCCCCccchHHHH
Q 042123          737 S-----------------------------------------------SNWTEFAGTCGYIAPELAYTMKITEKCDVYSF  769 (849)
Q Consensus       737 ~-----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~Sl  769 (849)
                      .                                               ......+||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                               00112468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccccccccccccccccC--C--CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCC---HHH
Q 042123          770 GVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--P--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPT---MKI  842 (849)
Q Consensus       770 Gvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~e  842 (849)
                      ||++|||++|+.||.......        ....+..  .  ..+.....    .....+++.+++ .+|++|++   +++
T Consensus       235 Gvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~~~~----s~~~~~li~~l~-~~p~~R~~~~~~~e  301 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLE--------TQMKVINWQTSLHIPPQAKL----SPEASDLIIKLC-RGPEDRLGKNGADE  301 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHH--------HHHHHHccCCCcCCCCcccC----CHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence            999999999999997432211        1111111  1  11111111    223556666665 49999987   888


Q ss_pred             HHhh
Q 042123          843 ISQQ  846 (849)
Q Consensus       843 il~~  846 (849)
                      +++|
T Consensus       302 i~~h  305 (382)
T cd05625         302 IKAH  305 (382)
T ss_pred             HhcC
Confidence            8765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.9e-32  Score=289.48  Aligned_cols=244  Identities=25%  Similarity=0.414  Sum_probs=183.1

Q ss_pred             hcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      .++|...+.||+|+||.||+|.+.      .+..||+|.+....   .......+.+|+.           ++++++.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC---SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            467888999999999999999664      35678999875432   1222344555543           356677777


Q ss_pred             CeeEEEEEeccCCChhhhhccccc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cE
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAA----AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---EA  722 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~  722 (849)
                      ...++||||+++|+|.+++++...    ...+++.++.+++.||+.|++|||+.   +++||||||+||+++.++   .+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~  158 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence            888999999999999999865432    12589999999999999999999999   999999999999998765   59


Q ss_pred             EEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042123          723 HVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      |++|||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |+.||......        ..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~--------~~  230 (277)
T cd05036         159 KIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ--------EV  230 (277)
T ss_pred             EeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--------HH
Confidence            99999999876432211  112233567999999998899999999999999999997 99998743211        11


Q ss_pred             cccccC-CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+.. .+...+.    .....+.+++.+||+.+|++|||+.+|+++|+
T Consensus       231 ~~~~~~~~~~~~~~----~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 MEFVTGGGRLDPPK----GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            111111 1111111    12234788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-32  Score=301.93  Aligned_cols=248  Identities=18%  Similarity=0.253  Sum_probs=181.4

Q ss_pred             cCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceeecCCeeEEEEEeccC
Q 042123          588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      ..|+..+.||+|+||.||+|. ..+++.||+|.....    ....+...++.     |.++++++......++|+|++. 
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~----~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-  166 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG----GTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-  166 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh----hhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-
Confidence            579999999999999999995 457899999975321    11222223332     3357788888889999999996 


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC-CCCe
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNW  740 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~  740 (849)
                      ++|..++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+..... ....
T Consensus       167 ~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~  240 (391)
T PHA03212        167 TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKY  240 (391)
T ss_pred             CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccc
Confidence            6888887543   3489999999999999999999998   9999999999999999999999999999754322 2223


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------------------cc--ccccc
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------------------SL--NTDVA  799 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------------------~~--~~~~~  799 (849)
                      ....||+.|+|||++.+..++.++||||+||++|||++|+.||.........                   ..  .....
T Consensus       241 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~  320 (391)
T PHA03212        241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQAN  320 (391)
T ss_pred             ccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHH
Confidence            4467999999999999989999999999999999999999886432211000                   00  00000


Q ss_pred             cccc----c-----CCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQM----L-----DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~~----~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....    .     .+...+...........+.+++.+||+.||++|||++|++++
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        321 LDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0000    0     000000011112234468899999999999999999999875

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=307.97  Aligned_cols=241  Identities=22%  Similarity=0.311  Sum_probs=177.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|+. .+++.||||++...... .......+..|+.           ++++++.+....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMF-KKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHH-HhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence            4788899999999999999954 57899999998542111 1111223333432           467788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++.+..
T Consensus        80 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          80 MEFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999998653   3588999999999999999999999   999999999999999999999999999864321


Q ss_pred             CCC-----------------------------------------------CeeeccCCccccccccccCCCCCccchHHH
Q 042123          736 DSS-----------------------------------------------NWTEFAGTCGYIAPELAYTMKITEKCDVYS  768 (849)
Q Consensus       736 ~~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~S  768 (849)
                      ...                                               ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            100                                               001246899999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCChhhHHHHHHHHHHHhhccCCCCCCC---CCHHHH
Q 042123          769 FGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESR---PTMKII  843 (849)
Q Consensus       769 lGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ei  843 (849)
                      |||++|||++|+.||......        .....+..  ..+..+..  ......+.+++.+|+. +|.+|   +|+.|+
T Consensus       234 lGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSH--------ETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHH--------HHHHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            999999999999999643221        11111111  11111110  0112347788889997 66664   699999


Q ss_pred             Hhh
Q 042123          844 SQQ  846 (849)
Q Consensus       844 l~~  846 (849)
                      +++
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.6e-32  Score=289.55  Aligned_cols=244  Identities=21%  Similarity=0.416  Sum_probs=182.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-----cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      ++|+..+.||+|+||.||+|..     .++..||+|.+....   .......+.+|+.           ++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN---NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            4678889999999999999963     356789999986432   1222234555543           35667777788


Q ss_pred             eEEEEEeccCCChhhhhcccc--------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 042123          652 SFLLYEFLERGSLAAILNTDA--------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD  717 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  717 (849)
                      .++||||+++|+|.+++....              ....+++.++..++.|++.|++|||+.   +++||||||+||+++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~  158 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIG  158 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEc
Confidence            999999999999999985321              123478999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 042123          718 LEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSL  794 (849)
Q Consensus       718 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~  794 (849)
                      .++.+|++|||+++.......  ......++..|+|||++.+..++.++||||||+++|||++ |..||......     
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-----  233 (283)
T cd05090         159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-----  233 (283)
T ss_pred             CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----
Confidence            999999999999986543321  1222345678999999988889999999999999999998 99998643211     


Q ss_pred             ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         ................   .....+.+++.+||+.+|++||++.+|.++|+
T Consensus       234 ---~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         234 ---EVIEMVRKRQLLPCSE---DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             ---HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence               1111111111111111   12234778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-33  Score=299.21  Aligned_cols=237  Identities=27%  Similarity=0.491  Sum_probs=186.5

Q ss_pred             CCcCceecCCccceEEEEEe-cCC----cEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeE
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSG----EVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSF  653 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~  653 (849)
                      ....++||+|+||+||||.| +.|    -+||+|++....   ......++++|           +.+++|+|.... ..
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            34567899999999999954 444    358888876542   23334455555           446888887765 78


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      ||++||+.|.|.++++..+  ..+..+..+.|..|||+||.|||.+   .+|||||.++|||+.+...+|+.|||+|+..
T Consensus       774 lvtq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            9999999999999997654  3588899999999999999999999   9999999999999999999999999999988


Q ss_pred             CCCCCCeeeccC--CccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc-CCCCC
Q 042123          734 KPDSSNWTEFAG--TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQML-DPRLP  809 (849)
Q Consensus       734 ~~~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  809 (849)
                      ..+...+....|  .+.|||-|.+....|+.++|||||||++||++| |..|++.......        -.-+- ..+++
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI--------~dlle~geRLs  920 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI--------PDLLEKGERLS  920 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh--------hHHHhccccCC
Confidence            876554444443  568999999999999999999999999999998 9999885442211        11111 12344


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      .++....    .+..++.+||..|++.||+++++...+
T Consensus       921 qPpiCti----DVy~~mvkCwmid~~~rp~fkel~~~f  954 (1177)
T KOG1025|consen  921 QPPICTI----DVYMVMVKCWMIDADSRPTFKELAEEF  954 (1177)
T ss_pred             CCCCccH----HHHHHHHHHhccCcccCccHHHHHHHH
Confidence            4443333    377888999999999999999998765

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-32  Score=290.77  Aligned_cols=243  Identities=26%  Similarity=0.465  Sum_probs=183.6

Q ss_pred             cCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      .+|.+.+.||+|+||.||++..      .++..+|+|.+....    ......+.+|+.           ++++++....
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS----DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC----HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            5788889999999999999963      235668999876431    122334555544           3567788888


Q ss_pred             eeEEEEEeccCCChhhhhcccc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDA----------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY  720 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  720 (849)
                      ..++||||+++++|.+++....          ....+++.++..++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            9999999999999999986432          123489999999999999999999998   999999999999999999


Q ss_pred             cEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 042123          721 EAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTD  797 (849)
Q Consensus       721 ~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~  797 (849)
                      .+|++|||+++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||......        
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--------  229 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--------  229 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------
Confidence            9999999999865432211  122335678999999998889999999999999999998 99998643211        


Q ss_pred             cccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .....+..........   .....+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       230 ~~~~~i~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~  277 (288)
T cd05093         230 EVIECITQGRVLQRPR---TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ  277 (288)
T ss_pred             HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            1111111111111111   11234889999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.2e-33  Score=305.06  Aligned_cols=247  Identities=20%  Similarity=0.329  Sum_probs=183.4

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH  648 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~  648 (849)
                      .++....++|+..+.||+|+||.||+|+.. +++.||+|.+...... .......+.+|+.           ++++++..
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~-~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            444555689999999999999999999654 6889999998642110 1111222333332           36667778


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      +...++||||+++|+|.+++...    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            88999999999999999998543    478899999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCC-CeeeccCCccccccccccCC----CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042123          729 IAKSLKPDSS-NWTEFAGTCGYIAPELAYTM----KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM  803 (849)
Q Consensus       729 ~a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  803 (849)
                      +++....... ......||+.|+|||++.+.    .++.++||||+||++|||++|+.||......        .....+
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i  259 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKI  259 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--------HHHHHH
Confidence            9987643322 22346799999999998654    3788999999999999999999999743321        111111


Q ss_pred             cC----CCCCCCChhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHhhh
Q 042123          804 LD----PRLPAPSRSAQEKLISIMEVAFSCFNESPES--RPTMKIISQQL  847 (849)
Q Consensus       804 ~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~L  847 (849)
                      ..    ..++...    .....+.+++..|++.++.+  ||+++|++++.
T Consensus       260 ~~~~~~~~~~~~~----~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         260 MNHKNSLTFPDDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HcCCCcccCCCcC----CCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            11    1111111    12234678888999854443  78999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2e-32  Score=292.07  Aligned_cols=239  Identities=22%  Similarity=0.388  Sum_probs=185.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+......    ....+.+|+.           .+++++..++..++|
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            6888999999999999999964 57999999998643221    1233444433           367777888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.+    ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            999999999999854    2478999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........+++.|+|||...+..++.++|||||||++|++++|+.||........        .........+ .....
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--------~~~~~~~~~~-~~~~~  238 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNGTP-ELQNP  238 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--------eeeeccCCCC-CCCCc
Confidence            43333445688899999999988899999999999999999999999964322110        0001100000 11111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++||++++++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1223347789999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-32  Score=292.76  Aligned_cols=239  Identities=23%  Similarity=0.390  Sum_probs=184.5

Q ss_pred             cCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .+|+..+.||.|+||.||+|. ..+++.||+|.+.....    .....+.+|+.           .+++++......++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ----PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC----chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            468889999999999999995 45799999998864321    11233444433           367777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      +||+++++|.+++...    .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          95 MEYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            9999999999988542    489999999999999999999999   999999999999999999999999999886654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........++..|+|||.+.+..++.++|||||||++|++++|+.||........        ........ .......
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--------~~~~~~~~-~~~~~~~  238 (296)
T cd06655         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNG-TPELQNP  238 (296)
T ss_pred             ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhcC-CcccCCc
Confidence            43333345688899999999988899999999999999999999999974332110        00010000 0001111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||..||++|||+.+|+++
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            1222347788999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.6e-32  Score=285.03  Aligned_cols=239  Identities=25%  Similarity=0.417  Sum_probs=186.9

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +++.+|+|.+.....      ...+.+|+.           .+++++......+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED------LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH------HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            67889999999999999999765 488999999864321      334555543           367777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      +||+++++|.+++....  ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          77 MEYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            99999999999985433  4589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........++..|+|||++.+..++.++||||||+++|+|++|+.||.........        .. +...........
T Consensus       152 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~--------~~-~~~~~~~~~~~~  222 (256)
T cd06612         152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI--------FM-IPNKPPPTLSDP  222 (256)
T ss_pred             CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh--------hh-hccCCCCCCCch
Confidence            432334456788999999999889999999999999999999999998743221100        00 000111111111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++|||+.|++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            1223458889999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=286.47  Aligned_cols=244  Identities=21%  Similarity=0.315  Sum_probs=185.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc-hhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ-TVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      ++|...+.||+|++|.||+|.. .++++||+|.+........ ......+.+|+.           ++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5788999999999999999954 5689999998864322111 112233444433           36778888889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |+||+++++|.+++...   ..+++..+.+++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.++...
T Consensus        82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            99999999999998653   3478999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          735 PDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       735 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      .....   .....++..|+|||.+.+..++.++||||+|+++||+++|+.||.......        ...........  
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~--  225 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA--------AIFKIATQPTN--  225 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH--------HHHHHhccCCC--
Confidence            32111   123457789999999999889999999999999999999999986432111        00111111110  


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ..........+.+++.+||+.+|++|||+.+++++.
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            001112233478899999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.3e-32  Score=285.14  Aligned_cols=240  Identities=20%  Similarity=0.303  Sum_probs=184.6

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||+++. .+++.+|+|.+.....   ......+..|+.           .+.+++...+..++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS---SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc---hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            477889999999999999955 4689999998854321   112223333322           3566778888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.... ...++++.+..++.|++.|+.|||+.   +++|+||||+||++++++.++++|||.+......
T Consensus        78 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  153 (255)
T cd08219          78 EYCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP  153 (255)
T ss_pred             eeCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence            9999999999886432 24578999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      ........+++.|+|||++.+..++.++||||||+++|+|++|+.||......        ..............+.   
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~---  222 (255)
T cd08219         154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK--------NLILKVCQGSYKPLPS---  222 (255)
T ss_pred             ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH--------HHHHHHhcCCCCCCCc---
Confidence            33344567889999999998888999999999999999999999999743211        1111111111111111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.+++.+||+.||++|||+.+++..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            122347789999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.3e-32  Score=286.02  Aligned_cols=240  Identities=23%  Similarity=0.418  Sum_probs=184.3

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV  655 (849)
                      .++|+..++||+|+||.||+|..++++.||+|.+.....     ....+.+|+..           +++++ ..+..++|
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v   78 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYII   78 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEE
Confidence            467889999999999999999888899999999865321     22345555442           34443 34568999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          79 TEYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            99999999999986543 34689999999999999999999998   999999999999999999999999999987653


Q ss_pred             CCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      ... ......++..|+|||++.+..++.++||||||+++||+++ |+.||.......        ....+... +.+.+.
T Consensus       155 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~  226 (260)
T cd05067         155 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--------VIQNLERGYRMPRPD  226 (260)
T ss_pred             CCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--------HHHHHHcCCCCCCCC
Confidence            221 1222345678999999988889999999999999999999 999997433111        11111111 111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          ....++.+++.+||+.+|++|||++++...|+
T Consensus       227 ----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         227 ----NCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence                11234888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.5e-32  Score=290.72  Aligned_cols=243  Identities=27%  Similarity=0.495  Sum_probs=184.7

Q ss_pred             cCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      ++|...+.||+|+||.||+|..      .++..+|+|.+....    ....+.+.+|+.           ++++++....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT----LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc----HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            4677888999999999999964      235668999875431    222334555544           3667778888


Q ss_pred             eeEEEEEeccCCChhhhhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 042123          651 HSFLLYEFLERGSLAAILNTDA-------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD  717 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  717 (849)
                      ..++||||+++++|.+++....             ....+++.++++++.|++.|++|||++   +|+||||||+||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~  157 (291)
T cd05094          81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG  157 (291)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence            8999999999999999986432             123489999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 042123          718 LEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSL  794 (849)
Q Consensus       718 ~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~  794 (849)
                      .++.++++|||++........  ......++..|+|||++.+..++.++||||||+++|||++ |+.||......     
T Consensus       158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----  232 (291)
T cd05094         158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----  232 (291)
T ss_pred             cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence            999999999999976543221  1223445778999999998899999999999999999998 99998643321     


Q ss_pred             ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         .....+..+.......   .....+.+++.+||+.+|++|||+++|++.|+
T Consensus       233 ---~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         233 ---EVIECITQGRVLERPR---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILH  280 (291)
T ss_pred             ---HHHHHHhCCCCCCCCc---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence               1111122222211111   12234789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-32  Score=312.53  Aligned_cols=255  Identities=16%  Similarity=0.236  Sum_probs=178.2

Q ss_pred             HHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc-hhhHHHHHHHHH-----------Hhhceeec-
Q 042123          583 IVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ-TVDQKEFLTEVE-----------AFYGFCSH-  648 (849)
Q Consensus       583 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~ei~-----------~~~~~~~~-  648 (849)
                      +....++|++.+.||+|+||+||+|.. .+++.||||++........ ...+..+++++.           .+++++.. 
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            334567899999999999999999955 4688999999864311111 111223333332           23444443 


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC--------
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY--------  720 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~--------  720 (849)
                      ..+.++|||++ +++|.+++.+.   ..+++.++..++.||+.||+|||+..  +|+||||||+|||++.++        
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccccccc
Confidence            35789999988 66888888643   35899999999999999999999732  899999999999998765        


Q ss_pred             --------cEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc
Q 042123          721 --------EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS  792 (849)
Q Consensus       721 --------~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~  792 (849)
                              .+||+|||.+.....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||+........
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             cccCCCCceEEECCCCccccCcc---ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                    499999998764322   234567999999999999999999999999999999999999999753321100


Q ss_pred             cc-------ccc--------cccccccC------CCCCC---------CChhhHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042123          793 SL-------NTD--------VALDQMLD------PRLPA---------PSRSAQEKLISIMEVAFSCFNESPESRPTMKI  842 (849)
Q Consensus       793 ~~-------~~~--------~~~~~~~~------~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  842 (849)
                      ..       ...        .....+.+      +...+         ...........+.+|+.+||++||++|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence            00       000        00000000      00000         00000011234779999999999999999999


Q ss_pred             HHhh
Q 042123          843 ISQQ  846 (849)
Q Consensus       843 il~~  846 (849)
                      +++|
T Consensus       435 ~L~H  438 (467)
T PTZ00284        435 MTTH  438 (467)
T ss_pred             HhcC
Confidence            9986

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=268.69  Aligned_cols=241  Identities=21%  Similarity=0.354  Sum_probs=181.8

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~lV  655 (849)
                      +.+...-||+|..|.||++++. +|..+|||.+...   ....+.++++..+.            +.+||+-.+..+++.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            3344567999999999999664 6899999998764   23334445554432            467777777788888


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||.|.. -++.++.+..  +++++.-.-++...++.||.||-+++  +|+|||+||+|||+|+.|++|++|||.+..+..
T Consensus       170 MelMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  170 MELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence            888854 5555554433  45788888899999999999999886  999999999999999999999999999987765


Q ss_pred             CCCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      +. ..+...|-+.|||||.+.   ...|+.++||||||+.++|+.||+.||.....       ..+.+..+++... +..
T Consensus       245 Sk-AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-------dFe~ltkvln~eP-P~L  315 (391)
T KOG0983|consen  245 SK-AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-------DFEVLTKVLNEEP-PLL  315 (391)
T ss_pred             cc-ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-------cHHHHHHHHhcCC-CCC
Confidence            43 345668999999999885   34688999999999999999999999974321       1223333333211 111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .........+.+|+..|+.+|+.+||...++++|
T Consensus       316 ~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  316 PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            1111244558899999999999999999999876

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-32  Score=288.73  Aligned_cols=237  Identities=21%  Similarity=0.295  Sum_probs=174.8

Q ss_pred             ecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCCC
Q 042123          596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       596 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ||+|+||.||+++. .+|+.||+|.+........ ........|+.           .+.+++..+...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~-~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKK-SGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcc-hhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            69999999999965 4699999999864211111 11112222322           35567777889999999999999


Q ss_pred             hhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeec
Q 042123          664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF  743 (849)
Q Consensus       664 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  743 (849)
                      |.+++.... ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++...... ......
T Consensus        80 L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~  154 (277)
T cd05607          80 LKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQR  154 (277)
T ss_pred             HHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeecc
Confidence            998885433 23488999999999999999999998   9999999999999999999999999998866432 223345


Q ss_pred             cCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHH
Q 042123          744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIM  823 (849)
Q Consensus       744 ~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  823 (849)
                      .++..|+|||++.+..++.++||||+||++|||++|+.||.......    ...................   ....++.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~  227 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLEDEVKFEHQ---NFTEESK  227 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhccccccccc---cCCHHHH
Confidence            68999999999998889999999999999999999999986432110    0111111122222211111   1233478


Q ss_pred             HHHhhccCCCCCCCCCHHHHHh
Q 042123          824 EVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       824 ~li~~cl~~dP~~RPt~~eil~  845 (849)
                      +++..||++||++||+++|+++
T Consensus       228 ~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         228 DICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHHhccCHhhCCCCccchh
Confidence            8999999999999999966553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2e-32  Score=292.04  Aligned_cols=245  Identities=23%  Similarity=0.425  Sum_probs=184.3

Q ss_pred             HhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS  647 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~  647 (849)
                      ..++|+..+.||+|+||.||+|...      ....+|+|.+.....   ......+.+|+.            ++++++.
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC---HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            4467888999999999999999653      236799998865321   112233444433            3566777


Q ss_pred             cCCeeEEEEEeccCCChhhhhccc-------------ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042123          648 HARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL  714 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  714 (849)
                      ..+..++||||+++|+|.+++...             .....+++.++++++.|++.|++|||+.   +|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence            788899999999999999998642             2234689999999999999999999998   999999999999


Q ss_pred             eecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 042123          715 LLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISS  791 (849)
Q Consensus       715 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~  791 (849)
                      +++.++.+|++|||.++........  .....++..|+|||...+..++.++|||||||++||+++ |..||......  
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  241 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--  241 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH--
Confidence            9999999999999999876543211  112234567999999988889999999999999999997 99998633211  


Q ss_pred             cccccccccccccCCC-CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          792 SSLNTDVALDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       792 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                            .......... ...+.    .....+.+++.+||+.+|++|||+.|++++|+
T Consensus       242 ------~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         242 ------ELFKLLKEGYRMEKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             ------HHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence                  1111111111 11111    12234788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-33  Score=302.62  Aligned_cols=233  Identities=21%  Similarity=0.287  Sum_probs=172.1

Q ss_pred             ecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH--------------HHHhhceeecCCeeEEEEEecc
Q 042123          596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE--------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       596 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e--------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ||+|+||+||+|+. .+++.||||++........ ........|              +..+++++......++||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAK-KEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhh-hHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            69999999999965 4689999999864211111 111111222              1224455667788999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.........
T Consensus        80 ~g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~  153 (330)
T cd05586          80 GGELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT  153 (330)
T ss_pred             CChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence            99999988643   3589999999999999999999999   99999999999999999999999999997654433334


Q ss_pred             eeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHH
Q 042123          741 TEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKL  819 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  819 (849)
                      ....||+.|+|||++.+. .++.++||||+||++|||++|+.||......        .....+.......+...   ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~---~~  222 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFGKVRFPKNV---LS  222 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcCCCCCCCcc---CC
Confidence            456799999999998754 4789999999999999999999998643211        11111211111111111   12


Q ss_pred             HHHHHHHhhccCCCCCCCC----CHHHHHhh
Q 042123          820 ISIMEVAFSCFNESPESRP----TMKIISQQ  846 (849)
Q Consensus       820 ~~l~~li~~cl~~dP~~RP----t~~eil~~  846 (849)
                      ..+.+++.+||+.||++||    ++.++++|
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            2467889999999999998    57777664

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-32  Score=288.48  Aligned_cols=245  Identities=22%  Similarity=0.372  Sum_probs=185.9

Q ss_pred             hcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      .++|+..+.||+|+||.||+|...      .+..||+|.+....   .......+.+|+.           ++++++...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA---SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            367888999999999999999653      24689999976432   1222344555544           366777788


Q ss_pred             CeeEEEEEeccCCChhhhhccccc-------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAA-------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA  722 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  722 (849)
                      ...++||||+++|+|.+++.....       ...+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCE
Confidence            899999999999999999864321       22478999999999999999999998   99999999999999999999


Q ss_pred             EEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042123          723 HVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      |++|||+++.......  ......++..|+|||.+.+..++.++|||||||++||+++ |..||......        ..
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~  230 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EV  230 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HH
Confidence            9999999886543321  1123345778999999988889999999999999999998 99998633211        11


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ............+..   ....+.+++.+||+.+|++|||+.++++.|+
T Consensus       231 ~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         231 LKFVIDGGHLDLPEN---CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHHhcCCCCCCCCC---CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111112111111111   1345789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.6e-32  Score=290.31  Aligned_cols=250  Identities=23%  Similarity=0.382  Sum_probs=181.8

Q ss_pred             cCCCcCceecCCccceEEEEEec-----------------CCcEEEEEEecccCCCCchhhHHHHHHHHH----------
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-----------------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----------  640 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~----------  640 (849)
                      ++|+..+.||+|+||.||+|...                 ++..||+|.+....   .......+.+|+.          
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA---NKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCc
Confidence            56889999999999999998532                 23468999886432   1222334555543          


Q ss_pred             -HhhceeecCCeeEEEEEeccCCChhhhhccccc--------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 042123          641 -AFYGFCSHARHSFLLYEFLERGSLAAILNTDAA--------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS  711 (849)
Q Consensus       641 -~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~  711 (849)
                       .+++++...+..++||||+++|+|.+++.....        ...+++.++..++.|++.|++|||+.   +++||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp  158 (296)
T cd05095          82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT  158 (296)
T ss_pred             ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence             366777788889999999999999999865321        12478889999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh--CCCCCCccc
Q 042123          712 KNLLLDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK--GKHPRDFLS  787 (849)
Q Consensus       712 ~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~Pf~~~~  787 (849)
                      +||+++.++.++++|||+++.+.....  ......++..|+|||...++.++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05095         159 RNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLS  238 (296)
T ss_pred             heEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccC
Confidence            999999999999999999986543321  1122334678999999888889999999999999999998  778876432


Q ss_pred             cccccccccccccccc-cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          788 SISSSSLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       788 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ........ ....... .....+.+..    ....+.+++.+||+.||++|||+.+|.+.|+
T Consensus       239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         239 DEQVIENT-GEFFRDQGRQVYLPKPAL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             hHHHHHHH-HHHHhhccccccCCCCCC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            21110000 0000000 0001111111    1234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.4e-32  Score=289.83  Aligned_cols=243  Identities=19%  Similarity=0.356  Sum_probs=182.5

Q ss_pred             CCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          589 DFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      +|+..+.||+|+||.||+|...      ++..||+|++.....   ......+.+|+.           .+++++.....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~   82 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE---GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP   82 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC---HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence            4667788999999999999653      357899999875321   122334444433           36677777788


Q ss_pred             eEEEEEeccCCChhhhhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 042123          652 SFLLYEFLERGSLAAILNTDA-------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL  718 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  718 (849)
                      .++++||+++++|.+++....             ....+++..+.+++.|++.|++|+|+.   +|+||||||+||+++.
T Consensus        83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~  159 (283)
T cd05091          83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFD  159 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecC
Confidence            999999999999999984211             123478899999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042123          719 EYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLN  795 (849)
Q Consensus       719 ~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~  795 (849)
                      ++.+|++|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....       
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------  232 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------  232 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            999999999998865432211  223345778999999988889999999999999999998 8888764321       


Q ss_pred             cccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       ......+.++.......   .....+.+++.+||+.+|++||++++|++.|+
T Consensus       233 -~~~~~~i~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         233 -QDVIEMIRNRQVLPCPD---DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             -HHHHHHHHcCCcCCCCC---CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence             11222222222211111   12234778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.3e-32  Score=289.03  Aligned_cols=243  Identities=26%  Similarity=0.409  Sum_probs=178.6

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCc--EEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGE--VVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~  652 (849)
                      ++|++.+.||+|+||.||+|..+ ++.  .+|+|.++....   ....+.+.+|+.            ++++++......
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS---ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC---HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            57889999999999999999664 333  478887764221   112233444432            456677777789


Q ss_pred             EEEEEeccCCChhhhhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          653 FLLYEFLERGSLAAILNTDA-------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      ++|+||+++|+|.+++....             ....+++.++..++.|++.|++|||+.   +|+||||||+||+++.+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~  155 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCC
Confidence            99999999999999986432             113488999999999999999999998   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDV  798 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~  798 (849)
                      +.+||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |..||......        .
T Consensus       156 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~--------~  226 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--------E  226 (297)
T ss_pred             CeEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------H
Confidence            9999999999864322111 111223457999999988889999999999999999997 99998643211        1


Q ss_pred             ccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          799 ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .............+.   .....+.+++.+||+.+|.+|||++++++.|+
T Consensus       227 ~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         227 LYEKLPQGYRMEKPR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLS  273 (297)
T ss_pred             HHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111111111111   12234778999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-32  Score=283.22  Aligned_cols=240  Identities=23%  Similarity=0.368  Sum_probs=196.6

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .+-|+..+.||+|.|+.|-.|++ -+|++||||++.+..-  ........++||.           ++|.+.......|+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            35677888999999999999954 4899999999976422  2333444555544           57777778889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-cCCCcEEEeeecCCccc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL-DLEYEAHVADFGIAKSL  733 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~DfG~a~~~  733 (849)
                      |.|.-++|+|.+|+.+...  .+.+.-..+++.||+.|+.|+|+.   .||||||||+||.+ .+-|-+|++|||++..+
T Consensus        95 iLELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEEecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999999987664  388999999999999999999998   89999999999876 55599999999999988


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .++ ....+.+|+..|.|||++.+..|+ ++.||||+|||+|.+++|+.||....        ..+.+..++|-+...+ 
T Consensus       170 ~PG-~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN--------DSETLTmImDCKYtvP-  239 (864)
T KOG4717|consen  170 QPG-KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN--------DSETLTMIMDCKYTVP-  239 (864)
T ss_pred             CCc-chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc--------chhhhhhhhcccccCc-
Confidence            765 456778999999999999999996 56899999999999999999998543        2344455566554443 


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         .....++.++|..|+..||.+|.+.++|+.+
T Consensus       240 ---shvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  240 ---SHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ---hhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence               3344558899999999999999999999764

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.8e-33  Score=292.07  Aligned_cols=246  Identities=27%  Similarity=0.468  Sum_probs=182.9

Q ss_pred             CCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhh----HHHHHHHH-----HHhhceeecCCeeEEEEEec
Q 042123          590 FDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVD----QKEFLTEV-----EAFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~----~~~~~~ei-----~~~~~~~~~~~~~~lV~e~~  659 (849)
                      |+..+.||+|+||+||+|+.. +++.||+|.+...........    +..+.+.+     ..+++++.+....++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567789999999999999654 567899999876532111110    11122222     23667777888999999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN  739 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  739 (849)
                      ++++|.+++..   ...+++.++..++.|+++||+|||+.   +++|+||||+||++++++.++|+|||.+.........
T Consensus        81 ~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNEN  154 (260)
T ss_dssp             TTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSE
T ss_pred             ccccccccccc---cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            99999999972   34589999999999999999999999   9999999999999999999999999999865333334


Q ss_pred             eeeccCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          740 WTEFAGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       740 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      .....++..|+|||.+. +..++.++||||+|+++|+|++|..||.......     ......+................
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  229 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD-----QLEIIEKILKRPLPSSSQQSREK  229 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH-----HHHHHHHHHHTHHHHHTTSHTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchh-----hhhhhhhcccccccccccccchh
Confidence            45567899999999988 7889999999999999999999999988541110     00111111111100000000001


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          819 LISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  230 SEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             HHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1458899999999999999999999876

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.8e-32  Score=290.38  Aligned_cols=251  Identities=24%  Similarity=0.396  Sum_probs=184.0

Q ss_pred             hcCCCcCceecCCccceEEEEEecC-----------------CcEEEEEEecccCCCCchhhHHHHHHHHH---------
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPS-----------------GEVVAVKKFHSLLPCDQTVDQKEFLTEVE---------  640 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~~ei~---------  640 (849)
                      ..+|++.+.||+|+||.||+|....                 +..||+|.+.....   ......+.+|+.         
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~   80 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS---DNAREDFLKEVKILSRLSDPN   80 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC---HHHHHHHHHHHHHHHhcCCCC
Confidence            3578899999999999999986532                 34689998765422   122344555543         


Q ss_pred             --HhhceeecCCeeEEEEEeccCCChhhhhcccc--------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 042123          641 --AFYGFCSHARHSFLLYEFLERGSLAAILNTDA--------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS  710 (849)
Q Consensus       641 --~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk  710 (849)
                        .+++++..++..++||||+++++|.+++....        ....+++.+++.++.|++.||+|||+.   +++|||||
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk  157 (296)
T cd05051          81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA  157 (296)
T ss_pred             EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence              35667777789999999999999999986533        112589999999999999999999998   99999999


Q ss_pred             CCCeeecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh--CCCCCCcc
Q 042123          711 SKNLLLDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK--GKHPRDFL  786 (849)
Q Consensus       711 ~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~Pf~~~  786 (849)
                      |+||+++.++.++++|||+++.......  ......++..|+|||++.+..++.++||||||+++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            9999999999999999999886543321  1223456778999999988889999999999999999998  67787643


Q ss_pred             ccccccccccccccccc-cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          787 SSISSSSLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       787 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......     ...... .+...............++.+++.+||+.||++|||+.||++.|+
T Consensus       238 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         238 TDQQVI-----ENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ChHHHH-----HHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            211100     000000 000000000000111235889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.1e-32  Score=285.51  Aligned_cols=247  Identities=22%  Similarity=0.303  Sum_probs=182.1

Q ss_pred             HHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      +.+++.+.....||+|+||.||+|.. .++..||+|.+....    ....+.+.+|+.           .+++++..++.
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD----SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF   79 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC----HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE
Confidence            34556666677999999999999964 467889999876432    122334444433           36778888889


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeecCC
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-EYEAHVADFGIA  730 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~a  730 (849)
                      .++|+||+++++|.+++.........++.++..++.||+.|++|||+.   +|+||||||+||+++. ++.++|+|||.+
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~  156 (268)
T cd06624          80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS  156 (268)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence            999999999999999986543221227888999999999999999998   9999999999999986 679999999998


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMK--ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ..............++..|+|||++.+..  ++.++||||||+++|+|++|+.||.........      ..........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~  230 (268)
T cd06624         157 KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA------MFKVGMFKIH  230 (268)
T ss_pred             eecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh------HhhhhhhccC
Confidence            76644333333456789999999986543  788999999999999999999998643211100      0000000011


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +.   .+......+.+++.+||+.+|++|||+.|++++
T Consensus       231 ~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         231 PE---IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CC---CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            10   111223347788999999999999999999876

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2e-32  Score=287.75  Aligned_cols=242  Identities=26%  Similarity=0.368  Sum_probs=180.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||.||+|+. .+++.||+|.++....    .....+.+|+.           .+++++...+..++|
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~----~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv   84 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG----EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC   84 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence            4677888999999999999954 5689999998864321    11222333432           356677778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++++|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          85 MEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            9999999999998643   3589999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .........|+..|+|||++.   ...++.++||||+||++|+|++|..||...........   ........+......
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~  235 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL---MTKSNFQPPKLKDKM  235 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh---hhccCCCCCcccccC
Confidence            333334457899999999874   45688899999999999999999999853321110000   000000011111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          .....+.+++.+||+.+|++|||+++|+++
T Consensus       236 ----~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         236 ----KWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             ----CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                112347789999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.5e-33  Score=304.77  Aligned_cols=241  Identities=23%  Similarity=0.346  Sum_probs=176.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+...... .......+..|+.           ++++++...+..++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADML-EKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            4688899999999999999955 46899999998642111 1111223333432           356677788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          80 MEFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             EeCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            9999999999998653   3489999999999999999999998   999999999999999999999999999875432


Q ss_pred             CCC-----------------------------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCC
Q 042123          736 DSS-----------------------------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK  780 (849)
Q Consensus       736 ~~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~  780 (849)
                      ...                                   .....+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            110                                   011346899999999999999999999999999999999999


Q ss_pred             CCCCccccccccccccccccccccC--CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCC---HHHHHhh
Q 042123          781 HPRDFLSSISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT---MKIISQQ  846 (849)
Q Consensus       781 ~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~  846 (849)
                      .||......        .....+..  .....+...  .....+.+++.+|+. +|.+|++   ++++++|
T Consensus       234 ~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         234 PPFCSETPQ--------ETYRKVMNWKETLVFPPEV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCHH--------HHHHHHHcCCCceecCCCC--CCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            999743321        11111111  111111100  012235667777664 9999984   6787765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.3e-32  Score=292.46  Aligned_cols=250  Identities=16%  Similarity=0.254  Sum_probs=181.0

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||.||+|+.+ +++.||+|.+........   ...+.+|           +..+++++..++..++|
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA---PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc---chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            57888999999999999999654 688899999864322111   1122333           23467788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++ +|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        83 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  156 (309)
T cd07872          83 FEYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSV  156 (309)
T ss_pred             EeCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence            999986 8888775432  3478999999999999999999998   999999999999999999999999999976544


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccc------c
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVAL------D  801 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~------~  801 (849)
                      .........+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...+......       .......      .
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         157 PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            3333344567899999998865 457899999999999999999999997433211000       0000000      0


Q ss_pred             cccCCCCCCC-----ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 QMLDPRLPAP-----SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+...+..     ..........+.+++.+|++.||.+|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000     00001123357789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=6.7e-32  Score=281.14  Aligned_cols=236  Identities=23%  Similarity=0.439  Sum_probs=177.6

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccC
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      +.||+|+||.||+|+. .+++.||+|.+.....   ......+.+|+.           ++++++......++||||+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            3699999999999965 4789999998764321   222334555543           366777888889999999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC--
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--  739 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--  739 (849)
                      ++|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||++.........  
T Consensus        78 ~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          78 GDFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             CcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            99999986432  3588999999999999999999998   9999999999999999999999999998764422111  


Q ss_pred             eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       740 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      ......+..|+|||.+.++.++.++||||||+++|||++ |..||.......         ....+.......  .+...
T Consensus       153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---------~~~~~~~~~~~~--~~~~~  221 (252)
T cd05084         153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---------TREAIEQGVRLP--CPELC  221 (252)
T ss_pred             CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---------HHHHHHcCCCCC--CcccC
Confidence            111123457999999998889999999999999999998 888986432110         111111111100  01112


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          819 LISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+.+++.+||+.+|++|||+.++.+.|+
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            335888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-32  Score=289.66  Aligned_cols=243  Identities=18%  Similarity=0.254  Sum_probs=180.0

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e  657 (849)
                      |+..+.||+|+||+||+|.. .+++.||+|.+...... .......+.+|+.           .+.+++..++..++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            66778899999999999955 47899999988643211 1111222334433           24556677788999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |+++|+|.+++.... ...+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.++++|||++.......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          81 IMNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE  156 (285)
T ss_pred             eccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence            999999998886433 23589999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHH
Q 042123          738 SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE  817 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  817 (849)
                       ......|+..|+|||++.+..++.++|+||+|+++|||++|+.||........    ...............+    ..
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~~~~----~~  227 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEEVYS----AK  227 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhccccccC----cc
Confidence             22345789999999999988999999999999999999999999974321100    0011111111111111    11


Q ss_pred             HHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          818 KLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       818 ~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                      ....+.+++..||+.||++||+     +++++++
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            2234778899999999999999     6677664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.2e-32  Score=289.90  Aligned_cols=244  Identities=18%  Similarity=0.273  Sum_probs=181.5

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||+|.. .+++.||||.+....... ......+.+|+..           +.+.+...+..++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccc-hHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            367778999999999999954 478999999986532211 1112334445432           455666778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.... ...+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.++++|||++......
T Consensus        80 e~~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          80 TLMNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             EecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            9999999999885433 23589999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      . ......|+..|+|||++.+..++.++||||+|+++|+|++|+.||.......     .........+.. ..  ....
T Consensus       156 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~~-~~--~~~~  226 (285)
T cd05630         156 Q-TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKEV-QE--EYSE  226 (285)
T ss_pred             c-cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhhh-hh--hcCc
Confidence            2 2233578999999999998899999999999999999999999997432110     000111111100 00  0011


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                      .....+.+++..||+.||++|||     ++|++++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            12234778999999999999999     8898875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.9e-33  Score=292.60  Aligned_cols=249  Identities=21%  Similarity=0.373  Sum_probs=184.3

Q ss_pred             cHHHHHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhce
Q 042123          579 LYDEIVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGF  645 (849)
Q Consensus       579 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~  645 (849)
                      +..++..+.+.|+..+.||+|+||.||+|.. .+++.+|+|.+.....     ....+..|+.            +++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~   81 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-----EEEEIKLEINMLKKYSHHRNIATYYGA   81 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-----HHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence            4455566778999999999999999999965 5688999998754311     1122333322            23444


Q ss_pred             ee------cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          646 CS------HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       646 ~~------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      +.      .....++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~  157 (282)
T cd06636          82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             hhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            42      2457899999999999999986533 24578889999999999999999998   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCCCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL  794 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~  794 (849)
                      +.++|+|||++..............++..|+|||.+.     ...++.++|||||||++|||++|..||........   
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~---  234 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA---  234 (282)
T ss_pred             CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh---
Confidence            9999999999876543333334467889999999875     34678899999999999999999999864321110   


Q ss_pred             ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                           .........+  ..........+.+++.+||+.||.+|||+.||+++
T Consensus       235 -----~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         235 -----LFLIPRNPPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -----hhhHhhCCCC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                 0001111000  00111223458899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.5e-33  Score=282.53  Aligned_cols=252  Identities=24%  Similarity=0.290  Sum_probs=181.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHH-----HHHHhhceeecCC-----eeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLT-----EVEAFYGFCSHAR-----HSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~-----ei~~~~~~~~~~~-----~~~lV~  656 (849)
                      -.|...+++|+|+||.||+|.. .+++.||||+..........  +-.+++     +|+++.-++....     ...+||
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knr--El~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl  101 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNR--ELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL  101 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcH--HHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence            3566778999999999999955 45799999998765443322  223333     3444444443321     345799


Q ss_pred             EeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCCcccC
Q 042123          657 EFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLK  734 (849)
Q Consensus       657 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a~~~~  734 (849)
                      |||+. +|+++++.. .....++...+.-+.+|+.+||+|||+.   +|+||||||.|+|+|.+ |.+||||||.|+...
T Consensus       102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen  102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            99998 999998742 1234578888999999999999999997   99999999999999988 999999999999887


Q ss_pred             CCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------ccccccccc------
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------SSLNTDVAL------  800 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------~~~~~~~~~------  800 (849)
                      .... ......|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|...+....       -+....+..      
T Consensus       178 ~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~  256 (364)
T KOG0658|consen  178 KGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPN  256 (364)
T ss_pred             cCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcc
Confidence            6543 466788999999998876 5799999999999999999999999876442211       000000000      


Q ss_pred             -ccccCCCCCCCCh---hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 -DQMLDPRLPAPSR---SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 -~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....+.+.....   .......+..+++.++++.+|.+|.++.|++++
T Consensus       257 y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  257 YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence             0111111111110   111223347899999999999999999998865

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.3e-32  Score=281.28  Aligned_cols=233  Identities=26%  Similarity=0.452  Sum_probs=175.1

Q ss_pred             eecCCccceEEEEEe---cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEecc
Q 042123          595 CIGNGGHASVYRAEL---PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      .||+|+||.||+|.+   .++..+|+|++.....  .......+..|+.           .+++++. .+..++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~   78 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN--DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAE   78 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC--cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence            589999999999954   3578899998764321  2223345555544           2455543 456789999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++...   ..+++..+.+++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.++.........
T Consensus        79 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          79 LGPLNKFLQKN---KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999998643   3489999999999999999999998   99999999999999999999999999998765433221


Q ss_pred             ---eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCChhh
Q 042123          741 ---TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-LPAPSRSA  815 (849)
Q Consensus       741 ---~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  815 (849)
                         ....++..|+|||.+....++.++||||||+++|||++ |+.||.......        ....+.... ...+.   
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~~~~~---  221 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------VTQMIESGERMECPQ---  221 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCCCCCCC---
Confidence               11223578999999988888999999999999999998 999987432211        111111111 11111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       .....+.+++.+||+.||++||++++|.+.|+
T Consensus       222 -~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         222 -RCPPEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             -CCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence             12234789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=9.8e-32  Score=279.55  Aligned_cols=235  Identities=23%  Similarity=0.425  Sum_probs=179.4

Q ss_pred             eecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCCC
Q 042123          595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      .||+|+||.||+|...++..+|+|.+.....   ......+.+|+.           .+++++......++||||+++|+
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP---QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            6899999999999888899999999765432   122234555543           35777788888999999999999


Q ss_pred             hhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC-eee
Q 042123          664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-WTE  742 (849)
Q Consensus       664 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~  742 (849)
                      |.+++....  ..+++.++..++.|++.|+.|+|+.   +++||||+|+||+++.++.+|++|||++......... ...
T Consensus        79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            999986433  3478999999999999999999998   9999999999999999999999999998754332111 112


Q ss_pred             ccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHH
Q 042123          743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLIS  821 (849)
Q Consensus       743 ~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (849)
                      ..++..|+|||++.+..++.++||||||+++|++++ |..||.........     ......  .+...+.    .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-----~~~~~~--~~~~~~~----~~~~~  222 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-----EQVEKG--YRMSCPQ----KCPDD  222 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-----HHHHcC--CCCCCCC----CCCHH
Confidence            234567999999988889999999999999999998 99998643221100     000000  0111111    12335


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          822 IMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       822 l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+++.+||+.+|++|||+.|+++.|.
T Consensus       223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         223 VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-32  Score=282.62  Aligned_cols=237  Identities=28%  Similarity=0.501  Sum_probs=183.8

Q ss_pred             ceecCCccceEEEEEecC----CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEe
Q 042123          594 YCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~  658 (849)
                      +.||+|+||.||+|....    +..||+|.+.......   ..+.+.+|+.           .+++++......++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE---ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh---HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            469999999999996643    8889999987643221   2344445543           356777778889999999


Q ss_pred             ccCCChhhhhccccc------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          659 LERGSLAAILNTDAA------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +++++|.+++.....      ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence            999999999976521      24689999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCC--CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-C
Q 042123          733 LKPDS--SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-L  808 (849)
Q Consensus       733 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~  808 (849)
                      .....  .......++..|+|||.+....++.++||||+|+++|||++ |+.||......        .......... .
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~  226 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--------EVLEYLRKGYRL  226 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            75432  12233456889999999988889999999999999999999 69998754211        1111111111 1


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.    .....+.+++.+||+.+|++|||+.|++++|+
T Consensus       227 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 PKPE----YCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CCCc----cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1111    11345889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.4e-32  Score=282.87  Aligned_cols=239  Identities=25%  Similarity=0.428  Sum_probs=182.1

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      ++|++.++||+|+||.||+|+..++..||+|++.....     ....+.+|+.           ++++++ .....++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv~   79 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVT   79 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEE-CCCCcEEEE
Confidence            56889999999999999999877777899999864321     1234445543           234444 345678999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.+.. ...+++.++..++.|++.||+|+|+.   +++||||||+||+++.++.++|+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          80 EYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EcCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            9999999999996543 23579999999999999999999998   9999999999999999999999999999866433


Q ss_pred             CCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCh
Q 042123          737 SSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSR  813 (849)
Q Consensus       737 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  813 (849)
                      ... .....++..|+|||+..+..++.++||||||+++||+++ |+.||......        ......... ..+.   
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--------~~~~~~~~~~~~~~---  224 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMPC---  224 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--------HHHHHHhcCCCCCC---
Confidence            221 122345678999999988889999999999999999999 88888643211        111111111 1111   


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       ..+....+.+++.+||+++|++|||+.++.+.|+
T Consensus       225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence             1223445889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.9e-32  Score=284.92  Aligned_cols=240  Identities=23%  Similarity=0.394  Sum_probs=177.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCc----EEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGE----VVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~  651 (849)
                      ++|+..+.||+|+||.||+|.+. +++    .+|+|.+....   ......++..|+           .++++++. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~   82 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS   82 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc---chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence            57888899999999999999653 444    47777764321   111223334332           23566654 355


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++|+||+++|+|.+++....  ..+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+|++|||.++
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccce
Confidence            778999999999999996543  3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CC
Q 042123          732 SLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-PR  807 (849)
Q Consensus       732 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~  807 (849)
                      .......  ......++..|+|||.+.++.++.++||||||+++||+++ |+.||.......         ..+.+. ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---------~~~~~~~~~  228 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---------VPDLLEKGE  228 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCCC
Confidence            6543322  1233456778999999988899999999999999999998 999986432211         011111 11


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ........   ...+.+++.+||+.+|++|||+.|+++.|.
T Consensus       229 ~~~~~~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         229 RLAQPQIC---TIDVYMVMVKCWMIDENVRPTFKELANEFT  266 (279)
T ss_pred             cCCCCCCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11111111   123677888999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-32  Score=289.63  Aligned_cols=250  Identities=22%  Similarity=0.377  Sum_probs=180.9

Q ss_pred             cCCCcCceecCCccceEEEEEecC---------------CcEEEEEEecccCCCCchhhHHHHHHHHH-----------H
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPS---------------GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------A  641 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~  641 (849)
                      ++|++.+.||+|+||.||++....               ...||+|.++....   ......+.+|+.           .
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT---KTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhCCCCCcCe
Confidence            578889999999999999986532               23489998865321   122334555544           3


Q ss_pred             hhceeecCCeeEEEEEeccCCChhhhhccccc---------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 042123          642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAA---------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK  712 (849)
Q Consensus       642 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~  712 (849)
                      +++++......++||||+++++|.+++.....         ...+++.++.+++.|++.|++|||+.   +++||||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence            56777788899999999999999999854321         12368899999999999999999998   9999999999


Q ss_pred             CeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh--CCCCCCcccc
Q 042123          713 NLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK--GKHPRDFLSS  788 (849)
Q Consensus       713 Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t--g~~Pf~~~~~  788 (849)
                      ||+++.++.+|++|||++.........  .....++..|+|||+..++.++.++||||||+++|+|++  |..||.....
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999999765432211  122344678999999988889999999999999999998  6677764321


Q ss_pred             ccccccccccccccccCCC-CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          789 ISSSSLNTDVALDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......... ......... ...+..    ....+.+++.+||+.+|++|||+++|++.|+
T Consensus       239 ~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIENTGE-FFRNQGRQIYLSQTPL----CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHH-hhhhccccccCCCCCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            110000000 000000000 000111    1235889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.3e-32  Score=282.72  Aligned_cols=240  Identities=26%  Similarity=0.461  Sum_probs=183.3

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV  655 (849)
                      .++|++.+.||+|+||.||+|..+++..+|+|.+.....     ....+.+|+..           +++++ .....++|
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~lv   78 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVV-SEEPIYIV   78 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEE-CCCCcEEE
Confidence            357888999999999999999888888999999865322     12345555442           34444 34567899


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||++++++.++++|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence            99999999999986533 24589999999999999999999998   999999999999999999999999999986643


Q ss_pred             CCCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          736 DSSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       736 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      .... .....++..|+|||...+..++.++||||||+++|||++ |..||......        .....+... ..+.+ 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~-  225 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--------EVLEQVERGYRMPCP-  225 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCCCCC-
Confidence            3211 122334568999999988889999999999999999999 89998643211        111111111 11111 


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         ......+.+++.+||+++|++|||++++.+.|+
T Consensus       226 ---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         226 ---QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             ---CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence               122345889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-32  Score=287.11  Aligned_cols=244  Identities=23%  Similarity=0.362  Sum_probs=184.0

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... ++..||+|.+.....   ......+.+|           +..+++++...+..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD---ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC---HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            36788899999999999999664 789999998864321   1122334444           33577788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|..++........+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.++++|||.+.....
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  155 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA  155 (286)
T ss_pred             EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence            999999999999876433346899999999999999999999742  899999999999999999999999999876543


Q ss_pred             CCCCeeeccCCccccccccccCC------CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTM------KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      .  ......+++.|+|||.+.+.      .++.++||||+||++|+|++|+.||......     ..........+...+
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~  228 (286)
T cd06622         156 S--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-----NIFAQLSAIVDGDPP  228 (286)
T ss_pred             C--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-----hHHHHHHHHhhcCCC
Confidence            2  22334678899999988554      3478999999999999999999999643210     001111112222111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .   ........+.+++.+||+.+|++||++++++.+
T Consensus       229 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         229 T---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             C---CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1   111233457889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.7e-32  Score=294.50  Aligned_cols=245  Identities=22%  Similarity=0.413  Sum_probs=179.8

Q ss_pred             hcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~  648 (849)
                      .++|++.+.||+|+||.||+|..      .+++.||||++......   .....+.+|+            ..+++++..
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACTK   82 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh---HHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence            35789999999999999999953      35788999998653211   1122333343            345555543


Q ss_pred             -CCeeEEEEEeccCCChhhhhccccc------------------------------------------------------
Q 042123          649 -ARHSFLLYEFLERGSLAAILNTDAA------------------------------------------------------  673 (849)
Q Consensus       649 -~~~~~lV~e~~~~gsL~~~l~~~~~------------------------------------------------------  673 (849)
                       +...++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence             3467899999999999999854210                                                      


Q ss_pred             ----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC--ee
Q 042123          674 ----------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WT  741 (849)
Q Consensus       674 ----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~  741 (849)
                                ...+++.++.+++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||++.........  ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      12478889999999999999999998   9999999999999999999999999999865432221  12


Q ss_pred             eccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCChhhHHHH
Q 042123          742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSRSAQEKL  819 (849)
Q Consensus       742 ~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  819 (849)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..||.......       ......... +...+..    ..
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~----~~  308 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMRAPDY----TT  308 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-------HHHHHHhccCCCCCCCC----CC
Confidence            2345677999999988889999999999999999997 999986432110       001111111 1111111    12


Q ss_pred             HHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          820 ISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       820 ~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .++.+++..||+.+|++|||+.||+++|+
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~  337 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLG  337 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            34788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.4e-32  Score=289.04  Aligned_cols=251  Identities=20%  Similarity=0.245  Sum_probs=181.2

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|++|.||+|.. .++..||||++.......  .....+.+|+           .++++++..+...++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE--GVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC--CchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            477889999999999999965 468999999986432111  1122333332           24777888888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||++ ++|.+++........+++.++..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++......
T Consensus        79 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          79 EFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             ecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            9998 58988886554445689999999999999999999998   9999999999999999999999999999765443


Q ss_pred             CCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc----------cc---ccccc--
Q 042123          737 SSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS----------LN---TDVAL--  800 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~----------~~---~~~~~--  800 (849)
                      ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||..........          ..   .....  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            3333444678899999987654 46889999999999999999999997432111000          00   00000  


Q ss_pred             -ccccCCCCCCC--ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 -DQMLDPRLPAP--SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 -~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ....+ .....  .........++.+++.+||+.||++|||+.+|+++
T Consensus       235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFP-KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhcc-ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             00000 00000  00000122346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.3e-32  Score=285.38  Aligned_cols=240  Identities=25%  Similarity=0.487  Sum_probs=179.0

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCc----EEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      .++|+..+.||+|+||+||+|++ .++.    +||+|.+....   .......+.+|+.           .+++++.. .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~   81 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S   81 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC---CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence            35788899999999999999964 3444    48999876432   1222334444533           24455543 4


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..++++||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          82 TVQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             CcEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence            5679999999999999986533  3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCe--eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-
Q 042123          731 KSLKPDSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-  806 (849)
Q Consensus       731 ~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  806 (849)
                      +.........  ....++..|+|||...+..++.++||||||+++|||++ |..||+......         ....+.. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~  227 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKG  227 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---------HHHHHHCC
Confidence            8765332211  11234568999999998899999999999999999998 999986432111         0111111 


Q ss_pred             -CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 -RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       ..+.+.    .....+.+++.+||+.||++||++.++++.|+
T Consensus       228 ~~~~~~~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         228 ERLPQPP----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFS  266 (279)
T ss_pred             CcCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             111111    12234788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.98  E-value=3.4e-32  Score=289.48  Aligned_cols=237  Identities=25%  Similarity=0.376  Sum_probs=181.1

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV~e  657 (849)
                      |.....||+|+||.||+|.. .++..||||.+....    ......+.+|           +..+++++...+..++|||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK----QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch----HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            33446799999999999955 468899999875421    1223334444           3346777788889999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |+++++|.+++...    .+++.++..++.||+.|++|||+.   +|+||||||+||+++.++.++|+|||++.......
T Consensus       100 ~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658         100 FLEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             CCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            99999999988532    488999999999999999999998   99999999999999999999999999987654433


Q ss_pred             CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHH
Q 042123          738 SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE  817 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  817 (849)
                      .......++..|+|||...+..++.++||||||+++|||++|+.||........     .........+......    .
T Consensus       173 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~----~  243 (292)
T cd06658         173 PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLPPRVKDSH----K  243 (292)
T ss_pred             ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCCCcccccc----c
Confidence            333445688999999999888899999999999999999999999874322110     0011111122222111    1


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          818 KLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       818 ~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....+.+++..||..||++|||+++++++
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            22347788899999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.98  E-value=4.5e-32  Score=287.46  Aligned_cols=239  Identities=23%  Similarity=0.384  Sum_probs=180.0

Q ss_pred             CCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e  657 (849)
                      |+..+.||+|+||.||+|... ++..+|+|.+....    ......+.+|+.           .+++++......++|||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC----HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567788999999999999654 57888999875431    122334445543           36677778889999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |+++|+|..++.+..  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||++.......
T Consensus        83 ~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          83 FCAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             ecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            999999998875432  3589999999999999999999998   99999999999999999999999999987654333


Q ss_pred             CCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          738 SNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .......++..|+|||++.     +..++.++|||||||++|||++|+.||.........     ........+....+.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~~  232 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL-----LKIAKSEPPTLAQPS  232 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH-----HHHhhcCCCCCCCcc
Confidence            3334456889999999873     455788999999999999999999998743311100     000000011111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          .....+.+++.+||+.+|++|||+.+++++
T Consensus       233 ----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         233 ----RWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                122347889999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.98  E-value=6.1e-32  Score=284.10  Aligned_cols=244  Identities=27%  Similarity=0.416  Sum_probs=186.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||.|+||+||+|.. .++..+|+|++.......   ....+.+|++           .+++.+......++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT---SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch---HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            4688899999999999999964 468899999986432211   3344555544           255666778889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++........+++..+..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++..+..
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~  154 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD  154 (267)
T ss_pred             EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence            99999999999997644334689999999999999999999998   999999999999999999999999999886654


Q ss_pred             CCCC----eeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC---C
Q 042123          736 DSSN----WTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP---R  807 (849)
Q Consensus       736 ~~~~----~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~  807 (849)
                      ....    .....++..|+|||++... .++.++||||||+++|+|++|+.||.......        ...+....   .
T Consensus       155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~  226 (267)
T cd06610         155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--------VLMLTLQNDPPS  226 (267)
T ss_pred             CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--------hHHHHhcCCCCC
Confidence            3322    1334688899999998776 78999999999999999999999997443211        11111111   1


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .... .........+.+++.+||+.+|++|||+++++++
T Consensus       227 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         227 LETG-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cCCc-cccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1110 0011233457899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.98  E-value=2.3e-32  Score=290.46  Aligned_cols=258  Identities=21%  Similarity=0.355  Sum_probs=186.4

Q ss_pred             cHHHHHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCch-hhHHHHHHHH------HHhhceee---
Q 042123          579 LYDEIVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQT-VDQKEFLTEV------EAFYGFCS---  647 (849)
Q Consensus       579 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~~~ei------~~~~~~~~---  647 (849)
                      .++.+..+.++|+..+.||+|+||.||+|.. .+++.+|+|.+......... ..+....+.+      .++++++.   
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            3456667789999999999999999999955 46889999987542111110 1111112222      23555542   


Q ss_pred             --cCCeeEEEEEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          648 --HARHSFLLYEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       648 --~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                        .+...++||||+++|+|.+++... .....+++..+..++.|++.|+.|||+.   +++||||||+||+++.++.+|+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence              345789999999999999987532 1234588999999999999999999998   9999999999999999999999


Q ss_pred             eeecCCcccCCCCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 042123          725 ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       725 ~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      +|||+++.............|++.|+|||++.     +..++.++||||+||++|||++|+.||..........     .
T Consensus       166 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-----~  240 (286)
T cd06638         166 VDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-----K  240 (286)
T ss_pred             ccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-----h
Confidence            99999987654333334456899999999875     3457889999999999999999999987443211000     0


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......+....+.    .....+.+++.+||+.+|++|||+.|++++.-
T Consensus       241 ~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         241 IPRNPPPTLHQPE----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             ccccCCCcccCCC----CcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            0000011111111    11234788999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.98  E-value=8.4e-32  Score=284.56  Aligned_cols=238  Identities=26%  Similarity=0.410  Sum_probs=185.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ..|+..+.||+|+||.||+|.. .++..||+|.+.....   ......+.+|+.           .+++++..+...++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            4577788999999999999965 4688999998764311   122334555543           366777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++..    ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          81 MEYLGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EecCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            999999999999864    2488999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........++..|+|||++.+..++.++||||||+++|||++|..||........        .. .+....+  +...
T Consensus       154 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--------~~-~~~~~~~--~~~~  222 (277)
T cd06640         154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--------LF-LIPKNNP--PTLT  222 (277)
T ss_pred             CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--------hh-hhhcCCC--CCCc
Confidence            33333445678899999999888899999999999999999999999874322110        00 0111111  1122


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++||++++++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2344568899999999999999999999876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.3e-32  Score=281.88  Aligned_cols=242  Identities=26%  Similarity=0.405  Sum_probs=186.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.+|+|.+......    ....+.+|+.           .+++++......++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD----DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh----hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            5788899999999999999965 46788999998654221    2334444433           467777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||.+.....
T Consensus        79 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          79 MEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EeCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            99999999999986542  3589999999999999999999998   999999999999999999999999999887654


Q ss_pred             CCCCeeeccCCccccccccccCC---CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC-CC
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTM---KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP-AP  811 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  811 (849)
                      .........++..|+|||.+.+.   .++.++||||||+++|||++|+.||........        .......... ..
T Consensus       154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--------~~~~~~~~~~~~~  225 (262)
T cd06613         154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--------LFLISKSNFPPPK  225 (262)
T ss_pred             hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhccCCCcc
Confidence            33333445788899999998776   789999999999999999999999874331110        0000001000 01


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........+.+++.+||+.+|.+|||+.+|+++
T Consensus       226 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         226 LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11122334568899999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.98  E-value=9.2e-32  Score=280.85  Aligned_cols=243  Identities=21%  Similarity=0.299  Sum_probs=189.7

Q ss_pred             CCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||.|+||.||.++ ..+++.+|+|.+.....  .....+.+.+|+.           .+++++.+.+..++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            47888999999999999995 45689999998764321  1222344555544           3677778888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.+.. ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.+......
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          79 EYANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             EecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            9999999999997543 34589999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      ........+++.|+|||...+..++.++||||||+++|||++|..||.....        ......+..+......   .
T Consensus       155 ~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~---~  223 (256)
T cd08221         155 YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIVQGNYTPVV---S  223 (256)
T ss_pred             cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCCc---c
Confidence            3333456789999999999888889999999999999999999999864221        1112222222222111   1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .....+.+++.+||+.+|++||+++++++++-
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence            22345788999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.98  E-value=1.1e-31  Score=284.01  Aligned_cols=242  Identities=24%  Similarity=0.364  Sum_probs=182.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+....   .......+..|+.           .+++++...+..++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            3678889999999999999954 578999999886432   1222344555544           356777788889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|..+.       .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++.....
T Consensus        78 ~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          78 TEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            9999999997652       367888999999999999999998   999999999999999999999999999976543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .  ......++..|+|||++.+..++.++||||||+++|+|++|+.||......... ...........+...+...  .
T Consensus       148 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~  222 (279)
T cd06619         148 S--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS-LMPLQLLQCIVDEDPPVLP--V  222 (279)
T ss_pred             c--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc-cchHHHHHHHhccCCCCCC--C
Confidence            2  223457899999999999889999999999999999999999999743211100 0000111111111111100  0


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ......+.+++.+||+.+|++||+++|++++-
T Consensus       223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence            11223478899999999999999999998763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=5.3e-32  Score=285.68  Aligned_cols=239  Identities=26%  Similarity=0.431  Sum_probs=184.8

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||.|+||.||+|... +++.||+|.+.....   ......+.+|+.           .+.+++..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA---EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc---chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            36778889999999999999654 689999999864321   112233444433           356677778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      +||+++++|.+++...    .+++.++..++.|++.|+.|||+.   +++||||+|+||++++++.++++|||.++....
T Consensus        78 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          78 MEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            9999999999998653    589999999999999999999998   999999999999999999999999999987764


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........+++.|+|||++.+..++.++||||||+++|+|++|+.||.......        ....+.....+..... 
T Consensus       151 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~-  221 (274)
T cd06609         151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKNNPPSLEGN-  221 (274)
T ss_pred             cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHHhhhcCCCCCccc-
Confidence            4333344578889999999998889999999999999999999999996432111        1111111111110000 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....+.+++.+||..+|++|||+++++++
T Consensus       222 -~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         222 -KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             -ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence             023347889999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.98  E-value=4.3e-32  Score=286.87  Aligned_cols=237  Identities=26%  Similarity=0.407  Sum_probs=182.5

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~  656 (849)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+.....   ......+.+|+           ..+++++......++||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc---hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            455667899999999999954 4688999998764321   11223344443           35777888888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++..    ..+++.++..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          82 EYLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             EccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            99999999998853    3488999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      ........++..|+|||++.+..++.++||||||+++|||++|+.||.......        ..........+   ....
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~~~~---~~~~  223 (277)
T cd06642         155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKNSPP---TLEG  223 (277)
T ss_pred             chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcCCCC---CCCc
Confidence            323334567889999999998889999999999999999999999986332111        00111111111   1111


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.+++.+||+.+|++|||+.+++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            223457889999999999999999999975

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.98  E-value=6.7e-32  Score=285.71  Aligned_cols=243  Identities=26%  Similarity=0.478  Sum_probs=182.7

Q ss_pred             cCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      .+|...+.||+|+||.||+|..      .++..+|+|.+....    ......+.+|+.           .+++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS----ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR   80 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC----HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence            5677889999999999999953      246689999876431    222334555543           3567777788


Q ss_pred             eeEEEEEeccCCChhhhhccccc------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAA------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL  718 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  718 (849)
                      ..++||||+++|+|.+++.....            ...+++.++..++.|++.|++|||+.   +++||||||+||++++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~  157 (280)
T cd05092          81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ  157 (280)
T ss_pred             ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence            89999999999999999865321            13478999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042123          719 EYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLN  795 (849)
Q Consensus       719 ~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~  795 (849)
                      ++.+||+|||++........  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......      
T Consensus       158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------  231 (280)
T cd05092         158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------  231 (280)
T ss_pred             CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------
Confidence            99999999999876543221  1122334678999999998899999999999999999998 99998643221      


Q ss_pred             cccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        ........+.......   .....+.+++.+||+.||++||++++|.+.|+
T Consensus       232 --~~~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 --EAIECITQGRELERPR---TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HHHHHHHcCccCCCCC---CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              1111111111111111   11234778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.98  E-value=4.8e-32  Score=288.07  Aligned_cols=247  Identities=21%  Similarity=0.380  Sum_probs=184.3

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCS  647 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~  647 (849)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.+.....   ......+.+|+.           ++++++.
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS---LRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            34678999999999999999999543      255799998764321   122234444533           3577777


Q ss_pred             cCCeeEEEEEeccCCChhhhhccccc-------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAA-------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY  720 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  720 (849)
                      .....++||||+++|+|.+++.....       ....++..+..++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~  156 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF  156 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence            78889999999999999999964321       13457788999999999999999998   999999999999999999


Q ss_pred             cEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 042123          721 EAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTD  797 (849)
Q Consensus       721 ~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~  797 (849)
                      .++++|||+++........  .....++..|+|||.+.++.++.++|||||||++|||++ |..||.....        .
T Consensus       157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~--------~  228 (288)
T cd05061         157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------E  228 (288)
T ss_pred             cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence            9999999999865432221  122234678999999998889999999999999999998 7889864321        1


Q ss_pred             cccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .......+........   .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 ~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  276 (288)
T cd05061         229 QVLKFVMDGGYLDQPD---NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK  276 (288)
T ss_pred             HHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1112222222111111   11235889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.98  E-value=8.5e-32  Score=286.88  Aligned_cols=241  Identities=22%  Similarity=0.390  Sum_probs=182.5

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+...    .....+.+.+|+.           .+++++..+...++|
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM   87 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence            56888899999999999999664 5889999998643    1222344555543           356667778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|..++.+..  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++|+|||.+.....
T Consensus        88 ~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          88 IEFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999988875433  3589999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      .........+++.|+|||++.     ...++.++|||||||++|||++|+.||......        ...........+.
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~  234 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPT  234 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--------HHHHHHhcCCCcc
Confidence            333334556888999999874     345678999999999999999999998643211        1111111111110


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ..........+.+++.+||+.+|++||++++++++
T Consensus       235 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         235 -LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             -CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence             00111223347889999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.98  E-value=6.6e-32  Score=296.25  Aligned_cols=249  Identities=20%  Similarity=0.295  Sum_probs=177.9

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC----
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA----  649 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~----  649 (849)
                      ..++|+..+.||+|+||.||+|.. .+|..||||++.....  .......+.+|+..           +++++...    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            457899999999999999999955 4689999999865322  11223344455442           44444332    


Q ss_pred             --CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          650 --RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       650 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                        ...++||||+++ ++.+.+.     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence              357999999976 5655553     2378899999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc---
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTD---  797 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~---  797 (849)
                      |+++..... .......+|+.|+|||.+.+..++.++||||+||++|+|++|+.||...+.....       .....   
T Consensus       168 g~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         168 GLARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             CCccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            999765332 2233457899999999999999999999999999999999999999743321000       00000   


Q ss_pred             ----cccccccCC--CCC--------------CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 ----VALDQMLDP--RLP--------------APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 ----~~~~~~~~~--~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          .........  ..+              ............+.+++.+||+.||++|||+.|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                000000000  000              0000000112347899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=3e-32  Score=295.11  Aligned_cols=246  Identities=21%  Similarity=0.295  Sum_probs=176.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+++.||+|.+...... .......+.+|+           ..+++++..++..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEML-KRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHh-hhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            4788999999999999999965 46899999998642110 111122333332           2356777888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+..  ..+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             EecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            99999999999986432  3589999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCC-CeeeccCCccccccccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYT-----MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ... ......||+.|+|||++..     ..++.++||||+||++|||++|+.||........    ............++
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~----~~~i~~~~~~~~~~  230 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNHKEHFQFP  230 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH----HHHHHcCCCcccCC
Confidence            322 2223468999999999863     4578899999999999999999999964321110    00000000000111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCC--CCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESP--ESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~eil~~  846 (849)
                      ...   ......+.+++.+|+..++  ..||++++++++
T Consensus       231 ~~~---~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         231 PDV---TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             Ccc---CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            111   1122346677777665433  348899999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.98  E-value=6.2e-32  Score=289.21  Aligned_cols=243  Identities=26%  Similarity=0.451  Sum_probs=179.7

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCc--EEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGE--VVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~  651 (849)
                      .++|+..+.||+|+||.||+|.+. ++.  .+|+|.+....   .......+.+|+.            ++++++...+.
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC---CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            467888999999999999999654 454  45777765432   1122334444433            35667777888


Q ss_pred             eEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 042123          652 SFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL  718 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  718 (849)
                      .++||||+++|+|.+++.....             ...+++.++..++.|++.|++|||+.   +++||||||+||+++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~  159 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGE  159 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecC
Confidence            9999999999999999965321             23578999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 042123          719 EYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTD  797 (849)
Q Consensus       719 ~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~  797 (849)
                      ++.+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||.......       
T Consensus       160 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------  231 (303)
T cd05088         160 NYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------  231 (303)
T ss_pred             CCcEEeCccccCcccchhh-hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-------
Confidence            9999999999986432111 1112234567999999988889999999999999999998 999986432111       


Q ss_pred             cccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          798 VALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       798 ~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       ........ ....+.    .....+.+++.+||+.+|++||+++++++.++
T Consensus       232 -~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         232 -LYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             -HHHHHhcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             11111111 111111    12234788999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.98  E-value=1e-31  Score=280.75  Aligned_cols=241  Identities=23%  Similarity=0.332  Sum_probs=182.8

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceee-cCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCS-HARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~-~~~~~~lV  655 (849)
                      +|+..+.||+|++|.||+|.. .+++.||+|++.....  .....+.+.+|+..           +.+.+. .....++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            478889999999999999954 4678999999864321  11122334444332           334443 34467899


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          79 MGFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ecccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            99999999999986532 34589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........+++.|+|||...+..++.++||||+|+++|++++|+.||+..+..        ...........+..   .
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~---~  223 (257)
T cd08223         155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN--------SLVYRIIEGKLPPM---P  223 (257)
T ss_pred             cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHhcCCCCC---c
Confidence            333334456889999999999999999999999999999999999998743211        11111122222111   1


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++|||+.+++++
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1233458899999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.98  E-value=5.8e-32  Score=297.75  Aligned_cols=246  Identities=23%  Similarity=0.400  Sum_probs=184.1

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhcee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFC  646 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~  646 (849)
                      ...++|.+.+.||+|+||.||+|++.      .++.||||++......   .....+.+|+.            .+++++
T Consensus        34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS---SEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh---hHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            34456778899999999999999753      3467999998754221   11233445544            356677


Q ss_pred             ecCCeeEEEEEeccCCChhhhhccccc-----------------------------------------------------
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAA-----------------------------------------------------  673 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------------  673 (849)
                      ...+..++||||+++|+|.+++++...                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            777889999999999999999965321                                                     


Q ss_pred             ------------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 042123          674 ------------------------------------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS  711 (849)
Q Consensus       674 ------------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~  711 (849)
                                                                ...+++.++.+++.|++.|++|||+.   +++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence                                                      12367888999999999999999998   999999999


Q ss_pred             CCeeecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccc
Q 042123          712 KNLLLDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSS  788 (849)
Q Consensus       712 ~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~  788 (849)
                      +||+++.++.+|++|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999986533221  1223356788999999988889999999999999999998 8999864321


Q ss_pred             ccccccccccccccccCCC--CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          789 ISSSSLNTDVALDQMLDPR--LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .        ......+...  ...+..    ....+.+++.+||+.+|.+||+++||++.|+
T Consensus       348 ~--------~~~~~~~~~~~~~~~p~~----~~~~l~~li~~cl~~~P~~RPs~~ell~~L~  397 (401)
T cd05107         348 N--------EQFYNAIKRGYRMAKPAH----ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG  397 (401)
T ss_pred             h--------HHHHHHHHcCCCCCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1        0111111111  111111    1235888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.98  E-value=6.8e-32  Score=289.67  Aligned_cols=244  Identities=23%  Similarity=0.397  Sum_probs=181.4

Q ss_pred             cCCCcCceecCCccceEEEEEec--------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP--------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS  647 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~  647 (849)
                      ++|.+.+.||+|+||.||+|...        ++..+|+|.+.....   ......+..|+.            .+++++.
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC---hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            57889999999999999999642        235699999875321   112233444433            3566777


Q ss_pred             cCCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL  714 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  714 (849)
                      ..+..++||||+++|+|.+++.....             ...+++.++.+++.|++.|++|||+.   +++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHhe
Confidence            78889999999999999999965421             13488999999999999999999998   999999999999


Q ss_pred             eecCCCcEEEeeecCCcccCCCCCCe--eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 042123          715 LLDLEYEAHVADFGIAKSLKPDSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISS  791 (849)
Q Consensus       715 ll~~~~~~kl~DfG~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~  791 (849)
                      +++.++.+|++|||.++.........  ....++..|+|||++.+..++.++|||||||++|||++ |..||......  
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--  249 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  249 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence            99999999999999987654322111  11223468999999988889999999999999999998 88888632211  


Q ss_pred             cccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          792 SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                            ..............+   ......+.+++.+||+.+|++|||+.++++.|+
T Consensus       250 ------~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~  297 (307)
T cd05098         250 ------ELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             ------HHHHHHHcCCCCCCC---CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                  111111111111111   112235778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.98  E-value=1.5e-31  Score=279.19  Aligned_cols=234  Identities=24%  Similarity=0.401  Sum_probs=174.0

Q ss_pred             eecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEEEecc
Q 042123          595 CIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~e~~~  660 (849)
                      .||+|+||.||+|.+.   .+..||+|.+....   .....+.+.+|+..           +++++. ....++||||++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN---EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc---ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            3899999999999653   35579999876532   12223445555442           455553 457789999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|+|.+++....  ..+++.++.+++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++.....+....
T Consensus        78 ~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          78 GGPLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999999986432  3589999999999999999999998   99999999999999999999999999998654432221


Q ss_pred             e---eccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          741 T---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       741 ~---~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      .   ...++..|+|||.+....++.++||||||+++||+++ |+.||.......        ....+........+.   
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~---  221 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------VMSFIEQGKRLDCPA---  221 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCCCCCCC---
Confidence            1   1223568999999988889999999999999999996 999987433211        111111111111111   


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....++.+++.+||+.+|++||++.+|.+.|+
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            12234778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.4e-33  Score=294.22  Aligned_cols=237  Identities=26%  Similarity=0.409  Sum_probs=185.7

Q ss_pred             CcCceecCCccceEEEEEec--CCc--EEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEE
Q 042123          591 DAKYCIGNGGHASVYRAELP--SGE--VVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLL  655 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV  655 (849)
                      ...+.||+|.||.|++|.|.  +|+  .||||.+.......   ....|++|+..           +||...+ ....+|
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~---~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA---IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch---hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            34568999999999999774  344  48999987653322   45678887653           5666555 667899


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||.++.|+|.+.|++ .....|-......++.|||.||.||.++   ++||||+.++|+++...-.+||+|||+.+.+..
T Consensus       189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999987 3345677888889999999999999999   999999999999999999999999999998876


Q ss_pred             CCCCeee---ccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCC
Q 042123          736 DSSNWTE---FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       736 ~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ....+..   ..-...|+|||.+....|+.++|||+|||++|||+| |+.||-.....        .+++.+-++....+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qIL~~iD~~erLpR  336 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QILKNIDAGERLPR  336 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HHHHhccccccCCC
Confidence            5544432   223568999999999999999999999999999998 89998754432        22332223333333


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +..+.+   .|.++++.||...|++|||+..|.+.
T Consensus       337 Pk~cse---dIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  337 PKYCSE---DIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             CCCChH---HHHHHHHHhccCCccccccHHHHHHh
Confidence            333333   48889999999999999999999754

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.98  E-value=3.3e-32  Score=304.82  Aligned_cols=253  Identities=21%  Similarity=0.240  Sum_probs=174.4

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceeec--------CCee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCSH--------ARHS  652 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~~--------~~~~  652 (849)
                      ..+|+..+.||+|+||.||+|.. .+++.||||++.....  ....+...++.     +..+.+++..        ....
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  142 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ--YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL  142 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence            45799999999999999999965 4689999998854311  11112222222     2234443321        1246


Q ss_pred             EEEEEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCC
Q 042123          653 FLLYEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIA  730 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a  730 (849)
                      ++||||+++ ++.+++... .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++ .+||+|||+|
T Consensus       143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            789999986 677766432 2234689999999999999999999999   999999999999999765 7999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cccccccc-
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVALD-  801 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~~-  801 (849)
                      +.+.... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..........       ........ 
T Consensus       219 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~  297 (440)
T PTZ00036        219 KNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE  297 (440)
T ss_pred             hhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            8765432 22345789999999988654 68999999999999999999999997533211000       00000000 


Q ss_pred             ---cccCCCCCCCC-h-----hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 ---QMLDPRLPAPS-R-----SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ---~~~~~~~~~~~-~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ...+..++... .     .+.....++.+++.+||++||.+|||+.|+++|
T Consensus       298 ~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence               00000001000 0     000112357899999999999999999999876

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.98  E-value=7e-32  Score=286.98  Aligned_cols=245  Identities=23%  Similarity=0.444  Sum_probs=185.3

Q ss_pred             hcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      .++|+..+.||+|+||.||+|...      ++..||+|.+....   .......+.+|+.           ++++++..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc---CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            467889999999999999999653      46789999886432   1222344555543           356777788


Q ss_pred             CeeEEEEEeccCCChhhhhcccc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDA-------------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS  710 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk  710 (849)
                      ...++||||+++|+|.+++....                   ....+++.+++.++.|++.||+|||+.   +++|||||
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~  157 (288)
T cd05050          81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA  157 (288)
T ss_pred             CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence            88999999999999999986321                   113478899999999999999999998   99999999


Q ss_pred             CCCeeecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccc
Q 042123          711 SKNLLLDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLS  787 (849)
Q Consensus       711 ~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~  787 (849)
                      |+||+++.++.++++|||.+........  .......+..|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~  237 (288)
T cd05050         158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA  237 (288)
T ss_pred             HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999876543221  1122234667999999988899999999999999999997 888885332


Q ss_pred             cccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          788 SISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .        ......+.+........   ....++.+++.+||+.+|++|||+.|+++.|+
T Consensus       238 ~--------~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         238 H--------EEVIYYVRDGNVLSCPD---NCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             H--------HHHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1        11112222222211111   12245888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.7e-33  Score=292.30  Aligned_cols=240  Identities=24%  Similarity=0.374  Sum_probs=186.0

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      -|.++-.||.|+||.||+|..+ ++...|.|.+...    ....-..|+-||+           .+++.|..++..||..
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk----seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK----SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc----chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            3455667999999999999554 3444566765432    2223344555543           4677777788999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      |||.||-.+.++-.-+  +.+++.++.-+++|++.||.|||++   +|+|||||+-|||++-+|.++++|||.+......
T Consensus       109 EFC~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t  183 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST  183 (1187)
T ss_pred             eecCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH
Confidence            9999999988875443  5699999999999999999999999   9999999999999999999999999998765544


Q ss_pred             CCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          737 SSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ......+.|||.|||||+.+     ..+|++++||||||+++.||..+.+|.......        ..+-.+.. .-|+.
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--------RVllKiaK-SePPT  254 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAK-SEPPT  254 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--------HHHHHHhh-cCCCc
Confidence            45567789999999999864     578999999999999999999999997644322        11111211 11222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .-.+..+...+.+|+.+|+.++|..||+++++++|
T Consensus       255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            22334555668999999999999999999999986

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.98  E-value=1.3e-31  Score=281.74  Aligned_cols=242  Identities=27%  Similarity=0.494  Sum_probs=182.9

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CC---cEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SG---EVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      .++|+..+.||+|+||.||+|..+ ++   ..+|+|.+.....   ......+..|+.           ++.+++...+.
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT---EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC---HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            357888899999999999999664 33   3799998764321   222344555544           25667777888


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~  155 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSR  155 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccce
Confidence            999999999999999986432  3589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCe-ee--ccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-
Q 042123          732 SLKPDSSNW-TE--FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-  806 (849)
Q Consensus       732 ~~~~~~~~~-~~--~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  806 (849)
                      ......... ..  ...+..|+|||++.+..++.++||||||+++||+++ |+.||......        .....+... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--------~~~~~i~~~~  227 (268)
T cd05063         156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--------EVMKAINDGF  227 (268)
T ss_pred             ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhcCC
Confidence            664332211 11  123457999999988889999999999999999997 99998643211        111111111 


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+...    .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       228 ~~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         228 RLPAPM----DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             CCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111111    12335789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.5e-31  Score=282.12  Aligned_cols=243  Identities=24%  Similarity=0.415  Sum_probs=180.1

Q ss_pred             CCcCceecCCccceEEEEEecC----CcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC----
Q 042123          590 FDAKYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR----  650 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~----  650 (849)
                      |.+.+.||+|+||.||+|....    +..||+|+++....  .......+.+|+..           +++++....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            5677899999999999996532    46799999865322  12223345555442           445544433    


Q ss_pred             --eeEEEEEeccCCChhhhhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 042123          651 --HSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVA  725 (849)
Q Consensus       651 --~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  725 (849)
                        ..++|+||+++|+|..++....   ....+++.++..++.|++.||+|||+.   +++||||||+||++++++.+||+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence              3789999999999999985432   223689999999999999999999998   99999999999999999999999


Q ss_pred             eecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 042123          726 DFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       726 DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      |||.++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||......        .....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--------~~~~~  227 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--------EIYDY  227 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHH
Confidence            99999876543221  112234678999999988889999999999999999999 88998643211        11122


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+......+   ......+.+++.+||+.||++|||+.|++++|+
T Consensus       228 ~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~  270 (273)
T cd05035         228 LRHGNRLKQP---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLE  270 (273)
T ss_pred             HHcCCCCCCC---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            2222111111   122345889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.98  E-value=3.5e-32  Score=299.79  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=178.9

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC-----e
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR-----H  651 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~-----~  651 (849)
                      +|+..+.||+|+||.||+|.. .+++.||||++.....  .....+.+.+|+.           .+++++....     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ--NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc--chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            578889999999999999965 5799999999864321  1222344555544           3566665555     7


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+. ++|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        79 ~~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          79 IYVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecccccee
Confidence            899999997 4787777543   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC-CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc----
Q 042123          732 SLKPDS-SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDV----  798 (849)
Q Consensus       732 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~----  798 (849)
                      ...... .......+++.|+|||.+.+. .++.++||||+||++|||++|+.||..........       .....    
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            654332 122334678999999998764 47899999999999999999999997543211000       00000    


Q ss_pred             ---cccc-ccCCCCCCCC-----hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ---ALDQ-MLDPRLPAPS-----RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ---~~~~-~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         .... +.......+.     .........+.+++.+|++.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence               0000 0000000000     0001113457889999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.1e-31  Score=281.02  Aligned_cols=241  Identities=25%  Similarity=0.489  Sum_probs=186.6

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|++.+.||+|+||.||+|..+++..||||.+.....     ....+.+|+.           ++++++......++|
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            468889999999999999999887788999999875321     1234444533           366677777889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||.+.....
T Consensus        80 ~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          80 TEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999999997643 34589999999999999999999999   999999999999999999999999999887653


Q ss_pred             CCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      ... .......+..|+|||.+.+..++.++||||+|+++|++++ |+.||.....        ......+... ..+.+.
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~  227 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVERGYRMPRPP  227 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCCC
Confidence            211 1122234568999999998889999999999999999998 9999863321        1111111111 111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..    ...+.+++.+||+.+|++||+++++.+.|+
T Consensus       228 ~~----~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         228 NC----PEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             CC----CHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence            11    234788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.98  E-value=2.3e-32  Score=296.07  Aligned_cols=244  Identities=21%  Similarity=0.308  Sum_probs=179.2

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|+.. +++.||+|.+..... ........+.+|+.           .+++++...+..|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            47889999999999999999654 688899999864211 11111223333432           255677788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+..  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             EeCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999996532  3588999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCC-eeeccCCccccccccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--C
Q 042123          736 DSSN-WTEFAGTCGYIAPELAYT-----MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP--R  807 (849)
Q Consensus       736 ~~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~  807 (849)
                      .... .....|++.|+|||++.+     +.++.++|||||||++|||++|+.||......        .....+...  +
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~  226 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV--------ETYGKIMNHEER  226 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH--------HHHHHHHcCCCc
Confidence            3322 223568999999998865     46788999999999999999999999643211        111111111  1


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHhh
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPES--RPTMKIISQQ  846 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~  846 (849)
                      .+.+. ........+.+++.+|+..++.+  |++++++++|
T Consensus       227 ~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 FQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            11111 11112345778888988866554  5689998876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.98  E-value=1.3e-31  Score=280.23  Aligned_cols=239  Identities=25%  Similarity=0.427  Sum_probs=181.4

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~  656 (849)
                      ++|...+.||+|+||.||+|....+..+|+|.+.....     ....+.+|+..           +++++ .....++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~   79 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-----MPEAFLQEAQIMKKLRHDKLVPLYAVV-SEEPIYIVT   79 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-----cHHHHHHHHHHHHhCCCCCeeeEEEEE-cCCCcEEEE
Confidence            56888899999999999999887777899998754321     12334444432           34444 345678999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.... ...+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          80 EFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            9999999999997543 23578999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCh
Q 042123          737 SS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSR  813 (849)
Q Consensus       737 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  813 (849)
                      .. ......++..|+|||...+..++.++||||||+++|||++ |+.||......        .....+... ..+.+  
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~--  225 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR--------EVLEQVERGYRMPCP--  225 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC--
Confidence            21 1122345678999999988889999999999999999999 89998643211        111111111 11111  


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        ......+.+++.+||+++|++||++++|.+.|+
T Consensus       226 --~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         226 --QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             --cccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence              122345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.98  E-value=1e-31  Score=289.89  Aligned_cols=189  Identities=21%  Similarity=0.314  Sum_probs=142.1

Q ss_pred             CceecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceee--cCCeeEEEEEeccCC
Q 042123          593 KYCIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCS--HARHSFLLYEFLERG  662 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~--~~~~~~lV~e~~~~g  662 (849)
                      .++||+|+||+||+|+..   +++.||+|.+...........+...++.     +.++++++.  .....++||||+.+ 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence            458999999999999654   5678999998653211111111122222     223455543  34568999999965 


Q ss_pred             Chhhhhcccc------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEeeecCCcc
Q 042123          663 SLAAILNTDA------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL----DLEYEAHVADFGIAKS  732 (849)
Q Consensus       663 sL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfG~a~~  732 (849)
                      +|.+++....      ....+++..+..++.||+.||+|||+.   +|+||||||+||++    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            8888774321      123588999999999999999999999   99999999999999    4567899999999987


Q ss_pred             cCCCCC---CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          733 LKPDSS---NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       733 ~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                      ......   ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            643321   2234578999999999876 4588999999999999999999999963

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.6e-31  Score=278.92  Aligned_cols=237  Identities=26%  Similarity=0.466  Sum_probs=184.3

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||.||+|... |+.||+|.+.....     ..+.+..|+.           ++++++......++|
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            357888999999999999999875 88999999875422     2344555543           356677778889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++..... ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||.++....
T Consensus        79 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccc
Confidence            999999999999865432 3589999999999999999999998   999999999999999999999999999987632


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCCCh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-PRLPAPSR  813 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  813 (849)
                      ..   .....+..|+|||++....++.++||||||+++||+++ |+.||.......        ....... .+...+. 
T Consensus       155 ~~---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~-  222 (256)
T cd05039         155 GQ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPHVEKGYRMEAPE-  222 (256)
T ss_pred             cc---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhcCCCCCCcc-
Confidence            21   12334567999999988889999999999999999997 999986432110        0010000 0111111 


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         .....+.+++.+||+.+|++|||++++++.|+
T Consensus       223 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         223 ---GCPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             ---CCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence               12345889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=1.5e-31  Score=283.73  Aligned_cols=247  Identities=23%  Similarity=0.357  Sum_probs=179.3

Q ss_pred             CCcCceecCCccceEEEEE-----ecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec--CCe
Q 042123          590 FDAKYCIGNGGHASVYRAE-----LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH--ARH  651 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~--~~~  651 (849)
                      |...+.||+|+||+||.+.     ..++..||+|.+.....   ......+.+|+..           +++++..  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG---QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            3778899999999998764     24678899999865321   1223445555442           4555543  345


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++...    .+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++++|||+++
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccc
Confidence            78999999999999998643    489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------ccccccccc
Q 042123          732 SLKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS------LNTDVALDQ  802 (849)
Q Consensus       732 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~------~~~~~~~~~  802 (849)
                      ........   .....++..|+|||.+.+..++.++||||||+++|||++|+.||..........      ........+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIE  235 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhh
Confidence            76543221   112235667999999988889999999999999999999999986432110000      000001111


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.....+  ........+.+++.+||+.+|++|||+++|++.|+
T Consensus       236 ~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~  279 (283)
T cd05080         236 LLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK  279 (283)
T ss_pred             hhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            111111100  01112345889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.98  E-value=1.7e-31  Score=281.63  Aligned_cols=242  Identities=24%  Similarity=0.402  Sum_probs=176.3

Q ss_pred             CCcCceecCCccceEEEEEecC-Cc--EEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec------C
Q 042123          590 FDAKYCIGNGGHASVYRAELPS-GE--VVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH------A  649 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~------~  649 (849)
                      |.+.+.||+|+||.||+|+..+ +.  .+|+|.+.....  .......+.+|+.           ++++++..      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   78 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC--TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY   78 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence            3456789999999999997653 32  689998765321  1222344555533           24444422      1


Q ss_pred             CeeEEEEEeccCCChhhhhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          650 RHSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                      ...++||||+++|+|.+++....   ....+++..+..++.|++.|++|||+.   +|+||||||+||++++++.+||+|
T Consensus        79 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~D  155 (272)
T cd05075          79 PSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVAD  155 (272)
T ss_pred             CCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECC
Confidence            24689999999999999874321   223589999999999999999999998   999999999999999999999999


Q ss_pred             ecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 042123          727 FGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQM  803 (849)
Q Consensus       727 fG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~  803 (849)
                      ||+++........  .....+++.|+|||+..+..++.++||||||+++|||++ |+.||......        .....+
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~  227 (272)
T cd05075         156 FGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--------EIYDYL  227 (272)
T ss_pred             CCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHH
Confidence            9999876433221  122245678999999998899999999999999999999 88898643211        111111


Q ss_pred             cCCCC-CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          804 LDPRL-PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       804 ~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..... ..+.    .....+.+++.+||+.+|++|||+.+++++|+
T Consensus       228 ~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  269 (272)
T cd05075         228 RQGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE  269 (272)
T ss_pred             HcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11111 1111    12234789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.98  E-value=1.1e-31  Score=284.22  Aligned_cols=244  Identities=23%  Similarity=0.396  Sum_probs=184.7

Q ss_pred             hcCCCcCceecCCccceEEEEEecC-----CcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-C
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPS-----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-A  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-~  649 (849)
                      .++|+..+.||+|+||.||+|.+.+     +..||+|++....   .......+.+|+.           .+++++.. +
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA---SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            4678889999999999999997654     6889999876432   2222344555543           25565554 4


Q ss_pred             CeeEEEEEeccCCChhhhhcccccc-----cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAA-----QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                      ...++++||+++|+|.+++......     ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+|+
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence            6789999999999999998654322     4589999999999999999999998   9999999999999999999999


Q ss_pred             eeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccc
Q 042123          725 ADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALD  801 (849)
Q Consensus       725 ~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~  801 (849)
                      +|||+++.+......  .....++..|+|||++.+..++.++||||||+++||+++ |+.||........        ..
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~  230 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM--------AA  230 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH--------HH
Confidence            999999866433221  112345678999999988889999999999999999999 9999974332111        11


Q ss_pred             cccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          802 QMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       802 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+. ......    .....+.+++.+||+.||++|||+.++++.|+
T Consensus       231 ~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         231 YLKDGYRLAQPI----NCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             HHHcCCCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            11111 111111    11234788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.98  E-value=3.2e-32  Score=295.22  Aligned_cols=244  Identities=22%  Similarity=0.321  Sum_probs=177.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+++.. +++.+|+|.+.+.... .......+.+|+.           .+++++......++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHH-HhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence            47888999999999999999654 5788999998542110 1111223344433           245667778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+..  ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        80 ~ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             EeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            99999999999996532  3488999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCC-eeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--C
Q 042123          736 DSSN-WTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP--R  807 (849)
Q Consensus       736 ~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~  807 (849)
                      .... .....||+.|+|||++.     ...++.++|||||||++|||++|+.||.......        ....+...  +
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~  226 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--------TYGKIMNHKER  226 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCcc
Confidence            3222 23357899999999886     3467889999999999999999999997432211        11111111  1


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHhh
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPES--RPTMKIISQQ  846 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~  846 (849)
                      ...+. ........+.+++.+|+..++++  |++++|+++|
T Consensus       227 ~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 FQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            11111 11112334677888888655444  7899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.98  E-value=1.1e-31  Score=285.64  Aligned_cols=252  Identities=23%  Similarity=0.303  Sum_probs=177.0

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCch----hhHHHHHHH--------HHHhhceeec-----CC
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQT----VDQKEFLTE--------VEAFYGFCSH-----AR  650 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----~~~~~~~~e--------i~~~~~~~~~-----~~  650 (849)
                      +|+..+.||+|+||+||+|.. .+++.||+|.+.........    ..+....+.        +.++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            477889999999999999955 46899999988653221111    111111222        2224444432     34


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..++||||+++ +|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999985 8888886543 23489999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccc---
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVAL---  800 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~---  800 (849)
                      +...... ......++..|+|||++.+..++.++||||+||++|||++|+.||..........       .......   
T Consensus       156 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         156 RIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             ccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            8764322 2234567899999999998889999999999999999999999986432110000       0000000   


Q ss_pred             ----ccccCCCCCCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 ----DQMLDPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 ----~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          .....+..+.+ ..........+.+++.+|+++||++|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                00000000000 00111223457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.98  E-value=1.1e-31  Score=280.30  Aligned_cols=241  Identities=20%  Similarity=0.317  Sum_probs=186.4

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||++.. .+++.||+|++......  ......+.+|+.           .+.+++...+..++||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS--PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC--hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            478889999999999999954 57899999998643211  122334555544           3666777888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++.... ...+++.++.+++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          79 DYCEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             ecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            9999999999986533 23578999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      ........+++.|+|||+..+..++.++||||||+++|++++|+.||.....        .......+.+..+...   .
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~~~~~~~~~---~  223 (256)
T cd08218         155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--------KNLVLKIIRGSYPPVS---S  223 (256)
T ss_pred             hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--------HHHHHHHhcCCCCCCc---c
Confidence            3333345678899999999988899999999999999999999999863221        1112222222222111   1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.+++.+||+.+|++||++.+|+++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            223348889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.98  E-value=1.8e-31  Score=284.15  Aligned_cols=241  Identities=24%  Similarity=0.453  Sum_probs=180.7

Q ss_pred             CCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          589 DFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      +|+..+.||+|+||.||+|...      ....+|+|.+.....   ......+.+|+.           ++++++...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS---SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC---HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            4677889999999999999642      235688888764321   122334555543           36677778888


Q ss_pred             eEEEEEeccCCChhhhhcccc---------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 042123          652 SFLLYEFLERGSLAAILNTDA---------------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS  710 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk  710 (849)
                      .++|+||+++|+|.+++....                     ....+++.++..++.|++.|++|||+.   +++|||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dik  154 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLA  154 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhh
Confidence            999999999999999975421                     123578999999999999999999998   99999999


Q ss_pred             CCCeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccc
Q 042123          711 SKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLS  787 (849)
Q Consensus       711 ~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~  787 (849)
                      |+||++++++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus       155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             hheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999999999999999999865432221  122345678999999988889999999999999999998 999986432


Q ss_pred             cccccccccccccccccCCC--CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          788 SISSSSLNTDVALDQMLDPR--LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       788 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..         ...+.....  ...+.    .....+.+++.+||+.+|++||+++++++.|+
T Consensus       235 ~~---------~~~~~~~~~~~~~~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         235 PE---------RLFNLLKTGYRMERPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELE  284 (290)
T ss_pred             HH---------HHHHHHhCCCCCCCCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            11         111111111  11111    12234788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.98  E-value=6.5e-32  Score=288.01  Aligned_cols=236  Identities=25%  Similarity=0.394  Sum_probs=180.1

Q ss_pred             CcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEEEEe
Q 042123          591 DAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV~e~  658 (849)
                      +....||+|+||.||+|.. .+++.||+|.+.....    .....+.+|           +..+++++..++..++||||
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc----chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            3345799999999999955 4789999999854321    112233344           33477788888899999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +++++|.+++..    ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||++........
T Consensus       100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999998743    3489999999999999999999998   999999999999999999999999999876554433


Q ss_pred             CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          739 NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       739 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      ......++..|+|||++.+..++.++||||||+++|||++|+.||........        ...+ ..............
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--------~~~~-~~~~~~~~~~~~~~  243 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--------MKRL-RDSPPPKLKNAHKI  243 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHH-hccCCCCccccCCC
Confidence            33446788999999999988899999999999999999999999864322110        0000 00000000111112


Q ss_pred             HHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          819 LISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+.+++.+||+.+|++||++++++++
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            2347788999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.98  E-value=9.2e-32  Score=294.77  Aligned_cols=250  Identities=20%  Similarity=0.271  Sum_probs=178.7

Q ss_pred             HHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC---
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA---  649 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~---  649 (849)
                      ...++|+..+.||+|+||.||+|.. ..++.||||++......  ......+.+|+.           .+++++...   
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   91 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN--QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL   91 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC--hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccc
Confidence            3457899999999999999999954 46899999998653221  112233344433           345554322   


Q ss_pred             ---CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          650 ---RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       650 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                         ...++||||+++ ++.+.+.     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          92 EEFQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             cccceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEee
Confidence               357999999976 6666653     2378899999999999999999998   999999999999999999999999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------cc---
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS--------LN---  795 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~--------~~---  795 (849)
                      ||+++..... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||..........        ..   
T Consensus       163 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         163 FGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             CcccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9999865432 22234578999999999999899999999999999999999999997433111000        00   


Q ss_pred             ---cccccccccC----------------CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          796 ---TDVALDQMLD----------------PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       796 ---~~~~~~~~~~----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         .........+                ...+............+.+++.+|++.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               0000000000                00000000111123357899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.98  E-value=7.5e-32  Score=288.28  Aligned_cols=244  Identities=23%  Similarity=0.405  Sum_probs=183.4

Q ss_pred             cCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHA  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~  649 (849)
                      ++|...+.||+|+||.||+|..      .++..||||.+.....   ......+.+|+.            ++++++...
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH---SSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC---hHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            5788999999999999999953      2355799998765321   112233444433            356677778


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      +..++||||+++|+|.+++.+... ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||+
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence            889999999999999999865332 3389999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC
Q 042123          730 AKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP  806 (849)
Q Consensus       730 a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  806 (849)
                      ++........  .....++..|+|||.+.+..++.++||||+||++|||++ |..||.......        .....+..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--------~~~~~~~~  259 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--------KFYKLIKE  259 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--------HHHHHHHc
Confidence            9866433221  122345678999999998889999999999999999998 999986432111        11111111


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .....  ........+.+++.+||+.+|++|||+.|+++.|+
T Consensus       260 ~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         260 GYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             CCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            11100  00111235888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.98  E-value=1e-31  Score=282.72  Aligned_cols=241  Identities=27%  Similarity=0.383  Sum_probs=170.6

Q ss_pred             eecCCccceEEEEEecC---CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEecc
Q 042123          595 CIGNGGHASVYRAELPS---GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      .||+|+||+||+|...+   ...+|+|.+....   .......+.+|+.           .+++++......++||||++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA---TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC---ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            58999999999996543   3468888765321   2223345555544           35777778888999999999


Q ss_pred             CCChhhhhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          661 RGSLAAILNTDAA--AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       661 ~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +|+|.+++.....  ....++..+..++.||+.|++|||+.   +|+||||||+||+++.++.+|++|||++........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchh
Confidence            9999999975432  22356788899999999999999999   999999999999999999999999999875433221


Q ss_pred             C--eeeccCCcccccccccc-------CCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 042123          739 N--WTEFAGTCGYIAPELAY-------TMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       739 ~--~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      .  .....++..|+|||+..       ...++.++|||||||++|||++ |..||........    ..... ...+..+
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~~~-~~~~~~~  230 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV----LKQVV-REQDIKL  230 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH----HHHHh-hccCccC
Confidence            1  12234567799999864       2456789999999999999999 7888864321100    00000 0011111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+ .........+.+++..|| .||++|||+++|++.|.
T Consensus       231 ~~~-~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKP-QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCC-cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111 111122334667888999 49999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.98  E-value=1.7e-31  Score=283.38  Aligned_cols=248  Identities=27%  Similarity=0.439  Sum_probs=179.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-----cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceee--cC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCS--HA  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~--~~  649 (849)
                      .+|+..+.||+|+||.||+|..     .+++.||+|++....    ....+.+.+|+..           +.+++.  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST----AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC----HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            4678889999999999999964     358899999986532    2223445555442           344432  23


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence            46789999999999999986543  3489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCCe---eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccc-------cc
Q 042123          730 AKSLKPDSSNW---TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTD-------VA  799 (849)
Q Consensus       730 a~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~-------~~  799 (849)
                      ++.........   ....++..|+|||+..+..++.++||||||+++|||++|..|+..............       ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH  234 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence            98765433211   111234469999999888899999999999999999998877542221100000000       00


Q ss_pred             cccccCC--CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.+..  ..+.+.    .....+.+++.+||+.+|++|||+.||++.|+
T Consensus       235 ~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05081         235 LIELLKNNGRLPAPP----GCPAEIYAIMKECWNNDPSQRPSFSELALQVE  281 (284)
T ss_pred             HHHHHhcCCcCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            0011111  111111    12234889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.98  E-value=4.6e-32  Score=288.80  Aligned_cols=251  Identities=23%  Similarity=0.355  Sum_probs=184.0

Q ss_pred             cHHHHHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhce
Q 042123          579 LYDEIVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGF  645 (849)
Q Consensus       579 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~  645 (849)
                      ..+++..+.++|+..+.||+|+||.||+|.. .+++.+|+|.+......     ...+.+|+            ..++++
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-----~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-----DEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-----HHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            3455566788999999999999999999965 57889999988643111     11122222            124445


Q ss_pred             eecC-----CeeEEEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          646 CSHA-----RHSFLLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       646 ~~~~-----~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      +...     ...++||||+++|+|.++++... ....+++..++.++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~  164 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCC
Confidence            4432     36899999999999999886422 234589999999999999999999998   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCCCCCeeeccCCccccccccccCC-----CCCccchHHHHHHHHHHHHhCCCCCCcccccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM-----KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL  794 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~  794 (849)
                      +.+|++|||.+..............++..|+|||.+...     .++.++|||||||++|||++|+.||.......    
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~----  240 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK----  240 (291)
T ss_pred             CCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH----
Confidence            999999999988765433333345688899999987543     36789999999999999999999986432211    


Q ss_pred             ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ....+.... .............+.+++.+||+.+|++||++.|++++
T Consensus       241 ----~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         241 ----TLFKIPRNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ----HHHHHhcCC-CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                111111110 00001111223358899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=2e-31  Score=280.09  Aligned_cols=241  Identities=25%  Similarity=0.464  Sum_probs=183.0

Q ss_pred             cCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      .+|+..+.||+|+||.||+|...    .+..+|+|.+.....   ....+.+..|+.           ++++++..++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT---EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            57888899999999999999653    234799998764321   122334555543           366777788899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++.+..  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            99999999999999996543  3589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCCeee---ccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042123          733 LKPDSSNWTE---FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-R  807 (849)
Q Consensus       733 ~~~~~~~~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~  807 (849)
                      ..........   ..++..|+|||++.+..++.++||||||+++||+++ |..||.......        ....+.+. +
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  227 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGYR  227 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCCc
Confidence            6543321111   123467999999998889999999999999999886 999986432211        11111111 1


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+.+.    ..+..+.+++.+||+.+|.+||++.++++.|.
T Consensus       228 ~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         228 LPAPM----DCPAALHQLMLDCWQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             CCCCC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence            11111    12234788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.98  E-value=1.8e-31  Score=286.36  Aligned_cols=248  Identities=23%  Similarity=0.358  Sum_probs=183.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .++..+|+|.+.....   ......+.+|+.           .+++++..++..++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK---PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            4688999999999999999965 4688899998764321   122334445543           367778888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+|++|||++.....
T Consensus        78 ~ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          78 MEHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             eeccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999999999999654   34889999999999999999999732  899999999999999999999999999876543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccc-------c-----------
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNT-------D-----------  797 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~-------~-----------  797 (849)
                      .  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.............       .           
T Consensus       153 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         153 S--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             c--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence            2  1234578899999999988889999999999999999999999986332111000000       0           


Q ss_pred             ----------cccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          798 ----------VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       798 ----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                                ...........+.  .........+.+++.+||+.+|++|||+.+++++-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPK--LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCcc--CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                      0000000000000  00001233588999999999999999999998863

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.98  E-value=1.2e-31  Score=282.30  Aligned_cols=247  Identities=22%  Similarity=0.408  Sum_probs=185.8

Q ss_pred             CCCcCceecCCccceEEEEEecC--CcEEEEEEecccCCC------CchhhHHHHHHHHH------------Hhhceeec
Q 042123          589 DFDAKYCIGNGGHASVYRAELPS--GEVVAVKKFHSLLPC------DQTVDQKEFLTEVE------------AFYGFCSH  648 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~------~~~~~~~~~~~ei~------------~~~~~~~~  648 (849)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+......      ........+.+|+.            .+++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999997654  788999987543211      11112233444433            35667778


Q ss_pred             CCeeEEEEEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          649 ARHSFLLYEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                      ++..++||||+++++|.+++... .....+++.++++++.|++.|+.|||+..  +++|+||+|+||+++.++.+|++||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            88999999999999999988542 22346899999999999999999999632  7999999999999999999999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      |.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......        ..........
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~--------~~~~~~~~~~  229 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML--------SLATKIVEAV  229 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH--------HHHHHHhhcc
Confidence            9998755432 334556889999999999888999999999999999999999998633211        1111111111


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+...  ......+.+++.+||+.||++||++.|+.++++
T Consensus       230 ~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YEPLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCcCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            111111  012234788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.98  E-value=1.1e-31  Score=281.92  Aligned_cols=243  Identities=24%  Similarity=0.383  Sum_probs=182.7

Q ss_pred             CCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCC--chhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCD--QTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +|...+.||+|+||+||+|...+++.+|||.+.......  .......+.+|+.           .+.+++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477888999999999999987789999999876432111  1111223444433           356777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.+.   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999998653   2478999999999999999999998   999999999999999999999999999875432


Q ss_pred             CC------CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          736 DS------SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       736 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ..      .......++..|+|||++.+..++.++||||+|+++|++++|+.||..........   .........+..+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~  231 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YIGAHRGLMPRLP  231 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH---HhhhccCCCCCCC
Confidence            11      11223467889999999998889999999999999999999999997432211000   0000000011111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .      .....+.+++.+||+.+|++|||+.+++++
T Consensus       232 ~------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         232 D------SFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             C------CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            1      122347889999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.98  E-value=1.9e-31  Score=283.97  Aligned_cols=239  Identities=23%  Similarity=0.391  Sum_probs=184.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .+|...+.||+|+||.||+|.. .++..||+|.+....    ......+..|+.           .+++++......++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc----chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            6888899999999999999954 468899999875421    112233444433           366777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      +||+++++|.+++.+.    .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999998643    478999999999999999999999   999999999999999999999999999876654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........+++.|+|||.+.+..++.++||||||+++|++++|+.||........        .........+ .....
T Consensus       168 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--------~~~~~~~~~~-~~~~~  238 (293)
T cd06647         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNGTP-ELQNP  238 (293)
T ss_pred             cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--------eeehhcCCCC-CCCCc
Confidence            43333445688899999999888899999999999999999999999974322110        0001100100 11111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++||++++++.+
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1223457889999999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.98  E-value=1.2e-31  Score=280.24  Aligned_cols=235  Identities=27%  Similarity=0.438  Sum_probs=179.3

Q ss_pred             ceecCCccceEEEEEecC--C--cEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEEEe
Q 042123          594 YCIGNGGHASVYRAELPS--G--EVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEF  658 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~e~  658 (849)
                      +.||+|++|.||+|.+.+  +  ..||||.+......   ...+.+.+|+..           +++++.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            368999999999997643  3  36899998764321   334455666542           4555555 788999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +++|+|.+++..... ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+|++|||+++.......
T Consensus        77 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~  152 (257)
T cd05040          77 APLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED  152 (257)
T ss_pred             cCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence            999999999976442 4689999999999999999999998   999999999999999999999999999987654322


Q ss_pred             C---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc--CCCCCCCC
Q 042123          739 N---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQML--DPRLPAPS  812 (849)
Q Consensus       739 ~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  812 (849)
                      .   .....++..|+|||++.+..++.++||||||+++|||++ |+.||.......        ......  ......+.
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~  224 (257)
T cd05040         153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--------ILKKIDKEGERLERPE  224 (257)
T ss_pred             ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHhcCCcCCCCc
Confidence            1   112456778999999998899999999999999999998 999986433211        011110  01111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          .....+.+++.+||+.+|++|||+.++++.|.
T Consensus       225 ----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         225 ----ACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                12235888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=2.2e-31  Score=278.67  Aligned_cols=229  Identities=23%  Similarity=0.388  Sum_probs=169.9

Q ss_pred             ceecCCccceEEEEEecC-------------CcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecC
Q 042123          594 YCIGNGGHASVYRAELPS-------------GEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHA  649 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~  649 (849)
                      +.||+|+||.||+|.+.+             ...||+|.+....    ......+.+|+           .++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH----RDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh----hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            368999999999996532             2358888765421    11223344442           2467788888


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-------E
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE-------A  722 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------~  722 (849)
                      ...++||||+++|+|..++....  ..+++.++.+++.||+.|++|||+.   +|+||||||+||+++.++.       +
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence            88999999999999999886433  3589999999999999999999998   9999999999999987664       8


Q ss_pred             EEeeecCCcccCCCCCCeeeccCCcccccccccc-CCCCCccchHHHHHHHHHHHH-hCCCCCCcccccccccccccccc
Q 042123          723 HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVAL  800 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~-tg~~Pf~~~~~~~~~~~~~~~~~  800 (849)
                      +++|||.+......    ....++..|+|||.+. +..++.++|||||||++|||+ +|..||.......         .
T Consensus       152 ~l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---------~  218 (262)
T cd05077         152 KLSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE---------K  218 (262)
T ss_pred             EeCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH---------H
Confidence            99999998765432    2346788999999886 466889999999999999998 5888876322110         0


Q ss_pred             ccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .............    ....+.+++.+||+.||.+||++.+|++++.
T Consensus       219 ~~~~~~~~~~~~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ERFYEGQCMLVTP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHHhcCccCCCC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0111111111111    1234788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.98  E-value=9.4e-32  Score=282.37  Aligned_cols=244  Identities=24%  Similarity=0.380  Sum_probs=186.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +++.+|+|.+.....   ......+.+|+.           .+++++......++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN---EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC---hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            36778889999999999999654 689999998865422   123344445533           467777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      +||+++++|.+++....  ..+++..+.+++.|++.|++|||+ .   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        78 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          78 MEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            99999999999987543  458899999999999999999999 7   99999999999999999999999999987654


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ....  ....++..|+|||...+..++.++||||||+++|+|++|+.||.......   ...............+...  
T Consensus       153 ~~~~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~--  225 (265)
T cd06605         153 NSLA--KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNEPPPRLP--  225 (265)
T ss_pred             HHHh--hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcCCCCCCC--
Confidence            3221  12668889999999998899999999999999999999999987432110   0111111222222211111  


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.+++.+||..+|++|||+.+++++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            11133458899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=1.9e-31  Score=280.54  Aligned_cols=241  Identities=24%  Similarity=0.370  Sum_probs=171.7

Q ss_pred             eecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEecc
Q 042123          595 CIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      .||+|+||.||+|...   .+..+|+|.+.....   ......+.+|+.           ++++++.+....++||||++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS---VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            5899999999999654   345799998765421   222334555543           35677777888999999999


Q ss_pred             CCChhhhhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          661 RGSLAAILNTDAA--AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       661 ~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +|+|.+++.....  ....++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999965332  23467788889999999999999998   999999999999999999999999999875433221


Q ss_pred             C--eeeccCCccccccccccCC-------CCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 042123          739 N--WTEFAGTCGYIAPELAYTM-------KITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       739 ~--~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      .  .....++..|+|||++.+.       .++.++||||||+++|||++ |+.||...........    ... ....+.
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~  230 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY----TVR-EQQLKL  230 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH----Hhh-cccCCC
Confidence            1  1224567889999987542       35789999999999999996 9999974332110000    000 000111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+. ........+.+++..|| .+|++|||++||++.|+
T Consensus       231 ~~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1110 00011223677888999 58999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.7e-32  Score=285.05  Aligned_cols=242  Identities=24%  Similarity=0.411  Sum_probs=184.5

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|++.+.||+|+||.||+|.. .++..||+|.+...    .......+.+|+.           ++++++..+...++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            35688889999999999999965 46899999998643    1222334555543           36667777889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++++|.+++....  ..+++.++..++.|++.|+.|||+.   +|+|+||+|+||+++.++.++++|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence            999999999999986533  3589999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          735 PDSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ..........+++.|+|||.+.     ...++.++||||||+++|||++|+.||......        .....+.....+
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~  226 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEPP  226 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCCCC
Confidence            4333344567899999999874     345678999999999999999999998743211        111111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ....+......+.+++.+||+.+|++||++++++++
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 -TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence             000111122347789999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1.8e-31  Score=286.04  Aligned_cols=245  Identities=22%  Similarity=0.391  Sum_probs=182.7

Q ss_pred             hcCCCcCceecCCccceEEEEEe--------cCCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhcee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL--------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFC  646 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~  646 (849)
                      .++|.+.+.||+|+||.||+|+.        .++..||+|.+.....   ....+.+.+|+            ..+++++
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   90 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT---EKDLSDLVSEMEMMKMIGKHKNIINLLGAC   90 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc---hHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence            36788889999999999999963        1345799998764321   11223333332            3467777


Q ss_pred             ecCCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                      ......++||||+++|+|.+++.....             ...+++.++..++.||+.|++|||+.   +++||||||+|
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N  167 (304)
T cd05101          91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARN  167 (304)
T ss_pred             ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccce
Confidence            888889999999999999999965321             23578899999999999999999998   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 042123          714 LLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSIS  790 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~  790 (849)
                      |+++.++.+|++|||.++........  .....+++.|+|||++.+..++.++||||||+++||+++ |..||...... 
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence            99999999999999999876543221  122345678999999988889999999999999999998 78887643211 


Q ss_pred             ccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                             .....+.........   ......+.+++.+||+.+|++|||+.|+++.|+
T Consensus       247 -------~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~  294 (304)
T cd05101         247 -------ELFKLLKEGHRMDKP---ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD  294 (304)
T ss_pred             -------HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence                   111111111111111   112334778899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=1.8e-31  Score=280.83  Aligned_cols=241  Identities=27%  Similarity=0.520  Sum_probs=181.9

Q ss_pred             cCCCcCceecCCccceEEEEEec-CC---cEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SG---EVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      .+|+..+.||+|+||.||+|... ++   ..||||.+....   .......+..|+.           ++.+++..+...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            45778899999999999999654 23   369999986532   1223345555544           356677778889


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          81 MIITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccc
Confidence            99999999999999986543  3589999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCCC--eee-cc--CCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc-C
Q 042123          733 LKPDSSN--WTE-FA--GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQML-D  805 (849)
Q Consensus       733 ~~~~~~~--~~~-~~--g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~-~  805 (849)
                      .......  ... ..  .+..|+|||++.+..++.++||||||+++||+++ |..||.......        ....+. +
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--------~~~~i~~~  227 (269)
T cd05065         156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAIEQD  227 (269)
T ss_pred             cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcC
Confidence            5432211  111 11  1347999999998899999999999999999886 999986432111        111111 1


Q ss_pred             CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       806 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+.+..    .+..+.+++.+||+.+|++||++++|+..|+
T Consensus       228 ~~~~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         228 YRLPPPMD----CPTALHQLMLDCWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             CcCCCccc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            12222221    2234778999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=1e-31  Score=285.58  Aligned_cols=251  Identities=20%  Similarity=0.315  Sum_probs=183.2

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +++.||+|++.......  ...+.+.+|+.           .+++++......++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP--VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc--cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence            46888899999999999999665 68999999886432111  11223344433           356777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||++++.+..+....   ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          79 FEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             EeccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            9999999888876543   2489999999999999999999998   999999999999999999999999999987755


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccc----------------ccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN----------------TDV  798 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~----------------~~~  798 (849)
                      .........++..|+|||++.+ ..++.++||||||+++|||++|+.||............                ...
T Consensus       153 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         153 PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            4433344567889999999876 45788999999999999999999999743321100000                000


Q ss_pred             ccccccCCCCCCCC---hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQMLDPRLPAPS---RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+......   .........+.+++.+||+.+|++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000000000000   0001123457899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=2.2e-31  Score=286.61  Aligned_cols=245  Identities=23%  Similarity=0.410  Sum_probs=181.3

Q ss_pred             hcCCCcCceecCCccceEEEEEec--------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhcee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP--------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFC  646 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~  646 (849)
                      .++|.+.+.||+|+||.||+|+..        ....+|+|.+.....   ......+..|+.            ++++++
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT---DKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC---hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            367888999999999999999642        245689998765322   112233444433            356677


Q ss_pred             ecCCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                      ......++||||+++|+|.+++.....             ...+++.++.+++.|++.|++|||+.   +++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence            777889999999999999999965321             23588999999999999999999998   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccCCCCCCe--eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 042123          714 LLLDLEYEAHVADFGIAKSLKPDSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSIS  790 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~  790 (849)
                      |+++.++.+|++|||.++.........  ....++..|+|||.+.+..++.++||||||+++|||++ |..||...... 
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-  243 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE-  243 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            999999999999999998664322211  11223467999999988889999999999999999999 88998643211 


Q ss_pred             ccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                             ................   ....++.+++.+||+.+|++|||+.++++.|+
T Consensus       244 -------~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~  291 (314)
T cd05099         244 -------ELFKLLREGHRMDKPS---NCTHELYMLMRECWHAVPTQRPTFKQLVEALD  291 (314)
T ss_pred             -------HHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                   1111111111111111   11234778999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=1.9e-31  Score=293.25  Aligned_cols=249  Identities=20%  Similarity=0.282  Sum_probs=177.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-----
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-----  648 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-----  648 (849)
                      ..++|...+.||+|+||.||+|.. ..++.||||++.....  .......+.+|+.           .+++++..     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence            457899999999999999999954 4688999999865322  1122233444433           23444332     


Q ss_pred             -CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          649 -ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       649 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                       ....++||||+++ ++.+.+.     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence             2357999999976 6777663     2378899999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc--
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDV--  798 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~--  798 (849)
                      |+++..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+......       .....  
T Consensus       171 G~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         171 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             CCccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            999865432 22234578999999999999999999999999999999999999997433211000       00000  


Q ss_pred             -----ccccccC--------------CC--CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 -----ALDQMLD--------------PR--LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 -----~~~~~~~--------------~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                           .......              +.  .+............+.+++.+|++.||++|||+.|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                 0000000              00  000000001112357899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=2.1e-31  Score=278.12  Aligned_cols=239  Identities=27%  Similarity=0.476  Sum_probs=182.2

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      .+|+..+.||+|+||.||+|.+.++..+|+|.+.....     ....+.+|+.           .+++++......++||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            46788899999999999999877788999998764321     1233444543           2566777778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++....  ..++++.+..++.|++.|++|||+.   +++||||||+||+++.++.++++|||.++.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          79 EFMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EcCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            9999999999986433  3478999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCh
Q 042123          737 SSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSR  813 (849)
Q Consensus       737 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  813 (849)
                      ... .....++..|+|||...++.++.++||||||+++|||++ |+.||......        ......... +...+..
T Consensus       154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  225 (256)
T cd05112         154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--------EVVETINAGFRLYKPRL  225 (256)
T ss_pred             cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHhCCCCCCCCCC
Confidence            111 112234568999999988889999999999999999998 99998632211        111111110 1100111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          ....+.+++.+||+.+|++|||+.+++++|.
T Consensus       226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                1234888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=2.2e-31  Score=279.82  Aligned_cols=241  Identities=24%  Similarity=0.364  Sum_probs=168.8

Q ss_pred             eecCCccceEEEEEecCC---cEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEEEecc
Q 042123          595 CIGNGGHASVYRAELPSG---EVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      .||+|+||.||+|...++   ..+++|.+....   .......+.+|+           .++++++......++||||++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA---SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC---ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            599999999999965433   345666654432   122344555553           346777888888999999999


Q ss_pred             CCChhhhhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC--
Q 042123          661 RGSLAAILNTDAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--  737 (849)
Q Consensus       661 ~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--  737 (849)
                      +|+|.+++.+... ....++..+..++.||+.||+|||+.   +++||||||+||+++.++.++++|||++.......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999975432 23466778889999999999999998   99999999999999999999999999986432211  


Q ss_pred             CCeeeccCCccccccccccC-------CCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 042123          738 SNWTEFAGTCGYIAPELAYT-------MKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      .......++..|+|||++..       ..++.++||||||+++|||++ |..||.....................++.+.
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE  235 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccC
Confidence            11233467889999998743       245788999999999999997 5678764321110000000011111222222


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..      ....+.+++..|| .+|++||++++|++.|.
T Consensus       236 ~~------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         236 LP------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CC------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11      2234677888999 57999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=1.7e-31  Score=281.35  Aligned_cols=228  Identities=22%  Similarity=0.370  Sum_probs=169.1

Q ss_pred             eecCCccceEEEEEecC-------------------------CcEEEEEEecccCCCCchhhHHHHHHHH----------
Q 042123          595 CIGNGGHASVYRAELPS-------------------------GEVVAVKKFHSLLPCDQTVDQKEFLTEV----------  639 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~~ei----------  639 (849)
                      .||+|+||.||+|.+..                         ...||+|.+....    ......+.+++          
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH----RDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH----HHHHHHHHHHHHHHhcCCCCC
Confidence            69999999999996421                         2358888875421    11223344443          


Q ss_pred             -HHhhceeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 042123          640 -EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL  718 (849)
Q Consensus       640 -~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  718 (849)
                       .++++++......++||||+++|+|..++.+..  ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~  152 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR  152 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence             247788888889999999999999999986533  3588999999999999999999998   9999999999999976


Q ss_pred             CC-------cEEEeeecCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHH-hCCCCCCccccc
Q 042123          719 EY-------EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSI  789 (849)
Q Consensus       719 ~~-------~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~-tg~~Pf~~~~~~  789 (849)
                      .+       .+|++|||.+......    ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~  228 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS  228 (274)
T ss_pred             cCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence            54       3799999988654322    22357788999998865 56889999999999999995 699998643221


Q ss_pred             cccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          790 SSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..         ..........+....    ..+.+++.+||+.+|++|||+.+|+++|+
T Consensus       229 ~~---------~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 EK---------ERFYEKKHRLPEPSC----KELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH---------HHHHHhccCCCCCCC----hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            10         111111111111111    24788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=265.82  Aligned_cols=243  Identities=22%  Similarity=0.304  Sum_probs=186.4

Q ss_pred             HhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhh-----HHHHHHH-----HHHhhceeecCCeeEE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVD-----QKEFLTE-----VEAFYGFCSHARHSFL  654 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~-----~~~~~~e-----i~~~~~~~~~~~~~~l  654 (849)
                      ..++|+..++||+|.||.|-.++ ..+++.+|+|++++.........     +.+.++.     +..+.-.++..+..+.
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            34688999999999999999994 45799999999887543222111     1111111     1112333456788999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||..||.|.-.+.+.+   .+++...+-+-..|+.||.|||++   +||+||+|.+|.++|.+|++||+|||+++.-.
T Consensus       246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999998887654   488888999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..+....+++|||.|.|||++....|..+.|.|.+||++|||++|+.||-..+.        +....-++-..+.-+...
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--------~kLFeLIl~ed~kFPr~l  391 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--------EKLFELILMEDLKFPRTL  391 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--------hHHHHHHHhhhccCCccC
Confidence            777778889999999999999999999999999999999999999999863321        122222222222222222


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      .+    +...++...+.+||.+|.     ++.||.++
T Consensus       392 s~----eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  392 SP----EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             CH----HHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            22    356777799999999995     45666553

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=1.7e-31  Score=283.85  Aligned_cols=251  Identities=21%  Similarity=0.355  Sum_probs=183.4

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +++.||+|++.......  ...+.+.+|+           .++++++..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc--hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            46888899999999999999764 58999999876532221  1223344443           3477888888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||++++++.++....   ..+++.++..++.||+.|++|||+.   +++||||+|+||++++++.++++|||++.....
T Consensus        79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          79 FEFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             EecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999998876543   2489999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cc--c------ccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS--------SL--N------TDV  798 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~--------~~--~------~~~  798 (849)
                      .........++..|+|||+..+ ..++.++||||||+++|||++|+.||.........        ..  .      ...
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            4333344567889999998875 44678999999999999999999998633211000        00  0      000


Q ss_pred             ccccccCCCCCCCC---hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQMLDPRLPAPS---RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+......   .........+.+++.+||+.+|++|||+.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00000000000000   0001123458899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.6e-31  Score=278.97  Aligned_cols=236  Identities=24%  Similarity=0.426  Sum_probs=178.8

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhcee-ecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFC-SHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~-~~~~~~~lV  655 (849)
                      .+|...+.||+|+||.||+|... |..||+|.+....      ..+.+..|+.           .+++++ ......++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   78 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc------hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEE
Confidence            57888899999999999999775 7889999875431      1233444443           245543 345678999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~  154 (256)
T cd05082          79 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  154 (256)
T ss_pred             EECCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence            99999999999986543 23478999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..   ....++..|+|||+..+..++.++||||||+++|||++ |+.||.......        .... +.......  .
T Consensus       155 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~-~~~~~~~~--~  220 (256)
T cd05082         155 TQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPR-VEKGYKMD--A  220 (256)
T ss_pred             cC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHH-HhcCCCCC--C
Confidence            22   22344568999999988889999999999999999997 999986322110        0000 10000000  0


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .......+.+++.+||+.+|++|||+.++++.|+
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence            0112234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.3e-31  Score=276.79  Aligned_cols=233  Identities=29%  Similarity=0.475  Sum_probs=175.1

Q ss_pred             ceecCCccceEEEEEec--C--CcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEEEe
Q 042123          594 YCIGNGGHASVYRAELP--S--GEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEF  658 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~e~  658 (849)
                      +.||+|+||.||+|...  +  +..+|+|.+......   ...+.+.+|+..           +++++. ....++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA---AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            46999999999999543  2  368999998754221   233455555442           445543 4567999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +++|+|.+++....   .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.++.......
T Consensus        77 ~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~  150 (257)
T cd05060          77 APLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD  150 (257)
T ss_pred             CCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence            99999999996543   589999999999999999999998   999999999999999999999999999986644332


Q ss_pred             Ceee---ccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCh
Q 042123          739 NWTE---FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSR  813 (849)
Q Consensus       739 ~~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  813 (849)
                      ....   ..++..|+|||.+.+..++.++||||||+++||+++ |+.||.......        ....+... ....+. 
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~-  221 (257)
T cd05060         151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------VIAMLESGERLPRPE-  221 (257)
T ss_pred             ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCcCCCCC-
Confidence            2111   123457999999998889999999999999999998 999997543211        00111111 111111 


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       222 ---~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~  253 (257)
T cd05060         222 ---ECPQEIYSIMLSCWKYRPEDRPTFSELESTFR  253 (257)
T ss_pred             ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence               12235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=9.3e-32  Score=312.15  Aligned_cols=248  Identities=21%  Similarity=0.331  Sum_probs=181.2

Q ss_pred             HHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec--C
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH--A  649 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~--~  649 (849)
                      ....++|.+.+.||+|+||+||+|.. .++..||+|.+.....  .......+..|+.           .+++++.+  .
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            34457899999999999999999955 4678899998764321  1222344555544           24555433  4


Q ss_pred             CeeEEEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCeeecCC-----
Q 042123          650 RHSFLLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCF----PPIVHRDISSKNLLLDLE-----  719 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~dlk~~Nill~~~-----  719 (849)
                      ..+|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+...    .+|+||||||+|||++.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            57899999999999999986532 22458999999999999999999998521    259999999999999642     


Q ss_pred             ------------CcEEEeeecCCcccCCCCCCeeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          720 ------------YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       720 ------------~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                                  +.+||+|||++....... ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        358999999998664322 2234578999999999854  4578999999999999999999999974


Q ss_pred             cccccccccccccccccccC-CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          786 LSSISSSSLNTDVALDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....       .....+.. +.++. .    .....+.+++..||+.+|.+|||+.|++.+
T Consensus       246 ~~~~~-------qli~~lk~~p~lpi-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        246 ANNFS-------QLISELKRGPDLPI-K----GKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCcHH-------HHHHHHhcCCCCCc-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            32211       11111111 11111 1    112347889999999999999999999854

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=9.2e-32  Score=285.36  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=185.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|.. ++++.||+|.+.....   ......+.+|++           ++++++......++|
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK---SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc---chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            5678888999999999999955 4688999998764321   222344555544           356777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++..+..++.+++.|+.|||+..  +++||||+|+||+++.++.++++|||++.....
T Consensus        82 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          82 MEFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             EecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            9999999999988653   34899999999999999999999742  899999999999999999999999999875532


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccc---cccccccccCCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN---TDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  812 (849)
                      ..  .....++..|+|||++.+..++.++|||||||++|++++|+.||............   .............+...
T Consensus       157 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd06620         157 SI--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP  234 (284)
T ss_pred             hc--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence            21  23457899999999998888999999999999999999999999744321100000   00111222221111110


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                        .......+.+++.+||++||++|||+.|++++.
T Consensus       235 --~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         235 --SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             --chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence              111334588899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=1.7e-31  Score=280.13  Aligned_cols=248  Identities=20%  Similarity=0.295  Sum_probs=184.7

Q ss_pred             HHHHHHhcCCCcCcee--cCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHH---HHHHHhhceeecCCeeEE
Q 042123          581 DEIVKATNDFDAKYCI--GNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFL---TEVEAFYGFCSHARHSFL  654 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~---~ei~~~~~~~~~~~~~~l  654 (849)
                      .+.....++|++.+.+  |+|+||.||++.. .++..+|+|.+................   ..+.++++++...+..++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            4445556677777766  9999999999954 578899999986532111111111111   123357777788889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCccc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSL  733 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~~~  733 (849)
                      ||||+++|+|.+++....   .+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++ .++++|||.+...
T Consensus        87 v~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~  160 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII  160 (267)
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence            999999999999986543   589999999999999999999999   999999999999999998 9999999998765


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ...    ....++..|+|||++.+..++.++||||+|+++|||++|+.||.......   .... ............   
T Consensus       161 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~-~~~~~~~~~~~~---  229 (267)
T PHA03390        161 GTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLE-SLLKRQQKKLPF---  229 (267)
T ss_pred             CCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHH-HHHHhhcccCCc---
Confidence            432    22467889999999998889999999999999999999999997332111   0001 111111111111   


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCC-HHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPT-MKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~~  846 (849)
                       .......+.+++.+||+.+|.+||+ +++++++
T Consensus       230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        230 -IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -ccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence             1123345888999999999999996 6999875

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=1.9e-31  Score=282.98  Aligned_cols=243  Identities=23%  Similarity=0.369  Sum_probs=179.4

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~~~~~~l  654 (849)
                      ++|+..+.||+|+||.||+|... +|+.||+|++.......   ....+..|+            .++++++..+...++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ---EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH---HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            46888999999999999999654 69999999986542211   122233332            236677778888999


Q ss_pred             EEEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          655 LYEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      ||||++ |+|.+++... .....+++.++..++.||+.|++|||++.  +++||||||+||+++.++.+||+|||.+...
T Consensus        78 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~  154 (283)
T cd06617          78 CMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL  154 (283)
T ss_pred             Ehhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999997 5888887542 22346899999999999999999999853  7999999999999999999999999999865


Q ss_pred             CCCCCCeeeccCCccccccccccC----CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYT----MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      .... ......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||......       ............+
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~  226 (283)
T cd06617         155 VDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVEEPSP  226 (283)
T ss_pred             cccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHhcCCC
Confidence            4321 2233467889999998764    45688999999999999999999998632110       0111111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+  .......+.+++.+||+.+|++|||+.+++++
T Consensus       227 ~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         227 QLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            000  01123357889999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3e-32  Score=284.02  Aligned_cols=242  Identities=24%  Similarity=0.414  Sum_probs=186.0

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~lV  655 (849)
                      ..|++.+.||+||.+.||++...+.+.||+|++....  .......-|..|+.            ++++|-..++..|||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~--~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE--ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh--cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            5688899999999999999998888899999875432  22333455666655            366676678899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||=+- +|..+|.+... ...+| .++.+..||+.|+.++|..   ||||.||||-|+|+ -.|.+||+|||.|..+..
T Consensus       439 mE~Gd~-DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECGDI-DLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eecccc-cHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence            998755 99999976542 22334 7888999999999999999   99999999999998 468999999999998877


Q ss_pred             CCC--CeeeccCCccccccccccCCC-----------CCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042123          736 DSS--NWTEFAGTCGYIAPELAYTMK-----------ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       736 ~~~--~~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      +..  .....+||+.||+||.+....           .+.++||||+|||+|+|+.|+.||....       .....+..
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~aKl~a  584 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIAKLHA  584 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHHHHHh
Confidence            643  245678999999999886432           4578999999999999999999997432       23344555


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +.++....++....+ ..+++++++.|++.||.+|||+.+++++
T Consensus       585 I~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  585 ITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             hcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            666633111111100 1127899999999999999999999875

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.3e-31  Score=282.91  Aligned_cols=245  Identities=25%  Similarity=0.413  Sum_probs=183.4

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceeec---
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH---  648 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~---  648 (849)
                      .++++|+..+.||+|++|.||+|... +++.+|+|.+.....     ....+.+|+.            ++++++..   
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   77 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP   77 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence            35689999999999999999999664 678999998865321     1223333332            35555543   


Q ss_pred             ---CCeeEEEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          649 ---ARHSFLLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       649 ---~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                         ....++||||+++++|.+++.... ....+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+|+
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence               335899999999999999986532 234689999999999999999999998   9999999999999999999999


Q ss_pred             eeecCCcccCCCCCCeeeccCCccccccccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 042123          725 ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-----MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       725 ~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      +|||.+..............++..|+|||.+..     ..++.++||||||+++|+|++|+.||.......        .
T Consensus       155 ~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~  226 (275)
T cd06608         155 VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--------A  226 (275)
T ss_pred             CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--------H
Confidence            999998765443333344568899999998753     346788999999999999999999986432111        1


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..++... ..............+.+++.+||+.||++|||+++++++
T Consensus       227 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         227 LFKIPRN-PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HHHhhcc-CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            1111111 111111112234458899999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=1.6e-31  Score=282.30  Aligned_cols=234  Identities=18%  Similarity=0.251  Sum_probs=172.1

Q ss_pred             eecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH--------------HHhhceeecCCeeEEEEEec
Q 042123          595 CIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV--------------EAFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei--------------~~~~~~~~~~~~~~lV~e~~  659 (849)
                      .||+|+||.||+|.. .+++.+|+|.+......... ....+.++.              ..+.+++...+..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccch-HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            489999999999965 46899999988653221111 111122221              12344556677899999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN  739 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  739 (849)
                      ++|+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||++++++.++++|||++.......  
T Consensus        80 ~~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          80 NGGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            999999988643   3489999999999999999999998   99999999999999999999999999987654322  


Q ss_pred             eeeccCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          740 WTEFAGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       740 ~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      .....|+..|+|||.+. +..++.++||||+||++|+|++|+.||........      ........ ..  ....+...
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~-~~--~~~~~~~~  222 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK------HEIDRMTL-TV--NVELPDSF  222 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH------HHHHHHhh-cC--CcCCcccc
Confidence            23346899999999886 45678999999999999999999999974321110      01111100 00  00111122


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          819 LISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      ...+.+++.+||+.||++||     |+.++++|
T Consensus       223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            34578899999999999999     69999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=4.2e-31  Score=280.30  Aligned_cols=249  Identities=22%  Similarity=0.380  Sum_probs=181.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-----cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC--
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA--  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~--  649 (849)
                      ..|+..+.||+|+||.||.|+.     .++..||+|.++....   ......+.+|+..           +.+++...  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc---HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            3567888999999999999963     3578899999864321   2223345555442           44555543  


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+++++|.+++.+..  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||+
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~  155 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  155 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcc
Confidence            56889999999999999986432  3589999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------cccccccc
Q 042123          730 AKSLKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------SSLNTDVA  799 (849)
Q Consensus       730 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------~~~~~~~~  799 (849)
                      ++........   .....++..|+|||++.+..++.++||||||+++||+++++.|+........       ........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05079         156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL  235 (284)
T ss_pred             ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence            9876543221   1234566789999999888899999999999999999998776432111000       00000000


Q ss_pred             cccccCCC-CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ........ .+.+.    .....+.+++.+||+.+|++|||++++++.++
T Consensus       236 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  281 (284)
T cd05079         236 VRVLEEGKRLPRPP----NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE  281 (284)
T ss_pred             HHHHHcCccCCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            00011111 11111    12345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=2.5e-31  Score=290.02  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=177.8

Q ss_pred             HHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec---
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH---  648 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~---  648 (849)
                      ....++|+..+.||+|+||.||+|.. .+++.||||++.....  .......+.+|+.           .+++++..   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS   88 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence            34567899999999999999999954 5788999999864321  1122233444433           34444432   


Q ss_pred             ---CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 042123          649 ---ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVA  725 (849)
Q Consensus       649 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  725 (849)
                         ....++++|++ +++|.+++..    ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          89 IENFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             ccccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence               24568999998 6799888753    3489999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc
Q 042123          726 DFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTD  797 (849)
Q Consensus       726 DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~  797 (849)
                      |||+++.....   .....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.........       .....
T Consensus       161 Dfg~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07878         161 DFGLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP  237 (343)
T ss_pred             CCccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99999865432   234578999999999876 56889999999999999999999999643211000       00000


Q ss_pred             ccc--------ccccCCCCCCCChh-h----HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 VAL--------DQMLDPRLPAPSRS-A----QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 ~~~--------~~~~~~~~~~~~~~-~----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...        ..... .++..... .    ......+.+++.+|++.||++|||+.|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         238 EVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000        00000 00000000 0    0112236789999999999999999999876

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-31  Score=280.08  Aligned_cols=238  Identities=26%  Similarity=0.449  Sum_probs=181.0

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH--------------HHhhceeecCCeeE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV--------------EAFYGFCSHARHSF  653 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei--------------~~~~~~~~~~~~~~  653 (849)
                      .|+..+.||+|+||.||+|.. .+++.||+|.+........   ...+.+|+              ..+++++......+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD---VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchh---HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            467788999999999999965 5789999998864322111   12222222              23566777788899


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++++|.+++...    .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  151 (277)
T cd06917          79 IIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL  151 (277)
T ss_pred             EEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence            999999999999998542    589999999999999999999998   9999999999999999999999999999877


Q ss_pred             CCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ...........|+..|+|||.+.++ .++.++||||||+++|+|++|+.||..........     .......+.++.  
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~--  224 (277)
T cd06917         152 NQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM-----LIPKSKPPRLED--  224 (277)
T ss_pred             CCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh-----ccccCCCCCCCc--
Confidence            6544334455788999999988654 46889999999999999999999997433211100     000000111111  


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ......+.+++.+||+.||++||++.+++++
T Consensus       225 ---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         225 ---NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence               1123458899999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2e-31  Score=259.55  Aligned_cols=252  Identities=19%  Similarity=0.367  Sum_probs=200.0

Q ss_pred             HHHHHHHhcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhcee
Q 042123          580 YDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFC  646 (849)
Q Consensus       580 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~  646 (849)
                      |++.-+-+++     .||+|+||.|--+ ...+|..||||++.+.    ....+.+..+||+            .++.|+
T Consensus        75 F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefF  145 (463)
T KOG0607|consen   75 FEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFF  145 (463)
T ss_pred             HHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHh
Confidence            4555555544     6999999999988 6788999999998764    3344566677765            467888


Q ss_pred             ecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEE
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---EAH  723 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k  723 (849)
                      +++..+|+|||-|.||+|...+.+..   .+++.++.++.++||.||.|||.+   ||.|||+||+|||.....   -+|
T Consensus       146 Edd~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  146 EDDTRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cccceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCcee
Confidence            99999999999999999999987654   489999999999999999999999   999999999999997664   489


Q ss_pred             EeeecCCcccCCC-------CCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCcccccc-
Q 042123          724 VADFGIAKSLKPD-------SSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSIS-  790 (849)
Q Consensus       724 l~DfG~a~~~~~~-------~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~-  790 (849)
                      |+||.++.-+...       .....+++|+..|||||+..     ...|+.+.|.||+|||+|-|++|..||...-... 
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            9999887643221       12245678899999999763     3457889999999999999999999997432211 


Q ss_pred             ---cc---ccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          791 ---SS---SLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       791 ---~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         +.   ..-.....+.+.++....|...|.....+..+++...+..|+.+|.++.+++.+
T Consensus       300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence               11   112234455667777777777888888888999999999999999999998864

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=3.4e-31  Score=277.92  Aligned_cols=243  Identities=26%  Similarity=0.404  Sum_probs=189.6

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|++|.||+|+.. +++.||||++......   .....+..|+.           .+++++......++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE---EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch---HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            36888899999999999999665 5999999998654221   23445555544           256677788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |||+++++|.+++...   ..+++..+..++.|+++|++|||+ .   +++||||+|+||+++.++.++++|||.+....
T Consensus        78 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          78 LEYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999654   458999999999999999999999 8   99999999999999999999999999998776


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........++..|+|||.+.+..++.++||||||+++|+|++|+.||......     ........+.....+.....
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  226 (264)
T cd06623         152 NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-----SFFELMQAICDGPPPSLPAE  226 (264)
T ss_pred             cCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-----CHHHHHHHHhcCCCCCCCcc
Confidence            5444333556888999999999888999999999999999999999998754310     11111122222111111111


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        .....+.+++.+||+.+|++|||+.+++++
T Consensus       227 --~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         227 --EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             --cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              023458889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=2.4e-31  Score=279.57  Aligned_cols=241  Identities=27%  Similarity=0.424  Sum_probs=182.3

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc-h----hhHHHHHHHHH-----------HhhceeecCCe
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ-T----VDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~----~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      +|.....||+|+||.||+|.. .+++.||+|.+........ .    ...+.+.+|+.           ++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999955 4688999998865432221 1    11123334433           36677778889


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++++|.+++...   ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            99999999999999999654   3488999999999999999999998   99999999999999999999999999988


Q ss_pred             ccCCCCC------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042123          732 SLKPDSS------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD  805 (849)
Q Consensus       732 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  805 (849)
                      .......      ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.........     ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~  229 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-----FKIGENAS  229 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-----HHHhccCC
Confidence            7653211      112345788999999999888999999999999999999999999743321100     00001111


Q ss_pred             CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       806 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +..+      ......+.+++.+||+.||++||++.+|+++
T Consensus       230 ~~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         230 PEIP------SNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CcCC------cccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            1111      1123347788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=3.2e-31  Score=277.34  Aligned_cols=241  Identities=22%  Similarity=0.418  Sum_probs=182.5

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||.||+|...++..+|+|.+....     .....+.+|+.           .+.+++.. ...++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v   78 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII   78 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence            46788999999999999999987778889999876421     12234444543           24455544 678999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+.. ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          79 TEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            99999999999996543 34578999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ... ......++..|+|||++....++.++||||||+++|++++ |+.||.......        ... .+......+  
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~-~~~~~~~~~--  223 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIR-ALERGYRMP--  223 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHH-HHhCCCCCC--
Confidence            221 1122345677999999988889999999999999999998 999986432111        000 111111100  


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ........+.+++.+||+.+|++||++.++.+.|+
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence            01122335889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=2.2e-31  Score=285.01  Aligned_cols=250  Identities=16%  Similarity=0.227  Sum_probs=180.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||.||+|+. .+++.||+|.+........   ...+.+|           +..+++++...+..++|
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA---PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc---hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            5788899999999999999965 4688999999864322111   1122233           33467788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||++ ++|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||++.....
T Consensus        83 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          83 FEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             Eeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99997 58988886533  3578999999999999999999998   999999999999999999999999999976544


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccccccc----
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTDVALDQM----  803 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~~~~~~~----  803 (849)
                      .........+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.....       ..........+    
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            3333344567889999998765 35788999999999999999999999743321000       00000000000    


Q ss_pred             --cCCCCCCCC-----hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 --LDPRLPAPS-----RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 --~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        .....+...     .........+.+++.+|++.||.+|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence              000000000     0001112347789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=272.77  Aligned_cols=235  Identities=23%  Similarity=0.356  Sum_probs=189.5

Q ss_pred             HhcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCch-h----hHHHHHH------HHHHhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQT-V----DQKEFLT------EVEAFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~-~----~~~~~~~------ei~~~~~~~~~~~~~~  653 (849)
                      ...+|....+||+|+||.|-.| +..+.+.+|||++++.+..... .    .+++.+.      -+.++..+++.-+..|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            3468889999999999999999 4446788999998765432211 1    1122111      1345777888889999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      .||||+.||+|.-.+.+..   ++.+..+.-+|..||-||-|||++   +|++||||..|||+|.+|++||+|||+++.-
T Consensus       427 FVMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             eEEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence            9999999999988776543   477889999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ..++....+++|||.|+|||++..++|..++|.|||||++|||+.|+.||+..+        .++..+.+.+....-+..
T Consensus       501 i~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--------E~elF~aI~ehnvsyPKs  572 (683)
T KOG0696|consen  501 IFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--------EDELFQAIMEHNVSYPKS  572 (683)
T ss_pred             ccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHHccCcCccc
Confidence            666777788999999999999999999999999999999999999999998543        344555566666554433


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCC
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRP  838 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RP  838 (849)
                      ...    +.+.++...+.+.|.+|.
T Consensus       573 lSk----EAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  573 LSK----EAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ccH----HHHHHHHHHhhcCCcccc
Confidence            333    366778888999999985

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-32  Score=280.50  Aligned_cols=239  Identities=21%  Similarity=0.307  Sum_probs=182.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCC-----CCchhhHHHHHHHHH-----HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLP-----CDQTVDQKEFLTEVE-----AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~~~~ei~-----~~~~~~~~~~~~~lV~  656 (849)
                      +.|+.-++||+|+||+||-++. .+|+.+|.|++.+...     ......++.+++.|.     .+.-.++..+..++|+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5778888999999999999954 4799999987654211     111112222222222     1333456678999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ..|.||+|.-++..... ..++++.++-++.+|+.||++||..   +||+||+||+|||+|+.|+++|+|.|+|..+...
T Consensus       265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999888865543 4699999999999999999999999   9999999999999999999999999999988765


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC-CCChhh
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP-APSRSA  815 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  815 (849)
                      .. ....+||.+|||||++....|+...|.||+||++|||+.|+.||..-.         ++...+-+|.++. .+...+
T Consensus       341 ~~-~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K---------eKvk~eEvdrr~~~~~~ey~  410 (591)
T KOG0986|consen  341 KP-IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK---------EKVKREEVDRRTLEDPEEYS  410 (591)
T ss_pred             Cc-cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh---------hhhhHHHHHHHHhcchhhcc
Confidence            43 455599999999999999999999999999999999999999997322         1111222333222 223333


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCH
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTM  840 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~  840 (849)
                      .....+..++....+++||++|.-.
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhccC
Confidence            4455567888889999999999643

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.3e-31  Score=284.86  Aligned_cols=244  Identities=23%  Similarity=0.305  Sum_probs=185.9

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....... ....+.+..|++           ++++++......++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccch-HHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            36888899999999999999654 58999999987542211 112334444433           466777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          80 MDYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EEecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            99999999999986432 34689999999999999999999998   999999999999999999999999999875532


Q ss_pred             CCC-----------------------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 042123          736 DSS-----------------------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFL  786 (849)
Q Consensus       736 ~~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~  786 (849)
                      ...                             ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            211                             111246788999999999888999999999999999999999999743


Q ss_pred             ccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCC----HHHHHhh
Q 042123          787 SSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT----MKIISQQ  846 (849)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~eil~~  846 (849)
                      ...        .......+.....+..  ......+.+++.+||+.+|++|||    +++++++
T Consensus       236 ~~~--------~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         236 NRD--------ETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             chH--------HHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            321        1112222222211111  113345889999999999999999    8888765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=5.1e-31  Score=277.42  Aligned_cols=236  Identities=26%  Similarity=0.455  Sum_probs=172.8

Q ss_pred             ceecCCccceEEEEEec-CCc--EEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEEEEEe
Q 042123          594 YCIGNGGHASVYRAELP-SGE--VVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~lV~e~  658 (849)
                      +.||+|+||.||+|..+ ++.  .+|+|.+.....   ......+.+|+.            ++++++......++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS---KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC---HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            36899999999999764 343  468888764321   112233444433            356677777888999999


Q ss_pred             ccCCChhhhhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 042123          659 LERGSLAAILNTDA-------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVA  725 (849)
Q Consensus       659 ~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  725 (849)
                      +++|+|.+++....             ....+++.++.+++.|++.|++|||+.   +++||||||+||+++.++.+|++
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEEC
Confidence            99999999986432             123478999999999999999999998   99999999999999999999999


Q ss_pred             eecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccccc
Q 042123          726 DFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQML  804 (849)
Q Consensus       726 DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~  804 (849)
                      |||++....... .......+..|+|||++....++.++||||||+++|||++ |..||......        .......
T Consensus       155 dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~  225 (270)
T cd05047         155 DFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLP  225 (270)
T ss_pred             CCCCccccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--------HHHHHHh
Confidence            999986432111 1111233567999999988889999999999999999997 99998643211        1111111


Q ss_pred             CC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          805 DP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       805 ~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .. ....+.    .....+.+++.+||+.+|.+|||+.++++.|+
T Consensus       226 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         226 QGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             CCCCCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence            11 111111    12234779999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=4.5e-31  Score=280.47  Aligned_cols=248  Identities=25%  Similarity=0.342  Sum_probs=184.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec--CCeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH--ARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~--~~~~~  653 (849)
                      ++|+..+.||.|++|.||+|.. .+++.+|+|.+.....   ......+.+|++.           +++++..  ....+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN---PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc---hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            4678889999999999999965 4688999998865321   1234456666552           4555543  34689


Q ss_pred             EEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          654 LLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +||||+++++|.+++.... ....+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            9999999999999875422 234588999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC---CC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR---LP  809 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~~  809 (849)
                      .....  .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||+......   ...........+..   +.
T Consensus       155 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~  229 (287)
T cd06621         155 LVNSL--AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP---LGPIELLSYIVNMPNPELK  229 (287)
T ss_pred             ccccc--cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC---CChHHHHHHHhcCCchhhc
Confidence            54322  123457889999999998899999999999999999999999997543210   00011111111111   11


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ............+.+++.+||+.+|++|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            1111111223458899999999999999999999885

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2e-31  Score=296.72  Aligned_cols=248  Identities=20%  Similarity=0.235  Sum_probs=178.6

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceeecCCeeEEEEEeccC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      ..|.+.+.||+|+||.||+|.+. .++.||||.....    ....+...++.     |.++++++...+..++|||++. 
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~----~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA----SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc----CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-
Confidence            46888999999999999999654 5888999964321    11122233332     4457888888889999999995 


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC--C
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS--N  739 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--~  739 (849)
                      ++|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.......  .
T Consensus       244 ~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        244 SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            68888875432  3589999999999999999999998   999999999999999999999999999986543221  1


Q ss_pred             eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC------CCCC----
Q 042123          740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD------PRLP----  809 (849)
Q Consensus       740 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~------~~~~----  809 (849)
                      .....||..|+|||++.+..++.++|||||||++|||++|..|+............... ..+++.      ...+    
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~-l~~~i~~~~~~~~~~~~~~~  397 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQ-ILRIIRQAQVHVDEFPQHAG  397 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHH-HHHHHHhhccccccCCCCcc
Confidence            22356899999999999999999999999999999999987664322111000000000 000000      0000    


Q ss_pred             -----------------C-CChhhH---HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 -----------------A-PSRSAQ---EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 -----------------~-~~~~~~---~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                       . ....+.   .....+.+++.+||+.||.+|||+.|++++
T Consensus       398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                             0 000000   112247789999999999999999999986

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=2.3e-31  Score=283.38  Aligned_cols=247  Identities=19%  Similarity=0.214  Sum_probs=167.4

Q ss_pred             cCCCcCceecCCccceEEEEEecC----CcEEEEEEecccCCCCchhhHHH---------HHHHHH-----------Hhh
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKE---------FLTEVE-----------AFY  643 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~---------~~~ei~-----------~~~  643 (849)
                      ++|.+.+.||+|+||.||+|...+    +..+|+|......  ........         ...+..           .++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~--~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN--ETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC--CchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            679999999999999999997643    3456666532211  11111111         111111           122


Q ss_pred             ceeecCC----eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          644 GFCSHAR----HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       644 ~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      +++....    ..++++|++.. ++.+.+...   ...++..+..++.|++.|++|||+.   +|+||||||+||+++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGN  162 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            2222211    34677777654 566655432   2357888999999999999999998   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCCCC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS  792 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~  792 (849)
                      +.++|+|||+|+.+.....       ......||+.|+|||+..+..++.++|||||||++|||++|+.||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            9999999999987643221       122346899999999999999999999999999999999999999754321110


Q ss_pred             c-cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          793 S-LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       793 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      . .........+..+.... ..    ....+.+++..||+.+|++||+++++.+.|.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLHEGKIKI-KN----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhhhhhhcc-CC----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            0 00001111222222111 11    1244788999999999999999999998763

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.3e-33  Score=266.71  Aligned_cols=240  Identities=26%  Similarity=0.360  Sum_probs=183.3

Q ss_pred             CceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEec
Q 042123          593 KYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~  659 (849)
                      ...||.|+||+|+|..+ +.|+..|||++.....   ..++++++.|            |++++|.+..++..|+.||.|
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~---~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI---EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc---hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            45799999999999954 5799999999976532   3344555554            557999999999999999999


Q ss_pred             cCCChhhhhccc--ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          660 ERGSLAAILNTD--AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       660 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      +- |++.+-+..  -....++++-.-+|..-.+.||.||-...  .|+|||+||+|||++..|.+|+||||.+..+..+ 
T Consensus       146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-  221 (361)
T KOG1006|consen  146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-  221 (361)
T ss_pred             hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence            76 766554321  12235788888899999999999998875  8999999999999999999999999998766533 


Q ss_pred             CCeeeccCCcccccccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC--CCCh
Q 042123          738 SNWTEFAGTCGYIAPELAY--TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP--APSR  813 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  813 (849)
                      ...+.-+|-..|||||.+.  +..|+.+|||||+|+++||+.||..||+.-..       ..+.+.+++.+..+  ....
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGDPPILLFDK  294 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCCCCeecCcc
Confidence            2334457888999999885  34589999999999999999999999873221       12223333333322  2222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+....+..++..|+.+|-.+||.+.++.++
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            333455668999999999999999999998753

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=2.5e-31  Score=287.82  Aligned_cols=249  Identities=16%  Similarity=0.247  Sum_probs=174.7

Q ss_pred             cCceecCC--ccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEEE
Q 042123          592 AKYCIGNG--GHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLYE  657 (849)
Q Consensus       592 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~e  657 (849)
                      ..++||+|  +||+||++.. .+|+.||+|++......  ......+.+|+           .++++++..++..++|||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT--NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc--HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            35689999  6889999954 57999999998653221  11122232332           246778888899999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |+++|+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+.......
T Consensus        80 ~~~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          80 FMAYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             ccCCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            999999999986432 23489999999999999999999998   99999999999999999999999998654432211


Q ss_pred             CC-------eeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccc-----
Q 042123          738 SN-------WTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM-----  803 (849)
Q Consensus       738 ~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~-----  803 (849)
                      ..       .....++..|+|||++.+  ..++.++|||||||++|||++|+.||....................     
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT  235 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence            10       112346678999999875  4588999999999999999999999974321110000000000000     


Q ss_pred             --------------cCC----------CCCC-----CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 --------------LDP----------RLPA-----PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 --------------~~~----------~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                    .+.          ..+.     ...........+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                          000          0000     000111223458899999999999999999999875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=4.8e-31  Score=276.86  Aligned_cols=242  Identities=23%  Similarity=0.359  Sum_probs=184.2

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceee--cCCeeEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCS--HARHSFL  654 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~--~~~~~~l  654 (849)
                      +|+..+.||.|+||.||+|.. .++..||+|.+.....  .......+..|+.           .+++++.  .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            477888999999999999954 5788999998864321  1222334444543           2444443  3456799


Q ss_pred             EEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          655 LYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLH-----HDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      +|||+++++|.+++.... ....+++.+++.++.|++.|++|||     +.   +++|+||+|+||+++.++.+|++|||
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g  155 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFG  155 (265)
T ss_pred             EehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccc
Confidence            999999999999986532 2346899999999999999999999     66   89999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ++..............+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....        ......+.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~  227 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--------LQLASKIKEGKF  227 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--------HHHHHHHhcCCC
Confidence            998776544323455789999999999988899999999999999999999999874321        111111122222


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +..   .......+.+++.+|++.+|++|||+.+|+++
T Consensus       228 ~~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 RRI---PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCC---ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            111   11223458899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.3e-31  Score=273.67  Aligned_cols=234  Identities=27%  Similarity=0.465  Sum_probs=178.9

Q ss_pred             ceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCC
Q 042123          594 YCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERG  662 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~g  662 (849)
                      +.||+|+||.||+|...+++.||+|.+......   .....+.+|+.           .+++++......++||||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP---DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH---HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            369999999999997766999999987654221   23345555544           2566777888899999999999


Q ss_pred             ChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe--
Q 042123          663 SLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW--  740 (849)
Q Consensus       663 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--  740 (849)
                      +|.+++....  ..+++..+..++.+++.|++|||+.   +++||||+|+||+++.++.+|++|||.+..........  
T Consensus        78 ~l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          78 SLLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             cHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9999986533  3478999999999999999999999   99999999999999999999999999987654221111  


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--CCCCCChhhHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRSAQE  817 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  817 (849)
                      .....+..|+|||.+.++.++.++||||||+++|||++ |..||......         .....+..  ....+    ..
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---------~~~~~~~~~~~~~~~----~~  219 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---------QTRERIESGYRMPAP----QL  219 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---------HHHHHHhcCCCCCCC----cc
Confidence            11223567999999988889999999999999999999 88888643211         00111111  11111    11


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          818 KLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       818 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....+.+++.+||+.+|++|||++|+++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            2335889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=5.7e-31  Score=276.26  Aligned_cols=242  Identities=27%  Similarity=0.401  Sum_probs=183.1

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+......  ....+.+..|+.           .+++++......++|+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND--PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc--hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            477889999999999999965 47899999998754321  223444555543           3566767778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          79 EYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             ecCCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            999999999998653   2478899999999999999999998   9999999999999999999999999998876543


Q ss_pred             CCCe----eeccCCccccccccccCCC---CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          737 SSNW----TEFAGTCGYIAPELAYTMK---ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       737 ~~~~----~~~~g~~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ....    ....++..|+|||++.+..   ++.++||||||+++|++++|+.||.......    ...........+..+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~  228 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF----QIMFHVGAGHKPPIP  228 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH----HHHHHHhcCCCCCCC
Confidence            3221    1246788999999988766   8899999999999999999999997432110    000000001111121


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..    ......+.+++.+||+.+|++|||+++++.+
T Consensus       229 ~~----~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         229 DS----LQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             cc----cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11    1123347789999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=2.1e-31  Score=282.75  Aligned_cols=251  Identities=18%  Similarity=0.258  Sum_probs=177.9

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||+|.. .+|+.||+|++.......  .....+.+|           +.++++++.+....++|+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~--~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE--GVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccc--cCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            477788999999999999965 478999999986432111  111122223           224677777888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++ +|.+++....  ..+++.++..++.||++||.|||+.   +++||||||+||+++.++.+||+|||+++.....
T Consensus        79 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          79 EYCDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             ecCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            99975 7888775432  3589999999999999999999998   9999999999999999999999999999866543


Q ss_pred             CCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccccc---cccccc
Q 042123          737 SSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS--------SLNTDV---ALDQML  804 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~--------~~~~~~---~~~~~~  804 (849)
                      ........++..|+|||.+.+. .++.++|||||||++|||++|+.||.........        ......   ...+..
T Consensus       153 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         153 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            3333445678899999988764 4688999999999999999999986432211000        000000   000000


Q ss_pred             CC----CCCCCC---hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          805 DP----RLPAPS---RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       805 ~~----~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      +.    ..+...   .........+.+++.+||+.||.+|||+++++++-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            00    000000   00011234577899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=1.3e-31  Score=286.47  Aligned_cols=252  Identities=21%  Similarity=0.261  Sum_probs=182.4

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc-hhhHHHHHHH-----------HHHhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ-TVDQKEFLTE-----------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV  655 (849)
                      +|+..+.||+|+||.||+|.. .+++.||||++........ ......+..|           +..+++++......++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999965 4689999999875432211 1112222333           33477888888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+ +|+|.+++....  ..+++.++..++.||++||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999996543  3589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cc------cccccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LN------TDVALD  801 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~------~~~~~~  801 (849)
                      .........+++.|+|||.+.+ ..++.++|||||||++|||++|..||..........       ..      ......
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            4333344456788999998854 457889999999999999999987776433211000       00      000000


Q ss_pred             cccCCCCCCC---ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 QMLDPRLPAP---SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........   ..........+.+++.+||+.+|++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000   00011223457899999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=4e-31  Score=280.38  Aligned_cols=238  Identities=24%  Similarity=0.362  Sum_probs=181.2

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      .|...+.||+|++|.||+|.. .+++.+|+|++....    ......+.+|+.           .+++++...+..++|+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~----~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc----hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            344557999999999999964 578999999875321    112233444433           3566677788999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++..    ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+......
T Consensus        96 e~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          96 EFLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             eccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            99999999999865    2489999999999999999999998   9999999999999999999999999988765443


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      ........|+..|+|||...+..++.++||||||+++|||++|+.||.........     ........+.....    .
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~----~  239 (285)
T cd06648         169 VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM-----KRIRDNLPPKLKNL----H  239 (285)
T ss_pred             CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHH-----HHHHhcCCCCCccc----c
Confidence            33334456889999999998888999999999999999999999998643211100     00001111111111    1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.+++.+||+.+|++|||+.+++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            122358899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.8e-31  Score=291.99  Aligned_cols=187  Identities=21%  Similarity=0.293  Sum_probs=151.5

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHH-----HHHHhhceeecCCeeEEEEEec
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLT-----EVEAFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~-----ei~~~~~~~~~~~~~~lV~e~~  659 (849)
                      ...+|++.+.||+|+||.||+|... +++.||+|......    ...+...++     .+.++++++......++||||+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~----~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc----cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            3457999999999999999999654 57889999754321    111222222     2456888888899999999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN  739 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  739 (849)
                      . |+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.++..... ..
T Consensus       140 ~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~  212 (357)
T PHA03209        140 S-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PA  212 (357)
T ss_pred             C-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC-cc
Confidence            5 58888875432  4589999999999999999999998   9999999999999999999999999999754322 22


Q ss_pred             eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 042123          740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPR  783 (849)
Q Consensus       740 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf  783 (849)
                      .....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            33457899999999999999999999999999999999865553

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=4.2e-31  Score=285.26  Aligned_cols=189  Identities=22%  Similarity=0.323  Sum_probs=141.2

Q ss_pred             CceecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceee--cCCeeEEEEEeccCC
Q 042123          593 KYCIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCS--HARHSFLLYEFLERG  662 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~--~~~~~~lV~e~~~~g  662 (849)
                      ..+||+|+||+||+|+..   ++..||+|.+...........+...+++     +.++++++.  .+...++||||+++ 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            357999999999999754   4578999988653211111111122222     223455553  34578999999875 


Q ss_pred             Chhhhhcccc------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEeeecCCcc
Q 042123          663 SLAAILNTDA------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL----DLEYEAHVADFGIAKS  732 (849)
Q Consensus       663 sL~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfG~a~~  732 (849)
                      +|.+++....      ....+++..+..++.||+.||+|||+.   +|+||||||+||++    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            7777764221      123588999999999999999999998   99999999999999    5667999999999987


Q ss_pred             cCCCCC---CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          733 LKPDSS---NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       733 ~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                      ......   ......+|+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            654321   1234567899999999876 4578999999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=6.3e-31  Score=276.15  Aligned_cols=242  Identities=21%  Similarity=0.332  Sum_probs=177.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC-chhhHHHHHHHHHH-----------hhceeec--CCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD-QTVDQKEFLTEVEA-----------FYGFCSH--ARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~ei~~-----------~~~~~~~--~~~~  652 (849)
                      .+|+..+.||+|+||.||+|.. .++..||+|++....... .......+.+|+..           +++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788899999999999999955 468999999876432211 11222334445432           4455443  3567


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++|+||+++++|.+++....   .+++..+..++.|++.||+|||+.   +|+||||+|+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999986432   478999999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCC---CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          733 LKPDS---SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       733 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      .....   .......++..|+|||++.+..++.++||||+||++||+++|+.||.......       ........+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~  228 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-------AIFKIATQPTNP  228 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-------HHHHHhcCCCCC
Confidence            53211   11223457889999999998889999999999999999999999987432111       011111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         .........+.+++ +||..+|++||+++||++|
T Consensus       229 ---~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         229 ---QLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence               11112223355565 7888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=4.4e-31  Score=276.07  Aligned_cols=240  Identities=24%  Similarity=0.352  Sum_probs=182.6

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCC-chhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD-QTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +|+..+.||+|+||.||+|... +++.||+|.+....... .....+.+.+|+.           ++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999665 78999999876432111 1122334444433           466777888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++.+.   ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999998653   2488999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCeeeccCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCCh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD-PRLPAPSR  813 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  813 (849)
                      .. ......++..|+|||.+.... ++.++|+||||+++|++++|+.||.......        ....... ...+.   
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--------~~~~~~~~~~~~~---  222 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--------AVFKIGRSKELPP---  222 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--------HHHHHHhcccCCC---
Confidence            32 223456888999999987766 8999999999999999999999987433111        0000000 11111   


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........+.+++.+||+.+|++|||+++++++
T Consensus       223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            111123347788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=5e-31  Score=279.90  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=183.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec--C
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH--A  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~--~  649 (849)
                      ++|+..+.||+|+||.||+|++.     ++..||||.+......   .....+.+|+.           .+++++..  .
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE---QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch---HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            45777889999999999999753     4788999998754221   23445555544           24556555  4


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+++++|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence            57899999999999999997543  2589999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCCCCCCee---eccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc--cc----cccccc
Q 042123          730 AKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS--SL----NTDVAL  800 (849)
Q Consensus       730 a~~~~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~--~~----~~~~~~  800 (849)
                      +...........   ...++..|+|||...+..++.++||||||+++|||++|+.||.........  ..    ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL  235 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence            987753322111   123456799999998888999999999999999999999997643211100  00    000011


Q ss_pred             ccccCC--CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          801 DQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       801 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+..  +.+.+.    ....++.+++.+||+.+|++|||+.||++.|+
T Consensus       236 ~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05038         236 LELLKEGERLPRPP----SCPDEVYDLMKLCWEAEPQDRPSFADLILIVD  281 (284)
T ss_pred             HHHHHcCCcCCCCc----cCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence            111111  111111    12245889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=6.1e-31  Score=275.70  Aligned_cols=236  Identities=27%  Similarity=0.438  Sum_probs=171.6

Q ss_pred             ceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceee-cCCeeEEEEE
Q 042123          594 YCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCS-HARHSFLLYE  657 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~-~~~~~~lV~e  657 (849)
                      +.||+|+||.||+|...    ++..||+|++....   .......+.+|+.           .+++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT---DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccC---CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            36899999999999643    24579999875421   1222344555543           3455543 4556889999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |+.+|+|.+++....  ...++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          78 YMKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             cCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            999999999986543  2467888899999999999999998   99999999999999999999999999997654321


Q ss_pred             C----CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCCCCCCCC
Q 042123          738 S----NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKG-KHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       738 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .    ......++..|+|||.+.+..++.++||||||+++|||++| ..||......        ........+......
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~  224 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF--------DITVYLLQGRRLLQP  224 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhcCCCCCCC
Confidence            1    11223456789999999888899999999999999999995 5556432211        111111221111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .   ..+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       225 ~---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~  257 (262)
T cd05058         225 E---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE  257 (262)
T ss_pred             C---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            1   11234788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=7.9e-31  Score=275.85  Aligned_cols=245  Identities=23%  Similarity=0.380  Sum_probs=184.5

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc--hhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ--TVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      +|+..+.||+|+||.||+|.. .+++.||+|.+........  ......+.+|+.           ++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477888999999999999954 6789999999864322111  112344555543           47788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCccc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSL  733 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~~~  733 (849)
                      ||||+++++|.+++.+.   ..+++..+..++.|++.|++|||+.   +++|+||+|+||+++.++ .+|++|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            99999999999998643   3588999999999999999999999   999999999999998776 5999999998876


Q ss_pred             CCCCC----CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          734 KPDSS----NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       734 ~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      .....    ......++..|+|||.+.+..++.++||||+|+++|++++|+.||.......     ......+.......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~  229 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-----HLALIFKIASATTA  229 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-----hHHHHHHHhccCCC
Confidence            54311    1223467889999999988889999999999999999999999986332110     00111111110111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        ..........+.+++.+||+.+|++|||+.+++++
T Consensus       230 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         230 --PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence              11112233458889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=2.2e-31  Score=278.16  Aligned_cols=229  Identities=23%  Similarity=0.416  Sum_probs=169.5

Q ss_pred             ceecCCccceEEEEEec-C-------CcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEE
Q 042123          594 YCIGNGGHASVYRAELP-S-------GEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~l  654 (849)
                      +.||+|+||.||+|... .       ..+||+|.+....    ......+.+|           +..+++++..+...++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH----RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh----HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence            36999999999999553 2       2348888764321    1112233333           3347778888888999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--------EEEee
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE--------AHVAD  726 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--------~kl~D  726 (849)
                      ||||+++|+|.+++....  ..+++..+..++.||+.|++|||+.   +|+||||||+||+++.++.        ++++|
T Consensus        77 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence            999999999999997543  2589999999999999999999998   9999999999999987765        69999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCC-CCCCcccccccccccccccccccc
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGK-HPRDFLSSISSSSLNTDVALDQML  804 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~-~Pf~~~~~~~~~~~~~~~~~~~~~  804 (849)
                      ||.+......    ....++..|+|||++.+ ..++.++||||||+++|||++|. .||.......         .....
T Consensus       152 ~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---------~~~~~  218 (258)
T cd05078         152 PGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---------KLQFY  218 (258)
T ss_pred             cccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---------HHHHH
Confidence            9998765432    23467889999999876 45789999999999999999985 5554322110         00111


Q ss_pred             CCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          805 DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       805 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+...+...    ..++.+++.+||+.+|++|||+++|++.|+
T Consensus       219 ~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         219 EDRHQLPAPK----WTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HccccCCCCC----cHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111111111    134789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=7.7e-31  Score=274.40  Aligned_cols=226  Identities=25%  Similarity=0.426  Sum_probs=170.9

Q ss_pred             ceecCCccceEEEEEecCCc-----------EEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCe
Q 042123          594 YCIGNGGHASVYRAELPSGE-----------VVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARH  651 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~  651 (849)
                      +.||+|+||.||+|...+..           .+++|.+.....    . ...+.+|+           ..+++++.. ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----D-SLAFFETASLMSQLSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----h-HHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence            36899999999999765332           477777654311    1 33444443           346777766 77


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-------cEEE
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-------EAHV  724 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-------~~kl  724 (849)
                      .++||||+++|+|.+++....  ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++       .+|+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence            899999999999999987543  2589999999999999999999998   999999999999999888       7999


Q ss_pred             eeecCCcccCCCCCCeeeccCCccccccccccCC--CCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccc
Q 042123          725 ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM--KITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALD  801 (849)
Q Consensus       725 ~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~  801 (849)
                      +|||++.....    .....++..|+|||++.+.  .++.++||||||+++||+++ |..||........        ..
T Consensus       150 ~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~--------~~  217 (259)
T cd05037         150 SDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK--------ER  217 (259)
T ss_pred             CCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH--------HH
Confidence            99999986543    1234567789999998876  78999999999999999999 5777764321110        00


Q ss_pred             cccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          802 QMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       802 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..... ..+.+. .     ..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       218 ~~~~~~~~~~~~-~-----~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         218 FYQDQHRLPMPD-C-----AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HHhcCCCCCCCC-c-----hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            01111 111111 1     45789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.1e-30  Score=276.30  Aligned_cols=240  Identities=26%  Similarity=0.466  Sum_probs=180.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCc----EEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGE----VVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~  651 (849)
                      .+|+..+.||+|+||.||+|... +|+    .+|+|.......   ......+.+|+..           +++++.. ..
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS---PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            57888899999999999999653 333    589998765422   2233445555442           5556655 67


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++....  ..+++..+..++.||+.|++|||+.   +++||||||+||+++.++.+||+|||.++
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~  157 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK  157 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccc
Confidence            889999999999999987543  2489999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCCeee--ccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-
Q 042123          732 SLKPDSSNWTE--FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-  807 (849)
Q Consensus       732 ~~~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  807 (849)
                      ...........  ..++..|+|||.+....++.++||||||+++||+++ |+.||+.....        .....+.... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~~  229 (279)
T cd05057         158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV--------EIPDLLEKGER  229 (279)
T ss_pred             cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhCCCC
Confidence            76543222111  223567999999988889999999999999999998 99998743211        1111111111 


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+.+....    ..+.+++.+||..+|++|||+.++++.|+
T Consensus       230 ~~~~~~~~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         230 LPQPPICT----IDVYMVLVKCWMIDAESRPTFKELINEFS  266 (279)
T ss_pred             CCCCCCCC----HHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            11111111    24778899999999999999999998774

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=6.6e-31  Score=285.41  Aligned_cols=244  Identities=23%  Similarity=0.395  Sum_probs=180.8

Q ss_pred             cCCCcCceecCCccceEEEEEec--------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP--------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS  647 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~  647 (849)
                      .+|.+.+.||+|+||.||+|+..        .+..||+|.+......   .....+.+|+.            .+++++.
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD---KDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCH---HHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            46888999999999999999542        1236899987643211   11223333322            3667777


Q ss_pred             cCCeeEEEEEeccCCChhhhhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDA-------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL  714 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  714 (849)
                      +.+..++||||+++|+|.+++.+..             ....+++.++..++.|++.|++|||+.   +++||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            7888999999999999999986532             123578999999999999999999998   999999999999


Q ss_pred             eecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 042123          715 LLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISS  791 (849)
Q Consensus       715 ll~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~  791 (849)
                      +++.++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|||++ |..||......  
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--  243 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--  243 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence            9999999999999999865432211  112233567999999999899999999999999999998 88888643211  


Q ss_pred             cccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          792 SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                            .....+..........   .....+.+++.+||+.+|++|||+.|++++|+
T Consensus       244 ------~~~~~~~~~~~~~~~~---~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         244 ------ELFKLLKEGHRMDKPA---NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             ------HHHHHHHcCCCCCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                  1111111111111111   12234788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=4.8e-31  Score=278.60  Aligned_cols=245  Identities=24%  Similarity=0.415  Sum_probs=183.1

Q ss_pred             cCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      ++|+..+.||+|+||.||+|+.+      +.+.||+|.+....   .......+.+|+.           .+++++....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK---DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc---chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            57888899999999999999753      34679999875431   1112334444433           3667777778


Q ss_pred             eeEEEEEeccCCChhhhhcccccc------cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAA------QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                      ..++||||+++|+|.+++......      ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+++
T Consensus        82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l  158 (275)
T cd05046          82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV  158 (275)
T ss_pred             cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence            899999999999999999754422      1589999999999999999999998   9999999999999999999999


Q ss_pred             eeecCCcccCCCC-CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 042123          725 ADFGIAKSLKPDS-SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       725 ~DfG~a~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      +|||++....... .......++..|+|||.+.+..++.++||||||+++|++++ |..||......        .....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--------~~~~~  230 (275)
T cd05046         159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--------EVLNR  230 (275)
T ss_pred             cccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--------HHHHH
Confidence            9999987543221 12233455678999999988888999999999999999998 88898633211        11111


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..........  .......+.+++.+||+.+|++|||+.|+++.|+
T Consensus       231 ~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         231 LQAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1111111100  0112234888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=6.9e-31  Score=279.51  Aligned_cols=237  Identities=24%  Similarity=0.317  Sum_probs=183.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+....... ......+.+|+.           .+++++.+....++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence            4688899999999999999965 468999999986431111 111223334432           466777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          80 MEYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            9999999999998654   3589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .   .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.....        ..............+... 
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~-  221 (290)
T cd05580         154 R---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGKVRFPSFF-  221 (290)
T ss_pred             C---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCccCCccC-
Confidence            3   2334688999999999888889999999999999999999999874331        111222222222222211 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                         ...+.+++.+||+.+|.+||     +++|++++
T Consensus       222 ---~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         222 ---SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ---CHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence               23477899999999999999     88888764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=1.3e-30  Score=272.24  Aligned_cols=240  Identities=21%  Similarity=0.330  Sum_probs=182.4

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||+|.. .+++.+|||.+.....  .......+.+|+.           .+++.+...+..++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            477889999999999999954 4788999999865321  1122344555543           3555666778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCCcccCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKP  735 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~  735 (849)
                      ||+++++|.+++.... ...+++.++.+++.|++.|++|||++   +++|+||+|+||+++.+ +.+|++|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          79 EYAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             ecCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            9999999999996543 34589999999999999999999998   99999999999999865 4689999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||+.....        ...............   
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~---  222 (256)
T cd08220         155 KS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--------ALVLKIMSGTFAPIS---  222 (256)
T ss_pred             Cc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH--------HHHHHHHhcCCCCCC---
Confidence            32 223356788999999999888999999999999999999999998643211        111111111111111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++|||++|++++
T Consensus       223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1123347889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=9.9e-31  Score=275.36  Aligned_cols=240  Identities=25%  Similarity=0.428  Sum_probs=179.6

Q ss_pred             cCCCcCceecCCccceEEEEEecC----CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ++|...+.||+|+||.||+|...+    ...||||.......   ....+.+.+|+.           ++++++.. ...
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS---PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC---HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            467788999999999999996543    34689998765421   222344555544           34555544 567


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            89999999999999996543  3489999999999999999999998   999999999999999999999999999886


Q ss_pred             cCCCCCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCC
Q 042123          733 LKPDSSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-PRLP  809 (849)
Q Consensus       733 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~  809 (849)
                      ....... .....++..|+|||.+....++.++||||||+++||+++ |..||.......        ....+.. .+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~~~~~  228 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENGERLP  228 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcCCcCC
Confidence            6443221 112234567999999988889999999999999999996 999987443211        1111111 1111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+..    ....+.+++.+||..+|++|||+.++++.|+
T Consensus       229 ~~~~----~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         229 MPPN----CPPTLYSLMTKCWAYDPSKRPRFTELKAQLS  263 (270)
T ss_pred             CCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111    1234788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=4.6e-31  Score=275.18  Aligned_cols=235  Identities=26%  Similarity=0.447  Sum_probs=178.5

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~  656 (849)
                      ++|+..+.||+|+||.||+|.. +++.||+|.+....      ....+.+|+..           +++++.+ +..++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~------~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV------TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc------hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEE
Confidence            4688899999999999999975 57889999876432      12344445432           4455544 4578999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++.... ...+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+|++|||.+......
T Consensus        78 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence            9999999999986543 24588999999999999999999998   9999999999999999999999999998754322


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                         ......+..|+|||++.+..++.++||||||+++|||++ |+.||.......        .. ..+.......  ..
T Consensus       154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--------~~-~~~~~~~~~~--~~  219 (254)
T cd05083         154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--------VK-ECVEKGYRME--PP  219 (254)
T ss_pred             ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--------HH-HHHhCCCCCC--CC
Confidence               122334568999999988899999999999999999997 999986432211        00 1111111110  01


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......+.+++.+||+.+|++||+++++++.|+
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            122345788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=2.6e-31  Score=294.37  Aligned_cols=250  Identities=19%  Similarity=0.234  Sum_probs=181.2

Q ss_pred             hcCCCcCceecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceeecCCeeEEEEEe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~~~~~~~lV~e~  658 (849)
                      ..+|.+.+.||+|+||.||+|...   .+..||||.+....   ....+...++.     +.++++++......++|||+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~---~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~  167 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK---TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK  167 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc---cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence            357999999999999999999543   46789999875431   11112223322     44567778888899999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +. ++|.+++..   ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++........
T Consensus       168 ~~-~~l~~~l~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        168 YK-CDLFTYVDR---SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             cC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            96 588888843   24589999999999999999999998   999999999999999999999999999976644322


Q ss_pred             --CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---------------ccccc----
Q 042123          739 --NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS---------------SLNTD----  797 (849)
Q Consensus       739 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~---------------~~~~~----  797 (849)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........               .....    
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence              123457899999999999999999999999999999999999998643211000               00000    


Q ss_pred             --cccccc---cCCCCCCCCh-hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 --VALDQM---LDPRLPAPSR-SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 --~~~~~~---~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        ....+.   ..+....+.. ........+.+++.+|+..||++|||+.|++.+
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence              000000   0000110000 000112357788999999999999999999875

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=1e-30  Score=274.37  Aligned_cols=242  Identities=21%  Similarity=0.317  Sum_probs=178.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC-chhhHHHHHHHHHH-----------hhceeec--CCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD-QTVDQKEFLTEVEA-----------FYGFCSH--ARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~ei~~-----------~~~~~~~--~~~~  652 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+....... .......+.+|+..           +++++.+  ....
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5788999999999999999965 468999999875322111 11222344445442           4455544  3467


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++++|.+++....   .+++..+.+++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999986432   478899999999999999999998   999999999999999999999999999876


Q ss_pred             cCCCC---CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          733 LKPDS---SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       733 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      .....   .......++..|+|||.+.+..++.++||||||+++|||++|+.||.......       ........+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~  228 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-------AIFKIATQPTNP  228 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-------HHHHHhcCCCCC
Confidence            53211   11233457889999999988889999999999999999999999986432111       011111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .   .+......+.+++.+||. +|++||+++||+++
T Consensus       229 ~---~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         229 V---LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             C---CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            1   112233457788889995 89999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=6.2e-31  Score=280.83  Aligned_cols=253  Identities=19%  Similarity=0.265  Sum_probs=178.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCe---
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARH---  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~---  651 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||||.+........  ....+.+|+.            ++++++.....   
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~--~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG--IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC--CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            4688899999999999999965 4789999998765322111  1122333322            34555544444   


Q ss_pred             --eEEEEEeccCCChhhhhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEee
Q 042123          652 --SFLLYEFLERGSLAAILNTDAA--AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-EYEAHVAD  726 (849)
Q Consensus       652 --~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~D  726 (849)
                        .|+||||+++ ++.+++.....  ...+++.++..++.||+.||+|||+.   +|+||||+|+||+++. ++.+|++|
T Consensus        79 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          79 PSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             ceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEee
Confidence              7999999986 88888764332  24589999999999999999999998   9999999999999998 89999999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDV  798 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~  798 (849)
                      ||.++.+...........+++.|+|||++.+ ..++.++||||||+++|+|++|..||..........       .....
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         155 LGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999866543333334456889999998865 457899999999999999999999986433211000       00000


Q ss_pred             cccc---cc----CCCCCCC--ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQ---ML----DPRLPAP--SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~---~~----~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....   ..    .+.....  .........++.+++.+||+++|++|||++|++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0000   00    0000000  00001223458899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=7e-31  Score=278.98  Aligned_cols=242  Identities=25%  Similarity=0.421  Sum_probs=186.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..+.|+..+.||+|+||.||+|... ++..||+|.+.....     ....+..|+.           .+++++......+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            4467888889999999999999665 689999999865322     2334445544           3566777788999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|+||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+...
T Consensus        92 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            9999999999999997543  3689999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ...........++..|+|||++.+..++.++||||||+++|+|++|+.||.......        ..........+. ..
T Consensus       167 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~-~~  237 (286)
T cd06614         167 TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--------ALFLITTKGIPP-LK  237 (286)
T ss_pred             ccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCC-Cc
Confidence            443322334457889999999988889999999999999999999999986432211        111111111111 11


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........+.+++.+||+.+|.+|||+.+++++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             chhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            111123457889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=265.45  Aligned_cols=249  Identities=22%  Similarity=0.366  Sum_probs=190.2

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHHHhhce---------
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF---------  645 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~~~---------  645 (849)
                      .++.....+++....+-+|.||+||+|.|.      +.+.|-||.++..   ........+++|--.++|.         
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~  353 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVL  353 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCcccee
Confidence            455555567778888999999999999553      3445667766543   2334445566665544442         


Q ss_pred             --e-ecCCeeEEEEEeccCCChhhhhc-----ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 042123          646 --C-SHARHSFLLYEFLERGSLAAILN-----TDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD  717 (849)
Q Consensus       646 --~-~~~~~~~lV~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  717 (849)
                        + ++....+.+|.++.-|+|..|+.     .....+.++-.+...++.|++.|++|||..   +|+|.||.++|.++|
T Consensus       354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID  430 (563)
T ss_pred             EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence              2 23456788999999999999997     333445678888999999999999999999   999999999999999


Q ss_pred             CCCcEEEeeecCCcccCCCCCCe--eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 042123          718 LEYEAHVADFGIAKSLKPDSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSL  794 (849)
Q Consensus       718 ~~~~~kl~DfG~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~  794 (849)
                      +..++|++|=.+++..-+.+...  .....+..||+||.+....|+.++|||||||++|||+| |+.||.+.++      
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP------  504 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP------  504 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH------
Confidence            99999999999999776655431  22234568999999999999999999999999999998 9999875443      


Q ss_pred             ccccccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          795 NTDVALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       795 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                        .+...-+.|+ ++..|.+++.    ++..+|.-||..+|++||+++|++.-|
T Consensus       505 --fEm~~ylkdGyRlaQP~NCPD----eLf~vMacCWallpeeRPsf~Qlv~cL  552 (563)
T KOG1024|consen  505 --FEMEHYLKDGYRLAQPFNCPD----ELFTVMACCWALLPEERPSFSQLVICL  552 (563)
T ss_pred             --HHHHHHHhccceecCCCCCcH----HHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence              2333334444 3444444444    388899999999999999999998765

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=8.5e-31  Score=279.07  Aligned_cols=252  Identities=19%  Similarity=0.233  Sum_probs=178.8

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~  653 (849)
                      ++++|...+.||+|+||.||+|.. .+++.||+|.+........   ...+.+|+           ..+.+++..+...+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   79 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV---PFTAIREASLLKGLKHANIVLLHDIIHTKETLT   79 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC---cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEE
Confidence            457899999999999999999954 4689999999865322111   11222332           23567777888999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+. +++.+++....  ..+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++..
T Consensus        80 lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          80 FVFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccccc
Confidence            9999996 67777764332  3478889999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccc--------
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS--------SLNT--------  796 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~--------~~~~--------  796 (849)
                      ...........+++.|+|||++.+. .++.++||||||+++|||++|+.||+........        ....        
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         154 SIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence            4333333444678899999998754 5788999999999999999999999743321000        0000        


Q ss_pred             --ccccccccCCCCCCCChh---hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          797 --DVALDQMLDPRLPAPSRS---AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       797 --~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        ............+.....   .......+.+++.+|++.||++|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence              000000000000000000   00112357788999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=1.1e-30  Score=279.73  Aligned_cols=239  Identities=26%  Similarity=0.476  Sum_probs=177.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCc----EEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      ++|+..+.||+|+||.||+|.+ .+++    .||+|.+....   ......++.+|+.           ++++++.. ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~   82 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PT   82 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CC
Confidence            5778889999999999999965 3444    47888775432   1222234444433           35666644 35


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++|+||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~  157 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccc
Confidence            678999999999999986532  3488999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC--C
Q 042123          732 SLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD--P  806 (849)
Q Consensus       732 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~--~  806 (849)
                      ........  .....++..|+|||++.+..++.++||||||+++||+++ |+.||.......         ..+.+.  .
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---------~~~~~~~~~  228 (303)
T cd05110         158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---------IPDLLEKGE  228 (303)
T ss_pred             cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---------HHHHHHCCC
Confidence            76533221  122335678999999988889999999999999999997 999986432110         011111  1


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.+..    ....+.+++..||..+|++||+++++++.|+
T Consensus       229 ~~~~~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         229 RLPQPPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             CCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111111    1234778899999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=1.4e-30  Score=275.15  Aligned_cols=238  Identities=26%  Similarity=0.415  Sum_probs=183.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +-|+..+.||+|+||.||+|.. .+++.||+|.+....   .......+.+|+.           .+++++..+...++|
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc---chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            3567788999999999999954 478999999875431   1122334444433           366777788899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++..    ..+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06641          81 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  153 (277)
T ss_pred             EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence            999999999999864    2489999999999999999999998   999999999999999999999999999876654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........++..|+|||.+.+..++.++|||||||++|+|++|..||.......        ..........+.   ..
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~---~~  222 (277)
T cd06641         154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNNPPT---LE  222 (277)
T ss_pred             chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCCCCC---CC
Confidence            3322334567889999999988888999999999999999999999986432111        111111111110   11


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++||++.+++++
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            1223347789999999999999999999885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1.2e-30  Score=275.01  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=181.0

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCch------hhHHHHHHHHH-----------HhhceeecCC
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQT------VDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~------~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      .|...+.||+|+||.||+|.. .+++.||+|.+.........      ...+.+.+|+.           .+++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            366778999999999999954 47899999987532111111      11123444433           3567777888


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..++||||+++|+|.+++.+.   ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998654   3589999999999999999999998   9999999999999999999999999998


Q ss_pred             cccCCCCC--CeeeccCCccccccccccCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042123          731 KSLKPDSS--NWTEFAGTCGYIAPELAYTMK--ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP  806 (849)
Q Consensus       731 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  806 (849)
                      +.......  ......++..|+|||......  ++.++||||+|+++|++++|..||..........    .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~  231 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF----KLGNKRSAP  231 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHH----HhhccccCC
Confidence            76543211  123345788999999987654  7889999999999999999999986332211000    000000111


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+  ..........+.+++.+||+.+|++|||+++|+++
T Consensus       232 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         232 PIP--PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCC--ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111  11111233458889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=1.6e-30  Score=271.78  Aligned_cols=240  Identities=27%  Similarity=0.453  Sum_probs=180.8

Q ss_pred             CCcCceecCCccceEEEEEecC-----CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          590 FDAKYCIGNGGHASVYRAELPS-----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      |++.+.||+|+||.||+|...+     +..||+|.+......   .....+..|+.           .+++++...+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE---QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh---HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            3567889999999999996643     388999998654221   12334444433           3667777778899


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++++|.+++..... ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+...
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~  153 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL  153 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence            99999999999999865432 2289999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCee-eccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCC
Q 042123          734 KPDSSNWT-EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       734 ~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ........ ...+++.|+|||...+..++.++||||+|+++|+|++ |+.||......        ..............
T Consensus       154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  225 (258)
T smart00219      154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--------EVLEYLKKGYRLPK  225 (258)
T ss_pred             ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhcCCCCCC
Confidence            54422211 2336789999999988889999999999999999998 88888642211        11111111111111


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ..   .....+.+++.+||+.+|++|||+.|+++.|
T Consensus       226 ~~---~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 PE---NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CC---cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            11   1233578899999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=1.1e-30  Score=277.91  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=183.0

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +++.||||.+......  ......+.+|+.           .+.+++..++..++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD--EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc--ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            36888999999999999999654 6889999988643221  111233444433           467788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||++++.+..+....   ..+++.++..++.||+.|++|||+.   +++|||++|+||+++.++.+|++|||.+.....
T Consensus        79 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          79 FEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             EecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            9999987777665432   3489999999999999999999998   999999999999999999999999999987665


Q ss_pred             CCC-CeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------ccc--ccc--cc
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS--------LNT--DVA--LD  801 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~--------~~~--~~~--~~  801 (849)
                      ... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||..........        ...  ...  ..
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            432 33446678899999999887 78999999999999999999999986432110000        000  000  00


Q ss_pred             cccCC-CCCCCC--h-----hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 QMLDP-RLPAPS--R-----SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ~~~~~-~~~~~~--~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....+ ..+...  .     .......++.+++.+||+.+|++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            00000 000000  0     000113558899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-31  Score=258.94  Aligned_cols=252  Identities=19%  Similarity=0.269  Sum_probs=191.2

Q ss_pred             HhcCCCcC-ceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHH----HHHHHhh----ceeecCCeeEEE
Q 042123          586 ATNDFDAK-YCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFL----TEVEAFY----GFCSHARHSFLL  655 (849)
Q Consensus       586 ~~~~f~~~-~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~----~ei~~~~----~~~~~~~~~~lV  655 (849)
                      .+++|.+. ++||-|-.|.|-.+ ...+|+++|+|.+...-. ......-.++    .+|+.++    ..+.......+|
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K-ARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV  137 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK-ARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV  137 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH-HHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence            34566654 47999999999988 455799999998764311 0000000000    1122233    333445678899


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeecCCcc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEAHVADFGIAKS  732 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~a~~  732 (849)
                      ||.|+||.|...+...+ ...+++.++..|+.||+.|+.|||+.   +|.||||||+|+|.+..   ..+|++|||+|+.
T Consensus       138 mE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  138 MECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccc
Confidence            99999999999997654 35699999999999999999999999   99999999999999644   5799999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ... .....+++-||.|.|||++...+|+...|+||+||++|-|++|.+||-......    .......++..+....+.
T Consensus       214 t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  214 TQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             cCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccCccCCC
Confidence            654 234566788999999999999999999999999999999999999997544321    112223333444444455


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ..|.+......++|...+..+|.+|.|+.+++.+=
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            67778888899999999999999999999998763

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.3e-30  Score=272.22  Aligned_cols=241  Identities=22%  Similarity=0.327  Sum_probs=183.8

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||+|... +|..+|+|.+......  ......+.+|+           ..+++.+......++|+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP--VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc--chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence            4777889999999999999654 6889999998643111  11122333443           34778888888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCcccCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSLKP  735 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  735 (849)
                      ||+++++|.+++.... ...+++..+..++.|++.|++|||+.   +++|+||+|+||++++++ .+|++|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          79 EYCDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             ecCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            9999999999986543 23579999999999999999999998   999999999999999886 469999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........|++.|+|||+..+..++.++||||||+++||+++|+.||......        ...............   
T Consensus       155 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---  223 (257)
T cd08225         155 SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--------QLVLKICQGYFAPIS---  223 (257)
T ss_pred             CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHhcccCCCCC---
Confidence            433334456889999999998888999999999999999999999998633211        111111121111111   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++|||+.|++++
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            1112347788999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=1.3e-30  Score=271.26  Aligned_cols=239  Identities=28%  Similarity=0.453  Sum_probs=185.7

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|++|.||+|... +++.+++|++.....    .....+.+|+.           .+.+++......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            4777889999999999999664 789999999876432    22344555544           2566777778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++|+|||.+......
T Consensus        77 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          77 EFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             ecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            9999999999986543  3589999999999999999999998   9999999999999999999999999999877654


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      .. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+......     .......+.....    .
T Consensus       152 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~~----~  221 (253)
T cd05122         152 KA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-----KIATNGPPGLRNP----E  221 (253)
T ss_pred             cc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-----HHHhcCCCCcCcc----c
Confidence            32 344578899999999988889999999999999999999999987442111100     0000001111111    1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.+++.+||+.||++|||+.|++++
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            113348889999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=7.7e-31  Score=281.23  Aligned_cols=243  Identities=22%  Similarity=0.296  Sum_probs=178.4

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||+|.+...... .......+.+|+.           .+++.+..++..++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhh-hHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            3688899999999999999965 46789999987653211 1112233444433           356677778889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++....
T Consensus        80 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          80 MEYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             EecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            9999999999999653   3489999999999999999999998   999999999999999999999999999864211


Q ss_pred             CCC---------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 042123          736 DSS---------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL  800 (849)
Q Consensus       736 ~~~---------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~  800 (849)
                      ...               ......++..|+|||.+.+..++.++||||||+++||+++|..||.....        ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~  225 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELF  225 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH
Confidence            000               01123567889999999888899999999999999999999999863221        1111


Q ss_pred             ccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCH---HHHHhh
Q 042123          801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTM---KIISQQ  846 (849)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~---~eil~~  846 (849)
                      ..........+... ......+.+++.+||+.+|++||++   .+++++
T Consensus       226 ~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 GQVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            12111111111110 0122347889999999999999984   555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.3e-31  Score=274.31  Aligned_cols=234  Identities=24%  Similarity=0.320  Sum_probs=173.3

Q ss_pred             ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      +.||+|+||.||+|.. .+++.||||.+......... ....+..|            +.++++++...+..++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKN-QVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHH-HHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            4689999999999965 46899999998643211111 11112222            2236677778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +++|.+++...   ..+++.++..++.|++.||.|||+.   +++||||+|+||++++++.++++|||+++....    .
T Consensus        81 ~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~  150 (260)
T cd05611          81 GGDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----N  150 (260)
T ss_pred             CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----c
Confidence            99999998653   3488999999999999999999998   999999999999999999999999999876432    2


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....++..|+|||.+.+..++.++||||+|+++|+|++|..||......        .............+.........
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~  222 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--------AVFDNILSRRINWPEEVKEFCSP  222 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhcccCCCCcccccCCH
Confidence            3346788999999998888899999999999999999999999643211        11111111111111111111234


Q ss_pred             HHHHHHhhccCCCCCCCCCH---HHHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTM---KIISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~---~eil~~  846 (849)
                      .+.+++.+||+.+|++||++   +|++++
T Consensus       223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         223 EAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             HHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            47899999999999999966   465543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=8.7e-31  Score=278.47  Aligned_cols=234  Identities=26%  Similarity=0.371  Sum_probs=178.6

Q ss_pred             CceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEEEecc
Q 042123          593 KYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ..+||+|+||.||+|.. .+++.||||++....    ......+.+|+           ..+++++...+..++||||++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK----QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc----hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            35799999999999965 578999999875321    12233344443           346677788899999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +++|.+++...    .+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++++|||++..........
T Consensus       101 ~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657         101 GGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             CCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            99999987532    478999999999999999999998   99999999999999999999999999987665433333


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      ....++..|+|||.+.+..++.++||||+|+++|+|++|..||........     .........+.....    .....
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~  244 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLPPKLKNL----HKVSP  244 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhhCCcccCCc----ccCCH
Confidence            445688999999999888889999999999999999999999864321110     000111111111111    11223


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+.+++.+||+.+|.+||++.+++++
T Consensus       245 ~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         245 SLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            47788999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=1e-30  Score=277.44  Aligned_cols=251  Identities=21%  Similarity=0.293  Sum_probs=180.0

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|++|.||+|+. .+++.||||++.......  .....+.+|+.           ++++++.+.+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc--ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            478889999999999999965 478999999886432211  11223444433           4677888888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+. ++|.+++.... ...+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+|++|||++......
T Consensus        79 e~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          79 EFLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             eccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9996 58988886543 34589999999999999999999998   9999999999999999999999999998866543


Q ss_pred             CCCeeeccCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc---ccccc--
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDV---ALDQM--  803 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~---~~~~~--  803 (849)
                      ........++..|+|||...+.. ++.++||||||+++|||+||+.||..........       .....   .....  
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         154 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            33334445688999999887644 5888999999999999999999986432110000       00000   00000  


Q ss_pred             ---cCCCCCCC-C-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 ---LDPRLPAP-S-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ---~~~~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ..+..... . .........+.+++.+||+.||++|||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence               00000000 0 0000112346789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-33  Score=310.22  Aligned_cols=416  Identities=26%  Similarity=0.317  Sum_probs=317.4

Q ss_pred             CCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCC
Q 042123           32 LAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLS  111 (849)
Q Consensus        32 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  111 (849)
                      ++.|++++|-+...+-+.....-+|+.|+|++|+++.       .+..+..+.+|+.|.++.|.|. ..|.+..++.+|+
T Consensus        23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~-------fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~   94 (1081)
T KOG0618|consen   23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISS-------FPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQ   94 (1081)
T ss_pred             HHhhhccccccccCchHHhhheeeeEEeecccccccc-------CCchhhhHHHHhhcccchhhHh-hCchhhhhhhcch
Confidence            8889999998865554555566679999999999872       3345567889999999999998 6678889999999


Q ss_pred             EEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCC
Q 042123          112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND  191 (849)
Q Consensus       112 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  191 (849)
                      +|.|.+|++. ..|..+..+.+|+.|++++|++. ..|..+..++.++.+..++|.....    ++... ++.++|..|.
T Consensus        95 ~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~  167 (1081)
T KOG0618|consen   95 YLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNV  167 (1081)
T ss_pred             hheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhh
Confidence            9999999998 78999999999999999999998 6788899999999999999933322    23322 8889999999


Q ss_pred             CcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCccc
Q 042123          192 LFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNI  271 (849)
Q Consensus       192 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~  271 (849)
                      +.+.++..+..++.  .|+|++|.+. .  ..+..+.+|+.|....|+++..   ......++.|+.++|.++...+.  
T Consensus       168 l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l---~~~g~~l~~L~a~~n~l~~~~~~--  237 (1081)
T KOG0618|consen  168 LGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSEL---EISGPSLTALYADHNPLTTLDVH--  237 (1081)
T ss_pred             cccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceE---EecCcchheeeeccCcceeeccc--
Confidence            98888887777766  7999999997 3  3567788888888888887621   12233466666666666632221  


Q ss_pred             CCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcE
Q 042123          272 CRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGT  351 (849)
Q Consensus       272 ~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  351 (849)
                      ..-.+|+++++++|+++ .+|+++..+.+|+.+...+|.++ ..|..+....+|++|+...|.+. -+|.....++.|++
T Consensus       238 p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~t  314 (1081)
T KOG0618|consen  238 PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRT  314 (1081)
T ss_pred             cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeee
Confidence            11235667777777776 34466666777777777777765 44555555566666666666665 33444455666666


Q ss_pred             EeccCCccccCCCCCc--------------------------cccccccccccccccccccCchhhcCCCCCcEEEccCc
Q 042123          352 LNVSMNNITGGLPREI--------------------------GNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGN  405 (849)
Q Consensus       352 L~Ls~N~i~~~~p~~~--------------------------~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  405 (849)
                      |+|..|+|. ..|..+                          ..+..|+.|++.+|+++...-..+.+.++|+.|+|++|
T Consensus       315 LdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyN  393 (1081)
T KOG0618|consen  315 LDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYN  393 (1081)
T ss_pred             eeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeeccc
Confidence            666666665 233211                          13466899999999999887778999999999999999


Q ss_pred             cccccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCcccc
Q 042123          406 QITGRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC  478 (849)
Q Consensus       406 ~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  478 (849)
                      +|.......+.++..|++|++|+  +..+|..+.+++.|+.|...+|+|. ..| .+..++.|+.+|+|.|.++-
T Consensus       394 rL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~  466 (1081)
T KOG0618|consen  394 RLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE  466 (1081)
T ss_pred             ccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence            99955556788999999999997  8999999999999999999999999 777 88999999999999999975

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=7e-31  Score=279.35  Aligned_cols=243  Identities=27%  Similarity=0.404  Sum_probs=177.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~l  654 (849)
                      ++|...+.||+|+||.||++.. .+++.||+|.+......   .....+.+|+.            ++++++..+...++
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~   80 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE---KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI   80 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh---HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence            3555677899999999999955 46899999998653221   22334444433            35677777788899


Q ss_pred             EEEeccCCChhhhhcc--cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          655 LYEFLERGSLAAILNT--DAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +|||+.. ++.++...  ......+++..+..++.|++.|++|||+..  +++||||||+||+++.++.+|++|||+++.
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            9999875 55554321  111245899999999999999999999743  899999999999999999999999999976


Q ss_pred             cCCCCCCeeeccCCccccccccccCC---CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC---C
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTM---KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD---P  806 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~---~  806 (849)
                      ...... .....++..|+|||.+.+.   .++.++||||+|+++|||++|+.||......       .....+...   +
T Consensus       158 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~  229 (288)
T cd06616         158 LVDSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-------FDQLTQVVKGDPP  229 (288)
T ss_pred             hccCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-------HHHHhhhcCCCCC
Confidence            543322 2334678899999998765   6889999999999999999999998743210       011111111   1


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+..  .........+.+++.+||+.+|++|||+++|+++
T Consensus       230 ~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 ILSN--SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCC--cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111  1111234458899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=276.33  Aligned_cols=250  Identities=20%  Similarity=0.254  Sum_probs=179.6

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e  657 (849)
                      |+..+.||+|++|.||+|.. .+|..||+|++.......  .....+..|+.           ++++++...+..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE--GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc--cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            56778999999999999965 479999999986432111  11122333332           46778888899999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |++ ++|.+++..... ..+++.++..++.|++.||+|||+.   +++||||+|+||+++.++.++++|||.+.......
T Consensus        79 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          79 FLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             ccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            995 689998865432 3589999999999999999999998   99999999999999999999999999997654333


Q ss_pred             CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------ccc----------cc
Q 042123          738 SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-------NTD----------VA  799 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-------~~~----------~~  799 (849)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........       ...          ..
T Consensus       154 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence            333334568899999987664 468899999999999999999999864332110000       000          00


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......................+.+++.+||+.+|++|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            00000000000000011122457889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=2.7e-30  Score=275.24  Aligned_cols=250  Identities=18%  Similarity=0.293  Sum_probs=179.0

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|++|.||+|... +++.||||.+........   ...+.+|+           .++++++......++|
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA---PFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC---chhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            67888999999999999999654 689999999865322111   11222333           3467788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++ +|.+++.+..  ..+++.++..++.|++.||.|||+.   +|+||||||+||+++.++.+|++|||.++....
T Consensus        82 ~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          82 FEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            999985 9999886543  3589999999999999999999998   999999999999999999999999999876533


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccccccc------
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS--------SLNTDVAL------  800 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~--------~~~~~~~~------  800 (849)
                      .........++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.........        ........      
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            2222233456888999998875 45788999999999999999999999643310000        00000000      


Q ss_pred             ccccCCCCCCC-Chh------hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 DQMLDPRLPAP-SRS------AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 ~~~~~~~~~~~-~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........... ...      .......+.+++.+|++.+|++|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00000000000 000      00011456789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=1.8e-30  Score=277.21  Aligned_cols=243  Identities=24%  Similarity=0.369  Sum_probs=179.9

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHH------------HHHHhhceeecCCeeE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLT------------EVEAFYGFCSHARHSF  653 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~------------ei~~~~~~~~~~~~~~  653 (849)
                      .++|+..+.||+|+||.||+|... +++.||||.+.......   ....+..            .+..+++++......+
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE---ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH---HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            367888999999999999999775 48999999986532211   1122222            2345788888889999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+.+ ++.+++....  ..+++.++..++.|++.|++|||+..  +|+||||+|+||+++.++.+||+|||++..+
T Consensus        91 ~v~e~~~~-~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          91 ICMELMST-CLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEeeccCc-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99999864 7777765432  36899999999999999999999732  8999999999999999999999999998765


Q ss_pred             CCCCCCeeeccCCccccccccccCCC----CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMK----ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      .... ......++..|+|||++.+..    ++.++||||||+++|+|++|+.||......       ............+
T Consensus       166 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~  237 (296)
T cd06618         166 VDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPP  237 (296)
T ss_pred             cCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCC
Confidence            4322 223345788999999987553    788999999999999999999998632110       1111112221111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .... ......++.+++.+||+.||++||++++++++
T Consensus       238 ~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         238 SLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1100 00123357889999999999999999999876

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=1.3e-30  Score=274.43  Aligned_cols=237  Identities=27%  Similarity=0.478  Sum_probs=177.0

Q ss_pred             ceecCCccceEEEEEecC-------CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          594 YCIGNGGHASVYRAELPS-------GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.||+|+||.||+|+..+       +..+|||.+.....   ......+.+|+.           ++++++...+..++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT---DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccc---hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            368999999999996542       25799998754321   122334455543           356777778889999


Q ss_pred             EEeccCCChhhhhcccc----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-----cEEEee
Q 042123          656 YEFLERGSLAAILNTDA----AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-----EAHVAD  726 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~D  726 (849)
                      |||+++|+|.+++....    ....+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++     .++++|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence            99999999999996432    123478999999999999999999998   999999999999999887     899999


Q ss_pred             ecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccc
Q 042123          727 FGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQM  803 (849)
Q Consensus       727 fG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~  803 (849)
                      ||+++.......  ......++..|+|||++.+..++.++||||||+++|||++ |+.||.......        ....+
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--------~~~~~  226 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--------VLQHV  226 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--------HHHHH
Confidence            999876543221  1122345678999999999999999999999999999998 999986432211        11111


Q ss_pred             cC-CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          804 LD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       804 ~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .. .....+    ......+.+++.+||+.+|++||++++|.+.|.
T Consensus       227 ~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         227 TAGGRLQKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             hcCCccCCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11 111111    122345789999999999999999999999874

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=2.1e-30  Score=275.48  Aligned_cols=250  Identities=21%  Similarity=0.317  Sum_probs=181.8

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|++.+.||+|+||.||+|.. .+|+.||||++.......  .....+.+|+.           .+++++......++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG--GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc--hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            477888999999999999965 478999999986542211  11233444433           3667777888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+ +++|.+++....  ..+++.+++.++.||+.||+|||+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        79 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          79 EYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             ccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            999 999999986543  4589999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CC-CeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccc----------cccccc------c
Q 042123          737 SS-NWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----------SSLNTD------V  798 (849)
Q Consensus       737 ~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----------~~~~~~------~  798 (849)
                      .. ......++..|+|||++.+. .++.++||||+|+++|||++|..||........          ......      .
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence            21 23345688999999988654 468899999999999999999888753321100          000000      0


Q ss_pred             ccccccCCCCCC-C-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQMLDPRLPA-P-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.... + .....+....+.+++.+|++.+|++|||++++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000000 0 00001123568899999999999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.8e-30  Score=274.34  Aligned_cols=234  Identities=18%  Similarity=0.274  Sum_probs=172.5

Q ss_pred             eecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH--------------HHHhhceeecCCeeEEEEEec
Q 042123          595 CIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE--------------VEAFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e--------------i~~~~~~~~~~~~~~lV~e~~  659 (849)
                      .||+|+||.||+|.. .+++.||+|.+......... ....+..+              +..+.+++...+..++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQ-GETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccch-hHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            489999999999965 46899999988653211111 11111111              122455666778899999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN  739 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  739 (849)
                      ++|+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||++.......  
T Consensus        80 ~g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          80 NGGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            999999988643   3589999999999999999999998   99999999999999999999999999987654322  


Q ss_pred             eeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHH
Q 042123          740 WTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK  818 (849)
Q Consensus       740 ~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  818 (849)
                      .....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||...........  . ..........+.      ..
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~--~-~~~~~~~~~~~~------~~  222 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--D-RMTLTMAVELPD------SF  222 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH--H-HHhhccCCCCCC------cC
Confidence            2335789999999998754 688999999999999999999999974321110000  0 000001111111      11


Q ss_pred             HHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          819 LISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       819 ~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      ...+.+++.+|++.+|.+||     ++.+++++
T Consensus       223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            33478889999999999999     99999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=3.6e-30  Score=273.29  Aligned_cols=251  Identities=20%  Similarity=0.300  Sum_probs=181.6

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||.|++|.||+|+.. +|+.||||.+.......   ....+.+|+.           .+++++...+..++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG---TPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccccc---chHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            4788899999999999999664 68999999986542211   1222333332           3677888888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++ +|.+++........+++.++..++.|++.|++|||+.   +++||||+|+||++++++.++++|||+++.....
T Consensus        78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~  153 (284)
T cd07836          78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP  153 (284)
T ss_pred             ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence            99985 8888876544334689999999999999999999998   9999999999999999999999999999865443


Q ss_pred             CCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cccccccc-----cc
Q 042123          737 SSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVALD-----QM  803 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~~-----~~  803 (849)
                      ........++..|+|||.+.+. .++.++||||||+++|++++|+.||..........       ........     ..
T Consensus       154 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         154 VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence            3333344678899999988654 56889999999999999999999987433210000       00000000     00


Q ss_pred             cCCCCCCCChh-----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDPRLPAPSRS-----AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.....     .......+.+++.+|++.||.+||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00111110000     01123457899999999999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=300.47  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=185.7

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeec
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSH  648 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~  648 (849)
                      .++.-..++|.+.++||+|+||.|..+++ .+++.||.|++.+...- .......|..|           |..+.-.+.+
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            34445568999999999999999999966 46899999998762110 11122334444           3345666788


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      +.+.|+|||||+||+|...+.+..   ++++..++.++..|+-||.-+|+.   |+|||||||+|||+|..|++|++|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence            999999999999999999997654   589999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCC-CeeeccCCcccccccccc----C-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042123          729 IAKSLKPDSS-NWTEFAGTCGYIAPELAY----T-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       729 ~a~~~~~~~~-~~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      .+-.+..++. .....+|||.|.+||++.    + +.|++.+|.||+||++|||+.|..||-...-..        ....
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve--------TY~K  292 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE--------TYGK  292 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH--------HHHH
Confidence            9988875544 355678999999999985    2 568899999999999999999999996322111        1111


Q ss_pred             ccCC--CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCC---HHHHHhh
Q 042123          803 MLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPT---MKIISQQ  846 (849)
Q Consensus       803 ~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~  846 (849)
                      +.+.  .+..|.  ....+....++|.+.+. +|+.|..   ++++..|
T Consensus       293 Im~hk~~l~FP~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  293 IMNHKESLSFPD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             HhchhhhcCCCc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            1211  111110  11133345566666554 6778876   8888765

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=2.3e-30  Score=270.68  Aligned_cols=241  Identities=24%  Similarity=0.341  Sum_probs=185.4

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||.|+||.||+|... +++.||+|.+....... ....+.+.+|+.           .+++++..+...++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVE-KGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcc-hhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            4778899999999999999664 68999999986532211 122344555543           3666777888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++...   ..+++.++..++.|++.|+.|||+.   +++|+||+|+||++++++.++++|||.+......
T Consensus        80 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          80 DLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             eCCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            999999999998654   3589999999999999999999998   9999999999999999999999999998876543


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      . ......++..|+|||.+....++.++|+||+|+++|+|++|+.||.......     ...............+.    
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~----  223 (258)
T cd05578         154 T-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQETADVLYPA----  223 (258)
T ss_pred             c-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhccccccCcc----
Confidence            2 2234567889999999988889999999999999999999999987543210     01111111111111111    


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCH--HHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTM--KIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~--~eil~~  846 (849)
                      .....+.+++.+||+.||.+||++  +|++++
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         224 TWSTEAIDAINKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             cCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence            122457889999999999999999  888754

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=1.6e-30  Score=274.82  Aligned_cols=237  Identities=20%  Similarity=0.281  Sum_probs=175.3

Q ss_pred             ecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCCC
Q 042123          596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       596 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ||+|+||+||+|.. .+|+.||+|.+...... .......+..|++           .+++++...+..++||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            69999999999954 46899999998643211 1112223334433           25566677788999999999999


Q ss_pred             hhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeec
Q 042123          664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF  743 (849)
Q Consensus       664 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  743 (849)
                      |.+++..... ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||.+...... ......
T Consensus        80 L~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~  154 (277)
T cd05577          80 LKYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGR  154 (277)
T ss_pred             HHHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Cccccc
Confidence            9999865432 3589999999999999999999998   9999999999999999999999999998765432 222345


Q ss_pred             cCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHH
Q 042123          744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIM  823 (849)
Q Consensus       744 ~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  823 (849)
                      .++..|+|||++.+..++.++||||+|+++|+|++|+.||........    ..............    ........+.
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~  226 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE----KEELKRRTLEMAVE----YPDKFSPEAK  226 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc----HHHHHhcccccccc----CCccCCHHHH
Confidence            678899999999888899999999999999999999999974332110    01111111111111    1111233478


Q ss_pred             HHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          824 EVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       824 ~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      +++.+||+.+|++||     ++.+++++
T Consensus       227 ~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         227 DLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             HHHHHHccCChhHccCCCcccHHHHHhC
Confidence            899999999999999     77777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=3.9e-30  Score=276.05  Aligned_cols=239  Identities=26%  Similarity=0.382  Sum_probs=179.8

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ..|+..+.||+|+||+||+|... +++.||+|.+...... .......+.+|+.           .+.+++......++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccC-cHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            45888899999999999999654 6899999988643221 1222334555544           256777888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||++ |++.+++....  ..+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++++|||++.....
T Consensus        94 ~e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            99997 57777765332  3589999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .    ....+++.|+|||.+.   ...++.++||||||+++|||++|+.||........        .........+.  
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--------~~~~~~~~~~~--  233 (307)
T cd06607         168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPT--  233 (307)
T ss_pred             C----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--------HHHHhcCCCCC--
Confidence            2    2346788999999874   45688899999999999999999999864332110        00000001110  


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      .........+.+++.+||+.+|++||++.+|+.+.
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            01112334588999999999999999999998763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=299.33  Aligned_cols=249  Identities=25%  Similarity=0.437  Sum_probs=190.7

Q ss_pred             HHHhcCCCcCceecCCccceEEEEEec--------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhh
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAELP--------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFY  643 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~  643 (849)
                      +...++..+.+.+|+|+||.|++|...        ....||||..+.....   ...+.+..|+.            .+.
T Consensus       292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~---~~~~~~~~El~~m~~~g~H~niv~ll  368 (609)
T KOG0200|consen  292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS---SEKKDLMSELNVLKELGKHPNIVNLL  368 (609)
T ss_pred             eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc---HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence            333445556669999999999999532        1456999998765332   33445555543            588


Q ss_pred             ceeecCCeeEEEEEeccCCChhhhhcccc-----c------c--cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 042123          644 GFCSHARHSFLLYEFLERGSLAAILNTDA-----A------A--QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS  710 (849)
Q Consensus       644 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk  710 (849)
                      |+|...+..++|+||++.|+|.+++...+     .      .  ..++......++.|||.||+||++.   +++|||+.
T Consensus       369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA  445 (609)
T KOG0200|consen  369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA  445 (609)
T ss_pred             eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence            99999899999999999999999997655     0      0  1388899999999999999999999   99999999


Q ss_pred             CCCeeecCCCcEEEeeecCCcccCCCCCCe-eeccC--CccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcc
Q 042123          711 SKNLLLDLEYEAHVADFGIAKSLKPDSSNW-TEFAG--TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFL  786 (849)
Q Consensus       711 ~~Nill~~~~~~kl~DfG~a~~~~~~~~~~-~~~~g--~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~  786 (849)
                      ++|||++++..+||+|||+|+......... ....+  ...|||||.+....|+.++|||||||++||++| |..||...
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            999999999999999999999766544332 22222  446999999999999999999999999999998 88898631


Q ss_pred             ccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          787 SSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .       ........+.++.....+..+.   .++.++|..||+.+|++||++.++++.++
T Consensus       526 ~-------~~~~l~~~l~~G~r~~~P~~c~---~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  526 P-------PTEELLEFLKEGNRMEQPEHCS---DEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             C-------cHHHHHHHHhcCCCCCCCCCCC---HHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence            1       0112233334444434443332   34778999999999999999999998764

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=2.1e-30  Score=276.42  Aligned_cols=246  Identities=22%  Similarity=0.288  Sum_probs=179.6

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC--CeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~--~~~~  653 (849)
                      ++|+..+.||+|+||.||+|... +++.+|+|.+.......  .....+.+|+.           .+.+++...  ...+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE--GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc--cchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            57888999999999999999665 68899999986432211  11222333433           245565555  7899


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++ +|.+++....  ..+++.++..++.||+.||+|||+.   +++||||+|+||+++.++.+|++|||.+...
T Consensus        83 lv~e~~~~-~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          83 MVMEYVEH-DLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EEehhcCc-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99999985 9998886543  2589999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCCeeeccCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccccc-------------------
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------------------  793 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------------------  793 (849)
                      ...........+++.|+|||.+.+.. ++.++||||+|+++|+|++|+.||..........                   
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            55433334456788999999887644 6889999999999999999999987432211000                   


Q ss_pred             cccc--cccccc----cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 LNTD--VALDQM----LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ~~~~--~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....  ......    +...++..     .....+.+++.+||+.+|++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPAL-----SLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhhhcccccc-----CCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0000  000000    00011100     013347789999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.97  E-value=4.5e-30  Score=268.03  Aligned_cols=240  Identities=21%  Similarity=0.280  Sum_probs=186.0

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||+|.. .+++.+|+|.+......  ......+.+|+.           .+.+++......++||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS--QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc--HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            477888999999999999954 47889999998653221  122333444433           3566777778999999


Q ss_pred             EeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          657 EFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||+++++|.+++.+.. ....++++++..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||++.....
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~  155 (256)
T cd08530          79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKK  155 (256)
T ss_pred             hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence            9999999999986532 234589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .  ......++..|+|||.+.+..++.++|+||+|+++|++++|+.||...+..        ...........+...   
T Consensus       156 ~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---  222 (256)
T cd08530         156 N--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ--------DLRYKVQRGKYPPIP---  222 (256)
T ss_pred             C--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCCCCCc---
Confidence            3  223346788999999999988999999999999999999999998743321        111111122222211   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.+|++|||+.+++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         223 PIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1334458899999999999999999999876

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=4.9e-30  Score=273.10  Aligned_cols=244  Identities=22%  Similarity=0.313  Sum_probs=177.5

Q ss_pred             CCCcCceecCCccceEEEEEe----cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCee
Q 042123          589 DFDAKYCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHS  652 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~  652 (849)
                      +|+..+.||+|+||.||+|..    .+|+.||+|.+............+.+..|+.            .+++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477788999999999999965    3689999999865321111111222333322            345566677788


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999998653   3488999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCCC-CCeeeccCCccccccccccCC--CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          733 LKPDS-SNWTEFAGTCGYIAPELAYTM--KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       733 ~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ..... .......++..|+|||.+.+.  .++.++||||||+++|+|++|+.||......    ...............+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~~~~~~~~~~~  230 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSEPP  230 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc----ccHHHHHHHhhccCCC
Confidence            64332 122345688999999998753  4678899999999999999999998632211    0111111111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      .+.    .....+.+++.+||+.+|++||     ++++++++
T Consensus       231 ~~~----~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         231 YPQ----EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CCc----cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            111    1223477889999999999997     77777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=5.5e-31  Score=298.03  Aligned_cols=181  Identities=24%  Similarity=0.460  Sum_probs=144.0

Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..||-||||+...+.+++++.....  .....++++++|+.|+.|+|++   |++||||||.||+++++..|||+|||+|
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLA  744 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLA  744 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccc
Confidence            3578899999988888886544211  4678899999999999999999   9999999999999999999999999999


Q ss_pred             cccC------------------CCCCCeeeccCCccccccccccCC---CCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 042123          731 KSLK------------------PDSSNWTEFAGTCGYIAPELAYTM---KITEKCDVYSFGVLMWEVIKGKHPRDFLSSI  789 (849)
Q Consensus       731 ~~~~------------------~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~  789 (849)
                      ....                  ......+..+||.-|+|||.+.+.   .|+.|+|+||+|||++||+.   ||.     
T Consensus       745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~-----  816 (1351)
T KOG1035|consen  745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG-----  816 (1351)
T ss_pred             hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCC-----
Confidence            8721                  011134567899999999998765   49999999999999999987   454     


Q ss_pred             cccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          790 SSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        ........+..+.++.++.+.....+....=..+|.+++++||++|||+.|+++.
T Consensus       817 --TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  817 --TSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             --chHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhc
Confidence              2233444556666777776644455555556688999999999999999999863

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=4.3e-30  Score=273.23  Aligned_cols=245  Identities=21%  Similarity=0.298  Sum_probs=178.1

Q ss_pred             CCCcCceecCCccceEEEEEe----cCCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeecCCee
Q 042123          589 DFDAKYCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSHARHS  652 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~~~~~  652 (849)
                      +|+..+.||+|+||.||+|+.    .+++.||||.+..............+..|+            ..+.+.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            467788999999999999954    357889999886432111111122233332            3355667777889


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +++||||+|+||+++.++.++++|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999998643   3488999999999999999999998   999999999999999999999999999886


Q ss_pred             cCCCCCC-eeeccCCccccccccccCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          733 LKPDSSN-WTEFAGTCGYIAPELAYTMK--ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       733 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ....... .....++..|+|||...+..  .+.++||||||+++|||++|..||.......    ..............+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~  230 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQSEISRRILKSKPP  230 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHHHHHHHHHccCCC
Confidence            5443221 22345788999999987655  6889999999999999999999986322110    011111112222222


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      .+..    ....+.+++.+||+.+|++|||+.++.+.|
T Consensus       231 ~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         231 FPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             CCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence            1111    223477889999999999999977665443

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=6.6e-30  Score=267.04  Aligned_cols=242  Identities=23%  Similarity=0.373  Sum_probs=186.4

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|+||.||+|... ++..||+|++......  ......+.+|++           .+.+.+......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS--EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC--hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            4778889999999999999654 6899999998653221  122334444433           3556666778999999


Q ss_pred             EeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          657 EFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||+++++|.+++.... ....+++.++..++.+++.|++|||+.   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  155 (258)
T cd08215          79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS  155 (258)
T ss_pred             EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence            9999999999987542 134689999999999999999999998   999999999999999999999999999987655


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........+++.|+|||...+..++.++||||+|+++|+|++|+.||+.....        ................  
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~--  225 (258)
T cd08215         156 TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--------ELALKILKGQYPPIPS--  225 (258)
T ss_pred             CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--------HHHHHHhcCCCCCCCC--
Confidence            433334456888999999998888999999999999999999999998743211        1111122222211111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....+.+++.+||+.+|++|||+.+++++
T Consensus       226 -~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         226 -QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             -CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             122347889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=6.1e-30  Score=271.24  Aligned_cols=246  Identities=18%  Similarity=0.255  Sum_probs=175.9

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecC--CeeEE
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHA--RHSFL  654 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~--~~~~l  654 (849)
                      |+..+.||+|+||.||+|.. .+++.||+|+++........   ....+|            +..+++++...  +..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~---~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ---VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh---hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            56778999999999999954 46899999998754322111   112222            22466677766  78999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++ ++.+++....  ..+++.++..++.|++.||+|||+.   +++||||+|+||+++. +.+||+|||.++...
T Consensus        78 v~e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~  150 (282)
T cd07831          78 VFELMDM-NLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIY  150 (282)
T ss_pred             EEecCCc-cHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccc
Confidence            9999974 8888775432  3589999999999999999999998   9999999999999999 999999999998764


Q ss_pred             CCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccccccccc----
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTDVALDQ----  802 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~~~~~~----  802 (849)
                      ... ......++..|+|||++.. ..++.++||||+||++|||++|..||...+.....       ..........    
T Consensus       151 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         151 SKP-PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             cCC-CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence            332 2233567889999997644 55788999999999999999999999643321100       0000000000    


Q ss_pred             -ccCCCCCCCC-----hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 -MLDPRLPAPS-----RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 -~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ..+...+...     .........+.+++.+||+++|++|||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence             0000000000     0011234568899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.3e-30  Score=265.32  Aligned_cols=239  Identities=24%  Similarity=0.400  Sum_probs=185.0

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~  656 (849)
                      +|+..+.||+|++|.||+|... +++.||+|.+......  ......+.+|++.           +.+++......++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK--EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC--HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            4778889999999999999554 6889999998764321  1233455555442           456667778899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++++|.+++...   ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++|+|||.+......
T Consensus        79 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          79 EYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             ecCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            999999999998654   3589999999999999999999998   9999999999999999999999999999877654


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      ........++..|+|||...+..++.++||||+|+++|+|++|+.||........        .........+...   .
T Consensus       153 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~~~~---~  221 (254)
T cd06627         153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--------LFRIVQDDHPPLP---E  221 (254)
T ss_pred             cccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--------HHHHhccCCCCCC---C
Confidence            4333445688899999998888889999999999999999999999874331110        0011111111111   1


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.+++.+||+.+|++|||+.+++.+
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            112347789999999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.4e-32  Score=307.45  Aligned_cols=242  Identities=26%  Similarity=0.368  Sum_probs=186.0

Q ss_pred             hcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~l  654 (849)
                      +-+|.....||.|.||.||-| ...+|+-.|+|.+.-....  ......+.+|           +++++|+-.|.+..+|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~--~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD--HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc--cccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            346677889999999999999 6678999999987543222  1111222222           4457777778888999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      .||||++|+|.+.+...+.   .++.....+..|++.|++|||+.   |||||||||.||+++.+|.+|++|||.|..+.
T Consensus      1312 FMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999976542   56667778899999999999999   99999999999999999999999999999876


Q ss_pred             CCCC----CeeeccCCccccccccccCC---CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042123          735 PDSS----NWTEFAGTCGYIAPELAYTM---KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       735 ~~~~----~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      ...+    ......||+.|||||++.+.   .-..++||||+|||+.||+||+.||...+..       ...+-.+..++
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh 1458 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGH 1458 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccC
Confidence            5432    23456799999999998753   3456899999999999999999999865432       22233333333


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .|..++.   ...+-.+|+.+|+..||++|-++.|++++
T Consensus      1459 ~Pq~P~~---ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 KPQIPER---LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCCCchh---hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            3332222   34456788889999999999999999875

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-29  Score=269.75  Aligned_cols=249  Identities=21%  Similarity=0.289  Sum_probs=179.2

Q ss_pred             CCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH--------------HHHhhceeecCCe---
Q 042123          590 FDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE--------------VEAFYGFCSHARH---  651 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e--------------i~~~~~~~~~~~~---  651 (849)
                      |++.+.||+|+||.||+|... +++.||+|.+........  ....+.+|              +.++++++...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~--~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch--hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            567789999999999999765 589999999875332111  11122222              2235666665555   


Q ss_pred             --eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          652 --SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       652 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                        .+++|||+++ +|.+++..... ..+++.++..++.|++.||+|||+.   +++|+||+|+||+++.++.+|++|||.
T Consensus        79 ~~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          79 LKLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             ceeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCc
Confidence              8999999975 89888865432 3589999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------c-cccccc-
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------L-NTDVAL-  800 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~-~~~~~~-  800 (849)
                      +........ .....++..|+|||.+.+..++.++||||||+++|||++|+.||..........       . ...... 
T Consensus       154 ~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         154 ARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ceeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            987643322 233457889999999998889999999999999999999999987433211000       0 000000 


Q ss_pred             -----ccccCCCCCCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 -----DQMLDPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 -----~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                           ........... ..........+.+++.+||+.||++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                 00001111111 11112334567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=7.3e-30  Score=270.78  Aligned_cols=248  Identities=21%  Similarity=0.326  Sum_probs=179.0

Q ss_pred             CCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHH------------HHHHhhceeecCCeeEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLT------------EVEAFYGFCSHARHSFLLY  656 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~------------ei~~~~~~~~~~~~~~lV~  656 (849)
                      |++.+.||+|++|+||+|... +++.||||++........   .....+            .+..+++++..++..++||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE---ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF   77 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh---HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence            567789999999999999765 588999999865432111   111111            2345677777888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+ +|+|.+++.... ...+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||.+......
T Consensus        78 e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~  152 (283)
T cd07830          78 EYM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR  152 (283)
T ss_pred             ecC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence            999 789999886543 24589999999999999999999998   9999999999999999999999999999866533


Q ss_pred             CCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------------ccccccccc
Q 042123          737 SSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------------LNTDVALDQ  802 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------------~~~~~~~~~  802 (849)
                      . ......++..|+|||++.+ ..++.++||||||+++|||++|+.||..........             .........
T Consensus       153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         153 P-PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             C-CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            2 2234567889999998754 457899999999999999999999986432111000             000000000


Q ss_pred             ccCCCCCCCCh-----hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 MLDPRLPAPSR-----SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+...+....     ........+.+++.+||+.+|++|||++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            11111110000     000112458899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=8.7e-30  Score=266.90  Aligned_cols=233  Identities=26%  Similarity=0.371  Sum_probs=179.1

Q ss_pred             ecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCCC
Q 042123          596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       596 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ||.|+||.||+|+.. +++.||+|.+....... ......+.+|+.           .+++++.++...++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVE-TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchh-hhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            699999999999664 58999999986542211 122344555543           35677778889999999999999


Q ss_pred             hhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeec
Q 042123          664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF  743 (849)
Q Consensus       664 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  743 (849)
                      |.+++.+..   .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||.+....... .....
T Consensus        80 L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~  152 (262)
T cd05572          80 LWTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTF  152 (262)
T ss_pred             HHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccc
Confidence            999996543   388999999999999999999998   99999999999999999999999999998765432 22334


Q ss_pred             cCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC--CCCCCCChhhHHHHHH
Q 042123          744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLIS  821 (849)
Q Consensus       744 ~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  821 (849)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....      ...........  .....+...    ...
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~----~~~  222 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLEFPNYI----DKA  222 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCCCCccc----CHH
Confidence            678899999999888899999999999999999999999874331      01111222221  111111111    345


Q ss_pred             HHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          822 IMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       822 l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                      +.+++.+||+.+|++||+     ++|++++
T Consensus       223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         223 AKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             HHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            889999999999999999     8888764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=1.1e-29  Score=267.97  Aligned_cols=242  Identities=25%  Similarity=0.424  Sum_probs=176.4

Q ss_pred             CCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC-----
Q 042123          590 FDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA-----  649 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~-----  649 (849)
                      |...+.||+|+||.||+|.+.    ++..||||.+......  ....+.+.+|+..           +++++...     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS--SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC--hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            556788999999999999643    4688999998653221  2223445555442           34443322     


Q ss_pred             -CeeEEEEEeccCCChhhhhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 042123          650 -RHSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVA  725 (849)
Q Consensus       650 -~~~~lV~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  725 (849)
                       ...++++||+++|+|.+++....   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence             13478999999999998874322   123478999999999999999999998   99999999999999999999999


Q ss_pred             eecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 042123          726 DFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       726 DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      |||.++........  .....+++.|++||......++.++||||||+++|||++ |+.||......        .....
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--------~~~~~  227 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--------EIYNY  227 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--------HHHHH
Confidence            99999866433211  122345678999999988889999999999999999999 88888643211        11111


Q ss_pred             ccCCC-CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          803 MLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       803 ~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..... ...+.    .....+.+++.+||+.+|++|||+.++++.|+
T Consensus       228 ~~~~~~~~~~~----~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~  270 (273)
T cd05074         228 LIKGNRLKQPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE  270 (273)
T ss_pred             HHcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111 11111    12235889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-29  Score=269.26  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=182.3

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~e  657 (849)
                      |+..+.||+|++|.||+|.. .+++.+|+|++.......  .....+.+|+           .++++++..+...++|+|
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE--GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc--hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence            56678899999999999965 478999999986543221  1122333333           246677778889999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |+++ ++.+++....  ..+++.++..++.|++.|++|||+.   +|+|+||+|+||+++.++.++++|||.+.......
T Consensus        79 ~~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          79 FMDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             ccCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            9986 8888876532  3589999999999999999999998   99999999999999999999999999998776543


Q ss_pred             CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccccccc-----
Q 042123          738 SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVALDQML-----  804 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~~~~~-----  804 (849)
                      .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||..........       ...........     
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            233345678899999998776 78999999999999999999999986433211000       00000000000     


Q ss_pred             ------CCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          805 ------DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       805 ------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                            ................++.+++.+||++||.+||++++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                  000011011122345568899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=8.2e-30  Score=274.69  Aligned_cols=238  Identities=26%  Similarity=0.384  Sum_probs=178.8

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      .|...+.||+|+||.||+|.. .++..||+|.+...... .......+.+|+.           .+++++..+...++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCC-chHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            467788999999999999965 46899999998643221 1122334555544           2567777888899999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+.+ ++.+.+....  ..+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.++++|||++......
T Consensus       105 e~~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         105 EYCLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             eCCCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            99975 7777765432  3589999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          737 SSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                          ....+++.|+|||++.   .+.++.++|||||||++|||++|+.||......        .....+.....+..  
T Consensus       179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~--  244 (317)
T cd06635         179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPTL--  244 (317)
T ss_pred             ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHhccCCCC--
Confidence                2346788999999874   456889999999999999999999998643211        11111111111111  


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ........+.+++.+||+.+|.+||++.+++++.
T Consensus       245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            1112233478899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=1e-29  Score=265.83  Aligned_cols=240  Identities=26%  Similarity=0.367  Sum_probs=185.4

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC--CeeEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFL  654 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~--~~~~l  654 (849)
                      +|...+.||+|++|.||+|... +++.|++|.+......  ......+.+|+.           .+++++...  ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS--EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc--hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            4677889999999999999665 7899999998654321  222344455544           245566666  78999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |+||+++++|.+++....   .+++.++..++.|++.|++|||+.   +++|+|++|+||+++.++.++|+|||.+....
T Consensus        79 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            999999999999986543   689999999999999999999998   99999999999999999999999999998776


Q ss_pred             CCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCC
Q 042123          735 PDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD-PRLPAP  811 (849)
Q Consensus       735 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  811 (849)
                      ....  ......++..|+|||...+..++.++||||||+++|+|++|+.||......       ......... ...+. 
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~-  224 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-------MAALYKIGSSGEPPE-  224 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHhccccCCCcC-
Confidence            5432  134456888999999998888999999999999999999999999754311       001111111 11111 


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        .+......+.+++.+|++.+|++||++.+++++
T Consensus       225 --~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         225 --IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             --CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence              111123458889999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=3.7e-30  Score=272.57  Aligned_cols=240  Identities=23%  Similarity=0.373  Sum_probs=184.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~l  654 (849)
                      ++|...+.||+|+||.||+|.. .++..||+|.+....... ....+.+..|            +..+++++...+..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIK-EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccc-hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence            4688889999999999999965 479999999986532111 1112233333            2235667777889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++++|.+++.+..   .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++....
T Consensus        80 v~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          80 VLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            999999999999996543   589999999999999999999998   99999999999999999999999999988664


Q ss_pred             CCCC--------------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc
Q 042123          735 PDSS--------------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL  794 (849)
Q Consensus       735 ~~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~  794 (849)
                      ....                    ......++..|+|||......++.++||||+|+++|++++|+.||......     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----  228 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-----  228 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-----
Confidence            3321                    122345788999999998888999999999999999999999998743311     


Q ss_pred             ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCH----HHHHhh
Q 042123          795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTM----KIISQQ  846 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~eil~~  846 (849)
                         .............+...    ...+.+++.+||+.+|++|||+    ++++++
T Consensus       229 ---~~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         229 ---LTFQKILKLEYSFPPNF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ---HHHHHHHhcCCCCCCcc----CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence               11122222222221111    2347889999999999999999    898876

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.5e-30  Score=294.98  Aligned_cols=256  Identities=20%  Similarity=0.254  Sum_probs=166.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-C----CcEEEEEEecccCCCCchhhHHHHHH----HHHH-hhce-----eecCC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-S----GEVVAVKKFHSLLPCDQTVDQKEFLT----EVEA-FYGF-----CSHAR  650 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~~----ei~~-~~~~-----~~~~~  650 (849)
                      ..++|+..+.||+|+||.||+|... +    +..||||++............ ....    .+.. +.++     +....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~~~~~~~~~~~~~~~~~~~~~~~  208 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRACPNSCADFVYGFLEPVSSKKED  208 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhhchhhHHHHHHhhhcccccccCC
Confidence            4578999999999999999999664 4    689999987643211111111 1111    0111 1111     24566


Q ss_pred             eeEEEEEeccCCChhhhhcccccc-----------------cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAA-----------------QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                      ..++||||+++++|.+++......                 .......+..++.|++.||+|||+.   +|+||||||+|
T Consensus       209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N  285 (566)
T PLN03225        209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN  285 (566)
T ss_pred             ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence            889999999999999998643210                 0112344568999999999999998   99999999999


Q ss_pred             eeecC-CCcEEEeeecCCcccCCCC-CCeeeccCCccccccccccCC----------------------CCCccchHHHH
Q 042123          714 LLLDL-EYEAHVADFGIAKSLKPDS-SNWTEFAGTCGYIAPELAYTM----------------------KITEKCDVYSF  769 (849)
Q Consensus       714 ill~~-~~~~kl~DfG~a~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~Dv~Sl  769 (849)
                      ||++. ++.+||+|||+|+...... .......+++.|+|||.+...                      .++.++||||+
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            99986 5899999999998654332 223456789999999965322                      23446799999


Q ss_pred             HHHHHHHHhCCCCCCcccc-----ccccccccccccccccCCCCCCC----ChhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 042123          770 GVLMWEVIKGKHPRDFLSS-----ISSSSLNTDVALDQMLDPRLPAP----SRSAQEKLISIMEVAFSCFNESPESRPTM  840 (849)
Q Consensus       770 Gvil~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~  840 (849)
                      ||++|||+++..|++....     ....... .........+.....    ............+++.+|++.||++|||+
T Consensus       366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYD-LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHHhCcCCCchHHHHHHHHHHhcCCc-HHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            9999999998777552110     0000000 000011111111000    00000011124579999999999999999


Q ss_pred             HHHHhh
Q 042123          841 KIISQQ  846 (849)
Q Consensus       841 ~eil~~  846 (849)
                      +|+++|
T Consensus       445 ~e~L~H  450 (566)
T PLN03225        445 KAALAH  450 (566)
T ss_pred             HHHhCC
Confidence            999986

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=278.06  Aligned_cols=237  Identities=21%  Similarity=0.267  Sum_probs=185.5

Q ss_pred             hcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhh----HHHHHHHHHHhhceeecCCeeEEEEEeccC
Q 042123          587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVD----QKEFLTEVEAFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~----~~~~~~ei~~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      ++.|.....+|.|+|+.|-.+ ...+++..+||++.+.....+...    ...-+..+..+.+.+.+..+.|+|||++.+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g  400 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG  400 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence            456777778999999999888 456788999999977522211111    112223466788889999999999999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-cCCCcEEEeeecCCcccCCCCCCe
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL-DLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      |-+.+.+....    ....++..|+.+|+.|+.|||++   ||||||+||+|||+ +..++++|+|||.++....+   .
T Consensus       401 ~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~  470 (612)
T KOG0603|consen  401 GELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---C  470 (612)
T ss_pred             cHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh---h
Confidence            98888775543    22277888999999999999998   99999999999999 68899999999999887654   3


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                      .+.+-|..|.|||+.....|++++|+||||+++|+|++|+.||..-.       ...+....+..+...      .....
T Consensus       471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P-------~~~ei~~~i~~~~~s------~~vS~  537 (612)
T KOG0603|consen  471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHP-------AGIEIHTRIQMPKFS------ECVSD  537 (612)
T ss_pred             cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCC-------chHHHHHhhcCCccc------cccCH
Confidence            44567889999999999999999999999999999999999987322       112233333333222      23444


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          821 SIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+++.+|++.||.+||+|.++..+
T Consensus       538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  538 EAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             HHHHHHHHhccCChhhCcChhhhccC
Confidence            57889999999999999999999765

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1.2e-29  Score=266.38  Aligned_cols=233  Identities=24%  Similarity=0.361  Sum_probs=175.9

Q ss_pred             ecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEEEEeccCCC
Q 042123          596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       596 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ||+|+||.||+|... +|+.+|+|.+....... ......+.+|           +.++++.+......++||||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIR-KNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhh-hhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999765 59999999986532211 1122233333           3346677778889999999999999


Q ss_pred             hhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC-----
Q 042123          664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS-----  738 (849)
Q Consensus       664 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-----  738 (849)
                      |.+++.+..   .+++.++..++.||+.||+|||+.   +++||||+|+||+++.++.++++|||++........     
T Consensus        80 L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          80 LASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            999986543   589999999999999999999998   999999999999999999999999999876543321     


Q ss_pred             ---CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          739 ---NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       739 ---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                         ......++..|+|||......++.++||||||+++|++++|+.||......        .............+... 
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~-  224 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE--------EIFQNILNGKIEWPEDV-  224 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhcCCcCCCccc-
Confidence               223345788999999998888899999999999999999999998743211        11111111121111111 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCH---HHHHh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTM---KIISQ  845 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~---~eil~  845 (849)
                       .....+.+++.+||+.+|++|||+   .++++
T Consensus       225 -~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         225 -EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             013457899999999999999999   66554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=8.6e-30  Score=271.79  Aligned_cols=252  Identities=19%  Similarity=0.266  Sum_probs=177.9

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|++|.||+|... +++.||+|.+......  ......+.+|+.           ++++++......++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED--EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc--ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            57888999999999999999654 7899999987543211  111223334433           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-EYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~a~~~~  734 (849)
                      |||++ +++.+++.... ...+++..+..++.||+.||+|||+.   +++||||+|+||+++. ++.+|++|||++....
T Consensus        80 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             Eeccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            99996 47887775433 23467888999999999999999998   9999999999999985 4679999999997654


Q ss_pred             CCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc------c
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVA------L  800 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~------~  800 (849)
                      ..........+++.|+|||++.+. .++.++||||+|+++|+|++|+.||..........       ......      .
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        155 IPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             CCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            433333445678899999988664 57889999999999999999999986432110000       000000      0


Q ss_pred             cccc--CCCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 DQML--DPRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 ~~~~--~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....  .+......  ........++.+++.+|++.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000  00000000  0001122347789999999999999999999875

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=1.3e-29  Score=277.32  Aligned_cols=249  Identities=20%  Similarity=0.311  Sum_probs=177.9

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-----
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-----  648 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-----  648 (849)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+.....  .......+.+|+.           ++++++..     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence            457899999999999999999954 5799999999864321  1112233444443           24444432     


Q ss_pred             -CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          649 -ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       649 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                       ....++||||+++ +|.+.+..     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+|++||
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          92 EFQDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             ccCcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence             2357999999965 88887743     278899999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc---
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTD---  797 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~---  797 (849)
                      |+++...... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.....       .....   
T Consensus       163 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         163 GLARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ccceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            9998654322 223346788999999999999999999999999999999999998643211000       00000   


Q ss_pred             -------------------cccccccCCCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 -------------------VALDQMLDPRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 -------------------~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                         ....+..........  .........+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                               000000000000000  0011223457799999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=4.1e-30  Score=279.45  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=176.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++.....   ......+.+|+.           .+++++...     
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH---QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            46899999999999999999954 5789999999864211   122233444433           244444322     


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++|+||+++ ++.+.+..    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~  152 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL  152 (336)
T ss_pred             ceEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence            357999999975 88877743    3489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCC---CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccccc
Q 042123          730 AKSLKPDSS---NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTDV  798 (849)
Q Consensus       730 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~~  798 (849)
                      +........   ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.........       .....+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         153 ARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE  232 (336)
T ss_pred             eeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence            876543221   1223467889999998654 56889999999999999999999999643211000       000000


Q ss_pred             ccccccCCC-------CCC----CCh-hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQMLDPR-------LPA----PSR-SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~~~~~~-------~~~----~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....+.+..       .+.    +.. ........+.+++.+||+.+|++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000000       000    000 001123458899999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=6.4e-30  Score=277.94  Aligned_cols=251  Identities=22%  Similarity=0.324  Sum_probs=179.2

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~-----  649 (849)
                      .++|...+.||+|+||+||+|.. .+++.||||.+......  ......+.+|+.           ++.+++...     
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN--RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            35788899999999999999954 57899999998653221  111223334433           345544332     


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+. ++|.+++...   ..+++.++..++.|++.||.|||+.   +++||||||+||+++.++.+||+|||+
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            35799999996 6888888643   3589999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc------------c---c
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS------------S---S  793 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~------------~---~  793 (849)
                      +..............++..|+|||.+.. ..++.++|||||||++|+|++|+.||........            .   .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         155 ARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            9876544333344567889999998764 4688999999999999999999999964321100            0   0


Q ss_pred             cccccccccccC--CCCCCC--ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 LNTDVALDQMLD--PRLPAP--SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........+.  +..+..  ..........+.+++.+||+.+|++|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000000000  000000  00011233457899999999999999999999986

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-29  Score=266.07  Aligned_cols=243  Identities=20%  Similarity=0.295  Sum_probs=180.4

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCC-CchhhHHHHHHHHHH-----------hhceeec--CCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPC-DQTVDQKEFLTEVEA-----------FYGFCSH--ARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~~~ei~~-----------~~~~~~~--~~~~  652 (849)
                      .+|+..+.||+|+||.||+|.. .++..||+|.+...... ........+.+|+..           +++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5788999999999999999954 56899999987532111 112223345555442           4455544  3467


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++|+||+++++|.+++...   ..+++..+.+++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||.++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            8999999999999998643   2478999999999999999999998   999999999999999999999999999986


Q ss_pred             cCCC---CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          733 LKPD---SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       733 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ....   ........++..|+|||++.+..++.++|||||||++|++++|+.||......        ....+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~  227 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--------AAIFKIATQPTK  227 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--------HHHHHHHcCCCC
Confidence            5321   11123356888999999998888999999999999999999999998743211        111111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                        ...+......+.+++.+||+ +|..|||+.+++.|-
T Consensus       228 --~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         228 --PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             --CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence              11112233458889999999 579999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=5.7e-30  Score=276.30  Aligned_cols=253  Identities=19%  Similarity=0.238  Sum_probs=176.7

Q ss_pred             CCCcCceecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecC--Cee
Q 042123          589 DFDAKYCIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHA--RHS  652 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~--~~~  652 (849)
                      .|+..+.||+|+||.||+|...   +++.||+|.+....... ........+|+           ..+++++...  ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-TGISQSACREIALLRELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc-cCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence            3677889999999999999654   47899999987632111 11112223332           2467777777  789


Q ss_pred             EEEEEeccCCChhhhhcccc--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC----CCcEEEee
Q 042123          653 FLLYEFLERGSLAAILNTDA--AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL----EYEAHVAD  726 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----~~~~kl~D  726 (849)
                      ++||||+++ ++.+++....  ....+++..+..++.||+.|++|||+.   +++||||||+||+++.    ++.+|++|
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~D  155 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGD  155 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECC
Confidence            999999986 6766664322  123588999999999999999999998   9999999999999999    89999999


Q ss_pred             ecCCcccCCCCC---CeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccc-ccccc--
Q 042123          727 FGIAKSLKPDSS---NWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-NTDVA--  799 (849)
Q Consensus       727 fG~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-~~~~~--  799 (849)
                      ||++........   ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........... .....  
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999986643322   12334678899999987664 578899999999999999999999974332110000 00000  


Q ss_pred             ----------------------cc----cccCCCCCC-CChhhH----HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 ----------------------LD----QMLDPRLPA-PSRSAQ----EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ----------------------~~----~~~~~~~~~-~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                            ..    .......+. ......    .....+.+++.+|++.||++|||+.|++++
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                                  00    000000110 000000    122358899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=7.5e-30  Score=274.22  Aligned_cols=254  Identities=25%  Similarity=0.281  Sum_probs=178.0

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCch----hhHHHHHHH-----HHHhhceeecC--CeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQT----VDQKEFLTE-----VEAFYGFCSHA--RHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----~~~~~~~~e-----i~~~~~~~~~~--~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++.........    ..+...++.     +.++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46899999999999999999965 46999999998643221111    011112222     22345555433  56899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++ +|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+....
T Consensus        86 v~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 8888876533  4589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cccccccccc---
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVALDQM---  803 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~~~~---  803 (849)
                      ..........++..|+|||.+.+ ..++.++||||+|+++|||++|+.||..........       ..........   
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         160 LPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            44333333456788999998865 457899999999999999999999996433211000       0000000000   


Q ss_pred             ---cCCCCCC-CChhh----HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 ---LDPRLPA-PSRSA----QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ---~~~~~~~-~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         -...... +....    ......+.+++.+|++.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               0000000 00000    0123457789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=7.1e-31  Score=279.57  Aligned_cols=237  Identities=22%  Similarity=0.343  Sum_probs=178.1

Q ss_pred             CceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC--eeEEEEEe
Q 042123          593 KYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR--HSFLLYEF  658 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~--~~~lV~e~  658 (849)
                      ..+||+|+|-+||||.. .+|..||=-.++...-........+|..|+.           +++.+|.+..  ..-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            45799999999999944 4577776221111111112223356777765           3555555443  47789999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCCcccCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a~~~~~~~  737 (849)
                      |..|+|..|+++.+   .+....+..|++||++||.|||++ .|+|+|||||.+||||+.+ |.|||+|+|+|...... 
T Consensus       125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            99999999997654   478899999999999999999997 5699999999999999876 99999999999987643 


Q ss_pred             CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHH
Q 042123          738 SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE  817 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  817 (849)
                       ......|||.|||||+.. ..|++..||||||++++||+|+.+||....       .......++..+..|..  ...-
T Consensus       200 -~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~SGiKP~s--l~kV  268 (632)
T KOG0584|consen  200 -HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVTSGIKPAA--LSKV  268 (632)
T ss_pred             -ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHHcCCCHHH--hhcc
Confidence             334579999999999876 689999999999999999999999997543       22334444444433321  1111


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          818 KLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       818 ~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...++.+||.+|+.. .++|||+.|++++
T Consensus       269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  269 KDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            234588999999999 8999999999874

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=5.6e-30  Score=276.08  Aligned_cols=194  Identities=29%  Similarity=0.471  Sum_probs=159.0

Q ss_pred             CCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec------CC
Q 042123          589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH------AR  650 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~------~~  650 (849)
                      .|...+.||+|+||.||+|+ ..+|+.||||.+....   .......+.+|++           ++++.-..      ..
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            34456689999999999997 5689999999997753   2223444455544           33332211      23


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--cCCCc--EEEee
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL--DLEYE--AHVAD  726 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~--~kl~D  726 (849)
                      ...+|||||.+|||...+.+......+++.+.+.+..+++.||.|||++   +|+||||||.||++  .++|+  .||+|
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeec
Confidence            5679999999999999999888888899999999999999999999998   99999999999998  34444  69999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSI  789 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~  789 (849)
                      ||.|+....+ ......+||+.|.+||.... +.|+...|.|||||++|+++||..||......
T Consensus       168 fG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  168 FGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9999988754 46788999999999999884 78888999999999999999999999755433

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=1.6e-29  Score=268.87  Aligned_cols=249  Identities=22%  Similarity=0.328  Sum_probs=179.0

Q ss_pred             CCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC--CeeEEE
Q 042123          590 FDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLL  655 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~--~~~~lV  655 (849)
                      |+..+.||+|+||.||+|... +++.+|+|++.....  .......+.+|+.           .+++++...  +..++|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE--KEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            567789999999999999665 588999999876431  1111223334432           366777776  789999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++ +|.+++....  ..+++.++..++.||+.|++|||+.   +++|+||+|+||++++++.+|++|||.+.....
T Consensus        79 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          79 FEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             eccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            999985 8888886542  3589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCC-CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----------ccccccccc-
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS----------LNTDVALDQ-  802 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~----------~~~~~~~~~-  802 (849)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........          ......... 
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            321 2233456788999998765 457899999999999999999999987433211000          000000000 


Q ss_pred             ----ccCCCCCCCCh---hhHH-HHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 ----MLDPRLPAPSR---SAQE-KLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ----~~~~~~~~~~~---~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ...+....+..   .... ....+.+++.+||+.+|.+|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                00000000000   0001 13468899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=1.3e-29  Score=275.32  Aligned_cols=252  Identities=23%  Similarity=0.335  Sum_probs=179.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceee----cCC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCS----HAR  650 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~----~~~  650 (849)
                      .++|+..+.||+|+||.||+|.. .+|+.||+|++......  ......+.+|+.           .+.+++.    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV--PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc--ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence            36888999999999999999954 57999999998753221  112233334433           2344433    335


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..++||||+. |+|.+++...   ..+++..+..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence            6899999996 5898888643   3489999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCC----CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccc--
Q 042123          731 KSLKPDSS----NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNT--  796 (849)
Q Consensus       731 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~--  796 (849)
                      ........    ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+.....       ....  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            76543221    1223468889999998765 45789999999999999999999999643321100       0000  


Q ss_pred             ------cccccccc---CCCCCCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          797 ------DVALDQML---DPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       797 ------~~~~~~~~---~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                            ........   ......+ ..........+.+++.+||+.+|++|||+++++.+-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                  00000000   0000100 000112245688999999999999999999998763

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.96  E-value=1.4e-29  Score=271.63  Aligned_cols=239  Identities=26%  Similarity=0.392  Sum_probs=177.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|+..+.||+|+||.||+|.. .++..+|+|.+...... .......+.+|+.           .+.+++......++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            3466678899999999999965 46888999988642111 1122234445543           356677778889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+. |++.+.+....  ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++.....
T Consensus        94 ~e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          94 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             EEccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            99997 58877764332  3488999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .    ....+++.|+|||.+.   ...++.++|||||||++|+|++|+.||.......        ..........+.. 
T Consensus       168 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~-  234 (308)
T cd06634         168 A----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPAL-  234 (308)
T ss_pred             c----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH--------HHHHHhhcCCCCc-
Confidence            2    2346788999999874   3567889999999999999999999986432111        1111111111110 


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                       ........+.+++.+||+.+|++||++.+++++-
T Consensus       235 -~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence             0112234478899999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.96  E-value=3.5e-29  Score=269.16  Aligned_cols=236  Identities=27%  Similarity=0.388  Sum_probs=174.9

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e  657 (849)
                      |...+.||+|+||+||+|+. .+++.||+|++....... ......+.+|+.           .+++++.+....|+|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQT-NEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            55567899999999999965 468899999986432211 112233444433           35677778888999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |+. |++.+++....  ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.+|++|||++.....  
T Consensus       102 ~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--  173 (313)
T cd06633         102 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--  173 (313)
T ss_pred             cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence            996 57777775432  3589999999999999999999998   999999999999999999999999999865332  


Q ss_pred             CCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          738 SNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                        .....++..|+|||++.   ...++.++||||||+++|+|++|..||........        .........+..  .
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--------~~~~~~~~~~~~--~  241 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--------LYHIAQNDSPTL--Q  241 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--------HHHHHhcCCCCC--C
Confidence              23356888999999974   45678899999999999999999999864332110        001111111100  0


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.+++.+||+++|++||++.+++++
T Consensus       242 ~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11112347789999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=8.6e-30  Score=271.19  Aligned_cols=241  Identities=22%  Similarity=0.322  Sum_probs=193.5

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      ...|.+...||+|.|+.|..|++ .++..||||.+++..-  .....+.+.+|+.           +++.+.......|+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl  132 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL  132 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence            35778888999999999999955 4799999999877532  2222333555644           47778888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+.+|.+.+++....   .+.+.++..++.|+..|++|||++   .|||||||++||+++.++.+||+|||++..+.
T Consensus       133 V~eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  133 VMEYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEEeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            999999999999997654   355588899999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      . .....+++|++.|.|||.+.+..| ++.+|+||+|+++|.|+.|..||+...-        ...-...+.+++..+..
T Consensus       207 ~-~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l--------k~Lr~rvl~gk~rIp~~  277 (596)
T KOG0586|consen  207 Y-GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL--------KELRPRVLRGKYRIPFY  277 (596)
T ss_pred             c-cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc--------ccccchheeeeecccce
Confidence            3 445677899999999999999887 5789999999999999999999984321        12223333344443332


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...    .+.+++.+++-.+|.+|+++++|.++-.
T Consensus       278 ms~----dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  278 MSC----DCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             eec----hhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            222    2667888999999999999999998754

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=3.1e-29  Score=265.89  Aligned_cols=249  Identities=22%  Similarity=0.294  Sum_probs=180.9

Q ss_pred             CCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV~e  657 (849)
                      |+..+.||+|+||.||+|+.. +++.||+|.+......  ......+..|           +..+++++...+..++|||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccccc--ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence            556778999999999999654 5999999998764311  1112233333           3346777778889999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |++ ++|.+++.+..  ..+++.++.+++.|++.|++|||+.   +|+||||+|+||+++.++.++|+|||.++......
T Consensus        79 ~~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          79 YCD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             CcC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            998 58999997543  3589999999999999999999999   99999999999999999999999999998765443


Q ss_pred             CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc---ccccc--c
Q 042123          738 SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDV---ALDQM--L  804 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~---~~~~~--~  804 (849)
                      .......++..|+|||.+.+. .++.++||||||+++||+++|+.||..........       .....   .....  .
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         153 RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            333344567789999998766 78999999999999999999999986433110000       00000   00000  0


Q ss_pred             CCCCCCC----C-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          805 DPRLPAP----S-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       805 ~~~~~~~----~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +...+..    . .........+.+++.+||+.+|++||++++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0000000    0 0001113458899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.8e-29  Score=273.95  Aligned_cols=249  Identities=22%  Similarity=0.334  Sum_probs=180.5

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC-----e
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR-----H  651 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~-----~  651 (849)
                      +|++.+.||+|+||.||+|+.. +++.||||++.....  .....+.+.+|+.           .+.+++....     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD--DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc--cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            4778899999999999999664 589999999875421  1122233444433           3566665554     7


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++ +|.+++.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++++|||.+.
T Consensus        79 ~~lv~e~~~~-~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          79 VYIVTELMET-DLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             eEEEecchhh-hHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            8999999985 8888886543   589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCC---CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccc-----
Q 042123          732 SLKPDS---SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLN-----  795 (849)
Q Consensus       732 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~-----  795 (849)
                      ......   .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||.........       ...     
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  231 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL  231 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHh
Confidence            765443   123345678899999999887 7899999999999999999999999643321100       000     


Q ss_pred             ---cccccccccCCCCCCCChh----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          796 ---TDVALDQMLDPRLPAPSRS----AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       796 ---~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ........+..........    .......+.+++.+||+++|++|||+++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               0000000000000000000    01123457889999999999999999999876

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=3.6e-29  Score=261.87  Aligned_cols=243  Identities=19%  Similarity=0.269  Sum_probs=179.5

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCc-hhhHHHHHHH-----------HHHhhceeecCCeeEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQ-TVDQKEFLTE-----------VEAFYGFCSHARHSFLL  655 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV  655 (849)
                      +|.+.+.||+|+||.||+|... .+..+++|..+....... ......+..|           +.++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4778889999999999999654 345566666543221111 1111112222           34577777888889999


Q ss_pred             EEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |||+++++|.+++.... ....+++.++..++.|++.|+.|||+.   +++|+||+|+||+++. +.++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999886422 234689999999999999999999998   9999999999999975 679999999998765


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........+++.|+|||...+..++.++||||||+++|+|++|..||......        ...........+..   
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--------~~~~~~~~~~~~~~---  225 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--------SVVLRIVEGPTPSL---  225 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCCCC---
Confidence            4443344556888999999998888899999999999999999999998632211        11111222222111   


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.+++.+||+.+|++||++.+++++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             cchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            12233457889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=7.5e-30  Score=277.63  Aligned_cols=251  Identities=22%  Similarity=0.336  Sum_probs=177.6

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeec--CC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSH--AR  650 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~--~~  650 (849)
                      ..++|+..+.||+|+||.||+|... +++.+|||++.......  .....+.+|+            .++++++..  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~--~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc--hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            3467888999999999999999654 68899999885432111  1112222332            345566543  33


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..++||||++ ++|.+++...    .+++..+..++.||+.||+|||+.   +|+||||+|+||+++.++.+|++|||.+
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            6899999997 4998888543    478999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCC-----CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccc-
Q 042123          731 KSLKPDSS-----NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNT-  796 (849)
Q Consensus       731 ~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~-  796 (849)
                      ........     ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........       .... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            86643321     2234568889999998765 45788999999999999999999998643211100       0000 


Q ss_pred             -----------ccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          797 -----------DVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       797 -----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                 .........................+.+++.+||+.+|++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                       00000000001110011111123458899999999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.96  E-value=6.3e-29  Score=258.40  Aligned_cols=232  Identities=24%  Similarity=0.342  Sum_probs=178.9

Q ss_pred             ecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEEEEeccCCC
Q 042123          596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       596 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ||+|+||.||++... +++.+|+|.+....... ......+..|+           ..+++.+..+...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIK-RKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcc-hHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999664 58999999986542211 11222333333           245677788889999999999999


Q ss_pred             hhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeec
Q 042123          664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF  743 (849)
Q Consensus       664 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  743 (849)
                      |.+++....   .+++.++..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||.+.............
T Consensus        80 L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (250)
T cd05123          80 LFSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF  153 (250)
T ss_pred             HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence            999986543   489999999999999999999998   99999999999999999999999999998765433333455


Q ss_pred             cCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHH
Q 042123          744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIM  823 (849)
Q Consensus       744 ~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  823 (849)
                      .++..|+|||...+...+.++|+||||+++|++++|+.||.....        ..............+...    ...+.
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~  221 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFPEFL----SPEAR  221 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCCCCC----CHHHH
Confidence            678899999999888889999999999999999999999964321        111222222222222211    23477


Q ss_pred             HHHhhccCCCCCCCCCH---HHHHhh
Q 042123          824 EVAFSCFNESPESRPTM---KIISQQ  846 (849)
Q Consensus       824 ~li~~cl~~dP~~RPt~---~eil~~  846 (849)
                      +++.+||..||++|||+   +++.++
T Consensus       222 ~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         222 DLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             HHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            89999999999999999   777664

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=3.3e-29  Score=270.05  Aligned_cols=246  Identities=18%  Similarity=0.224  Sum_probs=172.6

Q ss_pred             ceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCC
Q 042123          594 YCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERG  662 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~g  662 (849)
                      +.+|.|+++.||++.. +++.||||++.....  .......+.+|+.           .+++++......+++|||+++|
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC--SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEecccc--chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            3445555555555554 699999999865311  1122334445433           4677888888999999999999


Q ss_pred             ChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC----
Q 042123          663 SLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS----  738 (849)
Q Consensus       663 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~----  738 (849)
                      +|.+++.... ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.+........    
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999987543 23588999999999999999999999   999999999999999999999999998875532221    


Q ss_pred             ---CeeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc----------------ccc
Q 042123          739 ---NWTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL----------------NTD  797 (849)
Q Consensus       739 ---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~----------------~~~  797 (849)
                         ......++..|+|||++.+  ..++.++|||||||++|||++|+.||...........                ...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence               1123346778999999865  3578899999999999999999999974321100000                000


Q ss_pred             ccccc----ccCCCC--CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 VALDQ----MLDPRL--PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 ~~~~~----~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....    ..++..  .............+.+++.+||+.+|++|||+++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            00000    000000  00011112233468889999999999999999999876

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=277.89  Aligned_cols=251  Identities=21%  Similarity=0.383  Sum_probs=197.0

Q ss_pred             HHHHHHHhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHH----------HHHhhceee-
Q 042123          580 YDEIVKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------VEAFYGFCS-  647 (849)
Q Consensus       580 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~e----------i~~~~~~~~-  647 (849)
                      ++.....++.|++.++||.|.+|.||+++ .++++.+|||+.......+.   +.+...+          +..++|++. 
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---EiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---EIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---HHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34444556789999999999999999994 45788999998765433222   2222222          334566553 


Q ss_pred             ----cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEE
Q 042123          648 ----HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH  723 (849)
Q Consensus       648 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  723 (849)
                          .++..|+|||||.+||.-|+.+.-. +..+.|+.+..|++.++.|+.+||..   .++|||+|-.|||++.++.+|
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence                2468999999999999999997665 67799999999999999999999999   899999999999999999999


Q ss_pred             EeeecCCcccCCCCCCeeeccCCccccccccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 042123          724 VADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-----MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDV  798 (849)
Q Consensus       724 l~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~  798 (849)
                      ++|||.+...........+.+||+.|||||++..     ..|+.++|+||+|++..||.-|.+|+..+....        
T Consensus       164 LvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------  235 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------  235 (953)
T ss_pred             EeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--------
Confidence            9999999887766566778899999999999864     347788999999999999999999986443211        


Q ss_pred             ccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ..-.+.+..++...-+.....++.++|..|+.+|.+.||++.++++|
T Consensus       236 -aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 -ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence             11112222232233355667789999999999999999999999875

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=7.3e-29  Score=266.91  Aligned_cols=252  Identities=21%  Similarity=0.297  Sum_probs=174.0

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+........  ....+.+|+.           ++++++...     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG--FPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCC--chhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            36799999999999999999965 4689999998864322111  1112223322           345554433     


Q ss_pred             ---CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          650 ---RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       650 ---~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                         ...++||||+.+ ++.+.+....  ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence               345999999975 7888775432  3589999999999999999999998   999999999999999999999999


Q ss_pred             ecCCcccCCCCC----CeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc---------
Q 042123          727 FGIAKSLKPDSS----NWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS---------  792 (849)
Q Consensus       727 fG~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~---------  792 (849)
                      ||.+..+.....    ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.........         
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999986643221    12234567889999988664 4688999999999999999999998643211000         


Q ss_pred             ---ccccccccccccC-CCCCCCCh-hhH------HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          793 ---SLNTDVALDQMLD-PRLPAPSR-SAQ------EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       793 ---~~~~~~~~~~~~~-~~~~~~~~-~~~------~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ............+ ...+.... ...      .....+.+++.+||+.||++|||+++++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence               0000000000000 00000000 000      012346789999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=248.20  Aligned_cols=241  Identities=26%  Similarity=0.397  Sum_probs=187.6

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCch----hh-HHHHHHH------HHHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQT----VD-QKEFLTE------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----~~-~~~~~~e------i~~~~~~~~~~~~~~l  654 (849)
                      ..+|+..++||+|+|+.|-.+++ ++.+.+|+|++++..-.+..    .. ++...+.      ++-+..++..+...+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            36899999999999999999965 46888999998764332211    11 1111111      1125566777888999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |.||++||+|.-.+.+++   +++++.++-+...|.-||.|||++   ||++||+|..|+|+|..|.+|++|+|+++.-.
T Consensus       329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999977776544   599999999999999999999999   99999999999999999999999999999877


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc-ccCCCCCCCCh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ-MLDPRLPAPSR  813 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  813 (849)
                      .+.....+++|||.|.|||++.+..|....|.|++||+++||+.|+.||+-.+. ..+..+.+..+-+ ++...+..+-.
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm-~n~d~ntedylfqvilekqiriprs  481 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM-DNPDMNTEDYLFQVILEKQIRIPRS  481 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC-CCcccchhHHHHHHHhhhcccccce
Confidence            777777889999999999999999999999999999999999999999997663 3333333333333 33344433322


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCC
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRP  838 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RP  838 (849)
                      .    ..+...+++.-+++||.+|.
T Consensus       482 l----svkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  482 L----SVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             e----ehhhHHHHHHhhcCCcHHhc
Confidence            2    22355667788999999985

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=5e-29  Score=267.03  Aligned_cols=254  Identities=21%  Similarity=0.298  Sum_probs=177.5

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC---
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA---  649 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~---  649 (849)
                      .+.++|+..+.||+|+||.||+|..+ +++.||+|++........  ....+.+|+.           .+++++...   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~--~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~   81 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG--FPITAIREIKILRQLNHRNIVNLKEIVTDKQDA   81 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccC--chHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence            45678999999999999999999664 688999999865322111  1122333332           345555443   


Q ss_pred             -------CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 042123          650 -------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA  722 (849)
Q Consensus       650 -------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  722 (849)
                             ...++|+||+++ ++.+.+...  ...+++.++..++.|++.||+|||+.   +|+||||+|+||++++++.+
T Consensus        82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          82 LDFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             hhccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence                   378999999986 677776543  23589999999999999999999999   99999999999999999999


Q ss_pred             EEeeecCCcccCCCCC-CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc------
Q 042123          723 HVADFGIAKSLKPDSS-NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL------  794 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~------  794 (849)
                      ||+|||.+........ ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...........      
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~  235 (302)
T cd07864         156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG  235 (302)
T ss_pred             EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999999987654332 2223356778999998764 3568899999999999999999999974322110000      


Q ss_pred             -ccccccccc--------cCCCCC--CCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 -NTDVALDQM--------LDPRLP--APS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 -~~~~~~~~~--------~~~~~~--~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ........+        .++...  ... .........+.+++.+||+.+|++|||+++++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             000000000        000000  000 0000113457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.96  E-value=3.5e-29  Score=257.78  Aligned_cols=221  Identities=18%  Similarity=0.190  Sum_probs=167.9

Q ss_pred             CccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHH----HHHHHhhceeecCCeeEEEEEeccCCChhhhhccccc
Q 042123          599 GGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFL----TEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAA  673 (849)
Q Consensus       599 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~----~ei~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~  673 (849)
                      |.+|.||++.. .+++.||+|++.......  .......    ..+..+++++.+....++||||+++|+|.+++.+.. 
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~--~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-   80 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYS--RERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-   80 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhhhh--hHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-
Confidence            89999999954 578999999987542111  1111111    234457778888889999999999999999986532 


Q ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccc
Q 042123          674 AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE  753 (849)
Q Consensus       674 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE  753 (849)
                        .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||.+......   .....++..|+|||
T Consensus        81 --~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE  152 (237)
T cd05576          81 --NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPE  152 (237)
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCc
Confidence              489999999999999999999998   9999999999999999999999999987665432   12334577899999


Q ss_pred             cccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCC
Q 042123          754 LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNES  833 (849)
Q Consensus       754 ~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  833 (849)
                      ...+..++.++||||+|+++|||++|+.|++......          .......++.      .....+.+++.+|++.|
T Consensus       153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------~~~~~~~~~~------~~~~~~~~li~~~l~~d  216 (237)
T cd05576         153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------NTHTTLNIPE------WVSEEARSLLQQLLQFN  216 (237)
T ss_pred             ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------ccccccCCcc------cCCHHHHHHHHHHccCC
Confidence            9988889999999999999999999998875321100          0000011111      12234778899999999


Q ss_pred             CCCCCCH-----HHHHhh
Q 042123          834 PESRPTM-----KIISQQ  846 (849)
Q Consensus       834 P~~RPt~-----~eil~~  846 (849)
                      |++||++     +++++|
T Consensus       217 p~~R~~~~~~~~~~~~~h  234 (237)
T cd05576         217 PTERLGAGVAGVEDIKSH  234 (237)
T ss_pred             HHHhcCCCccchHHHHcC
Confidence            9999996     666654

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=7.1e-29  Score=268.77  Aligned_cols=245  Identities=20%  Similarity=0.274  Sum_probs=173.1

Q ss_pred             ceecCC--ccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEec
Q 042123          594 YCIGNG--GHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       594 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~  659 (849)
                      ..||+|  +||+||+|.. .+|+.||+|.+......  ....+.+.+|+.           ++++++..++..++|+||+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~   81 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT--EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFM   81 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecc
Confidence            356766  8999999965 57999999998643221  112233444432           4677888888999999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN  739 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  739 (849)
                      .+|++.+++.... ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+.........
T Consensus        82 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          82 AYGSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             cCCCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            9999999987543 23589999999999999999999998   9999999999999999999999999865433221111


Q ss_pred             -------eeeccCCccccccccccCC--CCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc------
Q 042123          740 -------WTEFAGTCGYIAPELAYTM--KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTD------  797 (849)
Q Consensus       740 -------~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~------  797 (849)
                             .....++..|+|||++.+.  .++.++||||+||++|||++|+.||.........       .....      
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence                   0112345679999998763  4788999999999999999999999743211000       00000      


Q ss_pred             ---------------cccc---------cccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 ---------------VALD---------QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 ---------------~~~~---------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                     ....         ......+.  ..........+.+++.+||+.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                           0000         00000000  11122344568899999999999999999999876

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=2.5e-29  Score=285.80  Aligned_cols=256  Identities=14%  Similarity=0.189  Sum_probs=170.0

Q ss_pred             HhcCCCcCceecCCccceEEEEEec--CCcEEEEEEec--------------ccCCCCchhhHHHHHHHHH---------
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP--SGEVVAVKKFH--------------SLLPCDQTVDQKEFLTEVE---------  640 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~--------------~~~~~~~~~~~~~~~~ei~---------  640 (849)
                      ..++|++.+.||+|+||+||++..+  .+..+++|.+.              +... ........+.+|+.         
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            4578999999999999999998543  23333333111              0000 01111223444433         


Q ss_pred             --HhhceeecCCeeEEEEEeccCCChhhhhccccc--ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 042123          641 --AFYGFCSHARHSFLLYEFLERGSLAAILNTDAA--AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL  716 (849)
Q Consensus       641 --~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  716 (849)
                        .+++++...+..|+|+|++.+ ++.+++.....  .......++..++.|++.||+|||+.   +|+||||||+|||+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl  300 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL  300 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence              467788888899999999964 77777643221  12234567889999999999999998   99999999999999


Q ss_pred             cCCCcEEEeeecCCcccCCCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC-CCcccccccccc
Q 042123          717 DLEYEAHVADFGIAKSLKPDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP-RDFLSSISSSSL  794 (849)
Q Consensus       717 ~~~~~~kl~DfG~a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~P-f~~~~~~~~~~~  794 (849)
                      +.++.+||+|||+++.+..... ......||..|+|||++.+..++.++|||||||++|||++|..+ |...........
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999987654322 22345789999999999999999999999999999999998754 432211100000


Q ss_pred             ---------------ccccccccccCC-CCCCCChhhH------HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 ---------------NTDVALDQMLDP-RLPAPSRSAQ------EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 ---------------~~~~~~~~~~~~-~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                     .........++. ..........      .....+.+++.+|++.||++|||+.|++++
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                           000000000000 0000000000      011236677889999999999999999875

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.96  E-value=4.4e-29  Score=271.42  Aligned_cols=252  Identities=21%  Similarity=0.234  Sum_probs=175.8

Q ss_pred             cCCCc-CceecCCccceEEEEEe-cCCcEEEEEEecccCCCCch----------hhHHHHHHHHH-----------Hhhc
Q 042123          588 NDFDA-KYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQT----------VDQKEFLTEVE-----------AFYG  644 (849)
Q Consensus       588 ~~f~~-~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~----------~~~~~~~~ei~-----------~~~~  644 (849)
                      ++|.. .+.||+|+||+||+|.. .+++.||||.+.........          .....+.+|+.           .+++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45543 46799999999999964 47999999988643221100          00112334433           3567


Q ss_pred             eeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       645 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                      ++...+..++||||++ |+|.+++...   ..+++.....++.|++.|++|||+.   +++||||+|+||+++.++.+++
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            7778889999999997 5899888543   3489999999999999999999998   9999999999999999999999


Q ss_pred             eeecCCcccCCC--------------CCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 042123          725 ADFGIAKSLKPD--------------SSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSI  789 (849)
Q Consensus       725 ~DfG~a~~~~~~--------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~  789 (849)
                      +|||.+.....+              ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||...+..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999998765411              1112223467889999998764 4688999999999999999999998744321


Q ss_pred             cccc-------cccccccccc--------cCCCCCCCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          790 SSSS-------LNTDVALDQM--------LDPRLPAPS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       790 ~~~~-------~~~~~~~~~~--------~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....       ........+.        .....+... .........+.+++.+||+.+|++|||++|++.+
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1000       0000000000        000000000 0001113457899999999999999999999875

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=6.4e-30  Score=248.42  Aligned_cols=195  Identities=23%  Similarity=0.336  Sum_probs=151.7

Q ss_pred             hcCCCcCceecCCccceEEEEEe-c--C--CcEEEEEEecccCCCCc----hhhHHHHHHHHH-----Hhhcee-ecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-P--S--GEVVAVKKFHSLLPCDQ----TVDQKEFLTEVE-----AFYGFC-SHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~--~--~~~vavK~~~~~~~~~~----~~~~~~~~~ei~-----~~~~~~-~~~~~  651 (849)
                      -..|+....||+|.||.||+|.- +  +  .+.+|+|+|+.......    ...+....+|+.     .+..++ .++..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            45788899999999999999933 2  2  33799999976532111    112223334433     344443 34789


Q ss_pred             eEEEEEeccCCChhhhhcc--cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC----CcEEEe
Q 042123          652 SFLLYEFLERGSLAAILNT--DAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE----YEAHVA  725 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~  725 (849)
                      +++++||.+. +|...++.  ....+.++...+..|++||+.|+.|||++   =|+||||||.|||+..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence            9999999988 89888853  33345789999999999999999999999   68999999999999877    899999


Q ss_pred             eecCCcccCCCCCC---eeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          726 DFGIAKSLKPDSSN---WTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       726 DfG~a~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                      |||+++.+..+-..   ....+.|.+|+|||.+.+ ..||.+.||||.|||+.||+|-++-|..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence            99999988755322   344677999999999876 5689999999999999999998776653

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=7.2e-29  Score=270.15  Aligned_cols=246  Identities=21%  Similarity=0.327  Sum_probs=173.3

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~-----  649 (849)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.......  .....+.+|+.           .+.+++...     
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE--IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc--cchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            37898999999999999999965 478999999986532211  11223334433           345555432     


Q ss_pred             -CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          650 -RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       650 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                       ...++|+||+.. ++.++..     ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+|++|||
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             CceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCC
Confidence             346899999975 7766642     2488999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cccc---
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTD---  797 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~---  797 (849)
                      +++.....   .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..........       ....   
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         163 LARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             CCcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            98765322   233467888999999876 458889999999999999999999997432111000       0000   


Q ss_pred             -----cccccccC--CCCCCCCh--hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 -----VALDQMLD--PRLPAPSR--SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 -----~~~~~~~~--~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                           .......+  +..+....  ........+.+++.+||+.||++||++++++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                 00000000  00000000  000122347799999999999999999999875

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=6.1e-29  Score=270.82  Aligned_cols=248  Identities=20%  Similarity=0.300  Sum_probs=176.2

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC---
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR---  650 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~---  650 (849)
                      ..++|+..+.||+|+||.||+|... ++..||||++......  ......+.+|+.           .+.+++....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE   90 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch--hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence            4578999999999999999999664 6889999987643211  111223333432           2444444333   


Q ss_pred             ---eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          651 ---HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       651 ---~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                         ..++|+||+ +++|.+++..    ..+++.++..++.|++.|++|||+.   +|+||||+|+||+++.++.++|+||
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence               389999999 5699998864    3489999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccccccc
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTDVA  799 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~~~  799 (849)
                      |++......   .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||.........       ....+..
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         163 GLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             ccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            999866432   233467889999998765 36788999999999999999999998643211000       0000000


Q ss_pred             ccc--------ccC---CCCCCCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQ--------MLD---PRLPAPS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~--------~~~---~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...        ...   ....... .........+.+++.+||+.+|++|||+.+|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            000        000   0000000 0000123458899999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=6.8e-29  Score=268.38  Aligned_cols=250  Identities=22%  Similarity=0.311  Sum_probs=178.0

Q ss_pred             HHHhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-CC
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-AR  650 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-~~  650 (849)
                      ..++++|+..+.||+|+||.||+|. ..+++.||||++......  ....+.+.+|+.           .+.+++.. ..
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST--PVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc--cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            4467889999999999999999995 457999999987643211  111233334433           24555543 55


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..++|+||+ +++|.+++..    ..+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.++++|||.+
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            789999998 4589888753    2478888999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccccccccc
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTDVALDQ  802 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~~~~~~  802 (849)
                      ......   .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........       .....+....
T Consensus       156 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         156 RIQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            754322   233467889999998765 56889999999999999999999999643211000       0000000000


Q ss_pred             ccC-----------CCCCCCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 MLD-----------PRLPAPS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~-----------~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+           ...+.+. .........+.+++.+||+.+|++|||+++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000           0000000 0001123458899999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.4e-28  Score=268.19  Aligned_cols=253  Identities=21%  Similarity=0.298  Sum_probs=178.4

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH  648 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~  648 (849)
                      .++..++++|+..+.||+|+||.||+|. ..+++.||+|++.....  .......+.+|+.           .+.+++..
T Consensus        10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877          10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            4556678999999999999999999995 45789999999865321  1122233444543           23444432


Q ss_pred             ------CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 042123          649 ------ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA  722 (849)
Q Consensus       649 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  722 (849)
                            ....+++++++ +++|.+++..    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCE
Confidence                  23467888887 7799888754    2489999999999999999999999   99999999999999999999


Q ss_pred             EEeeecCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cc
Q 042123          723 HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SL  794 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~  794 (849)
                      |++|||+++.....   .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.........       ..
T Consensus       160 kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         160 KILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             EEeccccccccccc---ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            99999998764322   233567889999998766 56788999999999999999999998633211100       00


Q ss_pred             ccccccc--------cccC--CCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 NTDVALD--------QMLD--PRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 ~~~~~~~--------~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......        ..+.  +..+...  .........+.+++.+|++.||.+|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0000000        0000  0000000  0000112347799999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=1.2e-28  Score=288.76  Aligned_cols=137  Identities=26%  Similarity=0.371  Sum_probs=112.2

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|.+.+.||+|+||.||+|... +++.||||++...... .......+..|+.           .+++++......|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMI-NKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhcc-CHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            67889999999999999999654 7899999998653211 1111233333332           355666778899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      |||+++++|.+++....   .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999986532   478999999999999999999998   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.2e-28  Score=268.33  Aligned_cols=248  Identities=21%  Similarity=0.296  Sum_probs=175.8

Q ss_pred             HhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC----
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA----  649 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~----  649 (849)
                      ..++|+..+.||+|+||.||+|. ..++..||||++.....  .......+..|+..           +.+++...    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            45789999999999999999995 55799999999864321  12222334444432           34444332    


Q ss_pred             --CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          650 --RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       650 --~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                        ...++||||+ +++|.+++..    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++++||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence              2458999999 6799888753    3489999999999999999999998   9999999999999999999999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVA  799 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~  799 (849)
                      |++......   .....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||..........       ......
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            999865432   233467889999998875 457889999999999999999999997432210000       000000


Q ss_pred             cc--------cccC--CCCCCC--ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LD--------QMLD--PRLPAP--SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~--------~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..        ....  +.....  ..........+.+++.+|++.||++|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00        0000  000000  00001122347899999999999999999999864

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=7.8e-30  Score=263.26  Aligned_cols=236  Identities=23%  Similarity=0.315  Sum_probs=190.6

Q ss_pred             CceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHHHhh-----------ceeecCCeeEEEEEecc
Q 042123          593 KYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY-----------GFCSHARHSFLLYEFLE  660 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~-----------~~~~~~~~~~lV~e~~~  660 (849)
                      .++||.|.||+||-|. .++|+.||||.+.+..-.  ...+.....|+..+.           --++..+..++|||-+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp--~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP--TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCC--CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            4689999999999994 458999999999764321  122344555665433           23455678899999997


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeecCCcccCCCC
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~a~~~~~~~  737 (849)
                      |.=|+.++...  .+.+++....-++.||+.||.|||.+   +|||+||||+|||+...   -++|++|||+|+.+... 
T Consensus       647 GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-  720 (888)
T KOG4236|consen  647 GDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-  720 (888)
T ss_pred             chHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-
Confidence            75555555433  24588888889999999999999999   99999999999999654   47999999999988653 


Q ss_pred             CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHH
Q 042123          738 SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE  817 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  817 (849)
                      ......+|||.|.|||++..+.|...-|+||.||++|.-++|..||.+.          ++.-+++....+..++..+.+
T Consensus       721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----------EdIndQIQNAaFMyPp~PW~e  790 (888)
T KOG4236|consen  721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----------EDINDQIQNAAFMYPPNPWSE  790 (888)
T ss_pred             hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----------cchhHHhhccccccCCCchhh
Confidence            4456789999999999999999999999999999999999999999742          234456666777777888888


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          818 KLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       818 ~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+++|...++..-.+|-|.+.-+.|
T Consensus       791 is~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  791 ISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             cCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            88889999999999999999998876654

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=1.1e-28  Score=268.71  Aligned_cols=247  Identities=20%  Similarity=0.270  Sum_probs=171.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-------
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-------  648 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-------  648 (849)
                      .+|...+.||.|+||.||+|.. .+++.||+|++.....    ...+.+.+|+.           .+++++..       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~----~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP----QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC----chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            5788899999999999999954 5789999998855322    11233334433           23333222       


Q ss_pred             -------CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CC
Q 042123          649 -------ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-EY  720 (849)
Q Consensus       649 -------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~  720 (849)
                             ....++||||++ ++|.+++..    ..+++.++..++.||+.|++|||+.   +|+||||||+||+++. ++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                   245789999997 488888753    2488999999999999999999998   9999999999999975 46


Q ss_pred             cEEEeeecCCcccCCCCC---CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---
Q 042123          721 EAHVADFGIAKSLKPDSS---NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS---  793 (849)
Q Consensus       721 ~~kl~DfG~a~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~---  793 (849)
                      .+|++|||.++.......   ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..........   
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            789999999976532211   1123357889999998654 567889999999999999999999996432211000   


Q ss_pred             ----cccccccc--------ccc-CCCCC-CCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 ----LNTDVALD--------QML-DPRLP-APS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ----~~~~~~~~--------~~~-~~~~~-~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ........        ... ..... .+. ........++.+++.+||+.||++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                00000000        000 00000 000 0001122457789999999999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=1.9e-28  Score=263.73  Aligned_cols=252  Identities=21%  Similarity=0.278  Sum_probs=173.8

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec------
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH------  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~------  648 (849)
                      .++|+..+.||+|+||.||+|.. .+++.+|||++.........  ...+.+|+.           .+++++..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF--PITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc--chhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            47899999999999999999965 46899999988543221111  111222222           34444322      


Q ss_pred             --CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          649 --ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       649 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                        ....++|+||+++ ++...+....  ..+++.++..++.|+++||+|||+.   +++||||||+||++++++.++++|
T Consensus        85 ~~~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          85 RKRGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             ccCceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence              2357999999976 6777665432  3589999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccCCCCCC-----------eeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-
Q 042123          727 FGIAKSLKPDSSN-----------WTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-  793 (849)
Q Consensus       727 fG~a~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-  793 (849)
                      ||+++........           .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||.......... 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999865432211           1223567889999987654 57899999999999999999999986433211000 


Q ss_pred             ------------ccccccccc----ccCCCCCCCCh-hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 ------------LNTDVALDQ----MLDPRLPAPSR-SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ------------~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                  .........    ......+.... ........+.+++.+|++.+|++|||+.|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence                        000000000    00011110000 001112457899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.96  E-value=9.8e-31  Score=262.30  Aligned_cols=313  Identities=21%  Similarity=0.193  Sum_probs=208.2

Q ss_pred             CCCCCcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCC
Q 042123            1 CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG   80 (849)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~   80 (849)
                      |++.| =+.+++...|+.....+.+    +..++++|..|+|+.+++.+|+.+++|+.||||+|+|+      .      
T Consensus        43 Cs~~~-g~~VdCr~~GL~eVP~~LP----~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is------~------  105 (498)
T KOG4237|consen   43 CSDVE-GGIVDCRGKGLTEVPANLP----PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS------F------  105 (498)
T ss_pred             cCCCC-CceEEccCCCcccCcccCC----CcceEEEeccCCcccCChhhccchhhhceecccccchh------h------
Confidence            56544 3456788888766644422    56899999999999999999999999999999999986      2      


Q ss_pred             CCccccCeEeccCCcccccCCccCCCCCCCCEEEccC-CcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCC
Q 042123           81 GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN-NKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLF  159 (849)
Q Consensus        81 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  159 (849)
                                        +-|.+|.++++|.+|-+-+ |+|+++...+|.+|..|+.|.+.-|++.-+..++|..+++|.
T Consensus       106 ------------------I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~  167 (498)
T KOG4237|consen  106 ------------------IAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLS  167 (498)
T ss_pred             ------------------cChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcc
Confidence                              3345555555554444443 666666666666666666666666666655566666666666


Q ss_pred             EEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccc
Q 042123          160 DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH  239 (849)
Q Consensus       160 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  239 (849)
                      .|.+.+|.+..+.-.+|..+..++++.+..|.+-     ..++++.|... +      ...|-.+++.+-..-..+.+++
T Consensus       168 lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~~-~------a~~~ietsgarc~~p~rl~~~R  235 (498)
T KOG4237|consen  168 LLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLADD-L------AMNPIETSGARCVSPYRLYYKR  235 (498)
T ss_pred             hhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhhH-H------hhchhhcccceecchHHHHHHH
Confidence            6666666666666566777777777777766632     12222222211 1      1222234444444444555555


Q ss_pred             ccCCCCcchhhh--hhhhhhccCcCCCCCC-CcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchh
Q 042123          240 LSGSIPPSLGNL--ILRQLLLSGNHFTGYL-PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNIS  316 (849)
Q Consensus       240 l~~~~p~~~~~~--~L~~L~L~~n~i~~~~-~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  316 (849)
                      +...-+..+..-  .+..-..+.+...++. ...|..+++|+.|+|++|+++.+-+.+|.++..+++|+|..|+|..+-.
T Consensus       236 i~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~  315 (498)
T KOG4237|consen  236 INQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSS  315 (498)
T ss_pred             hcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHH
Confidence            543333323222  1111112222222232 2347778888888888888888888888888899999999999888888


Q ss_pred             hhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccc
Q 042123          317 EALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT  360 (849)
Q Consensus       317 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~  360 (849)
                      .+|..+..|+.|+|++|+|+...|..|..+..|.+|+|-.|.+.
T Consensus       316 ~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  316 GMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             HhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            88888889999999999998888888888888888888877654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-29  Score=229.80  Aligned_cols=193  Identities=25%  Similarity=0.406  Sum_probs=155.7

Q ss_pred             HHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCe
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARH  651 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~  651 (849)
                      ...++......||+|+||.|-+.++ .+|...|||++.....   .+.+++.+.|+.            +++|...+.+.
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn---~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN---SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC---hHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            3344555567899999999988855 5799999999876543   344556666654            36777778889


Q ss_pred             eEEEEEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          652 SFLLYEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      .|+.||.|+. ||+.+-.+. ..+..+++.-.-+|+..|..||.|||++.  .|+|||+||+|||++.+|++|+||||.+
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence            9999999976 887775432 23456888899999999999999999986  8999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccCCcccccccccc----CCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAY----TMKITEKCDVYSFGVLMWEVIKGKHPRD  784 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~SlGvil~el~tg~~Pf~  784 (849)
                      ..+..+- ..+.-.|-..|||||.+.    ...|+.|+||||+|+.+.||.+++.||+
T Consensus       197 G~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  197 GYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             eeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            8765432 223346778999999875    3478999999999999999999999987

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.96  E-value=9.3e-29  Score=221.50  Aligned_cols=252  Identities=17%  Similarity=0.250  Sum_probs=182.1

Q ss_pred             CCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCch----hhHHHHHHH-----HHHhhceeecCCeeEEEEEe
Q 042123          589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQT----VDQKEFLTE-----VEAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~e-----i~~~~~~~~~~~~~~lV~e~  658 (849)
                      +|...++||+|.||+||+| .+.+++.||+|++.-....+..    ..+...++|     |+++++....+...-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566788999999999999 5567899999998654322221    112223333     44678887888889999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      |+. +|..+.+.-.  +.++.+.+..++.|+.+|+.|+|+.   ++.|||+||.|.+++.+|+.|++|||+++.+.-+-.
T Consensus        83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            987 8888887654  4589999999999999999999999   999999999999999999999999999998876544


Q ss_pred             CeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHh-CCCCCCccccccc----------cccccccccccccCC
Q 042123          739 NWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISS----------SSLNTDVALDQMLDP  806 (849)
Q Consensus       739 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~----------~~~~~~~~~~~~~~~  806 (849)
                      -+...+.|.+|++|.++.+. -|+...|+||-||++.|+.. |++-|...+..+.          ........+.+.-|.
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            45566789999999998875 57889999999999999997 5555543221110          111111111122221


Q ss_pred             C---CCCCChhhHHHHHH----HHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          807 R---LPAPSRSAQEKLIS----IMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       807 ~---~~~~~~~~~~~~~~----l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .   +-+....+.+...+    -.+++...+.-+|.+|.++++.+++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            1   11112223333222    3466667777899999999998875

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=252.32  Aligned_cols=253  Identities=18%  Similarity=0.273  Sum_probs=183.0

Q ss_pred             HhcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCc-hhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQ-TVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~-~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ..++|.+...+|+|.||.|-+. ....+..||||+++....... ...+.+..+.+.           ++.+|++..++.
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            3689999999999999999999 455689999999875422111 111112222221           366778888999


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--------------
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL--------------  718 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--------------  718 (849)
                      ++|+|.+ |-|+.+++.... ..+++..+++.|++|++++++|||+.   +++|.||||+||++.+              
T Consensus       167 Civfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             EEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence            9999998 449999997654 35688999999999999999999999   9999999999999831              


Q ss_pred             ------CCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccc----
Q 042123          719 ------EYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSS----  788 (849)
Q Consensus       719 ------~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~----  788 (849)
                            +..++++|||.|+.....   ....+.|.-|+|||++.+-.++.++||||+|||++|+.||..-|..-+.    
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL  318 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL  318 (415)
T ss_pred             eeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH
Confidence                  235899999999875433   3567889999999999999999999999999999999999987753221    


Q ss_pred             ---------ccccccccc-------------------cccccccCCCCCCC--ChhhHHHHHHHHHHHhhccCCCCCCCC
Q 042123          789 ---------ISSSSLNTD-------------------VALDQMLDPRLPAP--SRSAQEKLISIMEVAFSCFNESPESRP  838 (849)
Q Consensus       789 ---------~~~~~~~~~-------------------~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RP  838 (849)
                               .+.......                   .......+...+..  ..........+.+++..|+..||.+|+
T Consensus       319 aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~Ri  398 (415)
T KOG0671|consen  319 AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRI  398 (415)
T ss_pred             HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccc
Confidence                     000000000                   00000011000000  011123344699999999999999999


Q ss_pred             CHHHHHhh
Q 042123          839 TMKIISQQ  846 (849)
Q Consensus       839 t~~eil~~  846 (849)
                      |+.|++.|
T Consensus       399 Tl~EAL~H  406 (415)
T KOG0671|consen  399 TLREALSH  406 (415)
T ss_pred             cHHHHhcC
Confidence            99999875

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=2.9e-28  Score=264.46  Aligned_cols=249  Identities=22%  Similarity=0.346  Sum_probs=171.4

Q ss_pred             CCCcCceecCCccceEEEEEec-C--CcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee----cC
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-S--GEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS----HA  649 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~----~~  649 (849)
                      +|+..+.||+|+||.||+|+.. +  +..||+|++......  ....+.+.+|+.            ++++++.    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK--KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc--chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            4777889999999999999654 4  778999998643211  111223333433            2333221    12


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++++||+. ++|.+++...   ..+++.++..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||.
T Consensus        79 ~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          79 NELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             CcEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            35688899886 5898888543   3589999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCCCCC----CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------ccccc
Q 042123          730 AKSLKPDSS----NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTD  797 (849)
Q Consensus       730 a~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~  797 (849)
                      ++.......    ......|+..|+|||...+ ..++.++||||+|+++|++++|+.||.........       .....
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            986543211    1233568899999998765 46789999999999999999999998743211000       00000


Q ss_pred             cccccccCC----------CCC-CC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          798 VALDQMLDP----------RLP-AP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       798 ~~~~~~~~~----------~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+..+          ..+ .. ..........+.+++.+|++.+|++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000000          000 00 00000112357899999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=5.7e-28  Score=268.04  Aligned_cols=252  Identities=18%  Similarity=0.240  Sum_probs=168.9

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-----------------cCCcEEEEEEecccCCCCchhhHHHHHH-----------
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-----------------PSGEVVAVKKFHSLLPCDQTVDQKEFLT-----------  637 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~~~~~~-----------  637 (849)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++......    ..++|.+           
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~----~~~~fl~e~~~~~~~~e~  218 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG----VRQDFLKTGTLAKGSAET  218 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh----hHHHHHhhhhhhhcccch
Confidence            357899999999999999999953                 23568999998642110    0111111           


Q ss_pred             ---H----------------HHHhhceeec--------CCeeEEEEEeccCCChhhhhccccc-----------------
Q 042123          638 ---E----------------VEAFYGFCSH--------ARHSFLLYEFLERGSLAAILNTDAA-----------------  673 (849)
Q Consensus       638 ---e----------------i~~~~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~-----------------  673 (849)
                         |                +..++++|..        .+..|+||||+++|+|.++++....                 
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence               1                1234555542        3568999999999999999864211                 


Q ss_pred             ----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC-eeeccCCcc
Q 042123          674 ----AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-WTEFAGTCG  748 (849)
Q Consensus       674 ----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~g~~~  748 (849)
                          ...+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++........ .....+++.
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~  375 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR  375 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence                12356788899999999999999998   9999999999999999999999999999765432211 112234789


Q ss_pred             ccccccccCCC--------------------C--CccchHHHHHHHHHHHHhCCC-CCCccccccccccccccccc---c
Q 042123          749 YIAPELAYTMK--------------------I--TEKCDVYSFGVLMWEVIKGKH-PRDFLSSISSSSLNTDVALD---Q  802 (849)
Q Consensus       749 y~aPE~~~~~~--------------------~--~~~~Dv~SlGvil~el~tg~~-Pf~~~~~~~~~~~~~~~~~~---~  802 (849)
                      |+|||.+....                    +  ..+.||||+||++|+|++|.. ||..................   .
T Consensus       376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~  455 (507)
T PLN03224        376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM  455 (507)
T ss_pred             eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence            99999875432                    1  124699999999999999875 76533221111000000111   0


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCC---CCCCCHHHHHhh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESP---ESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~eil~~  846 (849)
                      .......  ............+++.+++.++|   .+|+|++|+++|
T Consensus       456 ~~~~~~~--~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 YKGQKYD--FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             hcccCCC--cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            1111111  11112223457788889998766   689999999987

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-29  Score=254.65  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=177.8

Q ss_pred             hcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHH----------HHHH-----HHHhhceeec-C
Q 042123          587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKE----------FLTE-----VEAFYGFCSH-A  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~----------~~~e-----i~~~~~~~~~-~  649 (849)
                      .++|-..+.||+|+|++||+| .+...+.||||+-.-..... ......          +++|     |+++|+|+.- .
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wr-dEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWR-DEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchh-hHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            356667789999999999999 66778889999754321111 111122          2222     3346777754 4


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEee
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---LEYEAHVAD  726 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~D  726 (849)
                      +.++-|.|||+|.+|+-+++..+   .+++.+++.|+.||+.||.||.+. .|+|+|-||||-|||+-   ..|.+||+|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            57788999999999999997654   489999999999999999999986 45899999999999994   348899999


Q ss_pred             ecCCcccCCCCCC-------eeeccCCccccccccccCC----CCCccchHHHHHHHHHHHHhCCCCCCccccccccccc
Q 042123          727 FGIAKSLKPDSSN-------WTEFAGTCGYIAPELAYTM----KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN  795 (849)
Q Consensus       727 fG~a~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~  795 (849)
                      ||+++.+..+...       .....||.+|.+||.+.-+    ..+.|.||||.||++|+++.|+.||......... ..
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI-Lq  695 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI-LQ  695 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-Hh
Confidence            9999988654322       3446799999999987643    4578899999999999999999999854321110 00


Q ss_pred             cccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHh
Q 042123          796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~  845 (849)
                      ....+. ...-.+++.+..    ..+...||.+|+++.-++|.+..++..
T Consensus       696 eNTIlk-AtEVqFP~KPvV----sseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 ENTILK-ATEVQFPPKPVV----SSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhchhc-ceeccCCCCCcc----CHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            000000 000112222222    223678899999999999988887754

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2e-29  Score=259.69  Aligned_cols=242  Identities=21%  Similarity=0.333  Sum_probs=184.8

Q ss_pred             cCCCcCceecCCccceEEEEEecCCc-EEEEEEecccCCCCchh-----hHHHHHHH-----HHHhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGE-VVAVKKFHSLLPCDQTV-----DQKEFLTE-----VEAFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~-----~~~~~~~e-----i~~~~~~~~~~~~~~lV~  656 (849)
                      .++..+..||-|+||.|=.+..++.. .+|+|.+++....+..+     .++.++.+     |+++|..+.+...+|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            34555668999999999998765433 37888776533222221     12233332     557888889999999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      |-|-||.++..+...   +.++.....-++..+.+|++|||+.   +|++|||||+|.+++.+|-+|+.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdR---g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDR---GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhc---CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            999999999999654   3588899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhH
Q 042123          737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ  816 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  816 (849)
                      .. .-+++|||.|.|||++..+..+.++|.||+|+++||+++|.+||...+.+..        ...++.+-  .....+.
T Consensus       574 ~K-TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt--------Yn~ILkGi--d~i~~Pr  642 (732)
T KOG0614|consen  574 RK-TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT--------YNLILKGI--DKIEFPR  642 (732)
T ss_pred             Cc-eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH--------HHHHHhhh--hhhhccc
Confidence            44 4568999999999999999999999999999999999999999986554321        11111110  0011112


Q ss_pred             HHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          817 EKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       817 ~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                      .......++|++.+..+|.+|.-     +.||.+|
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            22334668888999999999974     5666655

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=8.7e-27  Score=240.87  Aligned_cols=229  Identities=27%  Similarity=0.427  Sum_probs=175.1

Q ss_pred             ccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCCChhhh
Q 042123          600 GHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGSLAAI  667 (849)
Q Consensus       600 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~gsL~~~  667 (849)
                      +||.||+|... +++.+|+|++........   ...+.+|+.           .+.+++......++|+||+++++|.++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK---RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH---HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999765 589999999876432211   334444433           467777788899999999999999999


Q ss_pred             hcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCc
Q 042123          668 LNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC  747 (849)
Q Consensus       668 l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~  747 (849)
                      +....   .+++.++..++.+++.|+.|||+.   +++|+||+|+||+++.++.++++|||.+....... ......++.
T Consensus        78 ~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  150 (244)
T smart00220       78 LKKRG---RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTP  150 (244)
T ss_pred             HHhcc---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCc
Confidence            86543   288999999999999999999998   99999999999999999999999999998765432 234456788


Q ss_pred             cccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHh
Q 042123          748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAF  827 (849)
Q Consensus       748 ~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  827 (849)
                      .|+|||...+..++.++||||+|+++|++++|..||.....       ................. ........+.+++.
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~-------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~  222 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ-------LLELFKKIGKPKPPFPP-PEWKISPEAKDLIR  222 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------HHHHHHHHhccCCCCcc-ccccCCHHHHHHHH
Confidence            99999999888899999999999999999999999864211       11111111111111111 00002235888999


Q ss_pred             hccCCCCCCCCCHHHHHhh
Q 042123          828 SCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       828 ~cl~~dP~~RPt~~eil~~  846 (849)
                      +||..+|++||++.+++++
T Consensus       223 ~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      223 KLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHccCCchhccCHHHHhhC
Confidence            9999999999999999874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4e-28  Score=229.10  Aligned_cols=253  Identities=20%  Similarity=0.312  Sum_probs=173.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCC-Cchh---hHHHHH-----HHHHHhhceee--------cC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPC-DQTV---DQKEFL-----TEVEAFYGFCS--------HA  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~---~~~~~~-----~ei~~~~~~~~--------~~  649 (849)
                      ..|+...+||+|.||+||+|+. ++|+.||+|+..-.-.. .-..   .+...+     +++..++..|.        ..
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4556677899999999999954 46888999875321111 1111   111111     12223333332        23


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...|+||++|+. +|.-.+....  ..++..++.+++.++..||.|+|..   .|+|||+||.|+|++.+|.+|++|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence            468999999988 8888775432  4589999999999999999999999   899999999999999999999999999


Q ss_pred             CcccCCCC----CCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------------
Q 042123          730 AKSLKPDS----SNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------------  791 (849)
Q Consensus       730 a~~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------------  791 (849)
                      ++.+...+    ..++..+.|.+|++||.+.+ ..|+++.|||+.||++.||+||.+-+........             
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            98765432    23566778999999998875 5689999999999999999999887764321110             


Q ss_pred             ---cccccccccccccCCCCCCC-ChhhHHH------HHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          792 ---SSLNTDVALDQMLDPRLPAP-SRSAQEK------LISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       792 ---~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         +....-.....+--+.++.. .....+.      .....+++..++..||.+|+++++++.|
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence               00000000011100001100 0000111      1146688889999999999999999876

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=2.1e-27  Score=250.33  Aligned_cols=193  Identities=22%  Similarity=0.355  Sum_probs=154.1

Q ss_pred             CCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCC-----CchhhHHHHHHH-----HHHhhceeecCCeeEEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPC-----DQTVDQKEFLTE-----VEAFYGFCSHARHSFLLYE  657 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~~e-----i~~~~~~~~~~~~~~lV~e  657 (849)
                      -|..++.||-|+||+|..+ +..+...||.|.+.+...-     .....++.++.|     |+++|-.+.+.+..|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            4667789999999999999 4555777999987653110     111223444444     3356667788899999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC--
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP--  735 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~--  735 (849)
                      |++||++-.+|-+.+   .+.+.-++.++..+++|+++.|..   |++||||||+|||||.+|++||+|||++.-+..  
T Consensus       710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence            999999999986654   477888889999999999999999   999999999999999999999999999864321  


Q ss_pred             -------CCCC---------------------------------eeeccCCccccccccccCCCCCccchHHHHHHHHHH
Q 042123          736 -------DSSN---------------------------------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWE  775 (849)
Q Consensus       736 -------~~~~---------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~e  775 (849)
                             .+..                                 ....+||+.|+|||++....|+..+|.||.|||+||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence                   0000                                 011368999999999999999999999999999999


Q ss_pred             HHhCCCCCCccc
Q 042123          776 VIKGKHPRDFLS  787 (849)
Q Consensus       776 l~tg~~Pf~~~~  787 (849)
                      |+.|+.||-...
T Consensus       864 m~~g~~pf~~~t  875 (1034)
T KOG0608|consen  864 MLVGQPPFLADT  875 (1034)
T ss_pred             HhhCCCCccCCC
Confidence            999999997443

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.94  E-value=1.2e-28  Score=247.33  Aligned_cols=364  Identities=21%  Similarity=0.199  Sum_probs=205.0

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCC-CcccccCCcCCCCCCCCCEEEc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND-NQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      .-.+++|..|+|+.++|.+|..+++|+.|+|++|.|+.+.|++|.++.+|..|-+.+ |+|+.+..++|.+|..|+.|.+
T Consensus        68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll  147 (498)
T KOG4237|consen   68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL  147 (498)
T ss_pred             cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence            345555555555555555555555555555555555555555555555555554444 5555555555555555555555


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccC------------CCCcchhhhh-hh
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG------------SIPPSLGNLI-LR  254 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~------------~~p~~~~~~~-L~  254 (849)
                      .-|++.-...+.|..+++|..|.+.+|.+..+-..+|..+..++.+.+..|.+-.            ..|..++... ..
T Consensus       148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~  227 (498)
T KOG4237|consen  148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVS  227 (498)
T ss_pred             ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecc
Confidence            5555554455555555555555555555554333355555555555555555211            1111111111 23


Q ss_pred             hhhccCcCCCCCCCcccCCC-CCcc-eeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccC
Q 042123          255 QLLLSGNHFTGYLPYNICRG-GALE-IFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSR  332 (849)
Q Consensus       255 ~L~L~~n~i~~~~~~~~~~~-~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~  332 (849)
                      -..+.++++..+.+..|... .++. .+....+.........|..+++|+.|+|++|+|+++-+.+|.....++.|.|..
T Consensus       228 p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~  307 (498)
T KOG4237|consen  228 PYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTR  307 (498)
T ss_pred             hHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCc
Confidence            33444455544444333221 2221 112222233323344678888888888888888888888888888888888888


Q ss_pred             ccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccC-----chh-----------hcCCCC
Q 042123          333 NNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEI-----PKE-----------LGKLNP  396 (849)
Q Consensus       333 N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~-----~~~-----------~~~l~~  396 (849)
                      |++...-...|.++..|+.|+|.+|+|+...|..|..+.+|..|.|-.|.+.-.-     .+.           -..-..
T Consensus       308 N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~  387 (498)
T KOG4237|consen  308 NKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGF  387 (498)
T ss_pred             chHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCCCCch
Confidence            8888777777888888888888888888888888888888888888777653100     000           111224


Q ss_pred             CcEEEccCccccc---cCcccccc---------ccccccc-cccc--CCCCChhhhcccccceeccCCcccccCCCcccc
Q 042123          397 LTKLILRGNQITG---RLPKEIGS---------LTKLEYL-DFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFE  461 (849)
Q Consensus       397 L~~L~L~~N~l~~---~~p~~~~~---------l~~L~~L-~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~  461 (849)
                      ++.+.++.+.+..   ..|++.+.         ++-+.+. ..|+  ++.+|..+.  ..-..|++.+|.++ .+|..  
T Consensus       388 ~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP--~d~telyl~gn~~~-~vp~~--  462 (498)
T KOG4237|consen  388 VRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP--VDVTELYLDGNAIT-SVPDE--  462 (498)
T ss_pred             hccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC--chhHHHhcccchhc-ccCHH--
Confidence            5566666554431   12222211         1122211 1121  344444332  23456788888887 55555  


Q ss_pred             ccCCCcEEeccCCcccc
Q 042123          462 GMHGLSFIDMSYNELQC  478 (849)
Q Consensus       462 ~l~~L~~l~l~~N~l~~  478 (849)
                      .+.+| .+|+++|+|.-
T Consensus       463 ~~~~l-~~dls~n~i~~  478 (498)
T KOG4237|consen  463 LLRSL-LLDLSNNRISS  478 (498)
T ss_pred             HHhhh-hcccccCceeh
Confidence            55666 77888888763

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-27  Score=259.22  Aligned_cols=239  Identities=24%  Similarity=0.392  Sum_probs=168.4

Q ss_pred             CCcCceecCCccce-EEEEEecCCcEEEEEEecccCCCCchhhHHHHHHH------HHHhhceeecCCeeEEEEEeccCC
Q 042123          590 FDAKYCIGNGGHAS-VYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE------VEAFYGFCSHARHSFLLYEFLERG  662 (849)
Q Consensus       590 f~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e------i~~~~~~~~~~~~~~lV~e~~~~g  662 (849)
                      |...+++|.|+.|+ ||+|... |+.||||++-.... +....+...++|      |.++++.-.+....||+.|.|.. 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~~-~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEFF-DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHhH-HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            34456799999885 6999995 89999998754211 000111111111      33444444566789999999987 


Q ss_pred             Chhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---C--CcEEEeeecCCcccCCC
Q 042123          663 SLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL---E--YEAHVADFGIAKSLKPD  736 (849)
Q Consensus       663 sL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~--~~~kl~DfG~a~~~~~~  736 (849)
                      +|.++++... ..........+.+..|++.|+++||+.   +||||||||.||||+.   +  ..++|+|||+++.+..+
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            9999997641 111111144578899999999999997   9999999999999976   3  46899999999998766


Q ss_pred             CCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCC-C
Q 042123          737 SSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPA-P  811 (849)
Q Consensus       737 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  811 (849)
                      ...   .....||.+|+|||++....-+.++||||+||++|..++ |.+||...-.          +-..++.....- .
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~----------R~~NIl~~~~~L~~  734 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE----------RQANILTGNYTLVH  734 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH----------hhhhhhcCccceee
Confidence            543   344678999999999998888889999999999999998 5999973211          001111111000 0


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.  ...++|.+|++++|..||++.+|+.|
T Consensus       735 L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  735 LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            0000111  47789999999999999999999875

>PLN03210 Resistant to P

Probab=99.93  E-value=8e-25  Score=271.14  Aligned_cols=125  Identities=22%  Similarity=0.289  Sum_probs=69.7

Q ss_pred             ccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccccccccccc
Q 042123          299 TSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDL  378 (849)
Q Consensus       299 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L  378 (849)
                      ++|+.|++++|.....+|..++.+++|+.|+|++|...+.+|..+ .+++|+.|++++|.....+|..   ..+|+.|+|
T Consensus       778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L  853 (1153)
T PLN03210        778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL  853 (1153)
T ss_pred             ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence            455555555555444455555556666666665554333444433 4556666666665443334432   245666666


Q ss_pred             ccccccccCchhhcCCCCCcEEEccCc-cccccCcccccccccccccccccC
Q 042123          379 SLNHIVGEIPKELGKLNPLTKLILRGN-QITGRLPKEIGSLTKLEYLDFSAI  429 (849)
Q Consensus       379 ~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~l  429 (849)
                      ++|.++ .+|..+..+++|+.|+|++| ++. .+|..+..+++|+.+++++.
T Consensus       854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            666665 45666666666777776663 333 45555566666666665543

syringae 6; Provisional

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-27  Score=227.44  Aligned_cols=248  Identities=24%  Similarity=0.341  Sum_probs=177.0

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHHhhceeecC-----------------Ce
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHA-----------------RH  651 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~-----------------~~  651 (849)
                      .+..+.||-|+||.||.++. .+|+.||.|++....  ......+.+.+|++.+- ++.++                 ..
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf--q~L~s~krvFre~kmLc-fFkHdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF--QNLASCKRVFREIKMLS-SFRHDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHH--HHHHHHHHHHHHHHHHH-hhccccHHHHHHhcCCCCchHHHH
Confidence            34567899999999999955 479999999986542  23445667777766432 22222                 23


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .|+|+|.|.. +|..++-.   .+.++...+.-+.+||++||.|||+.   +|.||||||-|.+++.+...||+|||+|+
T Consensus       132 iYV~TELmQS-DLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  132 LYVLTELMQS-DLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHHHHHh-hhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence            4677888865 77776643   34588899999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCC-CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc---------------ccc
Q 042123          732 SLKPDSS-NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS---------------SSL  794 (849)
Q Consensus       732 ~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~---------------~~~  794 (849)
                      ....++. ..+..+.|-.|+|||++++ ..|+.+.||||.||++.|++.++.-|...+.+..               ...
T Consensus       205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~  284 (449)
T KOG0664|consen  205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY  284 (449)
T ss_pred             ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence            8765543 3555677889999999987 4689999999999999999999888865443221               000


Q ss_pred             ccccccccccCCCCCCCC-------hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          795 NTDVALDQMLDPRLPAPS-------RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      .-+.....++.+....+.       .+....-.+.+.+...++..||+.|.+.++.+.+.
T Consensus       285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            011111222222222111       11112222355677788999999999988877653

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-25  Score=229.88  Aligned_cols=126  Identities=24%  Similarity=0.427  Sum_probs=96.9

Q ss_pred             cCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCC-chhhHHHHHHHHH-------------Hhhceeec----
Q 042123          588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCD-QTVDQKEFLTEVE-------------AFYGFCSH----  648 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~ei~-------------~~~~~~~~----  648 (849)
                      .+|-+.++||-|.|++||.| .....+.||+|+.+...... ....+..+++.|.             ++++++.+    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN  157 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN  157 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence            67889999999999999999 66678899999987532111 1112222333222             35555543    


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD  717 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  717 (849)
                      +.|++||+|+. |.+|..++.... .+.++...+.+|++||+.||.|||..|  +|+|.||||+|||+.
T Consensus       158 G~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  158 GQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             CcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            56899999999 558989887654 345899999999999999999999998  999999999999993

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.93  E-value=1.2e-25  Score=209.58  Aligned_cols=243  Identities=17%  Similarity=0.284  Sum_probs=178.1

Q ss_pred             hcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHHHhh------------ceeec--CCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY------------GFCSH--ARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~------------~~~~~--~~~  651 (849)
                      .++|++.+++|+|.|++||.| ...+.++++||.++..       ..+.+.+|+..+.            +...+  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            368889999999999999999 5667899999998653       3556666766533            33322  346


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCC
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIA  730 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a  730 (849)
                      +.+|+||+++.+....-      ..++...++.++.+++.||.|+|++   ||+|||+||.|+++|.. -.++++|+|+|
T Consensus       110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence            77999999998887764      3478889999999999999999999   99999999999999876 46999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc------------------
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS------------------  791 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~------------------  791 (849)
                      ..+.+..+ +.-.+.+..|.-||.+.. ..|+.+-|+|||||++..|+..+.||-.......                  
T Consensus       181 EFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  181 EFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            98876544 455677888999998865 4578899999999999999999999864332111                  


Q ss_pred             --cccccccccccccCCCCCCCC------hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          792 --SSLNTDVALDQMLDPRLPAPS------RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       792 --~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        -....+.....+++.....+.      +...-...+.++++...+..|-.+|||+.|.++|
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence              000001111111111100000      0000012357789999999999999999998875

>PLN03210 Resistant to P

Probab=99.93  E-value=7.9e-25  Score=271.18  Aligned_cols=337  Identities=22%  Similarity=0.259  Sum_probs=214.5

Q ss_pred             CCccCCCCCCCCEEEccCCcc------cCCCCCCCcCCC-CCceeeccCcccccccccccCCCCCCCEEEcCCCcccccC
Q 042123          100 IPPHIGNLKFLSQLDLTNNKF------SGPIPLSFDNLS-NLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYI  172 (849)
Q Consensus       100 ~~~~~~~l~~L~~L~Ls~n~i------~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  172 (849)
                      .+.+|.++++|+.|.+.++..      ....|..|..++ +|+.|++.+|.++ .+|..| ...+|+.|+|.+|++.. .
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L  626 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-L  626 (1153)
T ss_pred             cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-c
Confidence            345577777777777765532      223455666653 5777777777776 455555 45777788888777765 3


Q ss_pred             CcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhh
Q 042123          173 PRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI  252 (849)
Q Consensus       173 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~  252 (849)
                      +..+..+++|++|+|++|.....+|+ +..+++|++|+|++|.....+|..+..+++|+.|++++|..-..+|..+....
T Consensus       627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~s  705 (1153)
T PLN03210        627 WDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKS  705 (1153)
T ss_pred             ccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCC
Confidence            45567777788888877654445554 66777788888877765556777777777788888777654446666553334


Q ss_pred             hhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCcccc-------CchhhhhCCCCCC
Q 042123          253 LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT-------GNISEALGIYPNL  325 (849)
Q Consensus       253 L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-------~~~~~~~~~l~~L  325 (849)
                      |+.|++++|.....+|..   ..+|+.|++++|.+. .+|..+ .+++|++|.+.++...       ...+..+...++|
T Consensus       706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL  780 (1153)
T PLN03210        706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL  780 (1153)
T ss_pred             CCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence            677777776554444432   346777777777776 455544 4667777777664321       1122223344677


Q ss_pred             CEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCc
Q 042123          326 TFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGN  405 (849)
Q Consensus       326 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  405 (849)
                      +.|+|++|.....+|..++.+++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|..   .++|+.|+|++|
T Consensus       781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n  856 (1153)
T PLN03210        781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT  856 (1153)
T ss_pred             hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence            777777777666677777777777777777765444566655 6777777777776554444432   356777777777


Q ss_pred             cccccCccccccccccccccccc---CCCCChhhhcccccceeccCCc
Q 042123          406 QITGRLPKEIGSLTKLEYLDFSA---IGELPSQICNMKSLEKLNLSHN  450 (849)
Q Consensus       406 ~l~~~~p~~~~~l~~L~~L~l~~---l~~lp~~~~~l~~L~~L~L~~N  450 (849)
                      .++ .+|.++..+++|++|++++   +..+|..+..+++|+.|++++|
T Consensus       857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCC
Confidence            776 5666666666666665543   4445555555555555555555

syringae 6; Provisional

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.92  E-value=9.1e-26  Score=233.45  Aligned_cols=256  Identities=20%  Similarity=0.244  Sum_probs=186.1

Q ss_pred             HHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCC-CCchhhHHHHHHH-----------HHHhhceeecCCe
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLP-CDQTVDQKEFLTE-----------VEAFYGFCSHARH  651 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~e-----------i~~~~~~~~~~~~  651 (849)
                      .....|.+....|+|-|++|.+|.. .-|..||||++...-. ......+-++++.           +.+++..|.+.+|
T Consensus       429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            3447888888999999999999954 4578999999865311 1111112222222           2346777788999


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCC
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIA  730 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a  730 (849)
                      .|+|+|-..- +|.+++++.+..-.|....+..++.|+.-||..|-..   +|+|.||||.|||+++. ..+||||||.|
T Consensus       509 LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccc
Confidence            9999998865 9999998776555688899999999999999999987   99999999999999887 56899999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccc-------------ccccccccc
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSS-------------ISSSSLNTD  797 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~-------------~~~~~~~~~  797 (849)
                      ......  ..+.+..+..|.|||++.+..|++..|+||.||++||+.||+.-|.....             ++.......
T Consensus       585 ~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg  662 (752)
T KOG0670|consen  585 SFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG  662 (752)
T ss_pred             cccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence            876532  23445567889999999999999999999999999999999988754221             010000000


Q ss_pred             cccccc--------------------------cCCC------CCC---CChhhHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 042123          798 VALDQM--------------------------LDPR------LPA---PSRSAQEKLISIMEVAFSCFNESPESRPTMKI  842 (849)
Q Consensus       798 ~~~~~~--------------------------~~~~------~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  842 (849)
                      ....+.                          +.|.      +..   .+.........+.+++..|+..||++|-|..+
T Consensus       663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq  742 (752)
T KOG0670|consen  663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ  742 (752)
T ss_pred             chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence            000000                          1110      000   11222344567889999999999999999999


Q ss_pred             HHhh
Q 042123          843 ISQQ  846 (849)
Q Consensus       843 il~~  846 (849)
                      .++|
T Consensus       743 AL~H  746 (752)
T KOG0670|consen  743 ALKH  746 (752)
T ss_pred             HhcC
Confidence            9876

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=9.8e-26  Score=215.47  Aligned_cols=235  Identities=20%  Similarity=0.338  Sum_probs=166.5

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-------------HHhhceeecCCee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-------------EAFYGFCSHARHS  652 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-------------~~~~~~~~~~~~~  652 (849)
                      .+.|.+.+.+|+|.||.+-.+++. +.+.+++|.++...     ...++|.+|.             ..+...++..+.+
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y   97 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY   97 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence            467888999999999999999664 67889999887642     2345566552             2355556667788


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee-cCC-CcEEEeeecCC
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL-DLE-YEAHVADFGIA  730 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill-~~~-~~~kl~DfG~a  730 (849)
                      +.++||++.|+|.+-+...    .+.+....+++.|++.|++|||+.   ++||||||.+|||+ +.+ ..+|++|||..
T Consensus        98 vF~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t  170 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLT  170 (378)
T ss_pred             EEeeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccc
Confidence            8999999999999887543    377888999999999999999999   99999999999999 333 58999999998


Q ss_pred             cccCCCCCCeeeccCCccccccccccC---C--CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYT---M--KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD  805 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~---~--~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  805 (849)
                      +....--   .....+-.|.+||....   +  ...+.+|||.||+++|.++||+.||+........ +.......+-..
T Consensus       171 ~k~g~tV---~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~-Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  171 RKVGTTV---KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP-YWEWEQWLKRKN  246 (378)
T ss_pred             cccCcee---hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch-HHHHHHHhcccC
Confidence            7643211   11223557899987642   2  2467899999999999999999999843322211 111111111122


Q ss_pred             CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCH
Q 042123          806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTM  840 (849)
Q Consensus       806 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  840 (849)
                      ++.|....   ....++.++.++-+.++|++|=..
T Consensus       247 ~~~P~~F~---~fs~~a~r~Fkk~lt~~~~drcki  278 (378)
T KOG1345|consen  247 PALPKKFN---PFSEKALRLFKKSLTPRFKDRCKI  278 (378)
T ss_pred             ccCchhhc---ccCHHHHHHHHHhcCCcccccchh
Confidence            23332222   122345566678899999998433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=3.4e-24  Score=216.13  Aligned_cols=201  Identities=32%  Similarity=0.577  Sum_probs=165.3

Q ss_pred             ecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEeccCCC
Q 042123          596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       596 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ||+|++|.||++... +++.+++|++.......   ....+.+|+.           .+++++......++|+||+++++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS---LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh---HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999775 48999999987643211   1233444433           25556666678999999999999


Q ss_pred             hhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeecCCcccCCCCCCeee
Q 042123          664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-EYEAHVADFGIAKSLKPDSSNWTE  742 (849)
Q Consensus       664 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~a~~~~~~~~~~~~  742 (849)
                      |.+++....  ..+++.++..++.+++.+++|||+.   +++|+||+|.||+++. ++.++++|||.+............
T Consensus        78 l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (215)
T cd00180          78 LKDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT  152 (215)
T ss_pred             HHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhc
Confidence            999986542  3489999999999999999999999   9999999999999999 899999999999876544322344


Q ss_pred             ccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHH
Q 042123          743 FAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLIS  821 (849)
Q Consensus       743 ~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  821 (849)
                      ..+...|++||..... .++.++|+|++|++++++                                           ..
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~  189 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PE  189 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HH
Confidence            5678899999998877 788999999999999998                                           34


Q ss_pred             HHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          822 IMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       822 l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      +.+++..|++.+|++||+++++++++
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            77889999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.92  E-value=9.2e-26  Score=221.34  Aligned_cols=247  Identities=20%  Similarity=0.286  Sum_probs=176.4

Q ss_pred             hcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~-----  649 (849)
                      ..+|...+.+|.|+- .|..| ..-.+++||+|+......  .....++..+|           +..++.++...     
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~--n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ--NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc--cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            356777788999998 66666 333689999998765422  22222333333           22345554432     


Q ss_pred             -CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          650 -RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       650 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                       ..+|+|||||+. +|...+.     ..++.+.+..+..|+.+|+.|||+.   +|+||||||+||++..++.+||.|||
T Consensus        93 ~~e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   93 FQEVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             HHhHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence             367999999976 8888875     3478889999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-----------------
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-----------------  791 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-----------------  791 (849)
                      +|+....+ -..+..+.+..|.|||++.+..|.+.+||||.||++.||++|+.-|...+..+.                 
T Consensus       164 ~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  164 LARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             hhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            99876544 345667889999999999998899999999999999999999988764332111                 


Q ss_pred             -------------cccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          792 -------------SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       792 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                   +++........+-|..++...+...-......+++.+|+..+|++|-+++++++|
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                         0000000000011111221111111122336688889999999999999999876

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=8.9e-26  Score=240.57  Aligned_cols=245  Identities=24%  Similarity=0.341  Sum_probs=187.5

Q ss_pred             cCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHH-------HHHHHHHHhhceeecCCeeEEEEEec
Q 042123          588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQK-------EFLTEVEAFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~-------~~~~ei~~~~~~~~~~~~~~lV~e~~  659 (849)
                      ++|+...++|.|.||.||||+ ...++..|||.++-.....-...++       .-+.+|..++|-+...+..|++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            678889999999999999995 4579999999886543222221122       22334778999888999999999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN  739 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  739 (849)
                      .+|+|++.-+.   .+.+++.++..+.+...+|++|||+.   +-+|||||--||+++..|.+|++|||.+..+..--..
T Consensus        95 gggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K  168 (829)
T KOG0576|consen   95 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK  168 (829)
T ss_pred             CCCcccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh
Confidence            99999998654   34689999999999999999999999   8899999999999999999999999999877655445


Q ss_pred             eeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC-CCCCCCChhh
Q 042123          740 WTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD-PRLPAPSRSA  815 (849)
Q Consensus       740 ~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  815 (849)
                      ...+.||+.|||||+..   .+.|...+|||+.|+...|+-.-+.|-..........    -....-.+ +++..+    
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~----LmTkS~~qpp~lkDk----  240 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF----LMTKSGFQPPTLKDK----  240 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH----HhhccCCCCCcccCC----
Confidence            66789999999999863   5679999999999999999988887733222111100    01111111 222221    


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+|++.|+.++|++|||++-++.|
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence            2233458889999999999999999887653

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=1.8e-24  Score=211.64  Aligned_cols=165  Identities=23%  Similarity=0.274  Sum_probs=123.9

Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCee
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT  741 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  741 (849)
                      |+|.+++....  ..+++.+++.++.||+.||+|||+.   +      ||+||+++.++.+|+  ||.++......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            68999986532  3599999999999999999999998   5      999999999999999  99988654322    


Q ss_pred             eccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH-
Q 042123          742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI-  820 (849)
Q Consensus       742 ~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  820 (849)
                       ..|++.|+|||++.+..++.++|||||||++|||++|+.||........   ......... ....+........... 
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~~~  138 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA---ILEILLNGM-PADDPRDRSNLESVSAA  138 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH---HHHHHHHHh-ccCCccccccHHHHHhh
Confidence             2688999999999999999999999999999999999999864322110   000000000 0110100011112222 


Q ss_pred             -HHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          821 -SIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       821 -~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       .+.+++.+||+.+|++|||+.|+++++.
T Consensus       139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      139 RSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             hhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence             5889999999999999999999999864

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.90  E-value=2.9e-24  Score=225.33  Aligned_cols=190  Identities=22%  Similarity=0.310  Sum_probs=155.8

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCC-C------------chhhH-----HHHHHHHHHhhceee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPC-D------------QTVDQ-----KEFLTEVEAFYGFCS  647 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~------------~~~~~-----~~~~~ei~~~~~~~~  647 (849)
                      ..+|...+.+|.|+||.|+.|.++ +...|+||.+.+...- +            .....     +.-+.+|.+++.+++
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            357888999999999999999665 4567888977542110 0            00101     111345778999999


Q ss_pred             cCCeeEEEEEeccC-CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          648 HARHSFLLYEFLER-GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       648 ~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                      +++.+|++||-... .+|.++++...   .+++.++..|++||+.|+++||+.   +|||||||-+||.++.+|-+|++|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            99999999997754 58889987644   489999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCC
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD  784 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~  784 (849)
                      ||.|.....  .+...++||..|.|||.+.+..| ...-|||++|+++|.++....||-
T Consensus       714 fgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999987653  34677899999999999999888 455899999999999999998863

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=1.4e-23  Score=240.66  Aligned_cols=267  Identities=24%  Similarity=0.316  Sum_probs=167.2

Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCC
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND  165 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  165 (849)
                      -..|+|++|.|+ .+|..+.  ++|+.|++++|+|+. +|.   ..++|++|+|++|+|+. +|..   .++|+.|+|++
T Consensus       203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~  271 (788)
T PRK15387        203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFS  271 (788)
T ss_pred             CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccC
Confidence            445666666666 3444443  356666666666663 332   13556666666666653 2321   24555666666


Q ss_pred             CcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCC
Q 042123          166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP  245 (849)
Q Consensus       166 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  245 (849)
                      |.+..++. .   .++|+.|+|++|+++ .+|.   .+++|+.|+|++|+|++ +|...   .+|+.|++++|.++ .+|
T Consensus       272 N~L~~Lp~-l---p~~L~~L~Ls~N~Lt-~LP~---~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP  338 (788)
T PRK15387        272 NPLTHLPA-L---PSGLCKLWIFGNQLT-SLPV---LPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLP  338 (788)
T ss_pred             Cchhhhhh-c---hhhcCEEECcCCccc-cccc---cccccceeECCCCcccc-CCCCc---ccccccccccCccc-ccc
Confidence            66554322 1   234555566666655 3333   13455566666665553 22211   23444455555544 222


Q ss_pred             cchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCC
Q 042123          246 PSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNL  325 (849)
Q Consensus       246 ~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  325 (849)
                      .                       .   ..+|+.|+|++|+|++ +|..   ..+|+.|++++|+|+.+ |..   ..+|
T Consensus       339 ~-----------------------l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~L-P~l---~~~L  384 (788)
T PRK15387        339 T-----------------------L---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSL-PAL---PSGL  384 (788)
T ss_pred             c-----------------------c---ccccceEecCCCccCC-CCCC---CcccceehhhccccccC-ccc---cccc
Confidence            1                       1   1367788888888874 4443   24677888889988854 332   3578


Q ss_pred             CEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCc
Q 042123          326 TFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGN  405 (849)
Q Consensus       326 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  405 (849)
                      +.|+|++|++.+ +|..   .++|+.|++++|.++ .+|..+   .+|+.|++++|+|+ .+|..+..+++|+.|+|++|
T Consensus       385 ~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N  455 (788)
T PRK15387        385 KELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN  455 (788)
T ss_pred             ceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence            999999999985 4433   357999999999998 467543   46889999999998 78999999999999999999


Q ss_pred             cccccCcccccccc
Q 042123          406 QITGRLPKEIGSLT  419 (849)
Q Consensus       406 ~l~~~~p~~~~~l~  419 (849)
                      +|++..|..+..+.
T Consensus       456 ~Ls~~~~~~L~~l~  469 (788)
T PRK15387        456 PLSERTLQALREIT  469 (788)
T ss_pred             CCCchHHHHHHHHh
Confidence            99987777665443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=5.3e-24  Score=256.36  Aligned_cols=191  Identities=16%  Similarity=0.170  Sum_probs=136.3

Q ss_pred             HHHHHhhcee-------ecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 042123          637 TEVEAFYGFC-------SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDI  709 (849)
Q Consensus       637 ~ei~~~~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl  709 (849)
                      ..|..+++++       .+....+.++||+ +++|.+++....  ..+++.++..++.||+.||+|||++   +|+||||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDl  106 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNV  106 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            3666777766       2334677889988 559999996432  4589999999999999999999998   9999999


Q ss_pred             CCCCeeecCC-------------------CcEEEeeecCCcccCCCC----------------CCeeeccCCcccccccc
Q 042123          710 SSKNLLLDLE-------------------YEAHVADFGIAKSLKPDS----------------SNWTEFAGTCGYIAPEL  754 (849)
Q Consensus       710 k~~Nill~~~-------------------~~~kl~DfG~a~~~~~~~----------------~~~~~~~g~~~y~aPE~  754 (849)
                      ||+|||++..                   +.+|++|||+++......                .......||+.|+|||+
T Consensus       107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  186 (793)
T PLN00181        107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE  186 (793)
T ss_pred             CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence            9999999653                   455666666665321100                00112357888999999


Q ss_pred             ccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCC
Q 042123          755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESP  834 (849)
Q Consensus       755 ~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  834 (849)
                      +.+..++.++|||||||++|||++|..|+......          .........++.  . ........+++.+||+++|
T Consensus       187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----------~~~~~~~~~~~~--~-~~~~~~~~~~~~~~L~~~P  253 (793)
T PLN00181        187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----------MSSLRHRVLPPQ--I-LLNWPKEASFCLWLLHPEP  253 (793)
T ss_pred             hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----------HHHHHHhhcChh--h-hhcCHHHHHHHHHhCCCCh
Confidence            99999999999999999999999998886522110          000000011110  0 1112235577889999999


Q ss_pred             CCCCCHHHHHhh
Q 042123          835 ESRPTMKIISQQ  846 (849)
Q Consensus       835 ~~RPt~~eil~~  846 (849)
                      .+|||+.|++++
T Consensus       254 ~~Rps~~eil~h  265 (793)
T PLN00181        254 SCRPSMSELLQS  265 (793)
T ss_pred             hhCcChHHHhhc
Confidence            999999999876

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=1.5e-23  Score=214.12  Aligned_cols=194  Identities=24%  Similarity=0.366  Sum_probs=151.8

Q ss_pred             HHHHhcCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHH------HHHhhceeecCCee
Q 042123          583 IVKATNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTE------VEAFYGFCSHARHS  652 (849)
Q Consensus       583 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~e------i~~~~~~~~~~~~~  652 (849)
                      +....+.|..+++||+|.|++||+|...    .++.||+|.+...........+.+.+.+      +..+.++...++.+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            4445578889999999999999999432    4788999998765433332233333322      34577788889999


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCCc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAK  731 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a~  731 (849)
                      .+|+||++.....++..      .++..++..+++.+..||.++|+.   |||||||||+|++.+.. +.-.|.|||+|.
T Consensus       111 ~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             EEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence            99999999998888863      377889999999999999999999   99999999999999866 678999999987


Q ss_pred             ccCCCC---------------------------------C-----------CeeeccCCccccccccccC-CCCCccchH
Q 042123          732 SLKPDS---------------------------------S-----------NWTEFAGTCGYIAPELAYT-MKITEKCDV  766 (849)
Q Consensus       732 ~~~~~~---------------------------------~-----------~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv  766 (849)
                      ......                                 .           ......||++|+|||++.. ...+.+.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            211000                                 0           0112468999999999875 456889999


Q ss_pred             HHHHHHHHHHHhCCCCCCc
Q 042123          767 YSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       767 ~SlGvil~el~tg~~Pf~~  785 (849)
                      ||.||++..++++++||-.
T Consensus       262 ws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             eeccceeehhhcccccccc
Confidence            9999999999999999864

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.90  E-value=3.1e-23  Score=237.85  Aligned_cols=268  Identities=23%  Similarity=0.268  Sum_probs=194.8

Q ss_pred             CCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCC
Q 042123           54 SNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSN  133 (849)
Q Consensus        54 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~  133 (849)
                      ..-..|+|+.|.|+. +|..+        .++|+.|++++|.|+. +|.   .+++|++|+|++|+|+.+ |..   .++
T Consensus       201 ~~~~~LdLs~~~Lts-LP~~l--------~~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsL-P~l---p~s  263 (788)
T PRK15387        201 NGNAVLNVGESGLTT-LPDCL--------PAHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSL-PVL---PPG  263 (788)
T ss_pred             CCCcEEEcCCCCCCc-CCcch--------hcCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcc-cCc---ccc
Confidence            456789999999983 33322        2479999999999995 454   258999999999999964 533   468


Q ss_pred             CceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccC
Q 042123          134 LIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQ  213 (849)
Q Consensus       134 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  213 (849)
                      |+.|+|++|.++. +|..+   .+|+.|+|++|+++.++.    .+++|++|+|++|++++ +|..   ..+|+.|++++
T Consensus       264 L~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~LP~----~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~  331 (788)
T PRK15387        264 LLELSIFSNPLTH-LPALP---SGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAYN  331 (788)
T ss_pred             cceeeccCCchhh-hhhch---hhcCEEECcCCccccccc----cccccceeECCCCcccc-CCCC---ccccccccccc
Confidence            9999999999984 44433   578899999999998643    35789999999999984 5543   34688999999


Q ss_pred             CcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCC
Q 042123          214 NQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPT  293 (849)
Q Consensus       214 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~  293 (849)
                      |+|+. +|..   ..+|++|+|++|+++ .+|...                          .+|+.|++++|+++. +|.
T Consensus       332 N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp--------------------------~~L~~L~Ls~N~L~~-LP~  379 (788)
T PRK15387        332 NQLTS-LPTL---PSGLQELSVSDNQLA-SLPTLP--------------------------SELYKLWAYNNRLTS-LPA  379 (788)
T ss_pred             Ccccc-cccc---ccccceEecCCCccC-CCCCCC--------------------------cccceehhhcccccc-Ccc
Confidence            99985 4532   247889999999987 455422                          123444445555442 333


Q ss_pred             CCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccc
Q 042123          294 SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQL  373 (849)
Q Consensus       294 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L  373 (849)
                      .   ..+|+.|++++|+|++.++ .   .++|+.|++++|++.+ +|..   ..+|+.|++++|+|+ .+|..+.++++|
T Consensus       380 l---~~~L~~LdLs~N~Lt~LP~-l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L  447 (788)
T PRK15387        380 L---PSGLKELIVSGNRLTSLPV-L---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSE  447 (788)
T ss_pred             c---ccccceEEecCCcccCCCC-c---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCC
Confidence            2   2456777777777775332 1   3578888888888874 4543   346788899999988 678888889999


Q ss_pred             cccccccccccccCchhhcCC
Q 042123          374 QAFDLSLNHIVGEIPKELGKL  394 (849)
Q Consensus       374 ~~L~L~~N~i~~~~~~~~~~l  394 (849)
                      +.|+|++|++++..+..+..+
T Consensus       448 ~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        448 TTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             CeEECCCCCCCchHHHHHHHH
Confidence            999999999988777766443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.89  E-value=1.9e-22  Score=205.80  Aligned_cols=188  Identities=30%  Similarity=0.488  Sum_probs=153.2

Q ss_pred             CCcCceecCCccceEEEEEecC-CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e  657 (849)
                      |+..+.||+|++|.||+|.... ++.+|+|.+......   .....+.+|+.           .+++++......++++|
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence            5567889999999999997654 899999998754222   12334444433           36667777788999999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      |+++++|.+++.....  .+++..+..++.+++.++.|||+.   +++|+|++|+||+++.++.++++|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       78 YCEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             ccCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            9999999999875432  178999999999999999999998   99999999999999999999999999998765432


Q ss_pred             -CCeeeccCCccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          738 -SNWTEFAGTCGYIAPELA-YTMKITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       738 -~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                       .......++..|++||.. ....++.++|||+||+++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence             122335677889999998 667788899999999999999999999963

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.1e-21  Score=224.58  Aligned_cols=224  Identities=25%  Similarity=0.425  Sum_probs=123.5

Q ss_pred             cccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEc
Q 042123           84 RYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL  163 (849)
Q Consensus        84 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  163 (849)
                      .+.+.|+++++.++. +|..+.  ++|+.|+|++|+|++ +|..+.  ++|++|++++|+++. +|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-IPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCcccc-CChhhh--ccccEEEC
Confidence            345677777777773 455443  467777777777774 343332  467777777777763 444433  36777777


Q ss_pred             CCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCC
Q 042123          164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS  243 (849)
Q Consensus       164 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  243 (849)
                      ++|.+..+ |..+.  .+|++|+|++|+|+ .+|+.+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|.++ .
T Consensus       249 s~N~L~~L-P~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt-~  318 (754)
T PRK15370        249 SINRITEL-PERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLT-A  318 (754)
T ss_pred             cCCccCcC-ChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCccc-c
Confidence            77777754 33332  46777777777776 4555443  467777777777774 343332  35677777777776 3


Q ss_pred             CCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCC
Q 042123          244 IPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYP  323 (849)
Q Consensus       244 ~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  323 (849)
                      +|..+. ..|+.|++++|.+++ +|..+.  ++|+.|++++|+++ .+|..+.  ++|+.|++++|+++.+++. +.  .
T Consensus       319 LP~~l~-~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~LP~~-l~--~  388 (754)
T PRK15370        319 LPETLP-PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLPEN-LP--A  388 (754)
T ss_pred             CCcccc-ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCCCHh-HH--H
Confidence            443322 235555555555553 232222  34555555555544 2333221  3445555555554433222 11  1


Q ss_pred             CCCEEeccCcccc
Q 042123          324 NLTFIDLSRNNFY  336 (849)
Q Consensus       324 ~L~~L~Ls~N~l~  336 (849)
                      .|+.|++++|++.
T Consensus       389 sL~~LdLs~N~L~  401 (754)
T PRK15370        389 ALQIMQASRNNLV  401 (754)
T ss_pred             HHHHHhhccCCcc
Confidence            3444445555444

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=2.1e-20  Score=184.34  Aligned_cols=246  Identities=16%  Similarity=0.237  Sum_probs=179.9

Q ss_pred             cCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHH------HhhceeecCCeeEEEEEecc
Q 042123          588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      -.|.+.++||+|+||++|.| .+-++++||||.-.......+...+-++.+-+.      .++-|..++.+-.+|+|.. 
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            47889999999999999999 566799999998665444333333334444332      3455566777888999998 


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-----cEEEeeecCCcccCC
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-----EAHVADFGIAKSLKP  735 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-----~~kl~DfG~a~~~~~  735 (849)
                      |-||+|+++-.  ++.++..++..+|.|++.-++|+|++   .+|+|||||+|+||...+     .+.++|||+|+.+..
T Consensus       107 GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  107 GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            66999988643  35699999999999999999999999   899999999999997654     488999999998865


Q ss_pred             CCCC-------eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          736 DSSN-------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       736 ~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      +...       .....||..||+-....+.+.+.+.|.=|+|-+++..+.|..||........     ....+++-+.+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-----K~kYeKIGe~Kr  256 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-----KEKYEKIGETKR  256 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-----HHHHHHhccccc
Confidence            4322       3345699999999999999999999999999999999999999987654322     122222322222


Q ss_pred             CCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042123          809 PAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIIS  844 (849)
Q Consensus       809 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil  844 (849)
                      ..+ ...+...+.++...+.-.-..+-.+-|+.+-+.
T Consensus       257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr  293 (449)
T KOG1165|consen  257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLR  293 (449)
T ss_pred             cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHH
Confidence            212 223333344455555555555666667765543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.9e-21  Score=185.93  Aligned_cols=234  Identities=19%  Similarity=0.313  Sum_probs=168.6

Q ss_pred             cCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEEEEEecc
Q 042123          592 AKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ...+|.+...|+.|+|+|+ |..+++|++...  .-.....+.|.+|           |..++|.|..+.+..++..||+
T Consensus       194 l~tkl~e~hsgelwrgrwq-gndivakil~vr--~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQ-GNDIVAKILNVR--EVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhccCCCccccccccc-Ccchhhhhhhhh--hcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            4457899999999999996 666777765421  1112223344444           4458899999999999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe-cCCCCCCeeecCCCcEEEe--eecCCcccCCCC
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH-RDISSKNLLLDLEYEAHVA--DFGIAKSLKPDS  737 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH-~dlk~~Nill~~~~~~kl~--DfG~a~~~~~~~  737 (849)
                      .|+|+..++.... -..+..++.+++.+||+|++|||+..  +++- --+.++.+++|++.+++|+  |--++  +... 
T Consensus       271 ~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfs--fqe~-  344 (448)
T KOG0195|consen  271 FGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFS--FQEV-  344 (448)
T ss_pred             chHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceee--eecc-
Confidence            9999999987653 45688899999999999999999964  4444 4789999999999988874  32221  1111 


Q ss_pred             CCeeeccCCccccccccccCCCC---CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          738 SNWTEFAGTCGYIAPELAYTMKI---TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                          ...-.|.||+||.+...+-   -.++|+|||++++||+.|+..||........    +.+..-+-+...+++.  .
T Consensus       345 ----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----gmkialeglrv~ippg--i  414 (448)
T KOG0195|consen  345 ----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----GMKIALEGLRVHIPPG--I  414 (448)
T ss_pred             ----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----hhhhhhccccccCCCC--c
Confidence                1123678999999876543   3569999999999999999999986654322    2222223333344432  2


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          ...+.+++.-|++.||.+||.++.|+-.|+
T Consensus       415 ----s~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  415 ----SRHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             ----cHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence                223667888999999999999999886654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=5.6e-21  Score=180.05  Aligned_cols=252  Identities=18%  Similarity=0.282  Sum_probs=186.3

Q ss_pred             HhcCCCcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHH------HhhceeecCCeeEEEEEe
Q 042123          586 ATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------AFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e~  658 (849)
                      ..+.|..+++||.|+||.+|.| ...+|+.||||.-...........+....+-+.      .+..|..+...-.+|||.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            3468999999999999999999 667899999999776655544444444444433      355667778888999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeecCCcccCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEAHVADFGIAKSLKP  735 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~a~~~~~  735 (849)
                      . |.||++.+.-..  +.++..+++-.+-|++.-++|+|.+   +++||||||+|+|..-+   ..+.++|||+|+.+..
T Consensus        93 L-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             c-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            8 669999886433  4588999999999999999999999   89999999999999644   5689999999998754


Q ss_pred             CCC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          736 DSS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       736 ~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ...       ......||..|.+-....+...+.+.|+=|+|.++..+-.|..||+........     ...+.+...+.
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~-----QKyEkI~EkK~  241 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK-----QKYEKISEKKM  241 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----HHHHHHHHhhc
Confidence            321       134457899999988888888889999999999999999999999866533211     11122222222


Q ss_pred             CCCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+. ..+...+.++.-.+.-|-..--++-|+..-+.+.++
T Consensus       242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            2221 122233344666777888777788888777766554

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.84  E-value=9.3e-21  Score=219.24  Aligned_cols=247  Identities=26%  Similarity=0.386  Sum_probs=171.3

Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      .+...|+++++++++ +|..+.  ++|+.|+|++|+|+. +|..+.  .+|+.|+|++|+++.++ ..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~LtsLP-~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLTT-IPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTSIP-ATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccccCC-hhhh--ccccEEEC
Confidence            457889999999995 555443  579999999999984 455443  48999999999998754 3332  47899999


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                      ++|++. .+|..+.  .+|+.|++++|+|+. +|..+.  ++|+.|+|++|+++ .+|..+. ..|+.|++++|+++.. 
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp-~sL~~L~Ls~N~Lt~L-  319 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLP-SGITHLNVQSNSLTAL-  319 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccch-hhHHHHHhcCCccccC-
Confidence            999998 6676654  579999999999984 566553  47888888888887 4554432 2366666666666532 


Q ss_pred             CcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCC
Q 042123          268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFP  347 (849)
Q Consensus       268 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  347 (849)
                                              |..+  .++|+.|++++|.++++ |..+.  ++|+.|+|++|++. .+|..+  .+
T Consensus       320 ------------------------P~~l--~~sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~  367 (754)
T PRK15370        320 ------------------------PETL--PPGLKTLEAGENALTSL-PASLP--PELQVLDVSKNQIT-VLPETL--PP  367 (754)
T ss_pred             ------------------------Cccc--cccceeccccCCccccC-Chhhc--CcccEEECCCCCCC-cCChhh--cC
Confidence                                    2221  13566666666666643 33332  57777777777776 344444  25


Q ss_pred             CCcEEeccCCccccCCCCCccccccccccccccccccccCch----hhcCCCCCcEEEccCcccc
Q 042123          348 KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPK----ELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       348 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~----~~~~l~~L~~L~L~~N~l~  408 (849)
                      +|+.|+|++|.++ .+|..+.  ..|+.|++++|++. .+|.    .+..++++..|+|.+|+++
T Consensus       368 ~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls  428 (754)
T PRK15370        368 TITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS  428 (754)
T ss_pred             CcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence            7888888888887 4565543  36888888888887 4444    3445688899999999887

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=5.3e-20  Score=197.48  Aligned_cols=247  Identities=20%  Similarity=0.235  Sum_probs=171.5

Q ss_pred             CCCcCceecCCccceEEEEEecCC--cEEEEEEecccCCCC--chhhHHHHHHHHH---------Hhhcee-ecCCeeEE
Q 042123          589 DFDAKYCIGNGGHASVYRAELPSG--EVVAVKKFHSLLPCD--QTVDQKEFLTEVE---------AFYGFC-SHARHSFL  654 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~--~~~~~~~~~~ei~---------~~~~~~-~~~~~~~l  654 (849)
                      .|.+.+.||+|+||.||.|.....  ..+|+|.........  ....+......+.         .+++.+ ..+...|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999965443  578888766532221  1122223333333         233444 35567899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-----CcEEEeeecC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-----YEAHVADFGI  729 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~DfG~  729 (849)
                      ||+.+ |.+|.++..... .+.++..++.+++.|++.+|+++|+.   |++||||||.|+.++..     ..+.+.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 669999875544 56799999999999999999999999   99999999999999865     3589999999


Q ss_pred             Cc--ccCCCCC-------C-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 042123          730 AK--SLKPDSS-------N-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       730 a~--~~~~~~~-------~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      ++  .+.....       . ...+.||..|+++..+.+...+.+.|+||++.++.|+..|..||................
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            99  3322111       1 234569999999999999999999999999999999999999996544221110000000


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      .......    .......   .+.++...+-..+..++|....+...+
T Consensus       254 ~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~Pdy~~~~~~l  294 (322)
T KOG1164|consen  254 RKLLTDR----FGDLKPE---EFAKILEYIDSLDYEDKPDYEKLAELL  294 (322)
T ss_pred             hhhcccc----ccCCChH---HHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence            0000110    0111112   244444455557899999998887664

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=8.9e-20  Score=207.42  Aligned_cols=244  Identities=19%  Similarity=0.238  Sum_probs=165.8

Q ss_pred             cCceecCCccceEEEEE-ecCCcEEEEEEecccC-CCCc-hhhHHHHHHHHHH-----------hhceeecCCeeEEEEE
Q 042123          592 AKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLL-PCDQ-TVDQKEFLTEVEA-----------FYGFCSHARHSFLLYE  657 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~-~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~e  657 (849)
                      ..+.+|.|++|.|+.+. ....+..+.|.+.... .... ......+..|+..           ....+.+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            45689999999888873 3345555655543110 1111 1111112222110           1111122222333499


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      ||++ +|..++.+.   ..++..++-.+++|+..|++|+|+.   ||.|||+|++|++++.+|.+||+|||.+..+.-+.
T Consensus       402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 999998764   2488899999999999999999999   99999999999999999999999999988665443


Q ss_pred             C----CeeeccCCccccccccccCCCCCcc-chHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          738 S----NWTEFAGTCGYIAPELAYTMKITEK-CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       738 ~----~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      +    .....+|+.+|+|||.+.+..|.+. .||||.|+++..|.+|+.||........... ......  .......+.
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-~~~~~~--~~~~~~~~~  551 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-TNNYSD--QRNIFEGPN  551 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-hhcccc--ccccccChH
Confidence            2    2455789999999999999999776 8999999999999999999975432211100 000000  000111122


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~  845 (849)
                      .........-..++.++++.+|.+|-|+++|++
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            223333445678888999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=4.5e-20  Score=207.65  Aligned_cols=236  Identities=22%  Similarity=0.242  Sum_probs=168.3

Q ss_pred             CCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH----------hhceeecCCeeEEEEEe
Q 042123          589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----------FYGFCSHARHSFLLYEF  658 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~----------~~~~~~~~~~~~lV~e~  658 (849)
                      ++...+.+|++.|=+|.+|++..|. |+||+|-+..+.-......+.++++..          +..+-......|+|-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            6777889999999999999887776 899998665433333333333333331          11111234456888899


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc--CCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL--KPD  736 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~--~~~  736 (849)
                      +.. +|+|.+....   -+..-+...|+.|+..|+..+|..   +|+|||||.+|||++.-..+.++||..-+..  +.+
T Consensus       103 vkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             Hhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            877 9999986543   367788899999999999999999   9999999999999999999999999876532  222


Q ss_pred             CCC-----eeeccCCccccccccccCC----------C-CCccchHHHHHHHHHHHHh-CCCCCCcccccccc---cccc
Q 042123          737 SSN-----WTEFAGTCGYIAPELAYTM----------K-ITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSS---SLNT  796 (849)
Q Consensus       737 ~~~-----~~~~~g~~~y~aPE~~~~~----------~-~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~---~~~~  796 (849)
                      ...     ..+......|.|||.+...          . .+++.||||+||+++|+++ |++||.-..-..+.   ....
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~  255 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDP  255 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCH
Confidence            211     2233345679999987531          1 5788999999999999998 78888743222221   1112


Q ss_pred             ccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          797 DVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +..++++-|.              .+..++..|++.||++|.++++.++.
T Consensus       256 e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence            2222222221              26788889999999999999999875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=6.2e-19  Score=187.77  Aligned_cols=160  Identities=19%  Similarity=0.211  Sum_probs=115.8

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec--CCcEEEEEEecccCCC-CchhhHHHHHHHHHHhhce--------eecCCeeE
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP--SGEVVAVKKFHSLLPC-DQTVDQKEFLTEVEAFYGF--------CSHARHSF  653 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~~~ei~~~~~~--------~~~~~~~~  653 (849)
                      ...+.|...+.||+|+||+||+|.+.  +++.||||+....... ........+.+|+..+...        ....+..|
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~   94 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDG   94 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcE
Confidence            34578999999999999999999654  5788899987532110 1122344566676542111        11234679


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeecCCCcEEEeeecCCcc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDI-SSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +||||+++++|... ..      ..   ...++.|++.||+|||+.   +|+|||| ||+||+++.++.+||+|||+|+.
T Consensus        95 LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~  161 (365)
T PRK09188         95 LVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASV  161 (365)
T ss_pred             EEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence            99999999999732 11      11   146788999999999998   9999999 99999999999999999999997


Q ss_pred             cCCCCCC--------eeeccCCccccccccccC
Q 042123          733 LKPDSSN--------WTEFAGTCGYIAPELAYT  757 (849)
Q Consensus       733 ~~~~~~~--------~~~~~g~~~y~aPE~~~~  757 (849)
                      +......        .....+++.|+|||++..
T Consensus       162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            6543211        134557788999998753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=4e-19  Score=180.65  Aligned_cols=225  Identities=20%  Similarity=0.291  Sum_probs=142.1

Q ss_pred             CCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHHHh---h------------------c--
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF---Y------------------G--  644 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~---~------------------~--  644 (849)
                      .+...+.||.|+++.||.+++. +++++|||.+.... .......+.+.+|...+   .                  +  
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            3445678999999999999664 68999999987554 33333344455443210   0                  0  


Q ss_pred             -------eeecC---C-----eeEEEEEeccCCChhhhhcc---ccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 042123          645 -------FCSHA---R-----HSFLLYEFLERGSLAAILNT---DAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPPIV  705 (849)
Q Consensus       645 -------~~~~~---~-----~~~lV~e~~~~gsL~~~l~~---~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iv  705 (849)
                             +....   .     ..+++|+-+. ++|.+++..   ... ...+....+..+..|+++.+++||+.   |++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceE
Confidence                   11111   1     2256777774 488887642   111 11233455677789999999999999   999


Q ss_pred             ecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccC--------CCCCccchHHHHHHHHHHHH
Q 042123          706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT--------MKITEKCDVYSFGVLMWEVI  777 (849)
Q Consensus       706 H~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~el~  777 (849)
                      |+||+|+|++++++|.++++||+.......   .......+..|.+||....        ..++++.|.|++|+++|.|+
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~---~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGT---RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTE---EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCc---eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999987765432   2222345677999997643        24788999999999999999


Q ss_pred             hCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCC
Q 042123          778 KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESR  837 (849)
Q Consensus       778 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  837 (849)
                      +|..||+..........                ....+.+.+..+..+|..+++++|.+|
T Consensus       245 C~~lPf~~~~~~~~~~~----------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW----------------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG----------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc----------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            99999984432211110                111122445568889999999999988

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.77  E-value=5.9e-21  Score=170.48  Aligned_cols=183  Identities=28%  Similarity=0.481  Sum_probs=134.1

Q ss_pred             CCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccccccc
Q 042123          295 LRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQ  374 (849)
Q Consensus       295 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~  374 (849)
                      +.++..+++|.|++|+++ ..|..+..+.+|+.|++++|++. .+|..++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus        29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le  105 (264)
T KOG0617|consen   29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE  105 (264)
T ss_pred             ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence            344566677777777777 34445666777777777777776 56666777777777777777777 6777777777777


Q ss_pred             ccccccccccc-cCchhhcCCCCCcEEEccCccccccCccccccccccccccccc--CCCCChhhhcccccceeccCCcc
Q 042123          375 AFDLSLNHIVG-EIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNN  451 (849)
Q Consensus       375 ~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~  451 (849)
                      .|||++|.+.. ..|..|..++.|+-|+|+.|.+. .+|..++.|++|+.|.+.+  +-++|.+++.+++|+.|.+.+|+
T Consensus       106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccce
Confidence            77777777753 45777777777777777777777 7777777777777777664  55778888888999999999999


Q ss_pred             cccCCCccccccCC---CcEEeccCCccccCCCC
Q 042123          452 LSGSIPSCFEGMHG---LSFIDMSYNELQCPVPN  482 (849)
Q Consensus       452 l~~~~p~~~~~l~~---L~~l~l~~N~l~~~~~~  482 (849)
                      ++ .+|..++.+.-   =+.+.+..|||.-++.+
T Consensus       185 l~-vlppel~~l~l~~~k~v~r~E~NPwv~pIae  217 (264)
T KOG0617|consen  185 LT-VLPPELANLDLVGNKQVMRMEENPWVNPIAE  217 (264)
T ss_pred             ee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence            98 77777766542   34566788888766544

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=1.7e-20  Score=167.59  Aligned_cols=165  Identities=35%  Similarity=0.559  Sum_probs=138.5

Q ss_pred             CCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCE
Q 042123           81 GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFD  160 (849)
Q Consensus        81 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  160 (849)
                      .++.++++|.|++|.++ .+|+.++.+.+|+.|++++|+|+ ..|..++.+++|+.|+++-|++. +.|..|+.++.|+.
T Consensus        30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev  106 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV  106 (264)
T ss_pred             cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence            34666777888888887 56778888899999999999998 67788889999999999999887 77888999999999


Q ss_pred             EEcCCCcccc-cCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccc
Q 042123          161 LQLNDNQLIG-YIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH  239 (849)
Q Consensus       161 L~L~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  239 (849)
                      |||.+|.+.. ..|+.|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+++|++|.+.+|+
T Consensus       107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr  184 (264)
T KOG0617|consen  107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR  184 (264)
T ss_pred             hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence            9998888864 46888888888999999999887 77888889999999999999887 578888999999999999999


Q ss_pred             ccCCCCcchhhh
Q 042123          240 LSGSIPPSLGNL  251 (849)
Q Consensus       240 l~~~~p~~~~~~  251 (849)
                      ++ .+|+.++++
T Consensus       185 l~-vlppel~~l  195 (264)
T KOG0617|consen  185 LT-VLPPELANL  195 (264)
T ss_pred             ee-ecChhhhhh
Confidence            87 777766655

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.76  E-value=1.4e-17  Score=181.29  Aligned_cols=249  Identities=25%  Similarity=0.401  Sum_probs=175.4

Q ss_pred             CCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEEEEE
Q 042123          590 FDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFLLYE  657 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~lV~e  657 (849)
                      |...+.+|.|+||.||++...  ..+|+|.+........ .....+.+|+.            .+.+++......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccch-hHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            566788999999999999775  7899998876543322 12334444433            23444555556799999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCcccCCC
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSLKPD  736 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~  736 (849)
                      |+.++++.+++........++......++.|++.+++|+|+.   +++|||+||+||+++..+ .++++|||.++.....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999997765432112588899999999999999999999   899999999999999998 7999999999865543


Q ss_pred             CC------CeeeccCCccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042123          737 SS------NWTEFAGTCGYIAPELAYT---MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       737 ~~------~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      ..      ......++..|+|||...+   ..+....|+||+|++++++++|..||........ .............+.
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA-TSQTLKIILELPTPS  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc-HHHHHHHHHhcCCcc
Confidence            32      2356789999999999987   5788899999999999999999999764332100 000000000000000


Q ss_pred             CCCCChh--hHHHHHHHHHHHhhccCCCCCCCCCHHHHHh
Q 042123          808 LPAPSRS--AQEKLISIMEVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       808 ~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~eil~  845 (849)
                      .......  .......+.+++..|+..+|..|.++.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            0000000  0111234778888999999999999887654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.75  E-value=2.8e-18  Score=185.53  Aligned_cols=204  Identities=25%  Similarity=0.463  Sum_probs=153.0

Q ss_pred             HHHHHHhhceeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCCCCCCe
Q 042123          636 LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI-VHRDISSKNL  714 (849)
Q Consensus       636 ~~ei~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-vH~dlk~~Ni  714 (849)
                      +.++..++|.+.++...+.|.+||..|+|.+.+....  .+++|.-...++++|+.||+|+|..   +| +|+.++++|.
T Consensus         6 h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    6 HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKSSNC   80 (484)
T ss_pred             hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeeccccc
Confidence            3467789999999999999999999999999997633  4689999999999999999999997   44 8999999999


Q ss_pred             eecCCCcEEEeeecCCcccCCC--CCCeeeccCCccccccccccCC-------CCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          715 LLDLEYEAHVADFGIAKSLKPD--SSNWTEFAGTCGYIAPELAYTM-------KITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       715 ll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                      +++....+|++|||+.......  ...........-|.|||.+...       ..+.+.||||||++++|+++.+.||+.
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998766421  1111122234569999988753       146779999999999999999999985


Q ss_pred             cccccccccccccccccccC-CCCCCCChh--hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          786 LSSISSSSLNTDVALDQMLD-PRLPAPSRS--AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .......    ++....+.+ +.-+..+..  ..+....+..++.+||..+|++||++++|...++
T Consensus       161 ~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  161 RNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             ccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            4332211    122222222 221111111  1133346889999999999999999999987664

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=2.7e-20  Score=201.07  Aligned_cols=110  Identities=19%  Similarity=0.095  Sum_probs=47.8

Q ss_pred             EEeCcCCccc-cCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccc------cCCccCCC
Q 042123           34 YLDLTWNGFF-GTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSG------FIPPHIGN  106 (849)
Q Consensus        34 ~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~------~~~~~~~~  106 (849)
                      .|+|+.+.+. +.....|..+.+|+.|+|+++.++......+.  ..+...+++++|+++++.+.+      .++..+..
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~--~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~   79 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALA--SALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTK   79 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHH--HHHhhCCCceEEeccccccCCcchHHHHHHHHHHh
Confidence            3455555554 33334444555566666666555422111111  112223334444444443331      12233444


Q ss_pred             CCCCCEEEccCCcccCCCCCCCcCCCC---CceeeccCcccc
Q 042123          107 LKFLSQLDLTNNKFSGPIPLSFDNLSN---LIFLYLYGNLLS  145 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~~~~~~~~~~l~~---L~~L~L~~N~l~  145 (849)
                      +++|++|++++|.+....+..|..+.+   |++|++++|+++
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~  121 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLG  121 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccc
Confidence            555555555555554333333333333   555555555544

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.74  E-value=1.6e-17  Score=162.79  Aligned_cols=135  Identities=22%  Similarity=0.244  Sum_probs=96.0

Q ss_pred             CceecCCccceEEEEEecCCcEEEEEEecccCCCCchh--------h--------------HHHHHHHHH---Hhhcee-
Q 042123          593 KYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTV--------D--------------QKEFLTEVE---AFYGFC-  646 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~--------~--------------~~~~~~ei~---~~~~~~-  646 (849)
                      ...||+|+||.||+|..++|++||||+++.........        .              ......|+.   .+...+ 
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            35799999999999987789999999987542211100        0              001112322   222111 


Q ss_pred             -----ecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeeecCCC
Q 042123          647 -----SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKNLLLDLEY  720 (849)
Q Consensus       647 -----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~Nill~~~~  720 (849)
                           ......++||||++++++.......   ..+++.+...++.|++.+|+|+ |+.   +|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CC
Confidence                 0112238999999998776543221   3588999999999999999999 677   999999999999998 57


Q ss_pred             cEEEeeecCCcccC
Q 042123          721 EAHVADFGIAKSLK  734 (849)
Q Consensus       721 ~~kl~DfG~a~~~~  734 (849)
                      .++++|||+|....
T Consensus       155 ~v~LiDFG~a~~~~  168 (190)
T cd05147         155 KLYIIDVSQSVEHD  168 (190)
T ss_pred             cEEEEEccccccCC
Confidence            89999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=4.1e-20  Score=199.62  Aligned_cols=57  Identities=19%  Similarity=0.138  Sum_probs=25.7

Q ss_pred             EeccCCccc-ccCCccCCCCCCCCEEEccCCcccCC----CCCCCcCCCCCceeeccCcccc
Q 042123           89 LVINDNSLS-GFIPPHIGNLKFLSQLDLTNNKFSGP----IPLSFDNLSNLIFLYLYGNLLS  145 (849)
Q Consensus        89 L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~  145 (849)
                      |+|..+.++ ......|..+.+|++|++++|.++..    ++..+...++|++|+++++.+.
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~   64 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG   64 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccC
Confidence            445555554 22333344445555555555555321    2223334444555555554443

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.71  E-value=7e-17  Score=159.17  Aligned_cols=134  Identities=23%  Similarity=0.276  Sum_probs=95.9

Q ss_pred             CceecCCccceEEEEEecCCcEEEEEEecccCCCCch----------------------hhHHHHHHHHH---Hhhceee
Q 042123          593 KYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT----------------------VDQKEFLTEVE---AFYGFCS  647 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~~~~~~~~ei~---~~~~~~~  647 (849)
                      ...||+|++|.||+|...+|+.||||.+.........                      ........|..   ++.....
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4579999999999998778999999998764221000                      00001112322   1111100


Q ss_pred             ------cCCeeEEEEEeccCCChhhh-hcccccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCC
Q 042123          648 ------HARHSFLLYEFLERGSLAAI-LNTDAAAQELGWSQRMNVIKAVAHALSYLHH-DCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       648 ------~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~  719 (849)
                            .....++||||++++++... +..    ..++..+..+++.|++.++.++|+ .   +|+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecCCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence                  01124799999999855433 322    247788999999999999999999 7   999999999999998 8


Q ss_pred             CcEEEeeecCCcccC
Q 042123          720 YEAHVADFGIAKSLK  734 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~  734 (849)
                      +.++++|||++....
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            999999999998764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.71  E-value=1.9e-17  Score=163.43  Aligned_cols=163  Identities=12%  Similarity=0.131  Sum_probs=117.0

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHH-----HHHHHHHH-----------hhceeec--
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQK-----EFLTEVEA-----------FYGFCSH--  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~-----~~~~ei~~-----------~~~~~~~--  648 (849)
                      .++|+..+.+|.|+||.||.+.. ++..+|||.+.............     .+.+|+..           ...++..  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            58899999999999999999866 57789999997654333222111     12344221           2222221  


Q ss_pred             ------CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 042123          649 ------ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA  722 (849)
Q Consensus       649 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  722 (849)
                            ....++||||++|.+|.++..       ++.    ....+++.++..+|+.   +++|||++|+||+++.+| +
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-E
Confidence                  245789999999999988731       222    2456999999999999   999999999999999999 9


Q ss_pred             EEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHH
Q 042123          723 HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI  777 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~  777 (849)
                      +++|||.......+...            ..+.....|..++|+||||+.+....
T Consensus       174 ~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        174 RIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence            99999988765322110            11344556778999999999877654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.70  E-value=1.4e-16  Score=184.19  Aligned_cols=191  Identities=22%  Similarity=0.233  Sum_probs=150.2

Q ss_pred             HhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCch---hhHHHHH----HHHHHhhceeecCCeeEEEEEe
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT---VDQKEFL----TEVEAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~----~ei~~~~~~~~~~~~~~lV~e~  658 (849)
                      .-+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....+--   +...+..    .-+..+..++.-.+..++|+||
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey  775 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY  775 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence            34577788899999999999998888999999986543322110   0011111    1122233444456777899999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-------CCcEEEeeecCCc
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-------EYEAHVADFGIAK  731 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~~~kl~DfG~a~  731 (849)
                      .+.|+|.+++..   .+.++|.-++.++.|+++.+++||..   +||||||||+|++|..       ...++|+|||.+.
T Consensus       776 ~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si  849 (974)
T KOG1166|consen  776 SPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI  849 (974)
T ss_pred             cccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence            999999999973   34589999999999999999999999   9999999999999943       2458999999987


Q ss_pred             ccC--CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 042123          732 SLK--PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP  782 (849)
Q Consensus       732 ~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~P  782 (849)
                      .+.  ++........+|-.+-.+|+..++.+++.+|-|.++.+++.|+.|++-
T Consensus       850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            553  334456677889999999999999999999999999999999999765

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.69  E-value=4.7e-18  Score=179.54  Aligned_cols=176  Identities=22%  Similarity=0.371  Sum_probs=138.9

Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      .+.|+.|++|+.++|.+|+.+.+.....++.....++.|++.|++|   +   +.+|+|+||.||+...+.++||.|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            3578999999999999999877777778899999999999999999   5   789999999999999999999999999


Q ss_pred             CcccCCCC------CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccccc
Q 042123          730 AKSLKPDS------SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       730 a~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      ........      ...+..+||..||+||.+.+..|+.++||||+|++++|+++ =..+|.           ......+
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~~d  471 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------RIATLTD  471 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhhhh
Confidence            88765543      12455679999999999999999999999999999999988 222221           2233344


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~  845 (849)
                      +.++.+++.  ...+... =..++.+++...|.+||++.+...
T Consensus       472 ~r~g~ip~~--~~~d~p~-e~~ll~~lls~~p~~RP~~~~~~~  511 (516)
T KOG1033|consen  472 IRDGIIPPE--FLQDYPE-EYTLLQQLLSPSPEERPSAIEVAL  511 (516)
T ss_pred             hhcCCCChH--HhhcCcH-HHHHHHHhcCCCcccCchHHHHhh
Confidence            455555522  2222222 236777999999999997766543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.67  E-value=8.7e-18  Score=181.01  Aligned_cols=217  Identities=25%  Similarity=0.338  Sum_probs=158.4

Q ss_pred             eecCCccceEEEEE----ecCCcEEEEEEecccCCCC----chhhHHHHHHHHH------HhhceeecCCeeEEEEEecc
Q 042123          595 CIGNGGHASVYRAE----LPSGEVVAVKKFHSLLPCD----QTVDQKEFLTEVE------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~----~~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ++|+|+||.|+.++    ...|.-+|.|...+.....    .....+.+..++.      .+.-.++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999773    2346778888765432211    1122333333333      12333455667889999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCe
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW  740 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  740 (849)
                      +|.+...+....   .+++.....+...+|-|++++|+.   +++|||+|++||+++.+|.+++.|||.++........ 
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999988876543   367788888999999999999999   9999999999999999999999999999876544322 


Q ss_pred             eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHH
Q 042123          741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI  820 (849)
Q Consensus       741 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  820 (849)
                         +||..|||||++.  ....++|.||||++++||+||..||..            +.+..+.......+.    +...
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~p~----~l~~  212 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEMPR----ELSA  212 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCCch----hhhH
Confidence               8999999999988  456789999999999999999999873            233333333443332    3333


Q ss_pred             HHHHHHhhccCCCCCCCCC
Q 042123          821 SIMEVAFSCFNESPESRPT  839 (849)
Q Consensus       821 ~l~~li~~cl~~dP~~RPt  839 (849)
                      ...+++..+...+|..|.-
T Consensus       213 ~a~~~~~~l~~r~p~nrLg  231 (612)
T KOG0603|consen  213 EARSLFRQLFKRNPENRLG  231 (612)
T ss_pred             HHHHHHHHHHhhCHHHHhc
Confidence            3566666788888887753

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=4.4e-16  Score=150.03  Aligned_cols=181  Identities=12%  Similarity=0.040  Sum_probs=126.7

Q ss_pred             CCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHHhhceee--------cCCeeEEEEEeccC
Q 042123          590 FDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCS--------HARHSFLLYEFLER  661 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~~~~~--------~~~~~~lV~e~~~~  661 (849)
                      +.....|++|+||+||.+.. .+.+++.+.+..............+.+|+..+.....        .-...++||||++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G   82 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAG   82 (218)
T ss_pred             cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecC
Confidence            34567899999999998866 5788887776543221111122245667665433211        11345899999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeeecCCCcEEEeeecCCcccCCCCCC-
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDI-SSKNLLLDLEYEAHVADFGIAKSLKPDSSN-  739 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dl-k~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  739 (849)
                      .+|......          ....++.|++.+++++|+.   ||+|||| ||.||+++.++.++|+|||+|......... 
T Consensus        83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~  149 (218)
T PRK12274         83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM  149 (218)
T ss_pred             ccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence            998754311          1235778999999999999   9999999 799999999999999999999865433211 


Q ss_pred             ------------eeeccCCccccccccccCC-CCC-ccchHHHHHHHHHHHHhCCCCCC
Q 042123          740 ------------WTEFAGTCGYIAPELAYTM-KIT-EKCDVYSFGVLMWEVIKGKHPRD  784 (849)
Q Consensus       740 ------------~~~~~g~~~y~aPE~~~~~-~~~-~~~Dv~SlGvil~el~tg~~Pf~  784 (849)
                                  ......++.|++|+..... ..+ .+.+.++-|.-+|.++||..|+.
T Consensus       150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence                        0011246777888754322 233 56789999999999999999965

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=1.6e-16  Score=179.41  Aligned_cols=206  Identities=23%  Similarity=0.340  Sum_probs=141.2

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHHHhhceeecCCeeEEEEEeccCCChhh
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAA  666 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~~~~~~~~~~~lV~e~~~~gsL~~  666 (849)
                      .+|+.++.|..|+||.||.++++ +.+++|.|. .+.         .-+.+++.      .-.+..+.|      |+-..
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq---------~lilRnil------t~a~npfvv------gDc~t  140 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ---------NLILRNIL------TFAGNPFVV------GDCAT  140 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcc-ccc---------chhhhccc------cccCCccee------chhhh
Confidence            58889999999999999999775 467788843 221         11222222      222344444      55555


Q ss_pred             hhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC--------
Q 042123          667 ILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS--------  738 (849)
Q Consensus       667 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~--------  738 (849)
                      .++...   .++.        +++.+++|+|+.   +|+|||+||+|.+|+.-|.+|++|||+++.......        
T Consensus       141 llk~~g---~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I  206 (1205)
T KOG0606|consen  141 LLKNIG---PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI  206 (1205)
T ss_pred             hcccCC---CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence            554322   2222        227899999998   999999999999999999999999999875422110        


Q ss_pred             -------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          739 -------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       739 -------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                             .....+||+.|+|||++..+.|....|.|++|+++||.+-|+.||+....        ++.+.+++...+..+
T Consensus       207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp--------eelfg~visd~i~wp  278 (1205)
T KOG0606|consen  207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFGQVISDDIEWP  278 (1205)
T ss_pred             HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH--------HHHHhhhhhhhcccc
Confidence                   02335799999999999999999999999999999999999999985432        122222222221111


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCC
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRP  838 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RP  838 (849)
                      .. ......+..+++.+.++.+|..|-
T Consensus       279 E~-dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  279 EE-DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cc-CcCCCHHHHHHHHHHHHhChHhhc
Confidence            11 111122367788899999999983

>smart00090 RIO RIO-like kinase

Probab=99.62  E-value=2.3e-15  Score=152.74  Aligned_cols=138  Identities=22%  Similarity=0.227  Sum_probs=99.9

Q ss_pred             CCCcCceecCCccceEEEEE--ecCCcEEEEEEecccCCCCch--------------------hhHHHHHHHHHH---hh
Q 042123          589 DFDAKYCIGNGGHASVYRAE--LPSGEVVAVKKFHSLLPCDQT--------------------VDQKEFLTEVEA---FY  643 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~ei~~---~~  643 (849)
                      -|++.+.||+|+||.||+|.  ..+|+.||||+++........                    .....+..|+..   +.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46778899999999999997  568999999998753211000                    001112233321   21


Q ss_pred             c-------eeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCee
Q 042123          644 G-------FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP-IVHRDISSKNLL  715 (849)
Q Consensus       644 ~-------~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~dlk~~Nil  715 (849)
                      .       .+. ....++||||++++++.......   ..+...+...++.|++.++++||+.   + |+||||||+||+
T Consensus       109 ~~~i~~p~~~~-~~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIl  181 (237)
T smart00090      109 EAGVPVPKPIA-WRRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNIL  181 (237)
T ss_pred             hcCCCCCeeeE-ecCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEE
Confidence            1       111 12458999999998887664222   2355667789999999999999999   8 999999999999


Q ss_pred             ecCCCcEEEeeecCCcccC
Q 042123          716 LDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       716 l~~~~~~kl~DfG~a~~~~  734 (849)
                      ++ ++.++++|||.+....
T Consensus       182 i~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      182 VH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EE-CCCEEEEEChhhhccC
Confidence            99 8899999999987543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.61  E-value=5.7e-15  Score=146.95  Aligned_cols=140  Identities=20%  Similarity=0.181  Sum_probs=99.9

Q ss_pred             HHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCch------------------hhHHHHHHHHH---H
Q 042123          583 IVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT------------------VDQKEFLTEVE---A  641 (849)
Q Consensus       583 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------~~~~~~~~ei~---~  641 (849)
                      +...-..|...+.||+|+||.||+|..++|+.||||++.........                  ........|+.   .
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33333447788899999999999998888999999987643210000                  00011222322   1


Q ss_pred             hhce------eecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 042123          642 FYGF------CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLL  715 (849)
Q Consensus       642 ~~~~------~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil  715 (849)
                      +.+.      .......++||||+++++|.+....         .....++.+++.++.++|+.   +|+||||+|+||+
T Consensus        90 l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nil  157 (198)
T cd05144          90 LYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNIL  157 (198)
T ss_pred             HHHcCCCCCceeecCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEE
Confidence            2111      0112355899999999998775421         34567889999999999998   9999999999999


Q ss_pred             ecCCCcEEEeeecCCcccC
Q 042123          716 LDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       716 l~~~~~~kl~DfG~a~~~~  734 (849)
                      +++++.++++|||++....
T Consensus       158 l~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         158 VDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             EcCCCcEEEEECCccccCC
Confidence            9999999999999996554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=7.9e-15  Score=148.43  Aligned_cols=181  Identities=22%  Similarity=0.334  Sum_probs=127.3

Q ss_pred             ecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCC--cE
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD--LEY--EA  722 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~--~~  722 (849)
                      .++...|+||.-++. +|..++....    .+.....-++.|+.+|+.|||.+   +|.|||+|++|||+.  .|+  ..
T Consensus       313 g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~L  384 (598)
T KOG4158|consen  313 GEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQL  384 (598)
T ss_pred             CCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEE
Confidence            356788999999977 9999997543    56677888999999999999999   999999999999993  333  57


Q ss_pred             EEeeecCCcccCCC------CCCeeeccCCccccccccccCCC------CCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 042123          723 HVADFGIAKSLKPD------SSNWTEFAGTCGYIAPELAYTMK------ITEKCDVYSFGVLMWEVIKGKHPRDFLSSIS  790 (849)
Q Consensus       723 kl~DfG~a~~~~~~------~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~  790 (849)
                      .++|||++-.....      ........|....||||+....+      --.|+|.|+.|.+.||+++...||-..+...
T Consensus       385 VvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~  464 (598)
T KOG4158|consen  385 VVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML  464 (598)
T ss_pred             EEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe
Confidence            89999987533221      11233456778899999875432      1247999999999999999999986422111


Q ss_pred             ccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHh
Q 042123          791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~  845 (849)
                      ..       ........++..++.   ....+.+++...++.||++|++..-...
T Consensus       465 L~-------~r~Yqe~qLPalp~~---vpp~~rqlV~~lL~r~pskRvsp~iAAN  509 (598)
T KOG4158|consen  465 LD-------TRTYQESQLPALPSR---VPPVARQLVFDLLKRDPSKRVSPNIAAN  509 (598)
T ss_pred             ec-------hhhhhhhhCCCCccc---CChHHHHHHHHHhcCCccccCCccHHHh
Confidence            10       011111222222221   2223678888999999999998754433

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.52  E-value=1.2e-13  Score=139.30  Aligned_cols=127  Identities=18%  Similarity=0.326  Sum_probs=96.3

Q ss_pred             ceecCCccceEEEEEecCCcEEEEEEecccCCCCch----hhHHHHHHHHHH-----------hhceeecCCeeEEEEEe
Q 042123          594 YCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT----VDQKEFLTEVEA-----------FYGFCSHARHSFLLYEF  658 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~e~  658 (849)
                      +.||+|++|.||+|.+ .|..++||+..........    .....+.+|+..           ...++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999987 6788999986543221111    111223334332           22334455677899999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++|++|.+++...      .+ ++..++.+++.++.++|+.   +++|||++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999988532      22 7889999999999999998   999999999999999 78999999998875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.51  E-value=1.1e-13  Score=136.56  Aligned_cols=133  Identities=23%  Similarity=0.236  Sum_probs=90.5

Q ss_pred             CceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHH--------------------HHHHHH---HHhhcee---
Q 042123          593 KYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQK--------------------EFLTEV---EAFYGFC---  646 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--------------------~~~~ei---~~~~~~~---  646 (849)
                      .+.||+|+||+||+|...+++.||||++.............                    ....|.   ..+....   
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            45799999999999988789999999886532211110000                    001111   1111110   


Q ss_pred             ---ecCCeeEEEEEeccCCChhhh-hcccccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCc
Q 042123          647 ---SHARHSFLLYEFLERGSLAAI-LNTDAAAQELGWSQRMNVIKAVAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYE  721 (849)
Q Consensus       647 ---~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~  721 (849)
                         ......++||||++++++... +....    .. .+...++.+++.++.++|. .   +|+||||||+||+++ ++.
T Consensus        82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~  152 (187)
T cd05119          82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGK  152 (187)
T ss_pred             CceEecCCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCc
Confidence               011345899999999654321 11100    11 5678999999999999999 7   999999999999999 899


Q ss_pred             EEEeeecCCcccC
Q 042123          722 AHVADFGIAKSLK  734 (849)
Q Consensus       722 ~kl~DfG~a~~~~  734 (849)
                      ++++|||.+....
T Consensus       153 ~~liDfg~a~~~~  165 (187)
T cd05119         153 VYIIDVPQAVEID  165 (187)
T ss_pred             EEEEECccccccc
Confidence            9999999997554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.50  E-value=1.8e-13  Score=136.61  Aligned_cols=124  Identities=17%  Similarity=0.316  Sum_probs=91.6

Q ss_pred             eecCCccceEEEEEecCCcEEEEEEecccCCCCc----hhhHHHHHHHHHH-----------hhceeecCCeeEEEEEec
Q 042123          595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ----TVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~e~~  659 (849)
                      .||+|+||.||+|.+ ++..+++|..........    .....++.+|+..           ...++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 578899998654321111    1112233344332           112233455668999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|++|.+++....         . .++.+++.++.++|+.   +++|||++|+||+++ ++.++++|||.+...
T Consensus        80 ~g~~l~~~~~~~~---------~-~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN---------D-ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH---------H-HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998874321         0 8899999999999998   999999999999999 899999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.47  E-value=4e-13  Score=154.40  Aligned_cols=132  Identities=17%  Similarity=0.262  Sum_probs=95.3

Q ss_pred             HhcCCCcCceecCCccceEEEEEecCCcEEEEEEe-cccCCCC---chhhHHHHHHHHHHh-----------hceeecCC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKF-HSLLPCD---QTVDQKEFLTEVEAF-----------YGFCSHAR  650 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~---~~~~~~~~~~ei~~~-----------~~~~~~~~  650 (849)
                      ....|...+.||+|+||+||+|.+... .+++|+. .+.....   .......+.+|+..+           ..++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            344556788999999999999987544 4444433 2211111   111223445554421           22334455


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..++||||+++++|.+++.           ....++.+++.++.|||+.   +++|||+||+||++ .++.++++|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccc
Confidence            6789999999999999874           3567899999999999998   99999999999999 6789999999998


Q ss_pred             ccc
Q 042123          731 KSL  733 (849)
Q Consensus       731 ~~~  733 (849)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            753

>PRK10345 hypothetical protein; Provisional

Probab=99.47  E-value=1.8e-13  Score=135.28  Aligned_cols=125  Identities=18%  Similarity=0.199  Sum_probs=86.9

Q ss_pred             CcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH----------------HhhceeecCC---e
Q 042123          591 DAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----------------AFYGFCSHAR---H  651 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~----------------~~~~~~~~~~---~  651 (849)
                      ...+.||+|+||.||.  +++....+||++......    ..+.+.+|+.                +++|++..+.   .
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~----~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~   78 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG----GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY   78 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccc----hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence            3456899999999996  443333479987643111    1233444433                3667666552   3


Q ss_pred             -eEEEEEe--ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeeecCC----CcEE
Q 042123          652 -SFLLYEF--LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL-SYLHHDCFPPIVHRDISSKNLLLDLE----YEAH  723 (849)
Q Consensus       652 -~~lV~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~dlk~~Nill~~~----~~~k  723 (849)
                       +.+|+||  +.+|+|.+++.+.    .+++.  ..++.|++.++ +|||+.   +|+||||||+||+++..    +.++
T Consensus        79 v~~~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         79 VYDVIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             EEEEEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence             3478999  6689999999653    25554  35677888777 999999   99999999999999743    4799


Q ss_pred             EeeecCC
Q 042123          724 VADFGIA  730 (849)
Q Consensus       724 l~DfG~a  730 (849)
                      |+||+-+
T Consensus       150 LiDg~G~  156 (210)
T PRK10345        150 VCDNIGE  156 (210)
T ss_pred             EEECCCC
Confidence            9995444

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.46  E-value=4.1e-15  Score=157.22  Aligned_cols=174  Identities=35%  Similarity=0.509  Sum_probs=122.0

Q ss_pred             cceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccC
Q 042123          277 LEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSM  356 (849)
Q Consensus       277 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  356 (849)
                      -...|++.|++. .+|..++.+..|+.+.|..|.+. .+|..+.++..|++|||+.|++. ..|..++.++ |+.|-+++
T Consensus        77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN  152 (722)
T KOG0532|consen   77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN  152 (722)
T ss_pred             hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence            345667777776 66777777777777777777776 56677777777777888877777 4555555554 77777888


Q ss_pred             CccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccccccccccccCCCCChhh
Q 042123          357 NNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQI  436 (849)
Q Consensus       357 N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~  436 (849)
                      |+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|.++..|                  
T Consensus       153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L------------------  211 (722)
T KOG0532|consen  153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL------------------  211 (722)
T ss_pred             Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC------------------
Confidence            8877 67777777777777888877776 56677777777777777777776 444444432                  


Q ss_pred             hcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCC
Q 042123          437 CNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPV  480 (849)
Q Consensus       437 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  480 (849)
                          .|.+||+|.|+++ .+|-+|..|..|++|-|.+|||+.+.
T Consensus       212 ----pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPP  250 (722)
T KOG0532|consen  212 ----PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPP  250 (722)
T ss_pred             ----ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence                3566667777776 66777777777777777777776544

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=2.3e-13  Score=151.27  Aligned_cols=199  Identities=36%  Similarity=0.553  Sum_probs=103.0

Q ss_pred             EEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCC-CCCEEeccCCcCccCCCcCccCccccchhhhccc
Q 042123          160 DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR-SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN  238 (849)
Q Consensus       160 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  238 (849)
                      .|.++.|.+.. ....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            45666665532 1223344456666666666666 4444455453 6666666666666 33445566666666666666


Q ss_pred             cccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhh
Q 042123          239 HLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEA  318 (849)
Q Consensus       239 ~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  318 (849)
                      ++. .+|...                                               ..++.|+.|++++|+++. +|..
T Consensus       174 ~l~-~l~~~~-----------------------------------------------~~~~~L~~L~ls~N~i~~-l~~~  204 (394)
T COG4886         174 DLS-DLPKLL-----------------------------------------------SNLSNLNNLDLSGNKISD-LPPE  204 (394)
T ss_pred             hhh-hhhhhh-----------------------------------------------hhhhhhhheeccCCcccc-Cchh
Confidence            665 232222                                               123333444444444432 1222


Q ss_pred             hCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCc
Q 042123          319 LGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLT  398 (849)
Q Consensus       319 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~  398 (849)
                      ......|++|++++|.+. ..+..+..+.++..|.+.+|++. ..+..+..+.+++.|++++|.++.. +. ++.+.+|+
T Consensus       205 ~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~  280 (394)
T COG4886         205 IELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLR  280 (394)
T ss_pred             hhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccc-cc-ccccCccC
Confidence            222333455555555322 23344455555555555555555 3355556666666666666666533 22 66666666


Q ss_pred             EEEccCccccccCccc
Q 042123          399 KLILRGNQITGRLPKE  414 (849)
Q Consensus       399 ~L~L~~N~l~~~~p~~  414 (849)
                      .|++++|.+....|..
T Consensus       281 ~L~~s~n~~~~~~~~~  296 (394)
T COG4886         281 ELDLSGNSLSNALPLI  296 (394)
T ss_pred             EEeccCccccccchhh
Confidence            7777666666444443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.41  E-value=8.3e-15  Score=154.96  Aligned_cols=199  Identities=30%  Similarity=0.373  Sum_probs=144.7

Q ss_pred             EEcCCCcccccCCcCC-CCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccc
Q 042123          161 LQLNDNQLIGYIPRPF-SNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH  239 (849)
Q Consensus       161 L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  239 (849)
                      |.|++-++...+-+++ ..+..-...||+.|++. .+|..++.+..|+.|.|.+|.+. .+|.++..+..|++|+|+.|+
T Consensus        55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~Nq  132 (722)
T KOG0532|consen   55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQ  132 (722)
T ss_pred             cccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccch
Confidence            4444445544433333 34555667899999998 78888888899999999999998 778899999999999999999


Q ss_pred             ccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhh
Q 042123          240 LSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEAL  319 (849)
Q Consensus       240 l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  319 (849)
                      ++ .+|..+..+.|+.|.+++|+++ .+|..+....+|..||.+.|.+. .+|..++++.+|+.|.+..|.+...++ .+
T Consensus       133 lS-~lp~~lC~lpLkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~~lp~-El  208 (722)
T KOG0532|consen  133 LS-HLPDGLCDLPLKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPE-EL  208 (722)
T ss_pred             hh-cCChhhhcCcceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCH-HH
Confidence            97 8888888888888888888887 45566666777777777777777 566677777777777777777764433 33


Q ss_pred             CCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcc
Q 042123          320 GIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIG  368 (849)
Q Consensus       320 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~  368 (849)
                      ..+ .|..||+|.|++. .+|-.|.++..|++|-|.+|.+. ..|..++
T Consensus       209 ~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC  254 (722)
T KOG0532|consen  209 CSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC  254 (722)
T ss_pred             hCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence            333 4666777777776 56666666666666666666666 4454443

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=5.4e-13  Score=148.25  Aligned_cols=196  Identities=32%  Similarity=0.424  Sum_probs=104.7

Q ss_pred             eeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCC-CCCEEEccCCCCcCcCcccccCCCCCCEEeccCC
Q 042123          136 FLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLT-SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQN  214 (849)
Q Consensus       136 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  214 (849)
                      .|.++.|.+.. ....+..++.++.|++.+|.++.+.+ ....+. +|++|++++|++. .+|..+..+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~~i~~-~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNITDIPP-LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeecccccccc-CchhhhcccceeEEecCCcccccCcc-ccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            45566665531 22333444566666666666665433 233442 6666666666665 44455666677777777777


Q ss_pred             cCccCCCcCccCccccchhhhccccccCCCCcchhhhh-hhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCC
Q 042123          215 QFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPT  293 (849)
Q Consensus       215 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~-L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~  293 (849)
                      ++.. +|...+.+++|+.|++++|++. .+|....... |+++.+++|++. ..+..+..+..+..+.+.+|++. ..+.
T Consensus       174 ~l~~-l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~  249 (394)
T COG4886         174 DLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE  249 (394)
T ss_pred             hhhh-hhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence            7663 3444446666777777777765 5555443333 555555555422 12333344444555555555554 2244


Q ss_pred             CCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCccc
Q 042123          294 SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS  340 (849)
Q Consensus       294 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  340 (849)
                      .++.+++++.|++++|.++.+.+  ++.+.+++.|++++|.+...++
T Consensus       250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~  294 (394)
T COG4886         250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP  294 (394)
T ss_pred             hhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence            45555555555555555554333  5555555555555555554333

>PLN03150 hypothetical protein; Provisional

Probab=99.39  E-value=9.3e-13  Score=152.78  Aligned_cols=118  Identities=33%  Similarity=0.593  Sum_probs=72.3

Q ss_pred             cccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccccccccccccCCCCChhhhcccccceeccCCcc
Q 042123          372 QLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNN  451 (849)
Q Consensus       372 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L~~N~  451 (849)
                      .++.|+|++|.+.+.+|..++.+++|+.|+|++|+++|.+|..++.+++                     |+.|+|++|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~---------------------L~~LdLs~N~  477 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITS---------------------LEVLDLSYNS  477 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCC---------------------CCEEECCCCC
Confidence            3677788888888888888888888888888888887666655554444                     4445555566


Q ss_pred             cccCCCccccccCCCcEEeccCCccccCCCCCcc--cccCcccccccCCCccCCCCCCCCCC
Q 042123          452 LSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTT--FRGASVEALKGNKGLCGSAKGLQPCK  511 (849)
Q Consensus       452 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~--~~~~~~~~~~~~~~~c~~~~~~~~~~  511 (849)
                      +++.+|+.+..+++|+.|+|++|+++|.+|....  ........+.+|+.+|+.+ ....|.
T Consensus       478 lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p-~l~~C~  538 (623)
T PLN03150        478 FNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP-GLRACG  538 (623)
T ss_pred             CCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCC-CCCCCc
Confidence            6666666666666666666666666655554311  1112223455666667643 345564

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=8e-14  Score=159.00  Aligned_cols=246  Identities=21%  Similarity=0.282  Sum_probs=172.4

Q ss_pred             cCCCcCceecCCccceEEEEEe--cCCcEEEEEEecccCCCCchhh---------HH-HHHHHHHHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL--PSGEVVAVKKFHSLLPCDQTVD---------QK-EFLTEVEAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~---------~~-~~~~ei~~~~~~~~~~~~~~lV  655 (849)
                      ..|...+.||+|+|+.|-.+..  .....+|+|.+...........         .. .-+..+..+++...+....+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4567777899999999988744  2345567776543321000000         00 0033455677888888899999


Q ss_pred             EEeccCCChhhhh-cccccccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCcc
Q 042123          656 YEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKS  732 (849)
Q Consensus       656 ~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~~  732 (849)
                      .||.++|++.+.+ +...  ...+......++.|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|..
T Consensus       100 ~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence            9999999999988 4332  13566778899999999999999 76   999999999999999999 999999999988


Q ss_pred             cCC-CC--CCeeeccC-CccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042123          733 LKP-DS--SNWTEFAG-TCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       733 ~~~-~~--~~~~~~~g-~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      +.. .+  .......| ++.|+|||...+..+ .+..|+||.|+++..+++|..||+.......       ....+...+
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------~~~~~~~~~  247 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------RYSSWKSNK  247 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-------cceeecccc
Confidence            765 22  22344567 999999999888544 5679999999999999999999885432211       111111111


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHh
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~  845 (849)
                      .......+........++...++..+|+.|.+.+++..
T Consensus       248 ~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            11001112222233566777888899999999888754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.36  E-value=7.3e-12  Score=118.86  Aligned_cols=130  Identities=18%  Similarity=0.177  Sum_probs=96.0

Q ss_pred             cCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-------hhceeecCCeeEEEEEeccCCCh
Q 042123          592 AKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-------FYGFCSHARHSFLLYEFLERGSL  664 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-------~~~~~~~~~~~~lV~e~~~~gsL  664 (849)
                      ..+.+|+|.++.||+++..+ ..+++|.............+....+.+..       ++++....+..+++|||++++.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~   80 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL   80 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence            35679999999999998754 78999987654321111222223333322       23444445578999999998777


Q ss_pred             hhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          665 AAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       665 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ..+          +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            654          4466778899999999999986434799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=3.8e-12  Score=126.41  Aligned_cols=193  Identities=19%  Similarity=0.323  Sum_probs=130.8

Q ss_pred             HHHHhhceeecCC-----eeEEEEEeccCCChhhhhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 042123          638 EVEAFYGFCSHAR-----HSFLLYEFLERGSLAAILNTDAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS  711 (849)
Q Consensus       638 ei~~~~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~  711 (849)
                      .+.++..|+.+..     ...++.|||+.|++..+|++.+. ...+....-.+|+-||..||.|||+ +.|+|+|+++..
T Consensus       128 nlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc  206 (458)
T KOG1266|consen  128 NLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTC  206 (458)
T ss_pred             HHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcch
Confidence            3556777776543     46789999999999999986543 3346667778999999999999999 567999999999


Q ss_pred             CCeeecCCCcEEEeeecCCcccCCCC-----CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 042123          712 KNLLLDLEYEAHVADFGIAKSLKPDS-----SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFL  786 (849)
Q Consensus       712 ~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~  786 (849)
                      +-|++..+|-+|+.- +........-     .......+-++|.|||+-.....+-++|||+||....||.-+..--...
T Consensus       207 ~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tns  285 (458)
T KOG1266|consen  207 DTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNS  285 (458)
T ss_pred             hheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCC
Confidence            999999999888742 1111111110     0011223567899999877777788899999999999998876542111


Q ss_pred             ccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          787 SSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       787 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .    .....++.....+...    .+..      =..++..|++..|..||+|++++.|
T Consensus       286 e----S~~~~ee~ia~~i~~l----en~l------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  286 E----SKVEVEENIANVIIGL----ENGL------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             c----ceeehhhhhhhheeec----cCcc------ccCcCcccccCCCCCCcchhhhhcC
Confidence            1    1111112212111111    0001      1245668999999999999998876

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.29  E-value=2.8e-11  Score=123.22  Aligned_cols=129  Identities=17%  Similarity=0.237  Sum_probs=90.1

Q ss_pred             Cceec-CCccceEEEEEecCCcEEEEEEecccC------CCC---chhhHHHHHHHHHH-------------hhceeec-
Q 042123          593 KYCIG-NGGHASVYRAELPSGEVVAVKKFHSLL------PCD---QTVDQKEFLTEVEA-------------FYGFCSH-  648 (849)
Q Consensus       593 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~---~~~~~~~~~~ei~~-------------~~~~~~~-  648 (849)
                      .+.|| .|+.|+||.+... +..++||++....      ...   .......+.+|+..             .+++... 
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45788 8999999999885 7789999885310      000   01122333444332             1222111 


Q ss_pred             CC---eeEEEEEeccC-CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          649 AR---HSFLLYEFLER-GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       649 ~~---~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                      ..   ..++||||+++ .+|.+++...    .++..    .+.+++.++.+||+.   ||+||||||.|||++.++.+++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence            11   23599999997 6898887542    24443    356899999999999   9999999999999999999999


Q ss_pred             eeecCCccc
Q 042123          725 ADFGIAKSL  733 (849)
Q Consensus       725 ~DfG~a~~~  733 (849)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.27  E-value=2.4e-11  Score=134.64  Aligned_cols=135  Identities=23%  Similarity=0.273  Sum_probs=92.4

Q ss_pred             CceecCCccceEEEEEecCCcEEEEEEecccCCCCchhh----------------------HH--------------HHH
Q 042123          593 KYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD----------------------QK--------------EFL  636 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~----------------------~~--------------~~~  636 (849)
                      .+.||.|++|.||+|++++|+.||||+.+.........+                      ..              .+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            368999999999999999999999999764321110000                      00              111


Q ss_pred             HHHH---Hhhceee-------------cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHH-HHHHHHhc
Q 042123          637 TEVE---AFYGFCS-------------HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH-ALSYLHHD  699 (849)
Q Consensus       637 ~ei~---~~~~~~~-------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~~  699 (849)
                      .|..   ++...+.             .....++||||++|+++.++......  ..   .+.+++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            1211   1221111             12345799999999999887643211  12   23456666666 46788987


Q ss_pred             CCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       700 ~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                         |++|+|++|.||+++.++.++++|||++..+..
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence               999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.26  E-value=4.4e-13  Score=134.53  Aligned_cols=197  Identities=26%  Similarity=0.345  Sum_probs=142.2

Q ss_pred             ccCCCCCCEEeccCCcCccCCCcC----ccCccccchhhhccccccCCCCcchhhh--hhhhhhccCcCCCCCCCcccCC
Q 042123          200 IGKMRSLSVLDLNQNQFKGVLPPS----ISNLTNLKELALLYNHLSGSIPPSLGNL--ILRQLLLSGNHFTGYLPYNICR  273 (849)
Q Consensus       200 ~~~l~~L~~L~L~~N~l~~~~~~~----~~~l~~L~~L~L~~N~l~~~~p~~~~~~--~L~~L~L~~n~i~~~~~~~~~~  273 (849)
                      +.+.++|++||||+|.+....+..    +..+..|++|.|.+|.+.   |..-+.+  .|..|.  .|+..       ..
T Consensus        88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg---~~ag~~l~~al~~l~--~~kk~-------~~  155 (382)
T KOG1909|consen   88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG---PEAGGRLGRALFELA--VNKKA-------AS  155 (382)
T ss_pred             HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC---hhHHHHHHHHHHHHH--HHhcc-------CC
Confidence            445668888888888876433333    456788999999999875   2222221  255554  22222       23


Q ss_pred             CCCcceeeecccccccc----cCCCCCCcccccEEEccCccccC----chhhhhCCCCCCCEEeccCccccCc----ccc
Q 042123          274 GGALEIFTVSENHFQGT----IPTSLRNCTSLIRVRLNGNNLTG----NISEALGIYPNLTFIDLSRNNFYGE----ISS  341 (849)
Q Consensus       274 ~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~  341 (849)
                      -+.|+++...+|++..-    +...|...+.|+.+.+..|.|..    .....|..+++|+.|||.+|-++..    +..
T Consensus       156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak  235 (382)
T KOG1909|consen  156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK  235 (382)
T ss_pred             CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence            35799999999998753    23346677899999999999862    3456788999999999999999753    455


Q ss_pred             cCCCCCCCcEEeccCCccccCCCCCcc-----cccccccccccccccccc----CchhhcCCCCCcEEEccCcccc
Q 042123          342 NWGKFPKLGTLNVSMNNITGGLPREIG-----NSSQLQAFDLSLNHIVGE----IPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       342 ~~~~l~~L~~L~Ls~N~i~~~~p~~~~-----~l~~L~~L~L~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                      .+..+++|+.|++++|.+.......|.     ..++|+.|.+.+|.|+..    +...+...+.|..|+|++|++.
T Consensus       236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            677889999999999999865444332     357899999999999742    3345567899999999999993

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.22  E-value=2.6e-12  Score=142.82  Aligned_cols=247  Identities=27%  Similarity=0.255  Sum_probs=127.8

Q ss_pred             CCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEE
Q 042123          107 LKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLR  186 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  186 (849)
                      +..++.+++..|.|.. .-..+..+++|+.|++.+|+|..+ ...+..+++|++|+|++|+|+.+  ..+..++.|+.|+
T Consensus        71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~  146 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELN  146 (414)
T ss_pred             hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccc--cchhhccchhhhe
Confidence            3445555555555553 223355556666666666666532 22255666666666666666655  3455566677777


Q ss_pred             ccCCCCcCcCcccccCCCCCCEEeccCCcCccCCC-cCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCC
Q 042123          187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLP-PSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTG  265 (849)
Q Consensus       187 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~  265 (849)
                      +++|.|...  ..+..+++|+.+++++|++..+.+ . ...+.+|+.+++.+|.+. .+...-....+..+++..|.++.
T Consensus       147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~-~i~~~~~~~~l~~~~l~~n~i~~  222 (414)
T KOG0531|consen  147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR-EIEGLDLLKKLVLLSLLDNKISK  222 (414)
T ss_pred             eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh-cccchHHHHHHHHhhccccccee
Confidence            777766522  235556677777777777764433 2 466666777777777665 22111111123334555555543


Q ss_pred             CCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCC
Q 042123          266 YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGK  345 (849)
Q Consensus       266 ~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  345 (849)
                      +-+.......                        .|+.+++++|.+... +..+..+..+..|++++|++...  ..+..
T Consensus       223 ~~~l~~~~~~------------------------~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~~  275 (414)
T KOG0531|consen  223 LEGLNELVML------------------------HLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNL--EGLER  275 (414)
T ss_pred             ccCcccchhH------------------------HHHHHhcccCccccc-cccccccccccccchhhcccccc--ccccc
Confidence            2211110000                        245555555555422 13444555666666666665422  12334


Q ss_pred             CCCCcEEeccCCccccC---CCCC-ccccccccccccccccccccCc
Q 042123          346 FPKLGTLNVSMNNITGG---LPRE-IGNSSQLQAFDLSLNHIVGEIP  388 (849)
Q Consensus       346 l~~L~~L~Ls~N~i~~~---~p~~-~~~l~~L~~L~L~~N~i~~~~~  388 (849)
                      .+.+..+....|.+...   .... ......++...+.+|.+....+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  276 LPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             cchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            44555555566655411   1111 3445667777777777765443

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.21  E-value=1.7e-12  Score=133.77  Aligned_cols=210  Identities=24%  Similarity=0.253  Sum_probs=116.5

Q ss_pred             CCCCCCEEeCcCCccccCCC-ccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCcc-CC
Q 042123           28 SFPHLAYLDLTWNGFFGTIP-PQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPH-IG  105 (849)
Q Consensus        28 ~l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~-~~  105 (849)
                      .+++|++..|.++.+..... .....+++++.||||+|-+..-.+.    -.....|++|+.|+|+.|.+....... -.
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v----~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~  194 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPV----LKIAEQLPSLENLNLSSNRLSNFISSNTTL  194 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHH----HHHHHhcccchhcccccccccCCccccchh
Confidence            44556666666665532221 3455566666666666655421111    112244666666666666665221111 12


Q ss_pred             CCCCCCEEEccCCcccCC-CCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCC-cCCCCCCCCC
Q 042123          106 NLKFLSQLDLTNNKFSGP-IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNLTSVS  183 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~  183 (849)
                      .+++|+.|.|+.|.++.. ........++|+.|+|..|..-........-++.|++|+|++|.+..... .....++.|.
T Consensus       195 ~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~  274 (505)
T KOG3207|consen  195 LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLN  274 (505)
T ss_pred             hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchh
Confidence            346677777777777631 12233455677777777775332334444556667777777777665321 2455667777


Q ss_pred             EEEccCCCCcCc-Cccc-----ccCCCCCCEEeccCCcCccC-CCcCccCccccchhhhcccccc
Q 042123          184 TLRLSRNDLFGS-IPDE-----IGKMRSLSVLDLNQNQFKGV-LPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       184 ~L~Ls~N~l~~~-~~~~-----~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      .|+++.+.|... .|++     ....++|+.|+++.|+|... .-..+..+++|+.|.+..|.++
T Consensus       275 ~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  275 QLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             hhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            777777776532 2332     24467777777777777421 1123455667777777777775

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.21  E-value=7.1e-12  Score=118.81  Aligned_cols=85  Identities=28%  Similarity=0.312  Sum_probs=23.4

Q ss_pred             CCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCC-cCCCCCCCCCEE
Q 042123          107 LKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNLTSVSTL  185 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L  185 (849)
                      +.+|+.|+|++|+|+.+.  .+..+++|++|++++|+|+.+.+.....+++|++|+|++|+|..+.. ..+..+++|++|
T Consensus        41 l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             -TT--EEE-TTS--S--T--T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             hcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            344555555555555331  24445555555555555543221111234555555555555544321 233445555555


Q ss_pred             EccCCCCc
Q 042123          186 RLSRNDLF  193 (849)
Q Consensus       186 ~Ls~N~l~  193 (849)
                      +|.+|.+.
T Consensus       119 ~L~~NPv~  126 (175)
T PF14580_consen  119 SLEGNPVC  126 (175)
T ss_dssp             E-TT-GGG
T ss_pred             eccCCccc
Confidence            55555554

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.20  E-value=4.9e-12  Score=123.73  Aligned_cols=205  Identities=22%  Similarity=0.205  Sum_probs=140.5

Q ss_pred             CccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccC-CcccccCC
Q 042123           23 DFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVIND-NSLSGFIP  101 (849)
Q Consensus        23 ~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~  101 (849)
                      .+.+..|++|..+.+|++.-..+ -+....-|.|+++...+..++... . +.+      ...+....-.. .-.+|..-
T Consensus       207 ~f~l~~f~~l~~~~~s~~~~~~i-~~~~~~kptl~t~~v~~s~~~~~~-~-l~p------e~~~~D~~~~E~~t~~G~~~  277 (490)
T KOG1259|consen  207 SFNLNAFRNLKTLKFSALSTENI-VDIELLKPTLQTICVHNTTIQDVP-S-LLP------ETILADPSGSEPSTSNGSAL  277 (490)
T ss_pred             ccchHHhhhhheeeeeccchhhe-eceeecCchhheeeeecccccccc-c-ccc------hhhhcCccCCCCCccCCceE
Confidence            34456677777777777654322 222234467888887776654211 1 111      11111111100 01111111


Q ss_pred             ccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCC
Q 042123          102 PHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTS  181 (849)
Q Consensus       102 ~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  181 (849)
                      ..+.....|++||||+|.|+ .+..+..-+++++.|++|.|.|..+  +.++.+++|+.||||+|.++.+ .++-..+-+
T Consensus       278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls~~-~Gwh~KLGN  353 (490)
T KOG1259|consen  278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLAEC-VGWHLKLGN  353 (490)
T ss_pred             EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhHhh-hhhHhhhcC
Confidence            22333467999999999999 5666778889999999999999743  4488999999999999999874 456678889


Q ss_pred             CCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCC-CcCccCccccchhhhccccccC
Q 042123          182 VSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVL-PPSISNLTNLKELALLYNHLSG  242 (849)
Q Consensus       182 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~  242 (849)
                      .++|.|+.|.|...  ..+.++.+|..||+++|+|.... ...++++|-|+.|.|.+|++.+
T Consensus       354 IKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  354 IKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             EeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            99999999998632  35788999999999999998432 3568999999999999999983

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.20  E-value=2.6e-10  Score=127.64  Aligned_cols=137  Identities=19%  Similarity=0.215  Sum_probs=87.3

Q ss_pred             hcCCCcCceecCCccceEEEEEecC-CcEEEEEEecccCCCC----------------------c----h----hhHH--
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPS-GEVVAVKKFHSLLPCD----------------------Q----T----VDQK--  633 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------~----~----~~~~--  633 (849)
                      ..+|+. +.||+|++|.||+|++++ |+.||||+.+......                      .    .    ...+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            356776 789999999999998877 9999999986432110                      0    0    0001  


Q ss_pred             ----HHHHH---HHHhhceeecC-------------CeeEEEEEeccCCChhhhh--cccc-cccCCCHHHHHHHHHHHH
Q 042123          634 ----EFLTE---VEAFYGFCSHA-------------RHSFLLYEFLERGSLAAIL--NTDA-AAQELGWSQRMNVIKAVA  690 (849)
Q Consensus       634 ----~~~~e---i~~~~~~~~~~-------------~~~~lV~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~~ia  690 (849)
                          .+.+|   +.++...+.+.             ...++||||++|+.+.++-  .... ....+....+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence                11122   12233333222             2345999999999998752  2111 00112233333344444 


Q ss_pred             HHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeecCCcccC
Q 042123          691 HALSYLHHDCFPPIVHRDISSKNLLLDLEY----EAHVADFGIAKSLK  734 (849)
Q Consensus       691 ~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG~a~~~~  734 (849)
                            ...   |++|+|+||.||+++.++    ++++.|||++..+.
T Consensus       277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  345   999999999999999988    99999999987664

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.17  E-value=3.7e-12  Score=124.56  Aligned_cols=130  Identities=28%  Similarity=0.297  Sum_probs=92.5

Q ss_pred             CCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEe
Q 042123          274 GGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLN  353 (849)
Q Consensus       274 ~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  353 (849)
                      ...|+++|||+|.|+ .+.++..-++.++.|+++.|.|+.+.  .+..+++|+.||||+|.++ .+..+-.++-++++|.
T Consensus       283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~  358 (490)
T KOG1259|consen  283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK  358 (490)
T ss_pred             Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence            345666666666666 45556666777888888888887443  3777888888888888887 4555556777888888


Q ss_pred             ccCCccccCCCCCccccccccccccccccccccC-chhhcCCCCCcEEEccCccccc
Q 042123          354 VSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEI-PKELGKLNPLTKLILRGNQITG  409 (849)
Q Consensus       354 Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~  409 (849)
                      |+.|.|..  -+.+..+.+|..||+++|+|.... ...++++|-|+.|.|.+|++.+
T Consensus       359 La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  359 LAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            88888762  345666777888888888886322 2467788888888888888873

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.17  E-value=8.5e-12  Score=138.71  Aligned_cols=197  Identities=28%  Similarity=0.308  Sum_probs=94.2

Q ss_pred             CCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCC
Q 042123          104 IGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVS  183 (849)
Q Consensus       104 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  183 (849)
                      +..+.+|..|++.+|+|+.+.. .+..+++|++|+|++|+|+.+  ..+..++.|+.|++++|.|+.+  ..|..++.|+
T Consensus        91 l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~  165 (414)
T KOG0531|consen   91 LSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNLSGNLISDI--SGLESLKSLK  165 (414)
T ss_pred             cccccceeeeeccccchhhccc-chhhhhcchheeccccccccc--cchhhccchhhheeccCcchhc--cCCccchhhh
Confidence            3444455555555555553221 144455555555555555432  2234444455555555555543  3344455555


Q ss_pred             EEEccCCCCcCcCc-ccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh--hhhhhhccC
Q 042123          184 TLRLSRNDLFGSIP-DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL--ILRQLLLSG  260 (849)
Q Consensus       184 ~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~--~L~~L~L~~  260 (849)
                      .+++++|++....+ . ...+.+|+.+++.+|.+..+  ..+..+..+..+++..|.++..-+ .....  .|+.+++++
T Consensus       166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~-l~~~~~~~L~~l~l~~  241 (414)
T KOG0531|consen  166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG-LNELVMLHLRELYLSG  241 (414)
T ss_pred             cccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccceeccC-cccchhHHHHHHhccc
Confidence            55555555553222 1 34555666666666666522  334444455555666666552211 11111  266666666


Q ss_pred             cCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCcccc
Q 042123          261 NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT  312 (849)
Q Consensus       261 n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  312 (849)
                      |.+.... ..+..+..+..+++.+|++...  ..+.....+..+.+..|.+.
T Consensus       242 n~i~~~~-~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  242 NRISRSP-EGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             Ccccccc-ccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence            6666321 3334445556666666665422  12233334444444444443

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.12  E-value=6.3e-12  Score=129.63  Aligned_cols=186  Identities=24%  Similarity=0.217  Sum_probs=80.1

Q ss_pred             CCCCCCCEEeCcCCcccc--CCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCccccc-CCcc
Q 042123           27 SSFPHLAYLDLTWNGFFG--TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGF-IPPH  103 (849)
Q Consensus        27 ~~l~~L~~L~L~~n~i~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~  103 (849)
                      ..+++++.||||+|-++.  ........||+|+.|+||.|++....     ..-.-..+++|++|.|+.|.++.. +-..
T Consensus       143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~-----~s~~~~~l~~lK~L~l~~CGls~k~V~~~  217 (505)
T KOG3207|consen  143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFI-----SSNTTLLLSHLKQLVLNSCGLSWKDVQWI  217 (505)
T ss_pred             hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCc-----cccchhhhhhhheEEeccCCCCHHHHHHH
Confidence            344555555555554422  22233344555555555555543111     111112344555555555555421 1112


Q ss_pred             CCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCccccccc-ccccCCCCCCCEEEcCCCcccccC-CcC-----C
Q 042123          104 IGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSI-LSSLGKLKSLFDLQLNDNQLIGYI-PRP-----F  176 (849)
Q Consensus       104 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-~~~-----~  176 (849)
                      ...+++|+.|+|..|....+....+.-+..|++|+|++|++.... ....+.++.|+.|+++.+.|.++. |+.     .
T Consensus       218 ~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt  297 (505)
T KOG3207|consen  218 LLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKT  297 (505)
T ss_pred             HHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhh
Confidence            233455555555555322233334444455555555555543211 123344555555555555554442 111     2


Q ss_pred             CCCCCCCEEEccCCCCcC-cCcccccCCCCCCEEeccCCcCc
Q 042123          177 SNLTSVSTLRLSRNDLFG-SIPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       177 ~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      ..+++|++|+++.|+|.. ..-+.+..+++|+.|.+..|.+.
T Consensus       298 ~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln  339 (505)
T KOG3207|consen  298 HTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN  339 (505)
T ss_pred             cccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence            334555555555555521 11122333444555555555554

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=4.6e-11  Score=113.33  Aligned_cols=108  Identities=30%  Similarity=0.378  Sum_probs=26.6

Q ss_pred             cCCCCCceeeccCcccccccccccC-CCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccc-cCCCCC
Q 042123          129 DNLSNLIFLYLYGNLLSGSILSSLG-KLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSL  206 (849)
Q Consensus       129 ~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L  206 (849)
                      .+..++++|+|++|.|+.+  ..++ .+.+|+.|+|++|+|+.+  +.+..++.|++|++++|+|+. +.+.+ ..+++|
T Consensus        16 ~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L   90 (175)
T PF14580_consen   16 NNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNL   90 (175)
T ss_dssp             ----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT-
T ss_pred             ccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcC
Confidence            3334455555555555432  1233 345555555555555554  235555666666666666652 22223 245566


Q ss_pred             CEEeccCCcCccCCC-cCccCccccchhhhcccccc
Q 042123          207 SVLDLNQNQFKGVLP-PSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       207 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  241 (849)
                      ++|++++|+|..... ..++.+++|+.|+|.+|++.
T Consensus        91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            666666666553211 23445555666666666554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.09  E-value=1.5e-10  Score=125.96  Aligned_cols=240  Identities=24%  Similarity=0.269  Sum_probs=164.3

Q ss_pred             CCCcCceecC--CccceEEEEEe---cCCcEEEEEEecccCC--CCchhhHHHHHH--------HHHHhhceeecCCeeE
Q 042123          589 DFDAKYCIGN--GGHASVYRAEL---PSGEVVAVKKFHSLLP--CDQTVDQKEFLT--------EVEAFYGFCSHARHSF  653 (849)
Q Consensus       589 ~f~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~~~~~--------ei~~~~~~~~~~~~~~  653 (849)
                      .|.....+|.  |.+|.||.++.   .++..+|+|+-+....  .......+++..        ...+.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556778999  99999999954   5788899997432211  111111111111        1223455667778889


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeec
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH----ALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFG  728 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG  728 (849)
                      +-+|++. .++.++.+...  ..++....+.+..+...    |+.++|+.   +++|-|+||.||+...+ ...+++|||
T Consensus       195 iqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             eeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcc
Confidence            9999996 58888876433  23667778888888888    99999999   99999999999999999 889999999


Q ss_pred             CCcccCCCCCCe-----eeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042123          729 IAKSLKPDSSNW-----TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM  803 (849)
Q Consensus       729 ~a~~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  803 (849)
                      +...+....-..     ....+...|++||... +.++..+|+||+|.+..+-.++..+.....      ...+......
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~~r~~  341 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQLRQG  341 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCC------CCCccccccc
Confidence            998876554221     1225778899999754 467889999999999999998876643110      0011111111


Q ss_pred             cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .     .+.+.+.....++...+..+++.+|-.|++++.+.++
T Consensus       342 ~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  342 Y-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             c-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            1     1122222223334457789999999999999888754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.02  E-value=2.2e-09  Score=104.04  Aligned_cols=125  Identities=20%  Similarity=0.176  Sum_probs=85.1

Q ss_pred             CceecCCccceEEEEEecCCcEEEEEEecccCC-CCchhhHHHHHHHHHH------hhceeecCCeeEEEEEeccCCChh
Q 042123          593 KYCIGNGGHASVYRAELPSGEVVAVKKFHSLLP-CDQTVDQKEFLTEVEA------FYGFCSHARHSFLLYEFLERGSLA  665 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~ei~~------~~~~~~~~~~~~lV~e~~~~gsL~  665 (849)
                      .+.++.|.++.||+++.. ++.|++|....... ......+....+.+..      ++.+  .....++||||+++.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCccc
Confidence            457899999999999875 78899998765421 1111112222222221      2222  233458999999998876


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          666 AILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC--FPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       666 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +.-           .....++.+++++++.||+..  ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            430           112345678999999999973  11369999999999999 67899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PLN03150 hypothetical protein; Provisional

Probab=98.99  E-value=6.3e-10  Score=129.32  Aligned_cols=109  Identities=30%  Similarity=0.441  Sum_probs=80.6

Q ss_pred             CceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccC
Q 042123          134 LIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQ  213 (849)
Q Consensus       134 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  213 (849)
                      ++.|+|++|.+++.+|..+..+++|+.|+|++|.+.+..|..+..+++|+.|+|++|++++.+|+.++++++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            66777777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CcCccCCCcCccCc-cccchhhhccccccC
Q 042123          214 NQFKGVLPPSISNL-TNLKELALLYNHLSG  242 (849)
Q Consensus       214 N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~  242 (849)
                      |++++.+|..+..+ .++..+++.+|...+
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc  529 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLC  529 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCcccc
Confidence            77777777766653 355667777776543

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.98  E-value=2.9e-10  Score=134.59  Aligned_cols=106  Identities=30%  Similarity=0.318  Sum_probs=55.2

Q ss_pred             CCCEEEccCCc--ccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEE
Q 042123          109 FLSQLDLTNNK--FSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLR  186 (849)
Q Consensus       109 ~L~~L~Ls~n~--i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  186 (849)
                      +|++|-+..|.  +..+.+..|..++.|+.|||++|.=-+.+|..+++|-+|++|+|++..+.. .|..+.+|+.|.+|+
T Consensus       546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~~-LP~~l~~Lk~L~~Ln  624 (889)
T KOG4658|consen  546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGISH-LPSGLGNLKKLIYLN  624 (889)
T ss_pred             ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCccc-cchHHHHHHhhheec
Confidence            45555555553  333333345555555555555554333555555555555555555555553 344555555555555


Q ss_pred             ccCCCCcCcCcccccCCCCCCEEeccCCc
Q 042123          187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQ  215 (849)
Q Consensus       187 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  215 (849)
                      +..+.-...+|.....|.+|++|.+....
T Consensus       625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  625 LEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             cccccccccccchhhhcccccEEEeeccc
Confidence            55554433444545555566665555543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.95  E-value=3.2e-08  Score=102.30  Aligned_cols=245  Identities=19%  Similarity=0.265  Sum_probs=152.6

Q ss_pred             CcCceecCCccceEEEE-EecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------------HhhceeecCCee
Q 042123          591 DAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------------AFYGFCSHARHS  652 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------------~~~~~~~~~~~~  652 (849)
                      ...+.||+|+-+.+|-. ..   ...+.|+++..-...    +.....++.                 .++|- ......
T Consensus        14 ~~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~i   85 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAA----QAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVI   85 (637)
T ss_pred             CCCccccCCccceeeecchh---hchhheeecCCCchH----HHHHHHHhccCCCCcchhhhhcccHHHhhCC-Ccccee
Confidence            35678999999999976 32   224557776542221    122222222                 23332 122235


Q ss_pred             EEEEEeccCCC-hhhhh---cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          653 FLLYEFLERGS-LAAIL---NTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       653 ~lV~e~~~~gs-L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      .+.|..+++.- ..++.   .+........|.-.+++++.+|.+.+.||..   |.+-+|+.++|+|+++++.+.+.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence            66777777641 22222   2222333578999999999999999999998   88999999999999999999998754


Q ss_pred             CCcccCCCCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhC-CCCCCccccccccccccc-----
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKG-KHPRDFLSSISSSSLNTD-----  797 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg-~~Pf~~~~~~~~~~~~~~-----  797 (849)
                      .-... ..+..+...+|...|.+||.-.     +..-+...|-|.+||++++++.| ++||.............+     
T Consensus       163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             ceeec-cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            32222 2234456678999999999643     34456779999999999999875 999985432211111111     


Q ss_pred             ---cccccccCCCCCCCChhhHHH-HHHHHHHHhhccCCC--CCCCCCHHHHHhhh
Q 042123          798 ---VALDQMLDPRLPAPSRSAQEK-LISIMEVAFSCFNES--PESRPTMKIISQQL  847 (849)
Q Consensus       798 ---~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~d--P~~RPt~~eil~~L  847 (849)
                         ....+...+..+.+...+-.. ...+..+..+|+...  +.-|||++..+..|
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl  297 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL  297 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence               011111122233332222222 234666677898653  56899999887665

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.94  E-value=7.1e-09  Score=100.53  Aligned_cols=133  Identities=21%  Similarity=0.251  Sum_probs=86.6

Q ss_pred             ceecCCccceEEEEEecC-------CcEEEEEEecccCC----------CCch-------hh-HHHHH----HHHHHhhc
Q 042123          594 YCIGNGGHASVYRAELPS-------GEVVAVKKFHSLLP----------CDQT-------VD-QKEFL----TEVEAFYG  644 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------~~~~-------~~-~~~~~----~ei~~~~~  644 (849)
                      -.||.|.=+.||.|...+       +..+|||.++....          .+..       .. .+.+.    +|...+..
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            368999999999996543       57999998753111          0000       00 11111    33332221


Q ss_pred             eeec---------CCeeEEEEEeccCCChhh-hhcccccccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCC
Q 042123          645 FCSH---------ARHSFLLYEFLERGSLAA-ILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKN  713 (849)
Q Consensus       645 ~~~~---------~~~~~lV~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~N  713 (849)
                      ....         ...-++||||+.++.+.. .+..    ..++.++...+..+++.+|..| |..   +++|||+++.|
T Consensus        83 l~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N  155 (197)
T cd05146          83 MQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN  155 (197)
T ss_pred             HHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            1111         134578999998754422 2211    1245566778889999999999 777   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccC
Q 042123          714 LLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~  734 (849)
                      |+++ ++.+.++|||.+....
T Consensus       156 IL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         156 MLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EEEE-CCcEEEEECCCceeCC
Confidence            9996 5789999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.93  E-value=8.7e-10  Score=120.01  Aligned_cols=236  Identities=22%  Similarity=0.222  Sum_probs=157.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEe--cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCe
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL--PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARH  651 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~  651 (849)
                      ...+|..+..||.|.|+.||+...  .++..|++|...+.....  .....-+.|+.            .++..+.....
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~--~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF--ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccch--HhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            346889999999999999999843  468889999876543211  11111222221            12233344556


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCC
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIA  730 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a  730 (849)
                      .|+--|||++++......   ....+++..++++..|++.++.++|+.   .++|+|++|+||++..+ +..++.|||.+
T Consensus       341 ~~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            678999999999877762   234578888999999999999999998   89999999999999887 77899999988


Q ss_pred             cccCCCCCCeeeccCCccc-cccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          731 KSLKPDSSNWTEFAGTCGY-IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y-~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ..+.-..  ......+..| .+|+......+..++|+||||.-+.+.+++..--...           .....+..+..+
T Consensus       415 t~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-----------~~~~~i~~~~~p  481 (524)
T KOG0601|consen  415 TRLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-----------VQSLTIRSGDTP  481 (524)
T ss_pred             cccceec--ccccccccccccchhhccccccccccccccccccccccccCcccCccc-----------ccceeeeccccc
Confidence            6432111  1111223334 3555555667788999999999999998875442110           011111222222


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......    ..+..+...+..+++..||.+.++..+
T Consensus       482 ~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  482 NLPGLK----LQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             CCCchH----HhhhhhhhhhcCCccccchhhhhhccc
Confidence            222111    335566678889999999999887654

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.93  E-value=4.3e-11  Score=120.40  Aligned_cols=238  Identities=17%  Similarity=0.184  Sum_probs=157.3

Q ss_pred             CCCCCCCCEEeCcCCccc----cCCCccccCCCCCCEeeCCCCcCcccccccccc-----cCCCCCccccCeEeccCCcc
Q 042123           26 FSSFPHLAYLDLTWNGFF----GTIPPQISNLSNLRYLYLGSNQFSGNILAEVSS-----ESSGGNLRYMSRLVINDNSL   96 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----~~~~~~l~~L~~L~l~~n~l   96 (849)
                      ...+..+++|+||+|.+.    ..+...+.+.++|+..++|.= ++|....++..     ..++...+.|+.|+||+|.+
T Consensus        26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~  104 (382)
T KOG1909|consen   26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAF  104 (382)
T ss_pred             hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHHHHHHhcCCceeEeecccccc
Confidence            455677888888888883    335566777788888888753 33333222211     23445566888888888888


Q ss_pred             cccCCcc----CCCCCCCCEEEccCCcccCCC-------------CCCCcCCCCCceeeccCccccccc----ccccCCC
Q 042123           97 SGFIPPH----IGNLKFLSQLDLTNNKFSGPI-------------PLSFDNLSNLIFLYLYGNLLSGSI----LSSLGKL  155 (849)
Q Consensus        97 ~~~~~~~----~~~l~~L~~L~Ls~n~i~~~~-------------~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l  155 (849)
                      ....++.    +.++..|++|+|.+|.+.-.-             ......-++|+++...+|++....    ...|+..
T Consensus       105 G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~  184 (382)
T KOG1909|consen  105 GPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSH  184 (382)
T ss_pred             CccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhc
Confidence            7443333    345678888888888876211             112344578888888888886432    3456777


Q ss_pred             CCCCEEEcCCCccccc----CCcCCCCCCCCCEEEccCCCCcCc----CcccccCCCCCCEEeccCCcCccCCCcCc---
Q 042123          156 KSLFDLQLNDNQLIGY----IPRPFSNLTSVSTLRLSRNDLFGS----IPDEIGKMRSLSVLDLNQNQFKGVLPPSI---  224 (849)
Q Consensus       156 ~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---  224 (849)
                      +.|+.+.++.|.|...    ...+|..+++|+.|||.+|-++..    +.+.++.+++|++|++++|.+...-..+|   
T Consensus       185 ~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~a  264 (382)
T KOG1909|consen  185 PTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDA  264 (382)
T ss_pred             cccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHH
Confidence            8888888888887532    234677888888888888888633    34456677888888888888874322222   


Q ss_pred             --cCccccchhhhccccccCCCCcc----hh-hhhhhhhhccCcCCC
Q 042123          225 --SNLTNLKELALLYNHLSGSIPPS----LG-NLILRQLLLSGNHFT  264 (849)
Q Consensus       225 --~~l~~L~~L~L~~N~l~~~~p~~----~~-~~~L~~L~L~~n~i~  264 (849)
                        ...++|+.|.|.+|.|+..-...    .. ...|+.|+|++|.+.
T Consensus       265 l~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  265 LKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             HhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence              23678888888888886321111    11 223888899999883

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.92  E-value=9e-10  Score=85.84  Aligned_cols=56  Identities=39%  Similarity=0.441  Sum_probs=20.7

Q ss_pred             CEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCC
Q 042123          111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDN  166 (849)
Q Consensus       111 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  166 (849)
                      ++|++++|+|+.+.+.+|.++++|++|++++|+|+.+.+.+|.++++|++|++++|
T Consensus         4 ~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N   59 (61)
T PF13855_consen    4 ESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN   59 (61)
T ss_dssp             SEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred             cEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence            33333333333333333333333333333333333333333333333333333333

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.92  E-value=9.2e-10  Score=85.81  Aligned_cols=59  Identities=37%  Similarity=0.422  Sum_probs=32.1

Q ss_pred             CCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCC
Q 042123          133 NLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND  191 (849)
Q Consensus       133 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  191 (849)
                      +|++|++++|+|+.+.+..|.++++|++|++++|.+..+.+++|.++++|++|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            45555555555554444555555555555555555555555555555555555555554

...

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.90  E-value=7e-10  Score=131.46  Aligned_cols=296  Identities=23%  Similarity=0.277  Sum_probs=156.3

Q ss_pred             CCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCc--ccccCCccCCCCCCCCEEEccCCcccCCCCCCCc
Q 042123           52 NLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNS--LSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFD  129 (849)
Q Consensus        52 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~  129 (849)
                      +....+...+-+|++..     +.  .. ...+.|+.|-+.+|.  +....++.|..++.|+.|||++|.=-+.+|..++
T Consensus       521 ~~~~~rr~s~~~~~~~~-----~~--~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~  592 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIEH-----IA--GS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIG  592 (889)
T ss_pred             chhheeEEEEeccchhh-----cc--CC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHh
Confidence            33566677777776541     11  11 123367777777775  5545555677788888888887765567888888


Q ss_pred             CCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCc--CcCcccccCCCCCC
Q 042123          130 NLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF--GSIPDEIGKMRSLS  207 (849)
Q Consensus       130 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~  207 (849)
                      .+-+|++|+|++..++ .+|..++++.+|.+|++..+.-....+.....+.+|++|.+......  ...-..+..+.+|+
T Consensus       593 ~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~  671 (889)
T KOG4658|consen  593 ELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLE  671 (889)
T ss_pred             hhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchh
Confidence            8888888888888887 67888888888888888877655555777777888888888765422  12222334444555


Q ss_pred             EEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeeccccc
Q 042123          208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHF  287 (849)
Q Consensus       208 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l  287 (849)
                      .+........  .-..+..+++|..+..                   .+.+.++. ....+..+..+.+|+.|.+.++.+
T Consensus       672 ~ls~~~~s~~--~~e~l~~~~~L~~~~~-------------------~l~~~~~~-~~~~~~~~~~l~~L~~L~i~~~~~  729 (889)
T KOG4658|consen  672 NLSITISSVL--LLEDLLGMTRLRSLLQ-------------------SLSIEGCS-KRTLISSLGSLGNLEELSILDCGI  729 (889)
T ss_pred             hheeecchhH--hHhhhhhhHHHHHHhH-------------------hhhhcccc-cceeecccccccCcceEEEEcCCC
Confidence            4444332220  1111223333332211                   11111111 112233445556666666666665


Q ss_pred             ccccCCCCCCc------ccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCcccc
Q 042123          288 QGTIPTSLRNC------TSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITG  361 (849)
Q Consensus       288 ~~~~~~~~~~l------~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~  361 (849)
                      ...........      +++..+...++... ..+.+....++|+.|++..+...+.+......+..++.+.+..+.+.+
T Consensus       730 ~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~  808 (889)
T KOG4658|consen  730 SEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEG  808 (889)
T ss_pred             chhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEeccccccc
Confidence            43222221111      11222222222111 112222345677777777666655555444455555555555555553


Q ss_pred             C-CCCCccccccccccccc
Q 042123          362 G-LPREIGNSSQLQAFDLS  379 (849)
Q Consensus       362 ~-~p~~~~~l~~L~~L~L~  379 (849)
                      . .-...++++++..+.++
T Consensus       809 l~~~~~l~~l~~i~~~~l~  827 (889)
T KOG4658|consen  809 LRMLCSLGGLPQLYWLPLS  827 (889)
T ss_pred             ceeeecCCCCceeEecccC
Confidence            3 22333444444444443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.75  E-value=8.8e-08  Score=97.31  Aligned_cols=135  Identities=19%  Similarity=0.242  Sum_probs=94.5

Q ss_pred             ceecCCccceEEEEEecCCcEEEEEEecccCC---CCchhhHHHHHHHHHH-------hhceeecC---CeeEEEEEecc
Q 042123          594 YCIGNGGHASVYRAELPSGEVVAVKKFHSLLP---CDQTVDQKEFLTEVEA-------FYGFCSHA---RHSFLLYEFLE  660 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~ei~~-------~~~~~~~~---~~~~lV~e~~~  660 (849)
                      +.++.|.++.||+++..+|+.+++|.......   ......+.+..+.+..       ++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999877678999998754321   1111222223332221       33333332   25689999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC----------------------------------------  700 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------  700 (849)
                      |+++.+.+..    ..++..+...++.++++++.+||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9888776532    23677788888888888888888521                                        


Q ss_pred             -------------CCCeEecCCCCCCeeecC--CCcEEEeeecCCcc
Q 042123          701 -------------FPPIVHRDISSKNLLLDL--EYEAHVADFGIAKS  732 (849)
Q Consensus       701 -------------~~~ivH~dlk~~Nill~~--~~~~kl~DfG~a~~  732 (849)
                                   ...++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         136799999999999998  56789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.72  E-value=6.4e-10  Score=121.43  Aligned_cols=127  Identities=29%  Similarity=0.292  Sum_probs=97.0

Q ss_pred             CcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEecc
Q 042123          276 ALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVS  355 (849)
Q Consensus       276 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  355 (849)
                      +|.+.+.+.|++. .+-.++.-++.|+.|+|++|+++..  +.+..+++|+.|||++|.+...+.-....+ +|+.|.++
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence            4555566666665 5566777788899999999999854  378888999999999999985443333344 49999999


Q ss_pred             CCccccCCCCCccccccccccccccccccccCc-hhhcCCCCCcEEEccCcccc
Q 042123          356 MNNITGGLPREIGNSSQLQAFDLSLNHIVGEIP-KELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       356 ~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~  408 (849)
                      +|.++.  -..+.+|.+|+.||+++|-|.+.-. .-++.|..|+.|+|.||++-
T Consensus       241 nN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  241 NNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            999983  3467889999999999999975321 23566788999999999886

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.72  E-value=2e-07  Score=102.77  Aligned_cols=159  Identities=17%  Similarity=0.231  Sum_probs=110.5

Q ss_pred             EecCCcEEEEEEecccCCCCchhhHHHHHH--------HHHHhhceeecCCeeEEEEEeccCCChhhhhcccccccCCCH
Q 042123          608 ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT--------EVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGW  679 (849)
Q Consensus       608 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~~--------ei~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~  679 (849)
                      +..++.+|.|..++.... ......++..+        .|.+++..+..+++.|+|+|-+.  .|..++++      ++.
T Consensus        33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~  103 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGK  103 (690)
T ss_pred             eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHH
Confidence            455677888877654322 11111111111        24457888888899999999985  57777653      345


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCC
Q 042123          680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK  759 (849)
Q Consensus       680 ~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  759 (849)
                      ..+..-+.||+.||.|||..+  +++|+++.-..|++++.|..||++|-++.....-.........--.|..|+.+....
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            677788999999999999776  899999999999999999999999988765432221111122223466676543322


Q ss_pred             CCccchHHHHHHHHHHHHhC
Q 042123          760 ITEKCDVYSFGVLMWEVIKG  779 (849)
Q Consensus       760 ~~~~~Dv~SlGvil~el~tg  779 (849)
                        ...|.|-||+++||++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              346999999999999999

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.65  E-value=3.8e-07  Score=85.05  Aligned_cols=123  Identities=21%  Similarity=0.342  Sum_probs=83.3

Q ss_pred             eecCCccceEEEEEecCCcEEEEEEe-cccCCCCc---hhhHHHHHHHHHH-----hhc------eeecCCeeEEEEEec
Q 042123          595 CIGNGGHASVYRAELPSGEVVAVKKF-HSLLPCDQ---TVDQKEFLTEVEA-----FYG------FCSHARHSFLLYEFL  659 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~~~~~vavK~~-~~~~~~~~---~~~~~~~~~ei~~-----~~~------~~~~~~~~~lV~e~~  659 (849)
                      .+++|+=+.+|.+.+. |.++++|.- ++......   .....+-..|...     -.|      |..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999875 555666642 22211111   1111222233221     112      234556777999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +|..|.+.+...          ...++..|=.-+.-||..   +|+|+|+.++||.+..+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888643          245556666777789999   999999999999997655 99999999874

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.64  E-value=1.6e-08  Score=115.86  Aligned_cols=240  Identities=20%  Similarity=0.267  Sum_probs=158.6

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH--HHH------hhce---eecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE--VEA------FYGF---CSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e--i~~------~~~~---~~~~~~~~  653 (849)
                      ..+.|.+.+.+-+|.++.++-++-. .|...++|....... -.....+...++  +..      ...+   +......+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~-i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK-IRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchh-hccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            4567777788899999999988443 343333333211100 000001111111  110      1111   12345678


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|++|..+++|...++...   ..+.+..+..+..+..+.+|||..   .+.|+|++|.|.+...++..+++|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            9999999999999987654   255566777888899999999997   7899999999999999999999999833211


Q ss_pred             CC---------------------CC----------CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 042123          734 KP---------------------DS----------SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP  782 (849)
Q Consensus       734 ~~---------------------~~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~P  782 (849)
                      ..                     +.          .......+|+.|.+||...+......+|.|+.|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            10                     00          002234689999999999999999999999999999999999999


Q ss_pred             CCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042123          783 RDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK  841 (849)
Q Consensus       783 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  841 (849)
                      |....        .+...+.+.....+.+ ..+.+......+++...+..+|.+|-.+.
T Consensus      1035 ~na~t--------pq~~f~ni~~~~~~~p-~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAET--------PQQIFENILNRDIPWP-EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcc--------hhhhhhccccCCCCCC-CCccccChhhhhhhhhhhccCchhccCcc
Confidence            97433        2233344444443332 22223344566777788888999996654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.61  E-value=6.7e-07  Score=82.87  Aligned_cols=136  Identities=19%  Similarity=0.324  Sum_probs=92.4

Q ss_pred             cCceecCCccceEEEEEecCCcEEEEEE-ecccCCCC---chhhHHHHHHHHHHh-----hc------eeecCCeeEEEE
Q 042123          592 AKYCIGNGGHASVYRAELPSGEVVAVKK-FHSLLPCD---QTVDQKEFLTEVEAF-----YG------FCSHARHSFLLY  656 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~~---~~~~~~~~~~ei~~~-----~~------~~~~~~~~~lV~  656 (849)
                      ....+-+|+-+.|+++.++ |+.+.||. +.+.....   .....++-.+|...+     .|      ++.+...-.++|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4567899999999999995 77777774 33222211   112233444454321     12      233445557899


Q ss_pred             EeccC-CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEEEeeecCCcc
Q 042123          657 EFLER-GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---EAHVADFGIAKS  732 (849)
Q Consensus       657 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfG~a~~  732 (849)
                      ||+++ .++.+++....... .+.+.....+.+|=..+.-||..   +|+|+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99987 57788876543322 22233378888999999999999   999999999999997664   358999999864

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.57  E-value=3.6e-10  Score=123.31  Aligned_cols=126  Identities=25%  Similarity=0.196  Sum_probs=68.3

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      .|...+.+.|.+. ....++.-++.|+.|+|++|+++..  +.+..++.|++|||+.|++..++--...+++ |+.|.|+
T Consensus       165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            3555555666655 4445555556666666666665532  2555566666666666666554333333333 6666666


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCC-CcCccCccccchhhhccccc
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVL-PPSISNLTNLKELALLYNHL  240 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l  240 (849)
                      +|.++..  ..+.+|++|+.||+++|-|.+.- -..++.|..|+.|+|.+|++
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl  291 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL  291 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence            6665522  23555666666666666655221 11244455666666666665

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=6.1e-07  Score=86.85  Aligned_cols=123  Identities=23%  Similarity=0.312  Sum_probs=72.5

Q ss_pred             eEEEEEecCCcEEEEEEecccCCC----------------------CchhhHHHHHHHHHHhhceeecC---------Ce
Q 042123          603 SVYRAELPSGEVVAVKKFHSLLPC----------------------DQTVDQKEFLTEVEAFYGFCSHA---------RH  651 (849)
Q Consensus       603 ~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~~~~~ei~~~~~~~~~~---------~~  651 (849)
                      .||.|...+|..+|||........                      ..........+|...+......+         ..
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            389998888999999987531110                      00111222334444333222211         12


Q ss_pred             eEEEEEecc--CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          652 SFLLYEFLE--RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       652 ~~lV~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      -.+||||++  |..+..+....     ++.++...++.+++..+..+ |..   +++|+|+.+.||+++++ .+.++|||
T Consensus        81 ~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GT
T ss_pred             CEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecC
Confidence            368999999  55554443221     12345667777888866664 676   99999999999999887 99999999


Q ss_pred             CCcccC
Q 042123          729 IAKSLK  734 (849)
Q Consensus       729 ~a~~~~  734 (849)
                      .+....
T Consensus       152 qav~~~  157 (188)
T PF01163_consen  152 QAVDSS  157 (188)
T ss_dssp             TEEETT
T ss_pred             cceecC
Confidence            887544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.53  E-value=2.5e-08  Score=110.16  Aligned_cols=149  Identities=19%  Similarity=0.314  Sum_probs=100.5

Q ss_pred             HHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC----eee-----ccCCcccccccccc
Q 042123          686 IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----WTE-----FAGTCGYIAPELAY  756 (849)
Q Consensus       686 ~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~----~~~-----~~g~~~y~aPE~~~  756 (849)
                      +.+++.|+.|+|...  ++||++|.|++|.++..+..|++.|+++.......+.    +..     ..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445669999999874  8999999999999999999999999988765442211    111     12356799999999


Q ss_pred             CCCCCccchHHHHHHHHHHHHhC-CCCCCccccccccc-cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCC
Q 042123          757 TMKITEKCDVYSFGVLMWEVIKG-KHPRDFLSSISSSS-LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESP  834 (849)
Q Consensus       757 ~~~~~~~~Dv~SlGvil~el~tg-~~Pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP  834 (849)
                      +...+.++|+||+|+.+|.+..| +.-++..+...... ........     .....    .+...++.+=+.+.+..++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-----~~~~s----~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-----AFGYS----NNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-----ccccc----ccCcHHHHHHHHHHhcCCc
Confidence            98889999999999999999954 44444322111110 00000000     01111    1222346666778999999


Q ss_pred             CCCCCHHHHHh
Q 042123          835 ESRPTMKIISQ  845 (849)
Q Consensus       835 ~~RPt~~eil~  845 (849)
                      ..||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99998777653

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.52  E-value=1.6e-06  Score=89.39  Aligned_cols=134  Identities=23%  Similarity=0.140  Sum_probs=90.1

Q ss_pred             ceecCCccceEEEEEecCCcEEEEEEecccCCCC---c----hhhHHHHHHHHHH-------------hhceeec-----
Q 042123          594 YCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCD---Q----TVDQKEFLTEVEA-------------FYGFCSH-----  648 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~----~~~~~~~~~ei~~-------------~~~~~~~-----  648 (849)
                      +.+-+.....|+++.+ +|+.|.||+........   .    ..-...+.+|...             .++++..     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455778777 57899999774321000   0    0000123344321             3344432     


Q ss_pred             CCeeEEEEEeccCC-ChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-------CC
Q 042123          649 ARHSFLLYEFLERG-SLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-------EY  720 (849)
Q Consensus       649 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-------~~  720 (849)
                      ....++|+|++++- +|.+++.... ....+...+..++.+++..+.-||..   ||+|+|++++|||++.       ++
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCc
Confidence            23578999999986 8988874321 12345677889999999999999999   9999999999999975       46


Q ss_pred             cEEEeeecCCcc
Q 042123          721 EAHVADFGIAKS  732 (849)
Q Consensus       721 ~~kl~DfG~a~~  732 (849)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998854

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.51  E-value=1.6e-08  Score=99.61  Aligned_cols=198  Identities=20%  Similarity=0.204  Sum_probs=114.0

Q ss_pred             CCCCEEeCcCCcc--ccCCCccccCCCCCCEeeCCCCcCcccccccccccCCC-CCccccCeEeccCCccccc-CCccCC
Q 042123           30 PHLAYLDLTWNGF--FGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG-GNLRYMSRLVINDNSLSGF-IPPHIG  105 (849)
Q Consensus        30 ~~L~~L~L~~n~i--~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~-~~l~~L~~L~l~~n~l~~~-~~~~~~  105 (849)
                      +++++|||.+|+|  ++.+...+.++|.|+.|+|+.|+++..+       +.. ..+.+|+.|.|++..+... ....+.
T Consensus        71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I-------~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~  143 (418)
T KOG2982|consen   71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI-------KSLPLPLKNLRVLVLNGTGLSWTQSTSSLD  143 (418)
T ss_pred             hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc-------ccCcccccceEEEEEcCCCCChhhhhhhhh
Confidence            6688888888888  3455666778888888888888887432       122 4577888888888877643 234566


Q ss_pred             CCCCCCEEEccCCcccC--CCCCCCcCC-CCCceeeccCccccc--ccccccCCCCCCCEEEcCCCcccccC-CcCCCCC
Q 042123          106 NLKFLSQLDLTNNKFSG--PIPLSFDNL-SNLIFLYLYGNLLSG--SILSSLGKLKSLFDLQLNDNQLIGYI-PRPFSNL  179 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~--~~~~~~~~l-~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l  179 (849)
                      .++.+++|++|.|.+..  +........ +.+++|++..|....  .....-.-.+++..+-+..|.+.+.. -..+..+
T Consensus       144 ~lP~vtelHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~  223 (418)
T KOG2982|consen  144 DLPKVTELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPF  223 (418)
T ss_pred             cchhhhhhhhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCC
Confidence            77788888888884432  111122111 234444443332210  00001122345666667777665443 2345566


Q ss_pred             CCCCEEEccCCCCcC-cCcccccCCCCCCEEeccCCcCccCCCc------CccCccccchhh
Q 042123          180 TSVSTLRLSRNDLFG-SIPDEIGKMRSLSVLDLNQNQFKGVLPP------SISNLTNLKELA  234 (849)
Q Consensus       180 ~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~  234 (849)
                      +.+.-|+|+.|+|.. ..-+++.++++|..|.+++|.+...+..      -++.+++++.|+
T Consensus       224 p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~vLN  285 (418)
T KOG2982|consen  224 PSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQVLN  285 (418)
T ss_pred             CcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEEec
Confidence            666677777777742 1234566677777777777776532211      134555555554

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.45  E-value=9.1e-08  Score=94.38  Aligned_cols=184  Identities=24%  Similarity=0.282  Sum_probs=88.0

Q ss_pred             CCCceeeccCccccc--ccccccCCCCCCCEEEcCCCcccccCCcCC-CCCCCCCEEEccCCCCcCc-CcccccCCCCCC
Q 042123          132 SNLIFLYLYGNLLSG--SILSSLGKLKSLFDLQLNDNQLIGYIPRPF-SNLTSVSTLRLSRNDLFGS-IPDEIGKMRSLS  207 (849)
Q Consensus       132 ~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~  207 (849)
                      +.+++|+|.+|.|+.  .+...+.+|+.|+.|+|+.|++...+. .+ ..+.+|+.|-|.+..+.-. ....+..++.++
T Consensus        71 ~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~-~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt  149 (418)
T KOG2982|consen   71 TDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIK-SLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT  149 (418)
T ss_pred             hhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccc-cCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence            445555555555542  122234455555555555555544221 12 3445555555555544311 122334455555


Q ss_pred             EEeccCCcCccCC--CcCccCc-cccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecc
Q 042123          208 VLDLNQNQFKGVL--PPSISNL-TNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE  284 (849)
Q Consensus       208 ~L~L~~N~l~~~~--~~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~  284 (849)
                      +|+++.|.+....  .+..... +.++.|.+..|              +..+.++-|++..++       +++..+.+.+
T Consensus       150 elHmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c--------------~~~~w~~~~~l~r~F-------pnv~sv~v~e  208 (418)
T KOG2982|consen  150 ELHMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPC--------------LEQLWLNKNKLSRIF-------PNVNSVFVCE  208 (418)
T ss_pred             hhhhccchhhhhccccccccccchhhhhhhcCCc--------------HHHHHHHHHhHHhhc-------ccchheeeec
Confidence            6655555332110  0001000 11222222111              223344444444333       3556666666


Q ss_pred             cccccc-cCCCCCCcccccEEEccCccccCchh-hhhCCCCCCCEEeccCccccC
Q 042123          285 NHFQGT-IPTSLRNCTSLIRVRLNGNNLTGNIS-EALGIYPNLTFIDLSRNNFYG  337 (849)
Q Consensus       285 N~l~~~-~~~~~~~l~~L~~L~L~~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~  337 (849)
                      |.+... ....+..++.+-.|+|+.|+|...-. +.+..++.|.-|.+++|.+.+
T Consensus       209 ~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d  263 (418)
T KOG2982|consen  209 GPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSD  263 (418)
T ss_pred             CcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccc
Confidence            666432 23345556666677777777764322 456677777777777777654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.44  E-value=1.7e-06  Score=85.66  Aligned_cols=131  Identities=23%  Similarity=0.217  Sum_probs=85.0

Q ss_pred             cCceecCCccceEEEEEecCCcEEEEEEecccC----------------CCCch--hhHHHHHHHHHHhhceeec-----
Q 042123          592 AKYCIGNGGHASVYRAELPSGEVVAVKKFHSLL----------------PCDQT--VDQKEFLTEVEAFYGFCSH-----  648 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~--~~~~~~~~ei~~~~~~~~~-----  648 (849)
                      +...||-|.=+.||.|..+.|.++|||.-+.-.                ...++  .......+|.+.+...+..     
T Consensus        95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP  174 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP  174 (304)
T ss_pred             hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence            456899999999999999899999999532100                00011  1122223344333322222     


Q ss_pred             ----CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          649 ----ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       649 ----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                          -+.-.+||||++|--|...-        ++.+..-.++..|.+-+.-.-..   ||||+|+++-||+++++|.+.+
T Consensus       175 ~P~~~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         175 KPIAWNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             Cccccccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEE
Confidence                13446899999996665542        12333444555555555544555   9999999999999999999999


Q ss_pred             eeecCCccc
Q 042123          725 ADFGIAKSL  733 (849)
Q Consensus       725 ~DfG~a~~~  733 (849)
                      +||--+...
T Consensus       244 IDwPQ~v~~  252 (304)
T COG0478         244 IDWPQAVPI  252 (304)
T ss_pred             EeCcccccC
Confidence            999766543

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.30  E-value=7.2e-08  Score=84.22  Aligned_cols=104  Identities=29%  Similarity=0.297  Sum_probs=49.5

Q ss_pred             ccEEEccCccccCchhh---hhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccc
Q 042123          301 LIRVRLNGNNLTGNISE---ALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFD  377 (849)
Q Consensus       301 L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~  377 (849)
                      +..++|++|++-. +++   .+....+|+..+|++|.+...++..-..++.++.|+|++|.|+ .+|..+..++.|+.|+
T Consensus        29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            4455666665541 222   2334445556666666666433333333445555555555555 3444444444444444


Q ss_pred             cccccccccCchhhcCCCCCcEEEccCccc
Q 042123          378 LSLNHIVGEIPKELGKLNPLTKLILRGNQI  407 (849)
Q Consensus       378 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  407 (849)
                      +++|.+. ..|..+..|.+|-.|+..+|.+
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~  135 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENAR  135 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence            4444444 3333344444444444444433

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.29  E-value=2.8e-08  Score=86.71  Aligned_cols=105  Identities=22%  Similarity=0.212  Sum_probs=58.9

Q ss_pred             CCEEEccCCcccCCCCCC---CcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEE
Q 042123          110 LSQLDLTNNKFSGPIPLS---FDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLR  186 (849)
Q Consensus       110 L~~L~Ls~n~i~~~~~~~---~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  186 (849)
                      +-.++|++|+|-. ++++   +.....|+..+|++|.+....+..-...+.++.|+|++|+|+.+ |..+..++.|+.|+
T Consensus        29 ~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdv-PeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDV-PEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhc-hHHHhhhHHhhhcc
Confidence            3445555555542 2222   33334455556666666533222223344566666666666654 33466666677777


Q ss_pred             ccCCCCcCcCcccccCCCCCCEEeccCCcCc
Q 042123          187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       187 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      ++.|.+. ..|..+..|.+|-.|+..+|.+.
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            7777666 55666666666666766666665

>PRK09902 hypothetical protein; Provisional

Probab=98.23  E-value=1.6e-05  Score=77.33  Aligned_cols=132  Identities=20%  Similarity=0.174  Sum_probs=93.8

Q ss_pred             ecCCccceEEEEEecCCcEEEEEEecccCCCCc--hhhHHHHHHHHHHhhc------------eee---c--CCeeEEEE
Q 042123          596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ--TVDQKEFLTEVEAFYG------------FCS---H--ARHSFLLY  656 (849)
Q Consensus       596 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~~ei~~~~~------------~~~---~--~~~~~lV~  656 (849)
                      -|+||.+.|++.... |..+-+|+-.......-  ...+..|.+|+..+..            ++.   .  ....++|+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            477999999999875 55788887642111110  1245566666543111            221   1  12468999


Q ss_pred             EeccC-CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--EEEeeecCCcc
Q 042123          657 EFLER-GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE--AHVADFGIAKS  732 (849)
Q Consensus       657 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfG~a~~  732 (849)
                      |-+++ -+|.+++.... ..+.+..++..++.+++.+++-||+.   ++.|+|+.++||+++.++.  ++++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            98875 58888875432 22467788899999999999999999   9999999999999986666  99999986654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.22  E-value=6.4e-06  Score=91.99  Aligned_cols=135  Identities=25%  Similarity=0.290  Sum_probs=86.2

Q ss_pred             ceecCCccceEEEEEecCCcEEEEEEecccCCCCch----------------------h----hHHHHHH----------
Q 042123          594 YCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT----------------------V----DQKEFLT----------  637 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------~----~~~~~~~----------  637 (849)
                      +.|+.++-|.||+|++++|+.||||+.+......-.                      .    ..+++.+          
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            689999999999999999999999987543221100                      0    0111111          


Q ss_pred             HHH---Hhhc-------------eeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 042123          638 EVE---AFYG-------------FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA-LSYLHHDC  700 (849)
Q Consensus       638 ei~---~~~~-------------~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~~~  700 (849)
                      |..   ++..             |++......++|||++|-.+.+...-..  ..++.   ..++..++++ +..+-.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHHHHHhc-
Confidence            110   1111             1122345679999999988888743222  22442   3333333333 2222223 


Q ss_pred             CCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       701 ~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                        |++|.|.+|-||+++.+|.+.+.|||+...+.+.
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              8899999999999999999999999998877543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	849
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		2e-38
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-11
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-38
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		2e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-32
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-32
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-27
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-27
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-25
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-24
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-22
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-22
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-21
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-20
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-19
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		8e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		9e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-14
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		5e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		5e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		9e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-12
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-12
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-12
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-12
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-12
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		9e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-11
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-11
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-11
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-11
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		7e-11
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-11
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-11
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-11
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-11
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-11
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		8e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		8e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		9e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-10
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-10
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-10
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		5e-10
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		5e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		5e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		8e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		8e-10
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		8e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-10
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		9e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-10
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-09
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-09
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-09
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-09
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		5e-09
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		5e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		6e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-08
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		6e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		6e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		6e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		6e-08
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		6e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		6e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-08
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-08
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-08
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-08
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		9e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		9e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		9e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		9e-08
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-07
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-07
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-07
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-07
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-07
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-07
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		4e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		5e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-07
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-07
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		6e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-07
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		7e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		7e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-07
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		9e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-06
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-06
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
3vq1_A	606	Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLE		2e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-06
3soa_A	444	Full-Length Human Camkii Length = 444		3e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-06
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		3e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
2z64_A	599	Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Comp		3e-06
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-06
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-06
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-06
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-06
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-06
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-06
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-06
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-06
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		4e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-06
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-06
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		4e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		4e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-06
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-06
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-06
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		5e-06
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		5e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		8e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		8e-06
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		9e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-05
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-05
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		2e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		3e-05
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		1e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		3e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-05
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-05
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-05
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-05
1sq0_B	288	Crystal Structure Of The Complex Of The Wild-Type V		9e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		9e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-05
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-04
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-04
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-04
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-04
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-04
3rfj_A	279	Design Of A Binding Scaffold Based On Variable Lymp		2e-04
3a79_B	562	Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len		2e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-04
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-04
2z66_A	306	Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A		4e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-04
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		4e-04
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-04
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		6e-04
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		7e-04
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		7e-04
2z7x_B	520	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		7e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  157 bits (398), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 166/545 (30%), Positives = 242/545 (44%), Gaps = 87/545 (15%)
Query: 23  DFS--FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG 80
           DFS   S+   L  L+++ N F G IPP    L +L+YL L  N+F+G I   +S     
Sbjct: 235 DFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLS----- 287
Query: 81  GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFXXXX 140
           G    ++ L ++ N   G +PP  G+   L  L L++N FSG +P+  D L  +      
Sbjct: 288 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM--DTLLKMRGLKV- 344
Query: 141 XXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLT-SVSTLRLSRNDLFGSIPDE 199
                               L L+ N+  G +P   +NL+ S+ TL LS N+  G I   
Sbjct: 345 --------------------LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 384
Query: 200 IGK--MRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQL 256
           + +    +L  L L  N F G +PP++SN + L  L L +N+LSG+IP SLG+L  LR L
Sbjct: 385 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 444
Query: 257 LLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNIS 316
            L  N   G +P  +     LE   +  N   G IP+ L NCT+L  + L+ N LTG I 
Sbjct: 445 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 504
Query: 317 EALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL-----------GTLNVSM--------- 356
           + +G   NL  + LS N+F G I +  G    L           GT+  +M         
Sbjct: 505 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAA 564
Query: 357 NNITG---------GLPREIGNSSQLQAFD----LSLNHIVGEIPKEL------GKLNP- 396
           N I G         G+ +E   +  L  F       LN +    P  +      G  +P 
Sbjct: 565 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 624
Query: 397 ------LTKLILRGNQITGRLPKEIGSLTKLEYLDF---SAIGELPSQICNMKSLEKLNL 447
                 +  L +  N ++G +PKEIGS+  L  L+       G +P ++ +++ L  L+L
Sbjct: 625 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 684
Query: 448 SHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGL 507
           S N L G IP     +  L+ ID+S N L  P+P    F          N GLCG    L
Sbjct: 685 SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--L 742
Query: 508 QPCKP 512
             C P
Sbjct: 743 PRCDP 747

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 239 HLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRG--GALEIFTVSEN--HFQGTIPTS 294
           H++GS+     +  L  L LS N  +G +      G    L+   VS N   F G +   
Sbjct: 85  HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 144
Query: 295 LR--------------------------NCTSLIRVRLNGNNLTGNISEALGIYPNLTFI 328
           L+                           C  L  + ++GN ++G++  +  +  NL F+
Sbjct: 145 LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV--NLEFL 202
Query: 329 DLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIP 388
           D+S NNF   I    G    L  L++S N ++G   R I   ++L+  ++S N  VG IP
Sbjct: 203 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 261
Query: 389 KELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFSA---IGELPSQICNMKSLEK 444
                L  L  L L  N+ TG +P  + G+   L  LD S     G +P    +   LE 
Sbjct: 262 PL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 319
Query: 445 LNLSHNNLSGSIP-SCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEAL 494
           L LS NN SG +P      M GL  +D+S+NE    +P S T   AS+  L
Sbjct: 320 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 370

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  157 bits (398), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 166/545 (30%), Positives = 242/545 (44%), Gaps = 87/545 (15%)
Query: 23  DFS--FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG 80
           DFS   S+   L  L+++ N F G IPP    L +L+YL L  N+F+G I   +S     
Sbjct: 238 DFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLS----- 290
Query: 81  GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFXXXX 140
           G    ++ L ++ N   G +PP  G+   L  L L++N FSG +P+  D L  +      
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM--DTLLKMRGLKV- 347
Query: 141 XXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLT-SVSTLRLSRNDLFGSIPDE 199
                               L L+ N+  G +P   +NL+ S+ TL LS N+  G I   
Sbjct: 348 --------------------LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN 387
Query: 200 IGK--MRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQL 256
           + +    +L  L L  N F G +PP++SN + L  L L +N+LSG+IP SLG+L  LR L
Sbjct: 388 LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 257 LLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNIS 316
            L  N   G +P  +     LE   +  N   G IP+ L NCT+L  + L+ N LTG I 
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Query: 317 EALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL-----------GTLNVSM--------- 356
           + +G   NL  + LS N+F G I +  G    L           GT+  +M         
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAA 567
Query: 357 NNITG---------GLPREIGNSSQLQAFD----LSLNHIVGEIPKEL------GKLNP- 396
           N I G         G+ +E   +  L  F       LN +    P  +      G  +P 
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627
Query: 397 ------LTKLILRGNQITGRLPKEIGSLTKLEYLDF---SAIGELPSQICNMKSLEKLNL 447
                 +  L +  N ++G +PKEIGS+  L  L+       G +P ++ +++ L  L+L
Sbjct: 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687
Query: 448 SHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGL 507
           S N L G IP     +  L+ ID+S N L  P+P    F          N GLCG    L
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP--L 745
Query: 508 QPCKP 512
             C P
Sbjct: 746 PRCDP 750

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 125/291 (42%), Gaps = 40/291 (13%)
Query: 239 HLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRG--GALEIFTVSEN--HFQGTIPTS 294
           H++GS+     +  L  L LS N  +G +      G    L+   VS N   F G +   
Sbjct: 88  HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
Query: 295 LR--------------------------NCTSLIRVRLNGNNLTGNISEALGIYPNLTFI 328
           L+                           C  L  + ++GN ++G++  +  +  NL F+
Sbjct: 148 LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV--NLEFL 205
Query: 329 DLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIP 388
           D+S NNF   I    G    L  L++S N ++G   R I   ++L+  ++S N  VG IP
Sbjct: 206 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 264
Query: 389 KELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFSA---IGELPSQICNMKSLEK 444
                L  L  L L  N+ TG +P  + G+   L  LD S     G +P    +   LE 
Sbjct: 265 PL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 445 LNLSHNNLSGSIP-SCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEAL 494
           L LS NN SG +P      M GL  +D+S+NE    +P S T   AS+  L
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTL 373

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  137 bits (346), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 92/288 (31%), Positives = 139/288 (48%), Gaps = 27/288 (9%)
Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA 641
           E+  A+++F  K  +G GG   VY+  L  G +VAVK+   L        + +F TEVE 
Sbjct: 32  ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR---LKEERXQGGELQFQTEVEM 88
Query: 642 -----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-LGWSQRMNVIKAV 689
                        GFC       L+Y ++  GS+A+ L     +Q  L W +R  +    
Sbjct: 89  ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 148
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK-PDSSNWTEFAGTCG 748
           A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +   D        GT G
Sbjct: 149 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIG 208
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP---------RDFLXXXXXXXLNTDVA 799
           +IAPE   T K +EK DV+ +GV++ E+I G+            D +       L  +  
Sbjct: 209 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 268
Query: 800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           L+ ++D  L    +   E++  +++VA  C   SP  RP M  + + L
Sbjct: 269 LEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  136 bits (342), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 92/289 (31%), Positives = 141/289 (48%), Gaps = 29/289 (10%)
Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD-QKEFLTEVE 640
           E+  A+++F  K  +G GG   VY+  L  G +VAVK+    L  ++T   + +F TEVE
Sbjct: 24  ELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKR----LKEERTQGGELQFQTEVE 79
Query: 641 A-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-LGWSQRMNVIKA 688
                         GFC       L+Y ++  GS+A+ L     +Q  L W +R  +   
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK-PDSSNWTEFAGTC 747
            A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +   D        G  
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP---------RDFLXXXXXXXLNTDV 798
           G+IAPE   T K +EK DV+ +GV++ E+I G+            D +       L  + 
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 799 ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            L+ ++D  L    +   E++  +++VA  C   SP  RP M  + + L
Sbjct: 260 KLEALVDVDLQGNYKD--EEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  121 bits (304), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 88/276 (31%), Positives = 137/276 (49%), Gaps = 22/276 (7%)
Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKF--HSLLPCDQTVDQKEFLT-- 637
           ++ +ATN+FD K+ IG+G    VY+  L  G  VA+K+    S    ++   + E L+  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 638 ---EVEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHAL 693
               + +  GFC       L+Y+++E G+L   L  +D     + W QR+ +    A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFA-GTCGYIA 751
            YLH      I+HRD+ S N+LLD  +   + DFGI+K   + D ++      GT GYI 
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKH------PRDFLXXXX-XXXLNTDVALDQML 804
           PE     ++TEK DVYSFGV+++EV+  +       PR+ +         + +  L+Q++
Sbjct: 210 PEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269
Query: 805 DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTM 840
           DP L    R   E L    + A  C   S E RP+M
Sbjct: 270 DPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  120 bits (300), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKF--HSLLPCDQTVDQKEFLT-- 637
           ++ +ATN+FD K+ IG+G    VY+  L  G  VA+K+    S    ++   + E L+  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 638 ---EVEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHAL 693
               + +  GFC       L+Y+++E G+L   L  +D     + W QR+ +    A  L
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF----AGTCGY 749
            YLH      I+HRD+ S N+LLD  +   + DFGI+K  K      T       GT GY
Sbjct: 153 HYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGY 207
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKH------PRDFLXXXX-XXXLNTDVALDQ 802
           I PE     ++TEK DVYSFGV+++EV+  +       PR+ +         + +  L+Q
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTM 840
           ++DP L    R   E L    + A  C   S E RP+M
Sbjct: 268 IVDPNLADKIRP--ESLRKFGDTAVKCLALSSEDRPSM 303

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  113 bits (282), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 94/293 (32%), Positives = 140/293 (47%), Gaps = 35/293 (11%)
Query: 572 LNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVK-----KFHSLLPC 626
           L F+G +  D++     D + K  IG G   +V+RAE   G  VAVK      FH+    
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA---- 75
Query: 627 DQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQ 675
            + V+  EFL EV             F G  +   +  ++ E+L RGSL  +L+   A +
Sbjct: 76  -ERVN--EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
           +L   +R+++   VA  ++YLH+   PPIVHRD+ S NLL+D +Y   V DFG+++    
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLN 795
                   AGT  ++APE+       EK DVYSFGV++WE+   + P   L         
Sbjct: 192 XFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---- 247
Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
             VA       RL  P R+   ++ +I+E    C+   P  RP+   I   LR
Sbjct: 248 --VAAVGFKCKRLEIP-RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 93/293 (31%), Positives = 141/293 (48%), Gaps = 35/293 (11%)
Query: 572 LNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVK-----KFHSLLPC 626
           L F+G +  D++     D + K  IG G   +V+RAE   G  VAVK      FH+    
Sbjct: 21  LYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHA---- 75
Query: 627 DQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQ 675
            + V+  EFL EV             F G  +   +  ++ E+L RGSL  +L+   A +
Sbjct: 76  -ERVN--EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
           +L   +R+++   VA  ++YLH+   PPIVHR++ S NLL+D +Y   V DFG+++    
Sbjct: 133 QLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
Query: 736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLN 795
              +    AGT  ++APE+       EK DVYSFGV++WE+   + P   L         
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---- 247
Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
             VA       RL  P R+   ++ +I+E    C+   P  RP+   I   LR
Sbjct: 248 --VAAVGFKCKRLEIP-RNLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  102 bits (255), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 135/293 (46%), Gaps = 35/293 (11%)
Query: 582 EIVKATNDFDAKYC------IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           E+   TN+FD +        +G GG   VY+  + +   VAVKK  +++       +++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 636 LTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
             E++              GF S      L+Y ++  GSL   L+       L W  R  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK--PDSSNWTE 742
           + +  A+ +++LH +     +HRDI S N+LLD  + A ++DFG+A++ +    +   + 
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR 194
Query: 743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKG-------KHPRDFLXXXXXXXLN 795
             GT  Y+APE A   +IT K D+YSFGV++ E+I G       + P+  L         
Sbjct: 195 IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253
Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                D  +D ++     ++ E + S   VA  C +E    RP +K + Q L+
Sbjct: 254 EKTIED-YIDKKMNDADSTSVEAMYS---VASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  102 bits (254), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 134/293 (45%), Gaps = 35/293 (11%)
Query: 582 EIVKATNDFDAKYC------IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           E+   TN+FD +        +G GG   VY+  + +   VAVKK  +++       +++F
Sbjct: 19  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 636 LTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
             E++              GF S      L+Y ++  GSL   L+       L W  R  
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK--PDSSNWTE 742
           + +  A+ +++LH +     +HRDI S N+LLD  + A ++DFG+A++ +    +     
Sbjct: 138 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR 194
Query: 743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKG-------KHPRDFLXXXXXXXLN 795
             GT  Y+APE A   +IT K D+YSFGV++ E+I G       + P+  L         
Sbjct: 195 IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253
Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                D  +D ++     ++ E + S   VA  C +E    RP +K + Q L+
Sbjct: 254 EKTIED-YIDKKMNDADSTSVEAMYS---VASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 134/293 (45%), Gaps = 35/293 (11%)
Query: 582 EIVKATNDFDAKYC------IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           E+   TN+FD +        +G GG   VY+  + +   VAVKK  +++       +++F
Sbjct: 13  ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 71
Query: 636 LTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
             E++              GF S      L+Y ++  GSL   L+       L W  R  
Sbjct: 72  DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 131
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTE 742
           + +  A+ +++LH +     +HRDI S N+LLD  + A ++DFG+A++ +  +       
Sbjct: 132 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXR 188
Query: 743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKG-------KHPRDFLXXXXXXXLN 795
             GT  Y+APE A   +IT K D+YSFGV++ E+I G       + P+  L         
Sbjct: 189 IVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 247
Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                D  +D ++     ++ E + S   VA  C +E    RP +K + Q L+
Sbjct: 248 EKTIED-YIDKKMNDADSTSVEAMYS---VASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 80/293 (27%), Positives = 128/293 (43%), Gaps = 35/293 (11%)
Query: 582 EIVKATNDFDAKYC------IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           E+   TN+FD +         G GG   VY+  + +   VAVKK  +++       +++F
Sbjct: 10  ELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 68
Query: 636 LTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
             E++              GF S      L+Y +   GSL   L+       L W  R  
Sbjct: 69  DQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCK 128
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK--PDSSNWTE 742
           + +  A+ +++LH +     +HRDI S N+LLD  + A ++DFG+A++ +        + 
Sbjct: 129 IAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR 185
Query: 743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKG-------KHPRDFLXXXXXXXLN 795
             GT  Y APE A   +IT K D+YSFGV++ E+I G       + P+  L         
Sbjct: 186 IVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 244
Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                D +      A S S +    +   VA  C +E    RP +K + Q L+
Sbjct: 245 EKTIEDYIDKKXNDADSTSVE----AXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 110/216 (50%), Gaps = 8/216 (3%)
Query: 166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSIS 225
           N L+G IP   + LT +  L ++  ++ G+IPD + ++++L  LD + N   G LPPSIS
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 226 NLTNLKELALLYNHLSGSIPPSLGNL--ILRQLLLSGNHFTGYLPYNICRGGALEIFTVS 283
           +L NL  +    N +SG+IP S G+   +   + +S N  TG +P        L    +S
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS 205
Query: 284 ENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
            N  +G       +  +  ++ L  N+L  ++ + +G+  NL  +DL  N  YG +    
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGL 264
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLS 379
            +   L +LNVS NN+ G +P+       LQ FD+S
Sbjct: 265 TQLKFLHSLNVSFNNLCGEIPQ----GGNLQRFDVS 296

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 110/263 (41%), Gaps = 26/263 (9%)
Query: 244 IPPSLGNLILRQLLLSG--NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSL 301
           IP SL NL     L  G  N+  G +P  I +   L    ++  +  G IP  L    +L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 302 IRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGT-LNVSMNNIT 360
           + +  + N L+G +  ++   PNL  I    N   G I  ++G F KL T + +S N +T
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLT 187
Query: 361 GGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTK 420
           G +P    N + L   DLS N + G+     G      K+ L  N +             
Sbjct: 188 GKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA------------ 234
Query: 421 LEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPV 480
               D   +G         K+L  L+L +N + G++P     +  L  +++S+N L   +
Sbjct: 235 ---FDLGKVGL-------SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
Query: 481 PNSTTFRGASVEALKGNKGLCGS 503
           P     +   V A   NK LCGS
Sbjct: 285 PQGGNLQRFDVSAYANNKCLCGS 307

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-19,   Method: Composition-based stats.
 Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 22/204 (10%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
           FYG CS     +++ E++  G L   L +     E   SQ + +   V   +++L    F
Sbjct: 68  FYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLESHQF 125
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
              +HRD++++N L+D +    V+DFG+ + +  D   SS  T+F     + APE+ +  
Sbjct: 126 ---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP--VKWSAPEVFHYF 180
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K DV++FG+LMWEV   GK P D          N++V L      RL  P  ++  
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEVVLKVSQGHRLYRPHLASD- 232
Query: 818 KLISIMEVAFSCFNESPESRPTMK 841
              +I ++ +SC++E PE RPT +
Sbjct: 233 ---TIYQIMYSCWHELPEKRPTFQ 253

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHS----LLPCDQTVDQKEFL------TEVEAFYGF 645
           IG GG   VYRA     EV      H     +    + V Q+  L        + A  G 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
           C    +  L+ EF   G L  +L+      ++     +N    +A  ++YLH +   PI+
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNYLHDEAIVPII 130
Query: 706 HRDISSKNLLLDLEYE--------AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
           HRD+ S N+L+  + E          + DFG+A+     +      AG   ++APE+   
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMAPEVIRA 188
Query: 758 MKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
              ++  DV+S+GVL+WE++ G+ P           +   VA++++    LP PS +  E
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVP---FRGIDGLAVAYGVAMNKL---ALPIPS-TCPE 241
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
               +ME    C+N  P SRP+   I  QL
Sbjct: 242 PFAKLME---DCWNPDPHSRPSFTNILDQL 268

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 44/270 (16%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G    V+     + + VA+K        +  + +++F+ E E             YG
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            C       L++EF+E G L+  L T     AA+ L     + +   V   ++YL   C 
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 121
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
             ++HRD++++N L+       V+DFG+ + +  D   SS  T+F     + +PE+    
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 177
Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           + + K DV+SFGVLMWEV  +GK P +          N++V  D     RL  P R A  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP-RLAST 229
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +  IM     C+ E PE RP    + +QL
Sbjct: 230 HVYQIMN---HCWKERPEDRPAFSRLLRQL 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 44/270 (16%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G    V+     + + VA+K        +  + +++F+ E E             YG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            C       L++EF+E G L+  L T     AA+ L     + +   V   ++YL   C 
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 123
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
             ++HRD++++N L+       V+DFG+ + +  D   SS  T+F     + +PE+    
Sbjct: 124 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 179
Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           + + K DV+SFGVLMWEV  +GK P +          N++V  D     RL  P R A  
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP-RLAST 231
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +  IM     C+ E PE RP    + +QL
Sbjct: 232 HVYQIMN---HCWKERPEDRPAFSRLLRQL 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 9e-17,   Method: Composition-based stats.
 Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 44/270 (16%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G    V+     + + VA+K        +  + +++F+ E E             YG
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            C       L++EF+E G L+  L T     AA+ L     + +   V   ++YL   C 
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 126
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
             ++HRD++++N L+       V+DFG+ + +  D   SS  T+F     + +PE+    
Sbjct: 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 182
Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           + + K DV+SFGVLMWEV  +GK P +          N++V  D     RL  P R A  
Sbjct: 183 RYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP-RLAST 234
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +  IM     C+ E PE RP    + +QL
Sbjct: 235 HVYQIMN---HCWRERPEDRPAFSRLLRQL 261

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C+  R  F++ E++  G L   L            Q + + K V  A+ YL    F
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
              +HRD++++N L++ +    V+DFG+++ +  D   SS  ++F     +  PE+    
Sbjct: 127 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFP--VRWSPPEVLMYS 181
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K D+++FGVLMWE+   GK P +          N++ A       RL  P   A E
Sbjct: 182 KFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRP-HLASE 233
Query: 818 KLISIMEVAFSCFNESPESRPTMKII 843
           K+ +IM   +SC++E  + RPT KI+
Sbjct: 234 KVYTIM---YSCWHEKADERPTFKIL 256

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C+  R  F++ E++  G L   L            Q + + K V  A+ YL    F
Sbjct: 75  LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF 132
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG------YIAPELA 755
              +HRD++++N L++ +    V+DFG+++ +  D     E+  + G      +  PE+ 
Sbjct: 133 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVL 184
Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRS 814
              K + K D+++FGVLMWE+   GK P +          N++ A       RL  P   
Sbjct: 185 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRP-HL 236
Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKII 843
           A EK+ +IM   +SC++E  + RPT KI+
Sbjct: 237 ASEKVYTIM---YSCWHEKADERPTFKIL 262

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C+  R  F++ E++  G L   L            Q + + K V  A+ YL    F
Sbjct: 68  LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF 125
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG------YIAPELA 755
              +HRD++++N L++ +    V+DFG+++ +  D     E+  + G      +  PE+ 
Sbjct: 126 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVL 177
Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRS 814
              K + K D+++FGVLMWE+   GK P +          N++ A       RL  P   
Sbjct: 178 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRP-HL 229
Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKII 843
           A EK+ +IM   +SC++E  + RPT KI+
Sbjct: 230 ASEKVYTIM---YSCWHEKADERPTFKIL 255

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C+  R  F++ E++  G L   L            Q + + K V  A+ YL    F
Sbjct: 69  LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF 126
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG------YIAPELA 755
              +HRD++++N L++ +    V+DFG+++ +  D     E+  + G      +  PE+ 
Sbjct: 127 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVL 178
Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRS 814
              K + K D+++FGVLMWE+   GK P +          N++ A       RL  P   
Sbjct: 179 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRP-HL 230
Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKII 843
           A EK+ +IM   +SC++E  + RPT KI+
Sbjct: 231 ASEKVYTIM---YSCWHEKADERPTFKIL 256

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C+  R  F++ E++  G L   L            Q + + K V  A+ YL    F
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG------YIAPELA 755
              +HRD++++N L++ +    V+DFG+++ +  D     E+  + G      +  PE+ 
Sbjct: 122 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVL 173
Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRS 814
              K + K D+++FGVLMWE+   GK P +          N++ A       RL  P   
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRP-HL 225
Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKII 843
           A EK+ +IM   +SC++E  + RPT KI+
Sbjct: 226 ASEKVYTIM---YSCWHEKADERPTFKIL 251

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 44/270 (16%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G    V+     + + VA+K        + ++ + +F+ E E             YG
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIK-----EGSMSEDDFIEEAEVMMKLSHPKLVQLYG 89
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            C       L++EF+E G L+  L T     AA+ L     + +   V   ++YL   C 
Sbjct: 90  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 143
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
             ++HRD++++N L+       V+DFG+ + +  D   SS  T+F     + +PE+    
Sbjct: 144 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 199
Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           + + K DV+SFGVLMWEV  +GK P +          N++V  D     RL  P R A  
Sbjct: 200 RYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP-RLAST 251
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +  IM     C+ E PE RP    + +QL
Sbjct: 252 HVYQIMN---HCWKERPEDRPAFSRLLRQL 278

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 28/209 (13%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C+  R  F++ E++  G L   L            Q + + K V  A+ YL    F
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG------YIAPELA 755
              +HRD++++N L++ +    V+DFG+++ +  D     E+  + G      +  PE+ 
Sbjct: 142 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVL 193
Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRS 814
              K + K D+++FGVLMWE+   GK P +          N++ A       RL  P   
Sbjct: 194 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRP-HL 245
Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKII 843
           A EK+ +IM   +SC++E  + RPT KI+
Sbjct: 246 ASEKVYTIM---YSCWHEKADERPTFKIL 271

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 114/263 (43%), Gaps = 45/263 (17%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEFL 659
           +GEV+ +K+   L+  D+   Q+ FL EV+            F G     +    + E++
Sbjct: 34  TGEVMVMKE---LIRFDEET-QRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89
Query: 660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE 719
           + G+L  I+ +     +  WSQR++  K +A  ++YLH      I+HRD++S N L+   
Sbjct: 90  KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVREN 144
Query: 720 YEAHVADFGIAKSL--------------KPDSSNWTEFAGTCGYIAPELAYTMKITEKCD 765
               VADFG+A+ +              KPD        G   ++APE+       EK D
Sbjct: 145 KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVD 204
Query: 766 VYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIME 824
           V+SFG+++ E+I +     D+L       LN    LD+   P  P           S   
Sbjct: 205 VFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP----------SFFP 254
Query: 825 VAFSCFNESPESRPTMKIISQQL 847
           +   C +  PE RP+   +   L
Sbjct: 255 ITVRCCDLDPEKRPSFVKLEHWL 277

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 77/270 (28%), Positives = 122/270 (45%), Gaps = 44/270 (16%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G    V+     + + VA+K        +  + +++F+ E E             YG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            C       L+ EF+E G L+  L T     AA+ L     + +   V   ++YL   C 
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC- 124
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
             ++HRD++++N L+       V+DFG+ + +  D   SS  T+F     + +PE+    
Sbjct: 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 180
Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           + + K DV+SFGVLMWEV  +GK P +          N++V  D     RL  P R A  
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP-RLAST 232
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +  IM     C+ E PE RP    + +QL
Sbjct: 233 HVYQIMN---HCWRERPEDRPAFSRLLRQL 259

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG C+  R  F++ E++  G L   L            Q + + K V  A+ YL    F
Sbjct: 84  LYGVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTM 758
              +HRD++++N L++ +    V+DFG+++ +  D    T   G+     +  PE+    
Sbjct: 142 ---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE--TSSVGSKFPVRWSPPEVLMYS 196
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K D+++FGVLMWE+   GK P +          N++ A       RL  P   A E
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETAEHIAQGLRLYRP-HLASE 248
Query: 818 KLISIMEVAFSCFNESPESRPTMKII 843
           K+ +IM   +SC++E  + RPT KI+
Sbjct: 249 KVYTIM---YSCWHEKADERPTFKIL 271

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 76/270 (28%), Positives = 122/270 (45%), Gaps = 44/270 (16%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G    V+     + + VA+K        +  + +++F+ E E             YG
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            C       L++EF+E G L+  L T     AA+ L     + +   V   ++YL     
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE--- 121
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---SSNWTEFAGTCGYIAPELAYTM 758
             ++HRD++++N L+       V+DFG+ + +  D   SS  T+F     + +PE+    
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP--VKWASPEVFSFS 179
Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           + + K DV+SFGVLMWEV  +GK P +          N++V  D     RL  P R A  
Sbjct: 180 RYSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP-RLAST 231
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +  IM     C+ E PE RP    + +QL
Sbjct: 232 HVYQIMN---HCWKERPEDRPAFSRLLRQL 258

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 46/291 (15%)
Query: 588 NDFDAKYCIGNGGHASVYRAE----LPSGE--VVAVKKFHSLLPCDQTVDQKE--FLTEV 639
            D   K+ +G G    V+ AE    LP  +  +VAVK         +   Q+E   LT +
Sbjct: 41  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 640 E-----AFYGFCSHARHSFLLYEFLERGSLAAILNT------------DAAAQELGWSQR 682
           +      F+G C+  R   +++E++  G L   L +            D A   LG  Q 
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           + V   VA  + YL    F   VHRD++++N L+       + DFG+++ +   S+++  
Sbjct: 161 LAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYR 215
Query: 743 FAGTC----GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTD 797
             G       ++ PE     K T + DV+SFGV++WE+   GK P           L+  
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------WYQLSNT 267
Query: 798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            A+D +   R     R+   ++ +IM     C+   P+ R ++K +  +L+
Sbjct: 268 EAIDCITQGRELERPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQ 315

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 46/291 (15%)
Query: 588 NDFDAKYCIGNGGHASVYRAE----LPSGE--VVAVKKFHSLLPCDQTVDQKE--FLTEV 639
            D   K+ +G G    V+ AE    LP  +  +VAVK         +   Q+E   LT +
Sbjct: 18  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 77
Query: 640 E-----AFYGFCSHARHSFLLYEFLERGSLAAILNT------------DAAAQELGWSQR 682
           +      F+G C+  R   +++E++  G L   L +            D A   LG  Q 
Sbjct: 78  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 137
Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           + V   VA  + YL    F   VHRD++++N L+       + DFG+++ +   S+++  
Sbjct: 138 LAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYR 192
Query: 743 FAGTC----GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTD 797
             G       ++ PE     K T + DV+SFGV++WE+   GK P           L+  
Sbjct: 193 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------WYQLSNT 244
Query: 798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            A+D +   R     R+   ++ +IM     C+   P+ R ++K +  +L+
Sbjct: 245 EAIDCITQGRELERPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQ 292

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 46/291 (15%)
Query: 588 NDFDAKYCIGNGGHASVYRAE----LPSGE--VVAVKKFHSLLPCDQTVDQKE--FLTEV 639
            D   K+ +G G    V+ AE    LP  +  +VAVK         +   Q+E   LT +
Sbjct: 12  RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 71
Query: 640 E-----AFYGFCSHARHSFLLYEFLERGSLAAILNT------------DAAAQELGWSQR 682
           +      F+G C+  R   +++E++  G L   L +            D A   LG  Q 
Sbjct: 72  QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 131
Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           + V   VA  + YL    F   VHRD++++N L+       + DFG+++ +   S+++  
Sbjct: 132 LAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYR 186
Query: 743 FAGTC----GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTD 797
             G       ++ PE     K T + DV+SFGV++WE+   GK P           L+  
Sbjct: 187 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--------WYQLSNT 238
Query: 798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            A+D +   R     R+   ++ +IM     C+   P+ R ++K +  +L+
Sbjct: 239 EAIDCITQGRELERPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQ 286

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 572 LNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTV 630
           L F+G   YD+      D   K+ +G G +  VY        + VAVK        + T+
Sbjct: 10  LYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTM 64
Query: 631 DQKEFLTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGW 679
           + +EFL E                G C+     +++ EF+  G+L   L  +   QE+  
Sbjct: 65  EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNA 123
Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
              + +   ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  
Sbjct: 124 VVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-- 178
Query: 740 WTEFAGT---CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXL 794
           +T  AG      + APE LAY  K + K DV++FGVL+WE+   G  P   +       L
Sbjct: 179 YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 237
Query: 795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
                L++  D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 238 -----LEK--DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 277

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 121/263 (46%), Gaps = 38/263 (14%)
Query: 596 IGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFY 643
           IG G    V R  L + G+  +     +L        ++EFL+E                
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G  +++    +L EF+E G+L + L  +    +    Q + +++ +A  + YL    +  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTVIQLVGMLRGIASGMRYLAEMSY-- 139
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHRD++++N+L++      V+DFG+++ L+ +SS+ TE +   G     + APE     
Sbjct: 140 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR 198
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPRLPAPSRSA 815
           K T   D +S+G++MWEV+  G+ P            N DV  A++Q  D RLP P    
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERP-------YWDMSNQDVINAIEQ--DYRLPPPPDCP 249
Query: 816 QEKLISIMEVAFSCFNESPESRP 838
                S+ ++   C+ +   +RP
Sbjct: 250 ----TSLHQLMLDCWQKDRNARP 268

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 64
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 123
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 232
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 233 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 64
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 123
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 232
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 233 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 59
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 118
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 227
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 228 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 63
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 122
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 123 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 177
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 178 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 231
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 232 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 268

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 76.6 bits (187), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 59
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 118
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 227
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 228 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 64
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 123
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+   T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAK 178
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 232
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 233 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 15/195 (7%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IG G   +VY A ++ +G+ VA+++ +      + +   E L   E       +   S+L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 655 L-------YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
           +        E+L  GSL  ++ T+    E    Q   V +    AL +LH +    ++HR
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S N+LL ++    + DFG    + P+ S  +E  GT  ++APE+        K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 768 SFGVLMWEVIKGKHP 782
           S G++  E+I+G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 128/291 (43%), Gaps = 47/291 (16%)
Query: 588 NDFDAKYCIGNGGHASVYRAEL----PSGE--VVAVKKFH--SLLPCDQTVDQKEFLTEV 639
            D   K  +G G    V+ AE     P+ +  +VAVK     +L        + E LT +
Sbjct: 15  RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 640 E-----AFYGFCSHARHSFLLYEFLERGSLAAILNT---DA----------AAQELGWSQ 681
           +      FYG C       +++E+++ G L   L     DA          A  ELG SQ
Sbjct: 75  QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 682 RMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT 741
            +++   +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++ 
Sbjct: 135 MLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYY 189
Query: 742 EFAGTC----GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNT 796
              G       ++ PE     K T + DV+SFGV++WE+   GK P   L        NT
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NT 242
Query: 797 DVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +V ++ +   R+    R   +++  +M     C+   P+ R  +K I + L
Sbjct: 243 EV-IECITQGRVLERPRVCPKEVYDVM---LGCWQREPQQRLNIKEIYKIL 289

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+  RG +   L   +   E    +    I  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANALS 127
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 182
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 59
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 118
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 227
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 228 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  TE  GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTELCGTLDYLPPEM 177
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 64
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 123
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 232
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 233 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 59
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 118
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 227
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 228 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 59
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 118
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 227
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 228 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 266
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 325
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HR+++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 326 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 380
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 381 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 434
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 435 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 471

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 10  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 64
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 65  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 123
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 124 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 179 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 232
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 233 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 5   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 59
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 118
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 119 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 174 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 227
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 228 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 251 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 305
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 306 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 364
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HR+++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 365 QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 419
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 420 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 473
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 474 --DYRMERP-EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 510

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 60
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 119
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+   T  AG  
Sbjct: 120 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAK 174
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 175 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 228
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 229 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 265

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 61
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 120
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 175
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 176 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 229
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 230 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 26/203 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G  + +    ++ EF+E GSL + L  +    +    Q + +++ +A  + YL    +  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMNY-- 156
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHRD++++N+L++      V+DFG+++ L+ D+S+ T  +   G     + APE     
Sbjct: 157 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 215
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPRLPAPSRSA 815
           K T   DV+S+G++MWEV+  G+ P            N DV  A++Q  D RLP P    
Sbjct: 216 KFTSASDVWSYGIVMWEVMSYGERP-------YWDMTNQDVINAIEQ--DYRLPPPMDCP 266
Query: 816 QEKLISIMEVAFSCFNESPESRP 838
                ++ ++   C+ +    RP
Sbjct: 267 S----ALHQLMLDCWQKDRNHRP 285

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 61
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 120
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 175
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 176 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 229
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 230 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 120/263 (45%), Gaps = 38/263 (14%)
Query: 596 IGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFY 643
           IG G    V R  L + G+  +     +L        ++EFL+E                
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G  +++    +L EF+E G+L + L  +    +    Q + +++ +A  + YL    +  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDG--QFTVIQLVGMLRGIASGMRYLAEMSY-- 137
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHRD++++N+L++      V+DFG+++ L+ +SS+ T  +   G     + APE     
Sbjct: 138 -VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR 196
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPRLPAPSRSA 815
           K T   D +S+G++MWEV+  G+ P            N DV  A++Q  D RLP P    
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERP-------YWDMSNQDVINAIEQ--DYRLPPPPDCP 247
Query: 816 QEKLISIMEVAFSCFNESPESRP 838
                S+ ++   C+ +   +RP
Sbjct: 248 ----TSLHQLMLDCWQKDRNARP 266

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 36/263 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           +GNG    V+         VA+K   +L P   T+  + FL E +             Y 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIK---TLKPG--TMSPESFLEEAQIMKKLKHDKLVQLYA 71
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
             S     +++ E++ +GSL   L  D   + L     +++   VA  ++Y+    +   
Sbjct: 72  VVSE-EPIYIVTEYMNKGSLLDFLK-DGEGRALKLPNLVDMAAQVAAGMAYIERMNY--- 126
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEK 763
           +HRD+ S N+L+       +ADFG+A+ ++ +     + A     + APE A   + T K
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 764 CDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLIS 821
            DV+SFG+L+ E++ KG+ P           +N    L+Q+    R+P P    Q+  IS
Sbjct: 187 SDVWSFGILLTELVTKGRVP--------YPGMNNREVLEQVERGYRMPCP----QDCPIS 234
Query: 822 IMEVAFSCFNESPESRPTMKIIS 844
           + E+   C+ + PE RPT + + 
Sbjct: 235 LHELMIHCWKKDPEERPTFEYLQ 257

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 6   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 60
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 61  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 119
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 120 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAK 174
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 175 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 228
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 229 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 265

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 46/217 (21%)
Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF----------YG 644
           C+G G +  V+R     GE VAVK F S        D+K +  E E +           G
Sbjct: 44  CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 95
Query: 645 FCSH---ARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           F +    +RHS    +L+  + E GSL   L        L     + ++ ++A  L++LH
Sbjct: 96  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLH 151
Query: 698 HDCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF-----AGTC 747
            + F     P I HRD+ SKN+L+    +  +AD G+A  +   S+N  +       GT 
Sbjct: 152 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTK 210
Query: 748 GYIAPE-LAYTMKIT-----EKCDVYSFGVLMWEVIK 778
            Y+APE L  T+++      ++ D+++FG+++WEV +
Sbjct: 211 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 247

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E
Sbjct: 7   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 61
Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMAT 120
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
            ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG  
Sbjct: 121 QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAK 175
Query: 747 --CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
               + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++
Sbjct: 176 FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEK 229
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
             D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 230 --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 40/274 (14%)
Query: 589 DFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
           D   K+ +G G +  VY        + VAVK        + T++ +EFL E         
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKH 66
Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                  G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ YL
Sbjct: 67  PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPE 753
               F   +HRD++++N L+   +   VADFG+++ +  D+   T  AG      + APE
Sbjct: 126 EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 180
Query: 754 -LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
            LAY  K + K DV++FGVL+WE+   G  P   +       L     L++  D R+  P
Sbjct: 181 SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK--DYRMERP 232
Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
                EK+  +M    +C+  +P  RP+   I Q
Sbjct: 233 -EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 46/217 (21%)
Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF----------YG 644
           C+G G +  V+R     GE VAVK F S        D+K +  E E +           G
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 645 FCSH---ARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           F +    +RHS    +L+  + E GSL   L        L     + ++ ++A  L++LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLH 122
Query: 698 HDCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF-----AGTC 747
            + F     P I HRD+ SKN+L+    +  +AD G+A  +   S+N  +       GT 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTK 181
Query: 748 GYIAPE-LAYTMKIT-----EKCDVYSFGVLMWEVIK 778
            Y+APE L  T+++      ++ D+++FG+++WEV +
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T+  GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEM 178
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+  RG +   L   +   E    +    I  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANALS 127
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLXGTLDYLPPEM 182
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T+  GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEM 177
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 127
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T+  GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEM 182
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IG G   +VY A ++ +G+ VA+++ +      + +   E L   E       +   S+L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 655 L-------YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
           +        E+L  GSL  ++ T+    E    Q   V +    AL +LH +    ++HR
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 768 SFGVLMWEVIKGKHP 782
           S G++  E+I+G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 46/217 (21%)
Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF----------YG 644
           C+G G +  V+R     GE VAVK F S        D+K +  E E +           G
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILG 66
Query: 645 FCSH---ARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           F +    +RHS    +L+  + E GSL   L        L     + ++ ++A  L++LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLH 122
Query: 698 HDCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF-----AGTC 747
            + F     P I HRD+ SKN+L+    +  +AD G+A  +   S+N  +       GT 
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTK 181
Query: 748 GYIAPE-LAYTMKIT-----EKCDVYSFGVLMWEVIK 778
            Y+APE L  T+++      ++ D+++FG+++WEV +
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 102/213 (47%), Gaps = 12/213 (5%)
Query: 577 KILYDEIVKATND-FDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKE 634
           K+  D + K   + FD    +G G + SVY+A    +G++VA+K+        + + +  
Sbjct: 17  KLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEIS 76
Query: 635 FLTEVEA-----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
            + + ++     +YG        +++ E+   GS++ I+      + L   +   ++++ 
Sbjct: 77  IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQST 134
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGY 749
              L YLH   F   +HRDI + N+LL+ E  A +ADFG+A  L    +      GT  +
Sbjct: 135 LKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +APE+   +      D++S G+   E+ +GK P
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IG G   +VY A ++ +G+ VA+++ +      + +   E L   E       +   S+L
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 655 L-------YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
           +        E+L  GSL  ++ T+    E    Q   V +    AL +LH +    ++HR
Sbjct: 89  VGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 141
Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K D++
Sbjct: 142 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201
Query: 768 SFGVLMWEVIKGKHP 782
           S G++  E+I+G+ P
Sbjct: 202 SLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 15/195 (7%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IG G   +VY A ++ +G+ VA+++ +      + +   E L   E       +   S+L
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 655 L-------YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
           +        E+L  GSL  ++ T+    E    Q   V +    AL +LH +    ++HR
Sbjct: 88  VGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S N+LL ++    + DFG    + P+ S  +   GT  ++APE+        K D++
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 768 SFGVLMWEVIKGKHP 782
           S G++  E+I+G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T+  GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDLCGTLDYLPPEM 177
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 126
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 181
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 209

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 148
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 149 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 203
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 177
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTXLCGTLDYLPPEM 177
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G  +  R + ++ E++E GSL   L T     +    Q + +++ V   + YL    +  
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGY-- 172
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYIAPELAYTMKI 760
            VHRD++++N+L+D      V+DFG+++ L+ D  + +T   G     + APE       
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           +   DV+SFGV+MWEV+  G+ P            N DV        RLPAP        
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERP-------YWNMTNRDVISSVEEGYRLPAPMGCPH--- 281
Query: 820 ISIMEVAFSCFNESPESRPTMKII 843
            ++ ++   C+++    RP    I
Sbjct: 282 -ALHQLMLDCWHKDRAQRPRFSQI 304

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 583 IVKATNDFDAKYC----IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT 637
           I+ +  D   KY     IG G   +VY A ++ +G+ VA+++ +      + +   E L 
Sbjct: 12  IIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 71
Query: 638 EVEAFYGFCSHARHSFLL-------YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
             E       +   S+L+        E+L  GSL  ++ T+    E    Q   V +   
Sbjct: 72  MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDE---GQIAAVCRECL 127
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
            AL +LH +    ++HR+I S N+LL ++    + DFG    + P+ S  +   GT  ++
Sbjct: 128 QALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 184
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           APE+        K D++S G++  E+I+G+ P
Sbjct: 185 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 121
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 176
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 177 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 204

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S    SS  T  +GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SCHAPSSRRTTLSGTLDYLPPEM 178
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 139
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 194
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 195 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 222

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 127
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 182
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 183 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 116/265 (43%), Gaps = 41/265 (15%)
Query: 595 CIGNGGHASVYRAELPSG----EV-VAVKKFHSLLPCDQTVDQKEFLTE----------- 638
            IG G    VY+  L +     EV VA+K   +     Q VD   FL E           
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD---FLGEAGIMGQFSHHN 107
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           +    G  S  +   ++ E++E G+L   L       E    Q + +++ +A  + YL +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLAN 165
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGTC--GYIAPELA 755
             +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE  
Sbjct: 166 MNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 756 YTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP-RLPAPSR 813
              K T   DV+SFG++MWEV+  G+ P           L+    +  + D  RLP P  
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP--------YWELSNHEVMKAINDGFRLPTPMD 274
Query: 814 SAQEKLISIMEVAFSCFNESPESRP 838
                  +I ++   C+ +    RP
Sbjct: 275 CPS----AIYQLMMQCWQQERARRP 295

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS   +  GT  Y+ PE+
Sbjct: 126 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEM 180
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 174
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 175 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 202

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
            + + +  +G G    V +A+  + +V A+K+  S        ++K F+ E+        
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES------ESERKAFIVELRQLSRVNH 61
Query: 641 ----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 YG C +     L+ E+ E GSL  +L+          +  M+     +  ++YL
Sbjct: 62  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           H      ++HRD+   NLLL        + DFG A  ++   ++ T   G+  ++APE+ 
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVF 176
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXL-NTDVALDQMLDPRLPAPSRS 814
                +EKCDV+S+G+++WEVI  + P D +       +          L   LP P  S
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 236
Query: 815 AQEKLISIMEVAFSCFNESPESRPTM----KIISQQLR 848
              +          C+++ P  RP+M    KI++  +R
Sbjct: 237 LMTR----------CWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/278 (24%), Positives = 120/278 (43%), Gaps = 39/278 (14%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
            + + +  +G G    V +A+  + +V A+K+  S        ++K F+ E+        
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAKDV-AIKQIES------ESERKAFIVELRQLSRVNH 60
Query: 641 ----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 YG C +     L+ E+ E GSL  +L+          +  M+     +  ++YL
Sbjct: 61  PNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           H      ++HRD+   NLLL        + DFG A  ++   ++ T   G+  ++APE+ 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVF 175
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXL-NTDVALDQMLDPRLPAPSRS 814
                +EKCDV+S+G+++WEVI  + P D +       +          L   LP P  S
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIES 235
Query: 815 AQEKLISIMEVAFSCFNESPESRPTM----KIISQQLR 848
              +          C+++ P  RP+M    KI++  +R
Sbjct: 236 LMTR----------CWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 26/203 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G  + +    ++ EF+E GSL + L  +    +    Q + +++ +A  + YL    +  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMNY-- 130
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHR ++++N+L++      V+DFG+++ L+ D+S+ T  +   G     + APE     
Sbjct: 131 -VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 189
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPRLPAPSRSA 815
           K T   DV+S+G++MWEV+  G+ P            N DV  A++Q  D RLP P    
Sbjct: 190 KFTSASDVWSYGIVMWEVMSYGERP-------YWDMTNQDVINAIEQ--DYRLPPPMDCP 240
Query: 816 QEKLISIMEVAFSCFNESPESRP 838
                ++ ++   C+ +    RP
Sbjct: 241 S----ALHQLMLDCWQKDRNHRP 259

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 148
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS   +  GT  Y+ PE+
Sbjct: 149 YCHSKR---VIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEM 203
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 231

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 438 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 491
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGYIAPELAYTMKI 760
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   T       + APE     K 
Sbjct: 492 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 550
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E +
Sbjct: 551 SSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE-M 602
Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +M +   C+    E+RP    +  +LR
Sbjct: 603 YDLMNL---CWTYDVENRPGFAAVELRLR 628

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G  +  R + ++ E++E GSL   L T     +    Q + +++ V   + YL    +  
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLGY-- 172
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLK--PDSSNWTEFAGT-CGYIAPELAYTMKI 760
            VHRD++++N+L+D      V+DFG+++ L+  PD++  T        + APE       
Sbjct: 173 -VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTF 231
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           +   DV+SFGV+MWEV+  G+ P            N DV        RLPAP        
Sbjct: 232 SSASDVWSFGVVMWEVLAYGERP-------YWNMTNRDVISSVEEGYRLPAPMGCPH--- 281
Query: 820 ISIMEVAFSCFNESPESRPTMKII 843
            ++ ++   C+++    RP    I
Sbjct: 282 -ALHQLMLDCWHKDRAQRPRFSQI 304

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 437 GICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 490
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGYIAPELAYTMKI 760
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   T       + APE     K 
Sbjct: 491 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E +
Sbjct: 550 SSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE-M 601
Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +M +   C+    E+RP    +  +LR
Sbjct: 602 YDLMNL---CWTYDVENRPGFAAVELRLR 627

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 115/265 (43%), Gaps = 27/265 (10%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKF--HSLLPCDQTVDQKEFLTEVEAFYGF 645
            DFD    IG G +A V    L   + +   K     L+  D+ +D  +  TE   F   
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ--TEKHVFEQA 66
Query: 646 CSH----ARHS--------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
            +H      HS        F + E++  G L   +      ++L           ++ AL
Sbjct: 67  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLAL 123
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFAGTCGYIAP 752
           +YLH      I++RD+   N+LLD E    + D+G+ K  L+P  +  + F GT  YIAP
Sbjct: 124 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAP 179
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E+          D ++ GVLM+E++ G+ P D +        NT+  L Q++  +     
Sbjct: 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 813 RSAQEKLISIMEVAFSCFNESPESR 837
           RS   K  S+++   S  N+ P+ R
Sbjct: 240 RSLSVKAASVLK---SFLNKDPKER 261

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 40/282 (14%)
Query: 581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTEV 639
           D+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E 
Sbjct: 4   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEA 58
Query: 640 EA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
                          G C+     +++ EF+  G+L   L  +   QE+     + +   
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQ 117
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-- 746
           ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 118 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKF 172
Query: 747 -CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM 803
              + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++ 
Sbjct: 173 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK- 225
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
            D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 226 -DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 117/267 (43%), Gaps = 31/267 (11%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVV----AVKKFHSLLPCDQTVDQKEFLTEVEAFY 643
            DFD    IG G +A V    L   + +     VKK   L+  D+ +D  +  TE   F 
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK--ELVNDDEDIDWVQ--TEKHVFE 107
Query: 644 GFCSH----ARHS--------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
              +H      HS        F + E++  G L   +      ++L           ++ 
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISL 164
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFAGTCGYI 750
           AL+YLH      I++RD+   N+LLD E    + D+G+ K  L+P  +  T F GT  YI
Sbjct: 165 ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYI 220
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPA 810
           APE+          D ++ GVLM+E++ G+ P D +        NT+  L Q++  +   
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 811 PSRSAQEKLISIMEVAFSCFNESPESR 837
             RS   K  S+++   S  N+ P+ R
Sbjct: 281 IPRSLSVKAASVLK---SFLNKDPKER 304

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 127
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE 
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEX 182
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 183 IEGRXHDEKVDLWSLGVLCYEFLVGKPP 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 85  YIVTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIASGMAYVERMNY---VHRDLRAA 140
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + WT   G      + APE A   + T K DV+SF
Sbjct: 141 NILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 198
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 199 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 246
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 247 QCWRKEPEERPTFEYLQ 263

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 115/265 (43%), Gaps = 27/265 (10%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKF--HSLLPCDQTVDQKEFLTEVEAFYGF 645
            DFD    IG G +A V    L   + +   K     L+  D+ +D  +  TE   F   
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ--TEKHVFEQA 62
Query: 646 CSH----ARHS--------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
            +H      HS        F + E++  G L   +      ++L           ++ AL
Sbjct: 63  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLAL 119
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFAGTCGYIAP 752
           +YLH      I++RD+   N+LLD E    + D+G+ K  L+P  +  + F GT  YIAP
Sbjct: 120 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAP 175
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E+          D ++ GVLM+E++ G+ P D +        NT+  L Q++  +     
Sbjct: 176 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 235
Query: 813 RSAQEKLISIMEVAFSCFNESPESR 837
           RS   K  S+++   S  N+ P+ R
Sbjct: 236 RSLSVKAASVLK---SFLNKDPKER 257

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 115/265 (43%), Gaps = 27/265 (10%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKF--HSLLPCDQTVDQKEFLTEVEAFYGF 645
            DFD    IG G +A V    L   + +   K     L+  D+ +D  +  TE   F   
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ--TEKHVFEQA 77
Query: 646 CSH----ARHS--------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
            +H      HS        F + E++  G L   +      ++L           ++ AL
Sbjct: 78  SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLAL 134
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS-LKPDSSNWTEFAGTCGYIAP 752
           +YLH      I++RD+   N+LLD E    + D+G+ K  L+P  +  + F GT  YIAP
Sbjct: 135 NYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAP 190
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E+          D ++ GVLM+E++ G+ P D +        NT+  L Q++  +     
Sbjct: 191 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 250
Query: 813 RSAQEKLISIMEVAFSCFNESPESR 837
           RS   K  S+++   S  N+ P+ R
Sbjct: 251 RSMSVKAASVLK---SFLNKDPKER 272

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 132
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   A T G     + APE     
Sbjct: 133 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK--AQTHGKWPVKWYAPECINYY 189
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE 242
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +  +M +   C+    E+RP    +  +LR
Sbjct: 243 -MYDLMNL---CWTYDVENRPGFAAVELRLR 269

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +A+FG   S+   SS  T   GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEM 180
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 85  GICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 138
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGYIAPELAYTMKI 760
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   T       + APE     K 
Sbjct: 139 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E +
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE-M 249
Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +M +   C+    E+RP    +  +LR
Sbjct: 250 YDLMNL---CWTYDVENRPGFAAVELRLR 275

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEM 177
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 134/298 (44%), Gaps = 42/298 (14%)
Query: 564 IPQGSLSILNFEGKILYDEIVKATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHS 622
           +P+GS   ++   K L      ATN   D     G  G     R +LPS + ++V    +
Sbjct: 15  VPRGSTQTVHEFAKEL-----DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKT 68
Query: 623 LLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGSLAAILNTD 671
           L        +++FL E                G  + ++   ++ E++E GSL + L   
Sbjct: 69  LKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 128
Query: 672 AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK 731
            A  +    Q + +++ +A  + YL    +   VHRD++++N+L++      V+DFG+++
Sbjct: 129 DA--QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSR 183
Query: 732 SLKPD-SSNWTEFAGT--CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLX 787
            L+ D  + +T   G     + +PE     K T   DV+S+G+++WEV+  G+ P   + 
Sbjct: 184 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 243
Query: 788 XXXXXXLNTDV--ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
                  N DV  A+D+    RLP P         ++ ++   C+ +   +RP  + I
Sbjct: 244 -------NQDVIKAVDEGY--RLPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 288

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 132/287 (45%), Gaps = 44/287 (15%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGE-VVAVKKFHSLLPCD-----QTVDQ-KEFLTE 638
           A N+ + +  IG GG   V++  L   + VVA+K   SL+  D     + +++ +EF  E
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQRE 73
Query: 639 V-----------EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
           V              YG   +     ++ EF+  G L   L     A  + WS ++ ++ 
Sbjct: 74  VFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLML 129
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE-----AHVADFGIAKSLKPDSSNWTE 742
            +A  + Y+ +   PPIVHRD+ S N+ L    E     A VADFG+++       + + 
Sbjct: 130 DIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSG 185
Query: 743 FAGTCGYIAPEL--AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVAL 800
             G   ++APE   A     TEK D YSF ++++ ++ G+ P D         +N  +  
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN--MIR 243
Query: 801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           ++ L P +P        +L +++E+   C++  P+ RP    I ++L
Sbjct: 244 EEGLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 93  GICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 146
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGYIAPELAYTMKI 760
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   T       + APE     K 
Sbjct: 147 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 205
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E +
Sbjct: 206 SSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE-M 257
Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +M +   C+    E+RP    +  +LR
Sbjct: 258 YDLMNL---CWTYDVENRPGFAAVELRLR 283

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKK-FHSLLPCDQTVDQKEFLTEVEA---- 641
            DFD    +G G   +VY A E  S  ++A+K  F + L       Q     E+++    
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYC 128
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H      ++HRDI  +NLLL    E  +ADFG   S+   SS  T   GT  Y+ PE+  
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIE 183
Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHP 782
                EK D++S GVL +E + G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 73  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 126
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   A T G     + APE     
Sbjct: 127 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYY 183
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE 236
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +  +M +   C+    E+RP    +  +LR
Sbjct: 237 -MYDLMNL---CWTYDVENRPGFAAVELRLR 263

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 75  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 128
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   A T G     + APE     
Sbjct: 129 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYY 185
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE 238
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +  +M +   C+    E+RP    +  +LR
Sbjct: 239 -MYDLMNL---CWTYDVENRPGFAAVELRLR 265

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 79  GIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 132
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-----YIAPELAYTM 758
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   A T G     + APE     
Sbjct: 133 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECINYY 189
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE 242
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +  +M +   C+    E+RP    +  +LR
Sbjct: 243 -MYDLMNL---CWTYDVENRPGFAAVELRLR 269

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 69/131 (52%), Gaps = 9/131 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQ-ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS 711
           ++L EFL+ G+L     TD  +Q  L   Q   V +AV  AL+YLH      ++HRDI S
Sbjct: 118 WVLMEFLQGGAL-----TDIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKS 169
Query: 712 KNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGV 771
            ++LL L+    ++DFG    +  D        GT  ++APE+        + D++S G+
Sbjct: 170 DSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGI 229
Query: 772 LMWEVIKGKHP 782
           ++ E++ G+ P
Sbjct: 230 MVIEMVDGEPP 240

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE+
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEM 177
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE+
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEM 180
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 208

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 40/282 (14%)
Query: 581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTEV 639
           D+      D   K+ +G G    VY        + VAVK        + T++ +EFL E 
Sbjct: 4   DKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEA 58
Query: 640 EA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
                          G C+     +++ EF+  G+L   L  +   QE+     + +   
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQ 117
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-- 746
           ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+   T  AG   
Sbjct: 118 ISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKF 172
Query: 747 -CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM 803
              + APE LAY  K + K DV++FGVL+WE+   G  P   +       L     L++ 
Sbjct: 173 PIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYEL-----LEK- 225
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
            D R+  P     EK+  +M    +C+  +P  RP+   I Q
Sbjct: 226 -DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 124
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +A+FG   S+   SS  T   GT  Y+ PE+
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEM 179
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G  + ++   ++ E++E GSL   L  +    +    Q + +++ ++  + YL    +  
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDG--QFTVIQLVGMLRGISAGMKYLSDMGY-- 145
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGTC--GYIAPELAYTMKI 760
            VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE     K 
Sbjct: 146 -VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKF 204
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           T   DV+S+G++MWEV+  G+ P            N DV        RLP+P        
Sbjct: 205 TSASDVWSYGIVMWEVVSYGERP-------YWEMTNQDVIKAVEEGYRLPSPMDCPA--- 254
Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQL 847
            ++ ++   C+ +   SRP    I   L
Sbjct: 255 -ALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE+
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEM 178
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 19/208 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           A  DF+    +G G   +VY A     + +   K       ++   + +   EVE     
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALS
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 124
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           Y H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE+
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEM 179
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  EK D++S GVL +E + GK P
Sbjct: 180 IEGRMHDEKVDLWSLGVLCYEFLVGKPP 207

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 95  GICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 148
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGYIAPELAYTMKI 760
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   T       + APE     K 
Sbjct: 149 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E +
Sbjct: 208 SSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE-M 259
Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +M +   C+    E+RP    +  +LR
Sbjct: 260 YDLMNL---CWTYDVENRPGFAAVELRLR 285

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 22/209 (10%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C  A    L+ E  E G L   L  +   ++      + ++  V+  + YL    F  
Sbjct: 95  GICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYLEESNF-- 148
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGYIAPELAYTMKI 760
            VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   T       + APE     K 
Sbjct: 149 -VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E +
Sbjct: 208 SSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE-M 259
Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +M +   C+    E+RP    +  +LR
Sbjct: 260 YDLMNL---CWTYDVENRPGFAAVELRLR 285

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGE-VVAVKKFHSLLPCD-----QTVDQ-KEFLTE 638
           A N+ + +  IG GG   V++  L   + VVA+K   SL+  D     + +++ +EF  E
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQRE 73
Query: 639 V-----------EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
           V              YG   +     ++ EF+  G L   L     A  + WS ++ ++ 
Sbjct: 74  VFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLML 129
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE-----AHVADFGIAKSLKPDSSNWTE 742
            +A  + Y+ +   PPIVHRD+ S N+ L    E     A VADFG ++       + + 
Sbjct: 130 DIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ---SVHSVSG 185
Query: 743 FAGTCGYIAPEL--AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVAL 800
             G   ++APE   A     TEK D YSF ++++ ++ G+ P D         +N  +  
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN--MIR 243
Query: 801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           ++ L P +P        +L +++E+   C++  P+ RP    I ++L
Sbjct: 244 EEGLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    F   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 161 KYLSDMGF---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+A+ L+ D  + +T   G     + 
Sbjct: 161 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 21/209 (10%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
           A  DF+    +G G   +VY A   + + +   K       ++   + +   EVE     
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE----I 61
Query: 646 CSHARH------------SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
            SH RH            S  +Y  LE   L  +        +    +    I  +A+AL
Sbjct: 62  QSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           SY H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE
Sbjct: 122 SYCHSK---KVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPE 176
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +       EK D++S GVL +E + GK P
Sbjct: 177 MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 205

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 114/260 (43%), Gaps = 36/260 (13%)
Query: 596 IGNGGHASVYRAELPSGE--VVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------F 642
           +G  G     R ++P      VA+K   +     Q   +++FL+E               
Sbjct: 18  VGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNIIHL 74
Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
            G  +  +   ++ E++E GSL A L  +     +   Q + +++ +   + YL    + 
Sbjct: 75  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSY- 131
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGTC--GYIAPELAYTMK 759
             VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE     K
Sbjct: 132 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 760 ITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEK 818
            T   DV+S+G++MWEV+  G+ P            N DV        RLP P     + 
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDVIKAIEEGYRLPPP----MDC 238
Query: 819 LISIMEVAFSCFNESPESRP 838
            I++ ++   C+ +    RP
Sbjct: 239 PIALHQLMLDCWQKERSDRP 258

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 114/260 (43%), Gaps = 36/260 (13%)
Query: 596 IGNGGHASVYRAELPSGE--VVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------F 642
           +G  G     R ++P      VA+K   +     Q   +++FL+E               
Sbjct: 24  VGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNIIHL 80
Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
            G  +  +   ++ E++E GSL A L  +     +   Q + +++ +   + YL    + 
Sbjct: 81  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSDMSY- 137
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGTC--GYIAPELAYTMK 759
             VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE     K
Sbjct: 138 --VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 760 ITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEK 818
            T   DV+S+G++MWEV+  G+ P            N DV        RLP P     + 
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDVIKAIEEGYRLPPP----MDC 244
Query: 819 LISIMEVAFSCFNESPESRP 838
            I++ ++   C+ +    RP
Sbjct: 245 PIALHQLMLDCWQKERSDRP 264

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 23/196 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 337 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 392
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 393 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 450
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 451 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 498
Query: 828 SCFNESPESRPTMKII 843
            C+ + PE RPT + +
Sbjct: 499 QCWRKEPEERPTFEYL 514

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ EF+ +GSL   L +D  +++    + ++    +A  ++++    +   +HRD+ + 
Sbjct: 85  YIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAA 140
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 141 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 200
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V        R+P P    +E L +IM     C+
Sbjct: 201 LLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPEE-LYNIM---MRCW 249
Query: 831 NESPESRPTMKIISQQL 847
              PE RPT + I   L
Sbjct: 250 KNRPEERPTFEYIQSVL 266

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 112/262 (42%), Gaps = 32/262 (12%)
Query: 597 GNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGF 645
           G  G     R +LP    VAV    +L        +++FL E           V    G 
Sbjct: 54  GEFGEVCSGRLKLPGKRDVAVA-IKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGV 112
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
            +  +   ++ EF+E G+L A L       +    Q + +++ +A  + YL    +   V
Sbjct: 113 VTRGKPVMIVIEFMENGALDAFLRKHDG--QFTVIQLVGMLRGIAAGMRYLADMGY---V 167
Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYIAPELAYTMKITE 762
           HRD++++N+L++      V+DFG+++ ++ D  + +T   G     + APE     K T 
Sbjct: 168 HRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTS 227
Query: 763 KCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLIS 821
             DV+S+G++MWEV+  G+ P            N DV        RLPAP          
Sbjct: 228 ASDVWSYGIVMWEVMSYGERP-------YWDMSNQDVIKAIEEGYRLPAPMDCPA----G 276
Query: 822 IMEVAFSCFNESPESRPTMKII 843
           + ++   C+ +    RP  + I
Sbjct: 277 LHQLMLDCWQKERAERPKFEQI 298

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 161 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 91/218 (41%), Gaps = 28/218 (12%)
Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKE--- 634
           +I     DF+    +G G    V+ AE         + A+KK   L+  D      E   
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 635 --------FLTEVEAFYGFCSHARHS--FLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
                   FLT +     FC+       F + E+L  G L   + +     +   S+   
Sbjct: 72  LSLAWEHPFLTHM-----FCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATF 123
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
               +   L +LH      IV+RD+   N+LLD +    +ADFG+ K      +   EF 
Sbjct: 124 YAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC 180
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YIAPE+    K     D +SFGVL++E++ G+ P
Sbjct: 181 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 15  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 131
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 132 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 239
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 240 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 271

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 23/196 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 81  YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 136
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 137 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 194
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 195 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 242
Query: 828 SCFNESPESRPTMKII 843
            C+ + PE RPT + +
Sbjct: 243 QCWRKEPEERPTFEYL 258

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 161 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 161 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 161 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 123/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+ + L+ D  + +T   G     + 
Sbjct: 161 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 73/133 (54%), Gaps = 9/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E+++  +L  I++T+     +   + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA---GTCGYIAPELAYTMKITEKCDVYSF 769
           N+++       V DFGIA+++    ++ T+ A   GT  Y++PE A    +  + DVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 770 GVLMWEVIKGKHP 782
           G +++EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 73/133 (54%), Gaps = 9/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E+++  +L  I++T+     +   + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA---GTCGYIAPELAYTMKITEKCDVYSF 769
           N+++       V DFGIA+++    ++ T+ A   GT  Y++PE A    +  + DVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 770 GVLMWEVIKGKHP 782
           G +++EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 254 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 309
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 310 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 368 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 415
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 416 QCWRKEPEERPTFEYLQ 432

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 73/133 (54%), Gaps = 9/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E+++  +L  I++T+     +   + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA---GTCGYIAPELAYTMKITEKCDVYSF 769
           N+++       V DFGIA+++    ++ T+ A   GT  Y++PE A    +  + DVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 770 GVLMWEVIKGKHP 782
           G +++EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  +YG        +++ E+L  GS   +L        L  +Q   +++ +   L YLH 
Sbjct: 87  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHS 142
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +     +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+    
Sbjct: 143 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 199
Query: 759 KITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEK 818
               K D++S G+   E+ +G+ P   L                 L P+   P+      
Sbjct: 200 AYDSKADIWSLGITAIELARGEPPHSELHPMKVL----------FLIPKNNPPTLEGNYS 249
Query: 819 LISIMEVAFSCFNESPESRPTMK 841
              + E   +C N+ P  RPT K
Sbjct: 250 K-PLKEFVEACLNKEPSFRPTAK 271

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 73/133 (54%), Gaps = 9/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E+++  +L  I++T+     +   + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA---GTCGYIAPELAYTMKITEKCDVYSF 769
           N+++       V DFGIA+++    ++ T+ A   GT  Y++PE A    +  + DVYS 
Sbjct: 146 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 770 GVLMWEVIKGKHP 782
           G +++EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 42  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 100
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  +
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 158
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 159 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 266
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 267 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 298

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 254 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 309
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 310 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 368 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 415
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 416 QCWRKEPEERPTFEYLQ 432

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+++ 
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLAAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 144 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 202 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 249
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 250 QCWRKDPEERPTFEYLQ 266

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 131/287 (45%), Gaps = 44/287 (15%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGE-VVAVKKFHSLLPCD-----QTVDQ-KEFLTE 638
           A N+ + +  IG GG   V++  L   + VVA+K   SL+  D     + +++ +EF  E
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK---SLILGDSEGETEMIEKFQEFQRE 73
Query: 639 V-----------EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
           V              YG   +     ++ EF+  G L   L     A  + WS ++ ++ 
Sbjct: 74  VFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLML 129
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE-----AHVADFGIAKSLKPDSSNWTE 742
            +A  + Y+ +   PPIVHRD+ S N+ L    E     A VADF +++       + + 
Sbjct: 130 DIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ---SVHSVSG 185
Query: 743 FAGTCGYIAPEL--AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVAL 800
             G   ++APE   A     TEK D YSF ++++ ++ G+ P D         +N  +  
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN--MIR 243
Query: 801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           ++ L P +P        +L +++E+   C++  P+ RP    I ++L
Sbjct: 244 EEGLRPTIP---EDCPPRLRNVIEL---CWSGDPKKRPHFSYIVKEL 284

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 23/196 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 77  YIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 132
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 133 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 190
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 191 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 238
Query: 828 SCFNESPESRPTMKII 843
            C+ + PE RPT + +
Sbjct: 239 QCWRKDPEERPTFEYL 254

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 54/196 (27%), Positives = 100/196 (51%), Gaps = 23/196 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 79  YIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 134
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 135 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 192
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 193 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 240
Query: 828 SCFNESPESRPTMKII 843
            C+ + PE RPT + +
Sbjct: 241 QCWRKDPEERPTFEYL 256

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 14/179 (7%)
Query: 611 SGEVVAVKKF------HSLLPCDQTVDQKEFLTE-VEAFYGFCSHARHSFLLYEFLERGS 663
           SG++VAVKK          L  ++ V  +++  E V   Y         +++ EFLE G+
Sbjct: 98  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157
Query: 664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH 723
           L  I+      +E    Q   V  AV  ALS LH      ++HRDI S ++LL  +    
Sbjct: 158 LTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVK 210
Query: 724 VADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           ++DFG    +  +        GT  ++APEL   +    + D++S G+++ E++ G+ P
Sbjct: 211 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 87/206 (42%), Gaps = 19/206 (9%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
            DFD    +G G   +VY A     + +   K       ++   + +   EVE       
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 641 ----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 YG+   A   +L+ E+   G++   L   +   E    +    I  +A+ALSY 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYC 128
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H      ++HRDI  +NLLL    E  +ADFG   S+   SS      GT  Y+ PE+  
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEMIE 183
Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHP 782
                EK D++S GVL +E + G  P
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/260 (23%), Positives = 113/260 (43%), Gaps = 36/260 (13%)
Query: 596 IGNGGHASVYRAELPSGE--VVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------F 642
           +G  G     R ++P      VA+K   +     Q   +++FL+E               
Sbjct: 39  VGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ---RRDFLSEASIMGQFDHPNIIHL 95
Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
            G  +  +   ++ E++E GSL A L  +     +   Q + +++ +   + YL      
Sbjct: 96  EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGSGMKYLSD---M 150
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGTC--GYIAPELAYTMK 759
             VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + APE     K
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 760 ITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEK 818
            T   DV+S+G++MWEV+  G+ P            N DV        RLP P     + 
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERP-------YWDMSNQDVIKAIEEGYRLPPP----MDC 259
Query: 819 LISIMEVAFSCFNESPESRP 838
            I++ ++   C+ +    RP
Sbjct: 260 PIALHQLMLDCWQKERSDRP 279

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  +YG        +++ E+L  GS   +L     A      Q   ++K +   L YLH 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHS 138
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +     +HRDI + N+LL  + +  +ADFG+A  L         F GT  ++APE+    
Sbjct: 139 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 759 KITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQM--LDPRLPAPSRSAQ 816
               K D++S G+   E+ KG+ P            N+D+   ++  L P+   P+    
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPP------------NSDMHPMRVLFLIPKNNPPTLVG- 242
Query: 817 EKLISIMEVAFSCFNESPESRPTMK 841
           +   S  E   +C N+ P  RPT K
Sbjct: 243 DFTKSFKEFIDACLNKDPSFRPTAK 267

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 73/133 (54%), Gaps = 9/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E+++  +L  I++T+     +   + + VI     AL++ H +    I+HRD+   
Sbjct: 109 YIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 162
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA---GTCGYIAPELAYTMKITEKCDVYSF 769
           N+++       V DFGIA+++    ++ T+ A   GT  Y++PE A    +  + DVYS 
Sbjct: 163 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 222
Query: 770 GVLMWEVIKGKHP 782
           G +++EV+ G+ P
Sbjct: 223 GCVLYEVLTGEPP 235

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 19/195 (9%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 88  YIVIEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       VADFG+A+ ++ +     + A     + APE A   + T K DV+SFG+
Sbjct: 144 NILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 203
Query: 772 LMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAFSC 829
           L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++   C
Sbjct: 204 LLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMCQC 251
Query: 830 FNESPESRPTMKIIS 844
           + + PE RPT + + 
Sbjct: 252 WRKDPEERPTFEYLQ 266

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKK--FHSLLPCDQTVDQKEFLTEVEA---- 641
           +DFD    +G G   +VY A     + +   K  F S L  +    Q     E+++    
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 Y +    +  +L+ EF  RG L   L       E    +    ++ +A AL Y 
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHYC 131
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H      ++HRDI  +NLL+  + E  +ADFG   S+   S       GT  Y+ PE+  
Sbjct: 132 HER---KVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHPRD 784
                EK D++  GVL +E + G  P D
Sbjct: 187 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/254 (24%), Positives = 108/254 (42%), Gaps = 47/254 (18%)
Query: 616 AVKKFHSLLPCDQTVDQKEFLTEVE-----AFYGFCSHARHSFLLYEFLERGSL------ 664
           A K FH          + E LT ++      FYG C       +++E+++ G L      
Sbjct: 58  ARKDFHR---------EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA 108
Query: 665 ----AAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY 720
               A ++       EL  SQ +++ + +A  + YL    F   VHRD++++N L+    
Sbjct: 109 HGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHF---VHRDLATRNCLVGENL 165
Query: 721 EAHVADFGIAKSLKPDSSNWTEFAGTC----GYIAPELAYTMKITEKCDVYSFGVLMWEV 776
              + DFG+++ +   S+++    G       ++ PE     K T + DV+S GV++WE+
Sbjct: 166 LVKIGDFGMSRDVY--STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 223
Query: 777 IK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESP 834
              GK P           L+ +  ++ +   R L  P    QE    + E+   C+   P
Sbjct: 224 FTYGKQP--------WYQLSNNEVIECITQGRVLQRPRTCPQE----VYELMLGCWQREP 271
Query: 835 ESRPTMKIISQQLR 848
             R  +K I   L+
Sbjct: 272 HMRKNIKGIHTLLQ 285

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 21/177 (11%)
Query: 606 RAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLA 665
           R EL   EVV ++ +H     D  VD           Y         +++ EFLE G+L 
Sbjct: 85  RRELLFNEVVIMRDYHH----DNVVD----------MYSSYLVGDELWVVMEFLEGGALT 130
Query: 666 AILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVA 725
            I+      +E    Q   V  +V  ALSYLH+     ++HRDI S ++LL  +    ++
Sbjct: 131 DIVTHTRMNEE----QIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLS 183
Query: 726 DFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           DFG    +  +        GT  ++APE+   +    + D++S G+++ E+I G+ P
Sbjct: 184 DFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH 
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHR 135
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  YIAPE+    
Sbjct: 136 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 192
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             + + DV+S G +M+ ++ GK P
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 254 YIVGEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 309
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 310 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 367
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 368 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 415
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 416 QCWRKEPEERPTFEYLQ 432

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 69  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 122
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L  + +N  EF GT  Y++PE  
Sbjct: 123 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN--EFVGTRSYMSPERL 178
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPR 783
                + + D++S G+ + E+  G++PR
Sbjct: 179 QGTHYSVQSDIWSMGLSLVEMAVGRYPR 206

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKF------HSLLPCDQTVDQKEFLTE-VEAFYGFCS 647
           IG G    V  A +  SG++VAVKK          L  ++ V  +++  E V   Y    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 648 HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
                +++ EFLE G+L  I+      +E    Q   V  AV  ALS LH      ++HR
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG---VIHR 149
Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    + D++
Sbjct: 150 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 768 SFGVLMWEVIKGKHP 782
           S G+++ E++ G+ P
Sbjct: 210 SLGIMVIEMVDGEPP 224

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKF------HSLLPCDQTVDQKEFLTE-VEAFYGFCS 647
           IG G    V  A +  SG++VAVKK          L  ++ V  +++  E V   Y    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 648 HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
                +++ EFLE G+L  I+      +E    Q   V  AV  ALS LH      ++HR
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG---VIHR 151
Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    + D++
Sbjct: 152 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 768 SFGVLMWEVIKGKHP 782
           S G+++ E++ G+ P
Sbjct: 212 SLGIMVIEMVDGEPP 226

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH 
Sbjct: 79  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHR 135
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  YIAPE+    
Sbjct: 136 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 192
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             + + DV+S G +M+ ++ GK P
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPP 216

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 88  YIVIEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 144 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 202 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 249
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 250 QCWRKDPEERPTFEYLQ 266

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 85  YIVTEYMNKGSLLDFLKGETG-KYLRLPQLVDMSAQIASGMAYVERMNY---VHRDLRAA 140
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 141 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 198
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 199 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 246
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 247 QCWRKEPEERPTFEYLQ 263

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH 
Sbjct: 83  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHR 139
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  YIAPE+    
Sbjct: 140 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKK 196
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             + + DV+S G +M+ ++ GK P
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPP 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKF------HSLLPCDQTVDQKEFLTE-VEAFYGFCS 647
           IG G    V  A +  SG++VAVKK          L  ++ V  +++  E V   Y    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 648 HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
                +++ EFLE G+L  I+      +E    Q   V  AV  ALS LH      ++HR
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG---VIHR 140
Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    + D++
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 768 SFGVLMWEVIKGKHP 782
           S G+++ E++ G+ P
Sbjct: 201 SLGIMVIEMVDGEPP 215

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 53/193 (27%), Positives = 98/193 (50%), Gaps = 19/193 (9%)
Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           ++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + N
Sbjct: 79  IVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAAN 134
Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGVL 772
           +L+       VADFG+A+ ++ +     + A     + APE A   + T K DV+SFG+L
Sbjct: 135 ILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 194
Query: 773 MWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAFSCF 830
           + E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++   C+
Sbjct: 195 LTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMCQCW 242
Query: 831 NESPESRPTMKII 843
            + PE RPT + +
Sbjct: 243 RKEPEERPTFEYL 255

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 144 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 202 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 249
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 250 QCWRKDPEERPTFEYLQ 266

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 85/179 (47%), Gaps = 14/179 (7%)
Query: 611 SGEVVAVKKF------HSLLPCDQTVDQKEFLTE-VEAFYGFCSHARHSFLLYEFLERGS 663
           SG++VAVKK          L  ++ V  +++  E V   Y         +++ EFLE G+
Sbjct: 175 SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 234
Query: 664 LAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH 723
           L  I+      +E    Q   V  AV  ALS LH      ++HRDI S ++LL  +    
Sbjct: 235 LTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVK 287
Query: 724 VADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           ++DFG    +  +        GT  ++APEL   +    + D++S G+++ E++ G+ P
Sbjct: 288 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 144 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 202 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 249
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 250 QCWRKDPEERPTFEYLQ 266

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 15/195 (7%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKF------HSLLPCDQTVDQKEFLTE-VEAFYGFCS 647
           IG G    V  A +  SG++VAVKK          L  ++ V  +++  E V   Y    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 648 HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
                +++ EFLE G+L  I+      +E    Q   V  AV  ALS LH      ++HR
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG---VIHR 144
Query: 708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
           DI S ++LL  +    ++DFG    +  +        GT  ++APEL   +    + D++
Sbjct: 145 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 768 SFGVLMWEVIKGKHP 782
           S G+++ E++ G+ P
Sbjct: 205 SLGIMVIEMVDGEPP 219

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  +YG        +++ E+L  GS   +L        L  +Q   +++ +   L YLH 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHS 137
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +     +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+    
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 759 KITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEK 818
               K D++S G+   E+ +G+ P   L                 L P+   P+      
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVL----------FLIPKNNPPTLEGNYS 244
Query: 819 LISIMEVAFSCFNESPESRPTMK 841
              + E   +C N+ P  RPT K
Sbjct: 245 K-PLKEFVEACLNKEPSFRPTAK 266

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 87/208 (41%), Gaps = 19/208 (9%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKK--FHSLLPCDQTVDQKEFLTEVEA---- 641
           +DFD    +G G   +VY A     + +   K  F S L  +    Q     E+++    
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 Y +    +  +L+ EF  RG L   L       E    +    ++ +A AL Y 
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHYC 130
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H      ++HRDI  +NLL+  + E  +ADFG   S+   S       GT  Y+ PE+  
Sbjct: 131 HER---KVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHPRD 784
                EK D++  GVL +E + G  P D
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 88  YIVCEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 144 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 202 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 249
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 250 QCWRKDPEERPTFEYLQ 266

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  +YG        +++ E+L  GS   +L        L  +Q   +++ +   L YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHS 122
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +     +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+    
Sbjct: 123 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 759 KITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEK 818
               K D++S G+   E+ +G+ P   L                 L P+   P+      
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVL----------FLIPKNNPPTLEGNYS 229
Query: 819 LISIMEVAFSCFNESPESRPTMK 841
              + E   +C N+ P  RPT K
Sbjct: 230 K-PLKEFVEACLNKEPSFRPTAK 251

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
            T  F   + I +  +   Y  ++   E+V       L   + T D++  L+ V      
Sbjct: 15  GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-----RLKQVEHTNDERLMLSIVTHPFII 69
Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
             +G    A+  F++ +++E G L ++L     +Q             V  AL YLH   
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSK- 125
Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI 760
              I++RD+  +N+LLD      + DFG AK + PD +      GT  YIAPE+  T   
Sbjct: 126 --DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT--YXLCGTPDYIAPEVVSTKPY 180
Query: 761 TEKCDVYSFGVLMWEVIKGKHP 782
            +  D +SFG+L++E++ G  P
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTP 202

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 9/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E+++  +L  I++T+     +   + + VI     AL++ H +    I+HRD+   
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQNG---IIHRDVKPA 145
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA---GTCGYIAPELAYTMKITEKCDVYSF 769
           N+L+       V DFGIA+++    ++  + A   GT  Y++PE A    +  + DVYS 
Sbjct: 146 NILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 205
Query: 770 GVLMWEVIKGKHP 782
           G +++EV+ G+ P
Sbjct: 206 GCVLYEVLTGEPP 218

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH 
Sbjct: 103 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHR 159
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  YIAPE+    
Sbjct: 160 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 216
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             + + DV+S G +M+ ++ GK P
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPP 240

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 18/203 (8%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  +YG        +++ E+L  GS   +L        L  +Q   +++ +   L YLH 
Sbjct: 67  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHS 122
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +     +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+    
Sbjct: 123 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 759 KITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEK 818
               K D++S G+   E+ +G+ P   L                 L P+   P+      
Sbjct: 180 AYDSKADIWSLGITAIELARGEPPHSELHPMKVL----------FLIPKNNPPTLEGNYS 229
Query: 819 LISIMEVAFSCFNESPESRPTMK 841
              + E   +C N+ P  RPT K
Sbjct: 230 K-PLKEFVEACLNKEPSFRPTAK 251

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH 
Sbjct: 101 VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHR 157
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  YIAPE+    
Sbjct: 158 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 214
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             + + DV+S G +M+ ++ GK P
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPP 238

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 588 NDFDAKYCIGNGGHASV-----------YRAELPSGEVVAVKKFHSLLPCDQTVDQKE-- 634
           NDFD    +G G    V           Y  ++   EV+  K   +    +  V Q    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 635 -FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHA 692
            FLT ++  Y F +H R  F++ E+   G L   L+ +    E    +R     A +  A
Sbjct: 65  PFLTALK--YAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+AP
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+          D +  GV+M+E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 255 YIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 310
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+ + +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 311 NILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 368
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 369 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 416
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 417 QCWRKDPEERPTFEYLQ 433

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 588 NDFDAKYCIGNGGHASV-----------YRAELPSGEVVAVKKFHSLLPCDQTVDQKE-- 634
           NDFD    +G G    V           Y  ++   EV+  K   +    +  V Q    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 635 -FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHA 692
            FLT ++  Y F +H R  F++ E+   G L   L+ +    E    +R     A +  A
Sbjct: 65  PFLTALK--YAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+AP
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+          D +  GV+M+E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 41/280 (14%)
Query: 588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFC 646
           +D++ +  IG+G  A V  A   P  E VA+K+  +L  C  ++D  E L E++A    C
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMD--ELLKEIQAM-SQC 70
Query: 647 SH------------ARHSFLLYEFLERGSLAAILNTDAAAQE-----LGWSQRMNVIKAV 689
            H                +L+ + L  GS+  I+    A  E     L  S    +++ V
Sbjct: 71  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK-----PDSSNWTEFA 744
              L YLH +     +HRD+ + N+LL  +    +ADFG++  L        +     F 
Sbjct: 131 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 745 GTCGYIAPELAYTMKITE-KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXL---NTDVAL 800
           GT  ++APE+   ++  + K D++SFG+   E+  G  P           L   N   +L
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 801 DQ-MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +  + D  +      +  K+IS+      C  + PE RPT
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMISL------CLQKDPEKRPT 281

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 123/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E +E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 161 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 588 NDFDAKYCIGNGGHASV-----------YRAELPSGEVVAVKKFHSLLPCDQTVDQKE-- 634
           NDFD    +G G    V           Y  ++   EV+  K   +    +  V Q    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 635 -FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHA 692
            FLT ++  Y F +H R  F++ E+   G L   L+ +    E    +R     A +  A
Sbjct: 65  PFLTALK--YAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+AP
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+          D +  GV+M+E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 123/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 15  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E +E GSL + L    A  +    Q + +++ +A  +
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 131
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL    +   VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 132 KYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 239
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 240 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 271

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 31/257 (12%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT--------EVEAFYGFC 646
           IG G    VY+  +  + EVVA+K        D+  D ++ +T         +  ++G  
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
             +   +++ E+L  GS   +L      +    +    +++ +   L YLH +     +H
Sbjct: 87  LKSTKLWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSER---KIH 139
Query: 707 RDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDV 766
           RDI + N+LL  + +  +ADFG+A  L         F GT  ++APE+        K D+
Sbjct: 140 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADI 199
Query: 767 YSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQM--LDPRLPAPSRSAQEKLISIME 824
           +S G+   E+ KG+ P            N+D+   ++  L P+   P+   Q       E
Sbjct: 200 WSLGITAIELAKGEPP------------NSDLHPMRVLFLIPKNSPPTLEGQHSK-PFKE 246
Query: 825 VAFSCFNESPESRPTMK 841
              +C N+ P  RPT K
Sbjct: 247 FVEACLNKDPRFRPTAK 263

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 588 NDFDAKYCIGNGGHASV-----------YRAELPSGEVVAVKKFHSLLPCDQTVDQKE-- 634
           NDFD    +G G    V           Y  ++   EV+  K   +    +  V Q    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 635 -FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHA 692
            FLT ++  Y F +H R  F++ E+   G L   L+ +    E    +R     A +  A
Sbjct: 65  PFLTALK--YAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+AP
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+          D +  GV+M+E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 121/280 (43%), Gaps = 41/280 (14%)
Query: 588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFC 646
           +D++ +  IG+G  A V  A   P  E VA+K+  +L  C  ++D  E L E++A    C
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMD--ELLKEIQAM-SQC 65
Query: 647 SH------------ARHSFLLYEFLERGSLAAILNTDAAAQE-----LGWSQRMNVIKAV 689
            H                +L+ + L  GS+  I+    A  E     L  S    +++ V
Sbjct: 66  HHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 125
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK-----PDSSNWTEFA 744
              L YLH +     +HRD+ + N+LL  +    +ADFG++  L        +     F 
Sbjct: 126 LEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 745 GTCGYIAPELAYTMKITE-KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXL---NTDVAL 800
           GT  ++APE+   ++  + K D++SFG+   E+  G  P           L   N   +L
Sbjct: 183 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 801 DQ-MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +  + D  +      +  K+IS+      C  + PE RPT
Sbjct: 243 ETGVQDKEMLKKYGKSFRKMISL------CLQKDPEKRPT 276

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  F+GF       F++ E   R SL  +     A  E    +    ++ +     YLH 
Sbjct: 77  VVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHR 133
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  YIAPE+    
Sbjct: 134 N---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             + + DV+S G +M+ ++ GK P
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPP 214

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 588 NDFDAKYCIGNGGHASV-----------YRAELPSGEVVAVKKFHSLLPCDQTVDQKE-- 634
           NDFD    +G G    V           Y  ++   EV+  K   +    +  V Q    
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 635 -FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHA 692
            FLT ++  Y F +H R  F++ E+   G L   L+ +    E    +R     A +  A
Sbjct: 68  PFLTALK--YAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 120
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+AP
Sbjct: 121 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 177
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+          D +  GV+M+E++ G+ P
Sbjct: 178 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 588 NDFDAKYCIGNGGHASV-----------YRAELPSGEVVAVKKFHSLLPCDQTVDQKE-- 634
           NDFD    +G G    V           Y  ++   EV+  K   +    +  V Q    
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 635 -FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHA 692
            FLT ++  Y F +H R  F++ E+   G L   L+ +    E    +R     A +  A
Sbjct: 70  PFLTALK--YAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 122
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+AP
Sbjct: 123 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 179
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+          D +  GV+M+E++ G+ P
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 588 NDFDAKYCIGNGGHASV-----------YRAELPSGEVVAVKKFHSLLPCDQTVDQKE-- 634
           NDFD    +G G    V           Y  ++   EV+  K   +    +  V Q    
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 635 -FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHA 692
            FLT ++  Y F +H R  F++ E+   G L   L+ +    E    +R     A +  A
Sbjct: 65  PFLTALK--YAFQTHDRLCFVM-EYANGGELFFHLSRERVFTE----ERARFYGAEIVSA 117
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YLH      +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+AP
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+          D +  GV+M+E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 27/203 (13%)
Query: 596 IGNGGHASVYR-AELPSGEVVA---VKKFHSLLPCDQTVDQKEFLT------------EV 639
           +G GG A  Y   ++ + EV A   V K   L P      QKE ++             V
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKP-----HQKEKMSTEIAIHKSLDNPHV 88
Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
             F+GF       +++ E   R SL  +     A  E    +    ++     + YLH++
Sbjct: 89  VGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNN 145
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK 759
               ++HRD+   NL L+ + +  + DFG+A  ++ D     +  GT  YIAPE+     
Sbjct: 146 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 202
Query: 760 ITEKCDVYSFGVLMWEVIKGKHP 782
            + + D++S G +++ ++ GK P
Sbjct: 203 HSFEVDIWSLGCILYTLLVGKPP 225

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 138
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 199 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 247
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 248 KERPEDRPTFDYLRSVL 264

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 138
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 199 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 247
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 248 KERPEDRPTFDYLRSVL 264

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 84  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 139
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 140 NILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 199
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 200 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 248
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 249 KERPEDRPTFDYLRSVL 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 85  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 140
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 141 NILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 200
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 201 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 249
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 250 KERPEDRPTFDYLRSVL 266

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +G L   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 88  YIVMEYMSKGCLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 144 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 202 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 249
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 250 QCWRKDPEERPTFEYLQ 266

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 39/127 (30%), Positives = 64/127 (50%), Gaps = 3/127 (2%)
Query: 653 FLLYEFLERGSLAAILNTDAAA-QELGWSQRMNVIKAVAHALSYLHH--DCFPPIVHRDI 709
           +++ E+ E G LA+++       Q L     + V+  +  AL   H   D    ++HRD+
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 710 SSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
              N+ LD +    + DFG+A+ L  D     EF GT  Y++PE    M   EK D++S 
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 770 GVLMWEV 776
           G L++E+
Sbjct: 203 GCLLYEL 209

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 653 FLLYEFLERGSLAAILNTDAAA-QELGWSQRMNVIKAVAHALSYLHH--DCFPPIVHRDI 709
           +++ E+ E G LA+++       Q L     + V+  +  AL   H   D    ++HRD+
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 710 SSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
              N+ LD +    + DFG+A+ L  D+S    F GT  Y++PE    M   EK D++S 
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 770 GVLMWEV 776
           G L++E+
Sbjct: 203 GCLLYEL 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Composition-based stats.
 Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 3/127 (2%)
Query: 653 FLLYEFLERGSLAAILNTDAAA-QELGWSQRMNVIKAVAHALSYLHH--DCFPPIVHRDI 709
           +++ E+ E G LA+++       Q L     + V+  +  AL   H   D    ++HRD+
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 710 SSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
              N+ LD +    + DFG+A+ L  D+S    F GT  Y++PE    M   EK D++S 
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 770 GVLMWEV 776
           G L++E+
Sbjct: 203 GCLLYEL 209

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ EF+ +GSL   L +D  +++    + ++    +A  ++++    +   +HRD+ + 
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAA 313
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 314 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V        R+P P    +E L +IM     C+
Sbjct: 374 LLMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPEE-LYNIM---MRCW 422
Query: 831 NESPESRPTMKIISQQL 847
              PE RPT + I   L
Sbjct: 423 KNRPEERPTFEYIQSVL 439

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 99/197 (50%), Gaps = 23/197 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +G L   L  +   + L   Q +++   +A  ++Y+    +   VHRD+ + 
Sbjct: 88  YIVTEYMSKGCLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---VHRDLRAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT---CGYIAPELAYTMKITEKCDVYSF 769
           N+L+       VADFG+A+ +  + + +T   G      + APE A   + T K DV+SF
Sbjct: 144 NILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 201
Query: 770 GVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQM-LDPRLPAPSRSAQEKLISIMEVAF 827
           G+L+ E+  KG+ P   +       +N +V LDQ+    R+P P    +    S+ ++  
Sbjct: 202 GILLTELTTKGRVPYPGM-------VNREV-LDQVERGYRMPCPPECPE----SLHDLMC 249
Query: 828 SCFNESPESRPTMKIIS 844
            C+ + PE RPT + + 
Sbjct: 250 QCWRKDPEERPTFEYLQ 266

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 48/218 (22%)
Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF----------YG 644
           C+G G +  V+R  L  GE VAVK F S        D++ +  E E +           G
Sbjct: 15  CVGKGRYGEVWRG-LWHGESVAVKIFSSR-------DEQSWFRETEIYNTVLLRHDNILG 66
Query: 645 FCSH---ARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           F +    +R+S    +L+  + E GSL   L        L     + +  + A  L++LH
Sbjct: 67  FIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLH 122
Query: 698 HDCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF-----AGTC 747
            + F     P I HRD  S+N+L+    +  +AD G+A  +    S++ +       GT 
Sbjct: 123 VEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTK 181
Query: 748 GYIAPELAYTMKITEKC-------DVYSFGVLMWEVIK 778
            Y+APE+    +I   C       D+++FG+++WE+ +
Sbjct: 182 RYMAPEV-LDEQIRTDCFESYKWTDIWAFGLVLWEIAR 218

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 89  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 144
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 145 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 204
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 205 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 253
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 254 KERPEDRPTFDYLRSVL 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 138
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 199 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 247
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 248 KERPEDRPTFDYLRSVL 264

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 78  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 133
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 134 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 193
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 194 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 242
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 243 KERPEDRPTFDYLRSVL 259

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 88  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 143
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 144 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 203
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 204 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 252
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 253 KERPEDRPTFDYLRSVL 269

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 44/273 (16%)
Query: 596 IGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFY 643
           IG G    V+   L +   +VAVK     LP D    + +FL E           +    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C+  +  +++ E ++ G     L T+ A   L     + ++   A  + YL   C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG-------YIAPELAY 756
            +HRD++++N L+  +    ++DFG+++  + D      +A + G       + APE   
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGV----YAASGGLRQVPVKWTAPEALN 288
Query: 757 TMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSA 815
             + + + DV+SFG+L+WE    G  P   L                    RLP P    
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-------RLPCPELCP 341
Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            + +  +ME    C+   P  RP+   I Q+L+
Sbjct: 342 -DAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 37/276 (13%)
Query: 586 ATN-DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE---- 640
           ATN   D     G  G     R +LPS + ++V    +L        +++FL E      
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA-IKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                     G  + ++   ++ E +E GSL + L    A  +    Q + +++ +A  +
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGM 160
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGT--CGYI 750
            YL        VHRD++++N+L++      V+DFG+++ L+ D  + +T   G     + 
Sbjct: 161 KYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPR 807
           +PE     K T   DV+S+G+++WEV+  G+ P            N DV  A+D+    R
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP-------YWEMSNQDVIKAVDEGY--R 268
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
           LP P         ++ ++   C+ +   +RP  + I
Sbjct: 269 LPPPMDCPA----ALYQLMLDCWQKDRNNRPKFEQI 300

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS----NWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 141 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAK 197
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 249
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 250 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 282

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 160 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 216
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 217 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 268
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 269 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 301

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 161 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 217
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 218 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 269
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 270 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 302

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 134 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 190
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 191 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 242
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 243 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 90/203 (44%), Gaps = 27/203 (13%)
Query: 596 IGNGGHASVYR-AELPSGEVVA---VKKFHSLLPCDQTVDQKEFLT------------EV 639
           +G GG A  Y   ++ + EV A   V K   L P      QKE ++             V
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKP-----HQKEKMSTEIAIHKSLDNPHV 104
Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
             F+GF       +++ E   R SL  +     A  E    +    ++     + YLH++
Sbjct: 105 VGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNN 161
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK 759
               ++HRD+   NL L+ + +  + DFG+A  ++ D     +  GT  YIAPE+     
Sbjct: 162 ---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG 218
Query: 760 ITEKCDVYSFGVLMWEVIKGKHP 782
            + + D++S G +++ ++ GK P
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPP 241

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V+  Y F +  +  +L+ +FL  G L   L+ +    E         +  +A AL +LH 
Sbjct: 90  VKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELALALDHLHS 145
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
                I++RD+  +N+LLD E    + DFG++K           F GT  Y+APE+    
Sbjct: 146 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             T+  D +SFGVLM+E++ G  P
Sbjct: 203 GHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V+  Y F +  +  +L+ +FL  G L   L+ +    E         +  +A AL +LH 
Sbjct: 89  VKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELALALDHLHS 144
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
                I++RD+  +N+LLD E    + DFG++K           F GT  Y+APE+    
Sbjct: 145 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             T+  D +SFGVLM+E++ G  P
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 7/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V+  Y F +  +  +L+ +FL  G L   L+ +    E         +  +A AL +LH 
Sbjct: 89  VKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELALALDHLHS 144
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
                I++RD+  +N+LLD E    + DFG++K           F GT  Y+APE+    
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             T+  D +SFGVLM+E++ G  P
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 109/277 (39%), Gaps = 52/277 (18%)
Query: 596 IGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFY 643
           IG G    V+   L +   +VAVK     LP D    + +FL E           +    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL---KAKFLQEARILKQYSHPNIVRLI 178
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C+  +  +++ E ++ G     L T+ A   L     + ++   A  + YL   C   
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC--- 233
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKS-----------LKPDSSNWTEFAGTCGYIAP 752
            +HRD++++N L+  +    ++DFG+++            L+     WT         AP
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWT---------AP 284
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           E     + + + DV+SFG+L+WE    G  P   L                    RLP P
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-------RLPCP 337
Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                + +  +ME    C+   P  RP+   I Q+L+
Sbjct: 338 ELCP-DAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 142 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 250
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 251 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 283

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 139 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 195
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 247
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 248 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 280

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-------FPPIV 705
           +L+  F E+GSL+  L  +  +    W++  ++ + +A  L+YLH D         P I 
Sbjct: 98  WLITAFHEKGSLSDFLKANVVS----WNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS 153
Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPE-----LAYTM 758
           HRDI SKN+LL     A +ADFG+A   +   S        GT  Y+APE     + +  
Sbjct: 154 HRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQR 213
Query: 759 KITEKCDVYSFGVLMWEV 776
               + D+Y+ G+++WE+
Sbjct: 214 DAFLRIDMYAMGLVLWEL 231

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE- 640
           I +   DF     +G G  A VYRAE + +G  VA+K           + Q+    EV+ 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKI 64
Query: 641 ----------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
                       Y +   + + +L+ E    G +   L      +    ++  + +  + 
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQII 122
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK-PDSSNWTEFAGTCGY 749
             + YLH      I+HRD++  NLLL       +ADFG+A  LK P   ++T   GT  Y
Sbjct: 123 TGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNY 178
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
           I+PE+A       + DV+S G + + ++ G+ P D
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 141 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 197
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 198 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 249
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 250 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 282

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 140 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 196
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 248
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 249 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 281

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 142 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 198
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 250
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 251 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 283

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 138
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++       E A     + APE       T K DV+SFG+
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 198
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 199 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 247
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 248 KERPEDRPTFDYLRSVL 264

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            Y   +     +++ E++ +GSL   L +D   + L   + ++    +A  ++Y+    +
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY 131
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKI 760
              +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       
Sbjct: 132 ---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 188
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL 819
           T K DV+SFG+L++E++  GK P            N DV        R+P       E L
Sbjct: 189 TIKSDVWSFGILLYEIVTYGKIP-------YPGRTNADVMTALSQGYRMPRVENCPDE-L 240
Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQL 847
             IM++   C+ E  E RPT   +   L
Sbjct: 241 YDIMKM---CWKEKAEERPTFDYLQSVL 265

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 89/218 (40%), Gaps = 28/218 (12%)
Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKE--- 634
           +I     DF     +G G    V+ AE         + A+KK   L+  D      E   
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 635 --------FLTEVEAFYGFCSHARHS--FLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
                   FLT +     FC+       F + E+L  G L   + +     +   S+   
Sbjct: 71  LSLAWEHPFLTHM-----FCTFQTKENLFFVMEYLNGGDLMYHIQS---CHKFDLSRATF 122
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
               +   L +LH      IV+RD+   N+LLD +    +ADFG+ K      +    F 
Sbjct: 123 YAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC 179
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YIAPE+    K     D +SFGVL++E++ G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + YL    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 137 VAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 245
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 246 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 278

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 21/210 (10%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            Y   +     +++ EF+ +GSL   L +D   + L   + ++    +A  ++Y+    +
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY 130
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKI 760
              +HRD+ + N+L+       +ADFG+A+ ++ +     E A     + APE       
Sbjct: 131 ---IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 187
Query: 761 TEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDV--ALDQMLDPRLPAPSRSAQE 817
           T K +V+SFG+L++E++  GK P            N DV  AL Q    R+P       E
Sbjct: 188 TIKSNVWSFGILLYEIVTYGKIP-------YPGRTNADVMSALSQGY--RMPRMENCPDE 238
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
            L  IM++   C+ E  E RPT   +   L
Sbjct: 239 -LYDIMKM---CWKEKAEERPTFDYLQSVL 264

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 76/136 (55%), Gaps = 13/136 (9%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           FL+++ + +G L   L    A  E    +  ++++++  A+S+LH +    IVHRD+  +
Sbjct: 176 FLVFDLMRKGELFDYLTEKVALSE---KETRSIMRSLLEAVSFLHANN---IVHRDLKPE 229
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKIT-----EKCDV 766
           N+LLD   +  ++DFG +  L+P      E  GT GY+APE L  +M  T     ++ D+
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEP-GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDL 288
Query: 767 YSFGVLMWEVIKGKHP 782
           ++ GV+++ ++ G  P
Sbjct: 289 WACGVILFTLLAGSPP 304

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 596 IGNGGHASVYR-AELPSGEVVA---VKKFHSLLPCDQTVDQKEFLTE-------VEAFYG 644
           +G GG A  Y   ++ + EV A   V K   L P  +     E           V  F+G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           F       +++ E   R SL  +     A  E    +    ++     + YLH++    +
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNN---RV 163
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKC 764
           +HRD+   NL L+ + +  + DFG+A  ++ D        GT  YIAPE+      + + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEV 223
Query: 765 DVYSFGVLMWEVIKGKHP 782
           D++S G +++ ++ GK P
Sbjct: 224 DIWSLGCILYTLLVGKPP 241

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 17/198 (8%)
Query: 596 IGNGGHASVYR-AELPSGEVVA---VKKFHSLLPCDQTVDQKEFLTE-------VEAFYG 644
           +G GG A  Y   ++ + EV A   V K   L P  +     E           V  F+G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           F       +++ E   R SL  +     A  E    +    ++     + YLH++    +
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTE---PEARYFMRQTIQGVQYLHNN---RV 163
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKC 764
           +HRD+   NL L+ + +  + DFG+A  ++ D        GT  YIAPE+      + + 
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEV 223
Query: 765 DVYSFGVLMWEVIKGKHP 782
           D++S G +++ ++ GK P
Sbjct: 224 DIWSLGCILYTLLVGKPP 241

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 75/270 (27%), Positives = 106/270 (39%), Gaps = 50/270 (18%)
Query: 596 IGNGGHASVYRAE--LPSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVEAFYGFCSHARH 651
           +G+G    V R E   PSG+ V+V     L P    Q     +F+ EV A +      R+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVA-VKCLKPDVLSQPEAMDDFIREVNAMHSL--DHRN 76
Query: 652 SFLLY------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              LY            E    GSL   L        LG   R  V   VA  + YL   
Sbjct: 77  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW-------TEFAGTCGYIAP 752
            F   +HRD++++NLLL       + DFG+ ++L  +  ++         FA    + AP
Sbjct: 135 RF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA----WCAP 187
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM--LDPRLP 809
           E   T   +   D + FGV +WE+   G+ P           LN    L ++     RLP
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLP 239
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPT 839
            P    Q+    I  V   C+   PE RPT
Sbjct: 240 RPEDCPQD----IYNVMVQCWAHKPEDRPT 265

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 75/270 (27%), Positives = 106/270 (39%), Gaps = 50/270 (18%)
Query: 596 IGNGGHASVYRAE--LPSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVEAFYGFCSHARH 651
           +G+G    V R E   PSG+ V+V     L P    Q     +F+ EV A +      R+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVA-VKCLKPDVLSQPEAMDDFIREVNAMHSL--DHRN 72
Query: 652 SFLLY------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              LY            E    GSL   L        LG   R  V   VA  + YL   
Sbjct: 73  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW-------TEFAGTCGYIAP 752
            F   +HRD++++NLLL       + DFG+ ++L  +  ++         FA    + AP
Sbjct: 131 RF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA----WCAP 183
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM--LDPRLP 809
           E   T   +   D + FGV +WE+   G+ P           LN    L ++     RLP
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLP 235
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPT 839
            P    Q+    I  V   C+   PE RPT
Sbjct: 236 RPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 75/270 (27%), Positives = 106/270 (39%), Gaps = 50/270 (18%)
Query: 596 IGNGGHASVYRAE--LPSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVEAFYGFCSHARH 651
           +G+G    V R E   PSG+ V+V     L P    Q     +F+ EV A +      R+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVA-VKCLKPDVLSQPEAMDDFIREVNAMHSL--DHRN 72
Query: 652 SFLLY------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              LY            E    GSL   L        LG   R  V   VA  + YL   
Sbjct: 73  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW-------TEFAGTCGYIAP 752
            F   +HRD++++NLLL       + DFG+ ++L  +  ++         FA    + AP
Sbjct: 131 RF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA----WCAP 183
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM--LDPRLP 809
           E   T   +   D + FGV +WE+   G+ P           LN    L ++     RLP
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLP 235
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPT 839
            P    Q+    I  V   C+   PE RPT
Sbjct: 236 RPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 17/189 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 91  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 146
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 147 NILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 206
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P  +  E+L  +M +   C+
Sbjct: 207 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPD-NCPEELYQLMRL---CW 255
Query: 831 NESPESRPT 839
            E PE RPT
Sbjct: 256 KERPEDRPT 264

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 630 VDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
           +D+  FLT++ +   F +  R  F++ E++  G L   +      +E    Q +     +
Sbjct: 76  LDKPPFLTQLHS--CFQTVDRLYFVM-EYVNGGDLMYHIQQVGKFKE---PQAVFYAAEI 129
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGY 749
           +  L +LH      I++RD+   N++LD E    +ADFG+ K    D     EF GT  Y
Sbjct: 130 SIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDY 186
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
           IAPE+       +  D +++GVL++E++ G+ P D
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 17/189 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 92  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 147
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 148 NILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 207
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P  +  E+L  +M +   C+
Sbjct: 208 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPD-NCPEELYQLMRL---CW 256
Query: 831 NESPESRPT 839
            E PE RPT
Sbjct: 257 KERPEDRPT 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 17/189 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 89  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 144
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 145 NILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 204
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P  +  E+L  +M +   C+
Sbjct: 205 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPD-NCPEELYQLMRL---CW 253
Query: 831 NESPESRPT 839
            E PE RPT
Sbjct: 254 KERPEDRPT 262

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 49/197 (24%), Positives = 95/197 (48%), Gaps = 17/197 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HR++ + 
Sbjct: 79  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRNLRAA 134
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 135 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 194
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P    +E L  +M +   C+
Sbjct: 195 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDNCPEE-LYQLMRL---CW 243
Query: 831 NESPESRPTMKIISQQL 847
            E PE RPT   +   L
Sbjct: 244 KERPEDRPTFDYLRSVL 260

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 85  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 138
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 139 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 194
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                + + D++S G+ + E+  G++P
Sbjct: 195 QGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + +L    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 201 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 309
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 310 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 342

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL---KPDS-SNWTEFA 744
           VA  + +L    F   VHRD++++N +LD ++   VADFG+A+ +   + DS  N T   
Sbjct: 143 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAK 199
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 251
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 252 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 284

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 19/156 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + +L    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 143 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 199
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNT-DVALDQM 803
               ++A E   T K T K DV+SFGVL+WE++    P           +NT D+ +  +
Sbjct: 200 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFDITVYLL 252
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
              RL  P          + EV   C++   E RP+
Sbjct: 253 QGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 284

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 94/189 (49%), Gaps = 17/189 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++E GSL   L T +  + L  ++ +++   +A  ++++    +   +HRD+ + 
Sbjct: 93  YIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERNY---IHRDLRAA 148
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG-TCGYIAPELAYTMKITEKCDVYSFGV 771
           N+L+       +ADFG+A+ ++ +     E A     + APE       T K DV+SFG+
Sbjct: 149 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGI 208
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF 830
           L+ E++  G+ P   +        N +V  +     R+  P  +  E+L  +M +   C+
Sbjct: 209 LLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPD-NCPEELYQLMRL---CW 257
Query: 831 NESPESRPT 839
            E PE RPT
Sbjct: 258 KERPEDRPT 266

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + +L    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 142 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 250
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 251 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 283

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 63/293 (21%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAF-- 642
           ND   +  IG G    V +A +    +    A+K+       D   D ++F  E+E    
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 81
Query: 643 ----------YGFCSHARHSFLLYEFLERGSL------AAILNTDAA-------AQELGW 679
                      G C H  + +L  E+   G+L      + +L TD A       A  L  
Sbjct: 82  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
            Q ++    VA  + YL    F   +HRD++++N+L+   Y A +ADFG+++  +     
Sbjct: 142 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQE----- 193
Query: 740 WTEFAGTCG-----YIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXX 792
                 T G     ++A E L Y++  T   DV+S+GVL+WE++  G  P   +      
Sbjct: 194 -VYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGM------ 245
Query: 793 XLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
              T   L + L    RL  P     E    + ++   C+ E P  RP+   I
Sbjct: 246 ---TCAELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQI 291

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + +L    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 147 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 203
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 204 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 255
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 256 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 288

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 71/140 (50%), Gaps = 19/140 (13%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC--------FPPI 704
           +L+  F ++GSL   L  +     + W++  +V + ++  LSYLH D          P I
Sbjct: 89  WLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSI 144
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGTCGYIAPE-----LAYT 757
            HRD  SKN+LL  +  A +ADFG+A   +P     +     GT  Y+APE     + + 
Sbjct: 145 AHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQ 204
Query: 758 MKITEKCDVYSFGVLMWEVI 777
                + D+Y+ G+++WE++
Sbjct: 205 RDAFLRIDMYAMGLVLWELV 224

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + +L    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 140 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 196
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 197 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 248
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 249 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 281

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 25/196 (12%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ EF+ +GSL   L +D  +++    + ++    +A  ++++    +   +HRD+ + 
Sbjct: 252 YIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRNY---IHRDLRAA 307
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+L+       +ADFG+A+        WT         APE       T K DV+SFG+L
Sbjct: 308 NILVSASLVCKIADFGLARVGAKFPIKWT---------APEAINFGSFTIKSDVWSFGIL 358
Query: 773 MWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFN 831
           + E++  G+ P   +        N +V        R+P P    +E L +IM     C+ 
Sbjct: 359 LMEIVTYGRIPYPGMS-------NPEVIRALERGYRMPRPENCPEE-LYNIM---MRCWK 407
Query: 832 ESPESRPTMKIISQQL 847
             PE RPT + I   L
Sbjct: 408 NRPEERPTFEYIQSVL 423

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFA 744
           VA  + +L    F   VHRD++++N +LD ++   VADFG+A+ +         N T   
Sbjct: 142 VAKGMKFLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 198
Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNT-DVALDQ 802
               ++A E   T K T K DV+SFGVL+WE++ +G  P           +NT D+ +  
Sbjct: 199 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--------YPDVNTFDITVYL 250
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +   RL  P          + EV   C++   E RP+
Sbjct: 251 LQGRRLLQPEYCPD----PLYEVMLKCWHPKAEMRPS 283

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 63/293 (21%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAF-- 642
           ND   +  IG G    V +A +    +    A+K+       D   D ++F  E+E    
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 71
Query: 643 ----------YGFCSHARHSFLLYEFLERGSL------AAILNTDAA-------AQELGW 679
                      G C H  + +L  E+   G+L      + +L TD A       A  L  
Sbjct: 72  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 131
Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
            Q ++    VA  + YL    F   +HRD++++N+L+   Y A +ADFG+++  +     
Sbjct: 132 QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQE----- 183
Query: 740 WTEFAGTCG-----YIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXX 792
                 T G     ++A E L Y++  T   DV+S+GVL+WE++  G  P   +      
Sbjct: 184 -VYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGM------ 235
Query: 793 XLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
              T   L + L    RL  P     E    + ++   C+ E P  RP+   I
Sbjct: 236 ---TCAELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQI 281

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT-----EF 743
           VA  + YL    F   VHRD++++N +LD  +   VADFG+A+ +  D   ++       
Sbjct: 133 VARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHA 188
Query: 744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQ 802
                + A E   T + T K DV+SFGVL+WE++ +G  P   +          D+    
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DLTHFL 241
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
               RLP P         S+ +V   C+   P  RPT +++
Sbjct: 242 AQGRRLPQPEYCPD----SLYQVMQQCWEADPAVRPTFRVL 278

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +H R  F++ E+   G L   L+ +    E     R     A +  AL
Sbjct: 69  FLTALK--YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSAL 121
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 122 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 179
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 180 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 104/266 (39%), Gaps = 42/266 (15%)
Query: 596 IGNGGHASVYRAEL--PSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVEAFYGFCSHARH 651
           +G+G    V R E   PSG+ V+V     L P    Q     +F+ EV A +      R+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVA-VKCLKPDVLSQPEAMDDFIREVNAMHSL--DHRN 76
Query: 652 SFLLY------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              LY            E    GSL   L        LG   R  V   VA  + YL   
Sbjct: 77  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 134
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAY 756
            F   +HRD++++NLLL       + DFG+ ++L  +  ++           + APE   
Sbjct: 135 RF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 757 TMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD--PRLPAPSR 813
           T   +   D + FGV +WE+   G+ P           LN    L ++     RLP P  
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPED 243
Query: 814 SAQEKLISIMEVAFSCFNESPESRPT 839
             Q+    I  V   C+   PE RPT
Sbjct: 244 CPQD----IYNVMVQCWAHKPEDRPT 265

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +H R  F++ E+   G L   L+ +    E     R     A +  AL
Sbjct: 70  FLTALK--YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSAL 122
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 123 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 180
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 104/266 (39%), Gaps = 42/266 (15%)
Query: 596 IGNGGHASVYRAEL--PSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVEAFYGFCSHARH 651
           +G+G    V R E   PSG+ V+V     L P    Q     +F+ EV A +      R+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVA-VKCLKPDVLSQPEAMDDFIREVNAMHSL--DHRN 82
Query: 652 SFLLY------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              LY            E    GSL   L        LG   R  V   VA  + YL   
Sbjct: 83  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAY 756
            F   +HRD++++NLLL       + DFG+ ++L  +  ++           + APE   
Sbjct: 141 RF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 757 TMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD--PRLPAPSR 813
           T   +   D + FGV +WE+   G+ P           LN    L ++     RLP P  
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPED 249
Query: 814 SAQEKLISIMEVAFSCFNESPESRPT 839
             Q+    I  V   C+   PE RPT
Sbjct: 250 CPQD----IYNVMVQCWAHKPEDRPT 271

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +H R  F++ E+   G L   L+ +    E     R     A +  AL
Sbjct: 71  FLTALK--YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSAL 123
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 124 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPE 181
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 182 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 86
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 87  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 147 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 200
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 201 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 258
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 259 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 66  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 119
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 175
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                + + D++S G+ + E+  G++P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 128 IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 181
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 182 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 237
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                + + D++S G+ + E+  G++P
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 52/284 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 109
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 223
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 281
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           P+  P P          +  +   C+   PE RP   II +++ 
Sbjct: 282 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 66  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 119
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 120 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 175
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                + + D++S G+ + E+  G++P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 66  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 119
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 120 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 175
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                + + D++S G+ + E+  G++P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKLNHQN 95
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 209
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 267
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 268 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL      ++  D+++ G ++++++ G  P
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 114/284 (40%), Gaps = 52/284 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKLNHQN 109
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 223
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 281
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           P+  P P          +  +   C+   PE RP   II +++ 
Sbjct: 282 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 95
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 209
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 267
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 268 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 75/270 (27%), Positives = 105/270 (38%), Gaps = 50/270 (18%)
Query: 596 IGNGGHASVYRAE--LPSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVEAFYGFCSHARH 651
           +G+G    V R E   PSG+ V+V     L P    Q     +F+ EV A +      R+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVA-VKCLKPDVLSQPEAMDDFIREVNAMHSL--DHRN 72
Query: 652 SFLLY------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              LY            E    GSL   L        LG   R  V   VA  + YL   
Sbjct: 73  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 130
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW-------TEFAGTCGYIAP 752
            F   +HRD++++NLLL       + DFG+ ++L  +  +          FA    + AP
Sbjct: 131 RF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFA----WCAP 183
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM--LDPRLP 809
           E   T   +   D + FGV +WE+   G+ P           LN    L ++     RLP
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLP 235
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPT 839
            P    Q+    I  V   C+   PE RPT
Sbjct: 236 RPEDCPQD----IYNVMVQCWAHKPEDRPT 261

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G   +VY+ +      VAVK  +   P  Q +  + F  EV             F G
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 87
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           + +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I
Sbjct: 88  YSTKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 141
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMK--- 759
           +HRD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+        
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 760 ITEKCDVYSFGVLMWEVIKGKHP 782
            + + DVY+FG++++E++ G+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 93  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 146
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 147 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 202
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                + + D++S G+ + E+  G++P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 101
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 102 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 162 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 215
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 216 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 273
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 274 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 18/199 (9%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           +G GG ++VY AE     +    K   + P ++    K F  EV            +   
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
                   +L+ E++E  +L+  + +      L     +N    +   + + H      I
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD---MRI 132
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPELAYTMKITEK 763
           VHRDI  +N+L+D      + DFGIAK+L   S   T    GT  Y +PE A      E 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 764 CDVYSFGVLMWEVIKGKHP 782
            D+YS G++++E++ G+ P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 66  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 119
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 120 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 175
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                + + D++S G+ + E+  G++P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 94
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 208
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 266
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 267 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +H R  F++ E+   G L   L+ +    E     R     A +  AL
Sbjct: 212 FLTALK--YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSAL 264
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 265 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 322
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 111
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 112 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 172 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 225
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 226 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 283
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 284 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V++ +  PSG V+A K  H  + P   +Q + + + L E     
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQE--LGWSQRMNVIKAVAHALSY 695
           +  FYG F S    S  + E ++ GSL  +L       E  LG      V  AV   L+Y
Sbjct: 66  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTY 119
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L       I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y++PE  
Sbjct: 120 LREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPERL 175
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                + + D++S G+ + E+  G++P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 635 FLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VAHAL 693
           FLT ++  Y F +H R  F++ E+   G L   L+ +    E     R     A +  AL
Sbjct: 209 FLTALK--YSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSAL 261
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            YLH +    +V+RD+  +NL+LD +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 262 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPE 319
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +          D +  GV+M+E++ G+ P
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 43/220 (19%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEVEAFYGF----- 645
           +G G +  V+++ +  +GEVVAVKK    F +     +T  +   LTE+           
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 646 ---CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
                + R  +L+++++E    A I      A  L    +  V+  +   + YLH     
Sbjct: 77  VLRADNDRDVYLVFDYMETDLHAVI-----RANILEPVHKQYVVYQLIKVIKYLHSGG-- 129
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKS---------------------LKPDSSNWT 741
            ++HRD+   N+LL+ E    VADFG+++S                        D    T
Sbjct: 130 -LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
Query: 742 EFAGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVIKGK 780
           ++  T  Y APE+   + K T+  D++S G ++ E++ GK
Sbjct: 189 DYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 590 FDAKYCIGNGGHASVYR-AELPSGEVVAVKKFHSLLPCDQTV---DQKEFLTEVEAFYGF 645
           ++ K  +G GG   V R     +GE VA+K+      C Q +   +++ +  E++     
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ------CRQELSPKNRERWCLEIQIMKKL 70
Query: 646 ----CSHARH-------------SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
                  AR                L  E+ E G L   LN       L       ++  
Sbjct: 71  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 130
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA---HVADFGIAKSLKPDSSNWTEFAG 745
           ++ AL YLH +    I+HRD+  +N++L    +     + D G AK L       TEF G
Sbjct: 131 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVG 186
Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T  Y+APEL    K T   D +SFG L +E I G  P
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 96/203 (47%), Gaps = 26/203 (12%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G   +VY+ +      VAVK  +   P  Q +  + F  EV             F G
Sbjct: 32  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 87
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           + S A    ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 141
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMK--- 759
           +HRD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+        
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 760 ITEKCDVYSFGVLMWEVIKGKHP 782
            + + DVY+FG++++E++ G+ P
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP 224

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG+G   +VY+ +      VAVK  +   P  Q +  + F  EV             F G
Sbjct: 20  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQL--QAFKNEVGVLRKTRHVNILLFMG 75
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           + +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I
Sbjct: 76  YSTKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---I 129
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMK--- 759
           +HRD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+        
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 760 ITEKCDVYSFGVLMWEVIKGKHP 782
            + + DVY+FG++++E++ G+ P
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQLP 212

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 90/217 (41%), Gaps = 34/217 (15%)
Query: 590 FDAKYCIGNGGHASVYR-AELPSGEVVAVKKFHSLLPCDQTV---DQKEFLTEVEAFYGF 645
           ++ K  +G GG   V R     +GE VA+K+      C Q +   +++ +  E++     
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQ------CRQELSPKNRERWCLEIQIMKKL 69
Query: 646 ----CSHARH-------------SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
                  AR                L  E+ E G L   LN       L       ++  
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA---HVADFGIAKSLKPDSSNWTEFAG 745
           ++ AL YLH +    I+HRD+  +N++L    +     + D G AK L       TEF G
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVG 185
Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T  Y+APEL    K T   D +SFG L +E I G  P
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 94
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 208
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 266
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 267 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKK-FHSLLPCDQTVDQKEFLTEVEA---- 641
           +DF+    +G G   +VY A E  S  +VA+K  F S +  +    Q     E++A    
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 Y +    R  +L+ E+  RG L   L       E    +   +++ +A AL Y 
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDE---QRTATIMEELADALMYC 139
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H      ++HRDI  +NLLL L+ E  +ADFG   S+   S       GT  Y+ PE+  
Sbjct: 140 HGK---KVIHRDIKPENLLLGLKGELKIADFGW--SVHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHP 782
                EK D++  GVL +E++ G  P
Sbjct: 195 GRMHNEKVDLWCIGVLCYELLVGNPP 220

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 95
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 96  IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 156 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY-RASYYRK--GGCAMLP 209
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 210 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 267
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 268 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFH-SLLPC--DQTVDQKEFLTE----- 638
           +DF+    +G G    V + +  PSG ++A K  H  + P   +Q + + + L E     
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 639 VEAFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           +  FYG F S    S  + E ++ GSL  +L     A+ +       V  AV   L+YL 
Sbjct: 76  IVGFYGAFYSDGEISICM-EHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLR 131
Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
                 I+HRD+   N+L++   E  + DFG++  L    +N   F GT  Y+APE    
Sbjct: 132 EKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMAPERLQG 187
Query: 758 MKITEKCDVYSFGVLMWEVIKGKHP 782
              + + D++S G+ + E+  G++P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 124/262 (47%), Gaps = 37/262 (14%)
Query: 596 IGNGGHASVYRAE------LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY-----G 644
           +G+G    VY+A+      L + +V+  K    L   +  + + E L   +  Y     G
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 75
Query: 645 FCSHARHSFLLYEFLERGSLAAI-LNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
              H    +++ EF   G++ AI L  D    E    Q   V + +  AL++LH      
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---R 129
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGI-AKSLKPDSSNWTEFAGTCGYIAPELAY--TMKI 760
           I+HRD+ + N+L+ LE +  +ADFG+ AK+LK        F GT  ++APE+    TMK 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKD 188
Query: 761 TE---KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           T    K D++S G+ + E+ + + P   L       +   + + +   P L  PS+ + E
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSDPPTLLTPSKWSVE 243
Query: 818 KLISIMEVAFSCFNESPESRPT 839
                +++A    +++PE+RP+
Sbjct: 244 -FRDFLKIA---LDKNPETRPS 261

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 34/210 (16%)
Query: 596 IGNGGHASVYR-AELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------------F 642
           IG G + SV +    PSG+++AVK+  S +      +QK+ L +++             F
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 643 YGFCSHARHSFLLYEFLERG------SLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
           YG        ++  E +          + ++L+ D   +E+     +  +KA+ H    L
Sbjct: 87  YGALFREGDCWICMELMSTSFDKFYKYVYSVLD-DVIPEEILGKITLATVKALNHLKENL 145
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL-- 754
                  I+HRDI   N+LLD      + DFGI+  L  DS   T  AG   Y+APE   
Sbjct: 146 K------IIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERID 198
Query: 755 --AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             A       + DV+S G+ ++E+  G+ P
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 86/180 (47%), Gaps = 22/180 (12%)
Query: 675 QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK 734
           +E+  S    ++  V+  + YL    F   VHRD++++N+LL   + A ++DFG++K+L 
Sbjct: 105 EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALG 161
Query: 735 PDSSNWTEFAGTCG-----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXX 788
            D S +T  A + G     + APE     K + + DV+S+GV MWE +  G+ P   +  
Sbjct: 162 ADDSYYT--ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219
Query: 789 XXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                      ++Q    R+  P     E L ++M     C+    E RP    + Q++R
Sbjct: 220 PEVMAF-----IEQ--GKRMECPPECPPE-LYALMS---DCWIYKWEDRPDFLTVEQRMR 268

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 7/124 (5%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L +   +  LG    +     V  A+ YL  + F   VHRD++++
Sbjct: 76  YIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAAR 131
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+L+  +  A V+DFG+ K     SS          + APE     K + K DV+SFG+L
Sbjct: 132 NVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188
Query: 773 MWEV 776
           +WE+
Sbjct: 189 LWEI 192

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 39/124 (31%), Positives = 65/124 (52%), Gaps = 7/124 (5%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L +   +  LG    +     V  A+ YL  + F   VHRD++++
Sbjct: 91  YIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAAR 146
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+L+  +  A V+DFG+ K     SS          + APE     K + K DV+SFG+L
Sbjct: 147 NVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 203
Query: 773 MWEV 776
           +WE+
Sbjct: 204 LWEI 207

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 114/283 (40%), Gaps = 52/283 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 121
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 122 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 182 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 235
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 236 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 293
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P+  P P          +  +   C+   PE RP   II +++
Sbjct: 294 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 98/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           S A    ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 73  STAPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 184
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 144 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 119 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 102 TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 212
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 74  TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 184
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 44  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 102 TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 212
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/283 (24%), Positives = 111/283 (39%), Gaps = 50/283 (17%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 135
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTC---- 747
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    + +    G      
Sbjct: 196 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLPV 250
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  P
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 308
Query: 807 R-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           +  P P          +  +   C+   PE RP   II +++ 
Sbjct: 309 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 341

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 142 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/285 (25%), Positives = 123/285 (43%), Gaps = 46/285 (16%)
Query: 581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTEV 639
           D+      D   K+ +G G +  VY        + VAVK        + T++ +EFL E 
Sbjct: 25  DKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEA 79
Query: 640 EA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
                          G C+     +++ E++  G+L   L  +   +E+     + +   
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLR-ECNREEVTAVVLLYMATQ 138
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-- 746
           ++ A+ YL    F   +HRD++++N L+   +   VADFG+++ +  D+  +T  AG   
Sbjct: 139 ISSAMEYLEKKNF---IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKF 193
Query: 747 -CGYIAPE-LAY-TMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
              + APE LAY T  I  K DV++FGVL+WE+   G  P               + L Q
Sbjct: 194 PIKWTAPESLAYNTFSI--KSDVWAFGVLLWEIATYGMSPY------------PGIDLSQ 239
Query: 803 MLDPRLPAPSRSAQEKLI--SIMEVAFSCFNESPESRPTMKIISQ 845
           + D  L    R  Q +     + E+  +C+  SP  RP+     Q
Sbjct: 240 VYD-LLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQ 283

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 79  TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 189
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 117 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 30/201 (14%)
Query: 651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
           H++LLY  LE G     L T            +  +  +A  + YL +  F   +HRD++
Sbjct: 129 HTYLLYSRLETGPKHIPLQT-----------LLKFMVDIALGMEYLSNRNF---LHRDLA 174
Query: 711 SKNLLLDLEYEAHVADFGIAKSLKP-DSSNWTEFAGT-CGYIAPELAYTMKITEKCDVYS 768
           ++N +L  +    VADFG++K +   D       A     +IA E       T K DV++
Sbjct: 175 ARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 234
Query: 769 FGVLMWEV-IKGKHPRDFLXXXXXXXLNTDVALDQMLD-PRLPAPSRSAQEKLISIMEVA 826
           FGV MWE+  +G  P           +      D +L   RL  P     E    + E+ 
Sbjct: 235 FGVTMWEIATRGMTP--------YPGVQNHEMYDYLLHGHRLKQPEDCLDE----LYEIM 282
Query: 827 FSCFNESPESRPTMKIISQQL 847
           +SC+   P  RPT  ++  QL
Sbjct: 283 YSCWRTDPLDRPTFSVLRLQL 303

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 36  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 94  TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 147
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 204
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 43  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 101 TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 154
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 211
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/293 (24%), Positives = 120/293 (40%), Gaps = 63/293 (21%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAF-- 642
           ND   +  IG G    V +A +    +    A+K+       D   D ++F  E+E    
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 78
Query: 643 ----------YGFCSHARHSFLLYEFLERGSL------AAILNTDAA-------AQELGW 679
                      G C H  + +L  E+   G+L      + +L TD A       A  L  
Sbjct: 79  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 138
Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
            Q ++    VA  + YL    F   +HR+++++N+L+   Y A +ADFG+++  +     
Sbjct: 139 QQLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSRGQE----- 190
Query: 740 WTEFAGTCG-----YIAPE-LAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXX 792
                 T G     ++A E L Y++  T   DV+S+GVL+WE++  G  P   +      
Sbjct: 191 -VYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGM------ 242
Query: 793 XLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
              T   L + L    RL  P     E    + ++   C+ E P  RP+   I
Sbjct: 243 ---TCAELYEKLPQGYRLEKPLNCDDE----VYDLMRQCWREKPYERPSFAQI 288

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 21  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 79  TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 132
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 189
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 118 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 18  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 76  TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 129
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 186
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 99/204 (48%), Gaps = 28/204 (13%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVD---------QKEFLTEVEAFYGFC 646
           IG+G   +VY+ +      VAVK  +   P  Q +          +K     +  F G+ 
Sbjct: 16  IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           +  + + ++ ++ E  SL   L+      E+   + +++ +  A  + YLH      I+H
Sbjct: 74  TKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 707 RDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK- 763
           RD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+   +++ +K 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDKN 184
Query: 764 -----CDVYSFGVLMWEVIKGKHP 782
                 DVY+FG++++E++ G+ P
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 116 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 141 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 70/140 (50%), Gaps = 20/140 (14%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           F+  E+ E G+L  +++++   Q+     R+   + +  ALSY+H      I+HRD+   
Sbjct: 91  FIQMEYCENGTLYDLIHSENLNQQRDEYWRL--FRQILEALSYIHSQG---IIHRDLKPM 145
Query: 713 NLLLDLEYEAHVADFGIAKS-------LKPDSS-------NWTEFAGTCGYIAPE-LAYT 757
           N+ +D      + DFG+AK+       LK DS        N T   GT  Y+A E L  T
Sbjct: 146 NIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205
Query: 758 MKITEKCDVYSFGVLMWEVI 777
               EK D+YS G++ +E+I
Sbjct: 206 GHYNEKIDMYSLGIIFFEMI 225

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 52/284 (18%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +       D+ +FL E           
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVY---SEQDELDFLMEALIISKFNHQN 109
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 110 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTCG--- 748
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +   +S + +  G C    
Sbjct: 170 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY-RASYYRK--GGCAMLP 223
Query: 749 --YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDP 281
Query: 806 PR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           P+  P P          +  +   C+   PE RP   II +++ 
Sbjct: 282 PKNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERIE 315

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 139 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/282 (24%), Positives = 111/282 (39%), Gaps = 50/282 (17%)
Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------- 638
           +G+G    VY  ++      PS   VAVK    +  C +  D+ +FL E           
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQ-DELDFLMEALIISKFNHQN 112
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALS 694
           +    G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 113 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVA---DFGIAKSLKPDSSNWTEFAGTC---- 747
           YL  + F   +HRDI+++N LL       VA   DFG+A+ +    + +    G      
Sbjct: 173 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLPV 227
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++ PE       T K D +SFGVL+WE+   G  P  +        L    +  +M  P
Sbjct: 228 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--YPSKSNQEVLEFVTSGGRMDPP 285
Query: 807 R-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  P P          +  +   C+   PE RP   II +++
Sbjct: 286 KNCPGP----------VYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 98/244 (40%), Gaps = 31/244 (12%)
Query: 590 FDAKYCIGNGGHASVYRAE----LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
           F+    +G GG+  V++        +G++ A+K     +      D        +A    
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT----AHTKAERNI 74
Query: 646 CSHARHSF---LLYEFLERGSLAAILNTDAAAQELGWSQRMNV---------IKAVAHAL 693
               +H F   L+Y F   G L  IL   +  +     +R  +         +  ++ AL
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            +LH      I++RD+  +N++L+ +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSR 813
           +          D +S G LM++++ G  P            N    +D++L  +L  P  
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP--------FTGENRKKTIDKILKCKLNLPPY 243
Query: 814 SAQE 817
             QE
Sbjct: 244 LTQE 247

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 124/262 (47%), Gaps = 37/262 (14%)
Query: 596 IGNGGHASVYRAE------LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY-----G 644
           +G+G    VY+A+      L + +V+  K    L   +  + + E L   +  Y     G
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 83
Query: 645 FCSHARHSFLLYEFLERGSLAAI-LNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
              H    +++ EF   G++ AI L  D    E    Q   V + +  AL++LH      
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQIQVVCRQMLEALNFLHSK---R 137
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGI-AKSLKPDSSNWTEFAGTCGYIAPELAY--TMKI 760
           I+HRD+ + N+L+ LE +  +ADFG+ AK+LK        F GT  ++APE+    TMK 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKD 196
Query: 761 TE---KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           T    K D++S G+ + E+ + + P   L       +   + + +   P L  PS+ + E
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHEL-----NPMRVLLKIAKSDPPTLLTPSKWSVE 251
Query: 818 KLISIMEVAFSCFNESPESRPT 839
                +++A    +++PE+RP+
Sbjct: 252 -FRDFLKIA---LDKNPETRPS 269

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/244 (22%), Positives = 98/244 (40%), Gaps = 31/244 (12%)
Query: 590 FDAKYCIGNGGHASVYRAE----LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
           F+    +G GG+  V++        +G++ A+K     +      D        +A    
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDT----AHTKAERNI 74
Query: 646 CSHARHSF---LLYEFLERGSLAAILNTDAAAQELGWSQRMNV---------IKAVAHAL 693
               +H F   L+Y F   G L  IL   +  +     +R  +         +  ++ AL
Sbjct: 75  LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMAL 134
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            +LH      I++RD+  +N++L+ +    + DFG+ K    D +    F GT  Y+APE
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSR 813
           +          D +S G LM++++ G  P            N    +D++L  +L  P  
Sbjct: 192 ILMRSGHNRAVDWWSLGALMYDMLTGAPP--------FTGENRKKTIDKILKCKLNLPPY 243
Query: 814 SAQE 817
             QE
Sbjct: 244 LTQE 247

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 146 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 23/198 (11%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L +   +  LG    +     V  A+ YL  + F   VHRD++++
Sbjct: 263 YIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAAR 318
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+L+  +  A V+DFG+ K     SS          + APE     K + K DV+SFG+L
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 773 MWEVI---KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSC 829
           +WE+    +  +PR  L          DV        ++ AP         ++ +V  +C
Sbjct: 376 LWEIYSFGRVPYPRIPL---------KDVVPRVEKGYKMDAPDGCPP----AVYDVMKNC 422
Query: 830 FNESPESRPTMKIISQQL 847
           ++    +RPT   + +QL
Sbjct: 423 WHLDAATRPTFLQLREQL 440

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 590 FDAKYCIGNGGHASVYRAELPSG----EVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           F  K  +G+G    V+  E  S      +  + K  S +P +Q   + E L  ++     
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 641 AFYGFCSHARHSFLLYEFLERGSL-AAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
             +       + +++ E  E G L   I++  A  + L       ++K + +AL+Y H  
Sbjct: 84  KIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143
Query: 700 CFPPIVHRDISSKNLLLDLEYEAH----VADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
               +VH+D+  +N+L   +   H    + DFG+A+  K D  + T  AGT  Y+APE+ 
Sbjct: 144 ---HVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALYMAPEV- 197
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +   +T KCD++S GV+M+ ++ G  P
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 138 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 5/96 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGT 746
           +  AL YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S  +    F GT
Sbjct: 123 IVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 25/211 (11%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCS 647
           + F+    IG G    V   +    + +   K+ +   C +  + +    E++   G   
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-- 72
Query: 648 HARHSFLL---YEFLERGSLAAILNTDAAAQELGWSQRMNV----------IKAVAHALS 694
              H FL+   Y F +   +  +++      +L +  + NV          I  +  AL 
Sbjct: 73  --EHPFLVNLWYSFQDEEDMFMVVDL-LLGGDLRYHLQQNVHFKEETVKLFICELVMALD 129
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           YL +     I+HRD+   N+LLD     H+ DF IA  L P  +  T  AGT  Y+APE+
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAGTKPYMAPEM 185
Query: 755 AYTMK---ITEKCDVYSFGVLMWEVIKGKHP 782
             + K    +   D +S GV  +E+++G+ P
Sbjct: 186 FSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 69/138 (50%), Gaps = 13/138 (9%)
Query: 649 ARHSFLLYEFLERGSL-AAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
            ++ +L+ EF E G L   I+N      +       N++K +   + YLH      IVHR
Sbjct: 118 KKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHK---HNIVHR 170
Query: 708 DISSKNLLLDLE---YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKC 764
           DI  +N+LL+ +       + DFG++     D     +  GT  YIAPE+    K  EKC
Sbjct: 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYIAPEVL-KKKYNEKC 228
Query: 765 DVYSFGVLMWEVIKGKHP 782
           DV+S GV+M+ ++ G  P
Sbjct: 229 DVWSCGVIMYILLCGYPP 246

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/266 (27%), Positives = 103/266 (38%), Gaps = 42/266 (15%)
Query: 596 IGNGGHASVYRAEL--PSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVEAFYGFCSHARH 651
           +G+G    V R E   PSG+ V+V     L P    Q     +F+ EV A +      R+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVA-VKCLKPDVLSQPEAMDDFIREVNAMHSL--DHRN 82
Query: 652 SFLLY------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              LY            E    GSL   L        LG   R  V   VA  + YL   
Sbjct: 83  LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESK 140
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAY 756
            F   +HRD++++NLLL       + DFG+ ++L  +  +            + APE   
Sbjct: 141 RF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 757 TMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLD--PRLPAPSR 813
           T   +   D + FGV +WE+   G+ P           LN    L ++     RLP P  
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP--------WIGLNGSQILHKIDKEGERLPRPED 249
Query: 814 SAQEKLISIMEVAFSCFNESPESRPT 839
             Q+    I  V   C+   PE RPT
Sbjct: 250 CPQD----IYNVMVQCWAHKPEDRPT 271

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAA-------QELGWSQRMNVIKAVAHALSYL 696
           G C+H     ++ E+   G L   L   A A       + L     ++    VA  +++L
Sbjct: 109 GACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL 168
Query: 697 -HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPE 753
              +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +        ++APE
Sbjct: 169 ASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 224
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIK-GKHPR-DFLXXXXXXXLNTDVALDQMLDPRLPAP 811
             +    T + DV+S+G+L+WE+   G +P    L       L  D    QM  P     
Sbjct: 225 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY--QMAQPAF--- 279
Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
              A + + SIM+   +C+   P  RPT + I   L+
Sbjct: 280 ---APKNIYSIMQ---ACWALEPTHRPTFQQICSFLQ 310

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 66/135 (48%), Gaps = 9/135 (6%)
Query: 651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
           H+FL+ E L  G L   +       E   ++   +++ +  A+S++H      +VHRD+ 
Sbjct: 80  HTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSHMHD---VGVVHRDLK 133
Query: 711 SKNLLLDLE---YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
            +NLL   E    E  + DFG A+   PD+        T  Y APEL       E CD++
Sbjct: 134 PENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLW 193
Query: 768 SFGVLMWEVIKGKHP 782
           S GV+++ ++ G+ P
Sbjct: 194 SLGVILYTMLSGQVP 208

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 7/144 (4%)
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V+  Y F +  +  +L+ +FL  G L   L+ +    E         +  +A  L +LH 
Sbjct: 93  VKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTE---EDVKFYLAELALGLDHLHS 148
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
                I++RD+  +N+LLD E    + DFG++K           F GT  Y+APE+    
Sbjct: 149 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ 205
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
             +   D +S+GVLM+E++ G  P
Sbjct: 206 GHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 60/297 (20%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY----------GF 645
           IG G    V+R +   GE VAVK F S        +++ +  E E +           GF
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 101
Query: 646 CSHARHS-------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
            +            +L+ ++ E GSL   LN      E      + +  + A  L++LH 
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 157
Query: 699 DCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT------EFAGTC 747
           +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T         GT 
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 215
Query: 748 GYIAPEL---AYTMKITE---KCDVYSFGVLMWEV-----IKGKHPR------DFLXXXX 790
            Y+APE+   +  MK  E   + D+Y+ G++ WE+     I G H        D +    
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 791 XXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                  V  +Q L P +P   +S  E L  + ++   C+  +  +R T   I + L
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTL 331

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAA-------QELGWSQRMNVIKAVAHALSYL 696
           G C+H     ++ E+   G L   L   A A       + L     ++    VA  +++L
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL 176
Query: 697 -HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPE 753
              +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +        ++APE
Sbjct: 177 ASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPE 232
Query: 754 LAYTMKITEKCDVYSFGVLMWEVIK-GKHPR-DFLXXXXXXXLNTDVALDQMLDPRLPAP 811
             +    T + DV+S+G+L+WE+   G +P    L       L  D    QM  P     
Sbjct: 233 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY--QMAQPAF--- 287
Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
              A + + SIM+   +C+   P  RPT + I
Sbjct: 288 ---APKNIYSIMQ---ACWALEPTHRPTFQQI 313

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 60/297 (20%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY----------GF 645
           IG G    V+R +   GE VAVK F S        +++ +  E E +           GF
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 88
Query: 646 CSHARHS-------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
            +            +L+ ++ E GSL   LN      E      + +  + A  L++LH 
Sbjct: 89  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 144
Query: 699 DCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT------EFAGTC 747
           +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T         GT 
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 202
Query: 748 GYIAPEL---AYTMKITE---KCDVYSFGVLMWEV-----IKGKHPR------DFLXXXX 790
            Y+APE+   +  MK  E   + D+Y+ G++ WE+     I G H        D +    
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 262
Query: 791 XXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                  V  +Q L P +P   +S  E L  + ++   C+  +  +R T   I + L
Sbjct: 263 SVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTL 318

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 25/151 (16%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAIL-------NTDAAAQELGWSQRMNVIKAVAHALS 694
            Y F    R+ +L+ E  + G L   +         DAA           +IK V   ++
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV----------IIKQVLSGVT 150
Query: 695 YLHHDCFPPIVHRDISSKNLLLD-LEYEA--HVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           YLH      IVHRD+  +NLLL+  E +A   + DFG++ ++  +     E  GT  YIA
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKKMKERLGTAYYIA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+    K  EKCDV+S GV+++ ++ G  P
Sbjct: 207 PEV-LRKKYDEKCDVWSIGVILFILLAGYPP 236

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 131/310 (42%), Gaps = 52/310 (16%)
Query: 564 IPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKK 619
           +P+GS ++  FE + L          F  +   GN G   + R + P    +GEVVAVKK
Sbjct: 15  VPRGSHNMTQFEERHL---------KFLQQLGKGNFGSVEMCRYD-PLQDNTGEVVAVKK 64
Query: 620 FHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYEFLERGSLAA 666
               L        ++F  E+E            + G C  A  R+  L+ E+L  GSL  
Sbjct: 65  ----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 120
Query: 667 ILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD 726
            L      + +   + +     +   + YL    +   +HRD++++N+L++ E    + D
Sbjct: 121 YLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGD 175
Query: 727 FGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMWEVI----KG 779
           FG+ K L  D      +  G     + APE     K +   DV+SFGV+++E+     K 
Sbjct: 176 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 235
Query: 780 KH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEVAFSCFNESP 834
           K  P +F+           +   L ++L  + RLP P     E    I  +   C+N + 
Sbjct: 236 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNV 291
Query: 835 ESRPTMKIIS 844
             RP+ + ++
Sbjct: 292 NQRPSFRDLA 301

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 25/195 (12%)
Query: 659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKNLLLD 717
           LE     AI N+ A+ ++L     ++    VA  +++L   +C    +HRD++++N+LL 
Sbjct: 148 LETDPAFAIANSTASTRDL-----LHFSSQVAQGMAFLASKNC----IHRDVAARNVLLT 198
Query: 718 LEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTMKITEKCDVYSFGVLMWE 775
             + A + DFG+A+ +  DS+   +        ++APE  +    T + DV+S+G+L+WE
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 776 VIK-GKHPR-DFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNES 833
           +   G +P    L       L  D    QM  P        A + + SIM+   +C+   
Sbjct: 259 IFSLGLNPYPGILVNSKFYKLVKDGY--QMAQPAF------APKNIYSIMQ---ACWALE 307
Query: 834 PESRPTMKIISQQLR 848
           P  RPT + I   L+
Sbjct: 308 PTHRPTFQQICSFLQ 322

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/310 (24%), Positives = 131/310 (42%), Gaps = 52/310 (16%)
Query: 564 IPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKK 619
           +P+GS ++  FE + L          F  +   GN G   + R + P    +GEVVAVKK
Sbjct: 15  VPRGSHNMTQFEERHL---------KFLQQLGKGNFGSVEMCRYD-PLQDNTGEVVAVKK 64
Query: 620 FHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYEFLERGSLAA 666
               L        ++F  E+E            + G C  A  R+  L+ E+L  GSL  
Sbjct: 65  ----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 120
Query: 667 ILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD 726
            L      + +   + +     +   + YL    +   +HRD++++N+L++ E    + D
Sbjct: 121 YLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGD 175
Query: 727 FGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMWEVI----KG 779
           FG+ K L  D      +  G     + APE     K +   DV+SFGV+++E+     K 
Sbjct: 176 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKS 235
Query: 780 KH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEVAFSCFNESP 834
           K  P +F+           +   L ++L  + RLP P     E    I  +   C+N + 
Sbjct: 236 KSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMIMTECWNNNV 291
Query: 835 ESRPTMKIIS 844
             RP+ + ++
Sbjct: 292 NQRPSFRDLA 301

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 53/281 (18%)
Query: 590 FDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH 648
           F+    +GNG +  VY+   + +G++ A+K        D T D++E + +        SH
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM------DVTGDEEEEIKQEINMLKKYSH 79
Query: 649 AR-------------------HSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKA 688
            R                     +L+ EF   GS+  ++ NT     +  W     + + 
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICRE 137
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +   LS+LH      ++HRDI  +N+LL    E  + DFG++  L         F GT  
Sbjct: 138 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194
Query: 749 YIAPELAYTMKITE-----KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQM 803
           ++APE+    +  +     K D++S G+   E+ +G  P           ++   AL   
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP--------LCDMHPMRAL--F 244
Query: 804 LDPRLPAP---SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           L PR PAP   S+   +K  S +E   SC  ++   RP  +
Sbjct: 245 LIPRNPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPATE 282

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +     + +  A+ Y H      IVHRD+ ++NL
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +       +   EF G+  Y APEL    K    + DV+S GV++
Sbjct: 145 LLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 60/297 (20%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY----------GF 645
           IG G    V+R +   GE VAVK F S        +++ +  E E +           GF
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 65
Query: 646 CSHARHS-------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
            +            +L+ ++ E GSL   LN      E      + +  + A  L++LH 
Sbjct: 66  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 121
Query: 699 DCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT------EFAGTC 747
           +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T         GT 
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 179
Query: 748 GYIAPEL---AYTMKITE---KCDVYSFGVLMWEV-----IKGKHPR------DFLXXXX 790
            Y+APE+   +  MK  E   + D+Y+ G++ WE+     I G H        D +    
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 239
Query: 791 XXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                  V  +Q L P +P   +S  E L  + ++   C+  +  +R T   I + L
Sbjct: 240 SVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTL 295

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 113/259 (43%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 41  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 96
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L   A A+ +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 97  YLPYGSLRDYLQ--AHAERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 151
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 211
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 267
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 268 MTECWNNNVNQRPSFRDLA 286

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 86/180 (47%), Gaps = 22/180 (12%)
Query: 675 QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK 734
           +E+  S    ++  V+  + YL    F   VHR+++++N+LL   + A ++DFG++K+L 
Sbjct: 431 EEIPVSNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALG 487
Query: 735 PDSSNWTEFAGTCG-----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXX 788
            D S +T  A + G     + APE     K + + DV+S+GV MWE +  G+ P   +  
Sbjct: 488 ADDSYYT--ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545
Query: 789 XXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                      ++Q    R+  P     E L ++M     C+    E RP    + Q++R
Sbjct: 546 PEVMAF-----IEQ--GKRMECPPECPPE-LYALMS---DCWIYKWEDRPDFLTVEQRMR 594

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 60/297 (20%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY----------GF 645
           IG G    V+R +   GE VAVK F S        +++ +  E E +           GF
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 68
Query: 646 CSHARHS-------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
            +            +L+ ++ E GSL   LN      E      + +  + A  L++LH 
Sbjct: 69  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 124
Query: 699 DCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT------EFAGTC 747
           +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T         GT 
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 182
Query: 748 GYIAPEL---AYTMKITE---KCDVYSFGVLMWEV-----IKGKHPR------DFLXXXX 790
            Y+APE+   +  MK  E   + D+Y+ G++ WE+     I G H        D +    
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 242
Query: 791 XXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                  V  +Q L P +P   +S  E L  + ++   C+  +  +R T   I + L
Sbjct: 243 SVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTL 298

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 644 GFCSHARHSFLLYEFLERGSL-------AAILNTDAA----AQELGWSQRMNVIKAVAHA 692
           G C+H     ++ E+   G L       + +L TD A       L     ++    VA  
Sbjct: 117 GACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQG 176
Query: 693 LSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGY 749
           +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +        +
Sbjct: 177 MAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW 232
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPR-DFLXXXXXXXLNTDVALDQMLDPR 807
           +APE  +    T + DV+S+G+L+WE+   G +P    L       L  D    QM  P 
Sbjct: 233 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY--QMAQPA 290
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                  A + + SIM+   +C+   P  RPT + I   L+
Sbjct: 291 F------APKNIYSIMQ---ACWALEPTHRPTFQQICSFLQ 322

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 38/124 (30%), Positives = 64/124 (51%), Gaps = 7/124 (5%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +++ E++ +GSL   L +   +  LG    +     V  A+ YL  + F   VHRD++++
Sbjct: 82  YIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGNNF---VHRDLAAR 137
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+L+  +  A V+DFG+ K     SS          + APE       + K DV+SFG+L
Sbjct: 138 NVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFGIL 194
Query: 773 MWEV 776
           +WE+
Sbjct: 195 LWEI 198

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 60/297 (20%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY----------GF 645
           IG G    V+R +   GE VAVK F S        +++ +  E E +           GF
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 63
Query: 646 CSHARHS-------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
            +            +L+ ++ E GSL   LN      E      + +  + A  L++LH 
Sbjct: 64  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 119
Query: 699 DCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT------EFAGTC 747
           +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T         GT 
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 177
Query: 748 GYIAPEL---AYTMKITE---KCDVYSFGVLMWEV-----IKGKHPR------DFLXXXX 790
            Y+APE+   +  MK  E   + D+Y+ G++ WE+     I G H        D +    
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 237
Query: 791 XXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                  V  +Q L P +P   +S  E L  + ++   C+  +  +R T   I + L
Sbjct: 238 SVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTL 293

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 45/79 (56%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I++RD+   N++LD E    +ADFG+ K    D      F GT  YIAPE+       + 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 764 CDVYSFGVLMWEVIKGKHP 782
            D ++FGVL++E++ G+ P
Sbjct: 202 VDWWAFGVLLYEMLAGQAP 220

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 29/79 (36%), Positives = 45/79 (56%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I++RD+   N++LD E    +ADFG+ K    D      F GT  YIAPE+       + 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 764 CDVYSFGVLMWEVIKGKHP 782
            D ++FGVL++E++ G+ P
Sbjct: 523 VDWWAFGVLLYEMLAGQAP 541

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 60/297 (20%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY----------GF 645
           IG G    V+R +   GE VAVK F S        +++ +  E E +           GF
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGF 62
Query: 646 CSHARHS-------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
            +            +L+ ++ E GSL   LN      E      + +  + A  L++LH 
Sbjct: 63  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 118
Query: 699 DCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT------EFAGTC 747
           +       P I HRD+ SKN+L+       +AD G+A  ++ DS+  T         GT 
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA--VRHDSATDTIDIAPNHRVGTK 176
Query: 748 GYIAPEL---AYTMKITE---KCDVYSFGVLMWEV-----IKGKHPR------DFLXXXX 790
            Y+APE+   +  MK  E   + D+Y+ G++ WE+     I G H        D +    
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 791 XXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                  V  +Q L P +P   +S  E L  + ++   C+  +  +R T   I + L
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTL 292

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 572 LNFEGKILYDEIVKATNDFDAKYCIG---NGGHASVYRAELPSGEVVAVKKFHSLLPCDQ 628
           L F+    Y+ + +  N  D    IG   +G    VY+A+     V+A  K   ++    
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK---VIDTKS 74
Query: 629 TVDQKEFLTEVEAFYGFCSH------------ARHSFLLYEFLERGSLAAILNTDAAAQE 676
             + ++++ E++     C H              + ++L EF   G++ A++      + 
Sbjct: 75  EEELEDYMVEIDIL-ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERP 131
Query: 677 LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD 736
           L  SQ   V K    AL+YLH +    I+HRD+ + N+L  L+ +  +ADFG++      
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 188
Query: 737 SSNWTEFAGTCGYIAPELAYTMKITE-----KCDVYSFGVLMWEVIKGKHP 782
                 F GT  ++APE+       +     K DV+S G+ + E+ + + P
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 572 LNFEGKILYDEIVKATNDFDAKYCIG---NGGHASVYRAELPSGEVVAVKKFHSLLPCDQ 628
           L F+    Y+ + +  N  D    IG   +G    VY+A+     V+A  K   ++    
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK---VIDTKS 74
Query: 629 TVDQKEFLTEVEAFYGFCSH------------ARHSFLLYEFLERGSLAAILNTDAAAQE 676
             + ++++ E++     C H              + ++L EF   G++ A++      + 
Sbjct: 75  EEELEDYMVEIDIL-ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERP 131
Query: 677 LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD 736
           L  SQ   V K    AL+YLH +    I+HRD+ + N+L  L+ +  +ADFG++      
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRX 188
Query: 737 SSNWTEFAGTCGYIAPELAYTMKITE-----KCDVYSFGVLMWEVIKGKHP 782
                 F GT  ++APE+       +     K DV+S G+ + E+ + + P
Sbjct: 189 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/220 (23%), Positives = 98/220 (44%), Gaps = 44/220 (20%)
Query: 596 IGNGGHASVYRAELPS------GEVVAVKKFHSLLPCDQTVD-QKEFLTEVE-------A 641
           IG G    V++A  P         +VAVK        D   D Q+E     E        
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAIL------------NTDAAAQE---------LGWS 680
             G C+  +   LL+E++  G L   L            ++D + +          L  +
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           +++ + + VA  ++YL    F   VHRD++++N L+       +ADFG+++++   S+++
Sbjct: 175 EQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRNIY--SADY 229
Query: 741 TEFAGTCG----YIAPELAYTMKITEKCDVYSFGVLMWEV 776
            +  G       ++ PE  +  + T + DV+++GV++WE+
Sbjct: 230 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 102/231 (44%), Gaps = 29/231 (12%)
Query: 572 LNFEGKILYDEIVKATNDFDAKYCIG---NGGHASVYRAELPSGEVVAVKKFHSLLPCDQ 628
           L F+    Y+ + +  N  D    IG   +G    VY+A+     V+A  K   ++    
Sbjct: 18  LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK---VIDTKS 74
Query: 629 TVDQKEFLTEVEAFYGFCSH------------ARHSFLLYEFLERGSLAAILNTDAAAQE 676
             + ++++ E++     C H              + ++L EF   G++ A++      + 
Sbjct: 75  EEELEDYMVEIDIL-ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERP 131
Query: 677 LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD 736
           L  SQ   V K    AL+YLH +    I+HRD+ + N+L  L+ +  +ADFG++      
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRX 188
Query: 737 SSNWTEFAGTCGYIAPELAYTMKITE-----KCDVYSFGVLMWEVIKGKHP 782
                 F GT  ++APE+       +     K DV+S G+ + E+ + + P
Sbjct: 189 IQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 239

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +  +  + +  A+ Y H      IVHRD+ ++NL
Sbjct: 86  LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENL 142
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +            F G+  Y APEL    K    + DV+S GV++
Sbjct: 143 LLDADMNIKIADFGFSNEFTV-GGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 201
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 202 YTLVSGSLPFD 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L+ ++L  GSL   +     A  LG    +N    +A  + YL       +VHR+++++N
Sbjct: 109 LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARN 163
Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGV 771
           +LL    +  VADFG+A  L PD     ++E      ++A E  +  K T + DV+S+GV
Sbjct: 164 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 223
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL--ISIMEVAFS 828
            +WE++  G  P   L       L             L    R AQ ++  I +  V   
Sbjct: 224 TVWELMTFGAEPYAGLRLAEVPDL-------------LEKGERLAQPQICTIDVYMVMVK 270
Query: 829 CFNESPESRPTMKIISQQ 846
           C+      RPT K ++ +
Sbjct: 271 CWMIDENIRPTFKELANE 288

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 166 IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 225
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 226 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPE--- 275
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 276 -MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/269 (23%), Positives = 114/269 (42%), Gaps = 37/269 (13%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQK---EFLTE-----------VE 640
           +G+G   +VY+   +P GE V +     +L  ++T   K   EF+ E           + 
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
              G C       L+ + +  G L   ++       +G    +N    +A  + YL    
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER- 159
Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTM 758
              +VHRD++++N+L+       + DFG+A+ L+ D   +    G     ++A E  +  
Sbjct: 160 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 217
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K T + DV+S+GV +WE++  G  P D +       L     L++    RLP P      
Sbjct: 218 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-----LEK--GERLPQPPICT-- 268
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQ 846
             I +  V   C+    +SRP  K ++ +
Sbjct: 269 --IDVYMVMVKCWMIDADSRPKFKELAAE 295

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 69/140 (49%), Gaps = 20/140 (14%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           F+  E+ E  +L  +++++   Q+     R+   + +  ALSY+H      I+HRD+   
Sbjct: 91  FIQMEYCENRTLYDLIHSENLNQQRDEYWRL--FRQILEALSYIHSQG---IIHRDLKPM 145
Query: 713 NLLLDLEYEAHVADFGIAKS-------LKPDSS-------NWTEFAGTCGYIAPE-LAYT 757
           N+ +D      + DFG+AK+       LK DS        N T   GT  Y+A E L  T
Sbjct: 146 NIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205
Query: 758 MKITEKCDVYSFGVLMWEVI 777
               EK D+YS G++ +E+I
Sbjct: 206 GHYNEKIDMYSLGIIFFEMI 225

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L+ ++L  GSL   +     A  LG    +N    +A  + YL       +VHR+++++N
Sbjct: 91  LVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARN 145
Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGV 771
           +LL    +  VADFG+A  L PD     ++E      ++A E  +  K T + DV+S+GV
Sbjct: 146 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
Query: 772 LMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKL--ISIMEVAFS 828
            +WE++  G  P   L       L             L    R AQ ++  I +  V   
Sbjct: 206 TVWELMTFGAEPYAGLRLAEVPDL-------------LEKGERLAQPQICTIDVYMVMVK 252
Query: 829 CFNESPESRPTMKIISQQ 846
           C+      RPT K ++ +
Sbjct: 253 CWMIDENIRPTFKELANE 270

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 114/270 (42%), Gaps = 37/270 (13%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQK---EFLTE-----------VE 640
           +G+G   +VY+   +P GE V +     +L  ++T   K   EF+ E           + 
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
              G C       L+ + +  G L   ++       +G    +N    +A  + YL    
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER- 136
Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTM 758
              +VHRD++++N+L+       + DFG+A+ L+ D   +    G     ++A E  +  
Sbjct: 137 --RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 194
Query: 759 KITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQE 817
           K T + DV+S+GV +WE++  G  P D +       L     L++    RLP P      
Sbjct: 195 KFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDL-----LEK--GERLPQPPICT-- 245
Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
             I +  V   C+    +SRP  K ++ + 
Sbjct: 246 --IDVYMVMVKCWMIDADSRPKFKELAAEF 273

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +  +  + +  A+ Y H      IVHRD+ ++NL
Sbjct: 89  LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENL 145
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +            F G   Y APEL    K    + DV+S GV++
Sbjct: 146 LLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 205 YTLVSGSLPFD 215

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 15/145 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTMKITE 762
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 226
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+S+G+ +WE+         L       +  D    +M+    R+ +P  +  E + 
Sbjct: 227 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE-MY 278
Query: 821 SIMEVAFSCFNESPESRPTMKIISQ 845
            IM+   +C++  P  RPT K I Q
Sbjct: 279 DIMK---TCWDADPLKRPTFKQIVQ 300

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 68/146 (46%), Gaps = 13/146 (8%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL       + DFG+A+ +   PD     +      ++APE  +    + 
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 763 KCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLIS 821
           K DV+S+GVL+WE+   G  P           ++ D         R+ AP  S  E    
Sbjct: 281 KSDVWSYGVLLWEIFSLGGSP------YPGVQMDEDFCSRLREGMRMRAPEYSTPE---- 330
Query: 822 IMEVAFSCFNESPESRPTMKIISQQL 847
           I ++   C++  P+ RP    + ++L
Sbjct: 331 IYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%)
Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           Q    I   A  +S L H     I++RD+  +N+LLD +    ++D G+A  LK   +  
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             +AGT G++APEL    +     D ++ GV ++E+I  + P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKML 62
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%)
Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           Q    I   A  +S L H     I++RD+  +N+LLD +    ++D G+A  LK   +  
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             +AGT G++APEL    +     D ++ GV ++E+I  + P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%)
Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           Q    I   A  +S L H     I++RD+  +N+LLD +    ++D G+A  LK   +  
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             +AGT G++APEL    +     D ++ GV ++E+I  + P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 221 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 270
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 271 -MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 41  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 96
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           FL  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 97  FLPYGSLREYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 151
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 211
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 267
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 268 MTECWNNNVNQRPSFRDLA 286

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 53/102 (51%)
Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           Q    I   A  +S L H     I++RD+  +N+LLD +    ++D G+A  LK   +  
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             +AGT G++APEL    +     D ++ GV ++E+I  + P
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 221 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 270
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 271 -MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 166 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 225
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 226 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 275
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 276 -MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 62
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 689 VAHALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
           VA  +++L   +C    +HRD++++N+LL       + DFG+A+ +K DS+   +     
Sbjct: 170 VAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 747 -CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLD 805
              ++APE  +    T + DV+S+G+ +WE+         L       +  D    +M+ 
Sbjct: 226 PVKWMAPESIFNCVYTFESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIK 278
Query: 806 P--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
              R+ +P  +  E +  IM+   +C++  P  RPT K I Q
Sbjct: 279 EGFRMLSPEHAPAE-MYDIMK---TCWDADPLKRPTFKQIVQ 316

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 15/145 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTMKITE 762
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+S+G+ +WE+         L       +  D    +M+    R+ +P  +  E + 
Sbjct: 250 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE-MY 301
Query: 821 SIMEVAFSCFNESPESRPTMKIISQ 845
            IM+   +C++  P  RPT K I Q
Sbjct: 302 DIMK---TCWDADPLKRPTFKQIVQ 323

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+    + +    F  T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG---FVATRWYRAPEIMLNWMHYNQT 199
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 18/208 (8%)
Query: 589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE------V 639
           D+D    +G G +  V  A    + E VAVK       + C + + ++  + +      V
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
             FYG        +L  E+   G L   +  D    E   +QR      +   + YLH  
Sbjct: 66  VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVVYLHG- 121
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYT 757
               I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+APEL   
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 758 MKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
            +   E  DV+S G+++  ++ G+ P D
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWD 207

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 15/145 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTMKITE 762
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 185 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 244
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+S+G+ +WE+         L       +  D    +M+    R+ +P  +  E + 
Sbjct: 245 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE-MY 296
Query: 821 SIMEVAFSCFNESPESRPTMKIISQ 845
            IM+   +C++  P  RPT K I Q
Sbjct: 297 DIMK---TCWDADPLKRPTFKQIVQ 318

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 266
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 267 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 316
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 317 -MYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 60/130 (46%), Gaps = 6/130 (4%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           F + EF+  G L   +       E   ++       +  AL +LH      I++RD+   
Sbjct: 100 FFVMEFVNGGDLMFHIQKSRRFDE---ARARFYAAEIISALMFLHDKG---IIYRDLKLD 153
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+LLD E    +ADFG+ K    +      F GT  YIAPE+   M      D ++ GVL
Sbjct: 154 NVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVL 213
Query: 773 MWEVIKGKHP 782
           ++E++ G  P
Sbjct: 214 LYEMLCGHAP 223

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +     + +  A+ Y H      IVHRD+ ++NL
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +       +    F G+  Y APEL    K    + DV+S GV++
Sbjct: 145 LLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 115/265 (43%), Gaps = 45/265 (16%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH------------ARHSF-LLYE 657
           +G +VAVK+     P DQ   Q++F  E++      S              R S  L+ E
Sbjct: 51  TGALVAVKQLQHSGP-DQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKNLLL 716
           +L  G L   L    A   L  S+ +     +   + YL    C    VHRD++++N+L+
Sbjct: 107 YLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILV 160
Query: 717 DLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           + E    +ADFG+AK L  D   +           + APE       + + DV+SFGV++
Sbjct: 161 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220
Query: 774 WEVI----KGKHPR-DFLXXXXXXXLNTDV-ALDQMLD-----PRLPAPSRSAQEKLISI 822
           +E+     K   P  +FL          DV AL ++L+      RLPAP     E    +
Sbjct: 221 YELFTYCDKSCSPSAEFL---RMMGCERDVPALSRLLELLEEGQRLPAPPACPAE----V 273
Query: 823 MEVAFSCFNESPESRPTMKIISQQL 847
            E+   C+  SP+ RP+   +  QL
Sbjct: 274 HELMKLCWAPSPQDRPSFSALGPQL 298

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 71/145 (48%), Gaps = 15/145 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTMKITE 762
           +HRD++++N+LL       + DFG+A+ +K DS+   +        ++APE  +    T 
Sbjct: 190 IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTF 249
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+S+G+ +WE+         L       +  D    +M+    R+ +P  +  E + 
Sbjct: 250 ESDVWSYGIFLWELFS-------LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAE-MY 301
Query: 821 SIMEVAFSCFNESPESRPTMKIISQ 845
            IM+   +C++  P  RPT K I Q
Sbjct: 302 DIMK---TCWDADPLKRPTFKQIVQ 323

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +     + +  A+ Y H      IVHRD+ ++NL
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +       +    F G+  Y APEL    K    + DV+S GV++
Sbjct: 145 LLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 221 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 270
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 271 -MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 161 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 220
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 221 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 270
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 271 -MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 215 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 275 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 324
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 325 -MYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +     + +  A+ Y H      IVHRD+ ++NL
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +       +    F G+  Y APEL    K    + DV+S GV++
Sbjct: 145 LLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 166
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 223
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 38/134 (28%), Positives = 73/134 (54%), Gaps = 12/134 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQEL-GWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS 711
           +L+++ +  G L      D  A+E    +   + I+ +  +++Y H +    IVHR++  
Sbjct: 81  YLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKP 133
Query: 712 KNLLLDLEYEA---HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYS 768
           +NLLL  + +     +ADFG+A  +  DS  W  FAGT GY++PE+      ++  D+++
Sbjct: 134 ENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 192
Query: 769 FGVLMWEVIKGKHP 782
            GV+++ ++ G  P
Sbjct: 193 CGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 38/134 (28%), Positives = 73/134 (54%), Gaps = 12/134 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQEL-GWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS 711
           +L+++ +  G L      D  A+E    +   + I+ +  +++Y H +    IVHR++  
Sbjct: 80  YLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKP 132
Query: 712 KNLLLDLEYEA---HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYS 768
           +NLLL  + +     +ADFG+A  +  DS  W  FAGT GY++PE+      ++  D+++
Sbjct: 133 ENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 191
Query: 769 FGVLMWEVIKGKHP 782
            GV+++ ++ G  P
Sbjct: 192 CGVILYILLVGYPP 205

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ-----TVDQKEFLTEVE-----AFYGF 645
           IG G +  VY+A+   GE  A+KK   L   D+     T+ +   L E++       Y  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
               +   L++E L++  L  +L+      E   ++  + +  + + ++Y H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDR---RVL 122
Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKC 764
           HRD+  +NLL++ E E  +ADFG+A++       +T    T  Y AP+ L  + K +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 765 DVYSFGVLMWEVIKG 779
           D++S G +  E++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 165
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 222
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 223 VDIWSVGCIMAELLTGR 239

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 115/265 (43%), Gaps = 45/265 (16%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH------------ARHSF-LLYE 657
           +G +VAVK+     P DQ   Q++F  E++      S              R S  L+ E
Sbjct: 38  TGALVAVKQLQHSGP-DQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 93
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKNLLL 716
           +L  G L   L    A   L  S+ +     +   + YL    C    VHRD++++N+L+
Sbjct: 94  YLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILV 147
Query: 717 DLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           + E    +ADFG+AK L  D   +           + APE       + + DV+SFGV++
Sbjct: 148 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 207
Query: 774 WEVI----KGKHPR-DFLXXXXXXXLNTDV-ALDQMLD-----PRLPAPSRSAQEKLISI 822
           +E+     K   P  +FL          DV AL ++L+      RLPAP     E    +
Sbjct: 208 YELFTYCDKSCSPSAEFLRMMGS---ERDVPALSRLLELLEEGQRLPAPPACPAE----V 260
Query: 823 MEVAFSCFNESPESRPTMKIISQQL 847
            E+   C+  SP+ RP+   +  QL
Sbjct: 261 HELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLT--- 637
           V    D+D    +G G +  V  A    + E VAVK       + C + + ++  +    
Sbjct: 3   VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAML 62
Query: 638 ---EVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 63  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 119
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 120 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 213 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 273 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 322
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 323 -MYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 172 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 231
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 232 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 281
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 282 -MYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 229
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 230 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 279
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 280 -MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 23/186 (12%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFL 659
           +G+  AVK   S     Q  D++  L EV+             Y F     + +L+ E  
Sbjct: 73  TGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 131
Query: 660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE 719
             G L   + +     E+  ++   +I+ V   ++Y+H +    IVHRD+  +NLLL+ +
Sbjct: 132 TGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESK 185
Query: 720 YEA---HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEV 776
            +     + DFG++   +  S    +  GT  YIAPE+ +     EKCDV+S GV+++ +
Sbjct: 186 SKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYIL 243
Query: 777 IKGKHP 782
           + G  P
Sbjct: 244 LSGCPP 249

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ-----TVDQKEFLTEVE-----AFYGF 645
           IG G +  VY+A+   GE  A+KK   L   D+     T+ +   L E++       Y  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
               +   L++E L++  L  +L+      E   ++  + +  + + ++Y H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDR---RVL 122
Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKC 764
           HRD+  +NLL++ E E  +ADFG+A++       +T    T  Y AP+ L  + K +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 765 DVYSFGVLMWEVIKG 779
           D++S G +  E++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/263 (25%), Positives = 111/263 (42%), Gaps = 46/263 (17%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 38  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 94  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 148
Query: 718 LEYEAHVADFGIAKSLKPDSSNWTEF-------AGTCGYIAPELAYTMKITEKCDVYSFG 770
            E    + DFG+ K L  D     EF            + APE     K +   DV+SFG
Sbjct: 149 NENRVKIGDFGLTKVLPQDK----EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 204
Query: 771 VLMWEVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLIS 821
           V+++E+     K K  P +F+           +   L ++L  + RLP P     E    
Sbjct: 205 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE---- 260
Query: 822 IMEVAFSCFNESPESRPTMKIIS 844
           I  +   C+N +   RP+ + ++
Sbjct: 261 IYMIMTECWNNNVNQRPSFRDLA 283

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 23/186 (12%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFL 659
           +G+  AVK   S     Q  D++  L EV+             Y F     + +L+ E  
Sbjct: 74  TGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 132
Query: 660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE 719
             G L   + +     E+  ++   +I+ V   ++Y+H +    IVHRD+  +NLLL+ +
Sbjct: 133 TGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESK 186
Query: 720 YEA---HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEV 776
            +     + DFG++   +  S    +  GT  YIAPE+ +     EKCDV+S GV+++ +
Sbjct: 187 SKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYIL 244
Query: 777 IKGKHP 782
           + G  P
Sbjct: 245 LSGCPP 250

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ-----TVDQKEFLTEVE-----AFYGF 645
           +G G +  VY+A+   G +VA+K+   L   D+      + +   L E+      +    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
               R   L++EF+E+  L  +L+ +     L  SQ    +  +   +++ H      I+
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKC 764
           HRD+  +NLL++ +    +ADFG+A++      ++T    T  Y AP+ L  + K +   
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 765 DVYSFGVLMWEVIKGK 780
           D++S G +  E+I GK
Sbjct: 202 DIWSIGCIFAEMITGK 217

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
           ++ +  +  +G G    V   +   +G+  AVK   S     Q  D++  L EV+     
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQL 89
Query: 641 ------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   Y F     + +L+ E    G L   + +     E+  ++   +I+ V   ++
Sbjct: 90  DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR---IIRQVLSGIT 146
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           Y+H +    IVHRD+  +NLLL+ + +     + DFG++   +  S    +  GT  YIA
Sbjct: 147 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIA 202
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+ +     EKCDV+S GV+++ ++ G  P
Sbjct: 203 PEVLHGT-YDEKCDVWSTGVILYILLSGCPP 232

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 23/186 (12%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFL 659
           +G+  AVK   S     Q  D++  L EV+             Y F     + +L+ E  
Sbjct: 50  TGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 108
Query: 660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE 719
             G L   + +     E+  ++   +I+ V   ++Y+H +    IVHRD+  +NLLL+ +
Sbjct: 109 TGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYMHKN---KIVHRDLKPENLLLESK 162
Query: 720 YE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEV 776
            +     + DFG++   +  S    +  GT  YIAPE+ +     EKCDV+S GV+++ +
Sbjct: 163 SKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYIL 220
Query: 777 IKGKHP 782
           + G  P
Sbjct: 221 LSGCPP 226

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           IG+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 151
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 222 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 282 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 331
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 332 -MYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ-----TVDQKEFLTEVE-----AFYGF 645
           +G G +  VY+A+   G +VA+K+   L   D+      + +   L E+      +    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIR-LDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
               R   L++EF+E+  L  +L+ +     L  SQ    +  +   +++ H      I+
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTG--LQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKC 764
           HRD+  +NLL++ +    +ADFG+A++      ++T    T  Y AP+ L  + K +   
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSV 201
Query: 765 DVYSFGVLMWEVIKGK 780
           D++S G +  E+I GK
Sbjct: 202 DIWSIGCIFAEMITGK 217

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +     + +  A+ Y H      IVHRD+ ++NL
Sbjct: 89  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKY---IVHRDLKAENL 145
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +       +    F G+  Y APEL    K    + DV+S GV++
Sbjct: 146 LLDGDMNIKIADFGFSNEFTV-GNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 204
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 205 YTLVSGSLPFD 215

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 20/165 (12%)
Query: 689 VAHALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
           VA  +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +     
Sbjct: 167 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 222
Query: 747 -CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPR-DFLXXXXXXXLNTDVALDQM 803
              ++APE  +    T + DV+S+G+L+WE+   G +P    L       L  D    QM
Sbjct: 223 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY--QM 280
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
             P        A + + SIM+   +C+   P  RPT + I   L+
Sbjct: 281 AQPAF------APKNIYSIMQ---ACWALEPTHRPTFQQICSFLQ 316

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 67/147 (45%), Gaps = 15/147 (10%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           +HRD++++N+LL  +    + DFG+A+ +   PD     +      ++APE  +    T 
Sbjct: 220 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDP--RLPAPSRSAQEKLI 820
           + DV+SFGVL+WE+         L       +  D    + L    R+ AP  +  E   
Sbjct: 280 QSDVWSFGVLLWEIFS-------LGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPE--- 329
Query: 821 SIMEVAFSCFNESPESRPTMKIISQQL 847
            + +    C++  P  RPT   + + L
Sbjct: 330 -MYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKE--------FLTEVEAFYGFCSH--ARHSFLLYEFLE 660
           +GE VAVK        +   D K+        +   +  + G C+        L+ EFL 
Sbjct: 49  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY 720
            GSL   L  +    ++   Q++     +   + YL    +   VHRD++++N+L++ E+
Sbjct: 109 SGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEH 163
Query: 721 EAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
           +  + DFG+ K+++ D    T   +      + APE     K     DV+SFGV + E++
Sbjct: 164 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 93/195 (47%), Gaps = 18/195 (9%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ-----TVDQKEFLTEVE-----AFYGF 645
           IG G +  VY+A+   GE  A+KK   L   D+     T+ +   L E++       Y  
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
               +   L++E L++  L  +L+      E   ++  + +  + + ++Y H      ++
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK--SFLLQLLNGIAYCHDR---RVL 122
Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKC 764
           HRD+  +NLL++ E E  +ADFG+A++       +T    T  Y AP+ L  + K +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 765 DVYSFGVLMWEVIKG 779
           D++S G +  E++ G
Sbjct: 183 DIWSVGCIFAEMVNG 197

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 156
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 157 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 213
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 214 VDIWSVGCIMAELLTGR 230

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 18/207 (8%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCS 647
           +DF     IG G    V  A   + EV    K        +  ++K  ++E         
Sbjct: 38  SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVL---LK 94
Query: 648 HARHSFLL---YEFLERGSLAAILNTDAAAQELGWSQRMNVI---------KAVAHALSY 695
           + +H FL+   + F     L  +L+     +     QR               +A AL Y
Sbjct: 95  NVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGY 154
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           LH      IV+RD+  +N+LLD +    + DFG+ K     +S  + F GT  Y+APE+ 
Sbjct: 155 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +        D +  G +++E++ G  P
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 109/265 (41%), Gaps = 45/265 (16%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH------------ARHSF-LLYE 657
           +G +VAVK+     P DQ   Q++F  E++      S              R S  L+ E
Sbjct: 39  TGALVAVKQLQHSGP-DQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 94
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKNLLL 716
           +L  G L   L    A   L  S+ +     +   + YL    C    VHRD++++N+L+
Sbjct: 95  YLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILV 148
Query: 717 DLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           + E    +ADFG+AK L  D   +           + APE       + + DV+SFGV++
Sbjct: 149 ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 208
Query: 774 WEVI----KGKHPR-DFLXXXXXXXLNTDV------ALDQMLDPRLPAPSRSAQEKLISI 822
           +E+     K   P  +FL          DV              RLPAP     E    +
Sbjct: 209 YELFTYCDKSCSPSAEFL---RMMGCERDVPALCRLLELLEEGQRLPAPPACPAE----V 261
Query: 823 MEVAFSCFNESPESRPTMKIISQQL 847
            E+   C+  SP+ RP+   +  QL
Sbjct: 262 HELMKLCWAPSPQDRPSFSALGPQL 286

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 81/180 (45%), Gaps = 18/180 (10%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKE--------FLTEVEAFYGFCSH--ARHSFLLYEFLE 660
           +GE VAVK        +   D K+        +   +  + G C+        L+ EFL 
Sbjct: 37  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 96
Query: 661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY 720
            GSL   L  +    ++   Q++     +   + YL    +   VHRD++++N+L++ E+
Sbjct: 97  SGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEH 151
Query: 721 EAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
           +  + DFG+ K+++ D    T   +      + APE     K     DV+SFGV + E++
Sbjct: 152 QVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 60/131 (45%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +     + +  A+ Y H      IVHRD+ ++NL
Sbjct: 88  LYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +       +    F G   Y APEL    K    + DV+S GV++
Sbjct: 145 LLDADMNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 643 YGFCSHARHSFLLYEFL-ERGSLAAILNTD---AAAQELGWSQRMNVIKAVAHALSYL-- 696
           + +CSH      L+EFL  R   + + +TD        L     ++++  +A  + YL  
Sbjct: 91  FSYCSHGD----LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           HH     +VH+D++++N+L+  +    ++D G+ + +   ++++ +  G       ++AP
Sbjct: 147 HH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVY--AADYYKLLGNSLLPIRWMAP 199
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR--LP 809
           E     K +   D++S+GV++WEV   G  P            N DV   +M+  R  LP
Sbjct: 200 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-------YCGYSNQDVV--EMIRNRQVLP 250
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            P          +  +   C+NE P  RP  K I  +LR
Sbjct: 251 CPDDCPA----WVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 31/214 (14%)
Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
           ++DF  K  +G G +  V  A   P+GE+VA+KK     P D+ +     L E++     
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKIL--- 63
Query: 646 CSHARHSFLLYEF-LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP- 703
             H +H  ++  F ++R       N     QEL  +    VI     +  ++ +  +   
Sbjct: 64  -KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 704 ----------IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WTEF 743
                     ++HRD+   NLL++   +  V DFG+A+ +   +++           TE+
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEY 182
Query: 744 AGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEV 776
             T  Y APE+  T  K +   DV+S G ++ E+
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/280 (23%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-- 640
           VKA +D +    +G G +  V +   +PSG+++AVK+  + +    + +QK  L +++  
Sbjct: 48  VKA-DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDIS 103
Query: 641 ----------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
                      FYG        ++  E ++              Q +       +  ++ 
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 163
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
            AL +LH      ++HRD+   N+L++   +  + DFGI+  L  DS   T  AG   Y+
Sbjct: 164 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DSVAKTIDAGCKPYM 220
Query: 751 APEL--------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQ 802
           APE          Y++    K D++S G+ M E+   + P D               L Q
Sbjct: 221 APERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGTPFQ-------QLKQ 269
Query: 803 MLD---PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +++   P+LPA   SA+      ++    C  ++ + RPT
Sbjct: 270 VVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPT 304

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 38  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 94  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 148
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 264
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 265 MTECWNNNVNQRPSFRDLA 283

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 41  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 96
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 97  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 151
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 152 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 211
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 267
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 268 MTECWNNNVNQRPSFRDLA 286

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 689 VAHALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
           VA  +++L   +C    +HRD++++N+LL   + A + DFG+A+ +  DS+   +     
Sbjct: 175 VAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 230
Query: 747 -CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPR-DFLXXXXXXXLNTDVALDQM 803
              ++APE  +    T + DV+S+G+L+WE+   G +P    L       L  D    QM
Sbjct: 231 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGY--QM 288
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
             P        A + + SIM+   +C+   P  RPT + I
Sbjct: 289 AQPAF------APKNIYSIMQ---ACWALEPTHRPTFQQI 319

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/275 (24%), Positives = 114/275 (41%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQ-KEFLTE-- 638
           I+K T     K  +G+G   +VY+   +P GE V +     +L  + +    KE L E  
Sbjct: 13  ILKETELRKVK-VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 71
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +  +     LG    +N    +
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRG--RLGSQDLLNWCMQI 128
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  +SYL       +VHRD++++N+L+       + DFG+A+ L  D + +    G    
Sbjct: 129 AKGMSYLED---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 185
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E     + T + DV+S+GV +WE++  G  P D +       L     L++    
Sbjct: 186 KWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL-----LEK--GE 238
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    E RP  +
Sbjct: 239 RLPQPPICT----IDVYMIMVKCWMIDSECRPRFR 269

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 157
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 158 IHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 215 VDIWSVGCIMAELLTGR 231

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 45  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 100
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 101 YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 155
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 156 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 215
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 216 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 271
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 272 MTECWNNNVNQRPSFRDLA 290

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 38  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 94  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 148
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 149 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 208
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 264
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 265 MTECWNNNVNQRPSFRDLA 283

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 643 YGFCSHARHSFLLYEFL-ERGSLAAILNTD---AAAQELGWSQRMNVIKAVAHALSYL-- 696
           + +CSH      L+EFL  R   + + +TD        L     ++++  +A  + YL  
Sbjct: 108 FSYCSHGD----LHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 163
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           HH     +VH+D++++N+L+  +    ++D G+ + +   ++++ +  G       ++AP
Sbjct: 164 HH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVY--AADYYKLLGNSLLPIRWMAP 216
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR--LP 809
           E     K +   D++S+GV++WEV   G  P            N DV   +M+  R  LP
Sbjct: 217 EAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-------YCGYSNQDVV--EMIRNRQVLP 267
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            P          +  +   C+NE P  RP  K I  +LR
Sbjct: 268 CPDDCPA----WVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-TMKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNAMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 151
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDXELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 43  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 98
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 99  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 153
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 154 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 213
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 214 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 269
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 270 MTECWNNNVNQRPSFRDLA 288

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 37  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 92
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 93  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 147
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 148 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 207
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 208 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 263
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 264 MTECWNNNVNQRPSFRDLA 282

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 144
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 145 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 202 VDIWSVGCIMAELLTGR 218

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 148
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDSELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 127/303 (41%), Gaps = 44/303 (14%)
Query: 567 GSLSILNFEG----KILYDEIVKATNDFDAKYCIGNGGHASVYRAELP---SGEVVAVKK 619
           G+L +L F+G     + +   +K   D       G+ G  S+Y  +     +GE+VAVK 
Sbjct: 13  GALEVL-FQGPGDPTVFHKRYLKKIRDLGE----GHFGKVSLYCYDPTNDGTGEMVAVKA 67
Query: 620 FHSLLPCDQTVDQKEFLTEVEAFY--------GFCSHARHSFL--LYEFLERGSLAAILN 669
             +          K+ +  +   Y        G C  A  + L  + E++  GSL   L 
Sbjct: 68  LKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP 127
Query: 670 TDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI 729
             +    +G +Q +   + +   ++YLH   +   +HRD++++N+LLD +    + DFG+
Sbjct: 128 RHS----IGLAQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGL 180
Query: 730 AKSLKPDSSNW---TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-----KGKH 781
           AK++      +    +      + APE     K     DV+SFGV ++E++         
Sbjct: 181 AKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240
Query: 782 PRDFLXXXXXXXLNTDV-ALDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESRP 838
           P  FL           V  L ++L+   RLP P +   E    +  +  +C+      RP
Sbjct: 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE----VYHLMKNCWETEASFRP 296
Query: 839 TMK 841
           T +
Sbjct: 297 TFE 299

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 153
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+     +   T +  T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 36  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 91
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 92  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 146
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 147 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 206
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 207 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 262
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 263 MTECWNNNVNQRPSFRDLA 281

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 69  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 125 YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 179
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 180 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 295
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 296 MTECWNNNVNQRPSFRDLA 314

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTE-- 638
           V    D+D    +G G    V  A    + E VAVK       + C + + ++  + +  
Sbjct: 2   VPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML 61
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
               V  FYG        +L  E+   G L   +  D    E   +QR      +   + 
Sbjct: 62  NHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD-AQRF--FHQLMAGVV 118
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAP 752
           YLH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+AP
Sbjct: 119 YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 753 ELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRD 784
           EL    +   E  DV+S G+++  ++ G+ P D
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 166
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 223
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 165
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 166 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 222
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 223 VDIWSVGCIMAELLTGR 239

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
           ++DF  K  +G G +  V  A   P+GE+VA+KK     P D+ +     L E++     
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKIL--- 63
Query: 646 CSHARHSFLLYEF-LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP- 703
             H +H  ++  F ++R       N     QEL  +    VI     +  ++ +  +   
Sbjct: 64  -KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 704 ----------IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WTEF 743
                     ++HRD+   NLL++   +  V DFG+A+ +   +++            EF
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 744 AGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEV 776
             T  Y APE+  T  K +   DV+S G ++ E+
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 153
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+     +   T +  T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 158
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 44  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 99
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 100 YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 154
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 155 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 214
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 215 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 270
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 271 MTECWNNNVNQRPSFRDLA 289

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 158
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 108/270 (40%), Gaps = 42/270 (15%)
Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH- 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF  H 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 81
Query: 649 ----------ARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
                      + + ++ E +  G L + L +     E           + + +   +A 
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TCGY 749
            ++YL+   F   VHRD++++N ++  ++   + DFG+ + +           G     +
Sbjct: 142 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLP 809
           +APE       T   D++SFGV++WE+         L       L+ +  L  ++D    
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPT 839
               +  E++  +M +   C+  +P+ RPT
Sbjct: 252 DQPDNCPERVTDLMRM---CWQFNPKMRPT 278

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 169
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 226
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 227 VDIWSVGCIMAELLTGR 243

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 148
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 143
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 201 VDIWSVGCIMAELLTGR 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 111/259 (42%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 42  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 97
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HRD++++N+L++
Sbjct: 98  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVE 152
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D      +  G     + APE     K +   DV+SFGV+++
Sbjct: 153 NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 212
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 213 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 268
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 269 MTECWNNNVNQRPSFRDLA 287

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 148
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 143
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 144 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 201 VDIWSVGCIMAELLTGR 217

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 69/135 (51%), Gaps = 10/135 (7%)
Query: 651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
           H ++++E + +G +  +      +++       ++IK +     YLH   +  I+HRDI 
Sbjct: 112 HLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGI----EYLH---YQKIIHRDIK 164
Query: 711 SKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKI--TEKCDVY 767
             NLL+  +    +ADFG++   K   +  +   GT  ++APE L+ T KI   +  DV+
Sbjct: 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVW 224
Query: 768 SFGVLMWEVIKGKHP 782
           + GV ++  + G+ P
Sbjct: 225 AMGVTLYCFVFGQCP 239

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 158
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 159 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 216 VDIWSVGCIMAELLTGR 232

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 108/270 (40%), Gaps = 42/270 (15%)
Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH- 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF  H 
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 78
Query: 649 ----------ARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
                      + + ++ E +  G L + L +     E           + + +   +A 
Sbjct: 79  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 138
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TCGY 749
            ++YL+   F   VHRD++++N ++  ++   + DFG+ + +           G     +
Sbjct: 139 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLP 809
           +APE       T   D++SFGV++WE+         L       L+ +  L  ++D    
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGYL 248
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPT 839
               +  E++  +M +   C+  +P+ RPT
Sbjct: 249 DQPDNCPERVTDLMRM---CWQFNPKMRPT 275

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 153
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+     +   T +  T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/272 (20%), Positives = 111/272 (40%), Gaps = 46/272 (16%)
Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH- 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF  H 
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 80
Query: 649 ----------ARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
                      + + ++ E +  G L + L +     E           + + +   +A 
Sbjct: 81  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 140
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----C 747
            ++YL+   F   VHRD++++N ++  ++   + DFG+ + +    +++    G      
Sbjct: 141 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 195
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
            ++APE       T   D++SFGV++WE+         L       L+ +  L  ++D  
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGG 248
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
                 +  E++  +M +   C+  +P+ RPT
Sbjct: 249 YLDQPDNCPERVTDLMRM---CWQFNPKMRPT 277

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 148
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 149 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 206 VDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/259 (24%), Positives = 112/259 (43%), Gaps = 38/259 (14%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--RHSFLLYE 657
           +GEVVAVKK    L        ++F  E+E            + G C  A  R+  L+ E
Sbjct: 39  TGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 94
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L  GSL   L      + +   + +     +   + YL    +   +HR+++++N+L++
Sbjct: 95  YLPYGSLRDYLQ--KHKERIDHIKLLQYTSQICKGMEYLGTKRY---IHRNLATRNILVE 149
Query: 718 LEYEAHVADFGIAKSLKPDSSNW-TEFAGTCG--YIAPELAYTMKITEKCDVYSFGVLMW 774
            E    + DFG+ K L  D   +  +  G     + APE     K +   DV+SFGV+++
Sbjct: 150 NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 209
Query: 775 EVI----KGKH-PRDFLXXXXXXXLNTDVA--LDQML--DPRLPAPSRSAQEKLISIMEV 825
           E+     K K  P +F+           +   L ++L  + RLP P     E    I  +
Sbjct: 210 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE----IYMI 265
Query: 826 AFSCFNESPESRPTMKIIS 844
              C+N +   RP+ + ++
Sbjct: 266 MTECWNNNVNQRPSFRDLA 284

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 151
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 152
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 151
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 152 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 209 VDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 145
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 146 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 202
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 203 VDIWSVGCIMAELLTGR 219

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 152
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDSELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 125/311 (40%), Gaps = 49/311 (15%)
Query: 563 QIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHS 622
           + P+ +L +    G+  + ++VKAT    A +  G  G+ +V    L   E  +  +   
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKAT----AFHLKGRAGYTTVAVKMLK--ENASPSELRD 72
Query: 623 LLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNT------------ 670
           LL     + Q      V   YG CS      L+ E+ + GSL   L              
Sbjct: 73  LLSEFNVLKQVNH-PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 671 -----------DAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE 719
                      D  A  +G    ++    ++  + YL       +VHRD++++N+L+   
Sbjct: 132 GSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEG 186
Query: 720 YEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
            +  ++DFG+++ +  + S      G     ++A E  +    T + DV+SFGVL+WE++
Sbjct: 187 RKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 778 K-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPES 836
             G +P   +       L            R+  P   ++E    +  +   C+ + P+ 
Sbjct: 247 TLGGNPYPGIPPERLFNLLKT-------GHRMERPDNCSEE----MYRLMLQCWKQEPDK 295
Query: 837 RPTMKIISQQL 847
           RP    IS+ L
Sbjct: 296 RPVFADISKDL 306

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 152
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 157
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 158 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 215 VDIWSVGCIMAELLTGR 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 153
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 154 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 211 VDIWSVGCIMAELLTGR 227

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 125/311 (40%), Gaps = 49/311 (15%)
Query: 563 QIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHS 622
           + P+ +L +    G+  + ++VKAT    A +  G  G+ +V    L   E  +  +   
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKAT----AFHLKGRAGYTTVAVKMLK--ENASPSELRD 72
Query: 623 LLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNT------------ 670
           LL     + Q      V   YG CS      L+ E+ + GSL   L              
Sbjct: 73  LLSEFNVLKQVNH-PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 671 -----------DAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE 719
                      D  A  +G    ++    ++  + YL       +VHRD++++N+L+   
Sbjct: 132 GSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEG 186
Query: 720 YEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
            +  ++DFG+++ +  + S      G     ++A E  +    T + DV+SFGVL+WE++
Sbjct: 187 RKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 778 K-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPES 836
             G +P   +       L            R+  P   ++E    +  +   C+ + P+ 
Sbjct: 247 TLGGNPYPGIPPERLFNLLKT-------GHRMERPDNCSEE----MYRLMLQCWKQEPDK 295
Query: 837 RPTMKIISQQL 847
           RP    IS+ L
Sbjct: 296 RPVFADISKDL 306

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 19/140 (13%)
Query: 653 FLLYEFLERGSLAAILNT--DAAAQELGWSQRMNVIKAV--AHALSYLHHDCFPPIVHRD 708
           +L+ ++   G L  +L+   D   +E+       ++ A+   H L Y         VHRD
Sbjct: 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY---------VHRD 200
Query: 709 ISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPELAYTM-----KITE 762
           I   N+L+D+     +ADFG    L  D +  +  A GT  YI+PE+   M     +   
Sbjct: 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGP 260
Query: 763 KCDVYSFGVLMWEVIKGKHP 782
           +CD +S GV M+E++ G+ P
Sbjct: 261 ECDWWSLGVCMYEMLYGETP 280

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 95  GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 154
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--- 746
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 155 RGMEYLASQKC----IHRDLTARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNG 206
Query: 747 ---CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 261
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E  + + +    C++  P  RPT K + + L
Sbjct: 262 --GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 300

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 168 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKNTTNG 219
Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 274
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E  + + +    C++  P  RPT K + + L
Sbjct: 275 --GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 313

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 168 RGMEYLASQKC----IHRDLAARNVLVTENNVMRIADFGLAR----DINNIDYYKKTTNG 219
Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 274
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E L  +M     C++  P  RPT K + + L
Sbjct: 275 --GHRMDKPANCTNE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 61/131 (46%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY  +E  S   + +   A   +   +     + +  A+ Y H      IVHRD+ ++NL
Sbjct: 81  LYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENL 137
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +       +    F G+  Y APEL    K    + DV+S GV++
Sbjct: 138 LLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVIL 196
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 197 YTLVSGSLPFD 207

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE---------- 638
           D++    IG G    V      S   V   K  S     +  D   F  E          
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 639 --VEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALSY 695
             V+ FY F    R+ +++ E++  G L  ++ N D   +   W++       V  AL  
Sbjct: 130 WVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVLALDA 183
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPEL 754
           +H   F   +HRD+   N+LLD      +ADFG    +  +     + A GT  YI+PE+
Sbjct: 184 IHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 240
Query: 755 AYTM----KITEKCDVYSFGVLMWEVIKGKHP 782
             +         +CD +S GV ++E++ G  P
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE---------- 638
           D++    IG G    V      S   V   K  S     +  D   F  E          
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 639 --VEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHALSY 695
             V+ FY F    R+ +++ E++  G L  ++ N D   +   W++       V  AL  
Sbjct: 135 WVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVLALDA 188
Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPEL 754
           +H   F   +HRD+   N+LLD      +ADFG    +  +     + A GT  YI+PE+
Sbjct: 189 IHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEV 245
Query: 755 AYTM----KITEKCDVYSFGVLMWEVIKGKHP 782
             +         +CD +S GV ++E++ G  P
Sbjct: 246 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 14/140 (10%)
Query: 649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN--VIKAVAHALSYLHHDCFPPIVH 706
            +H +L+ E +  G L      D   ++  +S+R    V+  +   + YLH      +VH
Sbjct: 93  GKHVYLVTELMRGGELL-----DKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVH 144
Query: 707 RDISSKNLLLDLEYE----AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           RD+   N+L   E        + DFG AK L+ ++        T  ++APE+       E
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDE 204
Query: 763 KCDVYSFGVLMWEVIKGKHP 782
            CD++S G+L++ ++ G  P
Sbjct: 205 GCDIWSLGILLYTMLAGYTP 224

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 11/144 (7%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            Y F    R+ +L+ E    G L    +     Q+        ++K V    +YLH    
Sbjct: 86  LYEFFEDKRNYYLVMEVYRGGEL---FDEIILRQKFSEVDAAVIMKQVLSGTTYLHKH-- 140
Query: 702 PPIVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
             IVHRD+  +NLLL+ +       + DFG++   +       E  GT  YIAPE+    
Sbjct: 141 -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKERLGTAYYIAPEVL-RK 197
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
           K  EKCDV+S GV+++ ++ G  P
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/272 (20%), Positives = 111/272 (40%), Gaps = 46/272 (16%)
Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH- 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF  H 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 81
Query: 649 ----------ARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
                      + + ++ E +  G L + L +     E           + + +   +A 
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----C 747
            ++YL+   F   VHRD++++N ++  ++   + DFG+ + +    +++    G      
Sbjct: 142 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 196
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
            ++APE       T   D++SFGV++WE+         L       L+ +  L  ++D  
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGG 249
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
                 +  E++  +M +   C+  +P+ RPT
Sbjct: 250 YLDQPDNCPERVTDLMRM---CWQFNPKMRPT 278

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 32/221 (14%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              +    ++L     ++    VA
Sbjct: 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 201
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--C 747
             + YL    C    +HRD++++N+L+  +    +ADFG+A+ +           G    
Sbjct: 202 RGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 257
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         
Sbjct: 258 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GH 310
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           R+  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 311 RMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 347

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           FL+++ +++G L   L       E    + M  +  V  AL  L+      IVHRD+  +
Sbjct: 87  FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPE 140
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK------ITEKCDV 766
           N+LLD +    + DFG +  L P      E  GT  Y+APE+             ++ D+
Sbjct: 141 NILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 199
Query: 767 YSFGVLMWEVIKGKHP 782
           +S GV+M+ ++ G  P
Sbjct: 200 WSTGVIMYTLLAGSPP 215

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 97  GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 156
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 157 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNG 208
Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 263
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E  + + +    C++  P  RPT K + + L
Sbjct: 264 --GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 302

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 107/270 (39%), Gaps = 42/270 (15%)
Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH- 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF  H 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 81
Query: 649 ----------ARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
                      + + ++ E +  G L + L +     E           + + +   +A 
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TCGY 749
            ++YL+   F   VHRD++++N ++  ++   + DFG+ + +           G     +
Sbjct: 142 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLP 809
           +APE       T   D++SFGV++WE+         L       L+ +  L  ++D    
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPT 839
               +  E++  +M +   C+  +P  RPT
Sbjct: 252 DQPDNCPERVTDLMRM---CWQFNPNMRPT 278

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/333 (20%), Positives = 141/333 (42%), Gaps = 48/333 (14%)
Query: 541 LISIFFILRKQKSDSGDRQSNNQIPQGSLSILNFEGKILY--DEIVKATNDFDAKYCIGN 598
           L+ + ++  +++++S   +  N +   S++   F    +Y  DE   A         +G 
Sbjct: 1   LVIMLYVFHRKRNNS---RLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQ 57
Query: 599 GGHASVYRAELPSGEV-------VAVKKFHSLLPCDQTVD-------QKEF-LTEVEAFY 643
           G    VY   +  G V       VA+K  +      + ++        KEF    V    
Sbjct: 58  GSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 116
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 117 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 176
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 177 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 231
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 284
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 285 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 314

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 86/214 (40%), Gaps = 27/214 (12%)
Query: 587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-------- 638
             D++    IG G    V      S   V   K  S     +  D   F  E        
Sbjct: 73  AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 639 ----VEAFYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHAL 693
               V+ FY F    R+ +++ E++  G L  ++ N D   +   W++       V  AL
Sbjct: 133 SPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---WARFYTA--EVVLAL 186
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAP 752
             +H   F   +HRD+   N+LLD      +ADFG    +  +     + A GT  YI+P
Sbjct: 187 DAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 243
Query: 753 ELAYTM----KITEKCDVYSFGVLMWEVIKGKHP 782
           E+  +         +CD +S GV ++E++ G  P
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 277

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/311 (21%), Positives = 126/311 (40%), Gaps = 49/311 (15%)
Query: 563 QIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHS 622
           + P+ +L +    G+  + ++VKAT    A +  G  G+ +V    L   E  +  +   
Sbjct: 19  EFPRKNLVLGKTLGEGEFGKVVKAT----AFHLKGRAGYTTVAVKMLK--ENASPSELRD 72
Query: 623 LLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAIL-------------- 668
           LL     + Q      V   YG CS      L+ E+ + GSL   L              
Sbjct: 73  LLSEFNVLKQVNH-PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 669 ---------NTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE 719
                    + D  A  +G    ++    ++  + YL       +VHRD++++N+L+   
Sbjct: 132 GSRNSSSLDHPDERALTMG--DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEG 186
Query: 720 YEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
            +  ++DFG+++ +  + S      G     ++A E  +    T + DV+SFGVL+WE++
Sbjct: 187 RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
Query: 778 K-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPES 836
             G +P   +       L            R+  P   ++E    +  +   C+ + P+ 
Sbjct: 247 TLGGNPYPGIPPERLFNLLKT-------GHRMERPDNCSEE----MYRLMLQCWKQEPDK 295
Query: 837 RPTMKIISQQL 847
           RP    IS+ L
Sbjct: 296 RPVFADISKDL 306

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/140 (30%), Positives = 67/140 (47%), Gaps = 20/140 (14%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           F+  E+ E  +L  +++++   Q+     R+   + +  ALSY+H      I+HR++   
Sbjct: 91  FIQXEYCENRTLYDLIHSENLNQQRDEYWRL--FRQILEALSYIHSQG---IIHRNLKPX 145
Query: 713 NLLLDLEYEAHVADFGIAKS-------LKPDSS-------NWTEFAGTCGYIAPE-LAYT 757
           N+ +D      + DFG+AK+       LK DS        N T   GT  Y+A E L  T
Sbjct: 146 NIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGT 205
Query: 758 MKITEKCDVYSFGVLMWEVI 777
               EK D YS G++ +E I
Sbjct: 206 GHYNEKIDXYSLGIIFFEXI 225

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 168 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNG 219
Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 274
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E L  +M     C++  P  RPT K + + L
Sbjct: 275 --GHRMDKPANCTNE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 100 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 159
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 160 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNG 211
Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 266
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E  + + +    C++  P  RPT K + + L
Sbjct: 267 --GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 305

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 213
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 214 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNG 265
Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 320
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E  + + +    C++  P  RPT K + + L
Sbjct: 321 --GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 359

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 111/271 (40%), Gaps = 39/271 (14%)
Query: 595 CIGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           CIG G    V++    S E     VA+K   +   C     +++FL E      F  H  
Sbjct: 45  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQF-DHPH 100
Query: 651 -----------HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
                        +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 101 IVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 158
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYT 757
            F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G     ++APE    
Sbjct: 159 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 214
Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQ 816
            + T   DV+ FGV MWE++  G  P   +        N DV        RLP P  +  
Sbjct: 215 RRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMPP-NCP 266
Query: 817 EKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             L S+M     C+   P  RP    +  QL
Sbjct: 267 PTLYSLMT---KCWAYDPSRRPRFTELKAQL 294

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 13/136 (9%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           FL+++ +++G L   L       E    + M  +  V  AL  L+      IVHRD+  +
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPE 153
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK------ITEKCDV 766
           N+LLD +    + DFG +  L P      E  GT  Y+APE+             ++ D+
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDP-GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 767 YSFGVLMWEVIKGKHP 782
           +S GV+M+ ++ G  P
Sbjct: 213 WSTGVIMYTLLAGSPP 228

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/211 (21%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 80  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 139
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TCGYIAPEL 754
           + + F   VHRD++++N ++  ++   + DFG+ + +           G     +++PE 
Sbjct: 140 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPES 196
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRS 814
                 T   DV+SFGV++WE+         L       L+ +  L  +++  L     +
Sbjct: 197 LKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKPDN 249
Query: 815 AQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
             + L+ +M +   C+  +P+ RP+ ++IIS
Sbjct: 250 CPDMLLELMRM---CWQYNPKMRPSFLEIIS 277

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 579 LYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKF---HSLLPCDQTV---DQ 632
           L  E+     DF+    IG G    V   ++ + E +   K      +L   +T    ++
Sbjct: 81  LVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREE 140
Query: 633 KEFLTE-----VEAFYGFCSHARHSFLLYEFLERGSLAAILNT--DAAAQELGWSQRMNV 685
           ++ L       + A +       H +L+ ++   G L  +L+   D   +++       +
Sbjct: 141 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 200
Query: 686 IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA- 744
           + A+  ++  LH+      VHRDI   N+LLD+     +ADFG    +  D +  +  A 
Sbjct: 201 VLAI-DSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 253
Query: 745 GTCGYIAPELAYTM-----KITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YI+PE+   M     K   +CD +S GV M+E++ G+ P
Sbjct: 254 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG- 748
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 168 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNG 219
Query: 749 -----YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 274
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E L  +M     C++  P  RPT K + + L
Sbjct: 275 --GHRMDKPANCTNE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 11/144 (7%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            Y F    R+ +L+ E    G L    +     Q+        ++K V    +YLH    
Sbjct: 69  LYEFFEDKRNYYLVMEVYRGGEL---FDEIILRQKFSEVDAAVIMKQVLSGTTYLHK--- 122
Query: 702 PPIVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
             IVHRD+  +NLLL+ +       + DFG++   +       E  GT  YIAPE+    
Sbjct: 123 HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKERLGTAYYIAPEV-LRK 180
Query: 759 KITEKCDVYSFGVLMWEVIKGKHP 782
           K  EKCDV+S GV+++ ++ G  P
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPP 204

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 110/271 (40%), Gaps = 39/271 (14%)
Query: 595 CIGNGG----HASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           CIG G     H  +Y +       VA+K   +   C     +++FL E      F  H  
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMRQF-DHPH 72
Query: 651 -----------HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
                        +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 73  IVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESK 130
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYT 757
            F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G     ++APE    
Sbjct: 131 RF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 186
Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQ 816
            + T   DV+ FGV MWE++  G  P   +        N DV        RLP P  +  
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMPP-NCP 238
Query: 817 EKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             L S+M     C+   P  RP    +  QL
Sbjct: 239 PTLYSLMT---KCWAYDPSRRPRFTELKAQL 266

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/140 (26%), Positives = 65/140 (46%), Gaps = 14/140 (10%)
Query: 649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN--VIKAVAHALSYLHHDCFPPIVH 706
            +H +L+ E +  G L      D   ++  +S+R    V+  +   + YLH      +VH
Sbjct: 93  GKHVYLVTELMRGGELL-----DKILRQKFFSEREASFVLHTIGKTVEYLHSQG---VVH 144
Query: 707 RDISSKNLLLDLEYE----AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           RD+   N+L   E        + DFG AK L+ ++        T  ++APE+       E
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDE 204
Query: 763 KCDVYSFGVLMWEVIKGKHP 782
            CD++S G+L++ ++ G  P
Sbjct: 205 GCDIWSLGILLYTMLAGYTP 224

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 30/205 (14%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQ-KEFLTEVEAFYGFCSHARHS-- 652
           IG+G   +VY+ +      V + K       D T +Q + F  EV          RH   
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKV-----VDPTPEQFQAFRNEVAVL----RKTRHVNI 94
Query: 653 FLLYEFLERGSLAAI--------LNTDAAAQELGWS--QRMNVIKAVAHALSYLHHDCFP 702
            L   ++ + +LA +        L      QE  +   Q +++ +  A  + YLH     
Sbjct: 95  LLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN-- 152
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPELAYTMK- 759
            I+HRD+ S N+ L       + DFG+A  KS    S    +  G+  ++APE+      
Sbjct: 153 -IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 760 --ITEKCDVYSFGVLMWEVIKGKHP 782
              + + DVYS+G++++E++ G+ P
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/280 (22%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-- 640
           VKA +D +    +G G +  V +   +PSG+++AVK+  + +    + +QK  L +++  
Sbjct: 4   VKA-DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDIS 59
Query: 641 ----------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
                      FYG        ++  E ++              Q +       +  ++ 
Sbjct: 60  MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
            AL +LH      ++HRD+   N+L++   +  + DFGI+  L  D +   + AG   Y+
Sbjct: 120 KALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYM 176
Query: 751 APEL--------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQ 802
           APE          Y++    K D++S G+ M E+   + P D               L Q
Sbjct: 177 APERINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGTPFQ-------QLKQ 225
Query: 803 MLD---PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
           +++   P+LPA   SA+      ++    C  ++ + RPT
Sbjct: 226 VVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPT 260

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 94/225 (41%), Gaps = 40/225 (17%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--- 746
             + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T   
Sbjct: 168 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTTNG 219
Query: 747 ---CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQ 802
                ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +     
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE----- 274
Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               R+  P+    E L  +M     C++  P  RPT K + + L
Sbjct: 275 --GHRMDKPANCTNE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              +    ++L     ++    VA
Sbjct: 101 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVA 160
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CG 748
             + YL        +HRD++++N+L+  +    +ADFG+A+ +           G     
Sbjct: 161 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVK 217
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
           ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         R
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GHR 270
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 271 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 306

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 110/271 (40%), Gaps = 39/271 (14%)
Query: 595 CIGNGG----HASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           CIG G     H  +Y +       VA+K   +   C     +++FL E      F  H  
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMRQF-DHPH 72
Query: 651 -----------HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
                        +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 73  IVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 130
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYT 757
            F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G     ++APE    
Sbjct: 131 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 186
Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQ 816
            + T   DV+ FGV MWE++  G  P   +        N DV        RLP P  +  
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMPP-NCP 238
Query: 817 EKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             L S+M     C+   P  RP    +  QL
Sbjct: 239 PTLYSLMT---KCWAYDPSRRPRFTELKAQL 266

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 93/214 (43%), Gaps = 31/214 (14%)
Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
           ++DF  K  +G G +  V  A   P+GE+VA+KK     P D+ +     L E++     
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE---PFDKPLFALRTLREIKIL--- 63
Query: 646 CSHARHSFLLYEF-LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP- 703
             H +H  ++  F ++R       N     QEL  +    VI     +  ++ +  +   
Sbjct: 64  -KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 704 ----------IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WTEF 743
                     ++HRD+   NLL++   +  V DFG+A+ +   +++           TE 
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEX 182
Query: 744 AGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEV 776
             T  Y APE+  T  K +   DV+S G ++ E+
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 169
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+    +      +  T  Y APE+    M   + 
Sbjct: 170 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG---YVATRWYRAPEIMLNWMHYNQT 226
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 227 VDIWSVGCIMAELLTGR 243

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 111/271 (40%), Gaps = 39/271 (14%)
Query: 595 CIGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           CIG G    V++    S E     VA+K   +   C     +++FL E      F  H  
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQF-DHPH 77
Query: 651 -----------HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
                        +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 78  IVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 135
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYT 757
            F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G     ++APE    
Sbjct: 136 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 191
Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQ 816
            + T   DV+ FGV MWE++  G  P   +        N DV        RLP P  +  
Sbjct: 192 RRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMPP-NCP 243
Query: 817 EKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             L S+M     C+   P  RP    +  QL
Sbjct: 244 PTLYSLMT---KCWAYDPSRRPRFTELKAQL 271

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN    +Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+ +         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDSELKILDFGLCRHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 152
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 153 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 210 VDIWSVGCIMAELLTGR 226

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFL 659
           +G+  AVK   S     Q  D++  L EV+             Y F     + +L+ E  
Sbjct: 50  TGQECAVKVI-SKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVY 108
Query: 660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE 719
             G L   + +     E+  ++   +I+ V   ++Y H +    IVHRD+  +NLLL+ +
Sbjct: 109 TGGELFDEIISRKRFSEVDAAR---IIRQVLSGITYXHKN---KIVHRDLKPENLLLESK 162
Query: 720 YEA---HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEV 776
            +     + DFG++   +  S    +  GT  YIAPE+ +     EKCDV+S GV+++ +
Sbjct: 163 SKDANIRIIDFGLSTHFEA-SKKXKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYIL 220
Query: 777 IKGKHP 782
           + G  P
Sbjct: 221 LSGCPP 226

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHS---LLPCDQTVDQKEFLTE-----VEAFYGFC 646
           +G G  A+V+R     +G++ A+K F++   L P D  + + E L +     +   +   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 647 SHA--RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
                RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  +    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 705 VHRDISSKNLLL----DLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL------ 754
           VHR+I   N++     D +    + DFG A+ L+ D   +    GT  Y+ P++      
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPDMYERAVL 192
Query: 755 --AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
              +  K     D++S GV  +    G  P
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 26/223 (11%)
Query: 579 LYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKF---HSLLPCDQTV---DQ 632
           L  E+     DF+    IG G    V   ++ + E +   K      +L   +T    ++
Sbjct: 65  LVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREE 124
Query: 633 KEFLTE-----VEAFYGFCSHARHSFLLYEFLERGSLAAILNT--DAAAQELGWSQRMNV 685
           ++ L       + A +       H +L+ ++   G L  +L+   D   +++       +
Sbjct: 125 RDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEM 184
Query: 686 IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA- 744
           + A+  ++  LH+      VHRDI   N+LLD+     +ADFG    +  D +  +  A 
Sbjct: 185 VLAI-DSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 237
Query: 745 GTCGYIAPELAYTM-----KITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YI+PE+   M     K   +CD +S GV M+E++ G+ P
Sbjct: 238 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 111/271 (40%), Gaps = 39/271 (14%)
Query: 595 CIGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           CIG G    V++    S E     VA+K   +   C     +++FL E      F  H  
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEALTMRQF-DHPH 72
Query: 651 -----------HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
                        +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 73  IVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLESK 130
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYT 757
            F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G     ++APE    
Sbjct: 131 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 186
Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQ 816
            + T   DV+ FGV MWE++  G  P   +        N DV        RLP P  +  
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMPP-NCP 238
Query: 817 EKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             L S+M     C+   P  RP    +  QL
Sbjct: 239 PTLYSLMT---KCWAYDPSRRPRFTELKAQL 266

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-- 746
           ++ AL+YL    F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G   
Sbjct: 123 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 178
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++APE     + T   DV+ FGV MWE++  G  P   +        N DV       
Sbjct: 179 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENG 231
Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            RLP P  +    L S+M     C+   P  RP    +  QL
Sbjct: 232 ERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 269

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + D+G+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDYGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/270 (21%), Positives = 109/270 (40%), Gaps = 42/270 (15%)
Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH- 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF  H 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 81
Query: 649 ----------ARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
                      + + ++ E +  G L + L +     E           + + +   +A 
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TCGY 749
            ++YL+   F   VHRD++++N ++  ++   + DFG+ + +   +       G     +
Sbjct: 142 GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLP 809
           +APE       T   D++SFGV++WE+         L       L+ +  L  ++D    
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGGYL 251
Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPT 839
               +  E++  +M +   C+  +P+ RPT
Sbjct: 252 DQPDNCPERVTDLMRM---CWQFNPKMRPT 278

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 18/159 (11%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGY 749
           AL+YL    F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G     +
Sbjct: 503 ALAYLESKRF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKW 558
Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRL 808
           +APE     + T   DV+ FGV MWE++  G  P   +        N DV        RL
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERL 611
Query: 809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P P  +    L S+M     C+   P  RP    +  QL
Sbjct: 612 PMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 646

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 40/213 (18%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCD---QTVDQKEFLTEVEAFYGFCS----- 647
           IG G +  V+  +   GE VAVK F +        +T   +  L   E   GF +     
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKG 103
Query: 648 --HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF---- 701
                  +L+ ++ E GSL   L +      L     + +  +    L +LH + F    
Sbjct: 104 TGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159
Query: 702 -PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW----TEFAGTCGYIAPEL-- 754
            P I HRD+ SKN+L+       +AD G+A     D++          GT  Y+ PE+  
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLD 219
Query: 755 ---------AYTMKITEKCDVYSFGVLMWEVIK 778
                    +Y M      D+YSFG+++WEV +
Sbjct: 220 ESLNRNHFQSYIM-----ADMYSFGLILWEVAR 247

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 60/103 (58%), Gaps = 8/103 (7%)
Query: 684 NVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSN 739
           + I  +  +++++H HD    IVHRD+  +NLLL  + +     +ADFG+A  ++ +   
Sbjct: 134 HCIHQILESVNHIHQHD----IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQA 189
Query: 740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           W  FAGT GY++PE+       +  D+++ GV+++ ++ G  P
Sbjct: 190 WFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK--PDSSNWTEFAGTC 747
             + YL    C    +HRD++++N+L+       +ADFG+A+ +         T      
Sbjct: 168 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +         
Sbjct: 224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-------GH 276
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           R+  P+    E L  +M     C++  P  RPT K + + L
Sbjct: 277 RMDKPANCTNE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/211 (21%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 89  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 148
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TCGYIAPEL 754
           + + F   VHRD++++N ++  ++   + DFG+ + +           G     +++PE 
Sbjct: 149 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPES 205
Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRS 814
                 T   DV+SFGV++WE+         L       L+ +  L  +++  L     +
Sbjct: 206 LKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKPDN 258
Query: 815 AQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
             + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 259 CPDMLFELMRM---CWQYNPKMRPSFLEIIS 286

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 57/101 (56%), Gaps = 8/101 (7%)
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---LEYEAHVADFGIAKSLKPDSSNWT 741
           +IK V   ++Y+H      IVHRD+  +N+LL+    + +  + DFG++   + ++    
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMK 181
Query: 742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +  GT  YIAPE+       EKCDV+S GV+++ ++ G  P
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 32/221 (14%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTD-------------AAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   +++ +   ++    +A
Sbjct: 108 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLA 167
Query: 691 HALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--C 747
             + YL    C    +HRD++++N+L+       +ADFG+A+ +           G    
Sbjct: 168 RGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +         
Sbjct: 224 KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH------- 276
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           R+  P+    E L  +M     C++  P  RPT K + + L
Sbjct: 277 RMDKPANCTNE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-- 746
           ++ AL+YL    F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G   
Sbjct: 122 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 177
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++APE     + T   DV+ FGV MWE++  G  P   +        N DV       
Sbjct: 178 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENG 230
Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            RLP P  +    L S+M     C+   P  RP    +  QL
Sbjct: 231 ERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 268

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 29/217 (13%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFH--------SLLPCDQTVDQKEFL 636
           AT+ ++    IG G + +VY+A  P SG  VA+K             LP   TV +   L
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPI-STVREVALL 65
Query: 637 TEVEAF--------YGFCSHARHS-----FLLYEFLERGSLAAILNTDAAAQELGWSQRM 683
             +EAF           C+ +R        L++E +++  L   L+  A    L      
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIK 123
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF 743
           ++++     L +LH +C   IVHRD+  +N+L+       +ADFG+A+ +       T  
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALTPV 179
Query: 744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK 780
             T  Y APE+          D++S G +  E+ + K
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K   + WT   GT  Y+A
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT-LCGTPEYLA 227
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 82  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 141
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 142 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 196
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 249
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 250 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 279

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T    T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGXVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 27/210 (12%)
Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHS---LLPCDQTVDQKEFLTE-----VEAFYGFC 646
           +G G  A+V+R     +G++ A+K F++   L P D  + + E L +     +   +   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 647 SHA--RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
                RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  +    I
Sbjct: 77  EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---I 133
Query: 705 VHRDISSKNLLL----DLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA----- 755
           VHR+I   N++     D +    + DFG A+ L+ D   +    GT  Y+ P++      
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 756 ---YTMKITEKCDVYSFGVLMWEVIKGKHP 782
              +  K     D++S GV  +    G  P
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 8/131 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAA--QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
           +++ ++ E G L   +N       QE    Q ++    +  AL ++H      I+HRDI 
Sbjct: 99  YIVMDYCEGGDLFKRINAQKGVLFQE---DQILDWFVQICLALKHVHDR---KILHRDIK 152
Query: 711 SKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFG 770
           S+N+ L  +    + DFGIA+ L           GT  Y++PE+        K D+++ G
Sbjct: 153 SQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212
Query: 771 VLMWEVIKGKH 781
            +++E+   KH
Sbjct: 213 CVLYELCTLKH 223

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 34/133 (25%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           F++ E++  G L   +      +E+   +   + + +  A+ Y H      +VHRD+  +
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEM---EARRLFQQILSAVDYCHRHM---VVHRDLKPE 140
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           N+LLD    A +ADFG++ ++  D     +  G+  Y APE ++  +    + D++S GV
Sbjct: 141 NVLLDAHMNAKIADFGLS-NMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGV 199
Query: 772 LMWEVIKGKHPRD 784
           +++ ++ G  P D
Sbjct: 200 ILYALLCGTLPFD 212

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN      +L       +I  +   L Y+H      I
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS---ADI 142
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M   + 
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 200 VDIWSVGCIMAELLTGR 216

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL 714
           LY   E  S   + +   A       +     + +  A+ Y H      IVHRD+ ++NL
Sbjct: 88  LYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENL 144
Query: 715 LLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLM 773
           LLD +    +ADFG +       +    F G   Y APEL    K    + DV+S GV++
Sbjct: 145 LLDADXNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL 203
Query: 774 WEVIKGKHPRD 784
           + ++ G  P D
Sbjct: 204 YTLVSGSLPFD 214

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/125 (24%), Positives = 62/125 (49%), Gaps = 5/125 (4%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           F+  EF ++G+L   +      ++L     + + + +   + Y+H      ++HRD+   
Sbjct: 110 FIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPS 165
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVL 772
           N+ L    +  + DFG+  SLK D    T   GT  Y++PE   +    ++ D+Y+ G++
Sbjct: 166 NIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 224
Query: 773 MWEVI 777
           + E++
Sbjct: 225 LAELL 229

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-- 746
           ++ AL+YL    F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G   
Sbjct: 500 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 555
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++APE     + T   DV+ FGV MWE++  G  P   +        N DV       
Sbjct: 556 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENG 608
Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            RLP P  +    L S+M     C+   P  RP    +  QL
Sbjct: 609 ERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 646

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 9/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +L+++ +  G L      D  A+E  +    +    +   L  ++H     IVHRD+  +
Sbjct: 79  YLVFDLVTGGELF----EDIVARE--YYSEADASHCIQQILESVNHCHLNGIVHRDLKPE 132
Query: 713 NLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLLL  + +     +ADFG+A  ++ D   W  FAGT GY++PE+       +  D+++ 
Sbjct: 133 NLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWAC 192
Query: 770 GVLMWEVIKGKHP 782
           GV+++ ++ G  P
Sbjct: 193 GVILYILLVGYPP 205

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 73/134 (54%), Gaps = 12/134 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQEL-GWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS 711
           +L+++ +  G L      D  A+E    +   + I+ +  +++Y H +    IVHR++  
Sbjct: 104 YLVFDLVTGGELF----EDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKP 156
Query: 712 KNLLLDLEYEA---HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYS 768
           +NLLL  + +     +ADFG+A  +  DS  W  FAGT GY++PE+      ++  D+++
Sbjct: 157 ENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWA 215
Query: 769 FGVLMWEVIKGKHP 782
            GV+++ ++ G  P
Sbjct: 216 CGVILYILLVGYPP 229

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-- 746
           ++ AL+YL    F   VHRDI+++N+L+       + DFG+++ ++ DS+ +    G   
Sbjct: 117 LSTALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 172
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLD 805
             ++APE     + T   DV+ FGV MWE++  G  P   +        N DV       
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENG 225
Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            RLP P  +    L S+M     C+   P  RP    +  QL
Sbjct: 226 ERLPMPP-NCPPTLYSLMT---KCWAYDPSRRPRFTELKAQL 263

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 89  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 148
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 149 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 203
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 256
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 257 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 286

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 28/82 (34%), Positives = 49/82 (59%), Gaps = 3/82 (3%)
Query: 704 IVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI 760
           +VHRD+  +NLLL  + +     +ADFG+A  ++ D   W  FAGT GY++PE+      
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 761 TEKCDVYSFGVLMWEVIKGKHP 782
            +  D+++ GV+++ ++ G  P
Sbjct: 184 GKPVDIWACGVILYILLVGYPP 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 68/133 (51%), Gaps = 9/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +L+++ +  G L      D  A+E  +    +    +   L  ++H     IVHRD+  +
Sbjct: 79  YLVFDLVTGGELF----EDIVARE--YYSEADASHCIQQILESVNHCHLNGIVHRDLKPE 132
Query: 713 NLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLLL  + +     +ADFG+A  ++ D   W  FAGT GY++PE+       +  D+++ 
Sbjct: 133 NLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWAC 192
Query: 770 GVLMWEVIKGKHP 782
           GV+++ ++ G  P
Sbjct: 193 GVILYILLVGYPP 205

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 166
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+    +         T  Y APE+    M   + 
Sbjct: 167 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG---XVATRWYRAPEIMLNWMHYNQT 223
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 224 VDIWSVGCIMAELLTGR 240

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 88  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 147
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 148 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 202
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 255
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 256 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 285

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +   L  LH +    IV+RD+  +N+LLD      ++D G+A  + P+        GT G
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVG 350
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           Y+APE+    + T   D ++ G L++E+I G+ P
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 86  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 145
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 146 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 200
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 253
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 254 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 283

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 95  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 155 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 209
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 262
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 263 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 292

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L+ E++  GSL   L        +G +Q +   + +   ++YLH   +   +HR ++++N
Sbjct: 90  LVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHY---IHRALAARN 142
Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFA----GTCGYIAPELAYTMKITEKCDVYSF 769
           +LLD +    + DFG+AK++ P+   +            + APE     K     DV+SF
Sbjct: 143 VLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSF 201
Query: 770 GVLMWEVI------KGKHPRDFLXXXXXXXLNTDVALDQMLD--PRLPAPSRSAQEKLIS 821
           GV ++E++      +  H +            T + L ++L+   RLP P R   E    
Sbjct: 202 GVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCE---- 257
Query: 822 IMEVAFSCFNESPESRPTMK 841
           I  +  +C+      RPT +
Sbjct: 258 IYHLMKNCWETEASFRPTFQ 277

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +   L  LH +    IV+RD+  +N+LLD      ++D G+A  + P+        GT G
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTVG 350
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           Y+APE+    + T   D ++ G L++E+I G+ P
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 69/265 (26%), Positives = 107/265 (40%), Gaps = 45/265 (16%)
Query: 611 SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSF-------------LLYE 657
           +G +VAVK+     P DQ   Q++F  E++      S     +             L+ E
Sbjct: 35  TGALVAVKQLQHSGP-DQ---QRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVME 90
Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL-HHDCFPPIVHRDISSKNLLL 716
           +L  G L   L    A   L  S+ +     +   + YL    C    VHRD++++N+L+
Sbjct: 91  YLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILV 144
Query: 717 DLEYEAHVADFGIAKSLKPDSSNWT---EFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           + E    +ADFG+AK L  D               + APE       + + DV+SFGV++
Sbjct: 145 ESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 204
Query: 774 WEVI----KGKHPR-DFLXXXXXXXLNTDV------ALDQMLDPRLPAPSRSAQEKLISI 822
           +E+     K   P  +FL          DV              RLPAP     E    +
Sbjct: 205 YELFTYCDKSCSPSAEFL---RMMGCERDVPALCRLLELLEEGQRLPAPPACPAE----V 257
Query: 823 MEVAFSCFNESPESRPTMKIISQQL 847
            E+   C+  SP+ RP+   +  QL
Sbjct: 258 HELMKLCWAPSPQDRPSFSALGPQL 282

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              +    ++L     ++    VA
Sbjct: 93  GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 152
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CG 748
             + YL        +HRD++++N+L+  +    +ADFG+A+ +           G     
Sbjct: 153 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 209
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
           ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         R
Sbjct: 210 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GHR 262
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 263 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 298

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              +    ++L     ++    VA
Sbjct: 90  GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 149
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CG 748
             + YL        +HRD++++N+L+  +    +ADFG+A+ +           G     
Sbjct: 150 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 206
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
           ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         R
Sbjct: 207 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GHR 259
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 260 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 295

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              +    ++L     ++    VA
Sbjct: 101 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVA 160
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CG 748
             + YL        +HRD++++N+L+  +    +ADFG+A+ +           G     
Sbjct: 161 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
           ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         R
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GHR 270
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 271 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 306

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 30/220 (13%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L                   ++L     ++    VA
Sbjct: 101 GACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 160
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CG 748
             + YL        +HRD++++N+L+  +    +ADFG+A+ +           G     
Sbjct: 161 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
           ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         R
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GHR 270
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 271 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 306

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 88  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 147
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 148 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 202
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 255
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 256 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 285

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 27/167 (16%)
Query: 689 VAHALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
           +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T 
Sbjct: 166 LARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTT 217
Query: 748 G------YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVAL 800
                  ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +   
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE--- 274
Query: 801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 R+  P+    E L  +M     C++  P  RPT K + + L
Sbjct: 275 ----GHRMDKPANCTNE-LYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 109/271 (40%), Gaps = 39/271 (14%)
Query: 595 CIGNGG----HASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           CIG G     H  +Y +       VA+K   +   C     +++FL E      F  H  
Sbjct: 17  CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEALTMRQF-DHPH 72
Query: 651 -----------HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
                        +++ E    G L + L     + +L  +  +     ++ AL+YL   
Sbjct: 73  IVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESK 130
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CGYIAPELAYT 757
            F   VHRDI+++N+L+       + DFG+++ ++ DS+      G     ++APE    
Sbjct: 131 RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESINF 186
Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQ 816
            + T   DV+ FGV MWE++  G  P   +        N DV        RLP P  +  
Sbjct: 187 RRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPMPP-NCP 238
Query: 817 EKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             L S+M     C+   P  RP    +  QL
Sbjct: 239 PTLYSLMT---KCWAYDPSRRPRFTELKAQL 266

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L+ E++  GSL   L        +G +Q +   + +   ++YLH   +   +HR+++++N
Sbjct: 95  LVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQHY---IHRNLAARN 147
Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFA----GTCGYIAPELAYTMKITEKCDVYSF 769
           +LLD +    + DFG+AK++ P+   +            + APE     K     DV+SF
Sbjct: 148 VLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 206
Query: 770 GVLMWEVI-----KGKHPRDFLXXXXXXXLNTDV-ALDQMLD--PRLPAPSRSAQEKLIS 821
           GV ++E++         P  FL           V  L ++L+   RLP P +   E    
Sbjct: 207 GVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCE---- 262
Query: 822 IMEVAFSCFNESPESRPTMK 841
           +  +  +C+      RPT +
Sbjct: 263 VYHLMKNCWETEASFRPTFE 282

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              +    ++L     ++    VA
Sbjct: 101 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 160
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CG 748
             + YL        +HRD++++N+L+  +    +ADFG+A+ +           G     
Sbjct: 161 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 217
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
           ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         R
Sbjct: 218 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GHR 270
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 271 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 306

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L+ E++  GSL   L        +G +Q +   + +   ++YLH   +   +HR ++++N
Sbjct: 89  LVMEYVPLGSLRDYLPRHC----VGLAQLLLFAQQICEGMAYLHAQHY---IHRALAARN 141
Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFA----GTCGYIAPELAYTMKITEKCDVYSF 769
           +LLD +    + DFG+AK++ P+   +            + APE     K     DV+SF
Sbjct: 142 VLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSF 200
Query: 770 GVLMWEVI------KGKHPRDFLXXXXXXXLNTDVALDQMLD--PRLPAPSRSAQEKLIS 821
           GV ++E++      +  H +            T + L ++L+   RLP P R   E    
Sbjct: 201 GVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCE---- 256
Query: 822 IMEVAFSCFNESPESRPTMK 841
           I  +  +C+      RPT +
Sbjct: 257 IYHLMKNCWETEASFRPTFQ 276

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     WT   GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +     E          S+ + +   +A  ++YL
Sbjct: 82  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYL 141
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N  +  ++   + DFG+ + +    +++    G       +++P
Sbjct: 142 NANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 196
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 249
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L+ +M +   C+  +P+ RP+ ++IIS
Sbjct: 250 DNCPDMLLELMRM---CWQYNPKMRPSFLEIIS 279

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              +    ++L     ++    VA
Sbjct: 94  GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 153
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CG 748
             + YL        +HRD++++N+L+  +    +ADFG+A+ +           G     
Sbjct: 154 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 210
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
           ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         R
Sbjct: 211 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GHR 263
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 264 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 299

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DF +A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDFYLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W   AGT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LAGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 27/167 (16%)
Query: 689 VAHALSYL-HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
           +A  + YL    C    +HRD++++N+L+       +ADFG+A+    D +N   +  T 
Sbjct: 166 LARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKTT 217
Query: 748 G------YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVAL 800
                  ++APE  +    T + DV+SFGVLMWE+   G  P   +       L  +   
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE--- 274
Query: 801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 R+  P+    E  + + +    C++  P  RPT K + + L
Sbjct: 275 ----GHRMDKPANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 313

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           YG C     + L+ EF++ GSL   L  +     + W  ++ V K +A A+ +L  +   
Sbjct: 78  YGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT-- 133
Query: 703 PIVHRDISSKNLLLDLEYEA--------HVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
            ++H ++ +KN+LL  E +          ++D GI+ ++ P             ++ PE 
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI----LQERIPWVPPEC 188
Query: 755 AYTMK-ITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
               K +    D +SFG  +WE+   G  P   L          D         +LPAP 
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH-------QLPAPK 241
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +    LI+      +C +  P+ RP+ + I + L
Sbjct: 242 AAELANLIN------NCMDYEPDHRPSFRAIIRDL 270

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  + ++ SG  +AVKK    F S++   +T  +   L  +  E   G    
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 175
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + DFG+A+         T +  T  Y APE+    M     
Sbjct: 176 IHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNMT 232
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 233 VDIWSVGCIMAELLTGR 249

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 91/220 (41%), Gaps = 30/220 (13%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILN-------------TDAAAQELGWSQRMNVIKAVA 690
           G C+     +++ E+  +G+L   L              +    ++L     ++    VA
Sbjct: 86  GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVA 145
Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT--CG 748
             + YL        +HRD++++N+L+  +    +ADFG+A+ +           G     
Sbjct: 146 RGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 202
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
           ++APE  +    T + DV+SFGVL+WE+   G  P   +       L  +         R
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-------GHR 255
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  PS    E  + + +    C++  P  RPT K + + L
Sbjct: 256 MDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDL 291

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +   A            S+ + +   +A  ++YL
Sbjct: 95  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 155 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 209
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 262
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 263 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 292

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     WT   GT  Y+A
Sbjct: 139 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWT-LCGTPEYLA 192
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 193 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 24/200 (12%)
Query: 654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L+ E++  GSL   L        +G +Q +   + +   ++YLH   +   +HR+++++N
Sbjct: 95  LVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQHY---IHRNLAARN 147
Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFA----GTCGYIAPELAYTMKITEKCDVYSF 769
           +LLD +    + DFG+AK++ P+   +            + APE     K     DV+SF
Sbjct: 148 VLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSF 206
Query: 770 GVLMWEVI-----KGKHPRDFLXXXXXXXLNTDV-ALDQMLD--PRLPAPSRSAQEKLIS 821
           GV ++E++         P  FL           V  L ++L+   RLP P +   E    
Sbjct: 207 GVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCE---- 262
Query: 822 IMEVAFSCFNESPESRPTMK 841
           +  +  +C+      RPT +
Sbjct: 263 VYHLMKNCWETEASFRPTFE 282

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/213 (21%), Positives = 98/213 (46%), Gaps = 27/213 (12%)
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAHALSYL 696
           G  S  + + ++ E + RG L + L +   A            S+ + +   +A  ++YL
Sbjct: 85  GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 144
Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----CGYIAP 752
           + + F   VHRD++++N ++  ++   + DFG+ + +    +++    G       +++P
Sbjct: 145 NANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVRWMSP 199
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
           E       T   DV+SFGV++WE+         L       L+ +  L  +++  L    
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIAT-------LAEQPYQGLSNEQVLRFVMEGGLLDKP 252
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIIS 844
            +  + L  +M +   C+  +P+ RP+ ++IIS
Sbjct: 253 DNCPDMLFELMRM---CWQYNPKMRPSFLEIIS 282

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 114/268 (42%), Gaps = 46/268 (17%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKF-----HSLLPCDQTVDQKEFLTEVE----AFYGF 645
           IG+G   +VY A ++ + EVVA+KK       S       + +  FL ++       Y  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAA-QELGWSQRMNVIKAVAHA----LSYLH-HD 699
           C    H+  L      GS + +L       QE+        I AV H     L+YLH H+
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-------IAAVTHGALQGLAYLHSHN 174
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM- 758
               ++HRD+ + N+LL       + DFG A  + P +     F GT  ++APE+   M 
Sbjct: 175 ----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMD 226
Query: 759 --KITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPA-PSRSA 815
             +   K DV+S G+   E+ + K P           +N   AL  +     PA  S   
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPP--------LFNMNAMSALYHIAQNESPALQSGHW 278
Query: 816 QEKLISIMEVAFSCFNESPESRPTMKII 843
            E   + ++   SC  + P+ RPT +++
Sbjct: 279 SEYFRNFVD---SCLQKIPQDRPTSEVL 303

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 34/133 (25%), Positives = 67/133 (50%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           F++ E++  G L   +      +E+   +   + + +  A+ Y H      +VHRD+  +
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEM---EARRLFQQILSAVDYCHRHM---VVHRDLKPE 140
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           N+LLD    A +ADFG++ ++  D        G+  Y APE ++  +    + D++S GV
Sbjct: 141 NVLLDAHMNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGV 199
Query: 772 LMWEVIKGKHPRD 784
           +++ ++ G  P D
Sbjct: 200 ILYALLCGTLPFD 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 33/198 (16%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKF---HSLLPCD-------------QTVDQKEFLTE 638
           +G G  A+VY+A +  + ++VA+KK    H     D             Q +     +  
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           ++AF     H  +  L+++F+E   L  I+  ++    L  S     +      L YLH 
Sbjct: 78  LDAF----GHKSNISLVFDFMET-DLEVIIKDNSLV--LTPSHIKAYMLMTLQGLEYLHQ 130
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
                I+HRD+   NLLLD      +ADFG+AKS    +  +     T  Y APEL +  
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGA 187
Query: 759 KITEKCDVYSFGVLMWEV 776
           ++      Y  GV MW V
Sbjct: 188 RM------YGVGVDMWAV 199

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           YG C     + L+ EF++ GSL   L  +     + W  ++ V K +A A+ +L  +   
Sbjct: 78  YGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT-- 133
Query: 703 PIVHRDISSKNLLLDLEYEA--------HVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
            ++H ++ +KN+LL  E +          ++D GI+ ++ P             ++ PE 
Sbjct: 134 -LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI----LQERIPWVPPEC 188
Query: 755 AYTMK-ITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPS 812
               K +    D +SFG  +WE+   G  P   L          D         +LPAP 
Sbjct: 189 IENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRH-------QLPAPK 241
Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +    LI+      +C +  P+ RP+ + I + L
Sbjct: 242 AAELANLIN------NCMDYEPDHRPSFRAIIRDL 270

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 97  LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 140
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 141 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 199 LLYDMVCGDIP 209

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 100 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 143
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 144 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 201
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 202 LLYDMVCGDIP 212

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 97  LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 140
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 141 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 199 LLYDMVCGDIP 209

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 55/300 (18%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEF----LTEVEAFYGF------ 645
           IG G + +VY+  L     VAVK F S       +++K      L E +    F      
Sbjct: 21  IGRGRYGAVYKGSLDE-RPVAVKVF-SFANRQNFINEKNIYRVPLMEHDNIARFIVGDER 78
Query: 646 -CSHARHSFLL-YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC--- 700
             +  R  +LL  E+   GSL   L+   +     W     +  +V   L+YLH +    
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 701 ---FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL---------KPDSSNWTEFAGTCG 748
               P I HRD++S+N+L+  +    ++DFG++  L         + D++  +E  GT  
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE-VGTIR 193
Query: 749 YIAPEL---AYTMKITE----KCDVYSFGVLMWEVIK-------GKHPRDFLXXXXXXXL 794
           Y+APE+   A  ++  E    + D+Y+ G++ WE+         G+   ++         
Sbjct: 194 YMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVG 253
Query: 795 NTDVALDQML-------DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           N     D  +        P+ P   +     + S+ E    C+++  E+R T +   +++
Sbjct: 254 NHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/272 (20%), Positives = 110/272 (40%), Gaps = 46/272 (16%)
Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH- 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF  H 
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 82
Query: 649 ----------ARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
                      + + ++ E +  G L + L +     E           + + +   +A 
Sbjct: 83  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 142
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----C 747
            ++YL+   F   VHR+++++N ++  ++   + DFG+ + +    +++    G      
Sbjct: 143 GMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 197
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
            ++APE       T   D++SFGV++WE+         L       L+ +  L  ++D  
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGG 250
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
                 +  E++  +M +   C+  +P  RPT
Sbjct: 251 YLDQPDNCPERVTDLMRM---CWQFNPNMRPT 279

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 8/102 (7%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---LEYEAHVADFGIAKSLKPDSSNW 740
            +IK V   ++Y+H      IVHRD+  +N+LL+    + +  + DFG++   + ++   
Sbjct: 125 RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KM 180
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            +  GT  YIAPE+       EKCDV+S GV+++ ++ G  P
Sbjct: 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 8/102 (7%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---LEYEAHVADFGIAKSLKPDSSNW 740
            +IK V   ++Y+H      IVHRD+  +N+LL+    + +  + DFG++   + ++   
Sbjct: 125 RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KM 180
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            +  GT  YIAPE+       EKCDV+S GV+++ ++ G  P
Sbjct: 181 KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 69/135 (51%), Gaps = 9/135 (6%)
Query: 651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
           H +L+++ +  G L        A +    +   + I+ +  A+ + H      +VHRD+ 
Sbjct: 95  HHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRDLK 148
Query: 711 SKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
            +NLLL  + +     +ADFG+A  ++ +   W  FAGT GY++PE+       +  D++
Sbjct: 149 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 208
Query: 768 SFGVLMWEVIKGKHP 782
           + GV+++ ++ G  P
Sbjct: 209 ACGVILYILLVGYPP 223

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 63/136 (46%), Gaps = 13/136 (9%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           FL+++ +++G L   L       E    + M  +  V  AL  L+      IVHRD+  +
Sbjct: 100 FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN------IVHRDLKPE 153
Query: 713 NLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK------ITEKCDV 766
           N+LLD +    + DFG +  L P         GT  Y+APE+             ++ D+
Sbjct: 154 NILLDDDMNIKLTDFGFSCQLDP-GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212
Query: 767 YSFGVLMWEVIKGKHP 782
           +S GV+M+ ++ G  P
Sbjct: 213 WSTGVIMYTLLAGSPP 228

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/292 (21%), Positives = 117/292 (40%), Gaps = 39/292 (13%)
Query: 581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCD--QTVDQKEFLTE 638
           ++++     F     +G G   SV  A+L   +   VK    +L  D   + D +EFL E
Sbjct: 16  EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 639 -----------VEAFYGFCSHARHS------FLLYEFLERGSLAAILNTDAAAQE---LG 678
                      V    G    +R         ++  F++ G L A L      +    L 
Sbjct: 76  AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 679 WSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS 738
               +  +  +A  + YL    F   +HRD++++N +L  +    VADFG+++ +     
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 739 NWTEFAGT--CGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLXXXXXXXLN 795
                A      ++A E       T   DV++FGV MWE++ +G+ P   +        N
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-------N 245
Query: 796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            ++    +   RL  P    +E    + ++ + C++  P+ RP+   +  +L
Sbjct: 246 AEIYNYLIGGNRLKQPPECMEE----VYDLMYQCWSADPKQRPSFTCLRMEL 293

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/272 (20%), Positives = 110/272 (40%), Gaps = 46/272 (16%)
Query: 596 IGNGGHASVYRA---ELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH- 648
           +G G    VY     ++  GE    VAVK  +      + +   EFL E     GF  H 
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI---EFLNEASVMKGFTCHH 81
Query: 649 ----------ARHSFLLYEFLERGSLAAILNTDAAAQE-------LGWSQRMNVIKAVAH 691
                      + + ++ E +  G L + L +     E           + + +   +A 
Sbjct: 82  VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 141
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT----C 747
            ++YL+   F   VHR+++++N ++  ++   + DFG+ + +    +++    G      
Sbjct: 142 GMAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 196
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPR 807
            ++APE       T   D++SFGV++WE+         L       L+ +  L  ++D  
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS-------LAEQPYQGLSNEQVLKFVMDGG 249
Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
                 +  E++  +M +   C+  +P  RPT
Sbjct: 250 YLDQPDNCPERVTDLMRM---CWQFNPNMRPT 278

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 132/307 (42%), Gaps = 47/307 (15%)
Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI 224
           +NQL      P  NLT +  + ++ N +    P  +  + +L+ L L  NQ   + P  +
Sbjct: 72  NNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 125
Query: 225 SNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE 284
            NLTNL  L L  N +S  I    G   L+QL  S N  T   P  +     LE   +S 
Sbjct: 126 KNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISS 182
Query: 285 NHFQG-TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           N     ++   L N  SLI      NN   +I+  LGI  NL            E+S N 
Sbjct: 183 NKVSDISVLAKLTNLESLIAT----NNQISDIT-PLGILTNL-----------DELSLNG 226
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
            +   +GTL  S+ N+T                DL+ N I    P  L  L  LT+L L 
Sbjct: 227 NQLKDIGTL-ASLTNLTD--------------LDLANNQISNLAP--LSGLTKLTELKLG 269
Query: 404 GNQITGRLP-KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIP-SCFE 461
            NQI+   P   + +LT LE L+ + + ++ S I N+K+L  L L  NN+S   P S   
Sbjct: 270 ANQISNISPLAGLTALTNLE-LNENQLEDI-SPISNLKNLTYLTLYFNNISDISPVSSLT 327
Query: 462 GMHGLSF 468
            +  L F
Sbjct: 328 KLQRLFF 334

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  +  FG+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILGFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 128/307 (41%), Gaps = 47/307 (15%)
Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI 224
           +NQL      P  NLT +  + ++ N +    P  +  + +L+ L L  NQ   + P  +
Sbjct: 72  NNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 125
Query: 225 SNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE 284
            NLTNL  L L  N +S  I    G   L+QL  S N  T   P  +     LE   +S 
Sbjct: 126 KNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFSSNQVTDLKP--LANLTTLERLDISS 182
Query: 285 NHFQG-TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           N     ++   L N  SLI      NN   +I+  LGI  NL            E+S N 
Sbjct: 183 NKVSDISVLAKLTNLESLIAT----NNQISDIT-PLGILTNL-----------DELSLNG 226
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
            +   +GTL  S+ N+T                DL+ N I    P  L  L  LT+L L 
Sbjct: 227 NQLKDIGTL-ASLTNLTD--------------LDLANNQISNLAP--LSGLTKLTELKLG 269
Query: 404 GNQITGRLPKEIGSLTKLEYLDFSAIG-ELPSQICNMKSLEKLNLSHNNLSGSIP-SCFE 461
            NQI+   P  +  LT L  L+ +    E  S I N+K+L  L L  NN+S   P S   
Sbjct: 270 ANQISNISP--LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLT 327
Query: 462 GMHGLSF 468
            +  L F
Sbjct: 328 KLQRLFF 334

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/248 (22%), Positives = 103/248 (41%), Gaps = 54/248 (21%)
Query: 564 IPQGSLSILNFEGKILYDEIVKATNDFDAKYC----IGNGGHASVYRA-ELPSGEVVAVK 618
           +P+GS+S++  +G     ++ K   +    Y     +G+G + SV  A +  SGE VA+K
Sbjct: 15  VPRGSMSLIRKKG-FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK 73
Query: 619 KFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAA---- 674
           K             + F +E+     F   A    LL + ++  ++  +L+    A    
Sbjct: 74  KL-----------SRPFQSEI-----FAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117
Query: 675 ---------------------QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
                                 E    +   ++  +   L Y+H      +VHRD+   N
Sbjct: 118 NFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGN 174
Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVL 772
           L ++ + E  + DFG+A+      +  T +  T  Y APE+  + M   +  D++S G +
Sbjct: 175 LAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCI 231
Query: 773 MWEVIKGK 780
           M E++ GK
Sbjct: 232 MAEMLTGK 239

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 73/269 (27%), Positives = 118/269 (43%), Gaps = 48/269 (17%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKF-----HSLLPCDQTVDQKEFLTEVE----AFYGF 645
           IG+G   +VY A ++ + EVVA+KK       S       + +  FL ++       Y  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 646 CSHARHS-FLLYEFLERGSLAAILNTDAAA-QELGWSQRMNVIKAVAHA----LSYLH-H 698
           C    H+ +L+ E+   GS + +L       QE+        I AV H     L+YLH H
Sbjct: 83  CYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVE-------IAAVTHGALQGLAYLHSH 134
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +    ++HRD+ + N+LL       + DFG A  + P +     F GT  ++APE+   M
Sbjct: 135 N----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAM 186
Query: 759 ---KITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPA-PSRS 814
              +   K DV+S G+   E+ + K P           +N   AL  +     PA  S  
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP--------LFNMNAMSALYHIAQNESPALQSGH 238
Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKII 843
             E   + ++   SC  + P+ RPT +++
Sbjct: 239 WSEYFRNFVD---SCLQKIPQDRPTSEVL 264

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 129
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 239
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 240 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 270

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + D G+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDRGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    VADFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
             YLH      +++RD+  +NLL+D +    VADFG AK +K     W    GT  Y+AP
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAP 208
Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           E+  +    +  D ++ GVL++E+  G  P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    VADFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    VADFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 15  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 130
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 240
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 241 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 271

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 60/102 (58%), Gaps = 7/102 (6%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSNW 740
           + I+ +  +++Y H +    IVHR++  +NLLL  + +     +ADFG+A  +  DS  W
Sbjct: 109 HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAW 164
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             FAGT GY++PE+      ++  D+++ GV+++ ++ G  P
Sbjct: 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + D G+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDAGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 128
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 238
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 239 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 269

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 89  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 144
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  TE   T  Y+APE+    K  + CD++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTEPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 204 GVIMYILLCGYPP 216

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 12  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHK--DNIGSQYLLNWCVQI 127
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 237
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 238 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 268

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 18  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 133
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 243
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 244 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 274

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 93/307 (30%), Positives = 132/307 (42%), Gaps = 47/307 (15%)
Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI 224
           +NQL      P  NLT +  + ++ N +    P  +  + +L+ L L  NQ   + P  +
Sbjct: 72  NNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 125
Query: 225 SNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE 284
            NLTNL  L L  N +S  I    G   L+QL  S N  T   P  +     LE   +S 
Sbjct: 126 KNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 182
Query: 285 NHFQG-TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           N     ++   L N  SLI      NN   +I+  LGI  NL            E+S N 
Sbjct: 183 NKVSDISVLAKLTNLESLIAT----NNQISDIT-PLGILTNL-----------DELSLNG 226
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
            +   +GTL  S+ N+T                DL+ N I    P  L  L  LT+L L 
Sbjct: 227 NQLKDIGTL-ASLTNLTD--------------LDLANNQISNLAP--LSGLTKLTELKLG 269
Query: 404 GNQITGRLP-KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIP-SCFE 461
            NQI+   P   + +LT LE L+ + + ++ S I N+K+L  L L  NN+S   P S   
Sbjct: 270 ANQISNISPLAGLTALTNLE-LNENQLEDI-SPISNLKNLTYLTLYFNNISDISPVSSLT 327
Query: 462 GMHGLSF 468
            +  L F
Sbjct: 328 KLQRLFF 334

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFH-----SLLPCDQTVDQKEFLTEV 639
           AT+ ++    IG G + +VY+A  P SG  VA+K          LP   TV +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 640 EAF--------YGFCSHARHS-----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVI 686
           EAF           C+ +R        L++E +++  L   L+  A    L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIKDLM 118
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
           +     L +LH +C   IVHRD+  +N+L+       +ADFG+A+ +            T
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMALAPVVVT 174
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK 780
             Y APE+          D++S G +  E+ + K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 12  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 127
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 128 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 185 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 237
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 238 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 268

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 36  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 151
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 152 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 209 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 261
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 262 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 38/220 (17%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFH-----SLLPCDQTVDQKEFLTEV 639
           AT+ ++    IG G + +VY+A  P SG  VA+K          LP   TV +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 640 EAF--------YGFCSHARHS-----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVI 686
           EAF           C+ +R        L++E +++  L   L+  A    L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIKDLM 118
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK------SLKPDSSNW 740
           +     L +LH +C   IVHRD+  +N+L+       +ADFG+A+      +L P     
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP----- 170
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK 780
                T  Y APE+          D++S G +  E+ + K
Sbjct: 171 --VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 129
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 239
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 240 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 270

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 126
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 236
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 237 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 18/197 (9%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFCSH 648
           +G+G + SV  A +  +G  VAVKK    F S++   +T  +   L  +  E   G    
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 649 ARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
              +  L EF    L    + A LN     Q+L       +I  +   L Y+H      I
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADI 146
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEK 763
           +HRD+   NL ++ + E  + D G+A+         T +  T  Y APE+    M   + 
Sbjct: 147 IHRDLKPSNLAVNEDCELKILDGGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E++ G+
Sbjct: 204 VDIWSVGCIMAELLTGR 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 129
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 239
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 240 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 270

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 128
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 238
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 239 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 269

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 144 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 187
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 188 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 246 LLYDMVCGDIP 256

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFH-----SLLPCDQTVDQKEFLTEV 639
           AT+ ++    IG G + +VY+A  P SG  VA+K          LP   TV +   L  +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPI-STVREVALLRRL 60
Query: 640 EAF--------YGFCSHARHS-----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVI 686
           EAF           C+ +R        L++E +++  L   L+  A    L      +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAETIKDLM 118
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
           +     L +LH +C   IVHRD+  +N+L+       +ADFG+A+      + +     T
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-T 174
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK 780
             Y APE+          D++S G +  E+ + K
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 102 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 145
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 146 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 203
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 204 LLYDMVCGDIP 214

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 144 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 187
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 188 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 246 LLYDMVCGDIP 256

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 17  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 132
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 133 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 189
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 242
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 243 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 273

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 130 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 173
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 174 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 232 LLYDMVCGDIP 242

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 32/227 (14%)
Query: 580 YDEIVKA-------TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQ 632
           Y++IVK          D+D    IG G    V      + + V   K  S     +  D 
Sbjct: 60  YEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS 119
Query: 633 KEFLTE--VEAFYG-------FCSHA--RHSFLLYEFLERGSLAAIL-NTDAAAQELGWS 680
             F  E  + AF         FC+    ++ +++ E++  G L  ++ N D   +   W+
Sbjct: 120 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK---WA 176
Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           +       V  AL  +H      ++HRD+   N+LLD      +ADFG    +       
Sbjct: 177 KFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVH 231
Query: 741 TEFA-GTCGYIAPELAYTM----KITEKCDVYSFGVLMWEVIKGKHP 782
            + A GT  YI+PE+  +         +CD +S GV ++E++ G  P
Sbjct: 232 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 278

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHK--DNIGSQYLLNWCVQI 126
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 236
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 237 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 130 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 173
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 174 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 232 LLYDMVCGDIP 242

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 590 FDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHA 649
           F+ +  +G G  + VYR +         +K ++L    +TVD+K   TE+       SH 
Sbjct: 55  FEVESELGRGATSIVYRCKQK-----GTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHP 108
Query: 650 RHSFL--LYEFLERGSLAAILNT-----DAAAQELGWSQR--MNVIKAVAHALSYLHHDC 700
               L  ++E     SL   L T     D   ++  +S+R   + +K +  A++YLH + 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 701 FPPIVHRDISSKNLLLDL---EYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
              IVHRD+  +NLL      +    +ADFG++K ++      T   GT GY APE+   
Sbjct: 169 ---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPGYCAPEILRG 224
Query: 758 MKITEKCDVYSFGVLMWEVIKGKHP 782
                + D++S G++ + ++ G  P
Sbjct: 225 CAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 130 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 173
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 174 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 232 LLYDMVCGDIP 242

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 129 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 172
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 173 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 231 LLYDMVCGDIP 241

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 149 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 192
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 193 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 250
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 251 LLYDMVCGDIP 261

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 8   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 123
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 124 AEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 181 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 233
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 234 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 264

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 126
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 236
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 237 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 124 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 167
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 168 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 225
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 226 LLYDMVCGDIP 236

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 144 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 187
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 188 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 245
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 246 LLYDMVCGDIP 256

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 129 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 172
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 173 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 231 LLYDMVCGDIP 241

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 129 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 172
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 173 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 231 LLYDMVCGDIP 241

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 130 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 173
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 174 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 231
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 232 LLYDMVCGDIP 242

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 129 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 172
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 173 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 230
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 231 LLYDMVCGDIP 241

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 136 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 179
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 180 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 238 LLYDMVCGDIP 248

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 101 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 144
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 145 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 202
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 203 LLYDMVCGDIP 213

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 117 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 160
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 161 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 218
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 219 LLYDMVCGDIP 229

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 102 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 145
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 146 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 203
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 204 LLYDMVCGDIP 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 45  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 160
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 161 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 218 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 270
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 271 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 301

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/91 (30%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-- 746
           VA  + +L    F   VHRD++++N+L+       + DFG+A+ +  DS+          
Sbjct: 181 VAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
             ++APE  +    T K DV+S+G+L+WE+ 
Sbjct: 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 116 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 159
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 160 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 217
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 218 LLYDMVCGDIP 228

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 102 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 145
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 146 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 203
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 204 LLYDMVCGDIP 214

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 116 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 159
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 160 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 217
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 218 LLYDMVCGDIP 228

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 101 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 144
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 145 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 202
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 203 LLYDMVCGDIP 213

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 117 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 160
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 161 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 218
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 219 LLYDMVCGDIP 229

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LXGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/131 (32%), Positives = 68/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+C   ++HRDI  +N
Sbjct: 117 LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HNC--GVLHRDIKDEN 160
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 161 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 218
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 219 LLYDMVCGDIP 229

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 174 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 227
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 228 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 596 IGNGGHASV---YRAELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFC 646
           +G+G + SV   Y A L   + VAVKK    F SL+   +T  +   L  +  E   G  
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 647 SHARHSFLLYEFLE----RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
                +  + +F E       + A LN    +Q L       ++  +   L Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG-- 151
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKIT 761
            I+HRD+   N+ ++ + E  + DFG+A+    +    T +  T  Y APE+    M   
Sbjct: 152 -IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMHYN 207
Query: 762 EKCDVYSFGVLMWEVIKGK 780
           +  D++S G +M E+++GK
Sbjct: 208 QTVDIWSVGCIMAELLQGK 226

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 3/79 (3%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+APE+  +    + 
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKA 239
Query: 764 CDVYSFGVLMWEVIKGKHP 782
            D ++ GVL++E+  G  P
Sbjct: 240 VDWWALGVLIYEMAAGYPP 258

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 148 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 201
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 202 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3VQ1|A Chain A, Crystal Structure Of Mouse Tlr4MD-2LIPID IVA COMPLEX Length = 606

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 313 GNISEALGIYPNLTF--IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS 370
           G+++  + + PN+T+  +D   +    +I S+         +++S N +         N 
Sbjct: 2   GSLNPCIEVVPNITYQCMDQKLSKVPDDIPSS------TKNIDLSFNPLKILKSYSFSNF 55
Query: 371 SQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL-----D 425
           S+LQ  DLS   I     K    L+ L+ LIL GN I    P     LT LE L      
Sbjct: 56  SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 426 FSAIGELPSQICNMKSLEKLNLSHNNL-SGSIPSCFEGMHGLSFIDMSYNELQCPVPNST 484
            +++   P  I  + +L+KLN++HN + S  +P+ F  +  L  +D+SYN +Q    N  
Sbjct: 116 LASLESFP--IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDL 173
Query: 485 TF 486
            F
Sbjct: 174 QF 175

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 126
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 236
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 237 RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 267

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 146 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 199
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 146 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 199
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 200 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 138 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 242

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 50/266 (18%)
Query: 549 RKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAE 608
           RK+ S  G +   ++I     +I NFE  +         N   ++  +G G   +V    
Sbjct: 6   RKRGSRGGKKGRKSRIA----NIPNFEQSL--------KNLVVSEKILGYGSSGTVVFQG 53
Query: 609 LPSGEVVAVKKFHSLLP-CDQTVDQKEFLTEVE----AFYGFCSHARHSFLLYEFLERGS 663
              G  VAVK+   L+  CD  + + + LTE +        +CS     FL Y  LE  +
Sbjct: 54  SFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL-YIALELCN 110
Query: 664 L---AAILNTDAAAQELGWSQRMN---VIKAVAHALSYLHHDCFPPIVHRDISSKNLLL- 716
           L     + + + + + L   +  N   +++ +A  +++LH      I+HRD+  +N+L+ 
Sbjct: 111 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVS 167
Query: 717 -------DLEYEAH-----VADFGIAKSLKPDS----SNWTEFAGTCGYIAPEL---AYT 757
                  D +  A      ++DFG+ K L         N    +GT G+ APEL   +  
Sbjct: 168 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTK 227
Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHP 782
            ++T   D++S G + + ++ KGKHP
Sbjct: 228 RRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 139 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 243

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 130 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 234

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 141 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 245

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF--------- 645
           +G G +  V +     +G +VA+KKF  L   D  + +K  + E++              
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 646 --CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFP 702
             C   +  +L++EF++   L    + +     L +      +  + + + + H H+   
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILD---DLELFPNGLDYQVVQKYLFQIINGIGFCHSHN--- 144
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-TMKIT 761
            I+HRDI  +N+L+       + DFG A++L      + +   T  Y APEL    +K  
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 762 EKCDVYSFGVLMWEVIKGK 780
           +  DV++ G L+ E+  G+
Sbjct: 204 KAVDVWAIGCLVTEMFMGE 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG+AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 14  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 129
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 130 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 187 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 239
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 240 RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 270

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 131 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 131 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 5   ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 120
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 230
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 231 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 261

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 133 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 237

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  
Sbjct: 135 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 140 TFEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 193
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 194 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/226 (19%), Positives = 94/226 (41%), Gaps = 42/226 (18%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF- 645
            DF+   C+G GG   V+ A+    +   A+K+    LP ++ + +++ + EV+A     
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR--LP-NRELAREKVMREVKALAKLE 61
Query: 646 ----------------------CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRM 683
                                  S   + ++  +   + +L   +N     +E   S  +
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF 743
           ++   +A A+ +LH      ++HRD+   N+   ++    V DFG+  ++  D    T  
Sbjct: 122 HIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 744 ------------AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
                        GT  Y++PE  +    + K D++S G++++E++
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 118/266 (44%), Gaps = 50/266 (18%)
Query: 549 RKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAE 608
           RK+ S  G +   ++I     +I NFE  +         N   ++  +G G   +V    
Sbjct: 6   RKRGSRGGKKGRKSRIA----NIPNFEQSL--------KNLVVSEKILGYGSSGTVVFQG 53
Query: 609 LPSGEVVAVKKFHSLLP-CDQTVDQKEFLTEVE----AFYGFCSHARHSFLLYEFLERGS 663
              G  VAVK+   L+  CD  + + + LTE +        +CS     FL Y  LE  +
Sbjct: 54  SFQGRPVAVKRM--LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFL-YIALELCN 110
Query: 664 L---AAILNTDAAAQELGWSQRMN---VIKAVAHALSYLHHDCFPPIVHRDISSKNLLL- 716
           L     + + + + + L   +  N   +++ +A  +++LH      I+HRD+  +N+L+ 
Sbjct: 111 LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVS 167
Query: 717 -------DLEYEAH-----VADFGIAKSLKPDS----SNWTEFAGTCGYIAPEL---AYT 757
                  D +  A      ++DFG+ K L         N    +GT G+ APEL   +  
Sbjct: 168 TSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTK 227
Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHP 782
            ++T   D++S G + + ++ KGKHP
Sbjct: 228 RRLTRSIDIFSMGCVFYYILSKGKHP 253

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 89/203 (43%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 81
Query: 655 LYEFLERGSLAAI-LNTDAAAQEL--------GWSQRMNVIKA------VAHALSYLHHD 699
            Y   E+  +  + L  D   + +           Q + VI        +  +L+Y+H  
Sbjct: 82  FYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELIFGA 197
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 110/275 (40%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 21  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 136
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +    G    
Sbjct: 137 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 194 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 246
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 247 RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 277

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 109/275 (39%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 128
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 238
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 239 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 269

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 42/226 (18%)
Query: 593 KYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV---EAFYG---- 644
           +  +  GG A VY A+ + SG   A+K+  S    ++    +  + EV   +   G    
Sbjct: 33  RRVLAEGGFAFVYEAQDVGSGREYALKRLLS----NEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 645 --FCSHA----------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
             FCS A          +  FLL   L +G L   L    +   L     + +      A
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK--PDSSNWTEFA------ 744
           + ++H    PPI+HRD+  +NLLL  +    + DFG A ++   PD S W+         
Sbjct: 149 VQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS-WSAQRRALVEE 206
Query: 745 -----GTCGYIAPE---LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                 T  Y  PE   L     I EK D+++ G +++ +   +HP
Sbjct: 207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG+AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           +N    +A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +  
Sbjct: 127 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 743 FAGTC--GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVA 799
             G     ++A E       T + DV+S+GV +WE++  G  P D +       +     
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----- 238
Query: 800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           L++    RLP P        I +  +   C+    +SRP  +
Sbjct: 239 LEK--GERLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 274

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 22/199 (11%)
Query: 596 IGNGGHASV---YRAELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFC 646
           +G+G + SV   Y A L   + VAVKK    F SL+   +T  +   L  +  E   G  
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 647 SHARHSFLLYEFLE----RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
                +  + +F E       + A LN     Q L       ++  +   L Y+H     
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS---A 150
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKIT 761
            I+HRD+   N+ ++ + E  + DFG+A+    +    T +  T  Y APE+    M   
Sbjct: 151 GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMHYN 207
Query: 762 EKCDVYSFGVLMWEVIKGK 780
           +  D++S G +M E+++GK
Sbjct: 208 QTVDIWSVGCIMAELLQGK 226

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 21/212 (9%)
Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-VEAFYGFC 646
            +F+    +G G +  V+     SG     K +   +    T+ QK   TE         
Sbjct: 54  ENFELLKVLGTGAYGKVFLVRKISGHDTG-KLYAMKVLKKATIVQKAKTTEHTRTERQVL 112
Query: 647 SHARHS-FLL---YEFLERGSLAAILN--------TDAAAQELGWSQRMNV-IKAVAHAL 693
            H R S FL+   Y F     L  IL+        T  + +E      + + +  +  AL
Sbjct: 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT-EFAGTCGYIAP 752
            +LH      I++RDI  +N+LLD      + DFG++K    D +    +F GT  Y+AP
Sbjct: 173 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 753 ELAY--TMKITEKCDVYSFGVLMWEVIKGKHP 782
           ++         +  D +S GVLM+E++ G  P
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 69/135 (51%), Gaps = 9/135 (6%)
Query: 651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
           H +L+++ +  G L        A +    +   + I+ +  A+ + H      +VHR++ 
Sbjct: 84  HHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLK 137
Query: 711 SKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
            +NLLL  + +     +ADFG+A  ++ +   W  FAGT GY++PE+       +  D++
Sbjct: 138 PENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLW 197
Query: 768 SFGVLMWEVIKGKHP 782
           + GV+++ ++ G  P
Sbjct: 198 ACGVILYILLVGYPP 212

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 81
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +  
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGA 197
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           +N    +A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +  
Sbjct: 127 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 743 FAGTC--GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVA 799
             G     ++A E       T + DV+S+GV +WE++  G  P D +       +     
Sbjct: 184 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----- 238
Query: 800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           L++    RLP P        I +  +   C+    +SRP  +
Sbjct: 239 LEK--GERLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 274

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIIISKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 55/291 (18%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-- 640
           VKA +D +    +G G +  V +   +PSG++ AVK+  + +    + +QK  L +++  
Sbjct: 31  VKA-DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATV---NSQEQKRLLXDLDIS 86
Query: 641 ----------AFYGFCSHARHSFLLYEF----LERGSLAAILNTDAAAQELGWSQRMNVI 686
                      FYG        ++  E     L++     I       +++     ++++
Sbjct: 87  XRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 146
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
           KA+ H  S L       ++HRD+   N+L++   +    DFGI+  L  D +   + AG 
Sbjct: 147 KALEHLHSKLS------VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID-AGC 199
Query: 747 CGYIAPEL--------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDV 798
             Y APE          Y++    K D++S G+   E+   + P D              
Sbjct: 200 KPYXAPERINPELNQKGYSV----KSDIWSLGITXIELAILRFPYDSWGTPFQ------- 248
Query: 799 ALDQMLD---PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ 846
            L Q+++   P+LPA   SA+      ++    C  ++ + RPT   + Q 
Sbjct: 249 QLKQVVEEPSPQLPADKFSAE-----FVDFTSQCLKKNSKERPTYPELXQH 294

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 40/222 (18%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----AFYGFCSHARH 651
           +G G   +V       G  VAVK+   +  CD  + + + LTE +        +CS    
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81
Query: 652 SFLLYEFLERGSL---AAILNTDAAAQELGWSQRMN---VIKAVAHALSYLHHDCFPPIV 705
            FL Y  LE  +L     + + + + + L   +  N   +++ +A  +++LH      I+
Sbjct: 82  RFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKII 137
Query: 706 HRDISSKNLLL--------DLEYEAH-----VADFGIAKSLKPDSS----NWTEFAGTCG 748
           HRD+  +N+L+        D +  A      ++DFG+ K L    S    N    +GT G
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 749 YIAPE-------LAYTMKITEKCDVYSFGVLMWEVI-KGKHP 782
           + APE       L    ++T   D++S G + + ++ KGKHP
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|2Z64|A Chain A, Crystal Structure Of Mouse Tlr4 And Mouse Md-2 Complex Length = 599

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 60/125 (48%), Gaps = 8/125 (6%)
Query: 368 GNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL--- 424
            N S+LQ  DLS   I     K    L+ L+ LIL GN I    P     LT LE L   
Sbjct: 48  SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 107
Query: 425 --DFSAIGELPSQICNMKSLEKLNLSHNNL-SGSIPSCFEGMHGLSFIDMSYNELQCPVP 481
               +++   P  I  + +L+KLN++HN + S  +P+ F  +  L  +D+SYN +Q    
Sbjct: 108 ETKLASLESFP--IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITV 165
Query: 482 NSTTF 486
           N   F
Sbjct: 166 NDLQF 170

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 105 LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 160
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 219
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 220 GVIMYILLCGYPP 232

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 97  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 152
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 211
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 212 GVIMYILLCGYPP 224

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 22/199 (11%)
Query: 596 IGNGGHASV---YRAELPSGEVVAVKK----FHSLLPCDQTVDQKEFLTEV--EAFYGFC 646
           +G+G + SV   Y A L   + VAVKK    F SL+   +T  +   L  +  E   G  
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 647 SHARHSFLLYEFLE----RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
                +  + +F E       + A LN     Q L       ++  +   L Y+H     
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS---A 142
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKIT 761
            I+HRD+   N+ ++ + E  + DFG+A+    +    T +  T  Y APE+    M   
Sbjct: 143 GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEM---TGYVATRWYRAPEIMLNWMHYN 199
Query: 762 EKCDVYSFGVLMWEVIKGK 780
           +  D++S G +M E+++GK
Sbjct: 200 QTVDIWSVGCIMAELLQGK 218

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 18  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 133
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G    
Sbjct: 134 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 190
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 191 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 243
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 244 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 274

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 41  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 94
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 95  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 154
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +  
Sbjct: 155 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGA 210
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 81
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELIFGA 197
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 29  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 82
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 83  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 142
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 143 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELIFGA 198
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 32  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 85
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 86  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 145
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 146 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 201
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 17/162 (10%)
Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           +N    +A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +  
Sbjct: 120 LNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 743 FAGTC--GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVA 799
             G     ++A E       T + DV+S+GV +WE++  G  P D +       +     
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----- 231
Query: 800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           L++    RLP P        I +  +   C+    +SRP  +
Sbjct: 232 LEK--GERLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 135 LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 250 GVIMYILLCGYPP 262

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 109/275 (39%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 15  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 130
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G    
Sbjct: 131 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 188 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 240
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 241 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 271

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 81
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 82  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELIFGA 197
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++++  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 93
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 154 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 209
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 95  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 150
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 209
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 210 GVIMYILLCGYPP 222

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 96  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 151
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 210
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 211 GVIMYILLCGYPP 223

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 90  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 145
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 204
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 205 GVIMYILLCGYPP 217

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S GV+M E+IKG
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 11  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 126
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G    
Sbjct: 127 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 236
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 237 RLPQPPICT----IDVYMIMVKCWMIDADSRPKFR 267

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 141 LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 196
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 255
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 256 GVIMYILLCGYPP 268

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 47  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 100
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 101 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 160
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 161 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 216
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 96/232 (41%), Gaps = 29/232 (12%)
Query: 565 PQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLL 624
           P   + +L  +GK      +  TN       IGNG    V++A+L   + VA+KK     
Sbjct: 21  PNKVIKVLASDGKTGEQREIAYTN----CKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-- 74
Query: 625 PCDQTVDQKEF----------LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAA 674
             D+    +E           + +++AF+      +    L   LE      +       
Sbjct: 75  --DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHY 131
Query: 675 QELGWSQRMNVIK----AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA-HVADFGI 729
            +L  +  M +IK     +  +L+Y+H      I HRDI  +NLLLD       + DFG 
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS 188
Query: 730 AKSLKPDSSNWTEFAGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVIKGK 780
           AK L     N +       Y APEL +     T   D++S G +M E+++G+
Sbjct: 189 AKILIAGEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL--DLEYEAHVADFGIAKSLKP----DS 737
           N+++ +  AL YLH+     I HRDI  +N L   +  +E  + DFG++K        + 
Sbjct: 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEY 228
Query: 738 SNWTEFAGTCGYIAPELAYTMKIT--EKCDVYSFGVLMWEVIKGKHP 782
              T  AGT  ++APE+  T   +   KCD +S GVL+  ++ G  P
Sbjct: 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NL++D +    V DFG AK +K     W    GT  Y+A
Sbjct: 154 TFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK--GRTWX-LCGTPEYLA 207
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 131/307 (42%), Gaps = 48/307 (15%)
Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI 224
           +NQL      P  NLT +  + ++ N +    P  +  + +L+ L L  NQ   + P  +
Sbjct: 72  NNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 125
Query: 225 SNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE 284
            NLTNL  L L  N +S     +L  L   Q L  GN  T   P  +     LE   +S 
Sbjct: 126 KNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFGNQVTDLKP--LANLTTLERLDISS 181
Query: 285 NHFQG-TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           N     ++   L N  SLI      NN   +I+  LGI  NL            E+S N 
Sbjct: 182 NKVSDISVLAKLTNLESLIAT----NNQISDIT-PLGILTNL-----------DELSLNG 225
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
            +   +GTL  S+ N+T                DL+ N I    P  L  L  LT+L L 
Sbjct: 226 NQLKDIGTL-ASLTNLTD--------------LDLANNQISNLAP--LSGLTKLTELKLG 268
Query: 404 GNQITGRLP-KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIP-SCFE 461
            NQI+   P   + +LT LE L+ + + ++ S I N+K+L  L L  NN+S   P S   
Sbjct: 269 ANQISNISPLAGLTALTNLE-LNENQLEDI-SPISNLKNLTYLTLYFNNISDISPVSSLT 326
Query: 462 GMHGLSF 468
            +  L F
Sbjct: 327 KLQRLFF 333

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 33  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 86
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 87  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 146
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +  
Sbjct: 147 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGA 202
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 203 TDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/76 (35%), Positives = 43/76 (56%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S GV+M E+IKG
Sbjct: 206 VDIWSVGVIMGEMIKG 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 19/196 (9%)
Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IG G +  V++     +G++VA+KKF  L   D  V +K  L E+        H     L
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDPVIKKIALREIRMLKQL-KHPNLVNL 67
Query: 655 LYEFLERGSLAAILN--TDAAAQELGWSQR---MNVIKAVA----HALSYLH-HDCFPPI 704
           L  F  +  L  +          EL   QR    +++K++      A+++ H H+C    
Sbjct: 68  LEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC---- 123
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-TMKITEK 763
           +HRD+  +N+L+       + DFG A+ L   S  + +   T  Y +PEL     +    
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP 183
Query: 764 CDVYSFGVLMWEVIKG 779
            DV++ G +  E++ G
Sbjct: 184 VDVWAIGCVFAELLSG 199

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 89  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPE 144
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 204 GVIMYILLCGYPP 216

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 131/307 (42%), Gaps = 48/307 (15%)
Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI 224
           +NQL      P  NLT +  + ++ N +    P  +  + +L+ L L  NQ   + P  +
Sbjct: 77  NNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 130
Query: 225 SNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE 284
            NLTNL  L L  N +S     +L  L   Q L  GN  T   P  +     LE   +S 
Sbjct: 131 KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKP--LANLTTLERLDISS 186
Query: 285 NHFQG-TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           N     ++   L N  SLI      NN   +I+  LGI  NL            E+S N 
Sbjct: 187 NKVSDISVLAKLTNLESLIAT----NNQISDIT-PLGILTNL-----------DELSLNG 230
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
            +   +GTL  S+ N+T                DL+ N I    P  L  L  LT+L L 
Sbjct: 231 NQLKDIGTL-ASLTNLTD--------------LDLANNQISNLAP--LSGLTKLTELKLG 273
Query: 404 GNQITGRLP-KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIP-SCFE 461
            NQI+   P   + +LT LE L+ + + ++ S I N+K+L  L L  NN+S   P S   
Sbjct: 274 ANQISNISPLAGLTALTNLE-LNENQLEDI-SPISNLKNLTYLTLYFNNISDISPVSSLT 331
Query: 462 GMHGLSF 468
            +  L F
Sbjct: 332 KLQRLFF 338

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 107 IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 160
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 161 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 220
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +  
Sbjct: 221 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGA 276
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 277 TDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 36  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 89
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 90  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 149
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 150 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 205
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 206 TDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 63/275 (22%), Positives = 109/275 (39%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    ++ + +  G L   +        +G    +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 128
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 238
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 239 RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 269

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 91  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 206 GVIMYILLCGYPP 218

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 40  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 93
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 94  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 153
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 154 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 209
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH      I HRD+  +
Sbjct: 91  LIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD++S 
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 770 GVLMWEVIKGKHP 782
           GV+M+ ++ G  P
Sbjct: 206 GVIMYILLCGYPP 218

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE 638
           +D      ++++    IGNG +  V  A    +G+ VA+KK  +    D   + K  L E
Sbjct: 47  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRE 104
Query: 639 VEAFYGFCSHARHSFLLY------------EFLERGSLAAILNTD-----AAAQELGWSQ 681
           ++       H +H  ++             EF     +  ++ +D      ++Q L    
Sbjct: 105 LK----ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 160
Query: 682 RMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSN 739
               +  +   L Y+H      ++HRD+   NLL++   E  + DFG+A+ L   P    
Sbjct: 161 VRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 217
Query: 740 W--TEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKH 781
           +  TE+  T  Y APEL  ++ + T+  D++S G +  E++  + 
Sbjct: 218 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 131/307 (42%), Gaps = 48/307 (15%)
Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI 224
           +NQL      P  NLT +  + ++ N +    P  +  + +L+ L L  NQ   + P  +
Sbjct: 76  NNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 129
Query: 225 SNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE 284
            NLTNL  L L  N +S     +L  L   Q L  GN  T   P  +     LE   +S 
Sbjct: 130 KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTDLKP--LANLTTLERLDISS 185
Query: 285 NHFQG-TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           N     ++   L N  SLI      NN   +I+  LGI  NL            E+S N 
Sbjct: 186 NKVSDISVLAKLTNLESLIAT----NNQISDIT-PLGILTNL-----------DELSLNG 229
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
            +   +GTL  S+ N+T                DL+ N I    P  L  L  LT+L L 
Sbjct: 230 NQLKDIGTL-ASLTNLTD--------------LDLANNQISNLAP--LSGLTKLTELKLG 272
Query: 404 GNQITGRLP-KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIP-SCFE 461
            NQI+   P   + +LT LE L+ + + ++ S I N+K+L  L L  NN+S   P S   
Sbjct: 273 ANQISNISPLAGLTALTNLE-LNENQLEDI-SPISNLKNLTYLTLYFNNISDISPVSSLT 330
Query: 462 GMHGLSF 468
            +  L F
Sbjct: 331 KLQRLFF 337

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 92/307 (29%), Positives = 131/307 (42%), Gaps = 48/307 (15%)
Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI 224
           +NQL      P  NLT +  + ++ N +    P  +  + +L+ L L  NQ   + P  +
Sbjct: 72  NNQLTDI--TPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--L 125
Query: 225 SNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE 284
            NLTNL  L L  N +S     +L  L   Q L  GN  T   P  +     LE   +S 
Sbjct: 126 KNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFGNQVTDLKP--LANLTTLERLDISS 181
Query: 285 NHFQG-TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           N     ++   L N  SLI      NN   +I+  LGI  NL            E+S N 
Sbjct: 182 NKVSDISVLAKLTNLESLIAT----NNQISDIT-PLGILTNL-----------DELSLNG 225
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
            +   +GTL  S+ N+T                DL+ N I    P  L  L  LT+L L 
Sbjct: 226 NQLKDIGTL-ASLTNLTD--------------LDLANNQISNLAP--LSGLTKLTELKLG 268
Query: 404 GNQITGRLP-KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIP-SCFE 461
            NQI+   P   + +LT LE L+ + + ++ S I N+K+L  L L  NN+S   P S   
Sbjct: 269 ANQISNISPLAGLTALTNLE-LNENQLEDI-SPISNLKNLTYLTLYFNNISDISPVSSLT 326
Query: 462 GMHGLSF 468
            +  L F
Sbjct: 327 KLQRLFF 333

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 64  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 117
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 118 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 177
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +  
Sbjct: 178 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGA 233
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 234 TDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 66  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 119
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 120 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 179
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +  
Sbjct: 180 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGA 235
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 236 TDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 115
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +  
Sbjct: 176 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGA 231
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 56  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 109
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 110 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 169
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +  
Sbjct: 170 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGA 225
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 226 TDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           IGNG    VY+A+L  SGE+VA+KK       D+    +E   ++      C+  R  + 
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNREL--QIMRKLDHCNIVRLRYF 115
Query: 655 LY---------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
            Y               +++         +   A Q L        +  +  +L+Y+H  
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 175
Query: 700 CFPPIVHRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-T 757
               I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +  
Sbjct: 176 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGA 231
Query: 758 MKITEKCDVYSFGVLMWEVIKGK 780
              T   DV+S G ++ E++ G+
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLL---LDLEYEAHVADFGIAKSLKPDSSNW 740
            +I  V  A+ YLH      IVHRD+  +NLL   LD + +  ++DFG++K   P S   
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T   GT GY+APE+      ++  D +S GV+ + ++ G  P
Sbjct: 177 TA-CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/225 (23%), Positives = 97/225 (43%), Gaps = 32/225 (14%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE 638
           +D      ++++    IGNG +  V  A    +G+ VA+KK  +    D   + K  L E
Sbjct: 46  FDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRE 103
Query: 639 VEAFYGFCSHARHSFLLY------------EFLERGSLAAILNTD-----AAAQELGWSQ 681
           ++       H +H  ++             EF     +  ++ +D      ++Q L    
Sbjct: 104 LK----ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEH 159
Query: 682 RMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL--KPDSSN 739
               +  +   L Y+H      ++HRD+   NLL++   E  + DFG+A+ L   P    
Sbjct: 160 VRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQ 216
Query: 740 W--TEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKH 781
           +  TE+  T  Y APEL  ++ + T+  D++S G +  E++  + 
Sbjct: 217 YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 109/275 (39%), Gaps = 34/275 (12%)
Query: 583 IVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTE-- 638
           I+K T +F     +G+G   +VY+   +P GE V +      L         KE L E  
Sbjct: 13  ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 639 ---------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                    V    G C  +    L+ + +  G L   +        +G    +N    +
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQI 128
Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC-- 747
           A  ++YL       +VHRD++++N+L+       + DFG AK L  +   +    G    
Sbjct: 129 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQMLDP 806
            ++A E       T + DV+S+GV +WE++  G  P D +       +     L++    
Sbjct: 186 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-----LEK--GE 238
Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           RLP P        I +  +   C+    +SRP  +
Sbjct: 239 RLPQPPICT----IDVYMIMRKCWMIDADSRPKFR 269

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLL---LDLEYEAHVADFGIAKSLKPDSSNW 740
            +I  V  A+ YLH      IVHRD+  +NLL   LD + +  ++DFG++K   P S   
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T   GT GY+APE+      ++  D +S GV+ + ++ G  P
Sbjct: 177 TA-CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 65/139 (46%), Gaps = 14/139 (10%)
Query: 650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN--VIKAVAHALSYLHHDCFPPIVHR 707
           ++ +++ E ++ G L      D   ++  +S+R    V+  +   + YLH      +VHR
Sbjct: 89  KYVYVVTELMKGGEL-----LDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHR 140
Query: 708 DISSKNLLLDLE----YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           D+   N+L   E        + DFG AK L+ ++        T  ++APE+         
Sbjct: 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAA 200
Query: 764 CDVYSFGVLMWEVIKGKHP 782
           CD++S GVL++ ++ G  P
Sbjct: 201 CDIWSLGVLLYTMLTGYTP 219

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/209 (21%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 589 DFDAKYCIGNGGHASVYRA------------------ELPSGEVVAVKKFH--SLLPCDQ 628
           DF     IG+GG   V++A                  E    EV A+ K    +++  + 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNG 71
Query: 629 TVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
             D  ++  E  +     S  +  F+  EF ++G+L   +      ++L     + + + 
Sbjct: 72  CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKVLALELFEQ 130
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           +   + Y+H      +++RD+   N+ L    +  + DFG+  SLK D        GT  
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-XRSKGTLR 186
Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVI 777
           Y++PE   +    ++ D+Y+ G+++ E++
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 31/215 (14%)
Query: 588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHS----------LLPCDQTVDQKEFL 636
           ND +    +G+G    V++     +G V+AVK+             L+  D  +   +  
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 637 TEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAA----QELGWSQRMNVIKAVAHA 692
             V+ F  F ++    F+  E +  G+ A  L          + LG   +M V  A+  A
Sbjct: 85  YIVQCFGTFITNT-DVFIAMELM--GTCAEKLKKRMQGPIPERILG---KMTV--AIVKA 136
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L YL       ++HRD+   N+LLD   +  + DFGI+  L  D +     AG   Y+AP
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAP 193
Query: 753 ELAYTMKITE-----KCDVYSFGVLMWEVIKGKHP 782
           E       T+     + DV+S G+ + E+  G+ P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 83/192 (43%), Gaps = 30/192 (15%)
Query: 658 FLER---GSLAAILNTDAA-----AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDI 709
           F+E+   GSL+A+L +         Q +G+       K +   L YLH +    IVHRDI
Sbjct: 97  FMEQVPGGSLSALLRSKWGPLKDNEQTIGF-----YTKQILEGLKYLHDN---QIVHRDI 148
Query: 710 SSKNLLLDLEYEA--HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT--MKITEKCD 765
              N+L++  Y     ++DFG +K L   +     F GT  Y+APE+         +  D
Sbjct: 149 KGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 766 VYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEV 825
           ++S G  + E+  GK P  F            V + + + P +P  S SA+ K       
Sbjct: 208 IWSLGCTIIEMATGKPP--FYELGEPQAAMFKVGMFK-VHPEIPE-SMSAEAKAF----- 258
Query: 826 AFSCFNESPESR 837
              CF   P+ R
Sbjct: 259 ILKCFEPDPDKR 270

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 84/192 (43%), Gaps = 30/192 (15%)
Query: 658 FLER---GSLAAILNTDAA-----AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDI 709
           F+E+   GSL+A+L +         Q +G+       K +   L YLH +    IVHRDI
Sbjct: 83  FMEQVPGGSLSALLRSKWGPLKDNEQTIGF-----YTKQILEGLKYLHDN---QIVHRDI 134
Query: 710 SSKNLLLDLEYEA--HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT--MKITEKCD 765
              N+L++  Y     ++DFG +K L   +     F GT  Y+APE+         +  D
Sbjct: 135 KGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 193
Query: 766 VYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIMEV 825
           ++S G  + E+  GK P  F            V + + + P +P  S SA+ K   +   
Sbjct: 194 IWSLGCTIIEMATGKPP--FYELGEPQAAMFKVGMFK-VHPEIPE-SMSAEAKAFIL--- 246
Query: 826 AFSCFNESPESR 837
              CF   P+ R
Sbjct: 247 --KCFEPDPDKR 256

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 85/216 (39%), Gaps = 29/216 (13%)
Query: 581 DEIVKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFH-------SLLPCDQTVDQ 632
           +E+  AT+       +G G    V+R E   +G   AVKK          L+ C      
Sbjct: 90  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSP 145
Query: 633 KEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
           +     +   YG         +  E LE GSL  ++       E    + +  +      
Sbjct: 146 R-----IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQALEG 197
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWT-----EFAGT 746
           L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +        GT
Sbjct: 198 LEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGT 254
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             ++APE+        K DV+S   +M  ++ G HP
Sbjct: 255 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 16/197 (8%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKF-------HSLLPCDQTVDQKEFLTEVEAFYGFCS 647
           IGNG    VY+A+L  SGE+VA+KK        +  L   + +D    +     FY    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 648 HARHSFL--LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
                +L  + +++         +   A Q L        +  +  +L+Y+H      I 
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---IC 144
Query: 706 HRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-TMKITEK 763
           HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +     T  
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGATDYTSS 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            DV+S G ++ E++ G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLL---LDLEYEAHVADFGIAKSLKPDSSNW 740
            +I  V  A+ YLH      IVHRD+  +NLL   LD + +  ++DFG++K   P S   
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T   GT GY+APE+      ++  D +S GV+ + ++ G  P
Sbjct: 177 TA-CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 86/197 (43%), Gaps = 16/197 (8%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKF-------HSLLPCDQTVDQKEFLTEVEAFYGFCS 647
           IGNG    VY+A+L  SGE+VA+KK        +  L   + +D    +     FY    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 648 HARHSFL--LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
                +L  + +++         +   A Q L        +  +  +L+Y+H      I 
Sbjct: 88  KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---IC 144
Query: 706 HRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-TMKITEK 763
           HRDI  +NLLLD +     + DFG AK L     N   +  +  Y APEL +     T  
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGATDYTSS 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            DV+S G ++ E++ G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLL---LDLEYEAHVADFGIAKSLKPDSSNW 740
            +I  V  A+ YLH      IVHRD+  +NLL   LD + +  ++DFG++K   P S   
Sbjct: 120 RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 176
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T   GT GY+APE+      ++  D +S GV+ + ++ G  P
Sbjct: 177 TA-CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 103/231 (44%), Gaps = 43/231 (18%)
Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE 638
           ++++ K T++      +G G +A V  A  L +G+  AVK    ++       +     E
Sbjct: 10  FEDMYKLTSEL-----LGEGAYAKVQGAVSLQNGKEYAVK----IIEKQAGHSRSRVFRE 60
Query: 639 VEAFYG------------FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVI 686
           VE  Y             F       +L++E L+ GS+ A +       E    +   V+
Sbjct: 61  VETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNE---REASRVV 117
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA---HVADFGIAKSLKPDSS----N 739
           + VA AL +LH      I HRD+  +N+L +   +     + DF +   +K ++S     
Sbjct: 118 RDVAAALDFLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 740 WTEFAGTCG---YIAPELA--YTMKIT---EKCDVYSFGVLMWEVIKGKHP 782
             E    CG   Y+APE+   +T + T   ++CD++S GV+++ ++ G  P
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPP 225

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/259 (22%), Positives = 101/259 (38%), Gaps = 21/259 (8%)
Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFH--------SLLPCDQTVDQKEFLTE--VEAFYG 644
           IG G  + VYRA  L  G  VA+KK          +   C + +D  + L    V  +Y 
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
                    ++ E  + G L+ ++      + L   +   V K      S L H     +
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER--TVWKYFVQLCSALEHMHSRRV 157
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKC 764
           +HRDI   N+ +       + D G+ +     ++      GT  Y++PE  +      K 
Sbjct: 158 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 217
Query: 765 DVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIME 824
           D++S G L++E+   + P            +    ++Q   P  P PS    E+L  ++ 
Sbjct: 218 DIWSLGCLLYEMAALQSP---FYGDKMNLYSLCKKIEQCDYP--PLPSDHYSEELRQLVN 272
Query: 825 VAFSCFNESPESRPTMKII 843
           +   C N  PE RP +  +
Sbjct: 273 M---CINPDPEKRPDVTYV 288

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----AFYGFCSHARH 651
           +G G   +V       G  VAVK+   +  CD  + + + LTE +        +CS    
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRM-LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD 81
Query: 652 SFLLYEFLERGSL---AAILNTDAAAQELGWSQRMN---VIKAVAHALSYLHHDCFPPIV 705
            FL Y  LE  +L     + + + + + L   +  N   +++ +A  +++LH      I+
Sbjct: 82  RFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKII 137
Query: 706 HRDISSKNLLL--------DLEYEAH-----VADFGIAKSLKPDS----SNWTEFAGTCG 748
           HRD+  +N+L+        D +  A      ++DFG+ K L         N    +GT G
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSG 197
Query: 749 YIAPE-------LAYTMKITEKCDVYSFGVLMWEVI-KGKHP 782
           + APE       L    ++T   D++S G + + ++ KGKHP
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT  Y+A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           P +  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PAIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 21/131 (16%)
Query: 655 LYEFL-ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
           L++F+ ERG+L          +EL  S    V++AV H      H+    ++HRDI  +N
Sbjct: 97  LFDFITERGALQ---------EELARSFFWQVLEAVRHC-----HN--XGVLHRDIKDEN 140
Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGV 771
           +L+DL   E  + DFG    LK   + +T+F GT  Y  PE + Y         V+S G+
Sbjct: 141 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198
Query: 772 LMWEVIKGKHP 782
           L+++++ G  P
Sbjct: 199 LLYDMVCGDIP 209

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 7/102 (6%)
Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADFGIAKSLKPDSSNW 740
            +I+ V  A+ YLH      IVHRD+  +NLL    D E +  ++DFG++K ++      
Sbjct: 124 TLIRQVLDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVM 179
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +   GT GY+APE+      ++  D +S GV+ + ++ G  P
Sbjct: 180 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 34/221 (15%)
Query: 582 EIVKATNDFDAKYC----IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFL 636
           E+ K   +  A Y     +G+G + +V  A +  +G  VA+KK +   P    +  K   
Sbjct: 15  EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAY 72
Query: 637 TEVEAFYGFCSHARHSFL------------LYEFLERGSLAAILNTDAAA----QELGWS 680
            E+        H RH  +            L +F +   +   + TD       ++LG  
Sbjct: 73  RELR----LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           +   ++  +   L Y+H      I+HRD+   NL ++ + E  + DFG+A+      S  
Sbjct: 129 RIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEM 182
Query: 741 TEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGK 780
                T  Y APE+    M+ T+  D++S G +M E+I GK
Sbjct: 183 XGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 16/197 (8%)
Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKF-------HSLLPCDQTVDQKEFLTEVEAFYGFCS 647
           IGNG    VY+A+L  SGE+VA+KK        +  L   + +D    +     FY    
Sbjct: 28  IGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFYSSGE 87
Query: 648 HARHSFL--LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
                +L  + +++         +   A Q L        +  +  +L+Y+H      I 
Sbjct: 88  KKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---IC 144
Query: 706 HRDISSKNLLLDLEYEA-HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-TMKITEK 763
           HRDI  +NLLLD +     + DFG AK L     N +       Y APEL +     T  
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSR-YYRAPELIFGATDYTSS 203
Query: 764 CDVYSFGVLMWEVIKGK 780
            DV+S G ++ E++ G+
Sbjct: 204 IDVWSAGCVLAELLLGQ 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 84/216 (38%), Gaps = 29/216 (13%)
Query: 581 DEIVKATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFH-------SLLPCDQTVDQ 632
           +E+  AT+       +G G    V+R E   +G   AVKK          L+ C      
Sbjct: 71  EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAEELMACAGLTSP 126
Query: 633 KEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
           +     +   YG         +  E LE GSL  ++       E    + +  +      
Sbjct: 127 R-----IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQALEG 178
Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSS-----NWTEFAGT 746
           L YLH      I+H D+ + N+LL  +   A + DFG A  L+PD             GT
Sbjct: 179 LEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGT 235
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             ++APE+        K DV+S   +M  ++ G HP
Sbjct: 236 ETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 114/284 (40%), Gaps = 51/284 (17%)
Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           +G GG + V   E L  G   A+K+    + C +  D++E   E +              
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKR----ILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 644 GFCSHAR----HSFLLYEFLERGSLA-AILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
            +C   R     ++LL  F +RG+L   I         L   Q + ++  +   L  +H 
Sbjct: 93  AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFG--------IAKSLKPDS-SNWTEFAGTCGY 749
             +    HRD+   N+LL  E +  + D G        +  S +  +  +W     T  Y
Sbjct: 153 KGY---AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 750 IAPELAYTMK---ITEKCDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVAL---DQM 803
            APEL        I E+ DV+S G +++ ++ G+ P D +           VAL   +Q+
Sbjct: 210 RAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK-----GDSVALAVQNQL 264
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             P+ P  S +  + L S+M V        P  RP + ++  QL
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTV-------DPHQRPHIPLLLSQL 301

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 88/200 (44%), Gaps = 19/200 (9%)
Query: 596 IGNGGHASVYRAELPSGEVVAVK-----KFHSLLPCDQTVDQKEFLT-----EVEAFYGF 645
           +G  G   V + EL +G  VAVK     K  SL    +   + + L       +   Y  
Sbjct: 26  VGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIV 705
            S     F++ E++  G L   +  +    E    +   + + +   + Y H      +V
Sbjct: 85  ISTPSDIFMVMEYVSGGELFDYICKNGRLDE---KESRRLFQQILSGVDYCHRHM---VV 138
Query: 706 HRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKC 764
           HRD+  +N+LLD    A +ADFG++ ++  D        G+  Y APE ++  +    + 
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEV 197
Query: 765 DVYSFGVLMWEVIKGKHPRD 784
           D++S GV+++ ++ G  P D
Sbjct: 198 DIWSSGVILYALLCGTLPFD 217

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 47/102 (46%), Gaps = 7/102 (6%)
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE----YEAHVADFGIAKSLKPDSSNW 740
           V+  +   + YLH      +VHRD+   N+L   E        + DFG AK L+ ++   
Sbjct: 121 VLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                T  ++APE+         CD++S GVL++  + G  P
Sbjct: 178 XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 111/266 (41%), Gaps = 41/266 (15%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLL 655
           IG+GG + V++      ++ A+K  +     +QT+D   +  E+        H+     L
Sbjct: 20  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 77
Query: 656 YEF----------LERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           Y++          +E G++   LN+    ++ +   +R +  K +  A+  +H      I
Sbjct: 78  YDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 132
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPELAYTMKITE 762
           VH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  + 
Sbjct: 133 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 191
Query: 763 K-----------CDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           +            DV+S G +++ +  GK P           +N    L  ++DP     
Sbjct: 192 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNHEIE 244
Query: 812 SRSAQEKLISIMEVAFSCFNESPESR 837
                EK   + +V   C    P+ R
Sbjct: 245 FPDIPEK--DLQDVLKCCLKRDPKQR 268

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 6/91 (6%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              YLH      +++RD+  +NLL+D +    V DFG AK +K     W    GT   +A
Sbjct: 153 TFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEALA 206
Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           PE+  +    +  D ++ GVL++E+  G  P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 69/161 (42%), Gaps = 28/161 (17%)
Query: 83  LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-PIPLSFDNLSNLIFXXXXX 141
           L  +  L +NDN L          LK L  L +T+NK    PI + FD L NL       
Sbjct: 60  LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGV-FDQLVNLA------ 112
Query: 142 XXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI- 200
                             +L+L+ NQL    PR F +LT ++ L L  N+L  S+P  + 
Sbjct: 113 ------------------ELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL-QSLPKGVF 153
Query: 201 GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS 241
            K+ SL  L L  NQ K V   +   LT LK L L  N L 
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK 194

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 111/266 (41%), Gaps = 41/266 (15%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLL 655
           IG+GG + V++      ++ A+K  +     +QT+D   +  E+        H+     L
Sbjct: 16  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 73
Query: 656 YEF----------LERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           Y++          +E G++   LN+    ++ +   +R +  K +  A+  +H      I
Sbjct: 74  YDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 128
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPELAYTMKITE 762
           VH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  + 
Sbjct: 129 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 187
Query: 763 K-----------CDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           +            DV+S G +++ +  GK P           +N    L  ++DP     
Sbjct: 188 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNHEIE 240
Query: 812 SRSAQEKLISIMEVAFSCFNESPESR 837
                EK   + +V   C    P+ R
Sbjct: 241 FPDIPEK--DLQDVLKCCLKRDPKQR 264

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 111/266 (41%), Gaps = 41/266 (15%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLL 655
           IG+GG + V++      ++ A+K  +     +QT+D   +  E+        H+     L
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 93
Query: 656 YEF----------LERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           Y++          +E G++   LN+    ++ +   +R +  K +  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 148
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPELAYTMKITE 762
           VH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  + 
Sbjct: 149 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 763 K-----------CDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           +            DV+S G +++ +  GK P           +N    L  ++DP     
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNHEIE 260
Query: 812 SRSAQEKLISIMEVAFSCFNESPESR 837
                EK   + +V   C    P+ R
Sbjct: 261 FPDIPEK--DLQDVLKCCLKRDPKQR 284

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE---- 638
            +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E    
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 639 -VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHAL 693
            +             +L++EFL +  L   ++  A          + +IK+    +   L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGL 116
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           S+ H      ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE
Sbjct: 117 SFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 754 LAYTMK-ITEKCDVYSFGVLMWEVIKGK 780
           +    K  +   D++S G +  E++  +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 207 VDIWSVGCIMGEMIKG 222

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE---- 638
            +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E    
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 639 -VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHAL 693
            +             +L++EFL +  L   ++  A          + +IK+    +   L
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGL 123
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           ++ H      ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE
Sbjct: 124 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 754 LAYTMK-ITEKCDVYSFGVLMWEVI 777
           +    K  +   D++S G +  E++
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 45/78 (57%), Gaps = 5/78 (6%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW--TEFAGTCGYIAPELAYTMKIT 761
           I+HRD+   N+++  +    + DFG+A++    S+N+  T +  T  Y APE+   M   
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYYRAPEVILGMGYK 201
Query: 762 EKCDVYSFGVLMWEVIKG 779
           E  D++S G +M E++KG
Sbjct: 202 ENVDIWSVGCIMGELVKG 219

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +     E   
Sbjct: 137 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 241

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLLL+   +  + DFG+A+   PD  +     E   
Sbjct: 138 ILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 242

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S     F  T  Y APE+   M   E 
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMVPFVVTRYYRAPEVILGMGYKEN 207
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 208 VDIWSVGCIMGEMIKG 223

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 34/284 (11%)
Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHF 263
           S+  L+L +++F  +   +    T L+EL L   HL G +P  +  L +L++L+LS NHF
Sbjct: 252 SVESLNLQEHRFSDISSTTFQCFTQLQELDLTATHLKG-LPSGMKGLNLLKKLVLSVNHF 310
Query: 264 TGYLPYNICRGGALEIFTVSENHFQGTIPT------SLRNCTSLIRVRLNGNNLTGN--I 315
                  +C+  A    +++  + +G +         L    +L  + L+ N++  +   
Sbjct: 311 D-----QLCQISAANFPSLTHLYIRGNVKKLHLGVGCLEKLGNLQTLDLSHNDIEASDCC 365
Query: 316 SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPRE-IGNSSQLQ 374
           S  L    +L  ++LS N   G  S  + + P+L  L+++   +    P+    N   LQ
Sbjct: 366 SLQLKNLSHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQSPFQNLHFLQ 425
Query: 375 AFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPS 434
             +L+   +       L  L  L  L L+GN        + G++TK   L    +G    
Sbjct: 426 VLNLTYCFLDTSNQHLLAGLPVLRHLNLKGNHF------QDGTITKTNLLQ--TVG---- 473
Query: 435 QICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC 478
                 SLE L LS   L       F  +  +S +D+S+N L C
Sbjct: 474 ------SLEVLILSSCGLLSIDQQAFHSLGKMSHVDLSHNSLTC 511

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 11/164 (6%)
Query: 328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEI 387
           ++L  + F    S+ +  F +L  L+++  ++ G LP  +   + L+   LS+NH     
Sbjct: 256 LNLQEHRFSDISSTTFQCFTQLQELDLTATHLKG-LPSGMKGLNLLKKLVLSVNHFDQLC 314
Query: 388 PKELGKLNPLTKLILRGNQITGRLPKEIGSLTKL---EYLDFSAIGELPSQIC-----NM 439
                    LT L +RGN    +L   +G L KL   + LD S      S  C     N+
Sbjct: 315 QISAANFPSLTHLYIRGN--VKKLHLGVGCLEKLGNLQTLDLSHNDIEASDCCSLQLKNL 372
Query: 440 KSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
             L+ LNLSHN   G     F+    L  +D+++  L    P S
Sbjct: 373 SHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQS 416

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 32/224 (14%)
Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVK---KFHSLLPCDQTVDQKEFLT 637
           E+    +DF+    IG G  + V   ++  +G+V A+K   K+  L   + +  ++E   
Sbjct: 55  EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 638 EVEAFYGFCSHARHSF-------LLYEFLERGSLAAILNT--DAAAQELGWSQRMNVIKA 688
            V     + +    +F       L+ E+   G L  +L+   +    E+       ++ A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 689 V--AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-G 745
           +   H L Y         VHRDI   N+LLD      +ADFG    L+ D +  +  A G
Sbjct: 175 IDSVHRLGY---------VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 746 TCGYIAPELAYTMKITE-------KCDVYSFGVLMWEVIKGKHP 782
           T  Y++PE+   +           +CD ++ GV  +E+  G+ P
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 111/266 (41%), Gaps = 41/266 (15%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLL 655
           IG+GG + V++      ++ A+K  +     +QT+D   +  E+        H+     L
Sbjct: 17  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 74
Query: 656 YEF----------LERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           Y++          +E G++   LN+    ++ +   +R +  K +  A+  +H      I
Sbjct: 75  YDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 129
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPELAYTMKITE 762
           VH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  + 
Sbjct: 130 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188
Query: 763 K-----------CDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           +            DV+S G +++ +  GK P           +N    L  ++DP     
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNHEIE 241
Query: 812 SRSAQEKLISIMEVAFSCFNESPESR 837
                EK   + +V   C    P+ R
Sbjct: 242 FPDIPEK--DLQDVLKCCLKRDPKQR 265

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE---- 638
            +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E    
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 639 -VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHAL 693
            +             +L++EFL +  L   ++  A          + +IK+    +   L
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGL 123
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           ++ H      ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE
Sbjct: 124 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 754 LAYTMK-ITEKCDVYSFGVLMWEVI 777
           +    K  +   D++S G +  E++
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/145 (26%), Positives = 76/145 (52%), Gaps = 21/145 (14%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +L++E +  GS+ + ++      EL  S    V++ VA AL +LH+     I HRD+  +
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEAS---VVVQDVASALDFLHNK---GIAHRDLKPE 140
Query: 713 NLLLDLEYEA---HVADFGIAKSLKPDSS----NWTEFAGTCG---YIAPEL--AYTMKI 760
           N+L +   +     + DFG+   +K +      +  E    CG   Y+APE+  A++ + 
Sbjct: 141 NILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 761 T---EKCDVYSFGVLMWEVIKGKHP 782
           +   ++CD++S GV+++ ++ G  P
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 24/205 (11%)
Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE---- 638
            +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E    
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 639 -VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHAL 693
            +             +L++EFL +  L   ++  A          + +IK+    +   L
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGL 116
Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           ++ H      ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE
Sbjct: 117 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 754 LAYTMK-ITEKCDVYSFGVLMWEVI 777
           +    K  +   D++S G +  E++
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMV 198

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 115
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y A
Sbjct: 116 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 172
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           A+ Y H      IVHRD+  +NLLLD      +ADFG++ ++  D +      G+  Y A
Sbjct: 120 AIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAA 175
Query: 752 PELAY-TMKITEKCDVYSFGVLMWEVIKGKHPRD 784
           PE+    +    + DV+S G++++ ++ G+ P D
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 13/108 (12%)
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAG 745
           +   L Y+H      ++HRD+   NLL++   +  + DFG+A+   P+  +    TE   
Sbjct: 153 ILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 746 TCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIK------GKHPRDFL 786
           T  Y APE+    K  T+  D++S G ++ E++       GKH  D L
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 257

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 24/197 (12%)
Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-----VEAFYGF 645
           IG G +  VY+A    +GEVVA+KK       +      + +   L E     +      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHALSYLHHDCF 701
                  +L++EFL +  L   ++  A          + +IK+    +   L++ H    
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-I 760
             ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+    K  
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 761 TEKCDVYSFGVLMWEVI 777
           +   D++S G +  E++
Sbjct: 182 STAVDIWSLGCIFAEMV 198

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 111/266 (41%), Gaps = 41/266 (15%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLL 655
           IG+GG + V++      ++ A+K  +     +QT+D   +  E+        H+     L
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 121
Query: 656 YEF----------LERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           Y++          +E G++   LN+    ++ +   +R +  K +  A+  +H      I
Sbjct: 122 YDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPELAYTMKITE 762
           VH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  + 
Sbjct: 177 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 235
Query: 763 K-----------CDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           +            DV+S G +++ +  GK P           +N    L  ++DP     
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNHEIE 288
Query: 812 SRSAQEKLISIMEVAFSCFNESPESR 837
                EK   + +V   C    P+ R
Sbjct: 289 FPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 22/207 (10%)
Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE---- 638
            +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E    
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 639 -VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQ---ELGWSQRMNVIKAVAHALS 694
            +             +L++EFL +  L   ++  A       L  S    +++ +A   S
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           +        ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+
Sbjct: 126 HR-------VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 178
Query: 755 AYTMK-ITEKCDVYSFGVLMWEVIKGK 780
               K  +   D++S G +  E++  +
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 24/197 (12%)
Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-----VEAFYGF 645
           IG G +  VY+A    +GEVVA+KK       +      + +   L E     +      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHALSYLHHDCF 701
                  +L++EFL +  L   ++  A          + +IK+    +   L++ H    
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-I 760
             ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 761 TEKCDVYSFGVLMWEVI 777
           +   D++S G +  E++
Sbjct: 181 STAVDIWSLGCIFAEMV 197

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 689 VAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
           +  A++YL   +C    VHRDI+ +N+L+       + DFG+++ +  +  ++ + + T 
Sbjct: 134 ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTR 187
Query: 747 --CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM 803
               +++PE     + T   DV+ F V MWE++  GK P  +L        N DV     
Sbjct: 188 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKDVIGVLE 240
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRP 838
              RLP P       L ++M     C++  P  RP
Sbjct: 241 KGDRLPKPDLCPP-VLYTLMT---RCWDYDPSDRP 271

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 24/200 (12%)
Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-----VEAFYGF 645
           IG G +  VY+A    +GEVVA+KK       +      + +   L E     +      
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHALSYLHHDCF 701
                  +L++EFL +  L   ++  A          + +IK+    +   L++ H    
Sbjct: 71  IHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHR- 123
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-I 760
             ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+    K  
Sbjct: 124 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 761 TEKCDVYSFGVLMWEVIKGK 780
           +   D++S G +  E++  +
Sbjct: 182 STAVDIWSLGCIFAEMVTRR 201

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 111/266 (41%), Gaps = 41/266 (15%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLL 655
           IG+GG + V++      ++ A+K  +     +QT+D   +  E+        H+     L
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 121
Query: 656 YEF----------LERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           Y++          +E G++   LN+    ++ +   +R +  K +  A+  +H      I
Sbjct: 122 YDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPELAYTMKITE 762
           VH D+   N L+ ++    + DFGIA  ++PD+++  + +  GT  Y+ PE    M  + 
Sbjct: 177 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 235
Query: 763 K-----------CDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           +            DV+S G +++ +  GK P           +N    L  ++DP     
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNHEIE 288
Query: 812 SRSAQEKLISIMEVAFSCFNESPESR 837
                EK   + +V   C    P+ R
Sbjct: 289 FPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 24/200 (12%)
Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-----VEAFYGF 645
           IG G +  VY+A    +GEVVA+KK       +      + +   L E     +      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHALSYLHHDCF 701
                  +L++EFL +  L   ++  A          + +IK+    +   L++ H    
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-I 760
             ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 761 TEKCDVYSFGVLMWEVIKGK 780
           +   D++S G +  E++  +
Sbjct: 181 STAVDIWSLGCIFAEMVTRR 200

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 43/209 (20%)
Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFL 654
           +G+G + SV  A +  SGE VA+KK             + F +E+     F   A    L
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKL-----------SRPFQSEI-----FAKRAYRELL 75
Query: 655 LYEFLERGSLAAILNTDAAAQEL--------------GWSQRMNVIKAVAHALSYLHHDC 700
           L + ++  ++  +L+    A  L                 Q++  +K     + YL +  
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 701 F--------PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
                      +VHRD+   NL ++ + E  + DFG+A+      +  T +  T  Y AP
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAP 192
Query: 753 ELAYT-MKITEKCDVYSFGVLMWEVIKGK 780
           E+  + M   +  D++S G +M E++ GK
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 8/133 (6%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
            ++ E L+ G L + +  D   Q     +   + K++  A+ YLH      I HRD+  +
Sbjct: 135 LIVXECLDGGELFSRIQ-DRGDQAFTEREASEIXKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 713 NLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSF 769
           NLL   +    +    DFG AK     +S  T    T  Y+APE+    K  + CD +S 
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDXWSL 249
Query: 770 GVLMWEVIKGKHP 782
           GV+ + ++ G  P
Sbjct: 250 GVIXYILLCGYPP 262

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 689 VAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
           +  A++YL   +C    VHRDI+ +N+L+       + DFG+++ +  +  ++ + + T 
Sbjct: 118 ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTR 171
Query: 747 --CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM 803
               +++PE     + T   DV+ F V MWE++  GK P  +L        N DV     
Sbjct: 172 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKDVIGVLE 224
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRP 838
              RLP P       L ++M     C++  P  RP
Sbjct: 225 KGDRLPKPDL-CPPVLYTLMT---RCWDYDPSDRP 255

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Composition-based stats.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 689 VAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT- 746
           +  A++YL   +C    VHRDI+ +N+L+       + DFG+++ +  +  ++ + + T 
Sbjct: 122 ICKAMAYLESINC----VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTR 175
Query: 747 --CGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLXXXXXXXLNTDVALDQM 803
               +++PE     + T   DV+ F V MWE++  GK P  +L        N DV     
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKDVIGVLE 228
Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRP 838
              RLP P       L ++M     C++  P  RP
Sbjct: 229 KGDRLPKPDL-CPPVLYTLMT---RCWDYDPSDRP 259

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISS 711
            ++ E +E G L + +  +   Q     +   +++ +  A+ +LH H+    I HRD+  
Sbjct: 102 LIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKP 156
Query: 712 KNLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYS 768
           +NLL   + +  V    DFG AK    ++     +  T  Y+APE+    K  + CD++S
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY--TPYYVAPEVLGPEKYDKSCDMWS 214
Query: 769 FGVLMWEVIKGKHP 782
            GV+M+ ++ G  P
Sbjct: 215 LGVIMYILLCGFPP 228

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 25/214 (11%)
Query: 584 VKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQ-----KEF 635
           + +++ F     +GNG +A+VY+     +G  VA+K  K  S      T  +     KE 
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL 60
Query: 636 LTE-VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQR---MNVIK---- 687
             E +   Y          L++EF++       L     ++ +G + R   +N++K    
Sbjct: 61  KHENIVRLYDVIHTENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
            +   L++ H +    I+HRD+  +NLL++   +  + DFG+A++     + ++    T 
Sbjct: 116 QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 748 GYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGK 780
            Y AP+ L  +   +   D++S G ++ E+I GK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 101/245 (41%), Gaps = 46/245 (18%)
Query: 572 LNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKK----FHSLLPC 626
           L F+G I+ +  VK  ++++ K+ IG G +  VY A +  + + VA+KK    F  L+ C
Sbjct: 14  LYFQGAIIKN--VKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDC 71
Query: 627 DQTVDQKEFLTEVEAFYGFCSHARHSFLLYE-FLERGSLAAILNTDAAAQELGWSQRMNV 685
            + + +   L  +++ Y       H  ++ E  L+   L  +L  + A  +L    +  +
Sbjct: 72  KRILREITILNRLKSDYII---RLHDLIIPEDLLKFDELYIVL--EIADSDLKKLFKTPI 126
Query: 686 IKAVAHALSYLHHDCFPP-------IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-- 736
                H  + L++            I+HRD+   N LL+ +    + DFG+A+++  D  
Sbjct: 127 FLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186
Query: 737 -----------------------SSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVL 772
                                      T    T  Y APEL    +  T   D++S G +
Sbjct: 187 IHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCI 246
Query: 773 MWEVI 777
             E++
Sbjct: 247 FAELL 251

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
           + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++ ++  D +      G+
Sbjct: 119 QQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGS 174
Query: 747 CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
             Y APE ++  +    + DV+S GV+++ ++  + P D
Sbjct: 175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 8/101 (7%)
Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADFGIAKSLKPDSSNWT 741
           VI+ V  A+ YLH +    IVHRD+  +NLL    +   +  + DFG++K     +   +
Sbjct: 111 VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMS 165
Query: 742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
              GT GY+APE+      ++  D +S GV+ + ++ G  P
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/134 (26%), Positives = 66/134 (49%), Gaps = 11/134 (8%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISS 711
            ++ E +E G L + +  +   Q     +   +++ +  A+ +LH H+    I HRD+  
Sbjct: 83  LIIMECMEGGELFSRIQ-ERGDQAFTEREAAEIMRDIGTAIQFLHSHN----IAHRDVKP 137
Query: 712 KNLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYS 768
           +NLL   + +  V    DFG AK    ++     +  T  Y+APE+    K  + CD++S
Sbjct: 138 ENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCY--TPYYVAPEVLGPEKYDKSCDMWS 195
Query: 769 FGVLMWEVIKGKHP 782
            GV+M+ ++ G  P
Sbjct: 196 LGVIMYILLCGFPP 209

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
           + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++ ++  D +      G+
Sbjct: 110 QQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGS 165
Query: 747 CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
             Y APE ++  +    + DV+S GV+++ ++  + P D
Sbjct: 166 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 61/147 (41%), Gaps = 12/147 (8%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG         +  E LE GSL  ++       E    + +  +      L YLH    
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR-- 183
Query: 702 PPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAG-----TCGYIAPELA 755
             I+H D+ + N+LL  +   A + DFG A  L+PD    +   G     T  ++APE+ 
Sbjct: 184 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 242
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  K D++S   +M  ++ G HP
Sbjct: 243 MGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 24/81 (29%), Positives = 40/81 (49%), Gaps = 5/81 (6%)
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG---YIAPELAYTMKIT 761
            HRD+  +N+L+  +  A++ DFGIA +        T+   T G   Y APE       T
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYXAPERFSESHAT 213
Query: 762 EKCDVYSFGVLMWEVIKGKHP 782
            + D+Y+   +++E + G  P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
           + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++ ++  D +      G+
Sbjct: 120 QQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGS 175
Query: 747 CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
             Y APE ++  +    + DV+S GV+++ ++  + P D
Sbjct: 176 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|1SQ0|B Chain B, Crystal Structure Of The Complex Of The Wild-Type Von Willebrand Factor A1 Domain And Glycoprotein Ib Alpha At 2.6 Angstrom Resolution Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 65/138 (47%), Gaps = 5/138 (3%)
Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
           G  P LGTL++S N +   LP        L   D+S N +       L  L  L +L L+
Sbjct: 74  GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132
Query: 404 GNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICN-MKSLEKLNLSHNNLSGSIPSCF 460
           GN++    P  +    KLE L  +   + ELP+ + N +++L+ L L  N+L  +IP  F
Sbjct: 133 GNELKTLPPGLLTPTPKLEKLSLANNDLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191
Query: 461 EGMHGLSFIDMSYNELQC 478
            G H L F  +  N   C
Sbjct: 192 FGSHLLPFAFLHGNPWLC 209

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
           + +  A+ Y H      IVHRD+  +NLLLD      +ADFG++ ++  D +      G+
Sbjct: 114 QQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGS 169
Query: 747 CGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
             Y APE ++  +    + DV+S GV+++ ++  + P D
Sbjct: 170 PNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 61/147 (41%), Gaps = 12/147 (8%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG         +  E LE GSL  ++       E    + +  +      L YLH    
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR-- 169
Query: 702 PPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAG-----TCGYIAPELA 755
             I+H D+ + N+LL  +   A + DFG A  L+PD    +   G     T  ++APE+ 
Sbjct: 170 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  K D++S   +M  ++ G HP
Sbjct: 229 MGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 53/103 (51%), Gaps = 7/103 (6%)
Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---EAHVADFGIAKSLKPDSSN 739
           + +IK +   + YLH +    IVH D+  +N+LL   Y   +  + DFG+++ +   +  
Sbjct: 134 IRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACE 189
Query: 740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             E  GT  Y+APE+     IT   D+++ G++ + ++    P
Sbjct: 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/266 (21%), Positives = 108/266 (40%), Gaps = 41/266 (15%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLL 655
           IG+GG + V++      ++ A+K  +     +QT+D   +  E+        H+     L
Sbjct: 36  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 93
Query: 656 YEF----------LERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           Y++          +E G++   LN+    ++ +   +R +  K +  A+  +H      I
Sbjct: 94  YDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 148
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPELAYTMKITE 762
           VH D+   N L+ ++    + DFGIA  ++PD     + +  GT  Y+ PE    M  + 
Sbjct: 149 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSR 207
Query: 763 K-----------CDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           +            DV+S G +++ +  GK P           +N    L  ++DP     
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNHEIE 260
Query: 812 SRSAQEKLISIMEVAFSCFNESPESR 837
                EK   + +V   C    P+ R
Sbjct: 261 FPDIPEK--DLQDVLKCCLKRDPKQR 284

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/76 (34%), Positives = 41/76 (53%), Gaps = 1/76 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T    T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPEVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKG 779
            D++S G +M E+IKG
Sbjct: 206 VDIWSVGCIMGEMIKG 221

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 61/147 (41%), Gaps = 12/147 (8%)
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            YG         +  E LE GSL  ++       E    + +  +      L YLH    
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR-- 185
Query: 702 PPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAG-----TCGYIAPELA 755
             I+H D+ + N+LL  +   A + DFG A  L+PD    +   G     T  ++APE+ 
Sbjct: 186 -RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 244
Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  K D++S   +M  ++ G HP
Sbjct: 245 MGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 577 KILYDEIVKATNDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           +I +D ++   + +D    +G G    V+R  E  +G   A K   +    D+   +KE 
Sbjct: 149 EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 205
Query: 636 LTEVEAFYGFCSHARHSF-------LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
            T     +    +   +F       ++YEF+  G L   +  +    ++   + +  ++ 
Sbjct: 206 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQ 263
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEY--EAHVADFGIAKSLKPDSSNWTEFAGT 746
           V   L ++H + +   VH D+  +N++   +   E  + DFG+   L P  S      GT
Sbjct: 264 VCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGT 319
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             + APE+A    +    D++S GVL + ++ G  P
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALT-----GIPLPLIKSYLFQLLQ 117
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 118 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 198
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 199 VDIWSVGCIMGEMVRHK 215

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 200 VDIWSVGCIMGEMVRHK 216

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 47/199 (23%), Positives = 89/199 (44%), Gaps = 22/199 (11%)
Query: 649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRD 708
           A H  L+  ++  GSL  +L+ +     +  SQ +     +A  +++LH     P++ R 
Sbjct: 81  APHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRH 137
Query: 709 -ISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEK--C 764
            ++S+++++D +  A ++   +  S +     +        ++APE L    + T +   
Sbjct: 138 ALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP-----AWVAPEALQKKPEDTNRRSA 192
Query: 765 DVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAPSRSAQEKLISIME 824
           D++SF VL+WE++  + P           +   VAL+  L P +P        KL+ I  
Sbjct: 193 DMWSFAVLLWELVTREVP---FADLSNMEIGMKVALEG-LRPTIPPGISPHVSKLMKI-- 246
Query: 825 VAFSCFNESPESRPTMKII 843
               C NE P  RP   +I
Sbjct: 247 ----CMNEDPAKRPKFDMI 261

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-ITE 762
           ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+    K  + 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 183
Query: 763 KCDVYSFGVLMWEVIKGK 780
             D++S G +  E++  +
Sbjct: 184 AVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-ITE 762
           ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+    K  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 763 KCDVYSFGVLMWEVIKGK 780
             D++S G +  E++  +
Sbjct: 183 AVDIWSLGCIFAEMVTRR 200

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 244 VDIWSVGCIMGEMVRHK 260

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 243
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 244 VDIWSVGCIMGEMVRHK 260

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 199
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 200 VDIWSVGCIMGEMVRHK 216

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/216 (22%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 577 KILYDEIVKATNDFDAKYCIGNGGHASVYR-AELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           +I +D ++   + +D    +G G    V+R  E  +G   A K   +    D+   +KE 
Sbjct: 43  EIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEI 99
Query: 636 LTEVEAFYGFCSHARHSF-------LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
            T     +    +   +F       ++YEF+  G L   +  +    ++   + +  ++ 
Sbjct: 100 QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH--NKMSEDEAVEYMRQ 157
Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEY--EAHVADFGIAKSLKPDSSNWTEFAGT 746
           V   L ++H + +   VH D+  +N++   +   E  + DFG+   L P  S      GT
Sbjct: 158 VCKGLCHMHENNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGT 213
Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             + APE+A    +    D++S GVL + ++ G  P
Sbjct: 214 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 204
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 205 VDIWSVGCIMGEMVRHK 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 207 VDIWSVGCIMGEMVRHK 223

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 206
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 207 VDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%), Gaps = 1/77 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           I+HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   M   E 
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKEN 205
Query: 764 CDVYSFGVLMWEVIKGK 780
            D++S G +M E+++ K
Sbjct: 206 VDIWSVGCIMGEMVRHK 222

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 117
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 118 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/78 (29%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-ITE 762
           ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE+    K  + 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 763 KCDVYSFGVLMWEVIKGK 780
             D++S G +  E++  +
Sbjct: 183 AVDIWSLGCIFAEMVTRR 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 118
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 119 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 175
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 117
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 118 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 116
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 117 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 115
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 116 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 116
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 117 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 114
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/107 (22%), Positives = 51/107 (47%), Gaps = 15/107 (14%)
Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           +++   +A A+ +LH      ++HRD+   N+   ++    V DFG+  ++  D    T 
Sbjct: 167 LHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 743 F------------AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
                         GT  Y++PE  +    + K D++S G++++E++
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 98/218 (44%), Gaps = 39/218 (17%)
Query: 590 FDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLP-CDQTVDQK-EFLTEVE----AFY 643
           F  K  +G+G   ++    +     VAVK+   +LP C    D++ + L E +       
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVIR 82
Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWS--QRMNVIKAVAHALSYLHHDCF 701
            FC+     F   +++     AA L      ++      + + +++     L++LH    
Sbjct: 83  YFCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS--- 136
Query: 702 PPIVHRDISSKNLLLDL-----EYEAHVADFGIAKSL---KPDSSNWTEFAGTCGYIAPE 753
             IVHRD+   N+L+ +     + +A ++DFG+ K L   +   S  +   GT G+IAPE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 754 LAYTMKITEKC--------DVYSFGVLMWEVI-KGKHP 782
           +     ++E C        D++S G + + VI +G HP
Sbjct: 197 M-----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 116
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 117 GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/266 (21%), Positives = 110/266 (41%), Gaps = 41/266 (15%)
Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLL 655
           IG+GG + V++      ++ A+K  +     +QT+D   +  E+        H+     L
Sbjct: 64  IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLD--SYRNEIAYLNKLQQHSDKIIRL 121
Query: 656 YEF----------LERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           Y++          +E G++   LN+    ++ +   +R +  K +  A+  +H      I
Sbjct: 122 YDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA--GTCGYIAPELAYTMKITE 762
           VH D+   N L+ ++    + DFGIA  ++PD+++  + +  G   Y+ PE    M  + 
Sbjct: 177 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235
Query: 763 K-----------CDVYSFGVLMWEVIKGKHPRDFLXXXXXXXLNTDVALDQMLDPRLPAP 811
           +            DV+S G +++ +  GK P           +N    L  ++DP     
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTP-------FQQIINQISKLHAIIDPNHEIE 288
Query: 812 SRSAQEKLISIMEVAFSCFNESPESR 837
                EK   + +V   C    P+ R
Sbjct: 289 FPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 114
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 16/197 (8%)
Query: 596 IGNGGHASVYR-AELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSF- 653
           +G+G    V+R  E  +G V   K  ++  P D+   + E     +  +    +   +F 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 654 ------LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR 707
                 L+ EFL  G L   +   A   ++  ++ +N ++     L ++H      IVH 
Sbjct: 119 DKYEMVLILEFLSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHL 173
Query: 708 DISSKNLLLDLEYEAHVA--DFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCD 765
           DI  +N++ + +  + V   DFG+A  L PD       A T  + APE+     +    D
Sbjct: 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEIVDREPVGFYTD 232
Query: 766 VYSFGVLMWEVIKGKHP 782
           +++ GVL + ++ G  P
Sbjct: 233 MWAIGVLGYVLLSGLSP 249

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 22/196 (11%)
Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-----VEAFYGF 645
           IG G +  VY+A    +GEVVA+KK       +      + +   L E     +      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQ---ELGWSQRMNVIKAVAHALSYLHHDCFP 702
                  +L++EFL +  L   ++  A       L  S    +++ +A   S+       
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------ 122
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-IT 761
            ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y APE+    K  +
Sbjct: 123 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 762 EKCDVYSFGVLMWEVI 777
              D++S G +  E++
Sbjct: 182 TAVDIWSLGCIFAEMV 197

>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 76/190 (40%), Gaps = 34/190 (17%)
Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
           I  L N+RYL LG     GN L ++S+     NL Y   L++  N L          L  
Sbjct: 59  IQYLPNVRYLALG-----GNKLHDISALKELTNLTY---LILTGNQLQSLPNGVFDKLTN 110
Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLI 169
           L +L L  N+        FD L+NL +                        L L  NQL 
Sbjct: 111 LKELVLVENQLQSLPDGVFDKLTNLTY------------------------LYLYHNQLQ 146
Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLT 228
                 F  LT+++ L L  N L  S+P+ +  K+  L  L LN NQ K V       LT
Sbjct: 147 SLPKGVFDKLTNLTRLDLDNNQL-QSLPEGVFDKLTQLKQLSLNDNQLKSVPDGVFDRLT 205
Query: 229 NLKELALLYN 238
           +L  + LL N
Sbjct: 206 SLTHIWLLNN 215

>pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 9/212 (4%)
Query: 324 NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREI--GNSSQLQAFDLSLN 381
           + TF++ ++N F   +        +L TL +  N +       +   N S L+  D+SLN
Sbjct: 354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLN 413
Query: 382 HIVGE-IPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMK 440
            +      +       +  L L  N +TG + + +    K+  L  + I  +P  + +++
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQ 473
Query: 441 SLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGL 500
           +L++LN++ N L       F+ +  L +I +  N   C  P     R  S E +  + G+
Sbjct: 474 ALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG---IRYLS-EWINKHSGV 529
Query: 501 CGSAKGLQPCKPLRQEKSNSGAKWFAIVFPLL 532
             ++ G     P   + S SG    +I+ P L
Sbjct: 530 VRNSAG--SVAPDSAKCSGSGKPVRSIICPTL 559

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 114
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 114
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 115 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 75/145 (51%), Gaps = 21/145 (14%)
Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK 712
           +L++E +  GS+ + ++      EL  S    V++ VA AL +LH+     I HRD+  +
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNK---GIAHRDLKPE 140
Query: 713 NLLLDLEYEA---HVADFGIAKSLKPDSS----NWTEFAGTCG---YIAPEL--AYTMKI 760
           N+L +   +     + DF +   +K +      +  E    CG   Y+APE+  A++ + 
Sbjct: 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEA 200
Query: 761 T---EKCDVYSFGVLMWEVIKGKHP 782
           +   ++CD++S GV+++ ++ G  P
Sbjct: 201 SIYDKRCDLWSLGVILYILLSGYPP 225

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 115
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 116 GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 24/197 (12%)
Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-----VEAFYGF 645
           IG G +  VY+A    +GEVVA+KK       +      + +   L E     +      
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAHALSYLHHDCF 701
                  +L++EFL +  L   ++  A          + +IK+    +   L++ H    
Sbjct: 70  IHTENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQGLAFCHSHR- 122
Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-I 760
             ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y APE+    K  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 761 TEKCDVYSFGVLMWEVI 777
           +   D++S G +  E++
Sbjct: 181 STAVDIWSLGCIFAEMV 197

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 22/196 (11%)
Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-----VEAFYGF 645
           IG G +  VY+A    +GEVVA+KK       +      + +   L E     +      
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 646 CSHARHSFLLYEFLERGSLAAILNTDAAAQ---ELGWSQRMNVIKAVAHALSYLHHDCFP 702
                  +L++EFL +  L   ++  A       L  S    +++ +A   S+       
Sbjct: 72  IHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR------ 124
Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-IT 761
            ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y APE+    K  +
Sbjct: 125 -VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 762 EKCDVYSFGVLMWEVI 777
              D++S G +  E++
Sbjct: 184 TAVDIWSLGCIFAEMV 199

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 588 NDFDAKYCIGNGGHASVY-------------------RAELPSGEVVAVKKFHSLLPCDQ 628
           NDF     IG GG   VY                   R ++  GE +A+ +   +L    
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 246
Query: 629 TVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
           T D   F+  V   Y F +  + SF+L + +  G L   L+      E      M    A
Sbjct: 247 TGDCP-FI--VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAD----MRFYAA 298
Query: 689 -VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL---KPDSSNWTEFA 744
            +   L ++H+     +V+RD+   N+LLD      ++D G+A      KP +S      
Sbjct: 299 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----V 350
Query: 745 GTCGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT GY+APE L   +      D +S G +++++++G  P
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 389

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL +  L   ++  A          + +IK+    +  
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALT-----GIPLPLIKSYLFQLLQ 114
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 115 GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 171
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVIKGK 780
           PE+    K  +   D++S G +  E++  +
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 588 NDFDAKYCIGNGGHASVY-------------------RAELPSGEVVAVKKFHSLLPCDQ 628
           NDF     IG GG   VY                   R ++  GE +A+ +   +L    
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 629 TVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
           T D   F+  V   Y F +  + SF+L + +  G L   L+      E      M    A
Sbjct: 248 TGDCP-FI--VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAD----MRFYAA 299
Query: 689 -VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL---KPDSSNWTEFA 744
            +   L ++H+     +V+RD+   N+LLD      ++D G+A      KP +S      
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----V 351
Query: 745 GTCGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT GY+APE L   +      D +S G +++++++G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 588 NDFDAKYCIGNGGHASVY-------------------RAELPSGEVVAVKKFHSLLPCDQ 628
           NDF     IG GG   VY                   R ++  GE +A+ +   +L    
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 629 TVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
           T D   F+  V   Y F +  + SF+L + +  G L   L+      E      M    A
Sbjct: 248 TGDCP-FI--VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAD----MRFYAA 299
Query: 689 -VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL---KPDSSNWTEFA 744
            +   L ++H+     +V+RD+   N+LLD      ++D G+A      KP +S      
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----V 351
Query: 745 GTCGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT GY+APE L   +      D +S G +++++++G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 41/219 (18%)
Query: 588 NDFDAKYCIGNGGHASVY-------------------RAELPSGEVVAVKKFHSLLPCDQ 628
           NDF     IG GG   VY                   R ++  GE +A+ +   +L    
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVS 247
Query: 629 TVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
           T D   F+  V   Y F +  + SF+L + +  G L   L+      E      M    A
Sbjct: 248 TGDCP-FI--VCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAD----MRFYAA 299
Query: 689 -VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL---KPDSSNWTEFA 744
            +   L ++H+     +V+RD+   N+LLD      ++D G+A      KP +S      
Sbjct: 300 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----V 351
Query: 745 GTCGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT GY+APE L   +      D +S G +++++++G  P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 26/227 (11%)
Query: 180 TSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQN--QFKGVLPPSISNLTNLKELALL 236
           +S + L L  N L  S+P  +  K+  L+ L L+ N   FKG    S    T+LK L L 
Sbjct: 28  SSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86
Query: 237 YNHLSGSIPPSLGNLILRQL---------LLSGNHFTGYLPYNICRGGALEIFTVSENHF 287
           +N   G I  S   L L QL         L   + F+ +L         L    +S  H 
Sbjct: 87  FN---GVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR-----NLIYLDISHTHT 138
Query: 288 QGTIPTSLRNCTSLIRVRLNGNNLTGN-ISEALGIYPNLTFIDLSRNNFYGEISSNWGKF 346
           +          +SL  +++ GN+   N + +      NLTF+DLS+        + +   
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198
Query: 347 PKLGTLNVSMNNI--TGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL 391
             L  LN+S NN       P +  NS  LQ  D SLNHI+    +EL
Sbjct: 199 SSLQVLNMSHNNFFSLDTFPYKCLNS--LQVLDYSLNHIMTSKKQEL 243

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL    L   ++  A          + +IK+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 117
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 118 GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/207 (23%), Positives = 87/207 (42%), Gaps = 24/207 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL    L   ++  A          + +IK+    +  
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 115
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 116 GLAFCHSHR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 172
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVI 777
           PE+    K  +   D++S G +  E++
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL    L   ++  A          + +IK+    +  
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALT-----GIPLPLIKSYLFQLLQ 117
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 118 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 174
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVIKGK 780
           PE+    K  +   D++S G +  E++  +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 27/208 (12%)
Query: 589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-------VEA 641
           DF      GN G A + R +L + E+VAVK        D+ V Q+E +         +  
Sbjct: 23  DFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGAAIDENV-QREIINHRSLRHPNIVR 80
Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
           F        H  ++ E+   G L   +     A      +     + +   +SY H    
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERI---CNAGRFSEDEARFFFQQLLSGVSYCHS--- 134
Query: 702 PPIVHRDISSKNLLLD--LEYEAHVADFGIAKS----LKPDSSNWTEFAGTCGYIAPELA 755
             I HRD+  +N LLD        + DFG +KS     +P S+      GT  YIAPE+ 
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVL 189
Query: 756 YTMKITEK-CDVYSFGVLMWEVIKGKHP 782
              +   K  DV+S GV ++ ++ G +P
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 24/210 (11%)
Query: 586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCD----QTVDQKEFLTE-- 638
           +  +F     IG G +  VY+A    +GEVVA+KK       +      + +   L E  
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 639 ---VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA----VAH 691
              +             +L++EFL    L   ++  A          + +IK+    +  
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALT-----GIPLPLIKSYLFQLLQ 116
Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L++ H      ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y A
Sbjct: 117 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRA 173
Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVIKGK 780
           PE+    K  +   D++S G +  E++  +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 80/195 (41%), Gaps = 15/195 (7%)
Query: 591 DAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           + K  +  G        ++P   V  V +F   +   +++D    +   E F        
Sbjct: 41  EVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF----EDNT 96
Query: 651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
             +L+ E    G L   +      +E   S    ++K V  A++Y H      + HRD+ 
Sbjct: 97  DIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHKLN---VAHRDLK 150
Query: 711 SKNLLL---DLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
            +N L      +    + DFG+A   KP     T+  GT  Y++P++   +   E CD +
Sbjct: 151 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-VGTPYYVSPQVLEGLYGPE-CDEW 208
Query: 768 SFGVLMWEVIKGKHP 782
           S GV+M+ ++ G  P
Sbjct: 209 SAGVMMYVLLCGYPP 223

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 24/78 (30%), Positives = 43/78 (55%), Gaps = 5/78 (6%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW--TEFAGTCGYIAPELAYTMKIT 761
           I+HRD+   N+++  +    + DFG+A++     +N+  T +  T  Y APE+   M   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYA 203
Query: 762 EKCDVYSFGVLMWEVIKG 779
              D++S G +M E++KG
Sbjct: 204 ANVDIWSVGCIMGELVKG 221

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 22/75 (29%), Positives = 40/75 (53%), Gaps = 1/75 (1%)
Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-ITE 762
           ++HRD+  +NLL++ E    +ADFG+A++       +     T  Y APE+    K  + 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYST 186
Query: 763 KCDVYSFGVLMWEVI 777
             D++S G +  E++
Sbjct: 187 AVDIWSLGCIFAEMV 201

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 80/195 (41%), Gaps = 15/195 (7%)
Query: 591 DAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHAR 650
           + K  +  G        ++P   V  V +F   +   +++D    +   E F        
Sbjct: 24  EVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF----EDNT 79
Query: 651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDIS 710
             +L+ E    G L   +      +E   S    ++K V  A++Y H      + HRD+ 
Sbjct: 80  DIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHKLN---VAHRDLK 133
Query: 711 SKNLLL---DLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
            +N L      +    + DFG+A   KP     T+  GT  Y++P++   +   E CD +
Sbjct: 134 PENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK-VGTPYYVSPQVLEGLYGPE-CDEW 191
Query: 768 SFGVLMWEVIKGKHP 782
           S GV+M+ ++ G  P
Sbjct: 192 SAGVMMYVLLCGYPP 206

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 70/173 (40%), Gaps = 10/173 (5%)
Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
           I  L N+RYL LG     GN L ++S+     NL Y   L++  N L          L  
Sbjct: 59  IQYLPNVRYLALG-----GNKLHDISALKELTNLTY---LILTGNQLQSLPNGVFDKLTN 110
Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFXXXXXXXXXXXXXXXXXXXXXXFDLQLNDNQLI 169
           L +L L  N+        FD L+NL +                       +L L+ NQL 
Sbjct: 111 LKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170
Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLP 221
                 F  LT +  LRL +N L  S+PD +  ++ SL  + L+ N +    P
Sbjct: 171 SLPEGVFDKLTQLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 84/201 (41%), Gaps = 24/201 (11%)
Query: 205 SLSVLDLNQN--QFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQL------ 256
           SL  LDL++N   FKG    S    T+LK L L +N   G I  S   L L QL      
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN---GVITMSSNFLGLEQLEHLDFQ 404
Query: 257 ---LLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG 313
              L   + F+ +L         L    +S  H +          +SL  +++ GN+   
Sbjct: 405 HSNLKQMSEFSVFLSLR-----NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 314 N-ISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNI--TGGLPREIGNS 370
           N + +      NLTF+DLS+        + +     L  LN+S NN       P +  NS
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 519
Query: 371 SQLQAFDLSLNHIVGEIPKEL 391
             LQ  D SLNHI+    +EL
Sbjct: 520 --LQVLDYSLNHIMTSKKQEL 538

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 95/253 (37%), Gaps = 60/253 (23%)
Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
           TL+   F+SFPHL  L+L  N      P   +NL NLR L L SN+              
Sbjct: 46  TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK------------ 93
Query: 80  GGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFXX 138
                               IP  +   L  L++LD++ NK    +   F +L NL    
Sbjct: 94  -------------------LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK--- 131
Query: 139 XXXXXXXXXXXXXXXXXXXXFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPD 198
                                 L++ DN L+    R FS L S+  L L + +L  SIP 
Sbjct: 132 ---------------------SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL-TSIPT 169
Query: 199 E-IGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELAL-LYNHLSGSIPPSLGNLILRQL 256
           E +  +  L VL L       +   S   L  LK L +  + +L    P  L  L L  L
Sbjct: 170 EALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSL 229
Query: 257 LLSGNHFTGYLPY 269
            ++  + T  +PY
Sbjct: 230 SITHCNLTA-VPY 241

>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 77/190 (40%), Gaps = 6/190 (3%)
Query: 328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT--GGLPREIGNSSQLQAFDLSLNHIVG 385
           +D S N     +  N G   +L TL + MN +     +         LQ  D+S N +  
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 386 EIPK-ELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEK 444
           +  K +      L  L +  N +T  + + +    K+  L  + I  +P Q+  +++L++
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQVVKLEALQE 448
Query: 445 LNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSA 504
           LN++ N L       F+ +  L  I +  N   C  P        S    K ++   GSA
Sbjct: 449 LNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR---IDYLSRWLNKNSQKEQGSA 505
Query: 505 KGLQPCKPLR 514
           K     KP+R
Sbjct: 506 KCSGSGKPVR 515

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 7/142 (4%)
Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
           + F  F   A H   L   L R  LA +++     Q +  S + ++   + H L  LH  
Sbjct: 96  DIFVHFEEPAMHKLYLVTELMRTDLAQVIHD----QRIVISPQ-HIQYFMYHILLGLHVL 150
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK 759
               +VHRD+   N+LL    +  + DF +A+    D +N T +     Y APEL    K
Sbjct: 151 HEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFK 209
Query: 760 -ITEKCDVYSFGVLMWEVIKGK 780
             T+  D++S G +M E+   K
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 64/142 (45%), Gaps = 7/142 (4%)
Query: 640 EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
           + F  F   A H   L   L R  LA +++     Q +  S + ++   + H L  LH  
Sbjct: 96  DIFVHFEEPAMHKLYLVTELMRTDLAQVIHD----QRIVISPQ-HIQYFMYHILLGLHVL 150
Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK 759
               +VHRD+   N+LL    +  + DF +A+    D +N T +     Y APEL    K
Sbjct: 151 HEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFK 209
Query: 760 -ITEKCDVYSFGVLMWEVIKGK 780
             T+  D++S G +M E+   K
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRK 231

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	849
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-127
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-120
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-117
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-58
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-29
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-16
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-91
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-75
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-63
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-39
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-86
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-81
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-80
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-79
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-67
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-63
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-42
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-78
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-76
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-66
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-58
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-55
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-04
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-77
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-72
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-59
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-51
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-28
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-26
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-07
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-71
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-71
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-70
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-12
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-69
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-68
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-68
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-63
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-61
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-43
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-31
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-21
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-10
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-66
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-63
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-59
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-58
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-32
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-25
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-60
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-58
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-56
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-33
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-58
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	8e-55
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-54
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-52
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-49
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-44
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-26
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-51
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-48
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-38
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-50
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-50
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	7e-45
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-40
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-23
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-49
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-24
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-16
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	4e-48
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-47
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-47
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-46
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-46
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-42
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-35
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-25
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-14
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-46
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-45
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-44
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-44
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-38
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-33
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-26
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-22
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-09
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-43
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-40
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-35
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-43
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-43
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	8e-38
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	7e-35
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-34
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-26
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-34
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-32
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-05
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-37
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-17
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-37
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-35
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-34
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-24
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	4e-20
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-35
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-34
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-36
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	4e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-30
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-27
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-36
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-33
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-32
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-21
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-35
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-20
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-18
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-31
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-22
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-33
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-28
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-24
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-04
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-32
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-26
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-08
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-29
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-23
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-05
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-28
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-25
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-20
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-16
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-10
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-27
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-27
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	9e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-24
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-06
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-20
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-26
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-26
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	6e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-15
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-26
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-26
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-26
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-26
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-26
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-26
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-21
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	8e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-25
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-25
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-21
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-15
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-14
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-14
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-21
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-11
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-24
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-24
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	9e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-23
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-23
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-23
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-22
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	4e-22
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	9e-20
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	5e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-22
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-22
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-21
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-21
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-21
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-18
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-11
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-21
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-21
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-21
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-21
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-20
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-20
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-20
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-20
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-20
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-07
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-19
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	8e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-11
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-09
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-19
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-19
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	5e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-12
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-19
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-19
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	9e-19
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-18
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-13
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-10
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-17
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-10
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-18
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-18
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-11
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-09
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-17
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	8e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	5e-05
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-17
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-17
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-17
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-17
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-17
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-17
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	9e-15
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-11
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-17
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-13
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-11
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-10
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-16
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-13
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-11
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-16
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-16
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	8e-16
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-12
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-04
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-15
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	7e-14
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	8e-11
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-07
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-15
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-14
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	7e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-05
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	3e-05
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-14
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-14
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-10
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	4e-04
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-14
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-14
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-14
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-14
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	5e-10
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-13
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-13
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-13
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-13
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-12
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-12
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	5e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-09
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-07
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-12
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	5e-04
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-11
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-08
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-11
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-11
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-11
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-11
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	9e-11
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-10
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	6e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-05
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-04
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-10
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-10
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-10
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-05
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-09
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-07
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	9e-05
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	9e-08
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-04
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-08
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-06
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-09
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-09
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-08
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	3e-04
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-08
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	2e-07
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	7e-05
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-08
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	8e-08
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-07
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-05
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-07
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	5e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	1e-05
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-05
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-07
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	4e-07
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-07
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-06
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-06
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	8e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	1e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-05
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	3e-05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-05
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	7e-05
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	7e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  399 bits (1028), Expect = e-127
 Identities = 134/480 (27%), Positives = 211/480 (43%), Gaps = 27/480 (5%)

Query: 10  ISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI---SNLSNLRYLYLGSNQF 66
           +++ +  ++             L  LDL+ N   G              L++L +  N+ 
Sbjct: 131 LNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI 190

Query: 67  SGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPL 126
           SG++               +  L ++ N+ S  IP  +G+   L  LD++ NK SG    
Sbjct: 191 SGDV--------DVSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSR 241

Query: 127 SFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRP-FSNLTSVSTL 185
           +    + L  L +  N   G I      LKSL  L L +N+  G IP        +++ L
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGL 299

Query: 186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPP-SISNLTNLKELALLYNHLSGSI 244
            LS N  +G++P   G    L  L L+ N F G LP  ++  +  LK L L +N  SG +
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359

Query: 245 PPSLGNLI--LRQLLLSGNHFTGYLPYNICRGG--ALEIFTVSENHFQGTIPTSLRNCTS 300
           P SL NL   L  L LS N+F+G +  N+C+     L+   +  N F G IP +L NC+ 
Sbjct: 360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE 419

Query: 301 LIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT 360
           L+ + L+ N L+G I  +LG    L  + L  N   GEI         L TL +  N++T
Sbjct: 420 LVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 479

Query: 361 GGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTK 420
           G +P  + N + L    LS N + GEIPK +G+L  L  L L  N  +G +P E+G    
Sbjct: 480 GEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS 539

Query: 421 LEYLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
           L +LD +     G +P+ +          ++ N ++G      +          + N L+
Sbjct: 540 LIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  380 bits (979), Expect = e-120
 Identities = 134/471 (28%), Positives = 221/471 (46%), Gaps = 30/471 (6%)

Query: 31  HLAYLDLT---WNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
            +  +DL+    N  F  +   + +L+ L  L+L ++  +G++       S       ++
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-------SGFKCSASLT 103

Query: 88  RLVINDNSLSGFIPP--HIGNLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGNLL 144
            L ++ NSLSG +     +G+   L  L++++N    P  +S    L++L  L L  N +
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163

Query: 145 SGSILSSL---GKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG 201
           SG+ +           L  L ++ N++ G +    S   ++  L +S N+    IP  +G
Sbjct: 164 SGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIP-FLG 220

Query: 202 KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSG 260
              +L  LD++ N+  G    +IS  T LK L +  N   G IPP    L  L+ L L+ 
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAE 278

Query: 261 NHFTGYLPYNIC-RGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI-SEA 318
           N FTG +P  +      L    +S NHF G +P    +C+ L  + L+ NN +G +  + 
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338

Query: 319 LGIYPNLTFIDLSRNNFYGEISSNWGKF-PKLGTLNVSMNNITGGLPREIGNS--SQLQA 375
           L     L  +DLS N F GE+  +       L TL++S NN +G +   +  +  + LQ 
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398

Query: 376 FDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA---IGEL 432
             L  N   G+IP  L   + L  L L  N ++G +P  +GSL+KL  L        GE+
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458

Query: 433 PSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
           P ++  +K+LE L L  N+L+G IPS       L++I +S N L   +P  
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  374 bits (962), Expect = e-117
 Identities = 144/505 (28%), Positives = 215/505 (42%), Gaps = 62/505 (12%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQ-ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNL 83
            F S   L  L L+ N F G +P   +  +  L+ L L  N+FSG +   +++ S+  +L
Sbjct: 313 FFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSA--SL 370

Query: 84  RYMSRLVINDNSLSGFIPPHIGN--LKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
                L ++ N+ SG I P++       L +L L NN F+G IP +  N S L+ L+L  
Sbjct: 371 LT---LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSF 427

Query: 142 NLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG 201
           N LSG+I SSLG L  L DL+L  N L G IP+    + ++ TL L  NDL G IP  + 
Sbjct: 428 NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487

Query: 202 KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSG 260
              +L+ + L+ N+  G +P  I  L NL  L L  N  SG+IP  LG+   L  L L+ 
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNT 547

Query: 261 NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRL--NGNNLTGNISEA 318
           N F G +P  + +    +   ++ N   G     ++N           N     G  SE 
Sbjct: 548 NLFNGTIPAAMFK----QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603

Query: 319 LGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDL 378
           L         +++   + G  S  +     +  L++S N ++G +P+EIG+   L   +L
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663

Query: 379 SLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICN 438
             N I G IP E+G                                             +
Sbjct: 664 GHNDISGSIPDEVG---------------------------------------------D 678

Query: 439 MKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNK 498
           ++ L  L+LS N L G IP     +  L+ ID+S N L  P+P    F          N 
Sbjct: 679 LRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738

Query: 499 GLCGSAKGLQPCKPLRQEKSNSGAK 523
           GLCG    L  C P   +      +
Sbjct: 739 GLCGY--PLPRCDPSNADGYAHHQR 761

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  213 bits (544), Expect = 1e-58
 Identities = 74/320 (23%), Positives = 125/320 (39%), Gaps = 42/320 (13%)

Query: 178 NLTSVSTLRLSRNDL---FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA 234
               V+++ LS   L   F ++   +  +  L  L L+ +   G +        +L  L 
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 235 LLYNHLSGSIPP--SLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTI 291
           L  N LSG +    SLG+   L+ L +S N                              
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGK----------------------- 143

Query: 292 PTSLRNCTSLIRVRLNGNNLTGNISEALGIY---PNLTFIDLSRNNFYGEISSNWGKFPK 348
            +      SL  + L+ N+++G       +      L  + +S N   G++     +   
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVN 201

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT 408
           L  L+VS NN + G+P  +G+ S LQ  D+S N + G+  + +     L  L +  NQ  
Sbjct: 202 LEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260

Query: 409 GRLPKEIGSLTKLEYLDFSA---IGELPSQIC-NMKSLEKLNLSHNNLSGSIPSCFEGMH 464
           G +P     L  L+YL  +     GE+P  +     +L  L+LS N+  G++P  F    
Sbjct: 261 GPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCS 318

Query: 465 GLSFIDMSYNELQCPVPNST 484
            L  + +S N     +P  T
Sbjct: 319 LLESLALSSNNFSGELPMDT 338

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  122 bits (309), Expect = 7e-29
 Identities = 44/172 (25%), Positives = 65/172 (37%), Gaps = 8/172 (4%)

Query: 14  NIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAE 73
           N                   +       F G    Q++ LS      + S  + G+    
Sbjct: 568 NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPT 627

Query: 74  VSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSN 133
                   N   M  L ++ N LSG+IP  IG++ +L  L+L +N  SG IP    +L  
Sbjct: 628 F------DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681

Query: 134 LIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPR--PFSNLTSVS 183
           L  L L  N L G I  ++  L  L ++ L++N L G IP    F       
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAK 733

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 81.9 bits (203), Expect = 4e-16
 Identities = 28/129 (21%), Positives = 45/129 (34%), Gaps = 10/129 (7%)

Query: 369 NSSQLQAFDLS---LNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLD 425
              ++ + DLS   LN     +   L  L  L  L L  + I G +         L  LD
Sbjct: 48  RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106

Query: 426 FSA---IGELPS--QICNMKSLEKLNLSHNNLSGSIP-SCFEGMHGLSFIDMSYNELQCP 479
            S     G + +   + +   L+ LN+S N L      S    ++ L  +D+S N +   
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 480 VPNSTTFRG 488
                    
Sbjct: 167 NVVGWVLSD 175

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  300 bits (770), Expect = 2e-91
 Identities = 76/517 (14%), Positives = 159/517 (30%), Gaps = 54/517 (10%)

Query: 1   CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFG----TIPPQISNLSNL 56
            N  GRV  +SL   G +G + D +      L  L L  +G         P  IS   + 
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 57  RYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLT 116
                    +    +     E    +   + +  IN +     I          +Q+   
Sbjct: 136 EQKQKMRMHYQKTFVDYDPRE----DFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQL 191

Query: 117 NNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPF 176
           +N  +  +  +   L+ L   Y+  +      +    + ++         Q        +
Sbjct: 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKW 245

Query: 177 SNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV--------LPPSISNLT 228
            NL  ++ + +        +P  +  +  + ++++  N+                     
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305

Query: 229 NLKELALLYNHL-SGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENH 286
            ++ + + YN+L +  +  SL  +  L  L    N   G           L    ++ N 
Sbjct: 306 KIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQ 364

Query: 287 FQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY--PNLTFIDLSRNNFYG------- 337
                         +  +    N L   I           ++ ID S N           
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423

Query: 338 EISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVG-------EIPKE 390
            +     K   + ++N+S N I+          S L + +L  N +         +  + 
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENEN 483

Query: 391 LGKLNPLTKLILRGNQITGRLPKEI--GSLTKLEYLDFS--AIGELPSQICNMKSLEKLN 446
                 LT + LR N++T  L  +    +L  L  +D S  +  + P+Q  N  +L+   
Sbjct: 484 FKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFG 542

Query: 447 LSH------NNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
           + +      N      P        L+ + +  N+++
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR 579

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  258 bits (661), Expect = 1e-75
 Identities = 71/459 (15%), Positives = 136/459 (29%), Gaps = 70/459 (15%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
           S +S   +  L L   G  G +P  I  L+ L  L LGS+    N               
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER------------- 122

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP--LSFDNLSNLIFLYLYGN 142
                         F P  I       Q       +          ++ S+LI   +  +
Sbjct: 123 -------------LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSD 169

Query: 143 LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGK 202
               SI  S         +    N +   + +    LT +    +  +        E  +
Sbjct: 170 PQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWE 228

Query: 203 MRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGN 261
             +                    NL +L ++ +        +P  L  L  ++ + ++ N
Sbjct: 229 NENSEYAQQY-----KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283

Query: 262 HFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT-GNISEALG 320
                                 +                +  + +  NNL    +  +L 
Sbjct: 284 RGIS----------------GEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQ 327

Query: 321 IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSL 380
               L  ++   N   G++ + +G   KL +LN++ N IT       G + Q++    + 
Sbjct: 328 KMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH 386

Query: 381 NHIVGEIPK--ELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICN 438
           N +   IP   +   ++ ++ +    N+I                +D      L      
Sbjct: 387 NKL-KYIPNIFDAKSVSVMSAIDFSYNEIGS--------------VDGKNFDPLDPTPFK 431

Query: 439 MKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
             ++  +NLS+N +S      F     LS I++  N L 
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  223 bits (571), Expect = 3e-63
 Identities = 69/420 (16%), Positives = 140/420 (33%), Gaps = 40/420 (9%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
            + S  GF      N  F  +LD+    +     +S ++   +  L L G   SG +  +
Sbjct: 45  KNWSQQGFGTQPGANWNFNKELDM----WGAQPGVSLNSNGRVTGLSLEGFGASGRVPDA 100

Query: 152 LGKLKSLFDLQLNDNQLIG----YIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGK--MRS 205
           +G+L  L  L L  +        + P+  S   S    +  R     +  D   +     
Sbjct: 101 IGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSD 160

Query: 206 LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFT 264
           L    +N +  +  +  S        ++  L N+++  +  ++  L  LRQ  +  + F 
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFV 219

Query: 265 GYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPN 324
                        E           T      N   L  V +        +   L   P 
Sbjct: 220 AENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPE 274

Query: 325 LTFIDLSRNNFYG--EISSNWGKFPKLG------TLNVSMNNITGG-LPREIGNSSQLQA 375
           +  I+++ N      ++  +W              + +  NN+    +   +    +L  
Sbjct: 275 MQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGM 334

Query: 376 FDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFS--AIGEL 432
            +   N + G++P   G    L  L L  NQIT  +P    G   ++E L F+   +  +
Sbjct: 335 LECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYI 392

Query: 433 PS--QICNMKSLEKLNLSHNNLSG-------SIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
           P+     ++  +  ++ S+N +          +         +S I++S N++       
Sbjct: 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKEL 452

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  152 bits (386), Expect = 8e-39
 Identities = 39/255 (15%), Positives = 73/255 (28%), Gaps = 23/255 (9%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPP--QISNLSNLRYLYLGSNQFSGNILAEVSSESSG-GN 82
                 +  L    N     IP      ++S +  +    N+                  
Sbjct: 373 CGFTEQVENLSFAHN-KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFK 431

Query: 83  LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-------PIPLSFDNLSNLI 135
              +S + +++N +S F          LS ++L  N  +            +F N   L 
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491

Query: 136 FLYLYGNLLSGSILS-SLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL------S 188
            + L  N L+          L  L  + L+ N      P    N +++    +       
Sbjct: 492 SIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQ 550

Query: 189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL 248
            N      P+ I    SL+ L +  N  +  +   I    N+  L +  N         +
Sbjct: 551 GNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYV 607

Query: 249 GNLI-LRQLLLSGNH 262
              I     +L  + 
Sbjct: 608 CPYIEAGMYMLFYDK 622

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  286 bits (735), Expect = 7e-86
 Identities = 104/485 (21%), Positives = 178/485 (36%), Gaps = 33/485 (6%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
            L   +F+ +  L  LD+ +N      P     L  L+ L L  N+ S        S+ +
Sbjct: 39  RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ------LSDKT 92

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYL 139
                 ++ L +  NS+           K L  LDL++N  S     +   L NL  L L
Sbjct: 93  FAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL 152

Query: 140 YGNLLSGSILSSLG--KLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
             N +       L      SL  L+L+ NQ+  + P  F  +  +  L L+   L  S+ 
Sbjct: 153 SNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT 212

Query: 198 DEIG---KMRSLSVLDLNQNQFKGVLPPSISNL--TNLKELALLYNHLSGSIPPSLGNLI 252
           +++       S+  L L+ +Q       +   L  TNL  L L YN+L+     S   L 
Sbjct: 213 EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLP 272

Query: 253 -LRQLLLSGNHFTGYLPYNICR---------GGALEIFTVSENHFQGTIPTSLRNCTSLI 302
            L    L  N+      +++             +    ++S          S +    L 
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332

Query: 303 RVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWG----KFPKLGTLNVSMNN 358
            + +  N++ G  S       NL ++ LS +       +N          L  LN++ N 
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNK 392

Query: 359 ITGGLPREIGNSSQLQAFDLSLNHIVGEIP-KELGKLNPLTKLILRGNQITGRLPKEIGS 417
           I+            L+  DL LN I  E+  +E   L  + ++ L  N+           
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452

Query: 418 LTKLEYLD-----FSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMS 472
           +  L+ L         +   PS    +++L  L+LS+NN++       EG+  L  +D+ 
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512

Query: 473 YNELQ 477
           +N L 
Sbjct: 513 HNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  274 bits (703), Expect = 3e-81
 Identities = 99/487 (20%), Positives = 173/487 (35%), Gaps = 40/487 (8%)

Query: 23  DFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGN 82
           +    +   L  L+L+ N      P     +  L  L+L + Q   ++  ++  E +  +
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223

Query: 83  LRYMSRLVINDNSLSGFIPPHIGNLKF--LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLY 140
           +R    L ++++ LS         LK+  L+ LDL+ N  +     SF  L  L + +L 
Sbjct: 224 IRN---LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLE 280

Query: 141 GNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI 200
            N +      SL  L ++  L L  +                    +S   L        
Sbjct: 281 YNNIQHLFSHSLHGLFNVRYLNLKRSFT---------------KQSISLASLPKIDDFSF 325

Query: 201 GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-----SLGNLILRQ 255
             ++ L  L++  N   G+     + L NLK L+L  +  S          SL +  L  
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 256 LLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIP-TSLRNCTSLIRVRLNGNNLTGN 314
           L L+ N  +          G LE+  +  N     +     R   ++  + L+ N     
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445

Query: 315 ISEALGIYPNLTFIDLSRNNFYG--EISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQ 372
              +  + P+L  + L R          S +     L  L++S NNI       +    +
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK 505

Query: 373 LQAFDLSLNHI--------VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL 424
           L+  DL  N++         G     L  L+ L  L L  N       +    L +L+ +
Sbjct: 506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKII 565

Query: 425 DFS--AIGELPSQI-CNMKSLEKLNLSHNNLSGSIPSCFE-GMHGLSFIDMSYNELQCPV 480
           D     +  LP+ +  N  SL+ LNL  N ++      F      L+ +DM +N   C  
Sbjct: 566 DLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTC 625

Query: 481 PNSTTFR 487
            +   F 
Sbjct: 626 ESIAWFV 632

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  271 bits (694), Expect = 5e-80
 Identities = 99/482 (20%), Positives = 168/482 (34%), Gaps = 34/482 (7%)

Query: 32  LAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVI 91
               D +       +P  +   +N+  L L  NQ            ++      ++ L +
Sbjct: 6   HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRR------LPAANFTRYSQLTSLDV 56

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
             N++S   P     L  L  L+L +N+ S     +F   +NL  L+L  N +     + 
Sbjct: 57  GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116

Query: 152 LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG--KMRSLSVL 209
             K K+L  L L+ N L          L ++  L LS N +     +E+      SL  L
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI----LRQLLLSGNHFTG 265
           +L+ NQ K   P     +  L  L L    L  S+   L   +    +R L LS +  + 
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 266 YLPYNI--CRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYP 323
                    +   L +  +S N+       S      L    L  NN+    S +L    
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLF 296

Query: 324 NLTFIDLSRNNFYGEISSN---------WGKFPKLGTLNVSMNNITGGLPREIGNSSQLQ 374
           N+ +++L R+     IS           +     L  LN+  N+I G           L+
Sbjct: 297 NVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK 356

Query: 375 AFDLSLNHIVGEIPKELG----KLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA-- 428
              LS +                 +PL  L L  N+I+         L  LE LD     
Sbjct: 357 YLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNE 416

Query: 429 -IGELPSQ-ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTF 486
              EL  Q    ++++ ++ LS+N       + F  +  L  + +    L+    + + F
Sbjct: 417 IGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476

Query: 487 RG 488
           + 
Sbjct: 477 QP 478

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  268 bits (687), Expect = 5e-79
 Identities = 103/497 (20%), Positives = 161/497 (32%), Gaps = 61/497 (12%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
            + +  F    +L  LDL+ NG   T       L NL+ L L +N+              
Sbjct: 111 KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA----------- 159

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYL 139
                      +    L  F          L +L+L++N+     P  F  +  L  L+L
Sbjct: 160 -----------LKSEELDIF------ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202

Query: 140 YGNLLSGSILSSLG---KLKSLFDLQLNDNQLIGYIPRPFSNL--TSVSTLRLSRNDLFG 194
               L  S+   L       S+ +L L+++QL       F  L  T+++ L LS N+L  
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV 262

Query: 195 SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN---------HLSGSIP 245
              D    +  L    L  N  + +   S+  L N++ L L  +          L     
Sbjct: 263 VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322

Query: 246 PSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSL----RNCTS 300
            S   L  L  L +  N   G           L+  ++S +       T+        + 
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382

Query: 301 LIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN-WGKFPKLGTLNVSMNNI 359
           L  + L  N ++   S+A     +L  +DL  N    E++   W     +  + +S N  
Sbjct: 383 LHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY 442

Query: 360 TGGLPREIGNSSQLQAFDLSLNHI--VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGS 417
                        LQ   L    +  V   P     L  LT L L  N I       +  
Sbjct: 443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEG 502

Query: 418 LTKLEYLDFS-----------AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGL 466
           L KLE LD               G     +  +  L  LNL  N         F+ +  L
Sbjct: 503 LEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562

Query: 467 SFIDMSYNELQCPVPNS 483
             ID+  N L     + 
Sbjct: 563 KIIDLGLNNLNTLPASV 579

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  234 bits (600), Expect = 8e-67
 Identities = 84/409 (20%), Positives = 149/409 (36%), Gaps = 41/409 (10%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
           +   L+  +P  +     ++ L+LT+N+       +F   S L  L +  N +S      
Sbjct: 12  SHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPEL 68

Query: 152 LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDL 211
             KL  L  L L  N+L     + F+  T+++ L L  N +     +   K ++L  LDL
Sbjct: 69  CQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDL 128

Query: 212 NQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNI 271
           + N        +   L NL+EL L  N +       L                       
Sbjct: 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS---------------- 172

Query: 272 CRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY---PNLTFI 328
                L+   +S N  +   P        L  + LN   L  +++E L +     ++  +
Sbjct: 173 -----LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNL 227

Query: 329 DLSRNNFYGEISSNWG--KFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGE 386
            LS +      ++ +   K+  L  L++S NN+            QL+ F L  N+I   
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHL 287

Query: 387 IPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLN 446
               L  L  +  L L+ +     +     SL  L  +D  +          +K LE LN
Sbjct: 288 FSHSLHGLFNVRYLNLKRSFTKQSI-----SLASLPKIDDFSFQ-------WLKCLEHLN 335

Query: 447 LSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALK 495
           +  N++ G   + F G+  L ++ +S +        + TF   +   L 
Sbjct: 336 MEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  223 bits (571), Expect = 7e-63
 Identities = 83/432 (19%), Positives = 137/432 (31%), Gaps = 34/432 (7%)

Query: 6   RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNL--SNLRYLYLGS 63
             + ++   +G + T       +   +  L L+ +    T       L  +NL  L L  
Sbjct: 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY 257

Query: 64  NQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNN----- 118
           N  +           S   L  +    +  N++       +  L  +  L+L  +     
Sbjct: 258 NNLNV------VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311

Query: 119 ----KFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL--FDLQLNDNQLIGYI 172
                       SF  L  L  L +  N + G   +    L +L    L  +   L    
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371

Query: 173 PRPFSNLTSVS--TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPS-ISNLTN 229
              F +L       L L++N +     D    +  L VLDL  N+    L       L N
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431

Query: 230 LKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTG--YLPYNICRGGALEIFTVSENH 286
           + E+ L YN        S   +  L++L+L           P        L I  +S N+
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491

Query: 287 FQGTIPTSLRNCTSLIRVRLNGNNLT--------GNISEALGIYPNLTFIDLSRNNFYGE 338
                   L     L  + L  NNL         G     L    +L  ++L  N F   
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551

Query: 339 ISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGK-LNPL 397
               +    +L  +++ +NN+         N   L++ +L  N I     K  G     L
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611

Query: 398 TKLILRGNQITG 409
           T+L +R N    
Sbjct: 612 TELDMRFNPFDC 623

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  164 bits (418), Expect = 1e-42
 Identities = 62/290 (21%), Positives = 105/290 (36%), Gaps = 14/290 (4%)

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHF 263
           S  V D +  +   V P  +   TN+  L L +N L      +      L  L +  N  
Sbjct: 5   SHEVADCSHLKLTQV-PDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 264 TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYP 323
           +   P    +   L++  +  N        +   CT+L  + L  N++    +       
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 324 NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIG--NSSQLQAFDLSLN 381
           NL  +DLS N           +   L  L +S N I      E+    +S L+  +LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 382 HIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIG---SLTKLEYLDFS--AIGELPSQI 436
            I    P     +  L  L L   Q+   L +++    + T +  L  S   +    +  
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 437 ---CNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
                  +L  L+LS+NNL+      F  +  L +  + YN +Q    +S
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHS 291

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  265 bits (679), Expect = 1e-78
 Identities = 103/487 (21%), Positives = 170/487 (34%), Gaps = 38/487 (7%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
            L  +SF SFP L  LDL+             +LS+L  L L  N           +  +
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS------LALGA 95

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKF-SGPIPLSFDNLSNLIFLY 138
              L  + +LV  + +L+      IG+LK L +L++ +N   S  +P  F NL+NL  L 
Sbjct: 96  FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLD 155

Query: 139 LYGNLLSGSILSSLGKLKSL----FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFG 194
           L  N +     + L  L  +      L L+ N +    P  F  +  +  L L  N    
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSL 214

Query: 195 SIPDE-IGKMRSLSVLDLNQNQFKG---VLPPSISNLTNLKELALLYNHLS------GSI 244
           ++    I  +  L V  L   +F+    +     S L  L  L +    L+        I
Sbjct: 215 NVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDI 274

Query: 245 PPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIR 303
                 L  +    L          ++   G   +   +    F       L++      
Sbjct: 275 IDLFNCLTNVSSFSLVSVTIERVKDFSYNFG--WQHLELVNCKFGQFPTLKLKSLKR--- 329

Query: 304 VRLNGNNLTGNISEALGIYPNLTFIDLSRN--NFYGEISSNWGKFPKLGTLNVSMNNITG 361
             L   +  G  + +    P+L F+DLSRN  +F G  S +      L  L++S N +  
Sbjct: 330 --LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI- 386

Query: 362 GLPREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEIGSLTK 420
            +        QL+  D   +++           L  L  L +               L+ 
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446

Query: 421 LEYLDFS----AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNEL 476
           LE L  +        LP     +++L  L+LS   L    P+ F  +  L  ++MS+N  
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506

Query: 477 QCPVPNS 483
                  
Sbjct: 507 FSLDTFP 513

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  258 bits (661), Expect = 5e-76
 Identities = 98/486 (20%), Positives = 176/486 (36%), Gaps = 36/486 (7%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
           T+ D ++ S  HL+ L LT N          S LS+L+ L       +            
Sbjct: 66  TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE------NFP 119

Query: 80  GGNLRYMSRLVINDNSLSGF-IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNL---- 134
            G+L+ +  L +  N +  F +P +  NL  L  LDL++NK           L  +    
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLN 179

Query: 135 IFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRNDLF 193
           + L L  N ++     +  ++  L  L L +N     + +     L  +   RL   +  
Sbjct: 180 LSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR 238

Query: 194 GSI---PDEIGKMRSLSVLDLNQNQ------FKGVLPPSISNLTNLKELALLYNHLSGSI 244
                   +   +  L  L + + +      +   +    + LTN+   +L+   +   +
Sbjct: 239 NEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-V 297

Query: 245 PPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRV 304
                N   + L L    F  +    +     L          +G    S  +  SL  +
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEFL 352

Query: 305 RLNGNNLT--GNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGG 362
            L+ N L+  G  S++     +L ++DLS N     +SSN+    +L  L+   +N+   
Sbjct: 353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQM 411

Query: 363 LPREI-GNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTK 420
               +  +   L   D+S  H           L+ L  L + GN        +I   L  
Sbjct: 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471

Query: 421 LEYLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
           L +LD S        P+   ++ SL+ LN+SHNN        ++ ++ L  +D S N + 
Sbjct: 472 LTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531

Query: 478 CPVPNS 483
                 
Sbjct: 532 TSKKQE 537

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  231 bits (591), Expect = 3e-66
 Identities = 77/410 (18%), Positives = 143/410 (34%), Gaps = 27/410 (6%)

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS 147
            L ++ N L         +   L  LDL+  +       ++ +LS+L  L L GN +   
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSL 91

Query: 148 ILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL-FGSIPDEIGKMRSL 206
            L +   L SL  L   +  L      P  +L ++  L ++ N +    +P+    + +L
Sbjct: 92  ALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 207 SVLDLNQNQFKGVLPPSISNLTNLK----ELALLYNHLSGSIPPSLGNLILRQLLLSGNH 262
             LDL+ N+ + +    +  L  +      L L  N ++   P +   + L +L L  N 
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211

Query: 263 FTGYLPYNICRG-GALEIFTVSENHFQGT------IPTSLRNCTSLIRVRLNGNNL---T 312
            +  +     +G   LE+  +    F+          ++L    +L         L    
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271

Query: 313 GNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQ 372
            +I +      N++   L       E   ++        L +                  
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTI--ERVKDFSYNFGWQHLELVNCKFGQ-----FPTLKL 324

Query: 373 LQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT--GRLPKEIGSLTKLEYLDFS--A 428
                L+     G        L  L  L L  N ++  G   +     T L+YLD S   
Sbjct: 325 KSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 429 IGELPSQICNMKSLEKLNLSHNNLSGSIP-SCFEGMHGLSFIDMSYNELQ 477
           +  + S    ++ LE L+  H+NL      S F  +  L ++D+S+   +
Sbjct: 385 VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  209 bits (533), Expect = 3e-58
 Identities = 88/467 (18%), Positives = 154/467 (32%), Gaps = 45/467 (9%)

Query: 20  TLHDFSFSSFPHLAY----LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVS 75
           +++         +      LDL+ N     I P       L  L L +N  S N++    
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLN-PMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221

Query: 76  SESSGGNLRYMSRLVI-NDNSLSGFIPPHIGNLKFLSQLDL---TNNKFSGPIPLSFDNL 131
              +G  +  +      N+ +L  F    +  L  L+  +      + +   I   F+ L
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281

Query: 132 SNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND 191
           +N+    L    +    +           L+L + +   +      +L       L+   
Sbjct: 282 TNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKR-----LTFTS 334

Query: 192 LFGSIPDEIGKMRSLSVLDL--NQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLG 249
             G        + SL  LDL  N   FKG    S    T+LK L L +N +   +  +  
Sbjct: 335 NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFL 393

Query: 250 NLI-LRQLLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLN 307
            L  L  L    ++      +++      L    +S  H +          +SL  +++ 
Sbjct: 394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 453

Query: 308 GNNLTGNI-SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPRE 366
           GN+   N   +      NLTF+DLS+        + +     L  LN+S NN        
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513

Query: 367 IGNSSQLQAFDLSLNHIVGEIPKELGKLNP-LTKLILRGNQITGRLPKEIGSLTKLEYLD 425
               + LQ  D SLNHI+    +EL      L  L L  N                    
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE------------- 560

Query: 426 FSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMS 472
                   S +  +K   +L +    +  + PS      G+  + ++
Sbjct: 561 ------HQSFLQWIKDQRQLLVEVERMECATPS---DKQGMPVLSLN 598

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  201 bits (514), Expect = 1e-55
 Identities = 82/406 (20%), Positives = 131/406 (32%), Gaps = 32/406 (7%)

Query: 100 IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLF 159
           IP ++        LDL+ N        SF +   L  L L    +      +   L  L 
Sbjct: 22  IPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 160 DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV 219
            L L  N +       FS L+S+  L     +L       IG +++L  L++  N  +  
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 220 -LPPSISNLTNLKELALLYNHLSGSIPPSLGNL-----ILRQLLLSGNHFTGYLPYNICR 273
            LP   SNLTNL+ L L  N +       L  L     +   L LS N      P    +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFK 198

Query: 274 GGALEIFTVSENHFQGTIP-TSLRNCTSLIRVRLNGNNLTGNI---SEALGIYPNLTFID 329
              L   T+  N     +  T ++    L   RL                     L  + 
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258

Query: 330 LSRNN------FYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI 383
           +          +  +I   +     + + ++    I     ++   +   Q  +L     
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKF 316

Query: 384 VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS-----AIGELPSQICN 438
                 +L  L  LT    +G             L  LE+LD S       G        
Sbjct: 317 GQFPTLKLKSLKRLTFTSNKGGNAFS-----EVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 439 MKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNST 484
             SL+ L+LS N +   + S F G+  L  +D  ++ L+     S 
Sbjct: 372 TTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 13/53 (24%), Positives = 22/53 (41%), Gaps = 2/53 (3%)

Query: 431 ELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
           ++P  +    S + L+LS N L       F     L  +D+S  E+Q     +
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  252 bits (646), Expect = 4e-77
 Identities = 88/283 (31%), Positives = 135/283 (47%), Gaps = 27/283 (9%)

Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV 639
             E+  A+++F  K  +G GG   VY+  L  G +VAVK+   L        + +F TEV
Sbjct: 22  LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR---LKEERTQGGELQFQTEV 78

Query: 640 EA-----------FYGFCSHARHSFLLYEFLERGSLA-AILNTDAAAQELGWSQRMNVIK 687
           E              GFC       L+Y ++  GS+A  +     +   L W +R  +  
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138

Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-WTEFAGT 746
             A  L+YLH  C P I+HRD+ + N+LLD E+EA V DFG+AK +    ++  T   GT
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198

Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN---------TD 797
            G+IAPE   T K +EK DV+ +GV++ E+I G+   D     +   +           +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTM 840
             L+ ++D  L        E++  +++VA  C   SP  RP M
Sbjct: 259 KKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKM 299

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  254 bits (649), Expect = 2e-72
 Identities = 61/480 (12%), Positives = 137/480 (28%), Gaps = 41/480 (8%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNI-LAEVSSESSGGNL 83
              +   +  L L   G  G +P  I  L+ L+ L  G++  + +  L      +   + 
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377

Query: 84  RYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNL 143
               R+ ++   +       +     L      N +       S  +L +     L   +
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI 437

Query: 144 LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKM 203
               I  ++ +L  L  +   ++                          + +       +
Sbjct: 438 --TFISKAIQRLTKLQIIYFANSPFTYDNIAVDWED-----ANSDYAKQYENEELSWSNL 490

Query: 204 RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG---------SIPPSLGNLI-L 253
           + L+ ++L        LP  + +L  L+ L +  N              +         +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

Query: 254 RQLLLSGNHFTGYLP--YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNL 311
           +   +  N+     P   ++ +   L +     N        +      L  ++L+ N +
Sbjct: 551 QIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQI 607

Query: 312 TGNISEALGIYPNLTFIDLSRNNFYG-EISSNWGKFPKLGTLNVSMNNITG-----GLPR 365
                +       +  +  S N         N      +G+++ S N I           
Sbjct: 608 EEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667

Query: 366 EIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT-------GRLPKEIGSL 418
           +           LS N I     +     +P++ +IL  N +T               + 
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNT 727

Query: 419 TKLEYLDFSA--IGELPSQI--CNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYN 474
             L  +D     +  L        +  L  +++S+N  S S P+       L    + + 
Sbjct: 728 YLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ 786

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  217 bits (555), Expect = 1e-59
 Identities = 75/469 (15%), Positives = 134/469 (28%), Gaps = 96/469 (20%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
              + S+S+   L  ++L        +P  + +L  L+ L +  N+              
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS----------- 529

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-PIPLSFDNLSNLIFLY 138
                          +    +         +    +  N     P   S   +  L  L 
Sbjct: 530 ----------AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLD 579

Query: 139 LYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPD 198
              N +    L + G    L DL+L+ NQ+        +    V  L  S N L   IP+
Sbjct: 580 CVHNKV--RHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKL-KYIPN 636

Query: 199 --EIGKMRSLSVLDLNQNQFKGV-----LPPSISNLTNLKELALLYNHLSGSIPPSLGNL 251
                 +  +  +D + N+                  N   + L YN +           
Sbjct: 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATG 696

Query: 252 I-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNN 310
             +  ++LS N  T  +P N                       + +N   L  + L  N 
Sbjct: 697 SPISTIILSNNLMTS-IPENSL----------------KPKDGNYKNTYLLTTIDLRFNK 739

Query: 311 LTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS 370
           LT  +S+                             P L  ++VS N  +   P +  NS
Sbjct: 740 LTS-LSDDFRA----------------------TTLPYLSNMDVSYNCFS-SFPTQPLNS 775

Query: 371 SQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--A 428
           SQL+AF +                         GN+I  + P  I +   L  L      
Sbjct: 776 SQLKAFGIRHQ------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSND 817

Query: 429 IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
           I ++  ++     L  L+++ N       +            + Y++ Q
Sbjct: 818 IRKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  192 bits (488), Expect = 6e-51
 Identities = 66/444 (14%), Positives = 133/444 (29%), Gaps = 61/444 (13%)

Query: 91  INDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGP-----------------------IPLS 127
           I     + +I  +         LD  N ++                            + 
Sbjct: 259 IQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVD 318

Query: 128 FDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL 187
            DN   +  L L G    G +  ++G+L  L  L    +              +      
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378

Query: 188 SRNDLFGSIPDEIGKM-RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG---- 242
            ++ +            + L++ DL Q+       P +  +     ++L    +      
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNR 436

Query: 243 --SIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCT 299
              I  ++  L  L+ +  + + FT             E               S  N  
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLK 491

Query: 300 SLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYG---------EISSNWGKFPKLG 350
            L  V L        + + L   P L  ++++ N              ++ +    PK+ 
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQ 551

Query: 351 TLNVSMNNITG-GLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG 409
              +  NN+        +    +L   D   N +     +  G    LT L L  NQI  
Sbjct: 552 IFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE 609

Query: 410 RLPKEIGS-LTKLEYLDFS--AIGELPS--QICNMKSLEKLNLSHNNLSGSIPSCFEGMH 464
            +P++  +   ++E L FS   +  +P+     ++  +  ++ S+N +     +    M 
Sbjct: 610 -IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMD 668

Query: 465 G-----LSFIDMSYNELQCPVPNS 483
                  S + +SYNE+Q      
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTEL 692

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  121 bits (304), Expect = 3e-28
 Identities = 33/247 (13%), Positives = 63/247 (25%), Gaps = 47/247 (19%)

Query: 18  NGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSE 77
                        + + + L++N          +  S +  + L +N  +          
Sbjct: 661 RNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS--------- 711

Query: 78  SSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-PIPLSFDNLSNLIF 136
                        I +NSL      +  N   L+ +DL  NK +          L  L  
Sbjct: 712 -------------IPENSLKP-KDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSN 757

Query: 137 LYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSI 196
           + +  N  S S  +       L    +   +                      N +    
Sbjct: 758 MDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRD------------------AEGNRILRQW 798

Query: 197 PDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL-SGSIPPSLGNLILRQ 255
           P  I    SL  L +  N  +  +   +     L  L +  N   S  +      +    
Sbjct: 799 PTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGM 855

Query: 256 LLLSGNH 262
            +L  + 
Sbjct: 856 YVLLYDK 862

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  114 bits (286), Expect = 4e-26
 Identities = 36/307 (11%), Positives = 79/307 (25%), Gaps = 37/307 (12%)

Query: 179 LTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN 238
           LT  + + +   +    I D          LD    ++      +  +  N      L +
Sbjct: 251 LTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKEL-D 309

Query: 239 HLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRN 297
                    L N   +  L L+G    G                         +P ++  
Sbjct: 310 MWGDQPGVDLDNNGRVTGLSLAGFGAKG------------------------RVPDAIGQ 345

Query: 298 CTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFP-KLGTLNVSM 356
            T L  +    ++ T +              +  ++         +  +  +L   ++  
Sbjct: 346 LTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ 405

Query: 357 NNITGGLPREIGNSSQLQAFDLSLNHIVG------EIPKELGKLNPLTKLILRGNQITGR 410
           + I      E+    +     L    I         I K + +L  L  +    +  T  
Sbjct: 406 DAINRNP--EMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYD 463

Query: 411 LPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFID 470
                      +Y              N+K L  + L +      +P     +  L  ++
Sbjct: 464 NIAVDWEDANSDYAKQY--ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLN 521

Query: 471 MSYNELQ 477
           ++ N   
Sbjct: 522 IACNRGI 528

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.8 bits (124), Expect = 8e-07
 Identities = 17/109 (15%), Positives = 33/109 (30%), Gaps = 21/109 (19%)

Query: 376 FDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQ 435
           F+  L+    +   +L     +T L L G    GR+P  IG LT+L+ L           
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLS---------- 353

Query: 436 ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNST 484
                         ++ + S     +        +   + ++       
Sbjct: 354 -----------FGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  237 bits (607), Expect = 1e-71
 Identities = 83/340 (24%), Positives = 134/340 (39%), Gaps = 55/340 (16%)

Query: 177 SNLTS-VSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV--LPPSISNLTNLKEL 233
           + L+S + T         G + D   +   ++ LDL+         +P S++NL  L  L
Sbjct: 22  TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81

Query: 234 ALL-YNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTI 291
            +   N+L G IPP++  L  L  L ++  + +G                         I
Sbjct: 82  YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG------------------------AI 117

Query: 292 PTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGT 351
           P  L    +L+ +  + N L+G +  ++   PNL  I    N   G I  ++G F KL T
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177

Query: 352 -LNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGR 410
            + +S N +TG +P    N + L   DLS N + G+     G      K+ L  N +   
Sbjct: 178 SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236

Query: 411 LPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFID 470
           L  ++G    L  LD                     L +N + G++P     +  L  ++
Sbjct: 237 LG-KVGLSKNLNGLD---------------------LRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 471 MSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPC 510
           +S+N L   +P     +   V A   NK LCGS   L  C
Sbjct: 275 VSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS--PLPAC 312

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  237 bits (606), Expect = 1e-71
 Identities = 70/304 (23%), Positives = 118/304 (38%), Gaps = 36/304 (11%)

Query: 35  LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSG--NILAEVSSESSGGNLRYMSRLVI- 91
            D     + G +    +    +  L L          I + +       NL Y++ L I 
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL------ANLPYLNFLYIG 84

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
             N+L G IPP I  L  L  L +T+   SG IP     +  L+ L    N LSG++  S
Sbjct: 85  GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS 144

Query: 152 LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVST-LRLSRNDLFGSIPDEIGKMRSLSVLD 210
           +  L +L  +  + N++ G IP  + + + + T + +SRN L G IP     + +L+ +D
Sbjct: 145 ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVD 203

Query: 211 LNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYN 270
           L++N  +G       +  N +++ L  N L+  +   +G                     
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSK------------------ 244

Query: 271 ICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDL 330
                 L    +  N   GT+P  L     L  + ++ NNL G I +  G          
Sbjct: 245 -----NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAY 298

Query: 331 SRNN 334
           + N 
Sbjct: 299 ANNK 302

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  233 bits (598), Expect = 2e-70
 Identities = 73/267 (27%), Positives = 122/267 (45%), Gaps = 14/267 (5%)

Query: 1   CNDAG---RVINISLPNIGVNGTLH-DFSFSSFPHLAYLDLT-WNGFFGTIPPQISNLSN 55
           C+      RV N+ L  + +        S ++ P+L +L +   N   G IPP I+ L+ 
Sbjct: 43  CDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQ 102

Query: 56  LRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDL 115
           L YLY+     SG I   +        ++ +  L  + N+LSG +PP I +L  L  +  
Sbjct: 103 LHYLYITHTNVSGAIPDFL------SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156

Query: 116 TNNKFSGPIPLSFDNLSNLI-FLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPR 174
             N+ SG IP S+ + S L   + +  N L+G I  +   L +L  + L+ N L G    
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215

Query: 175 PFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA 234
            F +  +   + L++N L   +  ++G  ++L+ LDL  N+  G LP  ++ L  L  L 
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 235 LLYNHLSGSIPPSLGNLILRQLLLSGN 261
           + +N+L G IP             + N
Sbjct: 275 VSFNNLCGEIPQGGNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 68.7 bits (169), Expect = 1e-12
 Identities = 25/103 (24%), Positives = 42/103 (40%), Gaps = 10/103 (9%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
            F S  +   + L  N     +  ++    NL  L L +N+  G +   +        L+
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGL------TQLK 268

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKF--SGPIP 125
           ++  L ++ N+L G IP   GNL+        NNK     P+P
Sbjct: 269 FLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSPLP 310

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  240 bits (615), Expect = 1e-69
 Identities = 89/475 (18%), Positives = 164/475 (34%), Gaps = 25/475 (5%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
           T+ + +FS   +L +LDLT    +        +   L  L L +N           +E++
Sbjct: 47  TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIF------MAETA 100

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYL 139
               + +  L      +S      + N K L  L L +N  S            L  L  
Sbjct: 101 LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDF 160

Query: 140 YGNLLSGSILSSLGKLKSL--FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
             N +       +  L+      L LN N  I  I     +     +L          I 
Sbjct: 161 QNNAIHYLSKEDMSSLQQATNLSLNLNGND-IAGIEPGAFDSAVFQSLNFGGTQNLLVIF 219

Query: 198 DEIG--KMRSLSVLDLNQNQFKGVLPPSISNL--TNLKELALLYNHLSGSIPPSLGNLI- 252
             +    ++SL +        + + P     L   +++ + L  ++       +      
Sbjct: 220 KGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG 279

Query: 253 LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
           L++L L+  H +  LP  +     L+   +S N F+     S  N  SL  + + GN   
Sbjct: 280 LQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338

Query: 313 GNI-SEALGIYPNLTFIDLSRNNFY--GEISSNWGKFPKLGTLNVSMNNITGGLPREIGN 369
             + +  L    NL  +DLS ++       +        L +LN+S N            
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKE 398

Query: 370 SSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS- 427
             QL+  DL+   +  +  +     L+ L  L L  + +     +    L  L++L+   
Sbjct: 399 CPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQG 458

Query: 428 -----AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
                   +  + +  +  LE L LS  +LS      F  +  ++ +D+S+N L 
Sbjct: 459 NHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT 513

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  238 bits (609), Expect = 1e-68
 Identities = 99/475 (20%), Positives = 164/475 (34%), Gaps = 24/475 (5%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
            + + + S    L +L     G        + N   L  LYLGSN  S   L        
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL------PK 148

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQ--LDLTNNKFSGPIPLSFDNLSNLIFL 137
           G     +  L   +N++       + +L+  +   L+L  N  +G I     + +    L
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSL 207

Query: 138 YLYGNLLSGSILSSLG--KLKSLFDLQLNDNQLIGYIPRPFSNL--TSVSTLRLSRNDLF 193
              G      I   L    ++SL+     D       P  F  L   SV ++ L ++  F
Sbjct: 208 NFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFF 267

Query: 194 GSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI- 252
               +       L  LDL        LP  +  L+ LK+L L  N        S  N   
Sbjct: 268 NISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPS 326

Query: 253 LRQLLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQ--GTIPTSLRNCTSLIRVRLNGN 309
           L  L + GN     L          L    +S +  +        LRN + L  + L+ N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386

Query: 310 NLTGNISEALGIYPNLTFIDLSRNNFYGEIS-SNWGKFPKLGTLNVSMNNITGGLPREIG 368
                 +EA    P L  +DL+      + + S +     L  LN+S + +     +   
Sbjct: 387 EPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFD 446

Query: 369 NSSQLQAFDLSLNHIVGEIPKELGKLNPLTK---LILRGNQITGRLPKEIGSLTKLEYLD 425
               LQ  +L  NH      ++   L  L +   L+L    ++        SL  + ++D
Sbjct: 447 GLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVD 506

Query: 426 FS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC 478
            S   +     +  +      LNL+ N++S  +PS    +     I++  N L C
Sbjct: 507 LSHNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  236 bits (604), Expect = 4e-68
 Identities = 81/457 (17%), Positives = 145/457 (31%), Gaps = 25/457 (5%)

Query: 35  LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDN 94
            +    G    IP  +   ++   L    N             ++   L  ++ L +   
Sbjct: 17  YNCENLGLN-EIPGTLP--NSTECLEFSFNVLPT------IQNTTFSRLINLTFLDLTRC 67

Query: 95  SLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGK 154
            +         +   L  L LT N        +      L  L+     +S      L  
Sbjct: 68  QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127

Query: 155 LKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSV--LDLN 212
            K+L  L L  N +             +  L    N +     +++  ++  +   L+LN
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLN 187

Query: 213 QNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI---LRQLLLSGNHFTG--YL 267
            N   G + P   +    + L          I   L N     L                
Sbjct: 188 GNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF 327
            +      ++E   + +++F      +    + L  + L   +L+  +   L     L  
Sbjct: 247 VFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKK 305

Query: 328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPRE-IGNSSQLQAFDLSLNHI--V 384
           + LS N F      +   FP L  L++  N     L    + N   L+  DLS + I   
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETS 365

Query: 385 GEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQ--ICNMK 440
                +L  L+ L  L L  N+      +      +LE LD +   +    +Q    N+ 
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425

Query: 441 SLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
            L+ LNLSH+ L  S    F+G+  L  +++  N   
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFP 462

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  221 bits (566), Expect = 9e-63
 Identities = 83/451 (18%), Positives = 151/451 (33%), Gaps = 22/451 (4%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
           ++      +   L  L L  N       P+      L+ L   +N        ++SS   
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQ- 177

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP--LSFDNLSNLIFL 137
                 +S L +N N ++G I P   +      L+    +    I   L    + +L   
Sbjct: 178 --QATNLS-LNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233

Query: 138 YLYGNLLSGSILSSLGKLK--SLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGS 195
                       +    L   S+  + L  +         F   + +  L L+   L   
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SE 292

Query: 196 IPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-L 253
           +P  +  + +L  L L+ N+F+ +   S SN  +L  L++  N     +    L NL  L
Sbjct: 293 LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352

Query: 254 RQLLLSGNHFT--GYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNL 311
           R+L LS +           +     L+   +S N        + + C  L  + L    L
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412

Query: 312 TGNISE-ALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIG-- 368
               ++        L  ++LS +         +   P L  LN+  N+   G  ++    
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472

Query: 369 -NSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS 427
               +L+   LS   +          L  +  + L  N++T     E  S  K  YL+ +
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLA 531

Query: 428 A---IGELPSQICNMKSLEKLNLSHNNLSGS 455
           +      LPS +  +     +NL  N L  +
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  217 bits (556), Expect = 2e-61
 Identities = 80/406 (19%), Positives = 132/406 (32%), Gaps = 18/406 (4%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
            +  L+  IP  +        L+ + N        +F  L NL FL L    +      +
Sbjct: 20  ENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 152 LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDL 211
                 L  L L  N LI       S   ++  L   +  +       +   ++L  L L
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136

Query: 212 NQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP---PSLGNLILRQLLLSGNHFTGYLP 268
             N    +  P       LK L    N +         SL       L L+GN   G + 
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IE 195

Query: 269 YNICRGGALEIFTVSENHFQGTIPTSLRNCT--SLIRVRLNGNNLTGNISEALGIYP--N 324
                    +            I   L+N T  SL        +               +
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255

Query: 325 LTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIV 384
           +  I+L ++ F+   S+ +  F  L  L+++  +++  LP  +   S L+   LS N   
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314

Query: 385 GEIPKELGKLNPLTKLILRGNQITGRLPKE-IGSLTKLEYLDFS-----AIGELPSQICN 438
                       LT L ++GN     L    + +L  L  LD S            Q+ N
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

Query: 439 MKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNST 484
           +  L+ LNLS+N         F+    L  +D+++  L+     S 
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  166 bits (423), Expect = 1e-43
 Identities = 61/329 (18%), Positives = 107/329 (32%), Gaps = 18/329 (5%)

Query: 24  FSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNL 83
           F       +  ++L  + FF          S L+ L L +   S          S    L
Sbjct: 248 FEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-------ELPSGLVGL 300

Query: 84  RYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPI-PLSFDNLSNLIFLYLYGN 142
             + +LV++ N           N   L+ L +  N     +     +NL NL  L L  +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360

Query: 143 LLSGSILS--SLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI 200
            +  S      L  L  L  L L+ N+ +      F     +  L L+   L        
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420

Query: 201 -GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI----LRQ 255
              +  L VL+L+ +            L  L+ L L  NH          +L     L  
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480

Query: 256 LLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGN 314
           L+LS    +  +  +       +    +S N    +   +L +   +  + L  N+++  
Sbjct: 481 LVLSFCDLSS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISII 538

Query: 315 ISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           +   L I      I+L +N      S+ +
Sbjct: 539 LPSLLPILSQQRTINLRQNPLDCTCSNIY 567

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  129 bits (327), Expect = 2e-31
 Identities = 53/262 (20%), Positives = 90/262 (34%), Gaps = 17/262 (6%)

Query: 19  GTLHDFSFSSFPHLAYLDLTWN--GFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSS 76
             L      +  +L  LDL+ +          Q+ NLS+L+ L L  N+           
Sbjct: 339 LELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS------LK 392

Query: 77  ESSGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLI 135
             +      +  L +    L          NL  L  L+L+++         FD L  L 
Sbjct: 393 TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ 452

Query: 136 FLYLYGNLLSGSI---LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL 192
            L L GN          +SL  L  L  L L+   L       F++L  ++ + LS N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512

Query: 193 FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI 252
             S  + +  ++ +  L+L  N    +LP  +  L+  + + L  N L  +      N+ 
Sbjct: 513 TSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC----SNIY 567

Query: 253 LRQLLLSGNHFTGYLPYNICRG 274
             +               +C  
Sbjct: 568 FLEWYKENMQKLEDTEDTLCEN 589

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 97.4 bits (243), Expect = 4e-21
 Identities = 31/231 (13%), Positives = 68/231 (29%), Gaps = 11/231 (4%)

Query: 292 PTSLRNCT---SLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK 348
            +S + C               L   I   L    +   ++ S N      ++ + +   
Sbjct: 2   TSSDQKCIEKEVNKTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLIN 58

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT 408
           L  L+++   I         +  +L    L+ N ++      L     L  L      I+
Sbjct: 59  LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS 118

Query: 409 GRLPKEIGSLTKLEYLDFS--AIGELPSQ-ICNMKSLEKLNLSHNNLSGSIPSCFEGMHG 465
                 + +   LE L      I  +        + L+ L+  +N +          +  
Sbjct: 119 SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178

Query: 466 LSFI--DMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLR 514
            + +  +++ N++    P +            G + L    KGL+      
Sbjct: 179 ATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS 229

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 28/188 (14%), Positives = 55/188 (29%), Gaps = 37/188 (19%)

Query: 6   RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQ 65
           + +N+   +          S  +   L  L L++           ++L  + ++ L  N+
Sbjct: 452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511

Query: 66  FSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP 125
                                         L+      + +LK +  L+L +N  S  +P
Sbjct: 512 ------------------------------LTSSSIEALSHLKGI-YLNLASNHISIILP 540

Query: 126 LSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFD-LQLNDNQLIGYIPRPFSNLTSVST 184
                LS    + L  N L  +            +  + N  +L         N   +  
Sbjct: 541 SLLPILSQQRTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPPLLRG 595

Query: 185 LRLSRNDL 192
           +RLS   L
Sbjct: 596 VRLSDVTL 603

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  224 bits (572), Expect = 1e-66
 Identities = 92/313 (29%), Positives = 139/313 (44%), Gaps = 36/313 (11%)

Query: 552 KSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPS 611
              S    S N     S  +     ++   ++ +ATN+FD K+ IG+G    VY+  L  
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 612 GEVVAVKKFHSLLPCDQTVDQ--KEFLTEVEA-----------FYGFCSHARHSFLLYEF 658
           G  VA+K+            Q  +EF TE+E              GFC       L+Y++
Sbjct: 63  GAKVALKR------RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY 116

Query: 659 LERGSLA-AILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +E G+L   +  +D     + W QR+ +    A  L YLH      I+HRD+ S N+LLD
Sbjct: 117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLD 173

Query: 718 LEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMW 774
             +   + DFGI+K    +       T   GT GYI PE     ++TEK DVYSFGV+++
Sbjct: 174 ENFVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 775 EVIKGKHPRDFLSSISSSSL-------NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAF 827
           EV+  +            +L       + +  L+Q++DP L    +   E L    + A 
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL--ADKIRPESLRKFGDTAV 290

Query: 828 SCFNESPESRPTM 840
            C   S E RP+M
Sbjct: 291 KCLALSSEDRPSM 303

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  221 bits (566), Expect = 9e-63
 Identities = 102/486 (20%), Positives = 168/486 (34%), Gaps = 37/486 (7%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
            L  +SFS+F  L +LDL+              L +L  L L  N           S  S
Sbjct: 46  ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQS------FSPGS 99

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-PIPLSFDNLSNLIFLY 138
              L  +  LV  +  L+      IG L  L +L++ +N      +P  F NL+NL+ + 
Sbjct: 100 FSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVD 159

Query: 139 LYGNLLSG---SILSSLGKLK-SLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFG 194
           L  N +     + L  L +       L ++ N +     + F  +  +  L L  N    
Sbjct: 160 LSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSS 218

Query: 195 SIPDEIGK-MRSLSVLDLNQNQFKG-----VLPPSI-SNLTNL--KELALLYNHLSGSIP 245
           +I     + +  L V  L   +FK      +  PSI   L ++   E  L Y +      
Sbjct: 219 NIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278

Query: 246 PSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRV 304
                L  +  + L+G         ++ +    +  ++     +      L    SL   
Sbjct: 279 VKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL--- 333

Query: 305 RLNGNNLTGNISEALGIYPNLTFIDLSRNNFY--GEISSNWGKFPKLGTLNVSMNNITGG 362
            L  N  +  IS      P+L+++DLSRN     G  S +      L  L++S N     
Sbjct: 334 TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-I 390

Query: 363 LPREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEIGSLTKL 421
           +        +LQ  D   + +           L  L  L +               LT L
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450

Query: 422 EYLDFS---AIGELPSQI-CNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
             L  +         S +  N  +L  L+LS   L       F+ +H L  ++MS+N L 
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510

Query: 478 CPVPNS 483
               + 
Sbjct: 511 FLDSSH 516

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  211 bits (539), Expect = 4e-59
 Identities = 84/479 (17%), Positives = 156/479 (32%), Gaps = 33/479 (6%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
           +    SFS    L  L              I  L  L+ L +  N      +      + 
Sbjct: 94  SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF-----IHSCKLPAY 148

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQ----LDLTNNKFSGPIPLSFDNLSNLI 135
             NL  +  + ++ N +       +  L+   Q    LD++ N        +F  +  L 
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLH 207

Query: 136 FLYLYGNLLSGSI-------LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLT--SVSTLR 186
            L L GN  S +I       L+ L   + +     ++  L  + P     L   ++   R
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267

Query: 187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP 246
           L+  + F     +   + ++S + L     K +    +      + L+++   L      
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTL 325

Query: 247 SLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRN--CTSLIRV 304
            L  L  + L L+ N  +  + +      +L    +S N    +   S  +    SL  +
Sbjct: 326 DLPFL--KSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381

Query: 305 RLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS-SNWGKFPKLGTLNVSMNNITGGL 363
            L+ N     +S        L  +D   +        S +    KL  L++S  N     
Sbjct: 382 DLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440

Query: 364 PREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEIGSLTKLE 422
                  + L    ++ N                LT L L   Q+         +L +L+
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500

Query: 423 YLDFS--AIGELPSQ-ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC 478
            L+ S   +  L S     + SL  L+ S N +  S          L+F +++ N + C
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVAC 559

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  208 bits (531), Expect = 5e-58
 Identities = 87/464 (18%), Positives = 157/464 (33%), Gaps = 39/464 (8%)

Query: 35  LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDN 94
                      +P  I   S+ + + L  N              S  N   +  L ++  
Sbjct: 16  YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKI------LKSYSFSNFSELQWLDLSRC 66

Query: 95  SLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGK 154
            +          L  LS L LT N      P SF  L++L  L      L+      +G+
Sbjct: 67  EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQ 126

Query: 155 LKSLFDLQLNDNQLIGY-IPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLS----VL 209
           L +L  L +  N +    +P  FSNLT++  + LS N +     +++  +R        L
Sbjct: 127 LITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSL 186

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI--LRQLLLSGNHFTGYL 267
           D++ N     +         L EL L  N  S +I  +    +  L    L    F    
Sbjct: 187 DMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245

Query: 268 PYNICRGGALE--------IFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEAL 319
              I     +E         F ++  +             ++  + L G ++     E +
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDV 303

Query: 320 GIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLS 379
             +     + + R       + +    P L +L ++MN  +  +  +      L   DLS
Sbjct: 304 PKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLS 358

Query: 380 LNHI--VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQ 435
            N +   G         N L  L L  N     +      L +L++LDF    +  +   
Sbjct: 359 RNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEF 417

Query: 436 --ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
               +++ L  L++S+ N        F G+  L+ + M+ N  +
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  186 bits (473), Expect = 4e-50
 Identities = 91/416 (21%), Positives = 152/416 (36%), Gaps = 33/416 (7%)

Query: 93  DNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL 152
           D  LS  +P  I +      +DL+ N        SF N S L +L L    +      + 
Sbjct: 20  DQKLSK-VPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW 76

Query: 153 GKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLN 212
             L  L +L L  N +  + P  FS LTS+  L      L       IG++ +L  L++ 
Sbjct: 77  HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA 136

Query: 213 QNQFKGV-LPPSISNLTNLKELALLYNHLSGSIPPSLGNL-----ILRQLLLSGNHFTGY 266
            N      LP   SNLTNL  + L YN++       L  L     +   L +S N    +
Sbjct: 137 HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-F 195

Query: 267 LPYNICRGGALEIFTVSENHFQGTIP-TSLRNCTSLIRVRLNGNNLTGNIS------EAL 319
           +     +G  L   T+  N     I  T L+N   L   RL         +        +
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255

Query: 320 GIYPNLTF--IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFD 377
               ++T     L+  N + +    +     +  ++++  +I      ++    + Q+  
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLS 313

Query: 378 LSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS-----AIGEL 432
           +    +  + P     L  L  L L  N+ +  +  +  +L  L YLD S       G  
Sbjct: 314 IIRCQL-KQFPT--LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCC 368

Query: 433 PSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRG 488
                   SL  L+LS N     + + F G+  L  +D  ++ L+  V   + F  
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLK-RVTEFSAFLS 422

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  133 bits (337), Expect = 1e-32
 Identities = 58/275 (21%), Positives = 90/275 (32%), Gaps = 31/275 (11%)

Query: 21  LHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQF-------------- 66
           L  F     P L  L LT N   G+I  +   L +L YL L  N                
Sbjct: 319 LKQFPTLDLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTN 376

Query: 67  -------SGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPH-IGNLKFLSQLDLTNN 118
                  S N    +S+      L  +  L    ++L          +L+ L  LD++  
Sbjct: 377 SLRHLDLSFNGAIIMSANFM--GLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434

Query: 119 KFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS-LGKLKSLFDLQLNDNQLIGYIPRPFS 177
                    F  L++L  L + GN    + LS+      +L  L L+  QL       F 
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFD 494

Query: 178 NLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLY 237
            L  +  L +S N+L         ++ SLS LD + N+ +           +L    L  
Sbjct: 495 TLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554

Query: 238 NHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNIC 272
           N ++  I          Q +     F   +    C
Sbjct: 555 NSVA-CICEHQK---FLQWVKEQKQFLVNVEQMTC 585

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  110 bits (276), Expect = 4e-25
 Identities = 44/244 (18%), Positives = 83/244 (34%), Gaps = 11/244 (4%)

Query: 242 GSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSL 301
           GS+ P +  +            +  +P +I    + +   +S N  +     S  N + L
Sbjct: 2   GSLNPCIEVVPNITYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSEL 58

Query: 302 IRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITG 361
             + L+   +     +A     +L+ + L+ N        ++     L  L      +  
Sbjct: 59  QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118

Query: 362 GLPREIGNSSQLQAFDLSLNHIVG-EIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTK 420
                IG    L+  +++ N I   ++P     L  L  + L  N I      ++  L +
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178

Query: 421 L----EYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPS-CFEGMHGLSFIDMSY 473
                  LD S   I  +  Q      L +L L  N  S +I   C + + GL    +  
Sbjct: 179 NPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLIL 238

Query: 474 NELQ 477
            E +
Sbjct: 239 GEFK 242

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  205 bits (525), Expect = 4e-60
 Identities = 78/290 (26%), Positives = 132/290 (45%), Gaps = 39/290 (13%)

Query: 580 YDEIVKATNDFDAKYC------IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQ- 632
           + E+   TN+FD +        +G GG   VY+  +     VAVKK  +    D T ++ 
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAA--MVDITTEEL 73

Query: 633 -KEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWS 680
            ++F  E++              GF S      L+Y ++  GSL   L+       L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133

Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
            R  + +  A+ +++LH +     +HRDI S N+LLD  + A ++DFG+A+      +  
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKFAQT 189

Query: 741 ---TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDF------LSSISS 791
              +   GT  Y+APE A   +IT K D+YSFGV++ E+I G    D       L  I  
Sbjct: 190 VMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE 248

Query: 792 SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
              + +  ++  +D ++   + +    + ++  VA  C +E    RP +K
Sbjct: 249 EIEDEEKTIEDYIDKKM---NDADSTSVEAMYSVASQCLHEKKNKRPDIK 295

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  205 bits (525), Expect = 2e-58
 Identities = 107/443 (24%), Positives = 171/443 (38%), Gaps = 41/443 (9%)

Query: 14  NIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAE 73
            +G        S +    +  L     G        +  L+NL  +   +NQ        
Sbjct: 30  VLGKTNVTDTVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQ-------- 79

Query: 74  VSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSN 133
           ++  +   NL  +  +++N+N ++   P  + NL  L+ L L NN+ +   PL   NL+N
Sbjct: 80  LTDITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPLK--NLTN 135

Query: 134 LIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF 193
           L  L L  N +S   +S+L  L SL  L    NQ+    P   +NLT++  L +S N + 
Sbjct: 136 LNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKV- 189

Query: 194 GSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI- 252
            S    + K+ +L  L    NQ   +    +  LTNL EL+L  N L      +L +L  
Sbjct: 190 -SDISVLAKLTNLESLIATNNQISDI--TPLGILTNLDELSLNGNQLKD--IGTLASLTN 244

Query: 253 LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
           L  L L+ N  +   P  +     L    +  N      P  L   T+L  + LN N L 
Sbjct: 245 LTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLE 300

Query: 313 GNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQ 372
                 +    NLT++ L  NN      S      KL  L    N ++      + N + 
Sbjct: 301 D--ISPISNLKNLTYLTLYFNNI--SDISPVSSLTKLQRLFFYNNKVSD--VSSLANLTN 354

Query: 373 LQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGEL 432
           +       N I    P  L  L  +T+L L     T   P    +   +     +  G L
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL 411

Query: 433 --PSQICNMKSLEKLNLSHNNLS 453
             P+ I +  S  + +++ N  S
Sbjct: 412 IAPATISDGGSYTEPDITWNLPS 434

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  198 bits (506), Expect = 9e-56
 Identities = 91/433 (21%), Positives = 168/433 (38%), Gaps = 41/433 (9%)

Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
            + L+      LG           V+   S  +L  ++ L  +   +       +  L  
Sbjct: 20  DTALAEKMKTVLGKTN--------VTDTVSQTDLDQVTTLQADRLGIK--SIDGVEYLNN 69

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
           L+Q++ +NN+ +   PL   NL+ L+ + +  N ++   ++ L  L +L  L L +NQ+ 
Sbjct: 70  LTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQIT 125

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
              P    NLT+++ L LS N +  S    +  + SL  L    NQ   + P  ++NLT 
Sbjct: 126 DIDP--LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTDLKP--LANLTT 178

Query: 230 LKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQ 288
           L+ L +  N +S      L  L  L  L+ + N  +   P  I     L+  +++ N   
Sbjct: 179 LERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQL- 233

Query: 289 GTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK 348
                +L + T+L  + L  N ++      L     LT + L  N       S       
Sbjct: 234 -KDIGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGLTA 288

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT 408
           L  L ++ N +       I N   L    L  N+I    P  +  L  L +L    N+++
Sbjct: 289 LTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVS 344

Query: 409 GRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGL 466
                 + +LT + +L      I +L   + N+  + +L L+    + +  +    +   
Sbjct: 345 D--VSSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTNAPVNYKANVSIP 401

Query: 467 SFIDMSYNELQCP 479
           + +      L  P
Sbjct: 402 NTVKNVTGALIAP 414

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  132 bits (335), Expect = 5e-33
 Identities = 60/291 (20%), Positives = 109/291 (37%), Gaps = 24/291 (8%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
             +   +L  L  T N      P  +  L+NL  L L  NQ        +    +  +L 
Sbjct: 194 VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQ--------LKDIGTLASLT 243

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
            ++ L + +N +S   P  +  L  L++L L  N+ S   PL+   L+ L  L L  N L
Sbjct: 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA--GLTALTNLELNENQL 299

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR 204
               +S +  LK+L  L L  N +    P   S+LT +  L    N +  S    +  + 
Sbjct: 300 ED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLT 353

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFT 264
           +++ L    NQ   +    ++NLT + +L L     + +      N+ +   + +     
Sbjct: 354 NINWLSAGHNQISDL--TPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGAL 411

Query: 265 GYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI 315
              P  I  GG+     ++ N             +  + +       +G +
Sbjct: 412 -IAPATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTV 460

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  201 bits (512), Expect = 3e-58
 Identities = 68/313 (21%), Positives = 116/313 (37%), Gaps = 60/313 (19%)

Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV 639
            + +   +           G    V++A+L   E VAVK F          D++ +  E 
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI-------QDKQSWQNEY 67

Query: 640 E-------------AFYGFCSHARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQR 682
           E              F G            +L+  F E+GSL+  L        + W++ 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNEL 123

Query: 683 MNVIKAVAHALSYLHHDCF-------PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
            ++ + +A  L+YLH D         P I HRDI SKN+LL     A +ADFG+A   + 
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 736 DSSNW--TEFAGTCGYIAPELA-----YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSS 788
             S        GT  Y+APE+      +      + D+Y+ G+++WE+       D    
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

Query: 789 IS----SSSLNTDVALDQM--------LDPRLPA--PSRSAQEKLISIMEVAFSCFNESP 834
                    +    +L+ M          P L       +    L   +E    C++   
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIE---ECWDHDA 300

Query: 835 ESRPTMKIISQQL 847
           E+R +   + +++
Sbjct: 301 EARLSAGCVGERI 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  192 bits (491), Expect = 2e-55
 Identities = 88/311 (28%), Positives = 143/311 (45%), Gaps = 34/311 (10%)

Query: 549 RKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAE 608
               SD     + N   QG++   + +  I + ++     +   K  IG G   +V+RAE
Sbjct: 7   HHPMSDYDIPTTENLYFQGAMDGDDMD--IPWCDL-----NIKEK--IGAGSFGTVHRAE 57

Query: 609 LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYE 657
              G  VAVK               EFL EV             F G  +   +  ++ E
Sbjct: 58  W-HGSDVAVKILME--QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114

Query: 658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD 717
           +L RGSL  +L+   A ++L   +R+++   VA  ++YLH+   PPIVHR++ S NLL+D
Sbjct: 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVD 173

Query: 718 LEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI 777
            +Y   V DFG+++       +    AGT  ++APE+       EK DVYSFGV++WE+ 
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233

Query: 778 KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESR 837
             + P  +  +++ + +   V        RL  P  +   ++ +I+E    C+   P  R
Sbjct: 234 TLQQP--W-GNLNPAQVVAAVGFKCK---RLEIPR-NLNPQVAAIIE---GCWTNEPWKR 283

Query: 838 PTMKIISQQLR 848
           P+   I   LR
Sbjct: 284 PSFATIMDLLR 294

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (483), Expect = 8e-55
 Identities = 75/272 (27%), Positives = 122/272 (44%), Gaps = 36/272 (13%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           IG GG   VYRA    G+ VAVK        D +   +    E +           A  G
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
            C    +  L+ EF   G L  +L+     + +     +N    +A  ++YLH +   PI
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPI 129

Query: 705 VHRDISSKNLLLDLEYEAH--------VADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           +HRD+ S N+L+  + E          + DFG+A+     +      AG   ++APE+  
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYAWMAPEVIR 187

Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQ 816
               ++  DV+S+GVL+WE++ G+ P   +  ++ +     VA++++    LP PS +  
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY---GVAMNKL---ALPIPS-TCP 240

Query: 817 EKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           E    +ME    C+N  P SRP+   I  QL 
Sbjct: 241 EPFAKLME---DCWNPDPHSRPSFTNILDQLT 269

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  188 bits (480), Expect = 6e-54
 Identities = 64/273 (23%), Positives = 121/273 (44%), Gaps = 33/273 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
            + + +  +G G    V +A+    + VA+K+  S        ++K F+ E+        
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES------ESERKAFIVELRQLSRVNH 60

Query: 641 ----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 YG C +     L+ E+ E GSL  +L+          +  M+     +  ++YL
Sbjct: 61  PNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYE-AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           H      ++HRD+   NLLL        + DFG A  ++   ++ T   G+  ++APE+ 
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVF 175

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
                +EKCDV+S+G+++WEVI  + P D +   +   +      +     R P    + 
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGT---RPPLIK-NL 229

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            + + S+M     C+++ P  RP+M+ I + + 
Sbjct: 230 PKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  191 bits (488), Expect = 2e-52
 Identities = 113/505 (22%), Positives = 185/505 (36%), Gaps = 60/505 (11%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQ-ISNLSNLRYLYLGSNQFSGNILAEVSSES 78
            L  +SF SFP L  LDL+      TI      +LS+L  L L  N           +  
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQS------LALG 94

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKF-SGPIPLSFDNLSNLIFL 137
           +   L  + +LV  + +L+      IG+LK L +L++ +N   S  +P  F NL+NL  L
Sbjct: 95  AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154

Query: 138 YLYGNLLSG---SILSSLGKLK-SLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF 193
            L  N +     + L  L ++      L L+ N +    P  F  +  +  L L  N   
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDS 213

Query: 194 GSIPDE-IGKMRSLSVLDLNQNQFKG---VLPPSISNLTNLKELALLYNHLSG------- 242
            ++    I  +  L V  L   +F+    +     S L  L  L +    L+        
Sbjct: 214 LNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDD 273

Query: 243 ----------------------SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIF 280
                                  +     N   + L L    F    P    +  +L+  
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPTLKLK--SLKRL 330

Query: 281 TVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT--GNISEALGIYPNLTFIDLSRNNFYGE 338
           T + N        S  +  SL  + L+ N L+  G  S++     +L ++DLS N     
Sbjct: 331 TFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-T 387

Query: 339 ISSNWGKFPKLGTLNVSMNNITGGLPREI-GNSSQLQAFDLSLNHIVGEIPKELGKLNPL 397
           +SSN+    +L  L+   +N+       +  +   L   D+S  H           L+ L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447

Query: 398 TKLILRGNQITGRLPKEI-GSLTKLEYLDFS--AIGELPSQI-CNMKSLEKLNLSHNNLS 453
             L + GN        +I   L  L +LD S   + +L      ++ SL+ LN++ N L 
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507

Query: 454 GSIPSCFEGMHGLSFIDMSYNELQC 478
                 F+ +  L  I +  N   C
Sbjct: 508 SVPDGIFDRLTSLQKIWLHTNPWDC 532

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  183 bits (466), Expect = 2e-49
 Identities = 85/472 (18%), Positives = 156/472 (33%), Gaps = 38/472 (8%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR 88
                 LDL++N           +   L+ L L   +           + +  +L ++S 
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ------TIEDGAYQSLSHLST 80

Query: 89  LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL-SGS 147
           L++  N +          L  L +L       +        +L  L  L +  NL+ S  
Sbjct: 81  LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140

Query: 148 ILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVS----TLRLSRNDLFGSIPDEIGKM 203
           +      L +L  L L+ N++          L  +     +L LS N +   I     K 
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE 199

Query: 204 RSLSVLDLNQNQFKGVLPP-SISNLTNLKELALLYN---------HLSGSIPPSLGNLIL 253
             L  L L  N     +    I  L  L+   L+               S    L NL +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259

Query: 254 RQLLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
            +  L+   +      ++      +  F++     +     S         + L      
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFG 317

Query: 313 GNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT--GGLPREIGNS 370
              +  L    +L  +  + N      S      P L  L++S N ++  G   +    +
Sbjct: 318 QFPTLKL---KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGT 372

Query: 371 SQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFSA- 428
           + L+  DLS N ++  +      L  L  L  + + +       +  SL  L YLD S  
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431

Query: 429 -IGELPSQIC-NMKSLEKLNLSHNNLSGSIPS-CFEGMHGLSFIDMSYNELQ 477
                 + I   + SLE L ++ N+   +     F  +  L+F+D+S  +L+
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  166 bits (423), Expect = 7e-44
 Identities = 88/461 (19%), Positives = 156/461 (33%), Gaps = 36/461 (7%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
           +L   +FS    L  L              I +L  L+ L +  N      +        
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL-----IQSFKLPEY 144

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLS----QLDLTNNKFSGPIPLSFDNLSNLI 135
             NL  +  L ++ N +       +  L  +      LDL+ N  +   P +F  +  L 
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLH 203

Query: 136 FLYLYGNLLSGSI-------LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTS--VSTLR 186
            L L  N  S ++       L+ L   + +     N+  L  +       L +  +   R
Sbjct: 204 KLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263

Query: 187 LSRNDLFGS-IPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP 245
           L+  D +   I D    + ++S   L     + V     S     + L L+         
Sbjct: 264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPT 321

Query: 246 PSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSEN--HFQGTIPTSLRNCTSLIR 303
             L +L  ++L  + N              +LE   +S N   F+G    S    TSL  
Sbjct: 322 LKLKSL--KRLTFTSNKGGNAFSEVDLP--SLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 304 VRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN-WGKFPKLGTLNVSMNNITGG 362
           + L+ N +   +S        L  +D   +N       + +     L  L++S  +    
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 363 LPREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEI-GSLTK 420
                   S L+   ++ N        +   +L  LT L L   Q+  +L      SL+ 
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSS 495

Query: 421 LEYLDFSA--IGELPSQI-CNMKSLEKLNLSHNNLSGSIPS 458
           L+ L+ ++  +  +P  I   + SL+K+ L  N    S P 
Sbjct: 496 LQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  114 bits (286), Expect = 2e-26
 Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 15/233 (6%)

Query: 18  NGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSE 77
           N     F       L  L  T N   G       +L +L +L L  N  S        S+
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSN--KGGNAFSEVDLPSLEFLDLSRNGLS---FKGCCSQ 367

Query: 78  SSGG--NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLS-FDNLSNL 134
           S  G  +L+Y   L ++ N +   +  +   L+ L  LD  ++        S F +L NL
Sbjct: 368 SDFGTTSLKY---LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423

Query: 135 IFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRNDLF 193
           I+L +       +       L SL  L++  N          F+ L +++ L LS+  L 
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL- 482

Query: 194 GSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP 245
             +       + SL VL++  NQ K V       LT+L+++ L  N    S P
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 535

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  182 bits (465), Expect = 2e-51
 Identities = 94/379 (24%), Positives = 155/379 (40%), Gaps = 56/379 (14%)

Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
            ++L+      L            V+   +   L  +++LV+    ++      I  L  
Sbjct: 18  DADLAEGIRAVLQKAS--------VTDVVTQEELESITKLVVAGEKVASI--QGIEYLTN 67

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
           L  L+L  N+ +   PLS  NL  L  LY+  N +  + +S+L  L +L +L LN++ + 
Sbjct: 68  LEYLNLNGNQITDISPLS--NLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNIS 123

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
                P +NLT + +L L  N    S    +  M  L+ L + +++ K V    I+NLT+
Sbjct: 124 DIS--PLANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDV--TPIANLTD 178

Query: 230 LKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQ 288
           L  L+L YN +    P  L +L  L       N  T                        
Sbjct: 179 LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD----------------------- 213

Query: 289 GTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK 348
               T + N T L  +++  N +T      L     LT++++  N       +      K
Sbjct: 214 ---ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQI--SDINAVKDLTK 266

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT 408
           L  LNV  N I+      + N SQL +  L+ N +  E  + +G L  LT L L  N IT
Sbjct: 267 LKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT 324

Query: 409 GRLPKEIGSLTKLEYLDFS 427
               + + SL+K++  DF+
Sbjct: 325 D--IRPLASLSKMDSADFA 341

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  174 bits (443), Expect = 2e-48
 Identities = 76/371 (20%), Positives = 140/371 (37%), Gaps = 51/371 (13%)

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
            + L       +   P +  +L+  I   L    ++   + +  +L+S+  L +   + +
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEK-V 56

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
             I      LT++  L L+ N +    P  +  +  L+ L +  N+       ++ NLTN
Sbjct: 57  ASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTN 111

Query: 230 LKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQ 288
           L+EL L  +++S   P  L NL  +  L L  NH                          
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL------------------------ 145

Query: 289 GTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK 348
            +  + L N T L  + +  + +       +    +L  + L+ N       S       
Sbjct: 146 -SDLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLASLTS 200

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT 408
           L      +N IT      + N ++L +  +  N I    P  L  L+ LT L +  NQI+
Sbjct: 201 LHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256

Query: 409 GRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGL 466
                 +  LTKL+ L+     I ++   + N+  L  L L++N L         G+  L
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQISDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313

Query: 467 SFIDMSYNELQ 477
           + + +S N + 
Sbjct: 314 TTLFLSQNHIT 324

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  146 bits (370), Expect = 1e-38
 Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 26/288 (9%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
            S+   L  L +  N    T    + NL+NLR LYL  +         +S  S   NL  
Sbjct: 84  LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDN--------ISDISPLANLTK 133

Query: 86  MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS 145
           M  L +  N     + P + N+  L+ L +T +K     P++  NL++L  L L  N + 
Sbjct: 134 MYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLSLNYNQIE 190

Query: 146 GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRS 205
              +S L  L SL       NQ+      P +N+T +++L++  N +    P  +  +  
Sbjct: 191 D--ISPLASLTSLHYFTAYVNQITDIT--PVANMTRLNSLKIGNNKITDLSP--LANLSQ 244

Query: 206 LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFT 264
           L+ L++  NQ   +   ++ +LT LK L +  N +S      L NL  L  L L+ N   
Sbjct: 245 LTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLG 300

Query: 265 GYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
                 I     L    +S+NH     P  L + + +         + 
Sbjct: 301 NEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  134 bits (341), Expect = 9e-35
 Identities = 55/241 (22%), Positives = 96/241 (39%), Gaps = 22/241 (9%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
             ++   +  L+L  N     + P +SN++ L YL +  ++        V   +   NL 
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESK--------VKDVTPIANLT 177

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
            +  L +N N +    P  + +L  L       N+ +   P++  N++ L  L +  N +
Sbjct: 178 DLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKI 233

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR 204
           +   LS L  L  L  L++  NQ+         +LT +  L +  N +  S    +  + 
Sbjct: 234 TD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQI--SDISVLNNLS 287

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHF 263
            L+ L LN NQ        I  LTNL  L L  NH++   P  L +L  +     +    
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345

Query: 264 T 264
            
Sbjct: 346 K 346

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  177 bits (450), Expect = 4e-50
 Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 38/275 (13%)

Query: 596 IGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQ---KEFLTEVE----------- 640
           IG GG   V++  L     VVA+K         +T      +EF  EV            
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
             YG   +     ++ EF+  G L   L     A  + WS ++ ++  +A  + Y+ +  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN-Q 141

Query: 701 FPPIVHRDISSKNLLLDLEYE-----AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
            PPIVHRD+ S N+ L    E     A VADFG+++     S   +   G   ++APE  
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSV--SGLLGNFQWMAPETI 198

Query: 756 YTMKI--TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR 813
              +   TEK D YSF ++++ ++ G+ P D  S      +N  +  + +   R   P  
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN-MIREEGL---RPTIPE- 253

Query: 814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
               +L +++E    C++  P+ RP    I ++L 
Sbjct: 254 DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  181 bits (462), Expect = 7e-50
 Identities = 92/468 (19%), Positives = 155/468 (33%), Gaps = 70/468 (14%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQF--------SGNILAEVSS 76
              +          W+ +    PP       +    L             +   L+ +  
Sbjct: 29  EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE 88

Query: 77  ESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIF 136
                +L     LV + NSL+  +P    +LK L   +      S       D    L +
Sbjct: 89  LP--PHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-------DLPPLLEY 135

Query: 137 LYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSI 196
           L +  N L    L  L     L  + +++N L   +P    +L     +    N L    
Sbjct: 136 LGVSNNQLEK--LPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF---IAAGNNQL--EE 187

Query: 197 PDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQ 255
             E+  +  L+ +  + N  K  LP    +L ++       N L     P L NL  L  
Sbjct: 188 LPELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV---AGNNIL--EELPELQNLPFLTT 241

Query: 256 LLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI 315
           +    N     LP        LE   V +N+    +P   ++ T L       + L+   
Sbjct: 242 IYADNNLLK-TLPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELP 296

Query: 316 SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQA 375
                  PNL +++ S N     +       P L  LNVS N +   LP        L+ 
Sbjct: 297 -------PNLYYLNASSNEI-RSLCDLP---PSLEELNVSNNKLI-ELPALPPR---LER 341

Query: 376 FDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQ 435
              S NH+  E+P+       L +L +  N +    P    S+  L     S + E+P  
Sbjct: 342 LIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMN--SHLAEVPEL 394

Query: 436 ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
             N   L++L++  N L    P   +    +  + M+   +  P   +
Sbjct: 395 PQN---LKQLHVETNPLR-EFP---DIPESVEDLRMNSERVVDPYEFA 435

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  167 bits (424), Expect = 7e-45
 Identities = 91/436 (20%), Positives = 149/436 (34%), Gaps = 69/436 (15%)

Query: 46  IPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG 105
           I P+  + + L+     S+      L E+  E+   N++  +      +      PP  G
Sbjct: 3   INPRNVSNTFLQEPLRHSSN-----LTEMPVEA--ENVKSKTEYYNAWSEWERNAPPGNG 55

Query: 106 NL-------------KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL 152
                          +   +L+L N   S  +P   +   +L  L    N L+  +    
Sbjct: 56  EQREMAVSRLRDCLDRQAHELELNNLGLS-SLP---ELPPHLESLVASCNSLT-ELPELP 110

Query: 153 GKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLN 212
             LKSL     N   L    P     L     L +S N L   +P E+     L ++D++
Sbjct: 111 QSLKSLLVDNNNLKALSDLPP----LLEY---LGVSNNQL-EKLP-ELQNSSFLKIIDVD 161

Query: 213 QNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNI 271
            N  K  LP    +L  +       N L     P L NL  L  +    N     LP   
Sbjct: 162 NNSLK-KLPDLPPSLEFIA---AGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLP 214

Query: 272 CRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLS 331
                LE      N         L+N   L  +  + N L   + +      +L  +++ 
Sbjct: 215 LS---LESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVR 265

Query: 332 RNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL 391
            N     ++        L  L+VS N  + GL     N   L   + S N I   +    
Sbjct: 266 DNY----LTDLPELPQSLTFLDVSENIFS-GLSELPPN---LYYLNASSNEIR-SLCDLP 316

Query: 392 GKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNN 451
                L +L +  N++   LP     L +L    F+ + E+P    N   L++L++ +N 
Sbjct: 317 PS---LEELNVSNNKLI-ELPALPPRLERL-IASFNHLAEVPELPQN---LKQLHVEYNP 368

Query: 452 LSGSIPSCFEGMHGLS 467
           L    P   E +  L 
Sbjct: 369 LR-EFPDIPESVEDLR 383

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  154 bits (391), Expect = 2e-40
 Identities = 77/395 (19%), Positives = 128/395 (32%), Gaps = 62/395 (15%)

Query: 99  FIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL 158
           FI P   +  FL +    ++  +  +P+  +N+ +    Y   +    +     G+ + +
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60

Query: 159 FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG 218
              +L D                   L L+   L  S+P+       L  L  + N    
Sbjct: 61  AVSRLRDC-----------LDRQAHELELNNLGL-SSLPELPP---HLESLVASCNSLT- 104

Query: 219 VLPPSISNLTNLKELALLYNHLSGSIP---------------PSLGNLI-LRQLLLSGNH 262
            LP    +L +L         LS   P               P L N   L+ + +  N 
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164

Query: 263 FTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY 322
               LP       +LE      N         L+N   L  +  + N+L   + +     
Sbjct: 165 LK-KLPDLP---PSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPL-- 215

Query: 323 PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNH 382
            +L  I    N    E        P L T+    N +   LP    +   L   D  L  
Sbjct: 216 -SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLT- 270

Query: 383 IVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSL 442
              ++P+       LT L +  N  +  L +   +L  L     + I  L        SL
Sbjct: 271 ---DLPELPQS---LTFLDVSENIFS-GLSELPPNLYYL-NASSNEIRSLCDL---PPSL 319

Query: 443 EKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
           E+LN+S+N L   +P+       L  +  S+N L 
Sbjct: 320 EELNVSNNKLI-ELPALPP---RLERLIASFNHLA 350

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  103 bits (259), Expect = 2e-23
 Identities = 50/287 (17%), Positives = 92/287 (32%), Gaps = 44/287 (15%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
                 L  +    N       P++ NL  L  +Y  +N          +      +L  
Sbjct: 211 PDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-------TLPDLPPSLEA 261

Query: 86  MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS 145
              L + DN L+  +P    +L FL   +   +  S       +   NL +L    N + 
Sbjct: 262 ---LNVRDNYLTD-LPELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIR 310

Query: 146 GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRS 205
            S+      L+ L    +++N+LI  +P     L     L  S N L   +P+      +
Sbjct: 311 -SLCDLPPSLEELN---VSNNKLI-ELPALPPRLER---LIASFNHL-AEVPELPQ---N 358

Query: 206 LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTG 265
           L  L +  N  +   P    ++ +L+      N     +P    N  L+QL +  N    
Sbjct: 359 LKQLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEVPELPQN--LKQLHVETNPLR- 409

Query: 266 YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
             P       ++E   ++          +      L       ++  
Sbjct: 410 EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 76.6 bits (189), Expect = 9e-15
 Identities = 40/247 (16%), Positives = 75/247 (30%), Gaps = 38/247 (15%)

Query: 11  SLPNIGVNGTLHDFSFS---------SFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYL 61
            LP +     L                 P L  L++  N +   +P    +L+ L     
Sbjct: 229 ELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDN-YLTDLPELPQSLTFLDVSEN 287

Query: 62  GSNQFSGNI-------LAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLD 114
             +  S           +     S       +  L +++N L   +P     L+   +L 
Sbjct: 288 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLI 343

Query: 115 LTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPR 174
            + N  +  +P   +   NL  L++  N L          ++ L       N  +  +P 
Sbjct: 344 ASFNHLAE-VP---ELPQNLKQLHVEYNPLR-EFPDIPESVEDL-----RMNSHLAEVPE 393

Query: 175 PFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA 234
              NL     L +  N L    PD      S+  L +N  +       +      L++  
Sbjct: 394 LPQNLK---QLHVETNPL-REFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDV 446

Query: 235 LLYNHLS 241
             ++H  
Sbjct: 447 FEHHHHH 453

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  183 bits (465), Expect = 2e-49
 Identities = 85/487 (17%), Positives = 160/487 (32%), Gaps = 43/487 (8%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            +      +  +L  L L  +    TI      +L +L +L L  N      L+ +SS  
Sbjct: 40  YIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDNH-----LSSLSSSW 93

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPH-IGNLKFLSQLDLT-NNKFSGPIPLSFDNLSNLIF 136
            G  L  +  L +  N            NL  L  L +     FS    + F  L++L  
Sbjct: 94  FG-PLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNE 152

Query: 137 LYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSI 196
           L +    L      SL  ++ +  L L+ ++    +      L+SV  L L   +L    
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212

Query: 197 PDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS--------------- 241
              +      S +     +   +   S + L  L    L  + +                
Sbjct: 213 FSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPS 272

Query: 242 ----GSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRN 297
                S    +  + +R+L +   +    L         ++  TV  +       +  ++
Sbjct: 273 ESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQH 332

Query: 298 CTSLIRVRLNGNNLTGNI---SEALGIYPNLTFIDLSRNNFYGEISSNWGKF---PKLGT 351
             SL  + L+ N +       S   G +P+L  + LS+N+    +            L +
Sbjct: 333 LKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTS 391

Query: 352 LNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRL 411
           L++S N     +P       +++  +LS   I   +   +     L  L +  N +    
Sbjct: 392 LDISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SF 446

Query: 412 PKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDM 471
              +  L +L Y+  + +  LP        L  + +S N L       F+ +  L  I +
Sbjct: 447 SLFLPRLQEL-YISRNKLKTLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWL 504

Query: 472 SYNELQC 478
             N   C
Sbjct: 505 HTNPWDC 511

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  158 bits (402), Expect = 3e-41
 Identities = 79/419 (18%), Positives = 144/419 (34%), Gaps = 33/419 (7%)

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS 147
            L ++ N ++      +     L  L L +++ +     +F +L +L  L L  N LS  
Sbjct: 30  SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSL 89

Query: 148 ILSSLGKLKSLFDLQLNDNQLIGYIPRP-FSNLTSVSTLRLSRNDLFGSIPDE-IGKMRS 205
             S  G L SL  L L  N          F NLT++ TLR+   + F  I       + S
Sbjct: 90  SSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149

Query: 206 LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFT 264
           L+ L++     +     S+ ++ ++  L L  +  +  +      L  +R L L   +  
Sbjct: 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA 209

Query: 265 GYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIR--VRLNGNNLTGNISEALGIY 322
            +    +                      S      L+R  + L+           LG +
Sbjct: 210 RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDF 269

Query: 323 P----------------NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPRE 366
                             +  + + +   + ++S+ +    K+  + V  + +       
Sbjct: 270 NPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329

Query: 367 IGNSSQLQAFDLSLNHIVGEIPKE---LGKLNPLTKLILRGNQITGRLPKEIG---SLTK 420
             +   L+  DLS N +V E  K     G    L  L+L  N +   + K      +L  
Sbjct: 330 SQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKN 388

Query: 421 LEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
           L  LD S      +P      + +  LNLS   +   + +C      L  +D+S N L 
Sbjct: 389 LTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR-VVKTC--IPQTLEVLDVSNNNLD 444

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  137 bits (347), Expect = 3e-34
 Identities = 70/388 (18%), Positives = 135/388 (34%), Gaps = 24/388 (6%)

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYI 172
            D  +  F+  IP      + +  L L  N ++      L    +L  L L  +++    
Sbjct: 10  CDGRSRSFTS-IP--SGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 173 PRPFSNLTSVSTLRLSRNDLFGSIPDE-IGKMRSLSVLDLNQNQFKGVLPPS-ISNLTNL 230
              F +L S+  L LS N L  S+     G + SL  L+L  N ++ +   S   NLTNL
Sbjct: 67  GDAFYSLGSLEHLDLSDNHL-SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125

Query: 231 KELALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQ 288
           + L +        I       L  L +L +       Y   ++     +   T+  +   
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185

Query: 289 GTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK 348
             +       +S+  + L   NL       L +    + +             ++ +  K
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNP--LTKLILRGNQ 406
           L    + ++ +      E  + +     D + +    ++  ELGK+    + +L +    
Sbjct: 246 LLRYILELSEV------EFDDCTLNGLGDFNPSES--DVVSELGKVETVTIRRLHIPQFY 297

Query: 407 ITGRLPKEIGSLTKLEYLDFS--AIGELPSQIC-NMKSLEKLNLSHNNLSGSI---PSCF 460
           +   L      L K++ +      +  +P     ++KSLE L+LS N +        +C 
Sbjct: 298 LFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357

Query: 461 EGMHGLSFIDMSYNELQCPVPNSTTFRG 488
                L  + +S N L+           
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLT 385

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  105 bits (264), Expect = 9e-24
 Identities = 49/324 (15%), Positives = 95/324 (29%), Gaps = 92/324 (28%)

Query: 18  NGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSE 77
           +  + +        +  L +     F  +    S L  ++ + + +++            
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF---------- 323

Query: 78  SSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
                                 +P                            +L +L FL
Sbjct: 324 ---------------------LVPCSF-----------------------SQHLKSLEFL 339

Query: 138 YLYGNLLSGSIL---SSLGKLKSLFDLQLNDNQL--IGYIPRPFSNLTSVSTLRLSRNDL 192
            L  NL+    L   +  G   SL  L L+ N L  +         L ++++L +SRN  
Sbjct: 340 DLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTF 399

Query: 193 FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI 252
              +PD       +  L+L+    + V+   I     L+ L +  N+L  S    L    
Sbjct: 400 -HPMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFLPR-- 452

Query: 253 LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
           L++L +S N                   T+ +                L+ ++++ N L 
Sbjct: 453 LQELYISRNKLK----------------TLPDASL----------FPVLLVMKISRNQLK 486

Query: 313 GNISEALGIYPNLTFIDLSRNNFY 336
                      +L  I L  N + 
Sbjct: 487 SVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 82.9 bits (205), Expect = 1e-16
 Identities = 34/193 (17%), Positives = 64/193 (33%), Gaps = 10/193 (5%)

Query: 297 NCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSM 356
           +C +         + T   S   G+   +  +DLS N        +      L  L +  
Sbjct: 3   SCDASGVCDGRSRSFT---SIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59

Query: 357 NNITGGLPREI-GNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG-RLPKE 414
           + I   +  +   +   L+  DLS NH+        G L+ L  L L GN      +   
Sbjct: 60  SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118

Query: 415 IGSLTKLEYLDFS---AIGELPSQ-ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFID 470
             +LT L+ L         E+       + SL +L +   +L        + +  +  + 
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178

Query: 471 MSYNELQCPVPNS 483
           +  +E    +   
Sbjct: 179 LHLSESAFLLEIF 191

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  173 bits (439), Expect = 4e-48
 Identities = 61/321 (19%), Positives = 112/321 (34%), Gaps = 65/321 (20%)

Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV 639
             E     ++      IG G + +VY+  L     VAVK F          +++ F+ E 
Sbjct: 5   ASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSF-------ANRQNFINEK 56

Query: 640 E-------------AFYGFCSHARHS-----FLLYEFLERGSLAAILNTDAAAQELGWSQ 681
                          F                L+ E+   GSL   L+         W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL----HTSDWVS 112

Query: 682 RMNVIKAVAHALSYLHHD------CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
              +  +V   L+YLH +        P I HRD++S+N+L+  +    ++DFG++  L  
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 736 DSSNWTEF--------AGTCGYIAPE-------LAYTMKITEKCDVYSFGVLMWEVIKGK 780
           +                GT  Y+APE       L       ++ D+Y+ G++ WE+    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 781 HPRDFLSSIS------SSSLNTDVALDQMLD--------PRLPAPSRSAQEKLISIMEVA 826
                  S+        + +      + M          P+ P   +     + S+ E  
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 827 FSCFNESPESRPTMKIISQQL 847
             C+++  E+R T +   +++
Sbjct: 293 EDCWDQDAEARLTAQXAEERM 313

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  170 bits (433), Expect = 7e-48
 Identities = 53/269 (19%), Positives = 103/269 (38%), Gaps = 36/269 (13%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           +       +++     G  + VK     +    T   ++F  E                G
Sbjct: 18  LNENHSGELWKGRW-QGNDIVVKVLK--VRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 645 FCSH--ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
            C    A H  L+  ++  GSL  +L+ +     +  SQ +     +A  +++LH    P
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL---AYTMK 759
            I    ++S+++++D +  A ++   +  S +              ++APE         
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEALQKKPEDT 187

Query: 760 ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKL 819
                D++SF VL+WE++  + P  F + +S+  +   VAL+ +   R   P       +
Sbjct: 188 NRRSADMWSFAVLLWELVTREVP--F-ADLSNMEIGMKVALEGL---RPTIPP-GISPHV 240

Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +M+    C NE P  RP   +I   L 
Sbjct: 241 SKLMK---ICMNEDPAKRPKFDMIVPILE 266

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  170 bits (433), Expect = 1e-47
 Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 60/298 (20%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------A 641
           C+G G +  V+R     GE VAVK F S        D+K +  E E              
Sbjct: 15  CVGKGRYGEVWRGSW-QGENVAVKIFSS-------RDEKSWFRETELYNTVMLRHENILG 66

Query: 642 FYGFCSHARHSFLLY----EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           F      +RHS         + E GSL   L        L     + ++ ++A  L++LH
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL----TTLDTVSCLRIVLSIASGLAHLH 122

Query: 698 HDCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS----NWTEFAGTCG 748
            + F     P I HRD+ SKN+L+    +  +AD G+A      ++          GT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 749 YIAPEL------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSIS---SSSLNTDVA 799
           Y+APE+             ++ D+++FG+++WEV +       +          +  D +
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 800 LDQMLD--------PRLPA--PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            + M          P +P    S      L  +M+    C+ ++P +R T   I + L
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTL 297

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  170 bits (433), Expect = 1e-47
 Identities = 65/279 (23%), Positives = 108/279 (38%), Gaps = 44/279 (15%)

Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           +G G      +     +GEV+ +K+            Q+ FL EV+            F 
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFD----EETQRTFLKEVKVMRCLEHPNVLKFI 73

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G     +    + E+++ G+L  I+ +     +  WSQR++  K +A  ++YLH      
Sbjct: 74  GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MN 128

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSL--------------KPDSSNWTEFAGTCGY 749
           I+HRD++S N L+       VADFG+A+ +              KPD        G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP 809
           +APE+       EK DV+SFG+++ E+I   +               D  L+        
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----LPRTMDFGLNVRGFLDRY 243

Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            P  +       I      C +  PE RP+   +   L 
Sbjct: 244 CPP-NCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWLE 278

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  168 bits (428), Expect = 1e-46
 Identities = 55/360 (15%), Positives = 108/360 (30%), Gaps = 57/360 (15%)

Query: 101 PPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFD 160
             H  +      L    +    P                                 +   
Sbjct: 5   HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNP-Q 59

Query: 161 LQLNDNQLIGYIPRPFSNLTSVS--TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG 218
           ++    + +        + T      L L    L    PD+  ++  L  + ++      
Sbjct: 60  IETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM- 117

Query: 219 VLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGAL 277
            LP ++     L+ L L  N L  ++P S+ +L  LR+L +        LP  +      
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA----- 171

Query: 278 EIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYG 337
                             +   +L  +RL    +                          
Sbjct: 172 ----------STDASGEHQGLVNLQSLRLEWTGIR------------------------- 196

Query: 338 EISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPL 397
            + ++      L +L +  + ++  L   I +  +L+  DL     +   P   G   PL
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255

Query: 398 TKLILRG-NQITGRLPKEIGSLTKLEYLDFS---AIGELPSQICNMKSLEKLNLSHNNLS 453
            +LIL+  + +   LP +I  LT+LE LD      +  LPS I  + +   + +  +  +
Sbjct: 256 KRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  166 bits (423), Expect = 6e-46
 Identities = 55/353 (15%), Positives = 99/353 (28%), Gaps = 55/353 (15%)

Query: 130 NLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSR 189
           + S    LY  G+         L + +  ++   N             N  +      + 
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTG 65

Query: 190 NDLFGSIPDEIG--KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS 247
             L  +  D +          L+L         P     L++L+ + +    L   +P +
Sbjct: 66  RAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122

Query: 248 LGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRL 306
           +     L  L L+ N                             +P S+ +   L  + +
Sbjct: 123 MQQFAGLETLTLARNPLR-------------------------ALPASIASLNRLRELSI 157

Query: 307 NGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPRE 366
                   + E L                             L +L +    I   LP  
Sbjct: 158 RACPELTELPEPLASTDASGEH---------------QGLVNLQSLRLEWTGIRS-LPAS 201

Query: 367 IGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLD- 425
           I N   L++  +  + +   +   +  L  L +L LRG       P   G    L+ L  
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260

Query: 426 --FSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNEL 476
              S +  LP  I  +  LEKL+L        +PS    +     I +  +  
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  157 bits (398), Expect = 2e-42
 Identities = 56/359 (15%), Positives = 105/359 (29%), Gaps = 46/359 (12%)

Query: 75  SSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNL 134
           SS     +      L    ++        +   +     D      +        N +N 
Sbjct: 3   SSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNP 58

Query: 135 IFLYLYGNLLSGSILSSLGKLKS--LFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL 192
                 G  L  +    L          L+L    L    P     L+ +  + +    L
Sbjct: 59  QIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL 116

Query: 193 FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI 252
              +PD + +   L  L L +N  +  LP SI++L  L+EL++        +P  L +  
Sbjct: 117 -MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTD 174

Query: 253 ----------LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLI 302
                     L+ L L        LP +I     L+   +  +     +  ++ +   L 
Sbjct: 175 ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE 232

Query: 303 RVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGG 362
            + L G     N     G    L  + L   +              L T           
Sbjct: 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCS-------------NLLT----------- 268

Query: 363 LPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKL 421
           LP +I   +QL+  DL     +  +P  + +L     +++  +           +    
Sbjct: 269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  136 bits (344), Expect = 2e-35
 Identities = 54/286 (18%), Positives = 92/286 (32%), Gaps = 28/286 (9%)

Query: 25  SFSSFPHLAYLDLTWNGF--FGTIPPQISNLS--NLRYLYLGSNQFSGNILAEVSSESSG 80
           S     +     +              + + +      L L S         +       
Sbjct: 48  SAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQA------ 100

Query: 81  GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLY 140
             L ++  + I+   L   +P  +     L  L L  N     +P S  +L+ L  L + 
Sbjct: 101 FRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIR 158

Query: 141 GN---------LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND 191
                      L S         L +L  L+L    +   +P   +NL ++ +L++  + 
Sbjct: 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSP 217

Query: 192 LFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALL-YNHLSGSIPPSLGN 250
           L  ++   I  +  L  LDL         PP       LK L L   ++L  ++P  +  
Sbjct: 218 LS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHR 275

Query: 251 LI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSL 295
           L  L +L L G      LP  I +  A  I  V   H Q  +    
Sbjct: 276 LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP-PHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  105 bits (264), Expect = 9e-25
 Identities = 34/202 (16%), Positives = 63/202 (31%), Gaps = 23/202 (11%)

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWG--KFP 347
                L           N  +     + +     N   I+          +        P
Sbjct: 27  PYHDVLSQWQRHYNADRNRWHSAWRQANS-----NNPQIETRTGRALKATADLLEDATQP 81

Query: 348 KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQI 407
               L +    +    P +    S LQ   +    ++ E+P  + +   L  L L  N +
Sbjct: 82  GRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL 139

Query: 408 TGRLPKEIGSLTKLEYLDFSA---IGELPSQICN---------MKSLEKLNLSHNNLSGS 455
              LP  I SL +L  L   A   + ELP  + +         + +L+ L L    +  S
Sbjct: 140 R-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-S 197

Query: 456 IPSCFEGMHGLSFIDMSYNELQ 477
           +P+    +  L  + +  + L 
Sbjct: 198 LPASIANLQNLKSLKIRNSPLS 219

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 18/139 (12%), Positives = 38/139 (27%), Gaps = 11/139 (7%)

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT 408
              L    +         +    +    D +  H            N        G  + 
Sbjct: 14  RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69

Query: 409 GRLPKEIGSLT--KLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMH 464
                 +   T      L+     + + P Q   +  L+ + +    L   +P   +   
Sbjct: 70  -ATADLLEDATQPGRVALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127

Query: 465 GLSFIDMSYNELQCPVPNS 483
           GL  + ++ N L+  +P S
Sbjct: 128 GLETLTLARNPLRA-LPAS 145

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  166 bits (423), Expect = 7e-46
 Identities = 71/328 (21%), Positives = 119/328 (36%), Gaps = 68/328 (20%)

Query: 567 GSLSILNFEGK-ILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLP 625
           GS S L    +  +  +I            IG G +  V+  +   GE VAVK F +   
Sbjct: 22  GSGSGLPLLVQRTIAKQIQMVK-------QIGKGRYGEVWMGKW-RGEKVAVKVFFT--- 70

Query: 626 CDQTVDQKEFLTEVE-------------AFYGFCSHARHS----FLLYEFLERGSLAAIL 668
                ++  +  E E              F         S    +L+ ++ E GSL   L
Sbjct: 71  ----TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL 126

Query: 669 NTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF-----PPIVHRDISSKNLLLDLEYEAH 723
            +      L     + +  +    L +LH + F     P I HRD+ SKN+L+       
Sbjct: 127 KS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182

Query: 724 VADFGIAKSLKPDSSNW----TEFAGTCGYIAPE-LAYTMKI-----TEKCDVYSFGVLM 773
           +AD G+A     D++          GT  Y+ PE L  ++           D+YSFG+++
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242

Query: 774 WEVIKGKHPRDFLSSI---SSSSLNTDVALDQMLD--------PRLPA--PSRSAQEKLI 820
           WEV +       +          + +D + + M +        P  P    S     ++ 
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302

Query: 821 SIMEVAFSCFNESPESRPTMKIISQQLR 848
            +M     C+  +P SR T   + + L 
Sbjct: 303 KLMT---ECWAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  162 bits (412), Expect = 2e-44
 Identities = 64/299 (21%), Positives = 112/299 (37%), Gaps = 60/299 (20%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------A 641
            IG G    V+R +   GE VAVK F S        +++ +  E E              
Sbjct: 49  SIGKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILG 100

Query: 642 FYGFCSHARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           F    +    +    +L+ ++ E GSL   LN       +     + +  + A  L++LH
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLH 156

Query: 698 HDCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS----NWTEFAGTCG 748
            +       P I HRD+ SKN+L+       +AD G+A      +           GT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 749 YIAPEL------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSIS---SSSLNTDVA 799
           Y+APE+          +  ++ D+Y+ G++ WE+ +                  + +D +
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276

Query: 800 LDQMLDP------RLPAPSR----SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           +++M         R   P+R     A   +  IM     C+  +  +R T   I + L 
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  169 bits (431), Expect = 7e-44
 Identities = 103/532 (19%), Positives = 185/532 (34%), Gaps = 57/532 (10%)

Query: 6   RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSN 64
           +++ +      +  T+   +F + P+L  LDL  +     + P     L +L  L L   
Sbjct: 51  QLLELGSQYTPL--TIDKEAFRNLPNLRILDLGSSK-IYFLHPDAFQGLFHLFELRLYFC 107

Query: 65  QFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGF-IPPHIGNLKFLSQLDLTNNKFSGP 123
             S  +L     +    NL+ ++RL ++ N +    + P  G L  L  +D ++N+    
Sbjct: 108 GLSDAVL----KDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163

Query: 124 IPLSFDNLS--NLIFLYLYGNLL----SGSILSSLGKLK--SLFDLQLNDNQLIGYIPRP 175
                + L    L F  L  N L    S      +   +   L  L ++ N     I   
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGN 223

Query: 176 FSN------------LTSVSTLRLSRNDLFGSIPDEIGKMR--SLSVLDLNQNQFKGVLP 221
           FSN               +       +++     +    +   S+  LDL+      +  
Sbjct: 224 FSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNS 283

Query: 222 PSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIF 280
                L +LK L L YN ++     +   L  L+ L LS N        N      +   
Sbjct: 284 RVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343

Query: 281 TVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS 340
            + +NH       + +    L  + L  N LT      +   P++  I LS N     + 
Sbjct: 344 DLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNK----LV 394

Query: 341 SNWGKFPKLGTLNVSMNNITGGLPREI-GNSSQLQAFDLSLNHIVGEIPKE--LGKLNPL 397
           +          +++S N +              LQ   L+ N        +    +   L
Sbjct: 395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF-SSCSGDQTPSENPSL 453

Query: 398 TKLILRGNQITGRLPKEI-----GSLTKLEYLDFS--AIGELPSQI-CNMKSLEKLNLSH 449
            +L L  N +      E+       L+ L+ L  +   +  LP  +  ++ +L  L+L+ 
Sbjct: 454 EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513

Query: 450 NNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLC 501
           N L+    +       L  +D+S N+L    PN   F   SV  +  NK +C
Sbjct: 514 NRLTVLSHNDLPAN--LEILDISRNQLL--APNPDVFVSLSVLDITHNKFIC 561

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  163 bits (414), Expect = 1e-41
 Identities = 93/474 (19%), Positives = 150/474 (31%), Gaps = 81/474 (17%)

Query: 51  SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI-GNLKF 109
             L+    L L     S N +  V++ S    L  +  L +        I      NL  
Sbjct: 21  QVLNTTERLLL-----SFNYIRTVTASSFP-FLEQLQLLELGSQYTPLTIDKEAFRNLPN 74

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
           L  LDL ++K     P +F  L +L  L LY   LS ++L                    
Sbjct: 75  LRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK------------------- 115

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFG-SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLT 228
                 F NL +++ L LS+N +    +    GK+ SL  +D + NQ   V    +  L 
Sbjct: 116 ---DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172

Query: 229 --NLKELALLYNHLSGSIPP-------SLGNLILRQLLLSGNHFTGYLPYNICRGGALEI 279
              L   +L  N L   +            N++L  L +SGN +T  +  N         
Sbjct: 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS------- 225

Query: 280 FTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALG--IYPNLTFIDLSRNNFYG 337
                N    +   SL     ++      +N+              ++  +DLS    + 
Sbjct: 226 -----NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFS 280

Query: 338 EISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPL 397
             S  +     L  LN++ N I             LQ  +LS N +          L  +
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340

Query: 398 TKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSG- 454
             + L+ N I     +    L KL+ LD    A+    + I  + S+  + LS N L   
Sbjct: 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL----TTIHFIPSIPDIFLSGNKLVTL 396

Query: 455 --------------------SIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRG 488
                                I      +  L  + ++ N          T   
Sbjct: 397 PKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS-CSGDQTPSE 449

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  153 bits (387), Expect = 2e-38
 Identities = 98/475 (20%), Positives = 157/475 (33%), Gaps = 65/475 (13%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLS--NLRYLYLGSNQFSGNILAEVSSESSGGN 82
           SF     L  +D + N  F     ++  L    L +  L +N         V        
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYS--RVSVDWGKCMNP 200

Query: 83  LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN 142
            R M                       L  LD++ N ++  I  +F             N
Sbjct: 201 FRNMV----------------------LEILDVSGNGWTVDITGNFS------------N 226

Query: 143 LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNL--TSVSTLRLSRNDLFGSIPDEI 200
            +S S   SL     +       + +       F+ L  +SV  L LS   +F       
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286

Query: 201 GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLS 259
             ++ L VL+L  N+   +   +   L NL+ L L YN L      +   L  +  + L 
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346

Query: 260 GNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEA 318
            NH    +     +    L+   + +N       T++    S+  + L+GN L       
Sbjct: 347 KNHIA-IIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKIN 400

Query: 319 LGIYPNLTFIDLSRNNFYG-EISSNWGKFPKLGTLNVSMNNITGGLPREI-GNSSQLQAF 376
           L        I LS N     +I     + P L  L ++ N  +     +    +  L+  
Sbjct: 401 L----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456

Query: 377 DLSLNHIVGEIPKEL-----GKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AI 429
            L  N +      EL       L+ L  L L  N +    P     LT L  L  +   +
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

Query: 430 GELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNST 484
             L        +LE L++S N L    P  F     LS +D+++N+  C    ST
Sbjct: 517 TVLSHND-LPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELST 567

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  137 bits (347), Expect = 2e-33
 Identities = 84/470 (17%), Positives = 152/470 (32%), Gaps = 38/470 (8%)

Query: 22  HDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSN------LRYLYLGSNQFSGNILAEVS 75
           H+        L++  L  N  +  +        N      L  L +  N ++ +I    S
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225

Query: 76  SESSGGN------LRYMSRLVINDNSLSGFIPPHIGNLKFLS--QLDLTNNKFSGPIPLS 127
           +  S           ++       +++          L   S   LDL++          
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285

Query: 128 FDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL 187
           F+ L +L  L L  N ++     +   L +L  L L+ N L       F  L  V+ + L
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345

Query: 188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS 247
            +N +          +  L  LDL  N        +I  + ++ ++ L  N L  ++P  
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPK- 398

Query: 248 LGNLILRQLLLSGNHFTGYLPYNICRGG--ALEIFTVSENHFQGTIPTSL-RNCTSLIRV 304
             NL    + LS N     L           L+I  +++N F             SL ++
Sbjct: 399 -INLTANLIHLSENRLEN-LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456

Query: 305 RLNGNNLTGNI-----SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNI 359
            L  N L          +      +L  + L+ N         +     L  L+++ N +
Sbjct: 457 FLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRL 516

Query: 360 TGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLT 419
           T  L       + L+  D+S N ++   P        L+ L +  N+       E+ +  
Sbjct: 517 T-VLSHND-LPANLEILDISRNQLLAPNP---DVFVSLSVLDITHNKFICEC--ELSTFI 569

Query: 420 KLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFI 469
                    I   P+ I  +       +S  +LS       E +  L F 
Sbjct: 570 NWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFS 619

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  114 bits (287), Expect = 3e-26
 Identities = 77/333 (23%), Positives = 124/333 (37%), Gaps = 38/333 (11%)

Query: 1   CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLY 60
              + R +++S   +    +L+   F +   L  L+L +N            L NL+ L 
Sbjct: 264 ARSSVRHLDLSHGFVF---SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLN 320

Query: 61  LGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKF 120
           L     S N+L E+ S +    L  ++ + +  N ++         L+ L  LDL +N  
Sbjct: 321 L-----SYNLLGELYSSNF-YGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374

Query: 121 SGP--------IPLSFDNLSNLIFLYLYGNLLSGS--------ILSSLGKLKSLFDLQLN 164
           +          I LS + L  L  + L  NL+  S        IL  L ++  L  L LN
Sbjct: 375 TTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434

Query: 165 DNQLIGYIPRP--FSNLTSVSTLRLSRNDLFGSIPDEI-----GKMRSLSVLDLNQNQFK 217
            N+           S   S+  L L  N L  +   E+       +  L VL LN N   
Sbjct: 435 QNR-FSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493

Query: 218 GVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGAL 277
            + P   S+LT L+ L+L  N L+  +  +     L  L +S N      P       +L
Sbjct: 494 SLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAPNPDVF---VSL 549

Query: 278 EIFTVSENHFQGTIPTS-LRNCTSLIRVRLNGN 309
            +  ++ N F      S   N  +   V + G 
Sbjct: 550 SVLDITHNKFICECELSTFINWLNHTNVTIAGP 582

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  102 bits (257), Expect = 1e-22
 Identities = 62/273 (22%), Positives = 97/273 (35%), Gaps = 33/273 (12%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQF------------- 66
            L+  +F   P +AY+DL  N            L  L+ L L  N               
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIF 387

Query: 67  -SGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-PI 124
            SGN L  +   +   NL ++S   + +  +  F    +  +  L  L L  N+FS    
Sbjct: 388 LSGNKLVTLPKINLTANLIHLSENRLENLDILYF----LLRVPHLQILILNQNRFSSCSG 443

Query: 125 PLSFDNLSNLIFLYLYGNLLSGSILSSL-----GKLKSLFDLQLNDNQLIGYIPRPFSNL 179
             +     +L  L+L  N+L  +  + L       L  L  L LN N L    P  FS+L
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHL 503

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH 239
           T++  L L+ N L   +        +L +LD+++NQ     P       +L  L + +N 
Sbjct: 504 TALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNP---DVFVSLSVLDITHNK 558

Query: 240 LSGSIPPSLGNLILRQLLLSGNHFTGYLPYNIC 272
                            L   N      P +I 
Sbjct: 559 FICECE----LSTFINWLNHTNVTIAGPPADIY 587

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.0 bits (148), Expect = 1e-09
 Identities = 22/116 (18%), Positives = 44/116 (37%), Gaps = 8/116 (6%)

Query: 377 DLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS---AIGELP 433
                ++  ++P+ L   N   +L+L  N I          L +L+ L+         + 
Sbjct: 10  FYRFCNLT-QVPQVL---NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65

Query: 434 SQIC-NMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRG 488
            +   N+ +L  L+L  + +    P  F+G+  L  + + +  L   V     FR 
Sbjct: 66  KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  164 bits (417), Expect = 1e-43
 Identities = 66/445 (14%), Positives = 128/445 (28%), Gaps = 57/445 (12%)

Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
             N +  +   +  +          +  S   +   +  L ++ N LS      +     
Sbjct: 6   KQNGNRYKIEKVTDSSLKQ------ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
           L  L+L++N     +    ++LS L  L L  N      +  L    S+  L   +N + 
Sbjct: 60  LELLNLSSNVLYETLD--LESLSTLRTLDLNNNY-----VQELLVGPSIETLHAANNNIS 112

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPS-ISNLT 228
                      +   + L+ N +      + G    +  LDL  N+   V      ++  
Sbjct: 113 RVSCSRGQGKKN---IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 229 NLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQ 288
            L+ L L YN +   +   +    L+ L LS N                           
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA------------------------ 204

Query: 289 GTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK 348
             +    ++   +  + L  N L   I +AL    NL   DL  N F+     ++     
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKN 261

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTK-----LILR 403
                V+   +     +     +                     +L  L +     L  +
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ 321

Query: 404 GNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQIC-NMKSLEKLNLSHNNLSGSIPSCF 460
           G++   RL  E  +  +   +D        +  Q+    ++   L      L   + +  
Sbjct: 322 GSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380

Query: 461 EGM---HGLSFIDMSYNELQCPVPN 482
                  G     +   ELQ     
Sbjct: 381 RAHAELDGTLQQAVGQIELQHATEE 405

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  154 bits (391), Expect = 3e-40
 Identities = 60/444 (13%), Positives = 127/444 (28%), Gaps = 32/444 (7%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
                   S  ++  LDL+ N         ++  + L  L L SN      L E     S
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV-----LYETLDLES 78

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYL 139
              LR    L +N+N +       +     +  L   NN  S    +S         +YL
Sbjct: 79  LSTLRT---LDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYL 127

Query: 140 YGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRP--FSNLTSVSTLRLSRNDLFGSIP 197
             N ++       G    +  L L  N+ I  +      ++  ++  L L  N ++  + 
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNE-IDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQL 256
            ++     L  LDL+ N+    + P   +   +  ++L  N L   I  +L     L   
Sbjct: 186 GQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 257 LLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNIS 316
            L GN F      +        + TV++   +     +   CT                +
Sbjct: 243 DLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301

Query: 317 EALGIYPNLTFIDLS----RNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQ 372
                   L   + +    + +    +        +   ++         + +       
Sbjct: 302 PFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQA 361

Query: 373 LQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG--RLPKEIGSLTKLEYLDFS-AI 429
               +     +  ++         L   + +           +E   L  L  +      
Sbjct: 362 KITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEE 421

Query: 430 GELPSQICNMKSLEKLNLSHNNLS 453
             +  Q     ++   ++  +  +
Sbjct: 422 MYVEQQSVQNNAIRDWDMYQHKET 445

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  143 bits (362), Expect = 2e-36
 Identities = 56/361 (15%), Positives = 125/361 (34%), Gaps = 20/361 (5%)

Query: 124 IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVS 183
           I     N +      +  + L  ++ S      ++ +L L+ N L        +  T + 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 184 TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS 243
            L LS N L      ++  + +L  LDLN N  +      +    +++ L    N++S  
Sbjct: 62  LLNLSSNVL--YETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113

Query: 244 IPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQG-TIPTSLRNCTSLI 302
           +  S G    + + L+ N  T     +      ++   +  N            +  +L 
Sbjct: 114 VSCSRGQG-KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLE 172

Query: 303 RVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGG 362
            + L  N +  ++   +     L  +DLS N     +   +     +  +++  N +   
Sbjct: 173 HLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-L 228

Query: 363 LPREIGNSSQLQAFDLSLNHIV-GEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKL 421
           + + +  S  L+ FDL  N    G +     K   +  +  +  +      +E  ++  L
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288

Query: 422 EYLDFSAIGELPSQ-ICNMKSLEKLNLSHNNLSGS----IPSCFEGMHGLSFIDMSYNEL 476
            +       +LP+     + +L++   +  +  GS    +    E       ID    + 
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348

Query: 477 Q 477
           +
Sbjct: 349 R 349

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  138 bits (349), Expect = 8e-35
 Identities = 58/330 (17%), Positives = 106/330 (32%), Gaps = 41/330 (12%)

Query: 195 SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-L 253
           +I +         +  +  +  K  L     +  N+KEL L  N LS      L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 254 RQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG 313
             L LS N                                 L + ++L  + LN N +  
Sbjct: 61  ELLNLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYVQ- 93

Query: 314 NISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQL 373
                L + P++  +  + NN    +S    +      + ++ N IT     + G  S++
Sbjct: 94  ----ELLVGPSIETLHAANNNI-SRVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 374 QAFDLSLNHIVG-EIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIG 430
           Q  DL LN I      +     + L  L L+ N I   +  ++    KL+ LD S   + 
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204

Query: 431 ELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGAS 490
            +  +  +   +  ++L +N L   I         L   D+  N   C        +   
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263

Query: 491 VEALKGNKGLCGSAKGLQPCKPLRQEKSNS 520
           V+ +        + +  + C         +
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTLGHYGA 293

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  159 bits (404), Expect = 2e-43
 Identities = 57/325 (17%), Positives = 113/325 (34%), Gaps = 56/325 (17%)

Query: 550 KQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAEL 609
              S    R    +  Q S+ +  ++  I ++++     +      IG G    VY    
Sbjct: 4   MNLSLLSARSFPRKASQTSIFLQEWD--IPFEQL-----EIGEL--IGKGRFGQVYHGRW 54

Query: 610 PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEF 658
             GEV A++        +  +  K F  EV             F G C    H  ++   
Sbjct: 55  -HGEV-AIRLIDIERDNEDQL--KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110

Query: 659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL 718
            +  +L +++    A   L  ++   + + +   + YLH      I+H+D+ SKN+  D 
Sbjct: 111 CKGRTLYSVVR--DAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD- 164

Query: 719 EYEAHVADFGIAK-----SLKPDSSNWTEFAGTCGYIAPELAYTMKI---------TEKC 764
             +  + DFG+                    G   ++APE+   +           ++  
Sbjct: 165 NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHS 224

Query: 765 DVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML-DPRLPAPSRSAQEKLISIM 823
           DV++ G + +E+   + P  F       +   +  + QM    +         +++  I+
Sbjct: 225 DVFALGTIWYELHAREWP--F------KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276

Query: 824 EVAFSCFNESPESRPTMKIISQQLR 848
                C+    E RPT   +   L 
Sbjct: 277 L---FCWAFEQEERPTFTKLMDMLE 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  156 bits (397), Expect = 8e-43
 Identities = 57/269 (21%), Positives = 119/269 (44%), Gaps = 32/269 (11%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           IG+G   +VY+ +   G+V AVK  +           + F  EV             F G
Sbjct: 32  IGSGSFGTVYKGKW-HGDV-AVKMLNV--TAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
           + +  + + ++ ++ E  SL   L+      +    + +++ +  A  + YLH      I
Sbjct: 88  YSTAPQLA-IVTQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHA---KSI 141

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIA--KSLKPDSSNWTEFAGTCGYIAPEL---AYTMK 759
           +HRD+ S N+ L  +    + DFG+A  KS    S  + + +G+  ++APE+     +  
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 760 ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKL 819
            + + DVY+FG++++E++ G+ P   +++        ++     L P L     +  +++
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 820 ISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +M     C  +  + RP+   I  ++ 
Sbjct: 259 KRLMA---ECLKKKRDERPSFPRILAEIE 284

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  145 bits (367), Expect = 8e-38
 Identities = 71/359 (19%), Positives = 128/359 (35%), Gaps = 19/359 (5%)

Query: 51  SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFL 110
              SNL+Y  +  +        +V        L     +   ++++       + + + +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIG 170
             L+L + +       +F     +  LY+  N +          +  L  L L  N L  
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 131

Query: 171 YIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
                F N   ++TL +S N+L   I D+      SL  L L+ N+   V    +S + +
Sbjct: 132 LPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPS 187

Query: 230 LKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQG 289
           L    + YN LS ++   +    + +L  S N     +   +     L I  +  N+   
Sbjct: 188 LFHANVSYNLLS-TLAIPIA---VEELDASHNSIN-VVRGPVNVE--LTILKLQHNNL-- 238

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL 349
           T    L N   L+ V L+ N L   +         L  + +S N     ++      P L
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTL 297

Query: 350 GTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT 408
             L++S N++   + R      +L+   L  N IV  +   L   + L  L L  N   
Sbjct: 298 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  136 bits (345), Expect = 7e-35
 Identities = 70/355 (19%), Positives = 126/355 (35%), Gaps = 33/355 (9%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            L      SF  +  L+L        I     +    ++ LY+G N      +  +    
Sbjct: 59  KLPAALLDSFRQVELLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNA-----IRYL-PPH 111

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
              N+  ++ LV+  N LS  +P  I  N   L+ L ++NN        +F   ++L  L
Sbjct: 112 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 170

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
            L  N L+  +   L  + SLF   ++ N L        +   +V  L  S N +   + 
Sbjct: 171 QLSSNRLT-HV--DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI-NVVR 221

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQ 255
             +     L++L L  N         + N   L E+ L YN L   I       +  L +
Sbjct: 222 GPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLER 276

Query: 256 LLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI 315
           L +S N     L         L++  +S NH    +  +      L  + L+ N++    
Sbjct: 277 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV--- 331

Query: 316 SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS 370
           +  L  +  L  + LS N++          F  +    V   +    +  ++ + 
Sbjct: 332 TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHG 384

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  134 bits (339), Expect = 4e-34
 Identities = 66/356 (18%), Positives = 127/356 (35%), Gaps = 32/356 (8%)

Query: 9   NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFS 67
           ++ +           F   +  +   +    +     +P  +  +   +  L L   Q  
Sbjct: 25  DVHIDMQT-QDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQ-- 80

Query: 68  GNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPL 126
              + E+ + +       + +L +  N++  ++PPH+  N+  L+ L L  N  S     
Sbjct: 81  ---IEEIDTYAFAY-AHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRG 135

Query: 127 SFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLR 186
            F N   L  L +  N L      +     SL +LQL+ N+L        S + S+    
Sbjct: 136 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHAN 192

Query: 187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP 246
           +S N L       +    ++  LD + N    V+   +     L  L L +N+L+     
Sbjct: 193 VSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TA 242

Query: 247 SLGNLI-LRQLLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRV 304
            L N   L ++ LS N     + Y+       LE   +S N     +    +   +L  +
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300

Query: 305 RLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT 360
            L+ N+L  ++      +  L  + L  N+    +         L  L +S N+  
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKL--STHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  111 bits (280), Expect = 2e-26
 Identities = 55/319 (17%), Positives = 107/319 (33%), Gaps = 46/319 (14%)

Query: 189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL 248
           R   +  I   +        + ++              L N K +    + +   +P +L
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64

Query: 249 -------------GNLI-------------LRQLLLSGNHFTGYLPYNICRG-GALEIFT 281
                           I             +++L +  N    YLP ++ +    L +  
Sbjct: 65  LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 123

Query: 282 VSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISS 341
           +  N           N   L  + ++ NNL     +      +L  + LS N     +  
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVDL 182

Query: 342 NWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLI 401
                P L   NVS N ++      +     ++  D S N I   +   +     LT L 
Sbjct: 183 --SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232

Query: 402 LRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQI-CNMKSLEKLNLSHNNLSGSIPS 458
           L+ N +T      + +   L  +D S   + ++       M+ LE+L +S+N L  ++  
Sbjct: 233 LQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNL 289

Query: 459 CFEGMHGLSFIDMSYNELQ 477
             + +  L  +D+S+N L 
Sbjct: 290 YGQPIPTLKVLDLSHNHLL 308

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  146 bits (370), Expect = 1e-37
 Identities = 82/422 (19%), Positives = 150/422 (35%), Gaps = 55/422 (13%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
           +       +P  I        LDL  N+        F +  +L  L L  N++S     +
Sbjct: 19  HRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGA 75

Query: 152 LGKLKSLFDLQLNDNQLIGYIPRP-FSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVL 209
              L +L  L L  N+ +  IP   F+ L++++ L +S N +   + D +   + +L  L
Sbjct: 76  FNNLFNLRTLGLRSNR-LKLIPLGVFTGLSNLTKLDISENKI-VILLDYMFQDLYNLKSL 133

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTGYL 267
           ++  N    +   + S L +L++L L   +L+ SIP  +L +L  L  L L   +     
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN--- 189

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF 327
                         + +  F+            L  + ++       ++       NLT 
Sbjct: 190 -------------AIRDYSFKR--------LYRLKVLEISHWPYLDTMTPNCLYGLNLTS 228

Query: 328 IDLSRNNFYGEISSN-WGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGE 386
           + ++  N    +          L  LN+S N I+      +    +LQ   L    +   
Sbjct: 229 LSITHCNL-TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AV 286

Query: 387 IPKE-LGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFSAIGELPSQI---CNMKS 441
           +       LN L  L + GNQ+T  L + +  S+  LE L   +     + +   C +  
Sbjct: 287 VEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDS-----NPLACDCRLLW 340

Query: 442 LEKLNLSHNNLSGSIPSCF--EGMHGLSFIDMS----YNELQCPVPNSTTFRGASVEALK 495
           +        N +   P+C   E + G  F D       N   C        +   V   +
Sbjct: 341 V-FRRRWRLNFNRQQPTCATPEFVQGKEFKDFPDVLLPNYFTCRRARIRDRKAQQVFVDE 399

Query: 496 GN 497
           G+
Sbjct: 400 GH 401

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  135 bits (341), Expect = 9e-34
 Identities = 74/320 (23%), Positives = 124/320 (38%), Gaps = 37/320 (11%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
           TL+   F+SFPHL  L+L  N     + P   +NL NLR L L SN+     L  +    
Sbjct: 46  TLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNR-----LKLIPLGV 99

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
             G L  +++L I++N +   +  ++  +L  L  L++ +N        +F  L++L  L
Sbjct: 100 FTG-LSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQL 157

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
            L    L+     +L  L  L  L+L    +       F  L  +  L +S      ++ 
Sbjct: 158 TLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQ 255
                  +L+ L +       V   ++ +L  L+ L L YN +S +I    L  L+ L++
Sbjct: 218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQE 276

Query: 256 LLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI 315
           + L G                  +  V    F+G           L  + ++GN LT   
Sbjct: 277 IQLVGGQ----------------LAVVEPYAFRGL--------NYLRVLNVSGNQLTTLE 312

Query: 316 SEALGIYPNLTFIDLSRNNF 335
                   NL  + L  N  
Sbjct: 313 ESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  131 bits (331), Expect = 1e-32
 Identities = 76/340 (22%), Positives = 117/340 (34%), Gaps = 47/340 (13%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
                 LDL  N    T+     ++  +L  L L  N  S                    
Sbjct: 31  PTETRLLDLGKN-RIKTLNQDEFASFPHLEELELNENIVS-------------------- 69

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS 147
              +   + +         L  L  L L +N+        F  LSNL  L +  N +   
Sbjct: 70  --AVEPGAFNN--------LFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVIL 119

Query: 148 ILSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRS 205
           +      L +L  L++ DN  + YI  R FS L S+  L L + +L  SIP E    +  
Sbjct: 120 LDYMFQDLYNLKSLEVGDND-LVYISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHG 177

Query: 206 LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLILRQLLLSGNHFT 264
           L VL L       +   S   L  LK L + +     ++ P  L  L L  L ++  + T
Sbjct: 178 LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT 237

Query: 265 GYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYP 323
             +PY   R    L    +S N       + L     L  ++L G  L      A     
Sbjct: 238 -AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLN 296

Query: 324 NLTFIDLSRNNFYGEISS-NWGKF---PKLGTLNVSMNNI 359
            L  +++S N     +++     F     L TL +  N +
Sbjct: 297 YLRVLNVSGNQ----LTTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 22/104 (21%), Positives = 43/104 (41%), Gaps = 10/104 (9%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            +   +     +L +L+L++N    TI   +   L  L+ + L   Q     LA V   +
Sbjct: 238 AVPYLAVRHLVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQ-----LAVVEPYA 291

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFS 121
               L Y+  L ++ N L+  +   +  ++  L  L L +N  +
Sbjct: 292 -FRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  144 bits (366), Expect = 3e-37
 Identities = 89/402 (22%), Positives = 158/402 (39%), Gaps = 43/402 (10%)

Query: 100 IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSI-LSSLGKLKSL 158
           +P H+      + +DL+ N  +     SF  L +L FL +        I  ++   L SL
Sbjct: 28  LPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81

Query: 159 FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGS-IPDEI-GKMRSLSVLDLNQNQF 216
             L+L+ NQ +      F+ L ++  L L++ +L G+ +       + SL +L L  N  
Sbjct: 82  IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI 141

Query: 217 KGVLPPSI-SNLTNLKELALLYNHLSGSIPP----SLGNLILRQLLLSGNH--------F 263
           K + P S   N+     L L +N +  SI      +        L LS            
Sbjct: 142 KKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWL 200

Query: 264 TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYP 323
                 N  +  ++    +S N F+ ++     +  +  +++    + + N+  +     
Sbjct: 201 GWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF---G 257

Query: 324 NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREI-GNSSQLQAFDLSLNH 382
           +  F D     F G  +S       + T ++S + I   L + +  + + L+   L+ N 
Sbjct: 258 HTNFKDPDNFTFKGLEASG------VKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNE 310

Query: 383 IVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFS--AIGELPSQI-C 437
           I  +I       L  L KL L  N +   +   +  +L KLE LD S   I  L  Q   
Sbjct: 311 IN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368

Query: 438 NMKSLEKLNLSHNNLSGSIPS-CFEGMHGLSFIDMSYNELQC 478
            + +L++L L  N L  S+P   F+ +  L  I +  N   C
Sbjct: 369 GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 409

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 83.3 bits (206), Expect = 7e-17
 Identities = 43/214 (20%), Positives = 83/214 (38%), Gaps = 13/214 (6%)

Query: 14  NIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNL---SNLRYLYLGSNQ----- 65
           N    G     +      +  LDL+ NGF  ++  +  +    + ++ L L ++      
Sbjct: 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS 255

Query: 66  FSGNILAEVSSESSGG-NLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGP 123
           F      +  + +  G     +    ++ + +   +   +  +   L QL L  N+ +  
Sbjct: 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKI 314

Query: 124 IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVS 183
              +F  L++L+ L L  N L          L  L  L L+ N +     + F  L ++ 
Sbjct: 315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK 374

Query: 184 TLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQF 216
            L L  N L  S+PD I  ++ SL  + L+ N +
Sbjct: 375 ELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 58.6 bits (142), Expect = 5e-09
 Identities = 32/216 (14%), Positives = 60/216 (27%), Gaps = 31/216 (14%)

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN-WGKFPK 348
            +P  +        V L+ N++      +     +L F+ + +      I +N +     
Sbjct: 27  ELPAHVN------YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 349 LGTLNVSMNNITGGLPREI-GNSSQLQAFDLSLNHI-VGEIPKEL-GKLNPLTKLILRGN 405
           L  L +  N     L        + L+   L+  ++    +       L  L  L+LR N
Sbjct: 81  LIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139

Query: 406 QITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHG 465
            I    P             F           NM+    L+L+ N +            G
Sbjct: 140 NIKKIQPASF----------FL----------NMRRFHVLDLTFNKVKSICEEDLLNFQG 179

Query: 466 LSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLC 501
             F  +  + +     N              N  + 
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSIT 215

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  146 bits (369), Expect = 9e-37
 Identities = 65/323 (20%), Positives = 112/323 (34%), Gaps = 64/323 (19%)

Query: 131 LSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN 190
            +    L +  + L+ ++   L     +  L + DN L   +P     L +   L +S N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRT---LEVSGN 91

Query: 191 DLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGN 250
            L  S+P     +  LS+           LP   S L  L    +  N L+ S+P     
Sbjct: 92  QL-TSLPVLPPGLLELSIFSNPLTH----LPALPSGLCKLW---IFGNQLT-SLPVLPPG 142

Query: 251 LILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNN 310
           L  ++L +S N                            ++P        L       N 
Sbjct: 143 L--QELSVSDNQLA-------------------------SLPALPSELCKL---WAYNNQ 172

Query: 311 LTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS 370
           LT ++         L  + +S N     + +      +L  L    N +T  LP      
Sbjct: 173 LT-SLPMLPS---GLQELSVSDNQL-ASLPTL---PSELYKLWAYNNRLTS-LPALPSG- 222

Query: 371 SQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIG 430
             L+   +S N +   +P    +L    +L++ GN++T  LP     L  L  +  + + 
Sbjct: 223 --LKELIVSGNRL-TSLPVLPSEL---KELMVSGNRLT-SLPMLPSGLLSL-SVYRNQLT 274

Query: 431 ELPSQICNMKSLEKLNLSHNNLS 453
            LP  + ++ S   +NL  N LS
Sbjct: 275 RLPESLIHLSSETTVNLEGNPLS 297

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  141 bits (356), Expect = 5e-35
 Identities = 80/369 (21%), Positives = 124/369 (33%), Gaps = 66/369 (17%)

Query: 31  HLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLV 90
             A L++  +G   T+P  +   +++  L +  N      L  + +      LR    L 
Sbjct: 41  GNAVLNVGESGL-TTLPDCL--PAHITTLVIPDNN-----LTSLPAL--PPELRT---LE 87

Query: 91  INDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILS 150
           ++ N L+  +P     L  LS                    S L  L+++GN L+ S+  
Sbjct: 88  VSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLT-SLPV 138

Query: 151 SLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLD 210
               L+ L    ++DNQL   +P   S L     L    N L  S+P        L  L 
Sbjct: 139 LPPGLQEL---SVSDNQL-ASLPALPSELCK---LWAYNNQL-TSLPMLPS---GLQELS 187

Query: 211 LNQNQFKGVLPPSISNLT-----------------NLKELALLYNHLSGSIPPSLGNLIL 253
           ++ NQ    LP   S L                   LKEL +  N L+ S+P     L  
Sbjct: 188 VSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLT-SLPVLPSEL-- 243

Query: 254 RQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG 313
           ++L++SGN  T  LP        L   +V  N     +P SL + +S   V L GN L+ 
Sbjct: 244 KELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS- 297

Query: 314 NISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGL-PREIGNSSQ 372
                L     +T            I  +                    L P   G  + 
Sbjct: 298 --ERTLQALREITSAPGYSGPI---IRFDMAGASAPRETRALHLAAADWLVPAREGEPAP 352

Query: 373 LQAFDLSLN 381
              + +   
Sbjct: 353 ADRWHMFGQ 361

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  139 bits (352), Expect = 1e-34
 Identities = 84/413 (20%), Positives = 145/413 (35%), Gaps = 63/413 (15%)

Query: 53  LSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQ 112
            +    L +       + L  +  +    ++     LVI DN+L+  +P     L+    
Sbjct: 39  NNGNAVLNV-----GESGLTTL-PDCLPAHIT---TLVIPDNNLT-SLPALPPELR---T 85

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKL--------------KSL 158
           L+++ N+ +  +P+    L  L         L  ++ S L KL                L
Sbjct: 86  LEVSGNQLTS-LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGL 143

Query: 159 FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG 218
            +L ++DNQL   +P   S L     L    N L  S+P        L  L ++ NQ   
Sbjct: 144 QELSVSDNQL-ASLPALPSELCK---LWAYNNQL-TSLPMLPS---GLQELSVSDNQLA- 194

Query: 219 VLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALE 278
            LP   S L  L       N L+ S+P       L++L++SGN  T  LP        L+
Sbjct: 195 SLPTLPSELYKLW---AYNNRLT-SLPALPSG--LKELIVSGNRLT-SLPVLP---SELK 244

Query: 279 IFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGE 338
              VS N    ++P       SL    +  N LT  + E+L    + T ++L  N     
Sbjct: 245 ELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPL--- 296

Query: 339 ISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLT 398
                    ++ +       I            + +A  L+    +  +P   G+  P  
Sbjct: 297 SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL--VPAREGEPAPAD 354

Query: 399 KLILRGNQI-TGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHN 450
           +  + G +         +  L++ E  +F       +QI +   L +L     
Sbjct: 355 RWHMFGQEDNADAFSLFLDRLSETE--NFIKDAGFKAQISSW--LAQLAEDEA 403

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  108 bits (271), Expect = 1e-24
 Identities = 55/267 (20%), Positives = 90/267 (33%), Gaps = 55/267 (20%)

Query: 27  SSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQF------------SGNILAEV 74
           +  P L  L+++ N    ++P     L  L                       GN L  +
Sbjct: 78  ALPPELRTLEVSGN-QLTSLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSL 136

Query: 75  SSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNL--- 131
                   L+    L ++DN L+  +P     L    +L   NN+ +  +P+    L   
Sbjct: 137 PVLP--PGLQE---LSVSDNQLAS-LPALPSELC---KLWAYNNQLTS-LPMLPSGLQEL 186

Query: 132 --------------SNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFS 177
                         S L  L+ Y N L+ S+ +    LK L    ++ N+L   +P   S
Sbjct: 187 SVSDNQLASLPTLPSELYKLWAYNNRLT-SLPALPSGLKEL---IVSGNRL-TSLPVLPS 241

Query: 178 NLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLY 237
            L     L +S N L  S+P        L  L + +NQ    LP S+ +L++   + L  
Sbjct: 242 ELKE---LMVSGNRL-TSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 293

Query: 238 NHLSGSIPPSLGNLILRQLLLSGNHFT 264
           N L  S         +           
Sbjct: 294 NPL--SERTLQALREITSAPGYSGPII 318

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 94.2 bits (234), Expect = 4e-20
 Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 31/233 (13%)

Query: 27  SSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYM 86
              P L  L ++ N    ++P   S L  L   +  +NQ +       S       L+  
Sbjct: 138 VLPPGLQELSVSDN-QLASLPALPSELCKL---WAYNNQLT-------SLPMLPSGLQ-- 184

Query: 87  SRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG 146
             L ++DN L+  +P     L    +L   NN+ +  +P      S L  L + GN L+ 
Sbjct: 185 -ELSVSDNQLA-SLPTLPSELY---KLWAYNNRLT-SLP---ALPSGLKELIVSGNRLT- 234

Query: 147 SILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSL 206
           S+     +LK L    ++ N+L   +P   S L S   L + RN L   +P+ +  + S 
Sbjct: 235 SLPVLPSELKELM---VSGNRLT-SLPMLPSGLLS---LSVYRNQL-TRLPESLIHLSSE 286

Query: 207 SVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLS 259
           + ++L  N        ++  +T+    +        +   +        L  +
Sbjct: 287 TTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  138 bits (351), Expect = 2e-36
 Identities = 63/337 (18%), Positives = 116/337 (34%), Gaps = 39/337 (11%)

Query: 124 IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVS 183
           I     N +      +  + L  ++ S      ++ +L L+ N L        +  T + 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 184 TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS 243
            L LS N L     D +  + +L  LDLN N  +      +    +++ L    N++S  
Sbjct: 62  LLNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113

Query: 244 IPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIR 303
           +  S G    + + L+ N  T  L                               + +  
Sbjct: 114 VSCSRGQG-KKNIYLANNKITM-LR-----------------------DLDEGCRSRVQY 148

Query: 304 VRLNGNNLTG-NISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGG 362
           + L  N +   N +E       L  ++L  N  Y ++      F KL TL++S N +   
Sbjct: 149 LDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-F 205

Query: 363 LPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT-GRLPKEIGSLTKL 421
           +  E  +++ +    L  N +V  I K L     L    LRGN    G L        ++
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264

Query: 422 EYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPS 458
           + +    + +L  Q     ++  L          +P+
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  138 bits (349), Expect = 3e-36
 Identities = 56/288 (19%), Positives = 98/288 (34%), Gaps = 41/288 (14%)

Query: 195 SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-L 253
           +I +         +  +  +  K  L     +  N+KEL L  N LS      L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 254 RQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG 313
             L LS N                                 L + ++L  + LN N +  
Sbjct: 61  ELLNLSSNVLY-------------------------ETL-DLESLSTLRTLDLNNNYVQ- 93

Query: 314 NISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQL 373
                L + P++  +  + NN    +S +  +      + ++ N IT     + G  S++
Sbjct: 94  ----ELLVGPSIETLHAANNNI-SRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRV 146

Query: 374 QAFDLSLNHIVG-EIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIG 430
           Q  DL LN I      +     + L  L L+ N I   +  ++    KL+ LD S   + 
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204

Query: 431 ELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC 478
            +  +  +   +  ++L +N L   I         L   D+  N   C
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC 251

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  137 bits (346), Expect = 1e-35
 Identities = 49/305 (16%), Positives = 102/305 (33%), Gaps = 42/305 (13%)

Query: 176 FSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELAL 235
             N       +++ + L  ++        ++  LDL+ N    +    ++  T L+ L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 236 LYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTS 294
             N L       L +L  LR L L+ N+                                
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYV-----------------------------QE 94

Query: 295 LRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNV 354
           L    S+  +    NN++  +S + G       I L+ N        + G   ++  L++
Sbjct: 95  LLVGPSIETLHAANNNIS-RVSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

Query: 355 SMNNITG-GLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPK 413
            +N I          +S  L+  +L  N I  ++  ++     L  L L  N++   +  
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGP 208

Query: 414 EIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLS-GSIPSCFEGMHGLSFID 470
           E  S   + ++      +  +   +   ++LE  +L  N    G++   F     +  + 
Sbjct: 209 EFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268

Query: 471 MSYNE 475
               +
Sbjct: 269 KQTVK 273

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  135 bits (343), Expect = 2e-35
 Identities = 59/352 (16%), Positives = 114/352 (32%), Gaps = 43/352 (12%)

Query: 104 IGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL 163
             N        +T++     +     +  N+  L L GN LS    + L     L  L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPS 223
           + N L         +L+++ TL L+ N +      E+    S+  L    N    V   S
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV---S 115

Query: 224 ISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTV 282
            S     K + L  N ++       G    ++ L L  N                   TV
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID----------------TV 159

Query: 283 SENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN 342
           +             +  +L  + L  N +  ++   +     L  +DLS N     +   
Sbjct: 160 NFAELAA-------SSDTLEHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKL-AFMGPE 209

Query: 343 WGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIV-GEIPKELGKLNPLTKLI 401
           +     +  +++  N +   + + +  S  L+ FDL  N    G +     K   +  + 
Sbjct: 210 FQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVA 268

Query: 402 LRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLS 453
            +  +      +E  ++  L +       +LP+          + L H++  
Sbjct: 269 KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA----DRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  135 bits (342), Expect = 4e-35
 Identities = 55/296 (18%), Positives = 99/296 (33%), Gaps = 17/296 (5%)

Query: 82  NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
           N        + D+SL   +     +   + +LDL+ N  S          + L  L L  
Sbjct: 8   NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67

Query: 142 NLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG 201
           N+L       L  L +L  L LN+N +     +      S+ TL  + N++   +    G
Sbjct: 68  NVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-SRVSCSRG 119

Query: 202 KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG-SIPPSLGNLI-LRQLLLS 259
             +    + L  N+   +        + ++ L L  N +   +      +   L  L L 
Sbjct: 120 --QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177

Query: 260 GNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEAL 319
            N     +   +     L+   +S N     +    ++   +  + L  N L   I +AL
Sbjct: 178 YNFIYD-VKGQVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233

Query: 320 GIYPNLTFIDLSRNNFYGEISSNW-GKFPKLGTLNVSMNNITGGLPREIGNSSQLQ 374
               NL   DL  N F+     ++  K  ++ T+         G   E      L 
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  133 bits (336), Expect = 2e-34
 Identities = 55/360 (15%), Positives = 101/360 (28%), Gaps = 52/360 (14%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
             +        +T +     +     +  N++ L L  N                     
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP-------------------- 45

Query: 86  MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS 145
                     LS      +     L  L+L++N     +    ++LS L  L L  N   
Sbjct: 46  ----------LSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY-- 91

Query: 146 GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRS 205
              +  L    S+  L   +N +            +   + L+ N +      + G    
Sbjct: 92  ---VQELLVGPSIETLHAANNNISRVSCSRGQGKKN---IYLANNKITMLRDLDEGCRSR 145

Query: 206 LSVLDLNQNQFKGVLPPS-ISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFT 264
           +  LDL  N+   V      ++   L+ L L YN +   +   +    L+ L LS N   
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA 204

Query: 265 GYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT-GNISEALGIYP 323
            ++         +   ++  N     I  +LR   +L    L GN    G + +      
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262

Query: 324 NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI 383
            +  +           +      P LG            LP         +   L  +H 
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYG---AYCCEDLP----APFADRLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  127 bits (321), Expect = 2e-32
 Identities = 54/296 (18%), Positives = 94/296 (31%), Gaps = 25/296 (8%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
                   S  ++  LDL+ N         ++  + L  L L SN      L E     S
Sbjct: 24  QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV-----LYETLDLES 78

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYL 139
              LR    L +N+N +       +     +  L   NN  S    +S         +YL
Sbjct: 79  LSTLRT---LDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VSCSRGQGKKNIYL 127

Query: 140 YGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRP--FSNLTSVSTLRLSRNDLFGSIP 197
             N ++       G    +  L L  N+ I  +      ++  ++  L L  N ++  + 
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNE-IDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQL 256
            ++     L  LDL+ N+    + P   +   +  ++L  N L   I  +L     L   
Sbjct: 186 GQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHF 242

Query: 257 LLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
            L GN F               + TV++   +     +   CT             
Sbjct: 243 DLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  144 bits (364), Expect = 4e-36
 Identities = 69/447 (15%), Positives = 141/447 (31%), Gaps = 72/447 (16%)

Query: 39  WNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSG 98
                   P      SNL+Y  +  +        +V        L     +   ++++  
Sbjct: 6   RYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK 65

Query: 99  FIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL 158
                + + + +  L+L + +       +F     +  LY+  N +          +  L
Sbjct: 66  LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLL 125

Query: 159 FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFK 217
             L L  N L       F N   ++TL +S N+L   I D+      SL  L L+ N+  
Sbjct: 126 TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT 184

Query: 218 GVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGAL 277
            V    +S + +L    + YN L                                     
Sbjct: 185 HV---DLSLIPSLFHANVSYNLL------------------------------------- 204

Query: 278 EIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYG 337
                          ++L    ++  +  + N++   +     +   LT + L  NN   
Sbjct: 205 ---------------STLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL-- 244

Query: 338 EISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPL 397
             ++    +P L  +++S N +   +        +L+   +S N +V  +      +  L
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL 303

Query: 398 TKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGS 455
             L L  N +   + +      +LE L     +I  L        +L+ L LSHN+    
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLS--THHTLKNLTLSHNDWD-- 358

Query: 456 IPSCFEGM-HGLSFIDMSYNELQCPVP 481
             +    +   ++   +   +  C + 
Sbjct: 359 -CNSLRALFRNVARPAVDDADQHCKID 384

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  136 bits (343), Expect = 2e-33
 Identities = 84/469 (17%), Positives = 155/469 (33%), Gaps = 50/469 (10%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            L      SF  +  L+L        I     +    ++ LY+G N      +  +    
Sbjct: 65  KLPAALLDSFRQVELLNLNDL-QIEEIDTYAFAYAHTIQKLYMGFNA-----IRYL-PPH 117

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
              N+  ++ LV+  N LS  +P  I  N   L+ L ++NN        +F   ++L  L
Sbjct: 118 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 176

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
            L  N L+  +   L  + SLF   ++ N L        +   +V  L  S N +   + 
Sbjct: 177 QLSSNRLT-HV--DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI-NVVR 227

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQ 255
             +     L++L L  N         + N   L E+ L YN L   I       +  L +
Sbjct: 228 GPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLER 282

Query: 256 LLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI 315
           L +S N     L         L++  +S NH    +  +      L  + L+ N++    
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV--- 337

Query: 316 SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQA 375
           +  L  +  L  + LS N++          F  +    V   +    +  ++ +    + 
Sbjct: 338 TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKE 395

Query: 376 FD-------------LSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLE 422
            D              S+   V          + +  +    + IT +    +    +LE
Sbjct: 396 SDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLE 455

Query: 423 ----YLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLS 467
                L          QI   + L+ L+   +          +G+   S
Sbjct: 456 AEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSS 504

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  131 bits (331), Expect = 4e-32
 Identities = 63/355 (17%), Positives = 125/355 (35%), Gaps = 30/355 (8%)

Query: 9   NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFS 67
           ++ +           F   +  +   +    +     +P  +  +   +  L L   Q  
Sbjct: 31  DVHIDMQT-QDVYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQVELLNLNDLQ-- 86

Query: 68  GNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLS 127
              + E+ + +       + +L +  N++    P    N+  L+ L L  N  S      
Sbjct: 87  ---IEEIDTYAFAY-AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGI 142

Query: 128 FDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL 187
           F N   L  L +  N L      +     SL +LQL+ N+ + ++    S + S+    +
Sbjct: 143 FHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR-LTHV--DLSLIPSLFHANV 199

Query: 188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS 247
           S N L       +    ++  LD + N    V+   +     L  L L +N+L+      
Sbjct: 200 SYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAW 249

Query: 248 LGNLI-LRQLLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVR 305
           L N   L ++ LS N     + Y+       LE   +S N     +    +   +L  + 
Sbjct: 250 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 307

Query: 306 LNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT 360
           L+ N+L  ++      +  L  + L  N+    +  +      L  L +S N+  
Sbjct: 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLKLST--HHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 96.5 bits (240), Expect = 7e-21
 Identities = 62/441 (14%), Positives = 134/441 (30%), Gaps = 37/441 (8%)

Query: 21  LHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG 80
           L     S  P L + ++++N         ++    +  L    N           +   G
Sbjct: 183 LTHVDLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSI---------NVVRG 228

Query: 81  GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLY 140
                ++ L +  N+L+      + N   L ++DL+ N+    +   F  +  L  LY+ 
Sbjct: 229 PVNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286

Query: 141 GNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI 200
            N L  ++      + +L  L L+ N L+ ++ R       +  L L  N +  ++   +
Sbjct: 287 NNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI-VTLK--L 341

Query: 201 GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSG 260
               +L  L L+ N +      ++    N+   A+        I   L + +      S 
Sbjct: 342 STHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLC--CKESD 397

Query: 261 NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALG 320
             +   L   I     +E    ++     T   +     S    +  G  L GN      
Sbjct: 398 KPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAE 457

Query: 321 IYP-NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT-GGLPREIGNSSQLQAFDL 378
           +         L+      +              N+    +   GL R   N +++     
Sbjct: 458 VNELRAEVQQLTNEQI--QQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLK 515

Query: 379 SLNHIVGEIPKELG-----KLNPLTKLILRGNQITGRLPKEIGSLTKLEY---LDFSAIG 430
                     +        K      L      +  +L  +     +L     L    + 
Sbjct: 516 ERQAFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKRAKQAELRQETSLKRQKVK 575

Query: 431 ELPSQICNMKSLEKLNLSHNN 451
           +L ++        +++  H++
Sbjct: 576 QLEAKKNRNPDTRRVSHHHHH 596

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  141 bits (356), Expect = 1e-35
 Identities = 93/475 (19%), Positives = 156/475 (32%), Gaps = 39/475 (8%)

Query: 30  PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRL 89
                L+++ N         I +LS LR L +  N+            S     + +  L
Sbjct: 21  QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY------LDISVFKFNQELEYL 74

Query: 90  VINDNSLSGFIPPHIGNLKFLSQLDLTNNKF-SGPIPLSFDNLSNLIFLYLYGNLLSGSI 148
            ++ N L         NLK L   DL+ N F + PI   F N+S L FL L    L  S 
Sbjct: 75  DLSHNKLVKISCHPTVNLKHL---DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSS 131

Query: 149 LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSV 208
           +  +  L     L +               L   +T  L            I  +   +V
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV 189

Query: 209 LDLNQNQFKGVL-----------PPSISNLTNLKELALLYNHLSGSIPPSLGNLI----L 253
            +L  +  K VL              +     L  L L     + +    +  L+    +
Sbjct: 190 ANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTV 249

Query: 254 RQLLLSGNHFTGYLPYNICRGG-----ALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNG 308
               +S     G L +           AL I  V  + F           +++       
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTV 309

Query: 309 NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIG 368
           +                  +D S N     +  N G   +L TL + MN +   L +   
Sbjct: 310 SGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAE 368

Query: 369 ---NSSQLQAFDLSLNHIVGEIPKEL-GKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL 424
                  LQ  D+S N +  +  K        L  L +  N +T  + + +    K+  L
Sbjct: 369 MTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDL 428

Query: 425 DFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSC-FEGMHGLSFIDMSYNELQC 478
             + I  +P Q+  +++L++LN++ N L  S+P   F+ +  L  I +  N   C
Sbjct: 429 HSNKIKSIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 482

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  113 bits (283), Expect = 3e-26
 Identities = 58/339 (17%), Positives = 107/339 (31%), Gaps = 39/339 (11%)

Query: 9   NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNL------RYLYLG 62
           +I  P       + D S  +  +L   ++            +S L+ L        L L 
Sbjct: 169 HIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLN 228

Query: 63  SNQFSGNILAEVSSESSGGNLRY--MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKF 120
           + + + N    +        + Y  +S + +              +LK LS   + ++ F
Sbjct: 229 NIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF 288

Query: 121 SGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLT 180
             P    ++  SN+       +      +    K+     L  ++N L   +     +LT
Sbjct: 289 GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLT 348

Query: 181 SVSTLRLSRNDLFGSIPDEIG---KMRSLSVLDLNQNQFKGVLPPSI-SNLTNLKELALL 236
            + TL L  N L   +        +M+SL  LD++QN           S   +L  L + 
Sbjct: 349 ELETLILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMS 407

Query: 237 YNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLR 296
            N L+ +I   L    ++ L L  N                            +IP  + 
Sbjct: 408 SNILTDTIFRCLPPR-IKVLDLHSNKIK-------------------------SIPKQVV 441

Query: 297 NCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNF 335
              +L  + +  N L            +L  I L  N +
Sbjct: 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 94.2 bits (234), Expect = 3e-20
 Identities = 69/411 (16%), Positives = 131/411 (31%), Gaps = 58/411 (14%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSES-SGGNLR 84
           F +   L +L L+      +    I++L+  + L +           +   E     N  
Sbjct: 111 FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE----TYGEKEDPEGLQDFNTE 166

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
            +  +   +      +   +  +  L   ++               L+ L       NL 
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL- 225

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG--- 201
                       +L +++   N  I          T+V    +S   L G +        
Sbjct: 226 ------------TLNNIETTWNSFIR--ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271

Query: 202 --KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLL 258
              +++LS+  +  + F           +N+       +            +     L  
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331

Query: 259 SGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT--GNIS 316
           S N  T    +  C                        + T L  + L  N L     I+
Sbjct: 332 SNNLLTD-TVFENC-----------------------GHLTELETLILQMNQLKELSKIA 367

Query: 317 EALGIYPNLTFIDLSRNNF-YGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQA 375
           E      +L  +D+S+N+  Y E   +      L +LN+S N +T  + R +    +++ 
Sbjct: 368 EMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKV 425

Query: 376 FDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLD 425
            DL  N I   IPK++ KL  L +L +  NQ+   +P  I   LT L+ + 
Sbjct: 426 LDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIW 474

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 88.8 bits (220), Expect = 2e-18
 Identities = 45/216 (20%), Positives = 89/216 (41%), Gaps = 16/216 (7%)

Query: 6   RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQ 65
           + ++I      V G    + +  F ++   + T +G         S +S   +L   +N 
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335

Query: 66  FSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG---NLKFLSQLDLTNNKF-S 121
            + + + E       G+L  +  L++  N L   +         +K L QLD++ N    
Sbjct: 336 LT-DTVFENC-----GHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSY 388

Query: 122 GPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTS 181
                      +L+ L +  N+L+ +I   L     +  L L+ N++   IP+    L +
Sbjct: 389 DEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI-KSIPKQVVKLEA 445

Query: 182 VSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQF 216
           +  L ++ N L  S+PD I  ++ SL  + L+ N +
Sbjct: 446 LQELNVASNQL-KSVPDGIFDRLTSLQKIWLHTNPW 480

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  136 bits (343), Expect = 1e-33
 Identities = 95/469 (20%), Positives = 166/469 (35%), Gaps = 37/469 (7%)

Query: 34  YLDLTWNGFFGTIPPQ-ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVIN 92
            L L+ N     +    IS LS LR L L  N+   ++   V         + +  L ++
Sbjct: 56  ALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFL-----FNQDLEYLDVS 108

Query: 93  DNSLSGFIPPHIGNLKFLSQLDLTNNKF-SGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
            N L   I      +  L  LDL+ N F   P+   F NL+ L FL L         L  
Sbjct: 109 HNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLP 165

Query: 152 LGKLK-SLFDLQLNDNQLIGYIPRPFSNL-TSVSTLRLSRNDLFGSIPDEIGKMR---SL 206
           +  L  S   L L    + G          T+V  L    N LF    +          L
Sbjct: 166 VAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQL 225

Query: 207 SVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS-----------IPPSLGNLILRQ 255
           S + LN    + ++            L +   H+  +            P  +  L +  
Sbjct: 226 SNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYN 285

Query: 256 LLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI 315
           L ++         Y+     +L I  V    F  +          +    L+ ++     
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345

Query: 316 SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT--GGLPREIGNSSQL 373
                   + TF++ ++N F   +        +L TL +  N +     +     N S L
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL 405

Query: 374 QAFDLSLNHI-VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IG 430
           +  D+SLN +      +       +  L L  N +TG + + +    K++ LD     I 
Sbjct: 406 ETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM 463

Query: 431 ELPSQICNMKSLEKLNLSHNNLSGSIP-SCFEGMHGLSFIDMSYNELQC 478
            +P  + ++++L++LN++ N L  S+P   F+ +  L +I +  N   C
Sbjct: 464 SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDC 511

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  106 bits (266), Expect = 5e-24
 Identities = 78/424 (18%), Positives = 142/424 (33%), Gaps = 51/424 (12%)

Query: 21  LHDFSFSSFPHLAYLDLTWNGFFGTIPP--QISNLSNLRYLYLGSNQFSGNILAEVSSES 78
           L + S      L +LDL++N  F  +P   +  NL+ L +L L + +F    L  V+   
Sbjct: 112 LQNISCCPMASLRHLDLSFND-FDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLH 170

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLY 138
               L  +    I            I N   L  +   N+ FS  + +S + L +L    
Sbjct: 171 LSCILLDLVSYHIKGGETESL---QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSN 227

Query: 139 LYGNLLSGSILSSLGKLK---------SLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSR 189
           +  N  +   L +              +L  ++      +      F     V  L +  
Sbjct: 228 IKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF--QFFWPRPVEYLNIYN 285

Query: 190 NDLFGSIPDEIG-----KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL-SGS 243
             +   I  E        ++SL +  +    F        S    +    L  +      
Sbjct: 286 LTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIH 345

Query: 244 IPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIR 303
           +           L  + N FT  +         L+   +  N  +           +  +
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-----------NFFK 394

Query: 304 VRLNGNNLTGNISEALGIYPNLTFIDLSRNNF-YGEISSNWGKFPKLGTLNVSMNNITGG 362
           V L   N++           +L  +D+S N+               +  LN+S N +TG 
Sbjct: 395 VALMTKNMS-----------SLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443

Query: 363 LPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTKL 421
           + R +    +++  DL  N I   IPK++  L  L +L +  NQ+   +P  +   LT L
Sbjct: 444 VFRCL--PPKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSL 499

Query: 422 EYLD 425
           +Y+ 
Sbjct: 500 QYIW 503

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 88.0 bits (218), Expect = 3e-18
 Identities = 50/348 (14%), Positives = 106/348 (30%), Gaps = 55/348 (15%)

Query: 7   VINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGF----FGTIPPQISNLSNLRYLYLG 62
           V+++      +     + S ++  HL   ++  N        T   +++    L  + L 
Sbjct: 198 VLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQ 257

Query: 63  SNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGN-----LKFLSQLDLTN 117
             + +     ++        + Y   L I + +++  I           LK L    + N
Sbjct: 258 HIETTWKCSVKLFQFFWPRPVEY---LNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314

Query: 118 NKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFS 177
             F       +   + +    L  +               +  +                
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSIS-----------DTPFIHMV-------------CPP 350

Query: 178 NLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLY 237
           + +S + L  ++N    S+      ++ L  L L +N  K           N+  L  L 
Sbjct: 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLD 409

Query: 238 NHLSGSIPPSLGNLI------LRQLLLSGNHFTG----YLPYNICRGGALEIFTVSENHF 287
             L+ S+     +        +  L LS N  TG     LP        +++  +  N  
Sbjct: 410 VSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPK------VKVLDLHNNRI 462

Query: 288 QGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNF 335
             +IP  + +  +L  + +  N L            +L +I L  N +
Sbjct: 463 M-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 51/310 (16%), Positives = 98/310 (31%), Gaps = 39/310 (12%)

Query: 195 SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS----LGN 250
            +P ++        L L+QN    +  P IS L+ L+ L L +N +  S+         +
Sbjct: 45  HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101

Query: 251 LILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTS--LRNCTSLIRVRLNG 308
             L  L +S N         +    +L    +S N F   +P      N T L  + L+ 
Sbjct: 102 --LEYLDVSHNRLQNISCCPM---ASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSA 155

Query: 309 NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW-GKFPKLGTLNVSMNNITGGLPREI 367
                     L    +L    +  +     I            T  + +      L    
Sbjct: 156 AKFR---QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ 212

Query: 368 GNSSQLQAFDLSLNHI---------VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSL 418
            N S      L L++I         +     EL +   L  + L+  + T +   ++   
Sbjct: 213 VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQF 272

Query: 419 ---TKLEYLDFSAI--------GELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLS 467
                +EYL+   +         E       +KSL   ++ +     S  + +     ++
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332

Query: 468 FIDMSYNELQ 477
              +S ++  
Sbjct: 333 IKMLSISDTP 342

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  133 bits (336), Expect = 3e-33
 Identities = 71/427 (16%), Positives = 131/427 (30%), Gaps = 73/427 (17%)

Query: 30  PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRL 89
            + A           T       L+ L  L   ++  +   +  +        L  +++L
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIE------KLTGLTKL 69

Query: 90  VINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSIL 149
           +   N+++      +     L+ L   +NK +    L    L+ L +L    N L+   +
Sbjct: 70  ICTSNNITTL---DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKLDV 123

Query: 150 SSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVL 209
           S    L  L       N L        S+ T ++ L    N     +   +     L+ L
Sbjct: 124 SQNPLLTYLN---CARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTL 175

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLP 268
           D + N+   +    +S    L  L    N+++  +   L   I L  L  S N  T    
Sbjct: 176 DCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT---- 225

Query: 269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFI 328
                                 I   +   T L     + N LT      L     LT +
Sbjct: 226 ---------------------EID--VTPLTQLTYFDCSVNPLTELDVSTL---SKLTTL 259

Query: 329 DLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIP 388
              + +    +  +     +L             L  ++ +++QL   D     I  E+ 
Sbjct: 260 HCIQTDL---LEIDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD 313

Query: 389 KELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLN 446
             L +   L  L L   ++T  L   +   TKL+ L      I +  S +  + +L    
Sbjct: 314 --LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQDFSS-VGKIPALNNNF 367

Query: 447 LSHNNLS 453
            +     
Sbjct: 368 EAEGQTI 374

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  127 bits (322), Expect = 2e-31
 Identities = 62/390 (15%), Positives = 121/390 (31%), Gaps = 53/390 (13%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
                 L  L  T N    T+   +S  +NL YL   SN+          +      L  
Sbjct: 60  IEKLTGLTKLICTSN-NITTLD--LSQNTNLTYLACDSNKL---------TNLDVTPLTK 107

Query: 86  MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS 145
           ++ L  + N L+      +     L+ L+   N  +    +   + + L  L  + N   
Sbjct: 108 LTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKI 161

Query: 146 GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRS 205
             +   +     L  L  + N++        S    ++ L    N++   +   + +   
Sbjct: 162 TKL--DVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQ 213

Query: 206 LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTG 265
           L+ LD + N+   +    ++ LT L       N L+  +  S     L  L         
Sbjct: 214 LTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELDVS-TLSKLTTLHCIQTDLL- 267

Query: 266 YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNL 325
                I      ++        +      + + T L  +      +T      L   P L
Sbjct: 268 ----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT---ELDLSQNPKL 320

Query: 326 TFIDLSRNNFYGEISS-NWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIV 384
            ++ L+       ++  +     KL +L+    +I       +G    L     +    +
Sbjct: 321 VYLYLNNTE----LTELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI 374

Query: 385 GEIPKELGKLNPLTKLI------LRGNQIT 408
             +PKE    N LT  +        GN + 
Sbjct: 375 -TMPKETLTNNSLTIAVSPDLLDQFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 99.0 bits (247), Expect = 6e-22
 Identities = 62/358 (17%), Positives = 106/358 (29%), Gaps = 52/358 (14%)

Query: 21  LHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQ-----FSGNILAEV- 74
           L +   +    L YL+   N     +   +S    L YL    N       S N      
Sbjct: 97  LTNLDVTPLTKLTYLNCDTN-KLTKLD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTEL 153

Query: 75  -------SSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLS 127
                   ++        ++ L  + N ++      +   K L++L+   N  +    L 
Sbjct: 154 DCHLNKKITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITK---LD 207

Query: 128 FDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL 187
            +    L FL    N L+  I   +  L  L     + N L        S L+ ++TL  
Sbjct: 208 LNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHC 261

Query: 188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS 247
            + DL   I   +     L        +   +    +++ T L  L      ++  +  S
Sbjct: 262 IQTDL-LEID--LTHNTQLIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGIT-ELDLS 315

Query: 248 LGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLN 307
             N  L  L L+    T  L  +      L+  +    H Q     S+    +L      
Sbjct: 316 -QNPKLVYLYLNNTELT-ELDVSHNT--KLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEA 369

Query: 308 GNNLTGNISEA-----LGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT 360
                    E      L I  +   +D   N    E           G  + + N IT
Sbjct: 370 EGQTITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDG-------GVYDQATNTIT 420

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 98.2 bits (245), Expect = 9e-22
 Identities = 43/304 (14%), Positives = 86/304 (28%), Gaps = 35/304 (11%)

Query: 18  NGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSE 77
           N  +     +    L  LD ++N     +   +S    L  L   +N           ++
Sbjct: 158 NKKITKLDVTPQTQLTTLDCSFNK-ITELD--VSQNKLLNRLNCDTNNI---------TK 205

Query: 78  SSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
                   ++ L  + N L+      +  L  L+  D + N  +    L    LS L  L
Sbjct: 206 LDLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTL 259

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
           +     L    L+   +L           + +       ++ T +  L      +   + 
Sbjct: 260 HCIQTDLLEIDLTHNTQLIYFQAEGCRKIKEL-----DVTHNTQLYLLDCQAAGI-TELD 313

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLL 257
             + +   L  L LN  +   +    +S+ T LK L+ +  H+            L    
Sbjct: 314 --LSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNF 367

Query: 258 LSGNHFTGYLPYNICRGGALEIFTVSE----NHFQGTIPTSLRNCTSLIRVRLNGNNLTG 313
            +       +P       +L I    +          I              +   NL+ 
Sbjct: 368 EAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLST 426

Query: 314 NISE 317
           +   
Sbjct: 427 DNPA 430

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  134 bits (338), Expect = 5e-33
 Identities = 65/309 (21%), Positives = 107/309 (34%), Gaps = 56/309 (18%)

Query: 123 PIPLSFDNLSNLIFLYLYGNL--LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLT 180
            I L  +N  +L     Y  +        S+  K +       N N+ +  +      + 
Sbjct: 2   SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLIN 59

Query: 181 SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
             S L+L+R +L  S+PD +     ++VL++ QN     LP   ++L  L       N L
Sbjct: 60  QFSELQLNRLNL-SSLPDNLPP--QITVLEITQNALI-SLPELPASLEYLD---ACDNRL 112

Query: 241 SGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTS 300
           S ++P    +L  + L +  N  T  LP        LE      N     +P      TS
Sbjct: 113 S-TLPELPASL--KHLDVDNNQLT-MLPELP---ALLEYINADNNQLT-MLPELP---TS 161

Query: 301 LIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT 360
           L  + +  N LT  + E                               L  L+VS N + 
Sbjct: 162 LEVLSVRNNQLTF-LPELPE---------------------------SLEALDVSTNLLE 193

Query: 361 GGLPREIGNSSQLQ----AFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIG 416
             LP     +   +     F    N I   IP+ +  L+P   +IL  N ++ R+ + + 
Sbjct: 194 S-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251

Query: 417 SLTKLEYLD 425
             T      
Sbjct: 252 QQTAQPDYH 260

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  119 bits (299), Expect = 4e-28
 Identities = 53/290 (18%), Positives = 91/290 (31%), Gaps = 57/290 (19%)

Query: 172 IPRPFSNLTSVSTLRLSRN--DLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
           I  P +N  S+S           +        K    ++   N+N+   +L   +  +  
Sbjct: 3   IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQ 60

Query: 230 LKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQG 289
             EL L   +LS S+P +L    +  L ++ N     LP       +LE     +N    
Sbjct: 61  FSELQLNRLNLS-SLPDNLPPQ-ITVLEITQNALI-SLPELP---ASLEYLDACDNRLS- 113

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL 349
           T+P    +   L    ++ N LT  + E                               L
Sbjct: 114 TLPELPASLKHL---DVDNNQLT-MLPELPA---------------------------LL 142

Query: 350 GTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG 409
             +N   N +T  LP    +   L+   +  N +   +P+    L     L +  N +  
Sbjct: 143 EYINADNNQLTM-LPELPTS---LEVLSVRNNQL-TFLPELPESL---EALDVSTNLLE- 193

Query: 410 RLPKEIGSLTKLE----YLDFSA--IGELPSQICNMKSLEKLNLSHNNLS 453
            LP         E    +       I  +P  I ++     + L  N LS
Sbjct: 194 SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLS 243

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  108 bits (271), Expect = 1e-24
 Identities = 61/386 (15%), Positives = 113/386 (29%), Gaps = 51/386 (13%)

Query: 48  PQISNLSNLRYLYLGSNQF----------------SGNILAEVSSESSGGNLRYMSRLVI 91
            +   ++    L L                     + N L  +       +L Y   L  
Sbjct: 53  LKECLINQFSELQLNRLNLSSLPDNLPPQITVLEITQNALISLPELP--ASLEY---LDA 107

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
            DN LS  +P    +LK    LD+ NN+ +  +P   +  + L ++    N L+  +   
Sbjct: 108 CDNRLS-TLPELPASLK---HLDVDNNQLTM-LP---ELPALLEYINADNNQLT-MLPEL 158

Query: 152 LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLS---- 207
              L+ L    + +NQL  ++P    +L     L +S N L  S+P    +         
Sbjct: 159 PTSLEVLS---VRNNQL-TFLPELPESLE---ALDVSTNLL-ESLPAVPVRNHHSEETEI 210

Query: 208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL 267
                +N+    +P +I +L     + L  N LS  I  SL     +        +    
Sbjct: 211 FFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMS 269

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF 327
                      +       F     + +           + N  +    + L    +   
Sbjct: 270 D-GQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARN 327

Query: 328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEI 387
               R      +++   K      L      +         +   L   +L    +V   
Sbjct: 328 TSGFREQ----VAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLV-HQ 382

Query: 388 PKELGKLNPLTKLILRGNQITGRLPK 413
             E    N    L+  G ++  RL  
Sbjct: 383 ASEGLFDNDTGALLSLGREM-FRLEI 407

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 32/239 (13%), Positives = 68/239 (28%), Gaps = 19/239 (7%)

Query: 27  SSFPHLAYLDLTWNGFFGTIPPQISNLSNLR----YLYLGSNQFSGNILAEVSSESSGGN 82
                L  LD++ N    ++P       +      +     N+ + +I   +       +
Sbjct: 177 ELPESLEALDVSTN-LLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENI------LS 228

Query: 83  LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN 142
           L     +++ DN LS  I   +      +Q D    +    +     N  +         
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQ--TAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286

Query: 143 LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGK 202
               +  S + ++   F+ + + N    ++ R  S+  S       R  +   +      
Sbjct: 287 WFPENKQSDVSQIWHAFEHEEHANTFSAFLDR-LSDTVSARNTSGFREQVAAWLEK---- 341

Query: 203 MRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGN 261
           + + + L             S  +   L    L    L       L +     LL  G 
Sbjct: 342 LSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSLGR 400

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  127 bits (322), Expect = 6e-32
 Identities = 64/277 (23%), Positives = 103/277 (37%), Gaps = 54/277 (19%)

Query: 596 IGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQK-EFLTEVEA-----------F 642
           IG G    V+   L +    VAVK            D K +FL E               
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVK----SCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
            G C+  +  +++ E ++ G     L T+     L     + ++   A  + YL   C  
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESKCC- 234

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-----------WTEFAGTCGYIA 751
             +HRD++++N L+  +    ++DFG+++                   WT         A
Sbjct: 235 --IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT---------A 283

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA 810
           PE     + + + DV+SFG+L+WE    G  P   LS       N           RLP 
Sbjct: 284 PEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS-------NQQTREFVEKGGRLPC 336

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P     + +  +ME    C+   P  RP+   I Q+L
Sbjct: 337 P-ELCPDAVFRLME---QCWAYEPGQRPSFSTIYQEL 369

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  118 bits (298), Expect = 3e-29
 Identities = 64/322 (19%), Positives = 106/322 (32%), Gaps = 66/322 (20%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            + D  F +  +L  L L  N     I P   + L  L  LYL  NQ             
Sbjct: 66  EIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVKLERLYLSKNQLKE---------- 114

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLY 138
                                +P  +   K L +L +  N+ +      F+ L+ +I + 
Sbjct: 115 ---------------------LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVE 151

Query: 139 LYGNLLSGSILSS--LGKLKSLFDLQLNDNQLIGYIPRP-FSNLTSVSTLRLSRNDLFGS 195
           L  N L  S + +     +K L  +++ D   I  IP+    +LT    L L  N +   
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGLPPSLT---ELHLDGNKI-TK 206

Query: 196 IPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-L 253
           +       + +L+ L L+ N    V   S++N  +L+EL L  N L   +P  L +   +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265

Query: 254 RQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT- 312
           + + L  N+ +                 +  N F    P       S   V L  N +  
Sbjct: 266 QVVYLHNNNIS----------------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQY 307

Query: 313 GNISE-ALGIYPNLTFIDLSRN 333
             I             + L   
Sbjct: 308 WEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (272), Expect = 8e-26
 Identities = 64/363 (17%), Positives = 122/363 (33%), Gaps = 76/363 (20%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
           +D  L   +P  +      + LDL NNK +      F NL NL  L L  N +S     +
Sbjct: 39  SDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 95

Query: 152 LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLD 210
              L  L  L L+ NQL     +    L     LR+  N++   +   +   +  + V++
Sbjct: 96  FAPLVKLERLYLSKNQLKELPEKMPKTLQE---LRVHENEIT-KVRKSVFNGLNQMIVVE 151

Query: 211 LNQNQFKGV-LPPSI-SNLTNLKELALLYNHLSGSIPPSL-GNLILRQLLLSGNHFTGYL 267
           L  N  K   +       +  L  + +   +++ +IP  L  +L   +L L GN  T   
Sbjct: 152 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPSL--TELHLDGNKIT--- 205

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF 327
                         V     +G          +L ++ L+ N+++   + +L   P+L  
Sbjct: 206 -------------KVDAASLKG--------LNNLAKLGLSFNSISAVDNGSLANTPHLRE 244

Query: 328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEI 387
           + L+ N    ++         +  + +  NNI+      IG++                 
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-----AIGSNDFCP------------- 285

Query: 388 PKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNL 447
           P    K    + + L  N +            +++   F            +     + L
Sbjct: 286 PGYNTKKASYSGVSLFSNPVQ---------YWEIQPSTFR----------CVYVRAAVQL 326

Query: 448 SHN 450
            + 
Sbjct: 327 GNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  108 bits (271), Expect = 8e-26
 Identities = 69/341 (20%), Positives = 120/341 (35%), Gaps = 57/341 (16%)

Query: 31  HLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLV 90
           HL  +  +  G    +P  +    +   L L +N+ +                       
Sbjct: 32  HLRVVQCSDLGL-EKVPKDLP--PDTALLDLQNNKIT----------------------E 66

Query: 91  INDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILS 150
           I D            NLK L  L L NNK S   P +F  L  L  LYL  N L   +  
Sbjct: 67  IKDGDFK--------NLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE 117

Query: 151 SLGKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRNDL-FGSIPDEI-GKMRSLS 207
            +   K+L +L++++N+ I  + +  F+ L  +  + L  N L    I +     M+ LS
Sbjct: 118 KM--PKTLQELRVHENE-ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 174

Query: 208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTG 265
            + +       + P  +    +L EL L  N ++  +   SL  L  L +L LS N  + 
Sbjct: 175 YIRIADTNITTI-PQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA 230

Query: 266 YLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG------NISEA 318
            +          L    ++ N     +P  L +   +  V L+ NN++            
Sbjct: 231 -VDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 288

Query: 319 LGIYPNLTFIDLSRNNF-YGEISSN-WGKFPKLGTLNVSMN 357
                + + + L  N   Y EI  + +        + +   
Sbjct: 289 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  106 bits (267), Expect = 4e-25
 Identities = 75/325 (23%), Positives = 122/325 (37%), Gaps = 44/325 (13%)

Query: 175 PFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA 234
           PF     +  ++ S   L   +P ++      ++LDL  N+   +      NL NL  L 
Sbjct: 26  PFRCQCHLRVVQCSDLGL-EKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLI 82

Query: 235 LLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIP 292
           L+ N +S  I P +   L+ L +L LS N     LP  + +   L+   V EN       
Sbjct: 83  LINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT--LQELRVHENEITKVRK 138

Query: 293 TSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTL 352
           +       +I V L  N L      + GI  N  F  +                 KL  +
Sbjct: 139 SVFNGLNQMIVVELGTNPLK-----SSGI-ENGAFQGM----------------KKLSYI 176

Query: 353 NVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRL 411
            ++  NIT  +P+  G    L    L  N I  ++    L  LN L KL L  N I+   
Sbjct: 177 RIADTNITT-IPQ--GLPPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVD 232

Query: 412 PKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSG------SIPSCFEGM 463
              + +   L  L  +   + ++P  + + K ++ + L +NN+S         P      
Sbjct: 233 NGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292

Query: 464 HGLSFIDMSYNELQCPVPNSTTFRG 488
              S + +  N +Q      +TFR 
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRC 317

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 19/102 (18%), Positives = 39/102 (38%), Gaps = 3/102 (2%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
            + + S ++ PHL  L L  N     +P  +++   ++ +YL +N  S     +      
Sbjct: 230 AVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGY 288

Query: 80  GGNLRYMSRLVINDNSLSGF-IPPHI-GNLKFLSQLDLTNNK 119
                  S + +  N +  + I P     +   + + L N K
Sbjct: 289 NTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  117 bits (296), Expect = 3e-29
 Identities = 53/242 (21%), Positives = 90/242 (37%), Gaps = 15/242 (6%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
                 L+L  N    ++P  +   L+ L  L L SN  S           S      + 
Sbjct: 27  PSSATRLELESNKL-QSLPHGVFDKLTQLTKLSLSSNGLSFKGC----CSQSDFGTTSLK 81

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGNLLSG 146
            L ++ N +   +  +   L+ L  LD  ++        S F +L NLI+L +       
Sbjct: 82  YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 140

Query: 147 SILSSLGKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRNDLFGSIPDEI-GKMR 204
           +       L SL  L++  N          F+ L +++ L LS+  L   +       + 
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLS 199

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS-LGNLI--LRQLLLSGN 261
           SL VL+++ N F  +       L +L+ L    NH+  +     L +    L  L L+ N
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

Query: 262 HF 263
            F
Sbjct: 259 DF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  112 bits (282), Expect = 2e-27
 Identities = 55/253 (21%), Positives = 98/253 (38%), Gaps = 16/253 (6%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
           N   L+  +P  I      ++L+L +NK        FD L+ L  L L  N LS     S
Sbjct: 15  NSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS 71

Query: 152 --LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDE--IGKMRSLS 207
                  SL  L L+ N +I  +   F  L  +  L    ++L   + +      +R+L 
Sbjct: 72  QSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLI 129

Query: 208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTG 265
            LD++    +       + L++L+ L +  N    +  P     L  L  L LS      
Sbjct: 130 YLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE- 188

Query: 266 YLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEAL--GIY 322
            L         +L++  +S N+F        +   SL  +  + N++     +       
Sbjct: 189 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFP 247

Query: 323 PNLTFIDLSRNNF 335
            +L F++L++N+F
Sbjct: 248 SSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  100 bits (251), Expect = 3e-23
 Identities = 52/200 (26%), Positives = 74/200 (37%), Gaps = 12/200 (6%)

Query: 21  LHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG 80
               S      L YLDL++NG   T+      L  L +L    +      L ++S  S  
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSN-----LKQMSEFSVF 122

Query: 81  GNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPI-PLSFDNLSNLIFLY 138
            +LR +  L I+           I   L  L  L +  N F     P  F  L NL FL 
Sbjct: 123 LSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD 181

Query: 139 LYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPD 198
           L    L     ++   L SL  L ++ N        P+  L S+  L  S N +  +   
Sbjct: 182 LSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-MTSKK 240

Query: 199 EI--GKMRSLSVLDLNQNQF 216
           +       SL+ L+L QN F
Sbjct: 241 QELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 58/307 (18%), Positives = 104/307 (33%), Gaps = 61/307 (19%)

Query: 181 SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
           S + +R +   L  S+P  I    S + L+L  N+ + +       LT L +L+L  N L
Sbjct: 8   SGTEIRCNSKGL-TSVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 241 S--GSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRN 297
           S  G    S      L+ L LS N                            T+ ++   
Sbjct: 65  SFKGCCSQSDFGTTSLKYLDLSFNGVI-------------------------TMSSNFLG 99

Query: 298 CTSLIRVRLNGNNLTGNISE--ALGIYPNLTFIDLSRNNFYGEISSNW-GKFPKLGTLNV 354
              L  +    +NL   +SE        NL ++D+S  +      +        L  L +
Sbjct: 100 LEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKM 157

Query: 355 SMNNITGGLPREI-GNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLP 412
           + N+       +I      L   DLS   +  ++       L+ L  L +  N       
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF---- 212

Query: 413 KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGM-HGLSFIDM 471
                   L+   +            + SL+ L+ S N++  S     +     L+F+++
Sbjct: 213 -------SLDTFPYK----------CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255

Query: 472 SYNELQC 478
           + N+  C
Sbjct: 256 TQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 29/125 (23%), Positives = 44/125 (35%), Gaps = 8/125 (6%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
              +  F+    L  L +  N F     P I + L NL +L L   Q     L ++S  +
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ-----LEQLSPTA 194

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNL-SNLIFL 137
               L  +  L ++ N+           L  L  LD + N           +  S+L FL
Sbjct: 195 FNS-LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFL 253

Query: 138 YLYGN 142
            L  N
Sbjct: 254 NLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 21/105 (20%), Positives = 37/105 (35%), Gaps = 11/105 (10%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
                 F+   +L +LDL+       + P   ++LS+L+ L +  N F            
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFF------SLDTF 217

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI--GNLKFLSQLDLTNNKFS 121
               L  +  L  + N +               L+ L+LT N F+
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  113 bits (284), Expect = 5e-28
 Identities = 72/276 (26%), Positives = 116/276 (42%), Gaps = 56/276 (20%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           IG+G    V+     + + VA+K        +  + +++F+ E E             YG
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
            C       L+ EF+E G L+  L T            + +   V   ++YL   C    
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEACV--- 125

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPD----SSN------WTEFAGTCGYIAPEL 754
           +HRD++++N L+       V+DFG+ + +  D    S+       W          +PE+
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA---------SPEV 176

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAP 811
               + + K DV+SFGVLMWEV  +GK P +  S       N++V   + +    RL  P
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVV--EDISTGFRLYKP 227

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            R A   +  IM     C+ E PE RP    + +QL
Sbjct: 228 -RLASTHVYQIMN---HCWRERPEDRPAFSRLLRQL 259

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  113 bits (286), Expect = 9e-28
 Identities = 73/313 (23%), Positives = 112/313 (35%), Gaps = 43/313 (13%)

Query: 29  FPHLAYLDLTWNGFFGTIPP-QISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
            P    LDL  N     +       L +L  L L +N+ S  I  +  S      LR + 
Sbjct: 53  SPDTTLLDLQNN-DISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFS-----PLRKLQ 105

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS 147
           +L I+ N L   IPP++     L +L + +N+        F  L N+  + + GN L  S
Sbjct: 106 KLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS 162

Query: 148 ILSS--LGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMR 204
                    LK L  L++++ +L G        L     L L  N +  +I  E   +  
Sbjct: 163 GFEPGAFDGLK-LNYLRISEAKLTGIPKDLPETLN---ELHLDHNKI-QAIELEDLLRYS 217

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHF 263
            L  L L  NQ + +   S+S L  L+EL L  N LS  +P  L +L  L+ + L  N+ 
Sbjct: 218 KLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276

Query: 264 TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT-GNISEAL--G 320
           T                 V  N F                + L  N +    +  A    
Sbjct: 277 T----------------KVGVNDFCPV--GFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

Query: 321 IYPNLTFIDLSRN 333
           +  +   I     
Sbjct: 319 V-TDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  107 bits (270), Expect = 1e-25
 Identities = 65/320 (20%), Positives = 112/320 (35%), Gaps = 47/320 (14%)

Query: 181 SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
            +  ++ S   L  ++P EI      ++LDL  N    +       L +L  L L+ N +
Sbjct: 34  HLRVVQCSDLGL-KAVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 241 SGSIPP-SLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNC 298
           S  I   +   L  L++L +S NH                   +  N             
Sbjct: 91  S-KIHEKAFSPLRKLQKLYISKNHLV----------------EIPPNLPS---------- 123

Query: 299 TSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFY-GEISSNWGKFPKLGTLNVSMN 357
            SL+ +R++ N +            N+  I++  N               KL  L +S  
Sbjct: 124 -SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182

Query: 358 NITGGLPREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEIG 416
            +TG +P+       L    L  N I   I  E L + + L +L L  NQI       + 
Sbjct: 183 KLTG-IPK--DLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238

Query: 417 SLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHG------LSF 468
            L  L  L      +  +P+ + ++K L+ + L  NN++    + F  +         + 
Sbjct: 239 FLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNG 298

Query: 469 IDMSYNELQCPVPNSTTFRG 488
           I +  N +        TFR 
Sbjct: 299 ISLFNNPVPYWEVQPATFRC 318

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  106 bits (266), Expect = 5e-25
 Identities = 67/339 (19%), Positives = 109/339 (32%), Gaps = 71/339 (20%)

Query: 25  SFSSFPHLAYLDLTWNGF------------------FGTIPPQISNLSNLRYLYLGSNQF 66
           + S  P L  L  T++                       +P +IS   +   L L +N  
Sbjct: 9   TTSGIPDLDSLPPTYSAMCPFGCHCHLRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDI 66

Query: 67  SGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPL 126
           S                       +  +            L+ L  L L NNK S     
Sbjct: 67  S----------------------ELRKDDFK--------GLQHLYALVLVNNKISKIHEK 96

Query: 127 SFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLR 186
           +F  L  L  LY+  N L   I  +L    SL +L+++DN++       FS L +++ + 
Sbjct: 97  AFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIE 153

Query: 187 LSRNDL-FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP 245
           +  N L              L+ L +++ +  G+ P  +     L EL L +N +  +I 
Sbjct: 154 MGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI-PKDL--PETLNELHLDHNKIQ-AIE 209

Query: 246 P-SLGNLI-LRQLLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLI 302
              L     L +L L  N     +          L    +  N     +P  L +   L 
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ 267

Query: 303 RVRLNGNNLTGNISE-------ALGIYPNLTFIDLSRNN 334
            V L+ NN+T  +                   I L  N 
Sbjct: 268 VVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNP 305

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  104 bits (261), Expect = 2e-24
 Identities = 65/352 (18%), Positives = 115/352 (32%), Gaps = 65/352 (18%)

Query: 109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQL 168
            L  +  ++      +P       +   L L  N +S         L+ L+ L L +N++
Sbjct: 34  HLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 169 IGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLT 228
                + FS L  +  L +S+N L   IP  +    SL  L ++ N+ + V     S L 
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHL-VEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147

Query: 229 NLKELALLYNHL-SGSIPP-SLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENH 286
           N+  + +  N L +    P +   L L  L +S    T  +P ++     L    +  N 
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE--TLNELHLDHNK 204

Query: 287 FQGTIPT-SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGK 345
            Q  I    L   + L R+ L  N +   I        N +   L               
Sbjct: 205 IQ-AIELEDLLRYSKLYRLGLGHNQIR-MI-------ENGSLSFL--------------- 240

Query: 346 FPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKE-------LGKLNPLT 398
            P L  L++  N ++  +P  + +   LQ   L  N+I  ++            K     
Sbjct: 241 -PTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYN 297

Query: 399 KLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHN 450
            + L  N +      E+   T      F            +     +   + 
Sbjct: 298 GISLFNNPVPYW---EVQPAT------FR----------CVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 52/252 (20%), Positives = 92/252 (36%), Gaps = 23/252 (9%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
            +H+ +FS    L  L ++ N     IPP +   S+L  L +  N+     + +V     
Sbjct: 92  KIHEKAFSPLRKLQKLYISKN-HLVEIPPNL--PSSLVELRIHDNR-----IRKVPKGVF 143

Query: 80  GGNLRYMSRLVINDNSL-SGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLY 138
            G LR M+ + +  N L +    P   +   L+ L ++  K +G   +  D    L  L+
Sbjct: 144 SG-LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG---IPKDLPETLNELH 199

Query: 139 LYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPD 198
           L  N +    L  L +   L+ L L  NQ+        S L ++  L L  N L   +P 
Sbjct: 200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVPA 258

Query: 199 EIGKMRSLSVLDLNQNQFKGVLPPSIS------NLTNLKELALLYNHLS-GSIPPSL--G 249
            +  ++ L V+ L+ N    V                   ++L  N +    + P+    
Sbjct: 259 GLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318

Query: 250 NLILRQLLLSGN 261
                 +     
Sbjct: 319 VTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 78.5 bits (194), Expect = 9e-16
 Identities = 31/206 (15%), Positives = 64/206 (31%), Gaps = 21/206 (10%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGF-FGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSES 78
            +    FS   ++  +++  N        P   +   L YL +   +     L  +    
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK-----LTGIPK-- 189

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLY 138
                  ++ L ++ N +       +     L +L L +N+       S   L  L  L+
Sbjct: 190 --DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELH 247

Query: 139 LYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP-------RPFSNLTSVSTLRLSRND 191
           L  N LS  + + L  LK L  + L+ N  I  +                 + + L  N 
Sbjct: 248 LDNNKLS-RVPAGLPDLKLLQVVYLHTNN-ITKVGVNDFCPVGFGVKRAYYNGISLFNNP 305

Query: 192 L-FGSIPDEI-GKMRSLSVLDLNQNQ 215
           + +  +       +     +     +
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 35/134 (26%), Positives = 54/134 (40%), Gaps = 6/134 (4%)

Query: 363 LPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLE 422
           +P+EI  S      DL  N I      +   L  L  L+L  N+I+    K    L KL+
Sbjct: 48  VPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105

Query: 423 YLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPV 480
            L  S   + E+P  +    SL +L +  N +       F G+  ++ I+M  N L+   
Sbjct: 106 KLYISKNHLVEIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG 163

Query: 481 PNSTTFRGASVEAL 494
                F G  +  L
Sbjct: 164 FEPGAFDGLKLNYL 177

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  111 bits (280), Expect = 3e-27
 Identities = 65/285 (22%), Positives = 110/285 (38%), Gaps = 60/285 (21%)

Query: 593 KYCIGNGGHASVYRAEL--PSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEA-------- 641
              +G G   SV +        ++ VA+K    L    +  D +E + E +         
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMMREAQIMHQLDNPY 71

Query: 642 ---FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
                G C       L+ E    G L   L      +E+  S    ++  V+  + YL  
Sbjct: 72  IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE 128

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN------------WTEFAGT 746
             F   VHRD++++N+LL   + A ++DFG++K+L  D S             W      
Sbjct: 129 KNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY----- 180

Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLD 805
               APE     K + + DV+S+GV MWE +  G+ P   +          +V     ++
Sbjct: 181 ----APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVM--AFIE 227

Query: 806 P--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
              R+  P      +L ++M     C+    E RP    + Q++R
Sbjct: 228 QGKRMECP-PECPPELYALM---SDCWIYKWEDRPDFLTVEQRMR 268

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  112 bits (282), Expect = 4e-27
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 46/275 (16%)

Query: 596 IGNGGHASVYRAEL---PSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEA---------- 641
           IG+G    V    L      +V VA+K   +L        +++FL+E             
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIK---ALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 642 -FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
              G  +  R + ++ E++E GSL   L T     +    Q + +++ V   + YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDLG 171

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APELA 755
           +   VHRD++++N+L+D      V+DFG+++ L+ D      +  T G I     APE  
Sbjct: 172 Y---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD--AAYTTTGGKIPIRWTAPEAI 226

Query: 756 YTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDV--ALDQMLDPRLPAPS 812
                +   DV+SFGV+MWEV+  G+ P   ++       N DV  ++++    RLPAP 
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT-------NRDVISSVEE--GYRLPAP- 276

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 L  +M     C+++    RP    I   L
Sbjct: 277 MGCPHALHQLM---LDCWHKDRAQRPRFSQIVSVL 308

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  110 bits (278), Expect = 4e-27
 Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 56/276 (20%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           +G+G    V   +      VAVK        + ++ + EF  E +            FYG
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-----EGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
            CS     +++ E++  G L   L +    + L  SQ + +   V   +++L    F   
Sbjct: 71  VCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQF--- 125

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPD----SSN------WTEFAGTCGYIAPEL 754
           +HRD++++N L+D +    V+DFG+ + +  D    S        W+         APE+
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS---------APEV 176

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAP 811
            +  K + K DV++FG+LMWEV   GK P D  +       N++V     +    RL  P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-------NSEVV--LKVSQGHRLYRP 227

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              A + +  IM    SC++E PE RPT + +   +
Sbjct: 228 -HLASDTIYQIMY---SCWHELPEKRPTFQQLLSSI 259

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  110 bits (277), Expect = 7e-27
 Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 56/276 (20%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           +G G    V   +      VA+K        + ++ + EF+ E +             YG
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
            C+  R  F++ E++  G L   L            Q + + K V  A+ YL    F   
Sbjct: 87  VCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF--- 141

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPD----SSN------WTEFAGTCGYIAPEL 754
           +HRD++++N L++ +    V+DFG+++ +  D    S        W+          PE+
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS---------PPEV 192

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAP 811
               K + K D+++FGVLMWE+   GK P +  +       N++ A  + +    RL  P
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-------NSETA--EHIAQGLRLYRP 243

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              A EK+ +IM    SC++E  + RPT KI+   +
Sbjct: 244 -HLASEKVYTIMY---SCWHEKADERPTFKILLSNI 275

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  111 bits (280), Expect = 9e-27
 Identities = 56/299 (18%), Positives = 102/299 (34%), Gaps = 32/299 (10%)

Query: 43  FGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPP 102
             +IP  ++    ++ L L +N+ +  I               +  LV+  N ++  I  
Sbjct: 43  LNSIPSGLT--EAVKSLDLSNNRIT-YISNSDLQ-----RCVNLQALVLTSNGIN-TIEE 93

Query: 103 HI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSIL--SSLGKLKSLF 159
               +L  L  LDL+ N  S      F  LS+L FL L GN    ++   S    L  L 
Sbjct: 94  DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152

Query: 160 DLQLNDNQLIGYIP-RPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFK 217
            L++ +      I  + F+ LT +  L +  +DL  S   +    ++++S L L+  Q  
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHI 211

Query: 218 GVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGAL 277
            +L   +   ++++ L L    L       L       L+         +          
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF---- 267

Query: 278 EIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFY 336
                        +   L   + L+ +  + N L            +L  I L  N + 
Sbjct: 268 ------------QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  105 bits (263), Expect = 1e-24
 Identities = 54/258 (20%), Positives = 94/258 (36%), Gaps = 22/258 (8%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            + +       +L  L LT NG   TI     S+L +L +L L  N  S N+ +      
Sbjct: 66  YISNSDLQRCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFK-- 121

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPL-SFDNLSNLIF 136
               L  ++ L +  N         +  +L  L  L + N      I    F  L+ L  
Sbjct: 122 ---PLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEE 178

Query: 137 LYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL---- 192
           L +  + L      SL  ++++  L L+  Q I  +       +SV  L L   DL    
Sbjct: 179 LEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238

Query: 193 FGSIP----DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS- 247
           F  +     + + K  +   + +        +   ++ ++ L EL    N L  S+P   
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGI 296

Query: 248 LGNLI-LRQLLLSGNHFT 264
              L  L+++ L  N + 
Sbjct: 297 FDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 93.3 bits (232), Expect = 1e-20
 Identities = 50/305 (16%), Positives = 104/305 (34%), Gaps = 51/305 (16%)

Query: 193 FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP----SL 248
             SIP  +    ++  LDL+ N+   +    +    NL+ L L  N ++ +I      SL
Sbjct: 43  LNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSL 99

Query: 249 GNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNG 308
           G+L    L LS N+ +  L                         +  +  +SL  + L G
Sbjct: 100 GSL--EHLDLSYNYLS-NLS-----------------------SSWFKPLSSLTFLNLLG 133

Query: 309 NNLTGNISE--ALGIYPNLTFIDLSRNNFYGEISSNW-GKFPKLGTLNVSMNNITGGLPR 365
           N     + E         L  + +   + + +I          L  L +  +++    P+
Sbjct: 134 NPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192

Query: 366 EIGNSSQLQAFDLSLNHIVGEIPKEL-GKLNPLTKLILRGNQITGRLPKEIGS------- 417
            + +   +    L +   +  + +      + +  L LR   +      E+ +       
Sbjct: 193 SLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLI 251

Query: 418 -LTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIP-SCFEGMHGLSFIDMSY 473
                  +  +  ++ ++   +  +  L +L  S N L  S+P   F+ +  L  I +  
Sbjct: 252 KKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHT 310

Query: 474 NELQC 478
           N   C
Sbjct: 311 NPWDC 315

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 23/96 (23%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 397 LTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQI-CNMKSLEKLNLSHNNLS 453
           +  L L  N+IT     ++     L+ L  ++  I  +      ++ SLE L+LS+N LS
Sbjct: 54  VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113

Query: 454 GSIPS-CFEGMHGLSFIDMSYNELQCPVPNSTTFRG 488
            ++ S  F+ +  L+F+++  N  +  +  ++ F  
Sbjct: 114 -NLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSH 147

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  114 bits (286), Expect = 1e-26
 Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 38/269 (14%)

Query: 595 CIGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEA-----------F 642
            +G G +  VY        + VAVK        + T++ +EFL E               
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQL 281

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
            G C+     +++ EF+  G+L   L      QE+     + +   ++ A+ YL    F 
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKNF- 339

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI---APELAYTMK 759
             +HR+++++N L+   +   VADFG+++ +  D+  +T  AG    I   APE     K
Sbjct: 340 --IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNK 395

Query: 760 ITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEK 818
            + K DV++FGVL+WE+   G  P   +         + V      D R+  P     EK
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMERP-EGCPEK 447

Query: 819 LISIMEVAFSCFNESPESRPTMKIISQQL 847
           +  +M    +C+  +P  RP+   I Q  
Sbjct: 448 VYELM---RACWQWNPSDRPSFAEIHQAF 473

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  113 bits (284), Expect = 1e-26
 Identities = 60/242 (24%), Positives = 94/242 (38%), Gaps = 24/242 (9%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
             +  YL+L  N     I      +L +L  L LG N      + ++   +  G L  ++
Sbjct: 74  PSNTRYLNLMEN-NIQMIQADTFRHLHHLEVLQLGRNS-----IRQIEVGAFNG-LASLN 126

Query: 88  RLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN---- 142
            L + DN L+  IP      L  L +L L NN        +F+ + +L+ L L       
Sbjct: 127 TLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE 185

Query: 143 LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDE-IG 201
            +S      L  LK L    L    +   +P   + L  +  L +S N     I      
Sbjct: 186 YISEGAFEGLFNLKYLN---LGMCNIK-DMP-NLTPLVGLEELEMSGNHF-PEIRPGSFH 239

Query: 202 KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL--GNLILRQLLLS 259
            + SL  L +  +Q   +   +   L +L EL L +N+LS S+P  L      L +L L 
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLH 298

Query: 260 GN 261
            N
Sbjct: 299 HN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  111 bits (280), Expect = 3e-26
 Identities = 63/249 (25%), Positives = 100/249 (40%), Gaps = 13/249 (5%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
               LS  +P  I        L+L  N        +F +L +L  L L  N +    + +
Sbjct: 62  TRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGA 118

Query: 152 LGKLKSLFDLQLNDNQLIGYIPRP-FSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVL 209
              L SL  L+L DN  +  IP   F  L+ +  L L  N +  SIP     ++ SL  L
Sbjct: 119 FNGLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRL 176

Query: 210 DL-NQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYL 267
           DL    + + +   +   L NLK L L   ++   + P+L  L+ L +L +SGNHF   +
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DM-PNLTPLVGLEELEMSGNHFP-EI 233

Query: 268 PYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLT 326
                 G  +L+   V  +        +     SL+ + L  NNL+    +       L 
Sbjct: 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293

Query: 327 FIDLSRNNF 335
            + L  N +
Sbjct: 294 ELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  109 bits (275), Expect = 2e-25
 Identities = 70/354 (19%), Positives = 116/354 (32%), Gaps = 61/354 (17%)

Query: 173 PRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKE 232
           P   S     S +  +R  L   +P  I    +   L+L +N  + +   +  +L +L+ 
Sbjct: 47  PSVCSCSNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEV 103

Query: 233 LALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGT 290
           L L  N +   I   +   L  L  L L  N  T                 +    F+  
Sbjct: 104 LQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT----------------VIPSGAFEYL 146

Query: 291 IPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN-WGKFPKL 349
                   + L  + L  N +    S A    P+L  +DL        IS   +     L
Sbjct: 147 --------SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNL 198

Query: 350 GTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQIT 408
             LN+ M NI   +P  +     L+  ++S NH   EI       L+ L KL +  +Q++
Sbjct: 199 KYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS 255

Query: 409 GRLPKEIGSLTKLEYLDFS--AIGELPSQIC-NMKSLEKLNLSHNNL------------- 452
                    L  L  L+ +   +  LP  +   ++ L +L+L HN               
Sbjct: 256 LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDILWLAWWL 315

Query: 453 -------SGSIPSCF--EGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGN 497
                  S     C     M G   +++     QC  P         +   +G 
Sbjct: 316 REYIPTNSTCCGRCHAPMHMRGRYLVEVDQASFQCSAPFIMDA-PRDLNISEGR 368

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 94.8 bits (236), Expect = 1e-20
 Identities = 48/200 (24%), Positives = 79/200 (39%), Gaps = 13/200 (6%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            +   +F+    L  L+L  N +   IP      LS LR L+L +N    +I        
Sbjct: 113 QIEVGAFNGLASLNTLELFDN-WLTVIPSGAFEYLSKLRELWLRNNPIE-SI-----PSY 165

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
           +   +  + RL + +     +I       L  L  L+L        +P +   L  L  L
Sbjct: 166 AFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEEL 223

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
            + GN        S   L SL  L + ++Q+       F  L S+  L L+ N+L  S+P
Sbjct: 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL-SSLP 282

Query: 198 DEI-GKMRSLSVLDLNQNQF 216
            ++   +R L  L L+ N +
Sbjct: 283 HDLFTPLRYLVELHLHHNPW 302

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  109 bits (275), Expect = 1e-26
 Identities = 51/264 (19%), Positives = 98/264 (37%), Gaps = 39/264 (14%)

Query: 595 CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AF 642
            IG G   +VY+  +  +   VA  +        ++ +++ F  E E            F
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCEL-QDRKLTKS-ERQRFKEEAEMLKGLQHPNIVRF 90

Query: 643 YG-FCSHARHSFLLY---EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           Y  + S  +    +    E +  G+L   L      + +      +  + +   L +LH 
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH- 146

Query: 699 DCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
              PPI+HRD+   N+ +        + D G+A   +   +      GT  ++APE+ Y 
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YE 203

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
            K  E  DVY+FG+ M E+   ++P         S       + + +   +   S    +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYRRVTSGVKPASF---D 252

Query: 818 KLISIMEVAF--SCFNESPESRPT 839
           K+           C  ++ + R +
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYS 276

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  109 bits (275), Expect = 1e-26
 Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 52/275 (18%)

Query: 596 IGNGGHASVYRAELPSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           +G G +  VY        + VAVK        + T++ +EFL E                
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKEAAVMKEIKHPNLVQLL 75

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G C+     +++ EF+  G+L   L  +   QE+     + +   ++ A+ YL    F  
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLEKKNF-- 132

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD----SSN------WTEFAGTCGYIAPE 753
            +HRD++++N L+   +   VADFG+++ +  D     +       WT         APE
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT---------APE 182

Query: 754 LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS 812
                K + K DV++FGVL+WE+   G  P   +         + V      D R+  P 
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMERP- 234

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               EK+  +M    +C+  +P  RP+   I Q  
Sbjct: 235 EGCPEKVYELMR---ACWQWNPSDRPSFAEIHQAF 266

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (282), Expect = 2e-26
 Identities = 65/270 (24%), Positives = 116/270 (42%), Gaps = 42/270 (15%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
            +G G    V+ A       VAVK          ++  + FL E               +
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMK-----PGSMSVEAFLAEANVMKTLQHDKLVKLH 249

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
              +     +++ EF+ +GSL   L +D    +    + ++    +A  ++++    +  
Sbjct: 250 AVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRNY-- 305

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI---APELAYTMKI 760
            +HRD+ + N+L+       +ADFG+A+ ++ +   +T   G    I   APE       
Sbjct: 306 -IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSF 362

Query: 761 TEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRSAQE 817
           T K DV+SFG+L+ E++  G+ P   +S       N +V   + L+   R+P P  +  E
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMS-------NPEVI--RALERGYRMPRP-ENCPE 412

Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +L +IM     C+   PE RPT + I   L
Sbjct: 413 ELYNIM---MRCWKNRPEERPTFEYIQSVL 439

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  109 bits (275), Expect = 2e-26
 Identities = 51/234 (21%), Positives = 90/234 (38%), Gaps = 29/234 (12%)

Query: 596 IGNGGHASVYRAELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFY 643
           +G GG   VY AE      +VA+K     L  D    +     E           V   +
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVF-RTRMQREARTAGRLQEPHVVPIH 100

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
            F       ++    +    LAA+L        L   + + +++ +  AL   H      
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA---G 154

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE---FAGTCGYIAPELAYTMKI 760
             HRD+  +N+L+  +  A++ DFGIA +        T+     GT  Y+APE       
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212

Query: 761 TEKCDVYSFGVLMWEVIKGKHPRDFLS---SISSSSLNTDVALDQMLDPRLPAP 811
           T + D+Y+   +++E + G  P  +     S+  + +N  +     + P +P  
Sbjct: 213 TYRADIYALTCVLYECLTGSPP--YQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  112 bits (281), Expect = 2e-26
 Identities = 59/239 (24%), Positives = 94/239 (39%), Gaps = 18/239 (7%)

Query: 29  FPHLAYLDLTWNGFFGTIPP-QISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
             +   L+L  N     I      +L +L  L L  N      +  +   +  G L  ++
Sbjct: 63  STNTRLLNLHEN-QIQIIKVNSFKHLRHLEILQLSRNH-----IRTIEIGAFNG-LANLN 115

Query: 88  RLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG-NLLS 145
            L + DN L+  IP      L  L +L L NN        +F+ + +L  L L     LS
Sbjct: 116 TLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS 174

Query: 146 GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMR 204
                +   L +L  L L    L   IP   + L  +  L LS N L  +I       + 
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHL-SAIRPGSFQGLM 231

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL--GNLILRQLLLSGN 261
            L  L + Q+Q + +   +  NL +L E+ L +N+L+  +P  L      L ++ L  N
Sbjct: 232 HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  110 bits (278), Expect = 6e-26
 Identities = 60/254 (23%), Positives = 99/254 (38%), Gaps = 36/254 (14%)

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG- 146
            L +++N +         +L+ L  L L+ N        +F+ L+NL  L L+ N L+  
Sbjct: 68  LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTI 127

Query: 147 --SILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKM 203
                  L KLK L+   L +N +       F+ + S+  L L        I +     +
Sbjct: 128 PNGAFVYLSKLKELW---LRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184

Query: 204 RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQLLLSGN 261
            +L  L+L     + +  P+++ L  L EL L  NHLS +I P S   L+ L++L +  +
Sbjct: 185 SNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQS 241

Query: 262 HFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGI 321
                            I  +  N F            SL+ + L  NNLT    +    
Sbjct: 242 Q----------------IQVIERNAFDNL--------QSLVEINLAHNNLTLLPHDLFTP 277

Query: 322 YPNLTFIDLSRNNF 335
             +L  I L  N +
Sbjct: 278 LHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  104 bits (262), Expect = 7e-24
 Identities = 74/310 (23%), Positives = 115/310 (37%), Gaps = 56/310 (18%)

Query: 173 PRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKE 232
           P   S     S +   R +L   +PD I    +  +L+L++NQ + +   S  +L +L+ 
Sbjct: 36  PSVCSCSNQFSKVICVRKNL-REVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEI 92

Query: 233 LALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGT 290
           L L  NH+  +I   +   L  L  L L  N  T                T+    F   
Sbjct: 93  LQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT----------------TIPNGAFVYL 135

Query: 291 IPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW-GKFPKL 349
                   + L  + L  N +    S A    P+L  +DL        IS         L
Sbjct: 136 --------SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNL 187

Query: 350 GTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQIT 408
             LN++M N+   +P  +    +L   DLS NH+   I       L  L KL +  +QI 
Sbjct: 188 RYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ 244

Query: 409 GRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSF 468
                          ++ +A   L S       L ++NL+HNNL+      F  +H L  
Sbjct: 245 --------------VIERNAFDNLQS-------LVEINLAHNNLTLLPHDLFTPLHHLER 283

Query: 469 IDMSYNELQC 478
           I + +N   C
Sbjct: 284 IHLHHNPWNC 293

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 94.0 bits (234), Expect = 2e-20
 Identities = 49/198 (24%), Positives = 79/198 (39%), Gaps = 13/198 (6%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
           T+   +F+   +L  L+L  N    TIP      LS L+ L+L +N    +I        
Sbjct: 102 TIEIGAFNGLANLNTLELFDN-RLTTIPNGAFVYLSKLKELWLRNNPIE-SI-----PSY 154

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
           +   +  + RL + +     +I       L  L  L+L        IP +   L  L  L
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDEL 212

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
            L GN LS     S   L  L  L +  +Q+       F NL S+  + L+ N+L   +P
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNL-TLLP 271

Query: 198 DEI-GKMRSLSVLDLNQN 214
            ++   +  L  + L+ N
Sbjct: 272 HDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 76.7 bits (189), Expect = 8e-15
 Identities = 37/151 (24%), Positives = 57/151 (37%), Gaps = 11/151 (7%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
           ++  ++F+  P L  LDL        I       LSNLRYL L                 
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR--------EIP 201

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
           +   L  +  L ++ N LS  I P     L  L +L +  ++       +FDNL +L+ +
Sbjct: 202 NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQL 168
            L  N L+         L  L  + L+ N  
Sbjct: 261 NLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  109 bits (275), Expect = 2e-26
 Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 49/276 (17%)

Query: 596 IGNGGHASVYRAEL--PSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G+G   +VY+        +V   VA+K    L         KE L E            
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 642 --FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
               G C       L+ + +  G L   +        +G    +N    +A  ++YL   
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APEL 754
                VHRD++++N+L+       + DFG+AK L  +     E+    G +     A E 
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALES 190

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAP 811
                 T + DV+S+GV +WE++  G  P D +         ++++   +L+   RLP P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEIS--SILEKGERLPQP 241

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                + +  IM     C+    +SRP  + +  + 
Sbjct: 242 PICTID-VYMIM---RKCWMIDADSRPKFRELIIEF 273

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  109 bits (274), Expect = 3e-26
 Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 49/285 (17%)

Query: 596 IGNGGHASVYRAELP-----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G G    V           +GE VAVK   SL P        +   E+E          
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVK---SLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 642 --FYGFCSHARHS--FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
             + G C+    +   L+ EFL  GSL   L  +    ++   Q++     +   + YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLG 143

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----AP 752
              +   VHRD++++N+L++ E++  + DFG+ K+++ D   +T              AP
Sbjct: 144 SRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT--VKDDRDSPVFWYAP 198

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSL-------NTDVALDQML 804
           E     K     DV+SFGV + E++         ++               T +     L
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV--NTL 256

Query: 805 DP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               RLP P     E +  +M     C+   P +R + + + +  
Sbjct: 257 KEGKRLPCPPNCPDE-VYQLMR---KCWEFQPSNRTSFQNLIEGF 297

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  109 bits (275), Expect = 3e-26
 Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 61/283 (21%)

Query: 596 IGNGGHASVYRAEL--PSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           IG G    VY+  L   SG+    VA+K   +L        + +FL E            
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIK---TLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 642 --FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
               G  S  +   ++ E++E G+L   L       E    Q + +++ +A  + YL + 
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN------------WTEFAGTC 747
            +   VHRD++++N+L++      V+DFG+++ L+ D               WT      
Sbjct: 167 NY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT------ 217

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP 806
              APE     K T   DV+SFG++MWEV+  G+ P   LS       N +V   + ++ 
Sbjct: 218 ---APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVM--KAIND 265

Query: 807 --RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             RLP P       +  +M     C+ +    RP    I   L
Sbjct: 266 GFRLPTP-MDCPSAIYQLMM---QCWQQERARRPKFADIVSIL 304

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  108 bits (272), Expect = 4e-26
 Identities = 59/257 (22%), Positives = 107/257 (41%), Gaps = 29/257 (11%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           +G GG ++VY AE       VA+K         +   ++ F  EV               
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
                    +L+ E++E  +L+  + +      L     +N    +   + + H      
Sbjct: 78  DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDM---R 131

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA-GTCGYIAPELAYTMKITE 762
           IVHRDI  +N+L+D      + DFGIAK+L   S   T    GT  Y +PE A      E
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDE 191

Query: 763 KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKL-IS 821
             D+YS G++++E++ G+ P +  +++S       +A+  + D  +P  +   ++ +  S
Sbjct: 192 CTDIYSIGIVLYEMLVGEPPFNGETAVS-------IAIKHIQDS-VPNVTTDVRKDIPQS 243

Query: 822 IMEVAFSCFNESPESRP 838
           +  V      +   +R 
Sbjct: 244 LSNVILRATEKDKANRY 260

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  108 bits (273), Expect = 4e-26
 Identities = 66/284 (23%), Positives = 109/284 (38%), Gaps = 46/284 (16%)

Query: 596 IGNGGHASVYRAELP-----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G G   SV           +G +VAVK+    L       Q++F  E++          
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQ----LQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 642 --FYGFCSHARHS--FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
             + G           L+ E+L  G L   L    A   L  S+ +     +   + YL 
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLG 144

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----AP 752
                  VHRD++++N+L++ E    +ADFG+AK L  D   +       G       AP
Sbjct: 145 SRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV--VREPGQSPIFWYAP 199

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALD-----QMLDP 806
           E       + + DV+SFGV+++E+           +                   ++L+ 
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 807 --RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
             RLPAP     E +  +M+    C+  SP+ RP+   +  QL 
Sbjct: 260 GQRLPAPPACPAE-VHELMK---LCWAPSPQDRPSFSALGPQLD 299

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  107 bits (270), Expect = 7e-26
 Identities = 68/275 (24%), Positives = 114/275 (41%), Gaps = 46/275 (16%)

Query: 596 IGNGGHASVYRAEL--PSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEA----------- 641
           +G+G   +V +           VAVK   +    +    + E L E              
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKN--EANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
             G C       L+ E  E G L   L  +   + +     + ++  V+  + YL    F
Sbjct: 83  MIGICEAESW-MLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APELAY 756
              VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   A T G       APE   
Sbjct: 139 ---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK--AQTHGKWPVKWYAPECIN 193

Query: 757 TMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSR 813
             K + K DV+SFGVLMWE    G+ P   +         ++V    ML+   R+  P  
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVT--AMLEKGERMGCP-A 243

Query: 814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
               ++  +M     C+    E+RP    +  +LR
Sbjct: 244 GCPREMYDLM---NLCWTYDVENRPGFAAVELRLR 275

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  107 bits (269), Expect = 8e-26
 Identities = 57/292 (19%), Positives = 115/292 (39%), Gaps = 55/292 (18%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
            DF+   C+G GG   V+ A+        A+K+    LP ++ + +++ + EV+A     
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR--IRLP-NRELAREKVMREVKALAKLE 61

Query: 642 ------FYGF---------CSHARHSFLLY---EFLERGSLAAILNTDAAAQELGWSQRM 683
                 ++              +     LY   +   + +L   +N     +E   S  +
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK--------- 734
           ++   +A A+ +LH      ++HRD+   N+   ++    V DFG+  ++          
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178

Query: 735 ---PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS 791
              P  +  T   GT  Y++PE  +    + K D++S G++++E++   +P  F + +  
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP--FSTQMER 233

Query: 792 SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
               TDV   +   P L       +  ++          + SP  RP    I
Sbjct: 234 VRTLTDVRNLKF--PPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI 277

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  109 bits (275), Expect = 1e-25
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 56/277 (20%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
            +G G    V+         VA+K          T+  + FL E +             Y
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLY 245

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
              S     +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +  
Sbjct: 246 AVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY-- 301

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WTEFAGTCGYIAPE 753
            VHRD+ + N+L+       VADFG+A+ ++ +             WT         APE
Sbjct: 302 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---------APE 351

Query: 754 LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPA 810
            A   + T K DV+SFG+L+ E+  KG+ P   +        N +V     ++   R+P 
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVL--DQVERGYRMPC 402

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P     E L  +M     C+ + PE RPT + +   L
Sbjct: 403 P-PECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 435

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  106 bits (267), Expect = 1e-25
 Identities = 64/273 (23%), Positives = 106/273 (38%), Gaps = 54/273 (19%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG 644
           IG G    V   +   G  VAVK              + FL E                G
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKC------IKNDATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 645 FCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
                +   +++ E++ +GSL   L +      LG    +     V  A+ YL  + F  
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF-- 138

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN------WTEFAGTCGYIAPELAYT 757
            VHRD++++N+L+  +  A V+DFG+ K              WT         APE    
Sbjct: 139 -VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALRE 188

Query: 758 MKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRS 814
            K + K DV+SFG+L+WE+   G+ P   +          DV     ++   ++ AP   
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVV--PRVEKGYKMDAP-DG 238

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               +  +M+   +C++     RP+   + +QL
Sbjct: 239 CPPAVYEVMK---NCWHLDAAMRPSFLQLREQL 268

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  107 bits (268), Expect = 2e-25
 Identities = 61/286 (21%), Positives = 114/286 (39%), Gaps = 51/286 (17%)

Query: 596 IGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G G    V           +GE+VAVK   +L        +  +  E++          
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVK---ALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 642 --FYGFCSHARHS--FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
             + G C  A  +   L+ E++  GSL   L        +G +Q +   + +   ++YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLH 151

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----AP 752
              +   +HRD++++N+LLD +    + DFG+AK++      +       G       AP
Sbjct: 152 AQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAP 206

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSL-------NTDVALDQML 804
           E     K     DV+SFGV ++E++      +   +                 +   ++L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT--ELL 264

Query: 805 DP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           +   RLP P +   E +  +M+   +C+      RPT + +   L+
Sbjct: 265 ERGERLPRPDKCPAE-VYHLMK---NCWETEASFRPTFENLIPILK 306

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  108 bits (271), Expect = 2e-25
 Identities = 67/275 (24%), Positives = 117/275 (42%), Gaps = 46/275 (16%)

Query: 596 IGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVEA---------- 641
           +G G    V    L         VA+K   +L        +++FL E             
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIK---TLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 642 -FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
              G  + ++   ++ E++E GSL + L    A  +    Q + +++ +A  + YL    
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG 167

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APELA 755
           +   VHRD++++N+L++      V+DFG+ + L+ D      +    G I     +PE  
Sbjct: 168 Y---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE--AAYTTRGGKIPIRWTSPEAI 222

Query: 756 YTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDV--ALDQMLDPRLPAPS 812
              K T   DV+S+G+++WEV+  G+ P   +S       N DV  A+D+    RLP P 
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-------NQDVIKAVDE--GYRLPPP- 272

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 L  +M     C+ +   +RP  + I   L
Sbjct: 273 MDCPAALYQLM---LDCWQKDRNNRPKFEQIVSIL 304

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  106 bits (266), Expect = 2e-25
 Identities = 59/248 (23%), Positives = 95/248 (38%), Gaps = 33/248 (13%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
               L   +P  I       ++ L  N+ S     SF    NL  L+L+ N+L+    ++
Sbjct: 19  PQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75

Query: 152 LGKLKSLFDLQLNDNQLIGYIP-RPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVL 209
              L  L  L L+DN  +  +    F  L  + TL L R  L   +   +   + +L  L
Sbjct: 76  FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYL 134

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTGYL 267
            L  N  + +   +  +L NL  L L  N +S S+P  +   L  L +LLL  N      
Sbjct: 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA--- 190

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF 327
                         V  + F+            L+ + L  NNL+   +EAL     L +
Sbjct: 191 -------------HVHPHAFRD--------LGRLMTLYLFANNLSALPTEALAPLRALQY 229

Query: 328 IDLSRNNF 335
           + L+ N +
Sbjct: 230 LRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  105 bits (263), Expect = 4e-25
 Identities = 58/240 (24%), Positives = 91/240 (37%), Gaps = 42/240 (17%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
                 + L  N     +P        NL  L+L SN  +                    
Sbjct: 31  PAASQRIFLHGNRI-SHVPAASFRACRNLTILWLHSNVLA-------------------- 69

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGNLLSG 146
              I+  + +G        L  L QLDL++N     +  + F  L  L  L+L    L  
Sbjct: 70  --RIDAAAFTG--------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ- 118

Query: 147 SI-LSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNLTSVSTLRLSRNDLFGSIPDEI-GKM 203
            +       L +L  L L DN  +  +P   F +L +++ L L  N +  S+P+     +
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNA-LQALPDDTFRDLGNLTHLFLHGNRI-SSVPERAFRGL 176

Query: 204 RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL--GNLILRQLLLSGN 261
            SL  L L+QN+   V P +  +L  L  L L  N+LS ++P         L+ L L+ N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 99.7 bits (249), Expect = 3e-23
 Identities = 55/200 (27%), Positives = 84/200 (42%), Gaps = 11/200 (5%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            +   SF +  +L  L L  N     I     + L+ L  L L  N      L  V   +
Sbjct: 46  HVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLALLEQLDLSDN----AQLRSVDPAT 100

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
             G L  +  L ++   L   + P +   L  L  L L +N        +F +L NL  L
Sbjct: 101 FHG-LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL 158

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
           +L+GN +S     +   L SL  L L+ N++    P  F +L  + TL L  N+L  ++P
Sbjct: 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL-SALP 217

Query: 198 DEI-GKMRSLSVLDLNQNQF 216
            E    +R+L  L LN N +
Sbjct: 218 TEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 48/231 (20%), Positives = 83/231 (35%), Gaps = 36/231 (15%)

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNL---- 143
           R+ ++ N +S          + L+ L L +N  +     +F  L+ L  L L  N     
Sbjct: 36  RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS 95

Query: 144 LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GK 202
           +  +    LG+L +L    L+   L    P  F  L ++  L L  N L  ++PD+    
Sbjct: 96  VDPATFHGLGRLHTLH---LDRCGLQELGPGLFRGLAALQYLYLQDNAL-QALPDDTFRD 151

Query: 203 MRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL--GNLILRQLLLSG 260
           + +L+ L L+ N+   V   +   L +L  L L  N ++  + P        L  L L  
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210

Query: 261 NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNL 311
           N+ +                 +                 +L  +RLN N  
Sbjct: 211 NNLS----------------ALPTEALAPL--------RALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 54/289 (18%), Positives = 89/289 (30%), Gaps = 79/289 (27%)

Query: 195 SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI- 252
           ++P  I    +   + L+ N+   V   S     NL  L L  N L+  I   +   L  
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL 81

Query: 253 LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
           L QL LS N     +                        P +      L  + L+   L 
Sbjct: 82  LEQLDLSDNAQLRSVD-----------------------PATFHGLGRLHTLHLDRCGLQ 118

Query: 313 GNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREI-GNSS 371
                           +L    F G           L  L +  N +   LP +   +  
Sbjct: 119 ----------------ELGPGLFRG--------LAALQYLYLQDNALQA-LPDDTFRDLG 153

Query: 372 QLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIG 430
            L    L  N I   +P+     L+ L +L+L  N++   +              F    
Sbjct: 154 NLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHA----------FR--- 198

Query: 431 ELPSQICNMKSLEKLNLSHNNLSGSIPS-CFEGMHGLSFIDMSYNELQC 478
                  ++  L  L L  NNLS ++P+     +  L ++ ++ N   C
Sbjct: 199 -------DLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWVC 239

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  111 bits (278), Expect = 2e-25
 Identities = 64/273 (23%), Positives = 113/273 (41%), Gaps = 42/273 (15%)

Query: 596 IGNGGHASVYRAEL--PSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEA----------- 641
           +G G   SV +        ++ VA+K    L    +  D +E + E +            
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK---VLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
             G C       L+ E    G L   L      +E+  S    ++  V+  + YL    F
Sbjct: 401 LIGVCQAEAL-MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKNF 457

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI---APELAYTM 758
              VHR+++++N+LL   + A ++DFG++K+L  D S +T  +     +   APE     
Sbjct: 458 ---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514

Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSRSA 815
           K + + DV+S+GV MWE +  G+ P   +          +V     ++   R+  P    
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQKPYKKMK-------GPEVM--AFIEQGKRMECP-PEC 564

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +L ++M     C+    E RP    + Q++R
Sbjct: 565 PPELYALM---SDCWIYKWEDRPDFLTVEQRMR 594

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  106 bits (267), Expect = 2e-25
 Identities = 62/264 (23%), Positives = 113/264 (42%), Gaps = 38/264 (14%)

Query: 596 IGNGGHASVYRAE---LPSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VE 640
           +G GG + V+ A          VAVK   + L  D +   + F  E            V 
Sbjct: 20  LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76

Query: 641 AF-YGF--CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
            +  G          +++ E+++  +L  I++T+     +   + + VI     AL++ H
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA---GTCGYIAPEL 754
            +    I+HRD+   N+++       V DFGIA+++    ++ T+ A   GT  Y++PE 
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
           A    +  + DVYS G +++EV+ G+ P    S +S       VA   + +     PS  
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVRED-PIPPSAR 242

Query: 815 AQEKLISIMEVAFSCFNESPESRP 838
            +     +  V      ++PE+R 
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRY 266

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  108 bits (273), Expect = 3e-25
 Identities = 65/274 (23%), Positives = 104/274 (37%), Gaps = 54/274 (19%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
            IG G    V   +   G  VAVK              + FL E                
Sbjct: 200 TIGKGEFGDVMLGDY-RGNKVAVKC------IKNDATAQAFLAEASVMTQLRHSNLVQLL 252

Query: 644 GFCSHARHSFLL-YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           G     +    +  E++ +GSL   L +      LG    +     V  A+ YL  + F 
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNF- 310

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN------WTEFAGTCGYIAPELAY 756
             VHRD++++N+L+  +  A V+DFG+ K              WT         APE   
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEALR 359

Query: 757 TMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPSR 813
             K + K DV+SFG+L+WE+   G+ P   +          DV     ++   ++ AP  
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVV--PRVEKGYKMDAP-D 409

Query: 814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                +  +M    +C++    +RPT   + +QL
Sbjct: 410 GCPPAVYDVM---KNCWHLDAATRPTFLQLREQL 440

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  106 bits (267), Expect = 3e-25
 Identities = 58/292 (19%), Positives = 107/292 (36%), Gaps = 49/292 (16%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
            +     +G GG + V   E L  G   A+K+    + C +  D++E   E +       
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKR----ILCHEQQDREEAQREADMHRLFNH 85

Query: 642 -----FYGFCSHARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQR--MNVIKAVA 690
                   +C   R +    +LL  F +RG+L   +           ++   + ++  + 
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGIC 144

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---------WT 741
             L  +H        HRD+   N+LL  E +  + D G                    W 
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201

Query: 742 EFAGTCGYIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTD 797
               T  Y APEL    ++ + I E+ DV+S G +++ ++ G+ P  +            
Sbjct: 202 AQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVAL 258

Query: 798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI 849
              +Q+  P+ P  S +  + L++ M          P  RP + ++  QL  
Sbjct: 259 AVQNQLSIPQSPRHSSALWQ-LLNSM------MTVDPHQRPHIPLLLSQLEA 303

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  105 bits (264), Expect = 3e-25
 Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 56/277 (20%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
            +G G    V+         VAVK          ++    FL E               Y
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQHQRLVRLY 74

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
              +     +++ E++E GSL   L T +   +L  ++ +++   +A  ++++    +  
Sbjct: 75  AVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERNY-- 130

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD----SSN------WTEFAGTCGYIAPE 753
            +HRD+ + N+L+       +ADFG+A+ ++ +             WT         APE
Sbjct: 131 -IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT---------APE 180

Query: 754 LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPA 810
                  T K DV+SFG+L+ E++  G+ P   ++       N +V   Q L+   R+  
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVI--QNLERGYRMVR 231

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P  +  E+L  +M     C+ E PE RPT   +   L
Sbjct: 232 P-DNCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  105 bits (265), Expect = 4e-25
 Identities = 62/272 (22%), Positives = 112/272 (41%), Gaps = 23/272 (8%)

Query: 14  NIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAE 73
             G +      + +    +  L     G   TI   +  L+NL  L L  NQ        
Sbjct: 25  AAGKSNVTDTVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIGLELKDNQ-------- 74

Query: 74  VSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSN 133
           ++  +   NL  ++ L ++ N L       I  L+ +  LDLT+ + +   PL+   LSN
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTPLA--GLSN 130

Query: 134 LIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF 193
           L  LYL  N ++   +S L  L +L  L + + Q +  +  P +NL+ ++TL+   N + 
Sbjct: 131 LQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQ-VSDLT-PLANLSKLTTLKADDNKI- 185

Query: 194 GSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLIL 253
             I   +  + +L  + L  NQ   V    ++N +NL  + L    ++ + P    N ++
Sbjct: 186 SDISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTIT-NQPVFYNNNLV 241

Query: 254 RQLLLSGNHFTGYLPYNICRGGALEIFTVSEN 285
              ++ G       P  I   G      ++ N
Sbjct: 242 VPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  103 bits (259), Expect = 3e-24
 Identities = 58/310 (18%), Positives = 110/310 (35%), Gaps = 31/310 (10%)

Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
              L+N   +  G +         V+   +  +L  ++ L      ++      +  L  
Sbjct: 15  DPALANAIKIAAGKSN--------VTDTVTQADLDGITTLSAFGTGVTTI--EGVQYLNN 64

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
           L  L+L +N+ +   PL   NL+ +  L L GN L    +S++  L+S+  L L   Q+ 
Sbjct: 65  LIGLELKDNQITDLAPLK--NLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQIT 120

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
                P + L+++  L L  N +  +    +  + +L  L +   Q   +    ++NL+ 
Sbjct: 121 DVT--PLAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSK 174

Query: 230 LKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQG 289
           L  L    N +S  I P      L ++ L  N  +   P  +     L I T++      
Sbjct: 175 LTTLKADDNKIS-DISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDL----SRNNFYGEISSNWGK 345
                  N      V+      +G       I  N T+       +  +F   +S  + +
Sbjct: 232 QPVFYNNNLVVPNVVK----GPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQ 287

Query: 346 FPKLGTLNVS 355
                   V 
Sbjct: 288 SVTFKNTTVP 297

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 65/333 (19%), Positives = 120/333 (36%), Gaps = 56/333 (16%)

Query: 90  VINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSIL 149
           +    +++   P     L    ++    +  +  +  +  +L  +  L  +G  ++   +
Sbjct: 3   ITQPTAINVIFP--DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--I 56

Query: 150 SSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVL 209
             +  L +L  L+L DNQ I  +  P  NLT ++ L LS N L       I  ++S+  L
Sbjct: 57  EGVQYLNNLIGLELKDNQ-ITDLA-PLKNLTKITELELSGNPL--KNVSAIAGLQSIKTL 112

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLP 268
           DL   Q   V    ++ L+NL+ L L  N ++ +I P L  L  L+ L +     +    
Sbjct: 113 DLTSTQITDV--TPLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS---- 164

Query: 269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFI 328
            ++                     T L N + L  ++ + N ++ +IS  L   PNL  +
Sbjct: 165 -DL---------------------TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEV 200

Query: 329 DLSRNNFYGEIS--SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGE 386
            L  N     IS  S       L  + ++   IT                 +  N + G 
Sbjct: 201 HLKNNQ----ISDVSPLANTSNLFIVTLTNQTIT-------NQPVFYNNNLVVPNVVKGP 249

Query: 387 IPKELGKLNPLTKLILRGNQITGRLPKEIGSLT 419
               +               +T  L   I +++
Sbjct: 250 SGAPIAPATISDNGTYASPNLTWNLTSFINNVS 282

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 60/312 (19%), Positives = 109/312 (34%), Gaps = 50/312 (16%)

Query: 147 SILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSL 206
           +++     L +   +    + +   +    ++L  ++TL      +  +I   +  + +L
Sbjct: 10  NVIFPDPALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGV-TTIE-GVQYLNNL 65

Query: 207 SVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTG 265
             L+L  NQ   +    + NLT + EL L  N L  ++   +  L  ++ L L+    T 
Sbjct: 66  IGLELKDNQITDL--APLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITD 121

Query: 266 YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNL 325
                                      T L   ++L  + L+ N +T NIS  L    NL
Sbjct: 122 V--------------------------TPLAGLSNLQVLYLDLNQIT-NIS-PLAGLTNL 153

Query: 326 TFIDLSRNNFYGEIS--SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI 383
            ++ +        +S  +      KL TL    N I+   P  + +   L    L  N I
Sbjct: 154 QYLSIGNAQ----VSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI 207

Query: 384 VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGEL--PSQICNMKS 441
               P  L   + L  + L    IT   P    +   +  +     G    P+ I +  +
Sbjct: 208 SDVSP--LANTSNLFIVTLTNQTITN-QPVFYNNNLVVPNVVKGPSGAPIAPATISDNGT 264

Query: 442 LEKLNLSHNNLS 453
               NL+ N  S
Sbjct: 265 YASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 42/196 (21%), Positives = 71/196 (36%), Gaps = 19/196 (9%)

Query: 285 NHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS--SN 342
                T   +  +   +  +   G  +T  I E +    NL  ++L  N     I+  + 
Sbjct: 27  GKSNVTDTVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQ----ITDLAP 80

Query: 343 WGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLIL 402
                K+  L +S N +       I     ++  DL+   I    P  L  L+ L  L L
Sbjct: 81  LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYL 136

Query: 403 RGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCF 460
             NQIT      +  LT L+YL      + +L   + N+  L  L    N +S  I    
Sbjct: 137 DLNQITN--ISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKIS-DISP-L 191

Query: 461 EGMHGLSFIDMSYNEL 476
             +  L  + +  N++
Sbjct: 192 ASLPNLIEVHLKNNQI 207

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 29/184 (15%), Positives = 65/184 (35%), Gaps = 15/184 (8%)

Query: 295 LRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNV 354
                + I++    +N+T   +        +T +                    L  L +
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLEL 70

Query: 355 SMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKE 414
             N IT   P  + N +++   +LS N +  +    +  L  +  L L   QIT      
Sbjct: 71  KDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITD--VTP 124

Query: 415 IGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMS 472
           +  L+ L+ L      I  +   +  + +L+ L++ +  +S  +      +  L+ +   
Sbjct: 125 LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKAD 181

Query: 473 YNEL 476
            N++
Sbjct: 182 DNKI 185

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 47/218 (21%), Positives = 79/218 (36%), Gaps = 42/218 (19%)

Query: 24  FSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNL 83
            + +    +  LDLT      T    ++ LSNL+ LYL  NQ +                
Sbjct: 101 SAIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQITN--------------- 143

Query: 84  RYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNL 143
                           I P +  L  L  L + N + S   PL+  NLS L  L    N 
Sbjct: 144 ----------------ISP-LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADDNK 184

Query: 144 LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKM 203
           +S   +S L  L +L ++ L +NQ+      P +N +++  + L+   +          +
Sbjct: 185 ISD--ISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNL 240

Query: 204 RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS 241
              +V+         + P +IS+        L +N  S
Sbjct: 241 VVPNVVKGPSGAP--IAPATISDNGTYASPNLTWNLTS 276

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  105 bits (264), Expect = 4e-25
 Identities = 55/243 (22%), Positives = 77/243 (31%), Gaps = 16/243 (6%)

Query: 9   NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSG 68
              +P+  + G L     S    L  L L      GT PP +   +      L     S 
Sbjct: 77  AARIPSRILFGALRVLGIS---GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133

Query: 69  NILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPL-- 126
                  +E        +  L I       F    +     LS LDL++N   G   L  
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193

Query: 127 -----SFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRP-FSNLT 180
                 F  L  L          SG   +       L  L L+ N L      P     +
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253

Query: 181 SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
            +++L LS   L   +P  +     LSVLDL+ N+      PS   L  +  L+L  N  
Sbjct: 254 QLNSLNLSFTGL-KQVPKGLP--AKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPF 308

Query: 241 SGS 243
             S
Sbjct: 309 LDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 96.9 bits (241), Expect = 4e-22
 Identities = 47/279 (16%), Positives = 80/279 (28%), Gaps = 40/279 (14%)

Query: 21  LHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG 80
           L+    S    L  +D   +         I    +L+ L + + +    IL         
Sbjct: 38  LYGGGRSLEYLLKRVDTEADLGQ---FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGI 94

Query: 81  GNLRYMSRLVINDNSLSGFIPPHIGNLKF--LSQLDLTNNKFSGPIP----LSFDNLSNL 134
             L+    L + +  ++G  PP +       L+ L+L N  ++        L       L
Sbjct: 95  SGLQE---LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151

Query: 135 IFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFS----NLTSVSTLRLSRN 190
             L +            +    +L  L L+DN  +G      +       ++  L L   
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211

Query: 191 ---DLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI-SNLTNLKELALLYNHLS---GS 243
                 G           L  LDL+ N  +           + L  L L +  L      
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG 271

Query: 244 IPPSL------GNLI-----------LRQLLLSGNHFTG 265
           +P  L       N +           +  L L GN F  
Sbjct: 272 LPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 94.6 bits (235), Expect = 3e-21
 Identities = 54/310 (17%), Positives = 92/310 (29%), Gaps = 62/310 (20%)

Query: 185 LRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSIS---NLTNLKELALLYNHLS 241
           L+    +       +I K  SL  L +   +    +         ++ L+EL L    ++
Sbjct: 49  LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108

Query: 242 GSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQG--TIPTSLRNC- 298
           G+ PP L       L                      I  +    +         L+   
Sbjct: 109 GTAPPPLLEATGPDL---------------------NILNLRNVSWATRDAWLAELQQWL 147

Query: 299 -TSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW----GKFPKLGTLN 353
              L  + +   +      E + ++P L+ +DLS N   GE          KFP L  L 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 354 VSMNNIT---GGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNP-LTKLILRGNQITG 409
           +    +    G          QLQ  DLS N +              L  L L    +  
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266

Query: 410 RLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFI 469
           ++PK + +                        L  L+LS+N L    PS  + +  +  +
Sbjct: 267 QVPKGLPA-----------------------KLSVLDLSYNRLD-RNPS-PDELPQVGNL 301

Query: 470 DMSYNELQCP 479
            +  N     
Sbjct: 302 SLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 91.5 bits (227), Expect = 3e-20
 Identities = 52/328 (15%), Positives = 79/328 (24%), Gaps = 57/328 (17%)

Query: 69  NILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP--- 125
           N L     E  GG       L   D          I     L +L +   +    I    
Sbjct: 29  NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA 88

Query: 126 LSFDNLSNLIFLYLYGNLLSGSILSSLGKL--KSLFDLQLNDNQLIGYIPRPFSNLTSVS 183
           L    +S L  L L    ++G+    L +     L  L L +           + L  + 
Sbjct: 89  LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT----RDAWLAELQ 144

Query: 184 TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS 243
                                 L VL + Q          +     L  L L  N   G 
Sbjct: 145 QWLKP----------------GLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188

Query: 244 IPPSLGNLI-----LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNC 298
                         L+ L L                              G         
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGM---------------------ETPSGVCSALAAAR 227

Query: 299 TSLIRVRLNGNNLTGNISEALGIYP-NLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMN 357
             L  + L+ N+L          +P  L  ++LS      ++        KL  L++S N
Sbjct: 228 VQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYN 284

Query: 358 NITGGLPREIGNSSQLQAFDLSLNHIVG 385
            +    P       Q+    L  N  + 
Sbjct: 285 RLD-RNPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 41/242 (16%), Positives = 73/242 (30%), Gaps = 34/242 (14%)

Query: 287 FQGTIPT--SLRNCTSLIRVRLNGNN-------LTGNISEALGIYPN------LTFIDLS 331
           F    P   S  NC     V L G            +    LG + +      L  + + 
Sbjct: 17  FSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVR 76

Query: 332 RNNFYGEISSNWGKF---PKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI-VGEI 387
                  I     +      L  L +    +TG  P  +  ++      L+L ++     
Sbjct: 77  AARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR 136

Query: 388 PKELGKLNP-----LTKLILRGNQITGRLPKEIGSLTKLEYLDFS-----AIGELPSQIC 437
              L +L       L  L +          +++     L  LD S         L S +C
Sbjct: 137 DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196

Query: 438 --NMKSLEKLNLSHNN---LSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVE 492
                +L+ L L +      SG   +       L  +D+S+N L+      +    + + 
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256

Query: 493 AL 494
           +L
Sbjct: 257 SL 258

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  108 bits (272), Expect = 6e-25
 Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 56/277 (20%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
            +G G    V+         VA+K          T+  + FL E +             Y
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRHEKLVQLY 328

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
              S     +++ E++ +GSL   L  +   + L   Q +++   +A  ++Y+    +  
Sbjct: 329 AVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMNY-- 384

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WTEFAGTCGYIAPE 753
            VHRD+ + N+L+       VADFG+A+ ++ +             WT         APE
Sbjct: 385 -VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT---------APE 434

Query: 754 LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPA 810
            A   + T K DV+SFG+L+ E+  KG+ P   +        N +V     ++   R+P 
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVL--DQVERGYRMPC 485

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           P     E L  +M     C+ + PE RPT + +   L
Sbjct: 486 P-PECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 518

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  103 bits (260), Expect = 1e-24
 Identities = 67/283 (23%), Positives = 102/283 (36%), Gaps = 60/283 (21%)

Query: 596 IGNGGHASVYRAEL--PSGEV--VAVKKFHSLLPCDQTVDQKEFLTEVEA---------- 641
           +G+G    V R E   PSG+   VAVK     +   Q     +F+ EV A          
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 642 -FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
             YG         ++ E    GSL   L                    VA  + YL    
Sbjct: 85  RLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR 141

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN------------WTEFAGTCG 748
           F   +HRD++++NLLL       + DFG+ ++L  +  +            W        
Sbjct: 142 F---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC------- 191

Query: 749 YIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP- 806
             APE   T   +   D + FGV +WE+   G+ P   L+        + +     +D  
Sbjct: 192 --APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQIL--HKIDKE 240

Query: 807 --RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             RLP P     + + ++M     C+   PE RPT   +   L
Sbjct: 241 GERLPRP-EDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFL 279

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  103 bits (260), Expect = 1e-24
 Identities = 55/289 (19%), Positives = 102/289 (35%), Gaps = 69/289 (23%)

Query: 596 IGNGGHASVYRAELPSGEV--------VAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
           +G G    +++                V +K     L        + F            
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKV----LDKAHRNYSESFFEAASMMSKLSH 71

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 YG C     + L+ EF++ GSL   L  +     +    ++ V K +A A+ +L
Sbjct: 72  KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFL 129

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAH--------VADFGIAKSLKPDSS-----NWTEF 743
             +     +H ++ +KN+LL  E +          ++D GI+ ++ P         W   
Sbjct: 130 EENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV-- 184

Query: 744 AGTCGYIAPE-LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALD 801
                   PE +     +    D +SFG  +WE+   G  P   L        +      
Sbjct: 185 -------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-------SQRKL-- 228

Query: 802 QMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           Q  +   +LPAP      +L +++    +C +  P+ RP+ + I + L 
Sbjct: 229 QFYEDRHQLPAPK---AAELANLIN---NCMDYEPDHRPSFRAIIRDLN 271

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  103 bits (259), Expect = 2e-24
 Identities = 64/293 (21%), Positives = 109/293 (37%), Gaps = 65/293 (22%)

Query: 596 IGNGGHASVYRAELP-----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G G   SV           +GEVVAVKK    L        ++F  E+E          
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 642 --FYGFCSHARHS--FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
             + G C  A      L+ E+L  GSL   L      + +   + +     +   + YL 
Sbjct: 74  VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 131

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN------------WTEFAG 745
              +   +HRD++++N+L++ E    + DFG+ K L  D               W     
Sbjct: 132 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY---- 184

Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL---------NT 796
                APE     K +   DV+SFGV+++E+           +     +           
Sbjct: 185 -----APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239

Query: 797 DVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +   ++L    RLP P     E +  IM     C+N +   RP+ + ++ ++
Sbjct: 240 HLI--ELLKNNGRLPRPDGCPDE-IYMIMT---ECWNNNVNQRPSFRDLALRV 286

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  103 bits (259), Expect = 3e-24
 Identities = 61/276 (22%), Positives = 107/276 (38%), Gaps = 49/276 (17%)

Query: 596 IGNGGHASVYRAEL--PSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G+G   +VY+        +V   VA+K    L         KE L E            
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIK---ELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 642 --FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
               G C       L+ + +  G L   +        +G    +N    +A  ++YL   
Sbjct: 80  CRLLGICL-TSTVQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APEL 754
                VHRD++++N+L+       + DFG+AK L  +     E+    G +     A E 
Sbjct: 137 RL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALES 190

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAP 811
                 T + DV+S+GV +WE++  G  P D +         ++++   +L+   RLP P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEIS--SILEKGERLPQP 241

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                + +  IM     C+    +SRP  + +  + 
Sbjct: 242 PICTID-VYMIM---VKCWMIDADSRPKFRELIIEF 273

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  102 bits (256), Expect = 4e-24
 Identities = 52/291 (17%), Positives = 107/291 (36%), Gaps = 59/291 (20%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
            DF     IG+GG   V++A+    G+   +K+           + ++   EV+A     
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK--------YNNEKAEREVKALAKLD 62

Query: 642 ------FYGF-------------CSHARHSFLLY---EFLERGSLAAILNTDAAAQELGW 679
                 + G               S    +  L+   EF ++G+L   +      ++L  
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-KRRGEKLDK 121

Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
              + + + +   + Y+H      +++RD+   N+ L    +  + DFG+  SLK D   
Sbjct: 122 VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178

Query: 740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA 799
                GT  Y++PE   +    ++ D+Y+ G+++ E++         S            
Sbjct: 179 TR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKF---------- 227

Query: 800 LDQMLDPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI 849
              + D  +     +  +  L+          ++ PE RP    I + L +
Sbjct: 228 FTDLRDGIISDIFDKKEKT-LLQ------KLLSKKPEDRPNTSEILRTLTV 271

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  104 bits (262), Expect = 5e-24
 Identities = 61/277 (22%), Positives = 106/277 (38%), Gaps = 46/277 (16%)

Query: 589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKE--FLTEVEA----- 641
            F  K  +G+G   ++    +     VAVK+   +LP   +   +E   L E +      
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81

Query: 642 -FYGFCSHARHSFLLYEFLER--GSLA-AILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
            ++      +     Y  +E    +L   +   D A   L   + + +++     L++LH
Sbjct: 82  RYFCTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHLH 135

Query: 698 HDCFPPIVHRDISSKNLLL-----DLEYEAHVADFGIAKSLKPDSS---NWTEFAGTCGY 749
                 IVHRD+   N+L+       + +A ++DFG+ K L          +   GT G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 750 IAPEL---AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLD 805
           IAPE+         T   D++S G + + VI +G HP        ++ L    +    LD
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACS----LD 248

Query: 806 PRLPAPSRSAQEK-LISIMEVAFSCFNESPESRPTMK 841
              P        + LI             P+ RP+ K
Sbjct: 249 CLHPEKHEDVIARELIE------KMIAMDPQKRPSAK 279

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (257), Expect = 5e-24
 Identities = 64/286 (22%), Positives = 110/286 (38%), Gaps = 51/286 (17%)

Query: 596 IGNGGHASVYRAELP-----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G G   SV           +GEVVAVKK    L        ++F  E+E          
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKK----LQHSTEEHLRDFEREIEILKSLQHDNI 104

Query: 642 --FYGFCSHARHS--FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
             + G C  A      L+ E+L  GSL   L      + +   + +     +   + YL 
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLG 162

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----AP 752
              +   +HRD++++N+L++ E    + DFG+ K L  D   +       G       AP
Sbjct: 163 TKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK--VKEPGESPIFWYAP 217

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL---------NTDVALDQM 803
           E     K +   DV+SFGV+++E+           +     +            +   ++
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI--EL 275

Query: 804 LDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           L    RLP P     E +  IM     C+N +   RP+ + ++ ++
Sbjct: 276 LKNNGRLPRPDGCPDE-IYMIMT---ECWNNNVNQRPSFRDLALRV 317

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  101 bits (255), Expect = 5e-24
 Identities = 61/282 (21%), Positives = 99/282 (35%), Gaps = 61/282 (21%)

Query: 596 IGNGGHASVYRAEL--PSGEV--VAVKKFHSLLPCDQTVDQKEFLTEVEA---------- 641
           +G G    VY        GE   VAVK   +        ++++F++E             
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVK---TCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 642 -FYGFCSHARHSFLL-YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              G          +  E    G L   L  +     L     +     +  A++YL   
Sbjct: 77  KLIGIIE--EEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI 132

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WTEFAGTCGY 749
                VHRDI+ +N+L+       + DFG+++ ++ +             W         
Sbjct: 133 NC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-------- 181

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP-- 806
            +PE     + T   DV+ F V MWE++  GK P  +L        N DV    +L+   
Sbjct: 182 -SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-------NKDVI--GVLEKGD 231

Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           RLP P       L ++M     C++  P  RP    +   L 
Sbjct: 232 RLPKP-DLCPPVLYTLMT---RCWDYDPSDRPRFTELVCSLS 269

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  102 bits (256), Expect = 7e-24
 Identities = 57/271 (21%), Positives = 90/271 (33%), Gaps = 50/271 (18%)

Query: 589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCS 647
            F     +G+G +  V++      G + AVK+  S+ P     D+   L EV +      
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 648 HA-----RHSFL----LYEFLE--RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
           H        ++     LY   E    SL       A    L  +Q    ++    AL++L
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCE--AWGASLPEAQVWGYLRDTLLALAHL 173

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL-- 754
           H      +VH D+   N+ L       + DFG+   L    +      G   Y+APEL  
Sbjct: 174 HSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPELLQ 229

Query: 755 -AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM----LDPRLP 809
            +Y        DV+S G+ + EV                         Q+    L P   
Sbjct: 230 GSY----GTAADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYLPPEFT 274

Query: 810 AP-SRSAQEKLISIMEVAFSCFNESPESRPT 839
           A  S   +  ++             P+ R T
Sbjct: 275 AGLSSELRS-VLV------MMLEPDPKLRAT 298

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (265), Expect = 9e-24
 Identities = 44/209 (21%), Positives = 80/209 (38%), Gaps = 37/209 (17%)

Query: 595 CIGNGGHASVYRAE---LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF--------- 642
           CI +GG   +Y A    + +G  V +K    L+       Q   + E +           
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLK---GLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 643 --YGFCSHARHS-----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
             + F  H         +++ E++   SL          Q+L  ++ +  +  +  ALSY
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPALSY 197

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           LH      +V+ D+  +N++L  E +  + D G    +           GT G+ APE+ 
Sbjct: 198 LHSI---GLVYNDLKPENIMLT-EEQLKLIDLGAVSRINSFGY----LYGTPGFQAPEIV 249

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
            T   T   D+Y+ G  +  +      R+
Sbjct: 250 RT-GPTVATDIYTVGRTLAALTLDLPTRN 277

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  101 bits (253), Expect = 2e-23
 Identities = 60/276 (21%), Positives = 105/276 (38%), Gaps = 49/276 (17%)

Query: 596 IGNGGHASVYRAEL----PSGEV-VAVKKFHSLLPCDQTVDQKEFLTEVEA--------- 641
           +G+G   +V++        S ++ V +K    +         +     + A         
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIK---VIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 642 --FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
               G C       L+ ++L  GSL   +        LG    +N    +A  + YL   
Sbjct: 78  VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH 134

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APEL 754
                VHR+++++N+LL    +  VADFG+A  L PD     +   +         A E 
Sbjct: 135 GM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK---QLLYSEAKTPIKWMALES 188

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAP 811
            +  K T + DV+S+GV +WE++  G  P   L          +V    +L+   RL  P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-------LAEVP--DLLEKGERLAQP 239

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                + +  +M     C+      RPT K ++ + 
Sbjct: 240 QICTID-VYMVM---VKCWMIDENIRPTFKELANEF 271

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  100 bits (252), Expect = 2e-23
 Identities = 72/308 (23%), Positives = 116/308 (37%), Gaps = 43/308 (13%)

Query: 551 QKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATN---DFDAKYCIGNGGHASVYRA 607
               SG       +   S  + + + K     +V   +     D+   IG G    V  A
Sbjct: 5   HHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLA 64

Query: 608 -ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL- 654
            E  SG  VAVK     +   +   ++    EV              Y   S+     L 
Sbjct: 65  REKHSGRQVAVKM----MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK--SYLVGEELW 118

Query: 655 -LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN 713
            L EFL+ G+L  I++       L   Q   V +AV  AL+YLH      ++HRDI S +
Sbjct: 119 VLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS 171

Query: 714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           +LL L+    ++DFG    +  D        GT  ++APE+        + D++S G+++
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231

Query: 774 WEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAF--SCFN 831
            E++ G+ P          S +   A+        P P      K+  ++   F      
Sbjct: 232 IEMVDGEPPY--------FSDSPVQAM--KRLRDSPPPKLKNSHKVSPVLR-DFLERMLV 280

Query: 832 ESPESRPT 839
             P+ R T
Sbjct: 281 RDPQERAT 288

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 60/270 (22%), Positives = 108/270 (40%), Gaps = 32/270 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------ 640
            D++  Y IG G +    +      G+++  K+           +++  ++EV       
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 63

Query: 641 -----AFYG-FCSHARHSFLLY-EFLERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHA 692
                 +Y         +  +  E+ E G LA+++      ++ L     + V+  +  A
Sbjct: 64  HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 693 LSYLH--HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
           L   H   D    ++HRD+   N+ LD +    + DFG+A+ L  D+S    F GT  Y+
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA 810
           +PE    M   EK D++S G L++E+     P  F +  S   L   +   +    R+P 
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAF-SQKELAGKIREGKF--RRIPY 238

Query: 811 P-SRSAQEKLISIMEVAFSCFNESPESRPT 839
             S    E +I+         N     RP+
Sbjct: 239 RYSDELNE-IIT------RMLNLKDYHRPS 261

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  100 bits (250), Expect = 4e-23
 Identities = 57/276 (20%), Positives = 105/276 (38%), Gaps = 35/276 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKE---FLTEVE--- 640
            +F  +  IG G  + VYRA  L  G  VA+KK    +     +D K     + E++   
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK----VQIFDLMDAKARADCIKEIDLLK 87

Query: 641 --------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAH 691
                    +Y          ++ E  + G L+ ++      +  +           +  
Sbjct: 88  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           AL ++H      ++HRDI   N+ +       + D G+ +     ++      GT  Y++
Sbjct: 148 ALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-SSLNTDVALDQMLDPRLPA 810
           PE  +      K D++S G L++E+   + P  F     +  SL   +       P LP+
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDY--PPLPS 260

Query: 811 PSRSAQ-EKLISIMEVAFSCFNESPESRPTMKIISQ 845
              S +  +L++       C N  PE RP +  +  
Sbjct: 261 DHYSEELRQLVN------MCINPDPEKRPDVTYVYD 290

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 66/276 (23%), Positives = 108/276 (39%), Gaps = 49/276 (17%)

Query: 596 IGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVEA---------- 641
           IG G    V++    S E     VA+K   +   C     +++FL E             
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIK---TCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 642 -FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
              G  +     +++ E    G L + L        L  +  +     ++ AL+YL    
Sbjct: 80  KLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR 136

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APELA 755
           F   VHRDI+++N+L+       + DFG+++ ++      T +  + G +     APE  
Sbjct: 137 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS----TYYKASKGKLPIKWMAPESI 189

Query: 756 YTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPS 812
              + T   DV+ FGV MWE++  G  P   +        N DV     ++   RLP P 
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVI--GRIENGERLPMP- 239

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +    L S+M     C+   P  RP    +  QL 
Sbjct: 240 PNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 272

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 99.0 bits (247), Expect = 1e-22
 Identities = 57/274 (20%), Positives = 93/274 (33%), Gaps = 48/274 (17%)

Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT-EVEA--- 641
            +    +  +G G    V+R  +  +G   AVKK          V  + F   E+ A   
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKK----------VRLEVFRVEELVACAG 106

Query: 642 --------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                    YG         +  E LE GSL  ++       E    + +  +      L
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGL 163

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTE-----FAGTC 747
            YLH      I+H D+ + N+LL  +   A + DFG A  L+PD    +        GT 
Sbjct: 164 EYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR 807
            ++APE+        K D++S   +M  ++ G HP         +          +    
Sbjct: 221 THMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW--------TQYFRGPLC--LKIAS 270

Query: 808 LPAPSRSAQEKLISIMEVAF--SCFNESPESRPT 839
            P P R       + +          + P  R +
Sbjct: 271 EPPPIREIPPSC-APLTAQAIQEGLRKEPVHRAS 303

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.8 bits (246), Expect = 2e-22
 Identities = 62/268 (23%), Positives = 104/268 (38%), Gaps = 28/268 (10%)

Query: 588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------ 640
           +DF+    +G G    V++    PSG V+A K  H  +   +   + + + E++      
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECN 89

Query: 641 -----AFYG-FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                 FYG F S    S  + E ++ GSL  +L       E        V  AV   L+
Sbjct: 90  SPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLT 145

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           YL       I+HRD+   N+L++   E  + DFG++  L  DS   + F GT  Y++PE 
Sbjct: 146 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSPER 201

Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHP----RDFLSSISSSSLNTDVALDQMLDPRLPA 810
                 + + D++S G+ + E+  G++P          +         A +    PR P 
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRP 838
              +            F   +      P
Sbjct: 262 RPLNKFGMDSRPPMAIFELLDYIVNEPP 289

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 43/268 (16%)

Query: 589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVD--QKE--FLTE----- 638
            F     IG G    V++  +  + +VVA+K    L   +  ++  Q+E   L++     
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 639 VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
           V  +YG        +++ E+L  GS   +L        L  +Q   +++ +   L YLH 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP----LDETQIATILREILKGLDYLHS 137

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
           +     +HRDI + N+LL    E  +ADFG+A  L         F GT  ++APE+    
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 194

Query: 759 KITEKCDVYSFGVLMWEVIKGK------HPRDFLSSISSSSLNTDVALDQMLDPRLPAP- 811
               K D++S G+   E+ +G+      HP   L  I  ++            P L    
Sbjct: 195 AYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-----------PPTLEGNY 243

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPT 839
           S+  +E  +       +C N+ P  RPT
Sbjct: 244 SKPLKE-FVE------ACLNKEPSFRPT 264

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 97.9 bits (244), Expect = 4e-22
 Identities = 52/265 (19%), Positives = 98/265 (36%), Gaps = 31/265 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------ 640
             +     IG G        +    G    +K+ +  +    + +++E   EV       
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--ISRMSSKEREESRREVAVLANMK 81

Query: 641 -----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                 +          +++ ++ E G L   +N           Q ++    +  AL +
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRIN-AQKGVLFQEDQILDWFVQICLALKH 140

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           +H      I+HRDI S+N+ L  +    + DFGIA+ L           GT  Y++PE+ 
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEIC 197

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP-SRS 814
                  K D+++ G +++E+   KH   F  + S  +L   +       P +    S  
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA--F-EAGSMKNLVLKIISGSF--PPVSLHYSYD 252

Query: 815 AQEKLISIMEVAFSCFNESPESRPT 839
            +  L+S        F  +P  RP+
Sbjct: 253 LRS-LVS------QLFKRNPRDRPS 270

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.4 bits (243), Expect = 4e-22
 Identities = 71/284 (25%), Positives = 113/284 (39%), Gaps = 54/284 (19%)

Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-------- 641
           +G+G    VY  ++      PS   VAVK   +L       D+ +FL E           
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 642 ---FYGFCSHARHSFLLYEFLERGSLAAIL----NTDAAAQELGWSQRMNVIKAVAHALS 694
                G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYI- 750
           YL  + F   +HRDI+++N LL       V    DFG+A+ +    +++    G C  + 
Sbjct: 155 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYR-KGGCAMLP 208

Query: 751 ----APE-LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQML 804
                PE        T K D +SFGVL+WE+   G  P    S       N +V L+ + 
Sbjct: 209 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEV-LEFVT 259

Query: 805 D-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              R+  P ++    +  IM     C+   PE RP   II +++
Sbjct: 260 SGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 299

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 97.5 bits (243), Expect = 5e-22
 Identities = 61/288 (21%), Positives = 103/288 (35%), Gaps = 56/288 (19%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH------ 648
           +  GG A VY A+ + SG   A+K+    L  ++    +  + EV        H      
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKR----LLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91

Query: 649 -------------ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                         +  FLL   L +G L   L    +   L     + +      A+ +
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN------------WTEF 743
           +H    PPI+HRD+  +NLLL  +    + DFG A ++                      
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 744 AGTCGYIAPELAYTMK---ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL 800
             T  Y  PE+        I EK D+++ G +++ +   +HP  F        +N   ++
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FEDGAKLRIVNGKYSI 268

Query: 801 DQMLDPRLPAPSRSAQ-EKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                P  P  ++      LI  M         +PE R ++  +  QL
Sbjct: 269 -----P--PHDTQYTVFHSLIRAM------LQVNPEERLSIAEVVHQL 303

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 49/205 (23%), Positives = 78/205 (38%), Gaps = 11/205 (5%)

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYI 172
           LDL+ N        SF +   L  L L    +      +   L  L  L L  N +    
Sbjct: 33  LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA 92

Query: 173 PRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSI-SNLTNL 230
              FS L+S+  L     +L  S+ +   G +++L  L++  N  +    P   SNLTNL
Sbjct: 93  LGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNL 151

Query: 231 KELALLYNHLSGSIPP----SLGNL--ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSE 284
           + L L  N +  SI       L  +  +   L LS N    ++     +   L+   +  
Sbjct: 152 EHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDT 209

Query: 285 NHFQGTIPTSLRNCTSLIRVRLNGN 309
           N  +          TSL ++ L+ N
Sbjct: 210 NQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 60/240 (25%), Positives = 87/240 (36%), Gaps = 49/240 (20%)

Query: 34  YLDLTWNGFFGTIPP-QISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVIN 92
            LDL++N     +      +   L+ L L   +                           
Sbjct: 32  NLDLSFNPL-RHLGSYSFFSFPELQVLDLSRCEIQ------------------------- 65

Query: 93  DNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
                  I      +L  LS L LT N        +F  LS+L  L      L+ S+ + 
Sbjct: 66  ------TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENF 118

Query: 152 L-GKLKSLFDLQLNDNQLIGYIPRP--FSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLS 207
             G LK+L +L +  N  I     P  FSNLT++  L LS N +  SI       +  + 
Sbjct: 119 PIGHLKTLKELNVAHNL-IQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLRVLHQMP 176

Query: 208 V----LDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQLLLSGN 261
           +    LDL+ N     + P       LKELAL  N L  S+P      L  L+++ L  N
Sbjct: 177 LLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 16/202 (7%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            L  +SF SFP L  LDL+      TI      +LS+L  L L  N      +  ++  +
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNP-----IQSLALGA 95

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKF-SGPIPLSFDNLSNLIFL 137
             G L  + +LV  + +L+      IG+LK L +L++ +N   S  +P  F NL+NL  L
Sbjct: 96  FSG-LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154

Query: 138 YLYGNLL---SGSILSSLGKLKSL-FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF 193
            L  N +     + L  L ++  L   L L+ N +    P  F  +  +  L L  N L 
Sbjct: 155 DLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQL- 212

Query: 194 GSIPDEI-GKMRSLSVLDLNQN 214
            S+PD I  ++ SL  + L+ N
Sbjct: 213 KSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 52/296 (17%), Positives = 86/296 (29%), Gaps = 90/296 (30%)

Query: 195 SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP----SLGN 250
            IPD +    S   LDL+ N  + +   S  +   L+ L L    +  +I      SL +
Sbjct: 21  KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 251 LILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNN 310
             L  L+L+GN     L                          +    +SL ++     N
Sbjct: 78  --LSTLILTGNPIQ-SLA-----------------------LGAFSGLSSLQKLVAVETN 111

Query: 311 LTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS 370
           L    +  +G    L  ++++ N     I S    F                        
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNL----IQS----FKLPE-------------------- 143

Query: 371 SQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLE------Y 423
                F                 L  L  L L  N+I   +       L ++        
Sbjct: 144 ----YFS---------------NLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLD 183

Query: 424 LDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPS-CFEGMHGLSFIDMSYNELQC 478
           L  + +  +         L++L L  N L  S+P   F+ +  L  I +  N   C
Sbjct: 184 LSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 238

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 97.8 bits (243), Expect = 5e-22
 Identities = 36/292 (12%), Positives = 66/292 (22%), Gaps = 63/292 (21%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVK------------------------------------ 618
           +  G  + V+   ++   E  A+K                                    
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 619 KFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-- 676
           +   LLP D    Q +      +         +  LL        L  + +T        
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 677 --LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK 734
              G      +   +    + L       +VH   +  NL +  +    + D        
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---W 242

Query: 735 PDSSNWTEFAGTCGYIAPEL--AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS 792
              +     +    Y   E   A T   T   + +  G+ ++ V     P   L +    
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG-LVTPGIK 301

Query: 793 SLNTDVALDQMLDPRLPAP-----SRSAQEKLISIMEVAFSCFNESPESRPT 839
                 +L       L            +  LI          N     R  
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-LIG------RFLNFDRRRRLL 346

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 97.5 bits (243), Expect = 8e-22
 Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 46/276 (16%)

Query: 596 IGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE----------- 640
           IG G    VY   L   +      AVK   SL       +  +FLTE             
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 641 AFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
           +  G C  +  S  ++  +++ G L   +  +           +     VA  + +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APEL 754
            F   VHRD++++N +LD ++   VADFG+A+ +     +      T   +     A E 
Sbjct: 212 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALES 267

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDV--ALDQMLDPRLPAP 811
             T K T K DV+SFGVL+WE++ +G  P   ++         D+   L Q    RL  P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQ--GRRLLQP 318

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                + L  +M     C++   E RP+   +  ++
Sbjct: 319 -EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 350

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 96.3 bits (240), Expect = 8e-22
 Identities = 68/277 (24%), Positives = 116/277 (41%), Gaps = 39/277 (14%)

Query: 580 YDEIVKATN---DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
            DE          FD    +G G + SVY+A    +G++VA+K+           D +E 
Sbjct: 18  LDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ------VPVESDLQEI 71

Query: 636 LTEVE-----------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
           + E+             +YG        +++ E+   GS++ I+      + L   +   
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIAT 129

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
           ++++    L YLH       +HRDI + N+LL+ E  A +ADFG+A  L    +      
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML 804
           GT  ++APE+   +      D++S G+   E+ +GK P         + ++   A+   +
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY--------ADIHPMRAI--FM 236

Query: 805 DPRLPAPSRSAQEKLISIMEVAF--SCFNESPESRPT 839
            P  P P+    E   S     F   C  +SPE R T
Sbjct: 237 IPTNPPPTFRKPELW-SDNFTDFVKQCLVKSPEQRAT 272

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.0 bits (241), Expect = 1e-21
 Identities = 45/306 (14%), Positives = 93/306 (30%), Gaps = 49/306 (16%)

Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAE------LPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           E    +      + +G G  A VY A         + +   +K      P +  +  +  
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 636 --LTEVE-----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQ--RMNVI 686
             L          FY        S L+ E    G+L   +N      E    Q   ++  
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH-----------VADFGIAKSLK- 734
             + + +  +H      I+H DI   N +L   +              + D G +  +K 
Sbjct: 179 MRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235

Query: 735 -PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP-------RDFL 786
            P  + +T    T G+   E+        + D +     ++ ++ G +            
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295

Query: 787 SSISSSSLNTDV---ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKII 843
             +     + D+       ML+         + + L   ++       +  +   T KI 
Sbjct: 296 EGLFRRLPHLDMWNEFFHVMLNIP-DCHHLPSLDLLRQKLK-------KVFQQHYTNKIR 347

Query: 844 SQQLRI 849
           + + R+
Sbjct: 348 ALRNRL 353

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 46/276 (16%)

Query: 596 IGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE----------- 640
           IG G    VY   L   +      AVK   SL       +  +FLTE             
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVK---SLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 641 AFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
           +  G C  +  S  ++  +++ G L   +  +           +     VA  + YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APEL 754
            F   VHRD++++N +LD ++   VADFG+A+ +  D   ++    T   +     A E 
Sbjct: 148 KF---VHRDLAARNCMLDEKFTVKVADFGLARDMY-DKEYYSVHNKTGAKLPVKWMALES 203

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAP 811
             T K T K DV+SFGVL+WE++ +G  P   ++         D+     L    RL  P
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDIT--VYLLQGRRLLQP 254

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                + L  +M     C++   E RP+   +  ++
Sbjct: 255 -EYCPDPLYEVML---KCWHPKAEMRPSFSELVSRI 286

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 50/204 (24%), Positives = 84/204 (41%), Gaps = 24/204 (11%)

Query: 595 CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AF 642
            +G G +  VY   +L +   +A+K+    +P   +   +    E+             +
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKE----IPERDSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
            G  S      +  E +  GSL+A+L +     +          K +   L YLH +   
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ-- 142

Query: 703 PIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI 760
            IVHRDI   N+L++  Y   +  +DFG +K L   +     F GT  Y+APE+      
Sbjct: 143 -IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPR 200

Query: 761 --TEKCDVYSFGVLMWEVIKGKHP 782
              +  D++S G  + E+  GK P
Sbjct: 201 GYGKAADIWSLGCTIIEMATGKPP 224

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 54/291 (18%), Positives = 99/291 (34%), Gaps = 65/291 (22%)

Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA---- 641
           T +F     IG+G   SV++  +   G + A+K+  S  P   +VD++  L EV A    
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKR--SKKPLAGSVDEQNALREVYAHAVL 67

Query: 642 --------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHA 692
                   ++   +   H  +  E+   GSLA  ++ +         ++  +++  V   
Sbjct: 68  GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLD-------------------LEYEAHVADFGIAKSL 733
           L Y+H      +VH DI   N+ +                     +    + D G    +
Sbjct: 128 LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 734 KPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSS---I 789
               S+     G   ++A E L        K D+++  + +      +           I
Sbjct: 185 ----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEI 240

Query: 790 SSSSLNTDVALDQMLDPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPT 839
               L           PR+P   S+   E L+          +  PE RP+
Sbjct: 241 RQGRL-----------PRIPQVLSQEFTE-LLK------VMIHPDPERRPS 273

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 65/275 (23%), Positives = 107/275 (38%), Gaps = 44/275 (16%)

Query: 596 IGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE----------- 640
           IG G    VY  E           A+K   SL    +    + FL E             
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIK---SLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 641 AFYGFCSHAR-HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
           A  G          +L  ++  G L   + +    +       ++    VA  + YL   
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APEL 754
            F   VHRD++++N +LD  +   VADFG+A+ +  D   ++        +     A E 
Sbjct: 144 KF---VHRDLAARNCMLDESFTVKVADFGLARDIL-DREYYSVQQHRHARLPVKWTALES 199

Query: 755 AYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLD-PRLPAPS 812
             T + T K DV+SFGVL+WE++ +G  P   +          D+    +    RLP P 
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID-------PFDL-THFLAQGRRLPQP- 250

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               + L  +M+    C+   P  RPT +++  ++
Sbjct: 251 EYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEV 282

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 95.9 bits (239), Expect = 2e-21
 Identities = 69/284 (24%), Positives = 110/284 (38%), Gaps = 54/284 (19%)

Query: 596 IGNGGHASVYRAELPSGE------VVAVKKFHSLLPCDQTVDQKEFLTEVEA-------- 641
           +G+G    VY  ++           VAVK   +L       D+ +FL E           
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVK---TLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 642 ---FYGFCSHARHSFLLYEFLERGSLAAIL----NTDAAAQELGWSQRMNVIKAVAHALS 694
                G    +   F+L E +  G L + L       +    L     ++V + +A    
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHV---ADFGIAKSLKPDSSNWTEFAGTCGYI- 750
           YL  + F   +HRDI+++N LL       V    DFG+A+ +    + +    G C  + 
Sbjct: 196 YLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KGGCAMLP 249

Query: 751 ----APE-LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQML 804
                PE        T K D +SFGVL+WE+   G  P    S       N +V L+ + 
Sbjct: 250 VKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMPYPSKS-------NQEV-LEFVT 300

Query: 805 D-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              R+  P ++    +  IM     C+   PE RP   II +++
Sbjct: 301 SGGRMDPP-KNCPGPVYRIMT---QCWQHQPEDRPNFAIILERI 340

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 97.5 bits (242), Expect = 4e-21
 Identities = 53/234 (22%), Positives = 89/234 (38%), Gaps = 22/234 (9%)

Query: 24  FSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNL 83
           F   +F      +L        +    + L+++  +   ++         + S      L
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD--------IKSVQGIQYL 64

Query: 84  RYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNL 143
             +++L +N N L+   P  + NLK L  L L  NK      L   +L  L  L L  N 
Sbjct: 65  PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNG 120

Query: 144 LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKM 203
           +  S ++ L  L  L  L L +N+ I  I    S LT + TL L  N +   I   +  +
Sbjct: 121 I--SDINGLVHLPQLESLYLGNNK-ITDIT-VLSRLTKLDTLSLEDNQI-SDIVP-LAGL 174

Query: 204 RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLL 257
             L  L L++N    +   +++ L NL  L L              NL++   +
Sbjct: 175 TKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTV 226

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.8 bits (222), Expect = 1e-18
 Identities = 51/248 (20%), Positives = 93/248 (37%), Gaps = 20/248 (8%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
               P++  L L  N     I P ++NL NL +L+L  N+     + ++SS      L+ 
Sbjct: 61  IQYLPNVTKLFLNGNKL-TDIKP-LTNLKNLGWLFLDENK-----IKDLSSLKDLKKLKS 113

Query: 86  MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS 145
              L +  N +S  I   + +L  L  L L NNK +    LS   L+ L  L L  N +S
Sbjct: 114 ---LSLEHNGISD-ING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS 166

Query: 146 GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRS 205
              +  L  L  L +L L+ N +     R  + L ++  L L   +      +    +  
Sbjct: 167 D--IVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 206 LSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTG 265
            + +           P  IS+  + ++  + ++    +   S        +  +   F G
Sbjct: 223 PNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280

Query: 266 YLPYNICR 273
            +   +  
Sbjct: 281 RVTQPLKE 288

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 89.4 bits (221), Expect = 2e-18
 Identities = 49/323 (15%), Positives = 99/323 (30%), Gaps = 45/323 (13%)

Query: 149 LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSV 208
           +             L    +   +    + L S+  +  + +D+  S+   I  + +++ 
Sbjct: 14  IFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSV-QGIQYLPNVTK 69

Query: 209 LDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYL 267
           L LN N+   + P  ++NL NL  L L  N +   +   L +L  L+ L L  N  +   
Sbjct: 70  LFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS--- 122

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF 327
             +I                       L +   L  + L  N +T +I+  L     L  
Sbjct: 123 --DI---------------------NGLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDT 157

Query: 328 IDLSRNNFYGEIS--SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVG 385
           + L  N     IS         KL  L +S N+I+    R +     L   +L     + 
Sbjct: 158 LSLEDNQ----ISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLN 211

Query: 386 EIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKL 445
           +       L     +      +            +   + +                  +
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 271

Query: 446 NLSHNNLSGSIPSCFEGMHGLSF 468
             +     G +    + ++ +S+
Sbjct: 272 GKAKARFHGRVTQPLKEVYTVSY 294

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 86.7 bits (214), Expect = 1e-17
 Identities = 59/329 (17%), Positives = 100/329 (30%), Gaps = 92/329 (27%)

Query: 158 LFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK 217
           + +        I  I  P           L +  +  ++     ++ S+  +  N +  K
Sbjct: 1   MGETITVSTP-IKQIF-PDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 218 GVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGA 276
            V    I  L N+ +L L  N L+  I P L NL  L  L L  N        ++     
Sbjct: 57  SVQG--IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-----DL----- 102

Query: 277 LEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFY 336
                           +SL++   L  + L  N ++ +I   L   P L  + L  N   
Sbjct: 103 ----------------SSLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNK-- 142

Query: 337 GEIS--SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKL 394
             I+  +   +  KL TL++  N I+                D+            L  L
Sbjct: 143 --ITDITVLSRLTKLDTLSLEDNQIS----------------DIV----------PLAGL 174

Query: 395 NPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSG 454
             L  L L  N I+                D  A+         +K+L+ L L       
Sbjct: 175 TKLQNLYLSKNHIS----------------DLRALA-------GLKNLDVLELFSQECLN 211

Query: 455 SIPSCFEGMHGLSFIDMSYNELQCPVPNS 483
              +    +   + +  +   L  P   S
Sbjct: 212 KPINHQSNLVVPNTVKNTDGSLVTPEIIS 240

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 66.7 bits (162), Expect = 2e-11
 Identities = 37/166 (22%), Positives = 59/166 (35%), Gaps = 16/166 (9%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
           S      L  L L  NG    I   + +L  L  LYLG+N+        ++  +    L 
Sbjct: 104 SLKDLKKLKSLSLEHNGI-SDING-LVHLPQLESLYLGNNK--------ITDITVLSRLT 153

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
            +  L + DN +S  +P  +  L  L  L L+ N  S    L+   L NL  L L+    
Sbjct: 154 KLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQEC 209

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN 190
               ++    L     ++  D  L    P   S+        +  +
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWH 253

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 69/294 (23%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVD--QKE--FLTE---- 638
           +D++ +  IG+G  A V  A   P  E VA+K+  +L  C  ++D   KE   +++    
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHP 73

Query: 639 -VEAFYGFCSHARHSFL----LY---EFLERGSLAAILNTDAAAQELGWSQRMN------ 684
            + ++Y        SF+    L+   + L  GS+  I+     A+    S  ++      
Sbjct: 74  NIVSYYT-------SFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIAT 125

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE-- 742
           +++ V   L YLH +     +HRD+ + N+LL  +    +ADFG++  L           
Sbjct: 126 ILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182

Query: 743 ---FAGTCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL 794
              F GT  ++APE+      Y      K D++SFG+   E+  G  P            
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGY----DFKADIWSFGITAIELATGAAPY--------HKY 230

Query: 795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFS---------CFNESPESRPT 839
                L  ML  +   PS     +   +++  +          C  + PE RPT
Sbjct: 231 PPMKVL--MLTLQNDPPSLETGVQDKEMLK-KYGKSFRKMISLCLQKDPEKRPT 281

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 56/281 (19%), Positives = 106/281 (37%), Gaps = 61/281 (21%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------A 641
            IG+GG + V++      ++ A+ K+ +L   D       +  E+               
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAI-KYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIR 92

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDC 700
            Y +    ++ +++ E      L + L    +       +R +  K +  A+  +H H  
Sbjct: 93  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG- 147

Query: 701 FPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNW--TEFAGTCGYIAPEL-- 754
              IVH D+   N L+    +  +   DFGIA  ++PD+++       GT  Y+ PE   
Sbjct: 148 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201

Query: 755 ---------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD 805
                        KI+ K DV+S G +++ +  GK P  F        +N    L  ++D
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIID 254

Query: 806 PRLPAP-----SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           P           +  Q+ ++        C    P+ R ++ 
Sbjct: 255 PNHEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIP 288

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 93.9 bits (234), Expect = 4e-21
 Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 48/273 (17%)

Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----- 640
              +     IG G   +VY A ++ +G+ VA+++    +   Q   ++  + E+      
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ----MNLQQQPKKELIINEILVMREN 74

Query: 641 ------AFYGFCSHARHSFL--LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
                  +    S+     L  + E+L  GSL  ++        +   Q   V +    A
Sbjct: 75  KNPNIVNYLD--SYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQA 128

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L +LH +    ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++AP
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGK------HPRDFLSSISSSSLNTDVALDQMLDP 806
           E+        K D++S G++  E+I+G+      +P   L  I+++             P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-----------P 234

Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPT 839
            L  P + +       +     C     E R +
Sbjct: 235 ELQNPEKLSAI-FRDFLNR---CLEMDVEKRGS 263

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 95.9 bits (238), Expect = 5e-21
 Identities = 38/292 (13%), Positives = 76/292 (26%), Gaps = 66/292 (22%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFH-SLLPCDQTVDQKE-------FLTEVEAFYGFC 646
           +G     +   A    +GE   V   + +  P    + Q +        L  ++      
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 647 SHARHS-----------------------------FLLYEFLER--GSLAAILNTDAAAQ 675
            H R                               F LY  ++    +   +L + ++  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 676 E-LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL- 733
           + L    R+ +   V   L+ LHH     +VH  +   +++LD      +  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 734 KPDSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSS 788
               S            A  +          +T   D ++ G+ ++ +     P      
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--NTDD 320

Query: 789 ISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTM 840
            +                 +P P R+    L+              E R   
Sbjct: 321 AALGGSEWIFR----SCKNIPQPVRA----LLE------GFLRYPKEDRLLP 358

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 97.1 bits (241), Expect = 6e-21
 Identities = 58/205 (28%), Positives = 81/205 (39%), Gaps = 22/205 (10%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKEF-------------LTEVE 640
           +G GG   V R     +GE VA+K+    L P ++     E                EV 
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
                 +      L  E+ E G L   LN       L       ++  ++ AL YLH + 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141

Query: 701 FPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
              I+HRD+  +N++L    +     + D G AK L         F GT  Y+APEL   
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAPELLEQ 197

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHP 782
            K T   D +SFG L +E I G  P
Sbjct: 198 KKYTVTVDYWSFGTLAFECITGFRP 222

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 93.6 bits (233), Expect = 7e-21
 Identities = 57/276 (20%), Positives = 98/276 (35%), Gaps = 47/276 (17%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFC 646
           ND +    +G+G    V++     +G V+AVK+        +  + K  L +++      
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR-RSGNKE--ENKRILMDLDVVLKSH 81

Query: 647 SH-----ARHSFL----LY---EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                     +F+    ++   E +   +            E        +  A+  AL 
Sbjct: 82  DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALY 138

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           YL       ++HRD+   N+LLD   +  + DFGI+  L  D       AG   Y+APE 
Sbjct: 139 YLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPER 195

Query: 755 AYTMKITE-----KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD---P 806
                 T+     + DV+S G+ + E+  G+ P     +           L ++L    P
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-------VLTKVLQEEPP 248

Query: 807 RLPAP---SRSAQEKLISIMEVAFSCFNESPESRPT 839
            LP     S   Q   +        C  +    RP 
Sbjct: 249 LLPGHMGFSGDFQS-FVK------DCLTKDHRKRPK 277

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 93.5 bits (233), Expect = 7e-21
 Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 63/289 (21%)

Query: 596 IGNGGHASVYRAELPSGEV---VAVKKFHSLLPCDQTVDQKEFLTEVE------------ 640
           IG G    V +A +    +    A+K    +       D ++F  E+E            
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIK---RMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 641 AFYGFCSHARHSFLLYEFLERGSL-------------AAILNTDAAAQELGWSQRMNVIK 687
              G C H  + +L  E+   G+L              A    ++ A  L   Q ++   
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
            VA  + YL    F   +HRD++++N+L+   Y A +ADFG+++        +     T 
Sbjct: 150 DVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSR----GQEVYV--KKTM 200

Query: 748 GYI-----APE-LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVAL 800
           G +     A E L Y+   T   DV+S+GVL+WE++  G  P   ++         ++  
Sbjct: 201 GRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELY- 251

Query: 801 DQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            + L    RL  P  +  +++  +M     C+ E P  RP+   I   L
Sbjct: 252 -EKLPQGYRLEKP-LNCDDEVYDLM---RQCWREKPYERPSFAQILVSL 295

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 56/281 (19%), Positives = 106/281 (37%), Gaps = 61/281 (21%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------A 641
            IG+GG + V++      ++ A+ K+ +L   D       +  E+               
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAI-KYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIR 73

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDC 700
            Y +    ++ +++ E      L + L    +       +R +  K +  A+  +H H  
Sbjct: 74  LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG- 128

Query: 701 FPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNW--TEFAGTCGYIAPEL-- 754
              IVH D+   N L+    +  +   DFGIA  ++PD+++       GT  Y+ PE   
Sbjct: 129 ---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 182

Query: 755 ---------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD 805
                        KI+ K DV+S G +++ +  GK P  F        +N    L  ++D
Sbjct: 183 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIID 235

Query: 806 PRLPAP-----SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           P           +  Q+ ++        C    P+ R ++ 
Sbjct: 236 PNHEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIP 269

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 60/290 (20%)

Query: 596 IGNGGHASVYRAELPSGE------VVAVKKFHSLLPCDQTVDQKEFLTEVEA-------- 641
           +G G    V+ AE  +        +VAVK     L       +++F  E E         
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKA----LKEASESARQDFQREAELLTMLQHQH 104

Query: 642 ---FYGFCSHARHSFLLYEFLERGSLAAIL------------NTDAAAQELGWSQRMNVI 686
              F+G C+  R   +++E++  G L   L              D A   LG  Q + V 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT 746
             VA  + YL    F   VHRD++++N L+       + DFG+++ +   S+++    G 
Sbjct: 165 SQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYR-VGG 218

Query: 747 CGYI-----APE-LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVA 799
              +      PE + Y  K T + DV+SFGV++WE+   GK P   LS       NT+  
Sbjct: 219 RTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWEIFTYGKQPWYQLS-------NTEA- 269

Query: 800 LDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           +D +     L  P R+   ++ +IM     C+   P+ R ++K +  +L+
Sbjct: 270 IDCITQGRELERP-RACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQ 315

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 66/279 (23%), Positives = 109/279 (39%), Gaps = 48/279 (17%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
            D      IG G + SV +    PSG+++AVK+  S +      +QK+ L +++      
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK---EQKQLLMDLDVVMRSS 78

Query: 642 -------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRM--NVIKAVAHA 692
                  FYG        ++  E +   S         +  +    + +   +  A   A
Sbjct: 79  DCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L++L  +    I+HRDI   N+LLD      + DFGI+  L  DS   T  AG   Y+AP
Sbjct: 138 LNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAP 194

Query: 753 E----LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD--- 805
           E     A       + DV+S G+ ++E+  G+ P    +S+          L Q++    
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-------QLTQVVKGDP 247

Query: 806 PRLPAP-----SRSAQEKLISIMEVAFSCFNESPESRPT 839
           P+L        S S     ++       C  +    RP 
Sbjct: 248 PQLSNSEEREFSPSFIN-FVN------LCLTKDESKRPK 279

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 59/284 (20%), Positives = 111/284 (39%), Gaps = 52/284 (18%)

Query: 596 IGNGGHASVYRAELPSGE------VVAVKKFHSLLPCDQTVDQKEFLTEVEA-------- 641
           +G G    VY               VA+K   ++       ++ EFL E           
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIK---TVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 642 ---FYGFCSHARHSFLLYEFLERGSLAAIL-------NTDAAAQELGWSQRMNVIKAVAH 691
                G  S  + + ++ E + RG L + L         +        S+ + +   +A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI- 750
            ++YL+ + F   VHRD++++N ++  ++   + DFG+ + +           G  G + 
Sbjct: 150 GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD---YYRKGGKGLLP 203

Query: 751 ----APELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLD 805
               +PE       T   DV+SFGV++WE+    + P   LS       N  V L  +++
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQV-LRFVME 255

Query: 806 -PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
              L  P  +  + L  +M     C+  +P+ RP+   I   ++
Sbjct: 256 GGLLDKP-DNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 295

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 93.0 bits (231), Expect = 2e-20
 Identities = 55/279 (19%), Positives = 106/279 (37%), Gaps = 57/279 (20%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------A 641
            IG+GG + V++      ++ A+ K+ +L   D       +  E+               
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAI-KYVNLEEADNQ-TLDSYRNEIAYLNKLQQHSDKIIR 120

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDC 700
            Y +    ++ +++ E      L + L    +       +R +  K +  A+  +H H  
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG- 175

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE--FAGTCGYIAPEL---- 754
              IVH D+   N L+  +    + DFGIA  ++PD+++  +    G   Y+ PE     
Sbjct: 176 ---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 755 -------AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR 807
                      KI+ K DV+S G +++ +  GK P  F        +N    L  ++DP 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIIDPN 284

Query: 808 LPAP-----SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                     +  Q+ ++        C    P+ R ++ 
Sbjct: 285 HEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIP 316

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 94.9 bits (236), Expect = 3e-20
 Identities = 64/276 (23%), Positives = 106/276 (38%), Gaps = 49/276 (17%)

Query: 596 IGNGGHASVYRAEL--PSGEV--VAVKKFHSLLPCDQTVDQKEFLTEVEA---------- 641
           IG G    V++     P      VA+K   +   C     +++FL E             
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIK---TCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 642 -FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
              G  +     +++ E    G L + L        L  +  +     ++ AL+YL    
Sbjct: 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR 511

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-----APELA 755
           F   VHRDI+++N+L+       + DFG+++ ++  +     +  + G +     APE  
Sbjct: 512 F---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIKWMAPESI 564

Query: 756 YTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPAPS 812
              + T   DV+ FGV MWE++  G  P   +        N DV     ++   RLP P 
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVI--GRIENGERLPMPP 615

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                 L S+M     C+   P  RP    +  QL 
Sbjct: 616 NCPPT-LYSLMT---KCWAYDPSRRPRFTELKAQLS 647

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 73/291 (25%), Positives = 123/291 (42%), Gaps = 61/291 (20%)

Query: 596 IGNGGHASVYRAELPSGE------VVAVKKFHSLLPCDQTVDQKEFLTEVE--------- 640
           +G G    V+ AE  +        +VAVK   +L        +K+F  E E         
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVK---ALKDPTLA-ARKDFQREAELLTNLQHEH 78

Query: 641 --AFYGFCSHARHSFLLYEFLERGSL-------------AAILNTDAAAQELGWSQRMNV 685
              FYG C       +++E+++ G L                     A  ELG SQ +++
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 686 IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG 745
              +A  + YL    F   VHRD++++N L+       + DFG+++ +   S+++    G
Sbjct: 139 ASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYR-VG 192

Query: 746 TCGYI-----APE-LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDV 798
               +      PE + Y  K T + DV+SFGV++WE+   GK P   LS       NT+V
Sbjct: 193 GHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTEV 244

Query: 799 ALDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            ++ +     L  P R   +++  +M     C+   P+ R  +K I + L 
Sbjct: 245 -IECITQGRVLERP-RVCPKEVYDVML---GCWQREPQQRLNIKEIYKILH 290

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 92.9 bits (231), Expect = 4e-20
 Identities = 60/306 (19%), Positives = 111/306 (36%), Gaps = 63/306 (20%)

Query: 581 DEIVKATNDFDAKYC----IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFL 636
             I                +G G   +V       G  VAVK+   L+            
Sbjct: 4   ANIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM--LIDFCDIALM---- 57

Query: 637 TEVEA------------FYGFCSHARHSFLLYEFLERGSLAAIL----NTDAAAQELGWS 680
            E++             +Y   +  R  ++  E     +L  ++     +D   +     
Sbjct: 58  -EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEY 115

Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH-------------VADF 727
             +++++ +A  +++LH      I+HRD+  +N+L+                    ++DF
Sbjct: 116 NPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172

Query: 728 GIAKSLKPDSSNWT----EFAGTCGYIAPEL-------AYTMKITEKCDVYSFGVLMWEV 776
           G+ K L    S++       +GT G+ APEL           ++T   D++S G + + +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232

Query: 777 I-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPE 835
           + KGKHP     S  S+ +    +LD+M      +    A + LIS         +  P 
Sbjct: 233 LSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPL 285

Query: 836 SRPTMK 841
            RPT  
Sbjct: 286 KRPTAM 291

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 66/283 (23%), Positives = 109/283 (38%), Gaps = 52/283 (18%)

Query: 596 IGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE----------- 640
           +G G   SV    L   +     VAVK         +  + +EFL+E             
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQR--EIEEFLSEAACMKDFSHPNVI 99

Query: 641 AFYGFCS-----HARHSFLLYEFLERGSLAAIL---NTDAAAQELGWSQRMNVIKAVAHA 692
              G C            ++  F++ G L   L     +   + +     +  +  +A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI-- 750
           + YL +  F   +HRD++++N +L  +    VADFG++K +   S ++    G    +  
Sbjct: 160 MEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYR-QGRIAKMPV 213

Query: 751 ---APELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDP 806
              A E       T K DV++FGV MWE+  +G  P   +        N ++     L  
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-------NHEMY--DYLLH 264

Query: 807 --RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
             RL  P     ++L  IM    SC+   P  RPT  ++  QL
Sbjct: 265 GHRLKQP-EDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 91.5 bits (227), Expect = 9e-20
 Identities = 48/298 (16%), Positives = 95/298 (31%), Gaps = 46/298 (15%)

Query: 587 TNDFDAKYCIGNGGH--ASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY 643
              ++    IG G     +V  A   P+GE V V++       +      E +T ++   
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI------NLEACSNEMVTFLQGEL 77

Query: 644 GFCSHARH--------SFL----LY---EFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
                  H        +F+    L+    F+  GS   ++ T      +       +++ 
Sbjct: 78  HVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYILQG 136

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL-------KPDSSNWT 741
           V  AL Y+HH      VHR + + ++L+ ++ + +++      S+       +       
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 742 EFAGTCGYIAPELAYTMKI--TEKCDVYSFGVLMWEVIKGK------HPRDFLSSISSS- 792
                  +++PE+          K D+YS G+   E+  G            L    +  
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253

Query: 793 --SLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
              L     +        P+ S +      S+        N    S P  +  S    
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 89.6 bits (223), Expect = 9e-20
 Identities = 63/278 (22%), Positives = 115/278 (41%), Gaps = 50/278 (17%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           +D +    +G G +  V +   +PSG+++AVK+  + +    + +QK  L +++      
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV---NSQEQKRLLMDLDISMRTV 63

Query: 642 -------FYGFCSHARHSFLLYEFLERGSLAAIL-NTDAAAQELGWSQRMNVIKAVAHAL 693
                  FYG        ++  E ++  SL           Q +       +  ++  AL
Sbjct: 64  DCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            +LH      ++HRD+   N+L++   +  + DFGI+  L  D       AG   Y+APE
Sbjct: 123 EHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPE 179

Query: 754 --------LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD 805
                     Y++    K D++S G+ M E+   + P D   +           L Q+++
Sbjct: 180 RINPELNQKGYSV----KSDIWSLGITMIELAILRFPYDSWGTPFQ-------QLKQVVE 228

Query: 806 ---PRLPAPSRSAQ-EKLISIMEVAFSCFNESPESRPT 839
              P+LPA   SA+     S       C  ++ + RPT
Sbjct: 229 EPSPQLPADKFSAEFVDFTS------QCLKKNSKERPT 260

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 35/214 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKEF-------------LTEVE 640
           +G G  A+V+R     +G++ A+K F+         V  +EF             L  +E
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
                 +  RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  + 
Sbjct: 77  ----EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132

Query: 701 FPPIVHRDISSKNLLLDLEYEAH----VADFGIAKSLKPDSSNWTEFAGTCGYIAPEL-- 754
              IVHR+I   N++  +  +      + DFG A+ L+ D   +    GT  Y+ P++  
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYE 188

Query: 755 ------AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                  +  K     D++S GV  +    G  P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 30/160 (18%), Positives = 66/160 (41%), Gaps = 9/160 (5%)

Query: 106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND 165
             K      L  +  +    ++   +++L ++ L    ++   L+ +    ++ DL +N+
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD--LTGIEYAHNIKDLTINN 75

Query: 166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSIS 225
                Y   P S L+++  LR+   D+       +  + SL++LD++ +     +   I+
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 226 NLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFT 264
            L  +  + L YN     I P L  L  L+ L +  +   
Sbjct: 134 TLPKVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH 172

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 33/213 (15%), Positives = 64/213 (30%), Gaps = 37/213 (17%)

Query: 30  PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRL 89
                      G   T     + +++L Y+ L +          V+  +       +  L
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANIN--------VTDLTGIEYAHNIKDL 71

Query: 90  VINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSIL 149
            IN+   + + P  I  L  L +L +     +     +   L++L  L +  +    SIL
Sbjct: 72  TINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL 129

Query: 150 SSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVL 209
           + +  L  +  + L+ N  I  I  P   L                          L  L
Sbjct: 130 TKINTLPKVNSIDLSYNGAITDIM-PLKTLP------------------------ELKSL 164

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSG 242
           ++  +         I +   L +L      + G
Sbjct: 165 NIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 38/207 (18%), Positives = 78/207 (37%), Gaps = 19/207 (9%)

Query: 275 GALEIFTVSENHFQGTIP-TSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRN 333
           GA E   +  +     IP ++ +   + +     G + T NI+EA     +LT+I L+  
Sbjct: 1   GAAEQTGLKASQDNVNIPDSTFKAYLNGL----LGQSSTANITEAQ--MNSLTYITLANI 54

Query: 334 NFYGEIS--SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL 391
           N    ++  +       +  L ++  + T   P  I   S L+   +    +  +    L
Sbjct: 55  N----VTDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNL 108

Query: 392 GKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGEL--PSQICNMKSLEKLNLSH 449
             L  LT L +  +     +  +I +L K+  +D S  G +     +  +  L+ LN+  
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQF 168

Query: 450 NNLSGSIPSCFEGMHGLSFIDMSYNEL 476
           + +        E    L+ +      +
Sbjct: 169 DGVHDYRG--IEDFPKLNQLYAFSQTI 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 74.2 bits (183), Expect = 3e-15
 Identities = 25/163 (15%), Positives = 58/163 (35%), Gaps = 14/163 (8%)

Query: 297 NCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS--SNWGKFPKLGTLNV 354
              SL  + L   N+T ++   +    N+  + ++  +     +  +       L  L +
Sbjct: 42  QMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH----ATNYNPISGLSNLERLRI 95

Query: 355 SMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGN-QITGRLPK 413
              ++T      +   + L   D+S +     I  ++  L  +  + L  N  IT     
Sbjct: 96  MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD--IM 153

Query: 414 EIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSG 454
            + +L +L+ L+     + +    I +   L +L      + G
Sbjct: 154 PLKTLPELKSLNIQFDGVHDY-RGIEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 21/121 (17%), Positives = 45/121 (37%), Gaps = 9/121 (7%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
            S   +L  L +          P +S L++L  L +  +    +IL +++       L  
Sbjct: 84  ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN------TLPK 137

Query: 86  MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS 145
           ++ + ++ N     I P +  L  L  L++  +       +   +   L  LY +   + 
Sbjct: 138 VNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIG 194

Query: 146 G 146
           G
Sbjct: 195 G 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 9/98 (9%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
           + S    L  LD++ +    +I  +I+ L  +  + L  N    +I            L 
Sbjct: 107 NLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-------MPLKTLP 159

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG 122
            +  L I  + +  +    I +   L+QL   +    G
Sbjct: 160 ELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 63/300 (21%), Positives = 105/300 (35%), Gaps = 70/300 (23%)

Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA---- 641
            +DF+    +G G    V +A         A+KK    +   +       L+EV      
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKK----IRHTE-EKLSTILSEVMLLASL 59

Query: 642 -------FYGFCSHARHSFL----------LY---EFLERGSLA-AILNTDAAAQELGWS 680
                  +Y      R+             L+   E+ E G+L   I + +   Q     
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR---D 116

Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
           +   + + +  ALSY+H      I+HRD+   N+ +D      + DFG+AK++       
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 741 --------------TEFAGTCGYIAPE-LAYTMKITEKCDVYSFGVLMWEVIK----GKH 781
                         T   GT  Y+A E L  T    EK D+YS G++ +E+I     G  
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGME 233

Query: 782 PRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
             + L  + S S+           P         ++K+I          +  P  RP  +
Sbjct: 234 RVNILKKLRSVSIE--------FPPDFDDNKMKVEKKIIR------LLIDHDPNKRPGAR 279

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 49/282 (17%)

Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
              F+    +GNG +  VY+   + +G++ A+K     +      +++E   E+     +
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKV----MDVTGD-EEEEIKQEINMLKKY 77

Query: 646 CSHA-----RHSFLLY-------------EFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
             H        +F+               EF   GS+  ++        L       + +
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICR 136

Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTC 747
            +   LS+LH      ++HRDI  +N+LL    E  + DFG++  L         F GT 
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTP 193

Query: 748 GYIAPELAYTMKITE-----KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ 802
            ++APE+    +  +     K D++S G+   E+ +G  P           ++   AL  
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--------CDMHPMRALFL 245

Query: 803 MLDPRLPAPSRSAQE---KLISIMEVAFSCFNESPESRPTMK 841
           +  PR PAP   +++   K  S +E    C  ++   RP  +
Sbjct: 246 I--PRNPAPRLKSKKWSKKFQSFIES---CLVKNHSQRPATE 282

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 60/282 (21%), Positives = 119/282 (42%), Gaps = 42/282 (14%)

Query: 580 YDEIVKATN---DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           Y+ + +  +    ++    +G+G    VY+A    +G + A K     +      + +++
Sbjct: 8   YEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKV----IETKSEEELEDY 63

Query: 636 LTEVE-----------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
           + E+E              G   H    +++ EF   G++ AI+      + L   Q   
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQV 121

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
           V + +  AL++LH      I+HRD+ + N+L+ LE +  +ADFG++            F 
Sbjct: 122 VCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178

Query: 745 GTCGYIAPELAYTMKITE-----KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA 799
           GT  ++APE+     + +     K D++S G+ + E+ + + P           LN    
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH--------HELNPMRV 230

Query: 800 LDQMLDPRLPAPSRSAQEKLISIMEVAF--SCFNESPESRPT 839
           L  +   +   P+     K  S+    F     +++PE+RP+
Sbjct: 231 L--LKIAKSDPPTLLTPSKW-SVEFRDFLKIALDKNPETRPS 269

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.5 bits (222), Expect = 3e-19
 Identities = 49/241 (20%), Positives = 84/241 (34%), Gaps = 21/241 (8%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
             +   L          I     S   +L  + +  N     I A+V S     NL  + 
Sbjct: 29  PRNAIELRFVLTKL-RVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFS-----NLPKLH 82

Query: 88  RLVI-NDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNL-- 143
            + I   N+L  +I P    NL  L  L ++N        +   +    + L +  N+  
Sbjct: 83  EIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141

Query: 144 --LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI- 200
             +  +    L        L LN N  I  I     N T +  L LS N+    +P+++ 
Sbjct: 142 HTIERNSFVGLSFE--SVILWLNKNG-IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198

Query: 201 GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSG 260
                  +LD+++ +    LP     L NLK+L     +    +P     + L +  L+ 
Sbjct: 199 HGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLKKLPTLEKLVALMEASLTY 255

Query: 261 N 261
            
Sbjct: 256 P 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 88.0 bits (218), Expect = 8e-19
 Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 20/226 (8%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            +   +FS F  L  ++++ N     I   + SNL  L  + +       N L  ++ E+
Sbjct: 44  VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA----NNLLYINPEA 99

Query: 79  SGG--NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP-LSFDNLS-NL 134
                NL+Y   L+I++  +      H  +      LD+ +N     I   SF  LS   
Sbjct: 100 FQNLPNLQY---LLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 156

Query: 135 IFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRP-FSNLTSVSTLRLSRNDLF 193
           + L+L  N +   I +S      L +L L+DN  +  +P   F   +    L +SR  + 
Sbjct: 157 VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI- 214

Query: 194 GSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN 238
            S+P      ++ L        +      P++  L  L E +L Y 
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLK----KLPTLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.0 bits (205), Expect = 4e-17
 Identities = 44/277 (15%), Positives = 100/277 (36%), Gaps = 37/277 (13%)

Query: 181 SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
           S        + +   IP ++   R+   L     + + +   + S   +L+++ +  N +
Sbjct: 10  SNRVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 241 SGSIPPS-LGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNC 298
              I      NL  L ++ +                          N+     P + +N 
Sbjct: 67  LEVIEADVFSNLPKLHEIRIEKA-----------------------NNLLYINPEAFQNL 103

Query: 299 TSLIRVRLNGNNLTGNISEALGIY-PNLTFIDLSRNNFYGEISSNW--GKFPKLGTLNVS 355
            +L  + ++   +  ++ +   I+      +D+  N     I  N   G   +   L ++
Sbjct: 104 PNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162

Query: 356 MNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKE 414
            N I   +     N +QL   +LS N+ + E+P +     +    L +   +I   LP  
Sbjct: 163 KNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSY 220

Query: 415 I-GSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHN 450
              +L KL       + +LP+ +  + +L + +L++ 
Sbjct: 221 GLENLKKLRARSTYNLKKLPT-LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 11/196 (5%)

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN-WGKFPK 348
            IP+ L    + I +R     L      A   + +L  I++S+N+    I ++ +   PK
Sbjct: 23  EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 349 LGTLNVS-MNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL-GKLNPLTKLILRGNQ 406
           L  + +   NN+    P    N   LQ   +S   I   +P            L ++ N 
Sbjct: 81  LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139

Query: 407 ITGRLPKE----IGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPS-CFE 461
               + +     +   + + +L+ + I E+ +   N   L++LNLS NN    +P+  F 
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFH 199

Query: 462 GMHGLSFIDMSYNELQ 477
           G  G   +D+S   + 
Sbjct: 200 GASGPVILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 61.0 bits (148), Expect = 6e-10
 Identities = 42/231 (18%), Positives = 78/231 (33%), Gaps = 14/231 (6%)

Query: 254 RQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG 313
           R  L   +  T  +P ++ R              +     +      L ++ ++ N++  
Sbjct: 12  RVFLCQESKVT-EIPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68

Query: 314 NI-SEALGIYPNLTFIDLSRNNFYGEISSNW-GKFPKLGTLNVSMNNITGGLPREIGNSS 371
            I ++     P L  I + + N    I+       P L  L +S   I         +S 
Sbjct: 69  VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128

Query: 372 QLQAFDLSLNHIVGEIPKEL--GKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA- 428
           Q    D+  N  +  I +    G       L L  N I   +     + T+L+ L+ S  
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187

Query: 429 --IGELPSQIC-NMKSLEKLNLSHNNLSGSIPS-CFEGMHGLSFIDMSYNE 475
             + ELP+ +         L++S   +  S+PS   E +  L        +
Sbjct: 188 NNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK 237

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 33/204 (16%), Positives = 60/204 (29%), Gaps = 15/204 (7%)

Query: 296 RNCT-SLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN-WGKFPKLGTLN 353
           R C  S        + +T        +  N   +          I    +  F  L  + 
Sbjct: 5   RICHCSNRVFLCQESKVT---EIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIE 60

Query: 354 VSMNNITGGLPREI-GNSSQLQAFDLS-LNHIVGEIPKELGKLNPLTKLILRGNQITGRL 411
           +S N++   +  ++  N  +L    +   N+++   P+    L  L  L++    I    
Sbjct: 61  ISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLP 120

Query: 412 PKEIGSLTKLEYLDFSA---IGELPSQ-ICNMKS-LEKLNLSHNNLSGSIPSCFEGMHGL 466
                   +   LD      I  +       +      L L+ N +     S F G    
Sbjct: 121 DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLD 180

Query: 467 SFIDMSYNELQCPVPNSTTFRGAS 490
                  N L+    +   F GAS
Sbjct: 181 ELNLSDNNNLEELPND--VFHGAS 202

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 88.9 bits (221), Expect = 3e-19
 Identities = 63/284 (22%), Positives = 109/284 (38%), Gaps = 53/284 (18%)

Query: 596 IGNGGHASVYRAELPSGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE----------- 640
           +G G   SV  A+L   +     VAVK   + +      D +EFL E             
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS--DIEEFLREAACMKEFDHPHVA 88

Query: 641 AFYGFCS------HARHSFLLYEFLERGSLAAIL---NTDAAAQELGWSQRMNVIKAVAH 691
              G               ++  F++ G L A L           L     +  +  +A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI- 750
            + YL    F   +HRD++++N +L  +    VADFG+++ +   S ++    G    + 
Sbjct: 149 GMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYR-QGCASKLP 202

Query: 751 ----APELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLD 805
               A E       T   DV++FGV MWE++ +G+ P   +        N ++     L 
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-------NAEIY--NYLI 253

Query: 806 P--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
              RL  P     E++  +M     C++  P+ RP+   +  +L
Sbjct: 254 GGNRLKQP-PECMEEVYDLMY---QCWSADPKQRPSFTCLRMEL 293

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 88.4 bits (219), Expect = 5e-19
 Identities = 36/223 (16%), Positives = 82/223 (36%), Gaps = 45/223 (20%)

Query: 645 FCSHARHSFLLY---EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
               +     LY   +   + +L   +N   + ++      +++   +A A+ +LH    
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG- 184

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS------------NWTEFAGTCGY 749
             ++HRD+   N+   ++    V DFG+  ++  D                T   GT  Y
Sbjct: 185 --LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD---- 805
           ++PE  +    + K D++S G++++E++   +             +T +   +++     
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELL---YS-----------FSTQMERVRIITDVRN 288

Query: 806 ---PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
              P L       +  ++          + SP  RP    I +
Sbjct: 289 LKFPLLFTQKYPQEHMMVQ------DMLSPSPTERPEATDIIE 325

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 89.1 bits (221), Expect = 5e-19
 Identities = 58/296 (19%), Positives = 108/296 (36%), Gaps = 64/296 (21%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKEF-------------LTEVE 640
           +G G  A+V+R     +G++ A+K F+         V  +EF             L  +E
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76

Query: 641 AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
                 +  RH  L+ EF   GSL  +L   + A  L  S+ + V++ V   +++L  + 
Sbjct: 77  ----EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132

Query: 701 FPPIVHRDISSKNLLLDLEYEAH----VADFGIAKSLKPDSSNWTEFAGTCGYIAPEL-- 754
              IVHR+I   N++  +  +      + DFG A+ L+ D   +    GT  Y+ P++  
Sbjct: 133 ---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYE 188

Query: 755 ------AYTMKITEKCDVYSFGV-----------------------LMWEVIKGKHPRDF 785
                  +  K     D++S GV                       +M+++I GK     
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAI 248

Query: 786 LSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                + +   D + D  +   L    +     +++ +           E      
Sbjct: 249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI------LEADQEKCWGFD 298

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 44/190 (23%), Positives = 68/190 (35%), Gaps = 18/190 (9%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS 87
                 L L+ N    T         + L  L L   +        ++     G L  + 
Sbjct: 30  PKDTTILHLSENLL-YTFSLATLMPYTRLTQLNLDRAE--------LTKLQVDGTLPVLG 80

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS-- 145
            L ++ N L   +P     L  L+ LD++ N+ +     +   L  L  LYL GN L   
Sbjct: 81  TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139

Query: 146 -GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR 204
              +L+   KL+ L    L +N L        + L ++ TL L  N L  +IP       
Sbjct: 140 PPGLLTPTPKLEKLS---LANNNLTELPAGLLNGLENLDTLLLQENSL-YTIPKGFFGSH 195

Query: 205 SLSVLDLNQN 214
            L    L+ N
Sbjct: 196 LLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 84.4 bits (209), Expect = 5e-18
 Identities = 54/179 (30%), Positives = 78/179 (43%), Gaps = 15/179 (8%)

Query: 137 LYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSI 196
           L+L  NLL    L++L     L  L L+  +L   +      L  + TL LS N L  S+
Sbjct: 36  LHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQ-VDGTLPVLGTLDLSHNQL-QSL 92

Query: 197 PDEIGKMRSLSVLDLNQNQFKGVLPPSI-SNLTNLKELALLYNHLSGSIPP----SLGNL 251
           P     + +L+VLD++ N+    LP      L  L+EL L  N L  ++PP         
Sbjct: 93  PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPK- 149

Query: 252 ILRQLLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGN 309
            L +L L+ N+ T  LP  +  G   L+   + EN    TIP        L    L+GN
Sbjct: 150 -LEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 43/253 (16%), Positives = 85/253 (33%), Gaps = 58/253 (22%)

Query: 175 PFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA 234
             S + S   +   + +L  ++P ++   +  ++L L++N        ++   T L +L 
Sbjct: 5   EVSKVASHLEVNCDKRNL-TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 235 LLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTS 294
           L    L+  +       +L  L LS N                            ++P  
Sbjct: 62  LDRAELT-KLQVDGTLPVLGTLDLSHNQLQ-------------------------SLPLL 95

Query: 295 LRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNV 354
            +   +L  + ++ N LT                 L      G          +L  L +
Sbjct: 96  GQTLPALTVLDVSFNRLT----------------SLPLGALRG--------LGELQELYL 131

Query: 355 SMNNITGGLPREI-GNSSQLQAFDLSLNHIVGEIPKEL-GKLNPLTKLILRGNQITGRLP 412
             N +   LP  +   + +L+   L+ N++  E+P  L   L  L  L+L+ N +   +P
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 413 KEIGSLTKLEYLD 425
           K       L +  
Sbjct: 189 KGFFGSHLLPFAF 201

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 48/189 (25%), Positives = 78/189 (41%), Gaps = 13/189 (6%)

Query: 294 SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLN 353
            +    S + V  +  NLT   +    +  + T + LS N  Y    +    + +L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT---ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 354 VSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPK 413
           +    +T  L    G    L   DLS N +   +P     L  LT L +  N++T  LP 
Sbjct: 62  LDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL 117

Query: 414 EI-GSLTKLEYLDFS--AIGELPSQIC-NMKSLEKLNLSHNNLSGSIPS-CFEGMHGLSF 468
                L +L+ L      +  LP  +      LEKL+L++NNL+  +P+    G+  L  
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDT 176

Query: 469 IDMSYNELQ 477
           + +  N L 
Sbjct: 177 LLLQENSLY 185

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 87.7 bits (218), Expect = 7e-19
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 33/206 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTEVE-----------AF 642
           +G GG A  +   +  + EV A K    SLL      ++     E+             F
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 106

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA------VAHALSYL 696
           +GF       F++ E   R SL  +             + +   +A      +     YL
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKR---------RKALTEPEARYYLRQIVLGCQYL 157

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  YIAPE+  
Sbjct: 158 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHP 782
               + + DV+S G +M+ ++ GK P
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 86.5 bits (215), Expect = 8e-19
 Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 31/212 (14%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVK-----KFHSLLPCDQTVDQKEFLTEVE- 640
            DF+    +G G   +VY A E  S  ++A+K     +        Q   + E  + +  
Sbjct: 9   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 641 ----AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA------VA 690
                 YG+   A   +L+ E+   G++   L             + +  +       +A
Sbjct: 69  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK---------LSKFDEQRTATYITELA 119

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
           +ALSY H      ++HRDI  +NLLL    E  +ADFG +    P S       GT  Y+
Sbjct: 120 NALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTD-LCGTLDYL 174

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            PE+       EK D++S GVL +E + GK P
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 87.7 bits (218), Expect = 9e-19
 Identities = 62/300 (20%), Positives = 108/300 (36%), Gaps = 80/300 (26%)

Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE--------- 640
           +G G    V  A         +   VAVK    L       +++  ++E++         
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 641 ---AFYGFCSHARHSFLLYEFLERGSLAAIL-----------NTDAAAQELGWSQRMNVI 686
                 G C+H     ++ E+   G L   L               A         ++  
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS-----SN-- 739
             VA  +++L        +HRD++++N+LL   + A + DFG+A+ +  DS      N  
Sbjct: 171 SQVAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227

Query: 740 ----WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHP-------RDFLS 787
               W          APE  +    T + DV+S+G+L+WE+   G +P         F  
Sbjct: 228 LPVKWM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK 278

Query: 788 SISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +                 ++  P   A + + SIM+   +C+   P  RPT + I   L
Sbjct: 279 LVKDGY-------------QMAQP-AFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFL 321

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 51/206 (24%), Positives = 84/206 (40%), Gaps = 33/206 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVK-KFHSLLPCDQTVDQKEFLTEVE-----------AF 642
           +G GG A  +   +  + EV A K    SLL      ++     E+             F
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK--MSMEISIHRSLAHQHVVGF 80

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA------VAHALSYL 696
           +GF       F++ E   R SL  +             + +   +A      +     YL
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKR---------RKALTEPEARYYLRQIVLGCQYL 131

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY 756
           H +    ++HRD+   NL L+ + E  + DFG+A  ++ D        GT  YIAPE+  
Sbjct: 132 HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

Query: 757 TMKITEKCDVYSFGVLMWEVIKGKHP 782
               + + DV+S G +M+ ++ GK P
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPP 214

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 49/224 (21%), Positives = 86/224 (38%), Gaps = 49/224 (21%)

Query: 585 KATNDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVK-----KFHSLLPCDQTVDQKE 634
            +T+ F   Y     +G G  + V R    P+ +  AVK        S    +    ++ 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 635 FLTEVE------------AFYGFCSHARHSFLLYEFLERGSL-AAILNT------DAAAQ 675
            L EV+                        FL+++ +++G L   +         +    
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127

Query: 676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
                    +++A+   +  LH      IVHRD+  +N+LLD +    + DFG +  L P
Sbjct: 128 --------KIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176

Query: 736 DSSNWTEFAGTCGYIAPE-LAYTMKI-----TEKCDVYSFGVLM 773
                 E  GT  Y+APE +  +M        ++ D++S GV+M
Sbjct: 177 GEK-LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 58/292 (19%), Positives = 114/292 (39%), Gaps = 62/292 (21%)

Query: 596 IGNGGHASVYRAELPSGE------VVAVKKFHSLLPCDQTVDQKEFLTEVE--------- 640
           +G      VY+  L           VA+K   +L    +   ++EF  E           
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIK---TLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 641 --AFYGFCSHARHSFLLYEFLERGSL-------------AAILNTDAAAQELGWSQRMNV 685
                G  +  +   +++ +   G L              +  +       L     +++
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 686 IKAVAHALSYL--HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF 743
           +  +A  + YL  HH     +VH+D++++N+L+  +    ++D G+ + +   ++++ + 
Sbjct: 134 VAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYK- 185

Query: 744 AGTCGYI-----APELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTD 797
                 +     APE     K +   D++S+GV++WEV   G  P    S       N D
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-------NQD 238

Query: 798 VALDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           V ++ + +   LP P       + ++M     C+NE P  RP  K I  +LR
Sbjct: 239 V-VEMIRNRQVLPCP-DDCPAWVYALMI---ECWNEFPSRRPRFKDIHSRLR 285

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 52/221 (23%), Positives = 85/221 (38%), Gaps = 21/221 (9%)

Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
               +      L            V+   +   L  + +++ N++ +       I  L  
Sbjct: 20  DDAFAETIKDNLKKKS--------VTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPN 69

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
           +++L L  NK +   PL+  NL NL +L+L  N +    LSSL  LK L  L L  N  I
Sbjct: 70  VTKLFLNGNKLTDIKPLA--NLKNLGWLFLDENKV--KDLSSLKDLKKLKSLSLEHNG-I 124

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
             I     +L  + +L L  N +  +    + ++  L  L L  NQ   +    ++ LT 
Sbjct: 125 SDIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTK 179

Query: 230 LKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYN 270
           L+ L L  NH+S  +    G   L  L L           +
Sbjct: 180 LQNLYLSKNHIS-DLRALAGLKNLDVLELFSQECLNKPINH 219

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 84.3 bits (209), Expect = 6e-18
 Identities = 57/283 (20%), Positives = 97/283 (34%), Gaps = 46/283 (16%)

Query: 175 PFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA 234
                       L +  +  ++     ++ S+  +  N +  K V    I  L N+ +L 
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLF 74

Query: 235 LLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPT 293
           L  N L+  I P L NL  L  L L  N        ++                     +
Sbjct: 75  LNGNKLT-DIKP-LANLKNLGWLFLDENKVK-----DL---------------------S 106

Query: 294 SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS--SNWGKFPKLGT 351
           SL++   L  + L  N ++ +I   L   P L  + L  N     I+  +   +  KL T
Sbjct: 107 SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNK----ITDITVLSRLTKLDT 160

Query: 352 LNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRL 411
           L++  N I+      +   ++LQ   LS NHI     + L  L  L  L L   +   + 
Sbjct: 161 LSLEDNQISD--IVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKP 216

Query: 412 PKEIGSLTKLEYL-DFSAIGELPSQICNMKSLEKLNLSHNNLS 453
                +L     + +       P  I +    EK N+  +   
Sbjct: 217 INHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 20/227 (8%)

Query: 14  NIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAE 73
           N+         + +    +  +    +    ++   I  L N+  L+L  N+        
Sbjct: 30  NLKKKSVTDAVTQNELNSIDQIIANNSDI-KSVQG-IQYLPNVTKLFLNGNK-------- 79

Query: 74  VSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSN 133
           ++      NL+ +  L +++N +       + +LK L  L L +N  S    L   +L  
Sbjct: 80  LTDIKPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDINGLV--HLPQ 135

Query: 134 LIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF 193
           L  LYL  N ++   ++ L +L  L  L L DNQ I  I  P + LT +  L LS+N + 
Sbjct: 136 LESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQ-ISDIV-PLAGLTKLQNLYLSKNHI- 190

Query: 194 GSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
            S    +  +++L VL+L   +         SNL     +      L
Sbjct: 191 -SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 39/189 (20%), Positives = 78/189 (41%), Gaps = 19/189 (10%)

Query: 293 TSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS--SNWGKFPKLG 350
            +     S+ ++  N +++  ++ + +   PN+T + L+ N     ++          LG
Sbjct: 40  VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNK----LTDIKPLANLKNLG 93

Query: 351 TLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGR 410
            L +  N +       + +  +L++  L  N I  +I   L  L  L  L L  N+IT  
Sbjct: 94  WLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD- 148

Query: 411 LPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSF 468
               +  LTKL+ L      I ++   +  +  L+ L LS N++S  +     G+  L  
Sbjct: 149 -ITVLSRLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDV 204

Query: 469 IDMSYNELQ 477
           +++   E  
Sbjct: 205 LELFSQECL 213

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 37/166 (22%), Positives = 60/166 (36%), Gaps = 16/166 (9%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
           S      L  L L  NG    I   + +L  L  LYLG+N+        ++  +    L 
Sbjct: 107 SLKDLKKLKSLSLEHNGI-SDING-LVHLPQLESLYLGNNK--------ITDITVLSRLT 156

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
            +  L + DN +S  +P  +  L  L  L L+ N  S    L+   L NL  L L+    
Sbjct: 157 KLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQEC 212

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN 190
               ++    L     ++  D  L+   P   S+        +  +
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWH 256

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 57/291 (19%), Positives = 105/291 (36%), Gaps = 59/291 (20%)

Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE--------- 640
           +G G    V  A+        +   VAVK    L       + +  ++E++         
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 641 ---AFYGFCSHA-RHSFLLYEFLERGSL-------------AAILNTDAAAQELGWSQRM 683
                 G C+       ++ EF + G+L               +   D     L     +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF 743
                VA  + +L        +HRD++++N+LL  +    + DFG+A+ +  D       
Sbjct: 152 CYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYV 205

Query: 744 AGTCGYI-----APELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTD 797
                 +     APE  +    T + DV+SFGVL+WE+   G  P   +        + +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEE 259

Query: 798 VALDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               ++ +  R+ AP      ++   M     C++  P  RPT   + + L
Sbjct: 260 F-CRRLKEGTRMRAP-DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 305

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 69/300 (23%), Positives = 105/300 (35%), Gaps = 70/300 (23%)

Query: 583 IVKATNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVK---------KFHSLLPCDQ 628
           + K        Y      G+G +  V    E       A+K           +S    + 
Sbjct: 27  VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86

Query: 629 TVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGSL-AAILN------T 670
               +E   E+              +      ++ +L+ EF E G L   I+N       
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146

Query: 671 DAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADF 727
           DAA          N++K +   + YLH      IVHRDI  +N+LL   +      + DF
Sbjct: 147 DAA----------NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDF 193

Query: 728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP----- 782
           G++     D     +  GT  YIAPE     K  EKCDV+S GV+M+ ++ G  P     
Sbjct: 194 GLSSFFSKDYK-LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQN 251

Query: 783 -RDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
            +D +  +       D              S  A+E LI +M             R T +
Sbjct: 252 DQDIIKKVEKGKYYFD-------FNDWKNISDEAKE-LIKLM------LTYDYNKRCTAE 297

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 87.0 bits (215), Expect = 2e-18
 Identities = 41/299 (13%), Positives = 81/299 (27%), Gaps = 77/299 (25%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQK-------EFLTEVEAFYGFC 646
           +G     +   A +  +GE   V   + +  P    + Q          L  ++      
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 647 SHARHS-----------------------------FLLYEFLERGSLA----AILNTDAA 673
            H R                               F LY    + +L      +L+  + 
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSHSST 199

Query: 674 AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL 733
            + L    R+ +   V   L+ LHH     +VH  +   +++LD      +  F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256

Query: 734 KPDSSNWTEFAGTCGYIAPEL-----------AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                     + + G+  PEL                +T   D ++ G++++ +     P
Sbjct: 257 ----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

Query: 783 RDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                  +  +              +P P R+    L+              E R    
Sbjct: 313 --I----TKDAALGGSEWIFRSCKNIPQPVRA----LLE------GFLRYPKEDRLLPL 355

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 42/224 (18%), Positives = 86/224 (38%), Gaps = 22/224 (9%)

Query: 48  PQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI-GN 106
           P +    + + L L         L  + S +    L  +SR+ ++ +     +  H   N
Sbjct: 27  PSLP--PSTQTLKLIETH-----LRTIPSHAFSN-LPNISRIYVSIDVTLQQLESHSFYN 78

Query: 107 LKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGNLLSGSI--LSSLGKLKSLFDLQL 163
           L  ++ +++ N +    I       L  L FL ++   L      L+ +      F L++
Sbjct: 79  LSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEI 137

Query: 164 NDNQLIGYIP-RPFSNLTSVS-TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLP 221
            DN  +  IP   F  L + + TL+L  N    S+         L  + LN+N++  V+ 
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVID 196

Query: 222 PSI-SNL-TNLKELALLYNHLSGSIPP-SLGNLILRQLLLSGNH 262
                 + +    L +    ++ ++P   L +  L++L+     
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEH--LKELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 44/226 (19%), Positives = 84/226 (37%), Gaps = 39/226 (17%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
           T+   +FS+ P+++ + ++ +     +      NLS + ++ + + +    I  +     
Sbjct: 45  TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALK-- 102

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPH--IGNLKFLSQLDLTNNKFSGPIPL-SFDNLSN-L 134
               L  +  L I +  L    P    + +      L++T+N +   IP+ +F  L N  
Sbjct: 103 ---ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNET 158

Query: 135 IFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRP-FSNLTSVSTLRLSRNDLF 193
           + L LY N  + S+         L  + LN N+ +  I +  F  + S            
Sbjct: 159 LTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYS------------ 205

Query: 194 GSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH 239
                        S+LD++Q      LP     L +LKEL      
Sbjct: 206 -----------GPSLLDVSQTSVT-ALPSKG--LEHLKELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.0 bits (159), Expect = 7e-12
 Identities = 41/252 (16%), Positives = 82/252 (32%), Gaps = 44/252 (17%)

Query: 183 STLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG 242
              R++  D+   IP       S   L L +   + +   + SNL N+  + +  +    
Sbjct: 14  EDFRVTCKDI-QRIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69

Query: 243 SIPP----SLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNC 298
            +      +L    +  + +       Y+                        P +L+  
Sbjct: 70  QLESHSFYNLSK--VTHIEIRNTRNLTYID-----------------------PDALKEL 104

Query: 299 TSLIRVRLNGNNLTGNISEALGIY--PNLTFIDLSRNNFYGEISSN--WGKFPKLGTLNV 354
             L  + +    L     +   +Y       ++++ N +   I  N   G   +  TL +
Sbjct: 105 PLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKL 163

Query: 355 SMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL--GKLNPLTKLILRGNQITGRLP 412
             N  T  +     N ++L A  L+ N  +  I K+   G  +  + L +    +T  LP
Sbjct: 164 YNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALP 221

Query: 413 KEIGSLTKLEYL 424
                L  L+ L
Sbjct: 222 S--KGLEHLKEL 231

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 31/198 (15%), Positives = 68/198 (34%), Gaps = 14/198 (7%)

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW-GKFPK 348
            IP+   +  +L   +L   +L    S A    PN++ I +S +    ++ S+      K
Sbjct: 25  RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81

Query: 349 LGTLNVSMNNITGGLPREI-GNSSQLQAFDLSLNHIVGEIPKE--LGKLNPLTKLILRGN 405
           +  + +        +  +       L+   +    +    P    +   +    L +  N
Sbjct: 82  VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDN 140

Query: 406 QITGRLP----KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPS-CF 460
                +P    + + + T    L  +    +     N   L+ + L+ N     I    F
Sbjct: 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAF 200

Query: 461 EGMH-GLSFIDMSYNELQ 477
            G++ G S +D+S   + 
Sbjct: 201 GGVYSGPSLLDVSQTSVT 218

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 40/218 (18%), Positives = 77/218 (35%), Gaps = 44/218 (20%)

Query: 587 TNDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKEFLTEVE 640
              F+  Y     IG G  + V R     +G+  AVK    +       +  ++   E  
Sbjct: 19  DVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78

Query: 641 -----------AFYGFCSHARHSFLLYEFL----------ERGSLAAILNTDAAAQELGW 679
                            S     ++++EF+          +R     + +   A+     
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS----- 133

Query: 680 SQRMNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKP 735
               + ++ +  AL Y H ++    I+HRD+    +LL  +  +    +  FG+A  L  
Sbjct: 134 ----HYMRQILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185

Query: 736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
                    GT  ++APE+       +  DV+  GV++
Sbjct: 186 SGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 87.1 bits (216), Expect = 5e-18
 Identities = 71/291 (24%), Positives = 114/291 (39%), Gaps = 62/291 (21%)

Query: 583 IVKATNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLT 637
           +  +T  F  +Y      G G    V    +  +G+  AVK   S     Q  D++  L 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVI-SKRQVKQKTDKESLLR 75

Query: 638 EVE-----------AFYGFCSHARHSFLLYEFLERGSL-AAILN------TDAAAQELGW 679
           EV+             Y F     + +L+ E    G L   I++       DAA      
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA------ 129

Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL-DLEYEAHV--ADFGIAKSLKPD 736
                +I+ V   ++Y+H +    IVHRD+  +NLLL     +A++   DFG++   +  
Sbjct: 130 ----RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182

Query: 737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP------RDFLSSIS 790
                +  GT  YIAPE+       EKCDV+S GV+++ ++ G  P       D L  + 
Sbjct: 183 KK-MKDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240

Query: 791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                 +        P+    S SA++ LI  M          P  R + +
Sbjct: 241 KGKYTFE-------LPQWKKVSESAKD-LIRKM------LTYVPSMRISAR 277

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.5 bits (212), Expect = 5e-18
 Identities = 64/273 (23%), Positives = 105/273 (38%), Gaps = 52/273 (19%)

Query: 590 FDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------- 640
           F     IG+G   +VY A ++ + EVVA+KK  S          ++ + EV         
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-SYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 641 ---AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
               + G       ++L+ E+    +   +       QE    +   V       L+YLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE---VEIAAVTHGALQGLAYLH 171

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
                 ++HRD+ + N+LL       + DFG A  + P +S    F GT  ++APE+   
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILA 224

Query: 758 MKITE---KCDVYSFGVLMWEVIKGK------HPRDFLSSISSSSLNTDVALDQMLDPRL 808
           M   +   K DV+S G+   E+ + K      +    L  I+ +             P L
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE-----------SPAL 273

Query: 809 PAPSRSAQEKLISIMEVAF--SCFNESPESRPT 839
            +   S   +        F  SC  + P+ RPT
Sbjct: 274 QSGHWSEYFR-------NFVDSCLQKIPQDRPT 299

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 84.0 bits (208), Expect = 6e-18
 Identities = 25/258 (9%), Positives = 61/258 (23%), Gaps = 57/258 (22%)

Query: 595 CIGNGGHASVYRAE---LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF--------- 642
             G       ++A    L     VA+            V  +E L+              
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDV-LQETLSRTLRLSRIDKPGVA 94

Query: 643 --YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
                        ++ E++  GSL  +               +  ++++A A    H   
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRA- 148

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI 760
              +         + + ++ +  +A         P                         
Sbjct: 149 --GVALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD----------------------- 183

Query: 761 TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI 820
               D+   G  ++ ++  + P        +   +     ++    +   P+   ++   
Sbjct: 184 ----DIRGIGASLYALLVNRWPLP-----EAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 821 SIMEVAFSCFNESPESRP 838
            I  VA          R 
Sbjct: 235 QISAVAARSVQGDGGIRS 252

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 85.3 bits (211), Expect = 7e-18
 Identities = 41/162 (25%), Positives = 69/162 (42%), Gaps = 16/162 (9%)

Query: 84  RYMSRLVINDNSLSGFIPPHI--GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
            Y + L ++ N+LS  +        L  L  L L++N  +     +F  + NL +L L  
Sbjct: 39  SYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97

Query: 142 NLLS---GSILSSLGKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRNDLFGSIP 197
           N L      + S L  L+ L    L +N  I  + R  F ++  +  L LS+N +    P
Sbjct: 98  NHLHTLDEFLFSDLQALEVLL---LYNNH-IVVVDRNAFEDMAQLQKLYLSQNQIS-RFP 152

Query: 198 DEI----GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELAL 235
            E+     K+  L +LDL+ N+ K +    +  L    +  L
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.0 bits (174), Expect = 4e-13
 Identities = 38/174 (21%), Positives = 62/174 (35%), Gaps = 37/174 (21%)

Query: 23  DFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSGG 81
           +++ +   +L  L L+ N     I  +    + NLRYL L SN                 
Sbjct: 57  EWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLH-------------- 101

Query: 82  NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
                    +++   S         L+ L  L L NN        +F++++ L  LYL  
Sbjct: 102 --------TLDEFLFSD--------LQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145

Query: 142 NLLS---GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTS--VSTLRLSRN 190
           N +S     ++    KL  L  L L+ N+L          L +   + L L  N
Sbjct: 146 NQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 70.3 bits (172), Expect = 5e-13
 Identities = 38/178 (21%), Positives = 62/178 (34%), Gaps = 27/178 (15%)

Query: 161 LQLNDNQLIGYIPRP-FSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKG 218
           L L+ N L         + LT++ +L LS N L   I  E    + +L  LDL+ N    
Sbjct: 44  LDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNHLHT 102

Query: 219 VLPPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTGYLPYNICRGGA 276
           +     S+L  L+ L L  NH+   +   +  ++  L++L LS N  +            
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS------------ 149

Query: 277 LEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNN 334
                      +            L+ + L+ N L       L   P      L  +N
Sbjct: 150 ----RFPVELIKD-----GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 37/172 (21%), Positives = 67/172 (38%), Gaps = 17/172 (9%)

Query: 320 GIYPNLTFIDLSRNNFYGEISSNW--GKFPKLGTLNVSMNNITGGLPREI-GNSSQLQAF 376
            +      +DLS NN    + + W   +   L +L +S N++   +  E       L+  
Sbjct: 36  SLPSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYL 93

Query: 377 DLSLNHIVGEIPKE-LGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFS--AIGEL 432
           DLS NH+   + +     L  L  L+L  N I   + +     + +L+ L  S   I   
Sbjct: 94  DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRF 151

Query: 433 PSQI----CNMKSLEKLNLSHNNLSGSIPSCFEGMHGLS--FIDMSYNELQC 478
           P ++      +  L  L+LS N L     +  + +       + +  N L+C
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.9 bits (140), Expect = 5e-09
 Identities = 31/130 (23%), Positives = 51/130 (39%), Gaps = 15/130 (11%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            +   +F   P+L YLDL+ N    T+   + S+L  L  L L +N     +        
Sbjct: 78  FISSEAFVPVPNLRYLDLSSN-HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFE-- 133

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI----GNLKFLSQLDLTNNKFSGPIPLSFDNLSNL 134
              ++  + +L ++ N +S   P  +      L  L  LDL++NK           L   
Sbjct: 134 ---DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW 189

Query: 135 --IFLYLYGN 142
               LYL+ N
Sbjct: 190 VKNGLYLHNN 199

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 85.9 bits (213), Expect = 1e-17
 Identities = 68/292 (23%), Positives = 109/292 (37%), Gaps = 65/292 (22%)

Query: 583 IVKATNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKEFL 636
           I          Y      G+G +  V    +  +    A+K    + +    T    + L
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS---TSSNSKLL 84

Query: 637 TEVE-----------AFYGFCSHARHSFLLYEFLERGSL-AAILN------TDAAAQELG 678
            EV              Y F    R+ +L+ E  + G L   I++       DAA     
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA----- 139

Query: 679 WSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKP 735
                 +IK V   ++YLH      IVHRD+  +NLLL+ + +     + DFG++   + 
Sbjct: 140 -----VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191

Query: 736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP------RDFLSSI 789
                 E  GT  YIAPE+    K  EKCDV+S GV+++ ++ G  P      ++ L  +
Sbjct: 192 QKK-MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249

Query: 790 SSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                  D        P     S  A++ LI  M           + R + +
Sbjct: 250 EKGKYTFD-------SPEWKNVSEGAKD-LIKQM------LQFDSQRRISAQ 287

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 83.9 bits (208), Expect = 1e-17
 Identities = 60/298 (20%), Positives = 112/298 (37%), Gaps = 73/298 (24%)

Query: 596 IGNGGHASVYRAELPSGE--------VVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
           +G G    V  AE    +         VAVK    L       D  + ++E+E       
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 641 -----AFYGFCSHARHSFLLYEFLERGSL-------------AAILNTDAAAQELGWSQR 682
                   G C+     +++ E+  +G+L              +        +++ +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-----S 737
           ++    +A  + YL        +HRD++++N+L+       +ADFG+A+ +        +
Sbjct: 160 VSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 738 SN------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSIS 790
           +N      W          APE  +    T + DV+SFGVLMWE+   G  P   +    
Sbjct: 217 TNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--- 264

Query: 791 SSSLNTDVALDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 ++    + +  R+  P  +   +L  +M     C++  P  RPT K + + L
Sbjct: 265 ----VEEL-FKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 313

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 85.4 bits (212), Expect = 2e-17
 Identities = 67/446 (15%), Positives = 136/446 (30%), Gaps = 105/446 (23%)

Query: 110 LSQLDLTNNKFSGP-IPLSFDNLSNLIFLYLYGNLLS----GSILSSLGKLKSLFDLQLN 164
           +  LD+   + S          L     + L    L+      I S+L    +L +L L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 165 DNQL----IGYIPRPF-SNLTSVSTLRLSRNDL----FGSIPDEIGKMRSLSVLDLNQNQ 215
            N+L    +  + +   +    +  L L    L     G +   +  + +L  L L+ N 
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124

Query: 216 F-----KGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-----LRQLLLSGNHFTG 265
                 + +    +     L++L L Y  LS +    L +++      ++L +S N    
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN---- 180

Query: 266 YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT----GNISEALGI 321
               +I   G   +    ++           +   L  ++L    +T     ++   +  
Sbjct: 181 ----DINEAGVRVLCQGLKD-----------SPCQLEALKLESCGVTSDNCRDLCGIVAS 225

Query: 322 YPNLTFIDLSRNNFYGE----ISSNWGK-FPKLGTLNVSMNNIT----GGLPREIGNSSQ 372
             +L  + L  N         +         +L TL +    IT    G L R +     
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285

Query: 373 LQAFDLSLNHI----VGEIPKELGKLNP-LTKLILRGNQITGRLPKEIGSLTKLEYLDFS 427
           L+   L+ N +       + + L +    L  L ++    T        S+         
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV--------- 336

Query: 428 AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLS-----------FIDMSYNEL 476
                   +   + L +L +S+N L         G+  L             + ++  ++
Sbjct: 337 --------LAQNRFLLELQISNNRLED------AGVRELCQGLGQPGSVLRVLWLADCDV 382

Query: 477 QCPVPNSTTFRGAS--VEALKGNKGL 500
                   +    S     L  N  L
Sbjct: 383 --------SDSSCSSLAATLLANHSL 400

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 83.9 bits (208), Expect = 5e-17
 Identities = 82/469 (17%), Positives = 147/469 (31%), Gaps = 100/469 (21%)

Query: 54  SNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLS----GFIPPHIGNLKF 109
            +++ L +   + S    AE+        L+    + ++D  L+      I   +     
Sbjct: 3   LDIQSLDIQCEELSDARWAELLP-----LLQQCQVVRLDDCGLTEARCKDISSALRVNPA 57

Query: 110 LSQLDLTNNKF--SGPIPLSF---DNLSNLIFLYLYGNLLS----GSILSSLGKLKSLFD 160
           L++L+L +N+    G   +          +  L L    L+    G + S+L  L +L +
Sbjct: 58  LAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQE 117

Query: 161 LQLNDNQ--------LIGYIPRPFSNLTSVSTLRLSRNDL----FGSIPDEIGKMRSLSV 208
           L L+DN         L   +  P   L     L+L    L       +   +        
Sbjct: 118 LHLSDNLLGDAGLQLLCEGLLDPQCRLE---KLQLEYCSLSAASCEPLASVLRAKPDFKE 174

Query: 209 LDLNQNQF--KGV--LPPSI-SNLTNLKELALLYNHLSGSIPPSLG-----NLILRQLLL 258
           L ++ N     GV  L   +  +   L+ L L    ++      L         LR+L L
Sbjct: 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELAL 234

Query: 259 SGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT----GN 314
             N             G  E+            P  L   + L  + +    +T    G+
Sbjct: 235 GSNKLGD--------VGMAEL-----------CPGLLHPSSRLRTLWIWECGITAKGCGD 275

Query: 315 ISEALGIYPNLTFIDLSRNNFYGE---------ISSNWGKFPKLGTLNVSMNNITGGLPR 365
           +   L    +L  + L+ N    E         +        +L +L V   + T     
Sbjct: 276 LCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG----CQLESLWVKSCSFTAACCS 331

Query: 366 EIG----NSSQLQAFDLSLNHI----VGEIPKELGKLNP-LTKLILRGNQITGRLPKEIG 416
                   +  L    +S N +    V E+ + LG+    L  L L    ++      + 
Sbjct: 332 HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLA 391

Query: 417 SL----TKLEYLDFS--AIGE-----LPSQICNMKS-LEKLNLSHNNLS 453
           +       L  LD S   +G+     L   +      LE+L L     S
Sbjct: 392 ATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 73.8 bits (182), Expect = 8e-14
 Identities = 71/445 (15%), Positives = 137/445 (30%), Gaps = 77/445 (17%)

Query: 32  LAYLDLTWNGF-FGTIPPQISNLSNLRYLYLGSNQFSGN---ILAEVSSESSGGNLRYMS 87
           +  LD+             +  L   + + L     +      ++     +    L    
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNP--ALAE-- 60

Query: 88  RLVINDNSLSGFIPPHIGN-LKF----LSQLDLTNNKFS----GPIPLSFDNLSNLIFLY 138
            L +  N L       +   L+     + +L L N   +    G +  +   L  L  L+
Sbjct: 61  -LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELH 119

Query: 139 LYGNLLSGSILSSLGKL-----KSLFDLQLNDNQL----IGYIPRPFSNLTSVSTLRLSR 189
           L  NLL  + L  L +        L  LQL    L       +            L +S 
Sbjct: 120 LSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSN 179

Query: 190 NDLFGSIPDEIGKM-----RSLSVLDLNQNQFK----GVLPPSISNLTNLKELALLYNHL 240
           ND+  +    + +        L  L L            L   +++  +L+ELAL  N L
Sbjct: 180 NDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239

Query: 241 SGS----IPPSL--GNLILRQLLLSGNHFT----GYLPYNICRGGALEIFTVSENHFQGT 290
                  + P L   +  LR L +     T    G L   +    +L+  +++ N     
Sbjct: 240 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299

Query: 291 ----IPTSLRNC-TSLIRVRLNGNNLTG----NISEALGIYPNLTFIDLSRNNFYGE--- 338
               +  +L      L  + +   + T     + S  L     L  + +S N        
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359

Query: 339 ------ISSNWGKFPKLGTLNVSMNNIT----GGLPREIGNSSQLQAFDLSLNHI----V 384
                           L  L ++  +++      L   +  +  L+  DLS N +    +
Sbjct: 360 ELCQGLGQPG----SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 415

Query: 385 GEIPKELGKLNP-LTKLILRGNQIT 408
            ++ + + +    L +L+L     +
Sbjct: 416 LQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 73.1 bits (180), Expect = 1e-13
 Identities = 61/412 (14%), Positives = 118/412 (28%), Gaps = 114/412 (27%)

Query: 132 SNLIFLYLYGNLLSGSILSSLGK-LKSLFDLQLNDNQL----IGYIPRPFSNLTSVSTLR 186
            ++  L +    LS +  + L   L+    ++L+D  L       I        +++ L 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 187 LSRNDLFGSIPDEIGKM-----RSLSVLDLNQNQFK----GVLPPSISNLTNLKELALLY 237
           L  N+L       + +        +  L L          GVL  ++  L  L+EL L  
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122

Query: 238 NHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRN 297
           N L  +                               G   +               L  
Sbjct: 123 NLLGDA-------------------------------GLQLLCE-----------GLLDP 140

Query: 298 CTSLIRVRLNGNNLT----GNISEALGIYPNLTFIDLSRNNFYGE---------ISSNWG 344
              L +++L   +L+      ++  L   P+   + +S N+               S   
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPC- 199

Query: 345 KFPKLGTLNVSMNNIT----GGLPREIGNSSQLQAFDLSLNHI----VGEIPKELGKLNP 396
              +L  L +    +T      L   + + + L+   L  N +    + E+   L   + 
Sbjct: 200 ---QLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256

Query: 397 -LTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGS 455
            L  L +    IT +                  +  +   +   +SL++L+L+ N L   
Sbjct: 257 RLRTLWIWECGITAK--------------GCGDLCRV---LRAKESLKELSLAGNELGDE 299

Query: 456 -----IPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASV--EALKGNKGL 500
                  +  E    L  + +             T    S     L  N+ L
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSF--------TAACCSHFSSVLAQNRFL 343

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 68.1 bits (167), Expect = 5e-12
 Identities = 69/424 (16%), Positives = 129/424 (30%), Gaps = 80/424 (18%)

Query: 26  FSSFPHLAYLDLTWNGF----FGTIPPQISNLS-NLRYLYLGSNQFSG---NILAEVSSE 77
               P LA L+L  N         +   +   S  ++ L L +   +G    +L+     
Sbjct: 52  LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRT 111

Query: 78  SSGGNLR--YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFS----GPIPLSFDNL 131
                L+  ++S  ++ D  L       +     L +L L     S     P+       
Sbjct: 112 LP--TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAK 169

Query: 132 SNLIFLYLYGNLLSGSILSSLGK-LK----SLFDLQLNDNQL----IGYIPRPFSNLTSV 182
            +   L +  N ++ + +  L + LK     L  L+L    +       +    ++  S+
Sbjct: 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL 229

Query: 183 STLRLSRNDLFGSIPDEIGKM-----RSLSVLDLNQNQF--KGV--LPPSISNLTNLKEL 233
             L L  N L      E+          L  L + +     KG   L   +    +LKEL
Sbjct: 230 RELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKEL 289

Query: 234 ALLYNHLSGSIPPSLGNLI------LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHF 287
           +L  N L       L   +      L  L +    FT                +V     
Sbjct: 290 SLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFT--------AACCSHFSSV----- 336

Query: 288 QGTIPTSLRNCTSLIRVRLNGNNLTG----NISEALGIY-PNLTFIDLSRNNF----YGE 338
                  L     L+ ++++ N L       + + LG     L  + L+  +        
Sbjct: 337 -------LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSS 389

Query: 339 ISSNWGKFPKLGTLNVSMNNIT--------GGLPREIGNSSQLQAFDLSLNHIVGEIPKE 390
           +++       L  L++S N +           + +       L+   L   +   E+   
Sbjct: 390 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ---PGCLLEQLVLYDIYWSEEMEDR 446

Query: 391 LGKL 394
           L  L
Sbjct: 447 LQAL 450

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.7 bits (109), Expect = 5e-05
 Identities = 24/125 (19%), Positives = 45/125 (36%), Gaps = 17/125 (13%)

Query: 370 SSQLQAFDLSLNHIVGEIPKELGKLNP-LTKLILRGNQITGRLPKEIGSL----TKLEYL 424
           S  +Q+ D+    +      EL  L      + L    +T    K+I S       L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 425 DFS--AIGEL-PSQICNM-----KSLEKLNLSHNNLS----GSIPSCFEGMHGLSFIDMS 472
           +     +G++    +          ++KL+L +  L+    G + S    +  L  + +S
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 473 YNELQ 477
            N L 
Sbjct: 122 DNLLG 126

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 84.3 bits (209), Expect = 2e-17
 Identities = 60/300 (20%), Positives = 111/300 (37%), Gaps = 77/300 (25%)

Query: 596 IGNGGHASVYRAEL--------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
           +G G    V  AE              VAVK    L       D  + ++E+E       
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK---MLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 641 -----AFYGFCSHARHSFLLYEFLERGSL-------------AAILNTDAAAQELGWSQR 682
                   G C+     +++ E+  +G+L              +        +++ +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 683 MNVIKAVAHALSYL--HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD---- 736
           ++    +A  + YL          +HRD++++N+L+       +ADFG+A+ +       
Sbjct: 206 VSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260

Query: 737 -SSN------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSS 788
            ++N      W          APE  +    T + DV+SFGVLMWE+   G  P   +  
Sbjct: 261 KTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP- 310

Query: 789 ISSSSLNTDVALDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                   ++    + +  R+  P  +   +L  +M     C++  P  RPT K + + L
Sbjct: 311 ------VEEL-FKLLKEGHRMDKP-ANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 359

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.5 bits (207), Expect = 2e-17
 Identities = 60/299 (20%), Positives = 111/299 (37%), Gaps = 74/299 (24%)

Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE--------- 640
           +G G    V  A         +   VAVK    L P     +++  ++E++         
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 641 ---AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA--------- 688
                 G C+    + ++ E+   G L   L     +     +    +            
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 689 ------VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-----S 737
                 VA  +++L        +HRD++++N+LL       + DFG+A+ +K D      
Sbjct: 148 LSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204

Query: 738 SN------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSIS 790
            N      W          APE  +    T + DV+S+G+ +WE+   G  P   +    
Sbjct: 205 GNARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV-- 253

Query: 791 SSSLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               ++     +M+    R+ +P   A  ++  IM+   +C++  P  RPT K I Q +
Sbjct: 254 ----DSKFY--KMIKEGFRMLSP-EHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLI 302

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 50/200 (25%), Positives = 84/200 (42%), Gaps = 20/200 (10%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK-FHSLLPCDQTVDQKEFLTEVE-----------AF 642
           +G G  A VYRA  + +G  VA+K      +     V +     EV+             
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR--VQNEVKIHCQLKHPSILEL 76

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           Y +   + + +L+ E    G +   L      +    ++  + +  +   + YLH     
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQIITGMLYLHSHG-- 132

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITE 762
            I+HRD++  NLLL       +ADFG+A  LK          GT  YI+PE+A       
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGL 191

Query: 763 KCDVYSFGVLMWEVIKGKHP 782
           + DV+S G + + ++ G+ P
Sbjct: 192 ESDVWSLGCMFYTLLIGRPP 211

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 84.3 bits (209), Expect = 2e-17
 Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 9/95 (9%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
           AL YL        I+HRD+   N+LLD     H+ DF IA  L  ++   T  AGT  Y+
Sbjct: 127 ALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAGTKPYM 181

Query: 751 APELAYTMKI---TEKCDVYSFGVLMWEVIKGKHP 782
           APE+  + K    +   D +S GV  +E+++G+ P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 61/292 (20%), Positives = 111/292 (38%), Gaps = 61/292 (20%)

Query: 596 IGNGGHASVYRAELP--------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
           +G G    V  AE              VAVK    L       D  + ++E+E       
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 641 -----AFYGFCSHARHSFLLYEFLERGSL-------------AAILNTDAAAQELGWSQR 682
                   G C+     +++ E+  +G+L              +   +    ++L     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE 742
           ++    VA  + YL        +HRD++++N+L+  +    +ADFG+A+ +         
Sbjct: 194 VSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHID---YY 247

Query: 743 FAGTCGYI-----APELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNT 796
              T G +     APE  +    T + DV+SFGVL+WE+   G  P   +          
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VE 300

Query: 797 DVALDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           ++    + +  R+  P  +   +L  +M     C++  P  RPT K + + L
Sbjct: 301 EL-FKLLKEGHRMDKP-SNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 347

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 84.3 bits (209), Expect = 3e-17
 Identities = 46/218 (21%), Positives = 90/218 (41%), Gaps = 51/218 (23%)

Query: 587 TNDFDAKYC----IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE- 640
              F  +Y     +G G  + V R  ++ +G+  A    ++        D ++   E   
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT--KKLSARDHQKLEREARI 63

Query: 641 ----------AFYGFCSHARHSFLLYEFLERGSLA-AILN------TDAAAQELGWSQRM 683
                       +   S   H +L+++ +  G L   I+        DA+          
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---------- 113

Query: 684 NVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKPDSSN 739
           + I+ +  A+ + H       +VHR++  +NLLL  + +     +ADFG+A  ++ +   
Sbjct: 114 HCIQQILEAVLHCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

Query: 740 WTEFAGTCGYIAPEL----AYTMKITEKCDVYSFGVLM 773
           W  FAGT GY++PE+     Y     +  D+++ GV++
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPY----GKPVDLWACGVIL 203

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 82.7 bits (205), Expect = 4e-17
 Identities = 48/221 (21%), Positives = 82/221 (37%), Gaps = 51/221 (23%)

Query: 582 EIVKATNDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFL 636
           ++ + +  F   Y     IG G ++   R     +    AVK            D  E  
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-----KSKRDPTE-- 64

Query: 637 TEVEAFYGFCSH------------ARHSFLLYEFLERGSL-AAILN------TDAAAQEL 677
            E+E    +  H             ++ +++ E ++ G L   IL        +A+A   
Sbjct: 65  -EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA--- 120

Query: 678 GWSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAH----VADFGIAKS 732
                  V+  +   + YLH       +VHRD+   N+L   E        + DFG AK 
Sbjct: 121 -------VLFTITKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169

Query: 733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           L+ ++        T  ++APE+         CD++S GVL+
Sbjct: 170 LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 45/219 (20%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFH--SLLPCDQTVDQKEFLTEVEAFYG 644
           +DFD    +G G   +VY A E  +  ++A+K      L        + +   E+E    
Sbjct: 14  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV---EHQLRREIEIQ-- 68

Query: 645 FCSHARHSFL--LY-------------EFLERGSLAAILNTDAAAQELGWSQRMNVIKA- 688
             SH RH  +  +Y             EF  RG L   L             R +  ++ 
Sbjct: 69  --SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK---------HGRFDEQRSA 117

Query: 689 -----VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF 743
                +A AL Y H      ++HRDI  +NLL+  + E  +ADFG +    P     T  
Sbjct: 118 TFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-M 172

Query: 744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            GT  Y+ PE+       EK D++  GVL +E + G  P
Sbjct: 173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 82.8 bits (205), Expect = 4e-17
 Identities = 54/258 (20%), Positives = 94/258 (36%), Gaps = 48/258 (18%)

Query: 550 KQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKY----CIGNGGHASVY 605
                   + ++ Q            G         A  +F  KY     IG G  + V 
Sbjct: 52  ANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVR 111

Query: 606 RA-ELPSGEVVAVK----KFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH 648
           R     +G   AVK        L P      ++    E                      
Sbjct: 112 RCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171

Query: 649 ARHSFLLYEFLERGSL-AAILNT------DAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
           +   FL+++ + +G L   +         +            ++++++  A+S+LH +  
Sbjct: 172 SSFMFLVFDLMRKGELFDYLTEKVALSEKETR----------SIMRSLLEAVSFLHANN- 220

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKI 760
             IVHRD+  +N+LLD   +  ++DFG +  L+P      E  GT GY+APE L  +M  
Sbjct: 221 --IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELCGTPGYLAPEILKCSMDE 277

Query: 761 TEK-----CDVYSFGVLM 773
           T        D+++ GV++
Sbjct: 278 THPGYGKEVDLWACGVIL 295

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 65/200 (32%), Positives = 89/200 (44%), Gaps = 20/200 (10%)

Query: 45  TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI 104
            IP  I   ++ + L L SN+ S ++ ++         L  +  L +NDN L   +P  I
Sbjct: 30  AIPSNIP--ADTKKLDLQSNKLS-SLPSKAFH-----RLTKLRLLYLNDNKLQ-TLPAGI 80

Query: 105 -GNLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGNL---LSGSILSSLGKLKSLF 159
              LK L  L +T+NK    +P+  FD L NL  L L  N    L   +  SL KL  L 
Sbjct: 81  FKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS 139

Query: 160 DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKG 218
              L  N+L       F  LTS+  LRL  N L   +P+    K+  L  L L+ NQ K 
Sbjct: 140 ---LGYNELQSLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKR 195

Query: 219 VLPPSISNLTNLKELALLYN 238
           V   +  +L  LK L L  N
Sbjct: 196 VPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 52/162 (32%), Positives = 74/162 (45%), Gaps = 17/162 (10%)

Query: 112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS---GSILSSLGKLKSLFDLQLNDNQL 168
           +LDL +NK S     +F  L+ L  LYL  N L      I   L  L++L+   + DN+L
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLW---VTDNKL 97

Query: 169 IGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSI-SN 226
                  F  L +++ LRL RN L  S+P  +   +  L+ L L  N+ +  LP  +   
Sbjct: 98  QALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDK 155

Query: 227 LTNLKELALLYNHLSGSIPP----SLGNLILRQLLLSGNHFT 264
           LT+LKEL L  N L   +P      L    L+ L L  N   
Sbjct: 156 LTSLKELRLYNNQLK-RVPEGAFDKLTE--LKTLKLDNNQLK 194

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 57/188 (30%), Positives = 86/188 (45%), Gaps = 20/188 (10%)

Query: 34  YLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSGG--NLRYMSRLV 90
            LDL  N    ++P +    L+ LR LYL  N+     L  + +       NL     L 
Sbjct: 41  KLDLQSNKL-SSLPSKAFHRLTKLRLLYLNDNK-----LQTLPAGIFKELKNLET---LW 91

Query: 91  INDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGNLLSGSI 148
           + DN L   +P  +   L  L++L L  N+    +P   FD+L+ L +L L  N L  S+
Sbjct: 92  VTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SL 148

Query: 149 LSSL-GKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSL 206
              +  KL SL +L+L +NQL       F  LT + TL+L  N L   +P+     +  L
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL-KRVPEGAFDSLEKL 207

Query: 207 SVLDLNQN 214
            +L L +N
Sbjct: 208 KMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 39/145 (26%), Positives = 56/145 (38%), Gaps = 14/145 (9%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSG--GN 82
           F    +L  L +T N     +P  +   L NL  L L  NQ          S       +
Sbjct: 81  FKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK--------SLPPRVFDS 131

Query: 83  LRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
           L  ++ L +  N L   +P  +   L  L +L L NN+       +FD L+ L  L L  
Sbjct: 132 LTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190

Query: 142 NLLSGSILSSLGKLKSLFDLQLNDN 166
           N L      +   L+ L  LQL +N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 59.6 bits (145), Expect = 8e-10
 Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 17/195 (8%)

Query: 291 IPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN-WGKFPKL 349
           IP   +      ++ L  N L+   S+A      L  + L+ N     + +  + +   L
Sbjct: 35  IPADTK------KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNL 87

Query: 350 GTLNVSMNNITGGLPREIGNS-SQLQAFDLSLNHIVGEIPKEL-GKLNPLTKLILRGNQI 407
            TL V+ N +   LP  + +    L    L  N +   +P  +   L  LT L L  N++
Sbjct: 88  ETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145

Query: 408 TGRLPKEI-GSLTKLE--YLDFSAIGELPSQIC-NMKSLEKLNLSHNNLSGSIPSCFEGM 463
              LPK +   LT L+   L  + +  +P      +  L+ L L +N L       F+ +
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSL 204

Query: 464 HGLSFIDMSYNELQC 478
             L  + +  N   C
Sbjct: 205 EKLKMLQLQENPWDC 219

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 80.1 bits (198), Expect = 9e-17
 Identities = 46/238 (19%), Positives = 83/238 (34%), Gaps = 26/238 (10%)

Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
              L+N     LG           V+   S   L  +     +++++       +     
Sbjct: 15  DPGLANAVKQNLGKQS--------VTDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTN 64

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
           L +L L++N+ S   PL   +L+ L  L +  N L    L+ +     L  L L++N+L 
Sbjct: 65  LKELHLSHNQISDLSPLK--DLTKLEELSVNRNRL--KNLNGIPSAC-LSRLFLDNNELR 119

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
                   +L ++  L +  N L       +G +  L VLDL+ N+        ++ L  
Sbjct: 120 D--TDSLIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKK 173

Query: 230 LKELALLYNHLSGSIPPSLGNLILRQLL--LSGNHFTGYLPYNICRGGALEIFTVSEN 285
           +  + L               L +   +    G   +   PY I  GG+     V   
Sbjct: 174 VNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS---PYYISNGGSYVDGCVLWE 228

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 35/214 (16%), Positives = 71/214 (33%), Gaps = 42/214 (19%)

Query: 149 LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSV 208
           +     L +     L    +   +      L+ V       +++       +    +L  
Sbjct: 12  VFPDPGLANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKE 67

Query: 209 LDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP 268
           L L+ NQ   +    + +LT L+EL++  N L  ++   + +  L +L L  N       
Sbjct: 68  LHLSHNQISDL--SPLKDLTKLEELSVNRNRLK-NLNG-IPSACLSRLFLDNN------- 116

Query: 269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFI 328
                    E+              SL +  +L  + +  N L  +I   LG    L  +
Sbjct: 117 ---------ELRDTD----------SLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVL 155

Query: 329 DLSRNNFYGEIS--SNWGKFPKLGTLNVSMNNIT 360
           DL  N     I+      +  K+  ++++     
Sbjct: 156 DLHGNE----ITNTGGLTRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 44/218 (20%), Positives = 82/218 (37%), Gaps = 23/218 (10%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
           S      +   +   +    ++   +   +NL+ L+L  NQ     ++++S       L 
Sbjct: 36  SQKELSGVQNFNGDNSNI-QSLAG-MQFFTNLKELHLSHNQ-----ISDLSPLKDLTKLE 88

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
               L +N N L       I +   LS+L L NN+      L   +L NL  L +  N L
Sbjct: 89  E---LSVNRNRLKNL--NGIPSAC-LSRLFLDNNELRDTDSLI--HLKNLEILSIRNNKL 140

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR 204
               +  LG L  L  L L+ N+ I       + L  V+ + L+       + + +    
Sbjct: 141 KS--IVMLGFLSKLEVLDLHGNE-ITNTG-GLTRLKKVNWIDLTGQKC---VNEPVKYQP 193

Query: 205 SLSVLD-LNQNQFKGVLPPSISNLTNLKELALLYNHLS 241
            L + + +     + + P  ISN  +  +  +L+    
Sbjct: 194 ELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 40/261 (15%), Positives = 85/261 (32%), Gaps = 51/261 (19%)

Query: 200 IGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLL 258
              + +    +L +     ++      L+ ++      +++  S+   +     L++L L
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70

Query: 259 SGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEA 318
           S N  +     ++                     + L++ T L  + +N N L  N++  
Sbjct: 71  SHNQIS-----DL---------------------SPLKDLTKLEELSVNRNRLK-NLNGI 103

Query: 319 LGIYPNLTFIDLSRNNFYGEIS--SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAF 376
                 L+ + L  N     +    +      L  L++  N +   +   +G  S+L+  
Sbjct: 104 PS--ACLSRLFLDNNE----LRDTDSLIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVL 155

Query: 377 DLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLP----KEIGSLTKLEYLDFSAIGEL 432
           DL  N I       L +L  +  + L G +     P     E+     ++  D   I   
Sbjct: 156 DLHGNEI--TNTGGLTRLKKVNWIDLTGQKCV-NEPVKYQPELYITNTVKDPDGRWIS-- 210

Query: 433 PSQICNMKSLEKLNLSHNNLS 453
           P  I N  S     +      
Sbjct: 211 PYYISNGGSYVDGCVLWELPV 231

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 33/172 (19%), Positives = 69/172 (40%), Gaps = 12/172 (6%)

Query: 306 LNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPR 365
                +   +        N    +L + +   ++ S   +   +   N   +NI      
Sbjct: 4   QRPTPIN-QVFP-DPGLANAVKQNLGKQSV-TDLVSQ-KELSGVQNFNGDNSNIQS--LA 57

Query: 366 EIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLD 425
            +   + L+   LS N I  ++   L  L  L +L +  N++          L++L +LD
Sbjct: 58  GMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSRL-FLD 114

Query: 426 FSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
            + + +  S + ++K+LE L++ +N L  SI      +  L  +D+  NE+ 
Sbjct: 115 NNELRDTDS-LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT 163

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 81.2 bits (201), Expect = 1e-16
 Identities = 59/300 (19%), Positives = 113/300 (37%), Gaps = 71/300 (23%)

Query: 596 IGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE--------- 640
           +G+G    V  A             VAVK    L     + +++  ++E++         
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 641 ---AFYGFCSHARHSFLLYEFLERGSL-----------AAILNTDAAAQELGWSQRMNVI 686
                 G C+ +   +L++E+   G L           +         + L   + +NV+
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 687 KA---------VAHALSYL--HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
                      VA  + +L          VHRD++++N+L+       + DFG+A+ +  
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 736 DSSNWTEFAGTCGYI-----APELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSI 789
           DS            +     APE  +    T K DV+S+G+L+WE+   G +P       
Sbjct: 225 DS---NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 274

Query: 790 SSSSLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               +  D    +++    ++  P   A E++  IM+   SC+      RP+   ++  L
Sbjct: 275 -YPGIPVDANFYKLIQNGFKMDQP-FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFL 329

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 62/301 (20%), Positives = 116/301 (38%), Gaps = 72/301 (23%)

Query: 596 IGNGGHASVYRAELPSGE------VVAVKKFHSLLPCDQTVDQKEFLTEVEA-------- 641
           IG G    V++A  P         +VAVK    L        Q +F  E           
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFDNPN 111

Query: 642 ---FYGFCSHARHSFLLYEFLERGSL---------------------AAILNTDAAAQEL 677
                G C+  +   LL+E++  G L                          +      L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 678 GWSQRMNVIKAVAHALSYL--HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
             ++++ + + VA  ++YL          VHRD++++N L+       +ADFG+++++  
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226

Query: 736 DSSNWTEFAGTCGYI-----APE-LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSS 788
                   A     I      PE + Y  + T + DV+++GV++WE+   G  P   ++ 
Sbjct: 227 AD---YYKADGNDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEIFSYGLQPYYGMA- 281

Query: 789 ISSSSLNTDVALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 + +V +  + D   L  P  +   +L ++M     C+++ P  RP+   I + L
Sbjct: 282 ------HEEV-IYYVRDGNILACP-ENCPLELYNLMR---LCWSKLPADRPSFCSIHRIL 330

Query: 848 R 848
           +
Sbjct: 331 Q 331

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.0 bits (203), Expect = 2e-16
 Identities = 68/294 (23%), Positives = 110/294 (37%), Gaps = 65/294 (22%)

Query: 581 DEIVKATNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKE 634
            E +     F  +Y I    G G    V +  +  + +  AVK  + +     +  D   
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA---KNKDTST 67

Query: 635 FLTEVE-----------AFYGFCSHARHSFLLYEFLERGSL-AAILN------TDAAAQE 676
            L EVE             +     +   +++ E    G L   I+        DAA   
Sbjct: 68  ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--- 124

Query: 677 LGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL-DLEYEAH--VADFGIAKSL 733
                   +IK V   ++Y+H      IVHRD+  +N+LL   E +    + DFG++   
Sbjct: 125 -------RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174

Query: 734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP------RDFLS 787
           + ++    +  GT  YIAPE+       EKCDV+S GV+++ ++ G  P       D L 
Sbjct: 175 QQNTK-MKDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK 232

Query: 788 SISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
            + +     D        P+    S  A++ LI  M          P  R T  
Sbjct: 233 RVETGKYAFD-------LPQWRTISDDAKD-LIRKM------LTFHPSLRITAT 272

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 62/301 (20%), Positives = 112/301 (37%), Gaps = 74/301 (24%)

Query: 596 IGNGGHASVYRAELPSGE------VVAVKKFHSLLPCDQTVDQKEFLTEVE--------- 640
           +G G    V +A     +       VAVK    L       + ++ L+E           
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 641 --AFYGFCSHARHSFLLYEFLERGSL---------AAILNTDAAAQELGWSQRMNVIKA- 688
               YG CS      L+ E+ + GSL                +       S      +A 
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 689 -----------VAHALSYL--HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
                      ++  + YL         +VHRD++++N+L+    +  ++DFG+++ +  
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 736 DSSNWTEFAGTCGYI-----APE-LAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSS 788
           +    +    + G I     A E L      T + DV+SFGVL+WE++  G +P   +  
Sbjct: 203 ED---SYVKRSQGRIPVKWMAIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNPYPGIP- 257

Query: 789 ISSSSLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ 846
                    +    +L    R+  P  +  E++  +M     C+ + P+ RP    IS+ 
Sbjct: 258 ------PERLF--NLLKTGHRMERP-DNCSEEMYRLML---QCWKQEPDKRPVFADISKD 305

Query: 847 L 847
           L
Sbjct: 306 L 306

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 55/203 (27%), Positives = 86/203 (42%), Gaps = 19/203 (9%)

Query: 45  TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI 104
             P      +      L     +           +   L  + +++ N++ +       I
Sbjct: 12  IFPDDAF--AETIKANLKKKSVT--------DAVTQNELNSIDQIIANNSDIKSV--QGI 59

Query: 105 GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN 164
             L  +  L L  NK    I  +   L+NL +L L GN L         KL +L +L L 
Sbjct: 60  QYLPNVRYLALGGNKLH-DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117

Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPS 223
           +NQL       F  LT+++ L L+ N L  S+P  +  K+ +L+ LDL+ NQ +  LP  
Sbjct: 118 ENQLQSLPDGVFDKLTNLTYLNLAHNQL-QSLPKGVFDKLTNLTELDLSYNQLQ-SLPEG 175

Query: 224 I-SNLTNLKELALLYNHLSGSIP 245
           +   LT LK+L L  N L  S+P
Sbjct: 176 VFDKLTQLKDLRLYQNQLK-SVP 197

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 68.9 bits (169), Expect = 7e-13
 Identities = 61/241 (25%), Positives = 83/241 (34%), Gaps = 55/241 (22%)

Query: 13  PNIGVNGT---LHDFSFSSFP------HLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGS 63
            +         L   S +          +  +    +         I  L N+RYL LG 
Sbjct: 15  DDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGG 72

Query: 64  NQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGP 123
           N+                              +S         L  L+ L LT N+    
Sbjct: 73  NKLH---------------------------DISAL-----KELTNLTYLILTGNQLQSL 100

Query: 124 IPLSFDNLSNLIFLYLYGNLLSGSILSSL-----GKLKSLFDLQLNDNQLIGYIPRPFSN 178
               FD L+NL  L L  N      L SL      KL +L  L L  NQL       F  
Sbjct: 101 PNGVFDKLTNLKELVLVENQ-----LQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDK 155

Query: 179 LTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLY 237
           LT+++ L LS N L  S+P+ +  K+  L  L L QNQ K V       LT+L+ + L  
Sbjct: 156 LTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD 214

Query: 238 N 238
           N
Sbjct: 215 N 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 21/161 (13%)

Query: 112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQL--I 169
           + +L     +  +    + L+++  +    + +    +  +  L ++  L L  N+L  I
Sbjct: 23  KANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--VQGIQYLPNVRYLALGGNKLHDI 78

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISN-L 227
                    LT+++ L L+ N L  S+P+ +  K+ +L  L L +NQ +  LP  + + L
Sbjct: 79  S----ALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132

Query: 228 TNLKELALLYNHLSGSIPP----SLGNLILRQLLLSGNHFT 264
           TNL  L L +N L  S+P      L N  L +L LS N   
Sbjct: 133 TNLTYLNLAHNQLQ-SLPKGVFDKLTN--LTELDLSYNQLQ 170

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 78.8 bits (195), Expect = 4e-16
 Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 51/217 (23%)

Query: 587 TNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKEFLTEVE 640
              F  +Y I    G G    V +  +  + +  AVK  + +        D    L EVE
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVE 73

Query: 641 -----------AFYGFCSHARHSFLLYEFLERGSL-AAILNT------DAAAQELGWSQR 682
                        +     +   +++ E    G L   I+        DAA         
Sbjct: 74  LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA--------- 124

Query: 683 MNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKPDSSN 739
             +IK V   ++Y+H      IVHRD+  +N+LL+ + +     + DFG++   + ++  
Sbjct: 125 -RIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179

Query: 740 WTEFAGTCGYIAPEL---AYTMKITEKCDVYSFGVLM 773
             +  GT  YIAPE+    Y     EKCDV+S GV++
Sbjct: 180 MKDRIGTAYYIAPEVLRGTY----DEKCDVWSAGVIL 212

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 79.2 bits (196), Expect = 4e-16
 Identities = 47/214 (21%), Positives = 80/214 (37%), Gaps = 47/214 (21%)

Query: 587 TNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE- 640
           T +    +      G+G  + V+   +  +G++ A+K                   E+  
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKK----SPAFRDSSLENEIAV 59

Query: 641 ----------AFYGFCSHARHSFLLYEFLERGSL-AAILN------TDAAAQELGWSQRM 683
                               H +L+ + +  G L   IL        DA+          
Sbjct: 60  LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---------- 109

Query: 684 NVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLL-DLEYEAHV--ADFGIAKSLKPDSSN 739
            VI+ V  A+ YLH +     IVHRD+  +NLL    E  + +   DFG++K  +     
Sbjct: 110 LVIQQVLSAVKYLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GI 163

Query: 740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
            +   GT GY+APE+      ++  D +S GV+ 
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 79.7 bits (197), Expect = 5e-16
 Identities = 58/299 (19%), Positives = 110/299 (36%), Gaps = 93/299 (31%)

Query: 581 DEIVKATNDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKE 634
           + ++ A+  F   Y     +G G  + V R     +G   A K  +   L      D ++
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQK 74

Query: 635 FLTEVE-----------AFYGFCSHARHSFLLYEFLERGSLA-AILN------TDAAAQE 676
              E               +         +L+++ +  G L   I+        DA+   
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--- 131

Query: 677 LGWSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKS 732
                  + I+ +  +++Y H +     IVHR++  +NLLL  + +     +ADFG+A  
Sbjct: 132 -------HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180

Query: 733 LKPDSSNWTEFAGTCGYIAPEL----AYTMKITEKCDVYSFGV----------------- 771
           +    + W  FAGT GY++PE+     Y    ++  D+++ GV                 
Sbjct: 181 VNDSEA-WHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPPFWDEDQ 235

Query: 772 --LMWEVIKGKH--PRDFLSSISSSSLNTDVALD---QML--DP--RLPAPSRSAQEKL 819
             L  ++  G +  P     +++        A      ML  +P  R+     +A + L
Sbjct: 236 HRLYAQIKAGAYDYPSPEWDTVTPE------AKSLIDSMLTVNPKKRI-----TADQAL 283

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 78.4 bits (194), Expect = 5e-16
 Identities = 58/289 (20%), Positives = 106/289 (36%), Gaps = 85/289 (29%)

Query: 587 TNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQTVDQKEFLTEVE 640
           +  F   Y +    G G  + V R     +G   A K  +   L      D ++   E  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREAR 57

Query: 641 -----------AFYGFCSHARHSFLLYEFLERGSLA-AILN------TDAAAQELGWSQR 682
                        +         +L+++ +  G L   I+        DA+         
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS--------- 108

Query: 683 MNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYE-AHV--ADFGIAKSLKPDSS 738
            + I+ +  +++Y H +     IVHR++  +NLLL  + + A V  ADFG+A  +    +
Sbjct: 109 -HCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163

Query: 739 NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGV-------------------LMWEVIKG 779
            W  FAGT GY++PE+      ++  D+++ GV                   L  ++  G
Sbjct: 164 -WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG 222

Query: 780 KH--PRDFLSSISSSSLNTDVALD---QML--DP--RLPAPSRSAQEKL 819
            +  P     +++        A      ML  +P  R+     +A + L
Sbjct: 223 AYDYPSPEWDTVTPE------AKSLIDSMLTVNPKKRI-----TADQAL 260

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 78.9 bits (195), Expect = 7e-16
 Identities = 53/251 (21%), Positives = 90/251 (35%), Gaps = 52/251 (20%)

Query: 550 KQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCI----GNGGHASVY 605
            +        S         + L  +  I         +     + +    G G  + VY
Sbjct: 15  TENLYFQSMSSVTASAAPGTASLVPDYWIDG----SNRDALSDFFEVESELGRGATSIVY 70

Query: 606 RA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF 653
           R  +  + +  A+K         +TVD+K   TE+                         
Sbjct: 71  RCKQKGTQKPYALKVL------KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124

Query: 654 LLYEFLERGSL-AAILN------TDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFPPIV 705
           L+ E +  G L   I+        DAA          + +K +  A++YLH +     IV
Sbjct: 125 LVLELVTGGELFDRIVEKGYYSERDAA----------DAVKQILEAVAYLHENG----IV 170

Query: 706 HRDISSKNLLL-DLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITE 762
           HRD+  +NLL      +A +  ADFG++K ++          GT GY APE+        
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGP 229

Query: 763 KCDVYSFGVLM 773
           + D++S G++ 
Sbjct: 230 EVDMWSVGIIT 240

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 78.7 bits (194), Expect = 8e-16
 Identities = 52/270 (19%), Positives = 91/270 (33%), Gaps = 65/270 (24%)

Query: 575 EGKILYDEIVKATNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH-SLLPCDQ 628
            G+        +  +   KY +    G G +  V  A E  +  + A+K  + + +    
Sbjct: 9   SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68

Query: 629 TVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGSL------------- 664
             D +   TEV              Y      ++  L+ E    G L             
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128

Query: 665 ----------------------AAILNTDAAAQELGWSQRM--NVIKAVAHALSYLHHDC 700
                                    ++    + +    +++  N+++ +  AL YLH+  
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ- 187

Query: 701 FPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKP----DSSNWTEFAGTCGYIAPEL 754
              I HRDI  +N L        +   DFG++K        +    T  AGT  ++APE+
Sbjct: 188 --GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV 245

Query: 755 --AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
                     KCD +S GVL+  ++ G  P
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 48/217 (22%), Positives = 78/217 (35%), Gaps = 50/217 (23%)

Query: 587 TNDFDAKY-------CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE 638
            + F   Y        +G G  +   +     S +  AVK             +     E
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK-------IISKRMEANTQKE 55

Query: 639 VE------------AFYGFCSHARHSFLLYEFLERGSL-AAILN------TDAAAQELGW 679
           +               +       H+FL+ E L  G L   I        T+A+      
Sbjct: 56  ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS------ 109

Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKPD 736
                +++ +  A+S++H      +VHRD+  +NLL   E +     + DFG A+   PD
Sbjct: 110 ----YIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162

Query: 737 SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           +        T  Y APEL       E CD++S GV++
Sbjct: 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 44/155 (28%), Positives = 64/155 (41%), Gaps = 8/155 (5%)

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS-- 145
           +L +    L+         L  L+ L+L  N+        FD+L+ L  L L  N L+  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98

Query: 146 -GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKM 203
              +   L +L     L L  NQL       F  LT +  LRL+ N L  SIP     K+
Sbjct: 99  PLGVFDHLTQLD---KLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFDKL 154

Query: 204 RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN 238
            +L  L L+ NQ + V   +   L  L+ + L  N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 48/156 (30%), Positives = 70/156 (44%), Gaps = 7/156 (4%)

Query: 112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGY 171
           +LDL +   +     +F  L+ L +L L  N L          L  L  L L +NQL   
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98

Query: 172 IPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSI-SNLTN 229
               F +LT +  L L  N L  S+P  +  ++  L  L LN NQ +  +P      LTN
Sbjct: 99  PLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTN 156

Query: 230 LKELALLYNHLSGSIPPSLGNLI--LRQLLLSGNHF 263
           L+ L+L  N L  S+P    + +  L+ + L GN F
Sbjct: 157 LQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 45/165 (27%), Positives = 66/165 (40%), Gaps = 24/165 (14%)

Query: 35  LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG--GNLRYMSRLVIN 92
           LDL   G           L+ L +L L  NQ          + S+G   +L  +  L + 
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ--------TLSAGVFDDLTELGTLGLA 91

Query: 93  DNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS 151
           +N L+  +P  +  +L  L +L L  N+        FD L+ L  L L  N L      S
Sbjct: 92  NNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-----S 145

Query: 152 L-----GKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRN 190
           +      KL +L  L L+ NQL   +P   F  L  + T+ L  N
Sbjct: 146 IPAGAFDKLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 43/153 (28%), Positives = 65/153 (42%), Gaps = 16/153 (10%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
           TL D +F     L +L+L +N    T+   +  +L+ L  L L +NQ +        S  
Sbjct: 49  TLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA--------SLP 99

Query: 79  SG--GNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLS-FDNLSNL 134
            G   +L  + +L +  N L   +P  +   L  L +L L  N+    IP   FD L+NL
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNL 157

Query: 135 IFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ 167
             L L  N L      +  +L  L  + L  NQ
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 44/176 (25%), Positives = 62/176 (35%), Gaps = 18/176 (10%)

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI-SNLTNLKELALLYN 238
                L L    L          +  L+ L+L+ NQ +  L   +  +LT L  L L  N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 239 HLSGSIPP----SLGNLILRQLLLSGNHFTGYLPYNICRG-GALEIFTVSENHFQGTIPT 293
            L+ S+P      L    L +L L GN     LP  +      L+   ++ N  Q +IP 
Sbjct: 94  QLA-SLPLGVFDHLTQ--LDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPA 148

Query: 294 SL-RNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS-----SNW 343
                 T+L  + L+ N L      A      L  I L  N F          S W
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQW 204

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.6 bits (98), Expect = 5e-04
 Identities = 46/193 (23%), Positives = 75/193 (38%), Gaps = 37/193 (19%)

Query: 291 IPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLG 350
           IP          ++ L    L             LT+++L  N      +  +    +LG
Sbjct: 33  IPADTE------KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELG 86

Query: 351 TLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGR 410
           TL ++ N +   LP  +        FD                L  L KL L GNQ+   
Sbjct: 87  TLGLANNQLAS-LPLGV--------FD---------------HLTQLDKLYLGGNQLK-S 121

Query: 411 LPKEI-GSLTKLEYLDFSA--IGELPSQICN-MKSLEKLNLSHNNLSGSIP-SCFEGMHG 465
           LP  +   LTKL+ L  +   +  +P+   + + +L+ L+LS N L  S+P   F+ +  
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGK 180

Query: 466 LSFIDMSYNELQC 478
           L  I +  N+  C
Sbjct: 181 LQTITLFGNQFDC 193

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 77.8 bits (192), Expect = 3e-15
 Identities = 48/226 (21%), Positives = 78/226 (34%), Gaps = 46/226 (20%)

Query: 580 YDEIVKATNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH----SLLPCDQTV 630
            D+          +Y +    G+G    V  A E  + + VA++       ++    +  
Sbjct: 123 VDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREAD 182

Query: 631 DQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGSL------AAILNTDAA 673
                 TE+E               F   A   +++ E +E G L         L     
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATC 241

Query: 674 AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIA 730
                          +  A+ YLH +    I+HRD+  +N+LL  + E     + DFG +
Sbjct: 242 K---------LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHS 289

Query: 731 KSLKPDSSNWTEFAGTCGYIAPE-LAYTMKI--TEKCDVYSFGVLM 773
           K L   S       GT  Y+APE L            D +S GV++
Sbjct: 290 KILGETSL-MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 78.3 bits (193), Expect = 4e-15
 Identities = 43/249 (17%), Positives = 80/249 (32%), Gaps = 42/249 (16%)

Query: 550 KQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCI----GNGGHASVY 605
             +     R            + +   +     +    +     Y I    G G    V+
Sbjct: 115 VDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVH 174

Query: 606 RA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF 653
           R  E  +G   A K     +      D++    E++             +          
Sbjct: 175 RVTERATGNNFAAK----FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230

Query: 654 LLYEFLERGSL-------AAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH 706
           ++YEF+  G L          ++ D A            ++ V   L ++H +     VH
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAV---------EYMRQVCKGLCHMHEN---NYVH 278

Query: 707 RDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKC 764
            D+  +N++   +    +   DFG+   L P   +     GT  + APE+A    +    
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYT 337

Query: 765 DVYSFGVLM 773
           D++S GVL 
Sbjct: 338 DMWSVGVLS 346

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 78.3 bits (192), Expect = 4e-15
 Identities = 53/319 (16%), Positives = 101/319 (31%), Gaps = 38/319 (11%)

Query: 156 KSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRS---------L 206
                +   +  L     RP +  + + TL L  ++   S+       R+         L
Sbjct: 245 LCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDL 304

Query: 207 SVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGY 266
               LN    +       +   + KE  LL +        S  +  L +  LS    T  
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-V 363

Query: 267 LPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLT 326
           L   +     L+           TI   +R    L+              E L  +  L 
Sbjct: 364 LQSELESCKELQELEPENKWCLLTIILLMRALDPLL-----------YEKETLQYFSTLK 412

Query: 327 FIDLSRNNFYGEISSNWGKFPKLG--------TLNVSMNNITGGLPREIGNSSQLQAFDL 378
            +D  R  +  ++ S +     +          L+++  ++T  +   +     +   DL
Sbjct: 413 AVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDL 470

Query: 379 SLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPS-- 434
           S N +   +P  L  L  L  L    N +   +   + +L +L+ L      + +  +  
Sbjct: 471 SHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQ 527

Query: 435 QICNMKSLEKLNLSHNNLS 453
            + +   L  LNL  N+L 
Sbjct: 528 PLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 74.4 bits (182), Expect = 7e-14
 Identities = 54/355 (15%), Positives = 100/355 (28%), Gaps = 18/355 (5%)

Query: 70  ILAEVSSESSGGNLRY-MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSF 128
              + + +S+    R+ + R   +D      +      L       LT     G + L  
Sbjct: 219 FFTDPNDQSAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMV 278

Query: 129 DNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS 188
           D     +           S +        L    LND          ++   S     L 
Sbjct: 279 DEAPLSVEWRTPDGRNRPSHVWLC----DLPAASLNDQLPQHTFRVIWTGSDSQKECVLL 334

Query: 189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL 248
           ++        +      L   +L+  +   VL   + +   L+EL         +I   +
Sbjct: 335 KDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLM 392

Query: 249 GNLILRQLLLSG-NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLN 307
             L           +F+     +  R           + F             +  + L 
Sbjct: 393 RALDPLLYEKETLQYFSTLKAVDPMR---AAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449

Query: 308 GNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREI 367
             +LT  +   L     +T +DLS N     +         L  L  S N +   +   +
Sbjct: 450 HKDLT-VL-CHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALEN-VD-GV 504

Query: 368 GNSSQLQAFDLSLNHIVG-EIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKL 421
            N  +LQ   L  N +      + L     L  L L+GN +  +       L ++
Sbjct: 505 ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 8e-11
 Identities = 56/309 (18%), Positives = 110/309 (35%), Gaps = 37/309 (11%)

Query: 27  SSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYM 86
           +         +                   R ++ GS+     +L +   E    +    
Sbjct: 289 TPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATD 348

Query: 87  SRLVINDNSL--SGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
            +L   + S+  S  +   + + K L +L+  N      I L    L  L+  Y    L 
Sbjct: 349 EQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLL--YEKETLQ 406

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR 204
             S L ++  +++ +   L    L+            V  L L+  DL  ++   + ++ 
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEY-ADVRVLHLAHKDL--TVLCHLEQLL 463

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHF 263
            ++ LDL+ N+ +  LPP+++ L  L+ L    N L  ++   + NL  L++LLL  N  
Sbjct: 464 LVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR- 519

Query: 264 TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT---GNISEALG 320
                          +   +           L +C  L+ + L GN+L    G       
Sbjct: 520 ---------------LQQSAA-------IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 557

Query: 321 IYPNLTFID 329
           + P+++ I 
Sbjct: 558 MLPSVSSIL 566

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 64.4 bits (156), Expect = 8e-11
 Identities = 35/198 (17%), Positives = 61/198 (30%), Gaps = 10/198 (5%)

Query: 282 VSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISS 341
           V                  L R  L+    T   SE L     L   +L   N +  ++ 
Sbjct: 332 VLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSE-LESCKELQ--ELEPENKWCLLTI 388

Query: 342 NWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLI 401
                  L  L      +      +  +  +    D   +  + E      +   +  L 
Sbjct: 389 IL-LMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLH 447

Query: 402 LRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSC 459
           L    +T  L   +  L  + +LD S   +  LP  +  ++ LE L  S N L  ++   
Sbjct: 448 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG- 503

Query: 460 FEGMHGLSFIDMSYNELQ 477
              +  L  + +  N LQ
Sbjct: 504 VANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 26/142 (18%), Positives = 42/142 (29%), Gaps = 40/142 (28%)

Query: 25  SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
                  + +LDL+ N     +PP ++ L  L  L    N                    
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE----------------- 499

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-PIPLSFDNLSNLIFLYLYGNL 143
                     ++ G     + NL  L +L L NN+           +   L+ L L GN 
Sbjct: 500 ----------NVDG-----VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544

Query: 144 LS------GSILSSLGKLKSLF 159
           L         +   L  + S+ 
Sbjct: 545 LCQEEGIQERLAEMLPSVSSIL 566

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 77.1 bits (190), Expect = 5e-15
 Identities = 45/228 (19%), Positives = 76/228 (33%), Gaps = 46/228 (20%)

Query: 573 NFEGKILYDEIVKATNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFHSLLPCD 627
           +   K +   +          Y I    G+G    V+R  E  +G V   K     +   
Sbjct: 32  DIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK----FINTP 87

Query: 628 QTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLERGSL-------AAILN 669
             +D+     E+              +          L+ EFL  G L          ++
Sbjct: 88  YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS 147

Query: 670 TDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--AD 726
                         N ++     L ++H H     IVH DI  +N++ + +  + V   D
Sbjct: 148 EAEVI---------NYMRQACEGLKHMHEHS----IVHLDIKPENIMCETKKASSVKIID 194

Query: 727 FGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGVLM 773
           FG+A  L PD         T  + APE +     +    D+++ GVL 
Sbjct: 195 FGLATKLNPDEIVKVTT-ATAEFAAPEIVDREP-VGFYTDMWAIGVLG 240

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 57/227 (25%)

Query: 587 TNDFDAKY-----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE 640
           +  F+  Y      +G G HA V     L + +  AVK    ++       +     EVE
Sbjct: 7   SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVK----IIEKQPGHIRSRVFREVE 62

Query: 641 AFYGFCSH------------ARHSFLLYEFLERGSL-AAILN------TDAAAQELGWSQ 681
             Y    H                +L++E +  GS+ + I         +A+        
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-------- 114

Query: 682 RMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKPDSS 738
              V++ VA AL +LH      I HRD+  +N+L +   +     + DF +   +K +  
Sbjct: 115 --VVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169

Query: 739 -------NWTEFAGTCGYIAPE-----LAYTMKITEKCDVYSFGVLM 773
                        G+  Y+APE             ++CD++S GV++
Sbjct: 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 46/218 (21%), Positives = 83/218 (38%), Gaps = 51/218 (23%)

Query: 589 DFDAKYCI----GNGGHASVYRA-ELPSGEVVAVK--KFHSLLPCDQTVDQKEFLTEVE- 640
             +  Y +    G+G  A V +  +  +G+  A K  K   L    + V ++E   EV  
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 641 ----------AFYGFCSHARHSFLLYEFL----------ERGSLAAILNTDAAAQELGWS 680
                       +    +     L+ E +          E+ SL     T+  A +    
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL-----TEDEATQF--- 113

Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL-DLEYEAH---VADFGIAKSLKPD 736
                +K +   + YLH      I H D+  +N++L D         + DFGIA  ++  
Sbjct: 114 -----LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165

Query: 737 SSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGVLM 773
           +  +    GT  ++APE + Y   +  + D++S GV+ 
Sbjct: 166 NE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 201

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 45/221 (20%), Positives = 76/221 (34%), Gaps = 58/221 (26%)

Query: 587 TNDFDAKY-----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE 640
                  Y      +G G +  V       +G+  A+K  +         D  +   EV+
Sbjct: 23  KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---------DSPKARQEVD 73

Query: 641 AFYGFCSH-------------ARHSFLLY---EFLERGSL-AAILN--------TDAAAQ 675
             +                        L    E +E G L + I           +AA  
Sbjct: 74  HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-- 131

Query: 676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKS 732
                    +++ +  A+ +LH      I HRD+  +NLL   + +     + DFG AK 
Sbjct: 132 --------EIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180

Query: 733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
              ++        T  Y+APE+    K  + CD++S GV+M
Sbjct: 181 TTQNA--LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 34/134 (25%), Positives = 56/134 (41%), Gaps = 9/134 (6%)

Query: 88  RLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS- 145
            L +N+N  +      I   L  L +++ +NNK +     +F+  S +  + L  N L  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95

Query: 146 --GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GK 202
               +   L  LK+   L L  N++       F  L+SV  L L  N +  ++       
Sbjct: 96  VQHKMFKGLESLKT---LMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI-TTVAPGAFDT 151

Query: 203 MRSLSVLDLNQNQF 216
           + SLS L+L  N F
Sbjct: 152 LHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.4 bits (160), Expect = 4e-12
 Identities = 30/133 (22%), Positives = 57/133 (42%), Gaps = 10/133 (7%)

Query: 137 LYLYGNLLSG-SILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGS 195
           L L  N  +         KL  L  +  ++N++       F   + V+ + L+ N L  +
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-EN 95

Query: 196 IPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP----SLGN 250
           +  ++   + SL  L L  N+   V   S   L++++ L+L  N ++ ++ P    +L +
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154

Query: 251 LILRQLLLSGNHF 263
             L  L L  N F
Sbjct: 155 --LSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.0 bits (151), Expect = 7e-11
 Identities = 36/158 (22%), Positives = 55/158 (34%), Gaps = 33/158 (20%)

Query: 35  LDLTWNGFFGTIPPQ--ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVIN 92
           L L  N F   +        L  LR +   +N+ +                       I 
Sbjct: 37  LRLNNNEF-TVLEATGIFKKLPQLRKINFSNNKIT----------------------DIE 73

Query: 93  DNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL 152
           + +  G           ++++ LT+N+        F  L +L  L L  N ++     S 
Sbjct: 74  EGAFEG--------ASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSF 125

Query: 153 GKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN 190
             L S+  L L DNQ+    P  F  L S+STL L  N
Sbjct: 126 IGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 25/134 (18%), Positives = 55/134 (41%), Gaps = 8/134 (5%)

Query: 351 TLNVSMNNITGGLPREI-GNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG 409
            L ++ N  T      I     QL+  + S N I           + + +++L  N++  
Sbjct: 36  ELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE- 94

Query: 410 RLPKEI-GSLTKLEYLDFSA--IGELPSQI-CNMKSLEKLNLSHNNLSGSIP-SCFEGMH 464
            +  ++   L  L+ L   +  I  + +     + S+  L+L  N ++ ++    F+ +H
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLH 153

Query: 465 GLSFIDMSYNELQC 478
            LS +++  N   C
Sbjct: 154 SLSTLNLLANPFNC 167

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 22/125 (17%), Positives = 41/125 (32%), Gaps = 34/125 (27%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            + + +F     +  + LT N     +  ++   L +L+ L L SN+ +           
Sbjct: 71  DIEEGAFEGASGVNEILLTSNRL-ENVQHKMFKGLESLKTLMLRSNRIT----------- 118

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
                                +       L  +  L L +N+ +   P +FD L +L  L
Sbjct: 119 --------------------CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTL 158

Query: 138 YLYGN 142
            L  N
Sbjct: 159 NLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 18/86 (20%), Positives = 36/86 (41%), Gaps = 6/86 (6%)

Query: 398 TKLILRGNQITGRLPKEI-GSLTKLEYLDFSA--IGELPSQI-CNMKSLEKLNLSHNNLS 453
            +L L  N+ T      I   L +L  ++FS   I ++          + ++ L+ N L 
Sbjct: 35  AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94

Query: 454 GSIPS-CFEGMHGLSFIDMSYNELQC 478
            ++    F+G+  L  + +  N + C
Sbjct: 95  -NVQHKMFKGLESLKTLMLRSNRITC 119

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 74.6 bits (184), Expect = 2e-14
 Identities = 47/206 (22%), Positives = 74/206 (35%), Gaps = 42/206 (20%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH----SLLPCDQTVDQKEFLTEVE---------- 640
           +G+G    V  A E  + + VA+K       ++    +        TE+E          
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 641 -AFYGFCSHARHSFLLYEFLERGSL------AAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                F   A   +++ E +E G L         L                    +  A+
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------LYFYQMLLAV 127

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKPDSSNWTEFAGTCGYI 750
            YLH +    I+HRD+  +N+LL  + E     + DFG +K L   S       GT  Y+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 183

Query: 751 APE-LAYTMKI--TEKCDVYSFGVLM 773
           APE L            D +S GV++
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVIL 209

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 40/131 (30%), Positives = 56/131 (42%), Gaps = 11/131 (8%)

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL-----GKLKSLFDLQLNDNQ 167
           L L +N+ +   P  FD+L NL  LYL  N      L +L       L  L  L L  NQ
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQ-----LGALPVGVFDSLTQLTVLDLGTNQ 99

Query: 168 LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNL 227
           L       F  L  +  L +  N L   +P  I ++  L+ L L+QNQ K +   +   L
Sbjct: 100 LTVLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158

Query: 228 TNLKELALLYN 238
           ++L    L  N
Sbjct: 159 SSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 39/157 (24%), Positives = 57/157 (36%), Gaps = 31/157 (19%)

Query: 34  YLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVIND 93
            L L  N      P    +L NL+ LYLGSNQ                            
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-------------------------- 77

Query: 94  NSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLG 153
            +L   +   +  L     LDL  N+ +      FD L +L  L++  N L+  +   + 
Sbjct: 78  -ALPVGVFDSLTQLT---VLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIE 132

Query: 154 KLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN 190
           +L  L  L L+ NQL       F  L+S++   L  N
Sbjct: 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 37/126 (29%), Positives = 55/126 (43%), Gaps = 13/126 (10%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            L    F S  +L  L L  N   G +P  +  +L+ L  L LG+NQ        ++   
Sbjct: 54  KLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQ--------LTVLP 104

Query: 79  SG--GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIF 136
           S     L ++  L +  N L+  +P  I  L  L+ L L  N+       +FD LS+L  
Sbjct: 105 SAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163

Query: 137 LYLYGN 142
            YL+GN
Sbjct: 164 AYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 47.4 bits (113), Expect = 6e-06
 Identities = 36/135 (26%), Positives = 53/135 (39%), Gaps = 10/135 (7%)

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI-SNLTNLKELALLYN 238
           T+   L L  N +    P     + +L  L L  NQ    LP  +  +LT L  L L  N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 239 HLSGSIPP----SLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTS 294
            L+  +P      L +  L++L +  N  T  LP  I R   L    + +N  +     +
Sbjct: 99  QLT-VLPSAVFDRLVH--LKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGA 154

Query: 295 LRNCTSLIRVRLNGN 309
               +SL    L GN
Sbjct: 155 FDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 42.0 bits (99), Expect = 4e-04
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 6/108 (5%)

Query: 374 QAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFSA--IG 430
           Q   L  N I    P     L  L +L L  NQ+   LP  +  SLT+L  LD     + 
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 431 ELPSQICN-MKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
            LPS + + +  L++L +  N L+  +P   E +  L+ + +  N+L+
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.8 bits (182), Expect = 3e-14
 Identities = 46/223 (20%), Positives = 84/223 (37%), Gaps = 50/223 (22%)

Query: 583 IVKATNDFDAKYCI-----GNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQ--TVDQKE 634
             ++  +F+  Y +     G G  A V +     +G+  A K     L   +     + E
Sbjct: 19  YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK----FLKKRRRGQDCRAE 74

Query: 635 FLTEVE------------AFYGFCSHARHSFLLYEFLERGSL--------AAILNTDAAA 674
            L E+               +    +     L+ E+   G +        A +++ +   
Sbjct: 75  ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI 134

Query: 675 QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAK 731
                     +IK +   + YLH +    IVH D+  +N+LL   Y      + DFG+++
Sbjct: 135 ---------RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182

Query: 732 SLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGVLM 773
            +        E  GT  Y+APE L Y   IT   D+++ G++ 
Sbjct: 183 KIGHACE-LREIMGTPEYLAPEILNYD-PITTATDMWNIGIIA 223

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 74.3 bits (183), Expect = 3e-14
 Identities = 40/207 (19%), Positives = 75/207 (36%), Gaps = 40/207 (19%)

Query: 589 DFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------- 640
                  +G G    V++  E  +G  +A K    ++      D++E   E+        
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAK----IIKTRGMKDKEEVKNEISVMNQLDH 145

Query: 641 ----AFYGFCSHARHSFLLYEFLERGSL-------AAILNTDAAAQELGWSQRMNVIKAV 689
                 Y          L+ E+++ G L       +  L                 +K +
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI---------LFMKQI 196

Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTC 747
              + ++H      I+H D+  +N+L        +   DFG+A+  KP       F GT 
Sbjct: 197 CEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-GTP 252

Query: 748 GYIAPE-LAYTMKITEKCDVYSFGVLM 773
            ++APE + Y   ++   D++S GV+ 
Sbjct: 253 EFLAPEVVNYD-FVSFPTDMWSVGVIA 278

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 73.4 bits (181), Expect = 3e-14
 Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 35/212 (16%)

Query: 587 TNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH--SLLPCDQTVDQKEFLTEV 639
               +  Y I    G+G  A V +  E  +G   A K           + V ++E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66

Query: 640 E-----------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQR--MNVI 686
                         +    +     L+ E +  G L      D  AQ+   S+    + I
Sbjct: 67  SILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-----FDFLAQKESLSEEEATSFI 121

Query: 687 KAVAHALSYLHHDCFPPIVHRDISSKNLLL-DLEYEAH---VADFGIAKSLKPDSSNWTE 742
           K +   ++YLH      I H D+  +N++L D         + DFG+A  ++     +  
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKN 177

Query: 743 FAGTCGYIAPE-LAYTMKITEKCDVYSFGVLM 773
             GT  ++APE + Y   +  + D++S GV+ 
Sbjct: 178 IFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 73.4 bits (181), Expect = 4e-14
 Identities = 45/221 (20%), Positives = 80/221 (36%), Gaps = 53/221 (23%)

Query: 587 TNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH--SLLPCDQTVDQKEFLTEV 639
             + D  Y      G+G  A V +  E  +G   A K           + V +++   EV
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 640 E-----------AFYGFCSHARHSFLLYEFL----------ERGSLAAILNTDAAAQELG 678
                         +    +     L+ E +          E+ SL     T+  A E  
Sbjct: 66  SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL-----TEEEATEF- 119

Query: 679 WSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLL-DLEYEAH---VADFGIAKSL 733
                  +K + + + YLH       I H D+  +N++L D         + DFG+A  +
Sbjct: 120 -------LKQILNGVYYLHSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168

Query: 734 KPDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGVLM 773
              +  +    GT  ++APE + Y   +  + D++S GV+ 
Sbjct: 169 DFGNE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 44/220 (20%), Positives = 79/220 (35%), Gaps = 51/220 (23%)

Query: 587 TNDFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFH--SLLPCDQTVDQKEFLTEV 639
               +  Y I    G+G  A V +  E  +G   A K           + V ++E   EV
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66

Query: 640 E-----------AFYGFCSHARHSFLLYEFL----------ERGSLAAILNTDAAAQELG 678
                         +    +     L+ E +          ++ SL     ++  A    
Sbjct: 67  SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-----SEEEATSF- 120

Query: 679 WSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL-DLEYEAH---VADFGIAKSLK 734
                  IK +   ++YLH      I H D+  +N++L D         + DFG+A  ++
Sbjct: 121 -------IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

Query: 735 PDSSNWTEFAGTCGYIAPE-LAYTMKITEKCDVYSFGVLM 773
                +    GT  ++APE + Y   +  + D++S GV+ 
Sbjct: 171 DGVE-FKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVIT 208

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 32/209 (15%)

Query: 587 TNDFDAKYC----IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE- 640
               D  +     +G+G    V+   E  SG    +K   ++      V  ++   E+E 
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIK---TINKDRSQVPMEQIEAEIEV 73

Query: 641 ----------AFYGFCSHARHSFLLYEFLERGSL-AAILNTDAAAQELGWSQRMNVIKAV 689
                       +       + +++ E  E G L   I++  A  + L       ++K +
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM 133

Query: 690 AHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKPDSSNWTEFAG 745
            +AL+Y H       +VH+D+  +N+L           + DFG+A+  K D    T  AG
Sbjct: 134 MNALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAG 188

Query: 746 TCGYIAPE-LAYTMKITEKCDVYSFGVLM 773
           T  Y+APE       +T KCD++S GV+M
Sbjct: 189 TALYMAPEVFKR--DVTFKCDIWSAGVVM 215

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 48/219 (21%), Positives = 77/219 (35%), Gaps = 53/219 (24%)

Query: 585 KATNDFDAKYCIGN----GGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV 639
               D +  Y + N    G    V  A +  +    A K     +P     D   F  E+
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAK----KIPKYFVEDVDRFKQEI 57

Query: 640 E-----------AFYGFCSHARHSFLLYEFLERGSL-AAILNT------DAAAQELGWSQ 681
           E             Y         +L+ E    G L   +++       DAA        
Sbjct: 58  EIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-------- 109

Query: 682 RMNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIAKSLKPDS 737
              ++K V  A++Y H  +    + HRD+  +N L   +       + DFG+A   KP  
Sbjct: 110 --RIMKDVLSAVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163

Query: 738 SNWTEFAGTCGYIAPEL---AYTMKITEKCDVYSFGVLM 773
                  GT  Y++P++    Y      +CD +S GV+M
Sbjct: 164 -MMRTKVGTPYYVSPQVLEGLY----GPECDEWSAGVMM 197

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 73.2 bits (180), Expect = 7e-14
 Identities = 46/340 (13%), Positives = 95/340 (27%), Gaps = 69/340 (20%)

Query: 156 KSLFDLQLNDNQL----IGYIPRPFSNLTSVSTLRLSRNDL----FGSIPDEIGKMRSLS 207
            S+    L  + +       +        SV  + LS N +       + + I   + L 
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 208 VLDLNQNQFK----------GVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI----- 252
           + + +                +L  ++     L  + L  N    +    L + +     
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 253 LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
           L  L L  N         +      +I   +    +  +    +N   L  +    N L 
Sbjct: 124 LEHLYLHNN--------GLGPQAGAKI---ARALQELAVNKKAKNAPPLRSIICGRNRLE 172

Query: 313 GN----ISEALGIYPNLTFIDLSRNNFYGE-----ISSNWGKFPKLGTLNVSMNNITG-- 361
                  ++    +  L  + + +N    E     +        +L  L++  N  T   
Sbjct: 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG 232

Query: 362 --GLPREIGNSSQLQAFDLSLNHI----VGEIPKELGKLNP--LTKLILRGNQITGRLPK 413
              L   + +   L+   L+   +       +     KL    L  L L+ N+I     +
Sbjct: 233 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 292

Query: 414 EIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLS 453
            + ++                    M  L  L L+ N  S
Sbjct: 293 TLKTVID----------------EKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 44/309 (14%), Positives = 90/309 (29%), Gaps = 72/309 (23%)

Query: 104 IGNLKFLSQLDLTNNKFSGP----IPLSFDNLSNLIFLYLYGNLLS----------GSIL 149
           +     + ++ L+ N         +  +  +  +L                       +L
Sbjct: 28  LLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLL 87

Query: 150 SSLGKLKSLFDLQLNDNQL----IGYIPRPFSNLTSVSTLRLSRNDL------------- 192
            +L K   L  ++L+DN         +    S  T +  L L  N L             
Sbjct: 88  QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQ 147

Query: 193 FGSIPDEIGKMRSLSVLDLNQNQF--KGV--LPPSISNLTNLKELALLYNHLSGS-IPPS 247
             ++  +      L  +   +N+     +     +  +   L  + ++ N +    I   
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHL 207

Query: 248 LGNLI-----LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLI 302
           L   +     L+ L L  N FT          G+  +               L++  +L 
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFT--------HLGSSALAIA------------LKSWPNLR 247

Query: 303 RVRLNGNNLTGN----ISEALGIYPN--LTFIDLSRNNFYGE-----ISSNWGKFPKLGT 351
            + LN   L+      + +A     N  L  + L  N    +      +    K P L  
Sbjct: 248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 307

Query: 352 LNVSMNNIT 360
           L ++ N  +
Sbjct: 308 LELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 60/367 (16%), Positives = 109/367 (29%), Gaps = 84/367 (22%)

Query: 32  LAYLDLTWNGF----FGTIPPQISNLSNLRYLYLGSNQFS---GNILAEVSSESSGGNLR 84
           +    L  +        ++   +    +++ + L  N         L+E  +     +L 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK--DLE 63

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQ----------LDLTNNKFS--GPIPLS--FDN 130
                  +D             L+ L Q          + L++N F      PL      
Sbjct: 64  ---IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSK 120

Query: 131 LSNLIFLYLYGN-------------LLSGSILSSLGKLKSLFDLQLNDNQL----IGYIP 173
            + L  LYL+ N             L   ++         L  +    N+L    +    
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA 180

Query: 174 RPFSNLTSVSTLRLSRNDLF-----GSIPDEIGKMRSLSVLDLNQNQF--KGV--LPPSI 224
           + F +   + T+++ +N +        + + +   + L VLDL  N F   G   L  ++
Sbjct: 181 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240

Query: 225 SNLTNLKELALLYNHLS-------GSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGAL 277
            +  NL+EL L    LS             L N+ L+ L L  N         I      
Sbjct: 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN--------EIELDAVR 292

Query: 278 EIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT------GNISEALGIYPNLTFIDLS 331
            + TV +                L+ + LNGN  +        I E           +L 
Sbjct: 293 TLKTVIDE-----------KMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 341

Query: 332 RNNFYGE 338
                 +
Sbjct: 342 DMEELTD 348

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 45/311 (14%), Positives = 98/311 (31%), Gaps = 83/311 (26%)

Query: 224 ISNLTNLKELALLYNHLSGSIPPSLGNLI-----LRQLLLSGNHFTGYLPYNICRGGALE 278
           ++  + ++  +L  + ++     S+  ++     +++++LSGN         I    A  
Sbjct: 1   MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGN--------TIGTEAARW 51

Query: 279 IFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNL----------TGNISEALGIYPNLTFI 328
           +               + +   L     +                 + +AL   P L  +
Sbjct: 52  LSEN------------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTV 99

Query: 329 DLSRNNFYGE--------ISSNWGKFPKLGTLNVSMNNIT-------------GGLPREI 367
            LS N F           +S +      L  L +  N +                + ++ 
Sbjct: 100 RLSDNAFGPTAQEPLIDFLSKH----TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKA 155

Query: 368 GNSSQLQAFDLSLNHI----VGEIPKELGKLNPLTKLILRGNQITGR-----LPKEIGSL 418
            N+  L++     N +    + E  K       L  + +  N I        L + +   
Sbjct: 156 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215

Query: 419 TKLEYLDFS--AIGE-----LPSQICNMKSLEKLNLSHNNLSG----SIPSCFEGMH--G 465
            +L+ LD             L   + +  +L +L L+   LS     ++   F  +   G
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG 275

Query: 466 LSFIDMSYNEL 476
           L  + + YNE+
Sbjct: 276 LQTLRLQYNEI 286

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 49/223 (21%), Positives = 81/223 (36%), Gaps = 56/223 (25%)

Query: 584 VKATNDFDAKYC----IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE 638
           +K     D        +G G +  V +     + E  A+K            D  +   E
Sbjct: 54  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARRE 104

Query: 639 VEAFYGFCSHA----------------RHSFLLYEFLERGSL-AAILN--------TDAA 673
           VE  +                      +   ++ E L+ G L + I +         +A+
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164

Query: 674 AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH---VADFGIA 730
                      ++K++  A+ YLH      I HRD+  +NLL   +       + DFG A
Sbjct: 165 ----------EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211

Query: 731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           K     +S  T    T  Y+APE+    K  + CD++S GV+M
Sbjct: 212 KETTSHNS-LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.9 bits (176), Expect = 1e-13
 Identities = 40/167 (23%), Positives = 70/167 (41%), Gaps = 26/167 (15%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
           VA  + +L        +HRD++++N+LL  +    + DFG+A+ +  D            
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---DYVRKGDA 255

Query: 749 YI-----APELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQ 802
            +     APE  +    T + DV+SFGVL+WE+   G  P           ++ +    +
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP------YPGVKIDEEFC--R 307

Query: 803 MLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            L    R+ AP      ++   M     C++  P  RPT   + + L
Sbjct: 308 RLKEGTRMRAP-DYTTPEMYQTML---DCWHGEPSQRPTFSELVEHL 350

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 72.9 bits (179), Expect = 2e-13
 Identities = 30/93 (32%), Positives = 49/93 (52%), Gaps = 8/93 (8%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGY 749
            L  LH +    IV+RD+  +N+LLD     H+  +D G+A  +    +      GT GY
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQTIKG-RVGTVGY 351

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +APE+    + T   D ++ G L++E+I G+ P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 15/100 (15%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTE-FAGTC 747
           A+  +H        VHRDI   N+L+D     H+  ADFG    L  D +  +    GT 
Sbjct: 187 AIDSVHQLH----YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAVGTP 240

Query: 748 GYIAPELAYTMKITEK-----CDVYSFGVLMWEVIKGKHP 782
            YI+PE+   M+  +      CD +S GV M+E++ G+ P
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 71.3 bits (175), Expect = 3e-13
 Identities = 35/230 (15%), Positives = 77/230 (33%), Gaps = 44/230 (19%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVK-----KFHSLLPCDQTVDQKEFLTEVEA- 641
           ND+     +  G    +   E    +  A+K              ++ + K  +      
Sbjct: 31  NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 642 ------------------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRM 683
                               G  ++    +++YE++E  S+           +  ++  +
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFI 148

Query: 684 NVIKA------VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS 737
            +         V ++ SY+H+     I HRD+   N+L+D      ++DFG ++    D 
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDK 205

Query: 738 SNWTEFAGTCG---YIAPELAYTMKIT--EKCDVYSFGVLMWEVIKGKHP 782
                   + G   ++ PE           K D++S G+ ++ +     P
Sbjct: 206 KIKG----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 44/212 (20%), Positives = 74/212 (34%), Gaps = 47/212 (22%)

Query: 589 DFDAKYCI----GNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE--- 640
           +   KY I    G G    V+R  E  S +    K         +  DQ     E+    
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILN 56

Query: 641 --------AFYGFCSHARHSFLLYEFLERGSL-------AAILNTDAAAQELGWSQRMNV 685
                     +          +++EF+    +       A  LN              + 
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV---------SY 107

Query: 686 IKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTE 742
           +  V  AL +LH H+    I H DI  +N++      + +   +FG A+ LKP  +    
Sbjct: 108 VHQVCEALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163

Query: 743 FAGTCGYIAPE-LAYTMKITEKCDVYSFGVLM 773
           F     Y APE   + + ++   D++S G L+
Sbjct: 164 F-TAPEYYAPEVHQHDV-VSTATDMWSLGTLV 193

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 71.7 bits (176), Expect = 4e-13
 Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGY 749
            L +LH      I++RD+  +N+LLD   + +V  +D G+A  LK   +    +AGT G+
Sbjct: 301 GLEHLHQRN---IIYRDLKPENVLLD--DDGNVRISDLGLAVELKAGQTKTKGYAGTPGF 355

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +APEL    +     D ++ GV ++E+I  + P
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 70.1 bits (172), Expect = 8e-13
 Identities = 30/102 (29%), Positives = 46/102 (45%), Gaps = 17/102 (16%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTE-FAGTC 747
           A+  +H        VHRDI   N+LLD     H+  ADFG    L+ D +  +    GT 
Sbjct: 174 AIDSVHRLG----YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 748 GYIAPELAYTMKITEK-------CDVYSFGVLMWEVIKGKHP 782
            Y++PE+   +            CD ++ GV  +E+  G+ P
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 68.8 bits (169), Expect = 9e-13
 Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 13/100 (13%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSN---WTE 742
           +  AL YLH       I+HRD+  +N+LL+   + H+   DFG AK L P+S      + 
Sbjct: 139 IVSALEYLHGKG----IIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARANS- 191

Query: 743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           F GT  Y++PEL       +  D+++ G ++++++ G  P
Sbjct: 192 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 69.8 bits (171), Expect = 1e-12
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 34/215 (15%)

Query: 588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEF---LTE----- 638
           N+F+    +G G    V   +   +G   A+K    +L  +  V + E    LTE     
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMK----ILKKEVIVAKDEVAHTLTENRVLQ 203

Query: 639 -------VEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA-VA 690
                      Y F +H R  F++ E+   G L   L+ +    E     R     A + 
Sbjct: 204 NSRHPFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIV 258

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFAGTC 747
            AL YLH +    +V+RD+  +NL+LD   + H+   DFG+ K  +K  ++  T F GT 
Sbjct: 259 SALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMKT-FCGTP 313

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            Y+APE+          D +  GV+M+E++ G+ P
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 29/99 (29%), Positives = 45/99 (45%), Gaps = 14/99 (14%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTE-FAGTC 747
           AL  +H        +HRD+   N+LLD     H+  ADFG    +  +     +   GT 
Sbjct: 180 ALDAIHSMG----FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 748 GYIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
            YI+PE+            +CD +S GV ++E++ G  P
Sbjct: 234 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 70.3 bits (172), Expect = 1e-12
 Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 10/94 (10%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGY 749
            L ++H+     +V+RD+   N+LLD     HV  +D G+A        +     GT GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLD--EHGHVRISDLGLACDFSKKKPH--ASVGTHGY 356

Query: 750 IAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           +APE L   +      D +S G +++++++G  P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 34/156 (21%), Positives = 57/156 (36%), Gaps = 33/156 (21%)

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYI 172
           + L  N      P +F     L  + L  N           ++  L              
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNN-----------QISELA------------- 72

Query: 173 PRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLK 231
           P  F  L S+++L L  N +   +P  +   + SL +L LN N+   +   +  +L NL 
Sbjct: 73  PDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN 131

Query: 232 ELALLYNHLSGSIPP----SLGNLILRQLLLSGNHF 263
            L+L  N L  +I       L    ++ + L+ N F
Sbjct: 132 LLSLYDNKLQ-TIAKGTFSPLRA--IQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 34/149 (22%), Positives = 61/149 (40%), Gaps = 14/149 (9%)

Query: 45  TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG--GNLRYMSRLVINDNSLSGFIPP 102
            IP  +     +  + L  N               G     + + R+ +++N +S  + P
Sbjct: 25  EIPTNLP--ETITEIRLEQNTIK--------VIPPGAFSPYKKLRRIDLSNNQIS-ELAP 73

Query: 103 HI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDL 161
                L+ L+ L L  NK +      F+ L +L  L L  N ++   + +   L +L  L
Sbjct: 74  DAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133

Query: 162 QLNDNQLIGYIPRPFSNLTSVSTLRLSRN 190
            L DN+L       FS L ++ T+ L++N
Sbjct: 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 31/149 (20%), Positives = 50/149 (33%), Gaps = 34/149 (22%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSES 78
            +   +FS +  L  +DL+ N     + P     L +L  L L  N+ +           
Sbjct: 46  VIPPGAFSPYKKLRRIDLSNN-QISELAPDAFQGLRSLNSLVLYGNKIT----------- 93

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
                                +P  +   L  L  L L  NK +     +F +L NL  L
Sbjct: 94  --------------------ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLL 133

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDN 166
            LY N L      +   L+++  + L  N
Sbjct: 134 SLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 30/133 (22%), Positives = 55/133 (41%), Gaps = 9/133 (6%)

Query: 208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP----SLGNLILRQLLLSGNHF 263
            + L QN  K + P + S    L+ + L  N +S  + P     L +  L  L+L GN  
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS--LNSLVLYGNKI 92

Query: 264 TGYLPYNICRG-GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY 322
           T  LP ++  G  +L++  ++ N        + ++  +L  + L  N L           
Sbjct: 93  T-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPL 151

Query: 323 PNLTFIDLSRNNF 335
             +  + L++N F
Sbjct: 152 RAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 35/133 (26%), Positives = 55/133 (41%), Gaps = 7/133 (5%)

Query: 351 TLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL-GKLNPLTKLILRGNQITG 409
            + +  N I    P       +L+  DLS N I  E+  +    L  L  L+L GN+IT 
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 410 RLPKEI-GSLTKLEYLDFSA--IGELPSQI-CNMKSLEKLNLSHNNLSGSIPSCFEGMHG 465
            LPK +   L  L+ L  +A  I  L      ++ +L  L+L  N L       F  +  
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153

Query: 466 LSFIDMSYNELQC 478
           +  + ++ N   C
Sbjct: 154 IQTMHLAQNPFIC 166

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 50.8 bits (122), Expect = 4e-07
 Identities = 24/85 (28%), Positives = 38/85 (44%), Gaps = 5/85 (5%)

Query: 398 TKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICN-MKSLEKLNLSHNNLSG 454
           T++ L  N I    P       KL  +D S   I EL       ++SL  L L  N ++ 
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93

Query: 455 SIPS-CFEGMHGLSFIDMSYNELQC 478
            +P   FEG+  L  + ++ N++ C
Sbjct: 94  ELPKSLFEGLFSLQLLLLNANKINC 118

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 64.7 bits (158), Expect = 6e-12
 Identities = 47/128 (36%), Positives = 58/128 (45%), Gaps = 2/128 (1%)

Query: 112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGY 171
            LDL  N         FD L++L  LYL GN L         KL SL  L L+ NQL   
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSL 91

Query: 172 IPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNL 230
               F  LT +  L L+ N L  S+PD +  K+  L  L L QNQ K V       LT+L
Sbjct: 92  PNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSL 150

Query: 231 KELALLYN 238
           + + L  N
Sbjct: 151 QYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 44/163 (26%), Positives = 58/163 (35%), Gaps = 42/163 (25%)

Query: 34  YLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVIND 93
           YLDL  N            L++L  LYLG N+                            
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-------------------------- 65

Query: 94  NSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL- 152
            SL   +   + +L     L+L+ N+        FD L+ L  L L  N      L SL 
Sbjct: 66  -SLPNGVFNKLTSLT---YLNLSTNQLQSLPNGVFDKLTQLKELALNTNQ-----LQSLP 116

Query: 153 ----GKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRN 190
                KL  L DL+L  NQL   +P   F  LTS+  + L  N
Sbjct: 117 DGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 9/90 (10%)

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISN-LTNLKELALLYN 238
              + L L  N L         ++ SL+ L L  N+ +  LP  + N LT+L  L L  N
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTN 86

Query: 239 HLSGSIPP----SLGNLILRQLLLSGNHFT 264
            L  S+P      L    L++L L+ N   
Sbjct: 87  QLQ-SLPNGVFDKLTQ--LKELALNTNQLQ 113

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 64.2 bits (157), Expect = 7e-12
 Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 13/109 (11%)

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS 147
            L ++ N  +  +P  + N K L+ +DL+NN+ S     SF N++ L+ L L  N     
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR---- 89

Query: 148 ILSSL-----GKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRN 190
            L  +       LKSL  L L+ N +   +P   F++L+++S L +  N
Sbjct: 90  -LRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 33/103 (32%), Positives = 52/103 (50%), Gaps = 3/103 (2%)

Query: 137 LYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSI 196
           LYL GN  +  +   L   K L  + L++N++     + FSN+T + TL LS N L   I
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL-RCI 93

Query: 197 PDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN 238
           P      ++SL +L L+ N    V   + ++L+ L  LA+  N
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 24/87 (27%), Positives = 44/87 (50%), Gaps = 6/87 (6%)

Query: 161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGV 219
           L L+ NQ    +P+  SN   ++ + LS N +  ++ ++    M  L  L L+ N+ +  
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 220 LPPSI-SNLTNLKELALLYNHLSGSIP 245
           +PP     L +L+ L+L  N +S  +P
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDIS-VVP 118

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 30/87 (34%), Positives = 41/87 (47%), Gaps = 10/87 (11%)

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI-SNLTNLKELALLYN 238
             V+ L L  N     +P E+   + L+++DL+ N+    L     SN+T L  L L YN
Sbjct: 31  RDVTELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88

Query: 239 HLSGSIPP----SLGNLILRQLLLSGN 261
            L   IPP     L +  LR L L GN
Sbjct: 89  RLR-CIPPRTFDGLKS--LRLLSLHGN 112

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 15/112 (13%)

Query: 35  LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG--GNLRYMSRLVIN 92
           L L  N F   +P ++SN  +L  + L +N+        +S+ S+    N+  +  L+++
Sbjct: 36  LYLDGNQF-TLVPKELSNYKHLTLIDLSNNR--------ISTLSNQSFSNMTQLLTLILS 86

Query: 93  DNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPL-SFDNLSNLIFLYLYGN 142
            N L   IPP     LK L  L L  N  S  +P  +F++LS L  L +  N
Sbjct: 87  YNRLRC-IPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 41.5 bits (98), Expect = 4e-04
 Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 8/110 (7%)

Query: 374 QAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFSA--IG 430
               L  N     +PKEL     LT + L  N+I+  L  +   ++T+L  L  S   + 
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR 91

Query: 431 ELPSQICN-MKSLEKLNLSHNNLSGSIP-SCFEGMHGLSFIDMSYNELQC 478
            +P +  + +KSL  L+L  N++S  +P   F  +  LS + +  N L C
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYC 140

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.0 bits (162), Expect = 9e-12
 Identities = 37/98 (37%), Positives = 58/98 (59%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           +A AL +LH       I++RD+  +N+LLD   E H+   DFG++K S+  +   ++ F 
Sbjct: 135 LALALDHLHSLG----IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKAYS-FC 187

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  Y+APE+      T+  D +SFGVLM+E++ G  P
Sbjct: 188 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 68.0 bits (165), Expect = 1e-11
 Identities = 89/577 (15%), Positives = 161/577 (27%), Gaps = 214/577 (37%)

Query: 164 NDNQLI--GYIPR--PFSNLTSVSTLRLSRND------LFGSIPDEIGKMRSLSVL---D 210
           NDNQ+     + R  P+  L   + L L          + GS     GK    + +    
Sbjct: 121 NDNQVFAKYNVSRLQPYLKLRQ-ALLELRPAKNVLIDGVLGS-----GK----TWVALDV 170

Query: 211 LNQNQFKGVLPPSIS--NLTN-------LKELALLYNHL----------SGSIPPSLGNL 251
               + +  +   I   NL N       L+ L  L   +          S +I   + ++
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSI 230

Query: 252 I--LRQLLLSGNHFTGYLPY-NICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNG 308
              LR+LL S  +    L   N+    A   F +              +C  L+      
Sbjct: 231 QAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL--------------SCKILL------ 270

Query: 309 NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGL-PREI 367
              T              F+  +                   T ++S+++ +  L P E 
Sbjct: 271 --TTRFKQ-------VTDFLSAAT------------------TTHISLDHHSMTLTPDE- 302

Query: 368 GNSSQLQAFDLSLNHIVGEIPKELGKLNPLT-KLI---LRGNQIT---------GRLPKE 414
                       L+    ++P+E+   NP    +I   +R    T          +L   
Sbjct: 303 ----VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTI 358

Query: 415 IG-SLTKLE-------YLDFSAIGE---LPSQI-----CNMKS------LEKLN----LS 448
           I  SL  LE       +   S       +P+ +      ++        + KL+    + 
Sbjct: 359 IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVE 418

Query: 449 HNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQ 508
                 +I      +  +      Y EL+  + N      + V+     K          
Sbjct: 419 KQPKESTI-----SIPSI------YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP 467

Query: 509 PC------------KPLRQEKSNSGAKWFAIVFPLLGALFVSIALISIFFILRKQKSDSG 556
                         K +   +             L   +F+        F+ +K + DS 
Sbjct: 468 YLDQYFYSHIGHHLKNIEHPER----------MTLFRMVFLDFR-----FLEQKIRHDS- 511

Query: 557 DRQSNNQIPQGSLSIL----NFEGKI-----LYDEIVKATNDFDAKYCIGNGGHASVYRA 607
              +        L+ L     ++  I      Y+ +V A  DF                 
Sbjct: 512 ---TAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF----------------- 551

Query: 608 ELPS-GEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFY 643
            LP   E +   K+  LL       +   + E EA +
Sbjct: 552 -LPKIEENLICSKYTDLL-------RIALMAEDEAIF 580

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.1 bits (129), Expect = 2e-07
 Identities = 61/500 (12%), Positives = 136/500 (27%), Gaps = 132/500 (26%)

Query: 380 LNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQI--- 436
           ++HI+       G L     L+ +  ++  +    +  + ++ Y  F     L S I   
Sbjct: 51  IDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKF---VEEVLRINY-KF-----LMSPIKTE 101

Query: 437 CNMKSL--EKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEAL 494
               S+         + L       F   + +S +   Y +L+  +      +   ++ +
Sbjct: 102 QRQPSMMTRMYIEQRDRLYNDNQV-FAKYN-VSRLQP-YLKLRQALLELRPAKNVLIDGV 158

Query: 495 KGNKGLCG-SAKGLQPCKPLR-QEKSNSGAKWFAIVFPLLGALFVSIALI----SIFFIL 548
            G     G +   L  C   + Q K +    W       L        ++     + + +
Sbjct: 159 LG----SGKTWVALDVCLSYKVQCKMDFKIFWLN-----LKNCNSPETVLEMLQKLLYQI 209

Query: 549 RKQKSDSGDRQSNNQIP----QGSLSILNFEGK-------ILYD----EIVKATNDFDAK 593
               +   D  SN ++     Q  L  L  + K       +L +    +   A   F+  
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRL-LKSKPYENCLLVLLNVQNAKAWNA---FNLS 265

Query: 594 YC--IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARH 651
            C  +       V         + A    H  L           LT  E           
Sbjct: 266 -CKILLTTRFKQVTDF------LSAATTTHISL-----DHHSMTLTPDEV---------- 303

Query: 652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS 711
                    +  L   L+     Q+L                +          +   +++
Sbjct: 304 ---------KSLLLKYLDCRP--QDL---------PREVLTTNPRRLSIIAESIRDGLAT 343

Query: 712 KNLLLDLEYEA--HVADFGIAKSLKPD--SSNWTEFAGTCGYIAPELAYTMKITEKCDVY 767
            +    +  +    + +  +   L+P      +   +     + P    +  I     + 
Sbjct: 344 WDNWKHVNCDKLTTIIESSL-NVLEPAEYRKMFDRLS-----VFPP---SAHIPTI--LL 392

Query: 768 SFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAF 827
           S   L+W  +        ++ +   SL     ++           +  +E  ISI  +  
Sbjct: 393 S---LIWFDVIKSDVMVVVNKLHKYSL-----VE-----------KQPKESTISIPSIYL 433

Query: 828 SCFNESPESRPTM--KIISQ 845
                  E+   +   I+  
Sbjct: 434 E-LKVKLENEYALHRSIVDH 452

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           +A AL YLH  +    IV+RD+  +N+LLD   + H+   DFG+ K +++ +S+  T F 
Sbjct: 148 IASALGYLHSLN----IVYRDLKPENILLD--SQGHIVLTDFGLCKENIEHNSTTST-FC 200

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  Y+APE+ +        D +  G +++E++ G  P
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 63.1 bits (154), Expect = 1e-11
 Identities = 32/147 (21%), Positives = 49/147 (33%), Gaps = 19/147 (12%)

Query: 293 TSLRNCTSLIRVRLNGNNLT--GNISEALGIYPNLTFIDLSRNNFYGEISS--NWGKFPK 348
               N      + L G  +    N+   L        ID S N    EI     +    +
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVIENLGATL---DQFDAIDFSDN----EIRKLDGFPLLRR 65

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI--VGEIPKELGKLNPLTKLILRGNQ 406
           L TL V+ N I             L    L+ N +  +G++   L  L  LT L +  N 
Sbjct: 66  LKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNP 124

Query: 407 ITGRLP----KEIGSLTKLEYLDFSAI 429
           +T          I  + ++  LDF  +
Sbjct: 125 VT-NKKHYRLYVIYKVPQVRVLDFQKV 150

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.4 bits (126), Expect = 7e-08
 Identities = 30/120 (25%), Positives = 42/120 (35%), Gaps = 10/120 (8%)

Query: 48  PQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNL 107
            Q +N    R L L      G  +  +  E+ G  L     +  +DN +          L
Sbjct: 13  AQYTNAVRDRELDL-----RGYKIPVI--ENLGATLDQFDAIDFSDNEIRKL--DGFPLL 63

Query: 108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG-SILSSLGKLKSLFDLQLNDN 166
           + L  L + NN+           L +L  L L  N L     L  L  LKSL  L +  N
Sbjct: 64  RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.7 bits (119), Expect = 5e-07
 Identities = 22/126 (17%), Positives = 48/126 (38%), Gaps = 15/126 (11%)

Query: 377 DLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPS 434
            L+   I  +   +        +L LRG +I   +     +L + + +DFS   I +L  
Sbjct: 3   KLTAELI-EQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-D 58

Query: 435 QICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEAL 494
               ++ L+ L +++N +        + +  L+ + ++ N L              ++ L
Sbjct: 59  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL---------GDLDPL 109

Query: 495 KGNKGL 500
              K L
Sbjct: 110 ASLKSL 115

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.3 bits (118), Expect = 7e-07
 Identities = 25/115 (21%), Positives = 43/115 (37%), Gaps = 6/115 (5%)

Query: 102 PHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDL 161
               N     +LDL   K      L    L     +    N +    L     L+ L  L
Sbjct: 13  AQYTNAVRDRELDLRGYKIPVIENLG-ATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTL 69

Query: 162 QLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL--FGSIPDEIGKMRSLSVLDLNQN 214
            +N+N++          L  ++ L L+ N L   G + D +  ++SL+ L + +N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 27/129 (20%), Positives = 44/129 (34%), Gaps = 8/129 (6%)

Query: 150 SSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVL 209
           +         +L L   + I  I    + L     +  S N++   +      +R L  L
Sbjct: 13  AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEI-RKLDG-FPLLRRLKTL 69

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLS--GSIPPSLGNLILRQLLLSGN---HFT 264
            +N N+   +       L +L EL L  N L   G + P      L  L +  N   +  
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 129

Query: 265 GYLPYNICR 273
            Y  Y I +
Sbjct: 130 HYRLYVIYK 138

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 65.7 bits (161), Expect = 2e-11
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           +   L +LH       IV+RD+   N+LLD   + H+  ADFG+ K ++  D+   T F 
Sbjct: 127 IILGLQFLHSKG----IVYRDLKLDNILLD--KDGHIKIADFGMCKENMLGDAKTNT-FC 179

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YIAPE+    K     D +SFGVL++E++ G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           ++ AL +LH       I++RD+  +N++L+  ++ HV   DFG+ K S+   +   T F 
Sbjct: 130 ISMALGHLHQKG----IIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTVTHT-FC 182

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  Y+APE+          D +S G LM++++ G  P
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 66.6 bits (162), Expect = 2e-11
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 9/97 (9%)

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFAG 745
           +A  L +L       I++RD+   N++LD   E H+  ADFG+ K ++    +  T F G
Sbjct: 451 IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKT-FCG 504

Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T  YIAPE+       +  D ++FGVL++E++ G+ P
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           +  AL YLH  D    +V+RDI  +NL+LD   + H+   DFG+ K  +   ++  T F 
Sbjct: 114 IVSALEYLHSRD----VVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATMKT-FC 166

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  Y+APE+          D +  GV+M+E++ G+ P
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.8 bits (156), Expect = 6e-11
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 12/97 (12%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTE-FAGTC 747
           AL +LH       I++RDI  +N+LLD     HV   DFG++K    D +     F GT 
Sbjct: 171 ALEHLHKLG----IIYRDIKLENILLD--SNGHVVLTDFGLSKEFVADETERAYDFCGTI 224

Query: 748 GYIAPELAYTMKI--TEKCDVYSFGVLMWEVIKGKHP 782
            Y+AP++         +  D +S GVLM+E++ G  P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 63.6 bits (155), Expect = 7e-11
 Identities = 53/271 (19%), Positives = 100/271 (36%), Gaps = 49/271 (18%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVK-----KFHSLLPCDQTVDQKEFLTEVEAFYGFCSHA 649
           +G+G    V+ A      + V VK     K       +     K  L E+        HA
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRV-EHA 89

Query: 650 RHSFLLYEFLE-RGSLAAILNTDAAAQEL----GWSQRMNVIKA------VAHALSYLHH 698
            +   + +  E +G    ++    +  +L        R++   A      +  A+ YL  
Sbjct: 90  -NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148

Query: 699 DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL---- 754
                I+HRDI  +N+++  ++   + DFG A  L+     +T F GT  Y APE+    
Sbjct: 149 KD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEVLMGN 204

Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
            Y      + +++S GV ++ ++  ++P   L     +++              P     
Sbjct: 205 PYRGP---ELEMWSLGVTLYTLVFEENPFCELEETVEAAI------------HPPYLVSK 249

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
               L+S +          PE R T++ +  
Sbjct: 250 ELMSLVSGL------LQPVPERRTTLEKLVT 274

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 63.8 bits (156), Expect = 7e-11
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           +A  L +L        I++RD+   N++LD   E H+  ADFG+ K ++    +  T F 
Sbjct: 130 IAIGLFFLQSKG----IIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKT-FC 182

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YIAPE+       +  D ++FGVL++E++ G+ P
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 63.8 bits (156), Expect = 7e-11
 Identities = 45/227 (19%), Positives = 75/227 (33%), Gaps = 48/227 (21%)

Query: 585 KATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE----- 638
           K  + F  +   G G   +V    E  +G  VA+KK            +   L       
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-----QDPRFRNRELQIMQDLA 74

Query: 639 -------VEAFYGFCSHARHSF------LLYEFLERGSLAAILNTDAAAQELGWSQRMNV 685
                  V+    F +            ++ E++   +L                     
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPP 128

Query: 686 IKA------VAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSS 738
           I        +  ++  LH      + HRDI   N+L++       + DFG AK L P   
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187

Query: 739 NWTEFAGTCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           N   +  +  Y APEL      YT  +    D++S G +  E++ G+
Sbjct: 188 N-VAYICSRYYRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE 229

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 63.4 bits (155), Expect = 8e-11
 Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           +  AL +LH       I++RD+   N+LLD  +E H   ADFG+ K  +    +  T F 
Sbjct: 133 IISALMFLHDKG----IIYRDLKLDNVLLD--HEGHCKLADFGMCKEGICNGVTTAT-FC 185

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YIAPE+   M      D ++ GVL++E++ G  P
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 63.5 bits (155), Expect = 9e-11
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 12/97 (12%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAG 745
           +     YLH  D    +++RD+  +NLL+D   + ++   DFG AK  +     WT   G
Sbjct: 150 IVLTFEYLHSLD----LIYRDLKPENLLID--QQGYIQVTDFGFAK--RVKGRTWT-LCG 200

Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           T   +APE+  +    +  D ++ GVL++E+  G  P
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 63.6 bits (155), Expect = 9e-11
 Identities = 44/207 (21%), Positives = 78/207 (37%), Gaps = 38/207 (18%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHS-- 652
           IG+G    V  A +      VA+KK     P       K    E+           H   
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSR--PFQNQTHAKRAYRELV----LMKCVNHKNI 86

Query: 653 -------------------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                              +++ E ++  +L  ++       EL   +   ++  +   +
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGI 140

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            +LH      I+HRD+   N+++  +    + DFG+A++        T +  T  Y APE
Sbjct: 141 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPE 196

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGK 780
           +   M   E  D++S G +M E+IKG 
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 64.1 bits (156), Expect = 9e-11
 Identities = 47/225 (20%), Positives = 85/225 (37%), Gaps = 42/225 (18%)

Query: 582 EIVKATNDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFL 636
           E+  +T     +Y     IG+G    V  A +      VA+KK     P       K   
Sbjct: 52  EVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--PFQNQTHAKRAY 109

Query: 637 TEVEAFYGFCSHARHS---------------------FLLYEFLERGSLAAILNTDAAAQ 675
            E+           H                      +L+ E ++  +L  ++       
Sbjct: 110 RELV----LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ-----M 159

Query: 676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
           EL   +   ++  +   + +LH      I+HRD+   N+++  +    + DFG+A++   
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-G 215

Query: 736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK 780
            S   T +  T  Y APE+   M   E  D++S G +M E+++ K
Sbjct: 216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 64/273 (23%), Positives = 102/273 (37%), Gaps = 51/273 (18%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVK---KFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARH 651
           +G GG  +V+    L     VA+K   + + +L      D      EV   +   +   H
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPR-NRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 652 SFL--LYEFLERGS-LAAILNTDAAAQEL----GWSQRMNVIKA------VAHALSYLHH 698
             +  L ++ E       +L     AQ+L         +    +      V  A+ + H 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157

Query: 699 DCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL--- 754
                +VHRDI  +N+L+DL    A + DFG   +L  D   +T+F GT  Y  PE    
Sbjct: 158 RG---VVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHD-EPYTDFDGTRVYSPPEWISR 212

Query: 755 -AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP-S 812
             Y         V+S G+L+++++ G  P +    I  + L              PA  S
Sbjct: 213 HQYHAL---PATVWSLGILLYDMVCGDIPFERDQEILEAEL------------HFPAHVS 257

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
                 LI        C    P SRP+++ I  
Sbjct: 258 PDCC-ALIR------RCLAPKPSSRPSLEEILL 283

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 71/318 (22%), Positives = 113/318 (35%), Gaps = 53/318 (16%)

Query: 553 SDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKY----CIGNGGHASVYRAE 608
           S      S+  +P+GS      +         K     +++Y     +G+GG  SVY   
Sbjct: 4   SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63

Query: 609 -LPSGEVVAVK---KFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHSFLLYEFLER-GS 663
            +     VA+K   K   +    +  +      EV       S       L ++ ER  S
Sbjct: 64  RVSDNLPVAIKHVEK-DRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122

Query: 664 LAAILNTDAAAQEL----GWSQRMNVIKA------VAHALSYLHHDCFPPIVHRDISSKN 713
              IL      Q+L         +    A      V  A+ + H+     ++HRDI  +N
Sbjct: 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDEN 179

Query: 714 LLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL----AYTMKITEKCDVYS 768
           +L+DL   E  + DFG   +L  D + +T+F GT  Y  PE      Y  +      V+S
Sbjct: 180 ILIDLNRGELKLIDFGSG-ALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGR---SAAVWS 234

Query: 769 FGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA-PSRSAQEKLISIMEVAF 827
            G+L+++++ G  P +    I    +                  S   Q  LI       
Sbjct: 235 LGILLYDMVCGDIPFEHDEEIIRGQV------------FFRQRVSSECQ-HLIR------ 275

Query: 828 SCFNESPESRPTMKIISQ 845
            C    P  RPT + I  
Sbjct: 276 WCLALRPSDRPTFEEIQN 293

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           ++ AL+YLH       I++RD+   N+LLD   E H+   D+G+ K  L+P  +  T F 
Sbjct: 119 ISLALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FC 171

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YIAPE+          D ++ GVLM+E++ G+ P
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 63.1 bits (154), Expect = 1e-10
 Identities = 36/98 (36%), Positives = 55/98 (56%), Gaps = 11/98 (11%)

Query: 689 VAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAK-SLKPDSSNWTEFA 744
           ++ AL+YLH       I++RD+   N+LLD   E H+   D+G+ K  L+P  +  T F 
Sbjct: 162 ISLALNYLHERG----IIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDTTST-FC 214

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP 782
           GT  YIAPE+          D ++ GVLM+E++ G+ P
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 13/110 (11%)

Query: 88  RLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG 146
            L++NDN L       + G L  L +L+L  N+ +G  P +F+  S++  L L  N    
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK--- 89

Query: 147 SILSSL-----GKLKSLFDLQLNDNQLIGYIPR-PFSNLTSVSTLRLSRN 190
             +  +       L  L  L L DNQ+   +    F +L S+++L L+ N
Sbjct: 90  --IKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 7/106 (6%)

Query: 137 LYLYGNLLSGSILSSLG---KLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF 193
           L L  N L    +SS G   +L  L  L+L  NQL G  P  F   + +  L+L  N + 
Sbjct: 34  LLLNDNELG--RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI- 90

Query: 194 GSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN 238
             I +++   +  L  L+L  NQ   V+P S  +L +L  L L  N
Sbjct: 91  KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 32/110 (29%), Positives = 43/110 (39%), Gaps = 12/110 (10%)

Query: 161 LQLNDNQLIGYIPR-PFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKG 218
           L LNDN+L        F  L  +  L L RN L   I          +  L L +N+ K 
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK- 91

Query: 219 VLPPSI-SNLTNLKELALLYNHLSGSIPP----SLGNLILRQLLLSGNHF 263
            +   +   L  LK L L  N +S  + P     L +  L  L L+ N F
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNS--LTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 10/88 (11%)

Query: 180 TSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGVLPPSI-SNLTNLKELALLY 237
              + L L+ N+L     D + G++  L  L+L +NQ  G + P+     ++++EL L  
Sbjct: 29  LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGE 87

Query: 238 NHLSGSIPP----SLGNLILRQLLLSGN 261
           N +   I       L    L+ L L  N
Sbjct: 88  NKIK-EISNKMFLGLHQ--LKTLNLYDN 112

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 41.1 bits (97), Expect = 5e-04
 Identities = 30/134 (22%), Positives = 47/134 (35%), Gaps = 42/134 (31%)

Query: 11  SLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGN 69
            + + G+        F   PHL  L+L  N     I P      S+++ L LG N+    
Sbjct: 43  RISSDGL--------FGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIKE- 92

Query: 70  ILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSF 128
                                         I   +   L  L  L+L +N+ S  +P SF
Sbjct: 93  ------------------------------ISNKMFLGLHQLKTLNLYDNQISCVMPGSF 122

Query: 129 DNLSNLIFLYLYGN 142
           ++L++L  L L  N
Sbjct: 123 EHLNSLTSLNLASN 136

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 64/277 (23%), Positives = 102/277 (36%), Gaps = 62/277 (22%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQ--TVDQKEFLTEVEA----------- 641
           IG G  A V  A  + +G  VA+K    ++   Q      ++   EV             
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK----IIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA------VAHALSY 695
            +      +  +L+ E+   G +   L             RM   +A      +  A+ Y
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVA---------HGRMKEKEARSKFRQIVSAVQY 129

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL- 754
            H      IVHRD+ ++NLLLD +    +ADFG +            F G   Y APEL 
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA-FCGAPPYAAPELF 185

Query: 755 ---AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
               Y      + DV+S GV+++ ++ G  P D          N     +++L  +   P
Sbjct: 186 QGKKYDGP---EVDVWSLGVILYTLVSGSLPFD--------GQNLKELRERVLRGKYRIP 234

Query: 812 ---SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ 845
              S    E L+    V       +P  R T++ I +
Sbjct: 235 FYMSTDC-ENLLKRFLVL------NPIKRGTLEQIMK 264

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 61.8 bits (151), Expect = 2e-10
 Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 22/99 (22%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCG 748
           AL YLH  D    I++RD+  +N+LLD     H+   DFG AK        +T   GT  
Sbjct: 118 ALEYLHSKD----IIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVTYT-LCGTPD 168

Query: 749 YIAPELAYTMKITEK-----CDVYSFGVLMWEVIKGKHP 782
           YIAPE+     ++ K      D +SFG+L++E++ G  P
Sbjct: 169 YIAPEV-----VSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 60/214 (28%), Positives = 88/214 (41%), Gaps = 50/214 (23%)

Query: 596 IGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAF 642
           IGNG    VY+A+L  SGE+VA+KK           D++    E            V   
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVL--------QDKRFKNRELQIMRKLDHCNIVRLR 113

Query: 643 YGFCSHARHS-----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH----AL 693
           Y F S           L+ +++         +   A Q L     +  +K   +    +L
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSL 169

Query: 694 SYLH-HDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           +Y+H       I HRDI  +NLLLD +     + DFG AK L     N   +  +  Y A
Sbjct: 170 AYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRA 224

Query: 752 PEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           PEL      YT  I    DV+S G ++ E++ G+
Sbjct: 225 PELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 61.1 bits (149), Expect = 4e-10
 Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 53/214 (24%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH----------------SLLPCDQTVDQKEF--- 635
           +G G +  V +     +G +VA+KKF                  LL        K+    
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLL--------KQLRHE 84

Query: 636 ----LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
               L EV      C   +  +L++EF++  ++   L  +     L +      +  + +
Sbjct: 85  NLVNLLEV------CKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIIN 135

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            + + H      I+HRDI  +N+L+       + DFG A++L      + +   T  Y A
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRA 192

Query: 752 PEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           PEL      Y   +    DV++ G L+ E+  G+
Sbjct: 193 PELLVGDVKYGKAV----DVWAIGCLVTEMFMGE 222

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 59.9 bits (146), Expect = 1e-09
 Identities = 44/214 (20%), Positives = 82/214 (38%), Gaps = 53/214 (24%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH----------------SLLPCDQTVDQKEF--- 635
           IG G +  V++     +G++VA+KKF                  +L        K+    
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRML--------KQLKHP 62

Query: 636 ----LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
               L EV          R   L++E+ +  ++   L  D   + +      ++      
Sbjct: 63  NLVNLLEV------FRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQ 113

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           A+++ H       +HRD+  +N+L+       + DFG A+ L   S  + +   T  Y +
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRS 170

Query: 752 PEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           PEL      Y   +    DV++ G +  E++ G 
Sbjct: 171 PELLVGDTQYGPPV----DVWAIGCVFAELLSGV 200

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 60.0 bits (146), Expect = 1e-09
 Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 40/217 (18%)

Query: 587 TNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF 645
              +     +G+G + +V  A +  +G  VA+KK +   P    +  K    E+      
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--PFQSELFAKRAYRELR----L 77

Query: 646 CSHARHS---------------------FLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
             H RH                      +L+  F+    L  ++      ++LG  +   
Sbjct: 78  LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH----EKLGEDRIQF 132

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
           ++  +   L Y+H      I+HRD+   NL ++ + E  + DFG+A+    +    T + 
Sbjct: 133 LVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYV 186

Query: 745 GTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGK 780
            T  Y APE+    M+ T+  D++S G +M E+I GK
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 57.1 bits (138), Expect = 1e-09
 Identities = 36/130 (27%), Positives = 49/130 (37%), Gaps = 12/130 (9%)

Query: 307 NGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISS--NWGKFPKLGTLNVSMNNITGGLP 364
           N  +  G I      + NL F+ L        + S  N  K PKL  L +S N I GGL 
Sbjct: 33  NCKSNDGKIEGLTAEFVNLEFLSLINVG----LISVSNLPKLPKLKKLELSENRIFGGLD 88

Query: 365 REIGNSSQLQAFDLSLNHI--VGEIPKELGKLNPLTKLILRGNQITGRL---PKEIGSLT 419
                   L   +LS N +  +  + + L KL  L  L L   ++T            L 
Sbjct: 89  MLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLP 147

Query: 420 KLEYLDFSAI 429
           +L YLD    
Sbjct: 148 QLTYLDGYDR 157

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 6/112 (5%)

Query: 106 NLKFLSQLDLTNNKFS-GPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN 164
               + +L L N K + G I        NL FL L    L    +S+L KL  L  L+L+
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79

Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDL--FGSIPDEIGKMRSLSVLDLNQN 214
           +N++ G +      L +++ L LS N L    ++ + + K+  L  LDL   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 27/119 (22%), Positives = 52/119 (43%), Gaps = 15/119 (12%)

Query: 387 IPKELGKLNP--LTKLILRGNQIT-GRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKS 441
           I  EL    P  + +L+L   +   G++         LE+L      +  + S +  +  
Sbjct: 14  IHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPK 72

Query: 442 LEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGL 500
           L+KL LS N + G +    E +  L+ +++S N+L+           +++E LK  + L
Sbjct: 73  LKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDI---------STLEPLKKLECL 122

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.6 bits (116), Expect = 9e-07
 Identities = 33/138 (23%), Positives = 54/138 (39%), Gaps = 11/138 (7%)

Query: 52  NLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLS 111
             + +R L L + +       +   E        +  L + +  L      ++  L  L 
Sbjct: 22  TPAAVRELVLDNCK-----SNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLK 74

Query: 112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG-SILSSLGKLKSLFDLQLNDN---Q 167
           +L+L+ N+  G + +  + L NL  L L GN L   S L  L KL+ L  L L +     
Sbjct: 75  KLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTN 134

Query: 168 LIGYIPRPFSNLTSVSTL 185
           L  Y    F  L  ++ L
Sbjct: 135 LNDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 29/126 (23%), Positives = 50/126 (39%), Gaps = 27/126 (21%)

Query: 327 FIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT--GGLPREIGNSSQLQAFDLSLNHIV 384
            +D  ++N  G+I     +F  L  L++    +     LP       +L+  +LS N I 
Sbjct: 30  VLDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVSNLP----KLPKLKKLELSENRIF 84

Query: 385 GEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEK 444
           G +     KL  LT L L GN++          ++ LE L              ++ L+ 
Sbjct: 85  GGLDMLAEKLPNLTHLNLSGNKLK--------DISTLEPLK------------KLECLKS 124

Query: 445 LNLSHN 450
           L+L + 
Sbjct: 125 LDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 24/100 (24%), Positives = 38/100 (38%), Gaps = 9/100 (9%)

Query: 44  GTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPH 103
           G I    +   NL +L L         L  VS+      L  + +L +++N + G +   
Sbjct: 39  GKIEGLTAEFVNLEFLSL-----INVGLISVSNLP---KLPKLKKLELSENRIFGGLDML 90

Query: 104 IGNLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGN 142
              L  L+ L+L+ NK      L     L  L  L L+  
Sbjct: 91  AEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 26/110 (23%), Positives = 46/110 (41%), Gaps = 5/110 (4%)

Query: 155 LKSLFDLQLNDNQL-IGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQ 213
             ++ +L L++ +   G I    +   ++  L L    L  S+ + + K+  L  L+L++
Sbjct: 23  PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVSN-LPKLPKLKKLELSE 80

Query: 214 NQFKGVLPPSISNLTNLKELALLYNHLS--GSIPPSLGNLILRQLLLSGN 261
           N+  G L      L NL  L L  N L    ++ P      L+ L L   
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 62/226 (27%)

Query: 596 IGNGGHASVYRA---ELPSGEVVAVKKF------------HSLLPCDQTVDQKEF----- 635
           +G G +  VY+A   +    +  A+K+              +LL        +E      
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALL--------RELKHPNV 80

Query: 636 --LTEVEAFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMN--VIKAVA 690
             L +V     F SHA    +LL+++ E   L  I+    A++      ++   ++K++ 
Sbjct: 81  ISLQKV-----FLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLL 134

Query: 691 H----ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH----VADFGIAKSLKPDSSNWTE 742
           +     + YLH +    ++HRD+   N+L+  E        +AD G A+          +
Sbjct: 135 YQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 743 FAG---TCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
                 T  Y APEL      YT  I    D+++ G +  E++  +
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 17/94 (18%), Positives = 35/94 (37%), Gaps = 1/94 (1%)

Query: 172 IPRPFSNLTSVSTLRLSRNDLFGSIPDE-IGKMRSLSVLDLNQNQFKGVLPPSISNLTNL 230
                    +++ L +        +    +  +  L  L + ++  + V P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 231 KELALLYNHLSGSIPPSLGNLILRQLLLSGNHFT 264
             L L +N L      ++  L L++L+LSGN   
Sbjct: 83  SRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.1 bits (137), Expect = 1e-08
 Identities = 23/99 (23%), Positives = 34/99 (34%), Gaps = 8/99 (8%)

Query: 45  TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI 104
                +    NL  LY+ +       L  +        L  +  L I  + L  F+ P  
Sbjct: 22  DSLHHLPGAENLTELYIENQ----QHLQHLELRDL-RGLGELRNLTIVKSGLR-FVAPDA 75

Query: 105 -GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN 142
                 LS+L+L+ N        +   LS L  L L GN
Sbjct: 76  FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.9 bits (134), Expect = 2e-08
 Identities = 21/94 (22%), Positives = 34/94 (36%), Gaps = 2/94 (2%)

Query: 100 IPPHIGNLKFLSQLDLTNNKFSGPIPL-SFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL 158
              H+   + L++L + N +    + L     L  L  L +  + L      +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 159 FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL 192
             L L+ N L     +    L S+  L LS N L
Sbjct: 83  SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 6/109 (5%)

Query: 183 STLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPP-SISNLTNLKELALLYNHLS 241
           S LR +R+         +    +L+ L +   Q    L    +  L  L+ L ++ + L 
Sbjct: 11  SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR 69

Query: 242 GSIPPS--LGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQ 288
             + P        L +L LS N     L +   +G +L+   +S N   
Sbjct: 70  -FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 48.6 bits (115), Expect = 5e-06
 Identities = 20/96 (20%), Positives = 35/96 (36%), Gaps = 8/96 (8%)

Query: 412 PKEIGSLTKLEYLDFS---AIGELPSQ-ICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLS 467
              +     L  L       +  L  + +  +  L  L +  + L    P  F     LS
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 468 FIDMSYNELQCPVPNSTTFRGASVE--ALKGNKGLC 501
            +++S+N L+       T +G S++   L GN   C
Sbjct: 84  RLNLSFNALESLSWK--TVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 22/117 (18%), Positives = 36/117 (30%), Gaps = 27/117 (23%)

Query: 221 PPSISNLTNLKELALLYNHLSGSIPP-SLGNLI-LRQLLLSGNHFTGYLPYNICRGGALE 278
              +    NL EL +        +    L  L  LR L +  +                 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG---------------- 67

Query: 279 IFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNF 335
           +  V+ + F  T          L R+ L+ N L  ++S       +L  + LS N  
Sbjct: 68  LRFVAPDAFHFT--------PRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 41/208 (19%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHARHS-- 652
           +G+G + SV  A +  SGE VA+KK     P    +  K    E+        H +H   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSR--PFQSEIFAKRAYRELL----LLKHMQHENV 85

Query: 653 -------------------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                              +L+  F++   L  I+       +    +   ++  +   L
Sbjct: 86  IGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMG-----LKFSEEKIQYLVYQMLKGL 139

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
            Y+H      +VHRD+   NL ++ + E  + DFG+A+    +    T +  T  Y APE
Sbjct: 140 KYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPE 193

Query: 754 LAYT-MKITEKCDVYSFGVLMWEVIKGK 780
           +  + M   +  D++S G +M E++ GK
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 59.2 bits (144), Expect = 2e-09
 Identities = 41/211 (19%), Positives = 78/211 (36%), Gaps = 48/211 (22%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH------ 648
           +G G ++ V+ A  + + E V VK           V +K+   E++              
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLRGGPNIITL 96

Query: 649 -----ARHSF---LLYEFLERGSLAAILN--TDAAAQELGWSQRMNVIKAVAHALSYLH- 697
                   S    L++E +       +    TD   +          +  +  AL Y H 
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFY--------MYEILKALDYCHS 148

Query: 698 HDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL-- 754
                 I+HRD+   N+++D E+ +  + D+G+A+   P    +     +  +  PEL  
Sbjct: 149 MG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPELLV 203

Query: 755 ---AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
               Y   +    D++S G ++  +I  K P
Sbjct: 204 DYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 50/313 (15%), Positives = 104/313 (33%), Gaps = 70/313 (22%)

Query: 177 SNLTSVSTLRLSRNDLFGSIPDEIGKM-----RSLSVLDLNQNQF-----KGVLPPSISN 226
           S    V++L LS N+L+     E+ +       S++ L+L+ N         ++    + 
Sbjct: 19  SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAI 78

Query: 227 LTNLKELALLYNHLSGSIPPSLG------NLILRQLLLSGNHFTGYLPYNICRGGALEIF 280
             N+  L L  N LS      L          +  L L  N        +     + E  
Sbjct: 79  PANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN--------DFSSKSSSEFK 130

Query: 281 TVSENHFQGTIPTSLRNC-TSLIRVRLNGNNLTGN----ISEALGIYP-NLTFIDLSRNN 334
                           N   S+  + L GN+L       + + L   P N+  ++L  NN
Sbjct: 131 QA------------FSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNN 178

Query: 335 FYGE----ISSNWGKFPK-LGTLNVSMNNITGGLPREIG-----NSSQLQAFDLSLNHIV 384
              +    ++      P  + +L++S N +      E+        + + + +L LN + 
Sbjct: 179 LASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238

Query: 385 GEIPKELGKL----NPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMK 440
           G   + L  L      L  + L  + +     ++  +L               +   N++
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALG--------------AAFPNIQ 284

Query: 441 SLEKLNLSHNNLS 453
            +  ++ +   + 
Sbjct: 285 KIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 58/370 (15%), Positives = 101/370 (27%), Gaps = 82/370 (22%)

Query: 130 NLSNLIFLYLYGNLLSGSILSSLGKL-----KSLFDLQLNDNQL----IGYIPRPF-SNL 179
               +  L L  N L       L +       S+  L L+ N L       + +   +  
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKM-----RSLSVLDLNQNQF--KGV--LPPSISNL-TN 229
            +V++L LS N L     DE+ K       +++VLDL  N F  K       + SNL  +
Sbjct: 80  ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 230 LKELALLYNHLSGSIPPSLG------NLILRQLLLSGNHFTGYLPYNICRGGALEIFTVS 283
           +  L L  N L       L          +  L L GN+               E+    
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA--------SKNCAELAKFL 191

Query: 284 ENHFQGTIPTSLRNCTSLIRVRLNGNNLTGN----ISEALGIYPN-LTFIDLSRNNFYGE 338
            +              S+  + L+ N L       ++      PN +  ++L  N  +G 
Sbjct: 192 AS-----------IPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240

Query: 339 ----ISSNWGKFPKLGTLNVSMNNITG-------GLPREIGNSSQLQAFDLSLNHIVGEI 387
               +         L T+ +  + +          L     N  ++   D +   I    
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSH 300

Query: 388 PKELGKL-----NPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSL 442
              +  L            L    +                            +     L
Sbjct: 301 SIPISNLIRELSGKADVPSLLNQCLIFA----------------QKHQTNIEDLNIPDEL 344

Query: 443 EKLNLSHNNL 452
            +   +   L
Sbjct: 345 RESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 51.2 bits (123), Expect = 8e-07
 Identities = 39/246 (15%), Positives = 82/246 (33%), Gaps = 48/246 (19%)

Query: 296 RNCTSLIRVRLNGNNLT----GNISEALGIYP-NLTFIDLSRNNFYGE----ISSNWGKF 346
               S+  + L+GN+L       + + L   P N+T ++LS N    +    +       
Sbjct: 48  NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAI 107

Query: 347 P-KLGTLNVSMNNITGGLPREIG-----NSSQLQAFDLSLNHI----VGEIPKELGKLN- 395
           P  +  L++  N+ +     E         + + + +L  N +      E+ + L  +  
Sbjct: 108 PFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPA 167

Query: 396 PLTKLILRGNQITGRLPKEIGSL-----TKLEYLDFS----------AIGELPSQICNMK 440
            +  L LRGN +  +   E+          +  LD S           +  + S      
Sbjct: 168 NVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSS--IPN 225

Query: 441 SLEKLNLSHNNLSGS----IPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGAS--VEAL 494
            +  LNL  N L G     +    + +  L  + + Y+ +      + +         A 
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIV-----KNMSKEQCKALGAAF 280

Query: 495 KGNKGL 500
              + +
Sbjct: 281 PNIQKI 286

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 56/400 (14%), Positives = 104/400 (26%), Gaps = 105/400 (26%)

Query: 50  ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF 109
            S    +  L L  N                          +   S    I         
Sbjct: 18  TSIPHGVTSLDLSLNN-------------------------LYSISTVELIQAFANTPAS 52

Query: 110 LSQLDLTNNKFS--GPIPLSF---DNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN 164
           ++ L+L+ N         L        +N+  L L GN LS      L K      L   
Sbjct: 53  VTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT-----LA-- 105

Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKM-----RSLSVLDLNQNQF--K 217
                       +   +++ L L  ND       E  +       S++ L+L  N    K
Sbjct: 106 ------------AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIK 153

Query: 218 GV--LPPSISNL-TNLKELALLYNHLSGSIPPSLG------NLILRQLLLSGNHFTGYLP 268
               L   ++ +  N+  L L  N+L+      L          +  L LS N       
Sbjct: 154 SSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLG---- 209

Query: 269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG----NISEALGIYPN 324
                    E+  +  +               ++ + L  N L G    N+        +
Sbjct: 210 ----LKSYAELAYIFSS-----------IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254

Query: 325 LTFIDLSRNNFYG-------EISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFD 377
           L  + L  +            + + +    K+  ++ +   I       I N  +  +  
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGK 314

Query: 378 LSLNHIVGEIPKELGKLNP----------LTKLILRGNQI 407
             +  ++ +      K             L + I     +
Sbjct: 315 ADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 44.7 bits (106), Expect = 9e-05
 Identities = 39/195 (20%), Positives = 74/195 (37%), Gaps = 33/195 (16%)

Query: 315 ISEALGIYPNLTFIDLSRNNFYGE----ISSNWGKFP-KLGTLNVSMNNITGGLPREIG- 368
           + E   I   +T +DLS NN Y      +   +   P  + +LN+S N++      E+  
Sbjct: 14  VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73

Query: 369 ----NSSQLQAFDLSLNHI----VGEIPKELGKLN-PLTKLILRGNQITGRLPKEIGSL- 418
                 + + + +LS N +      E+ K L  +   +T L L  N  + +   E     
Sbjct: 74  ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAF 133

Query: 419 ----TKLEYLDFS--AIGELPSQ-ICNM-----KSLEKLNLSHNNLS----GSIPSCFEG 462
                 +  L+     +G   S  +  +      ++  LNL  NNL+      +      
Sbjct: 134 SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLAS 193

Query: 463 MH-GLSFIDMSYNEL 476
           +   ++ +D+S N L
Sbjct: 194 IPASVTSLDLSANLL 208

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 53/226 (23%), Positives = 89/226 (39%), Gaps = 44/226 (19%)

Query: 582 EIVKATNDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFL 636
           E+ K   +   +Y     +G+G + SV  A +  +G  VAVKK     P    +  K   
Sbjct: 19  ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTY 76

Query: 637 TEVEAFYGFCSHARH-----------------SF----LLYEFLERGSLAAILNTDAAAQ 675
            E+        H +H                  F    L+   +    L  I+      Q
Sbjct: 77  RELR----LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC----Q 127

Query: 676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
           +L       +I  +   L Y+H      I+HRD+   NL ++ + E  + DFG+A+    
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184

Query: 736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGK 780
           +    T +  T  Y APE+    M   +  D++S G +M E++ G+
Sbjct: 185 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.1 bits (136), Expect = 3e-09
 Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 12/109 (11%)

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL-----GKLKSLFDLQLNDNQ 167
           L+L +NK        FD L+ L  L L  N      + SL      KL  L  L L++N+
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQ-----IQSLPDGVFDKLTKLTILYLHENK 87

Query: 168 LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQ 215
           L       F  LT +  L L  N L  S+PD I  ++ SL  + L+ N 
Sbjct: 88  LQSLPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNP 135

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 51.9 bits (125), Expect = 9e-08
 Identities = 33/87 (37%), Positives = 50/87 (57%), Gaps = 5/87 (5%)

Query: 161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGV 219
           L+L  N+L       F  LT ++ L LS+N +  S+PD +  K+  L++L L++N+ +  
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 220 LPPSI-SNLTNLKELALLYNHLSGSIP 245
           LP  +   LT LKELAL  N L  S+P
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLK-SVP 116

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 28/113 (24%), Positives = 47/113 (41%), Gaps = 14/113 (12%)

Query: 34  YLDLTWNGFFGTIPPQI-SNLSNLRYLYLGSNQFSGNILAEVSSESSG--GNLRYMSRLV 90
            L+L  N    ++P  +   L+ L  L L  NQ          S   G    L  ++ L 
Sbjct: 32  RLELESNKL-QSLPHGVFDKLTQLTKLSLSQNQI--------QSLPDGVFDKLTKLTILY 82

Query: 91  INDNSLSGFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN 142
           +++N L   +P  +   L  L +L L  N+        FD L++L  ++L+ N
Sbjct: 83  LHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 36/151 (23%), Positives = 57/151 (37%), Gaps = 18/151 (11%)

Query: 291 IPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLG 350
           +  +L    +   + L+ NN+   I  +L    NL  + L RN    +I +       L 
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96

Query: 351 TLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI--VGEIPKELGKLNPLTKLILRGNQIT 408
            L +S N I       I     L+   +S N I   GEI  +L  L+ L  L+L GN + 
Sbjct: 97  ELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPLY 153

Query: 409 GRLPKE----------IGSLTKLEYLDFSAI 429
               +           +  L  L+ LD   +
Sbjct: 154 NDYKENNATSEYRIEVVKRLPNLKKLDGMPV 184

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 32/179 (17%), Positives = 67/179 (37%), Gaps = 13/179 (7%)

Query: 86  MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN--NKFSGPIPLSFDNLSNLIFLYLYGNL 143
           M++     +++  F            +++L          +  +   L     L L  N 
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNN 59

Query: 144 LSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKM 203
           +    +SSL  +++L  L L  N  I  I    +   ++  L +S N +  +    I K+
Sbjct: 60  IE--KISSLSGMENLRILSLGRNL-IKKIENLDAVADTLEELWISYNQI--ASLSGIEKL 114

Query: 204 RSLSVLDLNQNQ---FKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLS 259
            +L VL ++ N+   +  +    ++ L  L++L L  N L      +      R  ++ 
Sbjct: 115 VNLRVLYMSNNKITNWGEIDK--LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVK 171

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 35/158 (22%), Positives = 53/158 (33%), Gaps = 32/158 (20%)

Query: 297 NCTSLIRVRLNG--NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNV 354
             T   +V L+G    +   +   L        + LS NN   +I S+      L  L++
Sbjct: 21  VATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSL 77

Query: 355 SMNNIT--GGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLP 412
             N I     L      +  L+   +S N I       + KL  L  L +  N+IT    
Sbjct: 78  GRNLIKKIENLD---AVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKIT---- 128

Query: 413 KEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHN 450
              G + KL                 +  LE L L+ N
Sbjct: 129 -NWGEIDKLA---------------ALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 22/103 (21%), Positives = 43/103 (41%), Gaps = 7/103 (6%)

Query: 377 DLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPS 434
              +  I  ++   L  L     L L  N I  ++   +  +  L  L      I ++ +
Sbjct: 31  HGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKKIEN 87

Query: 435 QICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
                 +LE+L +S+N ++ S+ S  E +  L  + MS N++ 
Sbjct: 88  LDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 31/124 (25%), Positives = 51/124 (41%), Gaps = 12/124 (9%)

Query: 46  IPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG 105
           +   +S L   ++L L +N        ++SS S   NLR    L +  N +   I     
Sbjct: 40  MDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRI---LSLGRNLIKK-IENLDA 90

Query: 106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG-SILSSLGKLKSLFDLQLN 164
               L +L ++ N+ +    +  + L NL  LY+  N ++    +  L  L  L DL L 
Sbjct: 91  VADTLEELWISYNQIASLSGI--EKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLA 148

Query: 165 DNQL 168
            N L
Sbjct: 149 GNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 38/127 (29%), Positives = 51/127 (40%), Gaps = 24/127 (18%)

Query: 23  DFSFSSFPHLAYLDLTWNGFFGTIPPQISNLS---NLRYLYLGSNQFSGNILAEVSSESS 79
           D + S+     +L L+ N        +IS+LS   NLR L LG N     I      E+ 
Sbjct: 41  DATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRNLIK-KI------ENL 88

Query: 80  GGNLRYMSRLVINDN---SLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSF-DNLSNLI 135
                 +  L I+ N   SLSG     I  L  L  L ++NNK +    +     L  L 
Sbjct: 89  DAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143

Query: 136 FLYLYGN 142
            L L GN
Sbjct: 144 DLLLAGN 150

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 58.5 bits (142), Expect = 4e-09
 Identities = 62/259 (23%), Positives = 100/259 (38%), Gaps = 53/259 (20%)

Query: 550 KQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDFDAKYCIGNGGHASVYRAEL 609
                +G + +    P   + +L  +GK      +     +     IGNG    V++A+L
Sbjct: 6   SNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIA----YTNCKVIGNGSFGVVFQAKL 61

Query: 610 PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHS----- 652
              + VA+KK           D++    E            V+    F S+         
Sbjct: 62  VESDEVAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH----ALSYLH-HDCFPPIVHR 707
            L+ E++      A  +     Q +     M +IK   +    +L+Y+H       I HR
Sbjct: 114 NLVLEYVPETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLAYIHSIG----ICHR 165

Query: 708 DISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL-----AYTMKIT 761
           DI  +NLLLD       + DFG AK L     N   +  +  Y APEL      YT  I 
Sbjct: 166 DIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYICSRYYRAPELIFGATNYTTNI- 223

Query: 762 EKCDVYSFGVLMWEVIKGK 780
              D++S G +M E+++G+
Sbjct: 224 ---DIWSTGCVMAELMQGQ 239

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 57.7 bits (140), Expect = 5e-09
 Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 11/99 (11%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-CG-- 748
            L YLH      IVH+DI   NLLL       ++  G+A++L P +++  +   T  G  
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD--DTCRTSQGSP 175

Query: 749 -YIAPELAYTMKITE--KCDVYSFGVLMWEVIKGKHPRD 784
            +  PE+A  +      K D++S GV ++ +  G +P +
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 6/94 (6%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            + YLH+     I+HRDI   NLL+  +    +ADFG++   K   +  +   GT  ++A
Sbjct: 149 GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMA 205

Query: 752 PELAYTMKIT---EKCDVYSFGVLMWEVIKGKHP 782
           PE     +     +  DV++ GV ++  + G+ P
Sbjct: 206 PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 16/96 (16%)

Query: 692 ALSYLH-HDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAGTCGY 749
           A+ ++H       I HRDI  +NLL++ +     + DFG AK L P   +   +  +  Y
Sbjct: 153 AVGFIHSLG----ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYICSRFY 207

Query: 750 IAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
            APEL      YT  I    D++S G +  E+I GK
Sbjct: 208 RAPELMLGATEYTPSI----DLWSIGCVFGELILGK 239

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 54.3 bits (131), Expect = 9e-09
 Identities = 27/119 (22%), Positives = 54/119 (45%), Gaps = 15/119 (12%)

Query: 387 IPKELGKLNP--LTKLILRGNQIT-GRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKS 441
           I  EL    P  + +L+L  ++   G+L        +LE+L      +  + + +  +  
Sbjct: 7   IHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNK 65

Query: 442 LEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGL 500
           L+KL LS N +SG +    E    L+ +++S N+++           +++E LK  + L
Sbjct: 66  LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL---------STIEPLKKLENL 115

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 33/137 (24%), Positives = 51/137 (37%), Gaps = 11/137 (8%)

Query: 296 RNCTSLIRVRLNGNNLT-GNISEALGIYPNLTFIDLSRNNFYGEISS--NWGKFPKLGTL 352
           R  + +  + L+ +    G +      +  L F+          ++S  N  K  KL  L
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG----LTSIANLPKLNKLKKL 69

Query: 353 NVSMNNITGGLPREIGNSSQLQAFDLSLNHIVG-EIPKELGKLNPLTKLILRGNQITGR- 410
            +S N ++GGL         L   +LS N I      + L KL  L  L L   ++T   
Sbjct: 70  ELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129

Query: 411 --LPKEIGSLTKLEYLD 425
                    L +L YLD
Sbjct: 130 DYRENVFKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.5 bits (116), Expect = 8e-07
 Identities = 27/116 (23%), Positives = 52/116 (44%), Gaps = 8/116 (6%)

Query: 52  NLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLS 111
             S+++ L L +++ +     E   E        +  L   +  L+     ++  L  L 
Sbjct: 15  TPSDVKELVLDNSRSN-----EGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLK 67

Query: 112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG-SILSSLGKLKSLFDLQLNDN 166
           +L+L++N+ SG + +  +   NL  L L GN +   S +  L KL++L  L L + 
Sbjct: 68  KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 7e-06
 Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 25/137 (18%)

Query: 126 LSFDNLSNLIFLYLYGN-LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVST 184
           L     S++  L L  +    G +     + + L  L   +   +  I      L  +  
Sbjct: 11  LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG-LTSIA-NLPKLNKLKK 68

Query: 185 LRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSI 244
           L LS N + G +     K  +L+ L+L+ N+        I +L+ ++ L  L N      
Sbjct: 69  LELSDNRVSGGLEVLAEKCPNLTHLNLSGNK--------IKDLSTIEPLKKLEN------ 114

Query: 245 PPSLGNLILRQLLLSGN 261
                   L+ L L   
Sbjct: 115 --------LKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.7 bits (106), Expect = 2e-05
 Identities = 30/125 (24%), Positives = 53/125 (42%), Gaps = 27/125 (21%)

Query: 328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT--GGLPREIGNSSQLQAFDLSLNHIVG 385
           +D SR+N  G++     +F +L  L+     +T    LP      ++L+  +LS N + G
Sbjct: 24  LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLELSDNRVSG 78

Query: 386 EIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKL 445
            +     K   LT L L GN+I          L+ +E L              +++L+ L
Sbjct: 79  GLEVLAEKCPNLTHLNLSGNKIK--------DLSTIEPLK------------KLENLKSL 118

Query: 446 NLSHN 450
           +L + 
Sbjct: 119 DLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 20/100 (20%), Positives = 35/100 (35%), Gaps = 9/100 (9%)

Query: 44  GTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPH 103
           G +         L +L           L  +++      L+    L ++DN +SG +   
Sbjct: 32  GKLEGLTDEFEELEFLST-----INVGLTSIANLPKLNKLKK---LELSDNRVSGGLEVL 83

Query: 104 IGNLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGN 142
                 L+ L+L+ NK      +     L NL  L L+  
Sbjct: 84  AEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 56.9 bits (138), Expect = 1e-08
 Identities = 49/207 (23%), Positives = 85/207 (41%), Gaps = 34/207 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK---FHSLLPCDQTVDQKEFLTE------VEAFYGF 645
           IG G +  V  A +  +   VA+KK   F     C +T+ + + L        +      
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94

Query: 646 CSHARHSF----LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            +          ++ + +E   L  +L T    Q L        +  +   L Y+H    
Sbjct: 95  RAPTIEQMKDVYIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS--- 146

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAGTCGYIAPEL---- 754
             ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+    
Sbjct: 147 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206

Query: 755 -AYTMKITEKCDVYSFGVLMWEVIKGK 780
             YT  I    D++S G ++ E++  +
Sbjct: 207 KGYTKSI----DIWSVGCILAEMLSNR 229

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 56.1 bits (136), Expect = 2e-08
 Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 55/217 (25%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH---------------SLLPCDQTVDQKEF---- 635
           +GNG +A+VY+     +G  VA+K+                 SL+        KE     
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLM--------KELKHEN 64

Query: 636 ---LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH- 691
              L +V              L++EF++   L   ++             +N++K     
Sbjct: 65  IVRLYDV------IHTENKLTLVFEFMDN-DLKKYMD-SRTVGNTPRGLELNLVKYFQWQ 116

Query: 692 ---ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
               L++ H +    I+HRD+  +NLL++   +  + DFG+A++     + ++    T  
Sbjct: 117 LLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173

Query: 749 YIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           Y AP++      Y+  I    D++S G ++ E+I GK
Sbjct: 174 YRAPDVLMGSRTYSTSI----DIWSCGCILAEMITGK 206

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 56.2 bits (136), Expect = 2e-08
 Identities = 48/248 (19%), Positives = 82/248 (33%), Gaps = 77/248 (31%)

Query: 582 EIVKATNDFDAKY----CIGNGGHASVYRAELPSGEVVAVKKFHSLL-------PCDQTV 630
           +++   +   + Y     I +G + +V       G  VA+K+  + +           + 
Sbjct: 12  DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSF 71

Query: 631 DQKEFLTEVEAFYGFCSHARHS--------------------FLLYEFLERGSLAAILNT 670
             K  L E+       +H  H                     +L+ E +          T
Sbjct: 72  LCKRVLREIR----LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR---------T 118

Query: 671 DAAAQELGWSQRMNVIKAVAHALSYLHHDCF-------------PPIVHRDISSKNLLLD 717
           D A           VI      +S  H   F               +VHRD+   N+LL 
Sbjct: 119 DLA----------QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLA 168

Query: 718 LEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL-----AYTMKITEKCDVYSFGVL 772
              +  + DF +A+    D +N T +     Y APEL      +T  +    D++S G +
Sbjct: 169 DNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLV----DMWSAGCV 223

Query: 773 MWEVIKGK 780
           M E+   K
Sbjct: 224 MAEMFNRK 231

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 76/490 (15%), Positives = 154/490 (31%), Gaps = 79/490 (16%)

Query: 21  LHDFSFSSFPHLAYLDLTWNGFFGTIPPQI----SNLSNLRYLYLGSNQFSGNILAEVSS 76
           L        P  A  +L    + G + P +    +NL  L+ ++      S   L  ++ 
Sbjct: 75  LRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLA- 133

Query: 77  ESSGGNLRYMSRLV----INDNSLSGFIPPHIGNLKFLSQLDLTNNKFS-------GPIP 125
           ++   +L  +  L        + L   +     + + +  L +  + FS         + 
Sbjct: 134 KARADDLETLK-LDKCSGFTTDGLLSIVT----HCRKIKTLLMEESSFSEKDGKWLHELA 188

Query: 126 LSFDNLSNLIFLYLYGNLLSGSILSSLGK-LKSLFDLQLNDNQLIGY--IPRPFSNLTSV 182
               +L  L F       +S   L ++ +  +SL  +++ D +++      +  +NL   
Sbjct: 189 QHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEF 248

Query: 183 STLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG 242
               L+ +         +   R L  L L+       +P        +++L LLY  L  
Sbjct: 249 CGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLET 307

Query: 243 SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLI 302
               +L                      I +   LE+           +    + C  L 
Sbjct: 308 EDHCTL----------------------IQKCPNLEVLETRNVIGDRGLEVLAQYCKQLK 345

Query: 303 RVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT-G 361
           R+R+        + +  G+      I L++               +L  + V +++IT  
Sbjct: 346 RLRIERGADEQGMEDEEGLVSQRGLIALAQG------------CQELEYMAVYVSDITNE 393

Query: 362 GLPREIGNSSQLQAF------------DLSLNHIVGEIPKELGKLNPLTKLILRGNQITG 409
            L         L  F            DL L++ V  +     KL       LR   +T 
Sbjct: 394 SLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFA-FYLRQGGLTD 452

Query: 410 RLPKEIGSL-TKLEYLDFSAIGE----LPSQICNMKSLEKLNLSHNNLS-GSIPSCFEGM 463
                IG     + ++    +GE    L        +L+KL +     S  +I +    +
Sbjct: 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKL 512

Query: 464 HGLSFIDMSY 473
             L ++ +  
Sbjct: 513 PSLRYLWVQG 522

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 43.4 bits (102), Expect = 3e-04
 Identities = 51/313 (16%), Positives = 94/313 (30%), Gaps = 40/313 (12%)

Query: 160 DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV 219
            + L        + R F NL S+      R  +F  IP+  G   +  V ++        
Sbjct: 56  TMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEI-------- 107

Query: 220 LPPSISNLTNLKELALLYNHLSGSIPPSLGNLI------LRQLLLSG-NHFTGYLPYNIC 272
                +NL  LK +      +S      L  L       L  L L   + FT     +I 
Sbjct: 108 ----SNNLRQLKSVHFRRMIVSDL---DLDRLAKARADDLETLKLDKCSGFTTDGLLSIV 160

Query: 273 RG-GALEIFTVSENHFQGTIPTSL----RNCTSLIRVRL---NGNNLTGNISEALGIY-P 323
                ++   + E+ F       L    ++ TSL  +         ++    E +     
Sbjct: 161 THCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR 220

Query: 324 NLTFIDLSRNNFYGEIS--SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLN 381
           +L  + +        +          +    +++ +         +    +L    L L+
Sbjct: 221 SLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC--RLGLS 278

Query: 382 HIVGEIPKELGKLNP-LTKLILRG-NQITGRLPKEIGSLTKLEYLDFS-AIGE--LPSQI 436
           ++       L      + KL L      T      I     LE L+    IG+  L    
Sbjct: 279 YMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLA 338

Query: 437 CNMKSLEKLNLSH 449
              K L++L +  
Sbjct: 339 QYCKQLKRLRIER 351

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 55.6 bits (135), Expect = 2e-08
 Identities = 52/214 (24%), Positives = 89/214 (41%), Gaps = 54/214 (25%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFH----------------SLLPCDQTVDQKEF---- 635
           IG G +  VY+A+   GE  A+KK                  S+L        KE     
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISIL--------KELKHSN 61

Query: 636 ---LTEVEAFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
              L +V        H +    L++E L++  L  +L  D     L      + +  + +
Sbjct: 62  IVKLYDVI-------HTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLLN 111

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            ++Y H      ++HRD+  +NLL++ E E  +ADFG+A++       +T    T  Y A
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168

Query: 752 PEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           P++      Y+  I    D++S G +  E++ G 
Sbjct: 169 PDVLMGSKKYSTTI----DIWSVGCIFAEMVNGT 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 55.7 bits (135), Expect = 3e-08
 Identities = 43/220 (19%), Positives = 82/220 (37%), Gaps = 61/220 (27%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH----------------SLLPCDQTVDQKEF--- 635
           +G G +  VY+A +  + E VA+K+                  SLL        KE    
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLL--------KELQHR 93

Query: 636 ----LTEVEAFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
               L  V        H  H   L++E+ E   L   ++      ++      + +  + 
Sbjct: 94  NIIELKSVI-------HHNHRLHLIFEYAEN-DLKKYMDK---NPDVSMRVIKSFLYQLI 142

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH-----VADFGIAKSLKPDSSNWTEFAG 745
           + +++ H       +HRD+  +NLLL +   +      + DFG+A++       +T    
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199

Query: 746 TCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           T  Y  PE+      Y+  +    D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHYSTSV----DIWSIACIWAEMLMKT 235

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 55.7 bits (133), Expect = 3e-08
 Identities = 27/162 (16%), Positives = 54/162 (33%), Gaps = 24/162 (14%)

Query: 313 GNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS-- 370
            ++S  L   P L  + +   N    +S      P L +L +    +   +  +I  S  
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTN---NLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 371 SQLQAFDLSL---NHIVGEIPKEL------GKLNPLTKLILRGNQITGRLPKEIGS---L 418
             L+   L +   ++                +   L  L +   +    + +       L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278

Query: 419 TKLEYLDFS-------AIGELPSQICNMKSLEKLNLSHNNLS 453
            +LE +D S           L   +  +K L+ +N+ +N LS
Sbjct: 279 PQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 53.0 bits (126), Expect = 2e-07
 Identities = 30/157 (19%), Positives = 53/157 (33%), Gaps = 13/157 (8%)

Query: 23  DFSFSSFPHLAYLDLTWNGFFGTIPPQI--SNLSNLRYL--YLGSNQFSGNI-LAEVSSE 77
                  P+L  L++   G   ++   I  S+L NL  L  Y+G   +  +  +      
Sbjct: 186 SIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL 245

Query: 78  SSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQL---DLTNNKFSG----PIPLSFDN 130
            S      +  L I D      +         L QL   D++    +      +    D 
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305

Query: 131 LSNLIFLYLYGNLLSGSILSSLGK-LKSLFDLQLNDN 166
           + +L F+ +  N LS  +   L K L    D+  +  
Sbjct: 306 IKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQE 342

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 44.9 bits (105), Expect = 7e-05
 Identities = 23/169 (13%), Positives = 50/169 (29%), Gaps = 20/169 (11%)

Query: 220 LPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGA--- 276
           L P +  +  L  L +     +           L+ L +        +  +I        
Sbjct: 164 LSPVLDAMPLLNNLKIKGT--NNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221

Query: 277 --LEIFTVSENHFQGTIPTSL------RNCTSLIRVRLNGNNLTGNISEALG---IYPNL 325
             L ++   E++                   +L  + +        + E      I P L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281

Query: 326 TFIDLSRNNFYGE----ISSNWGKFPKLGTLNVSMNNITGGLPREIGNS 370
             +D+S      E    +  +  K   L  +N+  N ++  + +E+  S
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 46/216 (21%), Positives = 80/216 (37%), Gaps = 43/216 (19%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKK--FHSLLPCDQT---------------VDQKEFLT 637
           +G GG+  V+ A +    + VA+KK                           V   E L 
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78

Query: 638 EVEAFYGFCSHARHSF----LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
              +       +        ++ E++E   LA +L        L        +  +   L
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGL 133

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSN---WTEFAGTCGY 749
            Y+H      ++HRD+   NL ++ E     + DFG+A+ + P  S+    +E   T  Y
Sbjct: 134 KYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWY 190

Query: 750 IAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
            +P L      YT  I    D+++ G +  E++ GK
Sbjct: 191 RSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.1 bits (133), Expect = 4e-08
 Identities = 33/100 (33%), Positives = 46/100 (46%), Gaps = 19/100 (19%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH--VADFGIAKSLKPDSSNWTEFAGTCG- 748
            +SY H      I HRD+  +N LLD        + DFG +KS    S   +    T G 
Sbjct: 128 GVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS----TVGT 180

Query: 749 --YIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHP 782
             YIAPE+     Y  K     DV+S GV ++ ++ G +P
Sbjct: 181 PAYIAPEVLLRQEYDGK---IADVWSCGVTLYVMLVGAYP 217

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 54.1 bits (131), Expect = 6e-08
 Identities = 53/213 (24%), Positives = 91/213 (42%), Gaps = 52/213 (24%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFH----------------SLLPCDQTVDQKEF---- 635
           +G G +  VY+A+   G +VA+K+                  SLL        KE     
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLL--------KELHHPN 80

Query: 636 ---LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
              L +V          R   L++EF+E+  L  +L  D     L  SQ    +  +   
Sbjct: 81  IVSLIDV------IHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLLRG 131

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           +++ H      I+HRD+  +NLL++ +    +ADFG+A++      ++T    T  Y AP
Sbjct: 132 VAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188

Query: 753 EL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           ++      Y+  +    D++S G +  E+I GK
Sbjct: 189 DVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 53.3 bits (129), Expect = 1e-07
 Identities = 41/205 (20%), Positives = 79/205 (38%), Gaps = 50/205 (24%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH----------------SLLPCDQTVDQKEF--- 635
           IG G + +V++A    + E+VA+K+                   LL        KE    
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL--------KELKHK 61

Query: 636 ----LTEVEAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
               L +V          +   L++EF ++  L      D+   +L      + +  +  
Sbjct: 62  NIVRLHDV------LHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQLLK 112

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L + H      ++HRD+  +NLL++   E  +A+FG+A++       ++    T  Y  
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRP 169

Query: 752 PELAYTMKITEKCDVYSFGVLMWEV 776
           P++ +         +YS  + MW  
Sbjct: 170 PDVLF------GAKLYSTSIDMWSA 188

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 45/214 (21%), Positives = 87/214 (40%), Gaps = 54/214 (25%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH---------------SLLPCDQTVDQKEF---- 635
           +G G +A+VY+     +  +VA+K+                 SLL        K+     
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL--------KDLKHAN 61

Query: 636 ---LTEVEAFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
              L ++        H   S  L++E+L++  L   L  D     +        +  +  
Sbjct: 62  IVTLHDII-------HTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQLLR 111

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
            L+Y H      ++HRD+  +NLL++   E  +ADFG+A++    +  +     T  Y  
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRP 168

Query: 752 PEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           P++      Y+ +I    D++  G + +E+  G+
Sbjct: 169 PDILLGSTDYSTQI----DMWGVGCIFYEMATGR 198

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 32/84 (38%), Positives = 41/84 (48%), Gaps = 12/84 (14%)

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL-----GKLKSLFDLQLNDNQ 167
           L L NN+ +   P  FD+L NL  LY   N      L+++      KL  L  L LNDN 
Sbjct: 38  LWLNNNQITKLEPGVFDHLVNLQQLYFNSNK-----LTAIPTGVFDKLTQLTQLDLNDNH 92

Query: 168 LIGYIPR-PFSNLTSVSTLRLSRN 190
           L   IPR  F NL S++ + L  N
Sbjct: 93  LKS-IPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 2/79 (2%)

Query: 161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGV 219
           L LN+NQ+    P  F +L ++  L  + N L  +IP  +  K+  L+ LDLN N  K +
Sbjct: 38  LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKL-TAIPTGVFDKLTQLTQLDLNDNHLKSI 96

Query: 220 LPPSISNLTNLKELALLYN 238
              +  NL +L  + L  N
Sbjct: 97  PRGAFDNLKSLTHIYLYNN 115

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 53.4 bits (129), Expect = 1e-07
 Identities = 57/219 (26%), Positives = 79/219 (36%), Gaps = 75/219 (34%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHA----- 649
           +G G  A+VY+A +  + ++VA+KK                    EA  G    A     
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIK-------------LGHRSEAKDGINRTALREIK 64

Query: 650 -----RHS---------------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                 H                 L+++F+E   L  I+     +  L  S     IKA 
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVII--KDNSLVLTPSH----IKAY 117

Query: 690 AH----ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS----LKPDSSN-- 739
                  L YLH      I+HRD+   NLLLD      +ADFG+AKS     +  +    
Sbjct: 118 MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174

Query: 740 --WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEV 776
             W        Y APEL +         +Y  GV MW V
Sbjct: 175 TRW--------YRAPELLF------GARMYGVGVDMWAV 199

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 52.2 bits (126), Expect = 2e-07
 Identities = 31/100 (31%), Positives = 50/100 (50%), Gaps = 17/100 (17%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG--- 748
           A+ Y H      +VHRD+  +N+LLD    A +ADFG++  +       T    +CG   
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT----SCGSPN 175

Query: 749 YIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
           Y APE+     Y      + D++S GV+++ ++ G  P D
Sbjct: 176 YAAPEVISGRLYA---GPEVDIWSCGVILYALLCGTLPFD 212

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 73/477 (15%), Positives = 144/477 (30%), Gaps = 69/477 (14%)

Query: 21  LHDFSFSSFPHLAYLDLTWNGFFGTIPPQI----SNLSNLRYLYLGSNQFSGNILAEVSS 76
           +        PH A  +L  +G+ G + P I    S+ + L  + L     + + L  ++ 
Sbjct: 68  VRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAK 127

Query: 77  ESSGGNLRYMSRLV----INDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSF---- 128
                N + +  L      + + L+          + L +LDL  +              
Sbjct: 128 SFK--NFKVLV-LSSCEGFSTDGLAAIA----ATCRNLKELDLRESDVDDVSGHWLSHFP 180

Query: 129 DNLSNLIFLYL--YGNLLSGSILSSLGK-LKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL 185
           D  ++L+ L +    + +S S L  L     +L  L+LN    +  +         +  L
Sbjct: 181 DTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEEL 240

Query: 186 RLS------RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH 239
                    R D++  +   +   + L  L    +     LP   S  + L  L L Y  
Sbjct: 241 GTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYAT 300

Query: 240 LS-------GSIPPSLGNLILR--------QLLLSGNHFTGYLPYNICRGGALEIFT-VS 283
           +            P L  L +         ++L S       L         +E    ++
Sbjct: 301 VQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALT 360

Query: 284 ENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY-PNLTFIDLSRNNFYGEISSN 342
           E        +    C  L  V      +T      +    PN+T   L        I   
Sbjct: 361 EQGLV----SVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCI------IEPK 410

Query: 343 WGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNP-LTKLI 401
              +  L  L++    I             L+   LS   +  ++ + +G     +  L 
Sbjct: 411 APDYLTLEPLDIGFGAIVEHCKD-------LRRLSLS-GLLTDKVFEYIGTYAKKMEMLS 462

Query: 402 LRGNQITGRLPKEIG-SLTKLEYLDFSA----IGELPSQICNMKSLEKLNLSHNNLS 453
           +     +      +      L  L+          L +    ++++  L +S  ++S
Sbjct: 463 VAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 52.2 bits (125), Expect = 5e-07
 Identities = 77/491 (15%), Positives = 151/491 (30%), Gaps = 80/491 (16%)

Query: 26  FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY 85
              FP +  ++L     F              Y ++ +   S   L E+           
Sbjct: 62  IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIR---------- 111

Query: 86  MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN-NKFSGP-IPLSFDNLSNLIFLYLYGNL 143
           + R+V+ D+ L         + K    L L++   FS   +        NL  L L  + 
Sbjct: 112 LKRMVVTDDCLELIAK----SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESD 167

Query: 144 LSG-------SILSSLGKLKSL----FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL 192
           +             +   L SL       +++ + L   +     NL S   L+L+R   
Sbjct: 168 VDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALE-RLVTRCPNLKS---LKLNRAVP 223

Query: 193 FGSIPDEIGKMRSLSVLDLN------QNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP 246
              +   + +   L  L         +      L  ++S    L+ L+  ++ +   +P 
Sbjct: 224 LEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPA 283

Query: 247 SLGNLI-LRQLLLSGNHFTGY-LPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRV 304
                  L  L LS      Y L   +C+   L+   V +      +      C  L  +
Sbjct: 284 VYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLREL 343

Query: 305 RLNG---------NNLTGNISEALGIY-PNLTFIDLSRNNFYGEISSNWG------KFPK 348
           R+             LT     ++ +  P L  +            +N          P 
Sbjct: 344 RVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQM-----TNAALITIARNRPN 398

Query: 349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT 408
           +    +        +  +  +   L+  D+    IV            L +L L G  +T
Sbjct: 399 MTRFRLC------IIEPKAPDYLTLEPLDIGFGAIVEHCKD-------LRRLSLSGL-LT 444

Query: 409 GRLPKEIGS-LTKLEYLDFSAIGE----LPSQICNMKSLEKLNLSHNNLSG-SIPSCFEG 462
            ++ + IG+   K+E L  +  G+    +   +    SL KL +        ++ +    
Sbjct: 445 DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASK 504

Query: 463 MHGLSFIDMSY 473
           +  +  + MS 
Sbjct: 505 LETMRSLWMSS 515

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.0 bits (114), Expect = 1e-05
 Identities = 58/407 (14%), Positives = 118/407 (28%), Gaps = 69/407 (16%)

Query: 110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI 169
           +  ++L          L  D     ++ ++     S + L  +     L  + + D+ L 
Sbjct: 68  VRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEI----RLKRMVVTDDCL- 122

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
             I + F N      L LS  + F +          L+ +               +   N
Sbjct: 123 ELIAKSFKNFKV---LVLSSCEGFST--------DGLAAI--------------AATCRN 157

Query: 230 LKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQG 289
           LKEL L  + +       L +       L   + +     +     ALE           
Sbjct: 158 LKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCL--ASEVSFSALERL--------- 206

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLS------RNNFYGEISSNW 343
                +  C +L  ++LN       ++  L   P L  +         R + Y  +S   
Sbjct: 207 -----VTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVAL 261

Query: 344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGE-IPKELGKLNPLTKLIL 402
               +L  L+   + +   LP      S+L   +LS   +    + K L +   L +L +
Sbjct: 262 SGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV 321

Query: 403 RGNQITGRLPKEIGS-LTKLEYLDFSAIGELPSQIC-------------NMKSLEKLNLS 448
             + I     + + S    L  L          +                   LE +   
Sbjct: 322 L-DYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYF 380

Query: 449 HNNLSG-SIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEAL 494
              ++  ++ +       ++   +   E + P   +         A+
Sbjct: 381 CRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAI 427

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 52.7 bits (127), Expect = 2e-07
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 17/100 (17%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCG--- 748
           A+ Y H      IVHRD+  +NLLLD      +ADFG++  +   +   T    +CG   
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT----SCGSPN 172

Query: 749 YIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
           Y APE+     Y      + DV+S G++++ ++ G+ P D
Sbjct: 173 YAAPEVINGKLYA---GPEVDVWSCGIVLYVMLVGRLPFD 209

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 50.3 bits (121), Expect = 2e-07
 Identities = 32/84 (38%), Positives = 40/84 (47%), Gaps = 12/84 (14%)

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL-----GKLKSLFDLQLNDNQ 167
           L L +N+ +   P  FD L+ L  L L  N      L+ L      KL  L  L LNDNQ
Sbjct: 35  LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQ-----LTVLPAGVFDKLTQLTQLSLNDNQ 89

Query: 168 LIGYIPR-PFSNLTSVSTLRLSRN 190
           L   IPR  F NL S++ + L  N
Sbjct: 90  LKS-IPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 28/79 (35%), Positives = 39/79 (49%), Gaps = 2/79 (2%)

Query: 161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI-GKMRSLSVLDLNQNQFKGV 219
           L L DNQ+    P  F  LT ++ L L  N L   +P  +  K+  L+ L LN NQ K +
Sbjct: 35  LYLYDNQITKLEPGVFDRLTQLTRLDLDNNQL-TVLPAGVFDKLTQLTQLSLNDNQLKSI 93

Query: 220 LPPSISNLTNLKELALLYN 238
              +  NL +L  + LL N
Sbjct: 94  PRGAFDNLKSLTHIWLLNN 112

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 51.8 bits (125), Expect = 3e-07
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 16/101 (15%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-CG-- 748
            + YLH      I HRDI  +NLLLD      ++DFG+A   + ++          CG  
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--RLLNKMCGTL 171

Query: 749 -YIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
            Y+APEL     +     E  DV+S G+++  ++ G+ P D
Sbjct: 172 PYVAPELLKRREFH---AEPVDVWSCGIVLTAMLAGELPWD 209

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 52.2 bits (126), Expect = 4e-07
 Identities = 47/220 (21%), Positives = 85/220 (38%), Gaps = 53/220 (24%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH----------------SLLPCDQTVDQKEF--- 635
           IG G    V++A    +G+ VA+KK                   +L        +     
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL--------QLLKHE 76

Query: 636 ----LTEV--EAFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
               L E+       +       +L+++F E   LA +L       +   S+   V++ +
Sbjct: 77  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL--SNVLVKFTLSEIKRVMQML 133

Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS----LKPDSSNWTEFAG 745
            + L Y+H +    I+HRD+ + N+L+  +    +ADFG+A++         + +T    
Sbjct: 134 LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190

Query: 746 TCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           T  Y  PEL      Y   I    D++  G +M E+    
Sbjct: 191 TLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 43/260 (16%), Positives = 87/260 (33%), Gaps = 19/260 (7%)

Query: 224 ISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVS 283
            S+ +  + L L   +L   +   L +  +       +     L  +        +   +
Sbjct: 43  ASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSN 102

Query: 284 ENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSR-----NNFYGE 338
                 T+   L  C+ L  + L G  L+  I   L    NL  ++LS            
Sbjct: 103 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT 162

Query: 339 ISSNWGKFPKLGTLNVS-MNNIT-GGLPREIG-NSSQLQAFDLS-LNHIVGEIP-KELGK 393
           + S+     +L  LN+S   + T   +   +   S  +   +LS     + +     L +
Sbjct: 163 LLSS---CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 219

Query: 394 LNP-LTKLILRG-NQITGRLPKEIGSLTKLEYLDFSAIGELPSQ----ICNMKSLEKLNL 447
             P L  L L     +     +E   L  L++L  S   ++  +    +  + +L+ L +
Sbjct: 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV 279

Query: 448 SHNNLSGSIPSCFEGMHGLS 467
                 G++    E +  L 
Sbjct: 280 FGIVPDGTLQLLKEALPHLQ 299

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 51.2 bits (123), Expect = 6e-07
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 16/101 (15%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-CG-- 748
            + YLH      I HRDI  +NLLLD      ++DFG+A   + ++          CG  
Sbjct: 117 GVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--RLLNKMCGTL 171

Query: 749 -YIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
            Y+APEL     +     E  DV+S G+++  ++ G+ P D
Sbjct: 172 PYVAPELLKRREFH---AEPVDVWSCGIVLTAMLAGELPWD 209

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 19/101 (18%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGT-CG-- 748
            + Y H      +VHRD+  +N+LLD    A +ADFG++  +        EF  T CG  
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-----EFLRTSCGSP 179

Query: 749 -YIAPEL----AYTMKITEKCDVYSFGVLMWEVIKGKHPRD 784
            Y APE+     Y      + D++S GV+++ ++ G  P D
Sbjct: 180 NYAAPEVISGRLYA---GPEVDIWSSGVILYALLCGTLPFD 217

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 26/109 (23%), Positives = 47/109 (43%), Gaps = 15/109 (13%)

Query: 683 MNVIKAVAH----ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH------VADFGIAKS 732
           +  +K ++      L Y+H  C   I+H DI  +N+L+++           +AD G A  
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187

Query: 733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKH 781
                 ++T    T  Y +PE+          D++S   L++E+I G  
Sbjct: 188 ---YDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 49.9 bits (120), Expect = 1e-06
 Identities = 49/214 (22%), Positives = 84/214 (39%), Gaps = 43/214 (20%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH-------------------SLLPCDQTVDQKEF 635
           IG G + +VY+A +  SG  VA+K                      +LL   +  +    
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 636 LTEVEAFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH--- 691
           +  ++      +       L++E +++  L   L+  A    L        IK +     
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPPGLP----AETIKDLMRQFL 130

Query: 692 -ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
             L +LH +C   IVHRD+  +N+L+       +ADFG+A+         T    T  Y 
Sbjct: 131 RGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYR 186

Query: 751 APEL----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           APE+     Y   +    D++S G +  E+ + K
Sbjct: 187 APEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 49.9 bits (120), Expect = 2e-06
 Identities = 45/212 (21%), Positives = 82/212 (38%), Gaps = 41/212 (19%)

Query: 596 IGNGGHASVYRA--ELPSGEVVAVKKFH----------------SLLPCDQTVDQKEFLT 637
           IG G +  V++A      G  VA+K+                  ++L   +T +    + 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78

Query: 638 EVEAFYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH----A 692
             +      +       L++E +++  L   L+      E G       IK +       
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK---VPEPGVP--TETIKDMMFQLLRG 132

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L +LH      +VHRD+  +N+L+    +  +ADFG+A+         T    T  Y AP
Sbjct: 133 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALTSVVVTLWYRAP 188

Query: 753 EL----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           E+    +Y   +    D++S G +  E+ + K
Sbjct: 189 EVLLQSSYATPV----DLWSVGCIFAEMFRRK 216

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 27/104 (25%), Positives = 48/104 (46%), Gaps = 22/104 (21%)

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN----------WT 741
           A+  LH      ++HRD+   NLL++   +  V DFG+A+ +   +++            
Sbjct: 124 AVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 742 EFAGTCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
           EF  T  Y APE+      Y+  +    DV+S G ++ E+   +
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 47.8 bits (114), Expect = 8e-06
 Identities = 51/384 (13%), Positives = 100/384 (26%), Gaps = 74/384 (19%)

Query: 109 FLSQLDL-TNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL----FDLQL 163
            L  L    N      +     NL  L         L       L   + L    F  + 
Sbjct: 2   LLVGLLSAHNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEF 61

Query: 164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKM-----RSLSVLDLNQNQF-- 216
            + +           L+S+  L L+   +       +  +      +L  ++L   Q   
Sbjct: 62  QNQRFS------AEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDP 115

Query: 217 KGVLPPSISN-LTNLKELALLYNHLSGSIPPSLGNLI------LRQLLLSGNHFTGYLPY 269
            G+   ++       ++L L  N L       L +L+      +  L LS N  T     
Sbjct: 116 AGLR--TLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTA---- 169

Query: 270 NICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGN----ISEALGIYPNL 325
                G   +               L   TS+  + L    L       ++  L     L
Sbjct: 170 ----AGVAVLMEG------------LAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQL 213

Query: 326 TFIDLSRNNFYGE----ISSNWGKFPKLGTLNVSMNNIT-------GGLPREIGNSSQLQ 374
             ++++ N         ++    + P L  L++  N ++         L       +++ 
Sbjct: 214 QELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVV 273

Query: 375 AFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPS 434
                   +       L ++        R      R   +      L  L+ S    L  
Sbjct: 274 VSLTEGTAVSEYWSVILSEV-------QRNLNSWDRARVQRHLELLLRDLEDSRGATLNP 326

Query: 435 Q-----ICNMKSLEKLNLSHNNLS 453
                 +     +  L     +  
Sbjct: 327 WRKAQLLRVEGEVRALLEQLGSSG 350

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 48/308 (15%), Positives = 92/308 (29%), Gaps = 60/308 (19%)

Query: 107 LKFLSQLDLTNNKFS--GPIPLSF---DNLSNLIFLYLYGNLLSGSILSSLGK-LKSLFD 160
           L  L QL+L   + +      ++         L  + L    L  + L +L         
Sbjct: 71  LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130

Query: 161 LQLNDNQL-------IGYIPRPFSNLTSVSTLRLSRNDL----FGSIPDEIGKMRSLSVL 209
           L L  N L       +  +     +   ++TLRLS N L       + + +    S++ L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLL--HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHL 188

Query: 210 DLNQNQF--KGV--LPPSISNLTNLKELALLYNHLSGSIPPSLG-----NLILRQLLLSG 260
            L       +G+  L   +     L+EL + YN    +   +L      +  L  L L  
Sbjct: 189 SLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYF 248

Query: 261 NHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALG 320
           N         +   G   +  +           +      ++     G  ++   S  L 
Sbjct: 249 NE--------LSSEGRQVLRDLGG---------AAEGGARVVVSLTEGTAVSEYWSVILS 291

Query: 321 -IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS----SQLQA 375
            +  NL   D +R            +  +L   ++  +      P           +++A
Sbjct: 292 EVQRNLNSWDRARVQ----------RHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRA 341

Query: 376 FDLSLNHI 383
               L   
Sbjct: 342 LLEQLGSS 349

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 46.5 bits (111), Expect = 2e-05
 Identities = 43/224 (19%), Positives = 75/224 (33%), Gaps = 79/224 (35%)

Query: 584 VKATNDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE 638
           +K     D        +G G +  V +     + E  A+K            D  +   E
Sbjct: 10  IKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARRE 60

Query: 639 V----------------EAFYGFCSHARHSFLLYEFLERGSL-AAILN--------TDAA 673
           V                + +    +  +   ++ E L+ G L + I +         +A+
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120

Query: 674 AQELGWSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISSKNLLLDLEYEAH---VADFGI 729
                      ++K++  A+ YLH  +    I HRD+  +NLL   +       + DFG 
Sbjct: 121 E----------IMKSIGEAIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGF 166

Query: 730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLM 773
           AK          E  G   Y            + CD++S GV+M
Sbjct: 167 AK----------ETTGE-KY-----------DKSCDMWSLGVIM 188

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 24/111 (21%), Positives = 43/111 (38%), Gaps = 14/111 (12%)

Query: 327 FIDLSRNNFYGEISSNWG-KFPKLGTLNVSMNNITG--GLPREIGNSSQLQAFDLSLNHI 383
            + L+R +             P+L +LN+S N +     +   +  +  L+  +LS N +
Sbjct: 149 DVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNEL 208

Query: 384 VGEIPKELGKLN--PLTKLILRGNQITGRLPKE-------IGSLTKLEYLD 425
             +  +EL K+    L +L L GN +      +            KL  LD
Sbjct: 209 --KSERELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 46.4 bits (110), Expect = 3e-05
 Identities = 28/170 (16%), Positives = 51/170 (30%), Gaps = 56/170 (32%)

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE------------------------- 719
           +I+ V   L YLH  C   I+H DI  +N+LL +                          
Sbjct: 151 IIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208

Query: 720 ------------------------YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
                                    +  +AD G A        ++TE   T  Y + E+ 
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVL 265

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD 805
                    D++S   + +E+  G +   F           +  +  +++
Sbjct: 266 IGSGYNTPADIWSTACMAFELATGDYL--FEPHSGEEYTRDEDHIALIIE 313

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185

 Score = 43.4 bits (103), Expect = 7e-05
 Identities = 22/135 (16%), Positives = 38/135 (28%), Gaps = 19/135 (14%)

Query: 295 LRNCTSLIRVRLNGNNLTGN-----ISEALGIYPNLTFIDLSRNNFYGEISSNWGKF--- 346
             N   L  V LN             +EAL     +    +        ++    +    
Sbjct: 32  QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKV 91

Query: 347 -PKLGTLNVSMNNITGGLPREIGNS----SQLQAFDLSLNH--IVGEIPKELG---KLNP 396
              L +LNV  N I+G     +  +    + L    +      +   +  E+    + N 
Sbjct: 92  NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNT 151

Query: 397 -LTKLILRGNQITGR 410
            L K      Q   R
Sbjct: 152 TLLKFGYHFTQQGPR 166

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 55/226 (24%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSHA----- 649
           +G G +  V+++ +  +GEVVAVKK         + D +    E+        H      
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFD--AFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 650 ---------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC 700
                    R  +L+++++E   L A++        L    +  V+  +   + YLH   
Sbjct: 75  LNVLRADNDRDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS-- 127

Query: 701 FPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--------------------- 739
              ++HRD+   N+LL+ E    VADFG+++S                            
Sbjct: 128 -GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186

Query: 740 WTEFAGTCGYIAPEL-----AYTMKITEKCDVYSFGVLMWEVIKGK 780
            T++  T  Y APE+      YT  I    D++S G ++ E++ GK
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILGEILCGK 228

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 48/280 (17%), Positives = 89/280 (31%), Gaps = 69/280 (24%)

Query: 549 RKQKSDSGDRQSNNQIPQGSLSILNFEGKILYDEIVKATNDF--DAKY----CIGNGGHA 602
             Q+ +SG + + +   Q                + +  +D+    +Y     IG G + 
Sbjct: 8   AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYG 67

Query: 603 SVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGFCSH------------- 648
            V  A +     VVA+KK       +  +D K  L E+ A     +H             
Sbjct: 68  HVCEAYDKLEKRVVAIKKIL--RVFEDLIDCKRILREI-AILNRLNHDHVVKVLDIVIPK 124

Query: 649 ARHSF----LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFPP 703
               F    ++ E  +      +  T      L       ++  +   + Y+H       
Sbjct: 125 DVEKFDELYVVLEIADS-DFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSAG---- 176

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN------------------------ 739
           I+HRD+   N L++ +    V DFG+A+++    +                         
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236

Query: 740 ---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEV 776
               T    T  Y APEL          + Y+  + +W +
Sbjct: 237 KRQLTGHVVTRWYRAPELILL------QENYTEAIDVWSI 270

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 41.8 bits (97), Expect = 7e-04
 Identities = 35/228 (15%), Positives = 59/228 (25%), Gaps = 62/228 (27%)

Query: 586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFH----SLLPCDQTVDQKEFLTEV-- 639
            T        IG G    V++        VA+K        L+        +E L E+  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 640 ---------------EAFYGFCSH-----ARHSFLLYEFL----ERGSLAAILNTDAAAQ 675
                          E F G  S      +    LL  +      +GS     +     Q
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 676 --------------------ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLL 715
                                   +   +++  +  +L+           HRD+   N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194

Query: 716 LDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEK 763
           L       +      KS             +CG     + YT+   E+
Sbjct: 195 LKKTSLKKLHYTLNGKSSTI---------PSCGLQVSIIDYTLSRLER 233

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	849
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.98
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.98
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.95
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.91
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.91
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.91
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.9
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.88
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.86
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.86
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.83
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.82
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.8
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.77
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.77
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.76
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.74
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.74
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.74
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.74
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.73
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.72
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.7
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.67
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.64
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.64
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.63
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.63
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.59
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.56
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.56
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.53
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.51
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.51
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.49
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.49
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.48
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.47
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.47
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.36
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.29
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.28
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.27
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.26
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.23
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.9
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.89
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.79
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.77
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.53
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.51
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.43
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.37
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.35
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.27
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.0
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.87
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.78
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.75
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.68
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.63
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.62
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.55
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.39
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.35
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.34
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.09
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.94
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.71
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.69
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.48
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.45
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.27
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.16
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.09
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.79
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.21
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	94.97
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.72
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	94.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	93.46
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.53
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	91.08
3mes_A	424	Choline kinase; malaria, structural genomics, stru	89.76
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.63
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	88.6
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	87.43
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	84.45

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=1.7e-63  Score=599.46  Aligned_cols=510  Identities=31%  Similarity=0.489  Sum_probs=337.2

Q ss_pred             CCCCCcEEEEecCCCceeee---eCC----------------------ccCCCCCCCCEEeCcCCccccCCCc--cccCC
Q 042123            1 CNDAGRVINISLPNIGVNGT---LHD----------------------FSFSSFPHLAYLDLTWNGFFGTIPP--QISNL   53 (849)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~---l~~----------------------~~~~~l~~L~~L~L~~n~i~~~~~~--~~~~l   53 (849)
                      |+ +|+||.++++..++.|.   +++                      ..|..+++|++|||++|.+.+.+|.  .++++
T Consensus        47 C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l  125 (768)
T 3rgz_A           47 CR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSC  125 (768)
T ss_dssp             EE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGC
T ss_pred             EC-CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCC
Confidence            66 79999999999999997   432                      3688899999999999999888888  88888


Q ss_pred             CCCCEeeCCCCcCccccccccc--------------------------------------------ccCCCCCccccCeE
Q 042123           54 SNLRYLYLGSNQFSGNILAEVS--------------------------------------------SESSGGNLRYMSRL   89 (849)
Q Consensus        54 ~~L~~L~L~~N~l~~~~~~~~~--------------------------------------------~~~~~~~l~~L~~L   89 (849)
                      ++|++|+|++|++++.++..+.                                            ....+..+++|++|
T Consensus       126 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L  205 (768)
T 3rgz_A          126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL  205 (768)
T ss_dssp             TTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEE
T ss_pred             CCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEE
Confidence            8899999888887755443210                                            00112334445555


Q ss_pred             eccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccc----------------------
Q 042123           90 VINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS----------------------  147 (849)
Q Consensus        90 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~----------------------  147 (849)
                      +|++|.+.+.+|. ++++++|++|+|++|++++..|.+|.++++|++|+|++|.+++.                      
T Consensus       206 ~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~  284 (768)
T 3rgz_A          206 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGE  284 (768)
T ss_dssp             ECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEES
T ss_pred             ECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCc
Confidence            5555555544443 55555555555555555555555555555555555555544432                      


Q ss_pred             cccccCCC-CCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCccc-ccCCCCCCEEeccCCcCccCCCcCcc
Q 042123          148 ILSSLGKL-KSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDE-IGKMRSLSVLDLNQNQFKGVLPPSIS  225 (849)
Q Consensus       148 ~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~  225 (849)
                      +|..+.++ ++|++|+|++|++.+..|..|..+++|++|+|++|++.+.+|.. +.++++|++|++++|++++.+|..+.
T Consensus       285 ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~  364 (768)
T 3rgz_A          285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT  364 (768)
T ss_dssp             CCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHH
T ss_pred             cCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHH
Confidence            22222222 34444444444444444444444444444444444444333332 44444444444444444444444443


Q ss_pred             Ccc-ccchhhhcccccc--------------------------CCCCcchhhh-hhhhhhccCcCCCCCCCcccCCCCCc
Q 042123          226 NLT-NLKELALLYNHLS--------------------------GSIPPSLGNL-ILRQLLLSGNHFTGYLPYNICRGGAL  277 (849)
Q Consensus       226 ~l~-~L~~L~L~~N~l~--------------------------~~~p~~~~~~-~L~~L~L~~n~i~~~~~~~~~~~~~L  277 (849)
                      .++ +|++|++++|.++                          +.+|..+... .|+.|++++|++++.+|..+..+++|
T Consensus       365 ~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L  444 (768)
T 3rgz_A          365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKL  444 (768)
T ss_dssp             HHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTC
T ss_pred             hhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCC
Confidence            333 3333333333322                          2223333222 24555555555555555555555555


Q ss_pred             ceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCC
Q 042123          278 EIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMN  357 (849)
Q Consensus       278 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  357 (849)
                      +.|++++|.+.+.+|..+..+++|++|++++|++++..|..+..+++|++|+|++|++.+.+|..++.+++|++|+|++|
T Consensus       445 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N  524 (768)
T 3rgz_A          445 RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN  524 (768)
T ss_dssp             CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred             CEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCC
Confidence            66666666665556666666666666666666666666666777777777777777777777777777777777777777


Q ss_pred             ccccCCCCCccccccccccccccccccccCchhh----------------------------------------------
Q 042123          358 NITGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL----------------------------------------------  391 (849)
Q Consensus       358 ~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~----------------------------------------------  391 (849)
                      .+++.+|..+.++++|+.|+|++|++++.+|..+                                              
T Consensus       525 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  604 (768)
T 3rgz_A          525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL  604 (768)
T ss_dssp             CCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGG
T ss_pred             cccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhh
Confidence            7777777777777777777777777776665433                                              


Q ss_pred             ------------------------cCCCCCcEEEccCccccccCccccccccccccccccc---CCCCChhhhcccccce
Q 042123          392 ------------------------GKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA---IGELPSQICNMKSLEK  444 (849)
Q Consensus       392 ------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~---l~~lp~~~~~l~~L~~  444 (849)
                                              ..+++|+.|+|++|+++|.+|.+|+++++|+.|+++.   .+.+|..++++++|+.
T Consensus       605 ~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~  684 (768)
T 3rgz_A          605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI  684 (768)
T ss_dssp             GGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCE
T ss_pred             hccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCE
Confidence                                    2346678888888888889999999999999999986   3589999999999999


Q ss_pred             eccCCcccccCCCccccccCCCcEEeccCCccccCCCCCcccccCcccccccCCCccCCCCCCCCCCCCc
Q 042123          445 LNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLR  514 (849)
Q Consensus       445 L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~~~~  514 (849)
                      |||++|+++|.+|..+..+++|++||+++|+++|.+|....|.......|.||+++||.+.  .+|.+..
T Consensus       685 LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l--~~C~~~~  752 (768)
T 3rgz_A          685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL--PRCDPSN  752 (768)
T ss_dssp             EECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS--CCCCSCC
T ss_pred             EECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC--cCCCCCc
Confidence            9999999999999999999999999999999999999999998888899999999999874  3787544

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=3.8e-57  Score=544.21  Aligned_cols=464  Identities=34%  Similarity=0.512  Sum_probs=380.5

Q ss_pred             EEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCcccc
Q 042123            7 VINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYM   86 (849)
Q Consensus         7 ~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L   86 (849)
                      .+.|+++.+.+.+.++.  |..+++|++|+|++|++++..|..|+++++|++|+|++|++++.++.        ..+++|
T Consensus       202 L~~L~Ls~n~l~~~~~~--l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~--------~~l~~L  271 (768)
T 3rgz_A          202 LEFLDVSSNNFSTGIPF--LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--------LPLKSL  271 (768)
T ss_dssp             CCEEECCSSCCCSCCCB--CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCC--------CCCTTC
T ss_pred             CCEEECcCCcCCCCCcc--cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCc--------cccCCC
Confidence            34455555555554443  55556666666666666555566666666666666666665532211        156777


Q ss_pred             CeEeccCCcccccCCccCCCC-CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccc-cCCCCCCCEEEcC
Q 042123           87 SRLVINDNSLSGFIPPHIGNL-KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSS-LGKLKSLFDLQLN  164 (849)
Q Consensus        87 ~~L~l~~n~l~~~~~~~~~~l-~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~  164 (849)
                      ++|+|++|.+++.+|..+.++ ++|++|+|++|++++..|..|.++++|++|+|++|.+++.+|.. |.++++|++|+|+
T Consensus       272 ~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls  351 (768)
T 3rgz_A          272 QYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS  351 (768)
T ss_dssp             CEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECC
T ss_pred             CEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCc
Confidence            777777777777777776664 77888888888887777777888888888888888877555544 7788888888888


Q ss_pred             CCcccccCCcCCCCCC-CCCEEEccCCCCcCcCcccccC--CCCCCEEeccCCcCccCCCcCccCccccchhhhcccccc
Q 042123          165 DNQLIGYIPRPFSNLT-SVSTLRLSRNDLFGSIPDEIGK--MRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       165 ~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      +|++.+..|..+..++ +|++|+|++|++++.+|..+..  +++|++|++++|++++.+|..+..+++|++|+|++|.++
T Consensus       352 ~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~  431 (768)
T 3rgz_A          352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS  431 (768)
T ss_dssp             SSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEE
T ss_pred             CCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCccc
Confidence            8888777777777776 7888888888887777776666  788999999999998889999999999999999999999


Q ss_pred             CCCCcchhhhh-hhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhC
Q 042123          242 GSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALG  320 (849)
Q Consensus       242 ~~~p~~~~~~~-L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  320 (849)
                      +.+|..+..+. |+.|++++|++++.+|..+..+++|+.|++++|++++.+|..+.++++|+.|++++|++++..|..++
T Consensus       432 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~  511 (768)
T 3rgz_A          432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIG  511 (768)
T ss_dssp             SCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred             CcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHh
Confidence            99999888774 99999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCC----------------------------------
Q 042123          321 IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPRE----------------------------------  366 (849)
Q Consensus       321 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~----------------------------------  366 (849)
                      .+++|++|+|++|++.+.+|..+..+++|+.|++++|.+++.+|..                                  
T Consensus       512 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  591 (768)
T 3rgz_A          512 RLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAG  591 (768)
T ss_dssp             GCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSE
T ss_pred             cCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccc
Confidence            9999999999999999999999999999999999999998776653                                  


Q ss_pred             ------------------------------------ccccccccccccccccccccCchhhcCCCCCcEEEccCcccccc
Q 042123          367 ------------------------------------IGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGR  410 (849)
Q Consensus       367 ------------------------------------~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  410 (849)
                                                          +..+++|+.|||++|++++.+|..|+.+++|+.|+|++|+++|.
T Consensus       592 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~  671 (768)
T 3rgz_A          592 NLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGS  671 (768)
T ss_dssp             EEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSC
T ss_pred             cccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCC
Confidence                                                34467899999999999999999999999999999999999999


Q ss_pred             Cccccccccccccccccc---CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCC
Q 042123          411 LPKEIGSLTKLEYLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVP  481 (849)
Q Consensus       411 ~p~~~~~l~~L~~L~l~~---l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~  481 (849)
                      +|..|+++++|++||++.   .+.+|..+.++++|+.|||++|+++|.+|.. ..+.++....+.+|+.-|-.|
T Consensus       672 ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~~  744 (768)
T 3rgz_A          672 IPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGYP  744 (768)
T ss_dssp             CCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEESTT
T ss_pred             CChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCCC
Confidence            999999999999999997   3589999999999999999999999999975 345556666788999777544

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=4e-55  Score=515.08  Aligned_cols=468  Identities=21%  Similarity=0.226  Sum_probs=387.1

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY   85 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~   85 (849)
                      .++.|+++.+.+.+... .+|..+++|++|+|++|++.++.|.+|+++++|++|+|++|++++.      .+..|+++++
T Consensus        34 ~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~------~~~~~~~l~~  106 (606)
T 3t6q_A           34 STECLEFSFNVLPTIQN-TTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFM------AETALSGPKA  106 (606)
T ss_dssp             TCCEEECTTCCCSEECT-TTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEE------CTTTTSSCTT
T ss_pred             cCcEEEccCCccCcCCh-hHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCccccc------Chhhhccccc
Confidence            56788888888776543 4788888888888888888888888888888888888888888742      3445678888


Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCC--EEEc
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLF--DLQL  163 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L  163 (849)
                      |++|++++|.+++..+..|+++++|++|++++|+++++....+..+++|++|++++|.+++..+..|+.+++|+  .|++
T Consensus       107 L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l  186 (606)
T 3t6q_A          107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL  186 (606)
T ss_dssp             CCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEEC
T ss_pred             ccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEec
Confidence            88888888888877677888888888888888888876655666688888888888888877778888888888  8888


Q ss_pred             CCCcccccCCcCCCCC---------------------------------------------------CCCCEEEccCCCC
Q 042123          164 NDNQLIGYIPRPFSNL---------------------------------------------------TSVSTLRLSRNDL  192 (849)
Q Consensus       164 ~~N~l~~~~~~~~~~l---------------------------------------------------~~L~~L~Ls~N~l  192 (849)
                      ++|.+.++.|..|...                                                   .+|++|++++|++
T Consensus       187 ~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l  266 (606)
T 3t6q_A          187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYF  266 (606)
T ss_dssp             TTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCC
T ss_pred             CCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCcc
Confidence            8888888777766432                                                   1677888888888


Q ss_pred             cCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh-hhhhhhccCcCCCCCCCc-c
Q 042123          193 FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFTGYLPY-N  270 (849)
Q Consensus       193 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~L~~n~i~~~~~~-~  270 (849)
                      ++..+..|.++++|++|++++|+++ .+|..+..+++|++|++++|.+.+..|..+... .|++|++++|.+.+.++. .
T Consensus       267 ~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~  345 (606)
T 3t6q_A          267 FNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGC  345 (606)
T ss_dssp             SSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSST
T ss_pred             CccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhh
Confidence            8777777888899999999999988 567788888999999999999886667666665 488999999988865544 4


Q ss_pred             cCCCCCcceeeeccccccccc--CCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccc-cCCCCC
Q 042123          271 ICRGGALEIFTVSENHFQGTI--PTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISS-NWGKFP  347 (849)
Q Consensus       271 ~~~~~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~  347 (849)
                      +..+++|+.|++++|.+++..  +..+.++++|+.|++++|++++..+..+..+++|+.|++++|++.+..+. .+..++
T Consensus       346 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~  425 (606)
T 3t6q_A          346 LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH  425 (606)
T ss_dssp             TTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCT
T ss_pred             hhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcc
Confidence            888899999999999988766  77888899999999999999888888888899999999999998876554 488889


Q ss_pred             CCcEEeccCCccccCCCCCcccccccccccccccccccc---CchhhcCCCCCcEEEccCccccccCccccccccccccc
Q 042123          348 KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGE---IPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL  424 (849)
Q Consensus       348 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~---~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  424 (849)
                      +|++|++++|.+++..|..+..+++|++|++++|++++.   .+..+..+++|+.|++++|++++..|..|+.+++|++|
T Consensus       426 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L  505 (606)
T 3t6q_A          426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV  505 (606)
T ss_dssp             TCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEE
Confidence            999999999999888888888899999999999998762   33668888999999999999998888889999999999


Q ss_pred             cccc--C-CCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCC
Q 042123          425 DFSA--I-GELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       425 ~l~~--l-~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      ++++  + +..|..+.++++| .|+|++|++++.+|..|..+++|+.|++++|||.|+|+.
T Consensus       506 ~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          506 DLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             ECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             ECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            9886  3 3446788888899 999999999988888888999999999999999998874

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=5.1e-54  Score=505.62  Aligned_cols=482  Identities=21%  Similarity=0.269  Sum_probs=425.3

Q ss_pred             EEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCe
Q 042123            9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR   88 (849)
Q Consensus         9 ~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~   88 (849)
                      .+++...++......  +  -+++++|||++|+|+++.|.+|+++++|++|+|++|++++      ..+.+|+++++|++
T Consensus        16 ~~~c~~~~l~~iP~~--l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------~~~~~~~~l~~L~~   85 (606)
T 3t6q_A           16 TYNCENLGLNEIPGT--L--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW------IHEDTFQSQHRLDT   85 (606)
T ss_dssp             EEECTTSCCSSCCTT--S--CTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCE------ECTTTTTTCTTCCE
T ss_pred             eEECCCCCcccCcCC--C--CCcCcEEEccCCccCcCChhHhccCccceEEECCCCccce------eChhhccCccccCe
Confidence            467777776544332  2  2479999999999999999999999999999999999974      34567889999999


Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcc
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQL  168 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  168 (849)
                      |+|++|.+.+..|..|+++++|++|++++|+|+++.+..|.++++|++|+|++|++++.....+.++++|++|+|++|.+
T Consensus        86 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l  165 (606)
T 3t6q_A           86 LVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI  165 (606)
T ss_dssp             EECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCC
T ss_pred             eeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcc
Confidence            99999999999999999999999999999999988889999999999999999999976656666799999999999999


Q ss_pred             cccCCcCCCCCCCCC--EEEccCCCCcCcCcccccCC-------------------------------------------
Q 042123          169 IGYIPRPFSNLTSVS--TLRLSRNDLFGSIPDEIGKM-------------------------------------------  203 (849)
Q Consensus       169 ~~~~~~~~~~l~~L~--~L~Ls~N~l~~~~~~~~~~l-------------------------------------------  203 (849)
                      .++.+..|..+++|+  +|++++|++.+..|..|...                                           
T Consensus       166 ~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~  245 (606)
T 3t6q_A          166 HYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP  245 (606)
T ss_dssp             CEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCG
T ss_pred             cccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccCh
Confidence            999999999999999  99999999997777655431                                           


Q ss_pred             --------CCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh-hhhhhhccCcCCCCCCCcccCCC
Q 042123          204 --------RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFTGYLPYNICRG  274 (849)
Q Consensus       204 --------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~L~~n~i~~~~~~~~~~~  274 (849)
                              .+|+.|++++|.++++.+..|..+++|++|++++|.++ .+|..+..+ .|++|++++|++++..|..+..+
T Consensus       246 ~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l  324 (606)
T 3t6q_A          246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF  324 (606)
T ss_dssp             GGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGC
T ss_pred             hHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhcc
Confidence                    16889999999999888888999999999999999998 788877665 49999999999999989999999


Q ss_pred             CCcceeeecccccccccCC-CCCCcccccEEEccCccccCch--hhhhCCCCCCCEEeccCccccCcccccCCCCCCCcE
Q 042123          275 GALEIFTVSENHFQGTIPT-SLRNCTSLIRVRLNGNNLTGNI--SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGT  351 (849)
Q Consensus       275 ~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  351 (849)
                      ++|+.|++++|.+.+.+|. .+..+++|+.|++++|.+++..  +..+..+++|++|++++|++.+..+..|..+++|++
T Consensus       325 ~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  404 (606)
T 3t6q_A          325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLEL  404 (606)
T ss_dssp             TTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSE
T ss_pred             CcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCe
Confidence            9999999999999866554 5899999999999999999776  778999999999999999999888999999999999


Q ss_pred             EeccCCccccCCCCC-ccccccccccccccccccccCchhhcCCCCCcEEEccCcccccc---Ccccccccccccccccc
Q 042123          352 LNVSMNNITGGLPRE-IGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGR---LPKEIGSLTKLEYLDFS  427 (849)
Q Consensus       352 L~Ls~N~i~~~~p~~-~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~l~  427 (849)
                      |++++|.+++..|.. +..+++|+.|++++|.+++..|..|..+++|++|++++|++++.   .+..+..+++|++|+++
T Consensus       405 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls  484 (606)
T 3t6q_A          405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS  484 (606)
T ss_dssp             EECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECT
T ss_pred             EECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECC
Confidence            999999999776654 89999999999999999998999999999999999999999863   34679999999999998


Q ss_pred             c--CCCC-ChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCC-cccccCcccccccCCCccC
Q 042123          428 A--IGEL-PSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS-TTFRGASVEALKGNKGLCG  502 (849)
Q Consensus       428 ~--l~~l-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~~~~~c~  502 (849)
                      .  +..+ |..+..+++|+.|+|++|++++..|..|..+++| .|++++|++++..|.. ..+.......+.+|+..|.
T Consensus       485 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  562 (606)
T 3t6q_A          485 FCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT  562 (606)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECS
T ss_pred             CCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCcccc
Confidence            6  4444 6789999999999999999999999999999999 9999999999877653 2334455566778887663

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1.2e-53  Score=509.34  Aligned_cols=490  Identities=22%  Similarity=0.231  Sum_probs=350.5

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY   85 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~   85 (849)
                      +++.|+++.+++.+.. ...|..+++|++|+|++|++.++.|.+|+++++|++|+|++|++++      ....+|+++++
T Consensus        26 ~l~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~------l~~~~~~~l~~   98 (680)
T 1ziw_A           26 NITVLNLTHNQLRRLP-AANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQ------LSDKTFAFCTN   98 (680)
T ss_dssp             TCSEEECCSSCCCCCC-GGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCC------CCTTTTTTCTT
T ss_pred             CCcEEECCCCCCCCcC-HHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCc------cChhhhccCCC
Confidence            6778888888877653 3368888999999999999988888889999999999999998873      23346788899


Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccC--CCCCCCEEEc
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLG--KLKSLFDLQL  163 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L  163 (849)
                      |++|+|++|.++++.|..|+++++|++|+|++|++++..|..|.++++|++|++++|.+++..+..+.  .+++|++|++
T Consensus        99 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L  178 (680)
T 1ziw_A           99 LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL  178 (680)
T ss_dssp             CSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEEC
T ss_pred             CCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEEC
Confidence            99999999999887778889999999999999999888888888889999999999888876665543  4567777777


Q ss_pred             CCCcccccCCcCCCCC---------------------------CCCCEEEccCCCCcCcCcccccCCCC--CCEEeccCC
Q 042123          164 NDNQLIGYIPRPFSNL---------------------------TSVSTLRLSRNDLFGSIPDEIGKMRS--LSVLDLNQN  214 (849)
Q Consensus       164 ~~N~l~~~~~~~~~~l---------------------------~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~L~~N  214 (849)
                      ++|++.++.|..|..+                           ++|++|++++|++.+..|..|.+++.  |++|++++|
T Consensus       179 ~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n  258 (680)
T 1ziw_A          179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN  258 (680)
T ss_dssp             TTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTS
T ss_pred             CCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCC
Confidence            7777776666544432                           23344444444444444444444432  555555555


Q ss_pred             cCccCCCcCccCccccchhhhccccccCCCCcc---------------------------------hhhh-hhhhhhccC
Q 042123          215 QFKGVLPPSISNLTNLKELALLYNHLSGSIPPS---------------------------------LGNL-ILRQLLLSG  260 (849)
Q Consensus       215 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~---------------------------------~~~~-~L~~L~L~~  260 (849)
                      ++++..|..|..+++|++|+|++|.+.+..|..                                 +... .|++|++++
T Consensus       259 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~  338 (680)
T 1ziw_A          259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED  338 (680)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCS
T ss_pred             CcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCC
Confidence            554444444555555555555555444333322                                 2222 377777777


Q ss_pred             cCCCCCCCcccCCCCCcceeeecc----------------------------cccccccCCCCCCcccccEEEccCcccc
Q 042123          261 NHFTGYLPYNICRGGALEIFTVSE----------------------------NHFQGTIPTSLRNCTSLIRVRLNGNNLT  312 (849)
Q Consensus       261 n~i~~~~~~~~~~~~~L~~L~l~~----------------------------N~l~~~~~~~~~~l~~L~~L~L~~n~l~  312 (849)
                      |++++..+..|..+++|+.|++++                            |++++..|..|..+++|+.|++++|.++
T Consensus       339 n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  418 (680)
T 1ziw_A          339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG  418 (680)
T ss_dssp             CCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCE
T ss_pred             CccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCc
Confidence            777777777676666665555544                            4455555666667777777777777776


Q ss_pred             Cchh-hhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccc--cCCCCCccccccccccccccccccccCch
Q 042123          313 GNIS-EALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT--GGLPREIGNSSQLQAFDLSLNHIVGEIPK  389 (849)
Q Consensus       313 ~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~--~~~p~~~~~l~~L~~L~L~~N~i~~~~~~  389 (849)
                      +..+ ..+..+++|++|++++|++.+..+..|..+++|+.|++++|.++  +..|..|.++++|+.|+|++|++++..+.
T Consensus       419 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~  498 (680)
T 1ziw_A          419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD  498 (680)
T ss_dssp             EECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             cccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChh
Confidence            5333 56677777777777777777666667777777777777777765  45677888888888888888888877777


Q ss_pred             hhcCCCCCcEEEccCccccccCc--------cccccccccccccccc--CCCCCh-hhhcccccceeccCCcccccCCCc
Q 042123          390 ELGKLNPLTKLILRGNQITGRLP--------KEIGSLTKLEYLDFSA--IGELPS-QICNMKSLEKLNLSHNNLSGSIPS  458 (849)
Q Consensus       390 ~~~~l~~L~~L~L~~N~l~~~~p--------~~~~~l~~L~~L~l~~--l~~lp~-~~~~l~~L~~L~L~~N~l~~~~p~  458 (849)
                      .|..+++|++|+|++|++++..+        ..|.++++|++|+++.  +..+|. .+.++++|+.|+|++|+|++..+.
T Consensus       499 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~  578 (680)
T 1ziw_A          499 MLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS  578 (680)
T ss_dssp             TTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT
T ss_pred             hhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHh
Confidence            88888888888888888875422        2377888888888875  677776 478888999999999999888888


Q ss_pred             cccccCCCcEEeccCCccccCCCCCc--ccccCcccccccCCCccC
Q 042123          459 CFEGMHGLSFIDMSYNELQCPVPNST--TFRGASVEALKGNKGLCG  502 (849)
Q Consensus       459 ~~~~l~~L~~l~l~~N~l~~~~~~~~--~~~~~~~~~~~~~~~~c~  502 (849)
                      .|..+++|+.|+|++|.+++..+...  .+.......+.+|+..|.
T Consensus       579 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~  624 (680)
T 1ziw_A          579 VFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT  624 (680)
T ss_dssp             TTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred             HhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence            88888899999999998887665432  344555666778888775

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=5.5e-53  Score=503.61  Aligned_cols=470  Identities=21%  Similarity=0.216  Sum_probs=362.5

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY   85 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~   85 (849)
                      .++.|+++.+.+.+... .+|..+++|++|+|++|++.++.+.+|+++++|++|+|++|++++.      ....|+++++
T Consensus        50 ~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~------~~~~~~~l~~  122 (680)
T 1ziw_A           50 QLTSLDVGFNTISKLEP-ELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI------KNNPFVKQKN  122 (680)
T ss_dssp             TCSEEECCSSCCCCCCT-THHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC------CSCTTTTCTT
T ss_pred             cCcEEECCCCccCccCH-HHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCcc------ChhHccccCC
Confidence            45677777777665543 3677778888888888888777777788888888888888877632      2345677777


Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCc--CCCCCceeeccCcccccccc--------------
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFD--NLSNLIFLYLYGNLLSGSIL--------------  149 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~--------------  149 (849)
                      |++|+|++|.+++..|..|.++++|++|++++|++++..+..|.  .+++|++|++++|.+++..+              
T Consensus       123 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  202 (680)
T 1ziw_A          123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL  202 (680)
T ss_dssp             CCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEEC
T ss_pred             CCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhc
Confidence            78888888877777777777777777777777777765554433  34566666666665554443              


Q ss_pred             -------------------------------------cccCCCCC--CCEEEcCCCcccccCCcCCCCCCCCCEEEccCC
Q 042123          150 -------------------------------------SSLGKLKS--LFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN  190 (849)
Q Consensus       150 -------------------------------------~~~~~l~~--L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  190 (849)
                                                           ..|.+++.  |++|+|++|++.++.+..|..+++|++|+|++|
T Consensus       203 ~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n  282 (680)
T 1ziw_A          203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN  282 (680)
T ss_dssp             TTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             cccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCC
Confidence                                                 34444433  788888888887777777888888888888888


Q ss_pred             CCcCcCcccccCC---------------------------------CCCCEEeccCCcCccCCCcCccCccccchhhhcc
Q 042123          191 DLFGSIPDEIGKM---------------------------------RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLY  237 (849)
Q Consensus       191 ~l~~~~~~~~~~l---------------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  237 (849)
                      ++.+..|..|.++                                 ++|++|++++|+++++.+..|.++++|++|++++
T Consensus       283 ~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~  362 (680)
T 1ziw_A          283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSN  362 (680)
T ss_dssp             CBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTT
T ss_pred             ccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCC
Confidence            7776655544443                                 4444444444555544445555555555555555


Q ss_pred             ccccCC-CC-cchhh---hhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccC-CCCCCcccccEEEccCccc
Q 042123          238 NHLSGS-IP-PSLGN---LILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIP-TSLRNCTSLIRVRLNGNNL  311 (849)
Q Consensus       238 N~l~~~-~p-~~~~~---~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~n~l  311 (849)
                      |.+... ++ ..+..   ..|+.|++++|+++++.|..+..+++|+.|++++|.+.+.+| ..|.++++|++|++++|++
T Consensus       363 n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l  442 (680)
T 1ziw_A          363 SFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKY  442 (680)
T ss_dssp             CBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSE
T ss_pred             CchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCc
Confidence            543211 11 11111   247778888899999999999999999999999999987665 6899999999999999999


Q ss_pred             cCchhhhhCCCCCCCEEeccCcccc--CcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCc-
Q 042123          312 TGNISEALGIYPNLTFIDLSRNNFY--GEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIP-  388 (849)
Q Consensus       312 ~~~~~~~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-  388 (849)
                      ++..+..|..+++|+.|++++|.+.  +..|..|..+++|+.|++++|.+++..+..|.++++|++|+|++|++++..+ 
T Consensus       443 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~  522 (680)
T 1ziw_A          443 LQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKH  522 (680)
T ss_dssp             EECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGST
T ss_pred             ceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchh
Confidence            9999999999999999999999987  5678899999999999999999998888889999999999999999986532 


Q ss_pred             -------hhhcCCCCCcEEEccCccccccCccccccccccccccccc--CCCCChh-hhcccccceeccCCcccccCCCc
Q 042123          389 -------KELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQ-ICNMKSLEKLNLSHNNLSGSIPS  458 (849)
Q Consensus       389 -------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~-~~~l~~L~~L~L~~N~l~~~~p~  458 (849)
                             ..|..+++|+.|+|++|+++...+..|.++++|++|+++.  +..+|.. +.++++|+.|+|++|+|++..|.
T Consensus       523 ~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~  602 (680)
T 1ziw_A          523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKK  602 (680)
T ss_dssp             TSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHH
T ss_pred             hccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChh
Confidence                   2488999999999999999965556799999999999985  7788875 68999999999999999999888


Q ss_pred             ccc-ccCCCcEEeccCCccccCCCC
Q 042123          459 CFE-GMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       459 ~~~-~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      .|. .+++|+.+++++|||.|+|+.
T Consensus       603 ~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          603 VFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             HHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             HhcccccccCEEEccCCCcccCCcc
Confidence            888 899999999999999999985

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=7.3e-53  Score=495.77  Aligned_cols=461  Identities=21%  Similarity=0.205  Sum_probs=319.1

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY   85 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~   85 (849)
                      .++.++++.+.+.+... .+|.++++|++|+|++|+++++.|.+|+++++|++|+|++|++++.      .+..|+++++
T Consensus        33 ~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~------~p~~~~~l~~  105 (606)
T 3vq2_A           33 STKNIDLSFNPLKILKS-YSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSF------SPGSFSGLTS  105 (606)
T ss_dssp             TCCEEECTTSCCCEECT-TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCC------CTTSSTTCTT
T ss_pred             CcCEEECCCCCcCEeCh-hhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCccccc------ChhhcCCccc
Confidence            34555555555544333 2455555555555555555555555555555555555555555431      2233455555


Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccC-CCCCCCcCCCCCceeeccCcccccccccccCCCCCCC----E
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-PIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLF----D  160 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~  160 (849)
                      |++|+|++|.+.+..+..|+++++|++|++++|++++ ..|..|.++++|++|++++|++++..+..|+.+++|+    .
T Consensus       106 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~  185 (606)
T 3vq2_A          106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLS  185 (606)
T ss_dssp             CCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCE
T ss_pred             CCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccce
Confidence            5555555555555544555555555555555555554 2355555555555555555555555555554444433    4


Q ss_pred             EEcCCCcccccCCcCCCCCCCCCEEEccCCCCc-----------------------------------------------
Q 042123          161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF-----------------------------------------------  193 (849)
Q Consensus       161 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-----------------------------------------------  193 (849)
                      |++++|.+.++.+..|... +|++|++++|.+.                                               
T Consensus       186 L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~  264 (606)
T 3vq2_A          186 LDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTID  264 (606)
T ss_dssp             EECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEE
T ss_pred             eeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHh
Confidence            5555555555555544444 5666666665442                                               


Q ss_pred             -----------CcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcC
Q 042123          194 -----------GSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNH  262 (849)
Q Consensus       194 -----------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~  262 (849)
                                 +..|. +..+++|+.|++++|.+.. +| .+..+++|++|++++|.+ +.+|.. ....|+.|++++|+
T Consensus       265 ~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp~~-~l~~L~~L~l~~n~  339 (606)
T 3vq2_A          265 EFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFPTL-DLPFLKSLTLTMNK  339 (606)
T ss_dssp             EEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCCCC-CCSSCCEEEEESCS
T ss_pred             heeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccccC-CCCccceeeccCCc
Confidence                       11222 4455667777777777653 34 677777888888888887 467744 44458888888885


Q ss_pred             CCCCCCcccCCCCCcceeeeccccccccc--CCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCccc
Q 042123          263 FTGYLPYNICRGGALEIFTVSENHFQGTI--PTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS  340 (849)
Q Consensus       263 i~~~~~~~~~~~~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  340 (849)
                      ..+..  .+..+++|+.|++++|++++..  |..+..+++|+.|++++|.+++. +..+..+++|+.|++++|++.+..+
T Consensus       340 ~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~  416 (606)
T 3vq2_A          340 GSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVTE  416 (606)
T ss_dssp             SCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-CCCCTTCTTCCEEECTTSEEESTTT
T ss_pred             Cccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccc-hhhccCCCCCCeeECCCCccCCccC
Confidence            54433  5667888888888888887653  67778888888999988888854 4778888899999999999887776


Q ss_pred             -ccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccc-cCchhhcCCCCCcEEEccCccccccCccccccc
Q 042123          341 -SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVG-EIPKELGKLNPLTKLILRGNQITGRLPKEIGSL  418 (849)
Q Consensus       341 -~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  418 (849)
                       ..|..+++|++|++++|.+++..|..+.++++|+.|++++|++++ .+|..|..+++|+.|+|++|++++..|..|+.+
T Consensus       417 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  496 (606)
T 3vq2_A          417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL  496 (606)
T ss_dssp             TTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             hhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhccc
Confidence             678888999999999999988888889999999999999999987 478888999999999999999998888889999


Q ss_pred             cccccccccc--CCCC-ChhhhcccccceeccCCcccccCCCccccccC-CCcEEeccCCccccCCCCC
Q 042123          419 TKLEYLDFSA--IGEL-PSQICNMKSLEKLNLSHNNLSGSIPSCFEGMH-GLSFIDMSYNELQCPVPNS  483 (849)
Q Consensus       419 ~~L~~L~l~~--l~~l-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~l~l~~N~l~~~~~~~  483 (849)
                      ++|++|++++  +..+ |..+.++++|+.|+|++|+|+ .+|..+..++ +|+.|++++|+|.|+|+..
T Consensus       497 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~  564 (606)
T 3vq2_A          497 HRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ  564 (606)
T ss_dssp             TTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred             ccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence            9999999886  4444 778888999999999999998 5666688887 5999999999999988763

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=7.9e-52  Score=503.13  Aligned_cols=460  Identities=23%  Similarity=0.239  Sum_probs=275.2

Q ss_pred             CCCCCcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCC
Q 042123            1 CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG   80 (849)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~   80 (849)
                      |.-.|+++  ++..+++.....     -.++|++|||++|.|+++.+..|.++++|++|+|++|.+.+.     ..+.+|
T Consensus         2 C~~~~~~~--dcs~~~L~~vP~-----lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~-----i~~~~f   69 (844)
T 3j0a_A            2 CSFDGRIA--FYRFCNLTQVPQ-----VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT-----IDKEAF   69 (844)
T ss_dssp             CBTTTEEE--EESCCCSSCCCS-----SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCE-----ECTTTT
T ss_pred             ceEeceEE--EccCCCCCCCCC-----CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccc-----cCHHHh
Confidence            55555443  334555444322     235666666666666666666666666666666666644321     233455


Q ss_pred             CCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCC--CcCCCCCceeeccCcccccccc-cccCCCCC
Q 042123           81 GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLS--FDNLSNLIFLYLYGNLLSGSIL-SSLGKLKS  157 (849)
Q Consensus        81 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~  157 (849)
                      +++++|+.|+|++|.|.+..|..|.++++|++|+|++|++++..|..  |.++++|++|+|++|.+++..+ ..|+++++
T Consensus        70 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~  149 (844)
T 3j0a_A           70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS  149 (844)
T ss_dssp             SSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSS
T ss_pred             cCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCC
Confidence            66666666666666666666666666666666666666666544333  6666666666666666665433 35666666


Q ss_pred             CCEEEcCCCcccccCCcCCCCC--CCCCEEEccCCCCcCcCcccccCC--------------------------------
Q 042123          158 LFDLQLNDNQLIGYIPRPFSNL--TSVSTLRLSRNDLFGSIPDEIGKM--------------------------------  203 (849)
Q Consensus       158 L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l--------------------------------  203 (849)
                      |++|+|++|.+.++.+..|..+  ++|++|+|+.|.+.+..|..+..+                                
T Consensus       150 L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~  229 (844)
T 3j0a_A          150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS  229 (844)
T ss_dssp             CCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSC
T ss_pred             CCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcC
Confidence            6666666666666555555544  445555555554444443333333                                


Q ss_pred             ------------------------------------CCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcc
Q 042123          204 ------------------------------------RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS  247 (849)
Q Consensus       204 ------------------------------------~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  247 (849)
                                                          ++|+.|++++|.+.+..+..|..+++|+.|+|++|.+++..|..
T Consensus       230 ~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~  309 (844)
T 3j0a_A          230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEA  309 (844)
T ss_dssp             SCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTT
T ss_pred             cccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHH
Confidence                                                34555555555555444555555555555555555555444444


Q ss_pred             hhhh-hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCC
Q 042123          248 LGNL-ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLT  326 (849)
Q Consensus       248 ~~~~-~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  326 (849)
                      +..+ .|++|+|++|++++..|..|..+++|+.|++++|++.+..+..|.++++|+.|+|++|.+++..     .+++|+
T Consensus       310 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~  384 (844)
T 3j0a_A          310 FYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIP  384 (844)
T ss_dssp             TTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCS
T ss_pred             hcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcc
Confidence            4433 2555555555555555555555555555555555555444445555555555555555554321     134444


Q ss_pred             EEeccCccccCcccc----------------------cCCCCCCCcEEeccCCccccCCCC-Cccccccccccccccccc
Q 042123          327 FIDLSRNNFYGEISS----------------------NWGKFPKLGTLNVSMNNITGGLPR-EIGNSSQLQAFDLSLNHI  383 (849)
Q Consensus       327 ~L~Ls~N~l~~~~~~----------------------~~~~l~~L~~L~Ls~N~i~~~~p~-~~~~l~~L~~L~L~~N~i  383 (849)
                      .|++++|++... |.                      .+..+++|+.|+|++|++++..+. .+..+++|+.|+|++|.+
T Consensus       385 ~L~l~~N~l~~l-~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l  463 (844)
T 3j0a_A          385 DIFLSGNKLVTL-PKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENML  463 (844)
T ss_dssp             EEEEESCCCCCC-CCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCC
T ss_pred             hhccCCCCcccc-cccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCcc
Confidence            444444444321 11                      123567777777777777744332 345567778888888877


Q ss_pred             c-----ccCchhhcCCCCCcEEEccCccccccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCC
Q 042123          384 V-----GEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSI  456 (849)
Q Consensus       384 ~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~  456 (849)
                      +     +..+..|..+++|+.|+|++|++++..|..|..+++|++|+++.  +..+|..... ++|+.|+|++|+|++..
T Consensus       464 ~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~~~  542 (844)
T 3j0a_A          464 QLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLAPN  542 (844)
T ss_dssp             SSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCCCC
T ss_pred             ccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCCCC
Confidence            6     33445677788888888888888877777788888888888875  5566554333 77888888888888887


Q ss_pred             CccccccCCCcEEeccCCccccCCCC
Q 042123          457 PSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       457 p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      |..|.   +|+.+++++|||.|+|+.
T Consensus       543 ~~~~~---~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          543 PDVFV---SLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SCCCS---SCCEEEEEEECCCCSSSC
T ss_pred             hhHhC---CcCEEEecCCCccccccc
Confidence            77654   678888888888888875

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-52  Score=506.92  Aligned_cols=436  Identities=23%  Similarity=0.194  Sum_probs=316.5

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCcc-ccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCcc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGF-FGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR   84 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~   84 (849)
                      .++.|+++.+.+.+... .+|..+++|++|||++|.+ ..+.|.+|+++++|++|+|++|++++.      .+..|++++
T Consensus        25 ~l~~LdLs~N~i~~i~~-~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~------~p~~~~~l~   97 (844)
T 3j0a_A           25 TTERLLLSFNYIRTVTA-SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFL------HPDAFQGLF   97 (844)
T ss_dssp             TCCEEEEESCCCCEECS-SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEE------CTTSSCSCS
T ss_pred             CcCEEECCCCcCCccCh-hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCccc------CHhHccCCc
Confidence            45566666666554432 2456666666666666533 233355566666666666666665421      233445555


Q ss_pred             ccCeEeccCCcccccCCcc--CCCCCCCCEEEccCCcccCCCC-CCCcCCCCCceeeccCcccccccc------------
Q 042123           85 YMSRLVINDNSLSGFIPPH--IGNLKFLSQLDLTNNKFSGPIP-LSFDNLSNLIFLYLYGNLLSGSIL------------  149 (849)
Q Consensus        85 ~L~~L~l~~n~l~~~~~~~--~~~l~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~------------  149 (849)
                      +|++|+|++|.+++..|..  |+++++|++|+|++|++++..+ ..|.++++|++|+|++|.+++..+            
T Consensus        98 ~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~  177 (844)
T 3j0a_A           98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLS  177 (844)
T ss_dssp             SCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSC
T ss_pred             ccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccc
Confidence            5666666666555433332  5555556666666665554433 345555555555555555544433            


Q ss_pred             --------------cccCCCCC------CCEEEcCCCcccccCCcCC---------------------------------
Q 042123          150 --------------SSLGKLKS------LFDLQLNDNQLIGYIPRPF---------------------------------  176 (849)
Q Consensus       150 --------------~~~~~l~~------L~~L~L~~N~l~~~~~~~~---------------------------------  176 (849)
                                    ..+..+.+      |+.|+|++|.+.+..+..+                                 
T Consensus       178 ~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~  257 (844)
T 3j0a_A          178 FFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQ  257 (844)
T ss_dssp             CCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGG
T ss_pred             eEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCCh
Confidence                          33333333      7888888876654333222                                 


Q ss_pred             ---CC--CCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh
Q 042123          177 ---SN--LTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL  251 (849)
Q Consensus       177 ---~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  251 (849)
                         .+  .++|++|+|++|.+.+..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|.+++..|..+..+
T Consensus       258 ~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  337 (844)
T 3j0a_A          258 NTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGL  337 (844)
T ss_dssp             TTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSC
T ss_pred             hhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCC
Confidence               22  2679999999999998889999999999999999999999999999999999999999999997778888766


Q ss_pred             -hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCch---------------
Q 042123          252 -ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI---------------  315 (849)
Q Consensus       252 -~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~---------------  315 (849)
                       .|+.|++++|++.++.+..|..+++|+.|++++|.+++..     .+++|+.|++++|+++..+               
T Consensus       338 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~-----~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~  412 (844)
T 3j0a_A          338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIH-----FIPSIPDIFLSGNKLVTLPKINLTANLIHLSENR  412 (844)
T ss_dssp             TTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCS-----SCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCC
T ss_pred             CCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCccc-----CCCCcchhccCCCCcccccccccccceeecccCc
Confidence             4999999999999999999999999999999999998532     2556666666666555321               


Q ss_pred             ------hhhhCCCCCCCEEeccCccccCcccc-cCCCCCCCcEEeccCCccc-----cCCCCCccccccccccccccccc
Q 042123          316 ------SEALGIYPNLTFIDLSRNNFYGEISS-NWGKFPKLGTLNVSMNNIT-----GGLPREIGNSSQLQAFDLSLNHI  383 (849)
Q Consensus       316 ------~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~i~-----~~~p~~~~~l~~L~~L~L~~N~i  383 (849)
                            +..+..+++|+.|+|++|++.+..+. .+..+++|+.|+|++|.++     +..+..|.++++|+.|+|++|++
T Consensus       413 l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l  492 (844)
T 3j0a_A          413 LENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL  492 (844)
T ss_dssp             CCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHH
T ss_pred             cccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcc
Confidence                  22355889999999999999865443 4567899999999999997     34456789999999999999999


Q ss_pred             cccCchhhcCCCCCcEEEccCccccccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCC
Q 042123          384 VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIP  457 (849)
Q Consensus       384 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p  457 (849)
                      ++..|..|..+++|+.|+|++|+|++..|..+.  ++|+.||++.  +..+++.  .+.+|+.|++++|.+....+
T Consensus       493 ~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~--~~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD--VFVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             TTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC--CCSSCCEEEEEEECCCCSSS
T ss_pred             cccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh--HhCCcCEEEecCCCcccccc
Confidence            999999999999999999999999987777776  8999999986  4444332  24589999999999986443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=9.3e-52  Score=486.39  Aligned_cols=475  Identities=19%  Similarity=0.190  Sum_probs=408.8

Q ss_pred             EEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCe
Q 042123            9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR   88 (849)
Q Consensus         9 ~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~   88 (849)
                      .+++.+.++.....+  +  .+++++|+|++|+++++.+..|.++++|++|+|++|++++      ..+.+|+++++|++
T Consensus        15 ~~~c~~~~l~~ip~~--~--~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~------i~~~~~~~l~~L~~   84 (606)
T 3vq2_A           15 TYQCMDQKLSKVPDD--I--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET------IEDKAWHGLHHLSN   84 (606)
T ss_dssp             EEECTTSCCSSCCTT--S--CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE------ECTTTTTTCTTCCE
T ss_pred             ceEccCCCcccCCCC--C--CCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccc------cCHHHhhchhhcCE
Confidence            477888887554333  2  3789999999999999999999999999999999999974      34556789999999


Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCccccc-ccccccCCCCCCCEEEcCCCc
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG-SILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~  167 (849)
                      |+|++|.+++..|..|+++++|++|+|++|+++++.+..|.++++|++|++++|.+++ .+|..|+++++|++|+|++|+
T Consensus        85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~  164 (606)
T 3vq2_A           85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNY  164 (606)
T ss_dssp             EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSC
T ss_pred             eECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCc
Confidence            9999999999889999999999999999999998888999999999999999999986 468999999999999999999


Q ss_pred             ccccCCcCCCCCCCCC----EEEccCCCCcCcCcccccCCCCCCEEeccCCcCc--------------------------
Q 042123          168 LIGYIPRPFSNLTSVS----TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK--------------------------  217 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--------------------------  217 (849)
                      ++++.+..|..+++|+    +|++++|++++..+..+... +|+.|++++|.+.                          
T Consensus       165 l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~  243 (606)
T 3vq2_A          165 IQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKD  243 (606)
T ss_dssp             CCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTT
T ss_pred             ceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhcccccccccccccccccc
Confidence            9999999998887776    89999999996666666554 8999999998764                          


Q ss_pred             --------------------------------cCCCcCccCccccchhhhccccccCCCCcchhhh-hhhhhhccCcCCC
Q 042123          218 --------------------------------GVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFT  264 (849)
Q Consensus       218 --------------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~L~~n~i~  264 (849)
                                                      +..|. +..+++|+.|++++|.+. .+| .+... .|+.|++++|.+ 
T Consensus       244 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-  319 (606)
T 3vq2_A          244 ERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-  319 (606)
T ss_dssp             SCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-
T ss_pred             CCcccccChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-
Confidence                                            12232 677888999999999986 566 44444 599999999999 


Q ss_pred             CCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCch--hhhhCCCCCCCEEeccCccccCccccc
Q 042123          265 GYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI--SEALGIYPNLTFIDLSRNNFYGEISSN  342 (849)
Q Consensus       265 ~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~  342 (849)
                      +.+| .+ .+++|+.|++++|+..+..  .+..+++|++|++++|++++..  +..+..+++|++|+|++|.+.+ +|..
T Consensus       320 ~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~  394 (606)
T 3vq2_A          320 KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSAN  394 (606)
T ss_dssp             SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCC
T ss_pred             cccc-cC-CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhh
Confidence            5666 45 8899999999999665433  6778999999999999999764  7889999999999999999985 5688


Q ss_pred             CCCCCCCcEEeccCCccccCCC-CCccccccccccccccccccccCchhhcCCCCCcEEEccCccccc-cCccccccccc
Q 042123          343 WGKFPKLGTLNVSMNNITGGLP-REIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG-RLPKEIGSLTK  420 (849)
Q Consensus       343 ~~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~  420 (849)
                      |..+++|+.|++++|.+++..| ..+.++++|+.|++++|.+++..|..|..+++|++|++++|++++ .+|..|+.+++
T Consensus       395 ~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~  474 (606)
T 3vq2_A          395 FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTN  474 (606)
T ss_dssp             CTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTT
T ss_pred             ccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCC
Confidence            9999999999999999998877 689999999999999999999999999999999999999999997 47999999999


Q ss_pred             cccccccc--CCCC-ChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCCcccc-cCccccccc
Q 042123          421 LEYLDFSA--IGEL-PSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFR-GASVEALKG  496 (849)
Q Consensus       421 L~~L~l~~--l~~l-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~-~~~~~~~~~  496 (849)
                      |++|++++  +..+ |..+..+++|+.|+|++|++++..|..|..+++|+.|++++|+++...+.-..+. ......+.+
T Consensus       475 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~  554 (606)
T 3vq2_A          475 LTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN  554 (606)
T ss_dssp             CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCS
T ss_pred             CCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccC
Confidence            99999987  4444 6779999999999999999999999999999999999999999995433322222 244556778


Q ss_pred             CCCccCC
Q 042123          497 NKGLCGS  503 (849)
Q Consensus       497 ~~~~c~~  503 (849)
                      |+..|.-
T Consensus       555 N~~~c~c  561 (606)
T 3vq2_A          555 NSVACIC  561 (606)
T ss_dssp             CCCCCSS
T ss_pred             CCcccCC
Confidence            8877743

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.4e-52  Score=482.92  Aligned_cols=458  Identities=20%  Similarity=0.220  Sum_probs=398.5

Q ss_pred             EEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCe
Q 042123            9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR   88 (849)
Q Consensus         9 ~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~   88 (849)
                      .+++.+.++......  +  .+++++|||++|+++++.+.+|.++++|++|+|++|++++      ....+|+++++|++
T Consensus        11 ~~~c~~~~l~~ip~~--l--~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~------i~~~~~~~l~~L~~   80 (570)
T 2z63_A           11 TYQCMELNFYKIPDN--L--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT------IEDGAYQSLSHLST   80 (570)
T ss_dssp             EEECCSSCCSSCCSS--S--CSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCE------ECTTTTTTCTTCCE
T ss_pred             EEEeCCCCccccCCC--c--cccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCc------cCcccccCchhCCE
Confidence            366677776544332  2  3579999999999998888899999999999999999874      34456788999999


Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccc-cccccCCCCCCCEEEcCCCc
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS-ILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~  167 (849)
                      |+|++|.+++..|..|.++++|++|++++|+++++.+..|.++++|++|++++|.+++. .|..|+++++|++|++++|+
T Consensus        81 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~  160 (570)
T 2z63_A           81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK  160 (570)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSC
T ss_pred             EeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCc
Confidence            99999999988888999999999999999999987777899999999999999999863 58889999999999999999


Q ss_pred             ccccCCcCCCCCCCC----CEEEccCCCCcCcCcccccCCCCCCEEeccCC-----------------------------
Q 042123          168 LIGYIPRPFSNLTSV----STLRLSRNDLFGSIPDEIGKMRSLSVLDLNQN-----------------------------  214 (849)
Q Consensus       168 l~~~~~~~~~~l~~L----~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-----------------------------  214 (849)
                      +.++.+..|..+++|    ++|++++|.+.+..|..|..+ +|+.|++++|                             
T Consensus       161 l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~  239 (570)
T 2z63_A          161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN  239 (570)
T ss_dssp             CCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCC
T ss_pred             cceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccC
Confidence            999888888888888    899999999987777777655 7888888876                             


Q ss_pred             -----------------------------cCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCC
Q 042123          215 -----------------------------QFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTG  265 (849)
Q Consensus       215 -----------------------------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~  265 (849)
                                                   .+.+..|..+..+++|++|++++|.+. .+|..+....|+.|++++|.+..
T Consensus       240 ~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~~L~~L~l~~n~~~~  318 (570)
T 2z63_A          240 EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQ  318 (570)
T ss_dssp             CSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCCCCSEEEEESCBCSS
T ss_pred             chhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccCCccEEeeccCcccc
Confidence                                         344556778888999999999999998 68887776689999999999984


Q ss_pred             CCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCch--hhhhCCCCCCCEEeccCccccCcccccC
Q 042123          266 YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI--SEALGIYPNLTFIDLSRNNFYGEISSNW  343 (849)
Q Consensus       266 ~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  343 (849)
                       +|.  ..+++|+.|++++|.+.+..+.  ..+++|+.|++++|++++..  +..+..+++|++|++++|.+.+..+. +
T Consensus       319 -l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~  392 (570)
T 2z63_A          319 -FPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-F  392 (570)
T ss_dssp             -CCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-E
T ss_pred             -cCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-c
Confidence             443  4678999999999999876655  78899999999999998665  77899999999999999999976555 9


Q ss_pred             CCCCCCcEEeccCCccccCCC-CCccccccccccccccccccccCchhhcCCCCCcEEEccCcccc-ccCcccccccccc
Q 042123          344 GKFPKLGTLNVSMNNITGGLP-REIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT-GRLPKEIGSLTKL  421 (849)
Q Consensus       344 ~~l~~L~~L~Ls~N~i~~~~p-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L  421 (849)
                      ..+++|++|++++|.+++..| ..+.++++|++|++++|.+.+..|..|..+++|++|+|++|+++ +.+|..+..+++|
T Consensus       393 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L  472 (570)
T 2z63_A          393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL  472 (570)
T ss_dssp             ETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             cccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCC
Confidence            999999999999999997766 57899999999999999999999999999999999999999998 6799999999999


Q ss_pred             ccccccc--CCCC-ChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCCc
Q 042123          422 EYLDFSA--IGEL-PSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNST  484 (849)
Q Consensus       422 ~~L~l~~--l~~l-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~  484 (849)
                      ++|+++.  +..+ |..+..+++|+.|+|++|++++..|..|..+++|+.|++++|+|+|.||...
T Consensus       473 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  538 (570)
T 2z63_A          473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  538 (570)
T ss_dssp             CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             CEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence            9999986  5555 7789999999999999999999999999999999999999999999999753

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.1e-51  Score=485.25  Aligned_cols=449  Identities=19%  Similarity=0.268  Sum_probs=306.5

Q ss_pred             CCCCCcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCcc------cc------CCCccccCCCCCCEeeCCCCcCcc
Q 042123            1 CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGF------FG------TIPPQISNLSNLRYLYLGSNQFSG   68 (849)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i------~~------~~~~~~~~l~~L~~L~L~~N~l~~   68 (849)
                      |+..|+|++|+++.+++.|++++ +|..+++|++|||++|.+      .+      .+|...  +..|+ +++++|.+.+
T Consensus        77 C~~~~~V~~L~L~~~~l~g~lp~-~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~  152 (636)
T 4eco_A           77 LNSNGRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDY  152 (636)
T ss_dssp             ECTTCCEEEEECTTSCCEEEECG-GGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCC
T ss_pred             EcCCCCEEEEEecCcccCCcCCh-HHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhcc
Confidence            77779999999999999999995 899999999999999976      22      223222  44566 7777777766


Q ss_pred             ccccccccc-------------CCCCCccccCeEecc--CCcccccCCccCCCCCCCCEEEccCCcccCC----------
Q 042123           69 NILAEVSSE-------------SSGGNLRYMSRLVIN--DNSLSGFIPPHIGNLKFLSQLDLTNNKFSGP----------  123 (849)
Q Consensus        69 ~~~~~~~~~-------------~~~~~l~~L~~L~l~--~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~----------  123 (849)
                      .++..+...             ........++.+.+.  .|.+++ +|..|+++++|++|+|++|++++.          
T Consensus       153 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~  231 (636)
T 4eco_A          153 DPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENEN  231 (636)
T ss_dssp             CGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTT
T ss_pred             CchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccc
Confidence            554433210             000111122222222  577877 777888888888888888888864          


Q ss_pred             -------CCCCCc--CCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc-ccc-cCCcCCCCC------CCCCEEE
Q 042123          124 -------IPLSFD--NLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ-LIG-YIPRPFSNL------TSVSTLR  186 (849)
Q Consensus       124 -------~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l------~~L~~L~  186 (849)
                             +|..+.  ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ ..|..+..+      ++|++|+
T Consensus       232 ~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~  311 (636)
T 4eco_A          232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY  311 (636)
T ss_dssp             SHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEE
T ss_pred             cchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEE
Confidence                   777777  88888888888888887888888888888888888887 776 566666655      7888888


Q ss_pred             ccCCCCcCcCcc--cccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh-h-hhhhhccCcC
Q 042123          187 LSRNDLFGSIPD--EIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-I-LRQLLLSGNH  262 (849)
Q Consensus       187 Ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~-L~~L~L~~n~  262 (849)
                      |++|+++ .+|.  .+.++++|++|++++|++++.+| .|..+++|++|+|++|.++ .+|..+..+ . |++|++++|+
T Consensus       312 L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~  388 (636)
T 4eco_A          312 IGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNK  388 (636)
T ss_dssp             CCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSC
T ss_pred             CCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCc
Confidence            8888887 6777  78888888888888888886677 7888888888888888887 666655544 3 6666666666


Q ss_pred             CCCCCCcccCCCC--CcceeeecccccccccCCCCC-------CcccccEEEccCccccCchhhhhCCCCCCCEEeccCc
Q 042123          263 FTGYLPYNICRGG--ALEIFTVSENHFQGTIPTSLR-------NCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRN  333 (849)
Q Consensus       263 i~~~~~~~~~~~~--~L~~L~l~~N~l~~~~~~~~~-------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N  333 (849)
                      ++ .+|..+....  +|+.|++++|++++..|..+.       .+++|+.|++++|++++.++..+..+++|++|+|++|
T Consensus       389 l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N  467 (636)
T 4eco_A          389 LK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN  467 (636)
T ss_dssp             CS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSS
T ss_pred             Cc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCC
Confidence            66 4555555443  666666666666666666665       5556666666666666555555555666666666666


Q ss_pred             cccCcccccCCCCC-------CCcEEeccCCccccCCCCCcc--ccccccccccccccccccCchhhcCCCCCcEEEccC
Q 042123          334 NFYGEISSNWGKFP-------KLGTLNVSMNNITGGLPREIG--NSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRG  404 (849)
Q Consensus       334 ~l~~~~~~~~~~l~-------~L~~L~Ls~N~i~~~~p~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~  404 (849)
                      ++....+..+....       +|+.|+|++|.++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++
T Consensus       468 ~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~  545 (636)
T 4eco_A          468 MLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN  545 (636)
T ss_dssp             CCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCS
T ss_pred             CCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCC
Confidence            66633322222221       5555555555555 4454444  55555555555555554 455555555555555543


Q ss_pred             ccccccCccccccccccccccccc---CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCC
Q 042123          405 NQITGRLPKEIGSLTKLEYLDFSA---IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVP  481 (849)
Q Consensus       405 N~l~~~~p~~~~~l~~L~~L~l~~---l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~  481 (849)
                      |+.                  ++.   .+.+|..+.++++|+.|+|++|+| +.+|..+.  ++|+.|++++|++.|...
T Consensus       546 N~~------------------ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~~~  604 (636)
T 4eco_A          546 QRD------------------AQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISIDL  604 (636)
T ss_dssp             CBC------------------TTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEEEC
T ss_pred             Ccc------------------cccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccccH
Confidence            320                  011   456777888888999999999999 57787766  899999999999987543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=4.5e-50  Score=466.29  Aligned_cols=458  Identities=20%  Similarity=0.230  Sum_probs=374.6

Q ss_pred             CCCCCcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCC
Q 042123            1 CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG   80 (849)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~   80 (849)
                      |...|+   ++++.+++......  +  .++|++|||++|+++++.|..|.++++|++|+|++|++++      ....+|
T Consensus         4 C~~~~~---c~~~~~~l~~ip~~--~--~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~------~~~~~~   70 (549)
T 2z81_A            4 CDASGV---CDGRSRSFTSIPSG--L--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT------IEGDAF   70 (549)
T ss_dssp             ECTTSE---EECTTSCCSSCCSC--C--CTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCE------ECTTTT
T ss_pred             CCCCce---EECCCCcccccccc--C--CCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCc------cChhhc
Confidence            555564   67788887644332  2  3789999999999999999999999999999999999984      234567


Q ss_pred             CCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCC-CCCCCcCCCCCceeeccCcc-cccccccccCCCCCC
Q 042123           81 GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGP-IPLSFDNLSNLIFLYLYGNL-LSGSILSSLGKLKSL  158 (849)
Q Consensus        81 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L  158 (849)
                      +++++|++|+|++|.+++..|..|+++++|++|+|++|++++. .|..|.++++|++|++++|. +....+..|.++++|
T Consensus        71 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L  150 (549)
T 2z81_A           71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSL  150 (549)
T ss_dssp             TTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEE
T ss_pred             cccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccccc
Confidence            8999999999999999988888899999999999999999974 46789999999999999998 554555789999999


Q ss_pred             CEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCccc-ccCCCCCCEEeccCCcCccCC--C-cCccCccccchhh
Q 042123          159 FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDE-IGKMRSLSVLDLNQNQFKGVL--P-PSISNLTNLKELA  234 (849)
Q Consensus       159 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~--~-~~~~~l~~L~~L~  234 (849)
                      ++|++++|++.+..|..|..+++|++|+++.|.+. .+|.. +..+++|++|++++|++++..  | .....+++|+.|+
T Consensus       151 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~  229 (549)
T 2z81_A          151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA  229 (549)
T ss_dssp             EEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEE
T ss_pred             CeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhccccee
Confidence            99999999999999999999999999999999987 44444 467999999999999998642  2 2344577888888


Q ss_pred             hccccccCCCCcchhh----h-hhhhhhccCcCCCCCCC-----------------------------------cccCCC
Q 042123          235 LLYNHLSGSIPPSLGN----L-ILRQLLLSGNHFTGYLP-----------------------------------YNICRG  274 (849)
Q Consensus       235 L~~N~l~~~~p~~~~~----~-~L~~L~L~~n~i~~~~~-----------------------------------~~~~~~  274 (849)
                      +++|.+.+..+..+..    . .++.+++++|.+.+...                                   ..+...
T Consensus       230 l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~  309 (549)
T 2z81_A          230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL  309 (549)
T ss_dssp             EESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHS
T ss_pred             ccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhc
Confidence            8888876544433321    1 26666777766554211                                   011223


Q ss_pred             CCcceeeecccccccccCCCC-CCcccccEEEccCccccCchhh---hhCCCCCCCEEeccCccccCccc--ccCCCCCC
Q 042123          275 GALEIFTVSENHFQGTIPTSL-RNCTSLIRVRLNGNNLTGNISE---ALGIYPNLTFIDLSRNNFYGEIS--SNWGKFPK  348 (849)
Q Consensus       275 ~~L~~L~l~~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~  348 (849)
                      ++|+.|++++|.+. .+|..+ .++++|+.|++++|++++..+.   .++.+++|++|+|++|++++..+  ..+..+++
T Consensus       310 ~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~  388 (549)
T 2z81_A          310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKN  388 (549)
T ss_dssp             TTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTT
T ss_pred             ccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCC
Confidence            56888888888887 455554 5789999999999999976643   37788999999999999986543  45888999


Q ss_pred             CcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCccccccccccccccccc
Q 042123          349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA  428 (849)
Q Consensus       349 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~  428 (849)
                      |++|++++|+++ .+|..+..+++|++|++++|+++. +|..+  .++|+.|+|++|++++..    +.+++|++|++++
T Consensus       389 L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~  460 (549)
T 2z81_A          389 LTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISR  460 (549)
T ss_dssp             CCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCS
T ss_pred             CCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc----ccCChhcEEECCC
Confidence            999999999999 688889999999999999999984 44433  268999999999998643    5789999999986


Q ss_pred             --CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCC
Q 042123          429 --IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       429 --l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                        +..+|. ...+++|+.|+|++|+|++.+|..|..+++|+.|++++|+|.|+||.
T Consensus       461 N~l~~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          461 NKLKTLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             SCCSSCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             CccCcCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence              778887 57899999999999999999999999999999999999999999984

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=3.8e-49  Score=470.32  Aligned_cols=445  Identities=20%  Similarity=0.221  Sum_probs=291.6

Q ss_pred             CCCCCcEEEEecCCCceeeeeCCccCCCCCCCCEEeC-cCCccccCCCccccCCC-CCCE--------------eeC-CC
Q 042123            1 CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDL-TWNGFFGTIPPQISNLS-NLRY--------------LYL-GS   63 (849)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L-~~n~i~~~~~~~~~~l~-~L~~--------------L~L-~~   63 (849)
                      |+.+|+|++|+|+.+++.|++++ +|..+++|++||| ++|.+.+..+....... .+..              +.. ..
T Consensus       319 C~~~~~V~~L~Ls~~~L~G~ip~-~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~  397 (876)
T 4ecn_A          319 LDNNGRVTGLSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR  397 (876)
T ss_dssp             ECTTSCEEEEECTTTCCEEEECG-GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGG
T ss_pred             ecCCCCEEEEECccCCCCCcCch-HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcc
Confidence            66678899999999888888885 7888888999998 88887766442211110 0000              000 00


Q ss_pred             CcCcccccccc-----cccCCCCCccccCeEeccC--CcccccCCccCCCCCCCCEEEccCCcccC--------------
Q 042123           64 NQFSGNILAEV-----SSESSGGNLRYMSRLVIND--NSLSGFIPPHIGNLKFLSQLDLTNNKFSG--------------  122 (849)
Q Consensus        64 N~l~~~~~~~~-----~~~~~~~~l~~L~~L~l~~--n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~--------------  122 (849)
                      ..+++.....+     ...........++.+.+..  |.+++ +|..|+++++|++|+|++|+|++              
T Consensus       398 ~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~  476 (876)
T 4ecn_A          398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY  476 (876)
T ss_dssp             GGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHH
T ss_pred             hhhhHHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCccccccccccccc
Confidence            00000000000     0000112223344444443  77776 67778888888888888888876              


Q ss_pred             ---CCCCCCc--CCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc-ccc-cCCcC-------CCCCCCCCEEEcc
Q 042123          123 ---PIPLSFD--NLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ-LIG-YIPRP-------FSNLTSVSTLRLS  188 (849)
Q Consensus       123 ---~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~-------~~~l~~L~~L~Ls  188 (849)
                         .+|..+.  ++++|++|+|++|.+.+.+|..|+++++|+.|+|++|+ +++ ..|..       +..+++|++|+|+
T Consensus       477 ~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls  556 (876)
T 4ecn_A          477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMG  556 (876)
T ss_dssp             HHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECC
T ss_pred             ccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEee
Confidence               2666665  78888888888888777777778888888888888887 765 44443       3344588888888


Q ss_pred             CCCCcCcCcc--cccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh-h-hhhhhccCcCCC
Q 042123          189 RNDLFGSIPD--EIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-I-LRQLLLSGNHFT  264 (849)
Q Consensus       189 ~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~-L~~L~L~~n~i~  264 (849)
                      +|+++ .+|.  .|.++++|++|+|++|+++ .+| .|..+++|++|+|++|.++ .+|..+..+ . |+.|+|++|+++
T Consensus       557 ~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~  632 (876)
T 4ecn_A          557 YNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK  632 (876)
T ss_dssp             SSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC
T ss_pred             CCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC
Confidence            88887 6776  7888888888888888887 556 7788888888888888887 677666554 3 777777777777


Q ss_pred             CCCCcccCCCCC--cceeeecccccccccCCCC---C--CcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccC
Q 042123          265 GYLPYNICRGGA--LEIFTVSENHFQGTIPTSL---R--NCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYG  337 (849)
Q Consensus       265 ~~~~~~~~~~~~--L~~L~l~~N~l~~~~~~~~---~--~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  337 (849)
                       .+|..+.....  |+.|++++|++.+.+|...   .  .+++|+.|+|++|+++..++..+..+++|+.|+|++|++..
T Consensus       633 -~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~  711 (876)
T 4ecn_A          633 -YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS  711 (876)
T ss_dssp             -SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSC
T ss_pred             -cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCc
Confidence             55666665543  8888888888877655332   2  33478888888888887666666788888888888888884


Q ss_pred             cccccCCCC-------CCCcEEeccCCccccCCCCCcc--ccccccccccccccccccCchhhcCCCCCcEEEccC----
Q 042123          338 EISSNWGKF-------PKLGTLNVSMNNITGGLPREIG--NSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRG----  404 (849)
Q Consensus       338 ~~~~~~~~l-------~~L~~L~Ls~N~i~~~~p~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~----  404 (849)
                      ..+..+...       ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++    
T Consensus       712 ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~l  789 (876)
T 4ecn_A          712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA  789 (876)
T ss_dssp             CCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCT
T ss_pred             cChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCc
Confidence            333333322       27888888888887 6677766  77788888888888875 677777788888887766    


Q ss_pred             --ccccccCcccccccccccccccccCCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCcccc
Q 042123          405 --NQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC  478 (849)
Q Consensus       405 --N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~  478 (849)
                        |++.+.+|..                     +.++++|+.|+|++|+| +.+|..+.  ++|+.|||++|++..
T Consensus       790 s~N~l~~~ip~~---------------------l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          790 EGNRILRQWPTG---------------------ITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNIS  841 (876)
T ss_dssp             TCCBCCCCCCTT---------------------GGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCE
T ss_pred             ccccccccChHH---------------------HhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCc
Confidence              4444444444                     44445555555555555 34444433  355555555555543

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.6e-49  Score=456.44  Aligned_cols=451  Identities=21%  Similarity=0.250  Sum_probs=385.7

Q ss_pred             EEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCe
Q 042123            9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR   88 (849)
Q Consensus         9 ~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~   88 (849)
                      .++++.+++.+. +. .+.  ++|++|+|++|++.++.|..|.++++|++|+|++|++++.      .+..|+++++|++
T Consensus         4 ~l~ls~n~l~~i-p~-~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~------~~~~~~~l~~L~~   73 (520)
T 2z7x_B            4 LVDRSKNGLIHV-PK-DLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYL------DISVFKFNQELEY   73 (520)
T ss_dssp             EEECTTSCCSSC-CC-SCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEE------EGGGGTTCTTCCE
T ss_pred             eEecCCCCcccc-cc-ccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCc------ChHHhhcccCCCE
Confidence            578899998854 33 232  8999999999999999999999999999999999999853      3456788999999


Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCC-CCCCCcCCCCCceeeccCcccccccccccCCCCCC--CEEEcCC
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGP-IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL--FDLQLND  165 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~  165 (849)
                      |+|++|.|+. +|..  .+++|++|+|++|+++++ .|..|.++++|++|++++|.+++   ..|..+++|  +.|+|++
T Consensus        74 L~Ls~N~l~~-lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~  147 (520)
T 2z7x_B           74 LDLSHNKLVK-ISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVL  147 (520)
T ss_dssp             EECCSSCCCE-EECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEE
T ss_pred             EecCCCceee-cCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeec
Confidence            9999999995 4544  899999999999999974 68899999999999999999985   457777888  9999999


Q ss_pred             Ccc--cccCCcCCCCCC-CCCEEEccCCCCcCcCcc-cccCCCCCCEEeccCCc-------CccCCCcCccCccccchhh
Q 042123          166 NQL--IGYIPRPFSNLT-SVSTLRLSRNDLFGSIPD-EIGKMRSLSVLDLNQNQ-------FKGVLPPSISNLTNLKELA  234 (849)
Q Consensus       166 N~l--~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~-------l~~~~~~~~~~l~~L~~L~  234 (849)
                      |.+  .+..|..|..+. +...+++++|++.+.+++ .+.++++|+.|++++|.       +.+.+| .+..+++|+.|+
T Consensus       148 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~  226 (520)
T 2z7x_B          148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLT  226 (520)
T ss_dssp             CTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEE
T ss_pred             ccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcc
Confidence            999  778888888776 355678899998765554 67889999999999998       665555 789999999999


Q ss_pred             hccccccCCCCcchh----hhhhhhhhccCcCCCCCCCccc-----CCCCCcceeeecccccccccC-CCCCCc---ccc
Q 042123          235 LLYNHLSGSIPPSLG----NLILRQLLLSGNHFTGYLPYNI-----CRGGALEIFTVSENHFQGTIP-TSLRNC---TSL  301 (849)
Q Consensus       235 L~~N~l~~~~p~~~~----~~~L~~L~L~~n~i~~~~~~~~-----~~~~~L~~L~l~~N~l~~~~~-~~~~~l---~~L  301 (849)
                      +++|.+++..+..+.    ...|++|++++|++++.+|..+     ..+++|+.++++.|.+  .+| ..+..+   .+|
T Consensus       227 l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L  304 (520)
T 2z7x_B          227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNI  304 (520)
T ss_dssp             EEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCC
T ss_pred             ccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCce
Confidence            999998754333222    2259999999999999999988     8999999999999999  444 444444   679


Q ss_pred             cEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCcccc--CCCCCccccccccccccc
Q 042123          302 IRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITG--GLPREIGNSSQLQAFDLS  379 (849)
Q Consensus       302 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~--~~p~~~~~l~~L~~L~L~  379 (849)
                      +.|++++|.+....  .+..+++|++|++++|++.+..|..+..+++|++|++++|++++  .+|..+..+++|+.|+++
T Consensus       305 ~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls  382 (520)
T 2z7x_B          305 KNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDIS  382 (520)
T ss_dssp             SEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECC
T ss_pred             eEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECC
Confidence            99999999987543  23688999999999999999899999999999999999999996  456778999999999999


Q ss_pred             cccccccCch-hhcCCCCCcEEEccCccccccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCC
Q 042123          380 LNHIVGEIPK-ELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSI  456 (849)
Q Consensus       380 ~N~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~  456 (849)
                      +|.+++.+|. .+..+++|++|++++|++++..|..+.  ++|++|+++.  +..+|..+..+++|+.|+|++|+|++..
T Consensus       383 ~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~  460 (520)
T 2z7x_B          383 QNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVP  460 (520)
T ss_dssp             SSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCC
T ss_pred             CCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccC
Confidence            9999985665 588999999999999999988887775  7899999986  7899999999999999999999999655


Q ss_pred             CccccccCCCcEEeccCCccccCCCC
Q 042123          457 PSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       457 p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      +..|..+++|+.|++++|+|+|+|+.
T Consensus       461 ~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          461 DGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             HHHhccCCcccEEECcCCCCcccCCc
Confidence            55599999999999999999999874

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=448.43  Aligned_cols=438  Identities=23%  Similarity=0.241  Sum_probs=392.0

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY   85 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~   85 (849)
                      .++.++++.+.+.+... .+|.++++|++|||++|++.++.+.+|+++++|++|+|++|++++      ..+..|+++++
T Consensus        29 ~l~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~------~~~~~~~~l~~  101 (570)
T 2z63_A           29 STKNLDLSFNPLRHLGS-YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS------LALGAFSGLSS  101 (570)
T ss_dssp             SCCEEECCSCCCCEECT-TTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE------ECTTTTTTCTT
T ss_pred             cccEEEccCCccCccCh-hHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCc------cCHhhhcCccc
Confidence            57889999999877644 489999999999999999999999999999999999999999974      23467889999


Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCC-CCCCCcCCCCCceeeccCcccccccccccCCCCCC----CE
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGP-IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL----FD  160 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~  160 (849)
                      |++|++++|.+++..+..|+++++|++|++++|+++++ .|..|.++++|++|++++|++++..+..|+.+++|    +.
T Consensus       102 L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~  181 (570)
T 2z63_A          102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  181 (570)
T ss_dssp             CCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             cccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhh
Confidence            99999999999987777899999999999999999974 58999999999999999999998888889888888    89


Q ss_pred             EEcCCCcccccCCcCCCCCCCCCEEEccCC--------------------------------------------------
Q 042123          161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRN--------------------------------------------------  190 (849)
Q Consensus       161 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N--------------------------------------------------  190 (849)
                      |++++|.+.++.+..|..+ +|++|++++|                                                  
T Consensus       182 L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~  260 (570)
T 2z63_A          182 LDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE  260 (570)
T ss_dssp             EECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEE
T ss_pred             cccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchh
Confidence            9999999999999988876 7999999887                                                  


Q ss_pred             --------CCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcC
Q 042123          191 --------DLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNH  262 (849)
Q Consensus       191 --------~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~  262 (849)
                              .+.+..|+.+..+++|++|++++|.++ .+|..+..+ +|++|++++|.+. .+|.. ....|+.|++++|.
T Consensus       261 ~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~-~l~~L~~L~l~~n~  336 (570)
T 2z63_A          261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTL-KLKSLKRLTFTSNK  336 (570)
T ss_dssp             EEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBC-BCSSCCEEEEESCB
T ss_pred             hhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcc-cccccCEEeCcCCc
Confidence                    333455677888999999999999998 578888888 9999999999998 66662 33359999999999


Q ss_pred             CCCCCCcccCCCCCcceeeeccccccccc--CCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCccc
Q 042123          263 FTGYLPYNICRGGALEIFTVSENHFQGTI--PTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS  340 (849)
Q Consensus       263 i~~~~~~~~~~~~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  340 (849)
                      +.+..+.  ..+++|+.|++++|++++..  |..+.++++|+.|++++|.+++.++. +..+++|+.|++++|.+.+..+
T Consensus       337 ~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~  413 (570)
T 2z63_A          337 GGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSE  413 (570)
T ss_dssp             SCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTT
T ss_pred             ccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccc
Confidence            9877765  77899999999999998654  67788999999999999999977666 9999999999999999997766


Q ss_pred             -ccCCCCCCCcEEeccCCccccCCCCCcccccccccccccccccc-ccCchhhcCCCCCcEEEccCccccccCccccccc
Q 042123          341 -SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIV-GEIPKELGKLNPLTKLILRGNQITGRLPKEIGSL  418 (849)
Q Consensus       341 -~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l  418 (849)
                       ..+..+++|++|++++|.+++..|..+.++++|+.|++++|.++ +.+|..|..+++|++|+|++|++++..|..|..+
T Consensus       414 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  493 (570)
T 2z63_A          414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL  493 (570)
T ss_dssp             SCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             hhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcc
Confidence             57899999999999999999999999999999999999999997 5789999999999999999999999889999999


Q ss_pred             cccccccccc--CCCCC-hhhhcccccceeccCCcccccCCCc
Q 042123          419 TKLEYLDFSA--IGELP-SQICNMKSLEKLNLSHNNLSGSIPS  458 (849)
Q Consensus       419 ~~L~~L~l~~--l~~lp-~~~~~l~~L~~L~L~~N~l~~~~p~  458 (849)
                      ++|++|++++  +..+| ..+.++++|+.|++++|++++..|.
T Consensus       494 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  536 (570)
T 2z63_A          494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  536 (570)
T ss_dssp             TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred             cCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence            9999999986  56665 4689999999999999999987774

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=7.2e-47  Score=450.73  Aligned_cols=440  Identities=17%  Similarity=0.224  Sum_probs=341.6

Q ss_pred             CCCCEEeCcCCccccCCCccccCCCCCCEeeC-CCCcCcccccccccccCCCCCccc-----c-----------------
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYL-GSNQFSGNILAEVSSESSGGNLRY-----M-----------------   86 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L-~~N~l~~~~~~~~~~~~~~~~l~~-----L-----------------   86 (849)
                      .+++.|+|++|++.+.+|++|++|++|++|+| ++|.++|..+.....  ....+..     +                 
T Consensus       323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~--~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~  400 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEE--LTPDMSEERKHRIRMHYKKMFLDYDQRLNL  400 (876)
T ss_dssp             SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBC--CCSSCCHHHHHHHHTHHHHHHTCCCGGGGS
T ss_pred             CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccc--cccccchhHHHHHHHhhhhhhhccCcchhh
Confidence            57999999999999999999999999999999 999988753322100  0000000     0                 


Q ss_pred             ---CeEeccCCcccccCCccCCCCCCCCEEEccC--CcccCCCCCCCcCCCCCceeeccCccccc---------------
Q 042123           87 ---SRLVINDNSLSGFIPPHIGNLKFLSQLDLTN--NKFSGPIPLSFDNLSNLIFLYLYGNLLSG---------------  146 (849)
Q Consensus        87 ---~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~--n~i~~~~~~~~~~l~~L~~L~L~~N~l~~---------------  146 (849)
                         ..-.+..+..  ..+-.......++.+.+..  |++++ +|..|.++++|++|+|++|++++               
T Consensus       401 s~l~~~~l~~~~~--~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~  477 (876)
T 4ecn_A          401 SDLLQDAINRNPE--MKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYA  477 (876)
T ss_dssp             CHHHHHHHHTCTT--SCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHH
T ss_pred             hHHHHHHhhhCcc--ccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccc
Confidence               0000000100  0111112334455555554  89997 78899999999999999999998               


Q ss_pred             --ccccccC--CCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCC-CcC-cCcccccCCC-------CCCEEeccC
Q 042123          147 --SILSSLG--KLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND-LFG-SIPDEIGKMR-------SLSVLDLNQ  213 (849)
Q Consensus       147 --~~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l~-------~L~~L~L~~  213 (849)
                        .+|..++  ++++|+.|+|++|.+.+..|..|.++++|++|+|++|+ +++ .+|..+..++       +|++|+|++
T Consensus       478 ~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~  557 (876)
T 4ecn_A          478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY  557 (876)
T ss_dssp             HHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCS
T ss_pred             cccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeC
Confidence              3788877  99999999999999999999999999999999999998 887 7887666655       999999999


Q ss_pred             CcCccCCCc--CccCccccchhhhccccccCCCCcchhhh-hhhhhhccCcCCCCCCCcccCCCCC-cceeeeccccccc
Q 042123          214 NQFKGVLPP--SISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFTGYLPYNICRGGA-LEIFTVSENHFQG  289 (849)
Q Consensus       214 N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~L~~n~i~~~~~~~~~~~~~-L~~L~l~~N~l~~  289 (849)
                      |+++ .+|.  .|.++++|++|+|++|.++ .+| .++.+ .|+.|+|++|+++ .+|..+..+++ |+.|++++|+++ 
T Consensus       558 N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-  632 (876)
T 4ecn_A          558 NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-  632 (876)
T ss_dssp             SCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-
T ss_pred             CcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-
Confidence            9999 7788  8999999999999999998 888 56555 4999999999998 77888888888 999999999988 


Q ss_pred             ccCCCCCCccc--ccEEEccCccccCchhhhh---C--CCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccC
Q 042123          290 TIPTSLRNCTS--LIRVRLNGNNLTGNISEAL---G--IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGG  362 (849)
Q Consensus       290 ~~~~~~~~l~~--L~~L~L~~n~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~  362 (849)
                      .+|..+..++.  |+.|++++|++++.+|...   .  ..++|+.|+|++|++...++..+..+++|+.|+|++|.++ .
T Consensus       633 ~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~  711 (876)
T 4ecn_A          633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-S  711 (876)
T ss_dssp             SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-C
T ss_pred             cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-c
Confidence            67888777654  9999999999987655322   2  3458899999999998554444557889999999999998 5


Q ss_pred             CCCCccc--------cccccccccccccccccCchhhc--CCCCCcEEEccCccccccCcccccccccccccccccCCCC
Q 042123          363 LPREIGN--------SSQLQAFDLSLNHIVGEIPKELG--KLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGEL  432 (849)
Q Consensus       363 ~p~~~~~--------l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~l  432 (849)
                      +|..+..        +++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..++.+++|+.|+++...  
T Consensus       712 ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~--  787 (876)
T 4ecn_A          712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR--  787 (876)
T ss_dssp             CCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB--
T ss_pred             cChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC--
Confidence            5554433        338899999999988 6777776  88899999999998885 67777777777777766422  


Q ss_pred             ChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCCcccccCcccccccCCC
Q 042123          433 PSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKG  499 (849)
Q Consensus       433 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~  499 (849)
                                   ++++|++.+.+|..|..+++|+.|+|++|++ +.+|... ++......+.+|+.
T Consensus       788 -------------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l-~~~L~~LdLs~N~l  839 (876)
T 4ecn_A          788 -------------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL-TPQLYILDIADNPN  839 (876)
T ss_dssp             -------------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CSSSCEEECCSCTT
T ss_pred             -------------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhh-cCCCCEEECCCCCC
Confidence                         5677999999999999999999999999999 7777652 23344444556653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.4e-47  Score=402.64  Aligned_cols=244  Identities=20%  Similarity=0.363  Sum_probs=193.7

Q ss_pred             cCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      .+++..+.||+|+||+||+|++.      +++.||||+++....   ....++|.+|+.           +++|+|.+++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~---~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~  102 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE---GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ  102 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC---C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC---hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence            35566789999999999999762      467899999875422   223456777755           4789999999


Q ss_pred             eeEEEEEeccCCChhhhhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 042123          651 HSFLLYEFLERGSLAAILNTDA-------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD  717 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  717 (849)
                      ..++|||||++|+|.+++....             ....++|.++.+|+.|||.||+|||+.   +|+||||||+|||++
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEEC
Confidence            9999999999999999996432             124589999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeeecCCcccCCCC--CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 042123          718 LEYEAHVADFGIAKSLKPDS--SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSL  794 (849)
Q Consensus       718 ~~~~~kl~DfG~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~  794 (849)
                      +++.+||+|||+|+.....+  .......||+.|||||++.++.|+.++|||||||++|||+| |+.||.....      
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------  253 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  253 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence            99999999999998764332  22345678999999999999999999999999999999998 8999975432      


Q ss_pred             ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        ......+..+..++.+..   .+..+.+++.+||+.||++||||+||+++|+
T Consensus       254 --~~~~~~i~~~~~~~~p~~---~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~  302 (308)
T 4gt4_A          254 --QDVVEMIRNRQVLPCPDD---CPAWVYALMIECWNEFPSRRPRFKDIHSRLR  302 (308)
T ss_dssp             --HHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --HHHHHHHHcCCCCCCccc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence              122222333332222222   2234788999999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=394.84  Aligned_cols=246  Identities=22%  Similarity=0.372  Sum_probs=186.5

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|...+.||+|+||+||+|++.  ..||||+++...  ......+.|.+|+.           +++|++.+ +..++|
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVD--PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence            467788899999999999999875  359999986432  22334567888866           36787755 568999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.++++...  ..++|.++..|+.|||.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus       110 mEy~~gGsL~~~l~~~~--~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE--TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             EECCSSCBHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             EEcCCCCCHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999999997543  3599999999999999999999998   999999999999999999999999999987643


Q ss_pred             CC--CCeeeccCCccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          736 DS--SNWTEFAGTCGYIAPELAYT---MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       736 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      ..  .......||+.|||||++.+   +.|+.++|||||||++|||+||+.||........   ...........+..+.
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~  261 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ---IIFMVGRGYASPDLSK  261 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHTTCCCCCSTT
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCCccc
Confidence            22  23455689999999999864   4589999999999999999999999975432110   0001111112222221


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..   ......+.+++.+||+.||++||||.||+++|+
T Consensus       262 ~~---~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le  296 (307)
T 3omv_A          262 LY---KNCPKAMKRLVADCVKKVKEERPLFPQILSSIE  296 (307)
T ss_dssp             SC---TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred             cc---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            11   122345788999999999999999999998875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=7.7e-47  Score=439.46  Aligned_cols=453  Identities=19%  Similarity=0.208  Sum_probs=330.3

Q ss_pred             EEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccC
Q 042123            8 INISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS   87 (849)
Q Consensus         8 ~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~   87 (849)
                      ..++++.+++.+....  +  .++|++|+|++|+|.++.+.+|.++++|++|+|++|++++      ..+.+|+++++|+
T Consensus        34 ~~l~ls~~~L~~ip~~--~--~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~------~~~~~~~~l~~L~  103 (562)
T 3a79_B           34 SMVDYSNRNLTHVPKD--L--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS------LDFHVFLFNQDLE  103 (562)
T ss_dssp             CEEECTTSCCCSCCTT--S--CTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCE------ECTTTTTTCTTCC
T ss_pred             cEEEcCCCCCccCCCC--C--CCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCc------CCHHHhCCCCCCC
Confidence            5566677776653222  2  2667777777777777776777777777777777777763      2334566677777


Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccCCC-CCCCcCCCCCceeeccCcccccccccccCCCCCC--CEEEcC
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPI-PLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL--FDLQLN  164 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~  164 (849)
                      +|+|++|.|+. +|..  .+++|++|+|++|+++++. |..|.++++|++|+|++|+++..   .+.++++|  ++|+|+
T Consensus       104 ~L~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~  177 (562)
T 3a79_B          104 YLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLD  177 (562)
T ss_dssp             EEECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEE
T ss_pred             EEECCCCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEee
Confidence            77777777774 3433  6777777777777777533 46677777777777777777642   34444444  777777


Q ss_pred             CCcc--cccCCcCCCCCC--CCCEEEccCCCCcCcCcc-cccCCCCCCEEeccCCcCc----cCCCcCccCccccchhhh
Q 042123          165 DNQL--IGYIPRPFSNLT--SVSTLRLSRNDLFGSIPD-EIGKMRSLSVLDLNQNQFK----GVLPPSISNLTNLKELAL  235 (849)
Q Consensus       165 ~N~l--~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L  235 (849)
                      +|++  .+..|..|..+.  .| .++++.|.+.+.+++ .+..+++|+.|++++|+..    ......+..+++|+.|++
T Consensus       178 ~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L  256 (562)
T 3a79_B          178 LVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTL  256 (562)
T ss_dssp             ESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEE
T ss_pred             cccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEe
Confidence            7777  666666666554  22 456667766654443 4556777788888777521    011234666777777777


Q ss_pred             ccccccCCC----CcchhhhhhhhhhccCcCCCCCCCccc-----CCCCCcceeeecccccccccC-CCCCCc---cccc
Q 042123          236 LYNHLSGSI----PPSLGNLILRQLLLSGNHFTGYLPYNI-----CRGGALEIFTVSENHFQGTIP-TSLRNC---TSLI  302 (849)
Q Consensus       236 ~~N~l~~~~----p~~~~~~~L~~L~L~~n~i~~~~~~~~-----~~~~~L~~L~l~~N~l~~~~~-~~~~~l---~~L~  302 (849)
                      +++.+.+..    +.......|++|++++|.+++.+|..+     ..++.|+.++++.|.+  .+| ..+..+   .+|+
T Consensus       257 ~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~  334 (562)
T 3a79_B          257 QHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIK  334 (562)
T ss_dssp             EEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCS
T ss_pred             cCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcce
Confidence            777665321    122222358899999999998888877     6677777777777776  233 222222   5699


Q ss_pred             EEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccC--CCCCcccccccccccccc
Q 042123          303 RVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGG--LPREIGNSSQLQAFDLSL  380 (849)
Q Consensus       303 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~--~p~~~~~l~~L~~L~L~~  380 (849)
                      .|++++|.+....  ....+++|++|++++|++.+..|..+..+++|++|++++|++++.  .|..+.++++|+.|++++
T Consensus       335 ~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~  412 (562)
T 3a79_B          335 MLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL  412 (562)
T ss_dssp             EEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTT
T ss_pred             EEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCC
Confidence            9999999987432  126889999999999999998999999999999999999999963  346789999999999999


Q ss_pred             ccccccCc-hhhcCCCCCcEEEccCccccccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCC
Q 042123          381 NHIVGEIP-KELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIP  457 (849)
Q Consensus       381 N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p  457 (849)
                      |++++.+| ..+..+++|++|+|++|++++..|..+.  ++|++|+++.  +..+|..+..+++|+.|+|++|+|++..+
T Consensus       413 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~  490 (562)
T 3a79_B          413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPD  490 (562)
T ss_dssp             SCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCT
T ss_pred             CcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCH
Confidence            99998455 4688999999999999999988777665  7899999986  78999999999999999999999996555


Q ss_pred             ccccccCCCcEEeccCCccccCCCCC
Q 042123          458 SCFEGMHGLSFIDMSYNELQCPVPNS  483 (849)
Q Consensus       458 ~~~~~l~~L~~l~l~~N~l~~~~~~~  483 (849)
                      ..|..+++|+.|++++|+|+|+|+..
T Consensus       491 ~~~~~l~~L~~L~l~~N~~~c~c~~~  516 (562)
T 3a79_B          491 GVFDRLTSLQYIWLHDNPWDCTCPGI  516 (562)
T ss_dssp             TSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred             HHHhcCCCCCEEEecCCCcCCCcchH
Confidence            55999999999999999999999753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=7.3e-46  Score=439.06  Aligned_cols=460  Identities=19%  Similarity=0.181  Sum_probs=350.7

Q ss_pred             EecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeE
Q 042123           10 ISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRL   89 (849)
Q Consensus        10 ~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L   89 (849)
                      ++|...++.......+    +++++|||++|+|+++.+.+|.++++|++|+|++|+|++      .++.+|.++++|++|
T Consensus        36 ~~c~~~~l~~vP~~lp----~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~------i~~~~f~~L~~L~~L  105 (635)
T 4g8a_A           36 YQCMELNFYKIPDNLP----FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT------IEDGAYQSLSHLSTL  105 (635)
T ss_dssp             EECTTSCCSSCCSSSC----TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE------ECTTTTTTCTTCCEE
T ss_pred             EECCCCCcCccCCCCC----cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCC------cChhHhcCCCCCCEE
Confidence            5788888765543321    479999999999999999999999999999999999973      456678999999999


Q ss_pred             eccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccc-cccccCCCCCCCEEEcCCCcc
Q 042123           90 VINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS-ILSSLGKLKSLFDLQLNDNQL  168 (849)
Q Consensus        90 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l  168 (849)
                      +|++|+|++..+.+|.++++|++|+|++|+|+++.+..|.++++|++|+|++|.++.. .|..++.+++|++|+|++|++
T Consensus       106 ~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l  185 (635)
T 4g8a_A          106 ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI  185 (635)
T ss_dssp             ECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCC
T ss_pred             EccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccc
Confidence            9999999988888999999999999999999998888999999999999999999754 577889999999999999999


Q ss_pred             cccCCcCCCCCCCCC----EEEccCCCCcCcCcccccCCCCCCEEeccCCcCcc--------------------------
Q 042123          169 IGYIPRPFSNLTSVS----TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG--------------------------  218 (849)
Q Consensus       169 ~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--------------------------  218 (849)
                      .++.+..|..+.+++    .++++.|.+....+..+ ....++.|++.+|....                          
T Consensus       186 ~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~  264 (635)
T 4g8a_A          186 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE  264 (635)
T ss_dssp             CEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTS
T ss_pred             cccccccccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccc
Confidence            999888887665544    68888888875444333 23344455555443210                          


Q ss_pred             -----CC---------------------------CcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCC
Q 042123          219 -----VL---------------------------PPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGY  266 (849)
Q Consensus       219 -----~~---------------------------~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~  266 (849)
                           ..                           +..+..+.+++.+.+.+|.+.. ++.......++.|++++|.+...
T Consensus       265 ~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~-~~~~~~~~~L~~L~l~~~~~~~~  343 (635)
T 4g8a_A          265 GNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQF  343 (635)
T ss_dssp             CCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEE-CGGGGSCCCCSEEEEESCEESSC
T ss_pred             cccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccc-ccccccchhhhhhhcccccccCc
Confidence                 00                           0111122222233333332221 11111111244444444444332


Q ss_pred             CCc-------------------ccCCCCCcceeeeccccccc--ccCCCCCCcccccEEEccCccccCchhhhhCCCCCC
Q 042123          267 LPY-------------------NICRGGALEIFTVSENHFQG--TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNL  325 (849)
Q Consensus       267 ~~~-------------------~~~~~~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L  325 (849)
                      .+.                   ....+++|+.++++.|.+..  ..+..+..+.+|+.|++..|.+.. .+..+..+++|
T Consensus       344 ~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L  422 (635)
T 4g8a_A          344 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQL  422 (635)
T ss_dssp             CCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTC
T ss_pred             CcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccc
Confidence            221                   22345667777777776643  233344556677777777777663 34567778899


Q ss_pred             CEEeccCccccCcc-cccCCCCCCCcEEeccCCccccCCCCCcccccccccccccccccc-ccCchhhcCCCCCcEEEcc
Q 042123          326 TFIDLSRNNFYGEI-SSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIV-GEIPKELGKLNPLTKLILR  403 (849)
Q Consensus       326 ~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~  403 (849)
                      +.+++++|...... +..|..+++++.++++.|.+.+..+..+..++.|+.|+|++|.+. +..|..|..+++|++|+|+
T Consensus       423 ~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls  502 (635)
T 4g8a_A          423 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS  502 (635)
T ss_dssp             CEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred             cchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECC
Confidence            99999888776544 456788999999999999999999999999999999999999854 4678899999999999999


Q ss_pred             CccccccCccccccccccccccccc--CCCCC-hhhhcccccceeccCCcccccCCCcccccc-CCCcEEeccCCccccC
Q 042123          404 GNQITGRLPKEIGSLTKLEYLDFSA--IGELP-SQICNMKSLEKLNLSHNNLSGSIPSCFEGM-HGLSFIDMSYNELQCP  479 (849)
Q Consensus       404 ~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~l~l~~N~l~~~  479 (849)
                      +|+|++..|..|+++++|++|++++  +..+| ..+..+++|+.|+|++|+|++..|..|..+ ++|+.|+|++|||+|+
T Consensus       503 ~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~  582 (635)
T 4g8a_A          503 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT  582 (635)
T ss_dssp             TSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred             CCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence            9999999999999999999999986  66665 568999999999999999999999999998 6899999999999999


Q ss_pred             CCC
Q 042123          480 VPN  482 (849)
Q Consensus       480 ~~~  482 (849)
                      |..
T Consensus       583 C~~  585 (635)
T 4g8a_A          583 CEH  585 (635)
T ss_dssp             GGG
T ss_pred             CCc
Confidence            974

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-47  Score=399.73  Aligned_cols=243  Identities=26%  Similarity=0.483  Sum_probs=193.3

Q ss_pred             cCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      ++|.+.+.||+|+||+||+|++.      ++..||||+++..    .....++|.+|+.           +++|+|.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~   88 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   88 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence            56788899999999999999763      4788999998753    2334567888866           4789999999


Q ss_pred             eeEEEEEeccCCChhhhhcccc----------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDA----------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY  720 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  720 (849)
                      ..++|||||++|+|.++++...          ....++|.++.+|+.|||.||+|||++   +|+||||||+|||+++++
T Consensus        89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence            9999999999999999997532          234699999999999999999999998   999999999999999999


Q ss_pred             cEEEeeecCCcccCCCCCCe--eeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccc
Q 042123          721 EAHVADFGIAKSLKPDSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTD  797 (849)
Q Consensus       721 ~~kl~DfG~a~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~  797 (849)
                      .+||+|||+|+.........  ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.....        .
T Consensus       166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~  237 (299)
T 4asz_A          166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------N  237 (299)
T ss_dssp             CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------H
T ss_pred             cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence            99999999998765433221  22468999999999999999999999999999999998 8999975432        1


Q ss_pred             cccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +....+..+..+..+...   +.++.+++.+||+.||++||||+||++.|+
T Consensus       238 ~~~~~i~~~~~~~~p~~~---~~~~~~li~~cl~~dP~~RPs~~~i~~~L~  285 (299)
T 4asz_A          238 EVIECITQGRVLQRPRTC---PQEVYELMLGCWQREPHMRKNIKGIHTLLQ  285 (299)
T ss_dssp             HHHHHHHHTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHcCCCCCCCccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            222223333222222222   234788999999999999999999988774

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=400.43  Aligned_cols=242  Identities=27%  Similarity=0.504  Sum_probs=187.9

Q ss_pred             cCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      ++|...++||+|+||+||+|++.      +++.||||+++..    .....++|.+|+.           +++|+|.+.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~  116 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFFGVCTEGR  116 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            46777889999999999999764      4788999998753    2334567888866           4789999999


Q ss_pred             eeEEEEEeccCCChhhhhcccc------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 042123          651 HSFLLYEFLERGSLAAILNTDA------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL  718 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  718 (849)
                      ..++|||||++|+|.++++...            ....++|.++.+|+.|||.||+|||+.   +|+||||||+|||+++
T Consensus       117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence            9999999999999999996532            124599999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccc
Q 042123          719 EYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLN  795 (849)
Q Consensus       719 ~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~  795 (849)
                      ++.+||+|||+|+.......  ......||+.|||||++.+..|+.++|||||||++|||+| |+.||......      
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------  267 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------  267 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------
Confidence            99999999999987654322  2344679999999999999999999999999999999999 89999754321      


Q ss_pred             cccccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          796 TDVALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       796 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        .....+..+ +.+.+...    ..++.+++.+||+.||++||||+||+++|+
T Consensus       268 --~~~~~i~~g~~~~~p~~~----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~  315 (329)
T 4aoj_A          268 --EAIDCITQGRELERPRAC----PPEVYAIMRGCWQREPQQRHSIKDVHARLQ  315 (329)
T ss_dssp             --HHHHHHHHTCCCCCCTTC----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred             --HHHHHHHcCCCCCCcccc----cHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence              122222222 22222222    234788999999999999999999999885

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.2e-47  Score=401.61  Aligned_cols=239  Identities=26%  Similarity=0.379  Sum_probs=192.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      ..|+..+.||+|+||+||+|+. .+|+.||||++.......    .+.+.+|+           .++++++.+++..|+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS----GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH----HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4688899999999999999965 579999999986532222    12233343           3578889999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++..    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       150 mEy~~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          150 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             ECCCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999999864    3499999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      ........+||+.|||||++.+..|+.++||||+||++|||++|+.||......        .....+.+. .+......
T Consensus       223 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~-~~~~~~~~  293 (346)
T 4fih_A          223 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDN-LPPRLKNL  293 (346)
T ss_dssp             SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHS-SCCCCSCG
T ss_pred             CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcC-CCCCCCcc
Confidence            655567789999999999999999999999999999999999999999743321        111111111 11111112


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||++||++|||++|+++|
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            2233458899999999999999999999886

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.5e-47  Score=401.70  Aligned_cols=242  Identities=20%  Similarity=0.319  Sum_probs=190.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.....  .....+.+.+|+.           ++++++.+++..|+|
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            6899999999999999999965 5799999999975432  2233456677755           378888899999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++.... ...+++.+++.|+.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+....
T Consensus       102 mEy~~gg~L~~~i~~~~-~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQK-GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             EECCTTCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             EeCCCCCcHHHHHHHcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            99999999999996543 24578999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      ........+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.        ......+.....+....  
T Consensus       178 ~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~~~~--  247 (350)
T 4b9d_A          178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM--------KNLVLKIISGSFPPVSL--  247 (350)
T ss_dssp             HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCCCT--
T ss_pred             CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHcCCCCCCCc--
Confidence            33334456899999999999999999999999999999999999999974332        12223333333322211  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....+.+++.+||++||++|||++|+++|
T Consensus       248 -~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          248 -HYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             -TSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -cCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             122347889999999999999999999875

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.3e-46  Score=442.16  Aligned_cols=448  Identities=19%  Similarity=0.269  Sum_probs=337.5

Q ss_pred             CCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccc--cc--cccccCCCCCccccCeEeccCCcccccCCccCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNI--LA--EVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG  105 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~--~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  105 (849)
                      .+++.|+|++|++.+.+|++|+++++|++|+|++|.+....  ..  ......+...+..|+ +++++|.+.+.+|..+.
T Consensus        81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~-l~l~~~~l~~~~~~~~~  159 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR-MHYQKTFVDYDPREDFS  159 (636)
T ss_dssp             CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHH-THHHHHHTCCCGGGGSC
T ss_pred             CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHH-hhHHHhhhccCchhhHH
Confidence            57999999999999999999999999999999999762110  00  000000001145566 77777777766665554


Q ss_pred             CC-------------------CCCCEEEcc--CCcccCCCCCCCcCCCCCceeeccCcccccc-----------------
Q 042123          106 NL-------------------KFLSQLDLT--NNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS-----------------  147 (849)
Q Consensus       106 ~l-------------------~~L~~L~Ls--~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------  147 (849)
                      .+                   ..++.+.+.  +|++++ +|.+|.++++|++|+|++|.+++.                 
T Consensus       160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~  238 (636)
T 4eco_A          160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQY  238 (636)
T ss_dssp             HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred             HHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhccc
Confidence            11                   122222332  578887 788899999999999999998875                 


Q ss_pred             cccccC--CCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCC-CcC-cCcccccCC------CCCCEEeccCCcCc
Q 042123          148 ILSSLG--KLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND-LFG-SIPDEIGKM------RSLSVLDLNQNQFK  217 (849)
Q Consensus       148 ~~~~~~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~-~~~~~~~~l------~~L~~L~L~~N~l~  217 (849)
                      +|..++  ++++|++|+|++|++.+..|..|.++++|++|+|++|+ +++ .+|..+..+      ++|++|++++|+++
T Consensus       239 ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             TTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             CchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            788888  89999999999999888888889999999999999998 887 788877776      88999999999998


Q ss_pred             cCCCc--CccCccccchhhhccccccCCCCcchhhh-hhhhhhccCcCCCCCCCcccCCCCC-cceeeecccccccccCC
Q 042123          218 GVLPP--SISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFTGYLPYNICRGGA-LEIFTVSENHFQGTIPT  293 (849)
Q Consensus       218 ~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~L~~n~i~~~~~~~~~~~~~-L~~L~l~~N~l~~~~~~  293 (849)
                       .+|.  .++.+++|++|++++|.++|.+| .+..+ .|+.|++++|+++ .+|..+..+++ |+.|++++|.++ .+|.
T Consensus       319 -~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~  394 (636)
T 4eco_A          319 -TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPN  394 (636)
T ss_dssp             -SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCS
T ss_pred             -ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccch
Confidence             6777  88889999999999999887888 55554 4888888888888 66777788877 888888888888 6677


Q ss_pred             CCCCcc--cccEEEccCccccCchhhhhC-------CCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCC
Q 042123          294 SLRNCT--SLIRVRLNGNNLTGNISEALG-------IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLP  364 (849)
Q Consensus       294 ~~~~l~--~L~~L~L~~n~l~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p  364 (849)
                      .+..++  +|+.|++++|.+++..|..+.       .+++|++|+|++|++.+..+..+..+++|++|+|++|.++ .+|
T Consensus       395 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~  473 (636)
T 4eco_A          395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIP  473 (636)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCC
T ss_pred             hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcC
Confidence            776654  788888888888877777777       6778888888888888555555556788888888888888 444


Q ss_pred             CC-cccc-------ccccccccccccccccCchhhc--CCCCCcEEEccCccccccCcccccccccccccccccCCCCCh
Q 042123          365 RE-IGNS-------SQLQAFDLSLNHIVGEIPKELG--KLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPS  434 (849)
Q Consensus       365 ~~-~~~l-------~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~  434 (849)
                      .. +..+       ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|++|+++...    
T Consensus       474 ~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~----  547 (636)
T 4eco_A          474 KNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR----  547 (636)
T ss_dssp             SSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB----
T ss_pred             HHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc----
Confidence            43 3322       27888888888887 5666666  78888888888888875 66666666666665555421    


Q ss_pred             hhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCCcccccCcccccccCCCccCC
Q 042123          435 QICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGS  503 (849)
Q Consensus       435 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~c~~  503 (849)
                                 ++++|++.+.+|..+..+++|+.|+|++|++ +.+|... ++......+.+|+..|..
T Consensus       548 -----------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~-~~~L~~L~Ls~N~l~~~~  603 (636)
T 4eco_A          548 -----------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKI-TPNISVLDIKDNPNISID  603 (636)
T ss_dssp             -----------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCC-CTTCCEEECCSCTTCEEE
T ss_pred             -----------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhH-hCcCCEEECcCCCCcccc
Confidence                       4578999999999999999999999999999 6677642 244555566777766543

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=6.8e-46  Score=431.09  Aligned_cols=452  Identities=19%  Similarity=0.190  Sum_probs=357.6

Q ss_pred             CCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCC
Q 042123           32 LAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLS  111 (849)
Q Consensus        32 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  111 (849)
                      ....|+++|+++.+++ .+.  ++|++|+|++|++++.      ....|+++++|++|+|++|.+++..|.+|.++++|+
T Consensus         7 ~~~c~~~~~~l~~ip~-~~~--~~L~~L~Ls~n~l~~~------~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~   77 (549)
T 2z81_A            7 SGVCDGRSRSFTSIPS-GLT--AAMKSLDLSFNKITYI------GHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLE   77 (549)
T ss_dssp             TSEEECTTSCCSSCCS-CCC--TTCCEEECCSSCCCEE------CSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             CceEECCCCccccccc-cCC--CCccEEECcCCccCcc------ChhhhhcCCcccEEECCCCCcCccChhhccccccCC
Confidence            3446888999976555 343  7899999999999843      345678999999999999999999999999999999


Q ss_pred             EEEccCCcccCCCCCCCcCCCCCceeeccCcccccc-cccccCCCCCCCEEEcCCCc-ccccCCcCCCCCCCCCEEEccC
Q 042123          112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS-ILSSLGKLKSLFDLQLNDNQ-LIGYIPRPFSNLTSVSTLRLSR  189 (849)
Q Consensus       112 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~  189 (849)
                      +|+|++|++++..|.+|.++++|++|+|++|.+++. .+..|+++++|++|++++|. +..+.+..|.++++|++|++++
T Consensus        78 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~  157 (549)
T 2z81_A           78 HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA  157 (549)
T ss_dssp             EEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEE
T ss_pred             EEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccC
Confidence            999999999988888899999999999999999863 56789999999999999998 6777778999999999999999


Q ss_pred             CCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCC--Ccchh--hhhhhhhhccCcCCCC
Q 042123          190 NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSI--PPSLG--NLILRQLLLSGNHFTG  265 (849)
Q Consensus       190 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~--~~~L~~L~L~~n~i~~  265 (849)
                      |++++..|..+..+++|++|++++|.+....+..+..+++|++|++++|++++..  |..+.  ...|+.|++++|.+++
T Consensus       158 n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~  237 (549)
T 2z81_A          158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD  237 (549)
T ss_dssp             TTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEH
T ss_pred             CcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccch
Confidence            9999889999999999999999999987443333467899999999999998632  22221  2348999999998876


Q ss_pred             CCCc----ccCCCCCcceeeecccccccccC------CCC-----------------------------CCcccccEEEc
Q 042123          266 YLPY----NICRGGALEIFTVSENHFQGTIP------TSL-----------------------------RNCTSLIRVRL  306 (849)
Q Consensus       266 ~~~~----~~~~~~~L~~L~l~~N~l~~~~~------~~~-----------------------------~~l~~L~~L~L  306 (849)
                      ..+.    .+..+.+|+.+++++|.+.+...      ..+                             ....+|+.|++
T Consensus       238 ~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l  317 (549)
T 2z81_A          238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITV  317 (549)
T ss_dssp             HHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEE
T ss_pred             hHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEe
Confidence            4433    34556788889998888765311      011                             11246778888


Q ss_pred             cCccccCchhhhhCCCCCCCEEeccCccccCccc---ccCCCCCCCcEEeccCCccccCCC--CCccccccccccccccc
Q 042123          307 NGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS---SNWGKFPKLGTLNVSMNNITGGLP--REIGNSSQLQAFDLSLN  381 (849)
Q Consensus       307 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~i~~~~p--~~~~~l~~L~~L~L~~N  381 (849)
                      ++|.++..+...+..+++|++|+|++|++.+..|   ..+..+++|++|++++|++++..+  ..+..+++|++|++++|
T Consensus       318 ~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N  397 (549)
T 2z81_A          318 ENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN  397 (549)
T ss_dssp             ESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTC
T ss_pred             ccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCC
Confidence            8888876555555678899999999999887653   347788899999999998885432  45788889999999999


Q ss_pred             cccccCchhhcCCCCCcEEEccCccccccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCCcc
Q 042123          382 HIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSC  459 (849)
Q Consensus       382 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~  459 (849)
                      +++ .+|..+..+++|++|++++|+++ .+|..+.  ++|++|++++  +..++   ..+++|+.|+|++|+|+ .+|. 
T Consensus       398 ~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~--~~L~~L~Ls~N~l~~~~---~~l~~L~~L~Ls~N~l~-~ip~-  468 (549)
T 2z81_A          398 TFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLDSFS---LFLPRLQELYISRNKLK-TLPD-  468 (549)
T ss_dssp             CCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSC--TTCSEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-SCCC-
T ss_pred             CCc-cCChhhcccccccEEECCCCCcc-cccchhc--CCceEEECCCCChhhhc---ccCChhcEEECCCCccC-cCCC-
Confidence            988 67888888889999999999887 4454443  5788888876  34433   57889999999999998 5665 


Q ss_pred             ccccCCCcEEeccCCccccCCCCC-cccccCcccccccCCCcc
Q 042123          460 FEGMHGLSFIDMSYNELQCPVPNS-TTFRGASVEALKGNKGLC  501 (849)
Q Consensus       460 ~~~l~~L~~l~l~~N~l~~~~~~~-~~~~~~~~~~~~~~~~~c  501 (849)
                      ...+++|+.|+|++|++++.+|.. ..+.......+.+|+..|
T Consensus       469 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  511 (549)
T 2z81_A          469 ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  511 (549)
T ss_dssp             GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred             cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence            467899999999999999877653 233444555566776544

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=422.30  Aligned_cols=446  Identities=18%  Similarity=0.167  Sum_probs=366.8

Q ss_pred             CEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCE
Q 042123           33 AYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQ  112 (849)
Q Consensus        33 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  112 (849)
                      ++||+++|++++ +|..+.  ++|++|+|++|++++..      ...|.++++|++|+|++|.|++..|..|+++++|++
T Consensus         3 ~~l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~   73 (520)
T 2z7x_B            3 FLVDRSKNGLIH-VPKDLS--QKTTILNISQNYISELW------TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEY   73 (520)
T ss_dssp             CEEECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCC------HHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCE
T ss_pred             ceEecCCCCccc-cccccc--ccccEEECCCCcccccC------hhhccccccccEEecCCCccCCcChHHhhcccCCCE
Confidence            689999999985 455554  89999999999998533      234678999999999999999988999999999999


Q ss_pred             EEccCCcccCCCCCCCcCCCCCceeeccCccccc-ccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCC--CEEEccC
Q 042123          113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG-SILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSV--STLRLSR  189 (849)
Q Consensus       113 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~Ls~  189 (849)
                      |+|++|+|+++ |..  .+++|++|+|++|++++ ..|..|+++++|++|+|++|++.+   ..|..+++|  ++|++++
T Consensus        74 L~Ls~N~l~~l-p~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~  147 (520)
T 2z7x_B           74 LDLSHNKLVKI-SCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVL  147 (520)
T ss_dssp             EECCSSCCCEE-ECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEE
T ss_pred             EecCCCceeec-Ccc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeec
Confidence            99999999954 444  89999999999999987 367899999999999999999986   467888888  9999999


Q ss_pred             CCC--cCcCcccccCCC-CCCEEeccCCcCccCCC-cCccCccccchhhhcccc-------ccCCCCcchhhh-hhhhhh
Q 042123          190 NDL--FGSIPDEIGKMR-SLSVLDLNQNQFKGVLP-PSISNLTNLKELALLYNH-------LSGSIPPSLGNL-ILRQLL  257 (849)
Q Consensus       190 N~l--~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~-------l~~~~p~~~~~~-~L~~L~  257 (849)
                      |++  .+..|..+..+. +...+++++|.+.+..+ ..+..+++|+.|++++|.       +.+.+| .+... .|+.|+
T Consensus       148 n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~  226 (520)
T 2z7x_B          148 GETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLT  226 (520)
T ss_dssp             CTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEE
T ss_pred             ccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcc
Confidence            999  778888887766 35567899999876544 468899999999999997       555555 33333 499999


Q ss_pred             ccCcCCCCCCCcccC---CCCCcceeeecccccccccCCCC-----CCcccccEEEccCccccCchhhhhCCC---CCCC
Q 042123          258 LSGNHFTGYLPYNIC---RGGALEIFTVSENHFQGTIPTSL-----RNCTSLIRVRLNGNNLTGNISEALGIY---PNLT  326 (849)
Q Consensus       258 L~~n~i~~~~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~~~~~~~l---~~L~  326 (849)
                      +++|.+++..+..+.   ..++|+.|++++|++++.+|..+     ..+++|+.+++++|.+ ..+...+..+   .+|+
T Consensus       227 l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~  305 (520)
T 2z7x_B          227 LNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIK  305 (520)
T ss_dssp             EEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCS
T ss_pred             ccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCcee
Confidence            999987753222211   13589999999999999999998     8999999999999999 4443555444   6899


Q ss_pred             EEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccc--cCchhhcCCCCCcEEEccC
Q 042123          327 FIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVG--EIPKELGKLNPLTKLILRG  404 (849)
Q Consensus       327 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~  404 (849)
                      .|++++|.+....  .+..+++|++|++++|.+++..|..+..+++|++|+|++|++++  .+|..+..+++|++|+|++
T Consensus       306 ~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~  383 (520)
T 2z7x_B          306 NFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ  383 (520)
T ss_dssp             EEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCS
T ss_pred             EEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCC
Confidence            9999999987432  13688999999999999998899999999999999999999997  5668899999999999999


Q ss_pred             ccccccCcc-cccccccccccccccC---CCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCC
Q 042123          405 NQITGRLPK-EIGSLTKLEYLDFSAI---GELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPV  480 (849)
Q Consensus       405 N~l~~~~p~-~~~~l~~L~~L~l~~l---~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~  480 (849)
                      |++++.+|. .+..+++|++|++++.   +.+|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+++. +
T Consensus       384 N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l  459 (520)
T 2z7x_B          384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-V  459 (520)
T ss_dssp             SCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-C
T ss_pred             CcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-c
Confidence            999985665 4889999999999873   34444443  79999999999999 778777799999999999999995 4


Q ss_pred             CCC--cccccCcccccccCCCcc
Q 042123          481 PNS--TTFRGASVEALKGNKGLC  501 (849)
Q Consensus       481 ~~~--~~~~~~~~~~~~~~~~~c  501 (849)
                      |..  ..+.......+.+|+..|
T Consensus       460 ~~~~~~~l~~L~~L~l~~N~~~c  482 (520)
T 2z7x_B          460 PDGIFDRLTSLQKIWLHTNPWDC  482 (520)
T ss_dssp             CTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CHHHhccCCcccEEECcCCCCcc
Confidence            443  223334445566776555

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=402.47  Aligned_cols=239  Identities=26%  Similarity=0.372  Sum_probs=193.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|+..+.||+|+||.||+|+. .+|+.||||++.......    .+.+.+|+.           ++++++..++..|+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV  226 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR----RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV  226 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS----GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH----HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence            5689999999999999999965 579999999986542222    123444433           478888999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++..    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.+..
T Consensus       227 mEy~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          227 MEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EECCTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EeCCCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            999999999999854    3499999999999999999999999   999999999999999999999999999998776


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      ........+||+.|||||++.+..|+.++||||+||++|||++|+.||.........     ........+......   
T Consensus       300 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~-----~~i~~~~~~~~~~~~---  371 (423)
T 4fie_A          300 EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM-----KMIRDNLPPRLKNLH---  371 (423)
T ss_dssp             SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCCSCTT---
T ss_pred             CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----HHHHcCCCCCCcccc---
Confidence            655567789999999999999999999999999999999999999999744321110     011111111222211   


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....+.+|+.+||++||++|||++|+++|
T Consensus       372 -~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          372 -KVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             -SSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             122347889999999999999999999886

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.1e-46  Score=387.53  Aligned_cols=238  Identities=19%  Similarity=0.314  Sum_probs=191.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+... ......+.+.+|+.           ++++++.+++..|+|
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            5799999999999999999954 5799999999864311 01122345566654           477888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++.+.   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus       111 mEy~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            9999999999999653   3599999999999999999999999   999999999999999999999999999997754


Q ss_pred             CC--CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          736 DS--SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       736 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ..  ......+||+.|||||++.+..|+.++||||+||++|||++|+.||...+.        ......+.......+..
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~~~~p~~  256 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLEYDFPEK  256 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCCTT
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCcc
Confidence            32  234567899999999999999999999999999999999999999974321        12222333333322222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIIS  844 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil  844 (849)
                      .    ..++.+++.+|+++||++|||++|+.
T Consensus       257 ~----s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          257 F----FPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             C----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             c----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence            2    23478899999999999999999864

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.7e-46  Score=397.63  Aligned_cols=251  Identities=22%  Similarity=0.402  Sum_probs=196.0

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hh
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AF  642 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~  642 (849)
                      ++++...++|++.+.||+|+||+||+|++.      .++.||||++....   .....+.+.+|+.            ++
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~---~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            455666789999999999999999999753      24679999987542   2223455666654            36


Q ss_pred             hceeec-CCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 042123          643 YGFCSH-ARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRD  708 (849)
Q Consensus       643 ~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d  708 (849)
                      +|+|.+ +...++|||||++|+|.++++....             ...+++.++..++.|||.||+|||++   +|+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence            777765 4578999999999999999965332             23489999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCc
Q 042123          709 ISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDF  785 (849)
Q Consensus       709 lk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~  785 (849)
                      |||+|||+++++.+||+|||+|+....+...  .....||+.|||||++.+..|+.++|||||||++|||+| |+.||..
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999977654332  234578999999999999999999999999999999998 9999974


Q ss_pred             cccccccccccccccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          786 LSSISSSSLNTDVALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....       +.....+.++ +.+.+...+    .++.+++.+||+.||++||||+||+++|+
T Consensus       291 ~~~~-------~~~~~~i~~g~~~~~p~~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~  343 (353)
T 4ase_A          291 VKID-------EEFCRRLKEGTRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLG  343 (353)
T ss_dssp             CCCS-------HHHHHHHHHTCCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHH-------HHHHHHHHcCCCCCCCccCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            3311       1111112121 222222222    34788999999999999999999999874

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3e-46  Score=395.76  Aligned_cols=243  Identities=21%  Similarity=0.267  Sum_probs=187.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHH-----HHHHHhhceeecCCeeEEEEEeccC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFL-----TEVEAFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~-----~ei~~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      +.|+..++||+|+||+||+|++ .+|+.||||+++.....   ..+...+     .+|.++++++.+++..|+|||||++
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~---~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g  134 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR---VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG  134 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH---HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence            4677888999999999999965 57999999998754221   1111122     2345688999999999999999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCcccCCCCCC-
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSLKPDSSN-  739 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~-  739 (849)
                      |+|.+++++.   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+| .+||+|||+|+....+... 
T Consensus       135 g~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          135 GSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            9999999653   3599999999999999999999999   999999999999999998 6999999999977543221 


Q ss_pred             ----eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          740 ----WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       740 ----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                          ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.......        ....+.....+. ...+
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~~~-~~~~  279 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------LCLKIASEPPPI-REIP  279 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--------CHHHHHHSCCGG-GGSC
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHcCCCCc-hhcC
Confidence                233579999999999999999999999999999999999999997433211        111111111100 0011


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......+.+++.+||++||++|||+.|++++|.
T Consensus       280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            122334788999999999999999999998763

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.2e-45  Score=375.90  Aligned_cols=238  Identities=21%  Similarity=0.302  Sum_probs=176.4

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+..... ......+.+|+.           ++++++..++..|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK-SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            6899999999999999999965 579999999987543221 222345666654           477888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+ +|+|.+++.+.   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 67999998653   3599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      . ......+||+.|||||++.+..| +.++||||+||++|||++|+.||.....        ......+.......+...
T Consensus       165 ~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~--------~~~~~~i~~~~~~~p~~~  235 (275)
T 3hyh_A          165 G-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI--------PVLFKNISNGVYTLPKFL  235 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCCTTS
T ss_pred             C-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC
Confidence            3 33456789999999999998876 5799999999999999999999974321        112222222222222222


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ...+.+++.+||++||++|||++|+++|
T Consensus       236 ----s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          236 ----SPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ----CHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ----CHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                2347789999999999999999999885

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.6e-45  Score=385.60  Aligned_cols=239  Identities=23%  Similarity=0.328  Sum_probs=187.1

Q ss_pred             cCCCcCceecCCccceEEEEEe----cCCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~  652 (849)
                      ++|++.+.||+|+||+||+|+.    .+++.||||+++.......  ....+.+|           |.++++++.+++..
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  101 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKL  101 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE--ECC------CCCCCCCCTTEECEEEEEEETTEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH--HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            6799999999999999999965    2478999999865321111  11234445           34578889999999


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      |+|||||+||+|.+++.+.   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus       102 ~ivmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          102 YLILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EEEECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            9999999999999999654   3599999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ...........+||+.|||||++.+..|+.++||||+||++|||+||+.||...+.        ......+.......+.
T Consensus       176 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~~~~~p~  247 (304)
T 3ubd_A          176 SIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR--------KETMTMILKAKLGMPQ  247 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT
T ss_pred             ccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH--------HHHHHHHHcCCCCCCC
Confidence            65554555667899999999999999999999999999999999999999974332        1222223333333222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTM-----KIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~~  846 (849)
                      ..    ..++.+++.+||++||++|||+     +|+++|
T Consensus       248 ~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          248 FL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             TS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             cC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            22    2347889999999999999984     688765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.5e-45  Score=385.44  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=184.1

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCC----ee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHAR----HS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~----~~  652 (849)
                      ++|.+.+.||+|+||+||+|++ +|+.||||++....     .....+..|+           .++++++.+++    ..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4577888999999999999988 58999999986431     1111122233           24677776543    57


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-----FPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                      |+|||||++|+|.++++..    .++|+++.+++.|+|.||+|||+++     .++|+||||||+|||++.++.+||+||
T Consensus        77 ~lV~Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF  152 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  152 (303)
T ss_dssp             EEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence            9999999999999999643    4899999999999999999999752     358999999999999999999999999


Q ss_pred             cCCcccCCCCC----CeeeccCCccccccccccCC------CCCccchHHHHHHHHHHHHhCCCCCCcccccccccc---
Q 042123          728 GIAKSLKPDSS----NWTEFAGTCGYIAPELAYTM------KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL---  794 (849)
Q Consensus       728 G~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~---  794 (849)
                      |+|+.......    .....+||+.|||||++.+.      .++.++|||||||++|||+||+.||........+..   
T Consensus       153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~  232 (303)
T 3hmm_A          153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  232 (303)
T ss_dssp             TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred             CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcc
Confidence            99987654332    12345799999999998754      467899999999999999999988764332211110   


Q ss_pred             ----ccccccccc----cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 ----NTDVALDQM----LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 ----~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          ........+    .++.++... ...+....+.+++.+||+.||++||||.||++.|+
T Consensus       233 ~~~~~~~~~~~~~~~~~~rp~~p~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  293 (303)
T 3hmm_A          233 PSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGG-GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             cccchHHHHHHHHhcccCCCCCCccc-cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence                011111112    222332211 12345567889999999999999999999999874

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.1e-45  Score=378.15  Aligned_cols=238  Identities=22%  Similarity=0.341  Sum_probs=182.4

Q ss_pred             CcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec----CCeeEE
Q 042123          591 DAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH----ARHSFL  654 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~----~~~~~l  654 (849)
                      +..+.||+|+||+||+|.+ .+++.||||++.....  .....+.+.+|+..           +++++..    +...|+
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            4566899999999999965 5789999999875422  22334567777653           5666543    356899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeecCCccc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-EYEAHVADFGIAKSL  733 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~a~~~  733 (849)
                      |||||++|+|.+++.+.   ..+++.++..|+.||+.||+|||++. ++|+||||||+|||++. ++.+||+|||+|+..
T Consensus       107 vmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            99999999999999653   35899999999999999999999981 13999999999999974 799999999999864


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ..  ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||......       ......+.....+.  .
T Consensus       183 ~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~~~~~--~  250 (290)
T 3fpq_A          183 RA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVKPA--S  250 (290)
T ss_dssp             CT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCCCG--G
T ss_pred             CC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcCCCCC--C
Confidence            32  34566789999999998865 6999999999999999999999999643211       11111222221111  1


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......++.+++.+||++||++|||++|+++|
T Consensus       251 ~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111122347889999999999999999999986

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=3.7e-43  Score=398.11  Aligned_cols=383  Identities=21%  Similarity=0.195  Sum_probs=264.1

Q ss_pred             CCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCccc-CCCCCCCcCCCCC
Q 042123           56 LRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFS-GPIPLSFDNLSNL  134 (849)
Q Consensus        56 L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L  134 (849)
                      -+.++.++++++.     ++.     -.++|++|+|++|.|++..|..|.++++|++|+|++|++. .+.+..|.++++|
T Consensus        12 ~~~~~c~~~~l~~-----lp~-----l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L   81 (455)
T 3v47_A           12 GYNAICINRGLHQ-----VPE-----LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL   81 (455)
T ss_dssp             TTEEECCSSCCSS-----CCC-----CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTC
T ss_pred             ccccCcCCCCccc-----CCC-----CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccC
Confidence            3467777777762     111     1267788888888888777777888888888888888776 3446677888888


Q ss_pred             ceeeccCcccccccccccCCCCCCCEEEcCCCcccccC--CcCCCCCCCCCEEEccCCCCcCcCccc-ccCCCCCCEEec
Q 042123          135 IFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYI--PRPFSNLTSVSTLRLSRNDLFGSIPDE-IGKMRSLSVLDL  211 (849)
Q Consensus       135 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~L  211 (849)
                      ++|+|++|++++..|..|+++++|++|+|++|++++..  +..|..+++|++|+|++|++++..|.. +.++++|++|++
T Consensus        82 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L  161 (455)
T 3v47_A           82 IILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDL  161 (455)
T ss_dssp             CEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEEC
T ss_pred             CEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeC
Confidence            88888888887777777888888888888888877633  334777888888888888887666665 677888888888


Q ss_pred             cCCcCccCCCcCccCc--cccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeeccccccc
Q 042123          212 NQNQFKGVLPPSISNL--TNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQG  289 (849)
Q Consensus       212 ~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~  289 (849)
                      ++|++++..+..+..+  .+|+.|++++|.+.+..+..+....               ...+..+++|+.|++++|++++
T Consensus       162 ~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~---------------~~~~~~~~~L~~L~Ls~n~l~~  226 (455)
T 3v47_A          162 TFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEK---------------CGNPFKNTSITTLDLSGNGFKE  226 (455)
T ss_dssp             TTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHH---------------HCCTTTTCEEEEEECTTSCCCH
T ss_pred             CCCcccccChhhhhccccccccccccccCcccccchhhccccc---------------cccccccceeeeEecCCCcccc
Confidence            8888877777777665  5677777777777643333221100               0112233456666666666655


Q ss_pred             ccCCCCCCc---ccccEEEccCccccCc----------hhhhhC--CCCCCCEEeccCccccCcccccCCCCCCCcEEec
Q 042123          290 TIPTSLRNC---TSLIRVRLNGNNLTGN----------ISEALG--IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNV  354 (849)
Q Consensus       290 ~~~~~~~~l---~~L~~L~L~~n~l~~~----------~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (849)
                      ..|..+...   ++|+.|++++|.+.+.          .+..+.  ..++|+.|++++|++.+..|..|..+++|++|+|
T Consensus       227 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  306 (455)
T 3v47_A          227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL  306 (455)
T ss_dssp             HHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             cchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEEC
Confidence            555444333   5566666665544321          111111  1256777777777777666777777777777777


Q ss_pred             cCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccccccccccccCCCCCh
Q 042123          355 SMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPS  434 (849)
Q Consensus       355 s~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~  434 (849)
                      ++|.+++..|..|.++++|+.|+|++|.+++..|..|..+++|++|+|++|++++..|.                     
T Consensus       307 s~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------------------  365 (455)
T 3v47_A          307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ---------------------  365 (455)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTT---------------------
T ss_pred             CCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChh---------------------
Confidence            77777766666777777777777777777766667777777777777777777654444                     


Q ss_pred             hhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCCc
Q 042123          435 QICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNST  484 (849)
Q Consensus       435 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~  484 (849)
                      .+..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|+|+||...
T Consensus       366 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~  415 (455)
T 3v47_A          366 SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  415 (455)
T ss_dssp             TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             hccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence            44556678888899999998888889999999999999999999999643

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=7e-43  Score=395.79  Aligned_cols=380  Identities=20%  Similarity=0.191  Sum_probs=305.4

Q ss_pred             EecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeE
Q 042123           10 ISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRL   89 (849)
Q Consensus        10 ~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L   89 (849)
                      +++.+.++.....     -.++|++|||++|+|+++.|..|+++++|++|+|++|++.+.     .....|.++++|++|
T Consensus        15 ~~c~~~~l~~lp~-----l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~-----i~~~~~~~l~~L~~L   84 (455)
T 3v47_A           15 AICINRGLHQVPE-----LPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV-----IRNNTFRGLSSLIIL   84 (455)
T ss_dssp             EECCSSCCSSCCC-----CCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCE-----ECTTTTTTCTTCCEE
T ss_pred             cCcCCCCcccCCC-----CCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccce-----ECcccccccccCCEE
Confidence            5566666533321     127799999999999988899999999999999999988632     334567788888888


Q ss_pred             eccCCcccccCCccCCCCCCCCEEEccCCcccCCCCC--CCcCCCCCceeeccCcccccccccc-cCCCCCCCEEEcCCC
Q 042123           90 VINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPL--SFDNLSNLIFLYLYGNLLSGSILSS-LGKLKSLFDLQLNDN  166 (849)
Q Consensus        90 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N  166 (849)
                      +|++|.+++..|..|+++++|++|+|++|++++..+.  .|.++++|++|+|++|.+++..|.. |.++++|++|+|++|
T Consensus        85 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n  164 (455)
T 3v47_A           85 KLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFN  164 (455)
T ss_dssp             ECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTC
T ss_pred             eCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCC
Confidence            8888888888888888888888888888888864433  4888888888888888888776665 788888888888888


Q ss_pred             cccccCCcCCCCC--CCCCEEEccCCCCcCcCccc--------ccCCCCCCEEeccCCcCccCCCcCccCc---cccchh
Q 042123          167 QLIGYIPRPFSNL--TSVSTLRLSRNDLFGSIPDE--------IGKMRSLSVLDLNQNQFKGVLPPSISNL---TNLKEL  233 (849)
Q Consensus       167 ~l~~~~~~~~~~l--~~L~~L~Ls~N~l~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L  233 (849)
                      ++.++.+..+..+  .+|+.|++++|.+....+..        +..+++|++|++++|++++..|..+..+   ++|+.|
T Consensus       165 ~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L  244 (455)
T 3v47_A          165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL  244 (455)
T ss_dssp             CBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred             cccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence            8888888877766  67888888888887544433        3356788888888888877666666554   678888


Q ss_pred             hhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCC--CCCcceeeecccccccccCCCCCCcccccEEEccCccc
Q 042123          234 ALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICR--GGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNL  311 (849)
Q Consensus       234 ~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~--~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l  311 (849)
                      ++++|.+.+..             +..+.+....+..+..  .++|+.|++++|.+.+..|..+..+++|+.|++++|++
T Consensus       245 ~l~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l  311 (455)
T 3v47_A          245 ILSNSYNMGSS-------------FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEI  311 (455)
T ss_dssp             ECTTCTTTSCC-------------TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred             eeccccccccc-------------cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcc
Confidence            88887765321             1222333333333332  36899999999999999999999999999999999999


Q ss_pred             cCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhh
Q 042123          312 TGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL  391 (849)
Q Consensus       312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~  391 (849)
                      ++..+..|..+++|++|+|++|++.+..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|
T Consensus       312 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~  391 (455)
T 3v47_A          312 NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIF  391 (455)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTT
T ss_pred             cccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHh
Confidence            99889999999999999999999998888899999999999999999998889999999999999999999998777788


Q ss_pred             cCCCCCcEEEccCccccccCc
Q 042123          392 GKLNPLTKLILRGNQITGRLP  412 (849)
Q Consensus       392 ~~l~~L~~L~L~~N~l~~~~p  412 (849)
                      ..+++|++|+|++|++++..|
T Consensus       392 ~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          392 DRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTCTTCCEEECCSSCBCCCTT
T ss_pred             ccCCcccEEEccCCCcccCCC
Confidence            999999999999999986655

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-43  Score=370.96  Aligned_cols=240  Identities=21%  Similarity=0.386  Sum_probs=177.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC-----
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR-----  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~-----  650 (849)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++....   .....+.+.+|+..           +++++.+.+     
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            4689999999999999999965 579999999986532   23334567777663           455554322     


Q ss_pred             -------eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEE
Q 042123          651 -------HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH  723 (849)
Q Consensus       651 -------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  723 (849)
                             ..|+|||||++|+|.+++.........++..++.++.||+.||+|||++   +|+||||||+|||++.++.+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEE
Confidence                   4689999999999999997665444567788999999999999999999   999999999999999999999


Q ss_pred             EeeecCCcccCCCCC------------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc
Q 042123          724 VADFGIAKSLKPDSS------------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS  791 (849)
Q Consensus       724 l~DfG~a~~~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~  791 (849)
                      |+|||+|+.......            .....+||+.|||||++.+..|+.++||||+||++|||++   ||....    
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----  231 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----  231 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence            999999987654321            1234579999999999999999999999999999999996   775221    


Q ss_pred             cccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          792 SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ..............+   ...........+++.+||++||++|||+.|+++|
T Consensus       232 ---~~~~~~~~~~~~~~p---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          232 ---ERVRTLTDVRNLKFP---PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             ---HHHHHHHHHHTTCCC---HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHHHHHHHHhcCCCC---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence               011112222222222   2223334456789999999999999999999885

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=2.7e-42  Score=401.11  Aligned_cols=450  Identities=17%  Similarity=0.120  Sum_probs=350.0

Q ss_pred             CCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCC
Q 042123           27 SSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGN  106 (849)
Q Consensus        27 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  106 (849)
                      +.....+++|+++|+++++ |..+.  ++|++|+|++|++++.      ....|+++++|++|+|++|.|++..|.+|.+
T Consensus        28 ~~~~~~~~l~ls~~~L~~i-p~~~~--~~L~~L~Ls~N~i~~~------~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~   98 (562)
T 3a79_B           28 FSNELESMVDYSNRNLTHV-PKDLP--PRTKALSLSQNSISEL------RMPDISFLSELRVLRLSHNRIRSLDFHVFLF   98 (562)
T ss_dssp             -----CCEEECTTSCCCSC-CTTSC--TTCCEEECCSSCCCCC------CGGGTTTCTTCCEEECCSCCCCEECTTTTTT
T ss_pred             cccCCCcEEEcCCCCCccC-CCCCC--CCcCEEECCCCCcccc------ChhhhccCCCccEEECCCCCCCcCCHHHhCC
Confidence            3344568999999999864 44443  8999999999999853      3356788999999999999999999999999


Q ss_pred             CCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccc-cccccCCCCCCCEEEcCCCcccccCCcCCCCCCCC--C
Q 042123          107 LKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS-ILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSV--S  183 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~  183 (849)
                      +++|++|+|++|+|+. +|..  .+++|++|+|++|++++. .|..|+++++|++|+|++|++...   .|..+++|  +
T Consensus        99 l~~L~~L~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~  172 (562)
T 3a79_B           99 NQDLEYLDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLS  172 (562)
T ss_dssp             CTTCCEEECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEE
T ss_pred             CCCCCEEECCCCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceee
Confidence            9999999999999995 4444  899999999999999874 358999999999999999999864   56666666  9


Q ss_pred             EEEccCCCC--cCcCcccccCCC--CCCEEeccCCcCccCCCc-CccCccccchhhhccccc-----cCCCCcchhh-hh
Q 042123          184 TLRLSRNDL--FGSIPDEIGKMR--SLSVLDLNQNQFKGVLPP-SISNLTNLKELALLYNHL-----SGSIPPSLGN-LI  252 (849)
Q Consensus       184 ~L~Ls~N~l--~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l-----~~~~p~~~~~-~~  252 (849)
                      +|+|++|++  ++..|..+..+.  .| .+++++|.+.+..+. .+..+++|+.|++++|..     .+.++ .+.. ..
T Consensus       173 ~L~L~~n~l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~-~l~~l~~  250 (562)
T 3a79_B          173 CILLDLVSYHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLS-ELTRGPT  250 (562)
T ss_dssp             EEEEEESSCCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHH-HHHSCSS
T ss_pred             EEEeecccccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHH-HHhccCc
Confidence            999999999  888888888765  34 668899998865553 577899999999999852     11111 1111 23


Q ss_pred             hhhhhccCcCCCCCC----CcccCCCCCcceeeecccccccccCCCC-----CCcccccEEEccCccccCchhhhhCC--
Q 042123          253 LRQLLLSGNHFTGYL----PYNICRGGALEIFTVSENHFQGTIPTSL-----RNCTSLIRVRLNGNNLTGNISEALGI--  321 (849)
Q Consensus       253 L~~L~L~~n~i~~~~----~~~~~~~~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~L~~n~l~~~~~~~~~~--  321 (849)
                      ++.++++++.+.+..    +..+ ...+|+.|++++|.+++.+|..+     ..++.|+.++++.|.+ ..+...+..  
T Consensus       251 L~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~-~~p~~~~~~~~  328 (562)
T 3a79_B          251 LLNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF-LFSKEALYSVF  328 (562)
T ss_dssp             CEEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-SSCHHHHHHHH
T ss_pred             ceEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-ecChhhhhhhh
Confidence            666666666654321    1111 23489999999999998889887     7788888888888877 233233322  


Q ss_pred             -CCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccccccccccccccccccc--CchhhcCCCCCc
Q 042123          322 -YPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGE--IPKELGKLNPLT  398 (849)
Q Consensus       322 -l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~--~~~~~~~l~~L~  398 (849)
                       ..+|+.|++++|.+....  ....+++|++|++++|.+++..|..+.++++|+.|+|++|++++.  +|..|..+++|+
T Consensus       329 ~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~  406 (562)
T 3a79_B          329 AEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLE  406 (562)
T ss_dssp             HTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCC
T ss_pred             ccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCC
Confidence             368999999999986432  126889999999999999998999999999999999999999973  357799999999


Q ss_pred             EEEccCccccccCcc-cccccccccccccccCC---CCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCC
Q 042123          399 KLILRGNQITGRLPK-EIGSLTKLEYLDFSAIG---ELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYN  474 (849)
Q Consensus       399 ~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~l~---~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N  474 (849)
                      +|+|++|++++.+|. .+..+++|++|++++..   .+|..+.  ++|+.|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus       407 ~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N  483 (562)
T 3a79_B          407 TLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASN  483 (562)
T ss_dssp             EEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSS
T ss_pred             EEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCC
Confidence            999999999984554 58899999999998743   3333332  69999999999999 56666669999999999999


Q ss_pred             ccccCCCCC--cccccCcccccccCCCcc
Q 042123          475 ELQCPVPNS--TTFRGASVEALKGNKGLC  501 (849)
Q Consensus       475 ~l~~~~~~~--~~~~~~~~~~~~~~~~~c  501 (849)
                      +++. +|..  ..+.......+.+|+..|
T Consensus       484 ~l~~-l~~~~~~~l~~L~~L~l~~N~~~c  511 (562)
T 3a79_B          484 QLKS-VPDGVFDRLTSLQYIWLHDNPWDC  511 (562)
T ss_dssp             CCCC-CCTTSTTTCTTCCCEECCSCCBCC
T ss_pred             CCCC-CCHHHHhcCCCCCEEEecCCCcCC
Confidence            9995 4443  233344445566776655

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=1e-40  Score=394.93  Aligned_cols=436  Identities=22%  Similarity=0.226  Sum_probs=346.4

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY   85 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~   85 (849)
                      .++.|+|+.+.+.+. ...+|.++++|++|||++|+|+++.+.+|.++++|++|+|++|+|++      .....|.++++
T Consensus        53 ~~~~LdLs~N~i~~l-~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~------l~~~~f~~L~~  125 (635)
T 4g8a_A           53 STKNLDLSFNPLRHL-GSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS------LALGAFSGLSS  125 (635)
T ss_dssp             TCCEEECTTSCCCEE-CTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE------ECGGGGTTCTT
T ss_pred             CCCEEEeeCCCCCCC-CHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC------CCHHHhcCCCC
Confidence            578999999998765 44589999999999999999999999999999999999999999974      23456789999


Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCC-CCCCCcCCCCCceeeccCcccccccccccCCCCCC----CE
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGP-IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL----FD  160 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~  160 (849)
                      |++|+|++|.|+++.+..|+++++|++|+|++|+++++ .|..+..+++|++|+|++|+|++..+..|..+.++    ..
T Consensus       126 L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~  205 (635)
T 4g8a_A          126 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS  205 (635)
T ss_dssp             CCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCE
T ss_pred             CCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhh
Confidence            99999999999988888899999999999999999864 57788999999999999999998888887665544    46


Q ss_pred             EEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCc---------------------------------------------
Q 042123          161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGS---------------------------------------------  195 (849)
Q Consensus       161 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---------------------------------------------  195 (849)
                      ++++.|.+..+.+..+..+ .+..|++++|.....                                             
T Consensus       206 ~~ls~n~l~~i~~~~~~~~-~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~  284 (635)
T 4g8a_A          206 LDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE  284 (635)
T ss_dssp             EECTTCCCCEECTTTTTTC-EEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEE
T ss_pred             hhcccCcccccCcccccch-hhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhh
Confidence            8888888887766554432 344455544422100                                             


Q ss_pred             -------------Cccc----------------------ccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccc
Q 042123          196 -------------IPDE----------------------IGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL  240 (849)
Q Consensus       196 -------------~~~~----------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  240 (849)
                                   .+..                      +....+|+.|++.+|.+....+   ..+..|+.+++..|.+
T Consensus       285 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~---~~l~~L~~l~l~~n~~  361 (635)
T 4g8a_A          285 EFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKG  361 (635)
T ss_dssp             EEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCC---CBCTTCCEEEEESCCS
T ss_pred             hhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCc---ccchhhhhcccccccC
Confidence                         0011                      2223344555555555443322   2234455555555554


Q ss_pred             cCCCCcchhhhhhhhhhccCcCCCC--CCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchh-h
Q 042123          241 SGSIPPSLGNLILRQLLLSGNHFTG--YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNIS-E  317 (849)
Q Consensus       241 ~~~~p~~~~~~~L~~L~L~~n~i~~--~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~-~  317 (849)
                      . ..+.......|+.+++++|.+..  ..+..+..+.+|+.++++.|.+.. .+..+..+++|+.+++..|+.....+ .
T Consensus       362 ~-~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~  439 (635)
T 4g8a_A          362 G-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFS  439 (635)
T ss_dssp             C-CBCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSC
T ss_pred             C-CCcccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccc
Confidence            3 22222233358899999998863  456667778899999999999874 56678889999999999888765544 5


Q ss_pred             hhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCcc-ccCCCCCccccccccccccccccccccCchhhcCCCC
Q 042123          318 ALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNI-TGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNP  396 (849)
Q Consensus       318 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i-~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~  396 (849)
                      .+..+++++.++++.|.+.+..+..+..++.|+.|+|++|.+ .+..|..|..+++|++|+|++|++++..|..|.++++
T Consensus       440 ~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~  519 (635)
T 4g8a_A          440 VFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS  519 (635)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCC
Confidence            688899999999999999999999999999999999999975 4467889999999999999999999999999999999


Q ss_pred             CcEEEccCccccccCccccccccccccccccc--CCCC-Chhhhcc-cccceeccCCccccc
Q 042123          397 LTKLILRGNQITGRLPKEIGSLTKLEYLDFSA--IGEL-PSQICNM-KSLEKLNLSHNNLSG  454 (849)
Q Consensus       397 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~--l~~l-p~~~~~l-~~L~~L~L~~N~l~~  454 (849)
                      |++|+|++|+|++..|..|..+++|++||++.  +..+ |..+..+ ++|+.|+|++|+++.
T Consensus       520 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C  581 (635)
T 4g8a_A          520 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC  581 (635)
T ss_dssp             CCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred             CCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence            99999999999988899999999999999986  4444 5677777 689999999999984

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.5e-41  Score=365.87  Aligned_cols=186  Identities=26%  Similarity=0.366  Sum_probs=153.2

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeec
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSH  648 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~  648 (849)
                      ...+.|++.+.||+|+||+||+|+.+    +++.||||++.....      ...+.+|+            .++++++.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~------~~~~~~E~~~l~~~~~h~nIv~l~~~~~~   91 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH------PIRIAAELQCLTVAGGQDNVMGVKYCFRK   91 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC------HHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC------HHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence            34578999999999999999999642    478899999865321      12233333            246778888


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeee
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADF  727 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~Df  727 (849)
                      .++.|+||||+++|+|.+++.      .+++.++..++.|++.||+|||++   +|+||||||+|||++.+ +.+||+||
T Consensus        92 ~~~~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           92 NDHVVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TTEEEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CCEEEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            899999999999999999983      389999999999999999999999   99999999999999887 89999999


Q ss_pred             cCCcccCCCC----------------------------CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHh
Q 042123          728 GIAKSLKPDS----------------------------SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIK  778 (849)
Q Consensus       728 G~a~~~~~~~----------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~t  778 (849)
                      |+|+......                            ......+||+.|+|||++.+. .|+.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            9998654321                            112345799999999998775 48999999999999999999


Q ss_pred             CCCCCCc
Q 042123          779 GKHPRDF  785 (849)
Q Consensus       779 g~~Pf~~  785 (849)
                      |+.||..
T Consensus       243 G~~Pf~~  249 (361)
T 4f9c_A          243 GRYPFYK  249 (361)
T ss_dssp             TCSSSSC
T ss_pred             CCCCCCC
Confidence            9999953

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-40  Score=361.69  Aligned_cols=250  Identities=22%  Similarity=0.340  Sum_probs=183.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceee------cC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCS------HA  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~------~~  649 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.....  .....+.+.+|+..           +++++.      +.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD--VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc--chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            5799999999999999999965 5799999999975432  22334556677653           344432      34


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      +..|+|||||+ |+|.+++...   +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~---~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSS---QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSS---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEeCCC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            67899999996 6899998654   3599999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCC----CCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cc--
Q 042123          730 AKSLKPD----SSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LN--  795 (849)
Q Consensus       730 a~~~~~~----~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~--  795 (849)
                      |+.+...    .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...+......       ..  
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~  284 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP  284 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876432    2234567899999999998875 46899999999999999999999997533211000       00  


Q ss_pred             ------cccccccc---cCCCCCCCCh-hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          796 ------TDVALDQM---LDPRLPAPSR-SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       796 ------~~~~~~~~---~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                            ........   ..+..+.+.. ........+.+|+.+||+.||++|||++|+++|
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                  00000000   0011111000 000112357899999999999999999999886

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=5.9e-40  Score=368.56  Aligned_cols=344  Identities=22%  Similarity=0.268  Sum_probs=135.0

Q ss_pred             EEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCC-------------CEeeCCCCcCccccccc
Q 042123            7 VINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNL-------------RYLYLGSNQFSGNILAE   73 (849)
Q Consensus         7 ~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~N~l~~~~~~~   73 (849)
                      +..++++.+++ |.+++ ++..+++|++|++++|++.+..|..++++++|             ++|++++|++++.+   
T Consensus        13 L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp---   87 (454)
T 1jl5_A           13 LQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLP---   87 (454)
T ss_dssp             -----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCC---
T ss_pred             chhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCC---
Confidence            34444444444 44443 34555555555555555544555555544432             44444444444210   


Q ss_pred             ccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccC
Q 042123           74 VSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLG  153 (849)
Q Consensus        74 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~  153 (849)
                        .     -.++|+.|++++|.+++ +|..   +++|++|++++|+++++.. .   .++|++|++++|++++ +| .|+
T Consensus        88 --~-----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~---~~~L~~L~L~~n~l~~-lp-~~~  150 (454)
T 1jl5_A           88 --E-----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L---PPLLEYLGVSNNQLEK-LP-ELQ  150 (454)
T ss_dssp             --S-----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C---CTTCCEEECCSSCCSS-CC-CCT
T ss_pred             --C-----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-C---CCCCCEEECcCCCCCC-Cc-ccC
Confidence              0     01344444444444443 2322   2344444444444443211 0   1344444444444443 22 344


Q ss_pred             CCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchh
Q 042123          154 KLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKEL  233 (849)
Q Consensus       154 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  233 (849)
                      ++++|++|++++|+++++ |..   ..+|++|++++|++++ +| .+.++++|++|++++|++++ +|...   ++|++|
T Consensus       151 ~l~~L~~L~l~~N~l~~l-p~~---~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L  220 (454)
T 1jl5_A          151 NSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESI  220 (454)
T ss_dssp             TCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEE
T ss_pred             CCCCCCEEECCCCcCccc-CCC---cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEE
Confidence            444444444444444442 111   1244444444444442 23 24444444444444444443 22211   244444


Q ss_pred             hhccccccCCCCcchhhh-hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCcccc
Q 042123          234 ALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT  312 (849)
Q Consensus       234 ~L~~N~l~~~~p~~~~~~-~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~  312 (849)
                      ++++|.++ .+|. ++.+ .|++|++++|++++. |..   .++|+.|++++|++++ +|..   +++|+.|++++|+++
T Consensus       221 ~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~  290 (454)
T 1jl5_A          221 VAGNNILE-ELPE-LQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFS  290 (454)
T ss_dssp             ECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS
T ss_pred             ECcCCcCC-cccc-cCCCCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccC
Confidence            44444444 3342 2222 244444444444432 111   1344444444444443 2222   134444444444444


Q ss_pred             CchhhhhCCCCCCCEEeccCccccCcccccCCCC-CCCcEEeccCCccccCCCCCccccccccccccccccccccCchhh
Q 042123          313 GNISEALGIYPNLTFIDLSRNNFYGEISSNWGKF-PKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKEL  391 (849)
Q Consensus       313 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~  391 (849)
                      +...    ..++|+.|++++|++.+. +    .+ ++|++|++++|++++ +|..   +++|+.|++++|++++ +|.  
T Consensus       291 ~l~~----~~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~-lp~--  354 (454)
T 1jl5_A          291 GLSE----LPPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE-VPE--  354 (454)
T ss_dssp             EESC----CCTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC--
T ss_pred             cccC----cCCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc-ccc--
Confidence            3210    113444444444444421 1    11 244444444444442 3322   2344444444444442 332  


Q ss_pred             cCCCCCcEEEccCccccc
Q 042123          392 GKLNPLTKLILRGNQITG  409 (849)
Q Consensus       392 ~~l~~L~~L~L~~N~l~~  409 (849)
                       .+++|++|++++|++++
T Consensus       355 -~l~~L~~L~L~~N~l~~  371 (454)
T 1jl5_A          355 -LPQNLKQLHVEYNPLRE  371 (454)
T ss_dssp             -CCTTCCEEECCSSCCSS
T ss_pred             -hhhhccEEECCCCCCCc
Confidence             23444444444444443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.2e-40  Score=372.29  Aligned_cols=324  Identities=20%  Similarity=0.215  Sum_probs=195.5

Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  167 (849)
                      .++++++.++ .+|..+.  +++++|+|++|+|+++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus        15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~   91 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR   91 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence            3445555554 3344433  466777777777776666677777777777777777776666677777777777777777


Q ss_pred             ccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcc
Q 042123          168 LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS  247 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  247 (849)
                      +..+++..|.++++|++|+|++|++.+..+..|.++++|++|++++|.+..+.+..|.++++|++|+|++|.+++ +|  
T Consensus        92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~--  168 (477)
T 2id5_A           92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS-IP--  168 (477)
T ss_dssp             CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS-CC--
T ss_pred             CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc-cC--
Confidence            777666667777777777777777766666667777777777777777766666666666666666666665542 11  


Q ss_pred             hhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCE
Q 042123          248 LGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF  327 (849)
Q Consensus       248 ~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  327 (849)
                                          +..+..+++|+.|++++|.+.+..+..|..+++|+.|++++|.                 
T Consensus       169 --------------------~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~-----------------  211 (477)
T 2id5_A          169 --------------------TEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP-----------------  211 (477)
T ss_dssp             --------------------HHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCT-----------------
T ss_pred             --------------------hhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCc-----------------
Confidence                                1122233344444444444444444444444445555554444                 


Q ss_pred             EeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccc
Q 042123          328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQI  407 (849)
Q Consensus       328 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  407 (849)
                             ..+.++..+....+|+.|++++|.++...+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|++
T Consensus       212 -------~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l  284 (477)
T 2id5_A          212 -------YLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL  284 (477)
T ss_dssp             -------TCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCC
T ss_pred             -------cccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCcc
Confidence                   4333333333344555555555555533323455555566666666666555555566666666666666666


Q ss_pred             cccCcccccccccccccccccCCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCC
Q 042123          408 TGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       408 ~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      ++..|..|.                     .+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|.|+|+.
T Consensus       285 ~~~~~~~~~---------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~  338 (477)
T 2id5_A          285 AVVEPYAFR---------------------GLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRL  338 (477)
T ss_dssp             SEECTTTBT---------------------TCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGG
T ss_pred             ceECHHHhc---------------------CcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccch
Confidence            654444333                     334455666666777766666777777777777777777777654

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.3e-40  Score=376.05  Aligned_cols=242  Identities=18%  Similarity=0.262  Sum_probs=186.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCC--Cchhh---HHHHHH--------HHHHhhceeecCCeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPC--DQTVD---QKEFLT--------EVEAFYGFCSHARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~---~~~~~~--------ei~~~~~~~~~~~~~~  653 (849)
                      ++|++.++||+|+||+||+|+. .+|+.||||++.+....  .....   .+..++        .|..+++++.+.+..|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            6799999999999999999965 57999999998643110  01110   111111        1334677888899999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|||||+||+|.+++.+.   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+.+
T Consensus       269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999999653   3599999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ...  .....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||.......     ...............+.
T Consensus       343 ~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~~~~~~p~  415 (689)
T 3v5w_A          343 SKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAVELPD  415 (689)
T ss_dssp             SSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHHCCCCCCT
T ss_pred             CCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcCCCCCCCc
Confidence            543  2345789999999999964 579999999999999999999999997432111     11112222222222222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                      ..    ...+.+++.+||++||++|++     ++||++|
T Consensus       416 ~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          416 SF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             TS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             cC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            22    234789999999999999998     6888775

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=4.4e-39  Score=361.53  Aligned_cols=387  Identities=24%  Similarity=0.296  Sum_probs=242.9

Q ss_pred             CCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCcccc-------------CeEeccCCc
Q 042123           29 FPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYM-------------SRLVINDNS   95 (849)
Q Consensus        29 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L-------------~~L~l~~n~   95 (849)
                      .++|++|++++|++ +.+|.+|+++++|++|+|++|++++..+.      .++.+++|             ++|++++|.
T Consensus        10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~------~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~   82 (454)
T 1jl5_A           10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPP------GNGEQREMAVSRLRDCLDRQAHELELNNLG   82 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCT------TSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred             cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCc------ccccchhcchhhhhhhhccCCCEEEecCCc
Confidence            57899999999999 78899999999999999999999875544      34667765             999999999


Q ss_pred             ccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcC
Q 042123           96 LSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRP  175 (849)
Q Consensus        96 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  175 (849)
                      +++. |..   .++|++|++++|++++ +|..   .++|++|++++|++++. +..   .++|++|++++|+++++ | .
T Consensus        83 l~~l-p~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~l-p-~  148 (454)
T 1jl5_A           83 LSSL-PEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEKL-P-E  148 (454)
T ss_dssp             CSCC-CSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSSC-C-C
T ss_pred             cccC-CCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCCC-c-c
Confidence            9864 432   3789999999999997 5543   47899999999999853 221   26899999999999985 4 5


Q ss_pred             CCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhh
Q 042123          176 FSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQ  255 (849)
Q Consensus       176 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~  255 (849)
                      |.++++|++|++++|++++ +|..+   .+|++|++++|++++ +| .+.++++|++|++++|.+++ +|...  ..|++
T Consensus       149 ~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~  219 (454)
T 1jl5_A          149 LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLES  219 (454)
T ss_dssp             CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCE
T ss_pred             cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc--CcccE
Confidence            9999999999999999984 56543   589999999999996 45 69999999999999999984 55433  25788


Q ss_pred             hhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccc
Q 042123          256 LLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNF  335 (849)
Q Consensus       256 L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  335 (849)
                      |++++|+++ .+| .+..+++|+.|++++|++++ +|..   +++|+.|++++|++++.+ .   ..++|+.|++++|++
T Consensus       220 L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~l~-~---~~~~L~~L~ls~N~l  289 (454)
T 1jl5_A          220 IVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTDLP-E---LPQSLTFLDVSENIF  289 (454)
T ss_dssp             EECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCC
T ss_pred             EECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccccC-c---ccCcCCEEECcCCcc
Confidence            888888888 445 37788888888888888875 3432   367888888888887633 2   236788888888888


Q ss_pred             cCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCcccc
Q 042123          336 YGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI  415 (849)
Q Consensus       336 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  415 (849)
                      ++. +..   .++|+.|++++|.+++ ++..   .++|+.|++++|++++ +|..   +++|+.|++++|+++ .+|.  
T Consensus       290 ~~l-~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~--  354 (454)
T 1jl5_A          290 SGL-SEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE--  354 (454)
T ss_dssp             SEE-SCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC--
T ss_pred             Ccc-cCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc--
Confidence            752 211   2578888888888874 2211   1477888888888875 4443   577888888888877 3444  


Q ss_pred             ccccccccccccc--CC---CCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCcccc--CCCC
Q 042123          416 GSLTKLEYLDFSA--IG---ELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC--PVPN  482 (849)
Q Consensus       416 ~~l~~L~~L~l~~--l~---~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~~  482 (849)
                       .+++|++|+++.  +.   .+|..+..+        +.|++.+.+|..   +++|+.|++++|++++  .+|.
T Consensus       355 -~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~  416 (454)
T 1jl5_A          355 -LPQNLKQLHVEYNPLREFPDIPESVEDL--------RMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIPE  416 (454)
T ss_dssp             -CCTTCCEEECCSSCCSSCCCCCTTCCEE--------ECCC---------------------------------
T ss_pred             -hhhhccEEECCCCCCCcCCCChHHHHhh--------hhcccccccccc---cCcCCEEECCCCcCCccccchh
Confidence             345555555543  11   233333332        112222222221   2667777777777776  4443

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.3e-39  Score=374.19  Aligned_cols=241  Identities=19%  Similarity=0.301  Sum_probs=194.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....    ......+.+|+.           ++++++.+....|+|
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~----~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc----hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            6899999999999999999955 579999999986532    223344555644           477888899999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC--CcEEEeeecCCccc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE--YEAHVADFGIAKSL  733 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfG~a~~~  733 (849)
                      ||||++|+|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       233 ~E~~~gg~L~~~i~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          233 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EECCCCCBHHHHHTCTT--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EeecCCCcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            99999999999986433  3589999999999999999999999   99999999999999865  89999999999987


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ... ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....        ......+.......+..
T Consensus       308 ~~~-~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~  378 (573)
T 3uto_A          308 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMDDS  378 (573)
T ss_dssp             CTT-SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCCCCCSG
T ss_pred             cCC-CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHhCCCCCCcc
Confidence            643 344567899999999999999999999999999999999999999974332        12222222222222222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........+.+|+.+||+.||++|||+.|+++|
T Consensus       379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222233457899999999999999999999986

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=2e-38  Score=359.52  Aligned_cols=350  Identities=28%  Similarity=0.363  Sum_probs=290.3

Q ss_pred             CCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCC
Q 042123           27 SSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGN  106 (849)
Q Consensus        27 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~  106 (849)
                      ..+++++.|++++|++..+.  .+..+++|++|+|++|++++..        .+.++++|++|++++|.+.+..+  +.+
T Consensus        43 ~~l~~l~~L~l~~~~i~~l~--~~~~l~~L~~L~Ls~n~l~~~~--------~~~~l~~L~~L~l~~n~l~~~~~--~~~  110 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDIT--------PLKNLTKLVDILMNNNQIADITP--LAN  110 (466)
T ss_dssp             HHHHTCCEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--------GGTTCTTCCEEECCSSCCCCCGG--GTT
T ss_pred             hHhccccEEecCCCCCccCc--chhhhcCCCEEECCCCccCCch--------hhhccccCCEEECCCCccccChh--hcC
Confidence            44678999999999997643  3889999999999999987432        16789999999999999986654  899


Q ss_pred             CCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEE
Q 042123          107 LKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLR  186 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  186 (849)
                      +++|++|++++|+++++.+  |.++++|++|++++|.+++.  ..+.++++|+.|+++ |.+.++.  .+.++++|++|+
T Consensus       111 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~  183 (466)
T 1o6v_A          111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLD  183 (466)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCC--GGGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEE
T ss_pred             CCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCC--hhhccCCcccEeecC-CcccCch--hhccCCCCCEEE
Confidence            9999999999999997644  89999999999999999853  358999999999997 5555543  488999999999


Q ss_pred             ccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh-hhhhhhccCcCCCC
Q 042123          187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHFTG  265 (849)
Q Consensus       187 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~L~~n~i~~  265 (849)
                      +++|++...  ..+..+++|++|++++|.+.+..|  ++.+++|++|++++|.+++ ++ .+..+ .|+.|++++|.+++
T Consensus       184 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~  257 (466)
T 1o6v_A          184 ISSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IG-TLASLTNLTDLDLANNQISN  257 (466)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCC
T ss_pred             CcCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-ch-hhhcCCCCCEEECCCCcccc
Confidence            999998743  348889999999999999986644  7889999999999999874 43 33333 48889999998887


Q ss_pred             CCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCC
Q 042123          266 YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGK  345 (849)
Q Consensus       266 ~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  345 (849)
                      ..+  +..+++|+.|++++|.+++..+  +..+++|+.|++++|++++..+  +..+++|+.|+|++|++.+..+  +..
T Consensus       258 ~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~  329 (466)
T 1o6v_A          258 LAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS  329 (466)
T ss_dssp             CGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGG
T ss_pred             chh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hcc
Confidence            655  7888899999999999886555  7888999999999999987665  7788999999999999987665  678


Q ss_pred             CCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCccc
Q 042123          346 FPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKE  414 (849)
Q Consensus       346 l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  414 (849)
                      +++|+.|++++|.+++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++ .|..
T Consensus       330 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~-~p~~  393 (466)
T 1o6v_A          330 LTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN-APVN  393 (466)
T ss_dssp             CTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC-CCBC
T ss_pred             CccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC-Cchh
Confidence            88999999999998854  468888999999999999987776  8889999999999999885 3443

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=4.2e-38  Score=356.87  Aligned_cols=348  Identities=22%  Similarity=0.344  Sum_probs=234.3

Q ss_pred             cCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcC
Q 042123           51 SNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDN  130 (849)
Q Consensus        51 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~  130 (849)
                      ..+++|+.|++++|.++.     +   ..+..+++|++|+|++|.+++..+  +.++++|++|++++|++++..+  |.+
T Consensus        43 ~~l~~l~~L~l~~~~i~~-----l---~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~  110 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGIKS-----I---DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN  110 (466)
T ss_dssp             HHHHTCCEEECCSSCCCC-----C---TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTT
T ss_pred             hHhccccEEecCCCCCcc-----C---cchhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcC
Confidence            345677777777777652     1   124556777777777777765433  6777777777777777775544  677


Q ss_pred             CCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEe
Q 042123          131 LSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLD  210 (849)
Q Consensus       131 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  210 (849)
                      +++|++|++++|.+++..+  +.++++|++|++++|.+.++.  .+..+++|++|+++ |.+.+. + .+.++++|++|+
T Consensus       111 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~-~-~~~~l~~L~~L~  183 (466)
T 1o6v_A          111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDL-K-PLANLTTLERLD  183 (466)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCC-G-GGTTCTTCCEEE
T ss_pred             CCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCc-h-hhccCCCCCEEE
Confidence            7777777777777765432  667777777777777766542  46677777777775 344422 2 266677777777


Q ss_pred             ccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccc
Q 042123          211 LNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGT  290 (849)
Q Consensus       211 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~  290 (849)
                      +++|.++..  ..+..+++|++|++++|.+.+..                       +  +..+++|+.|++++|++++.
T Consensus       184 l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~-----------------------~--~~~l~~L~~L~l~~n~l~~~  236 (466)
T 1o6v_A          184 ISSNKVSDI--SVLAKLTNLESLIATNNQISDIT-----------------------P--LGILTNLDELSLNGNQLKDI  236 (466)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG-----------------------G--GGGCTTCCEEECCSSCCCCC
T ss_pred             CcCCcCCCC--hhhccCCCCCEEEecCCcccccc-----------------------c--ccccCCCCEEECCCCCcccc
Confidence            777776643  33566666666666666655322                       1  33345666666666666643


Q ss_pred             cCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccc
Q 042123          291 IPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS  370 (849)
Q Consensus       291 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l  370 (849)
                        ..+..+++|+.|++++|.+++..+  +..+++|+.|++++|++.+..+  +..+++|+.|++++|.+++..+  +..+
T Consensus       237 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l  308 (466)
T 1o6v_A          237 --GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNL  308 (466)
T ss_dssp             --GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGC
T ss_pred             --hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCC
Confidence              246667777777777777776554  6677777777777777775444  6677777777777777775433  6677


Q ss_pred             ccccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccccccccccccCCCCChhhhcccccceeccCCc
Q 042123          371 SQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHN  450 (849)
Q Consensus       371 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L~~N  450 (849)
                      ++|+.|+|++|++++..|  +..+++|++|++++|++++.                       ..+.++++|+.|++++|
T Consensus       309 ~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-----------------------~~l~~l~~L~~L~l~~n  363 (466)
T 1o6v_A          309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV-----------------------SSLANLTNINWLSAGHN  363 (466)
T ss_dssp             TTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-----------------------GGGTTCTTCCEEECCSS
T ss_pred             CCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc-----------------------hhhccCCCCCEEeCCCC
Confidence            777777777777776554  66777777777777777632                       23456678889999999


Q ss_pred             ccccCCCccccccCCCcEEeccCCccccC
Q 042123          451 NLSGSIPSCFEGMHGLSFIDMSYNELQCP  479 (849)
Q Consensus       451 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  479 (849)
                      ++++..|  +..+++|+.|++++|+|++.
T Consensus       364 ~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          364 QISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             CCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             ccCccch--hhcCCCCCEEeccCCcccCC
Confidence            9998877  88999999999999999984

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.6e-38  Score=343.14  Aligned_cols=268  Identities=34%  Similarity=0.597  Sum_probs=210.5

Q ss_pred             ccccHHHHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhc
Q 042123          576 GKILYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG  644 (849)
Q Consensus       576 ~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~  644 (849)
                      ..+++.++..+.++|+..+.||+|+||.||+|+..+++.||||++........   ...+.+|+.           .+++
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG---ELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----C---CCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchH---HHHHHHHHHHHHhccCCCccceEE
Confidence            35678899999999999999999999999999888899999999875432211   113445543           4778


Q ss_pred             eeecCCeeEEEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEE
Q 042123          645 FCSHARHSFLLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH  723 (849)
Q Consensus       645 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  723 (849)
                      ++......++||||+++|+|.+++.... ....+++.++..++.|++.||+|||+.+.++|+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            8888889999999999999999997643 234589999999999999999999998666899999999999999999999


Q ss_pred             EeeecCCcccCCCCCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc---------c
Q 042123          724 VADFGIAKSLKPDSSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS---------S  793 (849)
Q Consensus       724 l~DfG~a~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~---------~  793 (849)
                      |+|||+++........ .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||+........         .
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999999876543332 33456899999999998888999999999999999999999999632211110         0


Q ss_pred             cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          794 LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...........+.....  ....+....+.+++.+||+.||++|||++||+++|+
T Consensus       255 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQG--NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTSSCCSTTSSCTTCTT--SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HhhchhhhhhcChhhcc--ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            11112222333333322  234556677999999999999999999999999985

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=9.6e-38  Score=350.92  Aligned_cols=356  Identities=18%  Similarity=0.175  Sum_probs=240.3

Q ss_pred             cCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccC
Q 042123           25 SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI  104 (849)
Q Consensus        25 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  104 (849)
                      ++..+++|++|+|++|+++++ | .|+.+++|++|+|++|++++.         .++.+++|++|++++|.+++. +  +
T Consensus        37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~---------~~~~l~~L~~L~Ls~N~l~~~-~--~  102 (457)
T 3bz5_A           37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL---------DLSQNTNLTYLACDSNKLTNL-D--V  102 (457)
T ss_dssp             EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC---------CCTTCTTCSEEECCSSCCSCC-C--C
T ss_pred             ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE---------ccccCCCCCEEECcCCCCcee-e--c
Confidence            577789999999999999876 3 689999999999999998752         267889999999999999865 3  8


Q ss_pred             CCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCE
Q 042123          105 GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVST  184 (849)
Q Consensus       105 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  184 (849)
                      +++++|++|++++|+++++ |  +..+++|++|++++|++++.   .++.+++|++|++++|+..+..  .+..+++|++
T Consensus       103 ~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~  174 (457)
T 3bz5_A          103 TPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTT  174 (457)
T ss_dssp             TTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCE
T ss_pred             CCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCE
Confidence            8899999999999999864 3  88889999999999999864   3788899999999999543322  5788899999


Q ss_pred             EEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh-hhhhhhccCcCC
Q 042123          185 LRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL-ILRQLLLSGNHF  263 (849)
Q Consensus       185 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~L~~L~L~~n~i  263 (849)
                      |++++|++++ +|  +..+++|+.|++++|++++.   .+..+++|++|++++|++++ +|  +... .|+.|++++|++
T Consensus       175 L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l  245 (457)
T 3bz5_A          175 LDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPL  245 (457)
T ss_dssp             EECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCC
T ss_pred             EECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcC
Confidence            9999999885 44  78888999999999998865   37888888888888888874 44  2222 255555555555


Q ss_pred             CCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccC
Q 042123          264 TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW  343 (849)
Q Consensus       264 ~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  343 (849)
                      ++..   +..+++|+.|+++.|              +|+.|++++|.+.+..|  ++.+++|+.|+|++|...+.+|.  
T Consensus       246 ~~~~---~~~l~~L~~L~l~~n--------------~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~--  304 (457)
T 3bz5_A          246 TELD---VSTLSKLTTLHCIQT--------------DLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC--  304 (457)
T ss_dssp             SCCC---CTTCTTCCEEECTTC--------------CCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC--
T ss_pred             CCcC---HHHCCCCCEEeccCC--------------CCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc--
Confidence            5432   223334444444333              23334445554443333  33445555555555554444432  


Q ss_pred             CCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccccccc
Q 042123          344 GKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEY  423 (849)
Q Consensus       344 ~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  423 (849)
                       ..++|+.|++++|             ++|+.|++++|++++. +  ++.+++|+.|++++|++++              
T Consensus       305 -~~~~L~~L~l~~~-------------~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------------  353 (457)
T 3bz5_A          305 -QAAGITELDLSQN-------------PKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------------  353 (457)
T ss_dssp             -TTCCCSCCCCTTC-------------TTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------------
T ss_pred             -CCCcceEechhhc-------------ccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------------
Confidence             2233333333333             3556666666666543 2  5556666666666666553              


Q ss_pred             cccccCCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCC
Q 042123          424 LDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS  483 (849)
Q Consensus       424 L~l~~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~  483 (849)
                                     ++.|..|++++|.++|.     ..+..|..+++++|.++|.+|..
T Consensus       354 ---------------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          354 ---------------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             ---------------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred             ---------------ccccccccccCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence                           23455566677777655     24455666777777777777653

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=354.20  Aligned_cols=321  Identities=22%  Similarity=0.202  Sum_probs=215.9

Q ss_pred             CEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCE
Q 042123           33 AYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQ  112 (849)
Q Consensus        33 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  112 (849)
                      +.++.++++++.+ |..+.  ++|+.|+|++|+|++.      ....|.++++|++|+|++|.+++..|..|.++++|++
T Consensus        14 ~~v~c~~~~l~~i-p~~~~--~~l~~L~L~~n~l~~~------~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~   84 (477)
T 2id5_A           14 RAVLCHRKRFVAV-PEGIP--TETRLLDLGKNRIKTL------NQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRT   84 (477)
T ss_dssp             TEEECCSCCCSSC-CSCCC--TTCSEEECCSSCCCEE------CTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             CEEEeCCCCcCcC-CCCCC--CCCcEEECCCCccceE------CHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCE
Confidence            4555555555433 22221  3566666666666531      2334555666666666666666666777778888888


Q ss_pred             EEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCC
Q 042123          113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL  192 (849)
Q Consensus       113 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  192 (849)
                      |+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|.+.++.+..|..+++|++|+|++|++
T Consensus        85 L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l  164 (477)
T 2id5_A           85 LGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNL  164 (477)
T ss_dssp             EECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCC
T ss_pred             EECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcC
Confidence            88888888877667777888888888888888777777788888888888888888887777888888888888888888


Q ss_pred             cCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccC
Q 042123          193 FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNIC  272 (849)
Q Consensus       193 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~  272 (849)
                      ++..+..|.++++|+.|+|++|.+.+..+..|..+++|++|++++|...+.+|....                       
T Consensus       165 ~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~-----------------------  221 (477)
T 2id5_A          165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL-----------------------  221 (477)
T ss_dssp             SSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTT-----------------------
T ss_pred             cccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccc-----------------------
Confidence            766666778888888888888888877777788888888888887766544443221                       


Q ss_pred             CCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEE
Q 042123          273 RGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTL  352 (849)
Q Consensus       273 ~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  352 (849)
                      ...+|+.|++++|+++...+..|.++++|+.|+|++|.+++..+..|..+++|+.|+|++|++.+..+..|..+++|+.|
T Consensus       222 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  301 (477)
T 2id5_A          222 YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVL  301 (477)
T ss_dssp             TTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEE
T ss_pred             cCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEE
Confidence            12245555555555554333455556666666666666666555566666666666666666666666666666666666


Q ss_pred             eccCCccccCCCCCccccccccccccccccccc
Q 042123          353 NVSMNNITGGLPREIGNSSQLQAFDLSLNHIVG  385 (849)
Q Consensus       353 ~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~  385 (849)
                      +|++|.+++..+..|..+++|+.|+|++|.+..
T Consensus       302 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c  334 (477)
T 2id5_A          302 NVSGNQLTTLEESVFHSVGNLETLILDSNPLAC  334 (477)
T ss_dssp             ECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred             ECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence            666666665555556666666666666666653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.5e-38  Score=336.23  Aligned_cols=239  Identities=23%  Similarity=0.397  Sum_probs=190.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|.. .+++.||||++......    ....+.+|+.           ++++++...+..++|
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc----HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            6899999999999999999964 57999999998653221    2333444443           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        96 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             EECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EECCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            9999999999998643    489999999999999999999999   999999999999999999999999999987766


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........||+.|+|||.+.+..++.++||||+|+++|||++|+.||..........     .......+....+    
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~~~~~~~~----  239 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNGTPELQNP----  239 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHHCSCCCSCG----
T ss_pred             cccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCCCCCCCCc----
Confidence            5555566789999999999999999999999999999999999999997433211100     0000011111111    


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ......+.+++.+||+.||++|||++|++++
T Consensus       240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1222347889999999999999999999886

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4.8e-38  Score=338.43  Aligned_cols=259  Identities=34%  Similarity=0.561  Sum_probs=203.0

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      .++..++++|+..+.||+|+||.||+|+..+++.||||++....    ....+.+.+|+.           ++++++.+.
T Consensus        32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES----SQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC----SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC----hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            34455678999999999999999999998889999999876532    223445666655           367788888


Q ss_pred             CeeEEEEEeccCCChhhhhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      +..++||||+++|+|.+++..... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            899999999999999999975432 23589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCCCC--CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------ccccc
Q 042123          729 IAKSLKPDS--SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-------NTDVA  799 (849)
Q Consensus       729 ~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-------~~~~~  799 (849)
                      +++......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........       .....
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            998654322  122345689999999999988999999999999999999999999974332111000       00111


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....+++....  ....+....+.+++.+||+.||++|||++|++++|+
T Consensus       265 ~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          265 LEQIVDPNLAD--KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CCSSSSSSCTT--CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhcChhhcc--ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            22333333322  223456677899999999999999999999999885

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1e-37  Score=345.45  Aligned_cols=334  Identities=19%  Similarity=0.222  Sum_probs=188.5

Q ss_pred             ccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEE
Q 042123           83 LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQ  162 (849)
Q Consensus        83 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  162 (849)
                      +++++.|++++|.+..+.+..|.++++|++|+|++|+++++.+.+|..+++|++|+|++|.+++..+..|+++++|++|+
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  123 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  123 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEE
Confidence            34555555555555544444455566666666666666655555666666666666666666655555566666666666


Q ss_pred             cCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccC
Q 042123          163 LNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG  242 (849)
Q Consensus       163 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  242 (849)
                      |++|++..+++..|..+++|++|+|++|++.+..+..|.++++|++|++++|++++.   .+..+++|++|++++|.++ 
T Consensus       124 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~-  199 (390)
T 3o6n_A          124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-  199 (390)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS-
T ss_pred             CCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc-
Confidence            666666655555556666666666666666555555555666666666666665533   1333444444444444433 


Q ss_pred             CCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCC
Q 042123          243 SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY  322 (849)
Q Consensus       243 ~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  322 (849)
                                                                    +.     ...++|+.|++++|.++..+.   ...
T Consensus       200 ----------------------------------------------~~-----~~~~~L~~L~l~~n~l~~~~~---~~~  225 (390)
T 3o6n_A          200 ----------------------------------------------TL-----AIPIAVEELDASHNSINVVRG---PVN  225 (390)
T ss_dssp             ----------------------------------------------EE-----ECCSSCSEEECCSSCCCEEEC---CCC
T ss_pred             ----------------------------------------------cc-----CCCCcceEEECCCCeeeeccc---ccc
Confidence                                                          10     111234444444444443211   112


Q ss_pred             CCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEc
Q 042123          323 PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLIL  402 (849)
Q Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  402 (849)
                      ++|+.|++++|.+.+.  ..+..+++|++|++++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|
T Consensus       226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L  302 (390)
T 3o6n_A          226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL  302 (390)
T ss_dssp             SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEEC
T ss_pred             ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEEC
Confidence            4455555555555432  234455555555555555555555555555555555555555553 3444556667777777


Q ss_pred             cCccccccCcccccccccccccccccCCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCC
Q 042123          403 RGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       403 ~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      ++|+++                      .+|..+..+++|+.|+|++|++++. |  +..+++|+.|++++|+|.|.+..
T Consensus       303 ~~n~l~----------------------~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~  357 (390)
T 3o6n_A          303 SHNHLL----------------------HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR  357 (390)
T ss_dssp             CSSCCC----------------------CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH
T ss_pred             CCCcce----------------------ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH
Confidence            777665                      3344455667788888888998855 3  67788999999999999997643


Q ss_pred             CcccccCcccccccCCCccCC
Q 042123          483 STTFRGASVEALKGNKGLCGS  503 (849)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~c~~  503 (849)
                      . .+.......+.++...|..
T Consensus       358 ~-~~~~~~~~~~~~~~~~c~~  377 (390)
T 3o6n_A          358 A-LFRNVARPAVDDADQHCKI  377 (390)
T ss_dssp             H-HTTTCCTTTBCCCCSCCCT
T ss_pred             H-HHHHHHhhcccccCceecc
Confidence            2 2232333344455555543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.6e-38  Score=337.79  Aligned_cols=246  Identities=32%  Similarity=0.484  Sum_probs=185.4

Q ss_pred             HHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ...++|++.+.||+|+||+||+|+. +|+.||||++.....  .......+.+|+.           .+++++......+
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS  110 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence            3456888999999999999999987 588999999875422  2223345666654           3677888888999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP--IVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      +||||+++|+|.+++........+++.++..++.|++.||+|||+.   +  |+||||||+||+++.++.+||+|||+++
T Consensus       111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            9999999999999997655444589999999999999999999998   7  9999999999999999999999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccc--cCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM--LDPRLP  809 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~  809 (849)
                      .............||+.|+|||.+.+..++.++||||||+++|||++|+.||.......        .....  ......
T Consensus       188 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~~~~~  259 (309)
T 3p86_A          188 LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ--------VVAAVGFKCKRLE  259 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH--------HHHHHHHSCCCCC
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhcCCCCC
Confidence            65544333455679999999999999999999999999999999999999997543211        11111  111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+...    ...+.+++.+||+.||++|||++++++.|+
T Consensus       260 ~~~~~----~~~l~~li~~~l~~dP~~Rps~~~ll~~L~  294 (309)
T 3p86_A          260 IPRNL----NPQVAAIIEGCWTNEPWKRPSFATIMDLLR  294 (309)
T ss_dssp             CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11122    224788999999999999999999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-37  Score=335.32  Aligned_cols=251  Identities=25%  Similarity=0.373  Sum_probs=197.4

Q ss_pred             ccccHHHHHHHhcC----------CCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH----
Q 042123          576 GKILYDEIVKATND----------FDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----  640 (849)
Q Consensus       576 ~~~~~~~~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~----  640 (849)
                      +.++++++..+++.          |+..+.||+|+||.||+|+.. +|+.||||++.....    .....+.+|+.    
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~   98 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ----QRRELLFNEVVIMRD   98 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CSHHHHHHHHHHHTT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch----hHHHHHHHHHHHHHh
Confidence            45677888877764          666779999999999999765 799999999865322    22344555654    


Q ss_pred             -------HhhceeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          641 -------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       641 -------~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                             .+++++...+..++||||+++|+|.+++...    .+++.++..++.|++.||+|||+.   +|+||||||+|
T Consensus        99 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N  171 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDS  171 (321)
T ss_dssp             CCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             CCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHH
Confidence                   3677888888999999999999999998643    489999999999999999999998   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc
Q 042123          714 LLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS  793 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~  793 (849)
                      |+++.++.+||+|||++..............||+.|+|||++.+..++.++||||||+++|||++|+.||........  
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~--  249 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA--  249 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred             EEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--
Confidence            999999999999999998776554444567899999999999999999999999999999999999999974322110  


Q ss_pred             cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         .........+....    .......+.+++.+||+.||++|||++|++++
T Consensus       250 ---~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          250 ---MKRLRDSPPPKLKN----SHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             ---HHHHHHSSCCCCTT----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---HHHHhcCCCCCcCc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00111111111111    11222347889999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6.9e-37  Score=327.32  Aligned_cols=264  Identities=28%  Similarity=0.518  Sum_probs=208.0

Q ss_pred             cccHHHHHHHhcCCCcC------ceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH----------
Q 042123          577 KILYDEIVKATNDFDAK------YCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE----------  640 (849)
Q Consensus       577 ~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~----------  640 (849)
                      .+.+.++..++++|...      +.||+|+||.||+|.. +++.||||++..............+.+|+.          
T Consensus        14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   92 (307)
T 2nru_A           14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL   92 (307)
T ss_dssp             ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred             cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence            56789999999999887      8999999999999987 588999999876433333334455666654          


Q ss_pred             -HhhceeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          641 -AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       641 -~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                       .+++++...+..++||||+++|+|.+++........+++.++..++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~  169 (307)
T 2nru_A           93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEA  169 (307)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTT
T ss_pred             EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCC
Confidence             36778888889999999999999999997655556699999999999999999999999   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc---
Q 042123          720 YEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL---  794 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~---  794 (849)
                      +.+||+|||+++........  .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...........   
T Consensus       170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  248 (307)
T 2nru_A          170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKE  248 (307)
T ss_dssp             CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHH
T ss_pred             CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHH
Confidence            99999999999876543222  223568999999998765 588999999999999999999999975432211000   


Q ss_pred             ---ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 ---NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         .........+++.....   .......+.+++.+||+.||++|||+++++++|+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~  302 (307)
T 2nru_A          249 EIEDEEKTIEDYIDKKMNDA---DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ  302 (307)
T ss_dssp             HHHTTSCCHHHHSCSSCSCC---CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             Hhhhhhhhhhhhcccccccc---chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence               01111223344443322   3344566889999999999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-37  Score=334.47  Aligned_cols=239  Identities=23%  Similarity=0.378  Sum_probs=192.0

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|++ .+|+.||||++.....  .....+.+.+|+.           ++++++...+..++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            36899999999999999999965 6899999999865422  2223345556654           36778888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             EECCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             EEECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999998653   3589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCeeeccCCccccccccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKIT-EKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      .. .......||+.|+|||.+.+..+. .++||||+||++|||++|+.||+....        ......+.......+..
T Consensus       166 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~p~~  236 (328)
T 3fe3_A          166 VG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL--------KELRERVLRGKYRIPFY  236 (328)
T ss_dssp             SS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTT
T ss_pred             CC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCC
Confidence            43 234556899999999999888775 789999999999999999999974321        11222222333332222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..    ..+.+++.+||+.||.+|||++|+++|
T Consensus       237 ~s----~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          237 MS----TDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             SC----HHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CC----HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            22    237789999999999999999999886

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.8e-37  Score=334.33  Aligned_cols=240  Identities=23%  Similarity=0.305  Sum_probs=190.0

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|.+.+.... .......+.+|+.           .+++++...+..++|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            67899999999999999999654 7999999998653110 1112233444433           366778888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999998653   3589999999999999999999999   999999999999999999999999999987554


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+... 
T Consensus       158 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~-  228 (337)
T 1o6l_A          158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPRTL-  228 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTTS-
T ss_pred             CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCCCC-
Confidence            44455667899999999999999999999999999999999999999974321        111122222222222222 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                         ...+.+++.+||+.||++||     +++|+++|
T Consensus       229 ---s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          229 ---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence               23478899999999999999     89999876

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=4e-37  Score=359.56  Aligned_cols=335  Identities=20%  Similarity=0.225  Sum_probs=204.8

Q ss_pred             ccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEE
Q 042123           83 LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQ  162 (849)
Q Consensus        83 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  162 (849)
                      +.+++.|++++|.+..+++..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|.+++..+..|+++++|++|+
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            45556666666666655555566666666666666666666666666666666666666666666666666666666666


Q ss_pred             cCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccC
Q 042123          163 LNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG  242 (849)
Q Consensus       163 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  242 (849)
                      |++|.++++++..|.++++|++|+|++|.+++..|..|.++++|++|+|++|.+++.   .+..+++|+.|++++|.++ 
T Consensus       130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~~l~~L~~L~l~~n~l~-  205 (597)
T 3oja_B          130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-  205 (597)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC---CGGGCTTCSEEECCSSCCS-
T ss_pred             eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc---ChhhhhhhhhhhcccCccc-
Confidence            666666666666666666666666666666665566666666666666666666543   1333444555555444443 


Q ss_pred             CCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCC
Q 042123          243 SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY  322 (849)
Q Consensus       243 ~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  322 (849)
                                                                    +     +....+|+.|++++|.++...+..   .
T Consensus       206 ----------------------------------------------~-----l~~~~~L~~L~ls~n~l~~~~~~~---~  231 (597)
T 3oja_B          206 ----------------------------------------------T-----LAIPIAVEELDASHNSINVVRGPV---N  231 (597)
T ss_dssp             ----------------------------------------------E-----EECCTTCSEEECCSSCCCEEECSC---C
T ss_pred             ----------------------------------------------c-----ccCCchhheeeccCCccccccccc---C
Confidence                                                          1     111123444444444444222211   1


Q ss_pred             CCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEc
Q 042123          323 PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLIL  402 (849)
Q Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  402 (849)
                      ++|+.|+|++|.+++  +..+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++ +|..+..+++|+.|+|
T Consensus       232 ~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L  308 (597)
T 3oja_B          232 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL  308 (597)
T ss_dssp             SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEEC
Confidence            345555555555543  2345555556666666666555555555566666666666666653 3455556677777777


Q ss_pred             cCccccccCcccccccccccccccccCCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCC
Q 042123          403 RGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       403 ~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      ++|+++                      .+|..+..+++|+.|+|++|+|++..   +..+++|+.|++++|+|.|.+..
T Consensus       309 s~N~l~----------------------~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~  363 (597)
T 3oja_B          309 SHNHLL----------------------HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLR  363 (597)
T ss_dssp             CSSCCC----------------------CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHH
T ss_pred             CCCCCC----------------------ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHH
Confidence            777665                      34455566778888889999998653   66788999999999999998643


Q ss_pred             CcccccCcccccccCCCccCCC
Q 042123          483 STTFRGASVEALKGNKGLCGSA  504 (849)
Q Consensus       483 ~~~~~~~~~~~~~~~~~~c~~~  504 (849)
                      . .+.......+.++...|+.+
T Consensus       364 ~-~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          364 A-LFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             H-HTTTCCTTTBCCCCCCCCTT
T ss_pred             H-HHHHHhhhccccccccCCcc
Confidence            2 34444444566777777653

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=2.1e-36  Score=340.05  Aligned_cols=345  Identities=18%  Similarity=0.176  Sum_probs=271.0

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccc
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRY   85 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~   85 (849)
                      +++.++++.+++.+. +  +|..+++|++|+|++|+++++ |  ++.+++|++|+|++|++++.         .++++++
T Consensus        43 ~L~~L~Ls~n~l~~~-~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~---------~~~~l~~  107 (457)
T 3bz5_A           43 TLTSLDCHNSSITDM-T--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL---------DVTPLTK  107 (457)
T ss_dssp             TCCEEECCSSCCCCC-T--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC---------CCTTCTT
T ss_pred             CCCEEEccCCCcccC-h--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee---------ecCCCCc
Confidence            578899999999875 3  589999999999999999876 3  99999999999999999852         2788999


Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCC
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND  165 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  165 (849)
                      |++|++++|.+++. |  ++++++|++|++++|+++++   .+..+++|++|++++|...+..  .+..+++|+.|++++
T Consensus       108 L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~  179 (457)
T 3bz5_A          108 LTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSF  179 (457)
T ss_dssp             CCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEECCC
Confidence            99999999999974 4  89999999999999999975   3889999999999999654444  588999999999999


Q ss_pred             CcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCC
Q 042123          166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP  245 (849)
Q Consensus       166 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  245 (849)
                      |++++++   +..+++|++|++++|++++.   .+..+++|++|++++|++++ +|  +..+++|++|++++|++++..+
T Consensus       180 n~l~~l~---l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~  250 (457)
T 3bz5_A          180 NKITELD---VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV  250 (457)
T ss_dssp             SCCCCCC---CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC
T ss_pred             Cccceec---cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH
Confidence            9999963   88999999999999999864   38899999999999999997 45  8899999999999999996544


Q ss_pred             cchhhh--------hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhh
Q 042123          246 PSLGNL--------ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISE  317 (849)
Q Consensus       246 ~~~~~~--------~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  317 (849)
                      ..+..+        .|+.|++++|.+.+.+|  +..+++|+.|++++|...+.+|..   ..+|+.|+++          
T Consensus       251 ~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~---~~~L~~L~l~----------  315 (457)
T 3bz5_A          251 STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQ---AAGITELDLS----------  315 (457)
T ss_dssp             TTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECT---TCCCSCCCCT----------
T ss_pred             HHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccC---CCcceEechh----------
Confidence            443332        13444444444443333  234455555555555544444421   2333333333          


Q ss_pred             hhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCC
Q 042123          318 ALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPL  397 (849)
Q Consensus       318 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  397 (849)
                         .+++|+.|+|++|++++.   .+..+++|+.|++++|++++        ++.|..|++++|.+.|.     ..+..|
T Consensus       316 ---~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l  376 (457)
T 3bz5_A          316 ---QNPKLVYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITM  376 (457)
T ss_dssp             ---TCTTCCEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEEC
T ss_pred             ---hcccCCEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeec
Confidence               346888999999998874   27888899999999998884        35677888888888865     345667


Q ss_pred             cEEEccCccccccCccccc
Q 042123          398 TKLILRGNQITGRLPKEIG  416 (849)
Q Consensus       398 ~~L~L~~N~l~~~~p~~~~  416 (849)
                      +.+++++|+++|.+|..+.
T Consensus       377 ~~l~l~~N~l~g~ip~~~~  395 (457)
T 3bz5_A          377 PKETLTNNSLTIAVSPDLL  395 (457)
T ss_dssp             CCBCCBTTBEEEECCTTCB
T ss_pred             CccccccCcEEEEcChhHh
Confidence            8889999999988887654

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.3e-37  Score=327.52  Aligned_cols=243  Identities=26%  Similarity=0.458  Sum_probs=189.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||+||+|.. .+++.||+|++...    .....+.+.+|+.           .+++++.+++..++|
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF----DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            6788899999999999999965 46999999988542    2334556667755           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMD--SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EECCTTCBHHHHHHHCC--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEecCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            99999999999997533  3589999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCCC--------------eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042123          736 DSSN--------------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD  801 (849)
Q Consensus       736 ~~~~--------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~  801 (849)
                      ....              .....||+.|+|||.+.+..++.++||||||+++|||++|..||.........   ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---~~~~~~  237 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---FGLNVR  237 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT---SSBCHH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH---Hhhhhh
Confidence            3221              11457899999999999999999999999999999999999998643221110   001111


Q ss_pred             cccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          802 QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       802 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+...+..  .    ...+.+++.+||+.||++|||++++++.|+
T Consensus       238 ~~~~~~~~~~--~----~~~l~~li~~~l~~dP~~Rps~~~l~~~L~  278 (310)
T 3s95_A          238 GFLDRYCPPN--C----PPSFFPITVRCCDLDPEKRPSFVKLEHWLE  278 (310)
T ss_dssp             HHHHHTCCTT--C----CTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccccccCCCC--C----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1111111111  1    113778999999999999999999998874

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7e-38  Score=339.88  Aligned_cols=242  Identities=24%  Similarity=0.368  Sum_probs=184.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHS  652 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~  652 (849)
                      ..++|+..+.||+|+||+||+|+. .+++.||||++...... .......+..|            +..+++++...+..
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL-QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhc-chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            347899999999999999999965 46899999998653110 11111222222            22467788888999


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      |+||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999998654   3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ...........+||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+.
T Consensus       174 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~  245 (353)
T 3txo_A          174 GICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILNDEVVYPT  245 (353)
T ss_dssp             SCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT
T ss_pred             cccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCC
Confidence            55444455667899999999999988899999999999999999999999974321        1222333333333222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCH------HHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTM------KIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~------~eil~~  846 (849)
                      ...    ..+.+++.+||++||++||++      +|+++|
T Consensus       246 ~~~----~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          246 WLH----EDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             TSC----HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CCC----HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            222    237789999999999999998      778765

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.8e-37  Score=340.42  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=190.8

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCc-----hhhHHHHHHH------HHHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQ-----TVDQKEFLTE------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~~~e------i~~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||+||+|+.. +++.||||++.+......     ...+...+..      +..+++++......++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            368999999999999999999654 688999999875422111     1112222222      3347788888999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999998653   3599999999999999999999999   99999999999999999999999999998755


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccc-cccccccccCCCCCCCCh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN-TDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  813 (849)
                      .........+||+.|+|||++.+..++.++||||+||++|||++|+.||............ .......+.......+..
T Consensus       205 ~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          205 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence            4445556678999999999999999999999999999999999999999743322111111 111222233333332222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCH------HHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTM------KIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~------~eil~~  846 (849)
                      ..    ..+.+++.+||+.||++||++      +||++|
T Consensus       285 ~s----~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          285 LS----VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             SC----HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             CC----HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            22    347789999999999999995      677765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4e-37  Score=334.75  Aligned_cols=245  Identities=19%  Similarity=0.263  Sum_probs=194.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc--hhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ--TVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      .+.|++.+.||+|+||.||+|+. .+|+.||||.+........  ......+.+|+.           .+++++......
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            36799999999999999999965 4799999999876432211  112345556654           367788888999


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeec
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY----EAHVADFG  728 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG  728 (849)
                      ++||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            9999999999999999653   3589999999999999999999999   999999999999998877    79999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ++...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.....        ......+.....
T Consensus       165 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~  235 (361)
T 2yab_A          165 LAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITAVSY  235 (361)
T ss_dssp             SCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTCC
T ss_pred             CceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcCC
Confidence            99876543 233456799999999999998999999999999999999999999974321        122222333332


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+...+......+.+++.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          236 DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            22222222233458899999999999999999999976

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7.3e-37  Score=335.03  Aligned_cols=244  Identities=23%  Similarity=0.405  Sum_probs=189.1

Q ss_pred             cCCCcCceecCCccceEEEEEe--------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL--------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS  647 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~  647 (849)
                      ++|+..+.||+|+||.||+|+.        .++..||||++....   .....+.+.+|+.            .+++++.
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC---BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc---CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            6788899999999999999965        245679999986542   2223344555544            3667788


Q ss_pred             cCCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNL  714 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Ni  714 (849)
                      ..+..|+||||+++|+|.+++.....             ...+++.++..++.||+.||+|||+.   +|+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhE
Confidence            88899999999999999999975431             23589999999999999999999999   999999999999


Q ss_pred             eecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccc
Q 042123          715 LLDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISS  791 (849)
Q Consensus       715 ll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~  791 (849)
                      +++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......  
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--  312 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  312 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            999999999999999986654322  1233456789999999999999999999999999999999 99998743211  


Q ss_pred             cccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          792 SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                            .....+........+.   .....+.+++.+||+.||++|||+.|++++|+
T Consensus       313 ------~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~  360 (370)
T 2psq_A          313 ------ELFKLLKEGHRMDKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  360 (370)
T ss_dssp             ------GHHHHHHTTCCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------HHHHHHhcCCCCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                  1111111211111111   11234788999999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=4.9e-37  Score=342.86  Aligned_cols=245  Identities=20%  Similarity=0.289  Sum_probs=192.4

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||.||+|.. .+|+.||+|.+.....  .......+.+|+.           ++++++.+.+..+
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            457899999999999999999954 5799999999875422  2223344555644           3678888899999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEeeecCC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---LEYEAHVADFGIA  730 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG~a  730 (849)
                      +||||+++|+|.+.+...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++   .++.+||+|||++
T Consensus        87 lv~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EEECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            999999999999998654   3489999999999999999999999   999999999999998   4578999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      ..............||+.|+|||++.+..++.++||||+||++|+|++|+.||.....        ......+.......
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~  232 (444)
T 3soa_A          161 IEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAGAYDF  232 (444)
T ss_dssp             BCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCC
T ss_pred             EEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhCCCCC
Confidence            8776555555567899999999999999999999999999999999999999964321        11122222222211


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +..........+.+++.+||+.||++|||++|+++|
T Consensus       233 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            111111223457899999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-37  Score=331.50  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=181.7

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHH-------HHHhhceeec----CCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-------VEAFYGFCSH----ARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-------i~~~~~~~~~----~~~~~lV  655 (849)
                      .++|+..+.||+|+||+||+|+. +++.||||++..... .....+.+....       +.++++++..    ....++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv   84 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRDE-KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI   84 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccccc-hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence            46899999999999999999988 689999999864311 000111111111       1124444322    3568999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH--------HDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                      |||+++|+|.++++..    .+++.++.+++.|++.||+|||        +.   +|+||||||+||+++.++.+||+||
T Consensus        85 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           85 THYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             ECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCC
T ss_pred             hhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeC
Confidence            9999999999999543    4899999999999999999999        76   9999999999999999999999999


Q ss_pred             cCCcccCCCCCC----eeeccCCccccccccccCC------CCCccchHHHHHHHHHHHHhC----------CCCCCccc
Q 042123          728 GIAKSLKPDSSN----WTEFAGTCGYIAPELAYTM------KITEKCDVYSFGVLMWEVIKG----------KHPRDFLS  787 (849)
Q Consensus       728 G~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg----------~~Pf~~~~  787 (849)
                      |+++........    .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            999765443222    2234789999999998876      456799999999999999999          67765322


Q ss_pred             cccccccccccccccc--cCCCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          788 SISSSSLNTDVALDQM--LDPRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       788 ~~~~~~~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .....    .......  .+...+..+  .........+.+++.+||+.||++|||++||++.|+
T Consensus       238 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  298 (301)
T 3q4u_A          238 PNDPS----FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT  298 (301)
T ss_dssp             CSSCC----HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             CCCcc----hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHh
Confidence            11100    0111111  111111111  122345567899999999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-37  Score=330.15  Aligned_cols=241  Identities=21%  Similarity=0.282  Sum_probs=192.6

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|.. .+++.||+|.+...     ......+.+|+.           ++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            36889999999999999999965 46889999998643     122334445544           36788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCcEEEeeecCCcc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL--EYEAHVADFGIAKS  732 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfG~a~~  732 (849)
                      ||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.  ++.+||+|||+++.
T Consensus        79 v~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            999999999999996543  3589999999999999999999999   9999999999999987  78999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .... .......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||.....        ......+.......+.
T Consensus       154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~~  224 (321)
T 1tki_A          154 LKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDE  224 (321)
T ss_dssp             CCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCH
T ss_pred             CCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHHcCCCCCCh
Confidence            7543 334556799999999999988899999999999999999999999974321        1222223333332222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .........+.+++.+||+.||++|||+.|+++|
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            2222234458899999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-37  Score=335.54  Aligned_cols=243  Identities=24%  Similarity=0.353  Sum_probs=188.5

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCe
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARH  651 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~  651 (849)
                      ...++|...+.||+|+||.||+|+.. +|+.||||+++...... .........|            +.++++++.....
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh-hhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            34578999999999999999999764 68999999986531100 0011122222            2246778888899


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .|+||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            99999999999999998653   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      .............||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p  238 (345)
T 1xjd_A          167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMDNPFYP  238 (345)
T ss_dssp             CCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC
T ss_pred             hcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence            755444445667899999999999999999999999999999999999999974321        111122222222111


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHH-HHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMK-IISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~~  846 (849)
                      ...    ...+.+++.+||+.||++||++. +|++|
T Consensus       239 ~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          239 RWL----EKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             TTS----CHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ccc----CHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            111    23477899999999999999998 77764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.4e-37  Score=330.76  Aligned_cols=248  Identities=26%  Similarity=0.367  Sum_probs=189.5

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~~~~~~l  654 (849)
                      ++|+..+.||+|+||.||+|+.. +++.||+|++........ .....+.+|.            ..+++++......++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch-HHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            57889999999999999999664 689999999976432211 1122233332            236677888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999998653   3589999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc-ccccccccccCCCCCCCCh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-NTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  813 (849)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||........... ........+.......+..
T Consensus       162 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  241 (345)
T 3a8x_A          162 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  241 (345)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred             CCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence            444445667899999999999999999999999999999999999999974332111111 1111112222222222222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCH------HHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTM------KIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~------~eil~~  846 (849)
                      .    ...+.+++.+||+.||++||++      +|+++|
T Consensus       242 ~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          242 L----SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             S----CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             C----CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            2    2347789999999999999995      677765

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3e-37  Score=335.89  Aligned_cols=248  Identities=19%  Similarity=0.252  Sum_probs=192.2

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCC-CCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLP-CDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      .+.|+..+.||+|+||.||+|.. .+++.||||++..... .........+.+|+.           ++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35799999999999999999965 5799999999853211 011112344555544           3677888889999


Q ss_pred             EEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEeeecC
Q 042123          654 LLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE---AHVADFGI  729 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG~  729 (849)
                      +||||+++|+|.+++.... ....+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988876443 233589999999999999999999999   9999999999999987654   99999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ++.............||+.|+|||++.+..++.++||||+||++|+|++|+.||....         ......+......
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGKYK  250 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTCCC
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCCCC
Confidence            9887654444455689999999999999999999999999999999999999997422         1122222222222


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+......+.+++.+||+.||++|||+.|+++|
T Consensus       251 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            2221222233458899999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.2e-37  Score=333.52  Aligned_cols=242  Identities=22%  Similarity=0.328  Sum_probs=189.4

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHS  652 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~  652 (849)
                      ..++|+..+.||+|+||.||+|+.. +++.||||++...... .......+..|..            .+++++...+..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            3478999999999999999999765 5889999998653110 0111223333322            356677788899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      |+||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        97 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999998653   3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ............||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+.
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~  242 (353)
T 2i0e_A          171 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK  242 (353)
T ss_dssp             CCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCT
T ss_pred             cccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhCCCCCCC
Confidence            55444445667899999999999999999999999999999999999999974321        1222223333332222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                      ..    ...+.+++.+||+.||++||+     +++|++|
T Consensus       243 ~~----s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          243 SM----SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             TS----CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CC----CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            22    234788999999999999995     5888765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=326.34  Aligned_cols=253  Identities=21%  Similarity=0.301  Sum_probs=192.1

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC--eeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR--HSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~--~~~  653 (849)
                      ++|.+.+.||+|+||+||+|+.. +++.||||++.....   ......+.+|+.           .+++++....  ..+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            57889999999999999999664 589999999875321   112334445544           3556665544  779


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEeeecC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL----DLEYEAHVADFGI  729 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfG~  729 (849)
                      +||||+++|+|.+++........+++.++..++.||+.||+|||+.   +|+||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999998766555599999999999999999999999   99999999999999    7788899999999


Q ss_pred             CcccCCCCCCeeeccCCcccccccccc--------CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccc-
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAY--------TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL-  800 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~-  800 (849)
                      ++...... ......||+.|+|||++.        +..++.++|||||||++|||++|+.||................. 
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            98775443 334567999999999876        57789999999999999999999999964322111000000000 


Q ss_pred             ----------c------cccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          801 ----------D------QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       801 ----------~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                                .      ....+..+............+.+++.+||+.||++|||++|++++.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence                      0      0011122332334455666788999999999999999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=328.27  Aligned_cols=244  Identities=19%  Similarity=0.267  Sum_probs=190.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc--hhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ--TVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      +.|+..+.||+|+||.||+|.. .+|+.||||.+........  ......+.+|+.           .+++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            5788999999999999999965 4699999999875432211  112344555544           3677888889999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeecC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY----EAHVADFGI  729 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG~  729 (849)
                      +||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++    .+||+|||+
T Consensus        91 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS---SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            999999999999999653   3589999999999999999999999   999999999999999887    899999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......        .....+......
T Consensus       165 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~~~~~~~~  235 (326)
T 2y0a_A          165 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANVSAVNYE  235 (326)
T ss_dssp             CEECCTTS-CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHTCCC
T ss_pred             CeECCCCC-ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHHhcCCC
Confidence            98765432 234567999999999999889999999999999999999999999643211        111111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+..........+.+++.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111111223457899999999999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=327.50  Aligned_cols=241  Identities=26%  Similarity=0.463  Sum_probs=187.0

Q ss_pred             cCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ++|++.+.||+|+||.||+|...    .+..||||++....   .....+.+.+|+.           .+++++...+..
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY---TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence            56788899999999999999763    35569999987532   2333456677755           367788888899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHD--GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEeeCCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            99999999999999996543  3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042123          733 LKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-R  807 (849)
Q Consensus       733 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~  807 (849)
                      .......   .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......        .....+... .
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~~~  272 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEEGYR  272 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCC
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCC
Confidence            7544322   122345778999999998899999999999999999999 99999743321        111111111 1


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+.+...    ...+.+++.+||+.||++|||+++|++.|+
T Consensus       273 ~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~eil~~L~  309 (325)
T 3kul_A          273 LPAPMGC----PHALHQLMLDCWHKDRAQRPRFSQIVSVLD  309 (325)
T ss_dssp             CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCc----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1222222    234788999999999999999999999875

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.6e-37  Score=328.99  Aligned_cols=242  Identities=21%  Similarity=0.330  Sum_probs=181.4

Q ss_pred             hcCCCcCceecCCccceEEEEEe----cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~  651 (849)
                      .++|+..+.||+|+||.||+|+.    .+++.||+|++..............+.+|+           .++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            36899999999999999999976    478999999987542211111122233332           246788888899


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999998653   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      .............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....        ......+.......+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~p  241 (327)
T 3a62_A          170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR--------KKTIDKILKCKLNLP  241 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHTCCCCC
T ss_pred             ccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence            654443344556799999999999998999999999999999999999999974321        112222222222222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      ....    ..+.+++.+||+.||++||     +++|+++|
T Consensus       242 ~~~~----~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          242 PYLT----QEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             TTSC----HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CCCC----HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            2222    3478899999999999999     78888875

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6.2e-37  Score=325.05  Aligned_cols=246  Identities=24%  Similarity=0.364  Sum_probs=186.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+. .+++.||+|.+..... ......+.+.+|+.           .+++++...+..++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            6799999999999999999964 5789999999865432 22333455666654           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999999654   3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC-Ch
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP-SR  813 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  813 (849)
                      ... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.......        .....+....+.. ..
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~~~~~~~~  235 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS--------IAIKHIQDSVPNVTTD  235 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH--------HHHHHHSSCCCCHHHH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhhccCCCcchh
Confidence            322 2334578999999999999999999999999999999999999997433211        1111111111110 00


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCC-CHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRP-TMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~  848 (849)
                      ........+.+++.+||++||++|| +++++.+.|+
T Consensus       236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence            1111223588899999999999998 8888887764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.9e-37  Score=333.71  Aligned_cols=246  Identities=20%  Similarity=0.311  Sum_probs=169.5

Q ss_pred             CceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHH------HHHHhhceeecCCeeEEEEEeccCCChh
Q 042123          593 KYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLT------EVEAFYGFCSHARHSFLLYEFLERGSLA  665 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~------ei~~~~~~~~~~~~~~lV~e~~~~gsL~  665 (849)
                      .+.||+|+||.||+|.. .+++.||||++..... .....+...++      .|..+++++.+....++||||+++|+|.
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH-HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChhhh-hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            47899999999999965 4689999999865311 01111111111      1334778888889999999999999999


Q ss_pred             hhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEEEeeecCCcccCCCCCCeee
Q 042123          666 AILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---EAHVADFGIAKSLKPDSSNWTE  742 (849)
Q Consensus       666 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~DfG~a~~~~~~~~~~~~  742 (849)
                      +++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++   .+||+|||+++...........
T Consensus        95 ~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  168 (325)
T 3kn6_A           95 ERIKKK---KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT  168 (325)
T ss_dssp             HHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccc
Confidence            999654   3589999999999999999999999   999999999999998765   8999999999877655555566


Q ss_pred             ccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHH
Q 042123          743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISI  822 (849)
Q Consensus       743 ~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  822 (849)
                      ..+|+.|+|||.+.+..++.++||||+|+++|+|++|+.||........ ..........+..+....+...+......+
T Consensus       169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  247 (325)
T 3kn6_A          169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKIKKGDFSFEGEAWKNVSQEA  247 (325)
T ss_dssp             ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHH
T ss_pred             cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHHHcCCCCCCcccccCCCHHH
Confidence            7789999999999999999999999999999999999999975332110 111122333344444444433333445568


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHhh
Q 042123          823 MEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       823 ~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+++.+||+.||++|||++|++++
T Consensus       248 ~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          248 KDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             HHHHHHHCCCChhHCCCHHHHhcC
Confidence            899999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5.2e-37  Score=331.67  Aligned_cols=250  Identities=16%  Similarity=0.225  Sum_probs=189.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH------HHhhceeecCCeeEEEEEecc
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------EAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ++|+..+.||+|+||.||+|+. .+++.||||.+...........+..+++.+      ..+++++......++||||+ 
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-   87 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-   87 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence            5789999999999999999964 679999999987543333233333344443      24677888888999999999 


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-----EEEeeecCCcccCC
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE-----AHVADFGIAKSLKP  735 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~DfG~a~~~~~  735 (849)
                      +|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.     +||+|||+++.+..
T Consensus        88 ~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           88 GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            999999997542  4699999999999999999999999   9999999999999999887     99999999987644


Q ss_pred             CCCC-------eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          736 DSSN-------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       736 ~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ....       .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......     .......+.....
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-----~~~~~~~i~~~~~  237 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-----LKERYQKIGDTKR  237 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-----HHHHHHHHHHHHH
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc-----HHHHHHHHHhhhc
Confidence            3221       245679999999999999999999999999999999999999997542111     0111111111111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+..........+.+++..||+.||.+||++++|.+.|+
T Consensus       238 ~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          238 ATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             cCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            1111100000115889999999999999999999998764

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.4e-36  Score=318.14  Aligned_cols=240  Identities=27%  Similarity=0.466  Sum_probs=189.5

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||.||+|+..++..||||++.....     ....+.+|+.           ++++++......++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIV   81 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEE
Confidence            367889999999999999999988888999999875422     1234455544           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++....  ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        82 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           82 TEYISNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EEccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            99999999999996543  3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCC
Q 042123          736 DSSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-LPAPS  812 (849)
Q Consensus       736 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  812 (849)
                      .... .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||+.....        .......... ...+.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~  228 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--------EVVLKVSQGHRLYRPH  228 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCCT
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--------HHHHHHHcCCCCCCCC
Confidence            3221 122345678999999998889999999999999999999 99999743321        1111111111 11111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..    ...+.+++.+||+.||++|||++|++++|+
T Consensus       229 ~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (268)
T 3sxs_A          229 LA----SDTIYQIMYSCWHELPEKRPTFQQLLSSIE  260 (268)
T ss_dssp             TS----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred             cC----hHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11    124778999999999999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-36  Score=331.51  Aligned_cols=244  Identities=21%  Similarity=0.323  Sum_probs=191.8

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+.....  .......+.+|+.           ++++++.+.+..+
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            456899999999999999999965 4689999999875422  1222344555544           3677888889999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeecCC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEAHVADFGIA  730 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~a  730 (849)
                      +||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.+   +.+||+|||++
T Consensus       105 lv~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             EEECCCCSCBHHHHHTTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            999999999999998654   3589999999999999999999999   99999999999999865   45999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      ...... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.....        ......+.......
T Consensus       179 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~~~~~~  249 (362)
T 2bdw_A          179 IEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKAGAYDY  249 (362)
T ss_dssp             BCCTTC-CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCC
T ss_pred             eEecCC-cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCC
Confidence            876543 233456899999999999998999999999999999999999999974321        11112222222222


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +...+......+.+++.+||+.||++|||++|++++
T Consensus       250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            222222233458899999999999999999999876

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8.9e-37  Score=333.29  Aligned_cols=235  Identities=23%  Similarity=0.291  Sum_probs=182.4

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH------------HHhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV------------EAFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei------------~~~~~~~~~~~~~~l  654 (849)
                      ++|+..+.||+|+||.||+|+.. +++.||||++.+..... ......+..|.            ..+++++...+..|+
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~-~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILK-KKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh-hHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            67999999999999999999664 68899999987542211 11122333332            236677888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999998653   3589999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.......+...
T Consensus       191 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~~  262 (373)
T 2r5t_A          191 EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKPLQLKPNI  262 (373)
T ss_dssp             CCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHSCCCCCSSS
T ss_pred             cCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcccCCCCCC
Confidence            444445667899999999999999999999999999999999999999974321        122222222222222222


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHH
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMK  841 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~  841 (849)
                      .    ..+.+++.+||+.||++||++.
T Consensus       263 ~----~~~~~li~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          263 T----NSARHLLEGLLQKDRTKRLGAK  285 (373)
T ss_dssp             C----HHHHHHHHHHTCSSGGGSTTTT
T ss_pred             C----HHHHHHHHHHcccCHHhCCCCC
Confidence            2    2377899999999999999974

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1e-36  Score=324.43  Aligned_cols=250  Identities=16%  Similarity=0.231  Sum_probs=188.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH------HHhhceeecCCeeEEEEEecc
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------EAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||||++...........+....+.+      ..+++++......++||||+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-   88 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   88 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence            5799999999999999999964 679999999986543322222222222222      23667788888999999999 


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-----EEEeeecCCcccCC
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE-----AHVADFGIAKSLKP  735 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-----~kl~DfG~a~~~~~  735 (849)
                      +++|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.     +||+|||+++....
T Consensus        89 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~  163 (298)
T 1csn_A           89 GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  163 (298)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             CCCHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence            999999997543  3589999999999999999999998   9999999999999987776     99999999987654


Q ss_pred             CCC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          736 DSS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       736 ~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ...       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........     ......+.....
T Consensus       164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~  238 (298)
T 1csn_A          164 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN-----KQKYERIGEKKQ  238 (298)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH-----HHHHHHHHHHHH
T ss_pred             ccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc-----HHHHHHHHhhcc
Confidence            322       13445789999999999999999999999999999999999999975432111     011111100000


Q ss_pred             CCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+ ..........+.+++.+||+.||++|||+++|++.|+
T Consensus       239 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~  279 (298)
T 1csn_A          239 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  279 (298)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence            000 0000112235889999999999999999999998874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.1e-36  Score=320.07  Aligned_cols=252  Identities=19%  Similarity=0.258  Sum_probs=185.8

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||+||+|+..+|+.||||++.....  .......+.+|+.           ++++++......++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            368999999999999999999888899999999865422  1222344455544           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++ +|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        98 ~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EcCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            999985 8888876543  3589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------------cccccccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------------LNTDVALD  801 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------------~~~~~~~~  801 (849)
                      .........+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||..........             ........
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            5444556678999999999876 568999999999999999999999997533211100             00000000


Q ss_pred             cccCCCCCCCCh-----hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 QMLDPRLPAPSR-----SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+.+........     .......++.+++.+||+.||++|||++|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000000000000     001112357899999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.1e-36  Score=327.64  Aligned_cols=252  Identities=25%  Similarity=0.382  Sum_probs=185.8

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC----e
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR----H  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~----~  651 (849)
                      .++|+..+.||+|+||+||+|+.. ++.||||++...     .........|+.           ++++++....    .
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD   96 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence            368899999999999999999875 899999998643     112223333443           3566665533    4


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCCeeecCCCcEEE
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-------FPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                      .++||||+++|+|.+++...    .+++.++..++.|++.||+|||+..       .++|+||||||+||+++.++.+||
T Consensus        97 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           97 LWLITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             EEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence            69999999999999999643    4899999999999999999999851       237999999999999999999999


Q ss_pred             eeecCCcccCCCCCC--eeeccCCccccccccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc---
Q 042123          725 ADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYT-----MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL---  794 (849)
Q Consensus       725 ~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~---  794 (849)
                      +|||+++........  .....||+.|+|||++.+     ..++.++|||||||++|||++|+.||...........   
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            999999876543321  233578999999999876     3566789999999999999999999975332111000   


Q ss_pred             -----ccccccccccCCCCCCC-Ch--hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 -----NTDVALDQMLDPRLPAP-SR--SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 -----~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                           ...............+. ..  ........+.+++.+||+.||++|||++||++.|+
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  314 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT  314 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                 00111111111111111 11  11234456889999999999999999999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-36  Score=326.96  Aligned_cols=238  Identities=20%  Similarity=0.281  Sum_probs=185.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++...... .......+.+|+.           .+++++......++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            6899999999999999999965 67999999998642111 1111233445543           467888888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+ +|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 67898888643   3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      .. ......||+.|+|||.+.+..+ ++++||||+||++|+|++|+.||+.....        .....+.......+...
T Consensus       161 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------~~~~~i~~~~~~~p~~~  231 (336)
T 3h4j_B          161 GN-FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP--------NLFKKVNSCVYVMPDFL  231 (336)
T ss_dssp             SB-TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST--------TCBCCCCSSCCCCCTTS
T ss_pred             Cc-ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH--------HHHHHHHcCCCCCcccC
Confidence            32 3345679999999999988776 68999999999999999999999743211        11111111111112112


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ...+.+++.+||+.||.+|||++|++++
T Consensus       232 ----s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          232 ----SPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ----CHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ----CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                2247789999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.9e-36  Score=322.15  Aligned_cols=252  Identities=17%  Similarity=0.261  Sum_probs=184.4

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------HhhceeecCCeeEEEEEe
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------AFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e~  658 (849)
                      ..++|+..+.||+|+||.||+|+. .+++.||||.+...........+....+.+.      .+..++......++||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~   86 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   86 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence            457899999999999999999965 6789999998765433332222333333322      133445677888999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeecCCcccCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~  735 (849)
                      + +|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||+++....
T Consensus        87 ~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           87 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             C-CCBHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             c-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            9 999999986432  3589999999999999999999999   99999999999999   7889999999999987654


Q ss_pred             CCC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          736 DSS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       736 ~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ...       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........     ..........
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~~~~~~~  235 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-----KYERISEKKM  235 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-----HHHHHHHHHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-----hhhhhhcccc
Confidence            322       1234578999999999999999999999999999999999999997543221111     1111111010


Q ss_pred             CCCC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+. .........+.+++.+||+.||++|||+++|++.|+
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (296)
T 4hgt_A          236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHH
Confidence            0000 000011235889999999999999999999998874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=323.11  Aligned_cols=240  Identities=20%  Similarity=0.313  Sum_probs=180.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc----------------------hhhHHHHHHHHH----
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ----------------------TVDQKEFLTEVE----  640 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----------------------~~~~~~~~~ei~----  640 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||||++........                      ......+.+|+.    
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            6899999999999999999965 5789999999865321110                      011233455544    


Q ss_pred             -------Hhhceeec--CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 042123          641 -------AFYGFCSH--ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISS  711 (849)
Q Consensus       641 -------~~~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~  711 (849)
                             ++++++..  ....++||||+++|+|.+++..    ..+++.++..++.||+.||+|||+.   +|+||||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp  165 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP  165 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence                   35666655  5688999999999999887643    3589999999999999999999999   999999999


Q ss_pred             CCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCC---CCccchHHHHHHHHHHHHhCCCCCCcccc
Q 042123          712 KNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK---ITEKCDVYSFGVLMWEVIKGKHPRDFLSS  788 (849)
Q Consensus       712 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~Pf~~~~~  788 (849)
                      +||+++.++.+||+|||+++.............||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.....
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            999999999999999999987765444445568999999999987655   37789999999999999999999974321


Q ss_pred             ccccccccccccccccCCC--CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          789 ISSSSLNTDVALDQMLDPR--LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       789 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..        ....+....  .+.....    ...+.+++.+||+.||++|||++|+++|
T Consensus       246 ~~--------~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          246 MC--------LHSKIKSQALEFPDQPDI----AEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HH--------HHHHHHHCCCCCCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HH--------HHHHHhcccCCCCCcccc----CHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            11        111111111  1111111    2247889999999999999999999876

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.6e-37  Score=334.33  Aligned_cols=248  Identities=19%  Similarity=0.293  Sum_probs=191.4

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------HHHhhceeecCCeeEEEEEe
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------VEAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------i~~~~~~~~~~~~~~lV~e~  658 (849)
                      ..++|+..+.||+|+||.||+|.. .+++.||||.+.......  ..+.+.+..      +..+++++.+....|+||||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~--~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP--TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCC--HHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCCh--HHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            346799999999999999999965 468999999997643221  122222222      34578888899999999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC----CcEEEeeecCCcccC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE----YEAHVADFGIAKSLK  734 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~----~~~kl~DfG~a~~~~  734 (849)
                      +++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||++..+    +.+||+|||+++...
T Consensus        98 ~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           98 MKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999998654   3489999999999999999999999   99999999999998543    359999999998776


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||......     ........+..+....+...
T Consensus       172 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~~~~i~~~~~~~~~~~  246 (342)
T 2qr7_A          172 AENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-----TPEEILARIGSGKFSLSGGY  246 (342)
T ss_dssp             CTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS-----CHHHHHHHHHHCCCCCCSTT
T ss_pred             CCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC-----CHHHHHHHHccCCcccCccc
Confidence            5544455678999999999998888999999999999999999999999743211     11122222222222222212


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +......+.+++.+||+.||++|||++++++|
T Consensus       247 ~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          247 WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             TTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            22233457889999999999999999999876

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-36  Score=323.42  Aligned_cols=236  Identities=22%  Similarity=0.243  Sum_probs=181.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~l  654 (849)
                      ++|+..++||+|+||+||+|+.. +++.||||++.....  ..........|+.            .+++++.+.+..++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            57999999999999999999665 799999999765322  1222233333322            36788888999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+ +++|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       135 v~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             EEECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             EEecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            99999 669999886543  4599999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....           ...+.....+  ...
T Consensus       209 ~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----------~~~~~~~~~~--~~~  273 (311)
T 3p1a_A          209 TAG-AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----------WQQLRQGYLP--PEF  273 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----------HHHHTTTCCC--HHH
T ss_pred             cCC-CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----------HHHHhccCCC--ccc
Confidence            432 2344568999999998876 789999999999999999999776542211           1111111111  111


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.+++.+||+.||++|||++|++++
T Consensus       274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          274 TAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            11223458899999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-36  Score=318.32  Aligned_cols=239  Identities=27%  Similarity=0.456  Sum_probs=189.4

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      ++|+..+.||+|+||.||+|...+++.||||++.....     ..+.+.+|+.           ++++++.+....++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            67888999999999999999888899999999875422     1234555544           3677888888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++....  ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCcHHHHHHhcC--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            9999999999996543  3589999999999999999999999   9999999999999999999999999999866432


Q ss_pred             C-CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCh
Q 042123          737 S-SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSR  813 (849)
Q Consensus       737 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  813 (849)
                      . .......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||......        .....+... ....+..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  231 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKPRL  231 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCCTT
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHhcCccCCCCCc
Confidence            1 11223456778999999998999999999999999999999 99999743321        111111111 1111111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .    ...+.+++.+||+.||++|||+++++++|+
T Consensus       232 ~----~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  262 (269)
T 4hcu_A          232 A----STHVYQIMNHCWRERPEDRPAFSRLLRQLA  262 (269)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----CHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            1    234788999999999999999999999885

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-36  Score=332.52  Aligned_cols=241  Identities=23%  Similarity=0.454  Sum_probs=178.4

Q ss_pred             cCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ++|+..+.||+|+||.||+|+..    ++..||||++....   .....+.+.+|+.           ++++++......
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY---TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            57889999999999999999764    57789999986532   2233456777755           367888888899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            99999999999999997543  3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042123          733 LKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-R  807 (849)
Q Consensus       733 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~  807 (849)
                      .......   .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......        .....+... +
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~--------~~~~~i~~~~~  268 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--------DVIKAVDEGYR  268 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH--------HHHHHHHTTEE
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            6543221   112234678999999999999999999999999999998 99999743321        111111111 1


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+.+...    ...+.+++.+||+.||++|||+++|++.|+
T Consensus       269 ~~~~~~~----~~~l~~li~~cl~~dp~~RPs~~~i~~~L~  305 (373)
T 2qol_A          269 LPPPMDC----PAALYQLMLDCWQKDRNNRPKFEQIVSILD  305 (373)
T ss_dssp             CCCCTTC----BHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCccc----cHHHHHHHHHHhCcChhhCcCHHHHHHHHH
Confidence            1111122    234788999999999999999999998874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.5e-37  Score=335.78  Aligned_cols=242  Identities=24%  Similarity=0.446  Sum_probs=187.7

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|...+.||+|+||.||+|++. +++.||||.+.....   ......+.+|+.           ++++++...+..++
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  189 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP---PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI  189 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC---HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC---HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence            467888999999999999999775 789999999865321   122233444443           47788888889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       190 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          190 VMELVQGGDFLTFLRTEG--ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             EEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999999996533  3589999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCC
Q 042123          735 PDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-PRLPA  810 (849)
Q Consensus       735 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~  810 (849)
                      .....  .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.......        ....+.. .+.+.
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~~  336 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--------TREFVEKGGRLPC  336 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--------HHHHHHTTCCCCC
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCCC
Confidence            32111  111234678999999998899999999999999999998 999987543211        1111111 12222


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +...+    ..+.+++.+||+.||++|||+++|++.|+
T Consensus       337 ~~~~~----~~l~~li~~cl~~dP~~Rps~~~i~~~L~  370 (377)
T 3cbl_A          337 PELCP----DAVFRLMEQCWAYEPGQRPSFSTIYQELQ  370 (377)
T ss_dssp             CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCC----HHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            22222    24778999999999999999999999874

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=330.67  Aligned_cols=240  Identities=22%  Similarity=0.292  Sum_probs=176.3

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----------HHHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----------i~~~~~~~~~~~~~~l  654 (849)
                      .+.|+..+.||+|+||.||+|+.. +++.||||++.....      .+.+.+|           +.++++++......++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD------KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh------HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            467899999999999999999665 688999999875421      1223333           3347788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL---EYEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG~a~  731 (849)
                      ||||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++
T Consensus       126 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             EECCCCSCBHHHHHTTC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            99999999999998654   3489999999999999999999999   9999999999999975   7899999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......       ......+........
T Consensus       200 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~~~~  271 (349)
T 2w4o_A          200 IVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEYYFI  271 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCCCCC
T ss_pred             ccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCCccC
Confidence            66433 2234567899999999999999999999999999999999999999643211       111222222222111


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........+.+++.+||+.||++|||++|++++
T Consensus       272 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          272 SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11112223457899999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3e-36  Score=322.56  Aligned_cols=237  Identities=23%  Similarity=0.345  Sum_probs=187.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+. .+|+.||+|.+...... .......+.+|+           .++++++.+....++|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            6789999999999999999965 47999999998653110 011122333333           2467788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            9999999999999653   3589999999999999999999999   999999999999999999999999999987543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+....
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~~~~p~~~~  227 (318)
T 1fot_A          159 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAELRFPPFFN  227 (318)
T ss_dssp             C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCCCCCTTSC
T ss_pred             c---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCCCC
Confidence            2   2346799999999999999999999999999999999999999974321        1122222222222222222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                          ..+.+++.+|++.||++||     +++|+++|
T Consensus       228 ----~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          228 ----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----HHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                2477899999999999999     89999875

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=2.4e-35  Score=326.48  Aligned_cols=311  Identities=21%  Similarity=0.193  Sum_probs=202.1

Q ss_pred             CCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCC
Q 042123           28 SFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNL  107 (849)
Q Consensus        28 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  107 (849)
                      .++++++|++++|.+..+++..|..+++|++|+|++|++++      .....|+.+++|++|+|++|.+++..|..|+++
T Consensus        43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  116 (390)
T 3o6n_A           43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEE------IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV  116 (390)
T ss_dssp             GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCE------ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred             ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccc------cChhhccCCCCcCEEECCCCCCCcCCHHHhcCC
Confidence            35788888898888888877778888888888888888763      122344555555555555555555555555555


Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      ++|++|+|++|+++++.+..|.++++|++|++++|.+++..+..|.++++|++|++++|+++++   .+..+++|++|++
T Consensus       117 ~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l  193 (390)
T 3o6n_A          117 PLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANV  193 (390)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEEC
T ss_pred             CCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeec
Confidence            5555555555555544444455555555555555555544444455555555555555555443   1333444455555


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                      ++|.+.+     +...++|++|++++|.+... |..                                            
T Consensus       194 ~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~--------------------------------------------  223 (390)
T 3o6n_A          194 SYNLLST-----LAIPIAVEELDASHNSINVV-RGP--------------------------------------------  223 (390)
T ss_dssp             CSSCCSE-----EECCSSCSEEECCSSCCCEE-ECC--------------------------------------------
T ss_pred             ccccccc-----cCCCCcceEEECCCCeeeec-ccc--------------------------------------------
Confidence            5544431     12223444444444444322 110                                            


Q ss_pred             CcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCC
Q 042123          268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFP  347 (849)
Q Consensus       268 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  347 (849)
                           ..++|+.|++++|.+++.  ..+..+++|++|++++|.+++..+..+..+++|+.|+|++|++.+ ++..+..++
T Consensus       224 -----~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~  295 (390)
T 3o6n_A          224 -----VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIP  295 (390)
T ss_dssp             -----CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCT
T ss_pred             -----ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCC
Confidence                 013455555555555532  356677888888888888888778888888888888888888874 455667788


Q ss_pred             CCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccc
Q 042123          348 KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG  409 (849)
Q Consensus       348 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  409 (849)
                      +|++|++++|.++ .+|..+..+++|+.|+|++|+++.. +  +..+++|+.|++++|++..
T Consensus       296 ~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~  353 (390)
T 3o6n_A          296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC  353 (390)
T ss_dssp             TCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred             CCCEEECCCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccc
Confidence            8999999999888 5677788888999999999998754 3  7788899999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.2e-37  Score=320.06  Aligned_cols=243  Identities=28%  Similarity=0.470  Sum_probs=176.8

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||.||+|.+. ++.||||.+............+.+.+|+.           .+++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367889999999999999999875 89999999865433222222344555544           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--------CCcEEEeee
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL--------EYEAHVADF  727 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--------~~~~kl~Df  727 (849)
                      |||+++++|.+++..    ..+++.++..++.|++.|++|||+...++|+||||||+||+++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999999853    35899999999999999999999982222999999999999986        678999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      |++.......  .....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||.......        .........
T Consensus       161 g~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~  230 (271)
T 3dtc_A          161 GLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA--------VAYGVAMNK  230 (271)
T ss_dssp             CC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH--------HHHHHHTSC
T ss_pred             Cccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHhhhcCC
Confidence            9998665432  234578999999999999899999999999999999999999997433211        111111111


Q ss_pred             --CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 --LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 --~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        .+.+...    ...+.+++.+||+.||++|||+.|++++|+
T Consensus       231 ~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~L~  269 (271)
T 3dtc_A          231 LALPIPSTC----PEPFAKLMEDCWNPDPHSRPSFTNILDQLT  269 (271)
T ss_dssp             CCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCccc----CHHHHHHHHHHhcCCcccCcCHHHHHHHHh
Confidence              1111111    234788999999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-36  Score=329.95  Aligned_cols=241  Identities=19%  Similarity=0.288  Sum_probs=189.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|+..+.||+|+||.||+|.. .+|+.||+|.+....    ......+.+|+.           .+++++......++|
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc----hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            6799999999999999999965 478999999986532    222345556654           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCcEEEeeecCCccc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL--EYEAHVADFGIAKSL  733 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfG~a~~~  733 (849)
                      |||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.  ++.+||+|||+++..
T Consensus       127 ~E~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          127 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceec
Confidence            99999999999986543  3589999999999999999999999   9999999999999974  478999999999877


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ....+.......+..
T Consensus       202 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~i~~~~~~~~~~  272 (387)
T 1kob_A          202 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDWEFDED  272 (387)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCCCCCSS
T ss_pred             CCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCCCcc
Confidence            543 33455689999999999999999999999999999999999999997433211        111111111111111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........+.+++.+||+.||++|||++|++++
T Consensus       273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            111223347899999999999999999999986

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.6e-36  Score=326.68  Aligned_cols=241  Identities=19%  Similarity=0.357  Sum_probs=186.7

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++....   .....+.+.+|+..           +++++.+.     
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            467899999999999999999765 79999999986532   22334566677653           44444322     


Q ss_pred             ----------------------------------------------------CeeEEEEEeccCCChhhhhcccccccCC
Q 042123          650 ----------------------------------------------------RHSFLLYEFLERGSLAAILNTDAAAQEL  677 (849)
Q Consensus       650 ----------------------------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l  677 (849)
                                                                          ...++||||+++|+|.+++.........
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                2379999999999999999876655567


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC------------CeeeccC
Q 042123          678 GWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS------------NWTEFAG  745 (849)
Q Consensus       678 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~------------~~~~~~g  745 (849)
                      ++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......            ......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            8888999999999999999999   999999999999999999999999999987754421            1233568


Q ss_pred             CccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHH
Q 042123          746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEV  825 (849)
Q Consensus       746 ~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  825 (849)
                      |+.|+|||.+.+..++.++||||+|+++|||++|..|+....          ...........   +.........+.++
T Consensus       239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~----------~~~~~~~~~~~---~~~~~~~~~~~~~l  305 (332)
T 3qd2_B          239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV----------RIITDVRNLKF---PLLFTQKYPQEHMM  305 (332)
T ss_dssp             CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH----------HHHHHHHTTCC---CHHHHHHCHHHHHH
T ss_pred             CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH----------HHHHHhhccCC---CcccccCChhHHHH
Confidence            999999999999999999999999999999999988753211          11111122222   22233444567899


Q ss_pred             HhhccCCCCCCCCCHHHHHhh
Q 042123          826 AFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       826 i~~cl~~dP~~RPt~~eil~~  846 (849)
                      +.+||+.||++|||++|++++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHccCCCCcCCCHHHHhhc
Confidence            999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.9e-36  Score=326.99  Aligned_cols=237  Identities=19%  Similarity=0.264  Sum_probs=188.3

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++...... .......+.+|+.           .+++++.+....|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            57889999999999999999654 7999999998643110 1112334445543           356777888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999999653   3589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+....
T Consensus       194 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~~  262 (350)
T 1rdq_E          194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRFPSHFS  262 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTTCC
T ss_pred             C---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCCCCCC
Confidence            2   2346799999999999999999999999999999999999999974321        1222223333332222222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                          ..+.+++.+||+.||++||+     ++||++|
T Consensus       263 ----~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          263 ----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----HHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                34788999999999999998     8998875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.7e-36  Score=319.90  Aligned_cols=251  Identities=17%  Similarity=0.262  Sum_probs=186.4

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------HhhceeecCCeeEEEEEec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------AFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e~~  659 (849)
                      .++|+..+.||+|+||.||+|+. .+++.||||++...........+....+.+.      .+..+.......++||||+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~   87 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL   87 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence            36899999999999999999965 6799999999865433222222222333222      1333445677889999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEeeecCCcccCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---LEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG~a~~~~~~  736 (849)
                       +++|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++   .++.+||+|||+++.....
T Consensus        88 -~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           88 -GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             -CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             -CCCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence             899999996433  3589999999999999999999999   999999999999994   7899999999999876543


Q ss_pred             CC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          737 SS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       737 ~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ..       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........     .....+......
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~~~~~~~~  236 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-----QKYERISEKKMS  236 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-----SHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-----hhhhhhcccccC
Confidence            22       124457899999999999999999999999999999999999999754321111     011111110000


Q ss_pred             CC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          810 AP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       810 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+ ..........+.+++.+||+.||++|||+++|++.|+
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  276 (296)
T 3uzp_A          237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  276 (296)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHH
T ss_pred             CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHH
Confidence            00 0000111234888999999999999999999998874

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.3e-36  Score=323.69  Aligned_cols=243  Identities=24%  Similarity=0.348  Sum_probs=185.8

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~l  654 (849)
                      .++|++.+.||+|+||+||+|... +++.||||++.......   ..+.+.+|+           ..+++++...+..++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD---CPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc---hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            368999999999999999999654 79999999986432211   112233332           347888888999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  156 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFR  156 (323)
T ss_dssp             EEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceec
Confidence            999999999999986543   489999999999999999999998   99999999999999999999999999998654


Q ss_pred             CCC--CCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          735 PDS--SNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       735 ~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ...  .......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.......       ..............
T Consensus       157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~~~~~~~~~~~  229 (323)
T 3tki_A          157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKTYLN  229 (323)
T ss_dssp             ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-------HHHHHHHTTCTTST
T ss_pred             cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHHhcccccCC
Confidence            221  22345679999999999987776 778999999999999999999997433211       11111111111111


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                        ........+.+++.+||+.||++|||++|++++-
T Consensus       230 --~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          230 --PWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             --TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             --ccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence              1112233477899999999999999999998863

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.2e-36  Score=334.56  Aligned_cols=247  Identities=21%  Similarity=0.286  Sum_probs=176.3

Q ss_pred             cCCCcC-ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHH------HHHHhhceeec----CCeeEEE
Q 042123          588 NDFDAK-YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLT------EVEAFYGFCSH----ARHSFLL  655 (849)
Q Consensus       588 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~------ei~~~~~~~~~----~~~~~lV  655 (849)
                      ++|... +.||+|+||+||+|.. .+++.||||++....   ....+...+.      .+..+++++..    ....|+|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~---~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv  137 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV  137 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch---hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEE
Confidence            566665 6899999999999965 478999999986421   1111111111      12335555543    5678999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeecCCcc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL---EYEAHVADFGIAKS  732 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG~a~~  732 (849)
                      |||+++|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.   ++.+||+|||+++.
T Consensus       138 ~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          138 MECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            99999999999997543 24589999999999999999999998   9999999999999998   78999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..........    .....+.......+.
T Consensus       214 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          214 TTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRMGQYEFPN  288 (400)
T ss_dssp             CC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC----SHHHHHHHTCCCCCT
T ss_pred             cCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH----HHHHHHHcCcccCCC
Confidence            6533 23345678999999999999999999999999999999999999997543221110    011111111111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+......+.+++.+||+.||++|||++|+++|
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111223357899999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.4e-36  Score=317.84  Aligned_cols=241  Identities=24%  Similarity=0.440  Sum_probs=187.1

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||.||+|++.++..||||++.....     ....+.+|+.           .+++++......++|
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            468889999999999999999988888999999875422     1234555544           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           98 TEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             ECCCTTCBHHHHHHCGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999997643  3589999999999999999999999   999999999999999999999999999986643


Q ss_pred             CC-CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          736 DS-SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       736 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      .. .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......        .....+........+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~  244 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRPH  244 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTTCCCCCCT
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcccCCCCCC
Confidence            21 11223346778999999998899999999999999999998 99999743321        1111111111111111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..   ...+.+++.+||+.||++|||+++++++|+
T Consensus       245 ~~---~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  276 (283)
T 3gen_A          245 LA---SEKVYTIMYSCWHEKADERPTFKILLSNIL  276 (283)
T ss_dssp             TC---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cC---CHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            11   124778999999999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.9e-36  Score=340.94  Aligned_cols=241  Identities=22%  Similarity=0.300  Sum_probs=184.8

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++...... .......+.+|+           ..+++++...+..++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV-AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhh-hhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            36799999999999999999964 57999999998643111 111122334443           346788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      ||||+++|+|.+++...   ..+++.++..++.||+.||+|||+ .   +|+||||||+|||++.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999998653   358999999999999999999998 7   8999999999999999999999999999875


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+..
T Consensus       300 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--------~~~~~i~~~~~~~p~~  371 (446)
T 4ejn_A          300 IKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--------KLFELILMEEIRFPRT  371 (446)
T ss_dssp             CC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTT
T ss_pred             cCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHHhCCCCCCcc
Confidence            55444556678999999999999999999999999999999999999999743221        1112222222222222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      ..    ..+.+++.+||+.||++||     |++|+++|
T Consensus       372 ~~----~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          372 LG----PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             SC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CC----HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            22    3478899999999999999     99999876

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.9e-37  Score=338.87  Aligned_cols=247  Identities=19%  Similarity=0.317  Sum_probs=189.5

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCC-----CCchhhHHHHHHH-----HHHhhceeecC
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLP-----CDQTVDQKEFLTE-----VEAFYGFCSHA  649 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~~e-----i~~~~~~~~~~  649 (849)
                      .++....++|+..+.||+|+||+||+|+.. +++.||+|++.+...     ......+...++.     +.++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344455689999999999999999999664 689999999864210     0111112222222     33578888899


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...|+||||+++|+|.+++...    .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccce
Confidence            9999999999999999998642    489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCC-CeeeccCCccccccccccCCC----CCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042123          730 AKSLKPDSS-NWTEFAGTCGYIAPELAYTMK----ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML  804 (849)
Q Consensus       730 a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  804 (849)
                      ++....... .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||......        .....+.
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--------~~~~~i~  286 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--------GTYSKIM  286 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHH
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--------hHHHHHH
Confidence            987654322 233568999999999997665    789999999999999999999999743221        1111121


Q ss_pred             C----CCCCCCChhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHhh
Q 042123          805 D----PRLPAPSRSAQEKLISIMEVAFSCFNESPES--RPTMKIISQQ  846 (849)
Q Consensus       805 ~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~  846 (849)
                      .    ...+......    ..+.+++.+|++.+|.+  ||+++||++|
T Consensus       287 ~~~~~~~~p~~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          287 NHKNSLTFPDDNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             THHHHCCCCTTCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             hccccccCCCccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            1    1222211112    24778899999999988  9999999987

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.3e-36  Score=332.90  Aligned_cols=252  Identities=22%  Similarity=0.399  Sum_probs=190.8

Q ss_pred             HHHHHHHhcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------H
Q 042123          580 YDEIVKATNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------A  641 (849)
Q Consensus       580 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~  641 (849)
                      ..++....++|+..+.||+|+||.||+|++      .+++.||||++....   .....+.+.+|+.            .
T Consensus        14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC---CHHHHHHHHHHHHHHHhhcCCcceee
Confidence            345555668999999999999999999963      356889999987542   2223345555544            2


Q ss_pred             hhceeecC-CeeEEEEEeccCCChhhhhccccc-----------------------------------------------
Q 042123          642 FYGFCSHA-RHSFLLYEFLERGSLAAILNTDAA-----------------------------------------------  673 (849)
Q Consensus       642 ~~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-----------------------------------------------  673 (849)
                      +++++... ...++||||+++|+|.+++.....                                               
T Consensus        91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (359)
T 3vhe_A           91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE  170 (359)
T ss_dssp             EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred             eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence            55666554 458999999999999999975432                                               


Q ss_pred             ----------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCC
Q 042123          674 ----------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       674 ----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  737 (849)
                                      ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                            11289999999999999999999999   99999999999999999999999999998764433


Q ss_pred             C--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCCh
Q 042123          738 S--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSR  813 (849)
Q Consensus       738 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  813 (849)
                      .  ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......       .....+... ....+..
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~  320 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------EFCRRLKEGTRMRAPDY  320 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-------HHHHHHHHTCCCCCCTT
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-------HHHHHHHcCCCCCCCCC
Confidence            2  2334567889999999999999999999999999999998 999997432111       111111111 1111111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .    ...+.+++.+||+.||++|||++|++++|+
T Consensus       321 ~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~  351 (359)
T 3vhe_A          321 T----TPEMYQTMLDCWHGEPSQRPTFSELVEHLG  351 (359)
T ss_dssp             C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----CHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            1    224788999999999999999999999985

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.4e-36  Score=326.95  Aligned_cols=242  Identities=22%  Similarity=0.348  Sum_probs=186.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||.||+|+. .+++.||+|.+..... ......+.+.+|+.           .+++++......++|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKC-VERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhc-ccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            6789999999999999999965 4688999999864311 11112344555544           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN---VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            9999999999999653   3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT---MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      . .......||+.|+|||++.+   ..++.++||||+||++|||++|+.||.......     .......+.......+.
T Consensus       168 ~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~p~  241 (384)
T 4fr4_A          168 E-TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-----SKEIVHTFETTVVTYPS  241 (384)
T ss_dssp             T-CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-----HHHHHHHHHHCCCCCCT
T ss_pred             C-CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-----HHHHHHHHhhcccCCCC
Confidence            3 33456789999999999863   458999999999999999999999997432211     11111111112222222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCC-HHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPT-MKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~~  846 (849)
                      ..    ...+.+++.+||+.||++||+ ++++.++
T Consensus       242 ~~----s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          242 AW----SQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             TS----CHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             cC----CHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            22    234788999999999999998 7777654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.1e-36  Score=315.05  Aligned_cols=242  Identities=24%  Similarity=0.417  Sum_probs=167.6

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|+. .+++.||||.+...... .......+.+|+.           ++++++.+.+..++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            36789999999999999999965 57999999998643110 1111234555544           36778888889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++++|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+....
T Consensus        89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999999987542  4589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........|++.|+|||.+.+..++.++||||+|+++|||++|+.||.......        ............+...
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~~~~~  235 (278)
T 3cok_A          164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--------TLNKVVLADYEMPSFL  235 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSCCCCCTTS
T ss_pred             CCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--------HHHHHhhcccCCcccc
Confidence            44333445678999999999998889999999999999999999999997433211        1111111111111111


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ...+.+++.+||+.||++|||+++++++
T Consensus       236 ----~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          236 ----SIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ----CHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----CHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                2347789999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.9e-36  Score=315.79  Aligned_cols=251  Identities=17%  Similarity=0.232  Sum_probs=184.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|+. .+++.||||++.....  .......+.+|+.           ++++++..+...++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            5788999999999999999965 4689999999875432  2222345556654           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++ ++.+.+....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EECCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            999986 5555554322  4589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCeeeccCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccc-----------cccccccccccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-----------SSLNTDVALDQM  803 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-----------~~~~~~~~~~~~  803 (849)
                      .........+|+.|+|||.+.+.. ++.++||||+||++|||++|..||........           ............
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            544455668899999999988766 79999999999999999999888642221100           000000000000


Q ss_pred             cCC-------CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDP-------RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+.       ...............+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000       0000000111122347789999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-35  Score=322.73  Aligned_cols=258  Identities=25%  Similarity=0.374  Sum_probs=184.1

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHH-------HHHHhhceeecC----
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLT-------EVEAFYGFCSHA----  649 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-------ei~~~~~~~~~~----  649 (849)
                      .......++|+..+.||+|+||.||+|+.. ++.||||++..... .....+.+...       .+..+++++...    
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~-~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc-chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            333445678999999999999999999885 89999999854311 00000111110       122355666555    


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCCcEEE
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-----FPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                      ...++||||+++|+|.+++...    .+++.++..++.|++.||+|||+..     .++|+||||||+||+++.++.+||
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             CceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            6789999999999999999543    4899999999999999999999752     238999999999999999999999


Q ss_pred             eeecCCcccCCCCCC----eeeccCCccccccccccCCCCCcc------chHHHHHHHHHHHHhC----------CCCCC
Q 042123          725 ADFGIAKSLKPDSSN----WTEFAGTCGYIAPELAYTMKITEK------CDVYSFGVLMWEVIKG----------KHPRD  784 (849)
Q Consensus       725 ~DfG~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~------~Dv~SlGvil~el~tg----------~~Pf~  784 (849)
                      +|||+++.+......    .....||+.|+|||++.+..++.+      +|||||||++|||++|          +.||.
T Consensus       184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~  263 (337)
T 3mdy_A          184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH  263 (337)
T ss_dssp             CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence            999999876543322    124578999999999987766654      9999999999999999          44544


Q ss_pred             ccccccccccccccccccc----cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          785 FLSSISSSSLNTDVALDQM----LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .......   .........    ..+..+. ..........+.+++.+||+.||++|||+.||+++|+
T Consensus       264 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  327 (337)
T 3mdy_A          264 DLVPSDP---SYEDMREIVCIKKLRPSFPN-RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA  327 (337)
T ss_dssp             TTSCSSC---CHHHHHHHHTTSCCCCCCCG-GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             hhcCCCC---chhhhHHHHhhhccCccccc-cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHH
Confidence            2211110   000011111    1111111 1112355667899999999999999999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.6e-36  Score=352.46  Aligned_cols=242  Identities=22%  Similarity=0.332  Sum_probs=191.6

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHS  652 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~  652 (849)
                      ..++|+..+.||+|+||.||+|+. .+++.||||++...... .......+..|..            .+++++...+..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            457899999999999999999965 46889999998653110 0111222333322            356677778899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      |+||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.
T Consensus       418 ~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999999754   3599999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ............||+.|+|||++.+..|+.++|||||||++|||++|+.||...+        .......+.......+.
T Consensus       492 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~~p~  563 (674)
T 3pfq_A          492 NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHNVAYPK  563 (674)
T ss_dssp             CCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSSCCCCCT
T ss_pred             cccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCCCCCCc
Confidence            5544455566789999999999999999999999999999999999999997432        12233334444433332


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTM-----KIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~~  846 (849)
                      ...    ..+.+++.+||++||++||++     +||++|
T Consensus       564 ~~s----~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          564 SMS----KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             TSC----HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             cCC----HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            222    347889999999999999998     788765

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.7e-36  Score=327.94  Aligned_cols=237  Identities=19%  Similarity=0.258  Sum_probs=182.1

Q ss_pred             cCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEec
Q 042123          592 AKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~  659 (849)
                      ..+.||+|+||.||+|.. .+|+.||||++....    ......+.+|+.           ++++++...+..++||||+
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG----MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            356899999999999965 579999999987532    233455666655           3677888889999999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee--cCCCcEEEeeecCCcccCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL--DLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill--~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      ++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||++  +.++.+||+|||+++......
T Consensus       169 ~~~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          169 DGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             TTCEEHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             CCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            9999999886433  3589999999999999999999999   99999999999999  567899999999998775432


Q ss_pred             CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHH
Q 042123          738 SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE  817 (849)
Q Consensus       738 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  817 (849)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......        .....+.......+......
T Consensus       244 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--------~~~~~i~~~~~~~~~~~~~~  314 (373)
T 2x4f_A          244 -KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--------ETLNNILACRWDLEDEEFQD  314 (373)
T ss_dssp             -BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCSCSGGGTT
T ss_pred             -ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhccCCCChhhhcc
Confidence             234457999999999999889999999999999999999999999743321        12222222222222222222


Q ss_pred             HHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          818 KLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       818 ~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....+.+++.+||+.||++|||++|++++
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            33458899999999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-36  Score=328.78  Aligned_cols=244  Identities=24%  Similarity=0.410  Sum_probs=189.3

Q ss_pred             hcCCCcCceecCCccceEEEEEec--------CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhcee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP--------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFC  646 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~  646 (849)
                      .++|.+.+.||+|+||+||+|+..        .+..||||++....   .......+.+|+.            ++++++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc---CHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            367888999999999999999642        34579999987542   2222344555543            367788


Q ss_pred             ecCCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                      ...+..++||||+++|+|.+++.....             ...+++.++..++.||+.||+|||+.   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            888899999999999999999975431             23589999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 042123          714 LLLDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSIS  790 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~  790 (849)
                      |+++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999987654322  2233456789999999999999999999999999999999 99998743211 


Q ss_pred             ccccccccccccccCCCCC-CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPRLP-APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                             .....+...... .+...    ...+.+++.+||+.||++|||++||+++|+
T Consensus       301 -------~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~  348 (382)
T 3tt0_A          301 -------ELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLD  348 (382)
T ss_dssp             -------HHHHHHHTTCCCCCCSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHHHHHHcCCCCCCCccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence                   111111111111 11111    234788999999999999999999999875

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8e-36  Score=321.00  Aligned_cols=245  Identities=19%  Similarity=0.262  Sum_probs=191.6

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCc--hhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQ--TVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      .+.|+..+.||+|+||.||+|+.. +|+.||||.+........  ......+.+|+.           .+++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            367899999999999999999654 689999999875432221  112445555544           367788888899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeec
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY----EAHVADFG  728 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG  728 (849)
                      ++||||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK---ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999999653   3589999999999999999999999   999999999999999887    79999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......        .....+.....
T Consensus       165 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~  235 (321)
T 2a2a_A          165 LAHEIEDGV-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ--------ETLANITSVSY  235 (321)
T ss_dssp             TCEECCTTC-CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHTTCC
T ss_pred             cceecCccc-cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhccc
Confidence            998765432 234567899999999999999999999999999999999999999643211        11122222222


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+..........+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            21111111223457899999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-36  Score=329.84  Aligned_cols=244  Identities=25%  Similarity=0.418  Sum_probs=187.8

Q ss_pred             cCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      ++|+..+.||+|+||+||+|++.      +++.||||++....   .......+.+|+.           .+++++....
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc---ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            67888999999999999999742      46789999986432   2233344555544           3677888888


Q ss_pred             eeEEEEEeccCCChhhhhcccc----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEE
Q 042123          651 HSFLLYEFLERGSLAAILNTDA----AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---EAH  723 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~k  723 (849)
                      ..++||||+++|+|.+++....    ....+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++   .+|
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEE
Confidence            8999999999999999997543    123589999999999999999999999   999999999999999655   599


Q ss_pred             EeeecCCcccCCC--CCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccccc
Q 042123          724 VADFGIAKSLKPD--SSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVAL  800 (849)
Q Consensus       724 l~DfG~a~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~  800 (849)
                      |+|||+++.....  ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....        ....
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~  296 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVL  296 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence            9999999754221  122334567899999999999999999999999999999998 9999974322        1112


Q ss_pred             ccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+...........   ....+.+++.+||+.||++|||+++|+++|+
T Consensus       297 ~~i~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps~~eil~~l~  341 (367)
T 3l9p_A          297 EFVTSGGRMDPPKN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIE  341 (367)
T ss_dssp             HHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCCCCCCcc---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            22222221111111   1224778999999999999999999999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4e-36  Score=318.06  Aligned_cols=251  Identities=22%  Similarity=0.297  Sum_probs=183.1

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      ++|+..+.||+|+||+||+|+..+++.||||++.....  .......+.+|+.           ++++++...+..++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            57889999999999999999888899999999865422  1112234555544           3677888888999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++ +|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             ECCSE-EHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EecCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            99986 8998886543  3589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc------------cccccccccc
Q 042123          737 SSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS------------LNTDVALDQM  803 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~------------~~~~~~~~~~  803 (849)
                      ........+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||..........            ..........
T Consensus       154 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            344455678999999999876 458999999999999999999999997533211000            0000000000


Q ss_pred             cCCCCCC----CC-hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDPRLPA----PS-RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~~~~~----~~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .++....    +. .........+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            1111100    00 0001122347789999999999999999999986

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-36  Score=325.00  Aligned_cols=255  Identities=19%  Similarity=0.291  Sum_probs=190.6

Q ss_pred             cccHHHHHHHhcCCCcC-ceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hh
Q 042123          577 KILYDEIVKATNDFDAK-YCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AF  642 (849)
Q Consensus       577 ~~~~~~~~~~~~~f~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~  642 (849)
                      .+.+.......+.|... +.||+|+||.||+|... +++.||||++.......  .....+.+|+.            .+
T Consensus        17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~iv~~   94 (327)
T 3lm5_A           17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ--DCRAEILHEIAVLELAKSCPRVINL   94 (327)
T ss_dssp             CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE--ECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch--HHHHHHHHHHHHHHhccCCCCEEEE
Confidence            44445555666788877 88999999999999654 69999999987543221  22334444433            36


Q ss_pred             hceeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---C
Q 042123          643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL---E  719 (849)
Q Consensus       643 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~  719 (849)
                      ++++......++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.   +
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~  170 (327)
T 3lm5_A           95 HEVYENTSEIILILEYAAGGEIFSLCLPEL-AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPL  170 (327)
T ss_dssp             EEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTB
T ss_pred             EEEEEeCCeEEEEEEecCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCC
Confidence            777888889999999999999999986542 34589999999999999999999999   9999999999999988   7


Q ss_pred             CcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      +.+||+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.......        .
T Consensus       171 ~~~kL~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~  241 (327)
T 3lm5_A          171 GDIKIVDFGMSRKIGHAC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--------T  241 (327)
T ss_dssp             CCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------H
T ss_pred             CcEEEeeCccccccCCcc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------H
Confidence            899999999998765432 2344679999999999999999999999999999999999999997433211        1


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+.......+..........+.+++.+||+.||++|||+++++++
T Consensus       242 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          242 YLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            11111111111111111223347789999999999999999999886

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.3e-35  Score=318.46  Aligned_cols=253  Identities=19%  Similarity=0.293  Sum_probs=173.7

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++.......   ....+.+|+.           ++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG---TPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTC---SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccc---cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            46899999999999999999965 468999999986542211   1233444543           46788888889999


Q ss_pred             EEEeccCCChhhhhcccc---cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDA---AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      ||||++ |+|.+++....   ....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  156 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR  156 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence            999998 59999886432   123589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----------ccccccc
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS----------LNTDVAL  800 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~----------~~~~~~~  800 (849)
                      .............+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..........          .......
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             ETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             ecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            77544444455678999999999876 468999999999999999999999997533211000          0000000


Q ss_pred             cc--ccCCCCCCC-Chhh---------HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 DQ--MLDPRLPAP-SRSA---------QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 ~~--~~~~~~~~~-~~~~---------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..  ...+.+... ....         ......+.+++.+||+.||++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            00  000000000 0000         0112358899999999999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.2e-35  Score=333.56  Aligned_cols=239  Identities=21%  Similarity=0.330  Sum_probs=190.3

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||.||+|+.. +|+.||||++...... .......+.+|+.           ++++++......++|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            67889999999999999999664 7999999998643110 1112334555554           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYICKN---GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTTSS---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            9999999999999653   3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      . .......||+.|+|||.+.+..+ +.++||||+||++|||++|+.||+....        ......+.+.....+...
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~  239 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICDGIFYTPQYL  239 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHTTCCCCCTTC
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhcCCcCCCccC
Confidence            3 33455689999999999988766 6899999999999999999999974321        112222333333222222


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .    ..+.+++.+||+.||++|||++|+++|
T Consensus       240 s----~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          240 N----PSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             C----HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             C----HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            2    247889999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.2e-36  Score=333.98  Aligned_cols=255  Identities=19%  Similarity=0.285  Sum_probs=190.4

Q ss_pred             HHHHHHHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCC-----CCchhhHHHHHHH-----HHHhhceeec
Q 042123          580 YDEIVKATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLP-----CDQTVDQKEFLTE-----VEAFYGFCSH  648 (849)
Q Consensus       580 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~~~~e-----i~~~~~~~~~  648 (849)
                      +.++....++|+..++||+|+||+||+|+.. +++.||||++.+...     ......+...+..     +..+++++.+
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3445556789999999999999999999765 588999999864210     0011112222221     3347788889


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      .+..|+||||+++|+|.+++.+..  ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFG  220 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE--DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG  220 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchh
Confidence            999999999999999999997532  3589999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCC-eeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042123          729 IAKSLKPDSSN-WTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       729 ~a~~~~~~~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      +|+........ ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||........    .......
T Consensus       221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~----~~~i~~~  296 (437)
T 4aw2_A          221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET----YGKIMNH  296 (437)
T ss_dssp             TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----HHHHHTH
T ss_pred             hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH----HHhhhhc
Confidence            99876544332 23467999999999987     56789999999999999999999999974332110    0011110


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCC--CCCHHHHHhh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPES--RPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~  846 (849)
                      ......+....   .....+.+++.+|+..+|++  ||+++|+++|
T Consensus       297 ~~~~~~p~~~~---~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          297 KERFQFPTQVT---DVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             HHHCCCCSSCC---CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cccccCCcccc---cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            00111121100   11224778899999888888  9999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=4.5e-36  Score=338.26  Aligned_cols=241  Identities=23%  Similarity=0.427  Sum_probs=189.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFL  654 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~l  654 (849)
                      ..++|+..+.||+|+||.||+|.+.++..||||++....     ...+.+.+|+..           +++++. ....++
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l  259 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI  259 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence            446788899999999999999998888999999987532     224566777553           556665 567899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       260 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             EECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             EEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            999999999999997543 23589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCCCCC
Q 042123          735 PDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-PRLPAP  811 (849)
Q Consensus       735 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  811 (849)
                      .... ......++..|+|||.+....++.++|||||||++|||++ |+.||......        .....+.. .+.+.+
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~~  407 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--------EVIRALERGYRMPRP  407 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHHTCCCCCC
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence            3211 1123346778999999998899999999999999999999 99999743321        11111111 122222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...    ...+.+++.+||+.||++|||+++|++.|+
T Consensus       408 ~~~----~~~l~~li~~cl~~dp~~RPt~~~i~~~L~  440 (454)
T 1qcf_A          408 ENC----PEELYNIMMRCWKNRPEERPTFEYIQSVLD  440 (454)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence            222    234788999999999999999999998875

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-36  Score=324.93  Aligned_cols=238  Identities=22%  Similarity=0.371  Sum_probs=179.1

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-------------HhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------AFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-------------~~~~~~~~~~~~~l  654 (849)
                      +.|++.+.||+|+||.||+|...+++.||||++.....  .......+.+|+.             .+++++......++
T Consensus         9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeecccc--chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            56889999999999999999888899999999865422  2222334444433             36677788889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||| +.+|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++ ++.+||+|||+++...
T Consensus        87 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~  158 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  158 (343)
T ss_dssp             EEC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred             EEe-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence            999 5678999999753   3589999999999999999999999   999999999999997 6889999999998765


Q ss_pred             CCCC--CeeeccCCccccccccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042123          735 PDSS--NWTEFAGTCGYIAPELAYT-----------MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD  801 (849)
Q Consensus       735 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~  801 (849)
                      ....  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....       ......
T Consensus       159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~  231 (343)
T 3dbq_A          159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLH  231 (343)
T ss_dssp             -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHH
T ss_pred             cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHHH
Confidence            4332  2345679999999999864           6789999999999999999999999974221       111122


Q ss_pred             cccCCCCC--CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 QMLDPRLP--APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+++...  .+...    ...+.+++.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~----~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          232 AIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhcCCcccCCcccC----CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            22222211  11111    1247789999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.1e-36  Score=326.26  Aligned_cols=253  Identities=24%  Similarity=0.276  Sum_probs=188.1

Q ss_pred             HHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCC-CCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          583 IVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLP-CDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       583 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      +....++|+..+.||+|+||.||+|.. .+++.||+|++..... .......+.+.+|+.           ++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345668999999999999999999965 5788999999864311 111223345555544           377888888


Q ss_pred             CeeEEEEEeccCCChhhhhccccc-------------------------------------ccCCCHHHHHHHHHHHHHH
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAA-------------------------------------AQELGWSQRMNVIKAVAHA  692 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~~  692 (849)
                      +..++||||+++|+|.+++.....                                     ...+++..+..++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            999999999999999999852110                                     1124577888999999999


Q ss_pred             HHHHHhcCCCCeEecCCCCCCeeecCCC--cEEEeeecCCcccCCCCC----CeeeccCCccccccccccC--CCCCccc
Q 042123          693 LSYLHHDCFPPIVHRDISSKNLLLDLEY--EAHVADFGIAKSLKPDSS----NWTEFAGTCGYIAPELAYT--MKITEKC  764 (849)
Q Consensus       693 l~~LH~~~~~~ivH~dlk~~Nill~~~~--~~kl~DfG~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~--~~~~~~~  764 (849)
                      |+|||+.   +|+||||||+||+++.++  .+||+|||+++.+.....    ......||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999   999999999999998776  899999999986533211    2345678999999999865  6788999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042123          765 DVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIIS  844 (849)
Q Consensus       765 Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil  844 (849)
                      ||||||+++|||++|+.||......        .....+.......+..........+.+++.+||+.||++|||+.|++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l  329 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDA--------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL  329 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChH--------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            9999999999999999999743321        12222222232222222222334588999999999999999999998


Q ss_pred             hh
Q 042123          845 QQ  846 (849)
Q Consensus       845 ~~  846 (849)
                      ++
T Consensus       330 ~h  331 (345)
T 3hko_A          330 QH  331 (345)
T ss_dssp             HS
T ss_pred             cC
Confidence            86

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=319.90  Aligned_cols=236  Identities=19%  Similarity=0.319  Sum_probs=187.4

Q ss_pred             HhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCc----------hhhHHHHHH-----HHHHhhceeecC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQ----------TVDQKEFLT-----EVEAFYGFCSHA  649 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~----------~~~~~~~~~-----ei~~~~~~~~~~  649 (849)
                      ..++|+..+.||+|+||.||+|. ..+++.||||++........          ...+...++     .+.++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            45789999999999999999996 45789999999875432111          111222222     234578888899


Q ss_pred             CeeEEEEEeccCC-ChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          650 RHSFLLYEFLERG-SLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       650 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      +..++||||+.+| +|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999877 9999986543   489999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      +++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....              .....
T Consensus       176 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------~~~~~  240 (335)
T 3dls_A          176 SAAYLERGK-LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------TVEAA  240 (335)
T ss_dssp             TCEECCTTC-CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------GTTTC
T ss_pred             cceECCCCC-ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------HHhhc
Confidence            998775443 3345679999999999988877 7899999999999999999999974221              11111


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+....    ..+.+++.+||+.||++|||+++++++
T Consensus       241 ~~~~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          241 IHPPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             cCCCcccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11111112    237889999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.1e-35  Score=337.63  Aligned_cols=247  Identities=19%  Similarity=0.297  Sum_probs=190.3

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||.||+|+.. +|+.||+|++...... .......+..|+.           .+++++......|+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            67888899999999999999764 6999999998643111 1111233444433           366777888899999


Q ss_pred             EEeccCCChhhhhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      |||+++|+|.+++..... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.+|.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999865432 34589999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||......    .........+.......+...
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~----~~~~~~~~~i~~~~~~~p~~~  416 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK----VENKELKQRVLEQAVTYPDKF  416 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC----CCHHHHHHHHHHCCCCCCTTS
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc----hhHHHHHHHHhhcccCCCccc
Confidence            5544445568999999999999999999999999999999999999999743211    011112222222222222222


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTM-----KIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~~  846 (849)
                          ...+.+++.+||++||++||++     ++|++|
T Consensus       417 ----s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          417 ----SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ----CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ----CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                2347789999999999999965     677654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-35  Score=313.19  Aligned_cols=243  Identities=21%  Similarity=0.325  Sum_probs=188.4

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|.. .+++.||+|++.....  .......+.+|+.           .+++++......++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            46899999999999999999965 4689999999865422  2222344455543           36778888889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE---AHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG~a~  731 (849)
                      ||||+++|+|.+.+...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.   +||+|||.+.
T Consensus        83 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            99999999999888653   3589999999999999999999999   9999999999999987655   9999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ..... .......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......        .....+.......+
T Consensus       157 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~  227 (284)
T 3kk8_A          157 EVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGAYDYP  227 (284)
T ss_dssp             ECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTCCCCC
T ss_pred             EcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh--------HHHHHHHhccccCC
Confidence            76543 2334567999999999999999999999999999999999999999643321        11111111111111


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            11111122347889999999999999999999886

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.1e-35  Score=313.65  Aligned_cols=240  Identities=23%  Similarity=0.375  Sum_probs=191.4

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||.||+|... +++.||+|.+...... .......+.+|+.           ++++++.+.+..++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhcc-CHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            67889999999999999999664 6889999998654222 1223345555544           367888888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999988643   3589999999999999999999999   999999999999999999999999999987764


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......        .....+.......+....
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~  239 (294)
T 2rku_A          168 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNEYSIPKHIN  239 (294)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCCCCTTSC
T ss_pred             CccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhhccCCCccccC
Confidence            444455567899999999999888999999999999999999999999743211        111112222222222222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ..+.+++.+||+.||++|||++|++++
T Consensus       240 ----~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          240 ----PVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                247788999999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.8e-36  Score=318.12  Aligned_cols=248  Identities=24%  Similarity=0.396  Sum_probs=182.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-----cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec--C
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH--A  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~--~  649 (849)
                      ++|+..+.||+|+||+||+|++     .+++.||||++...    .....+.+.+|+..           +++++..  .
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   85 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   85 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            6788999999999999999974     36889999998653    22334456666553           4455533  3


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        86 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           86 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             TSCEEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             CceEEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcc
Confidence            45899999999999999997543  3489999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCCCCC---CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----cccc----ccc
Q 042123          730 AKSLKPDSS---NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----SSLN----TDV  798 (849)
Q Consensus       730 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----~~~~----~~~  798 (849)
                      ++.......   ......++..|+|||.+.+..++.++||||||+++|||++|..||........    ....    ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  240 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence            987654322   12234567789999999999999999999999999999999999864321100    0000    000


Q ss_pred             ccccccC-CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          799 ALDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       799 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....... .+.+.+...    ...+.+++.+||+.||++|||++|+++.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~el~~~L~  287 (295)
T 3ugc_A          241 LIELLKNNGRLPRPDGC----PDEIYMIMTECWNNNVNQRPSFRDLALRVD  287 (295)
T ss_dssp             HHHHHHTTCCCCCCTTC----CHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhccCcCCCCcCc----CHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            1111111 122222222    234888999999999999999999999874

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.2e-35  Score=334.13  Aligned_cols=236  Identities=25%  Similarity=0.443  Sum_probs=184.7

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC-eeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR-HSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~-~~~l  654 (849)
                      .++|+..+.||+|+||.||+|++. ++.||||.++...      ..+.+.+|+.           ++++++.... ..++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT------TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch------HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            467888999999999999999885 7899999987542      2234555544           3566665544 7899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       265 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEECCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            999999999999997543 23479999999999999999999999   99999999999999999999999999998653


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      ..   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......        .....+..+ +...+.
T Consensus       341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~p~  409 (450)
T 1k9a_A          341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDAPD  409 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--------THHHHHHTTCCCCCCT
T ss_pred             cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCC
Confidence            22   123367889999999999999999999999999999998 99999744321        111111111 122222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..    ...+.+++.+||+.||++|||+.++++.|+
T Consensus       410 ~~----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~  441 (450)
T 1k9a_A          410 GC----PPAVYDVMKNCWHLDAATRPTFLQLREQLE  441 (450)
T ss_dssp             TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            22    234788999999999999999999998874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-35  Score=327.29  Aligned_cols=238  Identities=21%  Similarity=0.367  Sum_probs=180.5

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-------------HhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------AFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-------------~~~~~~~~~~~~~l  654 (849)
                      ..|++.+.||+|+||.||+|...+++.||||++.....  .......+.+|+.             .+++++...+..++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc--cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence            45899999999999999999888899999999865322  2222344445543             35667778888999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||| +.+++|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus       134 v~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EEE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             EEe-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            999 66889999987543   589999999999999999999999   999999999999995 5899999999998765


Q ss_pred             CCCC--CeeeccCCccccccccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccc
Q 042123          735 PDSS--NWTEFAGTCGYIAPELAYT-----------MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD  801 (849)
Q Consensus       735 ~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~  801 (849)
                      ....  ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....       ......
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~  278 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLH  278 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHH
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHH
Confidence            4322  2345679999999999865           4688999999999999999999999974321       111222


Q ss_pred             cccCCCCCC--CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 QMLDPRLPA--PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .++++....  +...    ...+.+++.+||+.||++|||+.|++++
T Consensus       279 ~~~~~~~~~~~~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          279 AIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCccccCCCCccc----hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            233322211  1111    2247789999999999999999999976

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.2e-36  Score=323.86  Aligned_cols=244  Identities=23%  Similarity=0.365  Sum_probs=178.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC----e
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR----H  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~----~  651 (849)
                      ++|++.+.||+|+||.||+|+. .+++.||||++...... .......+.+|+..           +++++....    .
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTT-SHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccC-CHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            6899999999999999999965 67899999998764322 22334456666553           455554433    3


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            49999999999999999653   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC---CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          732 SLKPDSS---NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       732 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      .......   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......        ..........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--------~~~~~~~~~~  236 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--------VAYQHVREDP  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHhcCCC
Confidence            7654322   1233568999999999999999999999999999999999999997433211        1111111111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+..........+.+++.+||+.||++||++.+++++
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence            11111111123458889999999999999988877654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.3e-35  Score=309.42  Aligned_cols=243  Identities=28%  Similarity=0.446  Sum_probs=182.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhh---HHHHHHHHHH-----------hhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVD---QKEFLTEVEA-----------FYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~---~~~~~~ei~~-----------~~~~~~~~~~~  652 (849)
                      ++|+..+.||+|+||+||+|+. .+++.||||++...........   .+.+.+|+..           +++++....  
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--   96 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--   96 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence            6788999999999999999965 5799999999865432222111   1456666553           455554433  


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCc-----EEEe
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP--IVHRDISSKNLLLDLEYE-----AHVA  725 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~-----~kl~  725 (849)
                      ++||||+++|+|.+++....  ..+++.++..++.|++.|++|||+.   +  |+||||||+||+++.++.     +||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence            79999999999999886543  4589999999999999999999998   7  999999999999988876     9999


Q ss_pred             eecCCcccCCCCCCeeeccCCcccccccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042123          726 DFGIAKSLKPDSSNWTEFAGTCGYIAPELAY--TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM  803 (849)
Q Consensus       726 DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  803 (849)
                      |||+++....   ......||+.|+|||.+.  ...++.++||||+|+++|||++|+.||..........  ........
T Consensus       172 Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~  246 (287)
T 4f0f_A          172 DFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF--INMIREEG  246 (287)
T ss_dssp             CCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH--HHHHHHSC
T ss_pred             CCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH--HHHHhccC
Confidence            9999985432   345567999999999983  4567899999999999999999999997433211000  00000111


Q ss_pred             cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+..+  ..    ....+.+++.+||+.||++|||++|+++.|+
T Consensus       247 ~~~~~~--~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  285 (287)
T 4f0f_A          247 LRPTIP--ED----CPPRLRNVIELCWSGDPKKRPHFSYIVKELS  285 (287)
T ss_dssp             CCCCCC--TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC--cc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            111111  11    1234788999999999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.8e-36  Score=335.01  Aligned_cols=250  Identities=17%  Similarity=0.291  Sum_probs=188.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------HhhceeecCCeeEEEEEecc
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ++|++.+.||+|+||.||+|.. .+++.||||++...........+.+.++.+.      .+..++......++||||+ 
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-   85 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-   85 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence            6899999999999999999965 6799999998765433333333333333322      2445666778899999999 


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeecCCcccCCCC
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~  737 (849)
                      +++|.+++....  ..+++.+++.++.||+.||+|||+.   +|+||||||+|||+   +.++.+||+|||+++.+....
T Consensus        86 g~sL~~ll~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           86 GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             CCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            999999996432  3599999999999999999999999   99999999999999   588999999999998765432


Q ss_pred             CC-------eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          738 SN-------WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       738 ~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      ..       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........     .....+.......
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~-----~~~~~i~~~~~~~  235 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-----QKYEKISEKKVAT  235 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH-----HHHHHHHHHHHHS
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH-----HHHHHHhhccccc
Confidence            21       22567999999999999999999999999999999999999999754321110     0011110000000


Q ss_pred             C-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 P-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      . ...+.....++.+++..||+.+|++||++++|++.|+
T Consensus       236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~  274 (483)
T 3sv0_A          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFR  274 (483)
T ss_dssp             CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            0 0000111235889999999999999999999998774

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.5e-35  Score=311.88  Aligned_cols=240  Identities=21%  Similarity=0.307  Sum_probs=189.2

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|... ++..||+|++......    ....+.+|+.           .+++++......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE----DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS----CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc----hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            467999999999999999999654 5789999998754322    2344555544           36778888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~a~  731 (849)
                      ||||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++.
T Consensus        84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           84 VMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEeccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            99999999999988653   3489999999999999999999999   99999999999999   788999999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ...... ......+|+.|+|||.+.+. ++.++||||+|+++|||++|+.||.....        ......+.......+
T Consensus       158 ~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~  227 (277)
T 3f3z_A          158 RFKPGK-MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIREGTFTFP  227 (277)
T ss_dssp             ECCTTS-CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCC
T ss_pred             eccCcc-chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence            765432 33456799999999987654 89999999999999999999999974321        112222222232222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........+.+++.+||+.||++|||+.+++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22111233458899999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-36  Score=324.53  Aligned_cols=247  Identities=23%  Similarity=0.436  Sum_probs=191.5

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCS  647 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~  647 (849)
                      ...++|+..+.||+|+||.||+|+..      +++.||||.+....   .......+.+|+.           .+++++.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34578999999999999999999764      34889999987542   2233445666655           3677888


Q ss_pred             cCCeeEEEEEeccCCChhhhhccccc---------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAA---------------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVH  706 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH  706 (849)
                      ..+..++||||+++|+|.+++.....                     ...+++.+++.++.||+.||+|||+.   +|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            88899999999999999999965321                     14689999999999999999999999   9999


Q ss_pred             cCCCCCCeeecCCCcEEEeeecCCcccCCCC--CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 042123          707 RDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPR  783 (849)
Q Consensus       707 ~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf  783 (849)
                      |||||+||+++.++.+||+|||+++......  .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            9999999999999999999999997654322  12234567889999999998899999999999999999999 99998


Q ss_pred             CccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          784 DFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       784 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .....        ......+.+......+..   ....+.+++.+||+.||++|||+.+++++|+
T Consensus       278 ~~~~~--------~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~  331 (343)
T 1luf_A          278 YGMAH--------EEVIYYVRDGNILACPEN---CPLELYNLMRLCWSKLPADRPSFCSIHRILQ  331 (343)
T ss_dssp             TTSCH--------HHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCh--------HHHHHHHhCCCcCCCCCC---CCHHHHHHHHHHcccCcccCCCHHHHHHHHH
Confidence            74322        111222222222211111   1234788999999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.8e-35  Score=322.83  Aligned_cols=242  Identities=22%  Similarity=0.288  Sum_probs=176.4

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||+||+|+.. +++.||||++.......     ..+.+|+           .++++++......++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC-----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc-----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            368999999999999999999664 79999999987542221     2233333           347788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--EEEeeecCCcc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE--AHVADFGIAKS  732 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfG~a~~  732 (849)
                      ||||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.  +||+|||+++.
T Consensus        94 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           94 IMEYASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            99999999999998643   3589999999999999999999999   9999999999999987765  99999999975


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCcc-chHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEK-CDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      .... .......||+.|+|||++.+..++.+ +||||+||++|+|++|+.||.......    ........+.......+
T Consensus       168 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~  242 (361)
T 3uc3_A          168 SVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQRILSVKYSIP  242 (361)
T ss_dssp             --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHHHHTTCCCCC
T ss_pred             cccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHHHhcCCCCCC
Confidence            4332 22344679999999999988887655 899999999999999999997433211    11111222222222111


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...  .....+.+++.+||+.||++|||++|+++|
T Consensus       243 ~~~--~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 DDI--RISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             TTS--CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CcC--CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            100  112347789999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.7e-35  Score=317.64  Aligned_cols=245  Identities=22%  Similarity=0.415  Sum_probs=189.7

Q ss_pred             hcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      .++|...+.||+|+||.||+|..      .+++.||||.+....   .....+.+.+|+.           ++++++.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   98 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA---SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD   98 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC---CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence            36788899999999999999964      345889999987532   2233455666655           367788888


Q ss_pred             CeeEEEEEeccCCChhhhhccccc---------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAA---------------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRD  708 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d  708 (849)
                      +..++||||+++|+|.+++.....                     ...+++.++..++.||+.||+|||+.   +|+|||
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d  175 (314)
T 2ivs_A           99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD  175 (314)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence            899999999999999999975432                     12488999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCc
Q 042123          709 ISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDF  785 (849)
Q Consensus       709 lk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~  785 (849)
                      |||+||+++.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876543321  223456788999999998889999999999999999999 9999974


Q ss_pred             cccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          786 LSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....        .....+..........   .....+.+++.+||+.||++|||++|++++|+
T Consensus       256 ~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~  307 (314)
T 2ivs_A          256 IPPE--------RLFNLLKTGHRMERPD---NCSEEMYRLMLQCWKQEPDKRPVFADISKDLE  307 (314)
T ss_dssp             CCGG--------GHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHH--------HHHHHhhcCCcCCCCc---cCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            3321        1111111111111111   11234788999999999999999999999875

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.5e-34  Score=337.67  Aligned_cols=311  Identities=19%  Similarity=0.191  Sum_probs=196.8

Q ss_pred             CCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCC
Q 042123           29 FPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLK  108 (849)
Q Consensus        29 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  108 (849)
                      +++++.|++++|.+..+++..|.++++|++|+|++|++++.      ....|+.+++|+.|+|++|.|++..|..|++++
T Consensus        50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~  123 (597)
T 3oja_B           50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI------DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVP  123 (597)
T ss_dssp             GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEE------CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred             CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCC------ChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCC
Confidence            46677777777777777777777777777777777776531      222344445555555555555444444444445


Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      +|++|+|++|+|+++++..|                        +++++|++|+|++|.+.++.|..|..+++|++|+|+
T Consensus       124 ~L~~L~L~~n~l~~l~~~~~------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  179 (597)
T 3oja_B          124 LLTVLVLERNDLSSLPRGIF------------------------HNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS  179 (597)
T ss_dssp             TCCEEECCSSCCCCCCTTTT------------------------TTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECT
T ss_pred             CCCEEEeeCCCCCCCCHHHh------------------------ccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECc
Confidence            55555555554444444444                        445555555555555554444455555555555555


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCC
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP  268 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~  268 (849)
                      +|++++..   +..+++|+.|++++|.+++.     ...++|++|++++|.+.. +|..                     
T Consensus       180 ~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~-~~~~---------------------  229 (597)
T 3oja_B          180 SNRLTHVD---LSLIPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINV-VRGP---------------------  229 (597)
T ss_dssp             TSCCSBCC---GGGCTTCSEEECCSSCCSEE-----ECCTTCSEEECCSSCCCE-EECS---------------------
T ss_pred             CCCCCCcC---hhhhhhhhhhhcccCccccc-----cCCchhheeeccCCcccc-cccc---------------------
Confidence            55554321   33344555555555555421     222344455555554431 1100                     


Q ss_pred             cccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCC
Q 042123          269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK  348 (849)
Q Consensus       269 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  348 (849)
                          ..++|+.|++++|.+++  +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|.+.+ +|..+..+++
T Consensus       230 ----~~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~  302 (597)
T 3oja_B          230 ----VNVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPT  302 (597)
T ss_dssp             ----CCSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTT
T ss_pred             ----cCCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCC
Confidence                01245666666666654  3567778888888888888888888888888888888888888885 4666777889


Q ss_pred             CcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCcccccc
Q 042123          349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGR  410 (849)
Q Consensus       349 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  410 (849)
                      |+.|+|++|.++ .+|..+..+++|+.|+|++|.+++. +  +..+++|+.|+|++|++.+.
T Consensus       303 L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~  360 (597)
T 3oja_B          303 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN  360 (597)
T ss_dssp             CCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred             CcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence            999999999998 6777888899999999999999854 3  67788999999999998753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.8e-35  Score=322.06  Aligned_cols=252  Identities=23%  Similarity=0.382  Sum_probs=191.8

Q ss_pred             HHHHHHHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCch----hhHHHHHHHHH------------Hh
Q 042123          580 YDEIVKATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQT----VDQKEFLTEVE------------AF  642 (849)
Q Consensus       580 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~----~~~~~~~~ei~------------~~  642 (849)
                      ........++|+..+.||+|+||.||+|... +|+.||||++.........    ...+.+.+|+.            .+
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3444555678999999999999999999764 7999999998654321111    11223333332            35


Q ss_pred             hceeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 042123          643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA  722 (849)
Q Consensus       643 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  722 (849)
                      ++++......++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i  239 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI  239 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            67788888999999999999999998643   3589999999999999999999998   99999999999999999999


Q ss_pred             EEeeecCCcccCCCCCCeeeccCCccccccccccC------CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccc
Q 042123          723 HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT------MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNT  796 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~  796 (849)
                      |++|||++....... ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||......       
T Consensus       240 kl~DfG~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-------  311 (365)
T 2y7j_A          240 RLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-------  311 (365)
T ss_dssp             EECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-------
T ss_pred             EEEecCcccccCCCc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-------
Confidence            999999998765432 3345689999999998863      35888999999999999999999999743211       


Q ss_pred             ccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          797 DVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       797 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....+...........+......+.+++.+||+.||++|||++|++++
T Consensus       312 -~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          312 -LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             -HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             1111111222211111111223458889999999999999999999986

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-36  Score=325.06  Aligned_cols=245  Identities=22%  Similarity=0.404  Sum_probs=186.1

Q ss_pred             HhcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS  647 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~  647 (849)
                      ..++|+..+.||+|+||.||+|+.      .++..||||.+......   .....+.+|+.            .+++++.
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS---SEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCH---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            457889999999999999999975      24668999998753211   11223334433            3677788


Q ss_pred             cCCeeEEEEEeccCCChhhhhccccc--------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAA--------------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR  707 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  707 (849)
                      ..+..++||||+++|+|.+++.....                    ...+++.++..++.||+.||+|||+.   +|+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            88899999999999999999975432                    13479999999999999999999999   99999


Q ss_pred             CCCCCCeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 042123          708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRD  784 (849)
Q Consensus       708 dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~  784 (849)
                      ||||+||+++.++.+||+|||++.........  .....+|+.|+|||.+.+..++.++||||||+++|||+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            99999999999999999999999876543322  223456789999999998899999999999999999998 999997


Q ss_pred             ccccccccccccccccccccCCC--CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          785 FLSSISSSSLNTDVALDQMLDPR--LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......        .....+...  ...+...    ...+.+++.+||+.||++|||+.+++++|+
T Consensus       277 ~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          277 GIPVDA--------NFYKLIQNGFKMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             TCCCSH--------HHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cCCcHH--------HHHHHHhcCCCCCCCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            433211        111111111  1111111    234788999999999999999999999885

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-35  Score=313.39  Aligned_cols=239  Identities=26%  Similarity=0.411  Sum_probs=184.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|.. .+++.||||++..... ........+.+|+.           .+++++......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            46789999999999999999955 4678999999854211 11112334455544           36788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            99999999999998653   3589999999999999999999998   99999999999999999999999999986544


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..  ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......        .....+.......+...
T Consensus       161 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  230 (279)
T 3fdn_A          161 SS--RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--------ETYKRISRVEFTFPDFV  230 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCTTS
T ss_pred             cc--cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH--------HHHHHHHhCCCCCCCcC
Confidence            32  234567899999999999999999999999999999999999999743211        11111111122211111


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .    ..+.+++.+||+.||++|||++|+++|
T Consensus       231 ~----~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          231 T----EGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             C----HHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             C----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            2    237789999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.8e-36  Score=329.36  Aligned_cols=249  Identities=18%  Similarity=0.259  Sum_probs=181.5

Q ss_pred             hcCCCcCceecCCccceEEEEEecC------CcEEEEEEecccCCCCchhhHHHHHH---------H-----------HH
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPS------GEVVAVKKFHSLLPCDQTVDQKEFLT---------E-----------VE  640 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~---------e-----------i~  640 (849)
                      .++|++.+.||+|+||.||+|.+..      ++.||||.+.....  ....+..+.+         +           +.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG--PLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH--HHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch--hHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4589999999999999999997654      47899999865421  1111112221         1           11


Q ss_pred             HhhceeecC----CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 042123          641 AFYGFCSHA----RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL  716 (849)
Q Consensus       641 ~~~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  716 (849)
                      .+++++...    ...++||||+ +|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill  185 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL  185 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence            245555443    4589999999 999999996532  4599999999999999999999999   99999999999999


Q ss_pred             c--CCCcEEEeeecCCcccCCCCC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 042123          717 D--LEYEAHVADFGIAKSLKPDSS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLS  787 (849)
Q Consensus       717 ~--~~~~~kl~DfG~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~  787 (849)
                      +  .++.+||+|||+++.+.....       ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            9  889999999999976643221       1233459999999999999999999999999999999999999997432


Q ss_pred             cccccc----cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          788 SISSSS----LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       788 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......    .........++++.++. ..    ....+.+++..||+.+|++|||+++|++.|+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~  325 (364)
T 3op5_A          266 KDPKYVRDSKIRYRENIASLMDKCFPA-AN----APGEIAKYMETVKLLDYTEKPLYENLRDILL  325 (364)
T ss_dssp             TCHHHHHHHHHHHHHCHHHHHHHHSCT-TC----CCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             cCHHHHHHHHHHhhhhHHHHHHHhccc-cc----CHHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Confidence            111000    00001111111111110 01    1234788999999999999999999998774

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.4e-35  Score=319.12  Aligned_cols=240  Identities=23%  Similarity=0.375  Sum_probs=190.8

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|...+.||+|+||.||+|... +++.||+|.+...... .......+.+|+.           ++++++.+.+..++|
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLL-KPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            67888999999999999999654 6889999998654221 1223444555544           367888888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999988643   3589999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........|++.|+|||.+.+..++.++||||||+++|||++|+.||......        .....+.......+....
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~  265 (335)
T 2owb_A          194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK--------ETYLRIKKNEYSIPKHIN  265 (335)
T ss_dssp             TTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTCCCCCTTSC
T ss_pred             CcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH--------HHHHHHhcCCCCCCccCC
Confidence            444455567999999999999988999999999999999999999999743211        111111111111111111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ..+.+++.+||+.||++|||++|++++
T Consensus       266 ----~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          266 ----PVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             ----HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ----HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                237788999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.2e-35  Score=318.03  Aligned_cols=246  Identities=23%  Similarity=0.434  Sum_probs=173.9

Q ss_pred             HhcCCCcCceecCCccceEEEEEecC-C---cEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPS-G---EVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR  650 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~  650 (849)
                      ..++|+..+.||+|+||.||+|+... +   ..||||.+.....  .....+.+.+|+..           +++++....
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            34689999999999999999997653 3   2799999865422  12234566666553           556665554


Q ss_pred             ee------EEEEEeccCCChhhhhccccc---ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc
Q 042123          651 HS------FLLYEFLERGSLAAILNTDAA---AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE  721 (849)
Q Consensus       651 ~~------~lV~e~~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~  721 (849)
                      ..      ++||||+++|+|.+++.....   ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCC
Confidence            44      899999999999999965432   12589999999999999999999999   9999999999999999999


Q ss_pred             EEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 042123          722 AHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDV  798 (849)
Q Consensus       722 ~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~  798 (849)
                      +||+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......        .
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~  247 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA--------E  247 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------G
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH--------H
Confidence            99999999987654322  1223456788999999999999999999999999999999 99998743321        1


Q ss_pred             ccccccCCC-CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          799 ALDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       799 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....+.... ...+...    ...+.+++.+||+.||++|||+.++++.|+
T Consensus       248 ~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  294 (323)
T 3qup_A          248 IYNYLIGGNRLKQPPEC----MEEVYDLMYQCWSADPKQRPSFTCLRMELE  294 (323)
T ss_dssp             HHHHHHTTCCCCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCcc----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            112222221 1111222    234788999999999999999999888764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-35  Score=320.67  Aligned_cols=240  Identities=24%  Similarity=0.441  Sum_probs=178.6

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcE----EEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEV----VAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      ++|+..+.||+|+||+||+|++. +++.    ||+|.+....   .....+.+.+|+.           .+++++... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~   90 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   90 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C
Confidence            57889999999999999999653 4444    5778765432   2223445666654           356676654 4


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++|+||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHST--TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             eEEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence            789999999999999997543  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042123          732 SLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-R  807 (849)
Q Consensus       732 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~  807 (849)
                      ........  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||+......        ....+... .
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~~~~~~~  237 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER  237 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--------HHHHHHcCCC
Confidence            76543322  233456789999999999999999999999999999999 999997433211        11111111 1


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+.+...    ...+.+++.+||+.||++|||+.+++++|+
T Consensus       238 ~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~ell~~l~  274 (327)
T 3poz_A          238 LPQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CCCCTTB----CHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             CCCCccC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            1222222    234788999999999999999999998874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.5e-36  Score=325.78  Aligned_cols=247  Identities=23%  Similarity=0.393  Sum_probs=187.4

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-C-----CcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-S-----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS  647 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~-----~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~  647 (849)
                      ..++|+..+.||+|+||.||+|... +     ...||||.+....   .......+.+|+.            .+++++.
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc---ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            4578999999999999999999653 2     2479999987542   1222344445543            3667788


Q ss_pred             cCCeeEEEEEeccCCChhhhhccccc-----------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAA-----------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL  716 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill  716 (849)
                      +.+..++||||+++|+|.+++.....           ...+++.++..++.|++.||+|||+.   +|+||||||+||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence            88899999999999999999965431           23579999999999999999999999   99999999999999


Q ss_pred             cCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc
Q 042123          717 DLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSS  793 (849)
Q Consensus       717 ~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~  793 (849)
                      +.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |..||........  
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--  275 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--  275 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--
Confidence            99999999999999866433222  223456788999999998899999999999999999998 9999874321110  


Q ss_pred             cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          794 LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        ..........  ...+...    ...+.+++.+||+.||++|||+.|++++|+
T Consensus       276 --~~~~~~~~~~--~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  322 (333)
T 2i1m_A          276 --FYKLVKDGYQ--MAQPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQ  322 (333)
T ss_dssp             --HHHHHHHTCC--CCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --HHHHHhcCCC--CCCCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence              0001111111  1111111    234788999999999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-35  Score=316.76  Aligned_cols=251  Identities=20%  Similarity=0.318  Sum_probs=182.2

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....  ......+.+.+|+.           .+++++...+..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            67899999999999999999664 69999999986542  22223344555544           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~e~~~~~~l~~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQ---RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             EECCSEEHHHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEeCCCchHHHHHhhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999999987643   3489999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccc------------ccccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTD------------VALDQ  802 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~------------~~~~~  802 (849)
                      .........+|+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||..............            .....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          155 PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred             cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence            4444556688999999999876 5679999999999999999999999975432111000000            00000


Q ss_pred             c-cCCCCCCCCh------hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 M-LDPRLPAPSR------SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~-~~~~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      . .....+.+..      ........+.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            0 0011111100      001122347889999999999999999999976

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=325.64  Aligned_cols=241  Identities=16%  Similarity=0.180  Sum_probs=181.1

Q ss_pred             hcCCCcCceecCCccceEEEEE------ecCCcEEEEEEecccCCCCchhhHHHHHHH--------HHHhhceeecCCee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAE------LPSGEVVAVKKFHSLLPCDQTVDQKEFLTE--------VEAFYGFCSHARHS  652 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~~~~~e--------i~~~~~~~~~~~~~  652 (849)
                      .++|...+.||+|+||+||+|.      ..+++.||||++...... .........+.        +..+++++...+..
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH-HHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh-HHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            3678899999999999999993      456899999998653211 11111111111        22356777788899


Q ss_pred             EEEEEeccCCChhhhhcccc--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-----------C
Q 042123          653 FLLYEFLERGSLAAILNTDA--AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-----------E  719 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----------~  719 (849)
                      ++||||+++|+|.+++....  ....+++.++..++.||+.||+|||+.   +|+||||||+|||++.           +
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~  219 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS  219 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence            99999999999999997532  234699999999999999999999998   9999999999999998           8


Q ss_pred             CcEEEeeecCCcccCC--CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccc
Q 042123          720 YEAHVADFGIAKSLKP--DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTD  797 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~  797 (849)
                      +.+||+|||+|+.+..  .........||+.|+|||++.+..++.++|||||||++|||++|+.||......       .
T Consensus       220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~  292 (365)
T 3e7e_A          220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-------E  292 (365)
T ss_dssp             TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT-------E
T ss_pred             CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC-------c
Confidence            9999999999975432  222345567999999999999999999999999999999999999998632211       0


Q ss_pred             cccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCC-CCHHHHHhhh
Q 042123          798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESR-PTMKIISQQL  847 (849)
Q Consensus       798 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~eil~~L  847 (849)
                      ..    +........  .   ...+.+++..|++.+|.+| |+++++.+.|
T Consensus       293 ~~----~~~~~~~~~--~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l  334 (365)
T 3e7e_A          293 CK----PEGLFRRLP--H---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKL  334 (365)
T ss_dssp             EE----ECSCCTTCS--S---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred             ee----echhccccC--c---HHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence            01    111111111  1   2236678889999999998 6777776655

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1e-35  Score=319.21  Aligned_cols=246  Identities=22%  Similarity=0.410  Sum_probs=189.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceeec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~  648 (849)
                      .++|+..+.||+|+||.||+|+.      .+++.||||.+....   .....+.+.+|+.            ++++++..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch---hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            36788999999999999999964      357889999987542   1222344555543            35677788


Q ss_pred             CCeeEEEEEeccCCChhhhhccccc---------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAA---------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                      .+..++||||+++|+|.+++.....               ...+++.++..++.|++.||+|||+.   +|+||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence            8899999999999999999975432               12489999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 042123          714 LLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSIS  790 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~  790 (849)
                      |+++.++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            99999999999999999877654332  223456788999999999899999999999999999999 999987433211


Q ss_pred             ccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .    ............  .+...    ...+.+++.+||+.||++|||++|++++|+
T Consensus       256 ~----~~~~~~~~~~~~--~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~  303 (313)
T 1t46_A          256 K----FYKMIKEGFRML--SPEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (313)
T ss_dssp             H----HHHHHHHTCCCC--CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H----HHHHhccCCCCC--CcccC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            0    000111111111  11111    234788999999999999999999999875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.4e-35  Score=321.64  Aligned_cols=257  Identities=19%  Similarity=0.224  Sum_probs=186.3

Q ss_pred             HHHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc-hhhHHHHHHH----------HHHhhceeecC
Q 042123          582 EIVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ-TVDQKEFLTE----------VEAFYGFCSHA  649 (849)
Q Consensus       582 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~e----------i~~~~~~~~~~  649 (849)
                      +.....++|++.+.||+|+||+||+|+. .+++.||||++........ ...+...++.          +..+++++...
T Consensus        29 ~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           29 KGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             TTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             cceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            3334457899999999999999999965 5789999999864211000 0111122222          22467778888


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-----------
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-----------  718 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----------  718 (849)
                      +..++||||+ +++|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.           
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchh
Confidence            8999999999 899999997543 23589999999999999999999999   9999999999999975           


Q ss_pred             --------------CCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042123          719 --------------EYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD  784 (849)
Q Consensus       719 --------------~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~  784 (849)
                                    ++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                          789999999999865432   234678999999999999999999999999999999999999997


Q ss_pred             cccccccc-------ccccccc--------cccc-----cCCCCCCCChhhH--------------HHHHHHHHHHhhcc
Q 042123          785 FLSSISSS-------SLNTDVA--------LDQM-----LDPRLPAPSRSAQ--------------EKLISIMEVAFSCF  830 (849)
Q Consensus       785 ~~~~~~~~-------~~~~~~~--------~~~~-----~~~~~~~~~~~~~--------------~~~~~l~~li~~cl  830 (849)
                      ........       .......        ....     .....+.......              .....+.+++.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            43311100       0000000        0000     0000111100000              01145779999999


Q ss_pred             CCCCCCCCCHHHHHhh
Q 042123          831 NESPESRPTMKIISQQ  846 (849)
Q Consensus       831 ~~dP~~RPt~~eil~~  846 (849)
                      +.||++|||++|+++|
T Consensus       341 ~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          341 QIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CSSGGGSCCHHHHTTS
T ss_pred             cCChhhCCCHHHHhcC
Confidence            9999999999999986

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-36  Score=332.41  Aligned_cols=250  Identities=21%  Similarity=0.298  Sum_probs=188.0

Q ss_pred             HHHHHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCC-----CchhhHHHHHHH-----HHHhhceeec
Q 042123          580 YDEIVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPC-----DQTVDQKEFLTE-----VEAFYGFCSH  648 (849)
Q Consensus       580 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~~e-----i~~~~~~~~~  648 (849)
                      +.+.....++|+..+.||+|+||+||+|+. .+|+.||||++.+....     .....+...+..     +..+++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            344445568999999999999999999966 47999999998642100     001111222221     2346778888


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      .+..|+||||+++|+|.+++.+..  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeech
Confidence            899999999999999999996532  3589999999999999999999998   99999999999999999999999999


Q ss_pred             CCcccCCCCCC-eeeccCCcccccccccc-------CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 042123          729 IAKSLKPDSSN-WTEFAGTCGYIAPELAY-------TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL  800 (849)
Q Consensus       729 ~a~~~~~~~~~-~~~~~g~~~y~aPE~~~-------~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~  800 (849)
                      +++........ ....+||+.|+|||++.       ...++.++|||||||++|||++|+.||......        ...
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~  279 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--------ETY  279 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHH
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--------HHH
Confidence            99877544322 23457999999999987       356899999999999999999999999743321        111


Q ss_pred             ccccC----CCCCCCChhhHHHHHHHHHHHhhccCCCCCCC---CCHHHHHhh
Q 042123          801 DQMLD----PRLPAPSRSAQEKLISIMEVAFSCFNESPESR---PTMKIISQQ  846 (849)
Q Consensus       801 ~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~eil~~  846 (849)
                      ..+..    ...+..   .......+.+++.+||. +|++|   |+++||++|
T Consensus       280 ~~i~~~~~~~~~p~~---~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          280 GKIVHYKEHLSLPLV---DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHHHTHHHHCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HHHHhcccCcCCCcc---ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            11111    111110   01122347889999999 99998   699999876

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2e-35  Score=326.90  Aligned_cols=253  Identities=16%  Similarity=0.242  Sum_probs=186.1

Q ss_pred             cCCCcCceecCC--ccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          588 NDFDAKYCIGNG--GHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ++|++.+.||+|  +||.||+|+.. +++.||||++.....  .......+.+|+.           ++++++...+..+
T Consensus        25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            678999999999  99999999664 799999999875422  1223344555544           3678888899999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus       103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHF-MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEccCCCCHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            9999999999999986543 23589999999999999999999999   9999999999999999999999999988654


Q ss_pred             CCCC-------CCeeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc
Q 042123          734 KPDS-------SNWTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML  804 (849)
Q Consensus       734 ~~~~-------~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~  804 (849)
                      ....       .......||+.|+|||++.+  ..++.++||||+||++|||++|+.||.....................
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  258 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL  258 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence            2211       11122468899999999987  67899999999999999999999999753322110000000000000


Q ss_pred             CCC---------------------------C-------CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          805 DPR---------------------------L-------PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       805 ~~~---------------------------~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +..                           .       .............+.+++.+||+.||++|||++|+++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000                           0       00000111223458899999999999999999999876

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.1e-35  Score=328.99  Aligned_cols=247  Identities=21%  Similarity=0.259  Sum_probs=178.3

Q ss_pred             HHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC----chhhHHHHHHHHH-----------Hhhceeec
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD----QTVDQKEFLTEVE-----------AFYGFCSH  648 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~~~ei~-----------~~~~~~~~  648 (849)
                      ...++|...+.||+|+||.||+|.. .+++.||||++.......    .......+.+|+.           ++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            3457999999999999999999954 578999999986532110    0111112334433           3666664 


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cEEEe
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---EAHVA  725 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~kl~  725 (849)
                      .+..++||||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++   .+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence            45679999999999999998654   3589999999999999999999999   999999999999997544   59999


Q ss_pred             eecCCcccCCCCCCeeeccCCccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042123          726 DFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT---MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       726 DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      |||+++..... .......||+.|+|||++.+   ..++.++||||+||++|+|++|+.||......       ......
T Consensus       285 DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~~~  356 (419)
T 3i6u_A          285 DFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-------VSLKDQ  356 (419)
T ss_dssp             CSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-------CCHHHH
T ss_pred             ecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-------HHHHHH
Confidence            99999876543 23345679999999999853   66888999999999999999999999743211       111112


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +........+.........+.+++.+||+.||++|||++|+++|
T Consensus       357 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            22222222222222234568899999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.4e-35  Score=333.90  Aligned_cols=241  Identities=25%  Similarity=0.439  Sum_probs=184.1

Q ss_pred             HhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      ..++|+..+.||+|+||.||+|.+.++..||||+++....     ..+.+.+|+.           ++++++.+ +..++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            3467888999999999999999988788899999875321     2345566654           35667655 67899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       256 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            999999999999997533 24589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 042123          735 PDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAP  811 (849)
Q Consensus       735 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  811 (849)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......        .....+... +.+.+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~~  403 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMPCP  403 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCC
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence            3321 1233456788999999998899999999999999999999 99998743221        111111111 22222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...    ...+.+++.+||+.||++|||+++|++.|+
T Consensus       404 ~~~----~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~  436 (452)
T 1fmk_A          404 PEC----PESLHDLMCQCWRKEPEERPTFEYLQAFLE  436 (452)
T ss_dssp             TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            222    234788999999999999999999998875

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-35  Score=336.21  Aligned_cols=245  Identities=19%  Similarity=0.266  Sum_probs=188.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++...... .......+.+|+.           .+++++...+..++|
T Consensus       184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            5788899999999999999966 47999999998642110 1111233444433           366778888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999986543 23489999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      . .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......    ........+.......+..  
T Consensus       339 ~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~----~~~~i~~~i~~~~~~~p~~--  411 (576)
T 2acx_A          339 G-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI----KREEVERLVKEVPEEYSER--  411 (576)
T ss_dssp             T-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC----CHHHHHHHHHHCCCCCCTT--
T ss_pred             C-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch----hHHHHHHHhhcccccCCcc--
Confidence            3 23455689999999999999899999999999999999999999997432111    1111111111111111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                        ....+.+++.+||+.||++||     +++||++|
T Consensus       412 --~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          412 --FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             --SCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             --CCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence              123478899999999999999     78999876

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-35  Score=316.31  Aligned_cols=240  Identities=26%  Similarity=0.460  Sum_probs=177.5

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV~  656 (849)
                      ++|+..+.||+|+||.||+|++. ++.||||++...      ...+.+.+|+..           +++++.  +..++||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~   78 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE------SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVM   78 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST------THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh------hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEE
Confidence            57888999999999999999885 789999998642      223455666543           444444  3478999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-EEEeeecCCcccCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE-AHVADFGIAKSLKP  735 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-~kl~DfG~a~~~~~  735 (849)
                      ||+++|+|.+++........+++.+++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++.....
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~  158 (307)
T 2eva_A           79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT  158 (307)
T ss_dssp             ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred             EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence            99999999999976654456899999999999999999999932128999999999999998886 79999999976543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......      ............+....  
T Consensus       159 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~--  227 (307)
T 2eva_A          159 H---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA------FRIMWAVHNGTRPPLIK--  227 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH------HHHHHHHHTTCCCCCBT--
T ss_pred             c---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH------HHHHHHHhcCCCCCccc--
Confidence            2   234568999999999999999999999999999999999999997432211      00111111111111111  


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       .....+.+++.+||+.||++|||+++++++|+
T Consensus       228 -~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          228 -NLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             -TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence             11234778999999999999999999999874

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-35  Score=337.35  Aligned_cols=241  Identities=25%  Similarity=0.418  Sum_probs=189.5

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|.+. ++..||||.+.....     ..+.+.+|+.           ++++++......++
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            467888999999999999999765 488999999875321     2345666644           36788888889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence            999999999999996533 24589999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 042123          735 PDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAP  811 (849)
Q Consensus       735 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  811 (849)
                      .... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......        .....+... +...+
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~  441 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKDYRMERP  441 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTTCCCCCC
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence            3321 1122345678999999998899999999999999999999 99998743321        111111111 11112


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...    ...+.+++.+||+.||++|||+++|++.|+
T Consensus       442 ~~~----~~~l~~li~~cl~~dP~~RPs~~el~~~L~  474 (495)
T 1opk_A          442 EGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFE  474 (495)
T ss_dssp             TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC----CHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence            222    234788999999999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.3e-35  Score=318.03  Aligned_cols=244  Identities=23%  Similarity=0.430  Sum_probs=186.5

Q ss_pred             hcCCCcCceecCCccceEEEEEe--------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhcee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL--------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFC  646 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~  646 (849)
                      .++|+..+.||+|+||.||+|+.        .++..||||++....   .......+.+|+.            .+++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC---cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            36888999999999999999975        357789999987542   2222334444433            367788


Q ss_pred             ecCCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                      ...+..++||||+++|+|.+++.....             ...+++.++..++.||+.||+|||+.   +|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccce
Confidence            888899999999999999999975432             23489999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 042123          714 LLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSIS  790 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~  790 (849)
                      |+++.++.+||+|||+++........  .....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... 
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-  266 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  266 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH-
Confidence            99999999999999999876543221  223356788999999988889999999999999999999 99998743211 


Q ss_pred             ccccccccccccccCCC-CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                             .....+.... ...+...    ...+.+++.+||+.||++|||++|++++|+
T Consensus       267 -------~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~  314 (334)
T 2pvf_A          267 -------ELFKLLKEGHRMDKPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLD  314 (334)
T ss_dssp             -------HHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHHHHHhcCCCCCCCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                   1111111111 1111111    234788999999999999999999999874

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-35  Score=315.00  Aligned_cols=255  Identities=25%  Similarity=0.321  Sum_probs=183.1

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC-------chhhHHHHHHH--------HHHhhceeecC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD-------QTVDQKEFLTE--------VEAFYGFCSHA  649 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~~~e--------i~~~~~~~~~~  649 (849)
                      ..++|+..+.||+|+||+||+|+. .+++.||||++.......       ....+...++.        +.++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            457999999999999999999975 578999999986432110       11111122222        22356666554


Q ss_pred             C-----eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEE
Q 042123          650 R-----HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       650 ~-----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl  724 (849)
                      .     ..++||||++ |+|.+++..... ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            3     5799999997 599999876542 3489999999999999999999999   9999999999999999999999


Q ss_pred             eeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-----------
Q 042123          725 ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-----------  793 (849)
Q Consensus       725 ~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-----------  793 (849)
                      +|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..........           
T Consensus       162 ~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          162 ADFGLARIYSYQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             CSCSCTTTSTTCC-CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeCccccccCCCc-ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9999998765432 3355678999999999999999999999999999999999999997433211000           


Q ss_pred             --ccccccc-ccccCCCCCCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 --LNTDVAL-DQMLDPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 --~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        ....... .....+..+.+ .....+....+.+++.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence              0000000 00000000000 00001122457889999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.3e-35  Score=311.06  Aligned_cols=241  Identities=22%  Similarity=0.397  Sum_probs=175.4

Q ss_pred             hcCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~  651 (849)
                      .++|+..+.||+|+||.||+|...    .+..||+|.+....   .....+.+.+|+..           +++++ ..+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~   89 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENP   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCc
Confidence            367888999999999999999653    24579999876532   22334556666553           55665 3467


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             cEEEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            889999999999999996432  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-C
Q 042123          732 SLKPDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-L  808 (849)
Q Consensus       732 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~  808 (849)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......        .....+.... .
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--------~~~~~i~~~~~~  236 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERL  236 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCC
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--------HHHHHHHcCCCC
Confidence            7654322 1233456788999999998899999999999999999996 99999743321        1111121211 1


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+...    ...+.+++.+||+.||++|||+.|++++|+
T Consensus       237 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  272 (281)
T 1mp8_A          237 PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLS  272 (281)
T ss_dssp             CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            111112    234778999999999999999999999875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.8e-35  Score=317.77  Aligned_cols=249  Identities=19%  Similarity=0.330  Sum_probs=181.3

Q ss_pred             cCCCcC-ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeE
Q 042123          588 NDFDAK-YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSF  653 (849)
Q Consensus       588 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~  653 (849)
                      +.|++. +.||+|+||.||+|.. .+++.||||++.....    .....+.+|+.            .+++++...+..+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG----HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS----CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc----hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            567774 7899999999999965 4799999999865422    12333444433            3667788889999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEeeecCC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE---AHVADFGIA  730 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~DfG~a  730 (849)
                      +||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.   +||+|||++
T Consensus        88 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEEcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            999999999999999653   3589999999999999999999999   9999999999999998876   999999999


Q ss_pred             cccCCCC-------CCeeeccCCccccccccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccc---
Q 042123          731 KSLKPDS-------SNWTEFAGTCGYIAPELAYT-----MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN---  795 (849)
Q Consensus       731 ~~~~~~~-------~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~---  795 (849)
                      .......       .......||+.|+|||.+.+     ..++.++||||+||++|||++|+.||............   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            8654221       11233568999999999875     45789999999999999999999999754321100000   


Q ss_pred             ----cccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          796 ----TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       796 ----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          .......+.......+..........+.+++.+||+.||++|||++|++++
T Consensus       242 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                001112222222222211111223458899999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-35  Score=321.67  Aligned_cols=238  Identities=26%  Similarity=0.396  Sum_probs=184.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|+..+.||+|+||.||+|+. .+++.||||++..... ......+.+.+|+.           .+++++......++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            4588889999999999999964 5799999999865422 22223345666654           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||++ |++.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99998 58888875432  4589999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC-CC
Q 042123          736 DSSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP-AP  811 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  811 (849)
                      .    ....||+.|+|||++.   ...++.++|||||||++|||++|+.||.......        ....+.....+ ..
T Consensus       207 ~----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--------~~~~~~~~~~~~~~  274 (348)
T 1u5q_A          207 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPALQ  274 (348)
T ss_dssp             B----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCCCCC
T ss_pred             C----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhcCCCCCC
Confidence            2    3457999999999884   5678999999999999999999999987433211        01111111111 01


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ...   ....+.+++.+||+.||++|||+++++++-
T Consensus       275 ~~~---~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          275 SGH---WSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             CCC---CCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            111   123477889999999999999999998763

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3e-35  Score=310.63  Aligned_cols=244  Identities=19%  Similarity=0.287  Sum_probs=187.0

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCc--hhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQ--TVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+........  ......+.+|+.           .+++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            56889999999999999999665 699999999875432211  112445555544           3677888888999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeecC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY----EAHVADFGI  729 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG~  729 (849)
                      +||||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|||.
T Consensus        85 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            999999999999998643   3589999999999999999999999   999999999999998877    899999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      +....... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......        .....+......
T Consensus       159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~  229 (283)
T 3bhy_A          159 AHKIEAGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ--------ETLTNISAVNYD  229 (283)
T ss_dssp             CEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCC
T ss_pred             ceeccCCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH--------HHHHHhHhcccC
Confidence            98765432 234457899999999999889999999999999999999999999743211        111111111211


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+..........+.+++.+||+.||++|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          230 FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            1111111223457889999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-35  Score=320.31  Aligned_cols=250  Identities=23%  Similarity=0.383  Sum_probs=179.7

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHH--HHHH-----------Hhhcee-----ec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFL--TEVE-----------AFYGFC-----SH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~--~ei~-----------~~~~~~-----~~  648 (849)
                      .++|+..+.||+|+||.||+|+. +++.||||++....       ...+.  .++.           ++++++     ..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~   83 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG   83 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-------hhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence            36889999999999999999977 58999999986431       11122  2221           233321     12


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeeecCCCcE
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC------FPPIVHRDISSKNLLLDLEYEA  722 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~dlk~~Nill~~~~~~  722 (849)
                      ....++||||+++|+|.+++....    .++.++..++.||+.||+|||+..      .++|+||||||+||+++.++.+
T Consensus        84 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           84 RMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             CEEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             CceEEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence            336789999999999999996433    589999999999999999999862      2389999999999999999999


Q ss_pred             EEeeecCCcccCCCC--------CCeeeccCCccccccccccC-------CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 042123          723 HVADFGIAKSLKPDS--------SNWTEFAGTCGYIAPELAYT-------MKITEKCDVYSFGVLMWEVIKGKHPRDFLS  787 (849)
Q Consensus       723 kl~DfG~a~~~~~~~--------~~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~  787 (849)
                      ||+|||+++.+....        .......||+.|+|||++.+       ..++.++|||||||++|||++|..||....
T Consensus       160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  239 (336)
T 3g2f_A          160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE  239 (336)
T ss_dssp             EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred             EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence            999999998764321        11234568999999999876       456778999999999999999988765332


Q ss_pred             cccccccc---------cccc-----cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          788 SISSSSLN---------TDVA-----LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       788 ~~~~~~~~---------~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ........         ....     ......+.++............+.+++.+||+.||++|||++|+++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~  314 (336)
T 3g2f_A          240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA  314 (336)
T ss_dssp             CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence            21110000         0000     0011122222222222334556889999999999999999999999874

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.2e-35  Score=309.54  Aligned_cols=239  Identities=20%  Similarity=0.327  Sum_probs=185.6

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC--CeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA--RHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~--~~~~l  654 (849)
                      ++|+..+.||+|+||.||+|+.. ++.||||++....  ......+.+.+|+..           +++++...  ...++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            57889999999999999999885 8999999987542  223334567777653           56676665  77899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP--IVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.   +  |+||||||+||+++.++.++++|||++..
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence            999999999999997643 23589999999999999999999998   7  99999999999999999999999998765


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCc---cchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITE---KCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ....     ...+|+.|+|||.+.+..++.   ++||||||+++|||++|+.||........    ..........+..+
T Consensus       163 ~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~  233 (271)
T 3kmu_A          163 FQSP-----GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI----GMKVALEGLRPTIP  233 (271)
T ss_dssp             TSCT-----TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH----HHHHHHSCCCCCCC
T ss_pred             eccc-----CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH----HHHHHhcCCCCCCC
Confidence            4332     246899999999998765544   79999999999999999999974332110    00001111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                        ...    ...+.+++.+||+.||++|||++++++.|+
T Consensus       234 --~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~  266 (271)
T 3kmu_A          234 --PGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILE  266 (271)
T ss_dssp             --TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --CCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence              111    234788999999999999999999999875

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.2e-35  Score=318.07  Aligned_cols=243  Identities=26%  Similarity=0.407  Sum_probs=180.3

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcE----EEEEEecccCCCCc---hhhHHHHHH-----HHHHhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEV----VAVKKFHSLLPCDQ---TVDQKEFLT-----EVEAFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~~~~~---~~~~~~~~~-----ei~~~~~~~~~~~~~~l  654 (849)
                      ++|+..+.||+|+||+||+|.+. +++.    ||+|.+........   ...+...++     .+..+++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57888999999999999999653 4544    78887754321111   111112221     2445777775 467889


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999997543  3589999999999999999999999   99999999999999999999999999998775


Q ss_pred             CCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCC
Q 042123          735 PDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPA  810 (849)
Q Consensus       735 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~  810 (849)
                      ....  ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......        ....+... ....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  238 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEKGERLAQ  238 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHTTCBCCC
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCCCCCC
Confidence            4432  2344567889999999998999999999999999999999 999997533211        11111111 1111


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +....    ..+.+++.+||+.||++|||+.+++++|+
T Consensus       239 ~~~~~----~~~~~li~~~l~~dp~~Rps~~el~~~l~  272 (325)
T 3kex_A          239 PQICT----IDVYMVMVKCWMIDENIRPTFKELANEFT  272 (325)
T ss_dssp             CTTBC----TTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred             CCcCc----HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111    13678899999999999999999999874

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=327.78  Aligned_cols=254  Identities=20%  Similarity=0.302  Sum_probs=190.8

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC--eeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR--HSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~--~~~  653 (849)
                      ++|.+.+.||+|+||+||+|+.. +|+.||||++.....   ......+.+|+.           .+++++....  ..+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            57889999999999999999664 599999999875321   112334445544           3556665544  779


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEeeecC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL----DLEYEAHVADFGI  729 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~DfG~  729 (849)
                      +||||+++|+|.+++........+++.++..++.||+.||+|||+.   +|+||||||+||++    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999998766555599999999999999999999999   99999999999999    7778899999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccC--------CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccc--
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYT--------MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA--  799 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~--  799 (849)
                      ++...... ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||................  
T Consensus       163 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          163 ARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             CEECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             ceEccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            98765432 2344679999999998864        567889999999999999999999996432211000000000  


Q ss_pred             ---------ccc------ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 ---------LDQ------MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ---------~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                               ...      ......+............+.+++.+||+.||++|||++|+++.++
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~  305 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHH
Confidence                     000      0111222223334556667889999999999999999999988763

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-36  Score=326.11  Aligned_cols=246  Identities=21%  Similarity=0.341  Sum_probs=185.5

Q ss_pred             cCCCcCceecCCccceEEEEEe----cCCcEEEEEEecccCC------CCchhhHHHHHHH------HHHhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLP------CDQTVDQKEFLTE------VEAFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~------~~~~~~~~~~~~e------i~~~~~~~~~~~~  651 (849)
                      ++|+..+.||+|+||.||+|+.    .+++.||||++.....      ......+...++.      +..+++++.....
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            6799999999999999999976    4789999999864211      1111223333333      3346778888889


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            99999999999999999653   3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC-CCeeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          732 SLKPDS-SNWTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       732 ~~~~~~-~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      .+.... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......    ..............
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~  283 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSEP  283 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHCCC
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----hHHHHHHHHhccCC
Confidence            664322 22334679999999999885  347889999999999999999999997432111    11111112222222


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRP-----TMKIISQQL  847 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~L  847 (849)
                      ..+...    ...+.+++.+||+.||++||     |++|++++.
T Consensus       284 ~~~~~~----~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          284 PYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CCCccc----CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            211112    23477899999999999999     999999875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.1e-35  Score=311.53  Aligned_cols=239  Identities=26%  Similarity=0.411  Sum_probs=189.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|+..+.||+|+||.||+|.. .+++.||||.+......   .....+.+|+.           .+++++......++|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE---DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS---TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence            5788999999999999999964 57899999998654321   22344555543           367778888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++..    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        99 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A           99 MEYLGGGSALDLLEP----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             EECCTTEEHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EEeCCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            999999999999864    3489999999999999999999999   999999999999999999999999999987655


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........     ........+...  ... 
T Consensus       172 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~--~~~-  243 (303)
T 3a7i_A          172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-----FLIPKNNPPTLE--GNY-  243 (303)
T ss_dssp             TBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCCC--SSC-
T ss_pred             cccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-----HHhhcCCCCCCc--ccc-
Confidence            443445567899999999999999999999999999999999999999743321100     000000011111  111 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                         ...+.+++.+||+.||++|||+++++++.
T Consensus       244 ---~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          244 ---SKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             ---CHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             ---CHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence               22378899999999999999999998863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.6e-35  Score=327.47  Aligned_cols=252  Identities=21%  Similarity=0.349  Sum_probs=173.4

Q ss_pred             HHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecC--
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHA--  649 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~--  649 (849)
                      ...++|+..+.||+|+||.||+|.. .+|+.||||++.....  .......+.+|+.            .+++++...  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~   83 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ--NSTDAQRTFREIMILTELSGHENIVNLLNVLRADND   83 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C--CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence            3457899999999999999999954 5799999999865322  2233344445543            245555433  


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...|+||||++ |+|.+++..    ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           84 RDVYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             SCEEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            37899999998 589988864    3589999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCC---------------------CCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccc
Q 042123          730 AKSLKPD---------------------SSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLS  787 (849)
Q Consensus       730 a~~~~~~---------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~  787 (849)
                      |+.+...                     .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            9865321                     112344679999999999876 678999999999999999999999997543


Q ss_pred             cccccc-------cccccccccc---------------c---CCCCCCCChhhH----------HHHHHHHHHHhhccCC
Q 042123          788 SISSSS-------LNTDVALDQM---------------L---DPRLPAPSRSAQ----------EKLISIMEVAFSCFNE  832 (849)
Q Consensus       788 ~~~~~~-------~~~~~~~~~~---------------~---~~~~~~~~~~~~----------~~~~~l~~li~~cl~~  832 (849)
                      ......       ..........               .   ............          .....+.+++.+||+.
T Consensus       236 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~  315 (388)
T 3oz6_A          236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF  315 (388)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred             HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence            211000       0000000000               0   000000000000          1123578999999999


Q ss_pred             CCCCCCCHHHHHhh
Q 042123          833 SPESRPTMKIISQQ  846 (849)
Q Consensus       833 dP~~RPt~~eil~~  846 (849)
                      ||++|||++|+++|
T Consensus       316 dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          316 NPNKRISANDALKH  329 (388)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999987

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-35  Score=309.37  Aligned_cols=240  Identities=26%  Similarity=0.434  Sum_probs=188.8

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||.||+|...+++.||+|.+.....     ..+.+.+|+.           ++++++...+..++|
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   81 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence            367888999999999999999888889999999876422     1234555544           367778888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             ECCCTTCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EeCCCCCcHHHHHhhCc--ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccc
Confidence            99999999999996543  3589999999999999999999999   999999999999999999999999999986643


Q ss_pred             CC-CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCC
Q 042123          736 DS-SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-LPAPS  812 (849)
Q Consensus       736 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  812 (849)
                      .. .......+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||......        .....+.... ...+.
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~  228 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKPR  228 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTCCCCCCT
T ss_pred             ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH--------HHHHHHhcCCcCCCCc
Confidence            21 11223456778999999998899999999999999999999 89998743211        1111111111 11111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..    ...+.+++.+||+.||++|||+++++++|+
T Consensus       229 ~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~L~  260 (267)
T 3t9t_A          229 LA----STHVYQIMNHCWRERPEDRPAFSRLLRQLA  260 (267)
T ss_dssp             TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cC----cHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11    234778999999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.2e-35  Score=311.84  Aligned_cols=242  Identities=24%  Similarity=0.362  Sum_probs=180.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|...+.||+|+||.||+|+. .++..||+|++......   .....+.+|+.           .+++++......++|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ---VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc---hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            6789999999999999999965 57899999998764321   12344555544           367888888999999


Q ss_pred             EEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeecCCc
Q 042123          656 YEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADFGIAK  731 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~a~  731 (849)
                      |||+++|+|.+++.... ....+++.++..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++.
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~  175 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE  175 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence            99999999999986542 235689999999999999999999999   99999999999999   456889999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ...... ......|++.|+|||.+. ..++.++||||+|+++|||++|+.||.........      .......+.....
T Consensus       176 ~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~------~~~~~~~~~~~~~  247 (285)
T 3is5_A          176 LFKSDE-HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ------QKATYKEPNYAVE  247 (285)
T ss_dssp             C-----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCCCCCC-
T ss_pred             ecCCcc-cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH------hhhccCCcccccc
Confidence            765432 234567899999999875 56899999999999999999999999743311100      0000011111110


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..   .....+.+++.+||+.||++|||++|++++
T Consensus       248 ~~---~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          248 CR---PLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             -C---CCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cC---cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00   012347789999999999999999999976

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.3e-35  Score=325.97  Aligned_cols=246  Identities=11%  Similarity=0.035  Sum_probs=176.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH---HHhh-----------------cee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV---EAFY-----------------GFC  646 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei---~~~~-----------------~~~  646 (849)
                      .+|...+.||+|+||.||+|++ .+++.||||++...... .......+.+|+   ..+.                 +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAEN-SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTT-HHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccc-cccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            4588899999999999999975 47899999999764321 222233333331   1111                 222


Q ss_pred             ecC-----------------CeeEEEEEeccCCChhhhhcccccccCCCHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 042123          647 SHA-----------------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQR------MNVIKAVAHALSYLHHDCFPP  703 (849)
Q Consensus       647 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~  703 (849)
                      ...                 ...++||||++ |+|.+++....  ..+++..+      ..++.||+.||+|||+.   +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~  214 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSK---G  214 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence            111                 34799999999 89999997643  23455566      78889999999999999   9


Q ss_pred             eEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCC
Q 042123          704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKH  781 (849)
Q Consensus       704 ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~  781 (849)
                      |+||||||+|||++.++.+||+|||+++....   ......+|+.|+|||++.+  ..++.++|||||||++|||++|+.
T Consensus       215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999986542   2224567799999999987  678999999999999999999999


Q ss_pred             CCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          782 PRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       782 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ||.............. ............+  ........+.+++.+||+.||++|||++++++|
T Consensus       292 Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRP-SLRVPGTDSLAFG--SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             STTBCCTTCTTCCCBC-CTTSCCCCSCCCT--TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCCcCcccccchhhh-hhhhccccccchh--hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9985432211111100 0000011111111  011122347889999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-35  Score=320.17  Aligned_cols=250  Identities=22%  Similarity=0.385  Sum_probs=192.6

Q ss_pred             HHHHHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhc
Q 042123          582 EIVKATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYG  644 (849)
Q Consensus       582 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~  644 (849)
                      ++....++|+..+.||+|+||.||+|...      +++.||||.+....   .......+.+|+.           ++++
T Consensus        19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc---CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            34445678999999999999999999653      47889999986532   2233445666655           3667


Q ss_pred             eeecCCeeEEEEEeccCCChhhhhcccccc-------cCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 042123          645 FCSHARHSFLLYEFLERGSLAAILNTDAAA-------QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD  717 (849)
Q Consensus       645 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  717 (849)
                      ++.+....++||||+++|+|.+++......       ..+++.++..++.|++.||+|||+.   +|+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence            788888999999999999999999754321       3578999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccc
Q 042123          718 LEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSL  794 (849)
Q Consensus       718 ~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~  794 (849)
                      .++.+||+|||+++........  .....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||......     
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----  247 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-----  247 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----
Confidence            9999999999999865432211  122346788999999998899999999999999999999 89998743211     


Q ss_pred             ccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         .....+..........   .....+.+++.+||+.||++|||+.|++++|+
T Consensus       248 ---~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~  295 (322)
T 1p4o_A          248 ---QVLRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  295 (322)
T ss_dssp             ---HHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             ---HHHHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence               1112222222211111   11234778999999999999999999999885

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=323.16  Aligned_cols=248  Identities=19%  Similarity=0.238  Sum_probs=177.3

Q ss_pred             cCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHH---------HHHHHHH-----------Hhh
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQK---------EFLTEVE-----------AFY  643 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~---------~~~~ei~-----------~~~  643 (849)
                      ++|...+.||+|+||.||+|...    ++..+|||++.....  ......         .+.+|+.           .++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG--PLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C--HHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc--chHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            57899999999999999999764    578899999875421  111111         2223322           355


Q ss_pred             ceeec----CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          644 GFCSH----ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       644 ~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      +++..    ....++||||+ +++|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.+
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence            66655    67899999999 999999997543   589999999999999999999999   99999999999999988


Q ss_pred             C--cEEEeeecCCcccCCCCC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc
Q 042123          720 Y--EAHVADFGIAKSLKPDSS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSIS  790 (849)
Q Consensus       720 ~--~~kl~DfG~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~  790 (849)
                      +  .+||+|||+++.+.....       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999986643211       1244578999999999999999999999999999999999999996321110


Q ss_pred             ccccccccccccccCCCCCCCChh---hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPRLPAPSRS---AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..    ...........++.....   .......+.+++.+||+.||++|||+++|++.|+
T Consensus       268 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  324 (345)
T 2v62_A          268 VA----VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILN  324 (345)
T ss_dssp             HH----HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHC
T ss_pred             HH----HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence            00    000000001111100000   0011235889999999999999999999999885

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.8e-35  Score=318.20  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=187.3

Q ss_pred             HHHHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHH-------------HHhhcee
Q 042123          580 YDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-------------EAFYGFC  646 (849)
Q Consensus       580 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-------------~~~~~~~  646 (849)
                      ........++|+..+.||+|+||.||+|+. +++.||||.+....       ...+.+|+             ..+++++
T Consensus        34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-------~~~~~~e~~~~~~~~l~h~ni~~~~~~~  105 (342)
T 1b6c_B           34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAAD  105 (342)
T ss_dssp             HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG-------HHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred             eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh-------HHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence            333445668999999999999999999988 48999999986431       12222332             2356666


Q ss_pred             ecCC----eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCe
Q 042123          647 SHAR----HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH--------HDCFPPIVHRDISSKNL  714 (849)
Q Consensus       647 ~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~dlk~~Ni  714 (849)
                      ....    ..++||||+++|+|.+++.+.    .+++.+++.++.|++.||+|||        +.   +|+||||||+||
T Consensus       106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NI  178 (342)
T 1b6c_B          106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNI  178 (342)
T ss_dssp             ECCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGE
T ss_pred             cccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHE
Confidence            6554    789999999999999999643    4899999999999999999999        66   999999999999


Q ss_pred             eecCCCcEEEeeecCCcccCCCCCC----eeeccCCccccccccccCC------CCCccchHHHHHHHHHHHHhC-----
Q 042123          715 LLDLEYEAHVADFGIAKSLKPDSSN----WTEFAGTCGYIAPELAYTM------KITEKCDVYSFGVLMWEVIKG-----  779 (849)
Q Consensus       715 ll~~~~~~kl~DfG~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg-----  779 (849)
                      +++.++.+||+|||++.........    .....||+.|+|||.+.+.      .++.++||||||+++|||++|     
T Consensus       179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~  258 (342)
T 1b6c_B          179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  258 (342)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence            9999999999999999876543321    2345789999999998765      334789999999999999999     


Q ss_pred             -----CCCCCccccccccccccccccccc----cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          780 -----KHPRDFLSSISSSSLNTDVALDQM----LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       780 -----~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                           +.||.......   .........+    ..+.++... ...+....+.+++.+||+.||++|||+++|+++|+
T Consensus       259 ~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          259 IHEDYQLPYYDLVPSD---PSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             BCCCCCCTTTTTSCSS---CCHHHHHHHHTTSCCCCCCCGGG-GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccccCccccCcCc---ccHHHHHHHHHHHHhCCCCcccc-cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence                 67775332111   0111111111    122222111 12345567889999999999999999999999885

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-35  Score=320.46  Aligned_cols=240  Identities=25%  Similarity=0.433  Sum_probs=174.0

Q ss_pred             CCCcCceecCCccceEEEEEec--C--CcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceee-cCCee
Q 042123          589 DFDAKYCIGNGGHASVYRAELP--S--GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCS-HARHS  652 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~-~~~~~  652 (849)
                      .|...+.||+|+||.||+|.+.  +  +..||||.+...   ......+.+.+|+.           ++++++. .++..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  166 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  166 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence            4566789999999999999653  2  236899987643   22234556777755           3566654 45678


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus       167 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~  241 (373)
T 3c1x_A          167 LVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD  241 (373)
T ss_dssp             EEEEECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEECCCCCCHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccc
Confidence            99999999999999996543  3588999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCC----CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 042123          733 LKPDSS----NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       733 ~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      ......    ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.......        ....+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--------~~~~~~~~~  313 (373)
T 3c1x_A          242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--------ITVYLLQGR  313 (373)
T ss_dssp             ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--------HHHHHHTTC
T ss_pred             ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--------HHHHHHcCC
Confidence            643221    1233456788999999999999999999999999999999 677776432211        111111111


Q ss_pred             C-CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 L-PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      . ..+...    ...+.+++.+||+.||++|||++|++++|+
T Consensus       314 ~~~~p~~~----~~~l~~li~~cl~~dp~~RPs~~ell~~L~  351 (373)
T 3c1x_A          314 RLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRIS  351 (373)
T ss_dssp             CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1 111112    224788999999999999999999999874

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2.1e-34  Score=313.72  Aligned_cols=306  Identities=23%  Similarity=0.353  Sum_probs=142.4

Q ss_pred             ccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCc
Q 042123           50 ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFD  129 (849)
Q Consensus        50 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~  129 (849)
                      +..+++|++|++++|.++..        ..+..+++|++|++++|.+++..+  +.++++|++|++++|+++++  .+|.
T Consensus        40 ~~~l~~L~~L~l~~~~i~~~--------~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~  107 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVASI--------QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQ  107 (347)
T ss_dssp             HHHHTTCSEEECCSSCCCCC--------TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGT
T ss_pred             chhcccccEEEEeCCccccc--------hhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHc
Confidence            44566666666666665421        123445555555555555553322  55555555555555555532  2355


Q ss_pred             CCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEE
Q 042123          130 NLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVL  209 (849)
Q Consensus       130 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  209 (849)
                      ++++|++|++++|.+++..+  +..+++|+.|++++|...... ..+..+++|++|++++|++....+  +..+++|++|
T Consensus       108 ~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L  182 (347)
T 4fmz_A          108 NLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL  182 (347)
T ss_dssp             TCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEE
T ss_pred             CCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEE
Confidence            55555555555555543222  455555555555555333222 224555555555555555542221  4445555555


Q ss_pred             eccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeeccccccc
Q 042123          210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQG  289 (849)
Q Consensus       210 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~  289 (849)
                      ++++|.+.+..+  +..+++|+.|++++|.+.                       +..+  +..+++|+.|++++|++++
T Consensus       183 ~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~-----------------------~~~~--~~~~~~L~~L~l~~n~l~~  235 (347)
T 4fmz_A          183 SLNYNQIEDISP--LASLTSLHYFTAYVNQIT-----------------------DITP--VANMTRLNSLKIGNNKITD  235 (347)
T ss_dssp             ECTTSCCCCCGG--GGGCTTCCEEECCSSCCC-----------------------CCGG--GGGCTTCCEEECCSSCCCC
T ss_pred             EccCCccccccc--ccCCCccceeecccCCCC-----------------------CCch--hhcCCcCCEEEccCCccCC
Confidence            555555543211  444444444444444443                       1111  2333444444444444443


Q ss_pred             ccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccc
Q 042123          290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGN  369 (849)
Q Consensus       290 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~  369 (849)
                      ..+  +..+++|++|++++|.+++.  ..+..+++|++|++++|++.+.  ..+..+++|+.|++++|.+++..|..+..
T Consensus       236 ~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~  309 (347)
T 4fmz_A          236 LSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGG  309 (347)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHT
T ss_pred             Ccc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhc
Confidence            322  44444555555555554432  2344444555555555544432  22444444555555555444444444444


Q ss_pred             cccccccccccccccccCchhhcCCCCCcEEEccCccc
Q 042123          370 SSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQI  407 (849)
Q Consensus       370 l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l  407 (849)
                      +++|+.|++++|++++..|  +..+++|++|++++|+|
T Consensus       310 l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i  345 (347)
T 4fmz_A          310 LTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI  345 (347)
T ss_dssp             CTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred             cccCCEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence            4444444454444443333  44444455555555444

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.5e-35  Score=315.23  Aligned_cols=247  Identities=22%  Similarity=0.332  Sum_probs=180.0

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||.||+|... +++.||||.+...... .......+.+|+.           .+++++...+..+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGG-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCccccc-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            3478999999999999999999654 7899999998754221 1222345556654           3677888889999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++...
T Consensus       111 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999999653   3589999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCC-CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          734 KPDS-SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       734 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||......         .....+....+.+.
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~~  255 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---------VMGAHINQAIPRPS  255 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---------HHHHHHHSCCCCGG
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---------HHHHHhccCCCCcc
Confidence            5432 2233457899999999999989999999999999999999999999743321         01111111111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCC-CHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRP-TMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~  848 (849)
                      .........+.+++.+||+.||++|| |++++++.|+
T Consensus       256 ~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~  292 (309)
T 2h34_A          256 TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAH  292 (309)
T ss_dssp             GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHH
Confidence            11111222477899999999999999 9999998874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.3e-35  Score=313.48  Aligned_cols=249  Identities=22%  Similarity=0.382  Sum_probs=185.4

Q ss_pred             cCCCcCceecCCccceEEEEEe-----cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC--
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA--  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~--  649 (849)
                      +.|+..+.||+|+||.||+|++     .+++.||||++.....   ......+.+|+.           .+++++...  
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc---chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            4688889999999999999973     4689999999875422   122344555554           256666655  


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence            56899999999999999996443  3589999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCC---CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccc------c-cccccccc
Q 042123          730 AKSLKPDSS---NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSIS------S-SSLNTDVA  799 (849)
Q Consensus       730 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~------~-~~~~~~~~  799 (849)
                      +........   ......+|..|+|||.+.+..++.++||||+|+++|||++|+.|+.......      . ........
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987765432   2234567888999999999999999999999999999999999865321100      0 00000111


Q ss_pred             cccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....... ..+.+...    ...+.+++.+||+.||++|||++++++.|+
T Consensus       253 ~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  298 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNC----PDEVYQLMRKCWEFQPSNRTSFQNLIEGFE  298 (302)
T ss_dssp             HHHHHTTCCCCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhccCCCCCCCCC----CHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence            1111111 11111112    234889999999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=315.57  Aligned_cols=241  Identities=25%  Similarity=0.413  Sum_probs=183.5

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||.||+|... +|+.||||.+.....      ...+.+|+.           .+++++......+
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC------CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH------HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            4578999999999999999999664 689999999875321      123344433           4677888888999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++|+|.+++...  ...+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||.+...
T Consensus       101 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            999999999999998632  24589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ...........|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........     ........+....+  
T Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~--  248 (314)
T 3com_A          176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-----FMIPTNPPPTFRKP--  248 (314)
T ss_dssp             BTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCCCCSSG--
T ss_pred             hhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCCcccCCc--
Confidence            54433445567899999999999989999999999999999999999999743321100     00000011111111  


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        ......+.+++.+||+.||++|||+.+++++
T Consensus       249 --~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          249 --ELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             --GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             --ccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence              1122347889999999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-35  Score=314.33  Aligned_cols=241  Identities=27%  Similarity=0.462  Sum_probs=180.8

Q ss_pred             cCCCcCceecCCccceEEEEEecC-----CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPS-----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      .+|+..+.||+|+||.||+|....     +..||||.+....   .......+.+|+.           ++++++...+.
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP  120 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCC
Confidence            456678899999999999996542     2459999987532   2233445666654           36778888889


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             cEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            999999999999999986532  4589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-
Q 042123          732 SLKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-  806 (849)
Q Consensus       732 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-  806 (849)
                      ........   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......        .....+.+. 
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~~~  267 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--------EVMKAINDGF  267 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTC
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHCCC
Confidence            76543221   122345778999999999999999999999999999999 99999643221        111222222 


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+.+...    ...+.+++.+||+.||++|||+.+++++|+
T Consensus       268 ~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  305 (333)
T 1mqb_A          268 RLPTPMDC----PSAIYQLMMQCWQQERARRPKFADIVSILD  305 (333)
T ss_dssp             CCCCCTTC----BHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             cCCCcccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            12222222    234788999999999999999999999874

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=9.5e-35  Score=311.13  Aligned_cols=250  Identities=19%  Similarity=0.290  Sum_probs=179.5

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++..... ........+.+|+.           ++++++...+..++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            35799999999999999999965 5799999999875322 12233455666654           35678888889999


Q ss_pred             EEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          655 LYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      ||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++...
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~  186 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF  186 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence            999999999999986532 234589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++|+.||......      .......+.....+... 
T Consensus       187 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~-  259 (310)
T 2wqm_A          187 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCDYPPLP-  259 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC------HHHHHHHHHTTCSCCCC-
T ss_pred             cCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh------HHHHHHHhhcccCCCCc-
Confidence            54443344567899999999999999999999999999999999999998643211      01111111111111111 


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       .......+.+++.+||+.||++|||+++|++.|+
T Consensus       260 -~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~  293 (310)
T 2wqm_A          260 -SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK  293 (310)
T ss_dssp             -TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence             0111234788999999999999999999998874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-35  Score=313.47  Aligned_cols=242  Identities=25%  Similarity=0.429  Sum_probs=189.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||.||+|... ++..||||.+....     ...+.+.+|+.           .+++++......+
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            4578889999999999999999665 58899999986532     22344555544           3677888888999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        86 ~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCC-TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhcc-cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            9999999999999996543 24589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCC
Q 042123          734 KPDSSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPA  810 (849)
Q Consensus       734 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~  810 (849)
                      ...... .....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.......        ....+... ....
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--------~~~~~~~~~~~~~  233 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYRMER  233 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCCCCC
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhccCCCCC
Confidence            543321 223346778999999998899999999999999999999 999987433211        11111111 1111


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +...    ...+.+++.+||+.||++|||++++++.|+
T Consensus       234 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~  267 (288)
T 3kfa_A          234 PEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFE  267 (288)
T ss_dssp             CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHH
Confidence            1111    234788999999999999999999999874

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.7e-35  Score=308.60  Aligned_cols=238  Identities=24%  Similarity=0.374  Sum_probs=187.3

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+...... .......+.+|+.           ++++++.+.+..++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            67889999999999999999654 6889999998642110 1111234455543           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999998654   3589999999999999999999998   999999999999999999999999999876543


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .  ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......        .....+.......+....
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~  236 (284)
T 2vgo_A          167 L--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT--------ETHRRIVNVDLKFPPFLS  236 (284)
T ss_dssp             S--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHTTCCCCCTTSC
T ss_pred             c--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh--------HHHHHHhccccCCCCcCC
Confidence            2  234467899999999999999999999999999999999999999743211        111222222222222222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ..+.+++.+||+.||++|||+++++++
T Consensus       237 ----~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          237 ----DGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             ----HHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             ----HHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                247789999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.5e-35  Score=311.02  Aligned_cols=246  Identities=22%  Similarity=0.431  Sum_probs=176.0

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||+||+|+..  ..||||++.....  .....+.+.+|+..           +++++ .....++|
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCC--CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            468999999999999999999874  3599999865432  23334566677653           44443 45668999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        98 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccc
Confidence            99999999999996543  4589999999999999999999999   999999999999999999999999999986543


Q ss_pred             C--CCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          736 D--SSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       736 ~--~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      .  ........||+.|+|||.+.   +..++.++||||+|+++|||++|+.||........   ...........+....
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~  249 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLSPDLSK  249 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH---HHHHHHHTSCCCCTTS
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH---HHHHhcccccCcchhh
Confidence            2  22234457899999999986   56788899999999999999999999974332110   0000000011111111


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         ........+.+++.+||+.||++|||++++++.|+
T Consensus       250 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~  284 (289)
T 3og7_A          250 ---VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIE  284 (289)
T ss_dssp             ---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence               11112234888999999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-35  Score=311.37  Aligned_cols=246  Identities=22%  Similarity=0.360  Sum_probs=187.3

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhcee--ecCCee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFC--SHARHS  652 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~--~~~~~~  652 (849)
                      .++|+..+.||+|+||.||+|+. .+++.||+|.+.....  .....+.+.+|+..           +++++  ......
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            36788999999999999999965 4789999999875322  22334456666543           45554  345688


Q ss_pred             EEEEEeccCCChhhhhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCCeeecCCCcEEEee
Q 042123          653 FLLYEFLERGSLAAILNTDAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPP-----IVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-----ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                      ++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+.   +     |+||||||+||+++.++.+||+|
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d  159 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD  159 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence            999999999999999975432 23489999999999999999999998   7     99999999999999999999999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP  806 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~  806 (849)
                      ||.++.............|++.|+|||.+.+..++.++||||||+++|+|++|+.||......        .....+...
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~  231 (279)
T 2w5a_A          160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREG  231 (279)
T ss_dssp             CCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHT
T ss_pred             CchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH--------HHHHHHhhc
Confidence            999987654333233457899999999999989999999999999999999999999744321        111111122


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+....   .....+.+++.+||+.||++|||++||++++.
T Consensus       232 ~~~~~~~---~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          232 KFRRIPY---RYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             CCCCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ccccCCc---ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence            2111111   11234788999999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-34  Score=326.39  Aligned_cols=248  Identities=20%  Similarity=0.292  Sum_probs=178.6

Q ss_pred             hcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|. ..+++.||||++....  ......+.+.+|+.           ++++++...     
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            4689999999999999999995 4578999999987542  12233445556654           355665433     


Q ss_pred             -CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          650 -RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       650 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                       ...|+||||++++ +.+.+..     .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       139 ~~~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          139 FQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             CCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             CCeEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence             4679999999874 6565532     389999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------------c
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS--------------L  794 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~--------------~  794 (849)
                      +++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+......              .
T Consensus       210 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          210 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             CC-----C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eeeecCCC-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            99876543 23455789999999999999999999999999999999999999997543111000              0


Q ss_pred             ccccccccccCCC----------------CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 NTDVALDQMLDPR----------------LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .........+...                .+............+.+++.+||+.||++|||++|+++|
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000000011100                111111122234568899999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.2e-35  Score=305.69  Aligned_cols=244  Identities=24%  Similarity=0.330  Sum_probs=187.6

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||.||+|... +++.||||.+.....   ......+.+|+.           ++++++.+.+..+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC---TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc---hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence            3468999999999999999999654 789999999864322   122344455543           3677888888999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+...
T Consensus        82 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           82 LFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            999999999999998653   3489999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCC--CCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          734 KPDS--SNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       734 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      ....  .......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||.......       .....+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~  228 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-------QEYSDWKEKKTYL  228 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-------HHHHHHHTTCTTS
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHhhhccccc
Confidence            4221  22344578999999999987765 778999999999999999999997433210       0111111111110


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      .  ........+.+++.+||+.||++|||++|++++-
T Consensus       229 ~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  263 (276)
T 2yex_A          229 N--PWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (276)
T ss_dssp             T--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             C--chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence            0  1112233477899999999999999999998863

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=4.4e-34  Score=311.23  Aligned_cols=308  Identities=23%  Similarity=0.319  Sum_probs=244.3

Q ss_pred             cCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccC
Q 042123           25 SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI  104 (849)
Q Consensus        25 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  104 (849)
                      .+..+++|++|++++|++..+.  .+..+++|++|+|++|++++..        .+..+++|++|++++|.+++.  +.|
T Consensus        39 ~~~~l~~L~~L~l~~~~i~~~~--~~~~~~~L~~L~l~~n~i~~~~--------~~~~l~~L~~L~L~~n~i~~~--~~~  106 (347)
T 4fmz_A           39 TQEELESITKLVVAGEKVASIQ--GIEYLTNLEYLNLNGNQITDIS--------PLSNLVKLTNLYIGTNKITDI--SAL  106 (347)
T ss_dssp             CHHHHTTCSEEECCSSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--------GGTTCTTCCEEECCSSCCCCC--GGG
T ss_pred             cchhcccccEEEEeCCccccch--hhhhcCCccEEEccCCccccch--------hhhcCCcCCEEEccCCcccCc--hHH
Confidence            3567899999999999997653  3999999999999999997421        167899999999999999864  479


Q ss_pred             CCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCE
Q 042123          105 GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVST  184 (849)
Q Consensus       105 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  184 (849)
                      .++++|++|++++|++++..+  +..+++|++|++++|..... +..+..+++|++|++++|.+.++.+  +..+++|++
T Consensus       107 ~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~  181 (347)
T 4fmz_A          107 QNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYS  181 (347)
T ss_dssp             TTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSE
T ss_pred             cCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCccc-ccchhhCCCCcEEEecCCCcCCchh--hccCCCCCE
Confidence            999999999999999996544  89999999999999966544 3459999999999999999988654  889999999


Q ss_pred             EEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCC
Q 042123          185 LRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFT  264 (849)
Q Consensus       185 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~  264 (849)
                      |++++|++.+. +. +..+++|+.|++++|.+.+..+  +..+++|++|++++|.+++ ++.                  
T Consensus       182 L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~------------------  238 (347)
T 4fmz_A          182 LSLNYNQIEDI-SP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP------------------  238 (347)
T ss_dssp             EECTTSCCCCC-GG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG------------------
T ss_pred             EEccCCccccc-cc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc------------------
Confidence            99999999844 43 8899999999999999986544  8889999999999998873 222                  


Q ss_pred             CCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCC
Q 042123          265 GYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWG  344 (849)
Q Consensus       265 ~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  344 (849)
                            +..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++.  ..+..+++|+.|++++|++.+..+..+.
T Consensus       239 ------~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~  308 (347)
T 4fmz_A          239 ------LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIG  308 (347)
T ss_dssp             ------GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred             ------hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence                  34455666677777666643  3466677777777777777754  3466777777777777777777777777


Q ss_pred             CCCCCcEEeccCCccccCCCCCcccccccccccccccccc
Q 042123          345 KFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIV  384 (849)
Q Consensus       345 ~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~  384 (849)
                      .+++|++|++++|.+++..|  +..+++|+.|++++|.|+
T Consensus       309 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            77777777777777775544  677777778888777764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=308.28  Aligned_cols=243  Identities=22%  Similarity=0.313  Sum_probs=182.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|.....||+|+||.||+|.. .+++.||||.+.....    .....+.+|+.           .+++++...+..++|
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch----HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            3455666999999999999965 5788999999865421    22334445543           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-CCcEEEeeecCCcccC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-EYEAHVADFGIAKSLK  734 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-~~~~kl~DfG~a~~~~  734 (849)
                      |||+++++|.+++........+++..+..++.|++.||+|||+.   +|+||||||+||+++. ++.+||+|||.+....
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999999997654444577899999999999999999999   9999999999999987 8999999999998765


Q ss_pred             CCCCCeeeccCCccccccccccCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMK--ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ..........|++.|+|||.+.+..  ++.++||||||+++|+|++|+.||.........   ..........+.++  .
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~--~  249 (295)
T 2clq_A          175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGMFKVHPEIP--E  249 (295)
T ss_dssp             C-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHHHCCCCCCC--T
T ss_pred             CCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhcccccccccc--c
Confidence            4433344567899999999987643  789999999999999999999999643211100   00000001111221  1


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..    ...+.+++.+||+.||++|||+++++++
T Consensus       250 ~~----~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          250 SM----SAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             TS----CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             cC----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11    2347788999999999999999999875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.5e-35  Score=316.60  Aligned_cols=252  Identities=22%  Similarity=0.396  Sum_probs=190.2

Q ss_pred             HHHHHHHhcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHHH------------
Q 042123          580 YDEIVKATNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------------  641 (849)
Q Consensus       580 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~------------  641 (849)
                      ..++....++|+..+.||+|+||.||+|+.      .+++.||||.+....   .....+.+.+|+..            
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC---CcHHHHHHHHHHHHHHhcccCCCeee
Confidence            344444567899999999999999999963      356889999987542   22233445555442            


Q ss_pred             hhceeecC-CeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 042123          642 FYGFCSHA-RHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHR  707 (849)
Q Consensus       642 ~~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  707 (849)
                      +++++... ...++||||+++|+|.+++.....             ...+++.++..++.|++.||+|||+.   +|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence            45555544 458999999999999999975432             12278999999999999999999999   99999


Q ss_pred             CCCCCCeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCC
Q 042123          708 DISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRD  784 (849)
Q Consensus       708 dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~  784 (849)
                      ||||+||+++.++.+||+|||+++........  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            99999999999999999999999876544332  223457889999999999999999999999999999998 999987


Q ss_pred             ccccccccccccccccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          785 FLSSISSSSLNTDVALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       785 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......       .....+... ....+...    ...+.+++.+||+.||++|||++|++++|+
T Consensus       253 ~~~~~~-------~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~  306 (316)
T 2xir_A          253 GVKIDE-------EFCRRLKEGTRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLG  306 (316)
T ss_dssp             TCCCSH-------HHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccchhH-------HHHHHhccCccCCCCCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            432110       111111111 11111111    224788999999999999999999999885

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-34  Score=306.61  Aligned_cols=240  Identities=25%  Similarity=0.408  Sum_probs=185.0

Q ss_pred             cCCCcCc-eecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCee
Q 042123          588 NDFDAKY-CIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~  652 (849)
                      ++|.+.. .||+|+||.||+|...   ++..||||.+....   .....+.+.+|+..           +++++ ..+..
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   84 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL   84 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc---chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence            4555555 8999999999999653   57889999987642   22334556666543           56666 45678


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            99999999999999996433  4589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-
Q 042123          733 LKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-  807 (849)
Q Consensus       733 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  807 (849)
                      .......   .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......        .....+.... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~i~~~~~  231 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKR  231 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCC
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHhcCCc
Confidence            7543321   122346789999999988889999999999999999998 99999743321        1111111111 


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+...    ...+.+++.+||+.||++|||+.+++++|+
T Consensus       232 ~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          232 MECPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCc----CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111112    234888999999999999999999999875

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.9e-34  Score=322.09  Aligned_cols=191  Identities=19%  Similarity=0.261  Sum_probs=154.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC-chhhHHHHHHHH-----------HHhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD-QTVDQKEFLTEV-----------EAFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~~~ei-----------~~~~~~~~~~~~~~l  654 (849)
                      .+|++.+.||+|+||.||+|.. .+++.||||++....... ....+..+++++           ..+++++......++
T Consensus        97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l  176 (429)
T 3kvw_A           97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM  176 (429)
T ss_dssp             TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred             CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence            5799999999999999999954 568999999986531100 001111222222           135667777889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc--EEEeeecCCcc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE--AHVADFGIAKS  732 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~--~kl~DfG~a~~  732 (849)
                      ||||++ ++|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.  +||+|||++..
T Consensus       177 v~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          177 TFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            999996 59999886543 23489999999999999999999999   9999999999999999987  99999999976


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFL  786 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~  786 (849)
                      ....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       252 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          252 EHQR---VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             TTCC---CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCc---ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            5432   23467899999999999999999999999999999999999999754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.3e-35  Score=311.53  Aligned_cols=240  Identities=20%  Similarity=0.296  Sum_probs=185.3

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+......    ....+.+|+.           .+++++......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF----RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL   83 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc----chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence            467899999999999999999654 7999999998753211    1223444433           36778888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~a~  731 (849)
                      ||||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||++   +.++.+||+|||++.
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           84 VMQLVSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEcCCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            99999999999998643   3589999999999999999999999   99999999999999   778999999999997


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      .....  ......|++.|+|||.+.+..++.++||||+|+++|+|++|+.||......        .....+.......+
T Consensus       158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~~~~~i~~~~~~~~  227 (304)
T 2jam_A          158 MEQNG--IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES--------KLFEKIKEGYYEFE  227 (304)
T ss_dssp             CCCCB--TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHCCCCCC
T ss_pred             ecCCC--ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCC
Confidence            65432  234456899999999999999999999999999999999999999743211        11111111111111


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........+.+++.+||+.||++|||++|++++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111222347889999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.6e-35  Score=306.41  Aligned_cols=240  Identities=23%  Similarity=0.408  Sum_probs=185.8

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||.||+|...++..||||.+.....     ....+.+|+.           ++++++. .+..++|
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            367888999999999999999988888999999865321     1334555544           2556654 4568899


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+.....
T Consensus        86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            99999999999997543 23589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      ... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......        .....+... ....+.
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~  233 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--------EVIQNLERGYRMVRPD  233 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCCT
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH--------HHHHHHhcccCCCCcc
Confidence            321 1122346778999999988889999999999999999999 99998743221        111111111 111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..    ...+.+++.+||+.||++|||++++++.|+
T Consensus       234 ~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  265 (279)
T 1qpc_A          234 NC----PEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (279)
T ss_dssp             TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cc----cHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            11    234788999999999999999999998874

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5e-35  Score=315.71  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=187.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-----cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceee--cC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCS--HA  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~--~~  649 (849)
                      ++|+..+.||+|+||.||+|++     .+++.||||++...    .....+.+.+|+..           +++++.  ..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   98 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR   98 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence            5788899999999999999973     46889999998753    22334456666553           445543  45


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           99 QSLRLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             CEEEEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             ceEEEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence            67899999999999999997543  3489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------cc-ccccc
Q 042123          730 AKSLKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS------SL-NTDVA  799 (849)
Q Consensus       730 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~------~~-~~~~~  799 (849)
                      ++........   .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.........      .. .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            9876544321   22345788899999999988999999999999999999999998643221000      00 00011


Q ss_pred             cccccCCC-CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDPR-LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ........ .+.+..    ....+.+++.+||+.||++|||++|++++|+
T Consensus       254 ~~~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  299 (327)
T 3lxl_A          254 LELLEEGQRLPAPPA----CPAEVHELMKLCWAPSPQDRPSFSALGPQLD  299 (327)
T ss_dssp             HHHHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHhhcccCCCCCCc----ccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111111 111111    2234788999999999999999999999885

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.2e-35  Score=317.80  Aligned_cols=251  Identities=21%  Similarity=0.350  Sum_probs=182.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|+.. +++.||||++....  ......+.+.+|+.           .+++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            67889999999999999999664 68999999986542  22223344555544           367888888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.++....   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       103 ~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          103 FEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             EECCSEEHHHHHHHST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EecCCcchHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999998886543   3489999999999999999999999   999999999999999999999999999987665


Q ss_pred             CCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccccc----------------cccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL----------------NTDV  798 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~----------------~~~~  798 (849)
                      .........+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||...........                ....
T Consensus       177 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          177 PGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             CccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            44445566799999999998775 689999999999999999999999975432110000                0000


Q ss_pred             ccccccCCCCCCCCh---hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALDQMLDPRLPAPSR---SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.......   ........+.+++.+||+.||++|||++|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000000111111000   001123458899999999999999999999876

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-35  Score=324.13  Aligned_cols=235  Identities=14%  Similarity=0.141  Sum_probs=175.2

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH--------------HHhh-------c
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV--------------EAFY-------G  644 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei--------------~~~~-------~  644 (849)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++...... .....+.+.+|+              .+++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-chHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            36788899999999999999975 56999999998743221 122234455554              2344       3


Q ss_pred             eeecCC-----------------eeEEEEEeccCCChhhhhccccc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 042123          645 FCSHAR-----------------HSFLLYEFLERGSLAAILNTDAA----AQELGWSQRMNVIKAVAHALSYLHHDCFPP  703 (849)
Q Consensus       645 ~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~  703 (849)
                      ++...+                 ..++||||+ +|+|.+++.....    ...+++..+..++.||+.||+|||+.   +
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---G  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            433332                 378999999 6799999975431    11244588889999999999999999   9


Q ss_pred             eEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCC-----------CCCccchHHHHHHH
Q 042123          704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM-----------KITEKCDVYSFGVL  772 (849)
Q Consensus       704 ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~Dv~SlGvi  772 (849)
                      |+||||||+|||++.++.+||+|||+++...   .......| +.|+|||++.+.           .++.++|||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999998643   23345567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          773 MWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       773 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +|||++|+.||.......        ....... ...   ..    ...+.+++.+||+.||++|||+.|++++
T Consensus       303 l~elltg~~Pf~~~~~~~--------~~~~~~~-~~~---~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          303 IYWIWCADLPITKDAALG--------GSEWIFR-SCK---NI----PQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHSSCCC------C--------CSGGGGS-SCC---CC----CHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHCCCCCccccccc--------chhhhhh-hcc---CC----CHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            999999999997433211        1111111 111   11    1247889999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.3e-34  Score=305.40  Aligned_cols=241  Identities=22%  Similarity=0.374  Sum_probs=182.0

Q ss_pred             hcCCCcCceecCCccceEEEEEecC----CcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~  651 (849)
                      .++|...+.||+|+||.||+|....    +..||||.+....   .....+.+.+|+..           +++++.+ +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC---TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS---CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc---CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            3678899999999999999996532    3469999987542   22234455666542           5566544 45


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++++|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNK--NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             CEEEEecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCc
Confidence            689999999999999996533  4589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CCC
Q 042123          732 SLKPDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-PRL  808 (849)
Q Consensus       732 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~  808 (849)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......        ....+.. ...
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~~~~  233 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKGDRL  233 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHTCCC
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcCCCC
Confidence            7654322 2233456789999999998899999999999999999998 999996432211        1111111 111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+...    ...+.+++.+||+.||++|||+.|++++|+
T Consensus       234 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~  269 (281)
T 3cc6_A          234 PKPDLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLS  269 (281)
T ss_dssp             CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence            111111    234788999999999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=322.47  Aligned_cols=250  Identities=17%  Similarity=0.249  Sum_probs=182.5

Q ss_pred             cCCCcCceecCCccceEEEEEec---------CCcEEEEEEecccCCCCchhhHHHHHHH-----HHH------------
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP---------SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEA------------  641 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~------------  641 (849)
                      ++|+..+.||+|+||.||+|+..         +++.||||.+...   .....+..+++.     +..            
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCS
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCccC
Confidence            67899999999999999999765         3789999998754   112222223322     222            


Q ss_pred             ---hhceeec-CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec
Q 042123          642 ---FYGFCSH-ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD  717 (849)
Q Consensus       642 ---~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~  717 (849)
                         +++++.. ....++||||+ +|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence               3455554 67889999999 999999997542 34699999999999999999999999   999999999999999


Q ss_pred             CCC--cEEEeeecCCcccCCCCC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccc
Q 042123          718 LEY--EAHVADFGIAKSLKPDSS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSS  788 (849)
Q Consensus       718 ~~~--~~kl~DfG~a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~  788 (849)
                      .++  .+||+|||+++.+.....       ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  273 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP  273 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence            998  899999999986643221       12345789999999999999999999999999999999999999975431


Q ss_pred             ccccccccccccccccC--CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          789 ISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       789 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....   ..........  ..+.............+.+++.+||+.||++|||+++|++.|+
T Consensus       274 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  332 (352)
T 2jii_A          274 NTED---IMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE  332 (352)
T ss_dssp             CHHH---HHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred             CHHH---HHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence            1100   0000000000  0000000000011234888999999999999999999998874

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=1.7e-33  Score=304.25  Aligned_cols=288  Identities=20%  Similarity=0.254  Sum_probs=186.1

Q ss_pred             ccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcC
Q 042123           85 YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN  164 (849)
Q Consensus        85 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  164 (849)
                      +++.+++++|.++ .+|..+.  ++|++|+|++|+|+++.|.+|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus        34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~  110 (332)
T 2ft3_A           34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS  110 (332)
T ss_dssp             ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred             cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence            3444455555444 3344432  567777777777776666677777777777777777776666777777777777777


Q ss_pred             CCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCc--cCCCcCccCccccchhhhccccccC
Q 042123          165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK--GVLPPSISNLTNLKELALLYNHLSG  242 (849)
Q Consensus       165 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~  242 (849)
                      +|++..+++..+   ++|++|++++|+++...+..|.++++|++|++++|.++  +..+..+..+ +|++|++++|.++ 
T Consensus       111 ~n~l~~l~~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-  185 (332)
T 2ft3_A          111 KNHLVEIPPNLP---SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-  185 (332)
T ss_dssp             SSCCCSCCSSCC---TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-
T ss_pred             CCcCCccCcccc---ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-
Confidence            777776544433   67777777777777655566777777777777777775  2556666666 7777777777776 


Q ss_pred             CCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCC
Q 042123          243 SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY  322 (849)
Q Consensus       243 ~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  322 (849)
                      .+|..+.                         ++|+.|++++|.+++..+..|..+++|+.|++++|++++..+..+..+
T Consensus       186 ~l~~~~~-------------------------~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l  240 (332)
T 2ft3_A          186 GIPKDLP-------------------------ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL  240 (332)
T ss_dssp             SCCSSSC-------------------------SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred             ccCcccc-------------------------CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence            2333221                         345555555555555555566666666666666666666666666666


Q ss_pred             CCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccc------cccccccccccccc--ccCchhhcCC
Q 042123          323 PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS------SQLQAFDLSLNHIV--GEIPKELGKL  394 (849)
Q Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l------~~L~~L~L~~N~i~--~~~~~~~~~l  394 (849)
                      ++|+.|+|++|++. .+|..+..+++|++|++++|.+++..+..|...      .+|+.|++++|.+.  +..|..|..+
T Consensus       241 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l  319 (332)
T 2ft3_A          241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV  319 (332)
T ss_dssp             TTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTB
T ss_pred             CCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCccccccc
Confidence            66666666666666 455556666677777777777765555555442      55777788888776  5667778888


Q ss_pred             CCCcEEEccCcc
Q 042123          395 NPLTKLILRGNQ  406 (849)
Q Consensus       395 ~~L~~L~L~~N~  406 (849)
                      ++|+.|++++|+
T Consensus       320 ~~L~~l~l~~n~  331 (332)
T 2ft3_A          320 TDRLAIQFGNYK  331 (332)
T ss_dssp             CCSTTEEC----
T ss_pred             chhhhhhccccc
Confidence            888888888774

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-35  Score=313.07  Aligned_cols=240  Identities=25%  Similarity=0.454  Sum_probs=177.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcE----EEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEV----VAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      ++|+..+.||+|+||.||+|.+ .+++.    ||+|.+....   .....+.+.+|+.           .+++++... .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~   90 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   90 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-S
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-C
Confidence            6799999999999999999965 34554    5777765432   2223455666654           356666554 4


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++|+||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             ceEEEEecCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            789999999999999996543  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-C
Q 042123          732 SLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-R  807 (849)
Q Consensus       732 ~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~  807 (849)
                      .......  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......        ....+... .
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~  237 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGER  237 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCC
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCC
Confidence            7644322  2233456778999999999999999999999999999999 999997433211        11111111 1


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+.+....    ..+.+++.+||+.||++|||+.|+++.|+
T Consensus       238 ~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~ell~~L~  274 (327)
T 3lzb_A          238 LPQPPICT----IDVYMIMRKCWMIDADSRPKFRELIIEFS  274 (327)
T ss_dssp             CCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCccCC----HHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            22222222    24788999999999999999999999874

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.8e-35  Score=331.09  Aligned_cols=242  Identities=21%  Similarity=0.337  Sum_probs=187.9

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|++.+.||+|+||+||+|.. .+++.||||++......  ......+.+|+.           ++++++......++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            46799999999999999999965 47999999998643211  112344555544           36788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---LEYEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG~a~  731 (849)
                      ||||+++|+|.+.+...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++   .++.+||+|||+++
T Consensus        99 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            99999999999988653   3589999999999999999999999   999999999999995   45679999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ..... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.....        ......+........
T Consensus       173 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~  242 (486)
T 3mwu_A          173 CFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETGKYAFD  242 (486)
T ss_dssp             TBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCSC
T ss_pred             ECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence            76543 23345679999999999876 599999999999999999999999974321        112222222222222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+......+.+++.+||+.||++|||+.|+++|
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            22222334458899999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3e-35  Score=311.65  Aligned_cols=234  Identities=23%  Similarity=0.434  Sum_probs=181.0

Q ss_pred             cCCCcCceecCCccceEEEEEec-CC-------cEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SG-------EVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH  648 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~  648 (849)
                      ++|...+.||+|+||.||+|... ++       ..||+|.+...    .....+.+.+|+.           ++++++..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG----GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc----cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            57888999999999999999554 33       47999998653    2233445666654           36778888


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc-------
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE-------  721 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~-------  721 (849)
                      .+..++||||+++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.       
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence            889999999999999999997543  3489999999999999999999999   9999999999999998887       


Q ss_pred             -EEEeeecCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCC-CCcccccccccccccc
Q 042123          722 -AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHP-RDFLSSISSSSLNTDV  798 (849)
Q Consensus       722 -~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~P-f~~~~~~~~~~~~~~~  798 (849)
                       +||+|||.+......    ....+++.|+|||.+.+ ..++.++||||||+++|||++|..| |......        .
T Consensus       159 ~~kl~Dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--------~  226 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--------R  226 (289)
T ss_dssp             EEEECCCCSCTTTSCH----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------H
T ss_pred             eeeeccCcccccccCc----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--------H
Confidence             999999998765322    33567899999999987 6789999999999999999995544 4322111        0


Q ss_pred             cccccc-CCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          799 ALDQML-DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       799 ~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...... ....+...      ...+.+++.+||+.||++|||++|++++|+
T Consensus       227 ~~~~~~~~~~~~~~~------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  271 (289)
T 4fvq_A          227 KLQFYEDRHQLPAPK------AAELANLINNCMDYEPDHRPSFRAIIRDLN  271 (289)
T ss_dssp             HHHHHHTTCCCCCCS------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhccCCCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            001111 11111111      113778899999999999999999999885

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-35  Score=317.49  Aligned_cols=253  Identities=16%  Similarity=0.252  Sum_probs=177.3

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCc---hhhHHHHH-----HHHHHhhceeecCCeeEEEEEe
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQ---TVDQKEFL-----TEVEAFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~-----~ei~~~~~~~~~~~~~~lV~e~  658 (849)
                      ++|...+.||+|+||+||+|+.. +++.||||++........   ...+...+     ..+..+++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999664 789999999864321111   01111122     1244578888889999999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      +++ +|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LDK-DLKQYLDDCG--NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             ccc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            985 8988886543  3589999999999999999999999   999999999999999999999999999987654444


Q ss_pred             CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------------cc---cccccc
Q 042123          739 NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------------LN---TDVALD  801 (849)
Q Consensus       739 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------------~~---~~~~~~  801 (849)
                      ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||..........             ..   ......
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            4555678999999999876 568999999999999999999999997543211000             00   000000


Q ss_pred             cccCCCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          802 QMLDPRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       802 ~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....+......  .........+.+++.+||+.||++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000000000  0001112347899999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-34  Score=305.21  Aligned_cols=239  Identities=21%  Similarity=0.324  Sum_probs=178.4

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|.+.+.||+|+||.||+|... +++.||||.+..... ........+.+|+.           .+++++...+..++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            67899999999999999999765 799999999864311 01112334455543           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999998653   3589999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      .. ......+++.|+|||.+.+..+ +.++||||+|+++|+|++|+.||......        .....+.......+...
T Consensus       164 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~~  234 (276)
T 2h6d_A          164 GE-FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP--------TLFKKIRGGVFYIPEYL  234 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTTS
T ss_pred             Cc-ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH--------HHHHHhhcCcccCchhc
Confidence            32 2344578999999999987765 68999999999999999999999743211        11111111111111111


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .    ..+.+++.+||+.||++|||++|++++
T Consensus       235 ~----~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          235 N----RSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             C----HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             C----HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            2    247789999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-34  Score=330.92  Aligned_cols=244  Identities=22%  Similarity=0.292  Sum_probs=188.0

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc---------hhhHHHHHHHHH-----------Hhhce
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ---------TVDQKEFLTEVE-----------AFYGF  645 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---------~~~~~~~~~ei~-----------~~~~~  645 (849)
                      .++|...+.||+|+||+||+|.. .+++.||||++........         ....+.+.+|+.           .++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            47899999999999999999965 4688999999875421110         122345555654           36788


Q ss_pred             eecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---cE
Q 042123          646 CSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---EA  722 (849)
Q Consensus       646 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---~~  722 (849)
                      +......++||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++   .+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccE
Confidence            88889999999999999999988653   3589999999999999999999999   999999999999998776   69


Q ss_pred             EEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042123          723 HVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      ||+|||++...... .......||+.|+|||++. +.++.++||||+||++|+|++|+.||.....        ......
T Consensus       189 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~  258 (504)
T 3q5i_A          189 KIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND--------QDIIKK  258 (504)
T ss_dssp             EECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred             EEEECCCCEEcCCC-CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence            99999999876543 2345567999999999876 4699999999999999999999999974322        122222


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +.......+...+......+.+++.+||+.||.+|||++|+++|
T Consensus       259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          259 VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            22333222222222233458899999999999999999999876

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.2e-34  Score=330.60  Aligned_cols=242  Identities=23%  Similarity=0.334  Sum_probs=184.6

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .+.|+..+.||+|+||+||+|+.. ++..||||++.......  .....+.+|+.           ++++++......++
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST--SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            357999999999999999999654 78999999987543211  12334555544           47788888999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~a~  731 (849)
                      ||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++..   +.+||+|||+++
T Consensus       114 v~e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          114 VMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            99999999999988643   3589999999999999999999999   99999999999999764   559999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ...... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||.....        ......+........
T Consensus       188 ~~~~~~-~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~~~~~  257 (494)
T 3lij_A          188 VFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEKGKYTFD  257 (494)
T ss_dssp             ECBTTB-CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCCC
T ss_pred             ECCCCc-cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCC
Confidence            765432 334567999999999876 5699999999999999999999999974332        112222222222222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+......+.+++.+||+.||++|||+.|+++|
T Consensus       258 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            22222233457899999999999999999999876

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.9e-34  Score=305.37  Aligned_cols=239  Identities=19%  Similarity=0.295  Sum_probs=184.3

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHS  652 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~  652 (849)
                      ..++|+..+.||+|+||.||+|... +++.||||++......  ......+.+|+.            ++++++.+.+..
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG--SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT--SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            3468999999999999999999664 7999999998754322  222344555543            367788888999


Q ss_pred             EEEEEeccCCChhhhhccccc-ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC------------
Q 042123          653 FLLYEFLERGSLAAILNTDAA-AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE------------  719 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~------------  719 (849)
                      ++||||+++|+|.+++..... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.+            
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~  163 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE  163 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence            999999999999999975432 24589999999999999999999999   99999999999999844            


Q ss_pred             -------CcEEEeeecCCcccCCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccc
Q 042123          720 -------YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS  791 (849)
Q Consensus       720 -------~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~  791 (849)
                             ..+|++|||.+.......    ...||+.|+|||.+.+. .+++++||||||+++|+|++|..|+.....   
T Consensus       164 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---  236 (289)
T 1x8b_A          164 DDWASNKVMFKIGDLGHVTRISSPQ----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---  236 (289)
T ss_dssp             ------CCCEEECCCTTCEETTCSC----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---
T ss_pred             ccccCCceEEEEcccccccccCCcc----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---
Confidence                   479999999998765432    24689999999998765 567899999999999999999887643211   


Q ss_pred             cccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          792 SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                              ...+.....+..+..   ....+.+++.+||+.||++|||++|++++-
T Consensus       237 --------~~~~~~~~~~~~~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          237 --------WHEIRQGRLPRIPQV---LSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             --------HHHHHTTCCCCCSSC---CCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             --------HHHHHcCCCCCCCcc---cCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence                    111112222111111   122478899999999999999999999873

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.1e-34  Score=308.91  Aligned_cols=247  Identities=25%  Similarity=0.399  Sum_probs=177.4

Q ss_pred             HhcCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR  650 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~  650 (849)
                      ..++|...+.||+|+||.||+|...    ++..||||.+.....  .....+.+.+|+..           +++++....
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS--SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc--chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            4467888999999999999999653    345899999865322  22234456666553           556665543


Q ss_pred             -----eeEEEEEeccCCChhhhhccc---ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcE
Q 042123          651 -----HSFLLYEFLERGSLAAILNTD---AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEA  722 (849)
Q Consensus       651 -----~~~lV~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~  722 (849)
                           ..++||||+++|+|.+++...   .....+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcE
Confidence                 359999999999999998432   1234689999999999999999999999   99999999999999999999


Q ss_pred             EEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042123          723 HVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       723 kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      ||+|||+++.......  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......        ..
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--------~~  258 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------EM  258 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GH
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--------HH
Confidence            9999999987654321  1233456889999999999999999999999999999999 88998743321        11


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..............   .....+.+++.+||+.||++|||+++++++|+
T Consensus       259 ~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  304 (313)
T 3brb_A          259 YDYLLHGHRLKQPE---DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE  304 (313)
T ss_dssp             HHHHHTTCCCCCBT---TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCc---cccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11122221111111   12234888999999999999999999999875

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-34  Score=313.37  Aligned_cols=245  Identities=20%  Similarity=0.292  Sum_probs=160.7

Q ss_pred             hcCCCcCc-eecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH--------HHHhhceeec----CCee
Q 042123          587 TNDFDAKY-CIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE--------VEAFYGFCSH----ARHS  652 (849)
Q Consensus       587 ~~~f~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e--------i~~~~~~~~~----~~~~  652 (849)
                      .++|.+.+ .||+|+||.||+|... +++.||||++...     ....+++..+        +..+++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            36788854 6999999999999664 7999999998642     1112222222        2235566544    4568


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeecC
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL---EYEAHVADFGI  729 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG~  729 (849)
                      ++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            99999999999999997543 24589999999999999999999999   9999999999999976   45599999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ++.....  ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||..........    ............
T Consensus       178 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~  251 (336)
T 3fhr_A          178 AKETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP----GMKRRIRLGQYG  251 (336)
T ss_dssp             CEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------C
T ss_pred             ceecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh----hHHHhhhccccc
Confidence            9866532  2344678999999999988889999999999999999999999997443211100    000111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+..........+.+++.+||+.||++|||++|++++
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111111223347889999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.3e-34  Score=306.25  Aligned_cols=241  Identities=26%  Similarity=0.433  Sum_probs=180.6

Q ss_pred             cCCCcCceecCCccceEEEEEecC----CcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhcee-ecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFC-SHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~-~~~~~  651 (849)
                      .+|+..+.||+|+||.||+|...+    ...||||.+....   .......+.+|+.           .+++++ ..++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT---DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC---CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            467788999999999999997532    2358999887532   2233445666654           355654 45568


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            899999999999999996533  4589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC----CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC
Q 042123          732 SLKPDS----SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP  806 (849)
Q Consensus       732 ~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~  806 (849)
                      ......    .......+|+.|+|||.+.+..++.++||||+|+++|||++ |..||......        .........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--------~~~~~~~~~  248 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--------DITVYLLQG  248 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT--------THHHHHHTT
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH--------HHHHHHhcC
Confidence            664322    12234457789999999999999999999999999999999 55565532211        111111111


Q ss_pred             CCCC-CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPA-PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .... +...+    ..+.+++.+||+.||++|||++|+++.|+
T Consensus       249 ~~~~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~  287 (298)
T 3f66_A          249 RRLLQPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRIS  287 (298)
T ss_dssp             CCCCCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111 11112    24788999999999999999999999874

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.3e-35  Score=333.11  Aligned_cols=243  Identities=23%  Similarity=0.365  Sum_probs=192.0

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|+.. +++.||||++...... .......+.+|+.           ++++++...+..++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            367999999999999999999654 7999999998654221 1223455666654           36788888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee---cCCCcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL---DLEYEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill---~~~~~~kl~DfG~a~  731 (849)
                      ||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||++   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            99999999999988654   3489999999999999999999999   99999999999999   567899999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      .+.... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......        .....+.......+
T Consensus       178 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--------~~~~~i~~~~~~~~  247 (484)
T 3nyv_A          178 HFEASK-KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY--------DILKKVEKGKYTFE  247 (484)
T ss_dssp             HBCCCC-SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCC
T ss_pred             Eccccc-ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHcCCCCCC
Confidence            765432 3455679999999999876 6999999999999999999999999743321        12222222222222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...+......+.+++.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            22222334458899999999999999999999976

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.6e-34  Score=307.62  Aligned_cols=245  Identities=22%  Similarity=0.337  Sum_probs=188.0

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC-----chhhHHHHHHHHH------------Hhhceeec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD-----QTVDQKEFLTEVE------------AFYGFCSH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~~~~ei~------------~~~~~~~~  648 (849)
                      .++|+..+.||+|+||.||+|.. .+++.||||.+.......     .....+.+.+|+.            .+++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            47899999999999999999966 468999999986532111     0112233444433            35677888


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      ....++||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +++||||||+||+++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence            88999999999999999999643   3589999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCcccccccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAY------TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      .+....... ......+++.|+|||.+.      ...++.++||||||+++|+|++|+.||......        .....
T Consensus       170 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~  240 (298)
T 1phk_A          170 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM--------LMLRM  240 (298)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHH
T ss_pred             chhhcCCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH--------HHHHH
Confidence            998765432 334567899999999875      456889999999999999999999998643211        11111


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +.......+..........+.+++.+||+.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          241 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            11112111111111223458899999999999999999999875

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-35  Score=318.27  Aligned_cols=257  Identities=22%  Similarity=0.287  Sum_probs=182.0

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCc-hhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQ-TVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      ...++|+..+.||+|+||.||+|+.. +|+.||||++........ ....+.+.+|+.           .+++++.+...
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999764 689999999864322111 111123344433           36778888889


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++ +|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 8888886543  3588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------------cccc
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------------LNTD  797 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------------~~~~  797 (849)
                      .............+|+.|+|||.+.+. .++.++||||+||++|||++|..||..........             ....
T Consensus       161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (346)
T 1ua2_A          161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM  240 (346)
T ss_dssp             TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred             eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence            776554455567889999999998764 48899999999999999999999987543211000             0000


Q ss_pred             cccccccC-CCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          798 VALDQMLD-PRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       798 ~~~~~~~~-~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      ....+.+. ...+...  .........+.+++.+||+.||++|||++|++++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            00000000 0001000  00011224588999999999999999999999863

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.2e-34  Score=311.28  Aligned_cols=245  Identities=24%  Similarity=0.392  Sum_probs=184.7

Q ss_pred             CCcCceecCCccceEEEEEec-----CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec--CCe
Q 042123          590 FDAKYCIGNGGHASVYRAELP-----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH--ARH  651 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~--~~~  651 (849)
                      |+..+.||+|+||+||+|.+.     +++.||||++....   .......+.+|+..           +++++..  ...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA---GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc---ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            488899999999999888542     68899999987542   22334556666543           5666665  467


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++...    .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence            89999999999999999653    389999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC---CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-----c-cccccccccc
Q 042123          732 SLKPDSS---NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-----S-SLNTDVALDQ  802 (849)
Q Consensus       732 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-----~-~~~~~~~~~~  802 (849)
                      .......   ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||........     . .........+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence            7764432   12334578889999999998999999999999999999999999874321100     0 0000001111


Q ss_pred             ccCCC--CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          803 MLDPR--LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       803 ~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+...  .+.+..    ....+.+++.+||+.||++|||++|+++.|+
T Consensus       263 ~~~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  306 (318)
T 3lxp_A          263 LLERGERLPRPDK----CPAEVYHLMKNCWETEASFRPTFENLIPILK  306 (318)
T ss_dssp             HHHTTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHhcccCCCCCcc----ccHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11111  111111    1234888999999999999999999998875

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=9.5e-35  Score=313.55  Aligned_cols=252  Identities=17%  Similarity=0.225  Sum_probs=177.0

Q ss_pred             HHhcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ...++|+..+.||+|+||+||+|. ..+++.||||++.....  .......+.+|+.           .+++++.+....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE--EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc--ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            345789999999999999999995 45799999999865422  1112233444443           467788888999


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-----CCCcEEEeee
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD-----LEYEAHVADF  727 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-----~~~~~kl~Df  727 (849)
                      ++||||+++ +|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++     .++.+||+||
T Consensus       109 ~lv~e~~~~-~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          109 HLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEEECCSE-EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEEecCCC-CHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            999999985 9999986543   489999999999999999999999   999999999999994     4556999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------------
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------------  793 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------------  793 (849)
                      |+++.............+|+.|+|||++.+. .++.++||||+||++|||++|+.||..........             
T Consensus       182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT  261 (329)
T ss_dssp             THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence            9998776444445556789999999998874 48999999999999999999999997533211000             


Q ss_pred             cccccccccccCCCCCCCCh-hhH-----HHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 LNTDVALDQMLDPRLPAPSR-SAQ-----EKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .........+ ....+.... ...     .....+.+++.+||+.||++|||++|+++|
T Consensus       262 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          262 WPGVTALPDW-KQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTGGGSTTC-CTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhh-hhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0000000000 000000000 000     012457899999999999999999999986

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=3.4e-33  Score=301.66  Aligned_cols=289  Identities=19%  Similarity=0.225  Sum_probs=172.6

Q ss_pred             ccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcC
Q 042123           85 YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN  164 (849)
Q Consensus        85 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  164 (849)
                      +++.++++++.++ .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus        32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (330)
T 1xku_A           32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS  108 (330)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence            4455555555554 3344333  466677777777776666667777777777777777766666667777777777777


Q ss_pred             CCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCcc--CCCcCccCccccchhhhccccccC
Q 042123          165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG--VLPPSISNLTNLKELALLYNHLSG  242 (849)
Q Consensus       165 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~  242 (849)
                      +|+++.++...+   ++|++|++++|++++..+..|.++++|++|++++|.++.  ..+..|..+++|++|++++|.++ 
T Consensus       109 ~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-  184 (330)
T 1xku_A          109 KNQLKELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-  184 (330)
T ss_dssp             SSCCSBCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             CCcCCccChhhc---ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-
Confidence            777665443332   567777777777776666667777777777777777753  55666677777777777776665 


Q ss_pred             CCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCC
Q 042123          243 SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY  322 (849)
Q Consensus       243 ~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  322 (849)
                      .+|..+.                         ++|+.|++++|++++..|..|..+++|+.|++++|.+++..+..+..+
T Consensus       185 ~l~~~~~-------------------------~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  239 (330)
T 1xku_A          185 TIPQGLP-------------------------PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT  239 (330)
T ss_dssp             SCCSSCC-------------------------TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGS
T ss_pred             cCCcccc-------------------------ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCC
Confidence            2332111                         345555555555555555555556666666666666665555556666


Q ss_pred             CCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccc------ccccccccccccccc--cCchhhcCC
Q 042123          323 PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS------SQLQAFDLSLNHIVG--EIPKELGKL  394 (849)
Q Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l------~~L~~L~L~~N~i~~--~~~~~~~~l  394 (849)
                      ++|+.|+|++|++. .+|..+..+++|++|++++|.|++..+..|...      ..|+.|++++|.+..  ..|..|..+
T Consensus       240 ~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~  318 (330)
T 1xku_A          240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV  318 (330)
T ss_dssp             TTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTC
T ss_pred             CCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccc
Confidence            66666666666665 445555666666666666666665444444332      445555566655542  344556666


Q ss_pred             CCCcEEEccCcc
Q 042123          395 NPLTKLILRGNQ  406 (849)
Q Consensus       395 ~~L~~L~L~~N~  406 (849)
                      ++|+.++|++|+
T Consensus       319 ~~l~~l~L~~N~  330 (330)
T 1xku_A          319 YVRAAVQLGNYK  330 (330)
T ss_dssp             CCGGGEEC----
T ss_pred             cceeEEEecccC
Confidence            666666666653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.9e-35  Score=335.95  Aligned_cols=241  Identities=25%  Similarity=0.439  Sum_probs=188.5

Q ss_pred             HhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      ..++|+..+.||+|+||.||+|.+.++..||||++.....     ..+.+.+|+.           ++++++.+ ...++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l  338 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  338 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence            3467888999999999999999988788899999875321     2345566654           35667655 67899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       339 v~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          339 VTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            999999999999997533 24589999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCC
Q 042123          735 PDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAP  811 (849)
Q Consensus       735 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  811 (849)
                      .... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......        .....+... +.+.+
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--------~~~~~i~~~~~~~~~  486 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--------EVLDQVERGYRMPCP  486 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--------HHHHHHHTTCCCCCC
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCC
Confidence            3211 1123346788999999998899999999999999999999 99999743221        111111111 12222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...    ...+.+++.+||+.||++|||+++|++.|+
T Consensus       487 ~~~----~~~l~~li~~cl~~dP~~RPt~~~l~~~L~  519 (535)
T 2h8h_A          487 PEC----PESLHDLMCQCWRKEPEERPTFEYLQAFLE  519 (535)
T ss_dssp             TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            222    234788999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.6e-34  Score=305.17  Aligned_cols=240  Identities=20%  Similarity=0.363  Sum_probs=185.4

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceeec-----------
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCSH-----------  648 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~~-----------  648 (849)
                      ...+|+..+.||+|+||.||+|... +++.||||++....  .....+...++.     +..+++++..           
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            3467999999999999999999765 79999999986532  111112222222     2235555532           


Q ss_pred             -----CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEE
Q 042123          649 -----ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH  723 (849)
Q Consensus       649 -----~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~k  723 (849)
                           ....++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEE
Confidence                 445799999999999999997543 34689999999999999999999999   999999999999999999999


Q ss_pred             EeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042123          724 VADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM  803 (849)
Q Consensus       724 l~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  803 (849)
                      |+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|..||.....          .....
T Consensus       163 l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~~~~~  231 (284)
T 2a19_B          163 IGDFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------FFTDL  231 (284)
T ss_dssp             ECCCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----------HHHHH
T ss_pred             ECcchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----------HHHHh
Confidence            99999998765432 23445789999999999998999999999999999999999999752211          11111


Q ss_pred             cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....++..  .    ...+.+++.+||+.||++|||+.|++++|+
T Consensus       232 ~~~~~~~~--~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~  270 (284)
T 2a19_B          232 RDGIISDI--F----DKKEKTLLQKLLSKKPEDRPNTSEILRTLT  270 (284)
T ss_dssp             HTTCCCTT--S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hccccccc--C----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            22222211  1    123778899999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-35  Score=313.80  Aligned_cols=243  Identities=23%  Similarity=0.382  Sum_probs=176.8

Q ss_pred             HHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceeec---
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH---  648 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~---  648 (849)
                      ...++|+..+.||+|+||.||+|+. .+++.||||++......     ...+.+|+.            .+++++..   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   95 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP   95 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence            3457899999999999999999966 57899999998653221     122333322            35566554   


Q ss_pred             ---CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEe
Q 042123          649 ---ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVA  725 (849)
Q Consensus       649 ---~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~  725 (849)
                         ....++||||+++|+|.+++.... ...+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           96 PGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             -CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred             ccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence               467899999999999999997543 34689999999999999999999999   99999999999999999999999


Q ss_pred             eecCCcccCCCCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 042123          726 DFGIAKSLKPDSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL  800 (849)
Q Consensus       726 DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~  800 (849)
                      |||++..............|++.|+|||.+.     +..++.++||||||+++|+|++|+.||..........     ..
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~  246 (326)
T 2x7f_A          172 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LI  246 (326)
T ss_dssp             CCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HH
T ss_pred             eCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH-----Hh
Confidence            9999987654433344567899999999986     5678899999999999999999999997433211100     00


Q ss_pred             ccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+.... ...    ...+.+++.+||+.||++|||+++++++
T Consensus       247 ~~~~~~~~~~-~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          247 PRNPAPRLKS-KKW----SKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HHSCCCCCSC-SCS----CHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hcCccccCCc-ccc----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000111111 111    2347889999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.3e-34  Score=322.19  Aligned_cols=189  Identities=24%  Similarity=0.390  Sum_probs=151.5

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|.. .+++.||||++....  ......+.+.+|+..           +++++...     
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            36899999999999999999965 568899999997542  233344566677553           45555444     


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...|+||||+++ +|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~L~~~~~~~---~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          103 DELYIVLEIADS-DLKKLFKTP---IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CCEEEEEECCSE-EHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CeEEEEEecCCc-CHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            578999999974 999998653   3589999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCC----------------------CeeeccCCccccccccc-cCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042123          730 AKSLKPDSS----------------------NWTEFAGTCGYIAPELA-YTMKITEKCDVYSFGVLMWEVIKGKHPRD  784 (849)
Q Consensus       730 a~~~~~~~~----------------------~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg~~Pf~  784 (849)
                      |+.......                      .....+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            987654321                      23567899999999986 56679999999999999999999776664

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-34  Score=311.57  Aligned_cols=242  Identities=26%  Similarity=0.461  Sum_probs=182.8

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEE--EEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVV--AVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~v--avK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~  652 (849)
                      ++|+..+.||+|+||.||+|+.. ++..+  |||.+......   ...+.+.+|+.            ++++++.+.+..
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~  101 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK---DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL  101 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccch---HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence            68889999999999999999653 56644  99988653221   12233444433            367778888899


Q ss_pred             EEEEEeccCCChhhhhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          653 FLLYEFLERGSLAAILNTDA-------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      ++||||+++|+|.+++....             ....+++.+++.++.||+.||+|||+.   +|+||||||+||+++.+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence            99999999999999997543             124689999999999999999999999   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccccccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDV  798 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~  798 (849)
                      +.+||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......        
T Consensus       179 ~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------  249 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------  249 (327)
T ss_dssp             GCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------
T ss_pred             CeEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--------
Confidence            99999999998754322 12233456889999999988889999999999999999998 999997433211        


Q ss_pred             ccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          799 ALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       799 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....+... ....+...    ...+.+++.+||+.||++|||+++++++|+
T Consensus       250 ~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~  296 (327)
T 1fvr_A          250 LYEKLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLN  296 (327)
T ss_dssp             HHHHGGGTCCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            11111111 11111112    234788999999999999999999999874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=312.13  Aligned_cols=239  Identities=22%  Similarity=0.335  Sum_probs=166.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhcee--------
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFC--------  646 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~--------  646 (849)
                      .+|+..+.||+|+||.||+|+. .+++.||||++...    .....+.+.+|+.            .+++++        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~  103 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD  103 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence            5788999999999999999965 47899999988543    1222334444443            244444        


Q ss_pred             ecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeecCCCcEEE
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP--IVHRDISSKNLLLDLEYEAHV  724 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~~~~~~kl  724 (849)
                      ......++||||++ |+|.+++........+++.++..++.||+.||+|||+.   +  |+||||||+||+++.++.+||
T Consensus       104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence            33446899999996 69999987644445699999999999999999999998   7  999999999999999999999


Q ss_pred             eeecCCcccCCCCCC------------eeeccCCccccccccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 042123          725 ADFGIAKSLKPDSSN------------WTEFAGTCGYIAPELA---YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSI  789 (849)
Q Consensus       725 ~DfG~a~~~~~~~~~------------~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~  789 (849)
                      +|||+++........            .....+|+.|+|||.+   .+..++.++||||||+++|||++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876543221            1134589999999998   5667899999999999999999999999743221


Q ss_pred             cccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          790 SSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .        .......  .+......    ..+.+++.+||+.||++|||++|++++|+
T Consensus       260 ~--------~~~~~~~--~~~~~~~~----~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 R--------IVNGKYS--IPPHDTQY----TVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             --------------CC--CCTTCCSS----GGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             H--------hhcCccc--CCcccccc----hHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            1        0111111  11111111    12678899999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=335.04  Aligned_cols=233  Identities=24%  Similarity=0.413  Sum_probs=178.4

Q ss_pred             eecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEecc
Q 042123          595 CIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       595 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      .||+|+||.||+|.+.   ++..||||+++...   .....+.+.+|+.           ++++++.. +..++||||++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~  418 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG  418 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCC
Confidence            7999999999999653   46679999987542   2223456667755           35677765 56899999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC-
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-  739 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  739 (849)
                      +|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++........ 
T Consensus       419 ~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  493 (613)
T 2ozo_A          419 GGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY  493 (613)
T ss_dssp             TCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred             CCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence            999999996543  4589999999999999999999999   9999999999999999999999999999876543221 


Q ss_pred             --eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCChhh
Q 042123          740 --WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-LPAPSRSA  815 (849)
Q Consensus       740 --~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  815 (849)
                        .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......        .....+.... ...+... 
T Consensus       494 ~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p~~~-  564 (613)
T 2ozo_A          494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKRMECPPEC-  564 (613)
T ss_dssp             --------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHTTCCCCCCTTC-
T ss_pred             eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCCCcC-
Confidence              122335678999999998999999999999999999998 99999754321        1111222221 2222222 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         ...+.+++.+||+.||++|||+++|++.|+
T Consensus       565 ---~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  594 (613)
T 2ozo_A          565 ---PPELYALMSDCWIYKWEDRPDFLTVEQRMR  594 (613)
T ss_dssp             ---CHHHHHHHHHTTCSSTTTSCCHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence               234888999999999999999999998874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.3e-34  Score=313.62  Aligned_cols=246  Identities=19%  Similarity=0.317  Sum_probs=187.9

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCch-------------hhHHHHHHHHH-----------Hh
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT-------------VDQKEFLTEVE-----------AF  642 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------~~~~~~~~ei~-----------~~  642 (849)
                      .++|+..+.||+|+||.||+|.. +++.||||.+.........             .....+.+|+.           .+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            36899999999999999999988 8999999998643211110             11145566654           36


Q ss_pred             hceeecCCeeEEEEEeccCCChhhh------hcccccccCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCee
Q 042123          643 YGFCSHARHSFLLYEFLERGSLAAI------LNTDAAAQELGWSQRMNVIKAVAHALSYLHH-DCFPPIVHRDISSKNLL  715 (849)
Q Consensus       643 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nil  715 (849)
                      ++++.+.+..++||||+++|+|.++      +.... ...+++.++..++.|++.||+|||+ .   +|+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEE
Confidence            7888888999999999999999998      54321 3568999999999999999999999 7   9999999999999


Q ss_pred             ecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCC-CCCc-cchHHHHHHHHHHHHhCCCCCCccccccccc
Q 042123          716 LDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM-KITE-KCDVYSFGVLMWEVIKGKHPRDFLSSISSSS  793 (849)
Q Consensus       716 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~  793 (849)
                      ++.++.+||+|||.+......  ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||......    
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            999999999999999876433  33456789999999999877 6666 899999999999999999999744321    


Q ss_pred             cccccccccccCCCCCCCC---------------hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 LNTDVALDQMLDPRLPAPS---------------RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ......+.......+.               .........+.+++.+||+.||++|||++|++++
T Consensus       259 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          259 ---VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             ---HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               0111111111111000               0001123358899999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.1e-34  Score=305.38  Aligned_cols=241  Identities=25%  Similarity=0.417  Sum_probs=182.9

Q ss_pred             hcCCCcCc-eecCCccceEEEEEe---cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCe
Q 042123          587 TNDFDAKY-CIGNGGHASVYRAEL---PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~  651 (849)
                      .++|...+ .||+|+||.||+|..   .+++.||||.+.....  .....+.+.+|+..           +++++ ..+.
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~   91 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES   91 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence            35677777 999999999999943   3478899999875422  22224456666553           56666 5567


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        92 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           92 WMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             cEEEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            89999999999999999653   3489999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC
Q 042123          732 SLKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       732 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      ........   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......        .....+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~  237 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGE  237 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC
Confidence            76544322   122345688999999998889999999999999999999 99999743321        1111111111


Q ss_pred             -CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 -LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       ...+..    ....+.+++.+||+.||++|||+.++++.|+
T Consensus       238 ~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~  275 (291)
T 1xbb_A          238 RMGCPAG----CPREMYDLMNLCWTYDVENRPGFAAVELRLR  275 (291)
T ss_dssp             CCCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             111111    1234888999999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.9e-34  Score=303.21  Aligned_cols=238  Identities=21%  Similarity=0.318  Sum_probs=180.9

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec----CCee
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH----ARHS  652 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~----~~~~  652 (849)
                      .|...+.||+|+||.||+|.. .++..||+|.+.....  .......+.+|+..           +++++..    ....
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            467778899999999999955 5688999999875322  22334556666553           4444433    4568


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeeec-CCCcEEEeeecC
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP--IVHRDISSKNLLLD-LEYEAHVADFGI  729 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~dlk~~Nill~-~~~~~kl~DfG~  729 (849)
                      ++||||+++|+|.+++...   ..+++.++..++.|++.||+|||+.   +  |+||||||+||+++ .++.+||+|||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            9999999999999999653   3589999999999999999999998   7  99999999999997 789999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      +.....  .......|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||......       ............+
T Consensus       179 ~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~  248 (290)
T 1t4h_A          179 ATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVKP  248 (290)
T ss_dssp             GGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCCC
T ss_pred             cccccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhccCCc
Confidence            976543  23455679999999998764 5899999999999999999999999743221       1111111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        ..........+.+++.+||+.||++|||++|++++
T Consensus       249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             --cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence              11111112348899999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.6e-35  Score=312.78  Aligned_cols=246  Identities=22%  Similarity=0.273  Sum_probs=180.6

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCC----CchhhHHHHHHHHH-----------HhhceeecC
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPC----DQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      ..++|...+.||+|+||.||+|.. .+++.||||.+......    ........+.+|+.           .+++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            346899999999999999999965 46899999998653211    01111122344433           356666554


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEee
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE---AHVAD  726 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~D  726 (849)
                       ..++||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.   +||+|
T Consensus        88 -~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 -DYYIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             -SEEEEEECCTTEETHHHHSTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             -ceEEEEecCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence             489999999999999998653   3589999999999999999999999   9999999999999987654   99999


Q ss_pred             ecCCcccCCCCCCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM  803 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  803 (849)
                      ||+++..... .......||+.|+|||++.   ...++.++||||||+++|+|++|+.||.......       .....+
T Consensus       161 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~  232 (322)
T 2ycf_A          161 FGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV-------SLKDQI  232 (322)
T ss_dssp             CTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS-------CHHHHH
T ss_pred             Cccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH-------HHHHHH
Confidence            9999876432 1223456899999999874   5678899999999999999999999997432110       011111


Q ss_pred             cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..................+.+++.+||+.||++|||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          233 TSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            1122221111112233458899999999999999999999876

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-34  Score=306.16  Aligned_cols=243  Identities=18%  Similarity=0.261  Sum_probs=182.2

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhcee--ecCCee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFC--SHARHS  652 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~--~~~~~~  652 (849)
                      .++|++.+.||+|+||.||+|.. .+++.||||.+..............+.+|+..           +++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            47899999999999999999966 46899999998653211112234556666553           55665  345678


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++| +.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||.+..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP-EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST-TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhCc-ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999986 777765433 34689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCC--CCeeeccCCccccccccccCCC--CCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          733 LKPDS--SNWTEFAGTCGYIAPELAYTMK--ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       733 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      .....  .......|++.|+|||.+.+..  ++.++||||+|+++|||++|+.||......        .....+.....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~i~~~~~  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY--------KLFENIGKGSY  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCCC
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH--------HHHHHHhcCCC
Confidence            65322  2234456899999999987644  377999999999999999999999743211        11111112222


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+....    ..+.+++.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 AIPGDCG----PPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CCCSSSC----HHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CCCCccC----HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2222222    247789999999999999999999976

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.4e-34  Score=312.15  Aligned_cols=245  Identities=26%  Similarity=0.431  Sum_probs=184.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHA  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~  649 (849)
                      .++|+..+.||+|+||.||+|++      .+++.||||.+....   .......+.+|+.           .+++++...
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC---SEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc---chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            36899999999999999999974      357789999986432   2233445666654           367788888


Q ss_pred             CeeEEEEEeccCCChhhhhccccc----ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcE
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAA----AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEA  722 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~  722 (849)
                      ...++||||+++|+|.+++.....    ...+++.+++.++.|++.||+|||+.   +|+||||||+||+++.+   ..+
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence            889999999999999999975431    13589999999999999999999999   99999999999999854   469


Q ss_pred             EEeeecCCcccCCCC--CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccc
Q 042123          723 HVADFGIAKSLKPDS--SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       723 kl~DfG~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      ||+|||+++......  .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......        ..
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~  254 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------EV  254 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--------HH
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH--------HH
Confidence            999999987553322  12234567889999999998899999999999999999998 99998743211        11


Q ss_pred             cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...+...........   ....+.+++.+||+.||++|||+.+++++|+
T Consensus       255 ~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  300 (327)
T 2yfx_A          255 LEFVTSGGRMDPPKN---CPGPVYRIMTQCWQHQPEDRPNFAIILERIE  300 (327)
T ss_dssp             HHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCC---CCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            111111111111111   1234788999999999999999999999875

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=2.1e-33  Score=303.53  Aligned_cols=290  Identities=22%  Similarity=0.287  Sum_probs=250.7

Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      .+++.+++++|.++. +|..+.  ++|+.|+|++|.+++..+..|.++++|++|+|++|+++++.|.+|.++++|++|+|
T Consensus        33 c~l~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  109 (332)
T 2ft3_A           33 CHLRVVQCSDLGLKA-VPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI  109 (332)
T ss_dssp             EETTEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred             ccCCEEECCCCCccc-cCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence            479999999999994 555553  68999999999999888889999999999999999999999999999999999999


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                      ++|+++ .+|..+.  ++|++|++++|+++.+.+..|.++++|++|++++|.++..                     +..
T Consensus       110 ~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~---------------------~~~  165 (332)
T 2ft3_A          110 SKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENS---------------------GFE  165 (332)
T ss_dssp             CSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGG---------------------GSC
T ss_pred             CCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccC---------------------CCC
Confidence            999998 5565554  8999999999999987777899999999999999988520                     123


Q ss_pred             CcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCC
Q 042123          268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFP  347 (849)
Q Consensus       268 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  347 (849)
                      +..+..+ +|+.|++++|++++ +|..+.  ++|+.|++++|.+++..+..+..+++|+.|+|++|++.+..+..|..++
T Consensus       166 ~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~  241 (332)
T 2ft3_A          166 PGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLP  241 (332)
T ss_dssp             TTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCT
T ss_pred             cccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCC
Confidence            3444455 77888888888875 455443  7899999999999999989999999999999999999988888999999


Q ss_pred             CCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCC------CCCcEEEccCcccc--ccCcccccccc
Q 042123          348 KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKL------NPLTKLILRGNQIT--GRLPKEIGSLT  419 (849)
Q Consensus       348 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l------~~L~~L~L~~N~l~--~~~p~~~~~l~  419 (849)
                      +|++|++++|.++ .+|..+..+++|+.|++++|++++..+..|...      ++|+.|++++|++.  +..|..|..++
T Consensus       242 ~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~  320 (332)
T 2ft3_A          242 TLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVT  320 (332)
T ss_dssp             TCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBC
T ss_pred             CCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccc
Confidence            9999999999999 788899999999999999999998877777654      67999999999998  67889999999


Q ss_pred             cccccccccC
Q 042123          420 KLEYLDFSAI  429 (849)
Q Consensus       420 ~L~~L~l~~l  429 (849)
                      +|+.+++++.
T Consensus       321 ~L~~l~l~~n  330 (332)
T 2ft3_A          321 DRLAIQFGNY  330 (332)
T ss_dssp             CSTTEEC---
T ss_pred             hhhhhhcccc
Confidence            9999998753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5e-34  Score=314.62  Aligned_cols=195  Identities=19%  Similarity=0.234  Sum_probs=153.8

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc-hhhHHHHHHHH-----------HHhhceeecCCee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ-TVDQKEFLTEV-----------EAFYGFCSHARHS  652 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~ei-----------~~~~~~~~~~~~~  652 (849)
                      ..++|+..+.||+|+||+||+|.. .+++.||||++........ ...+...++.+           ..+.+++...+..
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  131 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL  131 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence            357899999999999999999965 4688999999864311000 00111122222           1245667778899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCCcEEEeeecCC
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD--LEYEAHVADFGIA  730 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~DfG~a  730 (849)
                      ++||||++ |+|.+++.... ...+++.++..++.|++.||+|||+. ..+|+||||||+||+++  .++.+||+|||++
T Consensus       132 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          132 CLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            99999996 49999987543 23589999999999999999999952 11899999999999995  4688999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcc
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFL  786 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~  786 (849)
                      +.....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       209 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          209 CQLGQR---IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             EETTCC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecccc---cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            876432   23467899999999999999999999999999999999999999753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1e-34  Score=317.76  Aligned_cols=247  Identities=23%  Similarity=0.360  Sum_probs=186.1

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||.||+|... +++.||+|++....   .......+.+|+.           .+++++...+..++|
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC---CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc---CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            57889999999999999999654 78999999987542   2233455666655           367778888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++..+..++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||++.....
T Consensus       110 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  184 (360)
T ss_dssp             ECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EECCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence            9999999999999653   35899999999999999999999842  799999999999999999999999999875532


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc----------------------
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS----------------------  793 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~----------------------  793 (849)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........                      
T Consensus       185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          185 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             H--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             c--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence            2  2234578999999999999999999999999999999999999997433111000                      


Q ss_pred             ------------cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 ------------LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                  ...............+...  .......+.+++.+||+.||++|||++|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCC--TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCC--cccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                        0000000001111111000  00112348899999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-34  Score=324.51  Aligned_cols=183  Identities=24%  Similarity=0.373  Sum_probs=137.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceee-----cCC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCS-----HAR  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~-----~~~  650 (849)
                      ++|++.+.||+|+||.||+|.. .+++.||||++....  ......+.+.+|+..           +++++.     ...
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            6899999999999999999954 479999999986532  233344566667553           455552     235


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..|+||||++ |+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|
T Consensus       131 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          131 ELYVVLEIAD-SDFKKLFRTP---VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             CEEEEECCCS-EEHHHHHHSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEeccc-cchhhhcccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence            7899999985 6899988643   3589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC---------------------------CCeeeccCCccccccccc-cCCCCCccchHHHHHHHHHHHHhC
Q 042123          731 KSLKPDS---------------------------SNWTEFAGTCGYIAPELA-YTMKITEKCDVYSFGVLMWEVIKG  779 (849)
Q Consensus       731 ~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~SlGvil~el~tg  779 (849)
                      +......                           ......+||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            8764321                           123445789999999976 566799999999999999999994

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.3e-35  Score=308.41  Aligned_cols=244  Identities=24%  Similarity=0.377  Sum_probs=172.3

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSF  653 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~  653 (849)
                      .++|+..+.||+|+||+||+|+. .+++.||||++.....   .....+...+            +..+++++.+.+..+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN---SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C---HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC---cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            46889999999999999999965 5799999999865421   1122222222            223677888888999


Q ss_pred             EEEEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          654 LLYEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +||||+++ +|.+++... .....+++.++..++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||+++.
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            99999985 888877542 22346999999999999999999999853  899999999999999999999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELA----YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ..... ......||+.|+|||.+    .+..++.++||||+|+++|||++|+.||......       ............
T Consensus       160 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~  231 (290)
T 3fme_A          160 LVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-------FQQLKQVVEEPS  231 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-------HHHHHHHHHSCC
T ss_pred             ccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-------HHHHHHHhccCC
Confidence            65432 23345789999999995    5667899999999999999999999999742211       111111111111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +...  .......+.+++.+||+.||++|||++|++++
T Consensus       232 ~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          232 PQLP--ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             CCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCcc--cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            1110  01112347889999999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.9e-34  Score=314.49  Aligned_cols=251  Identities=20%  Similarity=0.290  Sum_probs=180.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-------
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-------  648 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-------  648 (849)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++.......  .....+.+|+.           .+++++..       
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE--GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS--SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc--cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            6899999999999999999966 579999999986543222  11223444443           35555544       


Q ss_pred             -CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          649 -ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       649 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                       .+..++||||+++ ++.+.+....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CCceEEEEEeccCC-CHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence             4568999999986 7777765433  3589999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCC----CCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc-----------
Q 042123          728 GIAKSLKPD----SSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-----------  791 (849)
Q Consensus       728 G~a~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-----------  791 (849)
                      |+++.+...    ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........           
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            999876432    122345678999999998876 4579999999999999999999999975332100           


Q ss_pred             -cccccccccccccC-CCC-CCCChhhHHH------HHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          792 -SSLNTDVALDQMLD-PRL-PAPSRSAQEK------LISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       792 -~~~~~~~~~~~~~~-~~~-~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .............+ ... ........+.      ...+.+++.+||+.||++|||++|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence             00000000000000 000 0000001111      2347899999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=5.9e-34  Score=309.13  Aligned_cols=246  Identities=18%  Similarity=0.268  Sum_probs=182.9

Q ss_pred             cCCCcCceecCCccceEEEEEe--cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------------HHhhceeec
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL--PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------------EAFYGFCSH  648 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------------~~~~~~~~~  648 (849)
                      ++|++.+.||+|+||.||+|..  .+++.||||++....     .....+.+|+                 ..+++++..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-----chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            6899999999999999999965  368899999986431     1122233332                 235667778


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC----------
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL----------  718 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~----------  718 (849)
                      .+..++||||+ +++|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.          
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCc
Confidence            88999999999 889999986543 23589999999999999999999999   9999999999999987          


Q ss_pred             ---------CCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 042123          719 ---------EYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSI  789 (849)
Q Consensus       719 ---------~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~  789 (849)
                               ++.+||+|||+++.....   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEH---HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSC---CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccccCCCceEeeCcccccCccc---cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                     668999999999865432   23467899999999999999999999999999999999999999753321


Q ss_pred             ccccc-------ccccccc-----cc-----cC---------------CCCCCCChhhHHHHHHHHHHHhhccCCCCCCC
Q 042123          790 SSSSL-------NTDVALD-----QM-----LD---------------PRLPAPSRSAQEKLISIMEVAFSCFNESPESR  837 (849)
Q Consensus       790 ~~~~~-------~~~~~~~-----~~-----~~---------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  837 (849)
                      .....       .......     ..     .+               ................+.+++.+||+.||++|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            10000       0000000     00     00               00000000111234568899999999999999


Q ss_pred             CCHHHHHhh
Q 042123          838 PTMKIISQQ  846 (849)
Q Consensus       838 Pt~~eil~~  846 (849)
                      ||++|++++
T Consensus       321 pt~~ell~h  329 (339)
T 1z57_A          321 ITLREALKH  329 (339)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999876

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-34  Score=315.10  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=177.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++....  ......+.+.+|+..           +++++...     
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            36799999999999999999965 579999999986532  222334455666553           45555543     


Q ss_pred             -CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          650 -RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       650 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                       ...|+||||+ +++|.+++..    ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             CceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence             3469999999 7899999864    3489999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------cccccccc
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------SLNTDVAL  800 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------~~~~~~~~  800 (849)
                      +++.....   .....+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||.........       ........
T Consensus       174 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          174 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccccc---cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99876432   344678999999999877 67899999999999999999999999754321100       00000000


Q ss_pred             c--------cccC--CCCCC-C-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 D--------QMLD--PRLPA-P-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 ~--------~~~~--~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .        ..+.  +.... . ..........+.+++.+||+.||++|||++|+++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            0        0000  00000 0 00001122347889999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.4e-35  Score=306.31  Aligned_cols=236  Identities=25%  Similarity=0.433  Sum_probs=176.7

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-CCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-ARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|+.. |+.||||.+....      ..+.+.+|+.           .+++++.. .+..++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh------HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            367889999999999999999874 8899999986532      2334555544           24555433 457899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus        93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  168 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  168 (278)
T ss_dssp             EECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEecCCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccc
Confidence            999999999999996543 23489999999999999999999999   99999999999999999999999999988654


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      ..   .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......        .....+... ....+.
T Consensus       169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~  237 (278)
T 1byg_A          169 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDAPD  237 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHHHHTTTCCCCCCT
T ss_pred             cc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHhcCCCCCCcc
Confidence            32   223467889999999998899999999999999999998 99998743211        111111111 111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..    ...+.+++.+||+.||++|||+.|+++.|+
T Consensus       238 ~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~  269 (278)
T 1byg_A          238 GC----PPAVYEVMKNCWHLDAAMRPSFLQLREQLE  269 (278)
T ss_dssp             TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             cC----CHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence            11    234788999999999999999999998874

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.6e-35  Score=311.70  Aligned_cols=242  Identities=23%  Similarity=0.393  Sum_probs=180.4

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+.....    .....+.+|+.           .+++++...+..++
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH----HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            368899999999999999999664 689999999865422    22344555543           36777888889999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++++|.+++....  ..+++.++..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||++....
T Consensus        94 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELD--RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EEECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999986432  4589999999999999999999999   99999999999999999999999999875432


Q ss_pred             CCCCCeeeccCCccccccccc-----cCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          735 PDSSNWTEFAGTCGYIAPELA-----YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ..........|++.|+|||.+     .+..++.++||||||+++|+|++|+.||.......        ..........+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~  240 (302)
T 2j7t_A          169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKSDPP  240 (302)
T ss_dssp             HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCCC
T ss_pred             ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--------HHHHHhccCCc
Confidence            211122345789999999988     36678999999999999999999999997543211        11111111111


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      . ..........+.+++.+||+.||++|||+++++++
T Consensus       241 ~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          241 T-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             C-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             c-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0 00111122347889999999999999999999876

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.1e-34  Score=312.43  Aligned_cols=247  Identities=20%  Similarity=0.279  Sum_probs=175.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC-----
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR-----  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~-----  650 (849)
                      ++|+..+.||+|+||.||+|.. .+++.||||++.....  .......+.+|+..           +++++....     
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC--ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            6899999999999999999954 5789999999875322  22334455566542           455554443     


Q ss_pred             -eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          651 -HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       651 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                       ..++||||+++ +|.+++.     ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  173 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  173 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence             78999999985 7877774     2489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc----
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDV----  798 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~----  798 (849)
                      ++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+......       .....    
T Consensus       174 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  252 (371)
T 2xrw_A          174 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  252 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred             ccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            9866432 22345678999999999999999999999999999999999999997543211000       00000    


Q ss_pred             ---c---------------cccccC-CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ---A---------------LDQMLD-PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ---~---------------~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         .               ...... ...+............+.+++.+||+.||++|||++|+++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence               0               000000 00111111222335568899999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-34  Score=301.66  Aligned_cols=240  Identities=25%  Similarity=0.414  Sum_probs=180.0

Q ss_pred             CCCcCceecCCccceEEEEEec-C---CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe-e
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-S---GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH-S  652 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~-~  652 (849)
                      .|...+.||+|+||+||+|.+. +   +..||+|.+....   .....+.+.+|+.           .+++++...+. .
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT---EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc---cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            4555688999999999999653 2   2379999986532   2233445666654           35666655544 4


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+.+|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             EEEEecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            99999999999999996533  4589999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCC----CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCC-CccccccccccccccccccccCCC
Q 042123          733 LKPDS----SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPR-DFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       733 ~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf-~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      .....    .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+ .....        ...........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--------~~~~~~~~~~~  245 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--------FDLTHFLAQGR  245 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--------GGHHHHHHTTC
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--------HHHHHHhhcCC
Confidence            54321    1223456788999999999999999999999999999999966554 32211        11111111111


Q ss_pred             -CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 -LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       .+.+...    ...+.+++.+||+.||++|||++++++.|+
T Consensus       246 ~~~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~  283 (298)
T 3pls_A          246 RLPQPEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVE  283 (298)
T ss_dssp             CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence             1111112    234788999999999999999999999874

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.9e-34  Score=308.41  Aligned_cols=245  Identities=23%  Similarity=0.372  Sum_probs=181.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceee----cCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCS----HARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~----~~~~  651 (849)
                      ++|+..+.||+|+||.||+|+. .+++.||||++...    .......+.+|+.           ++++++.    ....
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            6899999999999999999965 67999999988542    2233445555654           3556664    3347


Q ss_pred             eEEEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          652 SFLLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      .++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||.+
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~  181 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM  181 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence            899999999999999987532 234689999999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCCC---------eeeccCCccccccccccCCC---CCccchHHHHHHHHHHHHhCCCCCCcccccccccccccc
Q 042123          731 KSLKPDSSN---------WTEFAGTCGYIAPELAYTMK---ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDV  798 (849)
Q Consensus       731 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~---~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~  798 (849)
                      .........         .....||+.|+|||.+.+..   ++.++||||||+++|||++|+.||.......   .....
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~  258 (317)
T 2buj_A          182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG---DSVAL  258 (317)
T ss_dssp             EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---SCHHH
T ss_pred             hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---chhhH
Confidence            765321110         12235799999999987554   6889999999999999999999986321110   00000


Q ss_pred             ccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          799 ALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       799 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....  ....+.....    ...+.+++.+||+.||++|||+++++++|+
T Consensus       259 ~~~~--~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  302 (317)
T 2buj_A          259 AVQN--QLSIPQSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLE  302 (317)
T ss_dssp             HHHC--C--CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             Hhhc--cCCCCccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhh
Confidence            0011  1111111112    234888999999999999999999999885

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.1e-34  Score=317.66  Aligned_cols=247  Identities=20%  Similarity=0.253  Sum_probs=180.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-------------------Hhhceee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------------AFYGFCS  647 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-------------------~~~~~~~  647 (849)
                      ++|++.+.||+|+||+||+|+. .+++.||||++...     ......+.+|+.                   .+++++.
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~  111 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK  111 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence            6899999999999999999954 57899999998642     112233333332                   2344444


Q ss_pred             ----cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC---
Q 042123          648 ----HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY---  720 (849)
Q Consensus       648 ----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~---  720 (849)
                          .....++||||+ ++++.+.+.... ...+++.++..++.||+.||+|||+++  +|+||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          112 ISGVNGTHICMVFEVL-GHHLLKWIIKSN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EEETTEEEEEEEECCC-CCBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred             ecCCCCceEEEEEecc-CccHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence                456789999999 556666664332 245899999999999999999999964  799999999999999775   


Q ss_pred             ----------------------------------------------cEEEeeecCCcccCCCCCCeeeccCCcccccccc
Q 042123          721 ----------------------------------------------EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL  754 (849)
Q Consensus       721 ----------------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~  754 (849)
                                                                    .+||+|||.++.....   .....||+.|+|||+
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChh
Confidence                                                          7999999999876432   244578999999999


Q ss_pred             ccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccc-------------c------ccccccccCC--------C
Q 042123          755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLN-------------T------DVALDQMLDP--------R  807 (849)
Q Consensus       755 ~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~-------------~------~~~~~~~~~~--------~  807 (849)
                      +.+..++.++|||||||++|||++|+.||............             .      ..........        .
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999999743321110000             0      0000000000        0


Q ss_pred             CCC---------CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          808 LPA---------PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       808 ~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...         ...........+.+++.+||+.||++|||++|+++|
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            000         001224455678899999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.1e-34  Score=315.45  Aligned_cols=259  Identities=17%  Similarity=0.200  Sum_probs=171.6

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH--------HHHhhceeecCC-
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE--------VEAFYGFCSHAR-  650 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e--------i~~~~~~~~~~~-  650 (849)
                      .......++|+..+.||+|+||.||+|+. .+++.||||++........  ......+.        +..+++++.... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN--RELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCC--HHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH--HHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            44566778999999999999999999966 4789999998865322211  11222222        224566664322 


Q ss_pred             ------eeEEEEEeccCCChhhhhcc-cccccCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCeeecC-CC
Q 042123          651 ------HSFLLYEFLERGSLAAILNT-DAAAQELGWSQRMNVIKAVAHALSYLH--HDCFPPIVHRDISSKNLLLDL-EY  720 (849)
Q Consensus       651 ------~~~lV~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~dlk~~Nill~~-~~  720 (849)
                            ..++||||+++ ++.+.+.. ......+++..+..++.|++.|++|||  +.   +|+||||||+||+++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCC
Confidence                  37899999987 44444322 223346899999999999999999999  77   9999999999999997 89


Q ss_pred             cEEEeeecCCcccCCCCCCeeeccCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCcccccccccc-----
Q 042123          721 EAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-----  794 (849)
Q Consensus       721 ~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-----  794 (849)
                      .+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...........     
T Consensus       170 ~~kl~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EEEECCCTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            99999999998765433 234567899999999986654 89999999999999999999999975432110000     


Q ss_pred             --cccccccc---------ccCC-CCCC---CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 --NTDVALDQ---------MLDP-RLPA---PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 --~~~~~~~~---------~~~~-~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        ........         ..+. ..+.   ...........+.+++.+||+.||++|||+.|+++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence              00000000         0000 0000   000000123458899999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.8e-34  Score=304.41  Aligned_cols=240  Identities=22%  Similarity=0.363  Sum_probs=178.4

Q ss_pred             HhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-------------HhhceeecCCee
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------AFYGFCSHARHS  652 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-------------~~~~~~~~~~~~  652 (849)
                      ..++|+..+.||+|+||.||+|...+++.||||++.....  .......+.+|+.             .+++++......
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~  103 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA--DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  103 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc--cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence            3467999999999999999999888899999999865322  1222333444433             256677788899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||| +.+++|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++ ++.+||+|||+++.
T Consensus       104 ~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~  175 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  175 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEeecccccc
Confidence            99999 6678999998653   3589999999999999999999999   999999999999996 48999999999987


Q ss_pred             cCCCCC--CeeeccCCccccccccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccc
Q 042123          733 LKPDSS--NWTEFAGTCGYIAPELAYT-----------MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA  799 (849)
Q Consensus       733 ~~~~~~--~~~~~~g~~~y~aPE~~~~-----------~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~  799 (849)
                      ......  ......|++.|+|||.+.+           ..++.++||||||+++|||++|+.||......       ...
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~  248 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-------ISK  248 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHH
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-------HHH
Confidence            654322  1234578999999999865           46888999999999999999999999743211       111


Q ss_pred             cccccCCCCC--CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQMLDPRLP--APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....++...  .+...    ...+.+++.+||+.||++|||++|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          249 LHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHHHHCTTSCCCCCCCS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhcccccCCcccc----hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            1222222211  11111    1247788999999999999999999976

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.4e-34  Score=306.37  Aligned_cols=236  Identities=23%  Similarity=0.313  Sum_probs=184.9

Q ss_pred             HHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC--------chhhHHHHHHH-------HHHhhceeec
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD--------QTVDQKEFLTE-------VEAFYGFCSH  648 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~~~~e-------i~~~~~~~~~  648 (849)
                      ...++|+..+.||+|+||.||+|.. .+++.||||.+.......        ....+...++.       +..+++++..
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~  119 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER  119 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence            3457899999999999999999954 578999999986542211        11123333333       3347788888


Q ss_pred             CCeeEEEEEeccC-CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEee
Q 042123          649 ARHSFLLYEFLER-GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD-LEYEAHVAD  726 (849)
Q Consensus       649 ~~~~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~D  726 (849)
                      .+..++||||+.+ ++|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++ .++.+||+|
T Consensus       120 ~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~D  193 (320)
T 3a99_A          120 PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLID  193 (320)
T ss_dssp             SSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred             CCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEee
Confidence            8999999999986 8999998653   3589999999999999999999999   999999999999999 779999999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccC
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLD  805 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~  805 (849)
                      ||+++.....  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.......              .
T Consensus       194 fg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~  257 (320)
T 3a99_A          194 FGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------R  257 (320)
T ss_dssp             CTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------H
T ss_pred             Cccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------c
Confidence            9999876532  2344678999999999887665 688999999999999999999997432111              0


Q ss_pred             CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       806 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+...    ...+.+++.+||+.||++|||++|++++
T Consensus       258 ~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 GQVFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CCCCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccccccccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111111111    1247789999999999999999999986

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.9e-34  Score=306.26  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=171.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||.||+|.. .+++.||||++.....   ......+.+|+.           ++++++...+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC---QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc---chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            347899999999999999999965 4689999998764321   122334555544           4677888888999


Q ss_pred             EEEEeccCCChhhhhcccc-----cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          654 LLYEFLERGSLAAILNTDA-----AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      +||||+++|+|.+++....     ....+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            9999999999999986421     234589999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCC-----CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccc---
Q 042123          729 IAKSLKPDSS-----NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA---  799 (849)
Q Consensus       729 ~a~~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~---  799 (849)
                      ++........     ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||................   
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            9876543221     1234578999999999865 568999999999999999999999997543211100000000   


Q ss_pred             -cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 -LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....+....  .    .....+.+++.+||+.||++|||++|++++
T Consensus       247 ~~~~~~~~~~~--~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          247 LETGVQDKEML--K----KYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TTC-----CCC--C----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccccccchhh--h----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence             0000000000  0    112347789999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=9.3e-34  Score=306.36  Aligned_cols=242  Identities=19%  Similarity=0.264  Sum_probs=179.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceeec--CCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH--ARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~--~~~~  652 (849)
                      ++|+..+.||+|+||+||+|.. .+++.||||++....       ...+.+|+.            .+++++..  ....
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            6789999999999999999954 679999999986432       122333332            35566655  5678


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAK  731 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~  731 (849)
                      ++||||+++++|.+++.      .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++ .+||+|||+++
T Consensus       109 ~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEEEECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            99999999999999874      388999999999999999999999   999999999999999777 89999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------------------
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------------------  791 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------------------  791 (849)
                      ...... ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........                   
T Consensus       180 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          180 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             EcCCCC-ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence            765433 2345678999999999877 6789999999999999999999999953211100                   


Q ss_pred             -cccccccccccccCCCCCC------CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          792 -SSLNTDVALDQMLDPRLPA------PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       792 -~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ...................      ...........+.+++.+||+.||++|||++|+++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence             0000000000000000000      000011123458899999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.6e-34  Score=314.85  Aligned_cols=261  Identities=19%  Similarity=0.244  Sum_probs=183.4

Q ss_pred             cHHHHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCc-------hhhHHHHHHHHHH----------
Q 042123          579 LYDEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ-------TVDQKEFLTEVEA----------  641 (849)
Q Consensus       579 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------~~~~~~~~~ei~~----------  641 (849)
                      ...++....++|+..+.||+|+||.||+|...+|+.||||++........       ....+.+.+|+..          
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            45677888899999999999999999999888899999999865432211       1123456666543          


Q ss_pred             -hhceee-----cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCee
Q 042123          642 -FYGFCS-----HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLL  715 (849)
Q Consensus       642 -~~~~~~-----~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nil  715 (849)
                       +++++.     .....++||||++ |+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence             455552     2346799999998 58888876433  3589999999999999999999999   9999999999999


Q ss_pred             ecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc
Q 042123          716 LDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL  794 (849)
Q Consensus       716 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~  794 (849)
                      ++.++.+||+|||+++..... .......+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...........
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             ECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999999855433 22345678999999999876 6789999999999999999999999975331110000


Q ss_pred             c---------------cccccccccCCCC---CCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 N---------------TDVALDQMLDPRL---PAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 ~---------------~~~~~~~~~~~~~---~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .               ........+....   +...  .........+.+++.+||+.||++|||++|+++|
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            0               0000000111111   1000  0001112347899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=4.2e-34  Score=305.03  Aligned_cols=241  Identities=23%  Similarity=0.395  Sum_probs=175.1

Q ss_pred             HhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec-----
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH-----  648 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~-----  648 (849)
                      ..++|+..+.||+|+||.||+|+. .+++.||||++...     ......+.+|+..           +++++.+     
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV   78 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence            346799999999999999999965 47999999998542     2234456666553           3444322     


Q ss_pred             --------CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC
Q 042123          649 --------ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY  720 (849)
Q Consensus       649 --------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~  720 (849)
                              ....++||||+++|+|.+++....  ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++
T Consensus        79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             C------CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred             hhhcccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCC
Confidence                    457899999999999999997533  3478899999999999999999999   999999999999999999


Q ss_pred             cEEEeeecCCcccCCCC--------------CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          721 EAHVADFGIAKSLKPDS--------------SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       721 ~~kl~DfG~a~~~~~~~--------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                      .+||+|||++.......              .......|++.|+|||.+.+. .++.++||||+|+++|||++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            99999999998764321              122345689999999998764 68999999999999999998   5432


Q ss_pred             cccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          786 LSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...       .......+.......+..........+.+++.+||+.||++|||+++++++
T Consensus       231 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          231 GME-------RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHH-------HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             chh-------HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            110       011111111111111111122223347789999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.9e-34  Score=308.51  Aligned_cols=248  Identities=25%  Similarity=0.413  Sum_probs=184.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-----cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC--
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA--  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~--  649 (849)
                      ++|+..+.||+|+||.||+|++     .+++.||||++...    .....+.+.+|+..           +++++...  
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  116 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR  116 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence            5688899999999999999973     46899999998753    22234456666553           44554443  


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST--TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             CceEEEEECCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcc
Confidence            36799999999999999996543  3589999999999999999999998   999999999999999999999999999


Q ss_pred             CcccCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc----cccccc---cc
Q 042123          730 AKSLKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----SSLNTD---VA  799 (849)
Q Consensus       730 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----~~~~~~---~~  799 (849)
                      ++........   .....++..|+|||.+.+..++.++||||||+++|||++|..||........    ......   ..
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            9877544321   1223567789999999988899999999999999999999999763211000    000000   00


Q ss_pred             cccccC--CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          800 LDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       800 ~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.+.  .+.+.+...    ...+.+++.+||+.||++|||+.|+++.|+
T Consensus       272 ~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~Rps~~el~~~L~  318 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGC----PDEIYMIMTECWNNNVNQRPSFRDLALRVD  318 (326)
T ss_dssp             HHHHHHTTCCCCCCTTC----CHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            111111  111212222    234888999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5.4e-34  Score=332.62  Aligned_cols=234  Identities=26%  Similarity=0.431  Sum_probs=178.3

Q ss_pred             ceecCCccceEEEEEe---cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEec
Q 042123          594 YCIGNGGHASVYRAEL---PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~  659 (849)
                      +.||+|+||+||+|.+   ..++.||||+++....  .....+.+.+|+.           .+++++.. +..++||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~  451 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA  451 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG--CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence            4799999999999954   2467899999875422  2223455666654           36777754 5678999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN  739 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  739 (849)
                      ++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+......
T Consensus       452 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          452 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCCCHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999999643   3589999999999999999999999   9999999999999999999999999999876543321


Q ss_pred             ---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCChh
Q 042123          740 ---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-LPAPSRS  814 (849)
Q Consensus       740 ---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  814 (849)
                         .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......        .....+.... ...+...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~~~~~~p~~~  597 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGCPAGC  597 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCCTTC
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCCCC
Confidence               223346788999999999999999999999999999998 99999743321        1111121211 1111122


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          ...+.+++..||+.||++|||+++|++.|+
T Consensus       598 ----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~  627 (635)
T 4fl3_A          598 ----PREMYDLMNLCWTYDVENRPGFAAVELRLR  627 (635)
T ss_dssp             ----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence                234888999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3e-34  Score=304.34  Aligned_cols=242  Identities=27%  Similarity=0.422  Sum_probs=175.6

Q ss_pred             cCCCcCceecCCccceEEEEEec--CCc--EEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP--SGE--VVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~  652 (849)
                      ++|+..+.||+|+||.||+|++.  +++  .||||.++..... .....+.+.+|+..           +++++... ..
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~   95 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLS-QPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM   95 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-Cc
Confidence            57889999999999999999753  333  6899988654221 12234455666543           55665554 47


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999997543  3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC--
Q 042123          733 LKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP--  806 (849)
Q Consensus       733 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~--  806 (849)
                      .......   .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||......        .....+...  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKEGE  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTSCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH--------HHHHHHHccCC
Confidence            7544321   223456788999999998889999999999999999999 99999743321        111111111  


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.+..    ....+.+++.+||+.||++|||+.+++++|+
T Consensus       243 ~~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  280 (291)
T 1u46_A          243 RLPRPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  280 (291)
T ss_dssp             CCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            1111111    2234888999999999999999999999874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.3e-34  Score=313.15  Aligned_cols=247  Identities=21%  Similarity=0.300  Sum_probs=165.4

Q ss_pred             hcCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|. ..+|+.||||++....  ......+.+.+|+..           +++++...     
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            3689999999999999999995 4579999999986532  222334455566553           45555432     


Q ss_pred             -CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          650 -RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       650 -~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                       ...++|+||+ +++|.+++..    ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCCCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             CCeEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence             5679999999 6799998864    3489999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc--
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDV--  798 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~--  798 (849)
                      +++.....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..........       .....  
T Consensus       178 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          178 LARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccccc---CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99865432   345678999999999876 678999999999999999999999997543211000       00000  


Q ss_pred             ------ccccccC--CCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ------ALDQMLD--PRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ------~~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                            .....+.  +..+...  .........+.+++.+||+.||++|||++|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                  0000000  0001000  0000112347899999999999999999999876

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.1e-34  Score=316.96  Aligned_cols=253  Identities=21%  Similarity=0.238  Sum_probs=179.6

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceeecC------CeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCSHA------RHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~~~------~~~~lV~  656 (849)
                      .+|+..+.||+|+||.||+|+...+..||+|++.......  ..+...++.     +..+++++...      ...++||
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~--~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~  117 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK--NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVL  117 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC--CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH--HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEe
Confidence            5788999999999999999988777779999886542221  122233322     33466666332      2378999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEeeecCCcccCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD-LEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~  735 (849)
                      ||++++.+............+++..+..++.||+.||+|||+.   +|+||||||+||+++ .++.+||+|||+++....
T Consensus       118 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          118 EYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             ECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            9999855444433233345689999999999999999999999   999999999999999 789999999999987654


Q ss_pred             CCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------ccc---ccccccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS--------LNT---DVALDQM  803 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~--------~~~---~~~~~~~  803 (849)
                      .. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..........        ...   .......
T Consensus       195 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~  273 (394)
T 4e7w_A          195 GE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY  273 (394)
T ss_dssp             TC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred             CC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            32 23456789999999998764 58999999999999999999999997543211000        000   0000001


Q ss_pred             cCCCCCCCC-hh-----hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDPRLPAPS-RS-----AQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+... ..     .......+.+++.+||+.||++|||+.|+++|
T Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            111111000 00     00122358899999999999999999999876

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.7e-34  Score=314.23  Aligned_cols=256  Identities=20%  Similarity=0.229  Sum_probs=179.2

Q ss_pred             HHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceee----------
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCS----------  647 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~----------  647 (849)
                      ....++|+..+.||+|+||.||+|.. .+|+.||||++.......  ..+...++.     +..+++++.          
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~--~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK--NRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC--CHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH--HHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence            34567899999999999999999954 679999999986542221  112222222     334556552          


Q ss_pred             ----------------------------cCCeeEEEEEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHh
Q 042123          648 ----------------------------HARHSFLLYEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHH  698 (849)
Q Consensus       648 ----------------------------~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~  698 (849)
                                                  .....++||||+++ +|.+.+... .....+++..+..++.||+.||+|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                        23348899999985 888777542 223469999999999999999999999


Q ss_pred             cCCCCeEecCCCCCCeeec-CCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHH
Q 042123          699 DCFPPIVHRDISSKNLLLD-LEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEV  776 (849)
Q Consensus       699 ~~~~~ivH~dlk~~Nill~-~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el  776 (849)
                      .   +|+||||||+||+++ .++.+||+|||+++...... ......+|+.|+|||.+.+. .++.++||||+||++|||
T Consensus       160 ~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          160 L---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             T---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             C---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            8   999999999999997 68999999999998765433 23456789999999998765 489999999999999999


Q ss_pred             HhCCCCCCcccccccccc-------ccccc-------cccccCCCCCCCCh---hhHHHHHHHHHHHhhccCCCCCCCCC
Q 042123          777 IKGKHPRDFLSSISSSSL-------NTDVA-------LDQMLDPRLPAPSR---SAQEKLISIMEVAFSCFNESPESRPT  839 (849)
Q Consensus       777 ~tg~~Pf~~~~~~~~~~~-------~~~~~-------~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt  839 (849)
                      ++|+.||...........       .....       .....-+......-   ........+.+++.+||+.||++|||
T Consensus       236 l~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  315 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN  315 (383)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC
Confidence            999999975432110000       00000       00000000000000   00011234789999999999999999


Q ss_pred             HHHHHhh
Q 042123          840 MKIISQQ  846 (849)
Q Consensus       840 ~~eil~~  846 (849)
                      +.|+++|
T Consensus       316 ~~e~l~h  322 (383)
T 3eb0_A          316 PYEAMAH  322 (383)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhcC
Confidence            9999876

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-34  Score=319.13  Aligned_cols=194  Identities=21%  Similarity=0.328  Sum_probs=137.5

Q ss_pred             cCCCc-CceecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhcee--ecCCeeEEEE
Q 042123          588 NDFDA-KYCIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFC--SHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~--~~~~~~~lV~  656 (849)
                      +.|+. .++||+|+||+||+|+..   +++.||||++...........+...++.     +..+++++  ......++||
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            34555 558999999999999764   5789999998654221111111122222     22356666  3467899999


Q ss_pred             EeccCCChhhhhccccc------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee----cCCCcEEEee
Q 042123          657 EFLERGSLAAILNTDAA------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL----DLEYEAHVAD  726 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill----~~~~~~kl~D  726 (849)
                      ||+++ +|.+++.....      ...+++.++..++.||+.||+|||+.   +|+||||||+||++    +.++.+||+|
T Consensus       100 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            99975 88887753321      12489999999999999999999999   99999999999999    6778999999


Q ss_pred             ecCCcccCCCC---CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          727 FGIAKSLKPDS---SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       727 fG~a~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                      ||+++......   .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            99998765432   223456789999999998874 589999999999999999999999964

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.7e-34  Score=311.51  Aligned_cols=249  Identities=20%  Similarity=0.291  Sum_probs=181.6

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|.. .+++.||||++...   ........+.+|+..           +++++...     
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence            36899999999999999999965 47889999998643   222334556666553           44555433     


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||+++ +|.+++..    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       103 ~~~~iv~e~~~~-~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~  174 (364)
T 3qyz_A          103 KDVYIVQDLMET-DLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL  174 (364)
T ss_dssp             CCEEEEEECCSE-EHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEcccCc-CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcc
Confidence            468999999985 99998854    3489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCC---CeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------cccc
Q 042123          730 AKSLKPDSS---NWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-------NTDV  798 (849)
Q Consensus       730 a~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-------~~~~  798 (849)
                      ++.......   ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...........       ....
T Consensus       175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE  254 (364)
T ss_dssp             CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHH
T ss_pred             eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            987653321   1244579999999998654 4589999999999999999999999975432211000       0000


Q ss_pred             ccc------------cccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          799 ALD------------QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       799 ~~~------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...            ....+...............+.+++.+||+.||++|||++|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000            000000000000001112357899999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-33  Score=303.84  Aligned_cols=255  Identities=20%  Similarity=0.303  Sum_probs=184.1

Q ss_pred             HhcCCCcCceecCCccceEEEEEe--cCCcEEEEEEecccCCCC----chhhHHHHHHHH--------HHhhceee----
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAEL--PSGEVVAVKKFHSLLPCD----QTVDQKEFLTEV--------EAFYGFCS----  647 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~----~~~~~~~~~~ei--------~~~~~~~~----  647 (849)
                      +.++|+..+.||+|+||.||+|+.  .+++.||||++.......    ....+....+.+        .++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            447899999999999999999976  468899999986432211    111122222222        23566665    


Q ss_pred             -cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          648 -HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       648 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                       .....++||||++ |+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence             4567899999998 59999986543 23489999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc-------------c
Q 042123          727 FGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS-------------S  793 (849)
Q Consensus       727 fG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~-------------~  793 (849)
                      ||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++|+.||.........             .
T Consensus       164 fg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          164 FGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             CcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            9999865432 2234467899999999999989999999999999999999999999754321100             0


Q ss_pred             ccccccc-ccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 LNTDVAL-DQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ....... ...... ...............+.+++.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000000 000000 0000000111122347789999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.2e-33  Score=306.81  Aligned_cols=246  Identities=17%  Similarity=0.242  Sum_probs=178.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CC-cEEEEEEecccCCCCchhhHHHHHHHHH-----------------Hhhceeec
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SG-EVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------------AFYGFCSH  648 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------------~~~~~~~~  648 (849)
                      ++|++.+.||+|+||.||+|... ++ +.||||++....     .....+.+|+.                 .+.+++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            68999999999999999999653 44 689999986421     11222333322                 23456677


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeee------------
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLL------------  716 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill------------  716 (849)
                      .+..++||||+ ++++.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||++            
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENN-FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             CCeEEEEEecc-CCChHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccc
Confidence            78999999999 567777765432 23589999999999999999999998   99999999999999            


Q ss_pred             -------cCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccc
Q 042123          717 -------DLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSI  789 (849)
Q Consensus       717 -------~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~  789 (849)
                             +.++.+||+|||+++.....   .....||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEH---HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSC---CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccccCCCcEEEeecCcccccccc---ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                   56789999999999865432   24467899999999999999999999999999999999999999753321


Q ss_pred             cccc-------ccccccc------ccccCCC--CCCC-----------------ChhhHHHHHHHHHHHhhccCCCCCCC
Q 042123          790 SSSS-------LNTDVAL------DQMLDPR--LPAP-----------------SRSAQEKLISIMEVAFSCFNESPESR  837 (849)
Q Consensus       790 ~~~~-------~~~~~~~------~~~~~~~--~~~~-----------------~~~~~~~~~~l~~li~~cl~~dP~~R  837 (849)
                      ....       .......      .......  ....                 ..........+.+++.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            1000       0000000      0000000  0000                 00011223468899999999999999


Q ss_pred             CCHHHHHhh
Q 042123          838 PTMKIISQQ  846 (849)
Q Consensus       838 Pt~~eil~~  846 (849)
                      ||++|++++
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-33  Score=304.18  Aligned_cols=245  Identities=26%  Similarity=0.377  Sum_probs=164.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~l  654 (849)
                      ++|+..+.||+|+||.||+|.. .+|+.||||++.....   ......+..|+.            ++++++...+..++
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC---HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC---chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            6788899999999999999966 4799999999875421   222333444433            36778888899999


Q ss_pred             EEEeccCCChhhhhcccc--cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          655 LYEFLERGSLAAILNTDA--AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ||||+++ +|.+++....  ....+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.+||+|||+++.
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  175 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQ  175 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence            9999986 8888775321  1345899999999999999999999953  799999999999999999999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELA----YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ..... ......||+.|+|||.+    .+..++.++||||||+++|+|++|+.||.......       ...........
T Consensus       176 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~  247 (327)
T 3aln_A          176 LVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-------DQLTQVVKGDP  247 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCC
T ss_pred             ccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-------HHHHHHhcCCC
Confidence            65432 22344789999999998    46678999999999999999999999997432110       11111111111


Q ss_pred             CCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      +.. ..........+.+++.+||+.||++|||+++++++
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            100 00001122348889999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=7.9e-34  Score=300.33  Aligned_cols=244  Identities=21%  Similarity=0.334  Sum_probs=187.3

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++......  ......+.+|+.           ++++++......
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK--NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS--SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc--hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence            34578999999999999999999664 7899999998654221  122344555544           367788888899


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC---CcEEEeeecC
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE---YEAHVADFGI  729 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~---~~~kl~DfG~  729 (849)
                      ++||||+++++|.+++...   ..+++.++..++.|++.||+|||+.   +++||||||+||+++.+   +.+||+|||+
T Consensus        97 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            9999999999999988643   3589999999999999999999999   99999999999999764   4799999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      +....... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......        .....+......
T Consensus       171 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~  240 (287)
T 2wei_A          171 STCFQQNT-KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--------DILKRVETGKYA  240 (287)
T ss_dssp             GGTBCCCS-SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCC
T ss_pred             ceeecCCC-ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            98765432 2234568899999998865 4899999999999999999999999743321        111112222221


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+..........+.+++.+||+.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          241 FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            1111111223357889999999999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.4e-34  Score=306.05  Aligned_cols=243  Identities=20%  Similarity=0.314  Sum_probs=178.7

Q ss_pred             HhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHH-----------HHHHHhhceeecCCeeEE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFL-----------TEVEAFYGFCSHARHSFL  654 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~-----------~ei~~~~~~~~~~~~~~l  654 (849)
                      ..++|+..+.||+|+||.||+|+...  .+|+|.+.........  .+.+.           ..+..+++++......++
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQ--LKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCC--CCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHH--HHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence            45789999999999999999998753  5999988643211110  11122           234457888888899999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++++|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++ ++.+||+|||+++...
T Consensus       107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             EeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            999999999999997543  3589999999999999999999999   999999999999998 6899999999987543


Q ss_pred             CC-----CCCeeeccCCccccccccccC---------CCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccc
Q 042123          735 PD-----SSNWTEFAGTCGYIAPELAYT---------MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVAL  800 (849)
Q Consensus       735 ~~-----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~  800 (849)
                      ..     ........|++.|+|||.+.+         ..++.++||||||+++|||++|+.||.......        ..
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~  252 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--------II  252 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--------HH
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HH
Confidence            21     122334568999999999864         457889999999999999999999997433211        11


Q ss_pred             ccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          801 DQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       801 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..+.....+....  ......+.+++.+||+.||++|||++++++.|+
T Consensus       253 ~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~  298 (319)
T 2y4i_B          253 WQMGTGMKPNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDMLE  298 (319)
T ss_dssp             HHHHTTCCCCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred             HHhccCCCCCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            1111111110000  001123778999999999999999999999885

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.5e-33  Score=309.45  Aligned_cols=246  Identities=21%  Similarity=0.288  Sum_probs=178.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee--
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS--  652 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~--  652 (849)
                      .++|...+.||+|+||.||+|.. .+|+.||||++.....  .......+.+|+.           .+++++......  
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ--SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc--chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            36889999999999999999954 5799999999875422  2233445556654           356666655543  


Q ss_pred             ----EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          653 ----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       653 ----~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                          ++||||++ |+|.+++.     ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             ceeEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence                99999998 58888873     2389999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc-
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVA-  799 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~-  799 (849)
                      +++.....   .....+|+.|+|||.+.+ ..++.++||||+||++|+|++|+.||..........       ...... 
T Consensus       190 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          190 LARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             CC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccccC---cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            99865432   344678999999999877 678999999999999999999999997543211000       000000 


Q ss_pred             -------cccc---cCCCCCCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 -------LDQM---LDPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 -------~~~~---~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                             ....   +....... ..........+.+++.+||+.||++|||++|++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                   0000   00000000 00001123458899999999999999999999886

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-33  Score=308.92  Aligned_cols=247  Identities=19%  Similarity=0.239  Sum_probs=177.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH----------------------HHHhhc
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE----------------------VEAFYG  644 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e----------------------i~~~~~  644 (849)
                      ++|+..+.||+|+||+||+|+. .+++.||||++....     .....+.+|                      +..+++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~   93 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD   93 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-----cchhhhhHHHHHHHHhhcccccchhccccchHHHHHH
Confidence            6899999999999999999965 578999999986421     111222222                      223455


Q ss_pred             eeecCC----eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---
Q 042123          645 FCSHAR----HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---  717 (849)
Q Consensus       645 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---  717 (849)
                      ++...+    ..++||||+ +++|.+++.... ...+++.++..++.||+.||+|||+.+  +|+||||||+||+++   
T Consensus        94 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           94 HFNHKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             EEEEEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEE
T ss_pred             HhhccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccC
Confidence            555433    789999999 889999987543 234899999999999999999999953  799999999999994   


Q ss_pred             ---CCCcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc
Q 042123          718 ---LEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL  794 (849)
Q Consensus       718 ---~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~  794 (849)
                         ..+.+||+|||++......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence               4458999999999876532   2345789999999999999999999999999999999999999974332110000


Q ss_pred             c-----------------------------cccccccccCCCCC-------CCChhhHHHHHHHHHHHhhccCCCCCCCC
Q 042123          795 N-----------------------------TDVALDQMLDPRLP-------APSRSAQEKLISIMEVAFSCFNESPESRP  838 (849)
Q Consensus       795 ~-----------------------------~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RP  838 (849)
                      .                             .......+......       ............+.+++.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            0                             00000000000000       00011234556788999999999999999


Q ss_pred             CHHHHHhh
Q 042123          839 TMKIISQQ  846 (849)
Q Consensus       839 t~~eil~~  846 (849)
                      |++|+++|
T Consensus       327 t~~ell~h  334 (373)
T 1q8y_A          327 DAGGLVNH  334 (373)
T ss_dssp             CHHHHHTC
T ss_pred             CHHHHhhC
Confidence            99999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-33  Score=315.04  Aligned_cols=252  Identities=23%  Similarity=0.265  Sum_probs=177.2

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH-----HHHhhceeec------CCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE-----VEAFYGFCSH------ARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e-----i~~~~~~~~~------~~~~~lV  655 (849)
                      .+|+..+.||+|+||.||+|+.. +|+.||||++.......  ..+.+.++.     +.++++++..      ....++|
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv  131 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV  131 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSC--CHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhH--HHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence            46888899999999999999764 69999999986542211  122233332     3345555532      2246789


Q ss_pred             EEeccCCChhhhhccc-ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecCCccc
Q 042123          656 YEFLERGSLAAILNTD-AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSL  733 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~a~~~  733 (849)
                      |||+++ ++.+.+... .....+++..+..++.||+.||+|||+.   +|+||||||+|||++.+ +.+||+|||+++..
T Consensus       132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~  207 (420)
T 1j1b_A          132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  207 (420)
T ss_dssp             EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence            999986 666665432 2235699999999999999999999998   99999999999999965 67899999999876


Q ss_pred             CCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccccccc---
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVALDQ---  802 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~~~~---  802 (849)
                      .... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||..........       .........   
T Consensus       208 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~  286 (420)
T 1j1b_A          208 VRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  286 (420)
T ss_dssp             CTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS
T ss_pred             ccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            5432 23456789999999998764 78999999999999999999999997543211000       000000000   


Q ss_pred             -ccCCCCCCC-Chhh-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 -MLDPRLPAP-SRSA-----QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 -~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ..+..++.. ...+     ......+.+++.+||+.||++|||+.|+++|
T Consensus       287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence             000011100 0001     0112458899999999999999999999876

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.4e-33  Score=323.47  Aligned_cols=253  Identities=25%  Similarity=0.312  Sum_probs=183.6

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec------
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH------  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~------  648 (849)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....   .......+.+|+..           +++++..      
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~---~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC---CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            37899999999999999999965 568999999986532   23334556666553           3344332      


Q ss_pred             CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCc---EEEe
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE---AHVA  725 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~---~kl~  725 (849)
                      .+..++||||+++|+|.+++........+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.   +||+
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEc
Confidence            667899999999999999998755445689999999999999999999998   9999999999999997765   9999


Q ss_pred             eecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc------cccccccc
Q 042123          726 DFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS------SSLNTDVA  799 (849)
Q Consensus       726 DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~------~~~~~~~~  799 (849)
                      |||.+....... ......||+.|+|||.+.+..++.++||||+|+++|+|++|+.||........      ........
T Consensus       167 DFG~a~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~  245 (676)
T 3qa8_A          167 DLGYAKELDQGE-LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV  245 (676)
T ss_dssp             SCCCCCBTTSCC-CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CC
T ss_pred             cccccccccccc-ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhh
Confidence            999998765432 33456899999999999999999999999999999999999999964311100      00000000


Q ss_pred             ccc------ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 LDQ------MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...      ......+.+..........+.+++.+||+.||++|||++|++++
T Consensus       246 ~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h  298 (676)
T 3qa8_A          246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV  298 (676)
T ss_dssp             SCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred             hhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence            000      01112222222233345568899999999999999999886543

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.7e-33  Score=307.33  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=179.5

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA-----  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~-----  649 (849)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++...   ........+.+|+..           +++++...     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            368899999999999999999654 7899999998643   222233445556543           44444332     


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||++ |+|.+++..    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL  158 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence            67899999998 589998864    3489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCC----------eeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCcccccccc------
Q 042123          730 AKSLKPDSSN----------WTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS------  792 (849)
Q Consensus       730 a~~~~~~~~~----------~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~------  792 (849)
                      ++........          .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........      
T Consensus       159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  238 (353)
T 2b9h_A          159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGI  238 (353)
T ss_dssp             CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence            9876532211          223468999999998764 67899999999999999999999999754311000      


Q ss_pred             ----c------cccccccccccC--CCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          793 ----S------LNTDVALDQMLD--PRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       793 ----~------~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          .      ........+...  +..+...  .........+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                0      000000000000  0000000  0001123457899999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-33  Score=301.89  Aligned_cols=247  Identities=19%  Similarity=0.268  Sum_probs=173.6

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhcee---------
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFC---------  646 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~---------  646 (849)
                      ++|+..+.||+|+||.||+|... +++.||||++...    .....+.+.+|+..           +++++         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            67889999999999999999665 5899999998643    22334556666553           33333         


Q ss_pred             -----ecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCC
Q 042123          647 -----SHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD-LEY  720 (849)
Q Consensus       647 -----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~  720 (849)
                           .+....++||||++ |+|.+++..    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++ .++
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTT
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence                 34467899999998 599999864    3489999999999999999999999   999999999999997 567


Q ss_pred             cEEEeeecCCcccCCCC---CCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc---
Q 042123          721 EAHVADFGIAKSLKPDS---SNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS---  793 (849)
Q Consensus       721 ~~kl~DfG~a~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~---  793 (849)
                      .+||+|||+++......   .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..........   
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  238 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL  238 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999998764321   12234567899999998765 678999999999999999999999997543211000   


Q ss_pred             ----cccccccccc-----------cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 ----LNTDVALDQM-----------LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ----~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                          ........+.           ..................+.+++.+||+.||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence                0000000000           0000000000001123458899999999999999999999876

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=4.6e-32  Score=292.87  Aligned_cols=294  Identities=20%  Similarity=0.248  Sum_probs=213.2

Q ss_pred             CCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCC
Q 042123           26 FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG  105 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  105 (849)
                      +....+++.+++++++++.+ |..+.  +.|++|+|++|++++.      ....|+++++|++|+|++|.+++..|..|.
T Consensus        27 ~~c~c~l~~l~~~~~~l~~l-p~~~~--~~l~~L~L~~n~i~~~------~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   97 (330)
T 1xku_A           27 FRCQCHLRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEI------KDGDFKNLKNLHTLILINNKISKISPGAFA   97 (330)
T ss_dssp             TTCEEETTEEECTTSCCCSC-CCSCC--TTCCEEECCSSCCCCB------CTTTTTTCTTCCEEECCSSCCCCBCTTTTT
T ss_pred             CCCcCCCeEEEecCCCcccc-CccCC--CCCeEEECCCCcCCEe------ChhhhccCCCCCEEECCCCcCCeeCHHHhc
Confidence            33445788888888888644 43332  5788888888888742      234567788888888888888877778888


Q ss_pred             CCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccc--cCCcCCCCCCCCC
Q 042123          106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIG--YIPRPFSNLTSVS  183 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~  183 (849)
                      ++++|++|+|++|+++.+ |..+.  ++|++|++++|.+++..+..|.++++|+.|++++|.+..  +.+..|..+++|+
T Consensus        98 ~l~~L~~L~Ls~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~  174 (330)
T 1xku_A           98 PLVKLERLYLSKNQLKEL-PEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS  174 (330)
T ss_dssp             TCTTCCEEECCSSCCSBC-CSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCC
T ss_pred             CCCCCCEEECCCCcCCcc-Chhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcC
Confidence            888888888888888743 43333  678888888888877777778888888888888888754  5667778888888


Q ss_pred             EEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCC
Q 042123          184 TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHF  263 (849)
Q Consensus       184 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i  263 (849)
                      +|++++|+++ .+|..+.  ++|++|++++|++++..+..|..+++|++|+|++|.+++.                    
T Consensus       175 ~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~--------------------  231 (330)
T 1xku_A          175 YIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV--------------------  231 (330)
T ss_dssp             EEECCSSCCC-SCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE--------------------
T ss_pred             EEECCCCccc-cCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCcee--------------------
Confidence            8888888877 4454443  6788888888888777777777777777777777776643                    


Q ss_pred             CCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCC------CCCCCEEeccCccccC
Q 042123          264 TGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGI------YPNLTFIDLSRNNFYG  337 (849)
Q Consensus       264 ~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~------l~~L~~L~Ls~N~l~~  337 (849)
                         .+..+..+++|+.|++++|+++ .+|..+..+++|++|++++|+|++..+..|..      .+.++.|++++|.+..
T Consensus       232 ---~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~  307 (330)
T 1xku_A          232 ---DNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY  307 (330)
T ss_dssp             ---CTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred             ---ChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccc
Confidence               3334555667777777777777 66777777888888888888888777766654      3678888888888863


Q ss_pred             --cccccCCCCCCCcEEeccCCc
Q 042123          338 --EISSNWGKFPKLGTLNVSMNN  358 (849)
Q Consensus       338 --~~~~~~~~l~~L~~L~Ls~N~  358 (849)
                        ..|..|..+.+++.++|++|+
T Consensus       308 ~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          308 WEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             GGSCGGGGTTCCCGGGEEC----
T ss_pred             cccCccccccccceeEEEecccC
Confidence              566788888889999988874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.2e-33  Score=327.28  Aligned_cols=241  Identities=23%  Similarity=0.404  Sum_probs=182.8

Q ss_pred             hcCCCcCceecCCccceEEEEEec----CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      .++|+..+.||+|+||.||+|.+.    .+..||||++....   .....+.+.+|+.           ++++++. .+.
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~  464 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP  464 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence            467888899999999999999763    25679999876532   2233455666654           3567764 456


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus       465 ~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          465 VWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             CEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             eEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCe
Confidence            899999999999999996432  3589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CC
Q 042123          732 SLKPDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RL  808 (849)
Q Consensus       732 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~  808 (849)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......        .....+... ..
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--------~~~~~i~~~~~~  611 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERL  611 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHHTCCC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            7654322 1223456789999999998899999999999999999997 99999743321        111111111 11


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+...    ...+.+++.+||+.||++|||+.++++.|+
T Consensus       612 ~~~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~  647 (656)
T 2j0j_A          612 PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLS  647 (656)
T ss_dssp             CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            111222    234788999999999999999999999874

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-33  Score=300.19  Aligned_cols=237  Identities=23%  Similarity=0.327  Sum_probs=176.5

Q ss_pred             HHHhcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC--------chhhHHHHHHH---------HHHhhce
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD--------QTVDQKEFLTE---------VEAFYGF  645 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~~~~e---------i~~~~~~  645 (849)
                      ....++|+..+.||+|+||.||+|.. .+++.||||++.......        ....+...+..         +..++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44567899999999999999999965 578999999986532111        11112222222         3346777


Q ss_pred             eecCCeeEEEEEe-ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEE
Q 042123          646 CSHARHSFLLYEF-LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD-LEYEAH  723 (849)
Q Consensus       646 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~k  723 (849)
                      +...+..++|||| +.+++|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEE
Confidence            8788889999999 7899999999653   3589999999999999999999999   999999999999999 789999


Q ss_pred             EeeecCCcccCCCCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccc
Q 042123          724 VADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQ  802 (849)
Q Consensus       724 l~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  802 (849)
                      |+|||+++.....  ......|++.|+|||++.+..+ +.++||||+|+++|||++|+.||......             
T Consensus       181 l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------------  245 (312)
T 2iwi_A          181 LIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------------  245 (312)
T ss_dssp             ECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------------
T ss_pred             EEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------------
Confidence            9999999876543  2345678999999999877666 45899999999999999999998743211             


Q ss_pred             ccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .......+...    ...+.+++.+||+.||++|||++|++++
T Consensus       246 -~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 -LEAELHFPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -HHTCCCCCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -hhhccCCcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             11111111111    2247789999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-33  Score=314.70  Aligned_cols=246  Identities=21%  Similarity=0.328  Sum_probs=169.8

Q ss_pred             CCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHH------HHHhhceeecCCeeEEEEEeccCC
Q 042123          589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE------VEAFYGFCSHARHSFLLYEFLERG  662 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e------i~~~~~~~~~~~~~~lV~e~~~~g  662 (849)
                      .|...+.||+|+||+||.+...+|+.||||++..... .....+...+++      |.++++++......++||||++ |
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~-~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g   93 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L   93 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGH-HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHH-HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence            3445678999999999877666799999999864311 011111122222      2346777788889999999996 5


Q ss_pred             Chhhhhccccccc----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-------------CcEEEe
Q 042123          663 SLAAILNTDAAAQ----ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-------------YEAHVA  725 (849)
Q Consensus       663 sL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-------------~~~kl~  725 (849)
                      +|.+++.......    ..++..+..++.||+.||+|||+.   +|+||||||+||+++.+             +.+||+
T Consensus        94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~  170 (434)
T 2rio_A           94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS  170 (434)
T ss_dssp             EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred             CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence            9999997543211    113345678999999999999999   99999999999999754             489999


Q ss_pred             eecCCcccCCCCCC----eeeccCCccccccccccC-------CCCCccchHHHHHHHHHHHHh-CCCCCCccccccccc
Q 042123          726 DFGIAKSLKPDSSN----WTEFAGTCGYIAPELAYT-------MKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSS  793 (849)
Q Consensus       726 DfG~a~~~~~~~~~----~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~  793 (849)
                      |||+++........    .....||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......   
T Consensus       171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---  247 (434)
T 2rio_A          171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---  247 (434)
T ss_dssp             CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---
T ss_pred             ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH---
Confidence            99999877543321    234579999999999865       678999999999999999999 999996432110   


Q ss_pred             cccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ............. ...........+.+++.+||+.||++|||+.|+++|
T Consensus       248 ---~~i~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 ---SNIIRGIFSLDEM-KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             ---HHHHHTCCCCCCC-TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---HHHhcCCCCcccc-cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence               0111111111100 011122344568899999999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5e-33  Score=298.92  Aligned_cols=240  Identities=22%  Similarity=0.340  Sum_probs=164.4

Q ss_pred             hcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSF  653 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~  653 (849)
                      .++|+..+.||+|+||.||+|... +|+.||||++.....   .........+            +.++++++...+..+
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN---KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC---HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc---chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            367888999999999999999664 799999999875421   1112222222            224677888889999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +||||+ ++.+..+....  ...+++.++..++.|++.||+|||+..  +|+||||||+||+++.++.+||+|||++...
T Consensus       101 lv~e~~-~~~~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRM--QGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEECCC-SEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEecc-CCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            999999 44555554322  245899999999999999999999832  8999999999999999999999999999766


Q ss_pred             CCCCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP--  806 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--  806 (849)
                      .... ......+++.|+|||.+.     ...++.++||||||+++|||++|+.||......       ..........  
T Consensus       176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~  247 (318)
T 2dyl_A          176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-------FEVLTKVLQEEP  247 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-------HHHHHHHHHSCC
T ss_pred             cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-------HHHHHHHhccCC
Confidence            5432 234457899999999984     556889999999999999999999999743211       1111111111  


Q ss_pred             -CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          807 -RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       807 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ..+.....    ...+.+++.+||+.||.+|||+++++++
T Consensus       248 ~~~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 PLLPGHMGF----SGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CCCCSSSCC----CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCCCccCCC----CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             11111111    2247889999999999999999999875

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=3.7e-33  Score=298.33  Aligned_cols=249  Identities=29%  Similarity=0.454  Sum_probs=188.4

Q ss_pred             CcEEEEecCCCceee--eeCCccCCCCCCCCEEeCcC-CccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCC
Q 042123            5 GRVINISLPNIGVNG--TLHDFSFSSFPHLAYLDLTW-NGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGG   81 (849)
Q Consensus         5 ~~~~~~~~~~~~~~~--~l~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~   81 (849)
                      |+|+.++++.+++.|  .+.+ .|..+++|++|+|++ |++.+.+|..|+++++|++|+|++|++++.++.      .++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~------~~~  122 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD------FLS  122 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCG-GGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG------GGG
T ss_pred             ceEEEEECCCCCccCCcccCh-hHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCH------HHh
Confidence            778888888888877  5554 677788888888884 778777888888888888888888887654333      345


Q ss_pred             CccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCC-CCceeeccCcccccccccccCCCCCCCE
Q 042123           82 NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLS-NLIFLYLYGNLLSGSILSSLGKLKSLFD  160 (849)
Q Consensus        82 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~  160 (849)
                      .+++|++|+|++|.+++.+|..|.++++|++|+|++|++++..|..|..++ +|++|++++|++++..|..|..++ |+.
T Consensus       123 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~  201 (313)
T 1ogq_A          123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAF  201 (313)
T ss_dssp             GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSE
T ss_pred             CCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccE
Confidence            677888888888888777777788888888888888888777777777776 788888888888777777777776 888


Q ss_pred             EEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccc
Q 042123          161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL  240 (849)
Q Consensus       161 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  240 (849)
                      |+|++|++.+..|..|..+++|++|+|++|++++..|. +..+++|++|+|++|++++.+|..|..+++|++|+|++|++
T Consensus       202 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  280 (313)
T 1ogq_A          202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL  280 (313)
T ss_dssp             EECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEE
T ss_pred             EECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcc
Confidence            88888888777777788888888888888887755554 67778888888888888777777788888888888888887


Q ss_pred             cCCCCcchhhhhhhhhhccCcC
Q 042123          241 SGSIPPSLGNLILRQLLLSGNH  262 (849)
Q Consensus       241 ~~~~p~~~~~~~L~~L~L~~n~  262 (849)
                      ++.+|.......|+.+++++|+
T Consensus       281 ~~~ip~~~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          281 CGEIPQGGNLQRFDVSAYANNK  302 (313)
T ss_dssp             EEECCCSTTGGGSCGGGTCSSS
T ss_pred             cccCCCCccccccChHHhcCCC
Confidence            7777765222346666666665

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-33  Score=311.80  Aligned_cols=243  Identities=21%  Similarity=0.308  Sum_probs=173.0

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHH------HHHhhceeecCCeeEEEEEeccC
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTE------VEAFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e------i~~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      .+|...+.||+|+||+||.....+++.||||++...... ....+...+++      |.++++++.+....++||||++ 
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            468888999999999976555557999999998653221 12223333333      3457788888899999999997 


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-----CcEEEeeecCCcccCCC
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-----YEAHVADFGIAKSLKPD  736 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-----~~~kl~DfG~a~~~~~~  736 (849)
                      |+|.+++....  ...++.++..++.||+.||+|||+.   +|+||||||+||+++.+     ..+||+|||+++.....
T Consensus       102 g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~  176 (432)
T 3p23_A          102 ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG  176 (432)
T ss_dssp             EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred             CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence            59999987544  2345556789999999999999999   99999999999999532     35889999999876543


Q ss_pred             C---CCeeeccCCcccccccccc---CCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCC
Q 042123          737 S---SNWTEFAGTCGYIAPELAY---TMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       737 ~---~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      .   .......||+.|+|||++.   ...++.++||||+||++|||++ |..||.......         ..........
T Consensus       177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~---------~~~~~~~~~~  247 (432)
T 3p23_A          177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---------ANILLGACSL  247 (432)
T ss_dssp             ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---------HHHHTTCCCC
T ss_pred             CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---------HHHHhccCCc
Confidence            2   2234467999999999987   4567889999999999999999 999986322110         0111111000


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ............+.+++.+||+.||++|||++|+++|
T Consensus       248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            0011111223347789999999999999999999976

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.3e-33  Score=303.95  Aligned_cols=245  Identities=20%  Similarity=0.284  Sum_probs=176.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC-----
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR-----  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~-----  650 (849)
                      ++|...+.||+|+||.||+|.. .+|+.||||++....  ........+.+|+..           +++++....     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            6788999999999999999965 479999999987532  222234455555442           556665543     


Q ss_pred             -eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          651 -HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       651 -~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                       ..++||||++ |+|.+++..     .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~  172 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL  172 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred             eeEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence             3499999998 588887742     489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------cccccc--
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDVA--  799 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~~--  799 (849)
                      ++.....   .....+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||..........       ......  
T Consensus       173 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  249 (353)
T 3coi_A          173 ARHADAE---MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ  249 (353)
T ss_dssp             TTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHT
T ss_pred             ccCCCCC---ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            9865432   344578999999999876 678999999999999999999999997543211000       000000  


Q ss_pred             ----------cccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          800 ----------LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       800 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                ......................+.+++.+||+.||++|||++|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                      00000000000000111223358899999999999999999999876

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.8e-33  Score=310.07  Aligned_cols=234  Identities=15%  Similarity=0.127  Sum_probs=169.2

Q ss_pred             cCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHHHhhce---------------------
Q 042123          588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAFYGF---------------------  645 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~~~~---------------------  645 (849)
                      ..|...+.||+|+||.||+|+ ..+|+.||||++....... ....+.+.+|+..+...                     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~-~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPP-SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCcc-HHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            457778899999999999996 5579999999987432221 11223344443321100                     


Q ss_pred             ------------eec-----CCeeEEEEEeccCCChhhhhccc----ccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 042123          646 ------------CSH-----ARHSFLLYEFLERGSLAAILNTD----AAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI  704 (849)
Q Consensus       646 ------------~~~-----~~~~~lV~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  704 (849)
                                  +..     ....+++|+++ +++|.+++...    .....+++..+..++.||+.||+|||+.   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                        011     12346667665 57999988421    1123478889999999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccc----------cCCCCCccchHHHHHHHHH
Q 042123          705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA----------YTMKITEKCDVYSFGVLMW  774 (849)
Q Consensus       705 vH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~Dv~SlGvil~  774 (849)
                      +||||||+|||++.++.+||+|||+++.....   .....| +.|+|||++          .+..++.++|||||||++|
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            99999999999999999999999998865432   344567 999999998          5556889999999999999


Q ss_pred             HHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          775 EVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       775 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ||++|+.||.......        .....+.....    .+    ..+.+++.+||+.||++|||+.+++++
T Consensus       309 elltg~~Pf~~~~~~~--------~~~~~~~~~~~----~~----~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          309 WIWCADLPNTDDAALG--------GSEWIFRSCKN----IP----QPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHSSCCCCTTGGGS--------CSGGGGSSCCC----CC----HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHCCCCCCCcchhh--------hHHHHHhhccc----CC----HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            9999999997433211        11112221111    11    347889999999999999999988765

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.98  E-value=1.6e-36  Score=344.19  Aligned_cols=360  Identities=20%  Similarity=0.151  Sum_probs=221.9

Q ss_pred             CCCCEEeCcCCccccCCCcc-ccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccC-CCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQ-ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI-GNL  107 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-~~l  107 (849)
                      ++|++|||++|++....... +..+++|++|+|++|++++.....+  ...+..+++|++|+|++|.+.+..+..+ ..+
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l--~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l   80 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAELNLRSNELGDVGVHCVLQGL   80 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHH--HHHHHTCTTCCEEECTTCCCHHHHHHHHHHTT
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHH--HHHHHhCCCcCEEeCCCCcCChHHHHHHHHHH
Confidence            45677777777775544433 6667777777777777664322211  1223445667777777776664333222 223


Q ss_pred             C----CCCEEEccCCcccC----CCCCCCcCCCCCceeeccCccccccccccc-----CCCCCCCEEEcCCCcccccC--
Q 042123          108 K----FLSQLDLTNNKFSG----PIPLSFDNLSNLIFLYLYGNLLSGSILSSL-----GKLKSLFDLQLNDNQLIGYI--  172 (849)
Q Consensus       108 ~----~L~~L~Ls~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~--  172 (849)
                      +    +|++|+|++|+|+.    .++..|..+++|++|+|++|.++...+..+     ...++|++|+|++|++++..  
T Consensus        81 ~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~  160 (461)
T 1z7x_W           81 QTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE  160 (461)
T ss_dssp             CSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred             hhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH
Confidence            3    57777777777763    336667777777777777777764333322     23456777777777776533  


Q ss_pred             --CcCCCCCCCCCEEEccCCCCcCcCccccc-----CCCCCCEEeccCCcCccC----CCcCccCccccchhhhcccccc
Q 042123          173 --PRPFSNLTSVSTLRLSRNDLFGSIPDEIG-----KMRSLSVLDLNQNQFKGV----LPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       173 --~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                        +..+..+++|++|+|++|++....+..+.     ..++|++|++++|.++..    ++..+..+++|++|++++|.++
T Consensus       161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~  240 (461)
T 1z7x_W          161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG  240 (461)
T ss_dssp             HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred             HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence              34455567777777777777644333333     245777777777777642    3455566677777777777664


Q ss_pred             CCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccc----cCCCCCCcccccEEEccCccccCchhh
Q 042123          242 GSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGT----IPTSLRNCTSLIRVRLNGNNLTGNISE  317 (849)
Q Consensus       242 ~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~  317 (849)
                      ......+.                  +..+..+++|+.|++++|.++..    ++..+..+++|++|++++|.+++..+.
T Consensus       241 ~~~~~~l~------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~  302 (461)
T 1z7x_W          241 DVGMAELC------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR  302 (461)
T ss_dssp             HHHHHHHH------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred             hHHHHHHH------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence            21111000                  01112345677777777777653    455566677788888888877654443


Q ss_pred             hhC-----CCCCCCEEeccCccccCc----ccccCCCCCCCcEEeccCCccccCCCCCccc-----cccccccccccccc
Q 042123          318 ALG-----IYPNLTFIDLSRNNFYGE----ISSNWGKFPKLGTLNVSMNNITGGLPREIGN-----SSQLQAFDLSLNHI  383 (849)
Q Consensus       318 ~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~-----l~~L~~L~L~~N~i  383 (849)
                      .+.     ..++|+.|+|++|.+++.    ++..+..+++|++|++++|.+++..+..+..     .++|+.|+|++|.+
T Consensus       303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i  382 (461)
T 1z7x_W          303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV  382 (461)
T ss_dssp             HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence            333     235788888888877754    3445556677888888888777554444432     45788888888887


Q ss_pred             cc----cCchhhcCCCCCcEEEccCccccc
Q 042123          384 VG----EIPKELGKLNPLTKLILRGNQITG  409 (849)
Q Consensus       384 ~~----~~~~~~~~l~~L~~L~L~~N~l~~  409 (849)
                      ++    .+|..+..+++|++|+|++|++++
T Consensus       383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          383 SDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             CHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             ChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            75    567777778888888888887764

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.98  E-value=1.7e-32  Score=293.18  Aligned_cols=251  Identities=25%  Similarity=0.402  Sum_probs=153.0

Q ss_pred             hhhhccCcCCCC--CCCcccCCCCCcceeeecc-cccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEec
Q 042123          254 RQLLLSGNHFTG--YLPYNICRGGALEIFTVSE-NHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDL  330 (849)
Q Consensus       254 ~~L~L~~n~i~~--~~~~~~~~~~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  330 (849)
                      +.|+|++|.+++  .+|..+..+++|++|++++ |.+.+.+|..|.++++|++|++++|++++..|..+..+++|++|+|
T Consensus        53 ~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L  132 (313)
T 1ogq_A           53 NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF  132 (313)
T ss_dssp             EEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEEC
T ss_pred             EEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeC
Confidence            333344444443  3444444445555555552 5555555555555555555555555555455555555555555555


Q ss_pred             cCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccc-cccccccccccccccCchhhcCCCCCcEEEccCccccc
Q 042123          331 SRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSS-QLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG  409 (849)
Q Consensus       331 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~  409 (849)
                      ++|++.+.+|..|..+++|++|++++|.+++.+|..+..+. +|+.|++++|++++.+|..|..++ |+.|+|++|++++
T Consensus       133 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~  211 (313)
T 1ogq_A          133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG  211 (313)
T ss_dssp             CSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE
T ss_pred             CCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccC
Confidence            55555555555555555555555555555555555555554 555555555555555555555554 5555555555555


Q ss_pred             cCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCCcccc
Q 042123          410 RLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFR  487 (849)
Q Consensus       410 ~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~~  487 (849)
                      ..|..|..+++|++|+++.  +...++.+..+++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|....+.
T Consensus       212 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~  291 (313)
T 1ogq_A          212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ  291 (313)
T ss_dssp             CCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGG
T ss_pred             cCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCcccc
Confidence            5555555555555555543  23333345667788899999999998999999999999999999999999998887777


Q ss_pred             cCcccccccCCCccCCCC
Q 042123          488 GASVEALKGNKGLCGSAK  505 (849)
Q Consensus       488 ~~~~~~~~~~~~~c~~~~  505 (849)
                      ......+.+|+.+||.+.
T Consensus       292 ~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          292 RFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             GSCGGGTCSSSEEESTTS
T ss_pred             ccChHHhcCCCCccCCCC
Confidence            777778889999998753

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=2.6e-32  Score=290.39  Aligned_cols=226  Identities=20%  Similarity=0.294  Sum_probs=164.2

Q ss_pred             cCCCcC-ceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHH-H-----HHHHhhceeec----CCeeEEE
Q 042123          588 NDFDAK-YCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFL-T-----EVEAFYGFCSH----ARHSFLL  655 (849)
Q Consensus       588 ~~f~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~-~-----ei~~~~~~~~~----~~~~~lV  655 (849)
                      ++|... +.||+|+||.||+|.. .+++.||||++....   ....+.... +     .+..+++++..    ....++|
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv   93 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   93 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH---HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEE
Confidence            567776 7899999999999965 578999999986421   111111111 1     12235666655    6678999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeecCCcc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL---EYEAHVADFGIAKS  732 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG~a~~  732 (849)
                      |||+++|+|.+++.... ...+++.++..++.|++.||+|||+.   +|+||||||+||+++.   ++.+||+|||++..
T Consensus        94 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           94 MECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             ECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            99999999999997543 24589999999999999999999999   9999999999999998   78999999999865


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ..                      +..++.++||||+||++|||++|+.||.........    ..............+.
T Consensus       170 ~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          170 TT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----PGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             CT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------CCSCCSSCTTCCSSCH
T ss_pred             cc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----HHHHHHHhhccccCCc
Confidence            32                      235678999999999999999999999744322110    0011111111111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .........+.+++.+||+.||++|||++|+++|
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1111233458899999999999999999999986

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.97  E-value=1.2e-35  Score=337.14  Aligned_cols=386  Identities=16%  Similarity=0.127  Sum_probs=280.4

Q ss_pred             cEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCcccc----CCCccccCCCCCCEeeCCCCcCcccccccccccCCCC
Q 042123            6 RVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFG----TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGG   81 (849)
Q Consensus         6 ~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~   81 (849)
                      +++.++++.+.+........|..+++|++|+|++|++.+    .++..+..+++|++|+|++|++++..+..+.     .
T Consensus         4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~-----~   78 (461)
T 1z7x_W            4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVL-----Q   78 (461)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHH-----H
T ss_pred             cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHH-----H
Confidence            578899988887655433337889999999999999974    3567788999999999999999764443332     2


Q ss_pred             Ccc----ccCeEeccCCcccc----cCCccCCCCCCCCEEEccCCcccCCCCCC-----CcCCCCCceeeccCccccccc
Q 042123           82 NLR----YMSRLVINDNSLSG----FIPPHIGNLKFLSQLDLTNNKFSGPIPLS-----FDNLSNLIFLYLYGNLLSGSI  148 (849)
Q Consensus        82 ~l~----~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~-----~~~l~~L~~L~L~~N~l~~~~  148 (849)
                      .++    +|++|+|++|.++.    .++..+.++++|++|+|++|++++..+..     +...++|++|+|++|.++...
T Consensus        79 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~  158 (461)
T 1z7x_W           79 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS  158 (461)
T ss_dssp             TTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred             HHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHH
Confidence            233    79999999999984    45888999999999999999998543333     334678999999999998643


Q ss_pred             ----ccccCCCCCCCEEEcCCCcccccCCcCCC-----CCCCCCEEEccCCCCcCc----CcccccCCCCCCEEeccCCc
Q 042123          149 ----LSSLGKLKSLFDLQLNDNQLIGYIPRPFS-----NLTSVSTLRLSRNDLFGS----IPDEIGKMRSLSVLDLNQNQ  215 (849)
Q Consensus       149 ----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~  215 (849)
                          +..+..+++|++|+|++|.+....+..+.     ..++|++|+|++|.++..    ++..+..+++|++|++++|+
T Consensus       159 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~  238 (461)
T 1z7x_W          159 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK  238 (461)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSB
T ss_pred             HHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCc
Confidence                56677789999999999998875444443     367999999999999853    47778889999999999999


Q ss_pred             CccCC-----CcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccc
Q 042123          216 FKGVL-----PPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGT  290 (849)
Q Consensus       216 l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~  290 (849)
                      ++...     +..+..+++|++|++++|.++......                   ++..+..+++|+.|++++|.+.+.
T Consensus       239 l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~-------------------l~~~l~~~~~L~~L~Ls~n~i~~~  299 (461)
T 1z7x_W          239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD-------------------LCRVLRAKESLKELSLAGNELGDE  299 (461)
T ss_dssp             CHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHH-------------------HHHHHHHCTTCCEEECTTCCCHHH
T ss_pred             CChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHH-------------------HHHHHhhCCCcceEECCCCCCchH
Confidence            87532     223345788999999998876321000                   122233345677777777776544


Q ss_pred             cCCCCCC-----cccccEEEccCccccCc----hhhhhCCCCCCCEEeccCccccCcccccCCC-----CCCCcEEeccC
Q 042123          291 IPTSLRN-----CTSLIRVRLNGNNLTGN----ISEALGIYPNLTFIDLSRNNFYGEISSNWGK-----FPKLGTLNVSM  356 (849)
Q Consensus       291 ~~~~~~~-----l~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~  356 (849)
                      .+..+..     .++|+.|++++|.+++.    .+..+..+++|+.|+|++|++.+..+..+..     .++|++|++++
T Consensus       300 ~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~  379 (461)
T 1z7x_W          300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD  379 (461)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             HHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCC
Confidence            3333322     25788888888888754    4556667788888888888887654443332     56888888888


Q ss_pred             Ccccc----CCCCCccccccccccccccccccccCchhhc-----CCCCCcEEEccCccccccCcccc
Q 042123          357 NNITG----GLPREIGNSSQLQAFDLSLNHIVGEIPKELG-----KLNPLTKLILRGNQITGRLPKEI  415 (849)
Q Consensus       357 N~i~~----~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~p~~~  415 (849)
                      |.+++    .+|..+..+++|++|+|++|++++.....+.     ...+|+.|.+.++.+....+..+
T Consensus       380 n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~~~~l  447 (461)
T 1z7x_W          380 CDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL  447 (461)
T ss_dssp             SCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred             CCCChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHHHHHH
Confidence            88875    5677777788888888888888754322222     24468888888877765444433

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=1.7e-31  Score=281.37  Aligned_cols=219  Identities=11%  Similarity=0.084  Sum_probs=165.1

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||.||+|... +++.||||.+....... ....+.+.+|+.           ++++++...+..|+|
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLP-DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccC-HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            57999999999999999999664 58999999987643322 223345566544           367788888899999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++++|.+++...     ....++.+++.|++.||+|||+.   +|+||||||+||+++.++.+||+++|       
T Consensus       110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence            9999999999998532     45667899999999999999999   99999999999999999999998543       


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                                   |++       .++.++|||||||++|||++|+.||.........     .............+....
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  229 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-----APAERDTAGQPIEPADID  229 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-----EECCBCTTSCBCCHHHHC
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-----HHHHHHhccCCCChhhcc
Confidence                         233       3678999999999999999999999854322100     000111111111111111


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ......+.+++.+||+.||++| |++|+++.|+
T Consensus       230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~  261 (286)
T 3uqc_A          230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQ  261 (286)
T ss_dssp             TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHH
Confidence            1223458899999999999999 9999999874

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=1.8e-31  Score=288.98  Aligned_cols=237  Identities=16%  Similarity=0.117  Sum_probs=173.0

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCC----chhhHHHHHH-------------------------
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCD----QTVDQKEFLT-------------------------  637 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~~-------------------------  637 (849)
                      .++|+..+.||+|+||+||+|+. +|+.||||++.......    .....+.+.+                         
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            36788999999999999999987 68999999997543210    0111122222                         


Q ss_pred             ------------HHHHhhceeec-------------CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHH
Q 042123          638 ------------EVEAFYGFCSH-------------ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA  692 (849)
Q Consensus       638 ------------ei~~~~~~~~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  692 (849)
                                  .+.++++++..             ....++||||+++|++.+.+.+    ..+++.++..++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence                        22334444443             6789999999999977666643    348999999999999999


Q ss_pred             HHHHH-hcCCCCeEecCCCCCCeeecCCC--------------------cEEEeeecCCcccCCCCCCeeeccCCccccc
Q 042123          693 LSYLH-HDCFPPIVHRDISSKNLLLDLEY--------------------EAHVADFGIAKSLKPDSSNWTEFAGTCGYIA  751 (849)
Q Consensus       693 l~~LH-~~~~~~ivH~dlk~~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~a  751 (849)
                      |+||| +.   +|+||||||+|||++.++                    .+||+|||+|+.....     ...||+.|+|
T Consensus       174 L~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~a  245 (336)
T 2vuw_A          174 LAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMD  245 (336)
T ss_dssp             HHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTC
T ss_pred             HHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccC
Confidence            99999 88   999999999999999887                    8999999999876532     3479999999


Q ss_pred             cccccCCCCCccchHHHHHHH-HHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhcc
Q 042123          752 PELAYTMKITEKCDVYSFGVL-MWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCF  830 (849)
Q Consensus       752 PE~~~~~~~~~~~Dv~SlGvi-l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  830 (849)
                      ||++.+.. +.++||||+|++ .+++++|..||........   ..+..... ..................+.+++.+||
T Consensus       246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY---LTDKMLKQ-MTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH---HHHHHHHT-CCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             hhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhH---HHHhhhhh-hccCcccchhhhhhcCHHHHHHHHHHh
Confidence            99998766 889999998777 7788899999853211000   00011101 111112223334456677999999999


Q ss_pred             CCCCCCCCCHHHHH-hh
Q 042123          831 NESPESRPTMKIIS-QQ  846 (849)
Q Consensus       831 ~~dP~~RPt~~eil-~~  846 (849)
                      +.|     |++|++ +|
T Consensus       321 ~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          321 NFS-----SATDLLCQH  332 (336)
T ss_dssp             GSS-----SHHHHHHHC
T ss_pred             ccC-----CHHHHHhcC
Confidence            976     999999 65

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=4.2e-31  Score=312.79  Aligned_cols=222  Identities=23%  Similarity=0.318  Sum_probs=171.7

Q ss_pred             cCCCcCceecCCccceEEEEEec--CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe---
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP--SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH---  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~---  651 (849)
                      ++|++.+.||+|+||.||+|...  +++.||||++...   ........+.+|+.           .+++++.+.+.   
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            68999999999999999999764  6899999987643   12233445666654           35667665544   


Q ss_pred             --eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          652 --SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       652 --~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                        .|+||||+++++|.+++..     .+++.++..++.||+.||+|||+.   +|+||||||+||+++.+ .+||+|||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence              6999999999999987743     589999999999999999999999   99999999999999875 899999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      ++.....    ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.....                + .++
T Consensus       228 a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~----------------~-~~~  285 (681)
T 2pzi_A          228 VSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV----------------D-GLP  285 (681)
T ss_dssp             CEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC----------------S-SCC
T ss_pred             chhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc----------------c-ccc
Confidence            9876543    345799999999998765 48899999999999999999988763110                0 011


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIIS  844 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil  844 (849)
                      . ..........+.+++.+||++||++||+..+.+
T Consensus       286 ~-~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l  319 (681)
T 2pzi_A          286 E-DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEM  319 (681)
T ss_dssp             T-TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred             c-cccccccCHHHHHHHhhhccCChhhCCCHHHHH
Confidence            1 111222335688999999999999999655443

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.97  E-value=1.1e-29  Score=267.95  Aligned_cols=254  Identities=22%  Similarity=0.223  Sum_probs=219.5

Q ss_pred             EEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccC
Q 042123            8 INISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS   87 (849)
Q Consensus         8 ~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~   87 (849)
                      +.+++.+.++...    +..-.++|++|+|++|+++++.+..|.++++|++|+|++|++++      .....|+.+++|+
T Consensus        14 ~~~~c~~~~l~~i----p~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~------~~~~~~~~l~~L~   83 (285)
T 1ozn_A           14 VTTSCPQQGLQAV----PVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR------IDAAAFTGLALLE   83 (285)
T ss_dssp             CEEECCSSCCSSC----CTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE------ECTTTTTTCTTCC
T ss_pred             eEEEcCcCCcccC----CcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccce------eCHhhcCCccCCC
Confidence            5677788776544    33346799999999999999999999999999999999999974      2345678899999


Q ss_pred             eEeccCCc-ccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCC
Q 042123           88 RLVINDNS-LSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDN  166 (849)
Q Consensus        88 ~L~l~~n~-l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  166 (849)
                      +|++++|. +....|..|.++++|++|++++|+++++.|..|.++++|++|++++|.++...+..|.++++|++|+|++|
T Consensus        84 ~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n  163 (285)
T 1ozn_A           84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGN  163 (285)
T ss_dssp             EEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCC
Confidence            99999997 88777899999999999999999999988999999999999999999999887788999999999999999


Q ss_pred             cccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCc
Q 042123          167 QLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP  246 (849)
Q Consensus       167 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  246 (849)
                      +++++.+..|..+++|++|+|++|++++..|..|.++++|+.|++++|++++..+..+..+++|++|+|++|++.+..+.
T Consensus       164 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~  243 (285)
T 1ozn_A          164 RISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA  243 (285)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred             cccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc
Confidence            99999888999999999999999999988899999999999999999999987777899999999999999999865544


Q ss_pred             chhhhhhhhhhccCcCCCCCCCccc
Q 042123          247 SLGNLILRQLLLSGNHFTGYLPYNI  271 (849)
Q Consensus       247 ~~~~~~L~~L~L~~n~i~~~~~~~~  271 (849)
                      ......++.+..+.+.+....|..+
T Consensus       244 ~~~~~~l~~~~~~~~~~~c~~p~~l  268 (285)
T 1ozn_A          244 RPLWAWLQKFRGSSSEVPCSLPQRL  268 (285)
T ss_dssp             HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred             HHHHHHHHhcccccCccccCCchHh
Confidence            3222236666666666665555443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=4e-30  Score=280.32  Aligned_cols=276  Identities=18%  Similarity=0.148  Sum_probs=182.2

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      .....++++|+++. +|..+.  ++|++|++++|.+++..+..|.++++|++|+|++|+++++.+.+|.++++|++|+|+
T Consensus        32 ~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls  108 (353)
T 2z80_A           32 RNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS  108 (353)
T ss_dssp             TTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred             CCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence            33445666666663 333332  356666666666665555566666666666666666666666666666666666666


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCC-cCccCccccchhhhcccc-ccCCCCcchhhhhhhhhhccCcCCCCC
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLP-PSISNLTNLKELALLYNH-LSGSIPPSLGNLILRQLLLSGNHFTGY  266 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~~~L~~L~L~~n~i~~~  266 (849)
                      +|++++..+..|.++++|++|++++|+++.+.+ ..|..+++|++|++++|. +.                       ..
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~-----------------------~~  165 (353)
T 2z80_A          109 YNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT-----------------------KI  165 (353)
T ss_dssp             SSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC-----------------------EE
T ss_pred             CCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc-----------------------cc
Confidence            666664444446666666666666666664433 356666666666666663 32                       12


Q ss_pred             CCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCC--
Q 042123          267 LPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWG--  344 (849)
Q Consensus       267 ~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~--  344 (849)
                      .+..+..+++|+.|++++|++++..|..+..+++|++|++++|.++..+...+..+++|+.|+|++|++.+..+..+.  
T Consensus       166 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~  245 (353)
T 2z80_A          166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTG  245 (353)
T ss_dssp             CTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC-----
T ss_pred             CHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccc
Confidence            233445556677777777777767777888888888888888888876666667788899999999988876554433  


Q ss_pred             -CCCCCcEEeccCCcccc----CCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCcccccc
Q 042123          345 -KFPKLGTLNVSMNNITG----GLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGR  410 (849)
Q Consensus       345 -~l~~L~~L~Ls~N~i~~----~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~  410 (849)
                       ....++.++++++.+++    .+|..+..+++|+.|+|++|+++...+..|..+++|++|+|++|++.+.
T Consensus       246 ~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~  316 (353)
T 2z80_A          246 ETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  316 (353)
T ss_dssp             -CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             cccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence             34567778888877764    2566677788888888888888844444467888888888888888743

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.96  E-value=5.8e-30  Score=279.03  Aligned_cols=280  Identities=17%  Similarity=0.153  Sum_probs=206.5

Q ss_pred             ccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCc
Q 042123           50 ISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFD  129 (849)
Q Consensus        50 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~  129 (849)
                      -..++.....++++|+++.. |..+        .++|++|++++|.++++.+..|.++++|++|+|++|+|+++.+.+|.
T Consensus        27 ~~~C~~~~~c~~~~~~l~~i-P~~~--------~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~   97 (353)
T 2z80_A           27 SLSCDRNGICKGSSGSLNSI-PSGL--------TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFS   97 (353)
T ss_dssp             CCEECTTSEEECCSTTCSSC-CTTC--------CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred             CCCCCCCeEeeCCCCCcccc-cccc--------cccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcC
Confidence            34556666788999988732 2111        35789999999999987777899999999999999999988888899


Q ss_pred             CCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCC-cCCCCCCCCCEEEccCC-CCcCcCcccccCCCCCC
Q 042123          130 NLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNLTSVSTLRLSRN-DLFGSIPDEIGKMRSLS  207 (849)
Q Consensus       130 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~  207 (849)
                      ++++|++|+|++|++++..+..|.++++|++|+|++|++..+.+ ..|..+++|++|++++| .+....+..|.++++|+
T Consensus        98 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~  177 (353)
T 2z80_A           98 SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE  177 (353)
T ss_dssp             TCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEE
T ss_pred             CCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCC
Confidence            99999999999999987666668889999999999999988766 67888999999999998 47766677888899999


Q ss_pred             EEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeeccccc
Q 042123          208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHF  287 (849)
Q Consensus       208 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l  287 (849)
                      +|++++|++++..|..|..+++|++|++++|.+. .+|..+..                      .+++|+.|++++|.+
T Consensus       178 ~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~----------------------~~~~L~~L~L~~n~l  234 (353)
T 2z80_A          178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVD----------------------VTSSVECLELRDTDL  234 (353)
T ss_dssp             EEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHH----------------------HTTTEEEEEEESCBC
T ss_pred             EEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhh----------------------hcccccEEECCCCcc
Confidence            9999999998888888999999999999988885 34433221                      123444455555544


Q ss_pred             ccccCCCCC---CcccccEEEccCccccC----chhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccc
Q 042123          288 QGTIPTSLR---NCTSLIRVRLNGNNLTG----NISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT  360 (849)
Q Consensus       288 ~~~~~~~~~---~l~~L~~L~L~~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~  360 (849)
                      ++..+..+.   ....++.++++++.+++    .+|..+..+++|+.|+|++|+++...+..|..+++|++|++++|.+.
T Consensus       235 ~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~  314 (353)
T 2z80_A          235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD  314 (353)
T ss_dssp             TTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCcc
Confidence            443332221   23456666666666653    34566777777777777777777544444567777777777777776


Q ss_pred             c
Q 042123          361 G  361 (849)
Q Consensus       361 ~  361 (849)
                      +
T Consensus       315 ~  315 (353)
T 2z80_A          315 C  315 (353)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=2e-29  Score=269.15  Aligned_cols=247  Identities=23%  Similarity=0.251  Sum_probs=136.5

Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCccccccc--ccccCCCCCCCEEEcCC
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSI--LSSLGKLKSLFDLQLND  165 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~  165 (849)
                      .++++++.++ .+|..+.  ++|++|+|++|+++++.+..|.++++|++|+|++|.++...  +..+.++++|++|+|++
T Consensus        11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~   87 (306)
T 2z66_A           11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF   87 (306)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred             EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence            3444444444 2333332  45666666666666555555666666666666666665321  34445566666666666


Q ss_pred             CcccccCCcCCCCCCCCCEEEccCCCCcCcCc-ccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCC
Q 042123          166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP-DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSI  244 (849)
Q Consensus       166 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  244 (849)
                      |.+..+ |..|..+++|++|++++|++++..+ ..+..+++|++|++++|.+.+..+..|..+++|++|++++|.+.+. 
T Consensus        88 n~i~~l-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-  165 (306)
T 2z66_A           88 NGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN-  165 (306)
T ss_dssp             CSEEEE-EEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG-
T ss_pred             CccccC-hhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc-
Confidence            666553 3345566666666666666654333 3555666666666666666655555555555555555555555420 


Q ss_pred             CcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCC
Q 042123          245 PPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPN  324 (849)
Q Consensus       245 p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  324 (849)
                                           ..|..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++..+..+..+++
T Consensus       166 ---------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  224 (306)
T 2z66_A          166 ---------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS  224 (306)
T ss_dssp             ---------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTT
T ss_pred             ---------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCccc
Confidence                                 11223333444555555555555444555555566666666666665555555555566


Q ss_pred             CCEEeccCccccCcccccCCCCC-CCcEEeccCCccc
Q 042123          325 LTFIDLSRNNFYGEISSNWGKFP-KLGTLNVSMNNIT  360 (849)
Q Consensus       325 L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~i~  360 (849)
                      |+.|+|++|++.+..+..+..++ +|++|+|++|.++
T Consensus       225 L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          225 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             CCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred             CCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence            66666666666555555555553 5555555555555

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=1.3e-29  Score=270.61  Aligned_cols=247  Identities=21%  Similarity=0.243  Sum_probs=144.6

Q ss_pred             CEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccC--CcCCCCCCCCCEEEcc
Q 042123          111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYI--PRPFSNLTSVSTLRLS  188 (849)
Q Consensus       111 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls  188 (849)
                      +.+++++++++. +|..+.  ++|++|+|++|.++...+..|.++++|++|+|++|++..+.  +..+..+++|++|+|+
T Consensus        10 ~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls   86 (306)
T 2z66_A           10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS   86 (306)
T ss_dssp             TEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred             CEEEcCCCCccc-CCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence            567788888874 444332  57777778777777555556777777777777777776432  4455567777777777


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCC-cCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLP-PSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                      +|++. .+|..+.++++|++|++++|++++..+ ..+..+++|++|++++|.+.+                       ..
T Consensus        87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~~  142 (306)
T 2z66_A           87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-----------------------AF  142 (306)
T ss_dssp             SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEE-----------------------CS
T ss_pred             CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCc-----------------------cc
Confidence            77776 455567777777777777777765443 455666666655555555442                       22


Q ss_pred             CcccCCCCCcceeeeccccccc-ccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCC
Q 042123          268 PYNICRGGALEIFTVSENHFQG-TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKF  346 (849)
Q Consensus       268 ~~~~~~~~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l  346 (849)
                      +..+..+++|+.|++++|.+++ ..|..+..+++|+.|++++|++++..+..+..+++|+.|+|++|++.+..+..+..+
T Consensus       143 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  222 (306)
T 2z66_A          143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL  222 (306)
T ss_dssp             TTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTC
T ss_pred             hhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCc
Confidence            2333444555555555555554 345555555555555555555555545555555555555555555554444444455


Q ss_pred             CCCcEEeccCCccccCCCCCcccc-cccccccccccccc
Q 042123          347 PKLGTLNVSMNNITGGLPREIGNS-SQLQAFDLSLNHIV  384 (849)
Q Consensus       347 ~~L~~L~Ls~N~i~~~~p~~~~~l-~~L~~L~L~~N~i~  384 (849)
                      ++|++|++++|.+++..|..+..+ ++|+.|+|++|.++
T Consensus       223 ~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          223 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             TTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred             ccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence            555555555555554444444444 24445555554444

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=5.2e-29  Score=262.91  Aligned_cols=207  Identities=26%  Similarity=0.291  Sum_probs=120.3

Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc-ccccCCcCCCCCCCCCEEE
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ-LIGYIPRPFSNLTSVSTLR  186 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~  186 (849)
                      ++|++|+|++|+|+++.+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|. +..+.+..|..+++|++|+
T Consensus        32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~  111 (285)
T 1ozn_A           32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (285)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence            455555555555555555555555555555555555555545555555555555555554 5555555555555566666


Q ss_pred             ccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCC
Q 042123          187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGY  266 (849)
Q Consensus       187 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~  266 (849)
                      |++|++++..|..|.++++|++|++++|+++...+..|..+++|++|+|++|++++                       .
T Consensus       112 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-----------------------~  168 (285)
T 1ozn_A          112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-----------------------V  168 (285)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-----------------------E
T ss_pred             CCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccc-----------------------c
Confidence            66655555545555555566666666665554444445555555555555554431                       1


Q ss_pred             CCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccC
Q 042123          267 LPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYG  337 (849)
Q Consensus       267 ~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  337 (849)
                      .+..+..+++|+.|++++|++++..|..|..+++|+.|++++|++++.++..+..+++|+.|+|++|++.+
T Consensus       169 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  239 (285)
T 1ozn_A          169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (285)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             CHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccC
Confidence            11223334455555555555555556666677777777777777777666667777777777777777664

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=1e-28  Score=277.55  Aligned_cols=245  Identities=22%  Similarity=0.251  Sum_probs=173.8

Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  167 (849)
                      .++++++.++ .+|..+.  ++++.|+|++|+|+++.+..|.++++|++|+|++|.|+.+.+..|.++++|++|+|++|+
T Consensus        47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~  123 (440)
T 3zyj_A           47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR  123 (440)
T ss_dssp             EEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred             EEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence            4455555554 3444443  466677777777766666667777777777777777766666667777777777777777


Q ss_pred             ccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccC-CcCccCCCcCccCccccchhhhccccccCCCCc
Q 042123          168 LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQ-NQFKGVLPPSISNLTNLKELALLYNHLSGSIPP  246 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  246 (849)
                      ++.+.+..|..+++|++|+|++|++....+..|.++++|++|+|++ |.+..+.+..|.++++|++|+|++|.++ .+| 
T Consensus       124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-  201 (440)
T 3zyj_A          124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-  201 (440)
T ss_dssp             CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-
T ss_pred             CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-
Confidence            7766666677777777777777777655555667777777777776 4444444456777777777777777665 222 


Q ss_pred             chhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCC
Q 042123          247 SLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLT  326 (849)
Q Consensus       247 ~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  326 (849)
                                             .+..+++|+.|++++|++++..|..|.++++|+.|+|++|++++..+..|..+++|+
T Consensus       202 -----------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  258 (440)
T 3zyj_A          202 -----------------------NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLV  258 (440)
T ss_dssp             -----------------------CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCC
T ss_pred             -----------------------ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCC
Confidence                                   134456777777777777777778888888888888888888888888888888888


Q ss_pred             EEeccCccccCcccccCCCCCCCcEEeccCCccc
Q 042123          327 FIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT  360 (849)
Q Consensus       327 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~  360 (849)
                      .|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       259 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             EEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             EEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            8888888888777778888888888888888876

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=1.2e-28  Score=277.99  Aligned_cols=245  Identities=24%  Similarity=0.244  Sum_probs=163.1

Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  167 (849)
                      .++++++.++ .+|..+.  ++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        58 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~  134 (452)
T 3zyi_A           58 KVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW  134 (452)
T ss_dssp             EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred             EEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence            4444444444 2343332  456666666666666556666666666666666666665555666666666666666666


Q ss_pred             ccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccC-CcCccCCCcCccCccccchhhhccccccCCCCc
Q 042123          168 LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQ-NQFKGVLPPSISNLTNLKELALLYNHLSGSIPP  246 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  246 (849)
                      ++.+.+..|..+++|++|+|++|++....+..|.++++|++|++++ |.+..+.+..|.++++|++|+|++|.+++ +| 
T Consensus       135 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-  212 (452)
T 3zyi_A          135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-  212 (452)
T ss_dssp             CSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-
T ss_pred             CCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-
Confidence            6666666666666666666666666655555566666666666666 44444444456666666666666666552 22 


Q ss_pred             chhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCC
Q 042123          247 SLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLT  326 (849)
Q Consensus       247 ~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  326 (849)
                                             .+..+++|+.|++++|++++..|..|.++++|+.|++++|++++..+..|..+++|+
T Consensus       213 -----------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  269 (452)
T 3zyi_A          213 -----------------------NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLV  269 (452)
T ss_dssp             -----------------------CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             -----------------------cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCC
Confidence                                   133455677777777777777777788888888888888888888788888888888


Q ss_pred             EEeccCccccCcccccCCCCCCCcEEeccCCccc
Q 042123          327 FIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT  360 (849)
Q Consensus       327 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~  360 (849)
                      .|+|++|++++..+..|..+++|+.|+|++|.+.
T Consensus       270 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          270 ELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             EEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             EEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            8888888888777777888888888888888876

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=3.1e-28  Score=273.62  Aligned_cols=249  Identities=19%  Similarity=0.146  Sum_probs=186.7

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      ....++.++++++. +|..+.  ++++.|+|++|+|+...+..|.++++|++|+|++|+|..+.+.+|.++++|++|+|+
T Consensus        44 ~~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~  120 (440)
T 3zyj_A           44 QFSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF  120 (440)
T ss_dssp             TSCEEECCSCCCSS-CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred             CCCEEEeCCCCcCc-CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence            35678888888884 454443  577888888888887777788888888888888888888777788888888888888


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCC
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP  268 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~  268 (849)
                      +|+++...+..|.++++|++|+|++|+++.+.+..|..+++|++|+|++|+..                           
T Consensus       121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l---------------------------  173 (440)
T 3zyj_A          121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL---------------------------  173 (440)
T ss_dssp             SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTC---------------------------
T ss_pred             CCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCc---------------------------
Confidence            88887666667778888888888888887666667777777777776664321                           


Q ss_pred             cccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCC
Q 042123          269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK  348 (849)
Q Consensus       269 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  348 (849)
                                         ....+..|.++++|+.|++++|+++..+  .+..+++|+.|+|++|++.+..+..|..+++
T Consensus       174 -------------------~~i~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  232 (440)
T 3zyj_A          174 -------------------SYISEGAFEGLSNLRYLNLAMCNLREIP--NLTPLIKLDELDLSGNHLSAIRPGSFQGLMH  232 (440)
T ss_dssp             -------------------CEECTTTTTTCSSCCEEECTTSCCSSCC--CCTTCSSCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             -------------------ceeCcchhhcccccCeecCCCCcCcccc--ccCCCcccCEEECCCCccCccChhhhccCcc
Confidence                               1122334555666666666666666432  3666777888888888887777777888888


Q ss_pred             CcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCcccc
Q 042123          349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       349 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                      |+.|+|++|.+++..+..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++.
T Consensus       233 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             CCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            888888888888777778888888888888888888777778888889999999999886

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=3.3e-28  Score=274.42  Aligned_cols=228  Identities=21%  Similarity=0.163  Sum_probs=128.9

Q ss_pred             CCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF  109 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  109 (849)
                      +++++|+|++|+|+++.+..|.++++|++|+|++|+|++      .....|.++++|+.|+|++|.|+.+.+..|.++++
T Consensus        75 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~  148 (452)
T 3zyi_A           75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ------IEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSK  148 (452)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE------ECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTT
T ss_pred             CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC------cChhhccCcccCCEEECCCCcCCccChhhhcccCC
Confidence            455556666665555555555555556666666555542      12234455555555555555555544445555555


Q ss_pred             CCEEEccCCcccCCCCCCCcCCCCCceeeccC-cccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG-NLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       110 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      |++|+|++|+|+++.+..|.++++|++|++++ |.+....+..|.++++|++|+|++|++++++  .+..+++|++|+|+
T Consensus       149 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~Ls  226 (452)
T 3zyi_A          149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP--NLTPLVGLEELEMS  226 (452)
T ss_dssp             CCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC--CCTTCTTCCEEECT
T ss_pred             CCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc--cccccccccEEECc
Confidence            55555555555555555555555555555555 3344333344555555555555555555431  35555555555555


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCC
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP  268 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~  268 (849)
                      +|++++..|..|.++++|+.|+|++|+++++.+..|.++++|++|+|++|+                       +++..+
T Consensus       227 ~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-----------------------l~~~~~  283 (452)
T 3zyi_A          227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN-----------------------LSSLPH  283 (452)
T ss_dssp             TSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC-----------------------CSCCCT
T ss_pred             CCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCc-----------------------CCccCh
Confidence            555555555555555555555555555555555555555555555555554                       444555


Q ss_pred             cccCCCCCcceeeecccccc
Q 042123          269 YNICRGGALEIFTVSENHFQ  288 (849)
Q Consensus       269 ~~~~~~~~L~~L~l~~N~l~  288 (849)
                      ..|..+++|+.|++++|.+.
T Consensus       284 ~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          284 DLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             TSSTTCTTCCEEECCSSCEE
T ss_pred             HHhccccCCCEEEccCCCcC
Confidence            66777788999999999876

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=2.1e-27  Score=274.30  Aligned_cols=248  Identities=24%  Similarity=0.304  Sum_probs=146.6

Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      ++|++|+|++|+|+++ |.   .+++|++|+|++|+|+. +|.   .+++|++|+|++|+++++++    .+++|++|++
T Consensus        61 ~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L  128 (622)
T 3g06_A           61 AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWI  128 (622)
T ss_dssp             TTCSEEEECSCCCSCC-CC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEEC
T ss_pred             CCCcEEEecCCCCCCC-CC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEEC
Confidence            4455555555555432 22   23445555555555442 222   34455555555555544322    3445555555


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                      ++|+++. +|..   +++|++|+|++|+++++ |.   .+++|+.|++++|.++ .+|                      
T Consensus       129 ~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l-~~---~~~~L~~L~L~~N~l~-~l~----------------------  177 (622)
T 3g06_A          129 FGNQLTS-LPVL---PPGLQELSVSDNQLASL-PA---LPSELCKLWAYNNQLT-SLP----------------------  177 (622)
T ss_dssp             CSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCS-CCC----------------------
T ss_pred             CCCCCCc-CCCC---CCCCCEEECcCCcCCCc-CC---ccCCCCEEECCCCCCC-CCc----------------------
Confidence            5555542 3322   24555555555555432 22   1233444444444443 121                      


Q ss_pred             CcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCC
Q 042123          268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFP  347 (849)
Q Consensus       268 ~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~  347 (849)
                          ..+++|+.|++++|.+++ +|..   +++|+.|++++|.++..+.    .+++|+.|+|++|++++ +|   ..++
T Consensus       178 ----~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~~l~~----~~~~L~~L~Ls~N~L~~-lp---~~l~  241 (622)
T 3g06_A          178 ----MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTSLPA----LPSGLKELIVSGNRLTS-LP---VLPS  241 (622)
T ss_dssp             ----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSSCCC----CCTTCCEEECCSSCCSC-CC---CCCT
T ss_pred             ----ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcccccCC----CCCCCCEEEccCCccCc-CC---CCCC
Confidence                112445555555555553 3322   3567777777777774432    24778888888888875 34   4557


Q ss_pred             CCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccc
Q 042123          348 KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLT  419 (849)
Q Consensus       348 ~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  419 (849)
                      +|+.|+|++|.|+ .+|.   .+++|+.|+|++|+|+ .+|..|..+++|+.|+|++|++++..|..+..++
T Consensus       242 ~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          242 ELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            8899999999988 4555   5678999999999998 6788899999999999999999988777766654

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=6.7e-28  Score=259.06  Aligned_cols=234  Identities=19%  Similarity=0.257  Sum_probs=146.9

Q ss_pred             CCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhh
Q 042123          156 KSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELAL  235 (849)
Q Consensus       156 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  235 (849)
                      .+++.|+|++|.+..+ |..+..+++|++|+|++|.++ .+|..+.++++|++|+|++|+++ .+|..+..+++|++|+|
T Consensus        81 ~~l~~L~L~~n~l~~l-p~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           81 PGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI  157 (328)
T ss_dssp             TTCCEEEEESSCCSSC-CSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred             cceeEEEccCCCchhc-ChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence            5566666666666643 444555667777777777766 66666667777777777777776 45666777777777777


Q ss_pred             ccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCch
Q 042123          236 LYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI  315 (849)
Q Consensus       236 ~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~  315 (849)
                      ++|++.+.+|..+...              ..+..+..+++|+.|++++|+++ .+|..+.++++|+.|++++|++++.+
T Consensus       158 ~~n~~~~~~p~~~~~~--------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~  222 (328)
T 4fcg_A          158 RACPELTELPEPLAST--------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALG  222 (328)
T ss_dssp             EEETTCCCCCSCSEEE--------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCC
T ss_pred             CCCCCccccChhHhhc--------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCc
Confidence            7766665665544321              11223444556666666666666 55556666666666666666666433


Q ss_pred             hhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCC
Q 042123          316 SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLN  395 (849)
Q Consensus       316 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  395 (849)
                       ..+..+++|++|+|++|.+.+.+|..|..+++|++|+|++|.+.+.+|..+.++++|+.|+|++|.+.+.+|..++.++
T Consensus       223 -~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~  301 (328)
T 4fcg_A          223 -PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP  301 (328)
T ss_dssp             -GGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSC
T ss_pred             -hhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhcc
Confidence             3466666666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             CCcEEEccCcccc
Q 042123          396 PLTKLILRGNQIT  408 (849)
Q Consensus       396 ~L~~L~L~~N~l~  408 (849)
                      +|+.+++..|.+.
T Consensus       302 ~L~~l~l~~~~~~  314 (328)
T 4fcg_A          302 ANCIILVPPHLQA  314 (328)
T ss_dssp             TTCEEECCGGGSC
T ss_pred             CceEEeCCHHHHH
Confidence            6666666655443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=4.7e-29  Score=266.62  Aligned_cols=248  Identities=19%  Similarity=0.179  Sum_probs=182.9

Q ss_pred             ccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCC-CCCCcccC-------CCCCcceeeecccccccccCCCC
Q 042123          224 ISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFT-GYLPYNIC-------RGGALEIFTVSENHFQGTIPTSL  295 (849)
Q Consensus       224 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~-~~~~~~~~-------~~~~L~~L~l~~N~l~~~~~~~~  295 (849)
                      ++..++|++|++++|.+  .+|..+... ++.|+|++|+++ ..+|..+.       .+++|++|++++|++++..|..+
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~-L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  115 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI-IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL  115 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH-HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH-HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence            44455566666666666  455544433 666666666663 23343333       56778888888888887777765


Q ss_pred             --CCcccccEEEccCccccCchhhhhCCC-----CCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccC--CCCC
Q 042123          296 --RNCTSLIRVRLNGNNLTGNISEALGIY-----PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGG--LPRE  366 (849)
Q Consensus       296 --~~l~~L~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~--~p~~  366 (849)
                        ..+++|++|+|++|++++. |..+..+     ++|++|+|++|++.+..+..|..+++|++|++++|++.+.  .|..
T Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~  194 (312)
T 1wwl_A          116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISA  194 (312)
T ss_dssp             SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHH
T ss_pred             HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHH
Confidence              7788888888888888876 5666655     7888888888888877778888888888888888887644  2333


Q ss_pred             c--cccccccccccccccccc---cCchhhcCCCCCcEEEccCccccccCc-cccccccccccccccc--CCCCChhhhc
Q 042123          367 I--GNSSQLQAFDLSLNHIVG---EIPKELGKLNPLTKLILRGNQITGRLP-KEIGSLTKLEYLDFSA--IGELPSQICN  438 (849)
Q Consensus       367 ~--~~l~~L~~L~L~~N~i~~---~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~l~~--l~~lp~~~~~  438 (849)
                      +  ..+++|++|+|++|++++   .....+..+++|++|+|++|++++..| ..+..+++|++|+++.  +..+|..+. 
T Consensus       195 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~-  273 (312)
T 1wwl_A          195 LCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLP-  273 (312)
T ss_dssp             SCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSSCCSSCC-
T ss_pred             HHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccChhhhhcc-
Confidence            3  777888888888888873   222445677888888888888887665 4566678888888875  677888776 


Q ss_pred             ccccceeccCCcccccCCCccccccCCCcEEeccCCccccC
Q 042123          439 MKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCP  479 (849)
Q Consensus       439 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~  479 (849)
                       ++|+.|+|++|+|++. |. +..+++|++|++++|+|++.
T Consensus       274 -~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~  311 (312)
T 1wwl_A          274 -AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS  311 (312)
T ss_dssp             -SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred             -CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence             8999999999999977 66 99999999999999999863

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.95  E-value=6.9e-27  Score=270.07  Aligned_cols=269  Identities=22%  Similarity=0.254  Sum_probs=155.6

Q ss_pred             CCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF  109 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  109 (849)
                      .+++.|++++|+++ .+|..+.  ++|++|+|++|+|+.     +..     .+++|+.|+|++|.|++ +|.   .+++
T Consensus        40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~-----lp~-----~l~~L~~L~Ls~N~l~~-lp~---~l~~  102 (622)
T 3g06_A           40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-----LPA-----LPPELRTLEVSGNQLTS-LPV---LPPG  102 (622)
T ss_dssp             HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-----CCC-----CCTTCCEEEECSCCCSC-CCC---CCTT
T ss_pred             CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-----CCC-----cCCCCCEEEcCCCcCCc-CCC---CCCC
Confidence            34777888888876 4444443  677788888777762     111     24566666666666653 333   4456


Q ss_pred             CCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccC
Q 042123          110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSR  189 (849)
Q Consensus       110 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  189 (849)
                      |++|+|++|+|+++.+    .+++|+.|++++|+|+. +|..   +++|++|+|++|++++++.    .+.+|+.|++++
T Consensus       103 L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~  170 (622)
T 3g06_A          103 LLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPA----LPSELCKLWAYN  170 (622)
T ss_dssp             CCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCS
T ss_pred             CCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcCC----ccCCCCEEECCC
Confidence            6666666666664322    34556666666666553 2221   2555555555555554321    234455555555


Q ss_pred             CCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCc
Q 042123          190 NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPY  269 (849)
Q Consensus       190 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~  269 (849)
                      |+++. +|   ..+++|+.|++++|.+++ +|..   +++|                                       
T Consensus       171 N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L---------------------------------------  203 (622)
T 3g06_A          171 NQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSEL---------------------------------------  203 (622)
T ss_dssp             SCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTC---------------------------------------
T ss_pred             CCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchh---------------------------------------
Confidence            55552 33   234455555555555543 2211   1233                                       


Q ss_pred             ccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCC
Q 042123          270 NICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL  349 (849)
Q Consensus       270 ~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  349 (849)
                              +.|++++|.++ .+|..   +++|+.|++++|+|++++    ..+++|+.|+|++|+++. +|.   .+++|
T Consensus       204 --------~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~lp----~~l~~L~~L~Ls~N~L~~-lp~---~~~~L  263 (622)
T 3g06_A          204 --------YKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTSLP----VLPSELKELMVSGNRLTS-LPM---LPSGL  263 (622)
T ss_dssp             --------CEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCCC----CCCTTCCEEECCSSCCSC-CCC---CCTTC
T ss_pred             --------hEEECcCCccc-ccCCC---CCCCCEEEccCCccCcCC----CCCCcCcEEECCCCCCCc-CCc---ccccC
Confidence                    33344444433 22221   255666666666666533    445677777888877774 333   45778


Q ss_pred             cEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCC
Q 042123          350 GTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLN  395 (849)
Q Consensus       350 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  395 (849)
                      +.|+|++|.|+ .+|..+.++++|+.|+|++|.+++..|..+..++
T Consensus       264 ~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          264 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             CEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            88888888888 6677788888888888888888877777766554

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=7.2e-28  Score=258.83  Aligned_cols=224  Identities=19%  Similarity=0.218  Sum_probs=113.9

Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      .+++.|+|++|+++ .+|..+..+++|++|+|++|.++ .+|..|+++++|++|+|++|++.. .|..|..+++|++|+|
T Consensus        81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~-lp~~l~~l~~L~~L~L  157 (328)
T 4fcg_A           81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSI  157 (328)
T ss_dssp             TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCC-CCGGGGGCTTCCEEEE
T ss_pred             cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCcccc-CcHHHhcCcCCCEEEC
Confidence            44555555555555 33444555555555555555555 445555555555555555555553 3444555555555555


Q ss_pred             cCCCCcCcCccccc---------CCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhc
Q 042123          188 SRNDLFGSIPDEIG---------KMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLL  258 (849)
Q Consensus       188 s~N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L  258 (849)
                      ++|++.+.+|..+.         ++++|++|+|++|+++ .+|..+..+++|++|+|++|.++                 
T Consensus       158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-----------------  219 (328)
T 4fcg_A          158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-----------------  219 (328)
T ss_dssp             EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-----------------
T ss_pred             CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-----------------
Confidence            55554445554433         3555555555555555 34444555555555444444443                 


Q ss_pred             cCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCc
Q 042123          259 SGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGE  338 (849)
Q Consensus       259 ~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  338 (849)
                                                    + +|..+..+++|+.|++++|++.+..|..+..+++|++|+|++|.+.+.
T Consensus       220 ------------------------------~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~  268 (328)
T 4fcg_A          220 ------------------------------A-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT  268 (328)
T ss_dssp             ------------------------------C-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCB
T ss_pred             ------------------------------c-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhh
Confidence                                          1 222333444444444444444444444444455555555555555445


Q ss_pred             ccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccc
Q 042123          339 ISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHI  383 (849)
Q Consensus       339 ~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i  383 (849)
                      +|..+..+++|++|+|++|.+.+.+|..+.++++|+.+++..|.+
T Consensus       269 ~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~  313 (328)
T 4fcg_A          269 LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ  313 (328)
T ss_dssp             CCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred             cchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence            555555555555555555555555555555555555555554444

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=4e-29  Score=267.76  Aligned_cols=257  Identities=19%  Similarity=0.168  Sum_probs=141.3

Q ss_pred             CeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCC
Q 042123           87 SRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDN  166 (849)
Q Consensus        87 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  166 (849)
                      +.++++.+.+...+...+..+++|++|+|++|+|+++.|..|.++++|++|+|++|.+++..+  |..+++|++|+|++|
T Consensus        13 ~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n   90 (317)
T 3o53_A           13 KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN   90 (317)
T ss_dssp             EEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred             eEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence            344555555554444445555667777777777776666666777777777777777664433  666777777777777


Q ss_pred             cccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCc
Q 042123          167 QLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP  246 (849)
Q Consensus       167 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  246 (849)
                      +++++.     ..++|++|++++|++++..+.   .+++|++|++++|++++..+..+..+++|++|+|++|.+++..|.
T Consensus        91 ~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  162 (317)
T 3o53_A           91 YVQELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA  162 (317)
T ss_dssp             EEEEEE-----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG
T ss_pred             cccccc-----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH
Confidence            766543     236777777777777644333   245677777777777766566666666666666666666532222


Q ss_pred             chhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCC
Q 042123          247 SLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLT  326 (849)
Q Consensus       247 ~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  326 (849)
                      .+.                      ..+++|+.|++++|.+++. +. ...+++|+.|++++|++++.++. +..+++|+
T Consensus       163 ~~~----------------------~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~-~~~l~~L~  217 (317)
T 3o53_A          163 ELA----------------------ASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVT  217 (317)
T ss_dssp             GGG----------------------GGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCS
T ss_pred             HHh----------------------hccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhh-hcccCccc
Confidence            111                      1223444444444444432 11 11245555555555555543332 44455555


Q ss_pred             EEeccCccccCcccccCCCCCCCcEEeccCCccc-cCCCCCccccccccccccc
Q 042123          327 FIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNIT-GGLPREIGNSSQLQAFDLS  379 (849)
Q Consensus       327 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~-~~~p~~~~~l~~L~~L~L~  379 (849)
                      .|+|++|++. .+|..+..+++|+.|++++|.++ +..|..+..+++|+.|+++
T Consensus       218 ~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             EEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             EEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            5555555554 23444444555555555555554 3344444444444444444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=2.3e-29  Score=268.93  Aligned_cols=251  Identities=20%  Similarity=0.216  Sum_probs=183.1

Q ss_pred             CCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccc-cccccccC-------CCCCCCEEEcCCCcccccCCcC
Q 042123          104 IGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLS-GSILSSLG-------KLKSLFDLQLNDNQLIGYIPRP  175 (849)
Q Consensus       104 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~  175 (849)
                      +++.++|++|++++|++  ..|..+...  |+.|+|++|.++ ...+..+.       ++++|++|+|++|++++..|..
T Consensus        39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~  114 (312)
T 1wwl_A           39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP  114 (312)
T ss_dssp             EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred             EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence            44455677777777777  344444333  777777777774 23344443       5777888888888877666665


Q ss_pred             C--CCCCCCCEEEccCCCCcCcCcccccCC-----CCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcch
Q 042123          176 F--SNLTSVSTLRLSRNDLFGSIPDEIGKM-----RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL  248 (849)
Q Consensus       176 ~--~~l~~L~~L~Ls~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  248 (849)
                      +  ..+++|++|+|++|++++. |..+..+     ++|++|+|++|++++..|..|+.+++|++|+|++|++.+.++   
T Consensus       115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~---  190 (312)
T 1wwl_A          115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG---  190 (312)
T ss_dssp             SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHH---
T ss_pred             HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchH---
Confidence            5  7788888888888888755 6667666     788888888888877777777777777777777776542110   


Q ss_pred             hhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCC--CCCCcccccEEEccCccccC---chhhhhCCCC
Q 042123          249 GNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPT--SLRNCTSLIRVRLNGNNLTG---NISEALGIYP  323 (849)
Q Consensus       249 ~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~L~~n~l~~---~~~~~~~~l~  323 (849)
                                                                .+.  .+..+++|++|++++|++++   .....+..++
T Consensus       191 ------------------------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~  228 (312)
T 1wwl_A          191 ------------------------------------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV  228 (312)
T ss_dssp             ------------------------------------------HHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC
T ss_pred             ------------------------------------------HHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC
Confidence                                                      011  23556777888888888773   3335566788


Q ss_pred             CCCEEeccCccccCccc-ccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEc
Q 042123          324 NLTFIDLSRNNFYGEIS-SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLIL  402 (849)
Q Consensus       324 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L  402 (849)
                      +|+.|+|++|++.+..| ..+..+++|++|+|++|.|+ .+|..+.  ++|+.|+|++|+|++. |. +..+++|++|+|
T Consensus       229 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L  303 (312)
T 1wwl_A          229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSL  303 (312)
T ss_dssp             CCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEEC
T ss_pred             CCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEec
Confidence            99999999999987664 45667889999999999998 7787776  8899999999999866 65 899999999999


Q ss_pred             cCccccc
Q 042123          403 RGNQITG  409 (849)
Q Consensus       403 ~~N~l~~  409 (849)
                      ++|++++
T Consensus       304 ~~N~l~~  310 (312)
T 1wwl_A          304 KGNPFLD  310 (312)
T ss_dssp             TTCTTTC
T ss_pred             cCCCCCC
Confidence            9999874

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.95  E-value=9.9e-30  Score=272.49  Aligned_cols=150  Identities=19%  Similarity=0.164  Sum_probs=112.7

Q ss_pred             CCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhh-CCCCCCCEEeccCccccCcccccCCCCCCCcEEe
Q 042123          275 GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEAL-GIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLN  353 (849)
Q Consensus       275 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  353 (849)
                      ++|+.|++++|++++..+..+..+++|+.|++++|.+++..+..+ ..+++|++|+|++|++++...  ...+++|++|+
T Consensus       120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~  197 (317)
T 3o53_A          120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLD  197 (317)
T ss_dssp             SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEE
T ss_pred             CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEE
Confidence            345666666666666666667777778888888888877666655 367888888888888875522  23478888888


Q ss_pred             ccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCcccc-ccCccccccccccccccccc
Q 042123          354 VSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT-GRLPKEIGSLTKLEYLDFSA  428 (849)
Q Consensus       354 Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l~~  428 (849)
                      |++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++ +.+|..+..+++|+.++++.
T Consensus       198 Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~  271 (317)
T 3o53_A          198 LSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT  271 (317)
T ss_dssp             CCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHH
T ss_pred             CCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCC
Confidence            88888884 4555888888888888888887 46777888888888888888888 77788888888888888763

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.95  E-value=1.4e-30  Score=305.29  Aligned_cols=419  Identities=14%  Similarity=0.105  Sum_probs=236.1

Q ss_pred             CCCCCCCCEEeCcCCcc---ccCCCcccc------------CCCCCCEeeCCCCcCcccccccccccCCCCCcc-ccCeE
Q 042123           26 FSSFPHLAYLDLTWNGF---FGTIPPQIS------------NLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR-YMSRL   89 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i---~~~~~~~~~------------~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~-~L~~L   89 (849)
                      +..+++|++|+|+++..   .+..|..++            .+++|++|+|++|.+++..+..+...     ++ +|++|
T Consensus        69 ~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~-----~~~~L~~L  143 (592)
T 3ogk_B           69 SRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKA-----RADDLETL  143 (592)
T ss_dssp             HHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHH-----HGGGCCEE
T ss_pred             HHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHh-----ccccCcEE
Confidence            45567788888876532   123332222            56777777777777664433322110     22 37777


Q ss_pred             eccCCc-ccc-cCCccCCCCCCCCEEEccCCcccCCC----CCCCcCCCCCceeeccCccccc----ccccccCCCCCCC
Q 042123           90 VINDNS-LSG-FIPPHIGNLKFLSQLDLTNNKFSGPI----PLSFDNLSNLIFLYLYGNLLSG----SILSSLGKLKSLF  159 (849)
Q Consensus        90 ~l~~n~-l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~----~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~  159 (849)
                      +|++|. ++. .++....++++|++|+|++|.+++..    +..+.++++|++|++++|.+++    ..+..+.++++|+
T Consensus       144 ~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~  223 (592)
T 3ogk_B          144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV  223 (592)
T ss_dssp             EEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred             ECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence            777665 211 11122235666777777777665432    2233455666666776666652    2233345566666


Q ss_pred             EEEcCCCcccccCCcCCCCCCCCCEEEccCCCCc---CcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhc
Q 042123          160 DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF---GSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALL  236 (849)
Q Consensus       160 ~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  236 (849)
                      .|+|++|.+.++ +..+..+++|++|+++.+...   ...+..+..+++|+.|+++++... .+|..+..+++|++|+|+
T Consensus       224 ~L~L~~~~~~~l-~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls  301 (592)
T 3ogk_B          224 SVKVGDFEILEL-VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLL  301 (592)
T ss_dssp             EEECSSCBGGGG-HHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEET
T ss_pred             EEeccCccHHHH-HHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEecC
Confidence            666666666653 355666666666666643222   122334555666666666664333 345555566666666666


Q ss_pred             cccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEcc---------
Q 042123          237 YNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLN---------  307 (849)
Q Consensus       237 ~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~---------  307 (849)
                      +|.+++..                      .+..+..+++|+.|+++++-..+.++..+..+++|++|+++         
T Consensus       302 ~~~l~~~~----------------------~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~  359 (592)
T 3ogk_B          302 YALLETED----------------------HCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGME  359 (592)
T ss_dssp             TCCCCHHH----------------------HHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTS
T ss_pred             CCcCCHHH----------------------HHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccc
Confidence            66543111                      01123456678888887332222333344567778888888         


Q ss_pred             --CccccCch-hhhhCCCCCCCEEeccCccccCcccccCCC-CCCCcEEecc----CCccccC-----CCCCcccccccc
Q 042123          308 --GNNLTGNI-SEALGIYPNLTFIDLSRNNFYGEISSNWGK-FPKLGTLNVS----MNNITGG-----LPREIGNSSQLQ  374 (849)
Q Consensus       308 --~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~i~~~-----~p~~~~~l~~L~  374 (849)
                        .|.+++.. ...+..+++|++|+++.|.+++..+..+.. +++|+.|+++    .|.+++.     ++..+.++++|+
T Consensus       360 ~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~  439 (592)
T 3ogk_B          360 DEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLR  439 (592)
T ss_dssp             STTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCC
T ss_pred             cccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCC
Confidence              35665432 223445788888888888877665555554 7788888885    5666642     222355677888


Q ss_pred             cccccccc--ccccCchhhc-CCCCCcEEEccCccccc-cCcccccccccccccccccCC----CCChhhhcccccceec
Q 042123          375 AFDLSLNH--IVGEIPKELG-KLNPLTKLILRGNQITG-RLPKEIGSLTKLEYLDFSAIG----ELPSQICNMKSLEKLN  446 (849)
Q Consensus       375 ~L~L~~N~--i~~~~~~~~~-~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~l~~l~----~lp~~~~~l~~L~~L~  446 (849)
                      .|+|++|.  +++..+..+. .+++|++|+|++|++++ .++..+..+++|++|++++..    .++..+..+++|+.|+
T Consensus       440 ~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~  519 (592)
T 3ogk_B          440 RFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLW  519 (592)
T ss_dssp             EEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEE
T ss_pred             EEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeE
Confidence            88886433  5544444443 37788888888888775 234444566666666666543    1223345567777777


Q ss_pred             cCCcccccCCCccc-cccCCCcEEeccC
Q 042123          447 LSHNNLSGSIPSCF-EGMHGLSFIDMSY  473 (849)
Q Consensus       447 L~~N~l~~~~p~~~-~~l~~L~~l~l~~  473 (849)
                      |++|+++......+ ..++.+....+..
T Consensus       520 ls~n~it~~~~~~l~~~~p~l~~~~~~~  547 (592)
T 3ogk_B          520 VQGYRASMTGQDLMQMARPYWNIELIPS  547 (592)
T ss_dssp             EESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred             CcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence            77777765433323 3445555444443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.94  E-value=5.8e-30  Score=299.89  Aligned_cols=374  Identities=14%  Similarity=0.052  Sum_probs=249.6

Q ss_pred             CCCCCCEEeCcCCccccCCCccccCC-C-CCCEeeCCCCc-CcccccccccccCCCCCccccCeEeccCCccccc----C
Q 042123           28 SFPHLAYLDLTWNGFFGTIPPQISNL-S-NLRYLYLGSNQ-FSGNILAEVSSESSGGNLRYMSRLVINDNSLSGF----I  100 (849)
Q Consensus        28 ~l~~L~~L~L~~n~i~~~~~~~~~~l-~-~L~~L~L~~N~-l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~----~  100 (849)
                      .+++|++|+|++|.+++..+..+... + +|++|+|++|. ++...+.     .....+++|++|+|++|.+++.    +
T Consensus       110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~-----~~~~~~~~L~~L~L~~~~~~~~~~~~l  184 (592)
T 3ogk_B          110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLL-----SIVTHCRKIKTLLMEESSFSEKDGKWL  184 (592)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHH-----HHHHHCTTCSEEECTTCEEECCCSHHH
T ss_pred             hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHH-----HHHhhCCCCCEEECccccccCcchhHH
Confidence            68999999999999987777777764 4 49999999987 3211111     1123589999999999998765    3


Q ss_pred             CccCCCCCCCCEEEccCCcccCC----CCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCccc---ccCC
Q 042123          101 PPHIGNLKFLSQLDLTNNKFSGP----IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLI---GYIP  173 (849)
Q Consensus       101 ~~~~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~~~~  173 (849)
                      +..+.++++|++|++++|+++++    .+..+.++++|++|++++|.+.+ .+..+.++++|++|+++++...   ...+
T Consensus       185 ~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~  263 (592)
T 3ogk_B          185 HELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKY  263 (592)
T ss_dssp             HHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSS
T ss_pred             HHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHH
Confidence            33456789999999999999833    34446688999999999999985 6688999999999999864332   2234


Q ss_pred             cCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCC-cCccCccccchhhhccccccC-CCCcchhhh
Q 042123          174 RPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLP-PSISNLTNLKELALLYNHLSG-SIPPSLGNL  251 (849)
Q Consensus       174 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~~  251 (849)
                      ..+..+++|+.|+++++... .+|..+..+++|++|+|++|.++.... ..+..+++|++|+++ +.+.. .++......
T Consensus       264 ~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~  341 (592)
T 3ogk_B          264 MNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYC  341 (592)
T ss_dssp             SCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHC
T ss_pred             HHhhccccccccCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhC
Confidence            57788999999999987554 678888899999999999999764333 346889999999999 44432 122222222


Q ss_pred             -hhhhhhccC-----------cCCCCCCCcc-cCCCCCcceeeecccccccccCCCCCC-cccccEEEcc----CccccC
Q 042123          252 -ILRQLLLSG-----------NHFTGYLPYN-ICRGGALEIFTVSENHFQGTIPTSLRN-CTSLIRVRLN----GNNLTG  313 (849)
Q Consensus       252 -~L~~L~L~~-----------n~i~~~~~~~-~~~~~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~L~----~n~l~~  313 (849)
                       .|++|++++           |.++...... ...+++|+.|+++.|.+++..+..+.. +++|+.|+++    .|.+++
T Consensus       342 ~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~  421 (592)
T 3ogk_B          342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD  421 (592)
T ss_dssp             TTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSS
T ss_pred             CCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccC
Confidence             377777772           4444321111 233566777777666666554444443 6667777764    555654


Q ss_pred             c-----hhhhhCCCCCCCEEeccCcc--ccCcccccCC-CCCCCcEEeccCCcccc-CCCCCcccccccccccccccccc
Q 042123          314 N-----ISEALGIYPNLTFIDLSRNN--FYGEISSNWG-KFPKLGTLNVSMNNITG-GLPREIGNSSQLQAFDLSLNHIV  384 (849)
Q Consensus       314 ~-----~~~~~~~l~~L~~L~Ls~N~--l~~~~~~~~~-~l~~L~~L~Ls~N~i~~-~~p~~~~~l~~L~~L~L~~N~i~  384 (849)
                      .     .+..+..+++|+.|+|++|.  +++.....+. .+++|++|++++|.+++ .++..+.++++|+.|+|++|.++
T Consensus       422 ~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~  501 (592)
T 3ogk_B          422 LPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS  501 (592)
T ss_dssp             CCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred             chHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence            3     33345556667777775432  4433322222 35667777777766654 22333455666677777776665


Q ss_pred             cc-CchhhcCCCCCcEEEccCccccc
Q 042123          385 GE-IPKELGKLNPLTKLILRGNQITG  409 (849)
Q Consensus       385 ~~-~~~~~~~l~~L~~L~L~~N~l~~  409 (849)
                      +. ++..+..+++|++|+|++|++++
T Consensus       502 ~~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          502 ERAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             HHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             HHHHHHHHHhcCccCeeECcCCcCCH
Confidence            33 23333456667777777776653

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.8e-26  Score=242.18  Aligned_cols=226  Identities=19%  Similarity=0.195  Sum_probs=196.4

Q ss_pred             EEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCe
Q 042123            9 NISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR   88 (849)
Q Consensus         9 ~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~   88 (849)
                      .+++.+.++......  +  -++|++|+|++|+++++.+..|.++++|++|+|++|++++      .....|.++++|+.
T Consensus        11 ~~~c~~~~l~~ip~~--l--~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------~~~~~~~~l~~L~~   80 (276)
T 2z62_A           11 TYQCMELNFYKIPDN--L--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT------IEDGAYQSLSHLST   80 (276)
T ss_dssp             EEECTTSCCSSCCSS--S--CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCE------ECTTTTTTCTTCCE
T ss_pred             eEEecCCCccccCCC--C--CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCc------cCHHHccCCcCCCE
Confidence            356666665433322  2  2579999999999999999899999999999999999974      23456788999999


Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccc-cccccCCCCCCCEEEcCCCc
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS-ILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~  167 (849)
                      |+|++|.+++..+..|.++++|++|++++|+++++.+..|..+++|++|++++|.+++. .|..|.++++|++|+|++|+
T Consensus        81 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~  160 (276)
T 2z62_A           81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK  160 (276)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSC
T ss_pred             EECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCC
Confidence            99999999998889999999999999999999988888899999999999999999864 58899999999999999999


Q ss_pred             ccccCCcCCCCCCCCC----EEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCC
Q 042123          168 LIGYIPRPFSNLTSVS----TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS  243 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  243 (849)
                      ++++.+..|..+++|+    +|++++|++++..+..+. ..+|++|++++|++++..+..|..+++|++|+|++|++.+.
T Consensus       161 l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  239 (276)
T 2z62_A          161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  239 (276)
T ss_dssp             CCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred             CCcCCHHHhhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence            9999888888888877    899999999966665554 45899999999999988777889999999999999999876


Q ss_pred             CC
Q 042123          244 IP  245 (849)
Q Consensus       244 ~p  245 (849)
                      .|
T Consensus       240 c~  241 (276)
T 2z62_A          240 CP  241 (276)
T ss_dssp             TT
T ss_pred             CC
Confidence            65

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=4.9e-26  Score=238.82  Aligned_cols=208  Identities=19%  Similarity=0.206  Sum_probs=150.0

Q ss_pred             CcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEecc
Q 042123          276 ALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVS  355 (849)
Q Consensus       276 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  355 (849)
                      +|+.|++++|++++..+..|.++++|++|++++|++++..+..|..+++|++|+|++|++.+..+..|..+++|++|+++
T Consensus        29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~  108 (276)
T 2z62_A           29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV  108 (276)
T ss_dssp             TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred             CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence            56666666666665555566666777777777777766666666667777777777777766666666677777777777


Q ss_pred             CCccccCCCCCcccccccccccccccccccc-CchhhcCCCCCcEEEccCccccccCccccccccccc----cccccc--
Q 042123          356 MNNITGGLPREIGNSSQLQAFDLSLNHIVGE-IPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLE----YLDFSA--  428 (849)
Q Consensus       356 ~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~l~~--  428 (849)
                      +|.+++..+..+..+++|++|++++|.+++. +|..|..+++|+.|+|++|++++..+..+..+++|+    +|+++.  
T Consensus       109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~  188 (276)
T 2z62_A          109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP  188 (276)
T ss_dssp             TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred             CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence            7777655555666777777777777777653 466677777777777777777766666666666666    455543  


Q ss_pred             CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCC
Q 042123          429 IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNS  483 (849)
Q Consensus       429 l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~  483 (849)
                      +..+|.......+|+.|+|++|++++..+..|..+++|+.|++++|+|+|+|+.-
T Consensus       189 l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~l  243 (276)
T 2z62_A          189 MNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI  243 (276)
T ss_dssp             CCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTTT
T ss_pred             ccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCch
Confidence            5556655555668999999999999888888999999999999999999999864

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=1.5e-27  Score=270.32  Aligned_cols=236  Identities=21%  Similarity=0.234  Sum_probs=143.7

Q ss_pred             ccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEE
Q 042123           83 LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQ  162 (849)
Q Consensus        83 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  162 (849)
                      .++|+.|+|++|.+++..|..|.++++|++|+|++|+|++..|  |..+++|++|+|++|.|++..+     .++|+.|+
T Consensus        33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~  105 (487)
T 3oja_A           33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLH  105 (487)
T ss_dssp             GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEE
T ss_pred             CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEE
Confidence            3455566666666655555566666666666666666665444  6666666666666666653322     25666666


Q ss_pred             cCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCcc-Cccccchhhhcccccc
Q 042123          163 LNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSIS-NLTNLKELALLYNHLS  241 (849)
Q Consensus       163 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~  241 (849)
                      |++|.+.++.+..   +++|++|+|++|++++..|..|..+++|++|+|++|.+++..|..+. .+++|++|+|++|.++
T Consensus       106 L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~  182 (487)
T 3oja_A          106 AANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY  182 (487)
T ss_dssp             CCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred             CcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccc
Confidence            6666666554432   35566666666666655555666666666666666666655555554 4566666666666554


Q ss_pred             CCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCC
Q 042123          242 GSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGI  321 (849)
Q Consensus       242 ~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~  321 (849)
                      +. |.                        ...+++|+.|+|++|.+++..| .+..+++|+.|+|++|.+++ +|..+..
T Consensus       183 ~~-~~------------------------~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~  235 (487)
T 3oja_A          183 DV-KG------------------------QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRF  235 (487)
T ss_dssp             EE-EC------------------------CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCC
T ss_pred             cc-cc------------------------cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhcc
Confidence            22 11                        1234566666777776665333 36677777777777777774 4455677


Q ss_pred             CCCCCEEeccCcccc-CcccccCCCCCCCcEEecc
Q 042123          322 YPNLTFIDLSRNNFY-GEISSNWGKFPKLGTLNVS  355 (849)
Q Consensus       322 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls  355 (849)
                      +++|+.|++++|.+. +.+|..+..++.|+.|+++
T Consensus       236 l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             CCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            777777777777776 4555666677777777765

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.93  E-value=5.2e-27  Score=266.01  Aligned_cols=233  Identities=22%  Similarity=0.231  Sum_probs=156.6

Q ss_pred             CCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhc
Q 042123          157 SLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALL  236 (849)
Q Consensus       157 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  236 (849)
                      +|+.|+|++|.+.++.|..|..+++|++|+|++|.+++..|  |..+++|++|+|++|.|+++.+     .++|++|+++
T Consensus        35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~  107 (487)
T 3oja_A           35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA  107 (487)
T ss_dssp             GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred             CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence            45555555555554444445555555555555555543322  4455555555555555543211     1344444444


Q ss_pred             cccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchh
Q 042123          237 YNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNIS  316 (849)
Q Consensus       237 ~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  316 (849)
                      +|.+++.                       .+.   .+++|+.|++++|.+++..|..+.++++|+.|+|++|.+++..|
T Consensus       108 ~N~l~~~-----------------------~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  161 (487)
T 3oja_A          108 NNNISRV-----------------------SCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNF  161 (487)
T ss_dssp             SSCCCCE-----------------------EEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEG
T ss_pred             CCcCCCC-----------------------Ccc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcCh
Confidence            4444321                       111   12456677777777777777778888889999999999888777


Q ss_pred             hhhC-CCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCC
Q 042123          317 EALG-IYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLN  395 (849)
Q Consensus       317 ~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  395 (849)
                      ..+. .+++|+.|+|++|.+++..+  +..+++|+.|+|++|.+++ +|..+..+++|+.|+|++|.+++ +|..+..++
T Consensus       162 ~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~  237 (487)
T 3oja_A          162 AELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ  237 (487)
T ss_dssp             GGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCT
T ss_pred             HHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCC
Confidence            7775 78899999999999986633  3358899999999999995 45558899999999999999985 677899999


Q ss_pred             CCcEEEccCcccc-ccCccccccccccccccc
Q 042123          396 PLTKLILRGNQIT-GRLPKEIGSLTKLEYLDF  426 (849)
Q Consensus       396 ~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~l  426 (849)
                      +|+.|++++|++. +.+|..+..++.|+.+++
T Consensus       238 ~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~  269 (487)
T 3oja_A          238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK  269 (487)
T ss_dssp             TCCEEECTTCCBCHHHHHHHHTTCHHHHHHHH
T ss_pred             CCCEEEcCCCCCcCcchHHHHHhCCCCcEEec
Confidence            9999999999998 566666666666655554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=7.7e-25  Score=228.71  Aligned_cols=207  Identities=29%  Similarity=0.276  Sum_probs=168.7

Q ss_pred             CCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF  109 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  109 (849)
                      .+++.+++++++++. +|..+.  ++|++|+|++|++++.      ....|+++++|++|+|++|.++.+.+..|.++++
T Consensus        16 ~~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~------~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~   86 (270)
T 2o6q_A           16 NNKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSL------PSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN   86 (270)
T ss_dssp             TTTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCC------CTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTT
T ss_pred             CCCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCee------CHHHhcCCCCCCEEECCCCccCeeChhhhcCCCC
Confidence            456788888888865 343333  5788888888888632      3345677888888888888888776777788888


Q ss_pred             CCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccC
Q 042123          110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSR  189 (849)
Q Consensus       110 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  189 (849)
                      |++|+|++|+++++.+..|.++++|++|+|++|.++...+..|.++++|++|+|++|++.++.+..|..+++|++|+|++
T Consensus        87 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~  166 (270)
T 2o6q_A           87 LETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYN  166 (270)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecC
Confidence            99999999998887778888888999999999988887778888889999999999998888888888899999999999


Q ss_pred             CCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCC
Q 042123          190 NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP  245 (849)
Q Consensus       190 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  245 (849)
                      |++++..+..|.++++|++|+|++|+++++.+..|..+++|+.|+|++|++....+
T Consensus       167 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  222 (270)
T 2o6q_A          167 NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN  222 (270)
T ss_dssp             SCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred             CcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence            98887777778888999999999999887777778888899999999998875544

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=4.5e-25  Score=230.46  Aligned_cols=206  Identities=25%  Similarity=0.299  Sum_probs=184.7

Q ss_pred             CCcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCc
Q 042123            4 AGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNL   83 (849)
Q Consensus         4 ~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l   83 (849)
                      .+.++.++++..++......  +  .+++++|+|++|++.++.+.+|.++++|++|+|++|+++.      .....|.++
T Consensus        15 ~~~~~~l~~~~~~l~~ip~~--~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~------i~~~~~~~l   84 (270)
T 2o6q_A           15 NNNKNSVDCSSKKLTAIPSN--I--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT------LPAGIFKEL   84 (270)
T ss_dssp             ETTTTEEECTTSCCSSCCSC--C--CTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSC------CCTTTTSSC
T ss_pred             CCCCCEEEccCCCCCccCCC--C--CCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCe------eChhhhcCC
Confidence            34566788888887754322  2  2679999999999999999999999999999999999973      234567889


Q ss_pred             cccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEc
Q 042123           84 RYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL  163 (849)
Q Consensus        84 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  163 (849)
                      ++|++|+|++|.+++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|.+++..+..|.++++|++|+|
T Consensus        85 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  164 (270)
T 2o6q_A           85 KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRL  164 (270)
T ss_dssp             TTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEe
Confidence            99999999999999888888999999999999999999999999999999999999999999887788999999999999


Q ss_pred             CCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccC
Q 042123          164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV  219 (849)
Q Consensus       164 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  219 (849)
                      ++|+++++.+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+...
T Consensus       165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  220 (270)
T 2o6q_A          165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT  220 (270)
T ss_dssp             CSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred             cCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence            99999999999999999999999999999977777899999999999999998743

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=3.3e-26  Score=239.36  Aligned_cols=208  Identities=26%  Similarity=0.311  Sum_probs=140.4

Q ss_pred             CCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCC
Q 042123           26 FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG  105 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  105 (849)
                      +..+++|++|++++|.+....  .+..+++|++|+|++|++++.        ..+..+++|++|+|++|.+++..+..|.
T Consensus        37 ~~~l~~L~~L~l~~~~i~~~~--~l~~l~~L~~L~l~~n~l~~~--------~~l~~l~~L~~L~L~~n~l~~~~~~~~~  106 (272)
T 3rfs_A           37 QNELNSIDQIIANNSDIKSVQ--GIQYLPNVRYLALGGNKLHDI--------SALKELTNLTYLILTGNQLQSLPNGVFD  106 (272)
T ss_dssp             HHHHTTCCEEECTTSCCCCCT--TGGGCTTCCEEECTTSCCCCC--------GGGTTCTTCCEEECTTSCCCCCCTTTTT
T ss_pred             cccccceeeeeeCCCCccccc--ccccCCCCcEEECCCCCCCCc--------hhhcCCCCCCEEECCCCccCccChhHhc
Confidence            455677777777777775432  367777777777777777531        1345667777777777777766666667


Q ss_pred             CCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEE
Q 042123          106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  185 (849)
                      ++++|++|+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|+++++.+..|..+++|++|
T Consensus       107 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  186 (272)
T 3rfs_A          107 KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDL  186 (272)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEE
Confidence            77777777777777776666667777777777777777776666666777777777777777776666666777777777


Q ss_pred             EccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhh
Q 042123          186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGN  250 (849)
Q Consensus       186 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  250 (849)
                      +|++|++++..+..|..+++|+.|++++|.+.+.       +++|+.|+++.|.++|.+|..++.
T Consensus       187 ~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~  244 (272)
T 3rfs_A          187 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGS  244 (272)
T ss_dssp             ECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSC
T ss_pred             ECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCcccc
Confidence            7777777766666666677777777777766532       345666666666666666655543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=4e-25  Score=231.07  Aligned_cols=231  Identities=25%  Similarity=0.227  Sum_probs=206.7

Q ss_pred             CCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCC
Q 042123           28 SFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNL  107 (849)
Q Consensus        28 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  107 (849)
                      .+.++..+++..+.+.....  +..+++|+.|++++|.++.        ...+..+++|++|++++|.+.+.  ..+.++
T Consensus        17 ~~~~l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~--------~~~l~~l~~L~~L~l~~n~l~~~--~~l~~l   84 (272)
T 3rfs_A           17 AFAETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS--------VQGIQYLPNVRYLALGGNKLHDI--SALKEL   84 (272)
T ss_dssp             HHHHHHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCCC--------CTTGGGCTTCCEEECTTSCCCCC--GGGTTC
T ss_pred             hHHHHHHHHhcCcccccccc--cccccceeeeeeCCCCccc--------ccccccCCCCcEEECCCCCCCCc--hhhcCC
Confidence            34556677888888866644  7789999999999999863        22467799999999999999863  589999


Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      ++|++|+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|
T Consensus        85 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  164 (272)
T 3rfs_A           85 TNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL  164 (272)
T ss_dssp             TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence            99999999999999988888999999999999999999888888999999999999999999999999999999999999


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                      ++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|++.+..|      .++.++++.|.+++.+
T Consensus       165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~------~l~~l~~~~n~~~g~i  238 (272)
T 3rfs_A          165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP------GIRYLSEWINKHSGVV  238 (272)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT------TTHHHHHHHHHTGGGB
T ss_pred             CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc------HHHHHHHHHHhCCCcc
Confidence            9999998888888999999999999999999888889999999999999999987665      3889999999999999


Q ss_pred             CcccCCCCC
Q 042123          268 PYNICRGGA  276 (849)
Q Consensus       268 ~~~~~~~~~  276 (849)
                      |..++.+..
T Consensus       239 p~~~~~~~~  247 (272)
T 3rfs_A          239 RNSAGSVAP  247 (272)
T ss_dssp             BCTTSCBCG
T ss_pred             cCcccccCC
Confidence            988876654

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.92  E-value=1.9e-24  Score=227.70  Aligned_cols=205  Identities=21%  Similarity=0.207  Sum_probs=171.4

Q ss_pred             CCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCC
Q 042123           26 FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG  105 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  105 (849)
                      +..+++++++++++|+++.+++. +.  ++|+.|+|++|++++.      ....|.++++|+.|+|++|.|++..+.  +
T Consensus         6 ~~~l~~l~~l~~~~~~l~~ip~~-~~--~~l~~L~L~~N~l~~~------~~~~~~~l~~L~~L~L~~n~l~~~~~~--~   74 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLTALPPD-LP--KDTTILHLSENLLYTF------SLATLMPYTRLTQLNLDRAELTKLQVD--G   74 (290)
T ss_dssp             EECSTTCCEEECTTSCCSSCCSC-CC--TTCCEEECTTSCCSEE------EGGGGTTCTTCCEEECTTSCCCEEECC--S
T ss_pred             ccccCCccEEECCCCCCCcCCCC-CC--CCCCEEEcCCCcCCcc------CHHHhhcCCCCCEEECCCCccCcccCC--C
Confidence            56788899999999999755443 32  6789999999998742      234567889999999999999865443  7


Q ss_pred             CCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEE
Q 042123          106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  185 (849)
                      .+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..+..|.++++|++|+|++|+++++++..|..+++|++|
T Consensus        75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  153 (290)
T 1p9a_G           75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL  153 (290)
T ss_dssp             CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence            8899999999999998 567788899999999999999998777889999999999999999999888889999999999


Q ss_pred             EccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCC
Q 042123          186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS  243 (849)
Q Consensus       186 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  243 (849)
                      +|++|+++...+..|.++++|++|+|++|+++ .+|..+..+++|+.|+|++|++...
T Consensus       154 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~  210 (290)
T 1p9a_G          154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (290)
T ss_dssp             ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             ECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCc
Confidence            99999998666677888999999999999998 5677777888899999999988743

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.91  E-value=4.3e-28  Score=284.20  Aligned_cols=398  Identities=15%  Similarity=0.161  Sum_probs=182.9

Q ss_pred             CCCCCCCCEEeCcCCcccc---CCC------------ccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEe
Q 042123           26 FSSFPHLAYLDLTWNGFFG---TIP------------PQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLV   90 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i~~---~~~------------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~   90 (849)
                      +..+++|++|+|++|....   ..|            ..+..+++|++|+|++|.+++..+..+.     ..+++|+.|+
T Consensus        62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~-----~~~~~L~~L~  136 (594)
T 2p1m_B           62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIA-----KSFKNFKVLV  136 (594)
T ss_dssp             HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHH-----HHCTTCCEEE
T ss_pred             HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHH-----HhCCCCcEEe
Confidence            4556777777777764211   111            1123456666666666666543333221     1245666666


Q ss_pred             ccCC-ccccc-CCccCCCCCCCCEEEccCCcccCCCCCCC----cCCCCCceeeccCcc--cccc-cccccCCCCCCCEE
Q 042123           91 INDN-SLSGF-IPPHIGNLKFLSQLDLTNNKFSGPIPLSF----DNLSNLIFLYLYGNL--LSGS-ILSSLGKLKSLFDL  161 (849)
Q Consensus        91 l~~n-~l~~~-~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~----~~l~~L~~L~L~~N~--l~~~-~~~~~~~l~~L~~L  161 (849)
                      |++| .++.. ++..+.++++|++|+|++|.+++..+..+    ..+++|++|++++|.  +... ....+..+++|+.|
T Consensus       137 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L  216 (594)
T 2p1m_B          137 LSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSL  216 (594)
T ss_dssp             EESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEE
Confidence            6666 33321 22233355666666666666554332222    244455555555554  2110 11111234555555


Q ss_pred             EcCCC-cccccCCcCCCCCCCCCEEEccCCC-------CcCcCcccccCCCCCCEE-eccCCcCccCCCcCccCccccch
Q 042123          162 QLNDN-QLIGYIPRPFSNLTSVSTLRLSRND-------LFGSIPDEIGKMRSLSVL-DLNQNQFKGVLPPSISNLTNLKE  232 (849)
Q Consensus       162 ~L~~N-~l~~~~~~~~~~l~~L~~L~Ls~N~-------l~~~~~~~~~~l~~L~~L-~L~~N~l~~~~~~~~~~l~~L~~  232 (849)
                      +|++| .+.+ .+..+..+++|++|+++.+.       +. .++..+.++++|+.| .+.+.... .++..+..+++|++
T Consensus       217 ~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~~~L~~  293 (594)
T 2p1m_B          217 KLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYS-GLSVALSGCKELRCLSGFWDAVPA-YLPAVYSVCSRLTT  293 (594)
T ss_dssp             ECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHH-HHHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHHTTCCE
T ss_pred             ecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHH-HHHHHHhcCCCcccccCCcccchh-hHHHHHHhhCCCCE
Confidence            55555 2222 33344445555555543332       12 122234445555555 22222211 22222233444444


Q ss_pred             hhhccccccCCCCcchhhhhhhhhhccCcCCCCCC-CcccCCCCCcceeeecccccccc-cCCCCCCcccccEEEc----
Q 042123          233 LALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL-PYNICRGGALEIFTVSENHFQGT-IPTSLRNCTSLIRVRL----  306 (849)
Q Consensus       233 L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~-~~~~~~~~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~L----  306 (849)
                      |+|++|.++                       +.. ...+..+++|+.|++++| +... ++.....+++|++|++    
T Consensus       294 L~L~~~~l~-----------------------~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~  349 (594)
T 2p1m_B          294 LNLSYATVQ-----------------------SYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSE  349 (594)
T ss_dssp             EECTTCCCC-----------------------HHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSC
T ss_pred             EEccCCCCC-----------------------HHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCc
Confidence            444444432                       111 111234556666666666 3221 1212223566666666    


Q ss_pred             -----cCccccCchhhhhC-CCCCCCEEeccCccccCcccccCC-CCCCCcEEecc--C----CccccCC-----CCCcc
Q 042123          307 -----NGNNLTGNISEALG-IYPNLTFIDLSRNNFYGEISSNWG-KFPKLGTLNVS--M----NNITGGL-----PREIG  368 (849)
Q Consensus       307 -----~~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~i~~~~-----p~~~~  368 (849)
                           +.+.+++.....+. .+++|+.|+++.|.+++.....+. .+++|+.|+++  +    |.++...     +..+.
T Consensus       350 ~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~  429 (594)
T 2p1m_B          350 PFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVE  429 (594)
T ss_dssp             TTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHH
T ss_pred             ccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHh
Confidence                 23444433322222 356677776666666544433333 35666777666  3    3444111     11134


Q ss_pred             ccccccccccccccccccCchhhcC-CCCCcEEEccCccccccCcccccccccccccccccCCCCChhhhcccccceecc
Q 042123          369 NSSQLQAFDLSLNHIVGEIPKELGK-LNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNL  447 (849)
Q Consensus       369 ~l~~L~~L~L~~N~i~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L  447 (849)
                      .+++|+.|+|++ .++...+..+.. +++|+.|+|++|.+++..+..+                    ...+++|+.|+|
T Consensus       430 ~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l--------------------~~~~~~L~~L~L  488 (594)
T 2p1m_B          430 HCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHV--------------------LSGCDSLRKLEI  488 (594)
T ss_dssp             HCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHH--------------------HHHCTTCCEEEE
T ss_pred             hCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHH--------------------HhcCCCcCEEEC
Confidence            455666666655 444444444443 5666666666666654333222                    123445555555


Q ss_pred             CCcccccCCCc-cccccCCCcEEeccCCcc
Q 042123          448 SHNNLSGSIPS-CFEGMHGLSFIDMSYNEL  476 (849)
Q Consensus       448 ~~N~l~~~~p~-~~~~l~~L~~l~l~~N~l  476 (849)
                      ++|.+++..+. ....+++|+.|++++|++
T Consensus       489 ~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          489 RDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             ESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             cCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            55555332222 223345555555555554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.91  E-value=3.1e-26  Score=263.09  Aligned_cols=178  Identities=19%  Similarity=0.158  Sum_probs=120.2

Q ss_pred             eecCCccceEEEE-EecCCcEEEEEEecccCCCC------chhhHHHHHHHHHH------------hhceeecCCeeEEE
Q 042123          595 CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCD------QTVDQKEFLTEVEA------------FYGFCSHARHSFLL  655 (849)
Q Consensus       595 ~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~~~~ei~~------------~~~~~~~~~~~~lV  655 (849)
                      ..+.|+.|.+..+ +...|+.+|||.+.......      .....+++.+|++.            +++++.++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            3566777777666 44468999999987543211      22334567777663            67888999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||++||+|.+++.+..   .++..   +|+.||+.||+|+|++   ||+||||||+|||++.+|.+||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999997543   35554   5889999999999999   999999999999999999999999999998766


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP  782 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~P  782 (849)
                      +.......+||+.|+|||++.+ .+..++|+||+|++++++.++..|
T Consensus       392 ~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            5555566789999999999876 467789999999998887766544

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.91  E-value=1.3e-23  Score=221.27  Aligned_cols=200  Identities=22%  Similarity=0.220  Sum_probs=180.5

Q ss_pred             CcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCcc
Q 042123            5 GRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR   84 (849)
Q Consensus         5 ~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~   84 (849)
                      -.++.++++.+++......  +  .+++++|+|++|++.++.+..|.++++|++|+|++|+|++..        ..+.++
T Consensus        10 ~~l~~l~~~~~~l~~ip~~--~--~~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~--------~~~~l~   77 (290)
T 1p9a_G           10 ASHLEVNCDKRNLTALPPD--L--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--------VDGTLP   77 (290)
T ss_dssp             TTCCEEECTTSCCSSCCSC--C--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--------CCSCCT
T ss_pred             CCccEEECCCCCCCcCCCC--C--CCCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCccc--------CCCCCC
Confidence            4577889999987654332  2  378999999999999999999999999999999999998421        126799


Q ss_pred             ccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcC
Q 042123           85 YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN  164 (849)
Q Consensus        85 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  164 (849)
                      +|+.|+|++|.|+ .+|..+.++++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|+.|+|+
T Consensus        78 ~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  156 (290)
T 1p9a_G           78 VLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLA  156 (290)
T ss_dssp             TCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             cCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECC
Confidence            9999999999999 678889999999999999999999888999999999999999999998888889999999999999


Q ss_pred             CCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCcc
Q 042123          165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       165 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      +|+|+++++..|..+++|++|+|++|+++ .+|..+..+.+|+.|+|++|.+..
T Consensus       157 ~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C  209 (290)
T 1p9a_G          157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC  209 (290)
T ss_dssp             TSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred             CCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence            99999999999999999999999999998 778888889999999999999974

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=2.7e-24  Score=220.29  Aligned_cols=197  Identities=21%  Similarity=0.241  Sum_probs=160.5

Q ss_pred             CCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCc-CcccccccccccCCCCCccccCeEeccC-CcccccCCccCCCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQ-FSGNILAEVSSESSGGNLRYMSRLVIND-NSLSGFIPPHIGNL  107 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~~~~l~~L~~L~l~~-n~l~~~~~~~~~~l  107 (849)
                      ++|++|+|++|+++++.+..|.++++|++|+|++|+ +++      .....|.++++|++|++++ |.++++.+..|.++
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~------i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l  104 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ------LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKEL  104 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCE------ECTTTEESCTTCCEEEEEEETTCCEECTTSEECC
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcce------eCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCC
Confidence            479999999999998888899999999999999997 763      2344567788899999988 88887777888888


Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCc---eeeccCc-ccccccccccCCCCCCC-EEEcCCCcccccCCcCCCCCCCC
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLI---FLYLYGN-LLSGSILSSLGKLKSLF-DLQLNDNQLIGYIPRPFSNLTSV  182 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L  182 (849)
                      ++|++|++++|++++ +|. |..+++|+   +|++++| .++...+..|.++++|+ +|++++|+++.+++..|.. ++|
T Consensus       105 ~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L  181 (239)
T 2xwt_C          105 PLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKL  181 (239)
T ss_dssp             TTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEE
T ss_pred             CCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCC
Confidence            899999999998886 444 88888888   8899988 88877777788888888 8999888888877777776 788


Q ss_pred             CEEEccCCC-CcCcCcccccCC-CCCCEEeccCCcCccCCCcCccCccccchhhhccc
Q 042123          183 STLRLSRND-LFGSIPDEIGKM-RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN  238 (849)
Q Consensus       183 ~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  238 (849)
                      ++|+|++|+ ++...+..|.++ ++|+.|++++|+++.+.+.   .+++|+.|+++++
T Consensus       182 ~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~  236 (239)
T 2xwt_C          182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT  236 (239)
T ss_dssp             EEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred             CEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence            888998885 886667778888 8888888888888855443   4566777777655

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.91  E-value=3.3e-28  Score=285.20  Aligned_cols=393  Identities=16%  Similarity=0.120  Sum_probs=247.3

Q ss_pred             CCCCCCCEEeCcCCccccCCCcccc-CCCCCCEeeCCCC-cCcccccccccccCCCCCccccCeEeccCCcccccCCccC
Q 042123           27 SSFPHLAYLDLTWNGFFGTIPPQIS-NLSNLRYLYLGSN-QFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI  104 (849)
Q Consensus        27 ~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  104 (849)
                      ..+++|++|+|++|.+++..+..+. .+++|++|+|++| .+++..+..+     +.++++|++|+|++|.+++..+..+
T Consensus       102 ~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~-----~~~~~~L~~L~L~~~~i~~~~~~~l  176 (594)
T 2p1m_B          102 SSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAI-----AATCRNLKELDLRESDVDDVSGHWL  176 (594)
T ss_dssp             HHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHH-----HHHCTTCCEEECTTCEEECCCGGGG
T ss_pred             HhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHH-----HHhCCCCCEEeCcCCccCCcchHHH
Confidence            3578999999999999887777776 7999999999999 5553222222     2368999999999999886554444


Q ss_pred             ----CCCCCCCEEEccCCcccCCCCCC----CcCCCCCceeeccCc-ccccccccccCCCCCCCEEEcCCC-------cc
Q 042123          105 ----GNLKFLSQLDLTNNKFSGPIPLS----FDNLSNLIFLYLYGN-LLSGSILSSLGKLKSLFDLQLNDN-------QL  168 (849)
Q Consensus       105 ----~~l~~L~~L~Ls~n~i~~~~~~~----~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N-------~l  168 (849)
                          ..+++|++|++++|. ..+....    +.++++|++|+|++| .+.+ ++..+..+++|++|+++.+       .+
T Consensus       177 ~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~  254 (594)
T 2p1m_B          177 SHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVY  254 (594)
T ss_dssp             GGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHH
T ss_pred             HHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhH
Confidence                367799999999997 2222222    345699999999999 4553 6778889999999996654       34


Q ss_pred             cccCCcCCCCCCCCCEE-EccCCCCcCcCcccccCCCCCCEEeccCCcCccCC-CcCccCccccchhhhccccccCCCCc
Q 042123          169 IGYIPRPFSNLTSVSTL-RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVL-PPSISNLTNLKELALLYNHLSGSIPP  246 (849)
Q Consensus       169 ~~~~~~~~~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~  246 (849)
                      .++. ..+.++++|+.| .+.+... ..++..+..+++|++|+|++|.++... +..+..+++|++|++++| +......
T Consensus       255 ~~l~-~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~  331 (594)
T 2p1m_B          255 SGLS-VALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLE  331 (594)
T ss_dssp             HHHH-HHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHH
T ss_pred             HHHH-HHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHH
Confidence            4433 367889999999 5554433 245555667899999999999976432 223567899999999988 4311111


Q ss_pred             chhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeec---------ccccccccCCCC-CCcccccEEEccCccccCchh
Q 042123          247 SLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVS---------ENHFQGTIPTSL-RNCTSLIRVRLNGNNLTGNIS  316 (849)
Q Consensus       247 ~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~---------~N~l~~~~~~~~-~~l~~L~~L~L~~n~l~~~~~  316 (849)
                      .+.                      ..+++|+.|+++         .+.+++.....+ .++++|+.|.+..|.+++...
T Consensus       332 ~l~----------------------~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~  389 (594)
T 2p1m_B          332 VLA----------------------STCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAAL  389 (594)
T ss_dssp             HHH----------------------HHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHH
T ss_pred             HHH----------------------HhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHH
Confidence            111                      112344444442         233332211122 235666666666666665444


Q ss_pred             hhhC-CCCCCCEEecc--C----ccccCcc-----cccCCCCCCCcEEeccCCccccCCCCCccc-cccccccccccccc
Q 042123          317 EALG-IYPNLTFIDLS--R----NNFYGEI-----SSNWGKFPKLGTLNVSMNNITGGLPREIGN-SSQLQAFDLSLNHI  383 (849)
Q Consensus       317 ~~~~-~l~~L~~L~Ls--~----N~l~~~~-----~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~-l~~L~~L~L~~N~i  383 (849)
                      ..+. .+++|+.|+|+  +    |.+++..     +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+
T Consensus       390 ~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i  468 (594)
T 2p1m_B          390 ITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGD  468 (594)
T ss_dssp             HHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCS
T ss_pred             HHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCC
Confidence            4443 46667777776  3    3444211     11244556677777765 444433333433 56677777777776


Q ss_pred             cccCchhh-cCCCCCcEEEccCccccccCcc-cccccccccccccccCCCCChhh----hcccccceeccCCccc
Q 042123          384 VGEIPKEL-GKLNPLTKLILRGNQITGRLPK-EIGSLTKLEYLDFSAIGELPSQI----CNMKSLEKLNLSHNNL  452 (849)
Q Consensus       384 ~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~l~~lp~~~----~~l~~L~~L~L~~N~l  452 (849)
                      ++..+..+ ..+++|++|+|++|++++..+. .+..+++|++|++++...-+..+    ..+++|+...+..+.-
T Consensus       469 ~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~  543 (594)
T 2p1m_B          469 SDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGA  543 (594)
T ss_dssp             SHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSC
T ss_pred             cHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCc
Confidence            55444444 5567777777777777543333 33446777777776654433322    3456666666665543

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.90  E-value=2.6e-23  Score=214.51  Aligned_cols=179  Identities=25%  Similarity=0.265  Sum_probs=90.6

Q ss_pred             CCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCC
Q 042123           31 HLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFL  110 (849)
Q Consensus        31 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  110 (849)
                      ..+++++++++++.++ ..+.  ++|++|+|++|+++                              +..+..|.++++|
T Consensus        15 ~~~~l~~~~~~l~~~p-~~~~--~~l~~L~L~~n~l~------------------------------~~~~~~~~~l~~L   61 (251)
T 3m19_A           15 GKKEVDCQGKSLDSVP-SGIP--ADTEKLDLQSTGLA------------------------------TLSDATFRGLTKL   61 (251)
T ss_dssp             GGTEEECTTCCCSSCC-SCCC--TTCCEEECTTSCCC------------------------------CCCTTTTTTCTTC
T ss_pred             CCeEEecCCCCccccC-CCCC--CCCCEEEccCCCcC------------------------------ccCHhHhcCcccC
Confidence            3456666666665333 2232  45666666666665                              3333344444444


Q ss_pred             CEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCC
Q 042123          111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN  190 (849)
Q Consensus       111 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  190 (849)
                      ++|+|++|+|+++.+..|.++++|++|+|++|+++...+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|
T Consensus        62 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  141 (251)
T 3m19_A           62 TWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTN  141 (251)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCC
Confidence            44444444444444444444445555555555444444444444555555555555555444444455555555555555


Q ss_pred             CCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccC
Q 042123          191 DLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSG  242 (849)
Q Consensus       191 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  242 (849)
                      ++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++.+
T Consensus       142 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          142 QLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             cCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            5544444445555555555555555554444445555555555555555543

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.90  E-value=2.2e-23  Score=213.52  Aligned_cols=132  Identities=20%  Similarity=0.262  Sum_probs=92.8

Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcc-cccccccccCCCCCCCEEEcCC-CcccccCCcCCCCCCCCCEE
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNL-LSGSILSSLGKLKSLFDLQLND-NQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L  185 (849)
                      ++|++|++++|+|+++.+.+|.++++|++|++++|+ ++.+.+..|.++++|++|+|++ |+++.+.+..|.++++|++|
T Consensus        31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            367777777777776666677777777777777775 7666666777777777777776 77777777777777777777


Q ss_pred             EccCCCCcCcCcccccCCCCCC---EEeccCC-cCccCCCcCccCccccc-hhhhcccccc
Q 042123          186 RLSRNDLFGSIPDEIGKMRSLS---VLDLNQN-QFKGVLPPSISNLTNLK-ELALLYNHLS  241 (849)
Q Consensus       186 ~Ls~N~l~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~l~~L~-~L~L~~N~l~  241 (849)
                      ++++|++++ +|. |..+++|+   +|++++| +++.+.+..|.++++|+ +|++++|+++
T Consensus       111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~  169 (239)
T 2xwt_C          111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT  169 (239)
T ss_dssp             EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred             eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence            777777764 454 66666666   7777777 77666555666666666 6666666554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=4.1e-25  Score=241.26  Aligned_cols=154  Identities=20%  Similarity=0.196  Sum_probs=95.4

Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCC----CCCcCCC-CCceeeccCcccccccccccCCC-----CC
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP----LSFDNLS-NLIFLYLYGNLLSGSILSSLGKL-----KS  157 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~  157 (849)
                      .+.+++|.+++.+|..+...++|++|+|++|+|++..+    .+|..++ +|++|+|++|.|++..+..|..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            35677777777777766666668888888888776655    5666777 77777777777776655555553     67


Q ss_pred             CCEEEcCCCcccccCCcC----CCCC-CCCCEEEccCCCCcCcCccccc----C-CCCCCEEeccCCcCccCCCcC----
Q 042123          158 LFDLQLNDNQLIGYIPRP----FSNL-TSVSTLRLSRNDLFGSIPDEIG----K-MRSLSVLDLNQNQFKGVLPPS----  223 (849)
Q Consensus       158 L~~L~L~~N~l~~~~~~~----~~~l-~~L~~L~Ls~N~l~~~~~~~~~----~-l~~L~~L~L~~N~l~~~~~~~----  223 (849)
                      |++|+|++|++++..+..    +..+ ++|++|+|++|+++...+..+.    . .++|++|+|++|+++...+..    
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            777777777776655543    3333 6677777777777655444332    2 246777777777666332222    


Q ss_pred             ccCcc-ccchhhhcccccc
Q 042123          224 ISNLT-NLKELALLYNHLS  241 (849)
Q Consensus       224 ~~~l~-~L~~L~L~~N~l~  241 (849)
                      +..++ +|++|+|++|+++
T Consensus       162 l~~~~~~L~~L~Ls~n~l~  180 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLA  180 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGG
T ss_pred             HhcCCccccEeeecCCCCc
Confidence            22222 4555555555444

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.2e-23  Score=224.55  Aligned_cols=203  Identities=19%  Similarity=0.129  Sum_probs=96.9

Q ss_pred             CCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCC----ccCCCCCCCCEEEccCCcccCCCCCCCc
Q 042123           54 SNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIP----PHIGNLKFLSQLDLTNNKFSGPIPLSFD  129 (849)
Q Consensus        54 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~~L~~L~Ls~n~i~~~~~~~~~  129 (849)
                      ++|++|+|++|++++..+..+..    ..+++|+.|+|++|.+++..+    ..+..+++|++|+|++|+|+++.+..|.
T Consensus        91 ~~L~~L~l~~n~l~~~~~~~~~~----~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~  166 (310)
T 4glp_A           91 SRLKELTLEDLKITGTMPPLPLE----ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVR  166 (310)
T ss_dssp             SCCCEEEEESCCCBSCCCCCSSS----CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCC
T ss_pred             CceeEEEeeCCEeccchhhhhhh----ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhc
Confidence            44555555555554332221100    445555555555555554332    2233455555555555555555555555


Q ss_pred             CCCCCceeeccCcccccc--c--ccccCCCCCCCEEEcCCCcccccCCc---CCCCCCCCCEEEccCCCCcCcCcccccC
Q 042123          130 NLSNLIFLYLYGNLLSGS--I--LSSLGKLKSLFDLQLNDNQLIGYIPR---PFSNLTSVSTLRLSRNDLFGSIPDEIGK  202 (849)
Q Consensus       130 ~l~~L~~L~L~~N~l~~~--~--~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  202 (849)
                      ++++|++|+|++|++.+.  .  +..+..+++|++|+|++|+++.+.+.   .+..+++|++|+|++|++++..|..+..
T Consensus       167 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~  246 (310)
T 4glp_A          167 AFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPR  246 (310)
T ss_dssp             CCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSS
T ss_pred             cCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHh
Confidence            555555555555554321  1  12234555555555555555432111   2344555555555555555444444444


Q ss_pred             C---CCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCC
Q 042123          203 M---RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFT  264 (849)
Q Consensus       203 l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~  264 (849)
                      +   ++|++|+|++|+|+ .+|..+.  ++|++|+|++|++++ +|.......|+.|+|++|+++
T Consensus       247 ~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~-~~~~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          247 CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNR-APQPDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCS-CCCTTSCCCCSCEECSSTTTS
T ss_pred             ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCC-CchhhhCCCccEEECcCCCCC
Confidence            3   35555555555555 3343332  455555555555553 222111123555555555554

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.89  E-value=2.4e-22  Score=207.26  Aligned_cols=177  Identities=27%  Similarity=0.322  Sum_probs=126.7

Q ss_pred             EEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccC
Q 042123            8 INISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMS   87 (849)
Q Consensus         8 ~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~   87 (849)
                      +.++++..++......  +  .+++++|+|++|++.++.+..|.++++|++|+|++|+|++                   
T Consensus        17 ~~l~~~~~~l~~~p~~--~--~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-------------------   73 (251)
T 3m19_A           17 KEVDCQGKSLDSVPSG--I--PADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-------------------   73 (251)
T ss_dssp             TEEECTTCCCSSCCSC--C--CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC-------------------
T ss_pred             eEEecCCCCccccCCC--C--CCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc-------------------
Confidence            3577888887654332  2  2689999999999999999999999999999999999873                   


Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  167 (849)
                                 ..+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus        74 -----------~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  142 (251)
T 3m19_A           74 -----------LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQ  142 (251)
T ss_dssp             -----------CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             -----------cCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCc
Confidence                       233445556666666666666665555666666666666666666665555556666777777777777


Q ss_pred             ccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCcc
Q 042123          168 LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      |+++.+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus       143 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c  193 (251)
T 3m19_A          143 LQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC  193 (251)
T ss_dssp             CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred             CCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence            776666667777777777777777776666667777777777777777764

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.89  E-value=5.6e-25  Score=240.21  Aligned_cols=262  Identities=20%  Similarity=0.172  Sum_probs=146.1

Q ss_pred             EEEccCCcccCCCCCCCcCCCCCceeeccCcccccccc----cccCCCC-CCCEEEcCCCcccccCCcCCCCC-----CC
Q 042123          112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSIL----SSLGKLK-SLFDLQLNDNQLIGYIPRPFSNL-----TS  181 (849)
Q Consensus       112 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~  181 (849)
                      ++++++|++++.+|..+...++|++|+|++|.+++..+    ..|.+++ +|++|+|++|++.+..+..|..+     ++
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            35667777776666555555557777777777765554    5566666 67777777776666555555553     66


Q ss_pred             CCEEEccCCCCcCcCccccc----CC-CCCCEEeccCCcCccCCCcCccC-----ccccchhhhccccccCCCCcchhhh
Q 042123          182 VSTLRLSRNDLFGSIPDEIG----KM-RSLSVLDLNQNQFKGVLPPSISN-----LTNLKELALLYNHLSGSIPPSLGNL  251 (849)
Q Consensus       182 L~~L~Ls~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~p~~~~~~  251 (849)
                      |++|+|++|++++..+..+.    .+ ++|++|+|++|+++...+..+..     .++|++|+|++|.+++..+..    
T Consensus        82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~----  157 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDE----  157 (362)
T ss_dssp             CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHH----
T ss_pred             ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHH----
Confidence            66666666666655444333    23 56666666666666443333222     134555555555444211111    


Q ss_pred             hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcc-cccEEEccCccccCchhhh----hCCC-CCC
Q 042123          252 ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCT-SLIRVRLNGNNLTGNISEA----LGIY-PNL  325 (849)
Q Consensus       252 ~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~L~~n~l~~~~~~~----~~~l-~~L  325 (849)
                                                             ++..+..++ +|++|+|++|++++..+..    +... ++|
T Consensus       158 ---------------------------------------l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L  198 (362)
T 3goz_A          158 ---------------------------------------LIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV  198 (362)
T ss_dssp             ---------------------------------------HHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             ---------------------------------------HHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCC
Confidence                                                   111122222 5555555555555444332    2233 366


Q ss_pred             CEEeccCccccCc----ccccCCC-CCCCcEEeccCCccccCCC----CCcccccccccccccccccccc-------Cch
Q 042123          326 TFIDLSRNNFYGE----ISSNWGK-FPKLGTLNVSMNNITGGLP----REIGNSSQLQAFDLSLNHIVGE-------IPK  389 (849)
Q Consensus       326 ~~L~Ls~N~l~~~----~~~~~~~-l~~L~~L~Ls~N~i~~~~p----~~~~~l~~L~~L~L~~N~i~~~-------~~~  389 (849)
                      +.|||++|.+.+.    ++..+.. .++|++|+|++|.+++..+    ..+..+++|+.|+|++|.+...       ++.
T Consensus       199 ~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~  278 (362)
T 3goz_A          199 TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGA  278 (362)
T ss_dssp             CEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHT
T ss_pred             CEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHH
Confidence            6666666666542    2333333 2366666666666664333    2345556677777777774433       234


Q ss_pred             hhcCCCCCcEEEccCccccccCccccc
Q 042123          390 ELGKLNPLTKLILRGNQITGRLPKEIG  416 (849)
Q Consensus       390 ~~~~l~~L~~L~L~~N~l~~~~p~~~~  416 (849)
                      .+..+++|+.|++++|++....+..+.
T Consensus       279 ~~~~l~~L~~LdL~~N~l~~~~~~~~~  305 (362)
T 3goz_A          279 AFPNIQKIILVDKNGKEIHPSHSIPIS  305 (362)
T ss_dssp             TSTTCCEEEEECTTSCBCCGGGCHHHH
T ss_pred             HhccCCceEEEecCCCcCCCcchHHHH
Confidence            567788889999999988765554443

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=9.8e-24  Score=225.15  Aligned_cols=227  Identities=19%  Similarity=0.247  Sum_probs=132.9

Q ss_pred             CCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccC--CCCCCCCEEEccCCcccCCCC----CCC
Q 042123           55 NLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI--GNLKFLSQLDLTNNKFSGPIP----LSF  128 (849)
Q Consensus        55 ~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~Ls~n~i~~~~~----~~~  128 (849)
                      .++.|.++++.++......+..   +..+++|++|++++|.+.+..|..+  .++++|++|+|++|++++..+    ..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~---~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~  141 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALR---VLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQ  141 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHH---HHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHT
T ss_pred             ceeEEEEeCCcCCHHHHHHHHH---hcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHh
Confidence            4666777776665332222111   1123456666666666666666665  666666666666666665333    233


Q ss_pred             cCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccc---cC-CcCCCCCCCCCEEEccCCCCcCcCcc----cc
Q 042123          129 DNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIG---YI-PRPFSNLTSVSTLRLSRNDLFGSIPD----EI  200 (849)
Q Consensus       129 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~  200 (849)
                      ..+++|++|+|++|++++..+..|.++++|++|+|++|++.+   +. +..+..+++|++|+|++|+++ .++.    .+
T Consensus       142 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~  220 (310)
T 4glp_A          142 WLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALA  220 (310)
T ss_dssp             TBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHH
T ss_pred             hhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHH
Confidence            456666666666666665555666666666666666666543   21 222355666666666666665 2222    23


Q ss_pred             cCCCCCCEEeccCCcCccCCCcCccCc---cccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCc
Q 042123          201 GKMRSLSVLDLNQNQFKGVLPPSISNL---TNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGAL  277 (849)
Q Consensus       201 ~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L  277 (849)
                      ..+++|++|+|++|++++..|..+..+   ++|++|+|++|+++ .+|                       ..+.  ++|
T Consensus       221 ~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp-----------------------~~~~--~~L  274 (310)
T 4glp_A          221 AAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVP-----------------------KGLP--AKL  274 (310)
T ss_dssp             HHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCC-----------------------SCCC--SCC
T ss_pred             hcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chh-----------------------hhhc--CCC
Confidence            455666666666666665555555544   45666666666555 333                       3332  567


Q ss_pred             ceeeecccccccccCCCCCCcccccEEEccCccccC
Q 042123          278 EIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG  313 (849)
Q Consensus       278 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~  313 (849)
                      +.|++++|++++. |. +..+++|+.|++++|+++.
T Consensus       275 ~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          275 RVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             SCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred             CEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence            7777777777753 33 5677888888888888763

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.89  E-value=1.2e-22  Score=220.50  Aligned_cols=216  Identities=17%  Similarity=0.106  Sum_probs=153.0

Q ss_pred             EecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCe-
Q 042123           10 ISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR-   88 (849)
Q Consensus        10 ~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~-   88 (849)
                      +++++.++.....+  +  .+++++|+|++|+|+++.+.+|.++++|++|+|++|++.+     ..+..+|.+++++.. 
T Consensus        14 v~C~~~~Lt~iP~~--l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~-----~i~~~~f~~L~~l~~~   84 (350)
T 4ay9_X           14 FLCQESKVTEIPSD--L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-----VIEADVFSNLPKLHEI   84 (350)
T ss_dssp             EEEESTTCCSCCTT--C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCC-----EECTTSBCSCTTCCEE
T ss_pred             EEecCCCCCccCcC--c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCC-----ccChhHhhcchhhhhh
Confidence            45666666543222  2  3578888888888888888888888888888888888753     234456677777664 


Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccC-cccccccccccCCCC-CCCEEEcCCC
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG-NLLSGSILSSLGKLK-SLFDLQLNDN  166 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N  166 (849)
                      +.++.|+|+.+.|..|.++++|++|++++|+|+.+.+..+....++..|++.+ |++..+.+..|.++. .++.|+|++|
T Consensus        85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N  164 (350)
T 4ay9_X           85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN  164 (350)
T ss_dssp             EEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred             hcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence            55667888877777888888888888888888877777777777777887755 567666666676664 5777888888


Q ss_pred             cccccCCcCCCCCCCCCEEEccC-CCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhh
Q 042123          167 QLIGYIPRPFSNLTSVSTLRLSR-NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELAL  235 (849)
Q Consensus       167 ~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  235 (849)
                      +|+.+.+..|. ..+|++|++++ |.++...++.|.++++|++|+|++|+|+.+.+..|.++++|+.+++
T Consensus       165 ~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~  233 (350)
T 4ay9_X          165 GIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST  233 (350)
T ss_dssp             CCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC
T ss_pred             cccCCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC
Confidence            88777666664 35677777764 5666444456777788888888888877665555666666655443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=5.1e-23  Score=219.01  Aligned_cols=195  Identities=25%  Similarity=0.325  Sum_probs=169.1

Q ss_pred             cCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccC
Q 042123           25 SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI  104 (849)
Q Consensus        25 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  104 (849)
                      .++.+++|++|++++|++..+.  .+..+++|++|+|++|++++..     .   +..+++|+.|+|++|.+++.  ..+
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~~~-----~---~~~l~~L~~L~L~~n~l~~~--~~~  103 (308)
T 1h6u_A           36 TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDLA-----P---LKNLTKITELELSGNPLKNV--SAI  103 (308)
T ss_dssp             CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG-----G---GTTCCSCCEEECCSCCCSCC--GGG
T ss_pred             cHHHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCCCh-----h---HccCCCCCEEEccCCcCCCc--hhh
Confidence            3556899999999999997653  5899999999999999997421     1   67899999999999999864  478


Q ss_pred             CCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCE
Q 042123          105 GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVST  184 (849)
Q Consensus       105 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  184 (849)
                      .++++|++|++++|+++++.  .|..+++|++|++++|.+++..+  +..+++|+.|+|++|+++++.+  +..+++|++
T Consensus       104 ~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~  177 (308)
T 1h6u_A          104 AGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT  177 (308)
T ss_dssp             TTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             cCCCCCCEEECCCCCCCCch--hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCE
Confidence            99999999999999999754  38999999999999999986544  8899999999999999998654  899999999


Q ss_pred             EEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccccc
Q 042123          185 LRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       185 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      |+|++|++++..+  +..+++|++|++++|++++..  .+..+++|++|+|++|+++
T Consensus       178 L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~  230 (308)
T 1h6u_A          178 LKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTIT  230 (308)
T ss_dssp             EECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEE
T ss_pred             EECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeee
Confidence            9999999985433  889999999999999999654  3899999999999999997

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.88  E-value=8.2e-23  Score=221.85  Aligned_cols=150  Identities=16%  Similarity=0.131  Sum_probs=77.7

Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccc-cccccCCCCCCCE-EEcCCC
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS-ILSSLGKLKSLFD-LQLNDN  166 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~-L~L~~N  166 (849)
                      ++.+++.++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+. .+.+|.++++|++ +.+++|
T Consensus        14 v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N   90 (350)
T 4ay9_X           14 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN   90 (350)
T ss_dssp             EEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEET
T ss_pred             EEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCC
Confidence            444444444 3343331  3555555666655555555555555666666665555332 2344555555443 444445


Q ss_pred             cccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccC-CcCccCCCcCccCcc-ccchhhhcccccc
Q 042123          167 QLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQ-NQFKGVLPPSISNLT-NLKELALLYNHLS  241 (849)
Q Consensus       167 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~-~L~~L~L~~N~l~  241 (849)
                      ++..+.|++|..+++|++|++++|++....+..+....++..|++.+ |++..+.+..|..+. .++.|+|++|+++
T Consensus        91 ~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           91 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             TCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             cccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            55555555566666666666666665544444444555555555543 445544444454443 3455555555554

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.87  E-value=1.2e-22  Score=216.07  Aligned_cols=125  Identities=26%  Similarity=0.356  Sum_probs=63.5

Q ss_pred             CCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEE
Q 042123          106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  185 (849)
                      ++++|++|++++|+++.+ + .+..+++|++|+|++|.+++..+  +.++++|++|+|++|++.++  ..+..+++|++|
T Consensus        39 ~l~~L~~L~l~~~~i~~l-~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L  112 (308)
T 1h6u_A           39 DLDGITTLSAFGTGVTTI-E-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTL  112 (308)
T ss_dssp             HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCEE
T ss_pred             HcCCcCEEEeeCCCccCc-h-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCEE
Confidence            445555555555555532 2 35555555555555555553322  55555555555555555543  245555555555


Q ss_pred             EccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccc
Q 042123          186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL  240 (849)
Q Consensus       186 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  240 (849)
                      +|++|++++ ++. +..+++|++|++++|++++..+  +..+++|++|+|++|.+
T Consensus       113 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l  163 (308)
T 1h6u_A          113 DLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQV  163 (308)
T ss_dssp             ECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             ECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcC
Confidence            555555553 222 5555555555555555553321  44444444444444433

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=8.3e-24  Score=228.79  Aligned_cols=149  Identities=15%  Similarity=0.185  Sum_probs=85.6

Q ss_pred             cCeEeccCCcccccCCccCCCC--CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccc-cccccCCCCCCCEEE
Q 042123           86 MSRLVINDNSLSGFIPPHIGNL--KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS-ILSSLGKLKSLFDLQ  162 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~  162 (849)
                      ++.+++++|.+.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. .+..+..+++|++|+
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~  124 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS  124 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence            445555555543   2334444  5666666666666655444 34566677777777666544 555566666666666


Q ss_pred             cCCCcccccCCcCCCCCCCCCEEEccCC-CCcCc-CcccccCCCCCCEEeccCC-cCccC-CCcCccCcc-ccchhhhcc
Q 042123          163 LNDNQLIGYIPRPFSNLTSVSTLRLSRN-DLFGS-IPDEIGKMRSLSVLDLNQN-QFKGV-LPPSISNLT-NLKELALLY  237 (849)
Q Consensus       163 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~-~~~~~~~l~-~L~~L~L~~  237 (849)
                      |++|.+.+..+..|..+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+..++ +|++|++++
T Consensus       125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~  204 (336)
T 2ast_B          125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG  204 (336)
T ss_dssp             CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred             CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence            6666666555556666666666666666 45432 4444556666666666666 55532 233344444 444444444


Q ss_pred             c
Q 042123          238 N  238 (849)
Q Consensus       238 N  238 (849)
                      |
T Consensus       205 ~  205 (336)
T 2ast_B          205 Y  205 (336)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.87  E-value=5.6e-25  Score=242.73  Aligned_cols=283  Identities=19%  Similarity=0.215  Sum_probs=169.8

Q ss_pred             CCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccc----cccCCCCCCCEEEcCCCcccc---cCCcCC------
Q 042123          110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSIL----SSLGKLKSLFDLQLNDNQLIG---YIPRPF------  176 (849)
Q Consensus       110 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~---~~~~~~------  176 (849)
                      |+...++...+. .++..+..+++|++|+|++|.++...+    ..|..+++|++|+|++|.+..   ..|..+      
T Consensus        11 L~~~~l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~   89 (386)
T 2ca6_A           11 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA   89 (386)
T ss_dssp             CEESSCCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHH
T ss_pred             cccCCCCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHH
Confidence            333344444444 445566677778888888887765433    346677777777777754432   223222      


Q ss_pred             -CCCCCCCEEEccCCCCcC----cCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh
Q 042123          177 -SNLTSVSTLRLSRNDLFG----SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL  251 (849)
Q Consensus       177 -~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  251 (849)
                       ..+++|++|+|++|++..    .+|..+..+++|++|+|++|.++...+..+...  |..+  ..|.+.          
T Consensus        90 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~--l~~l--~~~~~~----------  155 (386)
T 2ca6_A           90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA--LQEL--AVNKKA----------  155 (386)
T ss_dssp             HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH--HHHH--HHHHHH----------
T ss_pred             HhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH--HHHH--hhhhhc----------
Confidence             566667777777776664    245556666666666666666653222222211  0000  011110          


Q ss_pred             hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccc-cccC---CCCCCcccccEEEccCccccC-----chhhhhCCC
Q 042123          252 ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQ-GTIP---TSLRNCTSLIRVRLNGNNLTG-----NISEALGIY  322 (849)
Q Consensus       252 ~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~-~~~~---~~~~~l~~L~~L~L~~n~l~~-----~~~~~~~~l  322 (849)
                              +            ..++|+.|++++|+++ ..++   ..+..+++|+.|++++|+++.     ..+..+..+
T Consensus       156 --------~------------~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~  215 (386)
T 2ca6_A          156 --------K------------NAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC  215 (386)
T ss_dssp             --------H------------TCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGC
T ss_pred             --------c------------cCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcC
Confidence                    0            0035556666666654 2223   345566677777777777762     233366777


Q ss_pred             CCCCEEeccCcccc----CcccccCCCCCCCcEEeccCCccccC----CCCCc--cccccccccccccccccc----cCc
Q 042123          323 PNLTFIDLSRNNFY----GEISSNWGKFPKLGTLNVSMNNITGG----LPREI--GNSSQLQAFDLSLNHIVG----EIP  388 (849)
Q Consensus       323 ~~L~~L~Ls~N~l~----~~~~~~~~~l~~L~~L~Ls~N~i~~~----~p~~~--~~l~~L~~L~L~~N~i~~----~~~  388 (849)
                      ++|+.|+|++|.++    ..++..+..+++|++|+|++|.+++.    ++..+  +.+++|+.|+|++|.+++    .+|
T Consensus       216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~  295 (386)
T 2ca6_A          216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK  295 (386)
T ss_dssp             TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred             CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence            77778888777775    45566677777888888888877754    34444  337788888888888886    367


Q ss_pred             hhh-cCCCCCcEEEccCccccccCc--cccc-ccccccccccc
Q 042123          389 KEL-GKLNPLTKLILRGNQITGRLP--KEIG-SLTKLEYLDFS  427 (849)
Q Consensus       389 ~~~-~~l~~L~~L~L~~N~l~~~~p--~~~~-~l~~L~~L~l~  427 (849)
                      ..+ .++++|++|+|++|++++..+  ..+. .+++++.+++.
T Consensus       296 ~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~  338 (386)
T 2ca6_A          296 TVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD  338 (386)
T ss_dssp             HHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEEC
T ss_pred             HHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchhh
Confidence            766 668999999999999987664  3332 34555544443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.86  E-value=1.1e-23  Score=227.86  Aligned_cols=198  Identities=19%  Similarity=0.242  Sum_probs=110.2

Q ss_pred             CCCEEEccCCCCcCcCcccccCC--CCCCEEeccCCcCccCCCcCccCccccchhhhccccccCC-CCcchhhhhhhhhh
Q 042123          181 SVSTLRLSRNDLFGSIPDEIGKM--RSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS-IPPSLGNLILRQLL  257 (849)
Q Consensus       181 ~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~~~L~~L~  257 (849)
                      .++.|++++|.+.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|            
T Consensus        48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~------------  111 (336)
T 2ast_B           48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLH------------  111 (336)
T ss_dssp             TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHH------------
T ss_pred             hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHH------------
Confidence            4678888888775   4556666  7888888888888765544 45677777777777766421 11            


Q ss_pred             ccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCc-cccCc-hhhhhCCCCCCCEEeccCc-c
Q 042123          258 LSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGN-NLTGN-ISEALGIYPNLTFIDLSRN-N  334 (849)
Q Consensus       258 L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~-~~~~~~~l~~L~~L~Ls~N-~  334 (849)
                                 ..+..+++|+.|++++|.+++..+..++.+++|++|++++| .+++. .+..+..+++|++|+|++| .
T Consensus       112 -----------~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~  180 (336)
T 2ast_B          112 -----------GILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFD  180 (336)
T ss_dssp             -----------HHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTT
T ss_pred             -----------HHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCC
Confidence                       12233345555555555555445555555555555555555 44431 3444555555555555555 5


Q ss_pred             ccCc-ccccCCCCC-CCcEEeccCC--ccc-cCCCCCcccccccccccccccc-ccccCchhhcCCCCCcEEEccCc
Q 042123          335 FYGE-ISSNWGKFP-KLGTLNVSMN--NIT-GGLPREIGNSSQLQAFDLSLNH-IVGEIPKELGKLNPLTKLILRGN  405 (849)
Q Consensus       335 l~~~-~~~~~~~l~-~L~~L~Ls~N--~i~-~~~p~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N  405 (849)
                      +++. ++..+..++ +|++|++++|  .++ +.+|..+..+++|+.|++++|. +++..+..+..+++|++|++++|
T Consensus       181 l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~  257 (336)
T 2ast_B          181 FTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC  257 (336)
T ss_dssp             CCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred             cChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence            5432 344444555 5555555555  232 2233344445555555555555 44444445555555555555555

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.86  E-value=3.5e-24  Score=236.36  Aligned_cols=150  Identities=15%  Similarity=0.134  Sum_probs=111.7

Q ss_pred             ccCCcccccCCccCCCCCCCCEEEccCCcccCCC----CCCCcCCCCCceeeccCccc---cccccccc-------CCCC
Q 042123           91 INDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPI----PLSFDNLSNLIFLYLYGNLL---SGSILSSL-------GKLK  156 (849)
Q Consensus        91 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~----~~~~~~l~~L~~L~L~~N~l---~~~~~~~~-------~~l~  156 (849)
                      +....+. .++..+..+++|++|+|++|+|+...    +..|..+++|++|+|++|.+   ++..|..+       ..++
T Consensus        16 l~~~~~~-~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~   94 (386)
T 2ca6_A           16 ITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCP   94 (386)
T ss_dssp             CCSHHHH-TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCT
T ss_pred             CCHHHHH-HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCC
Confidence            3333333 46677888999999999999999653    34588999999999999754   44445444       7899


Q ss_pred             CCCEEEcCCCcccc----cCCcCCCCCCCCCEEEccCCCCcCcCccccc----CC---------CCCCEEeccCCcCcc-
Q 042123          157 SLFDLQLNDNQLIG----YIPRPFSNLTSVSTLRLSRNDLFGSIPDEIG----KM---------RSLSVLDLNQNQFKG-  218 (849)
Q Consensus       157 ~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l---------~~L~~L~L~~N~l~~-  218 (849)
                      +|++|+|++|.+..    ..+..+..+++|++|+|++|.++...+..+.    .+         ++|++|+|++|+++. 
T Consensus        95 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~  174 (386)
T 2ca6_A           95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENG  174 (386)
T ss_dssp             TCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGG
T ss_pred             cccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcH
Confidence            99999999999987    3566788999999999999999754444443    33         889999999998872 


Q ss_pred             CCC---cCccCccccchhhhcccccc
Q 042123          219 VLP---PSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       219 ~~~---~~~~~l~~L~~L~L~~N~l~  241 (849)
                      ..+   ..+..+++|++|+|++|.++
T Consensus       175 ~~~~l~~~l~~~~~L~~L~L~~n~l~  200 (386)
T 2ca6_A          175 SMKEWAKTFQSHRLLHTVKMVQNGIR  200 (386)
T ss_dssp             GHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred             HHHHHHHHHHhCCCcCEEECcCCCCC
Confidence            222   24555666666666666554

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=3.6e-21  Score=192.43  Aligned_cols=178  Identities=26%  Similarity=0.258  Sum_probs=130.3

Q ss_pred             CEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCce
Q 042123           57 RYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIF  136 (849)
Q Consensus        57 ~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~  136 (849)
                      +.++++++.++...         .+-.++|++|++++|.+++..+..|.++++|++|++++|+++++.+..|..+++|++
T Consensus        10 ~~v~c~~~~l~~~p---------~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~   80 (208)
T 2o6s_A           10 TTVECYSQGRTSVP---------TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY   80 (208)
T ss_dssp             TEEECCSSCCSSCC---------SCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             CEEEecCCCccCCC---------CCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCE
Confidence            56777877775311         112457778888888887766667777888888888888888776667777888888


Q ss_pred             eeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcC
Q 042123          137 LYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQF  216 (849)
Q Consensus       137 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  216 (849)
                      |+|++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+
T Consensus        81 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  160 (208)
T 2o6s_A           81 LNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  160 (208)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred             EECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence            88888888766666677788888888888888777777777788888888888887766666677778888888888866


Q ss_pred             ccCCCcCccCccccchhhhccccccCCCCcchhh
Q 042123          217 KGVLPPSISNLTNLKELALLYNHLSGSIPPSLGN  250 (849)
Q Consensus       217 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  250 (849)
                      .+       .+++|++|+++.|.+++.+|..++.
T Consensus       161 ~~-------~~~~l~~L~~~~n~~~g~ip~~~~~  187 (208)
T 2o6s_A          161 DC-------TCPGIRYLSEWINKHSGVVRNSAGS  187 (208)
T ss_dssp             CC-------CTTTTHHHHHHHHHCTTTBBCTTSS
T ss_pred             ec-------CCCCHHHHHHHHHhCCceeeccCcc
Confidence            53       3456777777777777777765553

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.86  E-value=1e-20  Score=189.03  Aligned_cols=180  Identities=24%  Similarity=0.227  Sum_probs=96.8

Q ss_pred             CEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCE
Q 042123           33 AYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQ  112 (849)
Q Consensus        33 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  112 (849)
                      +.+++++++++.++.. +  .++|++|+|++|++++      .....|+.+++|++|++++|.++++.+..|.++++|++
T Consensus        10 ~~v~c~~~~l~~~p~~-~--~~~l~~L~l~~n~l~~------~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~   80 (208)
T 2o6s_A           10 TTVECYSQGRTSVPTG-I--PAQTTYLDLETNSLKS------LPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY   80 (208)
T ss_dssp             TEEECCSSCCSSCCSC-C--CTTCSEEECCSSCCCC------CCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             CEEEecCCCccCCCCC-C--CCCCcEEEcCCCccCc------CChhhhcccccCcEEECCCCccCccChhhcCCCCCcCE
Confidence            3455555555433321 1  2355556666555542      12223445555566666666555544445555555666


Q ss_pred             EEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCC
Q 042123          113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL  192 (849)
Q Consensus       113 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  192 (849)
                      |+|++|+|+++.+..|.++++|++|+|++|++++..+..|.++++|+.|+|++|+++++.+..|..+++|++|+|++|.+
T Consensus        81 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~  160 (208)
T 2o6s_A           81 LNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW  160 (208)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred             EECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence            66666655555555555555566666666655554444555555566666666655555555555555566666655554


Q ss_pred             cCcCcccccCCCCCCEEeccCCcCccCCCcCccCcc
Q 042123          193 FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLT  228 (849)
Q Consensus       193 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  228 (849)
                      .+       .+++|+.|+++.|++++.+|..++.++
T Consensus       161 ~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~  189 (208)
T 2o6s_A          161 DC-------TCPGIRYLSEWINKHSGVVRNSAGSVA  189 (208)
T ss_dssp             CC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred             ec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence            32       234555555555555555555555443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.85  E-value=1.3e-21  Score=223.37  Aligned_cols=177  Identities=14%  Similarity=0.186  Sum_probs=132.0

Q ss_pred             CcCceecCCccceEEEEEecCCcEEEEEEecccCCCCch----hhHHHHHHHHHH-----------hhceeecCCeeEEE
Q 042123          591 DAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT----VDQKEFLTEVEA-----------FYGFCSHARHSFLL  655 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~ei~~-----------~~~~~~~~~~~~lV  655 (849)
                      ...+.||+|+||.||+|+. .++.+|+|+..........    ...+.+.+|+..           +..++......++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3466899999999999965 4788999986543221111    113345666553           24455566778999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++..           +..++.|++.||+|||++   +|+||||||+||+++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999864           568999999999999999   9999999999999998  999999999998754


Q ss_pred             CCCC-------eeeccCCccccccccccC--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 042123          736 DSSN-------WTEFAGTCGYIAPELAYT--MKITEKCDVYSFGVLMWEVIKGKHPRD  784 (849)
Q Consensus       736 ~~~~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~SlGvil~el~tg~~Pf~  784 (849)
                      ....       .....||+.|+|||++..  ..|+...|+||..+-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            3221       135679999999999976  567888999999999999888777763

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.83  E-value=3e-20  Score=211.86  Aligned_cols=187  Identities=24%  Similarity=0.249  Sum_probs=150.8

Q ss_pred             CCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCC
Q 042123           31 HLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFL  110 (849)
Q Consensus        31 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  110 (849)
                      +|++|+|++|+|++ +|..+  .++|++|+|++|+|+. ++         ..+++|+.|+|++|.|++ +|. +.+  +|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~~-ip---------~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L  122 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALIS-LP---------ELPASLEYLDACDNRLST-LPE-LPA--SL  122 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCSC-CC---------CCCTTCCEEECCSSCCSC-CCC-CCT--TC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCcc-cc---------cccCCCCEEEccCCCCCC-cch-hhc--CC
Confidence            89999999999987 44444  3789999999999973 21         237899999999999997 565 665  89


Q ss_pred             CEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCC
Q 042123          111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN  190 (849)
Q Consensus       111 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  190 (849)
                      ++|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|+++++  |.  ++|++|+|++|
T Consensus       123 ~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~--l~--~~L~~L~Ls~N  190 (571)
T 3cvr_A          123 KHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE--LP--ESLEALDVSTN  190 (571)
T ss_dssp             CEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC--CC--TTCCEEECCSS
T ss_pred             CEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch--hh--CCCCEEECcCC
Confidence            999999999997 444   67899999999999986 444   57899999999999998544  65  89999999999


Q ss_pred             CCcCcCcccccCCCCC-------CEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh
Q 042123          191 DLFGSIPDEIGKMRSL-------SVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL  251 (849)
Q Consensus       191 ~l~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  251 (849)
                      +|+ .+|. |..  +|       +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus       191 ~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  253 (571)
T 3cvr_A          191 LLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ  253 (571)
T ss_dssp             CCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred             CCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence            998 6666 654  77       99999999998 467778889999999999999987777666554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.83  E-value=4.1e-20  Score=186.02  Aligned_cols=134  Identities=22%  Similarity=0.260  Sum_probs=68.5

Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      ++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+.+++..|.++++|++|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            34455555555555444444555555555555555554444445555555555555555555544444555555555555


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccccc
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      ++|+|++..|..|..+++|++|+|++|+|+++.+..|..+++|++|+|++|++.
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            555555444445555555555555555555444444555555555555555554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.82  E-value=4.3e-20  Score=185.89  Aligned_cols=152  Identities=24%  Similarity=0.294  Sum_probs=78.3

Q ss_pred             CEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCC-ccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCc
Q 042123           57 RYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIP-PHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLI  135 (849)
Q Consensus        57 ~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~  135 (849)
                      +.+++++|.++. +|..+        ...++.|+|++|.|++..+ ..|.++++|++|+|++|+|+++.+.+|.++++|+
T Consensus        14 ~~l~~s~n~l~~-iP~~~--------~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~   84 (220)
T 2v70_A           14 TTVDCSNQKLNK-IPEHI--------PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVN   84 (220)
T ss_dssp             TEEECCSSCCSS-CCSCC--------CTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             CEeEeCCCCccc-CccCC--------CCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCC
Confidence            466666666652 11111        1234455555555554433 3345555555555555555555455555555555


Q ss_pred             eeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCc
Q 042123          136 FLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQ  215 (849)
Q Consensus       136 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  215 (849)
                      +|+|++|+|++..+..|.++++|++|+|++|+|.++.|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.
T Consensus        85 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  164 (220)
T 2v70_A           85 EILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANP  164 (220)
T ss_dssp             EEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             EEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcC
Confidence            55555555554444445555555555555555555555555555555555555555554445555555555555555555


Q ss_pred             Cc
Q 042123          216 FK  217 (849)
Q Consensus       216 l~  217 (849)
                      +.
T Consensus       165 l~  166 (220)
T 2v70_A          165 FN  166 (220)
T ss_dssp             EE
T ss_pred             Cc
Confidence            44

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.82  E-value=3.6e-20  Score=201.78  Aligned_cols=158  Identities=25%  Similarity=0.259  Sum_probs=114.5

Q ss_pred             ccCeEeccCCcccccCCccCC-CCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEc
Q 042123           85 YMSRLVINDNSLSGFIPPHIG-NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL  163 (849)
Q Consensus        85 ~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  163 (849)
                      .++.|+|++|.|+++.+..|. ++++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+...+..|.++++|+.|+|
T Consensus        40 ~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  119 (361)
T 2xot_A           40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLL  119 (361)
T ss_dssp             TCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEEC
Confidence            355566666666656666666 7777777777777777777777777777777777777777666667777788888888


Q ss_pred             CCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccc---cCCCCCCEEeccCCcCccCCCcCccCccc--cchhhhccc
Q 042123          164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEI---GKMRSLSVLDLNQNQFKGVLPPSISNLTN--LKELALLYN  238 (849)
Q Consensus       164 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~~~~~~~~~l~~--L~~L~L~~N  238 (849)
                      ++|+|..+.+..|..+++|++|+|++|+|+...+..|   ..+++|+.|+|++|+|+.+.+..|..++.  |+.|+|++|
T Consensus       120 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N  199 (361)
T 2xot_A          120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN  199 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSS
T ss_pred             CCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCC
Confidence            8888877777778888888888888888875444444   45788888888888888665566777766  377788888


Q ss_pred             cccC
Q 042123          239 HLSG  242 (849)
Q Consensus       239 ~l~~  242 (849)
                      ++..
T Consensus       200 ~~~C  203 (361)
T 2xot_A          200 PLEC  203 (361)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            7763

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=2.5e-20  Score=196.29  Aligned_cols=172  Identities=24%  Similarity=0.362  Sum_probs=91.4

Q ss_pred             CCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCC
Q 042123           26 FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG  105 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  105 (849)
                      +..+++|++|++++|++.++.  .+..+++|++|+|++|++++..     .   +..+++|+.|+|++|.+++.  ..+.
T Consensus        42 ~~~l~~L~~L~l~~~~i~~~~--~~~~l~~L~~L~L~~n~l~~~~-----~---l~~l~~L~~L~l~~n~l~~~--~~l~  109 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK-----P---LANLKNLGWLFLDENKVKDL--SSLK  109 (291)
T ss_dssp             HHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG-----G---GTTCTTCCEEECCSSCCCCG--GGGT
T ss_pred             hhhcCcccEEEccCCCcccCh--hHhcCCCCCEEEccCCccCCCc-----c---cccCCCCCEEECCCCcCCCC--hhhc
Confidence            334566666666666665442  2566666666666666665311     1   44555555555555555532  2355


Q ss_pred             CCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEE
Q 042123          106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  185 (849)
                      ++++|++|+|++|+|+++  ..+..+++|++|++++|++++.  ..+..+++|+.|+|++|++.++.+  +..+++|++|
T Consensus       110 ~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L  183 (291)
T 1h6t_A          110 DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL  183 (291)
T ss_dssp             TCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             cCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEE
Confidence            555555555555555543  2455555555555555555532  345555555555555555555433  5555555555


Q ss_pred             EccCCCCcCcCcccccCCCCCCEEeccCCcCc
Q 042123          186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       186 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      +|++|+++. ++ .+..+++|+.|++++|++.
T Consensus       184 ~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          184 YLSKNHISD-LR-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             ECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEE
T ss_pred             ECCCCcCCC-Ch-hhccCCCCCEEECcCCccc
Confidence            555555542 22 2455555555555555554

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.82  E-value=6.3e-20  Score=209.23  Aligned_cols=189  Identities=25%  Similarity=0.355  Sum_probs=108.2

Q ss_pred             CCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhc
Q 042123          157 SLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALL  236 (849)
Q Consensus       157 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  236 (849)
                      +|+.|+|++|.++++++. +  .++|++|+|++|+|+ .+|   ..+++|++|+|++|+|++ +|. +..  +|++|+|+
T Consensus        60 ~L~~L~Ls~n~L~~lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls  128 (571)
T 3cvr_A           60 QFSELQLNRLNLSSLPDN-L--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD  128 (571)
T ss_dssp             TCSEEECCSSCCSCCCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred             CccEEEeCCCCCCccCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence            566666666666553322 2  245666666666665 344   234566666666666654 333 332  44444444


Q ss_pred             cccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchh
Q 042123          237 YNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNIS  316 (849)
Q Consensus       237 ~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  316 (849)
                      +|++++                                                +|.   .+++|+.|++++|+|++++.
T Consensus       129 ~N~l~~------------------------------------------------lp~---~l~~L~~L~Ls~N~l~~lp~  157 (571)
T 3cvr_A          129 NNQLTM------------------------------------------------LPE---LPALLEYINADNNQLTMLPE  157 (571)
T ss_dssp             SSCCSC------------------------------------------------CCC---CCTTCCEEECCSSCCSCCCC
T ss_pred             CCcCCC------------------------------------------------CCC---cCccccEEeCCCCccCcCCC
Confidence            444431                                                111   23344444444444443221


Q ss_pred             hhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccc-------cccccccccccccCch
Q 042123          317 EALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQL-------QAFDLSLNHIVGEIPK  389 (849)
Q Consensus       317 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L-------~~L~L~~N~i~~~~~~  389 (849)
                          .+++|+.|+|++|++++ +|. |.  ++|+.|+|++|.|+ .+|. |..  +|       +.|+|++|+|+ .+|.
T Consensus       158 ----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~  224 (571)
T 3cvr_A          158 ----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPE  224 (571)
T ss_dssp             ----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCG
T ss_pred             ----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCH
Confidence                34455566666666554 333 43  56666666666666 4454 443  55       88888888888 5777


Q ss_pred             hhcCCCCCcEEEccCccccccCccccccccc
Q 042123          390 ELGKLNPLTKLILRGNQITGRLPKEIGSLTK  420 (849)
Q Consensus       390 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~  420 (849)
                      .+..+++|+.|+|++|++++.+|..+..++.
T Consensus       225 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  255 (571)
T 3cvr_A          225 NILSLDPTCTIILEDNPLSSRIRESLSQQTA  255 (571)
T ss_dssp             GGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred             HHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence            7777999999999999999888887776654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.82  E-value=2.4e-20  Score=196.48  Aligned_cols=190  Identities=24%  Similarity=0.309  Sum_probs=155.5

Q ss_pred             CCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF  109 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  109 (849)
                      .++..+++..+.+.+..+  +..+++|++|++++|.+++.        ..+..+++|+.|+|++|.+++..+  +.++++
T Consensus        24 ~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~--------~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~   91 (291)
T 1h6t_A           24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--------QGIQYLPNVTKLFLNGNKLTDIKP--LANLKN   91 (291)
T ss_dssp             HHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC--------TTGGGCTTCCEEECCSSCCCCCGG--GTTCTT
T ss_pred             HHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC--------hhHhcCCCCCEEEccCCccCCCcc--cccCCC
Confidence            334556677777765544  56788999999999998632        235678999999999999986544  889999


Q ss_pred             CCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccC
Q 042123          110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSR  189 (849)
Q Consensus       110 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  189 (849)
                      |++|++++|+++++ + .+..+++|++|+|++|++++.  ..+..+++|+.|+|++|+++++  ..+..+++|++|+|++
T Consensus        92 L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~  165 (291)
T 1h6t_A           92 LGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLED  165 (291)
T ss_dssp             CCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCS
T ss_pred             CCEEECCCCcCCCC-h-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccC
Confidence            99999999999864 3 488899999999999999863  5688899999999999999886  6788999999999999


Q ss_pred             CCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccccc
Q 042123          190 NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       190 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      |++++..+  +..+++|++|++++|+++.+ + .+..+++|+.|++++|++.
T Consensus       166 N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~  213 (291)
T 1h6t_A          166 NQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL  213 (291)
T ss_dssp             SCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEE
T ss_pred             Cccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCccc
Confidence            99985544  88899999999999999864 3 4888999999999999887

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.81  E-value=8e-20  Score=199.07  Aligned_cols=177  Identities=21%  Similarity=0.220  Sum_probs=153.5

Q ss_pred             CEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCC-CccccCeEeccCCcccccCCccCCCCCCCC
Q 042123           33 AYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGG-NLRYMSRLVINDNSLSGFIPPHIGNLKFLS  111 (849)
Q Consensus        33 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~-~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  111 (849)
                      +.+++++|+++.+ |..+.  +.++.|+|++|+|++.      ....|. .+++|+.|+|++|.|+++.+..|.++++|+
T Consensus        21 ~~l~c~~~~l~~i-P~~~~--~~l~~L~Ls~N~l~~l------~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~   91 (361)
T 2xot_A           21 NILSCSKQQLPNV-PQSLP--SYTALLDLSHNNLSRL------RAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR   91 (361)
T ss_dssp             TEEECCSSCCSSC-CSSCC--TTCSEEECCSSCCCEE------CTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             CEEEeCCCCcCcc-CccCC--CCCCEEECCCCCCCcc------ChhhhhhcccccCEEECCCCcCCccChhhccCCCCCC
Confidence            6899999999754 44343  3589999999999742      234455 799999999999999988888999999999


Q ss_pred             EEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCC---CCCCCCCEEEcc
Q 042123          112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPF---SNLTSVSTLRLS  188 (849)
Q Consensus       112 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls  188 (849)
                      +|+|++|+|+++.+..|.++++|++|+|++|+|+...+..|.++++|+.|+|++|+|+.+++..|   ..+++|++|+|+
T Consensus        92 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~  171 (361)
T 2xot_A           92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLS  171 (361)
T ss_dssp             EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECC
T ss_pred             EEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECC
Confidence            99999999998888899999999999999999998889999999999999999999999888777   679999999999


Q ss_pred             CCCCcCcCcccccCCCC--CCEEeccCCcCcc
Q 042123          189 RNDLFGSIPDEIGKMRS--LSVLDLNQNQFKG  218 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~--L~~L~L~~N~l~~  218 (849)
                      +|+|+...+..|..++.  |+.|+|++|.+..
T Consensus       172 ~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C  203 (361)
T 2xot_A          172 SNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC  203 (361)
T ss_dssp             SSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred             CCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence            99999777778888887  4899999999973

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=5.1e-20  Score=212.52  Aligned_cols=188  Identities=24%  Similarity=0.310  Sum_probs=99.0

Q ss_pred             CCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCC
Q 042123           32 LAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLS  111 (849)
Q Consensus        32 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  111 (849)
                      +..++|+.+.+.++.+  +..+++|+.|+|++|.++..        ..+..+++|+.|+|++|.|.+..|  +.++++|+
T Consensus        23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l--------~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~   90 (605)
T 1m9s_A           23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--------QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLG   90 (605)
T ss_dssp             HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC--------TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCC
T ss_pred             HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCCC--------hHHccCCCCCEEEeeCCCCCCChh--hccCCCCC
Confidence            3344444444443333  34455555555555555421        123445555555555555554332  55555555


Q ss_pred             EEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCC
Q 042123          112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND  191 (849)
Q Consensus       112 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  191 (849)
                      .|+|++|+|+++ | .|..+++|+.|+|++|.|++.  ..+..+++|+.|+|++|++.++  ..|..+++|++|+|++|+
T Consensus        91 ~L~Ls~N~l~~l-~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~  164 (605)
T 1m9s_A           91 WLFLDENKIKDL-S-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQ  164 (605)
T ss_dssp             EEECCSSCCCCC-T-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSC
T ss_pred             EEECcCCCCCCC-h-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCc
Confidence            555555555532 2 455555555555555555532  3355555566666666655554  445555666666666666


Q ss_pred             CcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccccc
Q 042123          192 LFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       192 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      |.+..|  +..+++|+.|+|++|+|+++  +.+..+++|+.|+|++|++.
T Consensus       165 l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~  210 (605)
T 1m9s_A          165 ISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECL  210 (605)
T ss_dssp             CCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEE
T ss_pred             CCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCc
Confidence            554333  55556666666666665543  24555556666666666554

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.81  E-value=2e-19  Score=181.02  Aligned_cols=155  Identities=23%  Similarity=0.219  Sum_probs=138.1

Q ss_pred             CEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCE
Q 042123           33 AYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQ  112 (849)
Q Consensus        33 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  112 (849)
                      +.+++++|+++++ |..+.  +.+++|+|++|+|++.     .....|..+++|+.|+|++|.|+++.+..|.++++|++
T Consensus        14 ~~l~~s~n~l~~i-P~~~~--~~~~~L~L~~N~l~~~-----~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~   85 (220)
T 2v70_A           14 TTVDCSNQKLNKI-PEHIP--QYTAELRLNNNEFTVL-----EATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE   85 (220)
T ss_dssp             TEEECCSSCCSSC-CSCCC--TTCSEEECCSSCCCEE-----CCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             CEeEeCCCCcccC-ccCCC--CCCCEEEcCCCcCCcc-----CchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCE
Confidence            5899999999764 44443  3568999999999743     23445788999999999999999888889999999999


Q ss_pred             EEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCC
Q 042123          113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL  192 (849)
Q Consensus       113 L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  192 (849)
                      |+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|+++.|..|..+++|++|+|++|.+
T Consensus        86 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  165 (220)
T 2v70_A           86 ILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF  165 (220)
T ss_dssp             EECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred             EECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence            99999999998888999999999999999999988899999999999999999999999999999999999999999999


Q ss_pred             cCc
Q 042123          193 FGS  195 (849)
Q Consensus       193 ~~~  195 (849)
                      ...
T Consensus       166 ~c~  168 (220)
T 2v70_A          166 NCN  168 (220)
T ss_dssp             ECS
T ss_pred             cCC
Confidence            743

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=1.2e-19  Score=183.84  Aligned_cols=157  Identities=19%  Similarity=0.215  Sum_probs=121.5

Q ss_pred             ccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccccccccccccc
Q 042123          301 LIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSL  380 (849)
Q Consensus       301 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~  380 (849)
                      -+.++.+++.++.++..   ..++|++|+|++|++.+..+..|..+++|+.|+|++|.|+...+..|.++++|+.|+|++
T Consensus        21 ~~~v~c~~~~l~~ip~~---~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHASVPAG---IPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCSSCCSC---CCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcCccCCC---CCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            44566666666644332   226777788888887777777777788888888888888755556677788888888888


Q ss_pred             ccccccCchhhcCCCCCcEEEccCccccccCcccccccccccccccccCCCCChhhhcccccceeccCCcccccCCCccc
Q 042123          381 NHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCF  460 (849)
Q Consensus       381 N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~  460 (849)
                      |+|++..+..|..+++|++|+|++|+|+ .+                     |..+..+++|+.|+|++|+|++..+..|
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~l---------------------p~~~~~l~~L~~L~L~~N~l~~~~~~~~  155 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-EL---------------------PRGIERLTHLTHLALDQNQLKSIPHGAF  155 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SC---------------------CTTGGGCTTCSEEECCSSCCCCCCTTTT
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-cc---------------------CcccccCCCCCEEECCCCcCCccCHHHH
Confidence            8888776777788888888888888876 33                     4445566778888999999998888889


Q ss_pred             cccCCCcEEeccCCccccCCCC
Q 042123          461 EGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       461 ~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      ..+++|+.|++++|+|.|.|+.
T Consensus       156 ~~l~~L~~L~l~~N~~~c~c~~  177 (229)
T 3e6j_A          156 DRLSSLTHAYLFGNPWDCECRD  177 (229)
T ss_dssp             TTCTTCCEEECTTSCBCTTBGG
T ss_pred             hCCCCCCEEEeeCCCccCCcch
Confidence            9999999999999999999874

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=2.7e-19  Score=181.29  Aligned_cols=156  Identities=26%  Similarity=0.292  Sum_probs=124.8

Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCC
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND  165 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  165 (849)
                      -+.++++++.+. .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+...+..|.++++|+.|+|++
T Consensus        21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~   97 (229)
T 3e6j_A           21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT   97 (229)
T ss_dssp             TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence            455666666666 3444443  7788888888888887788888888888888888888766667788888888888888


Q ss_pred             CcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCC
Q 042123          166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP  245 (849)
Q Consensus       166 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  245 (849)
                      |+|+++.+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+.+.+..|..+++|+.|+|++|++.+..+
T Consensus        98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  176 (229)
T 3e6j_A           98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR  176 (229)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred             CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence            8888888888888888888888888888 677778888888888888888887777778888888888888888875543

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=3.6e-19  Score=179.17  Aligned_cols=135  Identities=27%  Similarity=0.347  Sum_probs=103.8

Q ss_pred             cccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEc
Q 042123           84 RYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL  163 (849)
Q Consensus        84 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  163 (849)
                      ++|+.|+|++|.|+++.+..|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+...+..|.++++|+.|+|
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L  111 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLL  111 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEEC
Confidence            34555555555555556667777778888888888887777777888888888888888887666666778888888888


Q ss_pred             CCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCcc
Q 042123          164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       164 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      ++|+|.++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|.+..
T Consensus       112 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c  166 (220)
T 2v9t_B          112 NANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC  166 (220)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence            8888888878888888888888888888887777778888888888888888763

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=8e-20  Score=210.87  Aligned_cols=187  Identities=24%  Similarity=0.313  Sum_probs=161.2

Q ss_pred             CCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCC
Q 042123           26 FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG  105 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  105 (849)
                      +..+++|++|+|++|.|..+.  .|..+++|+.|+|++|+|++..+        +..+++|+.|+|++|.|.+.  ..+.
T Consensus        39 ~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~~~~--------l~~l~~L~~L~Ls~N~l~~l--~~l~  106 (605)
T 1m9s_A           39 QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--------LTNLKNLGWLFLDENKIKDL--SSLK  106 (605)
T ss_dssp             HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCCCGG--------GGGCTTCCEEECCSSCCCCC--TTST
T ss_pred             hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCCChh--------hccCCCCCEEECcCCCCCCC--hhhc
Confidence            567899999999999997654  59999999999999999985321        67899999999999999863  3799


Q ss_pred             CCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEE
Q 042123          106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  185 (849)
                      ++++|++|+|++|+|+++  ..|..+++|+.|+|++|.|++.  ..|..+++|+.|+|++|+|.++.|  |..+++|++|
T Consensus       107 ~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L  180 (605)
T 1m9s_A          107 DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNL  180 (605)
T ss_dssp             TCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred             cCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEE
Confidence            999999999999999964  4689999999999999999865  679999999999999999998766  9999999999


Q ss_pred             EccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccch
Q 042123          186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKE  232 (849)
Q Consensus       186 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  232 (849)
                      +|++|+|++. + .+..+++|+.|+|++|++.......+..+..+..
T Consensus       181 ~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~~~p~~~~~~l~~~~~  225 (605)
T 1m9s_A          181 YLSKNHISDL-R-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT  225 (605)
T ss_dssp             ECCSSCCCBC-G-GGTTCTTCSEEECCSEEEECCCCCCCSSCEEECC
T ss_pred             ECcCCCCCCC-h-HHccCCCCCEEEccCCcCcCCcccccccEEeccc
Confidence            9999999854 4 5999999999999999998654444444444433

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.80  E-value=8.7e-20  Score=190.68  Aligned_cols=147  Identities=16%  Similarity=0.139  Sum_probs=108.7

Q ss_pred             HHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCc-----h---------hhHHHHHHHHHH------
Q 042123          582 EIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ-----T---------VDQKEFLTEVEA------  641 (849)
Q Consensus       582 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~---------~~~~~~~~ei~~------  641 (849)
                      .+......|...+.||+|+||.||+|...+|+.||||.++.......     .         .....+.+|+..      
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            33444456667799999999999999877899999999864321100     0         123345555543      


Q ss_pred             --hhceeecCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          642 --FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       642 --~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                        +.+++. .+..++||||+++|+|.+ +..         .+...++.|++.||+|||+.   +|+||||||+||+++ +
T Consensus       164 ~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~  228 (282)
T 1zar_A          164 LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E  228 (282)
T ss_dssp             SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred             CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence              333333 345689999999999998 422         12457999999999999998   999999999999999 9


Q ss_pred             CcEEEeeecCCcccCCCCCCeeeccCCcccccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAY  756 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~  756 (849)
                      +.+||+|||+|+..             ..|+|||++.
T Consensus       229 ~~vkl~DFG~a~~~-------------~~~~a~e~l~  252 (282)
T 1zar_A          229 EGIWIIDFPQSVEV-------------GEEGWREILE  252 (282)
T ss_dssp             TEEEECCCTTCEET-------------TSTTHHHHHH
T ss_pred             CcEEEEECCCCeEC-------------CCCCHHHHHH
Confidence            99999999998643             3367898864

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=1.1e-19  Score=188.18  Aligned_cols=169  Identities=18%  Similarity=0.263  Sum_probs=95.5

Q ss_pred             CCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCC
Q 042123           29 FPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLK  108 (849)
Q Consensus        29 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  108 (849)
                      +.+++.++++.|.++++.  .+..+++|++|+|++|+++.     +   ..+..+++|+.|+|++|.|++..+  +.+++
T Consensus        18 l~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-----l---~~l~~l~~L~~L~L~~N~i~~~~~--l~~l~   85 (263)
T 1xeu_A           18 LANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-----L---AGMQFFTNLKELHLSHNQISDLSP--LKDLT   85 (263)
T ss_dssp             HHHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-----C---TTGGGCTTCCEEECCSSCCCCCGG--GTTCS
T ss_pred             HHHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-----c---hHHhhCCCCCEEECCCCccCCChh--hccCC
Confidence            445566667777765544  46667777777777776652     1   134455666666666666654433  56666


Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      +|++|+|++|+++++.+.  .. ++|++|+|++|+|++.  ..+..+++|+.|+|++|+++++  ..+..+++|++|+|+
T Consensus        86 ~L~~L~L~~N~l~~l~~~--~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~--~~l~~l~~L~~L~L~  158 (263)
T 1xeu_A           86 KLEELSVNRNRLKNLNGI--PS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLH  158 (263)
T ss_dssp             SCCEEECCSSCCSCCTTC--CC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC--GGGGGCTTCCEEECT
T ss_pred             CCCEEECCCCccCCcCcc--cc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC--hHHccCCCCCEEECC
Confidence            666666666666643321  12 5566666666666542  2355556666666666665554  245555555566665


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCcc
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      +|++++.  ..+..+++|+.|++++|.+..
T Consensus       159 ~N~i~~~--~~l~~l~~L~~L~l~~N~~~~  186 (263)
T 1xeu_A          159 GNEITNT--GGLTRLKKVNWIDLTGQKCVN  186 (263)
T ss_dssp             TSCCCBC--TTSTTCCCCCEEEEEEEEEEC
T ss_pred             CCcCcch--HHhccCCCCCEEeCCCCcccC
Confidence            5555533  345555555555555555553

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.77  E-value=4.1e-21  Score=220.38  Aligned_cols=203  Identities=18%  Similarity=0.131  Sum_probs=118.9

Q ss_pred             CCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCc-------------CccCCCcCccCccccchhh-hccccccC
Q 042123          177 SNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQ-------------FKGVLPPSISNLTNLKELA-LLYNHLSG  242 (849)
Q Consensus       177 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~~  242 (849)
                      ..+++|+.|+|++|+++ .+|..++.+++|+.|++++|.             +.+..|..++.+++|+.|+ ++.|.+. 
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-  423 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-  423 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence            44556666666666665 456666666666666665543             2233344444455555554 4444331 


Q ss_pred             CCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCC
Q 042123          243 SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY  322 (849)
Q Consensus       243 ~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  322 (849)
                                                       .|..+.+++|.++...+      ..|+.|+|++|.|+++ |. ++.+
T Consensus       424 ---------------------------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l  462 (567)
T 1dce_A          424 ---------------------------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQL  462 (567)
T ss_dssp             ---------------------------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGG
T ss_pred             ---------------------------------hhhhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-cccc
Confidence                                             23334444444443222      1356666666666653 33 6666


Q ss_pred             CCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccC-chhhcCCCCCcEEE
Q 042123          323 PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEI-PKELGKLNPLTKLI  401 (849)
Q Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~  401 (849)
                      ++|+.|+|++|+++ .+|..|+.+++|+.|+|++|.|++ +| .+.++++|+.|+|++|+|++.. |..|+.+++|+.|+
T Consensus       463 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~  539 (567)
T 1dce_A          463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN  539 (567)
T ss_dssp             TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred             ccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence            66777777777666 556666677777777777777764 45 6667777777777777777655 77777777777777


Q ss_pred             ccCccccccCccc---ccccccccccc
Q 042123          402 LRGNQITGRLPKE---IGSLTKLEYLD  425 (849)
Q Consensus       402 L~~N~l~~~~p~~---~~~l~~L~~L~  425 (849)
                      |++|++++.+|..   +..+++|+.||
T Consensus       540 L~~N~l~~~~~~~~~l~~~lp~L~~L~  566 (567)
T 1dce_A          540 LQGNSLCQEEGIQERLAEMLPSVSSIL  566 (567)
T ss_dssp             CTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred             ecCCcCCCCccHHHHHHHHCcccCccC
Confidence            7777777544321   23356666665

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=1.2e-19  Score=187.94  Aligned_cols=171  Identities=20%  Similarity=0.259  Sum_probs=146.8

Q ss_pred             CCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCC
Q 042123           52 NLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNL  131 (849)
Q Consensus        52 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l  131 (849)
                      ++.+++.++|++|.+++.     .   .+..+++|+.|++++|.|+.. + .+..+++|++|+|++|+|+++.+  |.++
T Consensus        17 ~l~~l~~l~l~~~~i~~~-----~---~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l   84 (263)
T 1xeu_A           17 GLANAVKQNLGKQSVTDL-----V---SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP--LKDL   84 (263)
T ss_dssp             HHHHHHHHHHTCSCTTSE-----E---CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTC
T ss_pred             HHHHHHHHHhcCCCcccc-----c---chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh--hccC
Confidence            567788899999998732     1   356789999999999999854 4 78899999999999999997665  9999


Q ss_pred             CCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEec
Q 042123          132 SNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDL  211 (849)
Q Consensus       132 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  211 (849)
                      ++|++|+|++|++++.. . +.. ++|+.|+|++|+++++  ..+..+++|++|+|++|++++. + .+..+++|++|++
T Consensus        85 ~~L~~L~L~~N~l~~l~-~-~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L  157 (263)
T 1xeu_A           85 TKLEELSVNRNRLKNLN-G-IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDL  157 (263)
T ss_dssp             SSCCEEECCSSCCSCCT-T-CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEEC
T ss_pred             CCCCEEECCCCccCCcC-c-ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEEC
Confidence            99999999999998643 2 333 8999999999999986  4699999999999999999854 4 6889999999999


Q ss_pred             cCCcCccCCCcCccCccccchhhhccccccCC
Q 042123          212 NQNQFKGVLPPSISNLTNLKELALLYNHLSGS  243 (849)
Q Consensus       212 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  243 (849)
                      ++|++++.  ..+..+++|+.|++++|++.+.
T Consensus       158 ~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          158 HGNEITNT--GGLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             TTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred             CCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence            99999976  7799999999999999999744

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.77  E-value=3.3e-19  Score=191.71  Aligned_cols=118  Identities=11%  Similarity=0.155  Sum_probs=72.6

Q ss_pred             CCCCCEEEccCCccc--CCCCCCCcCCCCCceeeccCcccccccccccCC--------CCCCCEEEcCCCcccccCCcCC
Q 042123          107 LKFLSQLDLTNNKFS--GPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGK--------LKSLFDLQLNDNQLIGYIPRPF  176 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--------l~~L~~L~L~~N~l~~~~~~~~  176 (849)
                      +++|++|||++|+|.  ...+..+.   .++.+.+..|.|.   ..+|.+        +++|+.|+|.+ .++.+.+.+|
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF  120 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF  120 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred             hccCeEEecCcceeEEecCcccccc---ccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence            566777777777776  33332222   2455555555433   456666        77777777777 7777777777


Q ss_pred             CCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCc----CccCCCcCccCccccc
Q 042123          177 SNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQ----FKGVLPPSISNLTNLK  231 (849)
Q Consensus       177 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~l~~L~  231 (849)
                      .++++|++|++++|.+....+.+|.++.++..+.+..+.    .......+|.++.+|+
T Consensus       121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~  179 (329)
T 3sb4_A          121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLE  179 (329)
T ss_dssp             TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCE
T ss_pred             hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccc
Confidence            777777777777777766666677776666666665532    1223344455555554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.77  E-value=1.5e-19  Score=194.29  Aligned_cols=290  Identities=13%  Similarity=0.105  Sum_probs=197.9

Q ss_pred             CCCCCEEEccCCcccCCCCCCCcC-CCCCceeeccCcccc--cccccccCCCCCCCEEEcCCCcccccCCcCCCC-----
Q 042123          107 LKFLSQLDLTNNKFSGPIPLSFDN-LSNLIFLYLYGNLLS--GSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSN-----  178 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----  178 (849)
                      +.+++.|.++++ +....-..+.. +++|+.|+|++|+|.  ......+   +.++.+.+..|   .+++.+|.+     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~---~I~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMAN---FVPAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTT---EECTTTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---ccccccccccc---ccCHHHhccccccc
Confidence            456788888764 22111112333 788999999999998  3322222   33566777776   456788999     


Q ss_pred             ---CCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhh
Q 042123          179 ---LTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQ  255 (849)
Q Consensus       179 ---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~  255 (849)
                         +++|+.|+|.+ .++.+.+.+|.++++|+.|++++|.+..+.+.+|.++.++..+.+..+...              
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~--------------  161 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAY--------------  161 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHH--------------
T ss_pred             ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhh--------------
Confidence               99999999999 888777889999999999999999998888899999888877766553221              


Q ss_pred             hhccCcCCCCCCCcccCCCCCcc-eeeecccc-cccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCc
Q 042123          256 LLLSGNHFTGYLPYNICRGGALE-IFTVSENH-FQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRN  333 (849)
Q Consensus       256 L~L~~n~i~~~~~~~~~~~~~L~-~L~l~~N~-l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N  333 (849)
                           .....+...+|..+..|+ .+.+.... +.......--...++..+.+.++-...........+++|+.|+|++|
T Consensus       162 -----~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n  236 (329)
T 3sb4_A          162 -----RFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKT  236 (329)
T ss_dssp             -----HTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTB
T ss_pred             -----hccccccccccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCC
Confidence                 001112233344444444 33333221 11111111123456666666655322112222223678888888888


Q ss_pred             cccCcccccCCCCCCCcEEeccCCccccCCCCCcccccccc-ccccccccccccCchhhcCCCCCcEEEccCccccccCc
Q 042123          334 NFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQ-AFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLP  412 (849)
Q Consensus       334 ~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~-~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  412 (849)
                      +++...+..|..+.+|+.|+|.+| ++.+.+..|.++.+|+ .+++.+ .++.+.+.+|.++++|+.|++++|+++.+.+
T Consensus       237 ~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~  314 (329)
T 3sb4_A          237 NATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGD  314 (329)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECT
T ss_pred             CcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccch
Confidence            888777788888888888888887 7767778888888888 888888 7776777888889999999988888887777


Q ss_pred             ccccccccccccc
Q 042123          413 KEIGSLTKLEYLD  425 (849)
Q Consensus       413 ~~~~~l~~L~~L~  425 (849)
                      .+|.++++|+.++
T Consensus       315 ~aF~~~~~L~~ly  327 (329)
T 3sb4_A          315 ELFGNGVPSKLIY  327 (329)
T ss_dssp             TTTCTTCCCCEEE
T ss_pred             hhhcCCcchhhhc
Confidence            7888888887665

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.77  E-value=2.1e-19  Score=212.88  Aligned_cols=188  Identities=20%  Similarity=0.189  Sum_probs=100.0

Q ss_pred             CCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCC
Q 042123           29 FPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLK  108 (849)
Q Consensus        29 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~  108 (849)
                      -+.++.|+|.+|.+...      ....|+.++|++|.|.                    .+++..|.+. ..+..|..++
T Consensus       172 ~~~~~~l~L~~n~~~~~------~~~~l~~l~Ls~~~i~--------------------~~~~~~n~~~-~~~~~~~~l~  224 (727)
T 4b8c_D          172 TPLTPKIELFANGKDEA------NQALLQHKKLSQYSID--------------------EDDDIENRMV-MPKDSKYDDQ  224 (727)
T ss_dssp             -----------------------------------------------------------------------------CCC
T ss_pred             CCccceEEeeCCCCCcc------hhhHhhcCccCccccc--------------------Ccccccccee-cChhhhccCC
Confidence            36678888888887642      2234566677777664                    2344555555 5677788888


Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      +|+.|+|++|+|. .+|..+.++++|++|+|++|.|+ .+|..|.++++|+.|+|++|+|+. .|..|..+++|++|+|+
T Consensus       225 ~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~L~  301 (727)
T 4b8c_D          225 LWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTS-LPAELGSCFQLKYFYFF  301 (727)
T ss_dssp             CCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSS-CCSSGGGGTTCSEEECC
T ss_pred             CCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCc-cChhhcCCCCCCEEECC
Confidence            8888888888887 45555557788888888888887 667777778888888888888774 36677777778888888


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccc-cchhhhccccccCCCCcc
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN-LKELALLYNHLSGSIPPS  247 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~~p~~  247 (849)
                      +|.|+ .+|..|..+++|++|+|++|.|++.+|..+..+.. +..|+|++|.+++.+|..
T Consensus       302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~  360 (727)
T 4b8c_D          302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE  360 (727)
T ss_dssp             SSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_pred             CCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc
Confidence            87776 56666777777777777777777766666654432 234667777776666653

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=5e-19  Score=175.02  Aligned_cols=132  Identities=17%  Similarity=0.240  Sum_probs=88.6

Q ss_pred             CCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCE
Q 042123           81 GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFD  160 (849)
Q Consensus        81 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  160 (849)
                      ..+++|+.|++++|.++.  +..+.++++|++|++++|++++..+..|..+++|++|+|++|.+++..+..+..+++|++
T Consensus        63 ~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~  140 (197)
T 4ezg_A           63 EYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS  140 (197)
T ss_dssp             GGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCE
T ss_pred             hcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCE
Confidence            334455555555554432  235666777777777777777666677777777777777777777666777777777777


Q ss_pred             EEcCCCc-ccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCcc
Q 042123          161 LQLNDNQ-LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       161 L~L~~N~-l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      |+|++|. +..+ + .+..+++|++|++++|++++ ++ .+..+++|++|++++|++.+
T Consensus       141 L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          141 IDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             EECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred             EEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence            7777776 6554 2 57777888888888888774 33 57777888888888887753

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.76  E-value=1.8e-20  Score=214.97  Aligned_cols=214  Identities=15%  Similarity=0.145  Sum_probs=171.4

Q ss_pred             cCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCccee
Q 042123          201 GKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIF  280 (849)
Q Consensus       201 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L  280 (849)
                      ..+++|+.|+|++|+++ .+|..++.+++|++|++++|.....+|.     .+.     .+.+.+..|..+..+++|+.|
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----ll~-----~~~~~~~~~~~l~~l~~L~~L  414 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----LMR-----ALDPLLYEKETLQYFSTLKAV  414 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----HHH-----HHCTGGGHHHHHHHHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----HHH-----hcccccCCHHHHHHHHhcccC
Confidence            56889999999999998 6788999999999999977642111110     111     223344566677777788888


Q ss_pred             e-ecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCcc
Q 042123          281 T-VSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNI  359 (849)
Q Consensus       281 ~-l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i  359 (849)
                      + ++.|.+           .+|..+.+++|.++...+.      .|+.|+|++|.+++ +|. |..+++|+.|+|++|.|
T Consensus       415 ~~l~~n~~-----------~~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l  475 (567)
T 1dce_A          415 DPMRAAYL-----------DDLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRL  475 (567)
T ss_dssp             CGGGHHHH-----------HHHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCC
T ss_pred             cchhhccc-----------chhhhhhhhcccccccCcc------CceEEEecCCCCCC-CcC-ccccccCcEeecCcccc
Confidence            7 666654           3566777888888865442      59999999999996 565 99999999999999999


Q ss_pred             ccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccC-ccccccccccccccccc--CCCCChh-
Q 042123          360 TGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRL-PKEIGSLTKLEYLDFSA--IGELPSQ-  435 (849)
Q Consensus       360 ~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~--l~~lp~~-  435 (849)
                      + .+|..|+++++|+.|+|++|+|++ +| .|+.+++|+.|+|++|+|++.. |..++.+++|+.|++++  +..+|+. 
T Consensus       476 ~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~  552 (567)
T 1dce_A          476 R-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQ  552 (567)
T ss_dssp             C-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCT
T ss_pred             c-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHH
Confidence            9 789999999999999999999996 67 8999999999999999999876 99999999999999986  5555553 


Q ss_pred             ---hhcccccceecc
Q 042123          436 ---ICNMKSLEKLNL  447 (849)
Q Consensus       436 ---~~~l~~L~~L~L  447 (849)
                         +..+++|+.|++
T Consensus       553 ~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          553 ERLAEMLPSVSSILT  567 (567)
T ss_dssp             THHHHHCTTCSEEEC
T ss_pred             HHHHHHCcccCccCC
Confidence               345889999875

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.76  E-value=1.7e-18  Score=171.19  Aligned_cols=153  Identities=17%  Similarity=0.242  Sum_probs=131.2

Q ss_pred             CCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCE
Q 042123           81 GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFD  160 (849)
Q Consensus        81 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  160 (849)
                      +.+++|+.|++++|.+. .+| .+..+++|++|++++|.++..  ..+..+++|++|++++|++++..+..|.++++|++
T Consensus        41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~  116 (197)
T 4ezg_A           41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL  116 (197)
T ss_dssp             HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred             hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence            45788888899988888 445 688999999999999988743  47889999999999999999878889999999999


Q ss_pred             EEcCCCcccccCCcCCCCCCCCCEEEccCCC-CcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccc
Q 042123          161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRND-LFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH  239 (849)
Q Consensus       161 L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  239 (849)
                      |+|++|++++..+..|..+++|++|+|++|+ ++ .+| .+.++++|++|++++|++++. + .+..+++|++|++++|+
T Consensus       117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~~N~  192 (197)
T 4ezg_A          117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAFSQT  192 (197)
T ss_dssp             EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEECBC-
T ss_pred             EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEeeCcc
Confidence            9999999998778889999999999999998 66 555 688999999999999999864 3 78899999999999998


Q ss_pred             cc
Q 042123          240 LS  241 (849)
Q Consensus       240 l~  241 (849)
                      +.
T Consensus       193 i~  194 (197)
T 4ezg_A          193 IG  194 (197)
T ss_dssp             --
T ss_pred             cC
Confidence            86

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.74  E-value=1.3e-17  Score=164.00  Aligned_cols=129  Identities=25%  Similarity=0.322  Sum_probs=86.6

Q ss_pred             CeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCC-CCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCC
Q 042123           87 SRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPL-SFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND  165 (849)
Q Consensus        87 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  165 (849)
                      +.+++++|.++ .+|..+..  +|++|++++|+|+++.+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            56777777775 44544432  677777777777765553 366777777777777777666666677777777777777


Q ss_pred             CcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCcc
Q 042123          166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       166 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      |+|+++.+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c  140 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccC
Confidence            77776666666667777777777777666666666666666666666666653

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.74  E-value=9.2e-17  Score=176.16  Aligned_cols=253  Identities=12%  Similarity=0.094  Sum_probs=126.6

Q ss_pred             cCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCC
Q 042123           77 ESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLK  156 (849)
Q Consensus        77 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~  156 (849)
                      ..+|.+. +|+.+.+.+| +..+...+|.+ .+|+.+.+.+ .++.+.+.+|.++++|+.++|++|+++.+...+|. ..
T Consensus       129 ~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~  203 (401)
T 4fdw_A          129 KDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YA  203 (401)
T ss_dssp             TTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TC
T ss_pred             HhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ec
Confidence            3344442 4555555444 44444455555 3456665554 45545555566666666666665555554445554 35


Q ss_pred             CCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhc
Q 042123          157 SLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALL  236 (849)
Q Consensus       157 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  236 (849)
                      +|+.+.|.++ +..+...+|.++++|+.+++..| ++.....+|.+ .+|+.+.+ .+.++.+...+|.++++|+.+++.
T Consensus       204 ~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~  279 (401)
T 4fdw_A          204 GIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTY  279 (401)
T ss_dssp             CCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEE
T ss_pred             ccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeC
Confidence            5666666533 55555556666666666666543 34344445555 55666665 333444555556666666655555


Q ss_pred             cccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchh
Q 042123          237 YNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNIS  316 (849)
Q Consensus       237 ~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  316 (849)
                      +|.+.                  .+.+.                        ...+.+|.++++|+.+.+. +.++.+..
T Consensus       280 ~~~~~------------------~~~~~------------------------~I~~~aF~~c~~L~~l~l~-~~i~~I~~  316 (401)
T 4fdw_A          280 GSTFN------------------DDPEA------------------------MIHPYCLEGCPKLARFEIP-ESIRILGQ  316 (401)
T ss_dssp             SSCCC------------------CCTTC------------------------EECTTTTTTCTTCCEECCC-TTCCEECT
T ss_pred             Ccccc------------------CCccc------------------------EECHHHhhCCccCCeEEeC-CceEEEhh
Confidence            55432                  01111                        1233344444445544444 23444444


Q ss_pred             hhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccc-cccccccccccc
Q 042123          317 EALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSS-QLQAFDLSLNHI  383 (849)
Q Consensus       317 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~-~L~~L~L~~N~i  383 (849)
                      .+|..+++|+.++|..| +.......|..+ +|+.+++++|.+....+..|.+++ +++.|++..+.+
T Consensus       317 ~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~  382 (401)
T 4fdw_A          317 GLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESV  382 (401)
T ss_dssp             TTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred             hhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence            45555555555555333 333444455555 555555555555544444454442 455555555443

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.74  E-value=1.4e-17  Score=163.58  Aligned_cols=109  Identities=29%  Similarity=0.395  Sum_probs=55.4

Q ss_pred             ccCeEeccCCcccccCCc-cCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEc
Q 042123           85 YMSRLVINDNSLSGFIPP-HIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL  163 (849)
Q Consensus        85 ~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  163 (849)
                      +++.|++++|.|++..+. .|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            445555555555444332 2445555555555555555444555555555555555555555444444555555555555


Q ss_pred             CCCcccccCCcCCCCCCCCCEEEccCCCCc
Q 042123          164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDLF  193 (849)
Q Consensus       164 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  193 (849)
                      ++|+|+++.|..|..+++|++|+|++|.+.
T Consensus       110 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  139 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN  139 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred             CCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence            555555554555555555555555555544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.74  E-value=1.1e-16  Score=175.42  Aligned_cols=195  Identities=13%  Similarity=0.097  Sum_probs=164.1

Q ss_pred             CCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCC
Q 042123           26 FSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIG  105 (849)
Q Consensus        26 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~  105 (849)
                      +.....++.+.+. |.++.+...+|.+. +|+.+.|.+| ++      .+...+|.+. +|+.+.+.+ .+..+.+.+|.
T Consensus       109 ~~~~~~l~~i~ip-~~i~~I~~~aF~~~-~L~~i~l~~~-i~------~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~  177 (401)
T 4fdw_A          109 TEILKGYNEIILP-NSVKSIPKDAFRNS-QIAKVVLNEG-LK------SIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFY  177 (401)
T ss_dssp             EEECSSCSEEECC-TTCCEECTTTTTTC-CCSEEECCTT-CC------EECTTTTTTC-CCCEEECCT-TCCEECSSTTT
T ss_pred             EEecCCccEEEEC-CccCEehHhhcccC-CccEEEeCCC-cc------EECHHhcCCC-CceEEEeCC-CccEehHHHhh
Confidence            3445788999988 56788999999986 7999999887 54      2456677774 799999986 77778889999


Q ss_pred             CCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEE
Q 042123          106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       106 ~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  185 (849)
                      ++++|+.++|++|+++.+...+|. ..+|+.+.|..+ ++.+...+|.++++|+.++|.+| ++.+...+|.+ .+|+.+
T Consensus       178 ~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i  253 (401)
T 4fdw_A          178 YCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTV  253 (401)
T ss_dssp             TCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEE
T ss_pred             CcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEE
Confidence            999999999999999988888898 589999999855 77788899999999999999985 78889999999 899999


Q ss_pred             EccCCCCcCcCcccccCCCCCCEEeccCCcCc-----cCCCcCccCccccchhhhc
Q 042123          186 RLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK-----GVLPPSISNLTNLKELALL  236 (849)
Q Consensus       186 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~  236 (849)
                      .|. +.++.....+|.++++|+.+++.+|.+.     .+.+.+|.++++|+.+.|.
T Consensus       254 ~lp-~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~  308 (401)
T 4fdw_A          254 KLP-NGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP  308 (401)
T ss_dssp             EEE-TTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC
T ss_pred             EeC-CCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC
Confidence            994 5577677889999999999999998875     4566778888888777765

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.73  E-value=2.4e-18  Score=203.81  Aligned_cols=230  Identities=22%  Similarity=0.155  Sum_probs=124.9

Q ss_pred             CCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCC
Q 042123           54 SNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSN  133 (849)
Q Consensus        54 ~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~  133 (849)
                      +.++.|+|++|.+...            ....|+.++|++|.|.              .++++.|++. +.+..|..+++
T Consensus       173 ~~~~~l~L~~n~~~~~------------~~~~l~~l~Ls~~~i~--------------~~~~~~n~~~-~~~~~~~~l~~  225 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA------------NQALLQHKKLSQYSID--------------EDDDIENRMV-MPKDSKYDDQL  225 (727)
T ss_dssp             ----------------------------------------------------------------------------CCCC
T ss_pred             CccceEEeeCCCCCcc------------hhhHhhcCccCccccc--------------Ccccccccee-cChhhhccCCC
Confidence            4566677776666421            1223445555555543              3456667777 77889999999


Q ss_pred             CceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccC
Q 042123          134 LIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQ  213 (849)
Q Consensus       134 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  213 (849)
                      |+.|+|++|.+. .++..+.++++|++|+|++|.|+. .|..|..+++|++|+|++|+|+ .+|..|.++++|++|+|++
T Consensus       226 L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~-lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~  302 (727)
T 4b8c_D          226 WHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTE-LPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFD  302 (727)
T ss_dssp             CCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSC-CCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCS
T ss_pred             CcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcc-cChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCC
Confidence            999999999998 566667799999999999999995 6788999999999999999999 7799999999999999999


Q ss_pred             CcCccCCCcCccCccccchhhhccccccCCCCcchhhhh--hhhhhccCcCCCCCCCcccCCCCCcceeeeccccccccc
Q 042123          214 NQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI--LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTI  291 (849)
Q Consensus       214 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~--L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~  291 (849)
                      |.|+ .+|..|+.+++|++|+|++|.+++.+|..+....  ...++|++|.+++.+|..      |..|+++.|...   
T Consensus       303 N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~---  372 (727)
T 4b8c_D          303 NMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEP---  372 (727)
T ss_dssp             SCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------
T ss_pred             CCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeeccccc---
Confidence            9998 6688899999999999999999988888887654  445789999998877753      455566655111   


Q ss_pred             CCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCcccc
Q 042123          292 PTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFY  336 (849)
Q Consensus       292 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  336 (849)
                      -..++             .+++..+..+..+..+....+++|.+.
T Consensus       373 ~~~~~-------------~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          373 QREYD-------------SLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             ------------------------------------------CCC
T ss_pred             ccccC-------------Cccccccchhhcccccceeeeeccccc
Confidence            01111             223333344455556667777777765

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.72  E-value=2.6e-16  Score=173.45  Aligned_cols=327  Identities=12%  Similarity=0.045  Sum_probs=164.0

Q ss_pred             CCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCC
Q 042123           78 SSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKS  157 (849)
Q Consensus        78 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  157 (849)
                      .+|.++++|+.+.|..+ ++.+...+|.++++|+.++|.++ ++.+...+|.++.+|+.+.+..+ +..+...+|.+...
T Consensus        65 ~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~  141 (394)
T 4fs7_A           65 AAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDF  141 (394)
T ss_dssp             TTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCC
T ss_pred             HHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeecccc
Confidence            34444444444444322 33344455555555666655533 44455555666666665555443 33344455555543


Q ss_pred             CCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcc
Q 042123          158 LFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLY  237 (849)
Q Consensus       158 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  237 (849)
                      ++......  +..+...+|.++++|+.+.+.++. ......+|.++.+|+.+.+..| ++.+...+|.++..|+.+.+..
T Consensus       142 ~~~~~~~~--~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~  217 (394)
T 4fs7_A          142 KEITIPEG--VTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN  217 (394)
T ss_dssp             SEEECCTT--CCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred             cccccCcc--ccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence            33332222  233445566666666666665443 2244455666666666666555 4445555666666666665554


Q ss_pred             ccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhh
Q 042123          238 NHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISE  317 (849)
Q Consensus       238 N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  317 (849)
                      +... .....+....|+.+.+.. .++.+....|.....|+.+.+..+... .....|.++..++.+.+..+.+   ...
T Consensus       218 ~~~~-i~~~~~~~~~l~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i---~~~  291 (394)
T 4fs7_A          218 SLYY-LGDFALSKTGVKNIIIPD-SFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIV---PEK  291 (394)
T ss_dssp             TCCE-ECTTTTTTCCCCEEEECT-TCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEE---CTT
T ss_pred             CceE-eehhhcccCCCceEEECC-CceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceee---ccc
Confidence            4332 111111111233333321 122233445555566666666555333 4455566666666665554433   234


Q ss_pred             hhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCC
Q 042123          318 ALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPL  397 (849)
Q Consensus       318 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  397 (849)
                      .|....+|+.+.+..+ +.......|..+.+|+.+++.++ ++.+....|.++++|+.+++..| ++.+...+|.++++|
T Consensus       292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L  368 (394)
T 4fs7_A          292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL  368 (394)
T ss_dssp             TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred             cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence            5555666666666543 44344555666666666666533 44444555666666666666554 444445566666666


Q ss_pred             cEEEccCccccccCccccccccccc
Q 042123          398 TKLILRGNQITGRLPKEIGSLTKLE  422 (849)
Q Consensus       398 ~~L~L~~N~l~~~~p~~~~~l~~L~  422 (849)
                      +.+++..+ ++ .+..+|.++++|+
T Consensus       369 ~~i~lp~~-~~-~~~~~F~~c~~L~  391 (394)
T 4fs7_A          369 KKVELPKR-LE-QYRYDFEDTTKFK  391 (394)
T ss_dssp             CEEEEEGG-GG-GGGGGBCTTCEEE
T ss_pred             CEEEECCC-CE-EhhheecCCCCCc
Confidence            66666543 22 2233444444444

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.70  E-value=8.4e-16  Score=169.43  Aligned_cols=333  Identities=11%  Similarity=0.064  Sum_probs=220.8

Q ss_pred             eeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCccccc
Q 042123           20 TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGF   99 (849)
Q Consensus        20 ~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~   99 (849)
                      ++++.+|.+..+|+.++|. +.++.+...+|.++++|+.++|.++ ++      .+...+|.++.+|+.+.+..+ +..+
T Consensus        61 sIg~~AF~~c~~L~~i~lp-~~i~~I~~~aF~~c~~L~~i~lp~~-l~------~I~~~aF~~c~~L~~i~~p~~-l~~i  131 (394)
T 4fs7_A           61 SIGYAAFQGCRKVTEIKIP-STVREIGEFAFENCSKLEIINIPDS-VK------MIGRCTFSGCYALKSILLPLM-LKSI  131 (394)
T ss_dssp             EECTTTTTTCTTEEEEECC-TTCCEECTTTTTTCTTCCEECCCTT-CC------EECTTTTTTCTTCCCCCCCTT-CCEE
T ss_pred             EhHHHHhhCCCCceEEEeC-CCccCcchhHhhCCCCCcEEEeCCC-ce------EccchhhcccccchhhcccCc-eeee
Confidence            3556677777777777776 3466677777777777777777654 32      244566777777777666544 3435


Q ss_pred             CCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCC
Q 042123          100 IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNL  179 (849)
Q Consensus       100 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  179 (849)
                      ...+|.+...+... +. +.+..+...+|.++++|+.+.+.++. ..+...+|.++.+|+.+.+..| +..+...+|.++
T Consensus       132 ~~~aF~~~~~~~~~-~~-~~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~  207 (394)
T 4fs7_A          132 GVEAFKGCDFKEIT-IP-EGVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAEC  207 (394)
T ss_dssp             CTTTTTTCCCSEEE-CC-TTCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTC
T ss_pred             cceeeecccccccc-cC-ccccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCceEEEcCCC-ceEeCchhhccc
Confidence            55666665433322 22 22233455677777777777776553 3355666777777777777665 566666777777


Q ss_pred             CCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhcc
Q 042123          180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLS  259 (849)
Q Consensus       180 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~  259 (849)
                      ..|+.+.+..+...  +.+.+....+|+.+.+..+. +.+...+|.++.+|+.+.+..+...                  
T Consensus       208 ~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~------------------  266 (394)
T 4fs7_A          208 ILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR------------------  266 (394)
T ss_dssp             TTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE------------------
T ss_pred             cccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce------------------
Confidence            77777777665432  22333345667777665433 3344556666666666666554332                  


Q ss_pred             CcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcc
Q 042123          260 GNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEI  339 (849)
Q Consensus       260 ~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  339 (849)
                            +....|.....++.+....+.+   ....|.++.+|+.+.+.++ ++.+...+|....+|+.++|..+ ++...
T Consensus       267 ------i~~~~F~~~~~l~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~  335 (394)
T 4fs7_A          267 ------IGGSLFYNCSGLKKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIG  335 (394)
T ss_dssp             ------ECSCTTTTCTTCCEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEEC
T ss_pred             ------eeccccccccccceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEh
Confidence                  3344566666777777766543   2356788888988888654 66677788888899999999754 66666


Q ss_pred             cccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEE
Q 042123          340 SSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKL  400 (849)
Q Consensus       340 ~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  400 (849)
                      ..+|.++.+|+.+++..| ++.+....|.++.+|+.+++..+ +. .+..+|.++++|+.+
T Consensus       336 ~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          336 KRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             TTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             HHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            788889999999999877 66677788999999999999765 33 345678888888764

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.68  E-value=7.6e-17  Score=154.84  Aligned_cols=131  Identities=21%  Similarity=0.204  Sum_probs=61.8

Q ss_pred             ccCeEeccCCccc-ccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEc
Q 042123           85 YMSRLVINDNSLS-GFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQL  163 (849)
Q Consensus        85 ~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  163 (849)
                      +|+.|++++|.++ +.+|..+..+++|++|++++|+|+++  ..|..+++|++|+|++|++++..|..+.++++|+.|+|
T Consensus        25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  102 (168)
T 2ell_A           25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL  102 (168)
T ss_dssp             SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred             cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence            3444444444443 23344444455555555555555533  44455555555555555554434444444555555555


Q ss_pred             CCCcccccCC-cCCCCCCCCCEEEccCCCCcCcCc---ccccCCCCCCEEeccCCcCc
Q 042123          164 NDNQLIGYIP-RPFSNLTSVSTLRLSRNDLFGSIP---DEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       164 ~~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~  217 (849)
                      ++|+++++.+ ..|..+++|++|++++|++++..+   ..+..+++|++|++++|.+.
T Consensus       103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            5555544321 344445555555555555543322   24444555555555555444

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=4e-16  Score=153.11  Aligned_cols=126  Identities=25%  Similarity=0.357  Sum_probs=72.2

Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  167 (849)
                      .+++++|.++ .+|..+.  ++|++|+|++|+|+ .+|..|.++++|++|+|++|.|++..+..|.++++|++|+|++|+
T Consensus        14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            3444444444 2333332  35666666666665 344556666666666666666665555556666666666666666


Q ss_pred             ccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCc
Q 042123          168 LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      |+++.+.+|..+++|++|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  139 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY  139 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence            66665556666666666666666665444445555666666666666654

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=3.2e-16  Score=153.89  Aligned_cols=130  Identities=27%  Similarity=0.341  Sum_probs=118.7

Q ss_pred             CEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCC
Q 042123          111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN  190 (849)
Q Consensus       111 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  190 (849)
                      +.+++++|+++. +|..+.  ++|++|+|++|.|+ .+|..|.++++|+.|+|++|+|+++.+.+|.++++|++|+|++|
T Consensus        13 ~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           13 TVVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            689999999995 454443  68999999999998 56789999999999999999999999999999999999999999


Q ss_pred             CCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCC
Q 042123          191 DLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSI  244 (849)
Q Consensus       191 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  244 (849)
                      +|++..+..|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++|++.+..
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            999888889999999999999999999887778999999999999999997543

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.67  E-value=1.1e-16  Score=153.70  Aligned_cols=137  Identities=26%  Similarity=0.244  Sum_probs=121.4

Q ss_pred             CCCCCEEEccCCccc-CCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEE
Q 042123          107 LKFLSQLDLTNNKFS-GPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  185 (849)
                      .++|++|++++|+++ +.+|..|..+++|++|++++|.+++.  ..|..+++|++|+|++|++.+..|..+..+++|++|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            478999999999998 56788899999999999999999865  789999999999999999999888888889999999


Q ss_pred             EccCCCCcCcC-cccccCCCCCCEEeccCCcCccCCC---cCccCccccchhhhccccccCCCCc
Q 042123          186 RLSRNDLFGSI-PDEIGKMRSLSVLDLNQNQFKGVLP---PSISNLTNLKELALLYNHLSGSIPP  246 (849)
Q Consensus       186 ~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~~~p~  246 (849)
                      +|++|++++.. +..+..+++|++|++++|.+++..+   ..+..+++|++|++++|.+. .+|.
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            99999998542 2789999999999999999996655   47999999999999999987 4444

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=1.9e-16  Score=148.68  Aligned_cols=128  Identities=20%  Similarity=0.206  Sum_probs=77.9

Q ss_pred             ccccCeEeccCCccc-ccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEE
Q 042123           83 LRYMSRLVINDNSLS-GFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDL  161 (849)
Q Consensus        83 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  161 (849)
                      .++|+.|++++|.++ +.+|..+..+++|++|++++|+++++  ..|..+++|++|+|++|.+++..|..+.++++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            355666666666665 45566666667777777777776654  556666666666666666665455555556666666


Q ss_pred             EcCCCcccccC-CcCCCCCCCCCEEEccCCCCcCcCc---ccccCCCCCCEEecc
Q 042123          162 QLNDNQLIGYI-PRPFSNLTSVSTLRLSRNDLFGSIP---DEIGKMRSLSVLDLN  212 (849)
Q Consensus       162 ~L~~N~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~  212 (849)
                      ++++|+++++. +..+..+++|++|++++|++++..+   ..+..+++|+.|+++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            66666666542 2455666666666666666654433   345556666666554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.64  E-value=1.9e-15  Score=146.42  Aligned_cols=129  Identities=26%  Similarity=0.296  Sum_probs=79.5

Q ss_pred             CeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCC
Q 042123           87 SRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDN  166 (849)
Q Consensus        87 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  166 (849)
                      +.+++++|.++. +|..+.  ++|++|++++|+++++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus        10 ~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A           10 TEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            344445555442 232222  46666667666666655556666666666666666666555555666666666666666


Q ss_pred             cccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCcc
Q 042123          167 QLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       167 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      +++++.+..|..+++|++|+|++|++++..+..|..+++|++|++++|.+.+
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  138 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  138 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence            6666666666666666666666666665444455666666666666666653

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.64  E-value=9.6e-16  Score=148.49  Aligned_cols=134  Identities=26%  Similarity=0.263  Sum_probs=120.0

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      ..+.+++++|+++.+ |..+  .++|++|++++|++++..+..|.++++|++|+|++|+++++.+..|..+++|++|+|+
T Consensus         8 ~~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~   84 (177)
T 2o6r_A            8 SGTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH   84 (177)
T ss_dssp             ETTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCCEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence            357899999999965 4433  3689999999999998777889999999999999999999998899999999999999


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCC
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIP  245 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p  245 (849)
                      +|++++..+..|..+++|++|++++|+++++.+..|..+++|++|+|++|++.+..|
T Consensus        85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            999998777788999999999999999998777778999999999999999986554

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.63  E-value=2.1e-16  Score=148.45  Aligned_cols=129  Identities=23%  Similarity=0.230  Sum_probs=111.8

Q ss_pred             CCCCCEEEccCCccc-CCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEE
Q 042123          107 LKFLSQLDLTNNKFS-GPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTL  185 (849)
Q Consensus       107 l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  185 (849)
                      .++|++|++++|+++ +..|..+..+++|++|++++|.+++.  ..+.++++|+.|+|++|++++..|..+..+++|++|
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            378999999999998 67788889999999999999999865  778999999999999999998777788889999999


Q ss_pred             EccCCCCcCc-CcccccCCCCCCEEeccCCcCccCCC---cCccCccccchhhhcc
Q 042123          186 RLSRNDLFGS-IPDEIGKMRSLSVLDLNQNQFKGVLP---PSISNLTNLKELALLY  237 (849)
Q Consensus       186 ~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~  237 (849)
                      ++++|++++. .+..+..+++|++|++++|.+++..+   ..+..+++|++|++++
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence            9999999853 34788999999999999999987655   4788899999998863

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.63  E-value=5.6e-16  Score=159.81  Aligned_cols=133  Identities=20%  Similarity=0.144  Sum_probs=93.9

Q ss_pred             CCcCceecCCccceEEEEEe-cCCcE--EEEEEecccCCCC--------------------chhhHHHHHHHHHHhhcee
Q 042123          590 FDAKYCIGNGGHASVYRAEL-PSGEV--VAVKKFHSLLPCD--------------------QTVDQKEFLTEVEAFYGFC  646 (849)
Q Consensus       590 f~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~--------------------~~~~~~~~~~ei~~~~~~~  646 (849)
                      |+..+.||+|+||.||+|.. .+|+.  ||||.++......                    .......+.+|+..+....
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            56778999999999999977 68999  9999875431110                    0011123444543221110


Q ss_pred             ---------ecCCeeEEEEEeccC-C----ChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCC
Q 042123          647 ---------SHARHSFLLYEFLER-G----SLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH-HDCFPPIVHRDISS  711 (849)
Q Consensus       647 ---------~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~dlk~  711 (849)
                               ......++||||+.+ |    +|.++...      .++.++..++.|++.|+.||| +.   +|+||||||
T Consensus       129 ~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp  199 (258)
T 1zth_A          129 EAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE  199 (258)
T ss_dssp             HTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred             hCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence                     011345799999953 4    66665422      234567899999999999999 87   999999999


Q ss_pred             CCeeecCCCcEEEeeecCCccc
Q 042123          712 KNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       712 ~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999988  9999999999765

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.59  E-value=1.1e-15  Score=147.77  Aligned_cols=133  Identities=18%  Similarity=0.164  Sum_probs=96.2

Q ss_pred             cCCCCCCCCEEEccCCcccCCCCCCCcCCC-CCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCC
Q 042123          103 HIGNLKFLSQLDLTNNKFSGPIPLSFDNLS-NLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTS  181 (849)
Q Consensus       103 ~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  181 (849)
                      .+.++.+|++|++++|+++.+ |. +..+. +|++|+|++|.|++.  ..|.++++|+.|+|++|+|+++++..|..+++
T Consensus        14 ~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           14 QYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             hcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            345567777777777777744 43 44443 777777777777754  56777788888888888887776666677888


Q ss_pred             CCEEEccCCCCcCcCcc--cccCCCCCCEEeccCCcCccCCCc----CccCccccchhhhcccccc
Q 042123          182 VSTLRLSRNDLFGSIPD--EIGKMRSLSVLDLNQNQFKGVLPP----SISNLTNLKELALLYNHLS  241 (849)
Q Consensus       182 L~~L~Ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~  241 (849)
                      |++|+|++|+|+ .+|.  .+..+++|+.|++++|.+.. .|.    .+..+++|+.|+++.|.+.
T Consensus        90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A           90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            888888888886 4454  67778888888888888874 344    3777888888888888764

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.56  E-value=1.9e-15  Score=146.11  Aligned_cols=106  Identities=24%  Similarity=0.270  Sum_probs=65.1

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCC-cCCCCCCCCCEEEc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNLTSVSTLRL  187 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L  187 (849)
                      +|++|+|++|+|+++  ..|..+++|++|+|++|.|++..+..|.++++|+.|+|++|+|..+.+ ..+..+++|++|++
T Consensus        43 ~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l  120 (176)
T 1a9n_A           43 QFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI  120 (176)
T ss_dssp             CCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEEC
T ss_pred             CCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCCcchhhHhhhcCCCCCEEEe
Confidence            566666666666543  455666666666666666664444444666666666666666655432 25666677777777


Q ss_pred             cCCCCcCcCcc----cccCCCCCCEEeccCCcCc
Q 042123          188 SRNDLFGSIPD----EIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       188 s~N~l~~~~~~----~~~~l~~L~~L~L~~N~l~  217 (849)
                      ++|++. ..|.    .+..+++|+.||+++|.+.
T Consensus       121 ~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          121 LRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             CSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             cCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence            777766 3444    3667777777777777665

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.56  E-value=4.6e-15  Score=158.35  Aligned_cols=134  Identities=11%  Similarity=0.132  Sum_probs=94.6

Q ss_pred             CCCcCceecCCccceEEEEEecCCcEEEEEEecccCCC------C----chhhHHH--------H---HHHHHHhhceee
Q 042123          589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPC------D----QTVDQKE--------F---LTEVEAFYGFCS  647 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~----~~~~~~~--------~---~~ei~~~~~~~~  647 (849)
                      -|++...||+|++|.||+|...+|+.||||.++.....      .    .......        .   ++.+.+++....
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            38888999999999999999889999999987532110      0    0000001        1   122333333221


Q ss_pred             cCC------eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-
Q 042123          648 HAR------HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-  720 (849)
Q Consensus       648 ~~~------~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-  720 (849)
                      ...      ..++||||++|++|..+...         +....++.|++.+|.|||+.   +||||||||.|||+++++ 
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCC
Confidence            111      23699999999888765421         23457889999999999998   999999999999998876 


Q ss_pred             ---------cEEEeeecCCcccC
Q 042123          721 ---------EAHVADFGIAKSLK  734 (849)
Q Consensus       721 ---------~~kl~DfG~a~~~~  734 (849)
                               .+.|+||+-+....
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccccceEEEEeCCcccCC
Confidence                     38999999876543

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.53  E-value=5e-13  Score=147.11  Aligned_cols=290  Identities=13%  Similarity=0.109  Sum_probs=150.4

Q ss_pred             cCCccCCCCCCCCEEEccCCc---ccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcC
Q 042123           99 FIPPHIGNLKFLSQLDLTNNK---FSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRP  175 (849)
Q Consensus        99 ~~~~~~~~l~~L~~L~Ls~n~---i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  175 (849)
                      +...+|.++.+|+.+.++.|.   ++.+...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +..+...+
T Consensus        78 Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~  155 (394)
T 4gt6_A           78 IGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGM  155 (394)
T ss_dssp             ECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred             EhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccc
Confidence            444455555555555554442   44444555555555555555443 33344455555555555555432 34445555


Q ss_pred             CCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhh
Q 042123          176 FSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQ  255 (849)
Q Consensus       176 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~  255 (849)
                      |..+.+|+.+.+..+ ++.....+|.. .+|+.+.+..+-.. +...+|.++.+|+......+... .+...+..     
T Consensus       156 F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~-~~~~~~~~-----  226 (394)
T 4gt6_A          156 FSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYP-AIDNVLYE-----  226 (394)
T ss_dssp             TTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSC-BSSSCEEE-----
T ss_pred             eecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccc-cccceeec-----
Confidence            555555555555443 33233334432 44555555544322 34445555555554444333322 11110000     


Q ss_pred             hhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccc
Q 042123          256 LLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNF  335 (849)
Q Consensus       256 L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l  335 (849)
                          .+.........+.....+..+.+. +.++.....+|.++..|+.+.+.++.. .+...+|...++|+.+.+. +.+
T Consensus       227 ----~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i  299 (394)
T 4gt6_A          227 ----KSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRI  299 (394)
T ss_dssp             ----ECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTC
T ss_pred             ----ccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccc-eecCcccccccccccccCC-Ccc
Confidence                000000000001111223333332 223334455677777777777765433 3556677777777777775 345


Q ss_pred             cCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCcccc
Q 042123          336 YGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       336 ~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                      .......|..+.+|+.+++..+ ++.+....|.++.+|+.+.|..+ ++.+...+|.++++|+.+++.+|...
T Consensus       300 ~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~  370 (394)
T 4gt6_A          300 TELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ  370 (394)
T ss_dssp             CEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred             cccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence            5556667777777777777654 55455667777777777777644 55555677777778888777776543

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.51  E-value=5e-17  Score=160.69  Aligned_cols=89  Identities=20%  Similarity=0.228  Sum_probs=40.8

Q ss_pred             cCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCC-cCCCCCCC
Q 042123          103 HIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNLTS  181 (849)
Q Consensus       103 ~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~  181 (849)
                      .+.++++|++|++++|+|+ .+|..+..+++|++|+|++|++++. + .+..+++|+.|+|++|++.++.+ ..+..+++
T Consensus        65 ~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~  141 (198)
T 1ds9_A           65 SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDK  141 (198)
T ss_dssp             CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTT
T ss_pred             ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCC
Confidence            3444444555555555544 2333344444455555555554431 2 34444445555555554444322 23444555


Q ss_pred             CCEEEccCCCCcC
Q 042123          182 VSTLRLSRNDLFG  194 (849)
Q Consensus       182 L~~L~Ls~N~l~~  194 (849)
                      |++|++++|++.+
T Consensus       142 L~~L~l~~N~l~~  154 (198)
T 1ds9_A          142 LEDLLLAGNPLYN  154 (198)
T ss_dssp             CSEEEECSCHHHH
T ss_pred             CCEEEecCCcccc
Confidence            5555555555443

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.51  E-value=6.5e-13  Score=146.22  Aligned_cols=337  Identities=12%  Similarity=0.114  Sum_probs=184.4

Q ss_pred             eCCccCCCCC-CCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCccccc
Q 042123           21 LHDFSFSSFP-HLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGF   99 (849)
Q Consensus        21 l~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~   99 (849)
                      +.+.+|.+.+ .|+.+.+.. .++.+...+|.++++|+.+.++.|.-+                           .++.+
T Consensus        54 Ig~~aF~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~---------------------------~l~~I  105 (394)
T 4gt6_A           54 IGDRVFCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPS---------------------------CVKKI  105 (394)
T ss_dssp             ECTTTTTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCC---------------------------CCCEE
T ss_pred             cCHhhccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCC---------------------------eeeEe
Confidence            4445555543 356665553 355555556666666666655544311                           13333


Q ss_pred             CCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCC
Q 042123          100 IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNL  179 (849)
Q Consensus       100 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  179 (849)
                      ...+|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +..+...+|.++.+|+.+.+.++ +..+...+|.. 
T Consensus       106 g~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-  181 (394)
T 4gt6_A          106 GRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-  181 (394)
T ss_dssp             CTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-
T ss_pred             chhhchhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-
Confidence            3344545555555444432 33344445555555555555433 22234445555555555555443 44444555543 


Q ss_pred             CCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhcc
Q 042123          180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLS  259 (849)
Q Consensus       180 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~  259 (849)
                      .+|+.+.+..+-.. ....+|.++.+|+......+..... ...+..........+..      .|.   ...+..+.+ 
T Consensus       182 ~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~------~~~---~~~~~~~~i-  249 (394)
T 4gt6_A          182 TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAI-DNVLYEKSANGDYALIR------YPS---QREDPAFKI-  249 (394)
T ss_dssp             CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBS-SSCEEEECTTSCEEEEE------CCT---TCCCSEEEC-
T ss_pred             cceeEEEECCcccc-cccchhhhccccceecccccccccc-cceeecccccccccccc------ccc---ccccceEEc-
Confidence            34555555444322 4444555555555555554443311 11111100000000000      000   000111111 


Q ss_pred             CcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcc
Q 042123          260 GNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEI  339 (849)
Q Consensus       260 ~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  339 (849)
                      .+.++.+...+|..+..|+.+.+.++... .....|.++++|+.+.+. +.++.+...+|....+|+.++|..+ ++...
T Consensus       250 p~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~  326 (394)
T 4gt6_A          250 PNGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQIL  326 (394)
T ss_dssp             CTTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEEC
T ss_pred             CCcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEeh
Confidence            12233345667778888888888766543 666788899999999986 5677778889999999999999865 66566


Q ss_pred             cccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCcccc
Q 042123          340 SSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       340 ~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                      ..+|.++.+|+.+.+..+ ++.+....|.++++|+.+++.++....   ..|....+|+.+.+..|.+.
T Consensus       327 ~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          327 DDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             TTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred             HhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence            788999999999999755 665677889999999999999887542   56778888999888877653

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.49  E-value=1.3e-13  Score=132.19  Aligned_cols=104  Identities=24%  Similarity=0.373  Sum_probs=63.7

Q ss_pred             CEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCC
Q 042123          111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN  190 (849)
Q Consensus       111 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  190 (849)
                      ++|++++|+++. +|..+.  ++|++|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|
T Consensus        12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            455555555553 333331  55566666666666555556666666666666666666666666666666666666666


Q ss_pred             CCcCcCcccccCCCCCCEEeccCCcCc
Q 042123          191 DLFGSIPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       191 ~l~~~~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      +|++..+..|.++++|++|+|++|.+.
T Consensus        89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           89 QLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            666555555666667777777777665

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.49  E-value=1.5e-13  Score=131.74  Aligned_cols=105  Identities=30%  Similarity=0.305  Sum_probs=64.3

Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCC
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND  165 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  165 (849)
                      .+.+++++|.++. +|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            3556666666663 344332  5566666666666665566666666666666666666655555566666666666666


Q ss_pred             CcccccCCcCCCCCCCCCEEEccCCCCc
Q 042123          166 NQLIGYIPRPFSNLTSVSTLRLSRNDLF  193 (849)
Q Consensus       166 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  193 (849)
                      |+|+++.+..|..+++|++|+|++|++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            6666665556666666666666666665

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.48  E-value=3.3e-16  Score=154.74  Aligned_cols=133  Identities=25%  Similarity=0.295  Sum_probs=100.1

Q ss_pred             CcceeeecccccccccCC------CCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCC
Q 042123          276 ALEIFTVSENHFQGTIPT------SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL  349 (849)
Q Consensus       276 ~L~~L~l~~N~l~~~~~~------~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  349 (849)
                      .++.++++.+.+.+..|.      .+..+++|+.|++++|.+++. | .+..+++|++|+|++|++. .+|..+..+++|
T Consensus        19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L   95 (198)
T 1ds9_A           19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTL   95 (198)
T ss_dssp             CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-C-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred             cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-c-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence            445555555555555554      677778888888888888763 4 6777888888888888887 456666667888


Q ss_pred             cEEeccCCccccCCCCCccccccccccccccccccccCc-hhhcCCCCCcEEEccCccccccCcc
Q 042123          350 GTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIP-KELGKLNPLTKLILRGNQITGRLPK  413 (849)
Q Consensus       350 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~  413 (849)
                      ++|++++|.+++ +| .+..+++|+.|++++|++++..+ ..+..+++|++|++++|++++..|.
T Consensus        96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~  158 (198)
T 1ds9_A           96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred             CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence            888888888885 44 57888899999999999885433 5788899999999999999866554

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.47  E-value=2.3e-13  Score=130.85  Aligned_cols=104  Identities=21%  Similarity=0.309  Sum_probs=64.6

Q ss_pred             CEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCC
Q 042123          111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN  190 (849)
Q Consensus       111 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  190 (849)
                      +.+++++|+++. +|..+.  ++|++|+|++|+|++..+..|.++++|+.|+|++|+|+++++..|..+++|++|+|++|
T Consensus        15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            455555555553 333332  55666666666666555566666666666666666666666666666667777777777


Q ss_pred             CCcCcCcccccCCCCCCEEeccCCcCc
Q 042123          191 DLFGSIPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       191 ~l~~~~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      +|++..+..|.++++|++|+|++|.+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            766554445666777777777777766

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.47  E-value=2.7e-13  Score=130.41  Aligned_cols=104  Identities=31%  Similarity=0.340  Sum_probs=61.4

Q ss_pred             CeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCC
Q 042123           87 SRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDN  166 (849)
Q Consensus        87 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  166 (849)
                      +.+++++|.++ .+|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|.++++|+.|+|++|
T Consensus        15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N   91 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN   91 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence            45566666665 3344333  55666666666666555556666666666666666666554455566666666666666


Q ss_pred             cccccCCcCCCCCCCCCEEEccCCCCc
Q 042123          167 QLIGYIPRPFSNLTSVSTLRLSRNDLF  193 (849)
Q Consensus       167 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~  193 (849)
                      +|.++++..|..+++|++|+|++|.+.
T Consensus        92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           92 HLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             ccceeCHHHhccccCCCEEEeCCCCcc
Confidence            666655555666666666666666655

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.36  E-value=6.9e-15  Score=159.66  Aligned_cols=86  Identities=19%  Similarity=0.182  Sum_probs=40.2

Q ss_pred             CCCceeeccCcccccc----cccccCCCCCCCEEEcCCCcccccC----CcCCCCCCCCCEEEccCCCCcCc----Cccc
Q 042123          132 SNLIFLYLYGNLLSGS----ILSSLGKLKSLFDLQLNDNQLIGYI----PRPFSNLTSVSTLRLSRNDLFGS----IPDE  199 (849)
Q Consensus       132 ~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~  199 (849)
                      ++|++|+|++|.|+..    ++..+..+++|++|+|++|.|....    +..+...++|++|+|++|.|+..    ++..
T Consensus       155 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~  234 (372)
T 3un9_A          155 CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA  234 (372)
T ss_dssp             CCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred             CccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence            4455555555554421    1222344455555555555554321    23344445555555555555422    2222


Q ss_pred             ccCCCCCCEEeccCCcCc
Q 042123          200 IGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       200 ~~~l~~L~~L~L~~N~l~  217 (849)
                      +...++|++|+|++|.|+
T Consensus       235 L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          235 AREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HHHCSSCCEEECTTSSCC
T ss_pred             HHhCCCCCEEeccCCCCC
Confidence            333455555555555555

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.29  E-value=4e-12  Score=137.46  Aligned_cols=102  Identities=20%  Similarity=0.141  Sum_probs=52.8

Q ss_pred             EeccCC-cccccCCccCCCCCCCCEEEccC-CcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCC
Q 042123           89 LVINDN-SLSGFIPPHIGNLKFLSQLDLTN-NKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDN  166 (849)
Q Consensus        89 L~l~~n-~l~~~~~~~~~~l~~L~~L~Ls~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  166 (849)
                      ++++++ .|+. +|. +..+++|++|+|++ |+|+++.+.+|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus        13 v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           13 LRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             EECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            344444 4442 344 55555555555553 5555554455555555555555555555555555555555555555555


Q ss_pred             cccccCCcCCCCCCCCCEEEccCCCCc
Q 042123          167 QLIGYIPRPFSNLTSVSTLRLSRNDLF  193 (849)
Q Consensus       167 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~  193 (849)
                      +|+++++..|..++ |++|+|++|.+.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCcc
Confidence            55555444444444 555555555544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.28  E-value=4.4e-10  Score=122.95  Aligned_cols=106  Identities=14%  Similarity=0.102  Sum_probs=46.5

Q ss_pred             cCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCc
Q 042123          271 ICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLG  350 (849)
Q Consensus       271 ~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  350 (849)
                      |.....|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++.+...+|..+++|+.+.+.++.+.......|.++.+|+
T Consensus       236 f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~  313 (379)
T 4h09_A          236 FYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLS  313 (379)
T ss_dssp             TTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCC
T ss_pred             ccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCC
Confidence            333444444444433 33233344444455555544322 3333344444444555555544444434444444444455


Q ss_pred             EEeccCCccccCCCCCccccccccccccc
Q 042123          351 TLNVSMNNITGGLPREIGNSSQLQAFDLS  379 (849)
Q Consensus       351 ~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~  379 (849)
                      .+.|..+ ++.+....|.++.+|+.+.+.
T Consensus       314 ~i~lp~~-l~~I~~~aF~~C~~L~~i~ip  341 (379)
T 4h09_A          314 SVTLPTA-LKTIQVYAFKNCKALSTISYP  341 (379)
T ss_dssp             EEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             EEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence            5444332 332333444444444444443

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.27  E-value=1.7e-10  Score=126.23  Aligned_cols=129  Identities=14%  Similarity=0.024  Sum_probs=57.6

Q ss_pred             CCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccccc
Q 042123          293 TSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQ  372 (849)
Q Consensus       293 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~  372 (849)
                      ..+....+|+.+.+..+ ++.+...+|.....|+.+.+..+ ++......|..+.+|+.+.+..+ ++......|.++.+
T Consensus       211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~  287 (379)
T 4h09_A          211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSN  287 (379)
T ss_dssp             TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTT
T ss_pred             cccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccc
Confidence            34444445555544332 33333444445555555555443 33333444445555555555332 33233344445555


Q ss_pred             ccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccccccccc
Q 042123          373 LQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLD  425 (849)
Q Consensus       373 L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  425 (849)
                      |+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++++|+.+.
T Consensus       288 L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~  339 (379)
T 4h09_A          288 LTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTIS  339 (379)
T ss_dssp             CCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCC
T ss_pred             cccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEE
Confidence            555555544444444445555555555555432 3323333444444444333

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.26  E-value=7e-12  Score=135.52  Aligned_cols=105  Identities=25%  Similarity=0.215  Sum_probs=83.3

Q ss_pred             CEEEccCC-cccCCCCCCCcCCCCCceeeccC-cccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          111 SQLDLTNN-KFSGPIPLSFDNLSNLIFLYLYG-NLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       111 ~~L~Ls~n-~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      ..++++++ +|++ +|. |..+++|++|+|++ |+|++..+..|.++++|+.|+|++|+|+++.|..|.++++|++|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            34688887 7885 555 88888888888885 88887777788888888888888888888888888888888888888


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCcc
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      +|+|++..+..|..++ |+.|+|++|.+..
T Consensus        89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c  117 (347)
T 2ifg_A           89 FNALESLSWKTVQGLS-LQELVLSGNPLHC  117 (347)
T ss_dssp             SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred             CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence            8888866666666555 8888888888773

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.23  E-value=7.4e-14  Score=151.55  Aligned_cols=158  Identities=19%  Similarity=0.175  Sum_probs=100.5

Q ss_pred             cccCeEeccCCcccccCCcc----CC-CCCCCCEEEccCCcccCCCCCC-CcCCCCCceeeccCccccccccccc-----
Q 042123           84 RYMSRLVINDNSLSGFIPPH----IG-NLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGNLLSGSILSSL-----  152 (849)
Q Consensus        84 ~~L~~L~l~~n~l~~~~~~~----~~-~l~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~-----  152 (849)
                      +.|+.|+|++|.|+......    +. +.++|++|+|++|+|+...... +..+++|+.|+|++|.|+......+     
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            45556666666655322222    22 2257788888888776432222 2345678888888888875444443     


Q ss_pred             CCCCCCCEEEcCCCcccccC----CcCCCCCCCCCEEEccCCCCcCc----CcccccCCCCCCEEeccCCcCccC----C
Q 042123          153 GKLKSLFDLQLNDNQLIGYI----PRPFSNLTSVSTLRLSRNDLFGS----IPDEIGKMRSLSVLDLNQNQFKGV----L  220 (849)
Q Consensus       153 ~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~  220 (849)
                      ...++|++|+|++|.|+...    +..+..+++|++|+|++|+|+..    ++..+...++|++|+|++|.|+..    +
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l  231 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL  231 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence            34677888888888876532    33446677888888888888643    245566677888888888888742    2


Q ss_pred             CcCccCccccchhhhcccccc
Q 042123          221 PPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       221 ~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      ...+...++|++|+|++|.|+
T Consensus       232 ~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          232 ARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             HHHHHHCSSCCEEECTTSSCC
T ss_pred             HHHHHhCCCCCEEeccCCCCC
Confidence            233445577777777777765

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.90  E-value=6.8e-09  Score=107.06  Aligned_cols=139  Identities=16%  Similarity=0.095  Sum_probs=99.0

Q ss_pred             HHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCC--CCchhhHHHHHHHHH------HhhceeecCCeeEEE
Q 042123          584 VKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLP--CDQTVDQKEFLTEVE------AFYGFCSHARHSFLL  655 (849)
Q Consensus       584 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~~~ei~------~~~~~~~~~~~~~lV  655 (849)
                      ......|+.....+.|+.+.||++... ++.+++|.......  ......+...++.+.      ++++++...+..|+|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            445567888888898999999999765 68899999864211  111112222333222      356667777889999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-----------------------------------  700 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----------------------------------  700 (849)
                      |||++|.++.+...        +..+...++.+++++++.||+..                                   
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999887632        11234578889999999999810                                   


Q ss_pred             ---------------------CCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          701 ---------------------FPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       701 ---------------------~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                                           .+.++|+|++|.||+++.+..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 0358999999999999876556799998764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.89  E-value=1.3e-10  Score=124.78  Aligned_cols=63  Identities=19%  Similarity=0.286  Sum_probs=31.8

Q ss_pred             CCCCCEEEcCCCcccccCCcCC---CCCCCCCEEEccCCCCcCc----CcccccCCCCCCEEeccCCcCc
Q 042123          155 LKSLFDLQLNDNQLIGYIPRPF---SNLTSVSTLRLSRNDLFGS----IPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       155 l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      +++|+.|+|++|.+....+..+   ..+++|++|+|+.|.+...    ++..+..+++|+.|+|++|.|+
T Consensus       251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            4555555555555543111111   1345666666666666532    2222334566666666666655

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.79  E-value=6.6e-10  Score=119.29  Aligned_cols=135  Identities=18%  Similarity=0.231  Sum_probs=93.3

Q ss_pred             ccCCCCCCCCEEEccCCc-ccCCCCCCCcCCCCCceeeccCcccccccccccC--CCCCCCEEEcCC--Cc------ccc
Q 042123          102 PHIGNLKFLSQLDLTNNK-FSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLG--KLKSLFDLQLND--NQ------LIG  170 (849)
Q Consensus       102 ~~~~~l~~L~~L~Ls~n~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~--~l~~L~~L~L~~--N~------l~~  170 (849)
                      ..+..+++|+.|+|++|. +. . +. +. +++|++|+|..|.+.......+.  .+++|+.|+|+.  |.      +..
T Consensus       166 ~ll~~~P~L~~L~L~g~~~l~-l-~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~  241 (362)
T 2ra8_A          166 PVLDAMPLLNNLKIKGTNNLS-I-GK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNV  241 (362)
T ss_dssp             HHHHTCTTCCEEEEECCBTCB-C-CS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGG
T ss_pred             HHHhcCCCCcEEEEeCCCCce-e-cc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHH
Confidence            455667889999998873 32 2 22 33 78899999988888654444443  688899998853  22      111


Q ss_pred             cCCcCC--CCCCCCCEEEccCCCCcCcCccccc---CCCCCCEEeccCCcCccC----CCcCccCccccchhhhcccccc
Q 042123          171 YIPRPF--SNLTSVSTLRLSRNDLFGSIPDEIG---KMRSLSVLDLNQNQFKGV----LPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       171 ~~~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      +. ..+  ..+++|++|+|++|.+....+..+.   .+++|++|+|+.|.+...    ++..+..+++|+.|+|++|.++
T Consensus       242 l~-~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          242 FR-PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             TG-GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             HH-HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            11 122  3578999999999998744333333   478999999999999853    3344466789999999999876

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.77  E-value=2.5e-08  Score=102.60  Aligned_cols=131  Identities=19%  Similarity=0.143  Sum_probs=87.2

Q ss_pred             CCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-------HhhceeecCCeeEEEEEeccC
Q 042123          589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------AFYGFCSHARHSFLLYEFLER  661 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-------~~~~~~~~~~~~~lV~e~~~~  661 (849)
                      .+......+.|..+.||++...+|+.+++|..... .......+...++.+.       +++++...++..++||||++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G   99 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   99 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence            34433333456669999998877888999997653 1112222333333332       245555666678999999999


Q ss_pred             CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 042123          662 GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-----------------------------------------  700 (849)
Q Consensus       662 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----------------------------------------  700 (849)
                      .++.  ...      .+   ...++.+++..+..||+..                                         
T Consensus       100 ~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (264)
T 1nd4_A          100 QDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  168 (264)
T ss_dssp             EETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             cccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence            8884  211      11   2356777888888888642                                         


Q ss_pred             --------------CCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          701 --------------FPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       701 --------------~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                                    .+.++|+|++|.||+++.++.+.++|||.+.
T Consensus       169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                          0139999999999999877667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.53  E-value=2.7e-07  Score=99.78  Aligned_cols=135  Identities=14%  Similarity=0.247  Sum_probs=92.8

Q ss_pred             cCceecCCccceEEEEEecCCcEEEEEEec--ccCC---CCchhhHHHHHHHHH-------HhhceeecC---CeeEEEE
Q 042123          592 AKYCIGNGGHASVYRAELPSGEVVAVKKFH--SLLP---CDQTVDQKEFLTEVE-------AFYGFCSHA---RHSFLLY  656 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~~---~~~~~~~~~~~~ei~-------~~~~~~~~~---~~~~lV~  656 (849)
                      ..+.++.|.++.||+++.. +..+++|+..  ....   ......+..+++.+.       +++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4567999999999999876 4678888865  2210   111111222333322       244455444   4588999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC------------------------------------  700 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------  700 (849)
                      ||++|..+.+..     ...++..++..++.+++++|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998775422     123678889999999999999999831                                    


Q ss_pred             -------------------CCCeEecCCCCCCeeecCCCc--EEEeeecCCcc
Q 042123          701 -------------------FPPIVHRDISSKNLLLDLEYE--AHVADFGIAKS  732 (849)
Q Consensus       701 -------------------~~~ivH~dlk~~Nill~~~~~--~kl~DfG~a~~  732 (849)
                                         .+.++|||+++.||+++.++.  +.+.||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               136999999999999997753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.51  E-value=1.6e-08  Score=106.63  Aligned_cols=175  Identities=20%  Similarity=0.205  Sum_probs=109.4

Q ss_pred             CceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH--------------hhceeecCC---eeEEE
Q 042123          593 KYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--------------FYGFCSHAR---HSFLL  655 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~--------------~~~~~~~~~---~~~lV  655 (849)
                      .+.++.|....||++.    ..+++|.....      .....+.+|...              .+.++....   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~------~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS------RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH------HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc------chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4568999999999873    56889985432      112223333221              112221222   45889


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-----------------------------------  700 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----------------------------------  700 (849)
                      |||++|.++.+...     ..++.+++..++.+++..++.||+..                                   
T Consensus        95 m~~i~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ  169 (304)
T ss_dssp             EECCCCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred             EcccCCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence            99999988765332     24778888899999999999998611                                   


Q ss_pred             --------------------CCCeEecCCCCCCeeecC--CCcEEEeeecCCcccCCCCCC---eee-----------cc
Q 042123          701 --------------------FPPIVHRDISSKNLLLDL--EYEAHVADFGIAKSLKPDSSN---WTE-----------FA  744 (849)
Q Consensus       701 --------------------~~~ivH~dlk~~Nill~~--~~~~kl~DfG~a~~~~~~~~~---~~~-----------~~  744 (849)
                                          .+.++|+|++|.||+++.  ...+.++||+.+....+....   ...           ..
T Consensus       170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l  249 (304)
T 3sg8_A          170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL  249 (304)
T ss_dssp             HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence                                135899999999999998  456789999988653221000   000           00


Q ss_pred             CCccccc-cccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 042123          745 GTCGYIA-PELAYTMKITEKCDVYSFGVLMWEVIKGKHPRD  784 (849)
Q Consensus       745 g~~~y~a-PE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~  784 (849)
                      ...++.. |+....  .....+.|++|.++|.+.+|+.+|-
T Consensus       250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            0001111 222111  1223689999999999999988863

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.43  E-value=1.4e-08  Score=98.24  Aligned_cols=25  Identities=16%  Similarity=0.080  Sum_probs=14.9

Q ss_pred             CCCccccCCCCCCEeeCCCC-cCccc
Q 042123           45 TIPPQISNLSNLRYLYLGSN-QFSGN   69 (849)
Q Consensus        45 ~~~~~~~~l~~L~~L~L~~N-~l~~~   69 (849)
                      .+...+...+.|++|+|++| +|...
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~   52 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVP   52 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHH
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHH
Confidence            33445556666777777776 66543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.37  E-value=4.7e-08  Score=94.57  Aligned_cols=114  Identities=21%  Similarity=0.171  Sum_probs=70.4

Q ss_pred             CCCcccccEEEccCc-cccC----chhhhhCCCCCCCEEeccCccccCc----ccccCCCCCCCcEEeccCCccccC---
Q 042123          295 LRNCTSLIRVRLNGN-NLTG----NISEALGIYPNLTFIDLSRNNFYGE----ISSNWGKFPKLGTLNVSMNNITGG---  362 (849)
Q Consensus       295 ~~~l~~L~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~---  362 (849)
                      +...++|++|+|++| .|..    .+...+...++|++|+|++|.+...    +...+...+.|++|+|++|.|+..   
T Consensus        32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~  111 (185)
T 1io0_A           32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL  111 (185)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence            444556666666666 6553    2334455566677777777776532    223333445677777777777632   


Q ss_pred             -CCCCcccccccccccc--cccccccc----CchhhcCCCCCcEEEccCcccc
Q 042123          363 -LPREIGNSSQLQAFDL--SLNHIVGE----IPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       363 -~p~~~~~l~~L~~L~L--~~N~i~~~----~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                       +...+...+.|++|+|  ++|.|...    +...+...++|++|+|++|.+.
T Consensus       112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence             2334555567777777  67777643    3345556688999999998886

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.35  E-value=5.5e-08  Score=98.75  Aligned_cols=84  Identities=32%  Similarity=0.408  Sum_probs=46.1

Q ss_pred             CCCCCCCEEeccCccccC--cccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCC
Q 042123          320 GIYPNLTFIDLSRNNFYG--EISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPL  397 (849)
Q Consensus       320 ~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L  397 (849)
                      ..+++|+.|+||+|+|.+  .++..+..+++|+.|+|++|.|++.  ..+.                     .+..+ +|
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~---------------------~l~~l-~L  222 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELD---------------------KIKGL-KL  222 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGG---------------------GGTTS-CC
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhh---------------------hcccC-Cc
Confidence            446666777777776665  2234444556666666666665532  1111                     12223 56


Q ss_pred             cEEEccCccccccCcc-------cccccccccccccc
Q 042123          398 TKLILRGNQITGRLPK-------EIGSLTKLEYLDFS  427 (849)
Q Consensus       398 ~~L~L~~N~l~~~~p~-------~~~~l~~L~~L~l~  427 (849)
                      ++|+|++|++.+..|.       .+..+++|+.||-.
T Consensus       223 ~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg~  259 (267)
T 3rw6_A          223 EELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDGH  259 (267)
T ss_dssp             SEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESSC
T ss_pred             ceEEccCCcCccccCcchhHHHHHHHHCcccCeECCc
Confidence            6777777776654442       35566677766643

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.27  E-value=3.4e-08  Score=100.32  Aligned_cols=63  Identities=25%  Similarity=0.354  Sum_probs=30.0

Q ss_pred             CCCCCCEEEcCCCcccccC--CcCCCCCCCCCEEEccCCCCcCcCcccccCCC--CCCEEeccCCcCcc
Q 042123          154 KLKSLFDLQLNDNQLIGYI--PRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMR--SLSVLDLNQNQFKG  218 (849)
Q Consensus       154 ~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~  218 (849)
                      ++++|+.|+|++|+|+++.  +..+..+++|++|+|++|+|++.  ..+..++  +|++|+|++|.+.+
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~  234 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD  234 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence            3445555555555555432  23334455555555555555432  1222222  55555555555553

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.87  E-value=2.9e-06  Score=79.69  Aligned_cols=82  Identities=11%  Similarity=0.049  Sum_probs=35.2

Q ss_pred             CCceeeccCcccccccccccCCCCCCCEEEcCCCc-ccccCCcCCCCC----CCCCEEEccCCC-CcCcCcccccCCCCC
Q 042123          133 NLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ-LIGYIPRPFSNL----TSVSTLRLSRND-LFGSIPDEIGKMRSL  206 (849)
Q Consensus       133 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L  206 (849)
                      +|+.|+++++.|+......+.++++|++|+|++|. |++..-..+..+    ++|++|+|++|. |+...-..+.++++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            34444444444443333334444444444444442 322111122222    235555555542 443333334445555


Q ss_pred             CEEeccCC
Q 042123          207 SVLDLNQN  214 (849)
Q Consensus       207 ~~L~L~~N  214 (849)
                      ++|+|+++
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            55555554

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.78  E-value=1e-05  Score=75.93  Aligned_cols=82  Identities=10%  Similarity=0.060  Sum_probs=40.3

Q ss_pred             CcceeeecccccccccCCCCCCcccccEEEccCcc-ccCchhhhhCCC----CCCCEEeccCcc-ccCcccccCCCCCCC
Q 042123          276 ALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNN-LTGNISEALGIY----PNLTFIDLSRNN-FYGEISSNWGKFPKL  349 (849)
Q Consensus       276 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~~~~~~~l~~L  349 (849)
                      .|+.||++++.++...-..+.++++|+.|+|++|. |++.--..+..+    ++|++|+|++|. +++..-..+..+++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            45555555555544444444555556666666553 544333344433    245555555553 443333334445555


Q ss_pred             cEEeccCC
Q 042123          350 GTLNVSMN  357 (849)
Q Consensus       350 ~~L~Ls~N  357 (849)
                      ++|+|++|
T Consensus       142 ~~L~L~~c  149 (176)
T 3e4g_A          142 KYLFLSDL  149 (176)
T ss_dssp             CEEEEESC
T ss_pred             CEEECCCC
Confidence            55555554

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.75  E-value=2.8e-05  Score=69.71  Aligned_cols=43  Identities=21%  Similarity=0.315  Sum_probs=39.8

Q ss_pred             cccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCC
Q 042123          440 KSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPN  482 (849)
Q Consensus       440 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~  482 (849)
                      ++|+.|+|++|+|+.+.++.|..+++|+.|+|++|||.|+|..
T Consensus        31 ~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l   73 (130)
T 3rfe_A           31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL   73 (130)
T ss_dssp             TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred             cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence            4689999999999999999999999999999999999999864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.68  E-value=9.7e-05  Score=77.44  Aligned_cols=125  Identities=17%  Similarity=0.147  Sum_probs=79.0

Q ss_pred             CceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH--------------hhceee-cCCeeEEEEE
Q 042123          593 KYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--------------FYGFCS-HARHSFLLYE  657 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~--------------~~~~~~-~~~~~~lV~e  657 (849)
                      .+.++.|....||+.    |..+++|.....      .....+..|...              .+.++. ..+..++|||
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~~------~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKSQ------QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESSH------HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCCc------hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            456888999999998    567888884321      112233333221              222332 3455789999


Q ss_pred             eccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 042123          658 FLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD--------------------------------------  699 (849)
Q Consensus       658 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~--------------------------------------  699 (849)
                      |++|..+.+...     ..++..+...++.++++.++.||+.                                      
T Consensus        94 ~i~G~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~  168 (306)
T 3tdw_A           94 KVQGQILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL  168 (306)
T ss_dssp             CCCSEECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred             ccCCeECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence            999988766321     1234455555555555555555542                                      


Q ss_pred             -------------------CCCCeEecCCCCCCeeecC---CCc-EEEeeecCCcc
Q 042123          700 -------------------CFPPIVHRDISSKNLLLDL---EYE-AHVADFGIAKS  732 (849)
Q Consensus       700 -------------------~~~~ivH~dlk~~Nill~~---~~~-~kl~DfG~a~~  732 (849)
                                         ..+.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               1235799999999999987   455 48999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.63  E-value=0.00018  Score=77.26  Aligned_cols=31  Identities=19%  Similarity=0.201  Sum_probs=25.8

Q ss_pred             CCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +.++|+|+.+.||+++++..+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4789999999999999644578999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.62  E-value=0.00011  Score=75.64  Aligned_cols=123  Identities=19%  Similarity=0.150  Sum_probs=83.0

Q ss_pred             eecCCccc-eEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCeeEEEEEecc
Q 042123          595 CIGNGGHA-SVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       595 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      .+..|..| .||+.... ++..+++|+....       ....+..|..            ++++++.+.+..++|||+++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~  103 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIP  103 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH-------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC-------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeC
Confidence            45667666 58998654 4667899985432       1112223322            25667778889999999999


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC----------------------------------------  700 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~----------------------------------------  700 (849)
                      |.++.+.....       ..+...+..+++..+..||+..                                        
T Consensus       104 G~~~~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          104 GKTAFQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             SEEHHHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CccccccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            98877654321       1233456666777777777421                                        


Q ss_pred             ---------------CCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          701 ---------------FPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       701 ---------------~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                                     .+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                           0237899999999999987777799998775

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.35  E-value=0.00051  Score=73.18  Aligned_cols=30  Identities=27%  Similarity=0.411  Sum_probs=27.3

Q ss_pred             CCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          702 PPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      +.++|+|+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            489999999999999888899999999775

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.34  E-value=3e-05  Score=74.22  Aligned_cols=112  Identities=16%  Similarity=0.086  Sum_probs=54.6

Q ss_pred             CCCCCCCEEEccCC-cccC----CCCCCCcCCCCCceeeccCcccccccc----cccCCCCCCCEEEcCCCccccc----
Q 042123          105 GNLKFLSQLDLTNN-KFSG----PIPLSFDNLSNLIFLYLYGNLLSGSIL----SSLGKLKSLFDLQLNDNQLIGY----  171 (849)
Q Consensus       105 ~~l~~L~~L~Ls~n-~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~----  171 (849)
                      .+-+.|++|+|++| +|..    .+..++...+.|+.|+|++|.|.....    .++..-+.|++|+|++|+|...    
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            34455666666654 5542    122334445566666666666653322    2233445566666666665432    


Q ss_pred             CCcCCCCCCCCCEEEccCCC---CcC----cCcccccCCCCCCEEeccCCcC
Q 042123          172 IPRPFSNLTSVSTLRLSRND---LFG----SIPDEIGKMRSLSVLDLNQNQF  216 (849)
Q Consensus       172 ~~~~~~~l~~L~~L~Ls~N~---l~~----~~~~~~~~l~~L~~L~L~~N~l  216 (849)
                      ..+++..-+.|++|+|++|.   +..    .+.+.+..-++|+.|+++.|.+
T Consensus       118 la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            12334445556666665432   221    1223344445566666555543

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.27  E-value=3.1e-05  Score=74.15  Aligned_cols=121  Identities=15%  Similarity=0.161  Sum_probs=65.7

Q ss_pred             CCccccCCCCCCEeeCCCC-cCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCC
Q 042123           46 IPPQISNLSNLRYLYLGSN-QFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPI  124 (849)
Q Consensus        46 ~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~  124 (849)
                      +...+.+-+.|++|+|++| +|.+.....+                          ..++..-+.|+.|+|++|+|.+..
T Consensus        33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~l--------------------------a~aL~~N~~L~~L~L~~n~igd~g   86 (197)
T 1pgv_A           33 INRLREDDTDLKEVNINNMKRVSKERIRSL--------------------------IEAACNSKHIEKFSLANTAISDSE   86 (197)
T ss_dssp             HHHHHTTCSSCCEEECTTCCSSCHHHHHHH--------------------------HHHHTTCSCCCEEECTTSCCBHHH
T ss_pred             HHHHHhcCCCccEEECCCCCCCCHHHHHHH--------------------------HHHHhhCCCcCEEEccCCCCChHH
Confidence            3344455567777777774 6654332222                          123334455666666666665322


Q ss_pred             ----CCCCcCCCCCceeeccCccccccc----ccccCCCCCCCEEEcCCCc---cccc----CCcCCCCCCCCCEEEccC
Q 042123          125 ----PLSFDNLSNLIFLYLYGNLLSGSI----LSSLGKLKSLFDLQLNDNQ---LIGY----IPRPFSNLTSVSTLRLSR  189 (849)
Q Consensus       125 ----~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~---l~~~----~~~~~~~l~~L~~L~Ls~  189 (849)
                          ..++...+.|++|+|++|.|....    ..++..-+.|++|+|++|.   +...    ..+++..-+.|+.|+++.
T Consensus        87 a~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~  166 (197)
T 1pgv_A           87 ARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISF  166 (197)
T ss_dssp             HTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCC
T ss_pred             HHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccC
Confidence                223334566677777777665332    2345555667777776542   2221    223455566777788777


Q ss_pred             CCC
Q 042123          190 NDL  192 (849)
Q Consensus       190 N~l  192 (849)
                      |.+
T Consensus       167 ~~~  169 (197)
T 1pgv_A          167 ASM  169 (197)
T ss_dssp             CCH
T ss_pred             CCc
Confidence            654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.09  E-value=0.0018  Score=70.50  Aligned_cols=30  Identities=20%  Similarity=0.296  Sum_probs=25.6

Q ss_pred             CCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +.++|||+.+.||+++.+ .+++.||..+..
T Consensus       227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            379999999999999876 489999987764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.94  E-value=0.0012  Score=58.93  Aligned_cols=36  Identities=28%  Similarity=0.169  Sum_probs=22.4

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCccc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL  144 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l  144 (849)
                      +|++|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            466666666666665555666666666666666654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.71  E-value=0.0067  Score=63.13  Aligned_cols=134  Identities=18%  Similarity=0.178  Sum_probs=76.6

Q ss_pred             cCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH--------HhhceeecCCeeEEEEEeccCCC
Q 042123          592 AKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE--------AFYGFCSHARHSFLLYEFLERGS  663 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~--------~~~~~~~~~~~~~lV~e~~~~gs  663 (849)
                      ..+.|+.|....+|+... ++..++||...... ......+...++.+.        +.+.++...+..++||||+++..
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~~-~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~  117 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERSY-RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK  117 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGGG-HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCccc-HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence            346799999999999987 46788999865321 001111112222222        24455556678899999999976


Q ss_pred             hhh-----------hhccccc--c-------------c----CCCHHHHH---HHHHH----------------HH-HHH
Q 042123          664 LAA-----------ILNTDAA--A-------------Q----ELGWSQRM---NVIKA----------------VA-HAL  693 (849)
Q Consensus       664 L~~-----------~l~~~~~--~-------------~----~l~~~~~~---~i~~~----------------ia-~~l  693 (849)
                      +..           .+|....  .             +    .-+|.+..   ++..+                +. ...
T Consensus       118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~  197 (312)
T 3jr1_A          118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA  197 (312)
T ss_dssp             CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred             CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence            421           1222111  0             0    01454332   11111                11 112


Q ss_pred             HHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          694 SYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       694 ~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                      ..|.. ...|.++|+|+.+.|++++.++ +.|.|++
T Consensus       198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            23321 1235799999999999999887 8888874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.69  E-value=0.0079  Score=65.89  Aligned_cols=76  Identities=12%  Similarity=0.135  Sum_probs=46.6

Q ss_pred             CCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccC--CccccccccccCC---CCCccchHHHHHHHHHHH
Q 042123          702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAG--TCGYIAPELAYTM---KITEKCDVYSFGVLMWEV  776 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g--~~~y~aPE~~~~~---~~~~~~Dv~SlGvil~el  776 (849)
                      +.++|+|+++.||+++.++ ++++||+.+....+.-.. .....  ...|.+|+.....   .-....++.+....+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3799999999999998876 999999988653211000 00010  1345666654311   112235556777788877


Q ss_pred             HhC
Q 042123          777 IKG  779 (849)
Q Consensus       777 ~tg  779 (849)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.48  E-value=0.019  Score=60.30  Aligned_cols=153  Identities=16%  Similarity=0.174  Sum_probs=81.0

Q ss_pred             ccHHHHHHHhcCCCc-----CceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-------hhce
Q 042123          578 ILYDEIVKATNDFDA-----KYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-------FYGF  645 (849)
Q Consensus       578 ~~~~~~~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-------~~~~  645 (849)
                      ++.+++......|..     .+.|+.|....+|+....+| .+++|.............+..+.+.+..       ++..
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~   85 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR   85 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence            344566666666765     24577788899999977655 6889987652121222222233333322       1111


Q ss_pred             ------eecCCeeEEEEEeccCCChhh--------------hhcccc----cc--cCC---CHHHHHH------------
Q 042123          646 ------CSHARHSFLLYEFLERGSLAA--------------ILNTDA----AA--QEL---GWSQRMN------------  684 (849)
Q Consensus       646 ------~~~~~~~~lV~e~~~~gsL~~--------------~l~~~~----~~--~~l---~~~~~~~------------  684 (849)
                            ....+..++||+|++|..+..              .+|...    ..  ...   .|.....            
T Consensus        86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~  165 (322)
T 2ppq_A           86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  165 (322)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence                  112356789999999865321              011110    00  001   1222110            


Q ss_pred             HHHHHHHHHHHHHhcC----CCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          685 VIKAVAHALSYLHHDC----FPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       685 i~~~ia~~l~~LH~~~----~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      +...+...++++++..    .++++|+|+.+.||+++.++.+.++||+.+.
T Consensus       166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            0112444556665321    2378999999999999887666899998765

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.45  E-value=0.0096  Score=57.10  Aligned_cols=98  Identities=21%  Similarity=0.213  Sum_probs=64.4

Q ss_pred             ChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeee
Q 042123          663 SLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE  742 (849)
Q Consensus       663 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  742 (849)
                      +|.++|....  .+++++++|.++.|.+.+|.-+-.... + ..+=+.|..|++..+|.|...+ +.+.           
T Consensus        34 SL~eIL~~~~--~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLYN--QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHHcC--CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            7889987654  569999999999999999877632111 1 1333456889999999988764 1110           


Q ss_pred             ccCCccccccccccCCCCCccchHHHHHHHHHHHHh
Q 042123          743 FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK  778 (849)
Q Consensus       743 ~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t  778 (849)
                       .....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence             1122456888653 345688999999999999875

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.27  E-value=0.0089  Score=61.69  Aligned_cols=76  Identities=18%  Similarity=0.157  Sum_probs=45.0

Q ss_pred             CCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCch--hhHHHHHHHHHHhhce----eecCCeeEEEEEeccCC
Q 042123          589 DFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT--VDQKEFLTEVEAFYGF----CSHARHSFLLYEFLERG  662 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~ei~~~~~~----~~~~~~~~lV~e~~~~g  662 (849)
                      +....+.+|.|..+.||+.+..+|+.|+||+..........  ..+...++.+..-.+.    ....+..++||||++++
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~~   95 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDER   95 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCCC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeeccc
Confidence            44556789999999999999999999999986543221111  1122222222211010    00112347899999886


Q ss_pred             Ch
Q 042123          663 SL  664 (849)
Q Consensus       663 sL  664 (849)
                      ..
T Consensus        96 ~~   97 (288)
T 3f7w_A           96 PP   97 (288)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.16  E-value=0.025  Score=59.66  Aligned_cols=32  Identities=41%  Similarity=0.344  Sum_probs=27.5

Q ss_pred             CCeEecCCCCCCeeecCC----CcEEEeeecCCccc
Q 042123          702 PPIVHRDISSKNLLLDLE----YEAHVADFGIAKSL  733 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~----~~~kl~DfG~a~~~  733 (849)
                      +.++|||+.+.||+++.+    +.+.++||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            479999999999999875    67999999988653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.09  E-value=0.041  Score=57.05  Aligned_cols=30  Identities=20%  Similarity=0.219  Sum_probs=25.4

Q ss_pred             CCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +.++|+|+.+.||+ ..++.+.++||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            35899999999999 5667889999998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.79  E-value=0.068  Score=56.08  Aligned_cols=29  Identities=21%  Similarity=0.271  Sum_probs=25.0

Q ss_pred             CCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +.++|+|+++.||+++ + .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3688999999999998 4 899999987754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.21  E-value=0.13  Score=54.22  Aligned_cols=31  Identities=23%  Similarity=0.255  Sum_probs=27.4

Q ss_pred             CCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      +.++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3799999999999999888899999987754

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=94.97  E-value=0.047  Score=59.71  Aligned_cols=30  Identities=13%  Similarity=0.191  Sum_probs=23.4

Q ss_pred             CceecCCccceEEEEEecC--------CcEEEEEEecc
Q 042123          593 KYCIGNGGHASVYRAELPS--------GEVVAVKKFHS  622 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~  622 (849)
                      .+.|+.|....||++...+        ++.+++|+...
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~  115 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN  115 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC
Confidence            4568889999999997653        57899998743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.72  E-value=0.088  Score=56.25  Aligned_cols=135  Identities=18%  Similarity=0.257  Sum_probs=70.1

Q ss_pred             CceecCCccceEEEEEec--------CCcEEEEEEecccCCCCc-hhhHHHHHHHHH------HhhceeecCCeeEEEEE
Q 042123          593 KYCIGNGGHASVYRAELP--------SGEVVAVKKFHSLLPCDQ-TVDQKEFLTEVE------AFYGFCSHARHSFLLYE  657 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~-~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e  657 (849)
                      .+.+..|....+|+....        +++.+++|+......... ...+...++.+.      ++++++..    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            346777889999999775        247899998643211100 001111111111      13333322    28999


Q ss_pred             eccCCChhhh-----------------hcccc--cccCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 042123          658 FLERGSLAAI-----------------LNTDA--AAQELG--WSQRMNVIKAVAH-------------------ALSYL-  696 (849)
Q Consensus       658 ~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~l~~L-  696 (849)
                      |++|..+..-                 +|...  ......  |.++.++..++..                   .++.| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998654311                 11111  011122  4556666554422                   23333 


Q ss_pred             ---Hhc-CCCCeEecCCCCCCeeecCC----CcEEEeeecCCc
Q 042123          697 ---HHD-CFPPIVHRDISSKNLLLDLE----YEAHVADFGIAK  731 (849)
Q Consensus       697 ---H~~-~~~~ivH~dlk~~Nill~~~----~~~kl~DfG~a~  731 (849)
                         ... ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               221 12368999999999999876    789999998775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=94.30  E-value=0.18  Score=55.45  Aligned_cols=68  Identities=13%  Similarity=0.063  Sum_probs=36.9

Q ss_pred             CceecCCccceEEEEEecC-CcEEEEEEecccCCCC-chhhHHHHHHHHH------HhhceeecCCeeEEEEEeccCCCh
Q 042123          593 KYCIGNGGHASVYRAELPS-GEVVAVKKFHSLLPCD-QTVDQKEFLTEVE------AFYGFCSHARHSFLLYEFLERGSL  664 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e~~~~gsL  664 (849)
                      .+.|+.|....+|++...+ +..+++|+........ ....+...++.+.      .+++++.  +  .+||||++|.++
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            4578889999999998764 4788899875422111 1112222233322      1333331  2  359999998544

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=93.46  E-value=0.19  Score=53.67  Aligned_cols=28  Identities=18%  Similarity=0.345  Sum_probs=23.8

Q ss_pred             CeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          703 PIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       703 ~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++|+|+.+.||+++.++ +.++||..+.
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            689999999999998655 8999998775

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=91.08  E-value=0.21  Score=34.09  Aligned_cols=28  Identities=21%  Similarity=0.408  Sum_probs=12.6

Q ss_pred             eehhhhhHH-HHHHHHHHHhhhhhcccCC
Q 042123          527 IVFPLLGAL-FVSIALISIFFILRKQKSD  554 (849)
Q Consensus       527 i~~~~~~~~-~~~~~~~~~~~~~~~~~~~  554 (849)
                      |..++++.+ ++++++++.|+++|||+.+
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~   41 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIV   41 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhh
Confidence            444445433 3444444444455554443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=89.76  E-value=1.9  Score=46.60  Aligned_cols=29  Identities=21%  Similarity=0.400  Sum_probs=25.7

Q ss_pred             CeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          703 PIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       703 ~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      .++|+|+.+.||+ +.++.+.++||..|..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            6899999999999 7888999999988753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=88.63  E-value=0.46  Score=51.28  Aligned_cols=30  Identities=23%  Similarity=0.328  Sum_probs=24.7

Q ss_pred             CeEecCCCCCCeee------cCCCcEEEeeecCCcc
Q 042123          703 PIVHRDISSKNLLL------DLEYEAHVADFGIAKS  732 (849)
Q Consensus       703 ~ivH~dlk~~Nill------~~~~~~kl~DfG~a~~  732 (849)
                      .++|+|+.+.||++      +++..++++||-+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4457799999987753

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=88.60  E-value=0.3  Score=33.24  Aligned_cols=28  Identities=14%  Similarity=0.326  Sum_probs=12.9

Q ss_pred             eehhhhhH-HHHHHHHHHHhhhhhcccCC
Q 042123          527 IVFPLLGA-LFVSIALISIFFILRKQKSD  554 (849)
Q Consensus       527 i~~~~~~~-~~~~~~~~~~~~~~~~~~~~  554 (849)
                      |..++++. +.+++++.+.|+++|||+.+
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSS
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhh
Confidence            44445543 34444444444555554443

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=87.43  E-value=0.33  Score=32.90  Aligned_cols=28  Identities=14%  Similarity=0.400  Sum_probs=13.4

Q ss_pred             eehhhhhHHHHHHHHHHHhhhhhcccCC
Q 042123          527 IVFPLLGALFVSIALISIFFILRKQKSD  554 (849)
Q Consensus       527 i~~~~~~~~~~~~~~~~~~~~~~~~~~~  554 (849)
                      |+++++|++++++++++++++.|||+.+
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~~   41 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQK   41 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCSC
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhhh
Confidence            4445555444444444444555555443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=84.45  E-value=1.2  Score=42.57  Aligned_cols=83  Identities=8%  Similarity=0.088  Sum_probs=63.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCCeeeccCCccccccccc
Q 042123          676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA  755 (849)
Q Consensus       676 ~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~  755 (849)
                      .++...+++++.+|+....++++.     +|--+.|+|++++.++.+++.-.|+...+.                 |.  
T Consensus        77 ~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~~l~-----------------P~--  132 (215)
T 4ann_A           77 SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQNVVD-----------------PL--  132 (215)
T ss_dssp             GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETTTBS-----------------CC--
T ss_pred             hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCccCCC-----------------CC--
Confidence            478899999999999999777766     899999999999999999998777644332                 21  


Q ss_pred             cCCCCCccchHHHHHHHHHHHHhCCCCCCc
Q 042123          756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDF  785 (849)
Q Consensus       756 ~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~  785 (849)
                         ..++..=.-.+=+++..+++++..|+.
T Consensus       133 ---~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          133 ---PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             ---CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             ---CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence               112222334566788889999999863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	849
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-47
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-47
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-46
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-46
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-43
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-43
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-43
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-42
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-42
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-41
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-41
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-41
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-40
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-40
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-39
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-38
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-37
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-37
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-37
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-37
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-36
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-36
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-36
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-36
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-36
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-35
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-34
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-33
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-32
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-32
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-31
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-31
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-30
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-28
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-28
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-27
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-25
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-23
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-15
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-19
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-18
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-08
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	3e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-15
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-13
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-17
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-15
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-12
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	8e-08
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-10
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-07
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	9e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	6e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	3e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-08
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	9e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	8e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	2e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	8e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	2e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	7e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.004
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.003

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 1e-49
 Identities = 58/277 (20%), Positives = 113/277 (40%), Gaps = 32/277 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
                   IG+G   +VY+ +      VAVK  +   P  Q    + F  EV        
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRH 63

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                F G+ +      ++ ++ E  SL   L+      +    + +++ +  A  + YL
Sbjct: 64  VNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLH--IIETKFEMIKLIDIARQTAQGMDYL 120

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPEL 754
           H      I+HRD+ S N+ L  +    + DFG+A      S +  + + +G+  ++APE+
Sbjct: 121 HA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177

Query: 755 AYTMK---ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
                    + + DVY+FG++++E++ G+ P    S+I++      +     L P L   
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLP---YSNINNRDQIIFMVGRGYLSPDLSKV 234

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
             +  + +  +M     C  +  + RP    I   + 
Sbjct: 235 RSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-47
 Identities = 54/270 (20%), Positives = 110/270 (40%), Gaps = 30/270 (11%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
           D++  Y IG G +    +      G+++  K+           +++  ++EV        
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELKH 62

Query: 642 -----FYGFCSHARHS--FLLYEFLERGSLAAILNTDAAAQE-LGWSQRMNVIKAVAHAL 693
                +Y       ++  +++ E+ E G LA+++      ++ L     + V+  +  AL
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 694 SYLH--HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
              H   D    ++HRD+   N+ LD +    + DFG+A+ L  D+S    F GT  Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
           PE    M   EK D++S G L++E+     P          + +      ++ + +    
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREGKFRRI 234

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                ++L  I+       N     RP+++
Sbjct: 235 PYRYSDELNEIIT---RMLNLKDYHRPSVE 261

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 5e-47
 Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 32/273 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
           ++      IG+G    V+     + + VA+K        +  + +++F+ E E       
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-----EGAMSEEDFIEEAEVMMKLSH 59

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 YG C       L++EF+E G L+  L T            + +   V   +   
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGM--- 114

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE-FAGTCGYIAPELA 755
            +     ++HRD++++N L+       V+DFG+ + +  D    +        + +PE+ 
Sbjct: 115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
              + + K DV+SFGVLMWEV           S      N++V  D     RL  P  ++
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGFRLYKPRLAS 228

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                 + ++   C+ E PE RP    + +QL 
Sbjct: 229 TH----VYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (420), Expect = 1e-46
 Identities = 55/272 (20%), Positives = 104/272 (38%), Gaps = 32/272 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
                   +G G    V+         VAVK          ++    FL E         
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-----QGSMSPDAFLAEANLMKQLQH 67

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 Y   +     +++ E++E GSL   L T +   +L  ++ +++   +A  ++++
Sbjct: 68  QRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFI 125

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW-TEFAGTCGYIAPELA 755
                   +HRD+ + N+L+       +ADFG+A+ ++ +             + APE  
Sbjct: 126 EERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
                T K DV+SFG+L+ E++          +      N +V  +     R+  P    
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLERGYRMVRPDNCP 236

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +E    + ++   C+ E PE RPT   +   L
Sbjct: 237 EE----LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 4e-46
 Identities = 63/274 (22%), Positives = 110/274 (40%), Gaps = 34/274 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
            D      +G G    V   +      VA+K        + ++ + EF+ E +       
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-----EGSMSEDEFIEEAKVMMNLSH 58

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 YG C+  R  F++ E++  G L   L            Q + + K V  A+ YL
Sbjct: 59  EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYL 116

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-WTEFAGTCGYIAPELA 755
                   +HRD++++N L++ +    V+DFG+++ +  D             +  PE+ 
Sbjct: 117 ES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173

Query: 756 YTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
              K + K D+++FGVLMWE+   GK P +                + +           
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------RFTNSETAEHIAQGLRLYRPHL 225

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           A EK+ +IM    SC++E  + RPT KI+   + 
Sbjct: 226 ASEKVYTIMY---SCWHEKADERPTFKILLSNIL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 3e-45
 Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 54/300 (18%)

Query: 586 ATNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA--- 641
             +DF+    +G G    V++    PSG V+A K  H      +   + + + E++    
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH---LEIKPAIRNQIIRELQVLHE 60

Query: 642 --------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHAL 693
                   FYG         +  E ++ GSL  +L     A  +       V  AV   L
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117

Query: 694 SYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           +YL       I+HRD+   N+L++   E  + DFG++  L    +    F GT  Y++PE
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPE 173

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHP------------------------------R 783
                  + + D++S G+ + E+  G++P                               
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 784 DFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAF--SCFNESPESRPTMK 841
               S         +A+ ++LD  +  P       + S+    F   C  ++P  R  +K
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  160 bits (405), Expect = 2e-44
 Identities = 57/301 (18%), Positives = 115/301 (38%), Gaps = 56/301 (18%)

Query: 588 NDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA 641
           N+ +    IG G    V++A  P         +VAVK             Q +F  E   
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 69

Query: 642 -----------FYGFCSHARHSFLLYEFLERGSLAAIL---------------------N 669
                        G C+  +   LL+E++  G L   L                      
Sbjct: 70  MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 129

Query: 670 TDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI 729
           +      L  ++++ + + VA  ++YL        VHRD++++N L+       +ADFG+
Sbjct: 130 SSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 730 AKSLKPDSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLS 787
           ++++            A    ++ PE  +  + T + DV+++GV++WE+        +  
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY-- 244

Query: 788 SISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 +  +  +  + D  + A   +   +L ++M     C+++ P  RP+   I + L
Sbjct: 245 -----GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRIL 296

Query: 848 R 848
           +
Sbjct: 297 Q 297

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 6e-44
 Identities = 67/297 (22%), Positives = 114/297 (38%), Gaps = 56/297 (18%)

Query: 595 CIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------------- 641
            IG G    V+R +   GE VAVK F S        +++ +  E E              
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSS-------REERSWFREAEIYQTVMLRHENILG 61

Query: 642 FYGFCSHARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
           F    +    +    +L+ ++ E GSL   LN       +     + +  + A  L++LH
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLH 117

Query: 698 HDCF-----PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW----TEFAGTCG 748
            +       P I HRD+ SKN+L+       +AD G+A      +           GT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 749 YIAPELAYTM------KITEKCDVYSFGVLMWEVIKGKHP-----------RDFLSSISS 791
           Y+APE+          +  ++ D+Y+ G++ WE+ +                D + S  S
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 792 SSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                 V  +Q L P +P   +S  E L  + ++   C+  +  +R T   I + L 
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSC-EALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 1e-43
 Identities = 57/272 (20%), Positives = 105/272 (38%), Gaps = 32/272 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
                +  +G G    V+         VA+K          T+  + FL E +       
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-----PGTMSPEAFLQEAQVMKKLRH 71

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                 Y   S     +++ E++ +GSL          + L   Q +++   +A  ++Y+
Sbjct: 72  EKLVQLYAVVSE-EPIYIVTEYMSKGSLL-DFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD-SSNWTEFAGTCGYIAPELA 755
                   VHRD+ + N+L+       VADFG+A+ ++ +  +          + APE A
Sbjct: 130 ERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
              + T K DV+SFG+L+ E+                 +N +V        R+P P    
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRV------PYPGMVNREVLDQVERGYRMPCPPECP 240

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
           +     + ++   C+ + PE RPT + +   L
Sbjct: 241 ES----LHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  156 bits (395), Expect = 4e-43
 Identities = 66/300 (22%), Positives = 120/300 (40%), Gaps = 51/300 (17%)

Query: 580 YDEIVKATNDFDAKY---------CIGNGGHASVYRAELPS----GEVVAVKKFHSLLPC 626
           +++  +A  +F  +           IG G    V    L         VA+K   S    
Sbjct: 9   FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 627 DQTVDQKEFLTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQ 675
            Q   +++FL+E                G  + +    ++ EF+E GSL + L  +    
Sbjct: 69  KQ---RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125

Query: 676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
                Q + +++ +A  + YL        VHRD++++N+L++      V+DFG+++ L+ 
Sbjct: 126 T--VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 736 DSSNWTE-----FAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSI 789
           D+S+ T            + APE     K T   DV+S+G++MWEV+  G+ P       
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW----- 235

Query: 790 SSSSLNTDVALDQML-DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
               +     ++ +  D RLP P          + ++   C+ +    RP    I   L 
Sbjct: 236 ---DMTNQDVINAIEQDYRLPPPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLD 288

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  155 bits (393), Expect = 5e-43
 Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 34/283 (12%)

Query: 580 YDEIVKATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTE 638
           YD+      D   K+ +G G +  VY          VAVK        + T++ +EFL E
Sbjct: 9   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-----EDTMEVEEFLKE 63

Query: 639 VEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                           G C+     +++ EF+  G+L   L  +   QE+     + +  
Sbjct: 64  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMAT 122

Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN-WTEFAGT 746
            ++ A+ YL        +HRD++++N L+   +   VADFG+++ +  D+          
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 747 CGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML-D 805
             + APE     K + K DV++FGVL+WE+                 ++     + +  D
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY-------PGIDLSQVYELLEKD 232

Query: 806 PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            R+  P    ++    + E+  +C+  +P  RP+   I Q   
Sbjct: 233 YRMERPEGCPEK----VYELMRACWQWNPSDRPSFAEIHQAFE 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 6e-43
 Identities = 64/274 (23%), Positives = 103/274 (37%), Gaps = 38/274 (13%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
            +      IG G    V   +   G  VAVK   +          + FL E         
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN------DATAQAFLAEASVMTQLRH 59

Query: 642 -----FYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                  G     +   +++ E++ +GSL   L        LG    +     V  A+ Y
Sbjct: 60  SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L        VHRD++++N+L+  +  A V+DFG+ K     SS          + APE  
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEAL 172

Query: 756 YTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
              K + K DV+SFG+L+WE+   G+ P   +          DV        ++ AP   
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDAPDGC 225

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                  + EV  +C++     RP+   + +QL 
Sbjct: 226 PPA----VYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 64/266 (24%), Positives = 103/266 (38%), Gaps = 33/266 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
            DF+    +G G   +VY A    S  ++A+K           V + +   EVE      
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 64

Query: 642 ------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                  YG+   A   +L+ E+   G++   L       +    +    I  +A+ALSY
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSY 121

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
            H      ++HRDI  +NLLL    E  +ADFG +      SS  T   GT  Y+ PE+ 
Sbjct: 122 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMI 176

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
                 EK D++S GVL +E + GK P +        +        ++       P    
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTFPDFVT 228

Query: 816 QEKLISIMEVAFSCFNESPESRPTMK 841
           +     ++         +P  RP ++
Sbjct: 229 EG-ARDLIS---RLLKHNPSQRPMLR 250

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 3e-42
 Identities = 61/271 (22%), Positives = 105/271 (38%), Gaps = 38/271 (14%)

Query: 596 IGNGGHASVYRAEL---PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----------- 641
           +G G   SV +           VA+K         +  D +E + E +            
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLK---QGTEKADTEEMMREAQIMHQLDNPYIVR 73

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
             G C  A    L+ E    G L   L      +E+  S    ++  V+  + YL     
Sbjct: 74  LIGVC-QAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEE--- 127

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE---FAGTCGYIAPELAYTM 758
              VHRD++++N+LL   + A ++DFG++K+L  D S +T          + APE     
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 187

Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
           K + + DV+S+GV MWE +  G+ P           +     +  +   +          
Sbjct: 188 KFSSRSDVWSYGVTMWEALSYGQKPYK--------KMKGPEVMAFIEQGKRMECPPECPP 239

Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           +L ++M     C+    E RP    + Q++R
Sbjct: 240 ELYALMS---DCWIYKWEDRPDFLTVEQRMR 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-42
 Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 38/271 (14%)

Query: 596 IGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----------- 641
           +G+G   +V +         + VAVK   +    +    + E L E              
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKN--EANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
             G C       L+ E  E G L   L  +   + +     + ++  V+  + YL     
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEE--- 125

Query: 702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGYIAPELAYTM 758
              VHRD++++N+LL  ++ A ++DFG++K+L+ D + +   T       + APE     
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 759 KITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
           K + K DV+SFGVLMWE    G+ P   +         ++V        R+  P+   +E
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTAMLEKGERMGCPAGCPRE 238

Query: 818 KLISIMEVAFSCFNESPESRPTMKIISQQLR 848
               + ++   C+    E+RP    +  +LR
Sbjct: 239 ----MYDLMNLCWTYDVENRPGFAAVELRLR 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 5e-41
 Identities = 57/282 (20%), Positives = 116/282 (41%), Gaps = 38/282 (13%)

Query: 580 YDEIVKATN---DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEF 635
           Y+ + +  N    ++    +G+G    VY+A+   +  + A K   +        + +++
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT----KSEEELEDY 56

Query: 636 LTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
           + E++                  +  + ++L EF   G++ A++      + L  SQ   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML--ELERPLTESQIQV 114

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
           V K    AL+YLH      I+HRD+ + N+L  L+ +  +ADFG++            F 
Sbjct: 115 VCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 171

Query: 745 GTCGYIAPELAYTM-----KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA 799
           GT  ++APE+             K DV+S G+ + E+ + + P         + +   + 
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-----ELNPMRVLLK 226

Query: 800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           + +   P L  PSR +       ++    C  ++ ++R T  
Sbjct: 227 IAKSEPPTLAQPSRWSSN-FKDFLK---KCLEKNVDARWTTS 264

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 7e-41
 Identities = 56/264 (21%), Positives = 100/264 (37%), Gaps = 37/264 (14%)

Query: 596 IGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           IG G   +VY+     +   VA  +           +++ F  E E            FY
Sbjct: 17  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS--ERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 644 GFCSHA----RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
                     +   L+ E +  G+L   L      + +      +  + +   L +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 700 CFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM 758
             PPI+HRD+   N+ +        + D G+A   +   +      GT  ++APE+ Y  
Sbjct: 132 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPEM-YEE 187

Query: 759 KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP-SRSAQE 817
           K  E  DVY+FG+ M E+   ++P        S   N      ++     PA   + A  
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 818 KLISIMEVAFSCFNESPESRPTMK 841
           ++  I+E    C  ++ + R ++K
Sbjct: 241 EVKEIIE---GCIRQNKDERYSIK 261

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 7e-41
 Identities = 55/303 (18%), Positives = 112/303 (36%), Gaps = 61/303 (20%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPS------GEVVAVKKFHSLLPCDQTVDQKEFLTEVEA 641
            + +    +G+G    V  A             VAVK          + +++  ++E++ 
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKM 93

Query: 642 ------------FYGFCSHARHSFLLYEFLERGSLAAILNT------------------- 670
                         G C+ +   +L++E+   G L   L +                   
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 671 -DAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI 729
            +     L +   +     VA  + +L        VHRD++++N+L+       + DFG+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 730 AKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFL 786
           A+ +  DS+            ++APE  +    T K DV+S+G+L+WE+   G +P    
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP-- 268

Query: 787 SSISSSSLNTDVALDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIIS 844
                  +  D    +++    ++  P  + +E    I  +  SC+      RP+   ++
Sbjct: 269 ------GIPVDANFYKLIQNGFKMDQPFYATEE----IYIIMQSCWAFDSRKRPSFPNLT 318

Query: 845 QQL 847
             L
Sbjct: 319 SFL 321

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 2e-40
 Identities = 59/289 (20%), Positives = 106/289 (36%), Gaps = 45/289 (15%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPSG---EVVAVKKFHSLLPCDQTVDQKEFLTEVEA--- 641
           ND   +  IG G    V +A +         A+K+       D   D ++F  E+E    
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCK 66

Query: 642 ---------FYGFCSHARHSFLLYEFLERGSLAAIL-------------NTDAAAQELGW 679
                      G C H  + +L  E+   G+L   L               ++ A  L  
Sbjct: 67  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126

Query: 680 SQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN 739
            Q ++    VA  + YL        +HRD++++N+L+   Y A +ADFG+++  +     
Sbjct: 127 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 740 WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVA 799
                    ++A E       T   DV+S+GVL+WE++                +     
Sbjct: 184 TM-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-------PYCGMTCAEL 235

Query: 800 LDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +++          +  +++  +M     C+ E P  RP+   I   L 
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLN 281

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-40
 Identities = 59/270 (21%), Positives = 110/270 (40%), Gaps = 36/270 (13%)

Query: 588 NDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA- 641
            D   KY     IG G   +VY A ++ +G+ VA+++ +      Q   ++  + E+   
Sbjct: 16  GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVM 71

Query: 642 ----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
                     +          +++ E+L  GSL  ++        +   Q   V +    
Sbjct: 72  RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQ 127

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           AL +LH +    ++HRDI S N+LL ++    + DFG    + P+ S  +   GT  ++A
Sbjct: 128 ALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
           PE+        K D++S G++  E+I+G+ P       + + L     +     P L  P
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-----NENPLRALYLIATNGTPELQNP 239

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTMK 841
            + +       +     C +   E R + K
Sbjct: 240 EKLSAI-FRDFLN---RCLDMDVEKRGSAK 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 6e-40
 Identities = 57/297 (19%), Positives = 110/297 (37%), Gaps = 54/297 (18%)

Query: 588 NDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA 641
           N       +G G    V  A         +   VAVK      P     +++  ++E++ 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKV 79

Query: 642 ------------FYGFCSHARHSFLLYEFLERGSLAAILN---------------TDAAA 674
                         G C+    + ++ E+   G L   L                 +   
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 675 QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK 734
             L     ++    VA  +++L        +HRD++++N+LL       + DFG+A+ +K
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 735 PDSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS 792
            DS+            ++APE  +    T + DV+S+G+ +WE+                
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP------- 249

Query: 793 SLNTDVALDQMLD--PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +  D    +M+    R+ +P  +  E    + ++  +C++  P  RPT K I Q +
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAE----MYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 1e-39
 Identities = 60/272 (22%), Positives = 101/272 (37%), Gaps = 38/272 (13%)

Query: 596 IGNGGHASVYRAELP----SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA---------- 641
           IG G    VY   L          AVK  +         +  +FLTE             
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN---RITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 642 -FYGFCSHARHS-FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHD 699
              G C  +  S  ++  +++ G L   +  +     +       +  A       +   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFL 146

Query: 700 CFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS----SNWTEFAGTCGYIAPELA 755
                VHRD++++N +LD ++   VADFG+A+ +         N T       ++A E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
            T K T K DV+SFGVL+WE++    P     +        D+ +  +   RL  P    
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN------TFDITVYLLQGRRLLQPEYCP 260

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
                 + EV   C++   E RP+   +  ++
Sbjct: 261 DP----LYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 8e-39
 Identities = 64/288 (22%), Positives = 110/288 (38%), Gaps = 41/288 (14%)

Query: 581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGE-----VVAVKKFHSLLPCDQTVDQKEF 635
            EI    +    +  IG G    VY+  L +        VA+K             + +F
Sbjct: 2   TEI--HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDF 56

Query: 636 LTEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
           L E                G  S  +   ++ E++E G+L   L       E    Q + 
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVG 114

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---T 741
           +++ +A  + YL +      VHRD++++N+L++      V+DFG+++ L+ D       +
Sbjct: 115 MLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 171

Query: 742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD 801
                  + APE     K T   DV+SFG++MWEV+       +        L+    + 
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMK 224

Query: 802 QMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            + D  RLP P          I ++   C+ +    RP    I   L 
Sbjct: 225 AINDGFRLPTPMDCPSA----IYQLMMQCWQQERARRPKFADIVSILD 268

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (363), Expect = 1e-38
 Identities = 58/265 (21%), Positives = 106/265 (40%), Gaps = 36/265 (13%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           IG+G   +VY A  + + EVVA+KK             ++ + EV             + 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
           G       ++L+ E+    +   +       + L   +   V       L+YLH      
Sbjct: 82  GCYLREHTAWLVMEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HN 135

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTM---KI 760
           ++HRD+ + N+LL       + DFG A  + P +S    F GT  ++APE+   M   + 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAMDEGQY 191

Query: 761 TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLI 820
             K DV+S G+   E+ + K P   ++++               +      S    E   
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGHWSEYFR 244

Query: 821 SIMEVAFSCFNESPESRPTMKIISQ 845
           + ++   SC  + P+ RPT +++ +
Sbjct: 245 NFVD---SCLQKIPQDRPTSEVLLK 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-37
 Identities = 59/269 (21%), Positives = 97/269 (36%), Gaps = 33/269 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
            D+D    +G G +  V  A    + E VAVK              +    E+       
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD---MKRAVDCPENIKKEICINKMLN 61

Query: 642 ------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                 FYG        +L  E+   G L   +  D     +           +   + Y
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVY 118

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPE 753
           LH      I HRDI  +NLLLD      ++DFG+A   + ++      +  GT  Y+APE
Sbjct: 119 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 754 LAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS 812
           L    +   E  DV+S G+++  ++ G+ P D        S +     D         P 
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPW 229

Query: 813 RSAQEKLISIMEVAFSCFNESPESRPTMK 841
           +      ++++        E+P +R T+ 
Sbjct: 230 KKIDSAPLALLH---KILVENPSARITIP 255

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 1e-37
 Identities = 65/282 (23%), Positives = 97/282 (34%), Gaps = 40/282 (14%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-- 641
            D      +G+G    V R E  +       VAVK     +         +F+ EV A  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVNAMH 66

Query: 642 ---------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
                     YG         ++ E    GSL   L                    VA  
Sbjct: 67  SLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEG 123

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW---TEFAGTCGY 749
           + YL        +HRD++++NLLL       + DFG+ ++L  +  ++           +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQML--DP 806
            APE   T   +   D + FGV +WE+   G+ P           LN    L ++     
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--------GLNGSQILHKIDKEGE 232

Query: 807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           RLP P    Q+    I  V   C+   PE RPT   +   L 
Sbjct: 233 RLPRPEDCPQD----IYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  141 bits (356), Expect = 2e-37
 Identities = 50/268 (18%), Positives = 96/268 (35%), Gaps = 32/268 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           + +D    +G G    V+R  E  +G   A K   +        D++    E++      
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT----PHESDKETVRKEIQTMSVLR 81

Query: 642 ------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                  +          ++YEF+  G L   +       ++   + +  ++ V   L +
Sbjct: 82  HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCH 139

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           +H +     VH D+  +N++   +    +   DFG+   L P  S      GT  + APE
Sbjct: 140 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPE 195

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR 813
           +A    +    D++S GVL + ++ G  P  F       +L    + D  +D    +   
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAFSGIS 253

Query: 814 SAQEKLISIMEVAFSCFNESPESRPTMK 841
              +  I             P +R T+ 
Sbjct: 254 EDGKDFIR------KLLLADPNTRMTIH 275

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 50/279 (17%), Positives = 95/279 (34%), Gaps = 33/279 (11%)

Query: 585 KATNDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-- 641
           K   DF     +G G  ++V  A EL +    A+K         +         E +   
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKEN-KVPYVTRERDVMS 63

Query: 642 ---------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
                     Y         +    + + G L   +           +        +  A
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSA 120

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW--TEFAGTCGYI 750
           L YLH      I+HRD+  +N+LL+ +    + DFG AK L P+S       F GT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA 810
           +PEL       +  D+++ G ++++++ G  P          + N  +   +++      
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR--------AGNEYLIFQKIIKLEYDF 229

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLRI 849
           P +   +    ++E            R   + +     +
Sbjct: 230 PEKFFPK-ARDLVE---KLLVLDATKRLGCEEMEGYGPL 264

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 9e-37
 Identities = 60/278 (21%), Positives = 102/278 (36%), Gaps = 37/278 (13%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-- 641
              +   CIG G    V++    S       VA+K       C     +++FL E     
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMR 63

Query: 642 ---------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
                      G  +     +++ E    G L + L        L  +  +     ++ A
Sbjct: 64  QFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTA 120

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS-NWTEFAGTCGYIA 751
           L+YL        VHRDI+++N+L+       + DFG+++ ++  +    ++      ++A
Sbjct: 121 LAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177

Query: 752 PELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA 810
           PE     + T   DV+ FGV MWE++  G  P   +        N DV        RLP 
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPM 230

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           P          +  +   C+   P  RP    +  QL 
Sbjct: 231 PPNCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 2e-36
 Identities = 58/267 (21%), Positives = 99/267 (37%), Gaps = 32/267 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
            DF     +G G    V+ AE   + +  A+K     +      D +  + E        
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDD-DVECTMVEKRVLSLAW 60

Query: 642 -------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALS 694
                   +       + F + E+L  G L   +    +  +   S+       +   L 
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQ 117

Query: 695 YLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPEL 754
           +LH      IV+RD+   N+LLD +    +ADFG+ K      +    F GT  YIAPE+
Sbjct: 118 FLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174

Query: 755 AYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS 814
               K     D +SFGVL++E++ G+ P              +  L   +    P   R 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---------QDEEELFHSIRMDNPFYPRW 225

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMK 841
            +++   ++      F   PE R  ++
Sbjct: 226 LEKEAKDLLV---KLFVREPEKRLGVR 249

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-36
 Identities = 51/287 (17%), Positives = 105/287 (36%), Gaps = 42/287 (14%)

Query: 588 NDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA 641
                   +G G    VY               VA+K  +         ++ EFL E   
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 76

Query: 642 -----------FYGFCSHARHSFLLYEFLERGSLAAILNT-------DAAAQELGWSQRM 683
                        G  S  + + ++ E + RG L + L +       +        S+ +
Sbjct: 77  MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 136

Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS--NWT 741
            +   +A  ++YL+       VHRD++++N ++  ++   + DFG+ + +          
Sbjct: 137 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 193

Query: 742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD 801
           +      +++PE       T   DV+SFGV++WE+                 L+ +  L 
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ-------PYQGLSNEQVLR 246

Query: 802 QMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +++  L     +  + L  +M     C+  +P+ RP+   I   ++
Sbjct: 247 FVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 290

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-36
 Identities = 56/295 (18%), Positives = 105/295 (35%), Gaps = 51/295 (17%)

Query: 588 NDFDAKYCIGNGGHASVYRAELPS--------GEVVAVKKFHSLLPCDQTVDQKEFLTEV 639
           +       +G G    V  AE              VAVK   S        D  + ++E+
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK---DLSDLISEM 69

Query: 640 EA------------FYGFCSHARHSFLLYEFLERGSLAAIL-------------NTDAAA 674
           E               G C+     +++ E+  +G+L   L              +    
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 675 QELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK 734
           ++L     ++    VA  + YL        +HRD++++N+L+  +    +ADFG+A+ + 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186

Query: 735 PDSSNWT--EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS 792
                           ++APE  +    T + DV+SFGVL+WE+                
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-------P 239

Query: 793 SLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
            +  +     + +        +   +L  +M     C++  P  RPT K + + L
Sbjct: 240 GVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  137 bits (346), Expect = 6e-36
 Identities = 52/268 (19%), Positives = 98/268 (36%), Gaps = 32/268 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           + +D    +G+G    V+R  E  +G V   K  ++       +D+     E+       
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT----PYPLDKYTVKNEISIMNQLH 84

Query: 642 ------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                  +          L+ EFL  G L   +  +    ++  ++ +N ++     L +
Sbjct: 85  HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKH 142

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGYIAPE 753
           +H      IVH DI  +N++ + +  + V   DFG+A  L PD         T  + APE
Sbjct: 143 MHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV-TTATAEFAAPE 198

Query: 754 LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR 813
           +     +    D+++ GVL + ++ G  P  F       +L      D   D    +   
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSSVS 256

Query: 814 SAQEKLISIMEVAFSCFNESPESRPTMK 841
              +  I       +   + P  R T+ 
Sbjct: 257 PEAKDFIK------NLLQKEPRKRLTVH 278

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 6e-36
 Identities = 61/285 (21%), Positives = 112/285 (39%), Gaps = 40/285 (14%)

Query: 582 EIVKATNDFDAKYCIGNGGHASVYRAE-LPSGEV----VAVKKFHSLLPCDQTVDQKEFL 636
            I+K T +F     +G+G   +VY+   +P GE     VA+K+             KE L
Sbjct: 4   RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR---EATSPKANKEIL 59

Query: 637 TEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNV 685
            E                G C  +    L+ + +  G L  +         +G    +N 
Sbjct: 60  DEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCL--LDYVREHKDNIGSQYLLNW 116

Query: 686 IKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW--TEF 743
              +A  ++YL       +VHRD++++N+L+       + DFG+AK L  +   +     
Sbjct: 117 CVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 173

Query: 744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVI-KGKHPRDFLSSISSSSLNTDVALDQ 802
                ++A E       T + DV+S+GV +WE++  G  P D +         ++++   
Sbjct: 174 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------ASEISSIL 226

Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL 847
               RLP P     +    +  +   C+    +SRP  + +  + 
Sbjct: 227 EKGERLPQPPICTID----VYMIMVKCWMIDADSRPKFRELIIEF 267

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-35
 Identities = 51/260 (19%), Positives = 97/260 (37%), Gaps = 33/260 (12%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           +G G    V+R  E  S +    K         +  DQ     E+              +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV-----KGTDQVLVKKEISILNIARHRNILHLH 67

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
                     +++EF+    +   +NT A   EL   + ++ +  V  AL +LH      
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 704 IVHRDISSKNLLLDLEYEAHV--ADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKIT 761
           I H DI  +N++      + +   +FG A+ LKP  +          Y APE+     ++
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVHQHDVVS 181

Query: 762 EKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLIS 821
              D++S G L++ ++ G +P  FL+            ++ +++        + +E  I 
Sbjct: 182 TATDMWSLGTLVYVLLSGINP--FLAE------TNQQIIENIMNAEYTFDEEAFKEISIE 233

Query: 822 IMEVAFSCFNESPESRPTMK 841
            M+       +  +SR T  
Sbjct: 234 AMDFVDRLLVKERKSRMTAS 253

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  130 bits (329), Expect = 2e-34
 Identities = 54/277 (19%), Positives = 104/277 (37%), Gaps = 39/277 (14%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKE-----FLTEVEA- 641
           +++ K  +G G  + V R    P+ +  AVK          + ++ +      L EV+  
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 642 -----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
                                 FL+++ +++G L   L        L   +   +++A+ 
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 120

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYI 750
             +  LH      IVHRD+  +N+LLD +    + DFG +  L P      E  GT  Y+
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176

Query: 751 APELAYTM------KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML 804
           APE+             ++ D++S GV+M+ ++ G  P               + L  ++
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW--------HRKQMLMLRMIM 228

Query: 805 DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                  S    +   ++ ++        P+ R T +
Sbjct: 229 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (323), Expect = 2e-33
 Identities = 58/278 (20%), Positives = 97/278 (34%), Gaps = 41/278 (14%)

Query: 585 KATNDFDAKY----CIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEV 639
           K   D    Y     +G G  + V  AE   + ++VA+K             +     E+
Sbjct: 2   KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIA---KKALEGKEGSMENEI 58

Query: 640 EA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKA 688
                                 H +L+ + +  G L   +                +I  
Sbjct: 59  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GFYTERDASRLIFQ 115

Query: 689 VAHALSYLHHDCFPPIVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAG 745
           V  A+ YLH      IVHRD+  +NLL     E     ++DFG++K   P S   T   G
Sbjct: 116 VLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACG 171

Query: 746 TCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP--RDFLSSISSSSLNTDVALDQM 803
           T GY+APE+      ++  D +S GV+ + ++ G  P   +  + +    L  +   D  
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP 231

Query: 804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
               +   ++      I           + PE R T +
Sbjct: 232 YWDDISDSAKD----FIR------HLMEKDPEKRFTCE 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 3e-33
 Identities = 55/295 (18%), Positives = 105/295 (35%), Gaps = 49/295 (16%)

Query: 588 NDFDAKYCIGNGGHASVYRA------ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA 641
           +       +G G    V  A      +  +   VAVK            + +  ++E++ 
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 69

Query: 642 ------------FYGFCSHARHS-FLLYEFLERGSLAAILNT-------------DAAAQ 675
                         G C+       ++ EF + G+L+  L +             D    
Sbjct: 70  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 676 ELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP 735
            L     +     VA  + +L        +HRD++++N+LL  +    + DFG+A+ +  
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 736 DSSNW--TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS 793
           D       +      ++APE  +    T + DV+SFGVL+WE+                 
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVK 241

Query: 794 LNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
           ++ +         R+ AP  +  E    + +    C++  P  RPT   + + L 
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  127 bits (320), Expect = 3e-33
 Identities = 40/278 (14%), Positives = 85/278 (30%), Gaps = 41/278 (14%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------------F 642
           IG G    ++    L + + VA+K         +  D  +   E                
Sbjct: 13  IGEGSFGVIFEGTNLLNNQQVAIKFEP------RRSDAPQLRDEYRTYKLLAGCTGIPNV 66

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
           Y F     H+ L+ + L       +       ++          K +   +  +H     
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---K 120

Query: 703 PIVHRDISSKNLLLDLEYEAH-----VADFGIAKSLKPDSSN-------WTEFAGTCGYI 750
            +V+RDI   N L+      +     V DFG+ K  +   +            +GT  Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 751 APELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA 810
           +       + + + D+ + G +    ++G  P   L + ++      +   +   P    
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
            +   +E     M       N + ++ P    +     
Sbjct: 241 CAGFPEE-FYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  126 bits (317), Expect = 8e-33
 Identities = 61/282 (21%), Positives = 118/282 (41%), Gaps = 35/282 (12%)

Query: 587 TNDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA---- 641
           ++ ++    +G GG + V+ A  L     VAVK   + L  D +     F  E +     
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPS-FYLRFRREAQNAAAL 64

Query: 642 -------FYGFCSHARHS----FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
                   Y        +    +++ E+++  +L  I++T+     +   + + VI    
Sbjct: 65  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADAC 121

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTE---FAGTC 747
            AL++ H      I+HRD+   N+++       V DFGIA+++    ++ T+     GT 
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 748 GYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR 807
            Y++PE A    +  + DVYS G +++EV+ G+ P    +  S  S+      +  + P 
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP---FTGDSPVSVAYQHVREDPIPPS 235

Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRP-TMKIISQQLR 848
                 S    L +++        ++PE+R  T   +   L 
Sbjct: 236 ARHEGLS--ADLDAVVL---KALAKNPENRYQTAAEMRADLV 272

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  128 bits (323), Expect = 8e-33
 Identities = 50/269 (18%), Positives = 89/269 (33%), Gaps = 34/269 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           NDF     IG GG   VY      +G++ A+K             +   L E        
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR-IKMKQGETLALNERIMLSLVS 62

Query: 642 ---------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
                                 + + +  G L   L+      E   +        +   
Sbjct: 63  TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILG 119

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAP 752
           L ++H+     +V+RD+   N+LLD      ++D G+A        + +   GT GY+AP
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAP 174

Query: 753 E-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP 811
           E L   +      D +S G +++++++G  P          + +        L   +  P
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-----QHKTKDKHEIDRMTLTMAVELP 229

Query: 812 SRSAQEKLISIMEVAFSCFNESPESRPTM 840
              + E L S++E            R   
Sbjct: 230 DSFSPE-LRSLLE---GLLQRDVNRRLGC 254

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 3e-32
 Identities = 45/264 (17%), Positives = 95/264 (35%), Gaps = 33/264 (12%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFH--SLLPCDQTVDQKEFLTEVEA----------- 641
           +G+G  A V +  E  +G   A K           + V +++   EV             
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77

Query: 642 FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCF 701
            +    +     L+ E +  G L           E          + +   L+ +++   
Sbjct: 78  LHEVYENKTDVILILELVAGGEL------FDFLAEKESLTEEEATEFLKQILNGVYYLHS 131

Query: 702 PPIVHRDISSKNLLLDLE----YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
             I H D+  +N++L           + DFG+A  +   +  +    GT  ++APE+   
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEFVAPEIVNY 190

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQE 817
             +  + D++S GV+ + ++ G  P  FL      +L    A++   +    + + +  +
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP--FLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248

Query: 818 KLISIMEVAFSCFNESPESRPTMK 841
             I           + P+ R T++
Sbjct: 249 DFIR------RLLVKDPKKRMTIQ 266

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (313), Expect = 4e-32
 Identities = 38/277 (13%), Positives = 85/277 (30%), Gaps = 41/277 (14%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------------F 642
           IG+G    +Y    + +GE VA+K               +   E +              
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECV------KTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
               +   ++ ++ E L               ++      + +   +   + Y+H     
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSKN-- 123

Query: 703 PIVHRDISSKNLL---LDLEYEAHVADFGIAKSLKPDSSN-------WTEFAGTCGYIAP 752
             +HRD+   N L          ++ DFG+AK  +   ++            GT  Y + 
Sbjct: 124 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 753 ELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS 812
                ++ + + D+ S G ++     G  P   L +            +++ + ++  P 
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-----TKRQKYERISEKKMSTPI 237

Query: 813 RSAQEKL-ISIMEVAFSCFNESPESRPTMKIISQQLR 848
               +            C +   + +P    + Q  R
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 4e-32
 Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 40/267 (14%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------------- 640
           +G G +  V +     + E  A+K            D  +   EVE              
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQ---------DCPKARREVELHWRASQCPHIVRI 70

Query: 641 --AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHH 698
              +    +  +   ++ E L+ G L + +  D   Q     +   ++K++  A+ YLH 
Sbjct: 71  VDVYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLHS 129

Query: 699 DCFPPIVHRDISSKNLLLDLEYE---AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
                I HRD+  +NLL   +       + DFG AK     +S  T    T  Y+APE+ 
Sbjct: 130 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPEVL 185

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS- 814
              K  + CD++S GV+M+ ++ G  P  F S+   +         +M     P P  S 
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPP--FYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 815 AQEKLISIMEVAFSCFNESPESRPTMK 841
             E++  ++    +     P  R T+ 
Sbjct: 244 VSEEVKMLIR---NLLKTEPTQRMTIT 267

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  122 bits (306), Expect = 2e-31
 Identities = 57/275 (20%), Positives = 102/275 (37%), Gaps = 37/275 (13%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYG 644
           IG G +  VY+A+   GE  A+KK    L  +        + E+              Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 645 FCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
                +   L++E L++     +   +     L      + +  + + ++Y H      +
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHD---RRV 121

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LAYTMKITEK 763
           +HRD+  +NLL++ E E  +ADFG+A++       +T    T  Y AP+ L  + K +  
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181

Query: 764 CDVYSFGVLMWEVIKGKHP------RDFLSSI------SSSSLNTDVALDQMLDPRLPAP 811
            D++S G +  E++ G          D L  I       +S    +V      DP     
Sbjct: 182 IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241

Query: 812 SRSAQEKLISIMEVAF-----SCFNESPESRPTMK 841
                E  +  ++ +            P  R T K
Sbjct: 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  122 bits (307), Expect = 3e-31
 Identities = 52/269 (19%), Positives = 91/269 (33%), Gaps = 34/269 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
            DF     +G G    V+      +G   A+K     +        +    E        
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLK-QVEHTNDERLMLSIVT 62

Query: 642 ------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                  +G    A+  F++ +++E G L ++L                 +         
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLA 116

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L +     I++RD+  +N+LLD      + DFG AK +           GT  YIAPE+ 
Sbjct: 117 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVV 173

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
            T    +  D +SFG+L++E++ G  P            NT    +++L+  L  P    
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPP-FF 224

Query: 816 QEKLISIMEVAFSCFNESPESRPTMKIIS 844
            E +  ++             R       
Sbjct: 225 NEDVKDLLS---RLITRDLSQRLGNLQNG 250

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 5e-31
 Identities = 58/274 (21%), Positives = 97/274 (35%), Gaps = 47/274 (17%)

Query: 590 FDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFH--SLLPCDQTVDQKEFLTEVEA- 641
            +++Y     +G+GG  SVY    +     VA+K      +    +  +      EV   
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 642 ------------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAV 689
                          +        L+ E  E         T+     L      +    V
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV 119

Query: 690 AHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAGTCG 748
             A+ + H+     ++HRDI  +N+L+DL   E  + DFG    LK   + +T+F GT  
Sbjct: 120 LEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRV 174

Query: 749 YIAPE-LAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR 807
           Y  PE + Y         V+S G+L+++++ G  P +    I    +   V   Q +   
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI----IRGQVFFRQRVSSE 230

Query: 808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                    + LI        C    P  RPT +
Sbjct: 231 C--------QHLIR------WCLALRPSDRPTFE 250

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 2e-30
 Identities = 62/279 (22%), Positives = 104/279 (37%), Gaps = 42/279 (15%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFH-SLLPCDQTVDQKEFLTEVEA-----------F 642
           +G G  A+VY+A    + ++VA+KK         +    +  L E++             
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 643 YGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFP 702
                H  +  L+++F+E      I +       L  S     +      L YLH     
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 703 PIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMK-IT 761
            I+HRD+   NLLLD      +ADFG+AKS    +  +T    T  Y APEL +  +   
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 762 EKCDVYSFGVLMWEVIKGKHP------RDFLSSI-------------SSSSLNTDVALDQ 802
              D+++ G ++ E++            D L+ I                SL   V    
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 803 MLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
                L     +A + L+ +++     F  +P +R T  
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITAT 275

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 9e-29
 Identities = 50/293 (17%), Positives = 98/293 (33%), Gaps = 44/293 (15%)

Query: 585 KATNDFDAKYCIGNGGHASVYRAE--LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA- 641
           +A   ++    IG G +  V++A      G  VA+K+    +   +       + EV   
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVL 61

Query: 642 -------------FYGFCSHAR-----HSFLLYEFLERGSLAAILNTDAAAQELGWSQRM 683
                         +  C+ +R        L++E +++     +         +      
Sbjct: 62  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIK 119

Query: 684 NVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEF 743
           +++  +   L +LH      +VHRD+  +N+L+    +  +ADFG+A+      +  +  
Sbjct: 120 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-V 175

Query: 744 AGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP-------------RDFLSSIS 790
             T  Y APE+          D++S G +  E+ + K                D +    
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235

Query: 791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAF--SCFNESPESRPTMK 841
                 DVAL +       A         I  +       C   +P  R +  
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 1e-28
 Identities = 53/266 (19%), Positives = 93/266 (34%), Gaps = 31/266 (11%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           NDFD    +G G    V       +G   A+K     +   +  +    +TE        
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKD-EVAHTVTESRVLQNTR 63

Query: 642 ------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                              + E+   G L   L+ +    E             A  +S 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSA 117

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           L +     +V+RDI  +NL+LD +    + DFG+ K    D +    F GT  Y+APE+ 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
                    D +  GV+M+E++ G+ P          + + +   + +L   +  P   +
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFY--------NQDHERLFELILMEEIRFPRTLS 229

Query: 816 QEKLISIMEVAFSCFNESPESRPTMK 841
            E   S++        + P+ R    
Sbjct: 230 PE-AKSLLA---GLLKKDPKQRLGGG 251

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (283), Expect = 3e-28
 Identities = 55/283 (19%), Positives = 101/283 (35%), Gaps = 37/283 (13%)

Query: 589 DFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
           +F     IG G +  VY+A    +GEVVA+KK    L  +        + E+        
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR--LDTETEGVPSTAIREISLLKELNH 60

Query: 642 -----FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYL 696
                           +L++EFL +     +  +      +      + +  +   L++ 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFC 118

Query: 697 HHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPE-LA 755
           H      ++HRD+  +NLL++ E    +ADFG+A++       +T    T  Y APE L 
Sbjct: 119 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSIS------------SSSLNTDVALDQM 803
                +   D++S G +  E++  +      S I                +   V     
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235

Query: 804 LDPRLPAPSRSAQEKLISIMEVAF-----SCFNESPESRPTMK 841
             P  P  +R    K++  ++           +  P  R + K
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-27
 Identities = 52/272 (19%), Positives = 95/272 (34%), Gaps = 33/272 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-- 641
            +F+    +G G +  V+         +G++ A+K         +    +   TE +   
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 642 ----------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAH 691
                      +          L+ +++  G L   L+      E      +        
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 692 ALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWT-EFAGTCGYI 750
            +  L H     I++RDI  +N+LLD      + DFG++K    D +    +F GT  Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 751 APELAYTMK--ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL 808
           AP++         +  D +S GVLM+E++ G  P  F      +S           +P  
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQAEISRRILKSEPPY 255

Query: 809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTM 840
           P    +  + LI           + P+ R   
Sbjct: 256 PQEMSALAKDLIQ------RLLMKDPKKRLGC 281

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 2e-27
 Identities = 45/277 (16%), Positives = 96/277 (34%), Gaps = 39/277 (14%)

Query: 596 IGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           IG G + +V++A+   + E+VA+K+    L  D        L E+              +
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
                 +   L++EF ++       + +      G      V   +   L  L       
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRN 121

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKI-TE 762
           ++HRD+  +NLL++   E  +A+FG+A++       ++    T  Y  P++ +  K+ + 
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 763 KCDVYSFGVLMWEVIKGKHP--------------RDFLSSISSSSLNTDVALDQMLDPRL 808
             D++S G +  E+     P                 L + +     +   L       +
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 809 PAPSRSAQEKLISIMEVAFS----CFNESPESRPTMK 841
              + S    +  +              +P  R + +
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 2e-27
 Identities = 53/284 (18%), Positives = 98/284 (34%), Gaps = 47/284 (16%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           IG G +  V  A +  +   VA+KK     P +     +  L E++              
Sbjct: 16  IGEGAYGMVCSAYDNVNKVRVAIKKIS---PFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 644 GFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPP 703
                     +   +L    + A L      Q L        +  +   L Y+H      
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 129

Query: 704 IVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN---WTEFAGTCGYIAPELAYT-MK 759
           ++HRD+   NLLL+   +  + DFG+A+   PD  +    TE+  T  Y APE+      
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 760 ITEKCDVYSFGVLMWEVIKGKHP----------------------RDFLSSISSSSLNTD 797
            T+  D++S G ++ E++  +                         D    I+  + N  
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249

Query: 798 VALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           ++L             +A  K + +++        +P  R  ++
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVE 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 4e-27
 Identities = 54/279 (19%), Positives = 95/279 (34%), Gaps = 38/279 (13%)

Query: 589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------ 641
            +     IGNG    VY+A+L  SGE+VA+KK           D++    E++       
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDH 72

Query: 642 -----FYGFCSHA------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVA 690
                   F   +       +  L+ +++         +   A Q L        +  + 
Sbjct: 73  CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132

Query: 691 HALSYLHHDCFPPIVHRDISSKNLLLDLEYEAH-VADFGIAKSLKPDSSNWTEFAGTCGY 749
            +L+Y+H      I HRDI  +NLLLD +     + DFG AK L     N +        
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 750 IAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP 809
               +      T   DV+S G ++ E++ G+              +    L +++     
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPI--------FPGDSGVDQLVEIIKVLGT 241

Query: 810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR 848
                 +E   +  E  F      P ++        +  
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAI 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 3e-25
 Identities = 45/302 (14%), Positives = 99/302 (32%), Gaps = 59/302 (19%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           + ++    IG G    V++A    +G+ VA+KK    +  ++       L E++      
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQLLK 67

Query: 642 ------FYGFCSHA--------RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIK 687
                     C              +L+++F E      + N       L       + +
Sbjct: 68  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKR 121

Query: 688 AVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS----NWTEF 743
            +   L+ L++     I+HRD+ + N+L+  +    +ADFG+A++     +     +T  
Sbjct: 122 VMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 744 AGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHP-------------------- 782
             T  Y  PEL    +      D++  G +M E+                          
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241

Query: 783 -RDFLSSISSSSLNTDVALDQMLDPRLPA--PSRSAQEKLISIMEVAFSCFNESPESRPT 839
             +   ++ +  L   + L +    ++     +       + +++         P  R  
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRID 298

Query: 840 MK 841
             
Sbjct: 299 SD 300

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  104 bits (259), Expect = 1e-24
 Identities = 44/263 (16%), Positives = 87/263 (33%), Gaps = 34/263 (12%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           + FD    +G G    V   +   SG   A+K              +  L E        
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK-QIEHTLNEKRILQAVN 99

Query: 642 ------FYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSY 695
                          + +++ E++  G + + L                    +     Y
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEY 156

Query: 696 LHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELA 755
           LH      +++RD+  +NLL+D +    V DFG AK             GT   +APE+ 
Sbjct: 157 LHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEII 210

Query: 756 YTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA 815
            +    +  D ++ GVL++E+  G  P          +       ++++  ++  PS  +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFF--------ADQPIQIYEKIVSGKVRFPSHFS 262

Query: 816 QEKLISIMEVAFSCFNESPESRP 838
            +    + ++  +        R 
Sbjct: 263 SD----LKDLLRNLLQVDLTKRF 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 2e-23
 Identities = 53/299 (17%), Positives = 100/299 (33%), Gaps = 49/299 (16%)

Query: 582 EIVKATNDFDAKY----CIGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFL 636
           E+ K   +  A Y     +G+G + +V  A +  +G  VA+KK +   P    +  K   
Sbjct: 8   EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY--RPFQSELFAKRAY 65

Query: 637 TEVEA-----------FYGFCSHARHSFLLYEFLERGSLAAILNTD-AAAQELGWSQRMN 684
            E+                  +         +F                 ++LG  +   
Sbjct: 66  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQF 125

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFA 744
           ++  +   L Y+H        HRD+   NL ++ + E  + DFG+A+  + DS       
Sbjct: 126 LVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVV 180

Query: 745 GTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP---------------------R 783
                    +   M+ T+  D++S G +M E+I GK                        
Sbjct: 181 TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240

Query: 784 DFLSSISSSSL-NTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMK 841
           +F+  + S    N    L ++      +   +A    ++++E          E R T  
Sbjct: 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAG 296

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =   99 bits (248), Expect = 2e-23
 Identities = 41/212 (19%), Positives = 78/212 (36%), Gaps = 34/212 (16%)

Query: 588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA----- 641
           +D+     +G G ++ V+ A  + + E V VK           V +K+   E++      
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-------VKKKKIKREIKILENLR 87

Query: 642 -------FYGFCSHA--RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHA 692
                            R   L++E +       +       Q L        +  +  A
Sbjct: 88  GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKA 141

Query: 693 LSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIA 751
           L Y H      I+HRD+   N+++D E  +  + D+G+A+   P    +     +  +  
Sbjct: 142 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKG 197

Query: 752 PELAYTMK-ITEKCDVYSFGVLMWEVIKGKHP 782
           PEL    +      D++S G ++  +I  K P
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 97.8 bits (242), Expect = 7e-23
 Identities = 62/317 (19%), Positives = 108/317 (34%), Gaps = 40/317 (12%)

Query: 181 SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
            +  ++ S   L   +P ++      ++LDL  N+   +      NL NL  L L+ N +
Sbjct: 11  HLRVVQCSDLGL-EKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 241 SGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCT 299
           S   P +   L+ L +L LS N               L +        + ++   L    
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 300 SLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNI 359
            +  +  N    +G  + A      L++I ++  N                        I
Sbjct: 128 VVE-LGTNPLKSSGIENGAFQGMKKLSYIRIADTNI---------------------TTI 165

Query: 360 TGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLT 419
             GLP        L    L  N I       L  LN L KL L  N I+      + +  
Sbjct: 166 PQGLP------PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219

Query: 420 KLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHG------LSFIDM 471
            L  L  +   + ++P  + + K ++ + L +NN+S    + F            S + +
Sbjct: 220 HLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL 279

Query: 472 SYNELQCPVPNSTTFRG 488
             N +Q      +TFR 
Sbjct: 280 FSNPVQYWEIQPSTFRC 296

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 93.6 bits (231), Expect = 2e-21
 Identities = 60/313 (19%), Positives = 111/313 (35%), Gaps = 45/313 (14%)

Query: 161 LQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVL 220
           L L +N++       F NL ++ TL L  N +    P     +  L  L L++NQ K  L
Sbjct: 36  LDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-L 94

Query: 221 PPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIF 280
           P  +     L+EL +  N ++         L    ++  G +                  
Sbjct: 95  PEKMPK--TLQELRVHENEITKVRKSVFNGLNQMIVVELGTN------------------ 134

Query: 281 TVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEIS 340
                   G    + +    L  +R+   N+T   +   G+ P+LT + L  N      +
Sbjct: 135 ---PLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDA 188

Query: 341 SNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKL 400
           ++      L  L +S N+I+      + N+  L+   L+ N +V ++P  L     +  +
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247

Query: 401 ILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGS--IPS 458
            L  N I+            +   DF      P       S   ++L  N +      PS
Sbjct: 248 YLHNNNISA-----------IGSNDFC----PPGYNTKKASYSGVSLFSNPVQYWEIQPS 292

Query: 459 CFEGMHGLSFIDM 471
            F  ++  + + +
Sbjct: 293 TFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.8 bits (229), Expect = 3e-21
 Identities = 58/268 (21%), Positives = 94/268 (35%), Gaps = 14/268 (5%)

Query: 100 IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLF 159
           +P  +      + LDL NNK +      F NL NL  L L  N +S     +   L  L 
Sbjct: 25  VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82

Query: 160 DLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV 219
            L L+ NQL     +    L  +         +  S+ + + +M  +  L  N  +  G+
Sbjct: 83  RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141

Query: 220 LPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEI 279
              +   +  L  + +   +++ +IP  L    L +L L GN  T     ++     L  
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS-LTELHLDGNKITKVDAASLKGLNNLAK 199

Query: 280 FTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEI 339
             +S N        SL N   L  + LN N L             +  + L  NN    I
Sbjct: 200 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHK-YIQVVYLHNNNI-SAI 257

Query: 340 SSNW-------GKFPKLGTLNVSMNNIT 360
            SN         K      +++  N + 
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 90.1 bits (222), Expect = 3e-20
 Identities = 49/253 (19%), Positives = 79/253 (31%), Gaps = 10/253 (3%)

Query: 88  RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGS 147
            L + +N ++        NLK L  L L NNK S   P +F  L  L  LYL  N L   
Sbjct: 35  LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-E 93

Query: 148 ILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLS 207
           +   + K      +  N+   +        N   V  L  +     G        M+ LS
Sbjct: 94  LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLS 153

Query: 208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL 267
            + +       +         +L EL L  N ++     SL  L     L    +    +
Sbjct: 154 YIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV 210

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEA------LGI 321
                            N+    +P  L +   +  V L+ NN++   S           
Sbjct: 211 DNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 270

Query: 322 YPNLTFIDLSRNN 334
             + + + L  N 
Sbjct: 271 KASYSGVSLFSNP 283

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.5 bits (210), Expect = 1e-18
 Identities = 48/255 (18%), Positives = 90/255 (35%), Gaps = 24/255 (9%)

Query: 20  TLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESS 79
            + D  F +  +L  L L  N      P   + L  L  LYL  NQ           E  
Sbjct: 45  EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL---------KELP 95

Query: 80  GGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTN--NKFSGPIPLSFDNLSNLIFL 137
               + +  L +++N ++         L  +  ++L     K SG    +F  +  L ++
Sbjct: 96  EKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYI 155

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
            +    ++       G   SL +L L+ N++          L +++ L LS N +     
Sbjct: 156 RIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 212

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS--------LG 249
             +     L  L LN N+   V P  +++   ++ + L  N++S +I  +          
Sbjct: 213 GSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTK 270

Query: 250 NLILRQLLLSGNHFT 264
                 + L  N   
Sbjct: 271 KASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 85.1 bits (209), Expect = 1e-18
 Identities = 58/285 (20%), Positives = 97/285 (34%), Gaps = 32/285 (11%)

Query: 30  PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRL 89
           P  A LDL  N           NL NL  L L +N+ S           +   L  + RL
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS------PGAFAPLVKLERL 84

Query: 90  VINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG--NLLSGS 147
            ++ N L          L+ L       N+ +      F+ L+ +I + L       SG 
Sbjct: 85  YLSKNQLKELPEKMPKTLQELRVH---ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 148 ILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLS 207
              +   +K L  +++ D  +      P     S++ L L  N +       +  + +L+
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTI---PQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL 267
            L L+ N    V   S++N  +L+EL L  N L         +  ++ + L  N+ +   
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS--- 255

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT 312
                         +  N F    P       S   V L  N + 
Sbjct: 256 -------------AIGSNDFCP--PGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 73.9 bits (180), Expect = 9e-15
 Identities = 37/225 (16%), Positives = 74/225 (32%), Gaps = 3/225 (1%)

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL 349
            +P  L        + L  N +T           NL  + L  N         +    KL
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 350 GTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITG 409
             L +S N +     +      +L+  +  +  +   +   L ++  +  L     + +G
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140

Query: 410 RLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFI 469
                   + KL Y+  +             SL +L+L  N ++    +  +G++ L+ +
Sbjct: 141 IENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKL 200

Query: 470 DMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAKGLQPCKPLR 514
            +S+N +      S        E    N  L     GL   K ++
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQ 245

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 65.8 bits (159), Expect = 4e-12
 Identities = 43/268 (16%), Positives = 78/268 (29%), Gaps = 33/268 (12%)

Query: 242 GSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSL 301
           G + P      LR +  S       +P ++       +  +  N          +N  +L
Sbjct: 1   GPVCPFRCQCHLRVVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNL 57

Query: 302 IRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNI-- 359
             + L  N ++     A      L  + LS+N              +L      +  +  
Sbjct: 58  HTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRK 117

Query: 360 ---------------------TGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLT 398
                                +G          +L    ++  +I   IP+ L     LT
Sbjct: 118 SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLT 174

Query: 399 KLILRGNQITGRLPKEIGSLTKLEYLDFSAI---GELPSQICNMKSLEKLNLSHNNLSGS 455
           +L L GN+IT      +  L  L  L  S           + N   L +L+L++N L   
Sbjct: 175 ELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV 234

Query: 456 IPSCFEGMHGLSFIDMSYNELQCPVPNS 483
                     +  + +  N +     N 
Sbjct: 235 PGGLA-DHKYIQVVYLHNNNISAIGSND 261

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 94.3 bits (233), Expect = 3e-21
 Identities = 77/383 (20%), Positives = 139/383 (36%), Gaps = 33/383 (8%)

Query: 106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND 165
            L    +  L     +  +  +  +L  +  L      +    +  +  L +L  +  ++
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 75

Query: 166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPP--- 222
           NQL    P    NLT +  + ++ N +    P       +   L  NQ      L     
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 223 ---------SISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICR 273
                    +IS+++ L  L  L     G+    L  L     L   +  +  +      
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 274 GGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRN 333
                + ++   + Q +  T L   T+L  + LNGN L       L    NLT +DL+ N
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251

Query: 334 NFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGK 393
                         KL  L +  N I+   P  +   + L   +L+ N +    P     
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--N 305

Query: 394 LNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNN 451
           L  LT L L  N I+   P  + SLTKL+ L F+   + ++ S + N+ ++  L+  HN 
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSS-LANLTNINWLSAGHNQ 362

Query: 452 LSGSIPSCFEGMHGLSFIDMSYN 474
           +S   P     +  ++ + ++  
Sbjct: 363 ISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 90.8 bits (224), Expect = 5e-20
 Identities = 53/202 (26%), Positives = 83/202 (41%), Gaps = 33/202 (16%)

Query: 81  GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLY 140
             L  +  L+  +N +S   P  I     L +L L  N+      L+  +L+NL  L L 
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKDIGTLA--SLTNLTDLDLA 249

Query: 141 GNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP--------------------RPFSNLT 180
            N +S   L+ L  L  L +L+L  NQ+    P                     P SNL 
Sbjct: 250 NNQISN--LAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 181 SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
           +++ L L  N++    P  +  +  L  L    N+       S++NLTN+  L+  +N +
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363

Query: 241 SGSIPPSLGNLI-LRQLLLSGN 261
           S   P  L NL  + QL L+  
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 87.7 bits (216), Expect = 5e-19
 Identities = 53/221 (23%), Positives = 86/221 (38%), Gaps = 22/221 (9%)

Query: 18  NGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSE 77
           N        +   +L  L  T N      P  I   +NL  L L  NQ            
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--------I 234

Query: 78  SSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFL 137
            +  +L  ++ L + +N +S   P  +  L  L++L L  N+ S   P     L+ L  L
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 290

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
            L  N      +S +  LK+L  L L  N +      P S+LT +  L  + N +  S  
Sbjct: 291 ELNEN--QLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKV--SDV 344

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN 238
             +  + +++ L    NQ   + P  ++NLT + +L L   
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 87.7 bits (216), Expect = 5e-19
 Identities = 57/212 (26%), Positives = 88/212 (41%), Gaps = 17/212 (8%)

Query: 99  FIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSL 158
                +  L  L  L  TNN+ S   P     L+NL  L L GN L    + +L  L +L
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNL 243

Query: 159 FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKG 218
            DL L +NQ+    P   S LT ++ L+L  N +    P       +   L+ NQ +   
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED-- 299

Query: 219 VLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGAL 277
                ISNL NL  L L +N++S   P  + +L  L++L  + N  +     ++     +
Sbjct: 300 --ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353

Query: 278 EIFTVSENHFQGTIPTSLRNCTSLIRVRLNGN 309
              +   N      P  L N T + ++ LN  
Sbjct: 354 NWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 85.4 bits (210), Expect = 3e-18
 Identities = 71/382 (18%), Positives = 128/382 (33%), Gaps = 29/382 (7%)

Query: 7   VINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQF 66
            +   L    V  T+   S +    +  L     G        +  L+NL  +   +NQ 
Sbjct: 24  KMKTVLGKTNVTDTV---SQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQL 78

Query: 67  SGNI-------LAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNK 119
           +          L ++   ++          + N   L+ F           +  +L   +
Sbjct: 79  TDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138

Query: 120 FSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNL 179
            S         LS L  L         + L  L  L +L  L ++ N+         + L
Sbjct: 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK--VSDISVLAKL 196

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNH 239
           T++ +L  + N +    P  I  + +L  L LN NQ K     ++++LTNL +L L  N 
Sbjct: 197 TNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQ 252

Query: 240 LSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCT 299
           +S   P S G   L +L L  N  +   P              ++      I     N  
Sbjct: 253 ISNLAPLS-GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS----NLK 307

Query: 300 SLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNI 359
           +L  + L  NN++      +     L  +  + N       S+      +  L+   N I
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQI 363

Query: 360 TGGLPREIGNSSQLQAFDLSLN 381
           +   P  + N +++    L+  
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 67.7 bits (164), Expect = 2e-12
 Identities = 62/342 (18%), Positives = 107/342 (31%), Gaps = 51/342 (14%)

Query: 175 PFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA 234
             + L       L + ++  ++      +  ++ L  ++   K +    +  L NL ++ 
Sbjct: 17  TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQIN 72

Query: 235 LLYNHLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPT 293
              N L+   P  L NL  L  +L++ N      P              ++      +  
Sbjct: 73  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKN 130

Query: 294 SLRNCT------SLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN----- 342
                       ++  +       +           +L  +         +ISSN     
Sbjct: 131 LTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI 190

Query: 343 --WGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKL 400
               K   L +L  + N I+   P  I  +  L    L+ N +       L  L  LT L
Sbjct: 191 SVLAKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDL 246

Query: 401 ILRGNQITGRLPKEIGSLTKLEYLDFSAIG-----------------------ELPSQIC 437
            L  NQI+   P  +  LTKL  L   A                         E  S I 
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304

Query: 438 NMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCP 479
           N+K+L  L L  NN+S   P     +  L  +  + N++   
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV 344

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.5 bits (231), Expect = 5e-21
 Identities = 42/205 (20%), Positives = 76/205 (37%), Gaps = 30/205 (14%)

Query: 596 IGNGGHASVYRA-ELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FY 643
           IG+G    V  A +      VA+KK     P       K    E+               
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 644 GFCSHARHS------FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLH 697
              +  +        +L+ E ++      I        EL   +   ++  +   + +LH
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH 136

Query: 698 HDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYT 757
                  +HRD+   N+++  +    + DFG+A++    S   T +  T  Y APE+   
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILG 192

Query: 758 MKITEKCDVYSFGVLMWEVIKGKHP 782
           M   E  D++S G +M E+++ K  
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 3e-20
 Identities = 58/303 (19%), Positives = 95/303 (31%), Gaps = 57/303 (18%)

Query: 582 EIVKATNDFDAKY----CIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFL 636
           E+ K   +   +Y     +G+G + SV  A    +G  VAVKK     P    +  K   
Sbjct: 8   ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTY 65

Query: 637 TEVEA-----------FYGFCSHAR-----HSFLLYEFLERGSLAAILNTDAAAQELGWS 680
            E+                  + AR     +   L   L    L  I+      Q+L   
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC----QKLTDD 121

Query: 681 QRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSNW 740
               +I  +   L Y+H        HRD+   NL ++ + E  + DFG+A+    D    
Sbjct: 122 HVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMT 176

Query: 741 TEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHP------------------ 782
              A         +   M   +  D++S G +M E++ G+                    
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236

Query: 783 ----RDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRP 838
                      S S+ N   +L QM           A    + ++E          + R 
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRI 293

Query: 839 TMK 841
           T  
Sbjct: 294 TAA 296

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 85.6 bits (210), Expect = 1e-18
 Identities = 71/305 (23%), Positives = 116/305 (38%), Gaps = 28/305 (9%)

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNHLSG--SIPPSLGNLI-LRQLLLSGNH-FTG 265
           D     + GVL  + +    +  L L   +L     IP SL NL  L  L + G +   G
Sbjct: 32  DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91

Query: 266 YLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNL 325
            +P  I +   L    ++  +  G IP  L    +L+ +  + N L+G +  ++   PNL
Sbjct: 92  PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151

Query: 326 TFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVG 385
             I    N   G I  ++G F KL T      N   G       +  L   DLS N    
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM--- 208

Query: 386 EIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKL 445
                               +    +       T+  +L  +++     ++   K+L  L
Sbjct: 209 -------------------LEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL 249

Query: 446 NLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRGASVEALKGNKGLCGSAK 505
           +L +N + G++P     +  L  +++S+N L   +P     +   V A   NK LCGS  
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP- 308

Query: 506 GLQPC 510
            L  C
Sbjct: 309 -LPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 85.2 bits (209), Expect = 2e-18
 Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 27/288 (9%)

Query: 198 DEIGKMRSLSVLDLNQNQFKGV--LPPSISNLTNLKELALLYNH-LSGSIPPSLGNL-IL 253
           D   +   ++ LDL+         +P S++NL  L  L +   + L G IPP++  L  L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 254 RQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTG 313
             L ++  + +G +P  + +   L     S N   GT+P S+ +  +L+ +  +GN ++G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 314 NISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQL 373
            I ++ G +  L        N              L  +++S N + G      G+    
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223

Query: 374 QAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELP 433
           Q   L+ N +  ++ K     N      LR N+I G LP+ +  L  L  L+        
Sbjct: 224 QKIHLAKNSLAFDLGKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFLHSLN-------- 274

Query: 434 SQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVP 481
                        +S NNL G IP     +        + N+  C  P
Sbjct: 275 -------------VSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 79.8 bits (195), Expect = 1e-16
 Identities = 68/272 (25%), Positives = 106/272 (38%), Gaps = 32/272 (11%)

Query: 27  SSFPHLAYLDLTWNGFFG--TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLR 84
           +    +  LDL+         IP  ++NL  L +LY+G        +       +   L 
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPI-----PPAIAKLT 101

Query: 85  YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLL 144
            +  L I   ++SG IP  +  +K L  LD + N  SG +P S  +L NL+ +   GN +
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161

Query: 145 SGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL------------ 192
           SG+I  S G    LF         +     P     +++ + LSRN L            
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK 221

Query: 193 -----------FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS 241
                            ++G  ++L+ LDL  N+  G LP  ++ L  L  L + +N+L 
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 242 GSIPPSLGNLI-LRQLLLSGNHFTGYLPYNIC 272
           G I P  GNL        + N      P   C
Sbjct: 282 GEI-PQGGNLQRFDVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.1 bits (175), Expect = 4e-14
 Identities = 66/317 (20%), Positives = 118/317 (37%), Gaps = 55/317 (17%)

Query: 150 SSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVL 209
            +  +   + +L L+   L    P                                    
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYP------------------------------------ 67

Query: 210 DLNQNQFKGVLPPSISNLTNLKELALLYNH-LSGSIPPSLGNL-ILRQLLLSGNHFTGYL 267
                     +P S++NL  L  L +   + L G IPP++  L  L  L ++  + +G +
Sbjct: 68  ----------IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF 327
           P  + +   L     S N   GT+P S+ +  +L+ +  +GN ++G I ++ G +  L  
Sbjct: 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT 177

Query: 328 IDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEI 387
                 N              L  +++S N + G      G+    Q   L+ N +  ++
Sbjct: 178 SMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237

Query: 388 PKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA---IGELPSQICNMKSLEK 444
            K     N      LR N+I G LP+ +  L  L  L+ S     GE+P    N++  + 
Sbjct: 238 GKVGLSKNLNGLD-LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV 295

Query: 445 LNLSHNN-LSGS-IPSC 459
              ++N  L GS +P+C
Sbjct: 296 SAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.8 bits (125), Expect = 7e-08
 Identities = 23/106 (21%), Positives = 30/106 (28%), Gaps = 31/106 (29%)

Query: 22  HDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGG 81
                    +L  LDL  N  +GT+P  ++ L  L  L +  N   G I           
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI----------- 284

Query: 82  NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLS 127
                               P  GNL+        NNK     PL 
Sbjct: 285 --------------------PQGGNLQRFDVSAYANNKCLCGSPLP 310

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (205), Expect = 3e-18
 Identities = 54/261 (20%), Positives = 86/261 (32%), Gaps = 8/261 (3%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR 88
                 + L  N              NL  L+L SN  +        + +  G       
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID-----AAAFTGLALLEQL 85

Query: 89  LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSI 148
            + ++  L    P     L  L  L L         P  F  L+ L +LYL  N L    
Sbjct: 86  DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP 145

Query: 149 LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSV 208
             +   L +L  L L+ N++     R F  L S+  L L +N +    P     +  L  
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 209 LDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP 268
           L L  N    +   +++ L  L+ L L  N              L++   S +     LP
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLP 265

Query: 269 YNICRGGALEIFTVSENHFQG 289
             +  G   ++  ++ N  QG
Sbjct: 266 QRL-AG--RDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.6 bits (184), Expect = 2e-15
 Identities = 50/272 (18%), Positives = 85/272 (31%), Gaps = 32/272 (11%)

Query: 184 TLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYN----- 238
           T    +  L  ++P  I    +   + L+ N+   V   S     NL  L L  N     
Sbjct: 15  TTSCPQQGL-QAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 239 --------------------HLSGSIPPSLGNLI-LRQLLLSGNHFTGYLPYNICRGGAL 277
                                L    P +   L  L  L L         P       AL
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131

Query: 278 EIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYG 337
           +   + +N  Q     + R+  +L  + L+GN ++     A     +L  + L +N    
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191

Query: 338 EISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPL 397
                +    +L TL +  NN++      +     LQ   L+ N  V +          L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWL 250

Query: 398 TKLILRGNQITGRLPKEIG--SLTKLEYLDFS 427
            K     +++   LP+ +    L +L   D  
Sbjct: 251 QKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.1 bits (180), Expect = 5e-15
 Identities = 42/259 (16%), Positives = 81/259 (31%), Gaps = 8/259 (3%)

Query: 243 SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLI 302
           ++P  +     +++ L GN  +     +      L I  +  N        +      L 
Sbjct: 25  AVPVGIPAAS-QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83

Query: 303 RVRLNGNNLTGNI-SEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITG 361
           ++ L+ N    ++          L  + L R          +     L  L +  N +  
Sbjct: 84  QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143

Query: 362 GLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKL 421
                  +   L    L  N I     +    L+ L +L+L  N++    P     L +L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203

Query: 422 EYLDFSAIGEL---PSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC 478
             L   A          +  +++L+ L L+ N       +       L     S +E+ C
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPC 262

Query: 479 PVPNSTTFRGASVEALKGN 497
            +P      G  ++ L  N
Sbjct: 263 SLPQR--LAGRDLKRLAAN 279

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.5 bits (168), Expect = 2e-13
 Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 10/200 (5%)

Query: 19  GTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSES 78
            ++   +F     L  L L   G     P     L+ L+YLYL  N            + 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALP------DD 147

Query: 79  SGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLY 138
           +  +L  ++ L ++ N +S         L  L +L L  N+ +   P +F +L  L+ LY
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 139 LYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPD 198
           L+ N LS     +L  L++L  L+LNDN  +    R       +   R S +++  S+P 
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQ 266

Query: 199 EIGKMRSLSVLDLNQNQFKG 218
               +    +  L  N  +G
Sbjct: 267 R---LAGRDLKRLAANDLQG 283

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 83.2 bits (204), Expect = 1e-17
 Identities = 50/250 (20%), Positives = 96/250 (38%), Gaps = 33/250 (13%)

Query: 591 DAKY----CIGNGGHASVYRAE-LPSGEVVAVKKFH-SLLPCDQTVDQKEFLTEVE---- 640
           DA+Y     +G G  ++V+ A+ + +   VA+K      +  +   D+ + L  V     
Sbjct: 12  DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADN 71

Query: 641 ----------------AFYGFCSHARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMN 684
                            F     +  H  +++E L    LA I   +     L + +++ 
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI- 130

Query: 685 VIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGIAKSLKPDSS--NWT 741
             K +   L Y+H  C   I+H DI  +N+L+++     ++    IA          ++T
Sbjct: 131 -SKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187

Query: 742 EFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALD 801
               T  Y +PE+          D++S   L++E+I G    +     S +  +  +A  
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 802 QMLDPRLPAP 811
             L   LP+ 
Sbjct: 248 IELLGELPSY 257

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.5 bits (177), Expect = 4e-15
 Identities = 24/168 (14%), Positives = 47/168 (27%), Gaps = 24/168 (14%)

Query: 596 IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTV------DQKEFLTEVEAFYGFC--- 646
           +G G  ++V+           VK         + V          F              
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 647 -SHARHSFLLYEF-LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPI 704
               +   +   +  E  ++   L        +       V+  +   ++  +H     I
Sbjct: 68  LQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYHRG---I 124

Query: 705 VHRDISSKNLLLDLEYEAHVADFGIAKS---------LKPDSSNWTEF 743
           VH D+S  N+L+  E    + DF  +           L+ D  N   +
Sbjct: 125 VHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.9 bits (159), Expect = 2e-12
 Identities = 44/206 (21%), Positives = 75/206 (36%), Gaps = 6/206 (2%)

Query: 176 FSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELAL 235
            S + S   +   + +L  ++P ++ K    ++L L++N        ++   T L +L L
Sbjct: 6   VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 236 LYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSL 295
             +    +     G L +   L   ++    LP       AL +  VS N        +L
Sbjct: 63  --DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 296 RNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVS 355
           R    L  + L GN L       L   P L  + L+ NN     +        L TL + 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 356 MNNITGGLPREIGNSSQLQAFDLSLN 381
            N++   +P+    S  L    L  N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 55.5 bits (132), Expect = 7e-09
 Identities = 38/188 (20%), Positives = 61/188 (32%), Gaps = 10/188 (5%)

Query: 29  FPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSR 88
                 L L+ N  +      +   + L  L L   + +   +           L  +  
Sbjct: 30  PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP-----VLGTLDL 84

Query: 89  LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSI 148
                      +P     L  L+ LD++ N+ +     +   L  L  LYL GN L    
Sbjct: 85  SHNQLQ----SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLP 140

Query: 149 LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSV 208
              L     L  L L +N L        + L ++ TL L  N L+ +IP        L  
Sbjct: 141 PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPF 199

Query: 209 LDLNQNQF 216
             L+ N +
Sbjct: 200 AFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.4 bits (124), Expect = 8e-08
 Identities = 35/230 (15%), Positives = 67/230 (29%), Gaps = 27/230 (11%)

Query: 223 SISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTV 282
            +S + +  E+     +L+ ++PP L       L LS N    +    +     L    +
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPKD-TTILHLSENLLYTFSLATLMPYTRLTQLNL 62

Query: 283 SENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN 342
                             ++      +N   ++       P LT +D+S N         
Sbjct: 63  DRAELTKLQV---DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119

Query: 343 WGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLIL 402
                +L  L +  N +    P  +  + +L+   L+ N++       L  L  L  L+L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179

Query: 403 RGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNL 452
           + N +                        +P        L    L  N  
Sbjct: 180 QENSLY----------------------TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.0 bits (123), Expect = 1e-07
 Identities = 39/208 (18%), Positives = 67/208 (32%), Gaps = 3/208 (1%)

Query: 294 SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLN 353
            +    S + V  +  NLT   +    +  + T + LS N  Y    +    + +L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT---ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 354 VSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPK 413
           +    +T                  +    +  + + L  L  L     R   +     +
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 414 EIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSY 473
            +G L +L           P  +     LEKL+L++NNL+        G+  L  + +  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 474 NELQCPVPNSTTFRGASVEALKGNKGLC 501
           N L                 L GN  LC
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.6 bits (122), Expect = 1e-07
 Identities = 38/194 (19%), Positives = 59/194 (30%), Gaps = 26/194 (13%)

Query: 92  NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNL----LSGS 147
           +  +L+  +PP +      + L L+ N        +    + L  L L            
Sbjct: 18  DKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG 74

Query: 148 ILSSLGKLKSLFDLQ-----------------LNDNQLIGYIPRPFSNLTSVSTLRLSRN 190
            L  LG L    +                   ++ N+L          L  +  L L  N
Sbjct: 75  TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134

Query: 191 DLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGN 250
           +L    P  +     L  L L  N    +    ++ L NL  L L  N L  +IP     
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFG 193

Query: 251 LI-LRQLLLSGNHF 263
              L    L GN +
Sbjct: 194 SHLLPFAFLHGNPW 207

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 59.0 bits (141), Expect = 2e-10
 Identities = 44/193 (22%), Positives = 67/193 (34%), Gaps = 10/193 (5%)

Query: 296 RNCT-SLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW-GKFPKLGTLN 353
             C      V   G  L         I  + T + L+ N      S    G+ P L  L 
Sbjct: 4   AMCHCEGTTVDCTGRGLK---EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLE 60

Query: 354 VSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPK 413
           +  N +TG  P     +S +Q   L  N I     K    L+ L  L L  NQI+  +P 
Sbjct: 61  LKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG 120

Query: 414 EIGSLTKLEYLDFSAIGE--LPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDM 471
               L  L  L+ ++             + L K +L+        PS    +  +   D+
Sbjct: 121 SFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDL 177

Query: 472 SYNELQCPVPNST 484
            ++E +C   NS 
Sbjct: 178 PHSEFKCSSENSE 190

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 49.0 bits (115), Expect = 4e-07
 Identities = 40/173 (23%), Positives = 60/173 (34%), Gaps = 11/173 (6%)

Query: 45  TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI 104
            IP  I    +   L L  N+          S+   G L ++ +L +  N L+G  P   
Sbjct: 22  EIPRDIP--LHTTELLLNDNELGRIS-----SDGLFGRLPHLVKLELKRNQLTGIEPNAF 74

Query: 105 GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN 164
                + +L L  NK        F  L  L  L LY N +S  +  S   L SL  L L 
Sbjct: 75  EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLA 134

Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK 217
            N               +    L+        P +   +R + + DL  ++FK
Sbjct: 135 SNPFNC-NCHLAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFK 183

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.0 bits (89), Expect = 9e-04
 Identities = 43/178 (24%), Positives = 67/178 (37%), Gaps = 7/178 (3%)

Query: 111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSL-GKLKSLFDLQLNDNQLI 169
           + +D T       IP       +   L L  N L       L G+L  L  L+L  NQL 
Sbjct: 11  TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 170 GYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTN 229
           G  P  F   + +  L+L  N +          +  L  L+L  NQ   V+P S  +L +
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 230 LKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHF 287
           L  L L  N  + +   +     LR+  L+G       P  +     ++I  +  + F
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEF 182

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 56.0 bits (133), Expect = 9e-09
 Identities = 59/325 (18%), Positives = 93/325 (28%), Gaps = 23/325 (7%)

Query: 156 KSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQ 215
           +   +L+LN+  L   +P    +L S   L  S N L   +P+    ++SL V + N   
Sbjct: 38  RQAHELELNNLGL-SSLPELPPHLES---LVASCNSL-TELPELPQSLKSLLVDNNNLKA 92

Query: 216 FKGVLP----PSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNI 271
              + P      +SN    K   L  +     I     +L     L     F       +
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 272 CRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLS 331
                L+        +             L    +   N        L   P LT I   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 332 RNNFYGEISSNWGKFPKLGTLN--------VSMNNITGGLPREIGNSSQLQAFDLSLNHI 383
            N                   N                         S+L      LN  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 384 VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLE 443
             EI         L +L +  N++   LP     L +L    F+ + E+P    N   L+
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL-IASFNHLAEVPELPQN---LK 327

Query: 444 KLNLSHNNLSGSIPSCFEGMHGLSF 468
           +L++ +N L    P   E +  L  
Sbjct: 328 QLHVEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.6 bits (119), Expect = 4e-07
 Identities = 51/313 (16%), Positives = 82/313 (26%), Gaps = 26/313 (8%)

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLT-------NLKE 232
                L L+   L  S+P+       L  L  + N     LP    +L        NLK 
Sbjct: 38  RQAHELELNNLGL-SSLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 233 LALLYNHL-----SGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHF 287
           L+ L   L     S +    L  L     L   +     L        +LE      N  
Sbjct: 93  LSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQL 152

Query: 288 QGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFP 347
           +           + I    N      ++  +L        I                   
Sbjct: 153 EELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYAD 212

Query: 348 KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQI 407
                 +     +        N              +         L+ L   +   N  
Sbjct: 213 NNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNAS 272

Query: 408 TGRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHG 465
           +  +         LE L+ S   + ELP+       LE+L  S N+L+  +P        
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLIELPALPPR---LERLIASFNHLA-EVPEL---PQN 325

Query: 466 LSFIDMSYNELQC 478
           L  + + YN L+ 
Sbjct: 326 LKQLHVEYNPLRE 338

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.8 bits (117), Expect = 8e-07
 Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 9/94 (9%)

Query: 138 YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIP 197
             Y N  S  I S      SL +L +++N+LI  +P     L     L  S N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHL-AEVP 320

Query: 198 DEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLK 231
           +      +L  L +  N  +   P    ++ +L+
Sbjct: 321 ELPQ---NLKQLHVEYNPLRE-FPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 46.7 bits (109), Expect = 6e-06
 Identities = 22/113 (19%), Positives = 37/113 (32%), Gaps = 15/113 (13%)

Query: 22  HDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGG 81
            +  FS    L       N     I        +L  L + +N+            +   
Sbjct: 252 SENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-------ELPALPP 304

Query: 82  NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNL 134
            L    RL+ + N L+  +P    NLK   QL +  N      P   +++ +L
Sbjct: 305 RLE---RLIASFNHLAE-VPELPQNLK---QLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.4 bits (103), Expect = 4e-05
 Identities = 21/94 (22%), Positives = 32/94 (34%), Gaps = 9/94 (9%)

Query: 115 LTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPR 174
              N  S  I    D   +L  L +  N L   + +   +L+ L     + N L   +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHL-AEVPE 321

Query: 175 PFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSV 208
              NL     L +  N L    PD    +  L +
Sbjct: 322 LPQNLK---QLHVEYNPL-REFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 41.7 bits (96), Expect = 3e-04
 Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 10/77 (12%)

Query: 82  NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
               +  L +++N L   +P     L+   +L  + N  +  +P   +   NL  L++  
Sbjct: 282 LPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHLAE-VP---ELPQNLKQLHVEY 333

Query: 142 NLLSG--SILSSLGKLK 156
           N L     I  S+  L+
Sbjct: 334 NPLREFPDIPESVEDLR 350

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.3 bits (122), Expect = 2e-08
 Identities = 22/133 (16%), Positives = 40/133 (30%), Gaps = 18/133 (13%)

Query: 34  YLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVIND 93
            L L       T+   +  L  + +L L  N+          + ++   L  +       
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALP----PALAALRCLEVLQASDNAL 55

Query: 94  NSLSGFIPPHIGNLKFLSQLDLTNNKF-SGPIPLSFDNLSNLIFLYLYGNLLSG------ 146
            ++ G           L +L L NN+           +   L+ L L GN L        
Sbjct: 56  ENVDGVANLP-----RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 110

Query: 147 SILSSLGKLKSLF 159
            +   L  + S+ 
Sbjct: 111 RLAEMLPSVSSIL 123

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 3e-07
 Identities = 24/122 (19%), Positives = 45/122 (36%), Gaps = 6/122 (4%)

Query: 208 VLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL 267
           VL L            +  L  +  L L +N L   +PP+L  L   ++L + ++    +
Sbjct: 2   VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV 58

Query: 268 PYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT---GNISEALGIYPN 324
                     E+   +    Q      L +C  L+ + L GN+L    G       + P+
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

Query: 325 LT 326
           ++
Sbjct: 119 VS 120

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.0 bits (111), Expect = 5e-07
 Identities = 27/125 (21%), Positives = 44/125 (35%), Gaps = 9/125 (7%)

Query: 113 LDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYI 172
           L L +   +    L    L  +  L L  N L      +L  L+ L  LQ +DN      
Sbjct: 3   LHLAHKDLTVLCHLE--QLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNA--LEN 57

Query: 173 PRPFSNLTSVSTLRLSRNDLFG-SIPDEIGKMRSLSVLDLNQNQF---KGVLPPSISNLT 228
               +NL  +  L L  N L   +    +     L +L+L  N     +G+       L 
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117

Query: 229 NLKEL 233
           ++  +
Sbjct: 118 SVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.5 bits (107), Expect = 2e-06
 Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 5/105 (4%)

Query: 374 QAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS-AIGEL 432
           +   L+   +   +   L +L  +T L L  N++    P  + +L  LE L  S    E 
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57

Query: 433 PSQICNMKSLEKLNLSHNNL-SGSIPSCFEGMHGLSFIDMSYNEL 476
              + N+  L++L L +N L   +          L  +++  N L
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 8e-05
 Identities = 19/106 (17%), Positives = 35/106 (33%), Gaps = 5/106 (4%)

Query: 351 TLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGR 410
            L+++  ++T      +     +   DLS N +    P  L  L  L  L    N +   
Sbjct: 2   VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 411 LPKEIGSLTKLEYLDFSAIGELP--SQICNMKSLEKLNLSHNNLSG 454
                    +   L  + + +      + +   L  LNL  N+L  
Sbjct: 59  DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 9e-05
 Identities = 18/116 (15%), Positives = 39/116 (33%), Gaps = 7/116 (6%)

Query: 290 TIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL 349
           T+   L     +  + L+ N L       L     L  +  S N              + 
Sbjct: 11  TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDGVANLPRLQ- 68

Query: 350 GTLNVSMNNITGG-LPREIGNSSQLQAFDLSLNHIVGE--IPKELGKLNP-LTKLI 401
             L +  N +      + + +  +L   +L  N +  E  I + L ++ P ++ ++
Sbjct: 69  -ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.1 bits (126), Expect = 2e-08
 Identities = 42/226 (18%), Positives = 73/226 (32%), Gaps = 17/226 (7%)

Query: 106 NLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND 165
            L    ++    +  +  +  +  +L  +  L  +G  ++   +  +  L +L  L+L D
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72

Query: 166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSIS 225
           NQ+      P  NLT ++ L LS N L         +      L   Q      L    +
Sbjct: 73  NQI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 226 NLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSEN 285
                     LY  L+     S    +     LS  +        +     L      +N
Sbjct: 131 LQV-------LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 286 HFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLS 331
                 P  L +  +LI V L  N ++      L    NL  + L+
Sbjct: 184 KISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 37/239 (15%), Positives = 76/239 (31%), Gaps = 24/239 (10%)

Query: 190 NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLG 249
           N +F   PD    + +   +   ++     +  + ++L  +  L+     ++ +I   + 
Sbjct: 10  NVIF---PDP--ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG-VQ 60

Query: 250 NLI-LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNG 308
            L  L  L L  N        ++     L   T  E         S       I+     
Sbjct: 61  YLNNLIGLELKDNQI-----TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT 115

Query: 309 NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIG 368
           +     I++   +        L  +     I++            +S+ N        + 
Sbjct: 116 ST---QITDVTPLAGLSNLQVLYLDLNQ--ITNISPLAGLTNLQYLSIGNAQVSDLTPLA 170

Query: 369 NSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFS 427
           N S+L       N I    P  L  L  L ++ L+ NQI+   P  + + + L  +  +
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 9e-06
 Identities = 38/225 (16%), Positives = 68/225 (30%), Gaps = 17/225 (7%)

Query: 155 LKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQN 214
           L +   +    + +   +    ++L  ++TL      +  +  + +  + +L  L+L  N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDN 73

Query: 215 QFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRG 274
           Q        + NLT + EL L  N L      +    I    L S           +   
Sbjct: 74  QITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 275 GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNN 334
             L             I              L+  N   +    L     LT +    N 
Sbjct: 132 QVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNK 184

Query: 335 FYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLS 379
                 S     P L  +++  N I+   P  + N+S L    L+
Sbjct: 185 ISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.1 bits (100), Expect = 5e-05
 Identities = 31/227 (13%), Positives = 67/227 (29%), Gaps = 17/227 (7%)

Query: 129 DNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS 188
             L+N I +    + ++ ++  +   L  +  L      +          L ++  L L 
Sbjct: 16  PALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71

Query: 189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL 248
            N +    P +     +   L  N  +    +    S  T       + +    +   +L
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 249 GNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNG 308
             L               +       G   +  +S  + Q +  T L N + L  ++ + 
Sbjct: 132 QVL---------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 309 NNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVS 355
           N ++      L   PNL  + L  N               L  + ++
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 23/67 (34%), Positives = 34/67 (50%), Gaps = 5/67 (7%)

Query: 101 PPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFD 160
              + NL  L+ L   +NK S   PL+  +L NLI ++L  N +S   +S L    +LF 
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISD--VSPLANTSNLFI 221

Query: 161 LQLNDNQ 167
           + L  NQ
Sbjct: 222 VTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 2e-04
 Identities = 20/59 (33%), Positives = 31/59 (52%), Gaps = 4/59 (6%)

Query: 81  GNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYL 139
            NL  ++ L  +DN +S   P  + +L  L ++ L NN+ S   PL+  N SNL  + L
Sbjct: 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 4e-04
 Identities = 40/217 (18%), Positives = 74/217 (34%), Gaps = 18/217 (8%)

Query: 7   VINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQF 66
            I I+     V  T+   + +    +  L     G   T    +  L+NL  L L  NQ 
Sbjct: 21  AIKIAAGKSNVTDTV---TQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQI 75

Query: 67  -SGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIP 125
                L  ++  +         + V     L       + + +      L        + 
Sbjct: 76  TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLY 135

Query: 126 LSFDNLSNLIFL-------YLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSN 178
           L  + ++N+  L       YL       S L+ L  L  L  L+ +DN++    P   ++
Sbjct: 136 LDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LAS 193

Query: 179 LTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQ 215
           L ++  + L  N +    P  +    +L ++ L  NQ
Sbjct: 194 LPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 7e-04
 Identities = 33/223 (14%), Positives = 67/223 (30%), Gaps = 29/223 (13%)

Query: 52  NLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLS 111
            L+N   +  G +  +  +        +  +L  ++ L      ++      +  L  L 
Sbjct: 17  ALANAIKIAAGKSNVTDTV--------TQADLDGITTLSAFGTGVTTI--EGVQYLNNLI 66

Query: 112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGY 171
            L+L +N+ +   PL        + L         +I                 +     
Sbjct: 67  GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126

Query: 172 IPRPFSNLTSVSTLRLSRNDLFG--------------SIPDEIGKMRSLSVLDLNQNQFK 217
                  L        + + L G              S    +  +  L+ L  + N+  
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKIS 186

Query: 218 GVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLI-LRQLLLS 259
            +    +++L NL E+ L  N +S   P  L N   L  + L+
Sbjct: 187 DI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 8e-04
 Identities = 21/196 (10%), Positives = 53/196 (27%), Gaps = 19/196 (9%)

Query: 292 PTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGT 351
             +  +   +  +   G  +T    E +    NL  ++L  N                  
Sbjct: 34  TVTQADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELE 91

Query: 352 LNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRL 411
           L+ +       +       +         +         L  L      I   + + G  
Sbjct: 92  LSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLT 151

Query: 412 PKEIGSLTKLEYLDFSAIGELPS---------------QICNMKSLEKLNLSHNNLSGSI 456
             +  S+   +  D + +  L                  + ++ +L +++L +N +S   
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211

Query: 457 PSCFEGMHGLSFIDMS 472
           P        L  + ++
Sbjct: 212 P--LANTSNLFIVTLT 225

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 2e-07
 Identities = 43/279 (15%), Positives = 86/279 (30%), Gaps = 17/279 (6%)

Query: 137 LYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDL-FGS 195
           L L G  L   +   L     +   +   + +   +   FS    V  + LS + +   +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVST 62

Query: 196 IPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQ 255
           +   + +   L  L L   +    +  +++  +NL  L L                   +
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 256 LLL---------SGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRL 306
           L           +  H    + +       L +    +N  +  + T +R C +L+ + L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 307 NGN-NLTGNISEALGIYPNLTFIDLSRNNFY-GEISSNWGKFPKLGTLNVSMNNITGGLP 364
           + +  L  +  +       L  + LSR      E     G+ P L TL V      G L 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 365 REIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILR 403
                   L    ++ +H        +G         ++
Sbjct: 243 LLK---EALPHLQINCSHFTTIARPTIGNKKNQEIWGIK 278

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.5 bits (119), Expect = 3e-07
 Identities = 47/255 (18%), Positives = 98/255 (38%), Gaps = 10/255 (3%)

Query: 7   VINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGF-FGTIPPQISNLSNLRYLYLGSNQ 65
           VI    P   ++  L      S   + ++DL+ +     T+   +S  S L+ L L   +
Sbjct: 25  VIAFRCPRSFMDQPL--AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82

Query: 66  FSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPP--HIGNLKFLSQLDLTNNKFSGP 123
            S  I+  ++  S+   L        ++ +L   +     +  L      D T       
Sbjct: 83  LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVA 142

Query: 124 IPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGY-IPRPFSNLTSV 182
           +    + ++ L       NL    + + + +  +L  L L+D+ ++     + F  L  +
Sbjct: 143 VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYL 202

Query: 183 STLRLSR-NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS 241
             L LSR  D+      E+G++ +L  L +      G L      L +L+   +  +H +
Sbjct: 203 QHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFT 259

Query: 242 GSIPPSLGNLILRQL 256
               P++GN   +++
Sbjct: 260 TIARPTIGNKKNQEI 274

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.9 bits (115), Expect = 1e-06
 Identities = 38/286 (13%), Positives = 78/286 (27%), Gaps = 58/286 (20%)

Query: 209 LDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP 268
           LDL        +   + +   +       + +   +        ++ + LS +       
Sbjct: 5   LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEV--- 60

Query: 269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFI 328
                                T+   L  C+ L  + L G  L+  I   L    NL  +
Sbjct: 61  --------------------STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100

Query: 329 DL--------------------------------SRNNFYGEISSNWGKFPKLGTLNVSM 356
           +L                                +  +    ++       +L       
Sbjct: 101 NLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160

Query: 357 NNITGGLPREIGNSSQLQAFDLSLNHIV-GEIPKELGKLNPLTKLILRG-NQITGRLPKE 414
           N     L   +     L   DLS + ++  +  +E  +LN L  L L     I      E
Sbjct: 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLE 220

Query: 415 IGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCF 460
           +G +  L+ L    I    +     ++L  L ++ ++ +       
Sbjct: 221 LGEIPTLKTLQVFGIVPDGTLQLLKEALPHLQINCSHFTTIARPTI 266

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 9e-07
 Identities = 33/205 (16%), Positives = 62/205 (30%), Gaps = 15/205 (7%)

Query: 175 PFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA 234
                       L +  +  ++     ++ S+  +  N +  K V    I  L N+ +L 
Sbjct: 19  SDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLF 74

Query: 235 LLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTS 294
           L  N L+      L NL     L    +    L          ++ ++S  H   +    
Sbjct: 75  LNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLK---KLKSLSLEHNGISDING 129

Query: 295 LRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNV 354
           L +   L  + L  N +T     +     +         +             KL  L +
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPLAGLTKLQNLYL 185

Query: 355 SMNNITGGLPREIGNSSQLQAFDLS 379
           S N+I+    R +     L   +L 
Sbjct: 186 SKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 2e-05
 Identities = 37/209 (17%), Positives = 72/209 (34%), Gaps = 35/209 (16%)

Query: 290 TIPT------SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNW 343
           T+PT      S       I+  L   ++T  +++      ++  I  + ++    I S  
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSD----IKSVQ 62

Query: 344 G--KFPKLGTLNVSMNNITGG------------------LPREIGNSSQLQAFDLSLNHI 383
           G    P +  L ++ N +T                    +          +   LSL H 
Sbjct: 63  GIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 384 VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLE 443
                  L  L  L  L L  N+IT        +      L+ + I ++   +  +  L+
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQ 181

Query: 444 KLNLSHNNLSGSIPSCFEGMHGLSFIDMS 472
            L LS N++S  + +   G+  L  +++ 
Sbjct: 182 NLYLSKNHIS-DLRA-LAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.1 bits (95), Expect = 2e-04
 Identities = 31/195 (15%), Positives = 56/195 (28%), Gaps = 23/195 (11%)

Query: 82  NLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYG 141
                 +  +   S++  +      L  + Q+   N+       +    L N+  L+L G
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77

Query: 142 NLLSGSILSSLGKLKSLFDLQLNDN---------------QLIGYIPRPFSNLTSVSTLR 186
           N L+     +  K      L  N                  L        + L  +  L 
Sbjct: 78  NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137

Query: 187 LSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP 246
                        +    +       ++     + P ++ LT L+ L L  NH+S     
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD--LR 194

Query: 247 SLGNLI-LRQLLLSG 260
           +L  L  L  L L  
Sbjct: 195 ALAGLKNLDVLELFS 209

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (110), Expect = 2e-06
 Identities = 30/235 (12%), Positives = 67/235 (28%), Gaps = 8/235 (3%)

Query: 205 SLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQ---LLLSGN 261
           S  V    +++   + P  +    N  EL  +   L      +       +   +  +  
Sbjct: 9   SNRVFLCQESKVTEI-PSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 262 HFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNI--SEAL 319
                           EI     N+     P + +N  +L  + ++   +       +  
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 320 GIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLS 379
            +   L  I  + N    E +S  G   +   L ++ N I          +   +     
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 380 LNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPS 434
            N++           +    L +   +I       + +L KL       + +LP+
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 7/46 (15%), Positives = 13/46 (28%), Gaps = 1/46 (2%)

Query: 98  GFIPPHI-GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN 142
             +P  +         LD++  +         +NL  L     Y  
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (86), Expect = 0.003
 Identities = 8/51 (15%), Positives = 19/51 (37%), Gaps = 3/51 (5%)

Query: 196 IPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP 246
             D         +LD+++ +   +    + NL  L+  +    +L   +P 
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPT 240

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 5e-06
 Identities = 18/92 (19%), Positives = 28/92 (30%), Gaps = 18/92 (19%)

Query: 370 SSQLQAFDLSLNHIVGEIPKEL-GKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA 428
           S  +Q+ D+    +      EL   L     + L    +T    K+I S           
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA---------- 50

Query: 429 IGELPSQICNMKSLEKLNLSHNNLSGSIPSCF 460
                  +    +L +LNL  N L      C 
Sbjct: 51  -------LRVNPALAELNLRSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 8e-06
 Identities = 17/140 (12%), Positives = 40/140 (28%), Gaps = 10/140 (7%)

Query: 349 LGTLNVSMNNIT-GGLPREIGNSSQLQAFDLSLNHI----VGEIPKELGKLNPLTKLILR 403
           + +L++    ++       +    Q Q   L    +      +I   L     L +L LR
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 404 GNQITGRLPKEIGSL-----TKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPS 458
            N++       +         K++ L         +    + S  +   +   L  S   
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 123

Query: 459 CFEGMHGLSFIDMSYNELQC 478
             +    L    +   + + 
Sbjct: 124 LGDAGLQLLCEGLLDPQCRL 143

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 17/97 (17%), Positives = 30/97 (30%), Gaps = 9/97 (9%)

Query: 164 NDNQLIGYIPRPFSNLTSVSTLRLSRNDL----FGSIPDEIGKMRSLSVLDLNQNQFKGV 219
            D  +           + +  L L+  D+      S+   +    SL  LDL+ N     
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 220 LPPSIS-----NLTNLKELALLYNHLSGSIPPSLGNL 251
               +          L++L L   + S  +   L  L
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 6e-05
 Identities = 12/94 (12%), Positives = 30/94 (31%), Gaps = 11/94 (11%)

Query: 181 SVSTLRLSRNDL-FGSIPDEIGKMRSLSVLDLNQNQFKGV----LPPSISNLTNLKELAL 235
            + +L +   +L      + +  ++   V+ L+           +  ++     L EL L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 236 LYNHLSGSIPPSLGNLI------LRQLLLSGNHF 263
             N L       +   +      +++L L     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 13/99 (13%), Positives = 27/99 (27%), Gaps = 20/99 (20%)

Query: 369 NSSQLQAFDLSLNHIVGE----IPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYL 424
             S L+   L+   +       +   L   + L +L L  N +      ++    +    
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR---- 422

Query: 425 DFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGM 463
                            LE+L L     S  +    + +
Sbjct: 423 ------------QPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.8 bits (101), Expect = 7e-05
 Identities = 14/84 (16%), Positives = 31/84 (36%), Gaps = 9/84 (10%)

Query: 346 FPKLGTLNVSMNNITG----GLPREIGNSSQLQAFDLSLNHIVGEIPKELGK-----LNP 396
              L  L ++  +++      L   +  +  L+  DLS N +      +L +        
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 397 LTKLILRGNQITGRLPKEIGSLTK 420
           L +L+L     +  +   + +L K
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 15/94 (15%), Positives = 31/94 (32%), Gaps = 10/94 (10%)

Query: 133 NLIFLYLYGNLLSGSILSSL-GKLKSLFDLQLNDNQL----IGYIPRPFSNLTSVSTLRL 187
           ++  L +    LS +  + L   L+    ++L+D  L       I        +++ L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 188 SRNDLFGSIPDEIGKM-----RSLSVLDLNQNQF 216
             N+L       + +        +  L L     
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 14/97 (14%), Positives = 32/97 (32%), Gaps = 14/97 (14%)

Query: 55  NLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSG----FIPPHIGNLKFL 110
           +++ L +   + S    AE+        L+    + ++D  L+      I   +     L
Sbjct: 3   DIQSLDIQCEELSDARWAELLP-----LLQQCQVVRLDDCGLTEARCKDISSALRVNPAL 57

Query: 111 SQLDLTNNKFSGPIPLSF-----DNLSNLIFLYLYGN 142
           ++L+L +N+                   +  L L   
Sbjct: 58  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 15/90 (16%), Positives = 28/90 (31%), Gaps = 5/90 (5%)

Query: 110 LSQLDLTNNKFS-GPIPLSFDNLSNLIFLYLYGNLLSG----SILSSLGKLKSLFDLQLN 164
           +  LD+   + S          L     + L    L+      I S+L    +L +L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFG 194
            N+L               + ++ +  L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 3e-04
 Identities = 15/91 (16%), Positives = 29/91 (31%), Gaps = 5/91 (5%)

Query: 22  HDFSFSSFPHLAYLDLTWNGF----FGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSE 77
                     L  L L           ++   +    +LR L L +N      + ++  E
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VE 419

Query: 78  SSGGNLRYMSRLVINDNSLSGFIPPHIGNLK 108
           S       + +LV+ D   S  +   +  L+
Sbjct: 420 SVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 4e-04
 Identities = 16/73 (21%), Positives = 26/73 (35%), Gaps = 10/73 (13%)

Query: 203 MRSLSVLDLNQNQFKGV----LPPSISNLTNLKELALLYNHLSGSIPPSLGNLI------ 252
              L VL L            L  ++    +L+EL L  N L  +    L   +      
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 253 LRQLLLSGNHFTG 265
           L QL+L   +++ 
Sbjct: 428 LEQLVLYDIYWSE 440

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 8e-04
 Identities = 21/123 (17%), Positives = 30/123 (24%), Gaps = 31/123 (25%)

Query: 39  WNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSG 98
             G            S LR L+L     S +  +                          
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSS------------------------- 388

Query: 99  FIPPHIGNLKFLSQLDLTNNKFSGPIPLSF-----DNLSNLIFLYLYGNLLSGSILSSLG 153
            +   +     L +LDL+NN       L            L  L LY    S  +   L 
Sbjct: 389 -LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQ 447

Query: 154 KLK 156
            L+
Sbjct: 448 ALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 16/127 (12%), Positives = 32/127 (25%), Gaps = 27/127 (21%)

Query: 229 NLKELALLYNHLSGSIPPSLGNLI--LRQLLLSGNHFTGYLPYNICRGGALEIFTVSENH 286
           +++ L +    LS +    L  L+   + + L     T                      
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC------------------ 44

Query: 287 FQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALG-----IYPNLTFIDLSRNNFYGEISS 341
               I ++LR   +L  + L  N L       +          +  + L      G    
Sbjct: 45  --KDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCG 102

Query: 342 NWGKFPK 348
                 +
Sbjct: 103 VLSSTLR 109

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.001
 Identities = 16/77 (20%), Positives = 28/77 (36%), Gaps = 12/77 (15%)

Query: 291 IPTSLRNCTSLIRVRLNGNNLTG----NISEALGIYPNLTFIDLSRNNFYGEISSNWGKF 346
           +   L+ C  +   RL+   LT     +IS AL + P L  ++L  N           + 
Sbjct: 22  LLPLLQQCQVV---RLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 78

Query: 347 -----PKLGTLNVSMNN 358
                 K+  L++    
Sbjct: 79  LQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.002
 Identities = 15/84 (17%), Positives = 25/84 (29%), Gaps = 10/84 (11%)

Query: 306 LNGNNLTGN-ISEALGIYPNLTFIDLSRNNFYGE----ISSNWGKFPKLGTLNVSMNNIT 360
           +    L+    +E L +      + L            ISS     P L  LN+  N + 
Sbjct: 9   IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68

Query: 361 GGLPREIG-----NSSQLQAFDLS 379
                 +       S ++Q   L 
Sbjct: 69  DVGVHCVLQGLQTPSCKIQKLSLQ 92

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (88), Expect = 0.003
 Identities = 11/101 (10%), Positives = 29/101 (28%), Gaps = 10/101 (9%)

Query: 82  NLRY--MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG----PIPLSFDNLSNLI 135
           +++   +    ++D   +  +P     L+    + L +   +      I  +      L 
Sbjct: 3   DIQSLDIQCEELSDARWAELLP----LLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 58

Query: 136 FLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPF 176
            L L  N L    +  + +       ++    L        
Sbjct: 59  ELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA 99

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 19/95 (20%), Positives = 32/95 (33%), Gaps = 13/95 (13%)

Query: 128 FDNLSNLIFLYLYGNLLSG----SILSSLGKLKSLFDLQLNDNQLIGYIPRPFS-----N 178
               S L  L+L    +S     S+ ++L    SL +L L++N L               
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424

Query: 179 LTSVSTLRLSRNDLFGSIPDEIGKMR----SLSVL 209
              +  L L        + D +  +     SL V+
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (104), Expect = 9e-06
 Identities = 27/140 (19%), Positives = 39/140 (27%), Gaps = 7/140 (5%)

Query: 294 SLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLN 353
              N      + L G  +   I            ID S N         +    +L TL 
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69

Query: 354 VSMNNITGGLPREIGNSSQLQAFDLSLNHIVG-EIPKELGKLNPLTKLILRG---NQITG 409
           V+ N I             L    L+ N +V       L  L  LT L +          
Sbjct: 70  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKH 129

Query: 410 RLPKEIGSLTKLEYLDFSAI 429
                I  + ++  LDF  +
Sbjct: 130 YRLYVIYKVPQVRVLDFQKV 149

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (93), Expect = 2e-04
 Identities = 18/166 (10%), Positives = 42/166 (25%), Gaps = 23/166 (13%)

Query: 167 QLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISN 226
           +LI    + ++N      L L    +   I +    +     +D + N+ + +       
Sbjct: 6   ELIEQAAQ-YTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKL--DGFPL 61

Query: 227 LTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENH 286
           L  LK L +  N +                                      +  + +  
Sbjct: 62  LRRLKTLLVNNNRICRIGE---------------GLDQALPDLTELILTNNSLVELGDLD 106

Query: 287 FQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSR 332
              ++ +    C      R    N        +   P +  +D  +
Sbjct: 107 PLASLKSLTYLCIL----RNPVTNKKHYRLYVIYKVPQVRVLDFQK 148

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 8e-04
 Identities = 30/142 (21%), Positives = 44/142 (30%), Gaps = 13/142 (9%)

Query: 48  PQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNL 107
            Q +N    R L L   +           E+ G  L     +  +DN +          L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-------VIENLGATLDQFDAIDFSDNEIRKL--DGFPLL 62

Query: 108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYL-YGNLLSGSILSSLGKLKSLFDLQLND- 165
           + L  L + NN+           L +L  L L   +L+    L  L  LKSL  L +   
Sbjct: 63  RRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 122

Query: 166 --NQLIGYIPRPFSNLTSVSTL 185
                  Y       +  V  L
Sbjct: 123 PVTNKKHYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.001
 Identities = 19/96 (19%), Positives = 41/96 (42%), Gaps = 6/96 (6%)

Query: 387 IPKELGKLNP--LTKLILRGNQITGRLPKEIGSLTKLEYLDFS--AIGELPSQICNMKSL 442
           I +     N     +L LRG +I   +     +L + + +DFS   I +L      ++ L
Sbjct: 8   IEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF-PLLRRL 65

Query: 443 EKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQC 478
           + L +++N +        + +  L+ + ++ N L  
Sbjct: 66  KTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVE 101

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.6 bits (106), Expect = 2e-05
 Identities = 35/331 (10%), Positives = 81/331 (24%), Gaps = 45/331 (13%)

Query: 160 DLQLND--NQLIGYIPRPFSNLTSVSTLRLSRNDL----FGSIPDEIGKMRSLSVLDLNQ 213
            L+L+    +    +        SV  + LS N +       + + I   + L + + + 
Sbjct: 9   SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 214 NQ----------FKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL------ILRQLL 257
                          +L  ++     L  + L  N    +    L +       +    L
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 258 LSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISE 317
            +                 L +   ++N          RN      ++        +   
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 318 ALGIYPNL-TFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAF 376
                       +   +     ++            N   +  +  L   + +   L+  
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 377 DLSLNHIVGEIPKELG------KLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIG 430
            L+   +       +       +   L  L L+ N+I     + + ++            
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID---------- 298

Query: 431 ELPSQICNMKSLEKLNLSHNNLSGSIPSCFE 461
                   M  L  L L+ N  S       E
Sbjct: 299 ------EKMPDLLFLELNGNRFSEEDDVVDE 323

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.6 bits (98), Expect = 1e-04
 Identities = 38/330 (11%), Positives = 83/330 (25%), Gaps = 34/330 (10%)

Query: 108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG----SILSSLGKLKSLFDLQL 163
           K L    +T       +        ++  + L GN +       +  ++   K L   + 
Sbjct: 8   KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66

Query: 164 NDNQ---LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVL 220
           +D     +   IP     L          + +  S        +   +  L+++     L
Sbjct: 67  SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126

Query: 221 PPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIF 280
               + L       +       ++     N    + ++ G +                  
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186

Query: 281 TVSENHFQGTIPTSLRNCTSLIRVRLNGNNLT--------------GNISEALGIYPNLT 326
            +                  L+        L                 ++ AL  +PNL 
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 246

Query: 327 FIDLSRNNFYGEISSNWG------KFPKLGTLNVSMNNITGGLPREI-----GNSSQLQA 375
            + L+        ++         +   L TL +  N I     R +          L  
Sbjct: 247 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306

Query: 376 FDLSLNHIVGEIPKELGKLNPLTKLILRGN 405
            +L+ N    E    + ++  +     RG 
Sbjct: 307 LELNGNRF-SEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 6e-04
 Identities = 17/120 (14%), Positives = 34/120 (28%), Gaps = 21/120 (17%)

Query: 373 LQAFDLSLNHI----VGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSA 428
           ++   L L+ I       +   L + + + +++L GN I     + +             
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSEN---------- 54

Query: 429 IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTFRG 488
                  I + K LE    S            E +  L    +   +L     +   F  
Sbjct: 55  -------IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 107

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 2e-05
 Identities = 28/148 (18%), Positives = 56/148 (37%), Gaps = 15/148 (10%)

Query: 292 PTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDL-----SRNNFYGEISSNWGKF 346
           P  +     ++  R +G+    ++   L   P+L   ++      R++    +       
Sbjct: 6   PEQVEQLKLIMSKRYDGSQQALDLKG-LRSDPDLVAQNIDVVLNRRSSMAATLRIIEENI 64

Query: 347 PKLGTLNVSMNNITG--GLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRG 404
           P+L +LN+S N +     +   +  +  L+  +LS N +  E   +  K   L +L L G
Sbjct: 65  PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDG 124

Query: 405 NQITGRLPKE-------IGSLTKLEYLD 425
           N ++     +            KL  LD
Sbjct: 125 NSLSDTFRDQSTYISAIRERFPKLLRLD 152

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.3 bits (101), Expect = 3e-05
 Identities = 25/137 (18%), Positives = 43/137 (31%), Gaps = 8/137 (5%)

Query: 363 LPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLE 422
           L   +          L L  +      +L   N    L  R +     L     ++ +L 
Sbjct: 12  LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68

Query: 423 YLDFSAIG-----ELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQ 477
            L+ S        ++ S +    +L+ LNLS N L             L  + +  N L 
Sbjct: 69  SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128

Query: 478 CPVPNSTTFRGASVEAL 494
               + +T+  A  E  
Sbjct: 129 DTFRDQSTYISAIRERF 145

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 26/135 (19%), Positives = 46/135 (34%), Gaps = 8/135 (5%)

Query: 114 DLTNNKFSGPIPLSFDNLSNLIFLYL-YGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYI 172
           +L   +    + L      +     L    L S   L +      L       + +   +
Sbjct: 3   ELKPEQVEQ-LKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN----RRSSMAATL 57

Query: 173 PRPFSNLTSVSTLRLSRNDL--FGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNL 230
                N+  + +L LS N L     +   + K  +L +L+L+ N+ K            L
Sbjct: 58  RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKL 117

Query: 231 KELALLYNHLSGSIP 245
           +EL L  N LS +  
Sbjct: 118 EELWLDGNSLSDTFR 132

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.6 bits (88), Expect = 7e-04
 Identities = 25/145 (17%), Positives = 47/145 (32%), Gaps = 6/145 (4%)

Query: 35  LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDN 94
           L  T +G        +    NL  LY+ + Q   ++            L  +  L I  +
Sbjct: 13  LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHL-----ELRDLRGLGELRNLTIVKS 66

Query: 95  SLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGK 154
            L    P        LS+L+L+ N        +   LS    +     L     L  L +
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 155 LKSLFDLQLNDNQLIGYIPRPFSNL 179
            +      + + +L  +   P +++
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHM 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.001
 Identities = 24/148 (16%), Positives = 45/148 (30%), Gaps = 3/148 (2%)

Query: 180 TSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSI-SNLTNLKELALLYN 238
              S LR +R+         +    +L+ L +   Q    L       L  L+ L ++ +
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 239 HLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTI-PTSLRN 297
            L    P +         L    +    L +   +G +L+   +S N    +     L+ 
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 298 CTSLIRVRLNGNNLTGNISEALGIYPNL 325
                   +    L  +    L   PN 
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 23/113 (20%), Positives = 34/113 (30%), Gaps = 6/113 (5%)

Query: 371 SQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEI-GSLTKLEYLDFS-- 427
                   + +  + +    L     LT+L +   Q    L       L +L  L     
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 428 -AIGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCP 479
                 P        L +LNLS N L  S+         L  + +S N L C 
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 17/111 (15%), Positives = 37/111 (33%), Gaps = 3/111 (2%)

Query: 298 CTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSN-WGKFPKLGTLNVSM 356
                 +R   +    +    L    NLT + +        +         +L  L +  
Sbjct: 7   PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65

Query: 357 NNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQI 407
           + +    P     + +L   +LS N +   +  +  +   L +L+L GN +
Sbjct: 66  SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 27/187 (14%), Positives = 63/187 (33%), Gaps = 15/187 (8%)

Query: 281 TVSENHFQGTIPTS-LRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEI 339
            + + +   T+  + L   T+L   + +   +  +I + +    NLT I+ S N      
Sbjct: 24  VLGKTNVTDTVSQTDLDQVTTL---QADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDIT 78

Query: 340 SSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTK 399
                       +N +       L      +      +   +    +    L +L   + 
Sbjct: 79  PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSN 138

Query: 400 LILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSC 459
            I   + ++G    +  + +  +  D   +        N+ +LE+L++S N +S    S 
Sbjct: 139 TISDISALSGLTSLQQLNFSSNQVTDLKPLA-------NLTTLERLDISSNKVSD--ISV 189

Query: 460 FEGMHGL 466
              +  L
Sbjct: 190 LAKLTNL 196

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.3 bits (85), Expect = 0.004
 Identities = 33/206 (16%), Positives = 65/206 (31%), Gaps = 17/206 (8%)

Query: 123 PIPLSF--DNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLT 180
           PI   F    L+  +   L    ++ ++  S   L  +  LQ +    I  I      L 
Sbjct: 7   PINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLG-IKSID-GVEYLN 62

Query: 181 SVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHL 240
           +++ +  S N L    P +        +++ NQ      L    +          + +  
Sbjct: 63  NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122

Query: 241 SGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTS 300
                 +L  L            +  +       G   +  ++ +  Q T    L N T+
Sbjct: 123 PLKNLTNLNRL---------ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTT 173

Query: 301 LIRVRLNGNNLTGNISEALGIYPNLT 326
           L R+ ++ N ++      L    NL 
Sbjct: 174 LERLDISSNKVSD--ISVLAKLTNLE 197

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 30/191 (15%), Positives = 55/191 (28%), Gaps = 31/191 (16%)

Query: 149 LSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSV 208
           +    + KS+   +    +L G IP                      +   +  +++   
Sbjct: 11  IRIFEERKSVVATEAEKVELHGMIPP------------------IEKMDATLSTLKACKH 52

Query: 209 LDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP 268
           L L+ N  + +   S+S + NL+ L+L  N     I          + L    +    L 
Sbjct: 53  LALSTNNIEKI--SSLSGMENLRILSLGRNL-IKKIENLDAVADTLEELWISYNQIASLS 109

Query: 269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY------ 322
                     ++  +           L     L  + L GN L  +  E           
Sbjct: 110 GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169

Query: 323 ----PNLTFID 329
               PNL  +D
Sbjct: 170 VKRLPNLKKLD 180

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	849
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.98
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.94
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.92
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.9
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.86
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.83
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.79
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.78
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.75
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.58
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.57
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.52
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.48
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.45
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.45
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.45
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.4
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.36
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.35
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.32
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.54
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.48
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.93
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.72
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.7
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.46
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	97.06
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.97
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.48
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.84
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.58
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.87

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-45  Score=374.94  Aligned_cols=238  Identities=26%  Similarity=0.411  Sum_probs=192.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+++.||||++..... ........+.+|+.           ++++++.+++..|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHc-cChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            5789999999999999999966 4789999999864311 11122344555544           478889999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++.+.   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        85 mEy~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EeecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            9999999999999653   3599999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .  ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+... 
T Consensus       159 ~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~-  227 (263)
T d2j4za1         159 S--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVEFTFPDFV-  227 (263)
T ss_dssp             C--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCCCCCTTS-
T ss_pred             C--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCccC-
Confidence            3  34567899999999999999999999999999999999999999974321        122222333333222222 


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ...+.+++.+||++||++|||++|+++|
T Consensus       228 ---s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         228 ---TEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ---CHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---CHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence               2347789999999999999999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-45  Score=379.76  Aligned_cols=236  Identities=24%  Similarity=0.411  Sum_probs=192.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++.....    ...+.+.+|+.           ++++++..++..|+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            4699999999999999999965 5799999999865322    12344556644           478888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++.+    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        96 mEy~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EECCTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEecCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999998754    3489999999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccccccccccccc---CCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQML---DPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  812 (849)
                      .........||+.|+|||++.+..++.++||||+||++|||++|+.||.......        ......   .+.+..  
T Consensus       169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~~~~~~~~~~~~--  238 (293)
T d1yhwa1         169 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--------ALYLIATNGTPELQN--  238 (293)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHHCSCCCSS--
T ss_pred             ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH--------HHHHHHhCCCCCCCC--
Confidence            5555667789999999999999999999999999999999999999997433211        111111   111111  


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                        +......+.+++.+||++||++|||++|+++|
T Consensus       239 --~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         239 --PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             --GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             --cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              11223347889999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-45  Score=375.71  Aligned_cols=239  Identities=26%  Similarity=0.450  Sum_probs=181.3

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      ++|+..+.||+|+||+||+|++.+++.||||++....     ...+++.+|+.           +++|++..++..++||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-----MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-----CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            5788899999999999999998888999999986532     22345666655           4788998899999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+++|+|.+++....  ..+++.++..++.|||.||+|||+.   +|+||||||+||++++++.+||+|||+++.....
T Consensus        80 E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EecCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCC
Confidence            9999999999986543  4589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCccccccccccccccccccccCC-CCCCCCh
Q 042123          737 SS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKG-KHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSR  813 (849)
Q Consensus       737 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  813 (849)
                      .. ......||+.|+|||++.+..|+.++|||||||++|||+|+ +.||.....        ......+... +...+..
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--------~~~~~~i~~~~~~~~p~~  226 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTGFRLYKPRL  226 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--------HHHHHHHHHTCCCCCCTT
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHhcCCCCCccc
Confidence            32 23345789999999999999999999999999999999995 555542211        1111111111 1111111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .    ..++.+++.+||+.||++||||+||+++|+
T Consensus       227 ~----~~~l~~li~~cl~~~p~~Rps~~~il~~L~  257 (263)
T d1sm2a_         227 A----STHVYQIMNHCWKERPEDRPAFSRLLRQLA  257 (263)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             c----CHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            1    234788999999999999999999999985

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=379.73  Aligned_cols=246  Identities=22%  Similarity=0.406  Sum_probs=184.7

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~~~~lV  655 (849)
                      .++|++.+.||+|+||+||+|+++  ..||||+++....  .....+.+.+|+..           +++++.+ +..++|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence            468899999999999999999875  3599999865422  22345567777653           6676644 567999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++....  ..+++.++..++.|||+||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        82 ~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EecCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            99999999999996543  3589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CC--CCeeeccCCccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          736 DS--SNWTEFAGTCGYIAPELAYT---MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       736 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      ..  .......||+.|+|||++.+   ..|+.++|||||||++|||+||+.||........   ...........+....
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~---~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH---HHHHHHHTSCCCCGGG
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH---HHHHHhcCCCCCcchh
Confidence            32  23345679999999999864   3589999999999999999999999975432110   0000111111111111


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         ........+.+++.+||+.||++|||++||+++|+
T Consensus       234 ---~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         234 ---VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             ---SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence               11122235888999999999999999999999885

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-45  Score=374.78  Aligned_cols=241  Identities=24%  Similarity=0.335  Sum_probs=187.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++......   ...+.+.+|+.           ++++++.+++..|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV---DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc---hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            5799999999999999999965 57999999998653221   11234555544           478888999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   ..+++.++..++.||+.||+|||++   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        82 mEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EeccCCCcHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            9999999999999653   3599999999999999999999999   999999999999999999999999999987643


Q ss_pred             CC--CCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DS--SNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ..  ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||......       ............... 
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~~~~~~~~~~~-  227 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDWKEKKTYLN-  227 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-------SHHHHHHHTTCTTST-
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCC-
Confidence            32  23455689999999999988876 57899999999999999999999743211       111111111111111 


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ........+.+++.+||+.||++|||++|+++|
T Consensus       228 -~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         228 -PWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             111122347789999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-45  Score=374.72  Aligned_cols=246  Identities=22%  Similarity=0.356  Sum_probs=180.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec--CCeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH--ARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~--~~~~~  653 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||.+.....  .....+.+.+|+..           +++++.+  .+..|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            6799999999999999999965 5799999999876422  22334567777653           5666643  45689


Q ss_pred             EEEEeccCCChhhhhcccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          654 LLYEFLERGSLAAILNTDA-AAQELGWSQRMNVIKAVAHALSYLHHDCF--PPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~--~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      +|||||++|+|.+++.+.. ....+++.+++.++.||+.||+|||+...  .+|+||||||+|||++.++.+||+|||+|
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999999999999986543 23569999999999999999999999721  13999999999999999999999999999


Q ss_pred             cccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          731 KSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       731 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      +.............||+.|+|||++.+..|+.++|||||||++|||+||+.||...+..        .....+.....+.
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--------~~~~~i~~~~~~~  233 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--------ELAGKIREGKFRR  233 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHTCCCC
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            98765554556678999999999999999999999999999999999999999743321        1122222222222


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+..   ...++.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~---~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         234 IPYR---YSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCcc---cCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            1111   12347889999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-44  Score=366.62  Aligned_cols=240  Identities=25%  Similarity=0.470  Sum_probs=195.8

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||+||+|++++++.||||+++...     ...+++.+|+.           +++|++.+++..++|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            36899999999999999999999888899999987532     12346777755           478999989999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|++.+++....  ..+++..+.+++.|||+||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhccc--cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccC
Confidence            99999999999976543  4589999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCC-CCCCCC
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPS  812 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  812 (849)
                      ... ......+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......        +....+..+ +...+.
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--------~~~~~i~~~~~~~~p~  224 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQGLRLYRPH  224 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTTCCCCCCT
T ss_pred             CCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH--------HHHHHHHhCCCCCCcc
Confidence            432 2334678999999999999999999999999999999998 89999754321        112222222 222222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ..    ...+.+++.+||+.||++|||+++|+++|.
T Consensus       225 ~~----~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         225 LA----SEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             TC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             cc----cHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence            22    234889999999999999999999999873

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-45  Score=375.94  Aligned_cols=241  Identities=21%  Similarity=0.369  Sum_probs=188.7

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|+..+.||+|+||+||+|++++++.||||++....     ...+.+.+|+.           +++|++.+ +..++|
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            46788899999999999999999888999999986532     22345666655           36777654 567899


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++.... ...+++.++.+++.|||+||+|||+.   +|+||||||+|||+++++.+||+|||+|+....
T Consensus        86 ~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccC
Confidence            99999999999886544 34699999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC-CCCCCh
Q 042123          736 DSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR-LPAPSR  813 (849)
Q Consensus       736 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  813 (849)
                      ... ......||+.|+|||++.++.++.++|||||||++|||+||..|+.....       .......+..+. ...+..
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~~~~~~~p~~  234 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYRMVRPDN  234 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCCTT
T ss_pred             CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCccc
Confidence            322 23345688999999999999999999999999999999996665432211       111122222221 111122


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .    ...+.+++.+||+.||++||||+||++.|+
T Consensus       235 ~----~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         235 C----PEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             C----hHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            2    234788999999999999999999998774

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.3e-44  Score=375.89  Aligned_cols=240  Identities=26%  Similarity=0.471  Sum_probs=178.9

Q ss_pred             CCCcCceecCCccceEEEEEec-CC---cEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          589 DFDAKYCIGNGGHASVYRAELP-SG---EVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      +|+..+.||+|+||+||+|++. ++   ..||||++....   .....+.|.+|+.           +++|++..++..+
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc---CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            4555689999999999999764 23   358899876532   2334456777765           4788998899999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|||||++|+|.+++....  ..+++.++.+++.|||.||+|||+.   +|+||||||+|||++.++.+||+|||+|+..
T Consensus       104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEecCCCcceeeecccc--CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            9999999999999886543  3589999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCC-----eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-C
Q 042123          734 KPDSSN-----WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-P  806 (849)
Q Consensus       734 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~  806 (849)
                      ......     .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......        .....+.. .
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--------~~~~~i~~~~  250 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--------DVINAIEQDY  250 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTTC
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCC
Confidence            543221     122457899999999999999999999999999999998 89999744321        11122222 2


Q ss_pred             CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          807 RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       807 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+.+...    ...+.+++.+||+.||++|||++||++.|+
T Consensus       251 ~~~~~~~~----~~~l~~li~~cl~~~P~~RPs~~ei~~~L~  288 (299)
T d1jpaa_         251 RLPPPMDC----PSALHQLMLDCWQKDRNHRPKFGQIVNTLD  288 (299)
T ss_dssp             CCCCCTTC----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCCccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            22222222    234788999999999999999999999874

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-44  Score=375.38  Aligned_cols=242  Identities=25%  Similarity=0.411  Sum_probs=191.1

Q ss_pred             HhcCCCcCceecCCccceEEEEEec-CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          586 ATNDFDAKYCIGNGGHASVYRAELP-SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       586 ~~~~f~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      ..++|+..+.||+|+||+||+|++. +++.||||+++...     ...+.+.+|+.           ++++++.+++..+
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            3467888999999999999999764 68899999986532     12345666655           4788888899999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCccc
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSL  733 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~  733 (849)
                      +|||||++|+|.+++.... ...+++..+..++.|||.||+|||++   +|+||||||+|||+++++.+||+|||+|+..
T Consensus        90 iv~E~~~~g~l~~~l~~~~-~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~  165 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLM  165 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred             EEeecccCcchHHHhhhcc-ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeec
Confidence            9999999999999986543 34689999999999999999999999   9999999999999999999999999999877


Q ss_pred             CCCCCC-eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC--CCCC
Q 042123          734 KPDSSN-WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP--RLPA  810 (849)
Q Consensus       734 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  810 (849)
                      ..+... .....|++.|+|||++.+..|+.++|||||||++|||++|..||......       .. ..+.+..  +...
T Consensus       166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~-~~~~i~~~~~~~~  237 (287)
T d1opja_         166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQ-VYELLEKDYRMER  237 (287)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HH-HHHHHHTTCCCCC
T ss_pred             CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HH-HHHHHhcCCCCCC
Confidence            544322 22345788999999999999999999999999999999977775422211       11 1111111  1111


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +...    ...+.+++.+||+.||++|||++||++.|+
T Consensus       238 ~~~~----~~~l~~li~~cl~~dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         238 PEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             Cccc----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            1122    234788999999999999999999998774

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=375.36  Aligned_cols=241  Identities=22%  Similarity=0.348  Sum_probs=187.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----------HHhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----------EAFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----------~~~~~~~~~~~~~~lV  655 (849)
                      +.|++.+.||+|+||+||+|+. .+++.||||++.......    .+.+.+|+           .++++++.+++..++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~----~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE----LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG----GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH----HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence            4688899999999999999965 579999999987542221    22334443           3578889999999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++.+..  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        88 mEy~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            99999999999875432  4599999999999999999999999   999999999999999999999999999976543


Q ss_pred             CCCCeeeccCCcccccccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAY-----TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      .........||+.|+|||++.     +..|+.++||||+||++|||++|+.||......        .....+.....+.
T Consensus       163 ~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--------~~~~~i~~~~~~~  234 (288)
T d2jfla1         163 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--------RVLLKIAKSEPPT  234 (288)
T ss_dssp             HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--------GHHHHHHHSCCCC
T ss_pred             CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcCCCCC
Confidence            222234567999999999874     456899999999999999999999999754321        1112222211111


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ...+......+.+++.+||+.||++|||++|+++|
T Consensus       235 -~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         235 -LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11111223457889999999999999999999885

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-44  Score=371.76  Aligned_cols=239  Identities=19%  Similarity=0.309  Sum_probs=187.4

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++..... ......+.+.+|+.           ++++++.+++..|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence            6799999999999999999965 5799999999864211 01112334555544           367888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|.+++...   +.+++.++..++.|++.||+|||+.   +|+||||||+||++++++.+||+|||+|+.+..
T Consensus        87 mEy~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            9999999999988654   3599999999999999999999999   999999999999999999999999999987754


Q ss_pred             CC--CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          736 DS--SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       736 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ..  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.        ......+.......+..
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~~p~~  232 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLEYDFPEK  232 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCCCCCTT
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCCCCCCcc
Confidence            32  233456799999999999999999999999999999999999999974321        11222233333222222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~  845 (849)
                      .    ...+.+++.+||+.||++|||++|+.+
T Consensus       233 ~----s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         233 F----FPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             C----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             C----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            2    234788999999999999999999744

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-43  Score=373.18  Aligned_cols=242  Identities=24%  Similarity=0.303  Sum_probs=176.4

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .+.|++.+.||+|+||+||+|+. .+|+.||||++.......   ....+.+|+.           ++++++.+++..|+
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~---~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG---KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            36799999999999999999965 478999999987543211   1223444443           47888889999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec---CCCcEEEeeecCCc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD---LEYEAHVADFGIAK  731 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~---~~~~~kl~DfG~a~  731 (849)
                      |||||++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||++.   +++.+||+|||+|+
T Consensus        85 vmE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEeccCCCcHHHhhhcc---cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence            99999999999999653   3599999999999999999999999   999999999999995   57899999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      ..... ......+||+.|+|||++.+..|++++||||+||++|||++|+.||......        .....+.......+
T Consensus       159 ~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~~~~~  229 (307)
T d1a06a_         159 MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAEYEFD  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTCCCCC
T ss_pred             EccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccCCCCC
Confidence            66533 2345568999999999999999999999999999999999999999743211        12222222222211


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..........+.+++.+||++||++|||++|+++|
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            11112223457899999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=365.42  Aligned_cols=240  Identities=24%  Similarity=0.395  Sum_probs=187.3

Q ss_pred             cCCCcCc-eecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          588 NDFDAKY-CIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ++|...+ +||+|+||+||+|.+.   ++..||||+++...   .....+++.+|+.           +++|++.. +..
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC---CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc---CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            4455556 4999999999999653   35579999987542   2334556777755           36777754 567


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      |+||||+++|+|.+++...+  ..+++.++.+++.|||.||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEeCCCCcHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence            89999999999999985443  3589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCC
Q 042123          733 LKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       733 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      .......   .....||+.|+|||++.+..++.++|||||||++|||+| |+.||......        +....+..+..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--------~~~~~i~~~~~  230 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQGKR  230 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--------HHHHHHHTTCC
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            7543321   233467899999999999999999999999999999998 99999754321        11122222222


Q ss_pred             -CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 -PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 -~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       ..+...    +.++.+++.+||+.||++||||.+|++.|+
T Consensus       231 ~~~p~~~----~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         231 MECPPEC----PPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             CCCCTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCcC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence             222222    234788999999999999999999998774

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=375.14  Aligned_cols=244  Identities=22%  Similarity=0.408  Sum_probs=187.0

Q ss_pred             hcCCCcCceecCCccceEEEEEecC-C-----cEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPS-G-----EVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~  648 (849)
                      .++|++.+.||+|+||+||+|++.. +     ..||||.+.......   ....+.+|            |.++++++.+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS---EREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHH---HHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence            3678899999999999999997542 2     369999886532211   12233333            3347888888


Q ss_pred             CCeeEEEEEeccCCChhhhhccccc--------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDAA--------------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRD  708 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~d  708 (849)
                      .+..++|||||++|+|.+++.....                    ...+++.+++.++.||+.||+|||++   +|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence            9999999999999999999965431                    23589999999999999999999999   999999


Q ss_pred             CCCCCeeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCc
Q 042123          709 ISSKNLLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDF  785 (849)
Q Consensus       709 lk~~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~  785 (849)
                      |||+||+++.++.+||+|||+|+........  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332  234567999999999999999999999999999999998 8999974


Q ss_pred             cccccccccccccccccccCC--CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          786 LSSISSSSLNTDVALDQMLDP--RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       786 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....        ....+++..  +.+.+...    ...+.+++.+||+.||++|||++||+++|+
T Consensus       270 ~~~~--------~~~~~~~~~~~~~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPVD--------ANFYKLIQNGFKMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCCS--------HHHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCHH--------HHHHHHHhcCCCCCCCCcC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            3321        111112111  11222222    234888999999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-43  Score=375.89  Aligned_cols=248  Identities=23%  Similarity=0.369  Sum_probs=189.0

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~l  654 (849)
                      .++|+..+.||+|+||+||+|+. .+|+.||+|+++....   ......+.+|+.           ++++++.++++.++
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK---PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC---TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            47899999999999999999965 5799999999875422   223456677755           47788889999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.+.   ..+++.++..++.|++.||.|||+++  +|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 VmEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             EEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EEEcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            99999999999999654   35899999999999999999999732  79999999999999999999999999998764


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-----ccccc-------------
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-----SSLNT-------------  796 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-----~~~~~-------------  796 (849)
                      ..  .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||........     .....             
T Consensus       157 ~~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         157 DS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             HH--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             CC--ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            32  23456899999999999999999999999999999999999999974321100     00000             


Q ss_pred             ----------------ccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          797 ----------------DVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       797 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                                      ............+..+  ......++.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                            0000000000000000  00112347889999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-43  Score=364.20  Aligned_cols=244  Identities=23%  Similarity=0.387  Sum_probs=182.6

Q ss_pred             hcCCCcCceecCCccceEEEEEecCC-----cEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSG-----EVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHAR  650 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~  650 (849)
                      +..|+..+.||+|+||+||+|.++..     ..||||++....   .......+.+|+.           +++|++.+.+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc---ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            35688899999999999999976532     479999986532   2223445677755           4788888889


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCC
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIA  730 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a  730 (849)
                      ..++||||+++|++.+++....  ..+++.++.+++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+|
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             ceEEEEEecccCcchhhhhccc--ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence            9999999999999999875443  4589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCC---CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCC
Q 042123          731 KSLKPDSS---NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPR  807 (849)
Q Consensus       731 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  807 (849)
                      +.......   ......||+.|+|||++.++.++.++|||||||++|||++|..|+....       ........+.++.
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~  230 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAINDGF  230 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTC
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-------CHHHHHHHHhccC
Confidence            87654322   1233467899999999999999999999999999999999766654221       1112222222222


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .++.+..   ....+.+++.+||+.||++||||.||++.|+
T Consensus       231 ~~~~~~~---~~~~l~~li~~cl~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         231 RLPTPMD---CPSAIYQLMMQCWQQERARRPKFADIVSILD  268 (283)
T ss_dssp             CCCCCTT---CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCchh---hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHH
Confidence            2221111   2234788999999999999999999998774

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.3e-43  Score=374.14  Aligned_cols=241  Identities=19%  Similarity=0.300  Sum_probs=193.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....    ....+.+.+|+.           ++++++.+++..|+|
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH----ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS----HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc----hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            5899999999999999999965 579999999986532    223445556654           368888899999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC--CCcEEEeeecCCccc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL--EYEAHVADFGIAKSL  733 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~--~~~~kl~DfG~a~~~  733 (849)
                      ||||++|+|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+|||++.  ++.+||+|||+|+..
T Consensus       102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEcCCCCCHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            99999999999986433  3589999999999999999999999   9999999999999964  578999999999877


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+.        ......+.......+..
T Consensus       177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~  247 (350)
T d1koaa2         177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCDWNMDDS  247 (350)
T ss_dssp             CTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTCCCSCCG
T ss_pred             ccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCcc
Confidence            543 345667899999999999999999999999999999999999999974321        12222222222222222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........+.+++.+||+.||++|||++|+++|
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222233457899999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-43  Score=359.69  Aligned_cols=238  Identities=21%  Similarity=0.342  Sum_probs=181.2

Q ss_pred             CcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeec----CCeeEE
Q 042123          591 DAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSH----ARHSFL  654 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~----~~~~~l  654 (849)
                      +..+.||+|+||+||+|.. .+++.||+|++.....  .....+.+.+|+..           +++++..    ....|+
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            4566899999999999965 4688999999865422  22334567777653           5565543    356799


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec-CCCcEEEeeecCCccc
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD-LEYEAHVADFGIAKSL  733 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~-~~~~~kl~DfG~a~~~  733 (849)
                      ||||+++|+|.+++.+.   ..+++.++..++.||+.||+|||++. ++|+||||||+|||++ +++.+||+|||+|+..
T Consensus        90 vmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            99999999999999653   35899999999999999999999981 1399999999999996 5789999999999864


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ..  .......||+.|+|||++.+ .++.++||||+||++|||++|+.||......       ......+.....+  ..
T Consensus       166 ~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~~~~~--~~  233 (270)
T d1t4ha_         166 RA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSGVKP--AS  233 (270)
T ss_dssp             CT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTTCCC--GG
T ss_pred             cC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHcCCCC--cc
Confidence            43  33456789999999998865 5999999999999999999999999643211       1111122221111  11


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......++.+++.+||++||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            111122347889999999999999999999985

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-42  Score=372.53  Aligned_cols=241  Identities=19%  Similarity=0.284  Sum_probs=193.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|++.+.||+|+||+||+|+. .+|+.||||++....    ......+.+|+.           ++++++.+++..|+|
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY----PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc----hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            5799999999999999999965 579999999987532    223445666655           377888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeec--CCCcEEEeeecCCccc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLD--LEYEAHVADFGIAKSL  733 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~--~~~~~kl~DfG~a~~~  733 (849)
                      ||||++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+|||++  .++.+||+|||+|+..
T Consensus       105 mE~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         105 LEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEcCCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceec
Confidence            99999999998875433  3589999999999999999999999   999999999999998  5689999999999987


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ... .......||+.|+|||++.+..++.++||||+||++|||+||+.||......        .....+.......+..
T Consensus       180 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~  250 (352)
T d1koba_         180 NPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--------ETLQNVKRCDWEFDED  250 (352)
T ss_dssp             CTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--------HHHHHHHHCCCCCCSS
T ss_pred             CCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCCCCCCcc
Confidence            653 3456678999999999999999999999999999999999999999743321        1122222222221111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........+.+++.+||++||++|||++|+++|
T Consensus       251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            112223347899999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=368.85  Aligned_cols=240  Identities=23%  Similarity=0.306  Sum_probs=194.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+.... .....+.+.+|+.           .+++++.+.+..|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            6799999999999999999965 57999999998653111 1112344555544           367888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|+|.+++.+..   .+++.+++.++.||+.||+|||++   +|+||||||+|||++++|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            99999999999986543   589999999999999999999999   999999999999999999999999999997765


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      ........+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.        ......+....+..+....
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~~~~~p~~~s  229 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEIRFPRTLS  229 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTTSC
T ss_pred             CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcCCCCCCccCC
Confidence            55556678899999999999999999999999999999999999999974332        1222223333333222222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                          .++.+++.+||++||++||+     ++|+++|
T Consensus       230 ----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         230 ----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             ----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ----HHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                34778999999999999994     8888875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-43  Score=368.40  Aligned_cols=238  Identities=25%  Similarity=0.366  Sum_probs=186.7

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      +.|+..+.||+|+||+||+|+. .+++.||||++..... ......+.+.+|+.           ++++++.+++..|+|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            3588899999999999999964 5789999999875422 22233455667755           478888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|++..++...   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        94 ~E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          94 MEYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             EECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EEecCCCchHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            9999999997766432   3599999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCCCeeeccCCccccccccccC---CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT---MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      .    ....||+.|+|||++.+   ..|+.++|||||||++|||++|+.||......        .....+.....+...
T Consensus       168 ~----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~  235 (309)
T d1u5ra_         168 A----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPALQ  235 (309)
T ss_dssp             B----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSCCCCCS
T ss_pred             C----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCCCCCCC
Confidence            2    34679999999999864   46899999999999999999999999743221        111111111111111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .  ......+.+++.+||+.||++|||++|+++|
T Consensus       236 ~--~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         236 S--GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             C--TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C--CCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            0  0112347889999999999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=360.88  Aligned_cols=234  Identities=26%  Similarity=0.431  Sum_probs=180.3

Q ss_pred             ceecCCccceEEEEEec---CCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEEEec
Q 042123          594 YCIGNGGHASVYRAELP---SGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLYEFL  659 (849)
Q Consensus       594 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~~  659 (849)
                      +.||+|+||+||+|.+.   .++.||||+++....  .....+.+.+|+.           +++++|.. +..++||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~   89 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA   89 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcC
Confidence            46999999999999654   356899999865422  2233456777765           36777754 5678999999


Q ss_pred             cCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCCC
Q 042123          660 ERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSSN  739 (849)
Q Consensus       660 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  739 (849)
                      ++|+|.+++...   ..+++.++..++.|||.||+|||+.   +|+||||||+||+++.++.+|++|||+|+........
T Consensus        90 ~~g~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          90 ELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             TTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999998653   3599999999999999999999998   9999999999999999999999999999876544322


Q ss_pred             ---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-CCCCChh
Q 042123          740 ---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-LPAPSRS  814 (849)
Q Consensus       740 ---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  814 (849)
                         .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......        .....+..+. .+.+...
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--------~~~~~i~~~~~~~~p~~~  235 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGCPAGC  235 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--------HHHHHHHTTCCCCCCTTC
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH--------HHHHHHHcCCCCCCCccc
Confidence               233568999999999999999999999999999999998 89999754321        1111222222 2222222


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                          ..++.+++.+||+.||++|||+++|.+.|+
T Consensus       236 ----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         236 ----PREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             ----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence                234788999999999999999999987764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=364.35  Aligned_cols=244  Identities=19%  Similarity=0.273  Sum_probs=194.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC--chhhHHHHHHHHH-----------HhhceeecCCeeE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD--QTVDQKEFLTEVE-----------AFYGFCSHARHSF  653 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~~~~ei~-----------~~~~~~~~~~~~~  653 (849)
                      +.|++.+.||+|+||+||+|+. .+|+.||||++.......  .....+.+.+|+.           ++++++.+.+..|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            6799999999999999999965 579999999986543221  1223445666654           4788899999999


Q ss_pred             EEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC----cEEEeeecC
Q 042123          654 LLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY----EAHVADFGI  729 (849)
Q Consensus       654 lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~----~~kl~DfG~  729 (849)
                      +|||||++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++    .+|++|||+
T Consensus        90 iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence            999999999999998653   3599999999999999999999999   999999999999998876    499999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLP  809 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  809 (849)
                      |+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+......
T Consensus       164 a~~~~~~~-~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~~~  234 (293)
T d1jksa_         164 AHKIDFGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVNYE  234 (293)
T ss_dssp             CEECTTSC-BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTCCC
T ss_pred             hhhcCCCc-cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcCCC
Confidence            98775432 33456789999999999999999999999999999999999999974321        1122222232222


Q ss_pred             CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          810 APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       810 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+..........+.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2222222233457899999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-42  Score=360.75  Aligned_cols=241  Identities=24%  Similarity=0.415  Sum_probs=183.8

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      .++|++.+.||+|+||+||+|++++++.||||+++...     ...+.|.+|+.           ++++++.+ +..++|
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv   89 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV   89 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-----CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence            36799999999999999999998888899999986532     12345666654           37788754 567899


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+++|+|..++.... ...++|.++..++.|||.||+|||+.   +|+||||||+|||++.++++||+|||+|+....
T Consensus        90 ~Ey~~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             ECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EEecCCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccC
Confidence            99999999999987644 24599999999999999999999999   999999999999999999999999999987654


Q ss_pred             CC-CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCC-CCCCCCh
Q 042123          736 DS-SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDP-RLPAPSR  813 (849)
Q Consensus       736 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  813 (849)
                      .. .......||+.|+|||++..+.++.++|||||||++|||++|..||.....       ..+....+... +.+.+..
T Consensus       166 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~~~~~~~~~~  238 (285)
T d1fmka3         166 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPCPPE  238 (285)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCCCCCCTT
T ss_pred             CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCCCCCCcc
Confidence            33 233446789999999999999999999999999999999997666542211       11112222211 1122222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .    ..++.+++.+||+.||++|||+++|++.|+
T Consensus       239 ~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  269 (285)
T d1fmka3         239 C----PESLHDLMCQCWRKEPEERPTFEYLQAFLE  269 (285)
T ss_dssp             S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             c----CHHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence            2    234788999999999999999999998764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=366.74  Aligned_cols=247  Identities=22%  Similarity=0.389  Sum_probs=178.1

Q ss_pred             HHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHHH------------hhcee
Q 042123          585 KATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA------------FYGFC  646 (849)
Q Consensus       585 ~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~------------~~~~~  646 (849)
                      ...++|+..+.||+|+||.||+|++.      +++.||||+++...   .....+.+.+|+..            +++++
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc---CcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            34478999999999999999999653      35689999986532   22233444444332            34444


Q ss_pred             e-cCCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 042123          647 S-HARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSK  712 (849)
Q Consensus       647 ~-~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~  712 (849)
                      . .+...++|||||++|+|.++++....             ...+++.++..++.||+.||+|||++   +|+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCcc
Confidence            3 34578999999999999999965432             23489999999999999999999999   9999999999


Q ss_pred             CeeecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCC-CCCCccccc
Q 042123          713 NLLLDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK-HPRDFLSSI  789 (849)
Q Consensus       713 Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~-~Pf~~~~~~  789 (849)
                      |||++.++.+||+|||+|+.......  ......||+.|+|||++.+..++.++|||||||++|||+||. .||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654332  234467999999999999999999999999999999999964 567533211


Q ss_pred             cccccccccccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          790 SSSSLNTDVALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       790 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .       .....+..+ +...+...    ..++.+++.+||+.||++|||++||+++|+
T Consensus       244 ~-------~~~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         244 E-------EFCRRLKEGTRMRAPDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             H-------HHHHHHHHTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H-------HHHHHHhcCCCCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            0       111111111 11111112    224788999999999999999999999985

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=368.05  Aligned_cols=240  Identities=24%  Similarity=0.354  Sum_probs=190.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH------------HHHhhceeecCCeeEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE------------VEAFYGFCSHARHSFL  654 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e------------i~~~~~~~~~~~~~~l  654 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++++..... ....+.+..|            |.++++++.+++..|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-DDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH-TTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC-hHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            5799999999999999999965 579999999986421100 1111222222            3347888899999999


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++...   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+|+...
T Consensus        81 vmEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            99999999999999653   3589999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRS  814 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  814 (849)
                      ..........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..        .....+.......+...
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--------~~~~~i~~~~~~~p~~~  226 (320)
T d1xjda_         155 LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--------ELFHSIRMDNPFYPRWL  226 (320)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCCCCCCTTS
T ss_pred             cccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHHcCCCCCCccC
Confidence            5555566678999999999999999999999999999999999999999743321        11122222222222212


Q ss_pred             hHHHHHHHHHHHhhccCCCCCCCCCHH-HHHhh
Q 042123          815 AQEKLISIMEVAFSCFNESPESRPTMK-IISQQ  846 (849)
Q Consensus       815 ~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~~  846 (849)
                          ...+.+++.+||++||++|||+. ++++|
T Consensus       227 ----s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         227 ----EKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             ----CHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ----CHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                23478999999999999999995 77653

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.4e-42  Score=354.95  Aligned_cols=244  Identities=22%  Similarity=0.334  Sum_probs=191.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCch-----hhHHHHHHHHH------------HhhceeecC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQT-----VDQKEFLTEVE------------AFYGFCSHA  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~~~ei~------------~~~~~~~~~  649 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++........     .....+.+|+.            ++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999965 57999999998754322111     11223445543            367888899


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      +..|+|||||++|+|.+++...   ..+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999643   3599999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCCeeeccCCcccccccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccc
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAY------TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQM  803 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  803 (849)
                      ++...... ......||+.|+|||++.      ...++.++||||+||++|||++|+.||.....        ......+
T Consensus       157 a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~i  227 (277)
T d1phka_         157 SCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRMI  227 (277)
T ss_dssp             CEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred             eeEccCCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHHH
Confidence            98776533 345578999999999885      34578899999999999999999999974331        1112222


Q ss_pred             cCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .......+.........++.+++.+||++||++|||++|+++|
T Consensus       228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            2222211111112233458899999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-42  Score=363.37  Aligned_cols=249  Identities=22%  Similarity=0.420  Sum_probs=193.8

Q ss_pred             HHHHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhce
Q 042123          583 IVKATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGF  645 (849)
Q Consensus       583 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~  645 (849)
                      ++...++|+..+.||+|+||+||+|++.      +++.||||++....   .....+.+.+|+..           ++++
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc---ChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3334578999999999999999999753      45789999986532   22335567777653           6778


Q ss_pred             eecCCeeEEEEEeccCCChhhhhcccc---------------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 042123          646 CSHARHSFLLYEFLERGSLAAILNTDA---------------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPI  704 (849)
Q Consensus       646 ~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  704 (849)
                      +......++||||+++|+|.+++....                     ....+++.++..++.|+|.||+|||+.   +|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence            888889999999999999999985321                     123489999999999999999999999   99


Q ss_pred             EecCCCCCCeeecCCCcEEEeeecCCcccCCCC--CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCC-C
Q 042123          705 VHRDISSKNLLLDLEYEAHVADFGIAKSLKPDS--SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK-H  781 (849)
Q Consensus       705 vH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~-~  781 (849)
                      +||||||+|||++.++.+||+|||+|+......  .......+++.|+|||.+.+..|+.++|||||||++|||++|. .
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            999999999999999999999999998664332  2234567889999999999999999999999999999999986 5


Q ss_pred             CCCccccccccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          782 PRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       782 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ||.....        .+....+.++..++.+..   .+..+.+++.+||+.||++||||.||++.|+
T Consensus       242 p~~~~~~--------~e~~~~v~~~~~~~~p~~---~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         242 PYYGMAH--------EEVIYYVRDGNILACPEN---CPLELYNLMRLCWSKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             TTTTSCH--------HHHHHHHHTTCCCCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCH--------HHHHHHHHcCCCCCCCcc---chHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            6664322        222333344433322221   1234788999999999999999999999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=362.31  Aligned_cols=247  Identities=20%  Similarity=0.283  Sum_probs=185.7

Q ss_pred             cCCCcCc-eecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHH------HHHHhhceeec----CCeeEEE
Q 042123          588 NDFDAKY-CIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLT------EVEAFYGFCSH----ARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~------ei~~~~~~~~~----~~~~~lV  655 (849)
                      ++|.+.. .||+|+||+||+|+. .+++.||||+++...   ....+...+.      .|.++++++.+    ....|+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv   87 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP---KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV   87 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH---HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence            6788764 699999999999955 679999999986431   1111111111      12345666543    4678999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeecCCcc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL---EYEAHVADFGIAKS  732 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG~a~~  732 (849)
                      ||||++|+|.+++.... ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.   ++.+||+|||+|+.
T Consensus        88 mEy~~gg~L~~~i~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          88 MECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EECCCSEEHHHHHHSCS-CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EECCCCCcHHHHHHhcC-CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeee
Confidence            99999999999997543 24589999999999999999999999   9999999999999986   46799999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ..... ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||........    .......+.......+.
T Consensus       164 ~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~----~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         164 TTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----SPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             CCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSSCCT
T ss_pred             ccCCC-ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH----HHHHHHHHhcCCCCCCC
Confidence            76543 34557899999999999999999999999999999999999999974332111    11111122222222222


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........++.+++.+||++||++|||++|+++|
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            2333445568899999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-41  Score=359.71  Aligned_cols=237  Identities=23%  Similarity=0.340  Sum_probs=190.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..... .....+.+.+|+.           ++++++.+++..|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHcc-CHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            5799999999999999999965 57999999998643111 1122344555544           477888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      ||||++|++..++....   .+++.++..++.||+.||+|||++   +|+||||||+|||++.+|.+||+|||+|+....
T Consensus        83 mE~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eeecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            99999999999886543   478999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .   .....||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.        ......+.......+....
T Consensus       157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~s  225 (316)
T d1fota_         157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNAELRFPPFFN  225 (316)
T ss_dssp             C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHCCCCCCTTSC
T ss_pred             c---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcCCCCCCCCCC
Confidence            3   3456899999999999999999999999999999999999999974322        1222223333332222222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                          ..+.+++.+||++||++||     |++++++|
T Consensus       226 ----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         226 ----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             ----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----HHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                2377899999999999996     89999876

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.2e-41  Score=364.44  Aligned_cols=241  Identities=18%  Similarity=0.270  Sum_probs=185.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHH--------------HHHhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTE--------------VEAFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~e--------------i~~~~~~~~~~~~~  652 (849)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++...... .......+.+|              |..+++++...+..
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc-hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            6899999999999999999965 47999999998642110 01111112222              23467788888999


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      |+|||||++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.+|.+||+|||+|+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            9999999999999999654   3589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCC
Q 042123          733 LKPDSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAP  811 (849)
Q Consensus       733 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  811 (849)
                      +...  ......||+.|+|||++.. ..|+.++||||+||++|||+||+.||.......     ...............+
T Consensus       157 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~  229 (364)
T d1omwa3         157 FSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAVELP  229 (364)
T ss_dssp             CSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-----HHHHHHHSSSCCCCCC
T ss_pred             cCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcccCCCCCC
Confidence            6543  2345689999999999864 568999999999999999999999997432111     1111111222222222


Q ss_pred             ChhhHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHhh
Q 042123          812 SRSAQEKLISIMEVAFSCFNESPESRPT-----MKIISQQ  846 (849)
Q Consensus       812 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~  846 (849)
                      ....    ..+.+++.+||++||++|||     ++|+++|
T Consensus       230 ~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         230 DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            2222    34788999999999999999     6888875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=353.51  Aligned_cols=237  Identities=24%  Similarity=0.397  Sum_probs=179.3

Q ss_pred             hcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-CCeeEE
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-ARHSFL  654 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-~~~~~l  654 (849)
                      .++|+..+.||+|+||.||+|+++ |+.||||+++...      ..+.+.+|+.           +++|++.+ .+..++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l   78 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA------TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   78 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC--------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH------HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence            357888899999999999999985 7899999986532      2344566654           47787754 456899


Q ss_pred             EEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccC
Q 042123          655 LYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLK  734 (849)
Q Consensus       655 V~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~  734 (849)
                      ||||+++|+|.+++.... ...+++.++++++.||+.||+|||+.   +|+||||||+||+++.++.+|++|||+++...
T Consensus        79 v~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecC
Confidence            999999999999996543 23589999999999999999999998   99999999999999999999999999998754


Q ss_pred             CCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          735 PDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       735 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ..   .....++..|+|||++.++.++.++||||||+++|||+| |+.||......        .....+.....++.+.
T Consensus       155 ~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~--------~~~~~i~~~~~~~~~~  223 (262)
T d1byga_         155 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDAPD  223 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--------GHHHHHTTTCCCCCCT
T ss_pred             CC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCCCCCCc
Confidence            32   234567899999999999999999999999999999998 68887643321        1111222111111111


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                         ....++.+++.+||+.||++||||.+|+++|+
T Consensus       224 ---~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~  255 (262)
T d1byga_         224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  255 (262)
T ss_dssp             ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence               11234788999999999999999999999885

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=358.52  Aligned_cols=240  Identities=21%  Similarity=0.281  Sum_probs=192.5

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|.. .+|+.||||.++...     .....+.+|+.           ++++++.+++..|+|
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            6789999999999999999965 478999999987532     22334455544           478888889999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC--CcEEEeeecCCccc
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE--YEAHVADFGIAKSL  733 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~--~~~kl~DfG~a~~~  733 (849)
                      ||||++|+|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.+  +.+|++|||+++..
T Consensus        80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            99999999999997543  3589999999999999999999998   99999999999999854  58999999999876


Q ss_pred             CCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCCh
Q 042123          734 KPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSR  813 (849)
Q Consensus       734 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  813 (849)
                      ... .......+|+.|+|||...+..++.++||||+||++|+|++|+.||.....        ......+.......+..
T Consensus       155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEYTFDEE  225 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCCCHH
T ss_pred             ccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCChh
Confidence            543 334556889999999999999999999999999999999999999974321        12223333333332222


Q ss_pred             hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          814 SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       814 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ........+.+++.+||++||++|||++|+++|
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            222233457899999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-41  Score=354.83  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=181.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecC----Ce
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHA----RH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~----~~  651 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++..... .......+.+|+..           +++++...    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTT-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            6799999999999999999964 57999999999764332 22334567777663           44454433    24


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .|+||||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence            78999999999999988643   3599999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCC---CCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          732 SLKPDS---SNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       732 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ......   .......||+.|+|||++.+..+++++||||+||++|||+||+.||......        ......+....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~~~~~~~  231 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--------SVAYQHVREDP  231 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHHCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH--------HHHHHHHhcCC
Confidence            654332   2344567999999999999999999999999999999999999999743321        11111111111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCC-CHHHHHhhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRP-TMKIISQQL  847 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L  847 (849)
                      ..+..........+.+++.+||++||++|| |++++.+.|
T Consensus       232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l  271 (277)
T d1o6ya_         232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL  271 (277)
T ss_dssp             CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHH
Confidence            111111112223478899999999999999 899988765

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-41  Score=350.97  Aligned_cols=241  Identities=23%  Similarity=0.401  Sum_probs=178.4

Q ss_pred             hcCCCcCceecCCccceEEEEEecC----CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      .++|++.+.||+|+||+||+|.+..    +..||||.++...   .......+.+|+.           ++++++. .+.
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~   81 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   81 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCe
Confidence            3678899999999999999997642    4568999875432   2333456777755           3677775 467


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+++|++.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+
T Consensus        82 ~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          82 VWIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEEEeccCCcHHhhhhccC--CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence            899999999999999875433  4589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCC-CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-C
Q 042123          732 SLKPDSS-NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-L  808 (849)
Q Consensus       732 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~  808 (849)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||++ |..||......        .....+.... .
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~~~~~~  228 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGERL  228 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTCCC
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCCCC
Confidence            7654322 2344568899999999999999999999999999999998 89998754321        1122222222 2


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      +.+...    ...+.+++.+||+.||++|||++||+++|+
T Consensus       229 ~~~~~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         229 PMPPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            222222    234888999999999999999999999874

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-41  Score=353.16  Aligned_cols=248  Identities=23%  Similarity=0.367  Sum_probs=183.3

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHH--H-----------HHHhhceeecCC----
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLT--E-----------VEAFYGFCSHAR----  650 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~--e-----------i~~~~~~~~~~~----  650 (849)
                      ++|...+.||+|+||.||+|++ +|+.||||+++...       ...+..  |           |..+++++.+.+    
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-------~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~   74 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT   74 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-------hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence            5677888999999999999987 58999999986431       112222  2           224677776543    


Q ss_pred             eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeeecCCCcEEEe
Q 042123          651 HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC-----FPPIVHRDISSKNLLLDLEYEAHVA  725 (849)
Q Consensus       651 ~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~dlk~~Nill~~~~~~kl~  725 (849)
                      ..|+|||||++|+|.+++++.    .++|.++.+++.|+|.||+|+|+..     .++|+||||||+|||++.++.+||+
T Consensus        75 ~~~lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          75 QLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             EEEEEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence            679999999999999999653    4899999999999999999999731     2389999999999999999999999


Q ss_pred             eecCCcccCCCCC----CeeeccCCccccccccccCC------CCCccchHHHHHHHHHHHHhCCCCCCcccccccccc-
Q 042123          726 DFGIAKSLKPDSS----NWTEFAGTCGYIAPELAYTM------KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-  794 (849)
Q Consensus       726 DfG~a~~~~~~~~----~~~~~~g~~~y~aPE~~~~~------~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-  794 (849)
                      |||+++.......    ......||+.|+|||++.+.      .++.++|||||||++|||+||..||........... 
T Consensus       151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~  230 (303)
T d1vjya_         151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD  230 (303)
T ss_dssp             CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred             ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence            9999987654322    23456799999999998754      267789999999999999999988764332211111 


Q ss_pred             ------ccccccccccCCC----CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          795 ------NTDVALDQMLDPR----LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       795 ------~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                            ..........+..    ++... ...+....+.+++.+||+.||++|||+.||+++|+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~  293 (303)
T d1vjya_         231 LVPSDPSVEEMRKVVCEQKLRPNIPNRW-QSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGG-GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             cccccchHHHHHHHHhccccCCCCCccc-CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence                  1111111222222    22211 12344566889999999999999999999998875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.6e-41  Score=360.77  Aligned_cols=237  Identities=19%  Similarity=0.266  Sum_probs=190.0

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++..... ......+.+.+|+.           ++++++......++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence            5799999999999999999965 5799999999864211 11122344556654           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+.+|+|.+++.+..   .+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus       120 ~e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            99999999999986543   599999999999999999999999   999999999999999999999999999987753


Q ss_pred             CCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCChhh
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPSRSA  815 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  815 (849)
                      .   .....||+.|+|||++.+..++.++||||+||++|||+||+.||.....        ......+.......+....
T Consensus       194 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~~~~~p~~~s  262 (350)
T d1rdqe_         194 R---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGKVRFPSHFS  262 (350)
T ss_dssp             C---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCCCCTTCC
T ss_pred             c---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcCCCCCCccCC
Confidence            3   3456899999999999999999999999999999999999999974321        1122222223332222222


Q ss_pred             HHHHHHHHHHHhhccCCCCCCC-----CCHHHHHhh
Q 042123          816 QEKLISIMEVAFSCFNESPESR-----PTMKIISQQ  846 (849)
Q Consensus       816 ~~~~~~l~~li~~cl~~dP~~R-----Pt~~eil~~  846 (849)
                          ..+.+++.+||++||++|     ||++|+++|
T Consensus       263 ----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         263 ----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             ----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ----HHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                247889999999999999     499999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-41  Score=350.85  Aligned_cols=242  Identities=26%  Similarity=0.396  Sum_probs=178.5

Q ss_pred             cCCCcCceecCCccceEEEEEec--C--CcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP--S--GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~  652 (849)
                      ++|++.+.||+|+||+||+|++.  +  ...||||++....... ....+.|.+|+.           +++|++.+ +..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCC-HHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            67899999999999999999653  2  2368999986543222 233456777765           36777755 567


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      ++||||+++|++.+++....  ..+++.++..++.|||.||+|||++   +|+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             heeeeeecCcchhhhhhccc--CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence            89999999999999886543  3599999999999999999999998   999999999999999999999999999998


Q ss_pred             cCCCCCC---eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccCCC-
Q 042123          733 LKPDSSN---WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLDPR-  807 (849)
Q Consensus       733 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-  807 (849)
                      .......   .....++..|+|||.+.+..++.++|||||||++|||+| |+.||......        .....+.... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--------~~~~~i~~~~~  232 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--------QILHKIDKEGE  232 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHHHTSCC
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH--------HHHHHHHhCCC
Confidence            7554332   233457889999999999999999999999999999998 89999744322        1222222221 


Q ss_pred             -CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 -LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                       .+.+...    ...+.+++.+||+.||++||||+||.+.|+
T Consensus       233 ~~~~~~~~----~~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         233 RLPRPEDC----PQDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             CCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence             1111122    234788999999999999999999998774

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-41  Score=356.62  Aligned_cols=240  Identities=24%  Similarity=0.440  Sum_probs=182.7

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCc----EEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGE----VVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~  651 (849)
                      ++|+..+.||+|+||+||+|.+. +|+    +||||++....   .....+.+.+|+.           +++|+|.+ +.
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~   84 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT-ST   84 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence            47999999999999999999653 444    58899876432   2223456777765           36777765 45


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++|+||+.+|+|.+++....  ..+++.++.+++.|||.||+|||++   +|+||||||+||+++.++.+||+|||+|+
T Consensus        85 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~  159 (317)
T d1xkka_          85 VQLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  159 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred             eeEEEEeccCCcccccccccc--cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence            678899999999999876543  4689999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCccccccccccccccccccccC-CC
Q 042123          732 SLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSISSSSLNTDVALDQMLD-PR  807 (849)
Q Consensus       732 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~  807 (849)
                      ........  .....||+.|+|||++.++.++.++|||||||++|||+| |+.||+.....        .....+.. .+
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--------~~~~~i~~~~~  231 (317)
T d1xkka_         160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------EISSILEKGER  231 (317)
T ss_dssp             HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--------GHHHHHHHTCC
T ss_pred             ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcCCC
Confidence            77544332  234568999999999999999999999999999999998 88998744321        11111111 12


Q ss_pred             CCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          808 LPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       808 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .+.+...+    ..+.+++.+||+.||++|||+.||+++|+
T Consensus       232 ~~~p~~~~----~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         232 LPQPPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             CCCCTTBC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcccC----HHHHHHHHHhCCCChhhCcCHHHHHHHHH
Confidence            22222222    34788999999999999999999998863

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=350.51  Aligned_cols=238  Identities=25%  Similarity=0.402  Sum_probs=183.5

Q ss_pred             CceecCCccceEEEEEecC----CcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceeec-CCeeEEEE
Q 042123          593 KYCIGNGGHASVYRAELPS----GEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSH-ARHSFLLY  656 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~-~~~~~lV~  656 (849)
                      .++||+|+||+||+|++.+    ...||||+++..   ......+++.+|+.           +++|++.. ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            4689999999999997643    236899998643   23344567888866           36787654 56889999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      |||++|+|.+++....  ..+++.++.+++.|+|.||.|+|+.   +|+||||||+|||+++++.+||+|||+++.....
T Consensus       109 E~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             ECCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEeecCchhhhhcccc--ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999999987543  3578899999999999999999999   9999999999999999999999999999876543


Q ss_pred             CC----CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCCCC
Q 042123          737 SS----NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPAPS  812 (849)
Q Consensus       737 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  812 (849)
                      ..    ......||+.|+|||.+....++.++||||||+++|||+||+.||.....       .......+..+..+..+
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~~~~i~~g~~~~~p  256 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQGRRLLQP  256 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCC
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHcCCCCCCc
Confidence            22    12335689999999999999999999999999999999998888753221       11112222222222111


Q ss_pred             hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          813 RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       813 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ...   ...+.+++.+||+.||++||||.||+++|+
T Consensus       257 ~~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~  289 (311)
T d1r0pa_         257 EYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS  289 (311)
T ss_dssp             TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccC---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            111   234788999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-41  Score=354.89  Aligned_cols=242  Identities=26%  Similarity=0.451  Sum_probs=184.8

Q ss_pred             cCCCcCceecCCccceEEEEEec-CCc--EEEEEEecccCCCCchhhHHHHHHHHH------------HhhceeecCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAELP-SGE--VVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSHARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~~~~~  652 (849)
                      ++|+..+.||+|+||+||+|++. +|.  .||||++.......   ..+.+.+|+.            ++++++.+++..
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~   86 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   86 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH---HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence            68888999999999999999765 444  47888875432221   2334555544            478888889999


Q ss_pred             EEEEEeccCCChhhhhcccc-------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC
Q 042123          653 FLLYEFLERGSLAAILNTDA-------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE  719 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~  719 (849)
                      ++||||+++|+|.++++...             ....+++.++.+++.|||.||.|+|+.   +|+||||||+|||++.+
T Consensus        87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred             EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCC
Confidence            99999999999999996542             235699999999999999999999999   99999999999999999


Q ss_pred             CcEEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCC-CCCCcccccccccccccc
Q 042123          720 YEAHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK-HPRDFLSSISSSSLNTDV  798 (849)
Q Consensus       720 ~~~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~-~Pf~~~~~~~~~~~~~~~  798 (849)
                      +.+||+|||+|+...... ......||..|+|||.+.+..++.++|||||||++|||++|. .||.....        ..
T Consensus       164 ~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~--------~~  234 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE  234 (309)
T ss_dssp             GCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred             CceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH--------HH
Confidence            999999999998654332 223456899999999999999999999999999999999976 46653321        11


Q ss_pred             ccccccCC-CCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          799 ALDQMLDP-RLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       799 ~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      ....+..+ +...+...    ...+.+++.+||+.||++||||+||+++|+
T Consensus       235 ~~~~i~~~~~~~~~~~~----~~~~~~li~~cl~~dP~~RPs~~eil~~L~  281 (309)
T d1fvra_         235 LYEKLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPSFAQILVSLN  281 (309)
T ss_dssp             HHHHGGGTCCCCCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCCccC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            22222222 22222222    234788999999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-41  Score=351.40  Aligned_cols=245  Identities=23%  Similarity=0.392  Sum_probs=185.6

Q ss_pred             hcCCCcCceecCCccceEEEEEecC--------CcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhcee
Q 042123          587 TNDFDAKYCIGNGGHASVYRAELPS--------GEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFC  646 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~  646 (849)
                      .++|++.+.||+|+||.||+|+...        +..||||+++....   .....++.+|+.            .+++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~---~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~   88 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT---EKDLSDLISEMEMMKMIGKHKNIINLLGAC   88 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC---HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC---hHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence            3678889999999999999996532        34799999876432   222344444433            477888


Q ss_pred             ecCCeeEEEEEeccCCChhhhhccccc-------------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          647 SHARHSFLLYEFLERGSLAAILNTDAA-------------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       647 ~~~~~~~lV~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                      .+++..++||||+++|+|.+++.....             ...+++.++.+++.||+.||+|||+.   +|+||||||+|
T Consensus        89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N  165 (299)
T d1fgka_          89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  165 (299)
T ss_dssp             CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence            888999999999999999999965431             24589999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccCCCCC--CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHh-CCCCCCcccccc
Q 042123          714 LLLDLEYEAHVADFGIAKSLKPDSS--NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIK-GKHPRDFLSSIS  790 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~t-g~~Pf~~~~~~~  790 (849)
                      ||++.++.+||+|||+++.......  ......+++.|+|||.+.++.|+.++|||||||++|||++ |+.||...... 
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-  244 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  244 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-
Confidence            9999999999999999987654322  2344568999999999999999999999999999999998 78888643321 


Q ss_pred             ccccccccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                             .....+.++..+..+..   ....+.+++.+||+.||++|||++||++.|+
T Consensus       245 -------~~~~~i~~~~~~~~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~  292 (299)
T d1fgka_         245 -------ELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  292 (299)
T ss_dssp             -------HHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -------HHHHHHHcCCCCCCCcc---chHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence                   11122222211111111   1234889999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-41  Score=356.68  Aligned_cols=249  Identities=21%  Similarity=0.381  Sum_probs=195.5

Q ss_pred             HHHHhcCCCcCceecCCccceEEEEEec------CCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhce
Q 042123          583 IVKATNDFDAKYCIGNGGHASVYRAELP------SGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGF  645 (849)
Q Consensus       583 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~  645 (849)
                      ++...++|+..+.||+|+||+||+|.+.      +++.||||+++...   .......+.+|+..           ++++
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA---SMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS---CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc---ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            3444578899999999999999999653      35789999987532   33344567777663           6788


Q ss_pred             eecCCeeEEEEEeccCCChhhhhccccc-------ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC
Q 042123          646 CSHARHSFLLYEFLERGSLAAILNTDAA-------AQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL  718 (849)
Q Consensus       646 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~  718 (849)
                      +..++..++||||+++|+|.+++.....       ...+++.++.+++.|+|+||.|||+.   +|+||||||+|||++.
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~  168 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE  168 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence            8888899999999999999999864321       13478999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCC-CCCCccccccccccc
Q 042123          719 EYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGK-HPRDFLSSISSSSLN  795 (849)
Q Consensus       719 ~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~-~Pf~~~~~~~~~~~~  795 (849)
                      ++++||+|||+|+........  .....+|+.|+|||.+.+..++.++||||||+++|||+||. .||....        
T Consensus       169 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--------  240 (308)
T d1p4oa_         169 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------  240 (308)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------
T ss_pred             CceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--------
Confidence            999999999999876543322  23346899999999999999999999999999999999985 6665332        


Q ss_pred             cccccccccCCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          796 TDVALDQMLDPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                      .......+.++..+..+...   ...+.+++.+||+.+|++|||+++|+++|+
T Consensus       241 ~~~~~~~i~~~~~~~~p~~~---~~~l~~li~~cl~~~P~~RPs~~~il~~L~  290 (308)
T d1p4oa_         241 NEQVLRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIK  290 (308)
T ss_dssp             HHHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             HHHHHHHHHhCCCCCCcccc---hHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            22233333344333222222   234888999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-41  Score=354.54  Aligned_cols=245  Identities=22%  Similarity=0.411  Sum_probs=189.3

Q ss_pred             hcCCCcCceecCCccceEEEEEe------cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceeec
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL------PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCSH  648 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~~  648 (849)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++...   .......+.+|+.            ++++++..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC---CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc---CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            36888899999999999999965      346789999987542   2233445555543            36788888


Q ss_pred             CCeeEEEEEeccCCChhhhhcccc---------------cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 042123          649 ARHSFLLYEFLERGSLAAILNTDA---------------AAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKN  713 (849)
Q Consensus       649 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~N  713 (849)
                      ....++|||||++|+|.+++.+..               ....+++.++..++.||+.||+|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            889999999999999999986532               123589999999999999999999999   99999999999


Q ss_pred             eeecCCCcEEEeeecCCcccCCCCCC--eeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhC-CCCCCcccccc
Q 042123          714 LLLDLEYEAHVADFGIAKSLKPDSSN--WTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKG-KHPRDFLSSIS  790 (849)
Q Consensus       714 ill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg-~~Pf~~~~~~~  790 (849)
                      |+++.++.+|++|||.++........  .....||+.|+|||.+.++.++.++|||||||++|||+|+ .+||.....  
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~--  253 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--  253 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS--
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH--
Confidence            99999999999999999977644332  2335789999999999999999999999999999999995 555543221  


Q ss_pred             ccccccccccccccCCCCC-CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhhc
Q 042123          791 SSSLNTDVALDQMLDPRLP-APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQLR  848 (849)
Q Consensus       791 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  848 (849)
                            .....+++..... ..+..   ....+.+++.+||+.||++||||+||++.|+
T Consensus       254 ------~~~~~~~i~~~~~~~~~~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         254 ------DSKFYKMIKEGFRMLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             ------SHHHHHHHHHTCCCCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------HHHHHHHHhcCCCCCCccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                  1111222211111 11111   1234889999999999999999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=351.01  Aligned_cols=249  Identities=22%  Similarity=0.256  Sum_probs=180.5

Q ss_pred             cCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCch-hhHHHHHHHHH-----------HhhceeecCCeeEEEEEe
Q 042123          592 AKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQT-VDQKEFLTEVE-----------AFYGFCSHARHSFLLYEF  658 (849)
Q Consensus       592 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~e~  658 (849)
                      ..++||+|+||+||+|+. .+|+.||||++......... ...+.+.+|+.           ++++++..+++.|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999975 46999999998653221111 11223445543           478888999999999999


Q ss_pred             ccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCCCC
Q 042123          659 LERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPDSS  738 (849)
Q Consensus       659 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  738 (849)
                      ++++++..+....   ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9998877766432   3588999999999999999999999   999999999999999999999999999987766555


Q ss_pred             CeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccc-------------ccccccccccc-c
Q 042123          739 NWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------------SSLNTDVALDQ-M  803 (849)
Q Consensus       739 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------------~~~~~~~~~~~-~  803 (849)
                      .....+||+.|+|||++.+. .|+.++||||+||++|||++|+.||........             ........... .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            55567899999999988654 579999999999999999999999974332110             00000000000 0


Q ss_pred             cCCCCCCCCh--hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDPRLPAPSR--SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....+....  ........+.+++.+||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            0001111000  000112358899999999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=344.20  Aligned_cols=233  Identities=24%  Similarity=0.338  Sum_probs=182.4

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCC--------chhhHHHHHHH-------HHHhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCD--------QTVDQKEFLTE-------VEAFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~~~~e-------i~~~~~~~~~~~~  651 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.......        ....+...++.       |.++++++..++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            5799999999999999999965 579999999986432111        11122233332       4567888899999


Q ss_pred             eEEEEEeccC-CChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCC-CcEEEeeecC
Q 042123          652 SFLLYEFLER-GSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLE-YEAHVADFGI  729 (849)
Q Consensus       652 ~~lV~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~-~~~kl~DfG~  729 (849)
                      .++||||+.+ +++.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.+ +.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcccc
Confidence            9999999986 5777777543   3599999999999999999999999   99999999999999865 7999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCC-CccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKI-TEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      |+....  .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......              ....
T Consensus       158 a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~--------------~~~~  221 (273)
T d1xwsa_         158 GALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQV  221 (273)
T ss_dssp             CEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCC
T ss_pred             ceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHh--------------hccc
Confidence            986543  23456789999999999987765 577999999999999999999997432111              1111


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ..+....    .++.+++.+||+.||++|||++|+++|
T Consensus       222 ~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         222 FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1111111    247889999999999999999999875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-40  Score=346.61  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=184.8

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|.. .+|+.||||+++....  .......+.+|+.           ++++++.++...|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            5899999999999999999965 6799999999865322  1122345566654           478888899999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      |||+.++.+ +++.... ...+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||.|+....
T Consensus        80 ~e~~~~~~~-~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          80 FEFLHQDLK-KFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             EECCSEEHH-HHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             EeecCCchh-hhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence            999987544 4443222 24599999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCeeeccCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccc----------cccccccccccc-
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS----------SSLNTDVALDQM-  803 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~----------~~~~~~~~~~~~-  803 (849)
                      +........||+.|+|||...... ++.++||||+||++|+|++|+.||...+....          ............ 
T Consensus       155 ~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         155 PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            555556678999999999877665 47899999999999999999999975331110          000000000000 


Q ss_pred             -cCCCCCCCC-h----hhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 -LDPRLPAPS-R----SAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 -~~~~~~~~~-~----~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       .....+... .    ........+.+++.+||+.||++|||++|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             000000000 0    001112357889999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.7e-40  Score=342.89  Aligned_cols=251  Identities=21%  Similarity=0.281  Sum_probs=184.8

Q ss_pred             cCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLLY  656 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV~  656 (849)
                      ++|+..++||+|+||+||+|+.++|+.||||++.....  .......+.+|+.           ++++++.+.+..++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            57899999999999999999888999999999865432  2222345666655           3678888899999999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKPD  736 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  736 (849)
                      ||+.++.+..+....   ..+++.++..++.||+.||+|||+.   +|+||||||+|||++.++.+|++|||.|......
T Consensus        80 e~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             ECCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             EeehhhhHHHHHhhc---CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            999987777776433   4599999999999999999999998   9999999999999999999999999999887655


Q ss_pred             CCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccc-------------ccccccccccc
Q 042123          737 SSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------------SSLNTDVALDQ  802 (849)
Q Consensus       737 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------------~~~~~~~~~~~  802 (849)
                      ........+++.|+|||.+.+. .++.++||||+||++|||++|+.||........             ...........
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         154 VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            5555566789999999998754 468999999999999999999999974321110             00000000000


Q ss_pred             c---cCCCCCCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          803 M---LDPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       803 ~---~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .   .....+.+ ..........+.+++.+||+.||++|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0   00000000 00011122347899999999999999999999975

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.1e-39  Score=339.61  Aligned_cols=250  Identities=16%  Similarity=0.243  Sum_probs=179.6

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------HhhceeecCCeeEEEEEecc
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------AFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ++|++.+.||+|+||+||+|++ .+|+.||||.+...........+.+.++.+.      .+..+..+.+..++||||+.
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~   86 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG   86 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC
Confidence            4699999999999999999965 5789999998765433322222233333222      24556677888999999995


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC---CCcEEEeeecCCcccCCCC
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL---EYEAHVADFGIAKSLKPDS  737 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~---~~~~kl~DfG~a~~~~~~~  737 (849)
                       |++.+.+....  ..+++.++..++.|++.||+|||++   +|+||||||+||+++.   +..+|++|||+|+.+....
T Consensus        87 -~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          87 -PSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             -CBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             -Cchhhhhhhcc--CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence             46666654322  4599999999999999999999999   9999999999999864   4579999999998765432


Q ss_pred             C-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCCCC
Q 042123          738 S-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRLPA  810 (849)
Q Consensus       738 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  810 (849)
                      .       ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.............. ..........  
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~--  237 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-ISEKKMSTPI--  237 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH-HHHHHHHSCH--
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH-hhcccCCCCh--
Confidence            1       12345799999999999999999999999999999999999999975432211110000 0000000000  


Q ss_pred             CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          811 PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       811 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                       .......+.++.+++..||+.+|++||+++++.+.|
T Consensus       238 -~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l  273 (299)
T d1ckia_         238 -EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  273 (299)
T ss_dssp             -HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred             -hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence             000111223488899999999999999999887655

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-39  Score=338.64  Aligned_cols=254  Identities=19%  Similarity=0.293  Sum_probs=181.4

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cC-CcEEEEEEecccCCCCc----hhhHHHHHHH--------HHHhhceee-----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PS-GEVVAVKKFHSLLPCDQ----TVDQKEFLTE--------VEAFYGFCS-----  647 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~----~~~~~~~~~e--------i~~~~~~~~-----  647 (849)
                      .++|++.+.||+|+||+||+|+. ++ ++.||||+++.......    ...+...++.        +.++++++.     
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999975 44 66799999864322111    1112222222        223555553     


Q ss_pred             cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeee
Q 042123          648 HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADF  727 (849)
Q Consensus       648 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~Df  727 (849)
                      .....++||||+++|++.......  ...+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence            335789999999998776554332  24589999999999999999999999   9999999999999999999999999


Q ss_pred             cCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccc-------------ccc
Q 042123          728 GIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------------SSL  794 (849)
Q Consensus       728 G~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------------~~~  794 (849)
                      |.++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...+....             ...
T Consensus       161 g~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         161 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            998865433 234567899999999999999999999999999999999999999975432110             000


Q ss_pred             cccccc-ccccCCCC-CCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 NTDVAL-DQMLDPRL-PAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 ~~~~~~-~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      ...... ........ .............+.+++.+||++||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000 00000000 00001111122347789999999999999999999886

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-38  Score=332.28  Aligned_cols=249  Identities=16%  Similarity=0.216  Sum_probs=183.4

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH------HHhhceeecCCeeEEEEEecc
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV------EAFYGFCSHARHSFLLYEFLE  660 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei------~~~~~~~~~~~~~~lV~e~~~  660 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||.+...........+.+..+.+      ..+++++......++||||+ 
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-   83 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-   83 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence            5789999999999999999965 478999999886543222222122222211      13677788889999999999 


Q ss_pred             CCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecC-----CCcEEEeeecCCcccCC
Q 042123          661 RGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDL-----EYEAHVADFGIAKSLKP  735 (849)
Q Consensus       661 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~-----~~~~kl~DfG~a~~~~~  735 (849)
                      +|+|.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.     ++.+|++|||+|+....
T Consensus        84 ~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          84 GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            679999886433  4589999999999999999999999   9999999999999975     57899999999987643


Q ss_pred             CCC-------CeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          736 DSS-------NWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       736 ~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      ...       ......||+.|+|||++.+..+++++|||||||++|||++|+.||.........     .....+.....
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~-----~~~~~i~~~~~  233 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYERIGEKKQ  233 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHHHHHHHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH-----HHHHHHHhccC
Confidence            221       233467999999999999999999999999999999999999999744322110     00011100000


Q ss_pred             C-CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhhh
Q 042123          809 P-APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQL  847 (849)
Q Consensus       809 ~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L  847 (849)
                      . .........+.++.+++..||+.+|++||+++.+.+.|
T Consensus       234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l  273 (293)
T d1csna_         234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF  273 (293)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred             CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence            0 00000011123478889999999999999998887655

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=337.75  Aligned_cols=245  Identities=21%  Similarity=0.332  Sum_probs=185.4

Q ss_pred             cCCCcCceecCCccceEEEEEe----cCCcEEEEEEecccCCC------CchhhHHHHHHH------HHHhhceeecCCe
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL----PSGEVVAVKKFHSLLPC------DQTVDQKEFLTE------VEAFYGFCSHARH  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~------~~~~~~~~~~~e------i~~~~~~~~~~~~  651 (849)
                      ++|++.+.||+|+||+||+|..    .+|+.||||.+......      .....+.+.++.      |.++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5799999999999999999954    25889999988542110      111122233332      4457788888999


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .++||||+.+|+|.+++....   .+++.++..++.||+.|++|+|+.   +|+||||||+||+++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999986543   478899999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC-CCeeeccCCccccccccccCC--CCCccchHHHHHHHHHHHHhCCCCCCccccccccccccccccccccCCCC
Q 042123          732 SLKPDS-SNWTEFAGTCGYIAPELAYTM--KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSLNTDVALDQMLDPRL  808 (849)
Q Consensus       732 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  808 (849)
                      .+.... .......|++.|+|||.+.+.  .++.++||||+||++|||++|+.||.......    ..............
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~~~~  253 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKSEP  253 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcccCCC
Confidence            764332 234456799999999998764  46789999999999999999999997543221    11112222222222


Q ss_pred             CCCChhhHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHhh
Q 042123          809 PAPSRSAQEKLISIMEVAFSCFNESPESRP-----TMKIISQQ  846 (849)
Q Consensus       809 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~  846 (849)
                      +.+...    ...+.+++.+||++||++||     |++|+++|
T Consensus       254 ~~~~~~----s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         254 PYPQEM----SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CCcccC----CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            222222    23488899999999999999     58899875

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-38  Score=336.46  Aligned_cols=252  Identities=23%  Similarity=0.250  Sum_probs=178.9

Q ss_pred             CCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHH-----HHhhceeec------CCeeEEEE
Q 042123          589 DFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEV-----EAFYGFCSH------ARHSFLLY  656 (849)
Q Consensus       589 ~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei-----~~~~~~~~~------~~~~~lV~  656 (849)
                      +|+..++||+|+||+||+|+. .+|+.||||++.......  ..+..+++.+     .++++++..      ..+.++||
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   98 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK--NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL   98 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC--CHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH--HHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence            678889999999999999965 479999999987643222  2233344432     245565532      33578999


Q ss_pred             EeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCcccCC
Q 042123          657 EFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAKSLKP  735 (849)
Q Consensus       657 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  735 (849)
                      |||++|.+..+.+.......+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+||+|||+++....
T Consensus        99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            9998765555444333445699999999999999999999998   999999999999999875 899999999987754


Q ss_pred             CCCCeeeccCCccccccccccC-CCCCccchHHHHHHHHHHHHhCCCCCCccccccccc-------ccccc----ccccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYT-MKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------LNTDV----ALDQM  803 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~~~~~----~~~~~  803 (849)
                      .. ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||..........       .....    .....
T Consensus       176 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  254 (350)
T d1q5ka_         176 GE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  254 (350)
T ss_dssp             TS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred             Cc-ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence            33 3345689999999998765 568999999999999999999999997433211000       00000    00000


Q ss_pred             cCCCCCC---CC---hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          804 LDPRLPA---PS---RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       804 ~~~~~~~---~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .+...+.   ..   .........+.+++.+||+.||++|||++|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         255 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             -CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0001000   00   0001112347889999999999999999999975

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-37  Score=335.13  Aligned_cols=249  Identities=20%  Similarity=0.262  Sum_probs=177.2

Q ss_pred             cCCCcCceecCCccceEEEEE-ecCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC----e
Q 042123          588 NDFDAKYCIGNGGHASVYRAE-LPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR----H  651 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~----~  651 (849)
                      .+|+..+.||+|+||+||+|. ..+|+.||||++....   .....+.+.+|+..           +++++....    .
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE---HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT---CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc---ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence            568999999999999999995 4689999999986532   23334566777663           444543322    2


Q ss_pred             eEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          652 SFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       652 ~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      .+++++|+.+|+|.+++..    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+|+
T Consensus        85 ~~~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            3455677789999999854    3499999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCC---CCeeeccCCcccccccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCcccccccc--------cccc---
Q 042123          732 SLKPDS---SNWTEFAGTCGYIAPELAY-TMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS--------SLNT---  796 (849)
Q Consensus       732 ~~~~~~---~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~--------~~~~---  796 (849)
                      ......   ......+||+.|+|||.+. ...++.++||||+||++|||++|+.||.........        ....   
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            654332   1234567999999999985 456788999999999999999999999743311000        0000   


Q ss_pred             ------ccccccccCCCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          797 ------DVALDQMLDPRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       797 ------~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                            .........+......  ........++.+++.+|++.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  0000000000100000  0000112347899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-37  Score=325.06  Aligned_cols=251  Identities=17%  Similarity=0.222  Sum_probs=189.1

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------HhhceeecCCeeEEE
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCSHARHSFLL  655 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~~~~~~~lV  655 (849)
                      ++|++.+.||+|+||+||+|+. .+++.||||+++....  .......+.+|+.           ++++++.+....++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC--ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            5789999999999999999965 5789999999865422  2233456667765           367788888999999


Q ss_pred             EEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecCCcccCC
Q 042123          656 YEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGIAKSLKP  735 (849)
Q Consensus       656 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  735 (849)
                      +|++.++++..++...   +.+++.++..++.|++.||+|||++   +|+||||||+|||++.++.+|++|||.|+....
T Consensus        80 ~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          80 FEFCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             EECCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eeeccccccccccccc---cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence            9999999998877543   3589999999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCeeeccCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccc--------------ccccccccc
Q 042123          736 DSSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS--------------SSLNTDVAL  800 (849)
Q Consensus       736 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~--------------~~~~~~~~~  800 (849)
                      .........+++.|+|||.+.... ++.++||||+||++|||++|+.||........              .........
T Consensus       154 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            555555667888999999887665 68999999999999999999999743221100              000000000


Q ss_pred             ccccC----CCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          801 DQMLD----PRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       801 ~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....    ................+.+++.+|++.||.+|||++|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000    00000111111122347789999999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-37  Score=328.00  Aligned_cols=251  Identities=19%  Similarity=0.261  Sum_probs=176.1

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceee-------
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCS-------  647 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~-------  647 (849)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++......  ......+.+|+..           +++++.       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT--TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            37899999999999999999965 57999999998654222  1223345555542           333332       


Q ss_pred             -cCCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEee
Q 042123          648 -HARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVAD  726 (849)
Q Consensus       648 -~~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~D  726 (849)
                       ..++.++||||++++.+......   ...+++.++..++.|++.||+|||+.   +|+||||||+|||++.++.+|++|
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECC
T ss_pred             ccCceEEEEEeccCCCccchhhhc---ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeee
Confidence             24568999999998877665433   23589999999999999999999999   999999999999999999999999


Q ss_pred             ecCCcccCCCC----CCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------
Q 042123          727 FGIAKSLKPDS----SNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS--------  793 (849)
Q Consensus       727 fG~a~~~~~~~----~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~--------  793 (849)
                      ||+++.+....    .......||+.|+|||.+.+. .+++++||||+||++|||++|+.||..........        
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998665332    123345789999999998765 68999999999999999999999997433211100        


Q ss_pred             ---cc----cccccccccCCCCCCCChhhHH------HHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          794 ---LN----TDVALDQMLDPRLPAPSRSAQE------KLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       794 ---~~----~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ..    ........... .........+      ....+.+++.+||+.||++|||++|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCTTTSTTCCCC-------C-CSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CChhhccccchhhhhhhhcc-cccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence               00    00000000000 0000111111      12346789999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-37  Score=333.56  Aligned_cols=247  Identities=20%  Similarity=0.261  Sum_probs=175.3

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceeecCC----
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCSHAR----  650 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~~~~----  650 (849)
                      .++|++.+.||+|+||+||+|.. .+|+.||||+++....  .....+.+.+|+..           +++++...+    
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS--SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc--ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            36899999999999999999965 5799999999875322  22334556666553           556655433    


Q ss_pred             --eeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeec
Q 042123          651 --HSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFG  728 (849)
Q Consensus       651 --~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG  728 (849)
                        +.++||||+ +++|..+.+.    ..+++.++..++.||+.||+|||++   +|+||||||+|||++.++.+|++|||
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cceEEEEEecc-cccHHHHHHh----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence              569999999 5577777643    3599999999999999999999999   99999999999999999999999999


Q ss_pred             CCcccCCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCcccccccc---------------
Q 042123          729 IAKSLKPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSS---------------  792 (849)
Q Consensus       729 ~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~---------------  792 (849)
                      .|+.....   .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+.....               
T Consensus       167 ~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         167 LARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             TCEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ceeccCCc---cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            99876533   3456899999999998764 5689999999999999999999999754321100               


Q ss_pred             ---ccccccccccccCCCCCCC-ChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          793 ---SLNTDVALDQMLDPRLPAP-SRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       793 ---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                         ................... ..........+.+|+.+||+.||++|||++|+++|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               0000000000000000000 00001112347789999999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7.8e-37  Score=326.60  Aligned_cols=242  Identities=19%  Similarity=0.266  Sum_probs=178.2

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH------------Hhhceee--cCCee
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE------------AFYGFCS--HARHS  652 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~------------~~~~~~~--~~~~~  652 (849)
                      ++|++.+.||+|+||+||+|+. .+|+.||||+++...       .+.+.+|+.            ++++++.  .....
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            5799999999999999999965 579999999986532       223334433            2455554  34568


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC-cEEEeeecCCc
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY-EAHVADFGIAK  731 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~-~~kl~DfG~a~  731 (849)
                      ++||||+++|+|..+.      +.+++.++..++.||+.||+|||++   +|+||||||+|||++.++ .+|++|||+|+
T Consensus       108 ~~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             EEEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             eEEEeecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence            9999999999998764      3489999999999999999999999   999999999999998765 69999999998


Q ss_pred             ccCCCCCCeeeccCCccccccccccCC-CCCccchHHHHHHHHHHHHhCCCCCCccccccc-------------------
Q 042123          732 SLKPDSSNWTEFAGTCGYIAPELAYTM-KITEKCDVYSFGVLMWEVIKGKHPRDFLSSISS-------------------  791 (849)
Q Consensus       732 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~-------------------  791 (849)
                      ...... ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........                   
T Consensus       179 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         179 FYHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             ECCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred             eccCCC-cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhh
Confidence            765432 34556789999999998765 479999999999999999999999864321100                   


Q ss_pred             -cccccccccccccCCCCC------CCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          792 -SSLNTDVALDQMLDPRLP------APSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       792 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ..................      ...........++.+++.+|++.||++|||++|+++|
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             000000000000000000      0000111122357899999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-36  Score=325.25  Aligned_cols=247  Identities=20%  Similarity=0.275  Sum_probs=174.3

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHH-----------Hhhceee------cC
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-----------AFYGFCS------HA  649 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-----------~~~~~~~------~~  649 (849)
                      ++|++.++||+|+||+||+|.. .+|+.||||++.....  .......+.+|+.           ++++++.      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            5799999999999999999965 4799999999976432  2223345566655           2455553      34


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      .+.|+||||+.++.+..+ .     ..+++.+++.++.||+.||+|||++   +|+||||||+|||++.++.+|++|||+
T Consensus        95 ~~~~iv~Ey~~~~l~~~~-~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          95 QDVYLVMELMDANLCQVI-Q-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             CEEEEEEECCSEEHHHHH-T-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             ceeEEEEeccchHHHHhh-h-----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence            688999999987655444 2     3489999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCccccccccc--------------cc
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS--------------LN  795 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~--------------~~  795 (849)
                      ++..... .......+|+.|+|||++.+..+++++||||+||++|||++|+.||...+......              ..
T Consensus       166 ~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             hhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            8866543 23455678999999999999999999999999999999999999996332110000              00


Q ss_pred             ccccc---------------cccc-CCCCCCCChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          796 TDVAL---------------DQML-DPRLPAPSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       796 ~~~~~---------------~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                      .....               .... .................+.+|+.+|++.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00000               0000 011111222333455678899999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=325.68  Aligned_cols=248  Identities=20%  Similarity=0.268  Sum_probs=177.5

Q ss_pred             hcCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCchhhHHHHHHHHHH-----------hhceee-----cC
Q 042123          587 TNDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEA-----------FYGFCS-----HA  649 (849)
Q Consensus       587 ~~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~-----------~~~~~~-----~~  649 (849)
                      +++|++.+.||+|+||+||+|+. .+|+.||||++....  ......+.+.+|+..           +++++.     +.
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence            46899999999999999999964 679999999987542  223334456667653           344443     22


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++|++|+.+|+|.+++...    .+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+|++|||.
T Consensus        95 ~~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             CceEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            3446778888999999998643    499999999999999999999999   999999999999999999999999999


Q ss_pred             CcccCCCCCCeeeccCCccccccccccCCC-CCccchHHHHHHHHHHHHhCCCCCCccccccccc-------c-------
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPELAYTMK-ITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSS-------L-------  794 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~-------~-------  794 (849)
                      +.....   ......|++.|+|||...+.. ++.++||||+||++|+|++|+.||...+......       .       
T Consensus       168 a~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         168 ARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             --CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             hcccCc---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            976542   234467899999999877654 5889999999999999999999997433111000       0       


Q ss_pred             -ccccccccccC--CCCCCCC--hhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHhh
Q 042123          795 -NTDVALDQMLD--PRLPAPS--RSAQEKLISIMEVAFSCFNESPESRPTMKIISQQ  846 (849)
Q Consensus       795 -~~~~~~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  846 (849)
                       ...........  ...+...  .........+.+++.+|++.||++|||++|+++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence             00000000000  0111000  0000112347889999999999999999999985

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.98  E-value=5.3e-33  Score=301.61  Aligned_cols=254  Identities=17%  Similarity=0.216  Sum_probs=172.9

Q ss_pred             cCCCcCceecCCccceEEEEEe-cCCcEEEEEEecccCCCCc-hhhHHHHHHHHH----------------Hhhceeec-
Q 042123          588 NDFDAKYCIGNGGHASVYRAEL-PSGEVVAVKKFHSLLPCDQ-TVDQKEFLTEVE----------------AFYGFCSH-  648 (849)
Q Consensus       588 ~~f~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~~~ei~----------------~~~~~~~~-  648 (849)
                      ++|++.++||+|+||+||+|+. .+|+.||||++........ ...+..+++++.                .+++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            3589999999999999999965 5799999999875311000 011112222221                13444432 


Q ss_pred             -CCeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCC------c
Q 042123          649 -ARHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEY------E  721 (849)
Q Consensus       649 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~------~  721 (849)
                       ....++|++++..+..............+++..+..++.||+.|++|||+..  +|+||||||+|||++.++      .
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccce
Confidence             3456677777766654444333333456899999999999999999999832  899999999999998665      3


Q ss_pred             EEEeeecCCcccCCCCCCeeeccCCccccccccccCCCCCccchHHHHHHHHHHHHhCCCCCCcccccccccc-------
Q 042123          722 AHVADFGIAKSLKPDSSNWTEFAGTCGYIAPELAYTMKITEKCDVYSFGVLMWEVIKGKHPRDFLSSISSSSL-------  794 (849)
Q Consensus       722 ~kl~DfG~a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~SlGvil~el~tg~~Pf~~~~~~~~~~~-------  794 (849)
                      ++++|||.+......   .....||+.|+|||.+....++.++||||+||++++|++|+.||...........       
T Consensus       171 ~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~  247 (362)
T d1q8ya_         171 IKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  247 (362)
T ss_dssp             EEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eeEeecccccccccc---cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence            999999999865432   2446799999999999999999999999999999999999999974322110000       


Q ss_pred             ------ccc------cccccccC-----CCCCC------------CChhhHHHHHHHHHHHhhccCCCCCCCCCHHHHHh
Q 042123          795 ------NTD------VALDQMLD-----PRLPA------------PSRSAQEKLISIMEVAFSCFNESPESRPTMKIISQ  845 (849)
Q Consensus       795 ------~~~------~~~~~~~~-----~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~  845 (849)
                            ...      .......+     ..+..            ...........+.+|+.+|+..||.+|||++|+++
T Consensus       248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  000      00000000     00000            11122345567899999999999999999999998


Q ss_pred             h
Q 042123          846 Q  846 (849)
Q Consensus       846 ~  846 (849)
                      |
T Consensus       328 H  328 (362)
T d1q8ya_         328 H  328 (362)
T ss_dssp             C
T ss_pred             C
Confidence            6

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=3.9e-29  Score=273.47  Aligned_cols=165  Identities=19%  Similarity=0.323  Sum_probs=95.3

Q ss_pred             CCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEec
Q 042123          275 GALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNV  354 (849)
Q Consensus       275 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (849)
                      ++|+.|++++|+++..  ..+..+++|+.|++++|.+++..+  +..+++|+.|++++|++.+..+  +..++.++.+++
T Consensus       219 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~  292 (384)
T d2omza2         219 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL  292 (384)
T ss_dssp             TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred             CCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc--cccccccccccc
Confidence            3445555555544421  234445555555555555554332  4455555555555555543322  444555555555


Q ss_pred             cCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCcccccccccccccccccCCCCCh
Q 042123          355 SMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPS  434 (849)
Q Consensus       355 s~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~  434 (849)
                      +.|.+++  ...+..+++++.|++++|++++..  .+..+++|++|++++|+|+                      .+| 
T Consensus       293 ~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~----------------------~l~-  345 (384)
T d2omza2         293 NENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVS----------------------DVS-  345 (384)
T ss_dssp             CSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCC----------------------CCG-
T ss_pred             ccccccc--ccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCC----------------------CCh-
Confidence            5555542  223445555555555555555432  2455555555555555554                      333 


Q ss_pred             hhhcccccceeccCCcccccCCCccccccCCCcEEeccCC
Q 042123          435 QICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYN  474 (849)
Q Consensus       435 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N  474 (849)
                      .+.++++|+.|+|++|+|++..|  +.++++|+.|+|++|
T Consensus       346 ~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         346 SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            35667788889999999997665  889999999999988

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=1.3e-28  Score=269.40  Aligned_cols=354  Identities=25%  Similarity=0.321  Sum_probs=200.8

Q ss_pred             cCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEec
Q 042123           12 LPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVI   91 (849)
Q Consensus        12 ~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l   91 (849)
                      +...++.+.+.   .+.+.+|++|++++|+|+.+  ..+..+++|++|+|++|+|++.        ..++++++|++|++
T Consensus        29 l~~~~~~~~~~---~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l--------~~l~~L~~L~~L~L   95 (384)
T d2omza2          29 LGKTNVTDTVS---QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI--------TPLKNLTKLVDILM   95 (384)
T ss_dssp             TTCSSTTSEEC---HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC--------GGGTTCTTCCEEEC
T ss_pred             hCCCCCCCccC---HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC--------ccccCCcccccccc
Confidence            44444444433   34567889999999988765  3478888999999999988742        12677888888888


Q ss_pred             cCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCccccc
Q 042123           92 NDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGY  171 (849)
Q Consensus        92 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  171 (849)
                      ++|.+.+..  .++++++|+.|++++|.+++..+  ......+..+....|.+.......................+   
T Consensus        96 ~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~---  168 (384)
T d2omza2          96 NNNQIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL---  168 (384)
T ss_dssp             CSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC---
T ss_pred             ccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchh---
Confidence            888888543  37788888888888888885543  34456777778877777644443333333333332222222   


Q ss_pred             CCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhh
Q 042123          172 IPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNL  251 (849)
Q Consensus       172 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~  251 (849)
                        ..+.............|...  ....+..+++++.+++++|.+++..|  +..+++|++|++++|.++ .+| .+...
T Consensus       169 --~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~-~~~-~l~~l  240 (384)
T d2omza2         169 --KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG-TLASL  240 (384)
T ss_dssp             --GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGC
T ss_pred             --hhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCC-Ccc-hhhcc
Confidence              23444555555555555543  23445666777777777777665433  455566666666666665 222 12221


Q ss_pred             -hhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEec
Q 042123          252 -ILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDL  330 (849)
Q Consensus       252 -~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  330 (849)
                       .|+.|++++|++++..+  +..+++|+.|++++|++++..  .+..++.++.+.+++|.+++.  ..+..+++++.|++
T Consensus       241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~l  314 (384)
T d2omza2         241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTL  314 (384)
T ss_dssp             TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEEC
T ss_pred             cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccccccccccccccccccccc--cccchhcccCeEEC
Confidence             24444444444443321  344455555555555554332  244455555555555555532  12444555555555


Q ss_pred             cCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCc
Q 042123          331 SRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGN  405 (849)
Q Consensus       331 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N  405 (849)
                      ++|++.+..+  +..+++|++|++++|+|++ ++ .+.++++|++|++++|++++..|  +.++++|+.|+|++|
T Consensus       315 s~n~l~~l~~--l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         315 YFNNISDISP--VSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             CSSCCSCCGG--GGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CCCCCCCCcc--cccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence            5555554321  4455555555555555542 22 35555555555555555554332  455555555555554

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=1.6e-29  Score=268.04  Aligned_cols=254  Identities=28%  Similarity=0.457  Sum_probs=213.5

Q ss_pred             CCCC---CcEEEEecCCCceeeeeC-CccCCCCCCCCEEeCcC-CccccCCCccccCCCCCCEeeCCCCcCccccccccc
Q 042123            1 CNDA---GRVINISLPNIGVNGTLH-DFSFSSFPHLAYLDLTW-NGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVS   75 (849)
Q Consensus         1 ~~~~---~~~~~~~~~~~~~~~~l~-~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~   75 (849)
                      |+.+   +|||+++++.+++.|... ..++..+++|++|||++ |++.+.+|..|+++++|++|+|++|++++..+    
T Consensus        43 C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~----  118 (313)
T d1ogqa_          43 CDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP----  118 (313)
T ss_dssp             ECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC----
T ss_pred             EeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccccc----
Confidence            6643   379999999999988543 23789999999999987 88988999999999999999999999986433    


Q ss_pred             ccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCC-ceeeccCcccccccccccCC
Q 042123           76 SESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNL-IFLYLYGNLLSGSILSSLGK  154 (849)
Q Consensus        76 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~  154 (849)
                        ..+..+..|+.+++++|.+.+.+|..+.++++|+++++++|.+++.+|..+..+.++ +.+++++|++++..+..+..
T Consensus       119 --~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~  196 (313)
T d1ogqa_         119 --DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN  196 (313)
T ss_dssp             --GGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred             --ccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccc
Confidence              335668889999999999998999999999999999999999998888888888776 88999999999888888887


Q ss_pred             CCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhh
Q 042123          155 LKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELA  234 (849)
Q Consensus       155 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  234 (849)
                      +..+ .+++++|...+..|..+..+++|++|++++|.+.+.+| .+..+++|+.|+|++|++++.+|+.|+++++|++|+
T Consensus       197 l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~  274 (313)
T d1ogqa_         197 LNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN  274 (313)
T ss_dssp             CCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEE
T ss_pred             cccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEE
Confidence            7655 79999999988888899999999999999999986544 588889999999999999988999999999999999


Q ss_pred             hccccccCCCCcchhhhhhhhhhccCcC
Q 042123          235 LLYNHLSGSIPPSLGNLILRQLLLSGNH  262 (849)
Q Consensus       235 L~~N~l~~~~p~~~~~~~L~~L~L~~n~  262 (849)
                      |++|+++|.+|.......|+.+++++|+
T Consensus       275 Ls~N~l~g~iP~~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         275 VSFNNLCGEIPQGGNLQRFDVSAYANNK  302 (313)
T ss_dssp             CCSSEEEEECCCSTTGGGSCGGGTCSSS
T ss_pred             CcCCcccccCCCcccCCCCCHHHhCCCc
Confidence            9999998888754222236666666665

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=2.1e-29  Score=267.12  Aligned_cols=256  Identities=25%  Similarity=0.415  Sum_probs=214.0

Q ss_pred             hhhhhccCcCCCC--CCCcccCCCCCcceeeecc-cccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEe
Q 042123          253 LRQLLLSGNHFTG--YLPYNICRGGALEIFTVSE-NHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFID  329 (849)
Q Consensus       253 L~~L~L~~n~i~~--~~~~~~~~~~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  329 (849)
                      ++.|+|++|.+++  .+|..++.+++|++|+|++ |++.|.+|..|+++++|++|+|++|++.+..+..+..+++|+.++
T Consensus        52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~  131 (313)
T d1ogqa_          52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD  131 (313)
T ss_dssp             EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred             EEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccc
Confidence            4455555555554  3567788888888888886 788888888888888888888888888888888888888888999


Q ss_pred             ccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccc-cccccccccccccCchhhcCCCCCcEEEccCcccc
Q 042123          330 LSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQL-QAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       330 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L-~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                      +++|.+.+.+|..+..+++|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus       132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~  210 (313)
T d1ogqa_         132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE  210 (313)
T ss_dssp             CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred             cccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            98888888888888888888889999888888888888887775 788888888888888888877654 6888888888


Q ss_pred             ccCccccccccccccccccc--CCCCChhhhcccccceeccCCcccccCCCccccccCCCcEEeccCCccccCCCCCccc
Q 042123          409 GRLPKEIGSLTKLEYLDFSA--IGELPSQICNMKSLEKLNLSHNNLSGSIPSCFEGMHGLSFIDMSYNELQCPVPNSTTF  486 (849)
Q Consensus       409 ~~~p~~~~~l~~L~~L~l~~--l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~~  486 (849)
                      +.+|..++.+++|+.++++.  +...+..++.+++|+.|+|++|+|+|.+|..|.++++|++|||++|.++|.+|....+
T Consensus       211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L  290 (313)
T d1ogqa_         211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL  290 (313)
T ss_dssp             ECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTG
T ss_pred             ccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccC
Confidence            88888888888888888775  4444567888899999999999999999999999999999999999999999987777


Q ss_pred             ccCcccccccCCCccCCCCCCCCCC
Q 042123          487 RGASVEALKGNKGLCGSAKGLQPCK  511 (849)
Q Consensus       487 ~~~~~~~~~~~~~~c~~~~~~~~~~  511 (849)
                      .......+.+|+.+||.|  +.+|.
T Consensus       291 ~~L~~l~l~~N~~l~g~p--lp~c~  313 (313)
T d1ogqa_         291 QRFDVSAYANNKCLCGSP--LPACT  313 (313)
T ss_dssp             GGSCGGGTCSSSEEESTT--SSCCC
T ss_pred             CCCCHHHhCCCccccCCC--CCCCC
Confidence            777778899999999986  34663

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=6.2e-27  Score=247.05  Aligned_cols=281  Identities=22%  Similarity=0.253  Sum_probs=169.3

Q ss_pred             ccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcC
Q 042123           85 YMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN  164 (849)
Q Consensus        85 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  164 (849)
                      ..+.++.+++.++ .+|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+....+..|.++++|+.|+++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            4455666666666 3455553  567888888888876666677888888888888888777667777778888888888


Q ss_pred             CCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCc--cCCCcCccCccccchhhhccccccC
Q 042123          165 DNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK--GVLPPSISNLTNLKELALLYNHLSG  242 (849)
Q Consensus       165 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~  242 (849)
                      +|+++.++...   ...++.|++++|.+....+..+.....++.++...|...  ...+..|..+++|+.+++++|.+. 
T Consensus        88 ~n~l~~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-  163 (305)
T d1xkua_          88 KNQLKELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-  163 (305)
T ss_dssp             SSCCSBCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-
T ss_pred             CCccCcCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-
Confidence            88777654432   346777777777777666666666777777777776543  223344555555555555555543 


Q ss_pred             CCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCC
Q 042123          243 SIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIY  322 (849)
Q Consensus       243 ~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l  322 (849)
                      .+                                               |..+  .++|+.|++++|.++...+..|..+
T Consensus       164 ~l-----------------------------------------------~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~  194 (305)
T d1xkua_         164 TI-----------------------------------------------PQGL--PPSLTELHLDGNKITKVDAASLKGL  194 (305)
T ss_dssp             SC-----------------------------------------------CSSC--CTTCSEEECTTSCCCEECTGGGTTC
T ss_pred             cc-----------------------------------------------Cccc--CCccCEEECCCCcCCCCChhHhhcc
Confidence            11                                               1111  2344445555555544444455555


Q ss_pred             CCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCccccccccccccccccccccCc------hhhcCCCC
Q 042123          323 PNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIP------KELGKLNP  396 (849)
Q Consensus       323 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~------~~~~~l~~  396 (849)
                      +.+++|++++|.+.+..+..|..+++|++|+|++|.|+ .+|..|.++++|++|+|++|+|+.+..      ..+..+.+
T Consensus       195 ~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~  273 (305)
T d1xkua_         195 NNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS  273 (305)
T ss_dssp             TTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCC
T ss_pred             ccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCC
Confidence            55555555555555444555555555555555555555 344555555555555555555553322      23345678


Q ss_pred             CcEEEccCcccc--ccCccccccccccc
Q 042123          397 LTKLILRGNQIT--GRLPKEIGSLTKLE  422 (849)
Q Consensus       397 L~~L~L~~N~l~--~~~p~~~~~l~~L~  422 (849)
                      |+.|+|++|++.  ...|.+|..+....
T Consensus       274 L~~L~L~~N~~~~~~~~~~~f~~~~~~~  301 (305)
T d1xkua_         274 YSGVSLFSNPVQYWEIQPSTFRCVYVRA  301 (305)
T ss_dssp             CSEEECCSSSSCGGGSCGGGGTTCCCGG
T ss_pred             CCEEECCCCcCccCcCCHhHhcccccCc
Confidence            888999998875  34455555544433

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.2e-27  Score=246.27  Aligned_cols=252  Identities=21%  Similarity=0.207  Sum_probs=216.2

Q ss_pred             EecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeE
Q 042123           10 ISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRL   89 (849)
Q Consensus        10 ~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L   89 (849)
                      +++++.++......  +  .+++++|+|++|+|+++.+.+|.++++|++|++++|++..      .....+..+..+..+
T Consensus        16 v~c~~~~L~~iP~~--i--p~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~------i~~~~~~~~~~~~~l   85 (284)
T d1ozna_          16 TSCPQQGLQAVPVG--I--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR------IDAAAFTGLALLEQL   85 (284)
T ss_dssp             EECCSSCCSSCCTT--C--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCE------ECTTTTTTCTTCCEE
T ss_pred             EEcCCCCCCccCCC--C--CCCCCEEECcCCcCCCCCHHHhhccccccccccccccccc------ccccccccccccccc
Confidence            46778886533221  2  3579999999999999999999999999999999999973      345567778889988


Q ss_pred             ecc-CCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcc
Q 042123           90 VIN-DNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQL  168 (849)
Q Consensus        90 ~l~-~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  168 (849)
                      ... .|.+..+.+..|.++++|++|++++|++..+.+..+...++|+.+++++|+|+++.+..|..+++|+.|+|++|++
T Consensus        86 ~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l  165 (284)
T d1ozna_          86 DLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI  165 (284)
T ss_dssp             ECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             ccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcc
Confidence            764 7778888889999999999999999999988888999999999999999999988888999999999999999999


Q ss_pred             cccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcch
Q 042123          169 IGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSL  248 (849)
Q Consensus       169 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~  248 (849)
                      ..+.+.+|.++++|+++++++|++++..|..|.++++|++|++++|++.+..+..|..+++|++|+|++|++.+..+...
T Consensus       166 ~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~  245 (284)
T d1ozna_         166 SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP  245 (284)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHH
T ss_pred             cccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchH
Confidence            99999999999999999999999998899999999999999999999999888999999999999999999986654322


Q ss_pred             hhhhhhhhhccCcCCCCCCCccc
Q 042123          249 GNLILRQLLLSGNHFTGYLPYNI  271 (849)
Q Consensus       249 ~~~~L~~L~L~~n~i~~~~~~~~  271 (849)
                      -...++.+....+++....|..+
T Consensus       246 l~~~l~~~~~~~~~~~C~~p~~l  268 (284)
T d1ozna_         246 LWAWLQKFRGSSSEVPCSLPQRL  268 (284)
T ss_dssp             HHHHHHHCCSEECCCBEEESGGG
T ss_pred             HHHHHHhCcCCCCceEeCCchHH
Confidence            22236666666666665555444

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.94  E-value=1.6e-26  Score=243.75  Aligned_cols=245  Identities=22%  Similarity=0.312  Sum_probs=147.9

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      .++.+|-++++++.+ |..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|.+|.++++|++|+++
T Consensus        11 ~~~~~~C~~~~L~~l-P~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~   87 (305)
T d1xkua_          11 HLRVVQCSDLGLEKV-PKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS   87 (305)
T ss_dssp             ETTEEECTTSCCCSC-CCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             cCCEEEecCCCCCcc-CCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence            456677777777743 44443  467777777777775555567777777777777777777767777777777777777


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCC
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP  268 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~  268 (849)
                      +|+++ .+|..+  ...|+.|++++|.+..+.+..+.....+..++...|...                           
T Consensus        88 ~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~---------------------------  137 (305)
T d1xkua_          88 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK---------------------------  137 (305)
T ss_dssp             SSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCC---------------------------
T ss_pred             CCccC-cCccch--hhhhhhhhccccchhhhhhhhhhcccccccccccccccc---------------------------
Confidence            77776 344332  245666666666666443333333333333333222211                           


Q ss_pred             cccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCC
Q 042123          269 YNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPK  348 (849)
Q Consensus       269 ~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  348 (849)
                                        .....+..+..+++|+.+++++|.++.....   ..++|+.|++++|......+..|..++.
T Consensus       138 ------------------~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~---~~~~L~~L~l~~n~~~~~~~~~~~~~~~  196 (305)
T d1xkua_         138 ------------------SSGIENGAFQGMKKLSYIRIADTNITTIPQG---LPPSLTELHLDGNKITKVDAASLKGLNN  196 (305)
T ss_dssp             ------------------GGGBCTTGGGGCTTCCEEECCSSCCCSCCSS---CCTTCSEEECTTSCCCEECTGGGTTCTT
T ss_pred             ------------------ccCCCccccccccccCccccccCCccccCcc---cCCccCEEECCCCcCCCCChhHhhcccc
Confidence                              1112234455666777777777776643221   2456677777777666666666666666


Q ss_pred             CcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCcccc
Q 042123          349 LGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       349 L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                      ++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|.+|..+++|++|+|++|+|+
T Consensus       197 l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS  255 (305)
T ss_dssp             CCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred             ccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC
Confidence            666666666666655666666666666666666665 34556666666666666666665

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=6.5e-26  Score=236.27  Aligned_cols=223  Identities=25%  Similarity=0.279  Sum_probs=137.7

Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcC-CCc
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLN-DNQ  167 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~  167 (849)
                      ++++++.++ .+|..+.  +++++|+|++|+|+++.+.+|.++++|++|++++|++..+.+..+.++..++.+... .|.
T Consensus        16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~   92 (284)
T d1ozna_          16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ   92 (284)
T ss_dssp             EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred             EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccc
Confidence            344444554 3344333  456677777777766666667777777777777777666666666666666666543 455


Q ss_pred             ccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcc
Q 042123          168 LIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPS  247 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~  247 (849)
                      +..+.+..|.++++|++|++++|.+....+..+...++|+.+++++|+++++.+.+|..+++|++|++++|.++.     
T Consensus        93 ~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~-----  167 (284)
T d1ozna_          93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS-----  167 (284)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE-----
T ss_pred             cccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccc-----
Confidence            666666667777777777777776665555566666667777777777765555556666555555555555441     


Q ss_pred             hhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCE
Q 042123          248 LGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTF  327 (849)
Q Consensus       248 ~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  327 (849)
                                        +.+..|..+++|+.+++++|++++..|..|.++++|++|++++|++++.++..|..+++|++
T Consensus       168 ------------------l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~  229 (284)
T d1ozna_         168 ------------------VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY  229 (284)
T ss_dssp             ------------------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred             ------------------cchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence                              22333444455555555555555555666666666666666666666666666666666666


Q ss_pred             EeccCccccC
Q 042123          328 IDLSRNNFYG  337 (849)
Q Consensus       328 L~Ls~N~l~~  337 (849)
                      |+|++|++.+
T Consensus       230 L~l~~N~l~C  239 (284)
T d1ozna_         230 LRLNDNPWVC  239 (284)
T ss_dssp             EECCSSCEEC
T ss_pred             EEecCCCCCC
Confidence            6666666654

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=2.6e-24  Score=221.42  Aligned_cols=201  Identities=21%  Similarity=0.240  Sum_probs=107.7

Q ss_pred             CCCcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCC
Q 042123            3 DAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGN   82 (849)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~   82 (849)
                      .......++++.+++......  +  -+++++|||++|+|+++.+.+|.++++|++|+|++|+|+.     +   ..++.
T Consensus         8 ~~~~~~~v~C~~~~L~~iP~~--l--p~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-----l---~~~~~   75 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLTALPPD--L--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-----L---QVDGT   75 (266)
T ss_dssp             CSTTCCEEECTTSCCSSCCSC--C--CTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-----E---ECCSC
T ss_pred             ccCCCeEEEccCCCCCeeCcC--c--CcCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-----c---ccccc
Confidence            334445566666666532211  1  1456777777777766666667777777777777776652     1   12234


Q ss_pred             ccccCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEE
Q 042123           83 LRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQ  162 (849)
Q Consensus        83 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  162 (849)
                      +++|++|+|++|+++. .+..+.++++|++|++++|++.++.+..+..+.++++|++++|.++...+..+..+++|+.|+
T Consensus        76 l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~  154 (266)
T d1p9ag_          76 LPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS  154 (266)
T ss_dssp             CTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             cccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcc
Confidence            5555555555555552 344455555555555555555555555555555555555555555544444455555555555


Q ss_pred             cCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCc
Q 042123          163 LNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       163 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      +++|+++++.++.|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|.+.
T Consensus       155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             cccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence            5555555555555555555555555555554 44444444555555555555443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.90  E-value=2.8e-23  Score=213.57  Aligned_cols=203  Identities=21%  Similarity=0.222  Sum_probs=179.6

Q ss_pred             CCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCC
Q 042123           28 SFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNL  107 (849)
Q Consensus        28 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  107 (849)
                      ....+.+.|.++++++.+ |..+.  ++|++|+|++|+|++      ....+|.++++|++|+|++|.|+.+ | .++.+
T Consensus         8 ~~~~~~~v~C~~~~L~~i-P~~lp--~~l~~L~Ls~N~i~~------l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l   76 (266)
T d1p9ag_           8 KVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYT------FSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTL   76 (266)
T ss_dssp             CSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSE------EEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCC
T ss_pred             ccCCCeEEEccCCCCCee-CcCcC--cCCCEEECcCCcCCC------cCHHHhhcccccccccccccccccc-c-ccccc
Confidence            455667889999999865 54443  579999999999974      2345678899999999999999855 3 46789


Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      ++|++|+|++|+++. .+..+.++++|+.|++++|.+....+..+..+.++++|++++|.+..+.+..+..+++|++|++
T Consensus        77 ~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l  155 (266)
T d1p9ag_          77 PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL  155 (266)
T ss_dssp             TTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             ccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc
Confidence            999999999999994 5778999999999999999999888889999999999999999999999999999999999999


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCC
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGS  243 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  243 (849)
                      ++|++++..++.|..+++|++|+|++|+|+ .+|+.+..+++|+.|+|++|++...
T Consensus       156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             ccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence            999999888888999999999999999999 6788888999999999999998743

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.86  E-value=8.2e-20  Score=195.99  Aligned_cols=307  Identities=24%  Similarity=0.306  Sum_probs=191.6

Q ss_pred             CCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCC
Q 042123           30 PHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKF  109 (849)
Q Consensus        30 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~  109 (849)
                      .++++|||++|+++. +|+   ..++|++|+|++|+|+.     ++     ..+.+|+.|++++|+++.+ +. +  .+.
T Consensus        38 ~~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~~-----lp-----~~~~~L~~L~l~~n~l~~l-~~-l--p~~   99 (353)
T d1jl5a_          38 RQAHELELNNLGLSS-LPE---LPPHLESLVASCNSLTE-----LP-----ELPQSLKSLLVDNNNLKAL-SD-L--PPL   99 (353)
T ss_dssp             HTCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCSS-----CC-----CCCTTCCEEECCSSCCSCC-CS-C--CTT
T ss_pred             cCCCEEEeCCCCCCC-CCC---CCCCCCEEECCCCCCcc-----cc-----cchhhhhhhhhhhcccchh-hh-h--ccc
Confidence            368899999999975 453   35789999999999872     21     1246788889999988743 32 1  146


Q ss_pred             CCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccC
Q 042123          110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSR  189 (849)
Q Consensus       110 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~  189 (849)
                      |++|++++|.|+.+ | .+..+++|++|++++|.+... +   .....+..|.+.++....  ...+..++.++.|++++
T Consensus       100 L~~L~L~~n~l~~l-p-~~~~l~~L~~L~l~~~~~~~~-~---~~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~  171 (353)
T d1jl5a_         100 LEYLGVSNNQLEKL-P-ELQNSSFLKIIDVDNNSLKKL-P---DLPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADN  171 (353)
T ss_dssp             CCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSCC-C---CCCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCS
T ss_pred             cccccccccccccc-c-chhhhccceeecccccccccc-c---cccccccchhhccccccc--cccccccccceeccccc
Confidence            89999999998854 4 367788999999999888632 2   234567778887776643  45677888888999988


Q ss_pred             CCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCc
Q 042123          190 NDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPY  269 (849)
Q Consensus       190 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~  269 (849)
                      |.+.. .+.   .....+.+..+++.+. .. ..+..++.|+.+++++|... .+|...                     
T Consensus       172 n~~~~-~~~---~~~~~~~l~~~~~~~~-~~-~~~~~l~~L~~l~l~~n~~~-~~~~~~---------------------  223 (353)
T d1jl5a_         172 NSLKK-LPD---LPLSLESIVAGNNILE-EL-PELQNLPFLTTIYADNNLLK-TLPDLP---------------------  223 (353)
T ss_dssp             SCCSS-CCC---CCTTCCEEECCSSCCS-SC-CCCTTCTTCCEEECCSSCCS-SCCSCC---------------------
T ss_pred             ccccc-ccc---cccccccccccccccc-cc-cccccccccccccccccccc-cccccc---------------------
Confidence            88763 332   2234566777777665 23 34667788888888887765 333221                     


Q ss_pred             ccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCC
Q 042123          270 NICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKL  349 (849)
Q Consensus       270 ~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  349 (849)
                           .++..+.+.+|.+.. .+.   ...++...++..+.+.+..    .........++..|.+.+.    ...+++|
T Consensus       224 -----~~l~~~~~~~~~~~~-~~~---~~~~l~~~~~~~~~~~~l~----~l~~~~~~~~~~~~~~~~~----~~~~~~L  286 (353)
T d1jl5a_         224 -----PSLEALNVRDNYLTD-LPE---LPQSLTFLDVSENIFSGLS----ELPPNLYYLNASSNEIRSL----CDLPPSL  286 (353)
T ss_dssp             -----TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSEES----CCCTTCCEEECCSSCCSEE----CCCCTTC
T ss_pred             -----ccccccccccccccc-ccc---ccccccccccccccccccc----cccchhcccccccCccccc----cccCCCC
Confidence                 233444444444432 111   1233444444444443211    0112445556666655432    2234567


Q ss_pred             cEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCCCCcEEEccCccccccCccccc
Q 042123          350 GTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLNPLTKLILRGNQITGRLPKEIG  416 (849)
Q Consensus       350 ~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~  416 (849)
                      ++|+|++|+|+ .+|..   +++|+.|+|++|+|+ .+|.   .+++|++|+|++|+|+ .+|....
T Consensus       287 ~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~---~~~~L~~L~L~~N~L~-~lp~~~~  344 (353)
T d1jl5a_         287 EELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIPE  344 (353)
T ss_dssp             CEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-SCCCCCT
T ss_pred             CEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccc---ccCCCCEEECcCCcCC-CCCcccc
Confidence            77777777776 45543   456777777777776 4453   2456788888888877 5555433

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.84  E-value=4.1e-19  Score=190.45  Aligned_cols=136  Identities=25%  Similarity=0.248  Sum_probs=69.1

Q ss_pred             cCeEeccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCC
Q 042123           86 MSRLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLND  165 (849)
Q Consensus        86 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  165 (849)
                      +++|+|++|.++ .+|+.   .++|++|+|++|+|+. +|..   ..+|+.|++++|+++.. +. +  .++|++|++++
T Consensus        40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~-l--p~~L~~L~L~~  107 (353)
T d1jl5a_          40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SD-L--PPLLEYLGVSN  107 (353)
T ss_dssp             CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CS-C--CTTCCEEECCS
T ss_pred             CCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcc-cccc---hhhhhhhhhhhcccchh-hh-h--ccccccccccc
Confidence            444444444444 23332   2455666666666653 3433   23555666666655521 11 1  12466666666


Q ss_pred             CcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcccccc
Q 042123          166 NQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLS  241 (849)
Q Consensus       166 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  241 (849)
                      |.+..++  .+..+++|++|++++|.+.. .+.   ....+..+.+..+...  ....+..++.++.|++++|...
T Consensus       108 n~l~~lp--~~~~l~~L~~L~l~~~~~~~-~~~---~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~  175 (353)
T d1jl5a_         108 NQLEKLP--ELQNSSFLKIIDVDNNSLKK-LPD---LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK  175 (353)
T ss_dssp             SCCSSCC--CCTTCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred             ccccccc--chhhhccceeeccccccccc-ccc---ccccccchhhcccccc--ccccccccccceeccccccccc
Confidence            6666542  24556666666666666552 222   2344555555555543  2234555666666666666554

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=2.5e-20  Score=188.72  Aligned_cols=227  Identities=16%  Similarity=0.109  Sum_probs=181.0

Q ss_pred             CCCCCcEEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCC
Q 042123            1 CNDAGRVINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSG   80 (849)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~   80 (849)
                      |+-.|+++.  ++..++. .+++ .+  .+++++|||++|+|+.+.+.+|.++++|++|+|++|.+..     ..+..+|
T Consensus         6 C~C~~~~i~--c~~~~l~-~iP~-~l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~-----~i~~~~f   74 (242)
T d1xwdc1           6 CHCSNRVFL--CQESKVT-EIPS-DL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-----VIEADVF   74 (242)
T ss_dssp             EEECSSEEE--EESCSCS-SCCS-CS--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCC-----EECSSSE
T ss_pred             CCCcCCEEE--EeCCCCC-CcCC-CC--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccc-----eeecccc
Confidence            444566544  4555544 2322 12  3589999999999998888899999999999999999863     3445667


Q ss_pred             CCccccCeEecc-CCcccccCCccCCCCCCCCEEEccCCcccCCCCCC-CcCCCCCceeeccCcccccccccccCCCC-C
Q 042123           81 GNLRYMSRLVIN-DNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLS-FDNLSNLIFLYLYGNLLSGSILSSLGKLK-S  157 (849)
Q Consensus        81 ~~l~~L~~L~l~-~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~  157 (849)
                      .+++.++.+.+. .|.+....+..|.++++|++|++++|+++...+.. +..+..++.+..+++.+....+..|.+++ .
T Consensus        75 ~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~  154 (242)
T d1xwdc1          75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE  154 (242)
T ss_dssp             ESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSS
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccccc
Confidence            889999999876 47888888899999999999999999998654433 45567777778888889877778888775 8


Q ss_pred             CCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcc
Q 042123          158 LFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLY  237 (849)
Q Consensus       158 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  237 (849)
                      ++.|++++|+++.+.+..|.....++.+++++|+++...++.|.++++|++|+|++|+|+.+.+..|.++++|+.|++.+
T Consensus       155 l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~  234 (242)
T d1xwdc1         155 SVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN  234 (242)
T ss_dssp             CEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred             ceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence            99999999999998887776554455557888999866667799999999999999999977777899999999988754


Q ss_pred             c
Q 042123          238 N  238 (849)
Q Consensus       238 N  238 (849)
                      .
T Consensus       235 l  235 (242)
T d1xwdc1         235 L  235 (242)
T ss_dssp             S
T ss_pred             C
Confidence            3

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=2.7e-19  Score=173.50  Aligned_cols=156  Identities=22%  Similarity=0.244  Sum_probs=94.0

Q ss_pred             eEeccCCcccccCCccCCCCCCCCEEEccCCcccC-CCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCC
Q 042123           88 RLVINDNSLSGFIPPHIGNLKFLSQLDLTNNKFSG-PIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDN  166 (849)
Q Consensus        88 ~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  166 (849)
                      .++++++.++ .+|..+.  +++++|+|++|+|++ +.+..|.++++|++|+|++|.+....+..|..+++|++|+|++|
T Consensus        12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N   88 (192)
T d1w8aa_          12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN   88 (192)
T ss_dssp             EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred             EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence            4555555555 3344432  466677777777754 34556666777777777777776666666666777777777777


Q ss_pred             cccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCc
Q 042123          167 QLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPP  246 (849)
Q Consensus       167 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~  246 (849)
                      +|..+.+++|.++++|++|+|++|+|++..+++|..+++|++|+|++|.+.... +...-...++.+.+..|.+....|.
T Consensus        89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~-~~~~~~~~l~~~~l~~~~~~c~~p~  167 (192)
T d1w8aa_          89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC-HLAWFAEWLRKKSLNGGAARCGAPS  167 (192)
T ss_dssp             CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG-GGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred             cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc-chHHHhhhhhhhcccCCCeEeCCCh
Confidence            777666666777777777777777776666666666777777777777665321 1111122344555555555444443


Q ss_pred             c
Q 042123          247 S  247 (849)
Q Consensus       247 ~  247 (849)
                      .
T Consensus       168 ~  168 (192)
T d1w8aa_         168 K  168 (192)
T ss_dssp             T
T ss_pred             h
Confidence            3

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.79  E-value=3.1e-20  Score=180.11  Aligned_cols=161  Identities=15%  Similarity=0.149  Sum_probs=105.1

Q ss_pred             CcCceecCCccceEEEEEecCCcEEEEEEecccCCCCc--------------hhhHHHHHHHHH---Hhhceeec----C
Q 042123          591 DAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQ--------------TVDQKEFLTEVE---AFYGFCSH----A  649 (849)
Q Consensus       591 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------~~~~~~~~~ei~---~~~~~~~~----~  649 (849)
                      .+.++||+|+||+||+|...+|+.||||.++.......              .........|..   ++.++...    .
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35679999999999999888899999998753211100              001111222322   23222111    1


Q ss_pred             CeeEEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeeecCCCcEEEeeecC
Q 042123          650 RHSFLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDCFPPIVHRDISSKNLLLDLEYEAHVADFGI  729 (849)
Q Consensus       650 ~~~~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~  729 (849)
                      ...++||||++++.+.+          ++.....+++.|++.|++|||+.   +|+||||||+|||++++ .++++|||.
T Consensus        83 ~~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          83 EGNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             ETTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             cCCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCC
Confidence            12368999998865433          34455678999999999999998   99999999999999865 489999999


Q ss_pred             CcccCCCCCCeeeccCCccccccc-----cccCCCCCccchHHHHHHHH
Q 042123          730 AKSLKPDSSNWTEFAGTCGYIAPE-----LAYTMKITEKCDVYSFGVLM  773 (849)
Q Consensus       730 a~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~Dv~SlGvil  773 (849)
                      |.....+..        ..|....     .+..+.|..++|+||..--+
T Consensus       149 a~~~~~~~~--------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         149 SVEVGEEGW--------REILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CEETTSTTH--------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             cccCCCCCc--------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            976543211        0111110     01235678899999976443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=2.8e-19  Score=173.45  Aligned_cols=173  Identities=25%  Similarity=0.302  Sum_probs=144.4

Q ss_pred             CCEEEccCCcccCCCCCCCcCCCCCceeeccCccccc-ccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEcc
Q 042123          110 LSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSG-SILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLS  188 (849)
Q Consensus       110 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls  188 (849)
                      .++++.++++++. +|..+.  +++++|+|++|+|+. ..+..|.++++|+.|+|++|.+..+.++.|..+++|++|+|+
T Consensus        10 ~~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls   86 (192)
T d1w8aa_          10 GTTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG   86 (192)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred             CCEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence            4689999999995 455443  689999999999975 456788999999999999999999999999999999999999


Q ss_pred             CCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCC
Q 042123          189 RNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLP  268 (849)
Q Consensus       189 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~  268 (849)
                      +|+|+...+++|.++++|++|+|++|+|+.+.+++|..+++|++|+|++|.+....+.......++.+.+..+.++...|
T Consensus        87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p  166 (192)
T d1w8aa_          87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP  166 (192)
T ss_dssp             SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred             cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence            99999888899999999999999999999999999999999999999999998554433333347777888887776555


Q ss_pred             cccCCCCCcceeeecccccc
Q 042123          269 YNICRGGALEIFTVSENHFQ  288 (849)
Q Consensus       269 ~~~~~~~~L~~L~l~~N~l~  288 (849)
                      ..+   ..++.++|+.|.+.
T Consensus       167 ~~l---~~~~l~~L~~n~l~  183 (192)
T d1w8aa_         167 SKV---RDVQIKDLPHSEFK  183 (192)
T ss_dssp             TTT---TTSBGGGSCTTTCC
T ss_pred             hhh---cCCEeeecCHhhCc
Confidence            433   34555666666654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2.9e-19  Score=180.76  Aligned_cols=227  Identities=12%  Similarity=0.041  Sum_probs=133.5

Q ss_pred             CEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEEeccCCcCccC-CCcCccCccccchhhhcc
Q 042123          159 FDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGV-LPPSISNLTNLKELALLY  237 (849)
Q Consensus       159 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~  237 (849)
                      +.++.+++.++.++++.+   +++++|+|++|+|+...+..|.++++|++|++++|.+... .+.+|.+++++++|.+..
T Consensus        11 ~~i~c~~~~l~~iP~~l~---~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~   87 (242)
T d1xwdc1          11 RVFLCQESKVTEIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   87 (242)
T ss_dssp             SEEEEESCSCSSCCSCSC---SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred             CEEEEeCCCCCCcCCCCC---CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence            455666666665443322   3566666666666644444566666666666666665532 234455555555554432


Q ss_pred             ccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhh
Q 042123          238 NHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISE  317 (849)
Q Consensus       238 N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~  317 (849)
                                                                    .|.+....+..|.++++|+.|++++|.++...+.
T Consensus        88 ----------------------------------------------~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~  121 (242)
T d1xwdc1          88 ----------------------------------------------ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV  121 (242)
T ss_dssp             ----------------------------------------------CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC
T ss_pred             ----------------------------------------------cccccccccccccccccccccccchhhhcccccc
Confidence                                                          1223333334444555555555555555432221


Q ss_pred             -hhCCCCCCCEEeccCccccCcccccCCCCC-CCcEEeccCCccccCCCCCccccccccccccccccccccCchhhcCCC
Q 042123          318 -ALGIYPNLTFIDLSRNNFYGEISSNWGKFP-KLGTLNVSMNNITGGLPREIGNSSQLQAFDLSLNHIVGEIPKELGKLN  395 (849)
Q Consensus       318 -~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~i~~~~p~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~  395 (849)
                       .+..+..++.+..+++.+....+..|..++ .++.|++++|+++...+..+.....++.+++++|+++...+..|.+++
T Consensus       122 ~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~  201 (242)
T d1xwdc1         122 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGAS  201 (242)
T ss_dssp             TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSC
T ss_pred             cccccccccccccccccccccccccccccccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCC
Confidence             222334444455555555555555555543 677777777777754444444333344456777888766566788899


Q ss_pred             CCcEEEccCccccccCcccccccccccccccccCCCCCh
Q 042123          396 PLTKLILRGNQITGRLPKEIGSLTKLEYLDFSAIGELPS  434 (849)
Q Consensus       396 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~  434 (849)
                      +|++|+|++|+|+...+..|.++++|+++++..+..+|+
T Consensus       202 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~l~~lp~  240 (242)
T d1xwdc1         202 GPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT  240 (242)
T ss_dssp             CCSEEECTTSCCCCCCSSSCTTCCEEESSSEESSSCSCC
T ss_pred             CCCEEECCCCcCCccCHHHHcCCcccccCcCCCCCcCCC
Confidence            999999999999866666788888888888877777663

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=3.5e-19  Score=178.04  Aligned_cols=191  Identities=26%  Similarity=0.339  Sum_probs=159.0

Q ss_pred             cCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccC
Q 042123           25 SFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHI  104 (849)
Q Consensus        25 ~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~  104 (849)
                      .++++.+|++|++++|+|+.+.  .+.++++|++|+|++|++++.        ..+..+++|+.+++++|.++.+  +.+
T Consensus        36 ~~~~l~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~~--------~~l~~l~~l~~l~~~~n~~~~i--~~l  103 (227)
T d1h6ua2          36 TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITDL--------APLKNLTKITELELSGNPLKNV--SAI  103 (227)
T ss_dssp             CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC--------GGGTTCCSCCEEECCSCCCSCC--GGG
T ss_pred             CHHHcCCcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeecc--------cccccccccccccccccccccc--ccc
Confidence            4677889999999999998663  489999999999999998742        2367789999999999999853  468


Q ss_pred             CCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCE
Q 042123          105 GNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVST  184 (849)
Q Consensus       105 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  184 (849)
                      .++++|+++++++|.+.+..  .+...+.++.++++++.+...  ..+.+.++|+.|++++|++...  ..|.++++|++
T Consensus       104 ~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~  177 (227)
T d1h6ua2         104 AGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTT  177 (227)
T ss_dssp             TTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCE
T ss_pred             cccccccccccccccccccc--hhccccchhhhhchhhhhchh--hhhccccccccccccccccccc--hhhccccccee
Confidence            88999999999999987543  467788999999999988743  3477889999999999998764  34889999999


Q ss_pred             EEccCCCCcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhcc
Q 042123          185 LRLSRNDLFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLY  237 (849)
Q Consensus       185 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  237 (849)
                      |+|++|++++ ++ .+.++++|++|+|++|+++++.  .+.++++|++|++++
T Consensus       178 L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~lsn  226 (227)
T d1h6ua2         178 LKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN  226 (227)
T ss_dssp             EECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEE
T ss_pred             cccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEeeC
Confidence            9999999984 44 3889999999999999998653  388999999999864

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=8.1e-20  Score=182.72  Aligned_cols=203  Identities=23%  Similarity=0.364  Sum_probs=104.3

Q ss_pred             EEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCC
Q 042123          112 QLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRND  191 (849)
Q Consensus       112 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  191 (849)
                      .++++.+++++..  .+..+.+|+.|++++|.|+..  ..+..+++|++|++++|++.++.  .|..+++|++|++++|.
T Consensus        23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~--~l~~l~~l~~l~~~~n~   96 (227)
T d1h6ua2          23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLA--PLKNLTKITELELSGNP   96 (227)
T ss_dssp             HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCCSCCEEECCSCC
T ss_pred             HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeeccc--ccccccccccccccccc
Confidence            3445555555432  334455555555555555532  23555555555555555555432  25555555555555555


Q ss_pred             CcCcCcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCccc
Q 042123          192 LFGSIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNI  271 (849)
Q Consensus       192 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~  271 (849)
                      ++ .++ .+.++++|+.+++++|.....  ..+...+.++                                        
T Consensus        97 ~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~----------------------------------------  132 (227)
T d1h6ua2          97 LK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQ----------------------------------------  132 (227)
T ss_dssp             CS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCC----------------------------------------
T ss_pred             cc-ccc-ccccccccccccccccccccc--chhccccchh----------------------------------------
Confidence            54 222 344555555555555544422  1223333333                                        


Q ss_pred             CCCCCcceeeecccccccccCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcE
Q 042123          272 CRGGALEIFTVSENHFQGTIPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGT  351 (849)
Q Consensus       272 ~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  351 (849)
                             .+.++.+.+....  .+.++++|+.|++++|.++...  .+..+++|+.|+|++|++++. + .+..+++|++
T Consensus       133 -------~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~  199 (227)
T d1h6ua2         133 -------VLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-S-PLASLPNLIE  199 (227)
T ss_dssp             -------EEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCE
T ss_pred             -------hhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccCCC-h-hhcCCCCCCE
Confidence                   3333333333211  2444556666666666665432  255666666666666666543 2 2566666777


Q ss_pred             EeccCCccccCCCCCccccccccccccc
Q 042123          352 LNVSMNNITGGLPREIGNSSQLQAFDLS  379 (849)
Q Consensus       352 L~Ls~N~i~~~~p~~~~~l~~L~~L~L~  379 (849)
                      |+|++|++++. + .+.++++|+.|+++
T Consensus       200 L~Ls~N~lt~i-~-~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         200 VHLKNNQISDV-S-PLANTSNLFIVTLT  225 (227)
T ss_dssp             EECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred             EECcCCcCCCC-c-ccccCCCCCEEEee
Confidence            77777766643 2 25666677777665

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=1.8e-18  Score=168.69  Aligned_cols=177  Identities=24%  Similarity=0.361  Sum_probs=102.1

Q ss_pred             EeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEE
Q 042123           35 LDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLD  114 (849)
Q Consensus        35 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  114 (849)
                      ++++.+.+++..+  ...+++|++|++++|.++.     +   ..+..+++|++|++++|.|++..|  ++++++|++|+
T Consensus        23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-----l---~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~   90 (199)
T d2omxa2          23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-----I---DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL   90 (199)
T ss_dssp             HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-----C---TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-----c---cccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence            3445555544333  2345555666666665542     1   123445556666666665554322  66666666666


Q ss_pred             ccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcC
Q 042123          115 LTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFG  194 (849)
Q Consensus       115 Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  194 (849)
                      +++|.+..+.  .+.++++|+.|++++|.+...  ..+..+++|+.|++++|++..+  +.+..+++|++|++++|++++
T Consensus        91 l~~n~~~~~~--~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2          91 MNNNQIADIT--PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             CCSSCCCCCG--GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC
T ss_pred             cccccccccc--ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--ccccccccccccccccccccC
Confidence            6666666432  356666666666666666532  3356666677777777766543  346666777777777776663


Q ss_pred             cCcccccCCCCCCEEeccCCcCccCCCcCccCccccchh
Q 042123          195 SIPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKEL  233 (849)
Q Consensus       195 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  233 (849)
                      . + .+.++++|++|++++|+++++  +.++++++|++|
T Consensus       165 l-~-~l~~l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L  199 (199)
T d2omxa2         165 L-K-PLANLTTLERLDISSNKVSDI--SVLAKLTNLESL  199 (199)
T ss_dssp             C-G-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             C-c-cccCCCCCCEEECCCCCCCCC--ccccCCCCCCcC
Confidence            2 2 366677777777777776643  245666666543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.76  E-value=1.2e-21  Score=218.52  Aligned_cols=384  Identities=16%  Similarity=0.120  Sum_probs=173.6

Q ss_pred             EEEEecCCCceeeeeCCccCCCCCCCCEEeCcCCcccc----CCCccccCCCCCCEeeCCCCcCcccccccccccCCCCC
Q 042123            7 VINISLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFG----TIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGN   82 (849)
Q Consensus         7 ~~~~~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~   82 (849)
                      ++.||++.+.+++..-..-+..+++++.|+|++|+|+.    .+..++..+++|++|||++|+|++.....+.. .....
T Consensus         4 l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~-~l~~~   82 (460)
T d1z7xw1           4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ-GLQTP   82 (460)
T ss_dssp             EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH-TTCST
T ss_pred             CCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHH-HHhcC
Confidence            45555555555443212224445566666666665542    22334455566666666666654322222211 11112


Q ss_pred             ccccCeEeccCCccccc----CCccCCCCCCCCEEEccCCcccCCCCCCC-----cCCCCCceeeccCccccccc----c
Q 042123           83 LRYMSRLVINDNSLSGF----IPPHIGNLKFLSQLDLTNNKFSGPIPLSF-----DNLSNLIFLYLYGNLLSGSI----L  149 (849)
Q Consensus        83 l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~----~  149 (849)
                      ..+|+.|+|++|.+++.    ++..+..+++|++|+|++|.|+......+     ........+......+....    .
T Consensus        83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (460)
T d1z7xw1          83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA  162 (460)
T ss_dssp             TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred             CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence            23455555555555432    23344555555555555555542111110     01112222222222221100    1


Q ss_pred             cccCCCCCCCEEEcCCCcccccCC----cCC-CCCCCCCEEEccCCCCcCc----CcccccCCCCCCEEeccCCcCcc--
Q 042123          150 SSLGKLKSLFDLQLNDNQLIGYIP----RPF-SNLTSVSTLRLSRNDLFGS----IPDEIGKMRSLSVLDLNQNQFKG--  218 (849)
Q Consensus       150 ~~~~~l~~L~~L~L~~N~l~~~~~----~~~-~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~--  218 (849)
                      ..+.....++.++++++.+.....    ..+ ........|++..+.+...    ....+...+.++.+++++|++..  
T Consensus       163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~  242 (460)
T d1z7xw1         163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG  242 (460)
T ss_dssp             HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence            112233455555555554432100    000 1122344555555544311    11123334555566665555431  


Q ss_pred             ---CCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCCCcccCCCCCcceeeecccccccccCCCC
Q 042123          219 ---VLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYLPYNICRGGALEIFTVSENHFQGTIPTSL  295 (849)
Q Consensus       219 ---~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~~~~~~~~~~L~~L~l~~N~l~~~~~~~~  295 (849)
                         ..+..+.....|+.|++++|.+.......                   ....+...+.++.+++++|.+.......+
T Consensus       243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~-------------------~~~~l~~~~~l~~l~l~~n~i~~~~~~~l  303 (460)
T d1z7xw1         243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGD-------------------LCRVLRAKESLKELSLAGNELGDEGARLL  303 (460)
T ss_dssp             HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHH-------------------HHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred             cchhhccccccccccccccccccccccccccc-------------------ccccccccccccccccccccccccccchh
Confidence               11122233344555555555443110000                   01112234456666666666543211111


Q ss_pred             -----CCcccccEEEccCccccCchhh----hhCCCCCCCEEeccCccccCc----ccccCC-CCCCCcEEeccCCcccc
Q 042123          296 -----RNCTSLIRVRLNGNNLTGNISE----ALGIYPNLTFIDLSRNNFYGE----ISSNWG-KFPKLGTLNVSMNNITG  361 (849)
Q Consensus       296 -----~~l~~L~~L~L~~n~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~i~~  361 (849)
                           .....|+.+++++|.++.....    .+...++|+.|+|++|++.+.    ++..+. ..+.|++|+|++|.|+.
T Consensus       304 ~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~  383 (460)
T d1z7xw1         304 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD  383 (460)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCH
T ss_pred             hccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCCh
Confidence                 1234677777777776644322    334455777777777777532    222222 34567777777777763


Q ss_pred             C----CCCCccccccccccccccccccccCchhh----c-CCCCCcEEEccCcccccc
Q 042123          362 G----LPREIGNSSQLQAFDLSLNHIVGEIPKEL----G-KLNPLTKLILRGNQITGR  410 (849)
Q Consensus       362 ~----~p~~~~~l~~L~~L~L~~N~i~~~~~~~~----~-~l~~L~~L~L~~N~l~~~  410 (849)
                      .    ++..+...++|++|+|++|+|+......|    . ...+|+.|++.+|.+...
T Consensus       384 ~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~  441 (460)
T d1z7xw1         384 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEE  441 (460)
T ss_dssp             HHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHH
T ss_pred             HHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHH
Confidence            2    22334455677777777777764322222    2 233577777777776643

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.75  E-value=1.2e-21  Score=218.45  Aligned_cols=383  Identities=17%  Similarity=0.136  Sum_probs=207.4

Q ss_pred             CCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccc----cCCccCCCCCCCCEEEccCCcccCC----CCC
Q 042123           55 NLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSG----FIPPHIGNLKFLSQLDLTNNKFSGP----IPL  126 (849)
Q Consensus        55 ~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~Ls~n~i~~~----~~~  126 (849)
                      +|++||++.|++++..+.++     +..+++++.|+|++|.|+.    .++..+..+++|++|||++|+|+..    +..
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l-----~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~   77 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAEL-----LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ   77 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHH-----HHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CCCEEEeeCCcCChHHHHHH-----HHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHH
Confidence            68899999999986554443     2347888888888888873    2345567778888888888887531    122


Q ss_pred             CCc-CCCCCceeeccCcccccc----cccccCCCCCCCEEEcCCCcccccCCcC-----CCCCCCCCEEEccCCCCcCcC
Q 042123          127 SFD-NLSNLIFLYLYGNLLSGS----ILSSLGKLKSLFDLQLNDNQLIGYIPRP-----FSNLTSVSTLRLSRNDLFGSI  196 (849)
Q Consensus       127 ~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~-----~~~l~~L~~L~Ls~N~l~~~~  196 (849)
                      .+. ...+|++|+|++|.|+..    ++..+..+++|++|+|++|.+.......     ................+....
T Consensus        78 ~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~  157 (460)
T d1z7xw1          78 GLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAAS  157 (460)
T ss_dssp             TTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred             HHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhh
Confidence            232 234688888888887643    2445667777888888887765431111     112223444444444333111


Q ss_pred             ----cccccCCCCCCEEeccCCcCccCCCcC----c-cCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          197 ----PDEIGKMRSLSVLDLNQNQFKGVLPPS----I-SNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       197 ----~~~~~~l~~L~~L~L~~N~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                          ...+.....++.++++++.+.......    + ........+++..+.+...   ....                .
T Consensus       158 ~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~---~~~~----------------~  218 (460)
T d1z7xw1         158 CEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSD---NCRD----------------L  218 (460)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTT---HHHH----------------H
T ss_pred             hcccccccccccccccccccccccccccccccccccccccccccccccccccccch---hhhc----------------c
Confidence                112334566677777666654210000    0 0001122233333322100   0000                0


Q ss_pred             CcccCCCCCcceeeeccccccc-----ccCCCCCCcccccEEEccCccccCch----hhhhCCCCCCCEEeccCccccCc
Q 042123          268 PYNICRGGALEIFTVSENHFQG-----TIPTSLRNCTSLIRVRLNGNNLTGNI----SEALGIYPNLTFIDLSRNNFYGE  338 (849)
Q Consensus       268 ~~~~~~~~~L~~L~l~~N~l~~-----~~~~~~~~l~~L~~L~L~~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~  338 (849)
                      ...+.....++.++++.|.+..     ..+........++.+++++|.+....    ...+...+.++.+++++|.+...
T Consensus       219 ~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~  298 (460)
T d1z7xw1         219 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE  298 (460)
T ss_dssp             HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred             cccccccccccccchhhccccccccchhhccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            0111223455666666665432     12223344556777777777765322    23345567777777777777532


Q ss_pred             cccc-----CCCCCCCcEEeccCCccccCCCCCc----ccccccccccccccccccc----Cchhhc-CCCCCcEEEccC
Q 042123          339 ISSN-----WGKFPKLGTLNVSMNNITGGLPREI----GNSSQLQAFDLSLNHIVGE----IPKELG-KLNPLTKLILRG  404 (849)
Q Consensus       339 ~~~~-----~~~l~~L~~L~Ls~N~i~~~~p~~~----~~l~~L~~L~L~~N~i~~~----~~~~~~-~l~~L~~L~L~~  404 (849)
                      ....     ......|+.+++++|.++......+    ....+|++|+|++|+++..    ++..+. ..+.|++|+|++
T Consensus       299 ~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~  378 (460)
T d1z7xw1         299 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD  378 (460)
T ss_dssp             HHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred             ccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCC
Confidence            2111     1233467777777777764332222    2334677777777776532    222332 345677777777


Q ss_pred             ccccccCcccccccccccccccccCCCCChhhhcccccceeccCCcccccCCCccc----c-ccCCCcEEeccCCcccc
Q 042123          405 NQITGRLPKEIGSLTKLEYLDFSAIGELPSQICNMKSLEKLNLSHNNLSGSIPSCF----E-GMHGLSFIDMSYNELQC  478 (849)
Q Consensus       405 N~l~~~~p~~~~~l~~L~~L~l~~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~----~-~l~~L~~l~l~~N~l~~  478 (849)
                      |+|+..-..                 .+++.+..+++|++|+|++|+|+......+    . ....|+.|++.+|.+..
T Consensus       379 n~i~~~~~~-----------------~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         379 CDVSDSSCS-----------------SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             SCCCHHHHH-----------------HHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             CCCChHHHH-----------------HHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            776531111                 122345556778888888888874322222    1 23468888888888864

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.75  E-value=1.9e-18  Score=170.00  Aligned_cols=179  Identities=25%  Similarity=0.332  Sum_probs=95.9

Q ss_pred             eCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCCCCCCEEEc
Q 042123           36 DLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNLKFLSQLDL  115 (849)
Q Consensus        36 ~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L  115 (849)
                      ++..+.+++.++.  ..+.+|++|++++|++++.        ..+..+++|++|+|++|.|++..  .++++++|++|++
T Consensus        30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l--------~~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l   97 (210)
T d1h6ta2          30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV--------QGIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFL   97 (210)
T ss_dssp             HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC--------TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred             HhCcCccCCccCH--HHhcCccEEECcCCCCCCc--------hhHhhCCCCCEEeCCCccccCcc--ccccCcccccccc
Confidence            3444444433331  2344555555555555421        11334555555555555555332  2455566666666


Q ss_pred             cCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCcCc
Q 042123          116 TNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLFGS  195 (849)
Q Consensus       116 s~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  195 (849)
                      ++|+|+++ | .+.++++|+.|++++|.+..  ...+..+++|+.+++++|.+.+.  ..+..+++|+++++++|++++ 
T Consensus        98 ~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-  170 (210)
T d1h6ta2          98 DENKVKDL-S-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-  170 (210)
T ss_dssp             CSSCCCCG-G-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-
T ss_pred             cccccccc-c-cccccccccccccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccc-
Confidence            66666543 2 35556666666666666542  23455566666666666666542  345556666666666666653 


Q ss_pred             CcccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhc
Q 042123          196 IPDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALL  236 (849)
Q Consensus       196 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  236 (849)
                      ++ .+.++++|++|+|++|+|+.+ + .+.++++|++|+|+
T Consensus       171 i~-~l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         171 IV-PLAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CG-GGTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEE
T ss_pred             cc-cccCCCCCCEEECCCCCCCCC-h-hhcCCCCCCEEEcc
Confidence            22 256666666666666666532 2 46666666666654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=5e-18  Score=166.93  Aligned_cols=166  Identities=25%  Similarity=0.392  Sum_probs=143.5

Q ss_pred             CCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCccCCCC
Q 042123           28 SFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPHIGNL  107 (849)
Q Consensus        28 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  107 (849)
                      .+.+|++|++++|+++.+.+  +..+++|++|+|++|+|++.        ..++.+++|++|++++|+|+++ | .+.++
T Consensus        44 ~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l--------~~~~~l~~L~~L~l~~n~i~~l-~-~l~~l  111 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDI--------KPLANLKNLGWLFLDENKVKDL-S-SLKDL  111 (210)
T ss_dssp             HHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCC--------GGGTTCTTCCEEECCSSCCCCG-G-GGTTC
T ss_pred             HhcCccEEECcCCCCCCchh--HhhCCCCCEEeCCCccccCc--------cccccCcccccccccccccccc-c-ccccc
Confidence            46789999999999986654  88999999999999999742        1346799999999999999864 3 58899


Q ss_pred             CCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          108 KFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       108 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      ++|+.|++++|.+..+  ..+.++++|+.+++++|.+++  +..+..+++|+++++++|+++++.  .|.++++|++|+|
T Consensus       112 ~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~L  185 (210)
T d1h6ta2         112 KKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYL  185 (210)
T ss_dssp             TTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEEC
T ss_pred             cccccccccccccccc--ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCCEEEC
Confidence            9999999999999853  468899999999999999975  446788999999999999999864  4899999999999


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccC
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQ  213 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~  213 (849)
                      ++|+|+ .++ .+.++++|++|+|++
T Consensus       186 s~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         186 SKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             CSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             CCCCCC-CCh-hhcCCCCCCEEEccC
Confidence            999998 455 599999999999974

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=1.3e-17  Score=162.56  Aligned_cols=176  Identities=27%  Similarity=0.374  Sum_probs=145.6

Q ss_pred             ecCCCceeeeeCCccCCCCCCCCEEeCcCCccccCCCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEe
Q 042123           11 SLPNIGVNGTLHDFSFSSFPHLAYLDLTWNGFFGTIPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLV   90 (849)
Q Consensus        11 ~~~~~~~~~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~   90 (849)
                      .+....+.+...   ...++++++|++++|+|..+.  .++.+++|++|+|++|++++.        ..++++++|+.|+
T Consensus        24 ~l~~~~~~~~~~---~~~l~~l~~L~l~~~~i~~l~--~l~~l~nL~~L~Ls~N~l~~~--------~~l~~l~~L~~L~   90 (199)
T d2omxa2          24 VLGKTNVTDTVS---QTDLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTDI--------TPLKNLTKLVDIL   90 (199)
T ss_dssp             HTTCSSTTSEEC---HHHHTTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCC--------GGGTTCTTCCEEE
T ss_pred             HhCCCCCCCccC---HHHhcCCCEEECCCCCCCCcc--ccccCCCcCcCccccccccCc--------ccccCCccccccc
Confidence            344444444332   345789999999999998653  488999999999999999742        1267899999999


Q ss_pred             ccCCcccccCCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccc
Q 042123           91 INDNSLSGFIPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIG  170 (849)
Q Consensus        91 l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  170 (849)
                      +++|.+... + .+.++++|++|++++|.+...  ..+..+++|+.|++++|++..  ...+..+++|+.|++++|++++
T Consensus        91 l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~--~~~l~~~~~L~~L~l~~n~l~~  164 (199)
T d2omxa2          91 MNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLNFSSNQVTD  164 (199)
T ss_dssp             CCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC--CGGGTTCTTCSEEECCSSCCCC
T ss_pred             ccccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc--cccccccccccccccccccccC
Confidence            999999854 3 588999999999999999854  358889999999999999974  3468999999999999999998


Q ss_pred             cCCcCCCCCCCCCEEEccCCCCcCcCcccccCCCCCCEE
Q 042123          171 YIPRPFSNLTSVSTLRLSRNDLFGSIPDEIGKMRSLSVL  209 (849)
Q Consensus       171 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  209 (849)
                      +.  .|.++++|++|++++|+++. ++ .+.++++|++|
T Consensus       165 l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L  199 (199)
T d2omxa2         165 LK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL  199 (199)
T ss_dssp             CG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred             Cc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence            64  58999999999999999984 44 58899999986

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=6.3e-16  Score=144.16  Aligned_cols=129  Identities=19%  Similarity=0.129  Sum_probs=93.4

Q ss_pred             cCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCC
Q 042123          103 HIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSV  182 (849)
Q Consensus       103 ~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  182 (849)
                      .|.+..++++|+|++|+|+.+ +..+..+++|+.|+|++|+|+..  ..|..+++|++|++++|+++.+.+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence            355667788888888888754 55667778888888888888743  357778888888888888887777667778888


Q ss_pred             CEEEccCCCCcCcCc-ccccCCCCCCEEeccCCcCccCCC---cCccCccccchhh
Q 042123          183 STLRLSRNDLFGSIP-DEIGKMRSLSVLDLNQNQFKGVLP---PSISNLTNLKELA  234 (849)
Q Consensus       183 ~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~  234 (849)
                      ++|++++|+|+.... ..+..+++|++|++++|.++....   ..++.+++|+.||
T Consensus        90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            888888888863321 357778888888888888864321   2467777787776

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.57  E-value=1.3e-15  Score=142.01  Aligned_cols=107  Identities=23%  Similarity=0.223  Sum_probs=67.2

Q ss_pred             CccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCC-cCCCCC
Q 042123          101 PPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNL  179 (849)
Q Consensus       101 ~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l  179 (849)
                      +..+..+++|+.|+|++|+|+.+  ..|..+++|++|++++|+++...+..+..+++|+.|++++|+|..+.. ..+..+
T Consensus        34 ~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l  111 (162)
T d1a9na_          34 ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL  111 (162)
T ss_dssp             CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCCCGGGGGGGGGC
T ss_pred             CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccccccceeccccccccccccccccc
Confidence            33445556666666666666643  236666666666666666665544455566667777777776665432 456677


Q ss_pred             CCCCEEEccCCCCcCcCc----ccccCCCCCCEEe
Q 042123          180 TSVSTLRLSRNDLFGSIP----DEIGKMRSLSVLD  210 (849)
Q Consensus       180 ~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~  210 (849)
                      ++|++|++++|.++ ..|    ..+..+++|+.||
T Consensus       112 ~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_         112 KSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             TTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred             cccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence            77777777777776 333    2466777888776

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=1.4e-14  Score=128.07  Aligned_cols=87  Identities=25%  Similarity=0.370  Sum_probs=42.7

Q ss_pred             CCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCC-cCCCCCCCC
Q 042123          104 IGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIP-RPFSNLTSV  182 (849)
Q Consensus       104 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L  182 (849)
                      +.++++|++|++++|+|++ +|..|..+++|++|++++|.|+.. + .+..+++|++|++++|+|..+.. ..+..+++|
T Consensus        16 l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L   92 (124)
T d1dcea3          16 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALENV-D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL   92 (124)
T ss_dssp             GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTC
T ss_pred             cccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccccc-C-ccccccccCeEECCCCccCCCCCchhhcCCCCC
Confidence            4445555555555555552 333455555555555555555432 1 24555555555555555544332 344445555


Q ss_pred             CEEEccCCCCc
Q 042123          183 STLRLSRNDLF  193 (849)
Q Consensus       183 ~~L~Ls~N~l~  193 (849)
                      ++|++++|+++
T Consensus        93 ~~L~l~~N~i~  103 (124)
T d1dcea3          93 VLLNLQGNSLC  103 (124)
T ss_dssp             CEEECTTSGGG
T ss_pred             CEEECCCCcCC
Confidence            55555555543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.52  E-value=1.2e-14  Score=128.47  Aligned_cols=103  Identities=25%  Similarity=0.249  Sum_probs=86.3

Q ss_pred             CEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCC
Q 042123          111 SQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN  190 (849)
Q Consensus       111 ~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N  190 (849)
                      +.|+|++|+|+.+ + .+..+++|++|++++|+|+ .+|..|..+++|+.|++++|+|+++  +.|..+++|++|++++|
T Consensus         1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc--CccccccccCeEECCCC
Confidence            5789999999854 4 4889999999999999998 4567788999999999999999876  35889999999999999


Q ss_pred             CCcCcC-cccccCCCCCCEEeccCCcCcc
Q 042123          191 DLFGSI-PDEIGKMRSLSVLDLNQNQFKG  218 (849)
Q Consensus       191 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~~  218 (849)
                      +|+... ...+..+++|+.|++++|+++.
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            998443 2568888999999999999874

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.48  E-value=3.1e-16  Score=167.05  Aligned_cols=249  Identities=19%  Similarity=0.201  Sum_probs=136.1

Q ss_pred             CCCcCCCCCceeeccCcccccc----cccccCCCCCCCEEEcCCCcccccC----------CcCCCCCCCCCEEEccCCC
Q 042123          126 LSFDNLSNLIFLYLYGNLLSGS----ILSSLGKLKSLFDLQLNDNQLIGYI----------PRPFSNLTSVSTLRLSRND  191 (849)
Q Consensus       126 ~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----------~~~~~~l~~L~~L~Ls~N~  191 (849)
                      .++....+|+.|+|++|.|...    +...+...++|+.|+++++......          ...+...++|++|+|++|.
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~  104 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  104 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence            3455566777777777776532    2234556667777777665443221          1223445556666666665


Q ss_pred             CcCcC----cccccCCCCCCEEeccCCcCccCCCcCccCccccchhhhccccccCCCCcchhhhhhhhhhccCcCCCCCC
Q 042123          192 LFGSI----PDEIGKMRSLSVLDLNQNQFKGVLPPSISNLTNLKELALLYNHLSGSIPPSLGNLILRQLLLSGNHFTGYL  267 (849)
Q Consensus       192 l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~L~~L~L~~n~i~~~~  267 (849)
                      +....    ...+...++|++|++++|.+.......++  ..|..+.....                             
T Consensus       105 i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~--~~l~~~~~~~~-----------------------------  153 (344)
T d2ca6a1         105 FGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA--RALQELAVNKK-----------------------------  153 (344)
T ss_dssp             CCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH--HHHHHHHHHHH-----------------------------
T ss_pred             cccccccchhhhhcccccchheeccccccccccccccc--ccccccccccc-----------------------------
Confidence            54321    22233445556666655554311000010  01111111100                             


Q ss_pred             CcccCCCCCcceeeecccccccc----cCCCCCCcccccEEEccCccccCc-----hhhhhCCCCCCCEEeccCccccCc
Q 042123          268 PYNICRGGALEIFTVSENHFQGT----IPTSLRNCTSLIRVRLNGNNLTGN-----ISEALGIYPNLTFIDLSRNNFYGE  338 (849)
Q Consensus       268 ~~~~~~~~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~  338 (849)
                         ....+.|+.+++++|+++..    +...+...++|+.|+|++|.|+..     ....+...++|+.|+|++|.++..
T Consensus       154 ---~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~  230 (344)
T d2ca6a1         154 ---AKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL  230 (344)
T ss_dssp             ---HHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHH
T ss_pred             ---cccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccc
Confidence               01123455666666655422    222334556777777777777632     234456677788888888877532


Q ss_pred             ----ccccCCCCCCCcEEeccCCccccCCCCCcc------ccccccccccccccccccC----chhhc-CCCCCcEEEcc
Q 042123          339 ----ISSNWGKFPKLGTLNVSMNNITGGLPREIG------NSSQLQAFDLSLNHIVGEI----PKELG-KLNPLTKLILR  403 (849)
Q Consensus       339 ----~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~------~l~~L~~L~L~~N~i~~~~----~~~~~-~l~~L~~L~L~  403 (849)
                          +...+...++|++|+|++|.|++.....+.      ....|++|++++|.|+...    ...+. ++++|++|+|+
T Consensus       231 g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~  310 (344)
T d2ca6a1         231 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN  310 (344)
T ss_dssp             HHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECT
T ss_pred             ccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECC
Confidence                334456677888888888877643222221      1256888888888876432    33332 57789999999


Q ss_pred             Ccccc
Q 042123          404 GNQIT  408 (849)
Q Consensus       404 ~N~l~  408 (849)
                      +|++.
T Consensus       311 ~N~~~  315 (344)
T d2ca6a1         311 GNRFS  315 (344)
T ss_dssp             TSBSC
T ss_pred             CCcCC
Confidence            99986

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.45  E-value=2.1e-15  Score=160.54  Aligned_cols=141  Identities=14%  Similarity=0.106  Sum_probs=95.7

Q ss_pred             CCccCCCCCCCCEEEccCCcccC----CCCCCCcCCCCCceeeccCcccccc----------cccccCCCCCCCEEEcCC
Q 042123          100 IPPHIGNLKFLSQLDLTNNKFSG----PIPLSFDNLSNLIFLYLYGNLLSGS----------ILSSLGKLKSLFDLQLND  165 (849)
Q Consensus       100 ~~~~~~~l~~L~~L~Ls~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~----------~~~~~~~l~~L~~L~L~~  165 (849)
                      +...+.+...|++|+|++|.|..    .+...+...++|+.|+++++.....          +...+...++|+.|+|++
T Consensus        23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~  102 (344)
T d2ca6a1          23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD  102 (344)
T ss_dssp             TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred             HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence            45567778999999999999864    2334677889999999998765421          234467789999999999


Q ss_pred             CcccccC----CcCCCCCCCCCEEEccCCCCcCcCccc-------------ccCCCCCCEEeccCCcCccC----CCcCc
Q 042123          166 NQLIGYI----PRPFSNLTSVSTLRLSRNDLFGSIPDE-------------IGKMRSLSVLDLNQNQFKGV----LPPSI  224 (849)
Q Consensus       166 N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~----~~~~~  224 (849)
                      |.+....    ...+...++|++|++++|.+.......             ....+.|+.|++++|.+...    +...+
T Consensus       103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l  182 (344)
T d2ca6a1         103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF  182 (344)
T ss_dssp             CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred             cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence            9987642    234456889999999999885321111             13456788888888877522    11223


Q ss_pred             cCccccchhhhccccc
Q 042123          225 SNLTNLKELALLYNHL  240 (849)
Q Consensus       225 ~~l~~L~~L~L~~N~l  240 (849)
                      ...+.|++|+|++|.+
T Consensus       183 ~~~~~L~~L~L~~n~i  198 (344)
T d2ca6a1         183 QSHRLLHTVKMVQNGI  198 (344)
T ss_dssp             HHCTTCCEEECCSSCC
T ss_pred             hhhhhhcccccccccc
Confidence            3444555555555544

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=8.1e-15  Score=150.85  Aligned_cols=83  Identities=17%  Similarity=0.162  Sum_probs=37.2

Q ss_pred             CCCceeeccCcccccc-cccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCC-CCcCc-CcccccCCCCCCE
Q 042123          132 SNLIFLYLYGNLLSGS-ILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRN-DLFGS-IPDEIGKMRSLSV  208 (849)
Q Consensus       132 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~L~~  208 (849)
                      .+|++|+|++|.++.. +...+..+++|++|+|++|.+.+..+..+..+++|++|+|+++ .++.. +...+.++++|++
T Consensus        46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~  125 (284)
T d2astb2          46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE  125 (284)
T ss_dssp             BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred             CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence            3455555555444322 1223444555555555555544433344445555555555553 33311 1111234555555


Q ss_pred             EeccCC
Q 042123          209 LDLNQN  214 (849)
Q Consensus       209 L~L~~N  214 (849)
                      |+++++
T Consensus       126 L~ls~c  131 (284)
T d2astb2         126 LNLSWC  131 (284)
T ss_dssp             EECCCC
T ss_pred             cccccc
Confidence            655553

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=2.3e-15  Score=154.96  Aligned_cols=58  Identities=17%  Similarity=0.163  Sum_probs=29.0

Q ss_pred             CCCCCcEEEccCc-cccccCcccccccccccccccccCCCCC----hhhhcccccceeccCCc
Q 042123          393 KLNPLTKLILRGN-QITGRLPKEIGSLTKLEYLDFSAIGELP----SQICNMKSLEKLNLSHN  450 (849)
Q Consensus       393 ~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~l~~lp----~~~~~l~~L~~L~L~~N  450 (849)
                      .+++|++|++++| .+++..+..+..+++|++|++++...+.    ..++++++|+.|+++++
T Consensus       173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             ccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            4455555555543 2444444455555555555555433332    23445566666666665

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.40  E-value=2.7e-13  Score=125.13  Aligned_cols=102  Identities=21%  Similarity=0.100  Sum_probs=49.8

Q ss_pred             EeccCCcccccCCccCCCCCCCCEEEccCC-cccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCc
Q 042123           89 LVINDNSLSGFIPPHIGNLKFLSQLDLTNN-KFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus        89 L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  167 (849)
                      ++++++.+. ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+.+|.++++|++|+|++|+
T Consensus        13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~   91 (156)
T d2ifga3          13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA   91 (156)
T ss_dssp             EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred             EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence            334444433 23344444555555555433 2554444455555555555555555554444555555555555555555


Q ss_pred             ccccCCcCCCCCCCCCEEEccCCCC
Q 042123          168 LIGYIPRPFSNLTSVSTLRLSRNDL  192 (849)
Q Consensus       168 l~~~~~~~~~~l~~L~~L~Ls~N~l  192 (849)
                      |+.+.++.|..+ +|++|+|++|.+
T Consensus        92 l~~l~~~~~~~~-~l~~L~L~~Np~  115 (156)
T d2ifga3          92 LESLSWKTVQGL-SLQELVLSGNPL  115 (156)
T ss_dssp             CSCCCSTTTCSC-CCCEEECCSSCC
T ss_pred             CcccChhhhccc-cccccccCCCcc
Confidence            555444444433 355555555544

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.36  E-value=2.3e-15  Score=145.53  Aligned_cols=130  Identities=24%  Similarity=0.278  Sum_probs=89.1

Q ss_pred             CCccCCCCCCCCEEEccCCcccCCCCCCCcCCCCCceeeccCcccccccccccCCCCCCCEEEcCCCcccccCCcCCCCC
Q 042123          100 IPPHIGNLKFLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGNLLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNL  179 (849)
Q Consensus       100 ~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  179 (849)
                      ++..+..+++|++|+|++|+|+.+ + .|.++++|++|+|++|.|+. ++..+..+++|+.|++++|+|+.+  ..+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             hhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccc-cccccccccccccccccccccccc--cccccc
Confidence            345677777888888888888754 3 47777888888888888773 344444556788888888887765  346777


Q ss_pred             CCCCEEEccCCCCcCcCc-ccccCCCCCCEEeccCCcCccCCCcC----------ccCccccchhh
Q 042123          180 TSVSTLRLSRNDLFGSIP-DEIGKMRSLSVLDLNQNQFKGVLPPS----------ISNLTNLKELA  234 (849)
Q Consensus       180 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----------~~~l~~L~~L~  234 (849)
                      ++|++|+|++|+|+.... ..+..+++|+.|+|++|++....+..          +..+++|+.||
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence            788888888888763321 35777888888888888776443322          34566666654

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.35  E-value=1.1e-12  Score=120.99  Aligned_cols=107  Identities=25%  Similarity=0.141  Sum_probs=82.9

Q ss_pred             CCCEEEccCCcccCCCCCCCcCCCCCceeeccCc-ccccccccccCCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEc
Q 042123          109 FLSQLDLTNNKFSGPIPLSFDNLSNLIFLYLYGN-LLSGSILSSLGKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRL  187 (849)
Q Consensus       109 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  187 (849)
                      ..+.++.+++++. ..|..+.++++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.+++|..+++|++|+|
T Consensus         9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L   87 (156)
T d2ifga3           9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL   87 (156)
T ss_dssp             SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred             CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence            4456888888887 45667888888888888765 487777778888888888888888888888888888888888888


Q ss_pred             cCCCCcCcCcccccCCCCCCEEeccCCcCc
Q 042123          188 SRNDLFGSIPDEIGKMRSLSVLDLNQNQFK  217 (849)
Q Consensus       188 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  217 (849)
                      ++|+|+...++.|.. .+|+.|+|++|.+.
T Consensus        88 s~N~l~~l~~~~~~~-~~l~~L~L~~Np~~  116 (156)
T d2ifga3          88 SFNALESLSWKTVQG-LSLQELVLSGNPLH  116 (156)
T ss_dssp             CSSCCSCCCSTTTCS-CCCCEEECCSSCCC
T ss_pred             cCCCCcccChhhhcc-ccccccccCCCccc
Confidence            888888544444543 46888888888875

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.32  E-value=1.6e-14  Score=139.50  Aligned_cols=117  Identities=25%  Similarity=0.266  Sum_probs=91.8

Q ss_pred             cCCCCCCcccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcccccCCCCCCCcEEeccCCccccCCCCCcccc
Q 042123          291 IPTSLRNCTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEISSNWGKFPKLGTLNVSMNNITGGLPREIGNS  370 (849)
Q Consensus       291 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l  370 (849)
                      ++..+..+++|++|+|++|+|+.+.  .+..+++|+.|+|++|+++. ++..+..+++|+.|++++|.|+. + ..+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~i~--~l~~l~~L~~L~Ls~N~i~~-i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-L-SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESCCC--CHHHHTTCCEEECCEEEECS-CSSHHHHHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred             hhhHHhcccccceeECcccCCCCcc--cccCCccccChhhccccccc-ccccccccccccccccccccccc-c-cccccc
Confidence            4456777888999999999988652  47788899999999998874 45545556689999999999984 3 347788


Q ss_pred             ccccccccccccccccCc-hhhcCCCCCcEEEccCccccccCc
Q 042123          371 SQLQAFDLSLNHIVGEIP-KELGKLNPLTKLILRGNQITGRLP  412 (849)
Q Consensus       371 ~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p  412 (849)
                      ++|+.|++++|+|+.... ..+..+++|+.|+|++|++....+
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~  157 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK  157 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred             ccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence            999999999999975432 568899999999999999875433

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.54  E-value=1.1e-09  Score=101.16  Aligned_cols=41  Identities=24%  Similarity=0.088  Sum_probs=16.6

Q ss_pred             CCCCCCCEEEcCCCcccccCCcCCCCCCCCCEEEccCCCCc
Q 042123          153 GKLKSLFDLQLNDNQLIGYIPRPFSNLTSVSTLRLSRNDLF  193 (849)
Q Consensus       153 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  193 (849)
                      ..+++|+.|+|++|+|+.+.+-.+....+|++|++++|.+.
T Consensus        88 ~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~  128 (162)
T d1koha1          88 QKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS  128 (162)
T ss_dssp             HHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTS
T ss_pred             hhCCcccccccccCccccchhhhhhhccccceeecCCCCcC
Confidence            33444444444444444433222222333444444444443

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.48  E-value=7.8e-09  Score=95.26  Aligned_cols=87  Identities=21%  Similarity=0.139  Sum_probs=44.3

Q ss_pred             cccccEEEccCccccCchhhhhCCCCCCCEEeccCccccCcc--cccCCCCCCCcEEeccCCccccCCCCCccccccccc
Q 042123          298 CTSLIRVRLNGNNLTGNISEALGIYPNLTFIDLSRNNFYGEI--SSNWGKFPKLGTLNVSMNNITGGLPREIGNSSQLQA  375 (849)
Q Consensus       298 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~i~~~~p~~~~~l~~L~~  375 (849)
                      +..+..++..++.+. .++..+..+++|++|+|++|+|+...  +..+..+++|+.|+|++|.|+...+-.+.....|+.
T Consensus        41 ~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~  119 (162)
T d1koha1          41 QNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEE  119 (162)
T ss_dssp             TTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSS
T ss_pred             ccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccce
Confidence            333344444444333 34445556677777777777776432  233445566666666666665322212222234555


Q ss_pred             cccccccccc
Q 042123          376 FDLSLNHIVG  385 (849)
Q Consensus       376 L~L~~N~i~~  385 (849)
                      |++++|.+..
T Consensus       120 L~L~~Npl~~  129 (162)
T d1koha1         120 LWLDGNSLSD  129 (162)
T ss_dssp             CCCTTSTTSS
T ss_pred             eecCCCCcCc
Confidence            5555555543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.93  E-value=2.3e-05  Score=77.83  Aligned_cols=142  Identities=16%  Similarity=0.121  Sum_probs=89.6

Q ss_pred             HHHHHHhcCCCcCceecCCccceEEEEEecCCcEEEEEEecccCCCCch--hhHHHHHHHHH------HhhceeecCCee
Q 042123          581 DEIVKATNDFDAKYCIGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQT--VDQKEFLTEVE------AFYGFCSHARHS  652 (849)
Q Consensus       581 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~~~ei~------~~~~~~~~~~~~  652 (849)
                      .++.+..+.|+..+..+.++.+.||+... ++..++||+..........  ..+...++.+.      +++.+..+++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            45566667777666554455578999876 4666788887543221111  11222222221      245566677889


Q ss_pred             EEEEEeccCCChhhhhcccccccCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 042123          653 FLLYEFLERGSLAAILNTDAAAQELGWSQRMNVIKAVAHALSYLHHDC--------------------------------  700 (849)
Q Consensus       653 ~lV~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------  700 (849)
                      ++||++++|.++.+.....        ....+++.++++.++.||+..                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            9999999998876654211        123334556666666666421                                


Q ss_pred             ------------------------CCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          701 ------------------------FPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       701 ------------------------~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                                              .+.++|+|+.|.||++++++.+-+.||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    0237899999999999977666799998765

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.72  E-value=3.6e-06  Score=77.26  Aligned_cols=109  Identities=16%  Similarity=0.060  Sum_probs=54.3

Q ss_pred             CCCCCEEEccCC-cccCC----CCCCCcCCCCCceeeccCccccccc----ccccCCCCCCCEEEcCCCccccc----CC
Q 042123          107 LKFLSQLDLTNN-KFSGP----IPLSFDNLSNLIFLYLYGNLLSGSI----LSSLGKLKSLFDLQLNDNQLIGY----IP  173 (849)
Q Consensus       107 l~~L~~L~Ls~n-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~----~~  173 (849)
                      .++|++|+|+++ .++..    +..++...++|++|+|++|.+....    ...+...+.|++|+|++|.|...    ..
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~   93 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL   93 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence            345555555543 23311    1123444455666666666554221    12333445566666666665532    12


Q ss_pred             cCCCCCCCCCEEEccCCCCcCc-------CcccccCCCCCCEEeccCCc
Q 042123          174 RPFSNLTSVSTLRLSRNDLFGS-------IPDEIGKMRSLSVLDLNQNQ  215 (849)
Q Consensus       174 ~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~L~~N~  215 (849)
                      .++...+.|++|+|++|++...       +.+.+...++|+.|+++.+.
T Consensus        94 ~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          94 RSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             HHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            3455556667777766654421       23334445667777665554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.70  E-value=2.4e-06  Score=78.52  Aligned_cols=113  Identities=11%  Similarity=0.026  Sum_probs=60.1

Q ss_pred             CCCCCEEeCcCC-ccccC----CCccccCCCCCCEeeCCCCcCcccccccccccCCCCCccccCeEeccCCcccccCCcc
Q 042123           29 FPHLAYLDLTWN-GFFGT----IPPQISNLSNLRYLYLGSNQFSGNILAEVSSESSGGNLRYMSRLVINDNSLSGFIPPH  103 (849)
Q Consensus        29 l~~L~~L~L~~n-~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  103 (849)
                      -++|++|+|+++ .+...    +..++...++|++|+|++|.+.......+.                          ..
T Consensus        14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la--------------------------~~   67 (167)
T d1pgva_          14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLI--------------------------EL   67 (167)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHH--------------------------HH
T ss_pred             CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHh--------------------------hh
Confidence            466777777763 45322    233455666777777777777543322221                          22


Q ss_pred             CCCCCCCCEEEccCCcccCC----CCCCCcCCCCCceeeccCcccccc-------cccccCCCCCCCEEEcCCCc
Q 042123          104 IGNLKFLSQLDLTNNKFSGP----IPLSFDNLSNLIFLYLYGNLLSGS-------ILSSLGKLKSLFDLQLNDNQ  167 (849)
Q Consensus       104 ~~~l~~L~~L~Ls~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~L~~N~  167 (849)
                      +...+.|++|+|++|.|+..    +..++...+.|++|+|++|.+...       +...+...++|+.|+++.+.
T Consensus        68 L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          68 IETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             HHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             hhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            33345556666666655531    122344555666666666654321       23344455677777776654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.46  E-value=0.00018  Score=70.63  Aligned_cols=125  Identities=20%  Similarity=0.148  Sum_probs=76.1

Q ss_pred             eecCCcc-ceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHH-------HhhceeecCCeeEEEEEeccCCChhh
Q 042123          595 CIGNGGH-ASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVE-------AFYGFCSHARHSFLLYEFLERGSLAA  666 (849)
Q Consensus       595 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~-------~~~~~~~~~~~~~lV~e~~~~gsL~~  666 (849)
                      .+..|.. +.||+....++..+++|...... ......+...++.+.       +++.++.+++..++||||++|.++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            4555654 67899988888889999865432 122222333333332       24666677788899999999866533


Q ss_pred             hhcccccccCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 042123          667 ILNTDAAAQELGWSQRMNVIKAVAHALSYLH-------------------------------------------------  697 (849)
Q Consensus       667 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-------------------------------------------------  697 (849)
                      ..        ...   ...+.+++..++-||                                                 
T Consensus        96 ~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          96 SH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             SC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             cc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            21        010   011122223333333                                                 


Q ss_pred             --hcC----CCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          698 --HDC----FPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       698 --~~~----~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                        ...    .+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence              211    1247999999999999987667899998764

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=97.06  E-value=1.1e-05  Score=73.79  Aligned_cols=14  Identities=7%  Similarity=0.000  Sum_probs=6.6

Q ss_pred             CCCCCCCEEEccCC
Q 042123          177 SNLTSVSTLRLSRN  190 (849)
Q Consensus       177 ~~l~~L~~L~Ls~N  190 (849)
                      ...+.|++|+++.+
T Consensus       129 ~~n~~L~~L~l~~~  142 (166)
T d1io0a_         129 EKNTTLLKFGYHFT  142 (166)
T ss_dssp             HHCSSCCEEECCCS
T ss_pred             HhCCCcCEEeCcCC
Confidence            34445555555443

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.97  E-value=8.8e-05  Score=67.60  Aligned_cols=112  Identities=22%  Similarity=0.157  Sum_probs=61.9

Q ss_pred             CcccccEEEccC-ccccC----chhhhhCCCCCCCEEeccCccccCc----ccccCCCCCCCcEEeccCCccccCC----
Q 042123          297 NCTSLIRVRLNG-NNLTG----NISEALGIYPNLTFIDLSRNNFYGE----ISSNWGKFPKLGTLNVSMNNITGGL----  363 (849)
Q Consensus       297 ~l~~L~~L~L~~-n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~i~~~~----  363 (849)
                      +.++|++|++++ +.++.    .+...+...++|+.|+|++|.++..    +...+...+.++.+++++|.++...    
T Consensus        15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l   94 (166)
T d1io0a_          15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL   94 (166)
T ss_dssp             TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred             cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence            345666666665 34442    2334455666777777777766532    2223344566777777777665221    


Q ss_pred             CCCccccccccc--cccccccccc----cCchhhcCCCCCcEEEccCcccc
Q 042123          364 PREIGNSSQLQA--FDLSLNHIVG----EIPKELGKLNPLTKLILRGNQIT  408 (849)
Q Consensus       364 p~~~~~l~~L~~--L~L~~N~i~~----~~~~~~~~l~~L~~L~L~~N~l~  408 (849)
                      ...+...++|+.  |++++|.+..    .+...+...++|+.|+++.+...
T Consensus        95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~  145 (166)
T d1io0a_          95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  145 (166)
T ss_dssp             HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence            123444555654  3444556543    23445556777888877766543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.48  E-value=0.0051  Score=64.00  Aligned_cols=29  Identities=17%  Similarity=0.240  Sum_probs=25.2

Q ss_pred             CeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          703 PIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       703 ~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      .++|||+.+.|||+++++ ++|+||..|..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            689999999999998765 89999988764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.84  E-value=0.029  Score=56.07  Aligned_cols=153  Identities=16%  Similarity=0.102  Sum_probs=77.8

Q ss_pred             ccHHHHHHHhcCCCcCce-----ecCCccceEEEEEecCCcEEEEEEecccCCCCchhhHHHHHHHHHHh----------
Q 042123          578 ILYDEIVKATNDFDAKYC-----IGNGGHASVYRAELPSGEVVAVKKFHSLLPCDQTVDQKEFLTEVEAF----------  642 (849)
Q Consensus       578 ~~~~~~~~~~~~f~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~ei~~~----------  642 (849)
                      ++.+++.....+|.+.+.     |..|.--+.|+.+..+| .+++|++...........+..++..+..-          
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~g~pvp~pi~~   81 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPR   81 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhcccccccccee
Confidence            456788888888987553     44666678899987655 58999886532222222222333333320          


Q ss_pred             -hc--eeecCCeeEEEEEeccCCChhhhh--------------ccc------ccccCCC------------------HHH
Q 042123          643 -YG--FCSHARHSFLLYEFLERGSLAAIL--------------NTD------AAAQELG------------------WSQ  681 (849)
Q Consensus       643 -~~--~~~~~~~~~lV~e~~~~gsL~~~l--------------~~~------~~~~~l~------------------~~~  681 (849)
                       -|  +.......+.++.+..+......-              +..      .......                  ...
T Consensus        82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (316)
T d2ppqa1          82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  161 (316)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence             00  112234556677777764321100              000      0000000                  000


Q ss_pred             HHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeeecCCCcEEEeeecCCc
Q 042123          682 RMNVIKAVAHALSYLHH-DCFPPIVHRDISSKNLLLDLEYEAHVADFGIAK  731 (849)
Q Consensus       682 ~~~i~~~ia~~l~~LH~-~~~~~ivH~dlk~~Nill~~~~~~kl~DfG~a~  731 (849)
                      ....+..+...+.-.+. ....+++|+|+.+.||+++.+...-+.||+.+.
T Consensus       162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11112222222222221 112379999999999999988777899999875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.58  E-value=0.032  Score=56.04  Aligned_cols=29  Identities=21%  Similarity=0.157  Sum_probs=23.6

Q ss_pred             CCeEecCCCCCCeeecCCCcEEEeeecCCcc
Q 042123          702 PPIVHRDISSKNLLLDLEYEAHVADFGIAKS  732 (849)
Q Consensus       702 ~~ivH~dlk~~Nill~~~~~~kl~DfG~a~~  732 (849)
                      .+++|+|+.+.||+++. + ..+.||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            47899999999999974 3 45889998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.87  E-value=0.082  Score=54.55  Aligned_cols=29  Identities=14%  Similarity=0.167  Sum_probs=20.7

Q ss_pred             CceecCCccceEEEEEecCC--------cEEEEEEec
Q 042123          593 KYCIGNGGHASVYRAELPSG--------EVVAVKKFH  621 (849)
Q Consensus       593 ~~~lG~G~~g~Vy~~~~~~~--------~~vavK~~~  621 (849)
                      .+.|+.|-.=.+|++..+++        +.|.++...
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g   83 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF   83 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC
Confidence            35788899999999976542        456666654